Citrus Sinensis ID: 013790

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430------
Protein Sequence
MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKLGEHVEGASRRRLLIMQRAKVV
Secondary Structure (PSIPRED)
ccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHcccccccccHHHHHHHHHcccccccccccccccEEEEEEccccccccccccEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEccccccccEEEEEEEccccccHHHHccccccccccHHHHHHHHHHHcccccccccccccccEEcccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHccccccccccccccccccccHHHHcccccccccHHHHHHHHHHHHHcccccccHHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHccccccccEEEEEEEccccccccccccEEEEEEEccccccccHHHHHHHHHHHHHccccHEEEEEEEEccccccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEcccHcHEEccccccccHcHcccccccccccccEEEEEEccccccccHHHHHHcEEcHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHccccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccHHHHHHccccccccccccccHHHHHccccc
Coil and Loop (DISEMBL)
mkcfhyfkekklrrreersapelkeprksadysgaesdrfvksscsasvtsprgipelyEEKAHNLRVFSYSEMRQATNDFSRMLKigeggfgsvykssikpaagdgtsEATVVAIKKLNRDGLQGHKQWVAEVQFLgvlehpnlvKLIGYcavdgergIQRLLVYEFMLNRSLedhlfnrafpplpwktrLHIILGAAEGLAYLHEGLEVQVIYRDFkasnvlldenfrpklsdfglaregpmvghthVSTAVVgtfgyaapdyietghltaksDVWSFGVVLYEMLTgrrslernrpkTEQRLLEWVQqypadskkfglimdprlekeYSINEARKIGRladnclsksskdrpkmSQVVERLKQIVQVsnegdsfdKTFEEICeedpveaqtkqkqhepSEAWKRRMAHLAKLGEHVEGASRRRLLIMQRAKVV
Flexible Loop (DISEMBL)
mkcfhyfkekklrrreersapelkeprksadysgaesdrfvksscsasvtsprgipelyeeKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLtgrrslernrpkteqrllewvqqypadskkfglimdpRLEKEYSINearkigrladnclsksskdrpkmsqvVERLKQIvqvsnegdsfDKTFEEICEedpveaqtkqkqhepseAWKRRMAHLAKlgehvegasrrrlLIMQRAKVV
Low Complexity Region (SEG)
MKCFHYFkekklrrreerSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKLGEHVEGASRRRLLIMQRAKVV
Disordered region (IsUnstruct)
**************************************************************AHNLRVFSYSEM**ATNDFSRMLKIGEGGFGSVYKS***********EATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR************RLLEWVQQYPADSKKFGLIMDPRLEKEYSIN******************************************************************************************************
Disordered Region (DISOPRED)
MKCFH*************************************************************RVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLER***KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ****************************************************************QRAK**
Disordered Region (DISEMBL)
MKCFHYFKEKKL***************************************PRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDKTFEEICEED****************WKRRMAHLAKLGEHVEGASRRRLLIMQRAKVV
Disordered Region (DISPRO)
****************************************************************NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ*******************************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKLGEHVEGASRRRLLIMQRAKVV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	436	2.2.26 [Sep-21-2011]
Q9LTC0	410	Probable receptor-like pr	yes	no	0.850	0.904	0.592	1e-124
Q9LFP7	493	Probable receptor-like pr	no	no	0.788	0.697	0.498	5e-94
Q9SRH7	490	Receptor-like serine/thre	no	no	0.736	0.655	0.520	5e-93
P43293	389	Probable serine/threonine	no	no	0.724	0.812	0.502	2e-89
P46573	412	Protein kinase APK1B, chl	no	no	0.729	0.771	0.504	2e-88
Q06548	410	Protein kinase APK1A, chl	no	no	0.761	0.809	0.497	6e-88
Q8GXZ3	410	Serine/threonine-protein	no	no	0.672	0.714	0.548	7e-87
Q8H186	389	Probable receptor-like pr	no	no	0.676	0.758	0.508	5e-85
O49840	426	Protein kinase 2B, chloro	no	no	0.706	0.723	0.501	1e-84
O48814	395	Serine/threonine-protein	no	no	0.681	0.751	0.506	7e-84

>sp|Q9LTC0|Y5707_ARATH Probable receptor-like protein kinase At5g47070 OS=Arabidopsis thaliana GN=At5g47070 PE=1 SV=1

 Score =  446 bits (1148), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 225/380 (59%), Positives = 283/380 (74%), Gaps = 9/380 (2%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAE-SDRFVKSSCSA----SVTSPRGI 55
           M C   FK KK R++++ +    ++ ++    S  E ++R   SS +     S+ SPR I
Sbjct: 1   MNCLFLFKSKKPRKQQKDNNKNKRKGKELLQNSAPELTNRSETSSFNLQTPRSLPSPRSI 60

Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVA 115
            +LY E+  NLRVFSY E+ +AT  FSR L IGEGGFG VYK  I  + GD +    VVA
Sbjct: 61  KDLYTEREQNLRVFSYEELSKATYVFSRKLVIGEGGFGIVYKGKIL-SNGDSSDPPLVVA 119

Query: 116 IKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE 175
           IKKLNR GLQGHKQW+AEVQFLGV+ HPN+VKLIGYC+ DGE GI+RLLVYE+M NRSLE
Sbjct: 120 IKKLNRQGLQGHKQWLAEVQFLGVVNHPNVVKLIGYCSEDGETGIERLLVYEYMSNRSLE 179

Query: 176 DHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD 235
           DHLF R    LPWK RL I+LGAAEGL YLH+   ++VIYRDFK+SNVLLD+ F PKLSD
Sbjct: 180 DHLFPRRSHTLPWKKRLEIMLGAAEGLTYLHD---LKVIYRDFKSSNVLLDDQFCPKLSD 236

Query: 236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
           FGLAREGP   +THV+TA VGT GYAAP+Y++TGHL  KSDV+SFGVVLYE++TGRR++E
Sbjct: 237 FGLAREGPDGDNTHVTTARVGTHGYAAPEYVQTGHLRLKSDVYSFGVVLYEIITGRRTIE 296

Query: 296 RNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 355
           RN+P  E+RLL+WV++YPADS++F +I+DPRL   Y    AR + +LAD CL K+ K+RP
Sbjct: 297 RNKPVAERRLLDWVKEYPADSQRFSMIVDPRLRNNYPAAGARSLAKLADLCLKKNDKERP 356

Query: 356 KMSQVVERLKQIVQVSNEGD 375
            M  VVERLK+I++ S+  D
Sbjct: 357 TMEIVVERLKKIIEESDSED 376

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  345 bits (884), Expect = 5e-94,   Method: Compositional matrix adjust.
 Identities = 184/369 (49%), Positives = 242/369 (65%), Gaps = 25/369 (6%)

Query: 16  EERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMR 75
           E +SA E     KS D    +      +S + S +S   I E     +H LR F++++++
Sbjct: 83  ESKSANE-----KSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISSH-LRKFTFNDLK 136

Query: 76  QATNDFSRMLKIGEGGFGSVYK--------SSIKPAAGDGTSEATVVAIKKLNRDGLQGH 127
            +T +F     +GEGGFG V+K        + +KP  G        VA+K LN DGLQGH
Sbjct: 137 LSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTG------LTVAVKTLNPDGLQGH 190

Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
           K+W+AE+ FLG L HPNLVKL+GYC  D     QRLLVYEFM   SLE+HLF R+ P LP
Sbjct: 191 KEWLAEINFLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLP-LP 245

Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
           W  R+ I LGAA+GL++LHE     VIYRDFK SN+LLD ++  KLSDFGLA++ P  G 
Sbjct: 246 WSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGK 305

Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 307
           THVST V+GT+GYAAP+Y+ TGHLT+KSDV+SFGVVL EMLTGRRS+++NRP  E  L+E
Sbjct: 306 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 365

Query: 308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
           W + +  D ++F  ++DPRLE  +SI  A+K+ +LA  CLS+  K RPKMS VVE LK +
Sbjct: 366 WARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPL 425

Query: 368 VQVSNEGDS 376
             + +   S
Sbjct: 426 PHLKDMASS 434

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  342 bits (876), Expect = 5e-93,   Method: Compositional matrix adjust.
 Identities = 178/342 (52%), Positives = 234/342 (68%), Gaps = 21/342 (6%)

Query: 34  GAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFG 93
           G  S     S+  +S+++P  I E     +H L+ FS+ +++ AT +F     +GEGGFG
Sbjct: 91  GPVSSTTTTSNAESSLSTPI-ISEELNIYSH-LKKFSFIDLKLATRNFRPESLLGEGGFG 148

Query: 94  SVYK--------SSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
            V+K        + +KP  G        VA+K LN DGLQGHK+W+AE+ +LG L HPNL
Sbjct: 149 CVFKGWVEENGTAPVKPGTG------LTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNL 202

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VKL+GYC  D     QRLLVYEFM   SLE+HLF R+ P LPW  R+ I LGAA+GL++L
Sbjct: 203 VKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLSFL 257

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 265
           HE     VIYRDFK SN+LLD  +  KLSDFGLA++ P  G THVST V+GT+GYAAP+Y
Sbjct: 258 HEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEY 317

Query: 266 IETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDP 325
           + TGHLT+KSDV+SFGVVL EMLTGRRS+++NRP  E  L+EW + +  D ++F  ++DP
Sbjct: 318 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDP 377

Query: 326 RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
           RLE  +S+  A+K+ +LA  CLS+ SK RPKMS+VVE LK +
Sbjct: 378 RLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPL 419

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  329 bits (844), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 168/334 (50%), Positives = 236/334 (70%), Gaps = 18/334 (5%)

Query: 42  KSSCSASVT-SPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYK--- 97
           K S +AS +  PR   E+ +    NL+ FS SE++ AT +F     +GEGGFG V+K   
Sbjct: 30  KGSSTASFSYMPRTEGEILQNA--NLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWI 87

Query: 98  --SSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD 155
             SS+ P+   GT    V+A+K+LN++G QGH++W+AE+ +LG L+HPNLVKLIGYC  +
Sbjct: 88  DESSLAPSK-PGT--GIVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEE 144

Query: 156 GERGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQV 213
                 RLLVYEFM   SLE+HLF R   + PL W TR+ + LGAA GLA+LH   + QV
Sbjct: 145 E----HRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHNA-QPQV 199

Query: 214 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTA 273
           IYRDFKASN+LLD N+  KLSDFGLAR+GPM  ++HVST V+GT GYAAP+Y+ TGHL+ 
Sbjct: 200 IYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSV 259

Query: 274 KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSI 333
           KSDV+SFGVVL E+L+GRR++++N+P  E  L++W + Y  + ++   +MDPRL+ +YS+
Sbjct: 260 KSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSL 319

Query: 334 NEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
             A KI  LA +C+S  +K RP M+++V+ ++++
Sbjct: 320 TRALKIAVLALDCISIDAKSRPTMNEIVKTMEEL 353

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  326 bits (836), Expect = 2e-88,   Method: Compositional matrix adjust.
 Identities = 166/329 (50%), Positives = 226/329 (68%), Gaps = 11/329 (3%)

Query: 50  TSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTS 109
           T+PR   E+ +  + NL+ F+++E++ AT +F     +GEGGFGSV+K  I       + 
Sbjct: 40  TNPRTEGEILQ--SPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASK 97

Query: 110 EAT--VVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYE 167
             T  V+A+KKLN+DG QGH++W+AEV +LG   HPNLVKLIGYC  D      RLLVYE
Sbjct: 98  PGTGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDE----HRLLVYE 153

Query: 168 FMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL 225
           FM   SLE+HLF R   F PL W  RL + LGAA+GLA+LH   E  VIYRDFK SN+LL
Sbjct: 154 FMPRGSLENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNA-ETSVIYRDFKTSNILL 212

Query: 226 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLY 285
           D  +  KLSDFGLA++GP    +HVST ++GT+GYAAP+Y+ TGHLT KSDV+S+GVVL 
Sbjct: 213 DSEYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLL 272

Query: 286 EMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADN 345
           E+L+GRR++++NRP  EQ+L+EW +   A+ +K   ++D RL+ +YS+ EA K+  LA  
Sbjct: 273 EVLSGRRAVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALR 332

Query: 346 CLSKSSKDRPKMSQVVERLKQIVQVSNEG 374
           CL+   K RP M++VV  L+ I  ++  G
Sbjct: 333 CLTFEIKLRPNMNEVVSHLEHIQTLNEAG 361

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  325 bits (832), Expect = 6e-88,   Method: Compositional matrix adjust.
 Identities = 171/344 (49%), Positives = 232/344 (67%), Gaps = 12/344 (3%)

Query: 42  KSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIK 101
           K+S  +   SPR   E+ +    NL+ FS++E++ AT +F     +GEGGFG V+K  I 
Sbjct: 31  KASSVSVRPSPRTEGEILQSP--NLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWID 88

Query: 102 PAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG 159
             +   +   T  V+A+KKLN+DG QGH++W+AEV +LG   H +LVKLIGYC  D    
Sbjct: 89  EKSLTASRPGTGLVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDE--- 145

Query: 160 IQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRD 217
             RLLVYEFM   SLE+HLF R   F PL WK RL + LGAA+GLA+LH   E +VIYRD
Sbjct: 146 -HRLLVYEFMPRGSLENHLFRRGLYFQPLSWKLRLKVALGAAKGLAFLHSS-ETRVIYRD 203

Query: 218 FKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDV 277
           FK SN+LLD  +  KLSDFGLA++GP+   +HVST V+GT GYAAP+Y+ TGHLT KSDV
Sbjct: 204 FKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDV 263

Query: 278 WSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEAR 337
           +SFGVVL E+L+GRR++++NRP  E+ L+EW + Y  + +K   ++D RL+ +YS+ EA 
Sbjct: 264 YSFGVVLLELLSGRRAVDKNRPSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEAC 323

Query: 338 KIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE-GDSFDKT 380
           K+  L+  CL+   K RP MS+VV  L+ I  ++   G + DKT
Sbjct: 324 KVATLSLRCLTTEIKLRPNMSEVVSHLEHIQSLNAAIGGNMDKT 367

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  321 bits (823), Expect = 7e-87,   Method: Compositional matrix adjust.
 Identities = 164/299 (54%), Positives = 207/299 (69%), Gaps = 6/299 (2%)

Query: 69  FSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK 128
           F+  E+   T  F     +GEGGFG+VYK  I      G  ++  VA+K LN++GLQGH+
Sbjct: 57  FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGL-KSLPVAVKVLNKEGLQGHR 115

Query: 129 QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW 188
           +W+ EV FLG L HPNLVKLIGYC  D      RLLVYEFML  SLE+HLF +   PL W
Sbjct: 116 EWLTEVNFLGQLRHPNLVKLIGYCCEDD----HRLLVYEFMLRGSLENHLFRKTTAPLSW 171

Query: 189 KTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 248
             R+ I LGAA+GLA+LH   E  VIYRDFK SN+LLD ++  KLSDFGLA+ GP    T
Sbjct: 172 SRRMMIALGAAKGLAFLHNA-ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 230

Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW 308
           HVST V+GT+GYAAP+Y+ TGHLTA+SDV+SFGVVL EMLTGR+S+++ RP  EQ L++W
Sbjct: 231 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDW 290

Query: 309 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
            +    D +K   I+DPRLE +YS+  A+K   LA  CLS++ K RP MS VVE L+ +
Sbjct: 291 ARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1

 Score =  315 bits (806), Expect = 5e-85,   Method: Compositional matrix adjust.
 Identities = 158/311 (50%), Positives = 211/311 (67%), Gaps = 16/311 (5%)

Query: 65  NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYK-----SSIKPAAGDGTSEATVVAIKKL 119
            ++ FS++E++ AT +F     +GEGGFG V++     +++ P     +S   V+A+K+L
Sbjct: 45  TVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTK---SSSGLVIAVKRL 101

Query: 120 NRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF 179
           N DG QGH++W+ E+ +LG L HPNLVKLIGYC  D     QRLLVYEFM   SLE+HLF
Sbjct: 102 NPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDE----QRLLVYEFMHKGSLENHLF 157

Query: 180 ---NRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF 236
              N+ F PL W  R+ + L AA+GLA+LH    V+VIYRD KASN+LLD +F  KLSDF
Sbjct: 158 ANGNKDFKPLSWILRIKVALDAAKGLAFLHSD-PVKVIYRDIKASNILLDSDFNAKLSDF 216

Query: 237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLER 296
           GLAR+GPM   ++VST V+GTFGYAAP+Y+ TGHL A+SDV+SFGVVL E+L GR++L+ 
Sbjct: 217 GLARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDH 276

Query: 297 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK 356
           NRP  EQ L++W + Y    +K  LI+D RL  +Y    A ++  +A  CLS   K RP 
Sbjct: 277 NRPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPT 336

Query: 357 MSQVVERLKQI 367
           M QVV  L Q+
Sbjct: 337 MDQVVRALVQL 347

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  313 bits (803), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 164/327 (50%), Positives = 217/327 (66%), Gaps = 19/327 (5%)

Query: 48  SVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDG 107
           S+ +PR   E+      NL+ F+++E++ AT +F     +GEGGFG V+K  I     DG
Sbjct: 52  SLPTPRTEGEILSSP--NLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWI-----DG 104

Query: 108 TS-------EATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI 160
           T+          VVA+KKL  +G QGHK+W+ EV +LG L HPNLVKL+GYC V+GE   
Sbjct: 105 TTLTASKPGSGIVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYC-VEGE--- 160

Query: 161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKA 220
            RLLVYEFM   SLE+HLF R   PL W  R+ + +GAA+GL +LH+  + QVIYRDFKA
Sbjct: 161 NRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAIGAAKGLTFLHDA-KSQVIYRDFKA 219

Query: 221 SNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSF 280
           +N+LLD  F  KLSDFGLA+ GP    THVST V+GT GYAAP+Y+ TG LTAKSDV+SF
Sbjct: 220 ANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSF 279

Query: 281 GVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIG 340
           GVVL E+L+GRR++++++   EQ L++W   Y  D +K   IMD RL  +Y    A    
Sbjct: 280 GVVLLELLSGRRAVDKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAA 339

Query: 341 RLADNCLSKSSKDRPKMSQVVERLKQI 367
            LA  CL+  +K RPKMS+V+ +L Q+
Sbjct: 340 SLALQCLNPDAKLRPKMSEVLAKLDQL 366

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  311 bits (796), Expect = 7e-84,   Method: Compositional matrix adjust.
 Identities = 155/306 (50%), Positives = 214/306 (69%), Gaps = 9/306 (2%)

Query: 66  LRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDG 123
           ++ F+++E++ AT +F     IGEGGFG V+K  +  +    T   T  V+A+KKLN++G
Sbjct: 52  VKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEG 111

Query: 124 LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA- 182
            QGH++W+ E+ +LG L HPNLVKLIGYC  D      RLLVYEFM   SLE+HLF R  
Sbjct: 112 FQGHREWLTEINYLGQLSHPNLVKLIGYCLEDE----HRLLVYEFMQKGSLENHLFRRGA 167

Query: 183 -FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE 241
            F PLPW  R+++ L AA+GLA+LH    V+VIYRD KASN+LLD ++  KLSDFGLAR+
Sbjct: 168 YFKPLPWFLRVNVALDAAKGLAFLHSD-PVKVIYRDIKASNILLDADYNAKLSDFGLARD 226

Query: 242 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 301
           GPM   ++VST V+GT+GYAAP+Y+ +GHL A+SDV+SFGV+L E+L+G+R+L+ NRP  
Sbjct: 227 GPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAK 286

Query: 302 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 361
           E+ L++W + Y    +K  LI+D RL+ +Y   EA ++  +A  CLS   K RP M QVV
Sbjct: 287 EENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVV 346

Query: 362 ERLKQI 367
             L+Q+
Sbjct: 347 RALQQL 352

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	436
156105187	429	ser/thr protein kinase [Malus x domestic	0.983	1.0	0.766	0.0
255571079	447	ATP binding protein, putative [Ricinus c	0.977	0.953	0.738	0.0
356522988	430	PREDICTED: probable receptor-like protei	0.977	0.990	0.707	1e-179
449432360	426	PREDICTED: probable receptor-like protei	0.974	0.997	0.687	1e-176
356504531	430	PREDICTED: probable receptor-like protei	0.977	0.990	0.702	1e-176
357512951	435	Protein kinase 2B [Medicago truncatula]	0.981	0.983	0.695	1e-174
449487562	453	PREDICTED: LOW QUALITY PROTEIN: probable	0.974	0.938	0.647	1e-172
225453299	427	PREDICTED: probable receptor-like protei	0.977	0.997	0.710	1e-172
224137090	404	predicted protein [Populus trichocarpa]	0.864	0.933	0.756	1e-168
90900944	412	NAK-type protein kinase [Nicotiana tabac	0.896	0.949	0.641	1e-147

>gi|156105187|gb|ABU49132.1| ser/thr protein kinase [Malus x domestica]

 Score =  686 bits (1770), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 334/436 (76%), Positives = 381/436 (87%), Gaps = 7/436 (1%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
           MKCF+YFK+K  RRRE+RSAPELKE  KS DYSG   DR +KS+CSA+  SPRGIPE+YE
Sbjct: 1   MKCFNYFKDKA-RRREQRSAPELKEETKS-DYSGG-GDRVIKSTCSAN--SPRGIPEMYE 55

Query: 61  EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           EKAHNLR F+++E+RQATNDFSR+LKIGEGGFG+VYK SIK AA D  S+  VVAIKKLN
Sbjct: 56  EKAHNLRAFTFAELRQATNDFSRLLKIGEGGFGNVYKGSIK-AADDKGSDPVVVAIKKLN 114

Query: 121 RDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 180
            DGLQGHKQWVAEVQFL V+EHPNLVKLIGYCAVDGERGIQRLLVYEFM NRSLEDHLFN
Sbjct: 115 NDGLQGHKQWVAEVQFLSVVEHPNLVKLIGYCAVDGERGIQRLLVYEFMPNRSLEDHLFN 174

Query: 181 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 240
           + +  +PW+TRL IILGAA+GLAYLH+GLEVQVIYRDFK +NVLLD+NF+PKLSDFGLAR
Sbjct: 175 KVYSTVPWETRLQIILGAAQGLAYLHQGLEVQVIYRDFKCANVLLDDNFKPKLSDFGLAR 234

Query: 241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 300
           EGPMVGHTHVSTAVVGT+GYAAPDYIETGHLTAKSDVWSFGVVLYE+LTGRRSLERNRP+
Sbjct: 235 EGPMVGHTHVSTAVVGTYGYAAPDYIETGHLTAKSDVWSFGVVLYEILTGRRSLERNRPR 294

Query: 301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
            EQ+LLEWV+Q+P D KKFGLIMD RLE +YSI  ARKI  LA++CLSKS+KDRP MSQV
Sbjct: 295 REQKLLEWVKQFPCDGKKFGLIMDSRLENKYSITAARKIANLAESCLSKSAKDRPTMSQV 354

Query: 361 VERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKLGEHVE 420
           V++LKQI+Q S EG   D++ E + E D  ++ TK +Q E SE+W+RRMAHLAKLGEHVE
Sbjct: 355 VDKLKQIIQDSEEGIPSDRSPESV-ENDQADSVTKPRQLEASESWQRRMAHLAKLGEHVE 413

Query: 421 GASRRRLLIMQRAKVV 436
            ASRRR +IMQRA+V 
Sbjct: 414 SASRRRFMIMQRARVT 429

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255571079|ref|XP_002526490.1| ATP binding protein, putative [Ricinus communis] gi|223534165|gb|EEF35881.1| ATP binding protein, putative [Ricinus communis]

 Score =  673 bits (1736), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 336/455 (73%), Positives = 380/455 (83%), Gaps = 29/455 (6%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
           MKCF+YFK+K  R R++RSAPELKE  +  DYS  E+DR  KSSCS   TSPRGIPELY+
Sbjct: 1   MKCFYYFKDKS-RSRQQRSAPELKEKSRD-DYS--EADRITKSSCSE--TSPRGIPELYK 54

Query: 61  EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           EKAHNLRVFS+SE+R AT+DFSR+LKIGEGGFGSVYK SIKP  G G  E TVVAIKKLN
Sbjct: 55  EKAHNLRVFSFSELRNATSDFSRLLKIGEGGFGSVYKGSIKPVGGKG--EPTVVAIKKLN 112

Query: 121 RDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 180
           RDGLQGHKQWVAEVQFLGV+EHPNLVKLIGYC VDGERGIQRLLVYEFM N+SLE+HLF+
Sbjct: 113 RDGLQGHKQWVAEVQFLGVVEHPNLVKLIGYCGVDGERGIQRLLVYEFMQNKSLEEHLFD 172

Query: 181 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 240
           RA+P L WKTRL I+LGAA+GLAYLHEGLEVQVIYRDFK+SNVLLDENF+PKLSDFGLAR
Sbjct: 173 RAYPALAWKTRLQILLGAAQGLAYLHEGLEVQVIYRDFKSSNVLLDENFKPKLSDFGLAR 232

Query: 241 EGPMVGHTHVSTA-------------------VVGTFGYAAPDYIETGHLTAKSDVWSFG 281
           EGP+ G THVSTA                   VVGT+GYAAPDYIETGHLT KSDVWSFG
Sbjct: 233 EGPVAGRTHVSTAVALMPKYRANEELSILSDQVVGTYGYAAPDYIETGHLTTKSDVWSFG 292

Query: 282 VVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGR 341
           VVLYE+LTGRRSLERNRP+ EQ+LLEWV+ Y  +SKKFGLI+DPRLE +YSI+ ARKI +
Sbjct: 293 VVLYEILTGRRSLERNRPRVEQKLLEWVKHYTPESKKFGLIIDPRLENQYSISAARKIAK 352

Query: 342 LADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEP 401
           LAD+CL KS+KDRP+MS+VVE LKQI+Q S+EGDS  K+FE  CE D  ++  K  Q E 
Sbjct: 353 LADSCLLKSAKDRPRMSEVVESLKQIIQDSDEGDSPKKSFES-CETDSADSSKKPNQPEA 411

Query: 402 SEAWKRRMAHLAKLGEHVEG-ASRRRLLIMQRAKV 435
           +E+WKRRM HLAKLGE+VEG ASRRR +IMQRAKV
Sbjct: 412 TESWKRRMVHLAKLGENVEGAASRRRFMIMQRAKV 446

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356522988|ref|XP_003530124.1| PREDICTED: probable receptor-like protein kinase At5g47070-like [Glycine max]

 Score =  634 bits (1636), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 309/437 (70%), Positives = 367/437 (83%), Gaps = 11/437 (2%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
           MKCF+YF++K  R  ++RSAPELKE  K  ++SG E  R  KSSCS+  TSPRGIPELYE
Sbjct: 1   MKCFYYFRDKS-RSSKQRSAPELKEQEK-LEFSGPE--RVTKSSCSS--TSPRGIPELYE 54

Query: 61  EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           EK HNLR FS++E+++AT+DFSR+LKIGEGGFGSV+K +IKPA  DG   + +VAIK+LN
Sbjct: 55  EKGHNLRDFSFTELKRATSDFSRLLKIGEGGFGSVFKGTIKPA--DGNRNSVLVAIKRLN 112

Query: 121 RDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 180
           ++ LQGHKQW+ EVQFLGV++HPNLVKLIGYCA+D ERGIQRLLVYE+M N+SLE HLFN
Sbjct: 113 KNALQGHKQWLTEVQFLGVVQHPNLVKLIGYCALDDERGIQRLLVYEYMPNKSLEFHLFN 172

Query: 181 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 240
           +A+ PLPWKTRL I  GAA+GL YLHE LE+QVIYRDFKASNVLLDENF PKLSDFGLAR
Sbjct: 173 KAYDPLPWKTRLEIATGAAQGLTYLHEELEIQVIYRDFKASNVLLDENFNPKLSDFGLAR 232

Query: 241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 300
           EGP  G THVSTAV+GT+GYAAPDYIETGHLTAKSDVWSFGVVLYE+LTGRRS+E+NRPK
Sbjct: 233 EGPAAGDTHVSTAVMGTYGYAAPDYIETGHLTAKSDVWSFGVVLYEILTGRRSMEKNRPK 292

Query: 301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
           TE++LLEWV+QYP DSK+FG+IMDPRL+ EYSI  ARKI +LA +CL KS+KDRP MSQV
Sbjct: 293 TEKKLLEWVKQYPPDSKRFGMIMDPRLQGEYSIKGARKIAKLAQHCLRKSAKDRPSMSQV 352

Query: 361 VERLKQIVQVSNEGD--SFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKLGEH 418
           VERLKQI+Q S+E    + DK+  E+ E DPVEA+ +  Q   +E WK+RM HLAKLGE 
Sbjct: 353 VERLKQIIQDSDEEQHPADDKSI-EVSENDPVEAEEEANQSGSTELWKKRMEHLAKLGES 411

Query: 419 VEGASRRRLLIMQRAKV 435
           VE AS+RR + +QRA V
Sbjct: 412 VESASKRRFMTLQRANV 428

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449432360|ref|XP_004133967.1| PREDICTED: probable receptor-like protein kinase At5g47070-like [Cucumis sativus]

 Score =  625 bits (1611), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 299/435 (68%), Positives = 365/435 (83%), Gaps = 10/435 (2%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
           MKCF+YFK+K  R R +RSAP+LKE ++S D+SG    R   SSCS  +TSPR +PELYE
Sbjct: 1   MKCFYYFKDKS-RSRRQRSAPQLKEQQES-DFSGC--SRTAASSCS--LTSPRSVPELYE 54

Query: 61  EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           EKAHNLRVFS++E+RQAT DF+R+LKIG+GGFGSV+K SIKP   DG  +  VVAIK+L+
Sbjct: 55  EKAHNLRVFSFTELRQATQDFNRLLKIGQGGFGSVFKGSIKPV--DGNGDPLVVAIKQLS 112

Query: 121 RDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 180
           +DGLQGHKQW+AEVQFLG++EHPNLVKLIGYCAVDG RGIQRLLVYE+M NRSLEDHLFN
Sbjct: 113 KDGLQGHKQWLAEVQFLGIVEHPNLVKLIGYCAVDGSRGIQRLLVYEYMPNRSLEDHLFN 172

Query: 181 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 240
           +A PPL W+TRLHI+LGAA+GLAYLHEGLEVQ+IYRDFK+SNVLLDENF PKLSDFGLAR
Sbjct: 173 KALPPLAWRTRLHIVLGAAQGLAYLHEGLEVQIIYRDFKSSNVLLDENFHPKLSDFGLAR 232

Query: 241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 300
           EGP +G THVSTAV+GT GYAAPDYIETGHLTAKSDVWS GVVLYE+LTGRRSLERNR +
Sbjct: 233 EGPEIGRTHVSTAVMGTNGYAAPDYIETGHLTAKSDVWSLGVVLYEILTGRRSLERNRSR 292

Query: 301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
            E +L+EWV+ +  DSKKF LI+DPRLE +Y IN ARK+ +LAD CL+K++KDRP M++V
Sbjct: 293 FEHKLVEWVKHFNPDSKKFSLIIDPRLENQYPINAARKLAKLADTCLAKNAKDRPSMAEV 352

Query: 361 VERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKLGEHVE 420
           V  LK+I++  +    ++K+ + + +E  +E + ++   E  ++W+RRM+HL KLGEHVE
Sbjct: 353 VNSLKEIIKSEDNSKPYEKSPDSVIDEPDMEREPEKM--EAPKSWRRRMSHLQKLGEHVE 410

Query: 421 GASRRRLLIMQRAKV 435
           GASRRR +IMQ AKV
Sbjct: 411 GASRRRFMIMQSAKV 425

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356504531|ref|XP_003521049.1| PREDICTED: probable receptor-like protein kinase At5g47070-like [Glycine max]

 Score =  625 bits (1611), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 307/437 (70%), Positives = 367/437 (83%), Gaps = 11/437 (2%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
           MKCF+YF++K  R  ++RSAPELK+  K  + SG E  R  KSSCS++  SPRGI ELYE
Sbjct: 1   MKCFYYFRDKS-RSSKQRSAPELKDQEK-LELSGPE--RVTKSSCSSA--SPRGILELYE 54

Query: 61  EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           EK HNLR FS++E+++AT+DFS +LKIGEGGFGSV+K SIKP  G+G S   +VAIK+LN
Sbjct: 55  EKGHNLRNFSFTELKRATSDFSSLLKIGEGGFGSVFKGSIKPVDGNGNS--VLVAIKRLN 112

Query: 121 RDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 180
           ++ LQGHKQW+ EVQFLG++EHPNLVKLIGYCA+D ERGIQRLLVYE+M N+SLE HLFN
Sbjct: 113 KNALQGHKQWLTEVQFLGIVEHPNLVKLIGYCALDDERGIQRLLVYEYMPNKSLEFHLFN 172

Query: 181 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 240
           +A+ PLPWKTRL IIL AA+GL+YLHE LE+QVIYRDFKASNVLLDENF+PKLSDFGLAR
Sbjct: 173 KAYDPLPWKTRLEIILEAAQGLSYLHEELEIQVIYRDFKASNVLLDENFKPKLSDFGLAR 232

Query: 241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 300
           EGP+ G THVSTAV+GT+GYAAPDYIETGHLTAKSDVWSFGVVLYE+LTGRRS+ERNRPK
Sbjct: 233 EGPVAGDTHVSTAVMGTYGYAAPDYIETGHLTAKSDVWSFGVVLYEILTGRRSMERNRPK 292

Query: 301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
           TE++LLEWV+QYP DSK+F +I+DPRL+ EYSI  ARKI +LA +CL KS+KDRP MSQV
Sbjct: 293 TEKKLLEWVKQYPPDSKRFDMIVDPRLQGEYSIKGARKIAKLAAHCLRKSAKDRPSMSQV 352

Query: 361 VERLKQIVQVSNEGD--SFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKLGEH 418
           VERLK+I+  S+E    + DK+  E+ E DPVEA+ K  Q   +E WK+RM HLAKLGE 
Sbjct: 353 VERLKEIILDSDEEQQPADDKSI-EVSENDPVEAEDKTNQSGSTELWKKRMEHLAKLGES 411

Query: 419 VEGASRRRLLIMQRAKV 435
           VE ASRRR +I+QRA V
Sbjct: 412 VESASRRRFMILQRANV 428

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357512951|ref|XP_003626764.1| Protein kinase 2B [Medicago truncatula] gi|355520786|gb|AET01240.1| Protein kinase 2B [Medicago truncatula]

 Score =  617 bits (1591), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 306/440 (69%), Positives = 359/440 (81%), Gaps = 12/440 (2%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
           MKCF YFK K  + R +RSAPEL+E  K   +SG+E    V  S  +S +SPRGIP+LYE
Sbjct: 1   MKCFSYFKYKH-KGRGQRSAPELEEQEKH-QFSGSER---VTKSSCSSTSSPRGIPKLYE 55

Query: 61  EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           EK HNLRVFS+SE+ +AT+DF+R+LKIGEGGFGSV+K SIKP  G+G  +  +VAIK+LN
Sbjct: 56  EKGHNLRVFSFSELSRATSDFNRLLKIGEGGFGSVFKGSIKPVGGNG--DPVLVAIKRLN 113

Query: 121 RDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 180
           +D LQGHKQW+ EVQFLGV+EHPNLVKLIGYCAVDGERGIQRLLVYE+M NRSLE HLFN
Sbjct: 114 KDALQGHKQWLTEVQFLGVVEHPNLVKLIGYCAVDGERGIQRLLVYEYMPNRSLEAHLFN 173

Query: 181 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 240
           +++ P+PWKTRL I LGAA+GL+YLHE LEVQ+IYRDFK SNVLLDENF+PKLSDFGLAR
Sbjct: 174 KSYDPVPWKTRLEIALGAAQGLSYLHEELEVQIIYRDFKCSNVLLDENFKPKLSDFGLAR 233

Query: 241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 300
           EGP  G THVSTAV+GT GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL RNRPK
Sbjct: 234 EGPEAGDTHVSTAVMGTHGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLTRNRPK 293

Query: 301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
           TEQ+LLEWV+ YP DSKKF +IMDPRLE +YSIN ARK+ +LAD+CL KSSKDRP+MSQV
Sbjct: 294 TEQKLLEWVKNYPPDSKKFDMIMDPRLEGQYSINAARKLAKLADHCLRKSSKDRPRMSQV 353

Query: 361 VERLKQIVQVSNE-----GDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKL 415
           VERLK+I+Q S++      D  +    E+ E D  E Q +      +E W++RM HLAKL
Sbjct: 354 VERLKEIIQASDKEQEEHHDPNEINSAEVSENDSFEHQEESNSSGSTELWRKRMEHLAKL 413

Query: 416 GEHVEGASRRRLLIMQRAKV 435
           GEHVEGA+R+  +I QRA V
Sbjct: 414 GEHVEGANRKMFMIQQRANV 433

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449487562|ref|XP_004157688.1| PREDICTED: LOW QUALITY PROTEIN: probable receptor-like protein kinase At5g47070-like [Cucumis sativus]

 Score =  610 bits (1574), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 299/462 (64%), Positives = 366/462 (79%), Gaps = 37/462 (8%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
           MKCF+YFK+K  R R +RSAP+LKE ++S D+SG    R   SSCS  +TSPR +PELYE
Sbjct: 1   MKCFYYFKDKS-RSRRQRSAPQLKEQQES-DFSGC--SRTAASSCS--LTSPRSVPELYE 54

Query: 61  EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           EKAHNLRVFS++E+RQAT DF+R+LKIG+GGFGSV+K SIKP  G+G  +  VVAIK+L+
Sbjct: 55  EKAHNLRVFSFTELRQATQDFNRLLKIGQGGFGSVFKGSIKPVDGNG--DPLVVAIKQLS 112

Query: 121 RDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 180
           +DGLQGHKQW+AEVQFLG++EHPNLVKLIGYCAVDG RGIQRLLVYE+M NRSLEDHLFN
Sbjct: 113 KDGLQGHKQWLAEVQFLGIVEHPNLVKLIGYCAVDGSRGIQRLLVYEYMPNRSLEDHLFN 172

Query: 181 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 240
           +A PPL W+TRLHI+LGAA+GLAYLHEGLEVQ+IYRDFK+SNVLLDENF PKLSDFGLAR
Sbjct: 173 KALPPLAWRTRLHIVLGAAQGLAYLHEGLEVQIIYRDFKSSNVLLDENFHPKLSDFGLAR 232

Query: 241 EGPMVGHTHVSTA---------------------------VVGTFGYAAPDYIETGHLTA 273
           EGP +G THVSTA                           V+GT GYAAPDYIETGHLTA
Sbjct: 233 EGPEIGRTHVSTAVSFFFFFSLNHFQAHCCLHXTTFCTTXVMGTNGYAAPDYIETGHLTA 292

Query: 274 KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSI 333
           KSDVWS GVVLYE+LTGRRSLERNR + E +L+EWV+ +  DSKKF LI+DPRLE +Y I
Sbjct: 293 KSDVWSLGVVLYEILTGRRSLERNRSRFEHKLVEWVKHFNPDSKKFSLIIDPRLENQYPI 352

Query: 334 NEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQ 393
           N ARK+ +LAD CL+K++KDRP M++VV  LK+I++  +    ++K+ + + +E  +E +
Sbjct: 353 NAARKLAKLADTCLAKNAKDRPSMAEVVNSLKEIIKSEDNSKPYEKSPDSVIDEPDMERE 412

Query: 394 TKQKQHEPSEAWKRRMAHLAKLGEHVEGASRRRLLIMQRAKV 435
            ++   E  ++W+RRM+HL KLGEHVEGASRRR +IMQ AKV
Sbjct: 413 PEKM--EAPKSWRRRMSHLQKLGEHVEGASRRRFMIMQSAKV 452

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225453299|ref|XP_002268330.1| PREDICTED: probable receptor-like protein kinase At5g47070 [Vitis vinifera] gi|297734656|emb|CBI16707.3| unnamed protein product [Vitis vinifera]

 Score =  610 bits (1573), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 309/435 (71%), Positives = 361/435 (82%), Gaps = 9/435 (2%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
           MKCF+YFK+K  R + +RSAPELK   KS  YSG  SD  +KSSCS +      IPELYE
Sbjct: 1   MKCFYYFKDKT-RLKVQRSAPELKNQSKSY-YSG--SDLVIKSSCSTTSRR--SIPELYE 54

Query: 61  EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           EKA NLRVFS+SE+R AT+DFSRMLK+GEGGFG VYK SIKPA  DG  ++  VAIK+LN
Sbjct: 55  EKAQNLRVFSFSELRHATHDFSRMLKLGEGGFGCVYKGSIKPA--DGKGDSFEVAIKRLN 112

Query: 121 RDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 180
            DG+QGHKQWVAEVQFLG++EHPNLVKLIGYCAVDGERGIQRLLVYE+M N+SLEDHLFN
Sbjct: 113 PDGVQGHKQWVAEVQFLGIVEHPNLVKLIGYCAVDGERGIQRLLVYEYMPNKSLEDHLFN 172

Query: 181 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 240
           +A P LPW+TRL  +LGAA+GLAYLHE LEVQVIYRDFK+SNVLLD++F PKLSDFGLAR
Sbjct: 173 KAIPALPWQTRLQTVLGAAQGLAYLHEELEVQVIYRDFKSSNVLLDKDFNPKLSDFGLAR 232

Query: 241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 300
           EGP  G THVSTA VGTFGYAAPDYIETGHLT KSDVWSFGVVLYE+LTGRRS+ERN P+
Sbjct: 233 EGPADGFTHVSTAAVGTFGYAAPDYIETGHLTTKSDVWSFGVVLYEILTGRRSMERNHPR 292

Query: 301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
            EQ+LLEWV+ +PA+SKKF +IMD RLE +Y I+ ARKI +LAD+CLSKS+KDRPKMS+V
Sbjct: 293 AEQKLLEWVKHFPANSKKFHMIMDWRLENQYPISTARKIAKLADSCLSKSAKDRPKMSEV 352

Query: 361 VERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHLAKLGEHVE 420
           VE LKQI+Q+ +EG   +K+ E    +   +   K  Q  PS++WKRRMAHLA LGEHVE
Sbjct: 353 VETLKQIIQLPDEGGPSEKSPESFDNDS-DDKDKKADQPGPSDSWKRRMAHLASLGEHVE 411

Query: 421 GASRRRLLIMQRAKV 435
           G++R+R +IMQRAKV
Sbjct: 412 GSNRKRFMIMQRAKV 426

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224137090|ref|XP_002327019.1| predicted protein [Populus trichocarpa] gi|222835334|gb|EEE73769.1| predicted protein [Populus trichocarpa]

 Score =  598 bits (1541), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 289/382 (75%), Positives = 326/382 (85%), Gaps = 5/382 (1%)

Query: 1   MKCFHYFKEKKLRRREERSAPELKEPRKS-ADYSGAESDRFVKSSCSASVTSPRGIPELY 59
           MKCF Y+ + K R R  RSAPELK+   +  D S   SD  +KSSCS   TS RGI E+Y
Sbjct: 1   MKCFQYYFKDKSRSRGRRSAPELKQRSITKTDDSLCTSDGMIKSSCSE--TSQRGISEMY 58

Query: 60  EEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL 119
           EEKAHNLRVFS+SE+R ATN FSR+ KIGEGGFG+VYK SIKPA G+G  +  VVAIKKL
Sbjct: 59  EEKAHNLRVFSFSELRNATNGFSRLFKIGEGGFGNVYKGSIKPAGGEG--DPIVVAIKKL 116

Query: 120 NRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF 179
           N DG QGHKQWV EVQFLGVLEHPNLVKL+GYCAVDGERGIQRLLVYEFM N+SL+DHLF
Sbjct: 117 NADGFQGHKQWVTEVQFLGVLEHPNLVKLLGYCAVDGERGIQRLLVYEFMRNKSLDDHLF 176

Query: 180 NRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA 239
           N+A+P LPWKTRL IILGAA+GLA+LHEGLEVQVIYRDFK SNVLLDE+ +PKLSDFGLA
Sbjct: 177 NKAYPVLPWKTRLQIILGAAQGLAFLHEGLEVQVIYRDFKTSNVLLDEDLKPKLSDFGLA 236

Query: 240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           REGPM G THVSTAVVGT+GYAAPDYIETGHLTA+SDVWSFGVVLYE+LTGRRSLERNRP
Sbjct: 237 REGPMAGRTHVSTAVVGTYGYAAPDYIETGHLTARSDVWSFGVVLYEILTGRRSLERNRP 296

Query: 300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
           K EQ+LLEWV+Q+PADSKKFGLIMDPRLE +YS++ AR+I RLAD+CL KS+K RPKMSQ
Sbjct: 297 KVEQKLLEWVKQFPADSKKFGLIMDPRLENQYSMSAARRIARLADSCLLKSAKGRPKMSQ 356

Query: 360 VVERLKQIVQVSNEGDSFDKTF 381
           V E L+QI+Q S+EG     +F
Sbjct: 357 VAETLEQIIQDSSEGSPSKNSF 378

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|90900944|gb|ABE01834.1| NAK-type protein kinase [Nicotiana tabacum]

 Score =  528 bits (1359), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 256/399 (64%), Positives = 315/399 (78%), Gaps = 8/399 (2%)

Query: 1   MKCFHYFKEKKLRRREERSAPEL-KEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELY 59
           +KCF+ FK+K   RR   SAPEL  E R+  +   +E  +  KS+   SV+S R IP++Y
Sbjct: 2   LKCFYIFKDKSRSRRRGESAPELSNESRRDGN---SEGKKVAKST--GSVSSARSIPQMY 56

Query: 60  EEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL 119
            EK  NLRVFS SE+++AT  F+RMLKIGEGGFGSVYK +I+P +G G  +  VVAIKKL
Sbjct: 57  REKEQNLRVFSLSELKEATRSFNRMLKIGEGGFGSVYKGTIQPPSGRG--DPIVVAIKKL 114

Query: 120 NRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF 179
           N  GLQGH+QWVAEVQFLGVLEHPNLVKL+GYCA DGERGIQRLLVYE+M N+SLEDHLF
Sbjct: 115 NTLGLQGHRQWVAEVQFLGVLEHPNLVKLLGYCATDGERGIQRLLVYEYMQNKSLEDHLF 174

Query: 180 NRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA 239
           NRA P +PWKTRL IILGAA+G+AYLHEGLEVQVIYRDFK+SNVLLDE+F P LSDFGLA
Sbjct: 175 NRAVPVIPWKTRLKIILGAAQGMAYLHEGLEVQVIYRDFKSSNVLLDEDFNPWLSDFGLA 234

Query: 240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           REGP    +HVSTA VGT GYAAP+Y+ETGHL+ KSD+WSFGVVLYE+LTGRR+LERN P
Sbjct: 235 REGPAGDRSHVSTAPVGTLGYAAPEYVETGHLSVKSDIWSFGVVLYEILTGRRTLERNLP 294

Query: 300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
             +Q+L++WV+Q+PADS+KF +I+DPRL  E+S+  AR+I +LAD+CL+K +K+RPKMS+
Sbjct: 295 VMQQKLIDWVKQFPADSRKFSMIIDPRLRNEFSLVAARRIAKLADSCLNKIAKERPKMSE 354

Query: 360 VVERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQ 398
           VV+ L Q VQ S E  S + T        P +  + ++Q
Sbjct: 355 VVQILTQAVQESQETTSLEITGPGPGPSRPTQLASPKQQ 393

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	436
TAIR|locus:2151992	410	AT5G47070 [Arabidopsis thalian	0.788	0.839	0.613	1.6e-111
TAIR|locus:2064920	435	AT2G39110 [Arabidopsis thalian	0.892	0.894	0.516	4.2e-102
TAIR|locus:2129326	388	AT4G17660 [Arabidopsis thalian	0.736	0.827	0.597	2.1e-100
TAIR|locus:2053250	462	AT2G28940 [Arabidopsis thalian	0.821	0.774	0.536	6.4e-99
TAIR|locus:2085069	418	AT3G09830 [Arabidopsis thalian	0.782	0.815	0.549	2.5e-97
TAIR|locus:2142639	420	AT5G03320 [Arabidopsis thalian	0.788	0.819	0.534	3.8e-94
TAIR|locus:2147805	493	AT5G15080 [Arabidopsis thalian	0.841	0.744	0.488	6e-87
TAIR|locus:2100282	490	AT3G01300 [Arabidopsis thalian	0.75	0.667	0.523	2.6e-86
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.793	0.763	0.505	4.3e-86
TAIR|locus:2053240	423	PK1B "protein kinase 1B" [Arab	0.772	0.796	0.498	1.2e-83

TAIR|locus:2151992 AT5G47070 [Arabidopsis thaliana (taxid:3702)]

 Score = 1101 (392.6 bits), Expect = 1.6e-111, P = 1.6e-111
 Identities = 219/357 (61%), Positives = 272/357 (76%)

Query:    19 SAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQAT 78
             SAPEL    +++ ++  ++ R        S+ SPR I +LY E+  NLRVFSY E+ +AT
Sbjct:    33 SAPELTNRSETSSFN-LQTPR--------SLPSPRSIKDLYTEREQNLRVFSYEELSKAT 83

Query:    79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
               FSR L IGEGGFG VYK  I  + GD +    VVAIKKLNR GLQGHKQW+AEVQFLG
Sbjct:    84 YVFSRKLVIGEGGFGIVYKGKIL-SNGDSSDPPLVVAIKKLNRQGLQGHKQWLAEVQFLG 142

Query:   139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
             V+ HPN+VKLIGYC+ DGE GI+RLLVYE+M NRSLEDHLF R    LPWK RL I+LGA
Sbjct:   143 VVNHPNVVKLIGYCSEDGETGIERLLVYEYMSNRSLEDHLFPRRSHTLPWKKRLEIMLGA 202

Query:   199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
             AEGL YLH+   ++VIYRDFK+SNVLLD+ F PKLSDFGLAREGP   +THV+TA VGT 
Sbjct:   203 AEGLTYLHD---LKVIYRDFKSSNVLLDDQFCPKLSDFGLAREGPDGDNTHVTTARVGTH 259

Query:   259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 318
             GYAAP+Y++TGHL  KSDV+SFGVVLYE++TGRR++ERN+P  E+RLL+WV++YPADS++
Sbjct:   260 GYAAPEYVQTGHLRLKSDVYSFGVVLYEIITGRRTIERNKPVAERRLLDWVKEYPADSQR 319

Query:   319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGD 375
             F +I+DPRL   Y    AR + +LAD CL K+ K+RP M  VVERLK+I++ S+  D
Sbjct:   320 FSMIVDPRLRNNYPAAGARSLAKLADLCLKKNDKERPTMEIVVERLKKIIEESDSED 376

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

TAIR|locus:2064920 AT2G39110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1012 (361.3 bits), Expect = 4.2e-102, P = 4.2e-102
 Identities = 206/399 (51%), Positives = 274/399 (68%)

Query:     1 MKCFHYFXXXXXXXXXXXSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYE 60
             MKCF YF           +  +      +   SG+E +    +S + S+TS   +  L E
Sbjct:    16 MKCF-YFSKDKTQDDEAKTR-KFGSATMARGGSGSEFNS--DTSTATSITSSLHV--LSE 69

Query:    61 EKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
               ++NL+VF   +++ AT +FSR L IGEGGFG V++  I+    D   +  + A+K+L+
Sbjct:    70 THSNNLKVFVLDDLKTATKNFSRSLMIGEGGFGGVFRGVIQNPQ-DSRKKIDI-AVKQLS 127

Query:   121 RDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 180
             R GLQGHK+WV EV  LGV+EHPNLVKLIGYCA D ERGIQRLLVYE++ NRS++DHL N
Sbjct:   128 RRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLVYEYVQNRSVQDHLSN 187

Query:   181 RAF-PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA 239
             R    PLPW TRL I    A GLAYLH+G+E Q+I+RDFK+SN+LLDEN+  KLSDFGLA
Sbjct:   188 RFIVTPLPWSTRLKIAQDTARGLAYLHQGMEFQIIFRDFKSSNILLDENWNAKLSDFGLA 247

Query:   240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
             R GP  G THVSTAVVGT GYAAP+YI+TGHLTAKSDVWS+G+ LYE++TGRR  +RNRP
Sbjct:   248 RMGPSDGITHVSTAVVGTIGYAAPEYIQTGHLTAKSDVWSYGIFLYELITGRRPFDRNRP 307

Query:   300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
             + EQ +LEW++ + +D KKF +I+DPRLE  Y +  A K+  +A+ CL   +K RP MSQ
Sbjct:   308 RNEQNILEWIRPHLSDIKKFKMIIDPRLEGNYYLKSALKLAAVANRCLMVKAKARPTMSQ 367

Query:   360 VVERLKQIVQVSNEG-DSFDKTFEEICEEDPVEAQTKQK 397
             V E L++IV+ S++G  S     + +  +D  EA  +++
Sbjct:   368 VSEMLERIVETSSDGAPSGLPLMKSLTPKDAFEASRRER 406

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2129326 AT4G17660 [Arabidopsis thaliana (taxid:3702)]

 Score = 996 (355.7 bits), Expect = 2.1e-100, P = 2.1e-100
 Identities = 199/333 (59%), Positives = 248/333 (74%)

Query:    48 SVTSPRGIPELYEEKAHN----LRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIK-P 102
             S+ SP  I +LY ++  N    LRVFS+ E+  AT +FSR LKIGEGGFGSVYK++I  P
Sbjct:    54 SLPSPTSIKDLYTDREQNQNQNLRVFSFKELSDATCEFSRKLKIGEGGFGSVYKATINNP 113

Query:   103 AAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQR 162
               GD  S    VA+KKLNR  LQGHKQW+AEV FLGV+ HPN+V+L+GYC+ D ER    
Sbjct:   114 TVGDSHSSPLTVAVKKLNRQSLQGHKQWLAEVHFLGVVNHPNVVRLLGYCSEDRER---- 169

Query:   163 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN 222
             LLVYE M NRSLEDHLF      L WK RL I+LGAA+GLAYLHE   +QVIYRDFK+SN
Sbjct:   170 LLVYELMSNRSLEDHLFTLRTLTLSWKQRLEIMLGAAQGLAYLHE---IQVIYRDFKSSN 226

Query:   223 VLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGV 282
             VLL+E F PKLSDFGLAREGP   +THV+TA VGT GYAAP+Y+ TGHL    DV+SFGV
Sbjct:   227 VLLNEEFHPKLSDFGLAREGPEGDNTHVTTARVGTDGYAAPEYVITGHLKTHCDVYSFGV 286

Query:   283 VLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRL 342
             VLYE++TGRR+LER +P  EQ+LLEWV++YP +SK+F +I+D +L  +Y I   R++ +L
Sbjct:   287 VLYEIITGRRTLERMKPLAEQKLLEWVKKYPINSKRFKMIVDSKLCNKYPIAMVRRVAKL 346

Query:   343 ADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGD 375
             AD+C++K  K+RP M+ VVE L  I++ SN  D
Sbjct:   347 ADHCVNKIDKERPTMAFVVESLTNIIEESNSED 379

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2053250 AT2G28940 [Arabidopsis thaliana (taxid:3702)]

 Score = 982 (350.7 bits), Expect = 6.4e-99, P = 6.4e-99
 Identities = 197/367 (53%), Positives = 263/367 (71%)

Query:    51 SPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSE 110
             S R I  L  E  ++L+VF++ E++ AT  F+R L IGEGGFG VY+  +  +  +G   
Sbjct:    74 SQRWIGGLVPE--NDLKVFTFKELKIATKGFNRGLLIGEGGFGCVYRGVVDVSDSNGFDS 131

Query:   111 ATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFML 170
                VA+K+LNR GLQGHK+W+ EV FLGV+ HPNLVKL+GYCA D ERG+QRLLVYE M 
Sbjct:   132 KINVAVKQLNRQGLQGHKEWINEVNFLGVVNHPNLVKLVGYCADDDERGMQRLLVYELMC 191

Query:   171 NRSLEDHLFNRAFP-PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF 229
             N+SLEDHL  R     LPW  RL I   AA+GLAYLHE ++ Q+I+RDFK+SN+LLDE F
Sbjct:   192 NKSLEDHLVGRVVSVSLPWMMRLKIAQDAAQGLAYLHEEMDFQLIFRDFKSSNILLDERF 251

Query:   230 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
               KLSDFGLAR+GP  G  HVST+VVGT GYAAP+Y++TG LTAKSDVWSFGVVLYE++T
Sbjct:   252 GAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGKLTAKSDVWSFGVVLYELIT 311

Query:   290 GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEY-SINEARKIGRLADNCLS 348
             GRR+++RNRP+ EQ+LLEWV+ Y +DSKKF LI+DPRLE +Y  +   +++  LA+ CL 
Sbjct:   312 GRRAVDRNRPRGEQKLLEWVKPYVSDSKKFHLIVDPRLEGQYYCMKSVQRVAALANKCLM 371

Query:   349 KSSKDRPKMSQVVERLKQIVQVSNEG---DSFDKTFEEICEEDPVEAQTKQKQHEPSEAW 405
             K  K RPKMS+VV  L +I+    E       D+T EEI + + +  +++ +  +   ++
Sbjct:   372 KQPKSRPKMSEVVSLLGRIIDEEAENVPPPVADET-EEIIKAE-LNGESEPELKKQGSSY 429

Query:   406 KRRMAHL 412
             ++++  L
Sbjct:   430 RKKVLDL 436

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2085069 AT3G09830 [Arabidopsis thaliana (taxid:3702)]

 Score = 967 (345.5 bits), Expect = 2.5e-97, P = 2.5e-97
 Identities = 190/346 (54%), Positives = 255/346 (73%)

Query:    33 SGAE-SDRFVK-SSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEG 90
             SG+E + R V  +S  +S+      P +   +A NLR FS ++++ AT +FSR + IGEG
Sbjct:    35 SGSEFNSRDVSGTSTESSMGRKNSYPPV-STRASNLREFSITDLKSATKNFSRSVMIGEG 93

Query:    91 GFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIG 150
             GFG V++ +++    + +S    VA+K+L + GLQGHK+WV EV FLG++EH NLVKL+G
Sbjct:    94 GFGCVFRGTVRNL--EDSSVKIEVAVKQLGKRGLQGHKEWVTEVNFLGIVEHTNLVKLLG 151

Query:   151 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLE 210
             YCA D ERGIQRLLVYE+M NRS+E HL  R+   L W  RL I   AA GL YLHE +E
Sbjct:   152 YCAEDDERGIQRLLVYEYMPNRSVEFHLSPRSLTVLTWDLRLRIAQDAARGLTYLHEEME 211

Query:   211 VQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH 270
              Q+I+RDFK+SN+LLDE+++ KLSDFGLAR GP  G THVST VVGT GYAAP+YI+TG 
Sbjct:   212 FQIIFRDFKSSNILLDEDWKAKLSDFGLARLGPSEGLTHVSTDVVGTMGYAAPEYIQTGR 271

Query:   271 LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKE 330
             LT+KSDVW +GV LYE++TGRR ++RNRPK EQ+LLEWV+ Y +D++KF LI+DPRLE +
Sbjct:   272 LTSKSDVWGYGVFLYELITGRRPVDRNRPKGEQKLLEWVRPYLSDTRKFKLILDPRLEGK 331

Query:   331 YSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS 376
             Y I   +K+  +A+ CL ++SK RPKMS+V+E + +IV+ S+   S
Sbjct:   332 YPIKSVQKLAVVANRCLVRNSKARPKMSEVLEMVNKIVEASSGNGS 377

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2142639 AT5G03320 [Arabidopsis thaliana (taxid:3702)]

 Score = 937 (334.9 bits), Expect = 3.8e-94, P = 3.8e-94
 Identities = 186/348 (53%), Positives = 252/348 (72%)

Query:    33 SGAE-SDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGG 91
             SG++ S R V  + + S T  R        + +NLR F+  +++ AT +FSR   IGEGG
Sbjct:    33 SGSDFSPRDVSGTSTVSSTG-RNSNTSMSARENNLREFTIGDLKSATRNFSRSGMIGEGG 91

Query:    92 FGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGY 151
             FG V+  +IK    +  S+   VA+K+L + GLQGHK+WV EV FLGV+EH NLVKL+G+
Sbjct:    92 FGCVFWGTIKNL--EDPSKKIEVAVKQLGKRGLQGHKEWVTEVNFLGVVEHSNLVKLLGH 149

Query:   152 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEV 211
             CA D ERGIQRLLVYE+M N+S+E HL  R+   L W  RL I   AA GL YLHE ++ 
Sbjct:   150 CAEDDERGIQRLLVYEYMPNQSVEFHLSPRSPTVLTWDLRLRIAQDAARGLTYLHEEMDF 209

Query:   212 QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL 271
             Q+I+RDFK+SN+LLDEN+  KLSDFGLAR GP  G +HVST VVGT GYAAP+YI+TG L
Sbjct:   210 QIIFRDFKSSNILLDENWTAKLSDFGLARLGPSPGSSHVSTDVVGTMGYAAPEYIQTGRL 269

Query:   272 TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEY 331
             T+KSDVW +GV +YE++TGRR L+RN+PK EQ+LLEWV+ Y +D+++F LI+DPRLE +Y
Sbjct:   270 TSKSDVWGYGVFIYELITGRRPLDRNKPKGEQKLLEWVRPYLSDTRRFRLIVDPRLEGKY 329

Query:   332 SINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDK 379
              I   +K+  +A+ CL++++K RPKMS+V+E + +IV+ S+ G+   K
Sbjct:   330 MIKSVQKLAVVANLCLTRNAKARPKMSEVLEMVTKIVEASSPGNGGKK 377

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)]

 Score = 869 (311.0 bits), Expect = 6.0e-87, P = 6.0e-87
 Identities = 187/383 (48%), Positives = 251/383 (65%)

Query:    28 KSADYS-GAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLK 86
             KS D   G  S     S+  +S ++P  I E     +H LR F++++++ +T +F     
Sbjct:    90 KSNDQPVGQVSSTTTTSNAESSSSTPV-ISEELNISSH-LRKFTFNDLKLSTRNFRPESL 147

Query:    87 IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
             +GEGGFG V+K  I+          T   VA+K LN DGLQGHK+W+AE+ FLG L HPN
Sbjct:   148 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPN 207

Query:   145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
             LVKL+GYC  D     QRLLVYEFM   SLE+HLF R+ P LPW  R+ I LGAA+GL++
Sbjct:   208 LVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLSF 262

Query:   205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 264
             LHE     VIYRDFK SN+LLD ++  KLSDFGLA++ P  G THVST V+GT+GYAAP+
Sbjct:   263 LHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPE 322

Query:   265 YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD 324
             Y+ TGHLT+KSDV+SFGVVL EMLTGRRS+++NRP  E  L+EW + +  D ++F  ++D
Sbjct:   323 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLD 382

Query:   325 PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS--FDKTFE 382
             PRLE  +SI  A+K+ +LA  CLS+  K RPKMS VVE LK +  + +   S  + +T +
Sbjct:   383 PRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMASSSYYFQTMQ 442

Query:   383 -EICEEDPVEAQ---TKQKQHEP 401
              E  +     +Q   ++  QH+P
Sbjct:   443 AERLKNGSGRSQGFGSRNGQHQP 465

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)]

 Score = 863 (308.9 bits), Expect = 2.6e-86, P = 2.6e-86
 Identities = 176/336 (52%), Positives = 232/336 (69%)

Query:    34 GAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFG 93
             G  S     S+  +S+++P  I E     +H L+ FS+ +++ AT +F     +GEGGFG
Sbjct:    91 GPVSSTTTTSNAESSLSTPI-ISEELNIYSH-LKKFSFIDLKLATRNFRPESLLGEGGFG 148

Query:    94 SVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGY 151
              V+K  ++          T   VA+K LN DGLQGHK+W+AE+ +LG L HPNLVKL+GY
Sbjct:   149 CVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGY 208

Query:   152 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEV 211
             C  D     QRLLVYEFM   SLE+HLF R+ P LPW  R+ I LGAA+GL++LHE    
Sbjct:   209 CIEDD----QRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLSFLHEEALK 263

Query:   212 QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL 271
              VIYRDFK SN+LLD  +  KLSDFGLA++ P  G THVST V+GT+GYAAP+Y+ TGHL
Sbjct:   264 PVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHL 323

Query:   272 TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEY 331
             T+KSDV+SFGVVL EMLTGRRS+++NRP  E  L+EW + +  D ++F  ++DPRLE  +
Sbjct:   324 TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHF 383

Query:   332 SINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
             S+  A+K+ +LA  CLS+ SK RPKMS+VVE LK +
Sbjct:   384 SVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPL 419

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 861 (308.1 bits), Expect = 4.3e-86, P = 4.3e-86
 Identities = 181/358 (50%), Positives = 238/358 (66%)

Query:    23 LKEPRKSADYSGAESDRFVKSSCSASVTS-PRGIPEL-YEEKAHNLRVFSYSEMRQATND 80
             + EP+K  +           + C+ S +S P    EL Y  K   LR+F +++++ AT +
Sbjct:    46 IAEPKKVIEKLEGHPAPTKDTGCAESGSSTPLMSGELKYSSK---LRIFMFNDLKLATRN 102

Query:    81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVAEVQFLG 138
             F     +GEGGFG V+K  I+          T   VA+K LN DGLQGHK+W+AE+ FLG
Sbjct:   103 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLG 162

Query:   139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
              L HP+LVKL+GYC  +     QRLLVYEFM   SLE+HLF R  P LPW  R+ I LGA
Sbjct:   163 NLVHPSLVKLVGYCMEED----QRLLVYEFMPRGSLENHLFRRTLP-LPWSVRMKIALGA 217

Query:   199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
             A+GLA+LHE  E  VIYRDFK SN+LLD  +  KLSDFGLA++ P    +HVST V+GT+
Sbjct:   218 AKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEKKSHVSTRVMGTY 277

Query:   259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 318
             GYAAP+Y+ TGHLT KSDV+SFGVVL E+LTGRRS++++RP  EQ L+EWV+ +  D K+
Sbjct:   278 GYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNGEQNLVEWVRPHLLDKKR 337

Query:   319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS 376
             F  ++DPRLE  YSI  A+K  ++A  CL++ SK RPKMS+VVE LK +  + +   S
Sbjct:   338 FYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVVEALKPLPNLKDFASS 395

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)]

 Score = 838 (300.0 bits), Expect = 1.2e-83, P = 1.2e-83
 Identities = 175/351 (49%), Positives = 235/351 (66%)

Query:    29 SADYSGAES-DRFVKSSCSASV-TSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLK 86
             S  Y  +E+ D     S S S+ T+PR   E+ +    NL+ F+++E++ AT +F     
Sbjct:    28 SPKYMSSEANDSLGSKSSSVSIRTNPRTEGEILQSP--NLKSFTFAELKAATRNFRPDSV 85

Query:    87 IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
             +GEGGFGSV+K  I       +   T  V+A+KKLN+DG QGH++W+AEV +LG   HPN
Sbjct:    86 LGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPN 145

Query:   145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGL 202
             LVKLIGYC  D  R    LLVYEFM   SLE+HLF R   F PL W  RL + LGAA+GL
Sbjct:   146 LVKLIGYCLEDEHR----LLVYEFMPRGSLENHLFRRGSYFQPLSWTLRLKVALGAAKGL 201

Query:   203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
             A+LH   E  VIYRDFK SN+LLD  +  KLSDFGLA++GP    +HVST ++GT+GYAA
Sbjct:   202 AFLHNA-ETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAA 260

Query:   263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
             P+Y+ TGHLT KSDV+S+GVVL E+L+GRR++++NRP  EQ+L+EW +   A+ +K   +
Sbjct:   261 PEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARPLLANKRKLFRV 320

Query:   323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE 373
             +D RL+ +YS+ EA K+  LA  CL+   K RP M++VV  L+ I Q  NE
Sbjct:   321 IDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHI-QTLNE 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9LTC0	Y5707_ARATH	2, ., 7, ., 1, 1, ., 1	0.5921	0.8509	0.9048	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00019023001 SubName- Full=Chromosome chr15 scaffold_19, whole genome shotgun sequence; (427 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	436
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-49
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-48
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-47
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-44
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-35
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-34
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-33
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-29
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-25
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-23
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-22
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-22
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-22
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-21
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-21
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-21
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-20
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-20
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-20
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-20
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-20
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-19
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-18
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-18
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-17
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-17
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-16
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-15
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-15
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-14
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-13
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-13
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-13
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-13
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	9e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-11
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-10
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	9e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	8e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	7e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.001
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.002

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  166 bits (424), Expect = 8e-49
 Identities = 85/285 (29%), Positives = 131/285 (45%), Gaps = 39/285 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
           K+GEG FG VYK  +K   G        VA+K L  D   Q  ++++ E + +  L+HPN
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKK---VEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +VKL+G C  +        +V E+M    L  +L     P L     L   L  A G+ Y
Sbjct: 63  VVKLLGVCTEEEPL----YIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSFALQIARGMEY 117

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP-----MVGHTHVSTAVVGTFG 259
           L        I+RD  A N L+ EN   K+SDFGL+R+             +         
Sbjct: 118 LES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR------ 168

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 319
           + AP+ ++ G  T+KSDVWSFGV+L+E+ T           + + +LE+++         
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPG--MSNEEVLEYLKN-------- 218

Query: 320 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 364
           G     RL +  +     ++  L   C ++  +DRP  S++VE L
Sbjct: 219 GY----RLPQPPNCPP--ELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  166 bits (422), Expect = 1e-48
 Identities = 82/280 (29%), Positives = 130/280 (46%), Gaps = 28/280 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
           K+GEG FG VYK ++K            VA+K L  D   Q  ++++ E + +  L+HPN
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKE---VEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +VKL+G C  +       ++V E+M    L D+L       L     L   L  A G+ Y
Sbjct: 63  IVKLLGVCTEEE----PLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 264
           L        I+RD  A N L+ EN   K+SDFGL+R+       +          + AP+
Sbjct: 119 LES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPE 174

Query: 265 YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD 324
            ++ G  T+KSDVWSFGV+L+E+ T           +   +LE++++        G  + 
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPG--MSNAEVLEYLKK--------GYRLP 224

Query: 325 PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 364
                        ++ +L   C ++  +DRP  S++VE L
Sbjct: 225 KPPNCP------PELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  163 bits (414), Expect = 2e-47
 Identities = 87/291 (29%), Positives = 137/291 (47%), Gaps = 41/291 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPN 144
           K+GEG FG VYK  +K        + T VA+K L  D   +  K ++ E + +  L HPN
Sbjct: 2   KLGEGAFGEVYKGKLK----GKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPN 57

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-------FPPLPWKTRLHIILG 197
           +V+L+G C  +        LV E+M    L D+L              L  K  L   + 
Sbjct: 58  VVRLLGVCTEEEPL----YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
            A+G+ YL      + ++RD  A N L+ E+   K+SDFGL+R+     +    T     
Sbjct: 114 IAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP 170

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQQYPA 314
             + AP+ ++ G  T+KSDVWSFGV+L+E+ T   +     P    + + +LE++++   
Sbjct: 171 IRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT-----PYPGLSNEEVLEYLRK--- 222

Query: 315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
                G     RL K        ++  L  +C     +DRP  S++VERL+
Sbjct: 223 -----GY----RLPK--PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  160 bits (408), Expect = 5e-47
 Identities = 71/204 (34%), Positives = 104/204 (50%), Gaps = 20/204 (9%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNL 145
           +GEGGFG+VY +  K            VAIK + ++      +  + E++ L  L HPN+
Sbjct: 1   LGEGGFGTVYLARDK-------KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNI 53

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VKL G    +    +    V E+    SL+D L       L     L I+L   EGL YL
Sbjct: 54  VKLYGVFEDENHLYL----VMEYCEGGSLKDLLKEN-EGKLSEDEILRILLQILEGLEYL 108

Query: 206 HEGLEVQVIYRDFKASNVLLDE-NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 264
           H      +I+RD K  N+LLD  N + KL+DFGL++   +     +   +VGT  Y AP+
Sbjct: 109 HS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPE 163

Query: 265 YIE-TGHLTAKSDVWSFGVVLYEM 287
            +   G+ + KSD+WS GV+LYE+
Sbjct: 164 VLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  161 bits (410), Expect = 7e-47
 Identities = 85/282 (30%), Positives = 126/282 (44%), Gaps = 36/282 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHP 143
           K+G G FG+VYK+      G       +VA+K L +     +  +    E++ L  L HP
Sbjct: 6   KLGSGSFGTVYKA-KHKGTGK------IVAVKILKKRSEKSKKDQTARREIRILRRLSHP 58

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
           N+V+LI              LV E+     L D+L      PL       I L    GL 
Sbjct: 59  NIVRLIDAFEDKDHL----YLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLE 112

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH      +I+RD K  N+LLDEN   K++DFGLA++  ++  +   T  VGT  Y AP
Sbjct: 113 YLHS---NGIIHRDLKPENILLDENGVVKIADFGLAKK--LLKSSSSLTTFVGTPWYMAP 167

Query: 264 DYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
           + +  G     K DVWS GV+LYE+LTG +         +Q             +    I
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTG-KPPFSGENILDQL------------QLIRRI 214

Query: 323 MDPRLE--KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
           + P LE  +    + + +   L   CL+K    RP   ++++
Sbjct: 215 LGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  155 bits (394), Expect = 1e-44
 Identities = 76/284 (26%), Positives = 116/284 (40%), Gaps = 46/284 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGH-KQWVAEVQFLGVLEH 142
           K+GEG FG VY             + T  +VAIK + +  ++   ++ + E++ L  L+H
Sbjct: 6   KLGEGSFGKVYL---------ARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKH 56

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           PN+V+L      + +      LV E+     L D L  +    L        +      L
Sbjct: 57  PNIVRLYDVFEDEDKL----YLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSAL 110

Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
            YLH      +++RD K  N+LLDE+   KL+DFGLAR+   +      T  VGT  Y A
Sbjct: 111 EYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFVGTPEYMA 164

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
           P+ +         D+WS GV+LYE+LTG+       P            +P D +   L 
Sbjct: 165 PEVLLGKGYGKAVDIWSLGVILYELLTGK------PP------------FPGDDQLLELF 206

Query: 323 MDPRLEKEYSINEARKIGRLA----DNCLSKSSKDRPKMSQVVE 362
                 K         I   A       L K  + R    + ++
Sbjct: 207 KKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  153 bits (389), Expect = 1e-43
 Identities = 88/286 (30%), Positives = 133/286 (46%), Gaps = 40/286 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
           K+GEG FG VYK ++K   GDG    T VA+K L      +  ++++ E   +  L HPN
Sbjct: 6   KLGEGAFGEVYKGTLK---GDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +V+L+G C     +G    +V E+M    L D L       L  K  L + L  A+G+ Y
Sbjct: 63  IVRLLGVC----TQGEPLYIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIAKGMEY 117

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA--- 261
           L        ++RD  A N L+ EN   K+SDFGL+R+                 G     
Sbjct: 118 LES---KNFVHRDLAARNCLVTENLVVKISDFGLSRD-----IYEDDYYRKRGGGKLPIK 169

Query: 262 --APDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK 318
             AP+ ++ G  T+KSDVWSFGV+L+E+ T G +        + + +LE ++        
Sbjct: 170 WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPG---MSNEEVLELLED------- 219

Query: 319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 364
                  RL +    N   ++  L   C +   +DRP  S++VE L
Sbjct: 220 -----GYRLPR--PENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  129 bits (327), Expect = 7e-35
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 26/214 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKK--LNRDGLQGHKQWVAEVQFLGVLE 141
            +G G FGSVY             + T  ++A+K   L+ D  +  +    E++ L  L+
Sbjct: 7   LLGRGSFGSVYL---------ALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ 57

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT-RLHI--ILGA 198
           HPN+V+  G    D E+     +  E++   SL   L  + F  LP    R +   IL  
Sbjct: 58  HPNIVRYYG-SERDEEKN-TLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQIL-- 111

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
            EGLAYLH      +++RD K +N+L+D +   KL+DFG A+    +     + +V GT 
Sbjct: 112 -EGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
            + AP+ I        +D+WS G  + EM TG+ 
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  128 bits (324), Expect = 3e-34
 Identities = 88/294 (29%), Positives = 139/294 (47%), Gaps = 25/294 (8%)

Query: 83  RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLE 141
            + ++GEG FG V      P  GD T E   VA+K LN  G + H+  +  E++ L  L+
Sbjct: 8   FIKQLGEGHFGKVELCRYDPL-GDNTGE--QVAVKSLNHSGEEQHRSDFEREIEILRTLD 64

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIILGAAE 200
           H N+VK  G C   G R ++  L+ E++ + SL D+L  +R    +  K  L       +
Sbjct: 65  HENIVKYKGVCEKPGGRSLR--LIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICK 120

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG---T 257
           G+ YL      + I+RD  A N+L++     K+SDFGLA+  P     +      G    
Sbjct: 121 GMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE-DKDYYYVKEPGESPI 176

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS 316
           F YA P+ + T   ++ SDVWSFGV LYE+ T G  S     P    R++   Q     +
Sbjct: 177 FWYA-PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS--PPAEFLRMIGIAQGQMIVT 233

Query: 317 KKFGLIMD-PRLEKEYSI-NEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV 368
           +   L+ +  RL +  S  +E   +  L   C     +DRP  + ++  + ++ 
Sbjct: 234 RLLELLKEGERLPRPPSCPDE---VYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  126 bits (319), Expect = 1e-33
 Identities = 68/212 (32%), Positives = 100/212 (47%), Gaps = 18/212 (8%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
            F  + KIG+GGFG VYK+  K            VAIK +  +  +  ++ + E+Q L  
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKR-------TGKEVAIKVIKLESKEKKEKIINEIQILKK 53

Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
            +HPN+VK  G      E  I    V EF    SL+D L       L      ++     
Sbjct: 54  CKHPNIVKYYGSYLKKDELWI----VMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELL 108

Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           +GL YLH      +I+RD KA+N+LL  +   KL DFGL+ +   +  T     +VGT  
Sbjct: 109 KGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQ---LSDTKARNTMVGTPY 162

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           + AP+ I       K+D+WS G+   E+  G+
Sbjct: 163 WMAPEVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  126 bits (318), Expect = 1e-33
 Identities = 74/212 (34%), Positives = 105/212 (49%), Gaps = 28/212 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK--LNRDGLQGHKQWVAEVQFLGVLEHP 143
            IG G FG VYK          T +   VAIK+  L +   +  K  + E+  L  L+HP
Sbjct: 7   LIGRGAFGVVYK-----GLNLETGD--FVAIKQISLEKIKEEALKSIMQEIDLLKNLKHP 59

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP---WKTRLHIILGAAE 200
           N+VK IG         I    + E+  N SL   +  + F P P       ++ +L   +
Sbjct: 60  NIVKYIGSIETSDSLYI----ILEYAENGSLRQII--KKFGPFPESLVAVYVYQVL---Q 110

Query: 201 GLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           GLAYLHE    Q VI+RD KA+N+L  ++   KL+DFG+A +   V       +VVGT  
Sbjct: 111 GLAYLHE----QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPY 164

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           + AP+ IE    +  SD+WS G  + E+LTG 
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  117 bits (296), Expect = 2e-30
 Identities = 68/208 (32%), Positives = 99/208 (47%), Gaps = 27/208 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG+G FG V           G      VA+K L  D     + ++AE   +  L HPNLV
Sbjct: 14  IGKGEFGDVML---------GDYRGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLV 63

Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 206
           +L+G         +   +V E+M   SL D+L +R    +    +L   L   EG+ YL 
Sbjct: 64  QLLGVVLQGN--PL--YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119

Query: 207 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPD 264
           E      ++RD  A NVL+ E+   K+SDFGLA+E    G         G     + AP+
Sbjct: 120 EK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEA-SQGQD------SGKLPVKWTAPE 169

Query: 265 YIETGHLTAKSDVWSFGVVLYEMLT-GR 291
            +     + KSDVWSFG++L+E+ + GR
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  118 bits (295), Expect = 1e-29
 Identities = 88/337 (26%), Positives = 131/337 (38%), Gaps = 44/337 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV---AEVQFLGVL-E 141
           K+GEG FG VY +  +           +VA+K L +      K+      E+Q L  L  
Sbjct: 7   KLGEGSFGEVYLARDRK----------LVALKVLAKKLESKSKEVERFLREIQILASLNH 56

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP-PLPWKTRLHIILGAAE 200
            PN+VKL  +   +G       LV E++   SLED L       PL     L I+     
Sbjct: 57  PPNIVKLYDFFQDEG----SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAR----EGPMVGHTHVSTAVV 255
            L YLH      +I+RD K  N+LLD +    KL DFGLA+     G       + +  V
Sbjct: 113 ALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169

Query: 256 GTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLER-NRPKTEQRLLEWVQQ 311
           GT GY AP+ +      + ++ SD+WS G+ LYE+LTG    E         + L+ + +
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229

Query: 312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS 371
            P  S    L          + ++      L    L+K  K+R   S  +          
Sbjct: 230 LPTPSLASPLSPSNPELISKAASD------LLKKLLAKDPKNRLSSSSDLSHDLLA---- 279

Query: 372 NEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRR 408
                  K  +      P ++   +    PS      
Sbjct: 280 ---HLKLKESDLSDLLKPDDSAPLRLSLPPSLEALIS 313

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  113 bits (286), Expect = 6e-29
 Identities = 71/289 (24%), Positives = 127/289 (43%), Gaps = 39/289 (13%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK--LNRDGLQGHKQWVAEVQFL 137
            +  + +IG+G FG VY    K       S+  +  +K+  L+    +  +  + EV+ L
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRK-------SDGKLYVLKEIDLSNMSEKEREDALNEVKIL 53

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHII 195
             L HPN++K       +  +     +V E+     L   +  +     P P +  L   
Sbjct: 54  KKLNHPNIIKYYE-SFEEKGK---LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF 109

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           +     L YLH     ++++RD K  N+ L  N   KL DFG+++   +     ++  VV
Sbjct: 110 VQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVV 164

Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYPA 314
           GT  Y +P+  +      KSD+WS G VLYE+ T +   E  N  +   ++L+   QYP 
Sbjct: 165 GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--GQYPP 222

Query: 315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 363
                       +  +YS     ++  L  + L K  ++RP ++Q+++ 
Sbjct: 223 ------------IPSQYS----SELRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  110 bits (277), Expect = 1e-27
 Identities = 100/300 (33%), Positives = 143/300 (47%), Gaps = 37/300 (12%)

Query: 83  RMLK----IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFL 137
           R LK    +GEG FG V      PA  DGT E  +VA+K L R+ G Q    W  E+  L
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPA-NDGTGE--MVAVKTLKRECGQQNTSGWKKEINIL 60

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
             L H N+VK  G C+  G +G+Q  L+ E++   SL D+L      P        ++L 
Sbjct: 61  KTLYHENIVKYKGCCSEQGGKGLQ--LIMEYVPLGSLRDYL------PKHKLNLAQLLLF 112

Query: 198 A---AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           A    EG+AYLH       I+RD  A NVLLD +   K+ DFGLA+  P  GH +     
Sbjct: 113 AQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVRE 168

Query: 255 VG---TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 311
            G    F YA  + ++    +  SDVWSFGV LYE+LT   S +    K E+ ++     
Sbjct: 169 DGDSPVFWYA-VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIG---- 222

Query: 312 YPADSKKFGLIMDPRLEKEYSI----NEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
            P   +   + +   LE+   +    N  +++  L  NC    +K RP    ++  LK++
Sbjct: 223 -PKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  109 bits (274), Expect = 2e-27
 Identities = 76/287 (26%), Positives = 128/287 (44%), Gaps = 34/287 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFL 137
           +D   + ++G G  G V K   +P          ++A+K +  +      KQ + E+  L
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTG-------KIMAVKTIRLEINEAIQKQILRELDIL 53

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
                P +V   G    +G+  I      E+M   SL D +       +P +    I + 
Sbjct: 54  HKCNSPYIVGFYGAFYNNGDISI----CMEYMDGGSL-DKILKEVQGRIPERILGKIAVA 108

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
             +GL YLHE    ++I+RD K SN+L++   + KL DFG++ +  +V    ++   VGT
Sbjct: 109 VLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQ--LV--NSLAKTFVGT 162

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL--ERNRPKTEQRLLEWVQQYPAD 315
             Y AP+ I+    + KSD+WS G+ L E+ TGR     E + P     LL+++   P  
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP- 221

Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                    PRL       + +      + CL K  ++RP   +++E
Sbjct: 222 ---------PRLPSGKFSPDFQD---FVNLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 5e-27
 Identities = 78/293 (26%), Positives = 129/293 (44%), Gaps = 49/293 (16%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLNRDGLQGHKQW--VAEVQFLGVLEHP 143
           IG G FG V +  +K        +  + VAIK L + G    ++   + E   +G  +HP
Sbjct: 12  IGGGEFGEVCRGRLKL-----PGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHP 65

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
           N+++L G       +    +++ E+M N SL+  L             + ++ G A G+ 
Sbjct: 66  NIIRLEGVVT----KSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMK 120

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG---- 259
           YL E   +  ++RD  A N+L++ N   K+SDFGL+R          S A   T G    
Sbjct: 121 YLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSR------RLEDSEATYTTKGGKIP 171

Query: 260 --YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS 316
             + AP+ I     T+ SDVWSFG+V++E+++ G R              +   Q    +
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW-----------DMSNQDVIKA 220

Query: 317 KKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV 368
                + D  RL        A  + +L  +C  K   +RP  SQ+V  L +++
Sbjct: 221 -----VEDGYRLPPPMDCPSA--LYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 2e-26
 Identities = 82/292 (28%), Positives = 125/292 (42%), Gaps = 55/292 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPN 144
           KIG+G FG VYK  +K          T VA+K          K+ ++ E + L   +HPN
Sbjct: 2   KIGKGNFGDVYKGVLK--------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPN 53

Query: 145 LVKLIGYCAVDGERGIQR---LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           +VKLIG C        Q+    +V E +   SL   L  +    L  K  L + L AA G
Sbjct: 54  IVKLIGVCV-------QKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAG 105

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---- 257
           + YL        I+RD  A N L+ EN   K+SDFG++RE        + T   G     
Sbjct: 106 MEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREE----EGGIYTVSDGLKQIP 158

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK 317
             + AP+ +  G  T++SDVWS+G++L+E  +   +        + R             
Sbjct: 159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR------------- 205

Query: 318 KFGLIMDPRLEKEYSINEAR----KIGRLADNCLSKSSKDRPKMSQVVERLK 365
                   R+E  Y +   +    +I RL   C +   ++RP  S++   L+
Sbjct: 206 -------ERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 1e-25
 Identities = 73/210 (34%), Positives = 101/210 (48%), Gaps = 24/210 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G FG V+         +GT   T VA+K L + G    + ++ E Q +  L H  L
Sbjct: 13  KLGAGQFGEVWM-----GTWNGT---TKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKL 63

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y     E  I   +V E+M   SL D L +     L     + +    AEG+AYL
Sbjct: 64  VQL--YAVCSEEEPI--YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
                   I+RD  A N+L+ EN   K++DFGLAR    +      TA  G      + A
Sbjct: 120 ES---RNYIHRDLAARNILVGENLVCKIADFGLAR----LIEDDEYTAREGAKFPIKWTA 172

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT-GR 291
           P+    G  T KSDVWSFG++L E++T GR
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  104 bits (261), Expect = 2e-25
 Identities = 70/214 (32%), Positives = 102/214 (47%), Gaps = 25/214 (11%)

Query: 80  DFSRMLKIGEGGFGSVY----KSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQ 135
           +F+   K+G G FG V+    K+ ++            VAIK L  D L   + +  EVQ
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVR------------VAIKILKSDDLLKQQDFQKEVQ 54

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  L H +L+ L   C+V     I    + E M   SL   L +     LP  + + + 
Sbjct: 55  ALKRLRHKHLISLFAVCSVGEPVYI----ITELMEKGSLLAFLRSPEGQVLPVASLIDMA 110

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
              AEG+AYL E      I+RD  A N+L+ E+   K++DFGLAR      +      + 
Sbjct: 111 CQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI- 166

Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
             + + AP+    G  + KSDVWSFG++LYEM T
Sbjct: 167 -PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  103 bits (259), Expect = 2e-25
 Identities = 84/289 (29%), Positives = 136/289 (47%), Gaps = 40/289 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           ++ + + +IG G FG V+             E   VAIK + R+G    + ++ E Q + 
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWL--------EKRKVAIKTI-REGAMSEEDFIEEAQVMM 54

Query: 139 VLEHPNLVKLIGYCAVDGERGIQR---LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L HP LV+L G C        +R    LV+EFM +  L D+L  +       +T L + 
Sbjct: 55  KLSHPKLVQLYGVC-------TERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMC 106

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           L   EG+AYL       VI+RD  A N L+ EN   K+SDFG+ R      +T  ST   
Sbjct: 107 LDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTK 162

Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
               +++P+       ++KSDVWSFGV+++E+ +  ++   NR  +E      V+   A 
Sbjct: 163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV-----VETINAG 217

Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 364
            +    +  PRL        ++ +  L  +C  +  +DRP  S ++ +L
Sbjct: 218 FR----LYKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 2e-25
 Identities = 72/237 (30%), Positives = 104/237 (43%), Gaps = 30/237 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV---AEVQFLGVLEHP 143
           +G+G FG V     K           + A+K L +  +   K+      E   L  + HP
Sbjct: 1   LGKGSFGKVLLVRKK-------DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHP 53

Query: 144 NLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE-- 200
            +VKL  + A   E    +L LV E+     L  HL            R +    AAE  
Sbjct: 54  FIVKL--HYAFQTEE---KLYLVLEYAPGGELFSHLSKEGRFSEER-ARFY----AAEIV 103

Query: 201 -GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
             L YLH    + +IYRD K  N+LLD +   KL+DFGLA+E    G    +    GT  
Sbjct: 104 LALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPE 158

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYPAD 315
           Y AP+ +         D WS GV+LYEMLTG+      +R +  +++L+   ++P  
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEF 215

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  103 bits (258), Expect = 3e-25
 Identities = 62/206 (30%), Positives = 90/206 (43%), Gaps = 14/206 (6%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPN 144
           K+G+G FG V +     + G        VA+K L  D L      ++ E   +  L+H N
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIP----VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHEN 57

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           L++L G            ++V E     SL D L   A       T     +  A G+ Y
Sbjct: 58  LIRLYGVVLTH-----PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRY 112

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT-FGYAAP 263
           L      + I+RD  A N+LL  + + K+ DFGL R  P     +V    +   F + AP
Sbjct: 113 LESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169

Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLT 289
           + + T   +  SDVW FGV L+EM T
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  102 bits (257), Expect = 5e-25
 Identities = 78/290 (26%), Positives = 139/290 (47%), Gaps = 47/290 (16%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA--EVQFL 137
           DF  + KIG+G FG V+K   K       ++  V A+K+++   +   ++  A  E + L
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRK-------ADKRVYAMKQIDLSKMNRREREEAIDEARVL 53

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLP----WKTRL 192
             L+   +++      +D      +L +V E+  N  L   L  +   PLP    W+  +
Sbjct: 54  AKLDSSYIIRYYE-SFLDK----GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI 108

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+LG    LA+LH     ++++RD K+ N+ LD     K+ D G+A+   +  +T+ + 
Sbjct: 109 QILLG----LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFAN 159

Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQ 311
            +VGT  Y +P+  E      KSDVW+ GVVLYE  TG+   +  N+     +++  V  
Sbjct: 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-- 217

Query: 312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 361
           +P  S+ +                ++++ +L D CL+K  + RP   Q++
Sbjct: 218 FPPVSQMY----------------SQQLAQLIDQCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  101 bits (255), Expect = 2e-24
 Identities = 70/221 (31%), Positives = 113/221 (51%), Gaps = 35/221 (15%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKL----NRDGLQGHKQWVAEV 134
           + ++ K+GEG +G VYK            + T  +VA+KK+      +G+      + E+
Sbjct: 1   YEKLEKLGEGTYGVVYK---------ARDKKTGEIVALKKIRLDNEEEGIP--STALREI 49

Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
             L  L+HPN+VKL+       ER +   LV+E+  +  L+ +L ++   PL       I
Sbjct: 50  SLLKELKHPNIVKLLDVIH--TERKL--YLVFEYC-DMDLKKYL-DKRPGPLSPNLIKSI 103

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVST 252
           +     GLAY H     ++++RD K  N+L++ +   KL+DFGLAR    P+  +TH   
Sbjct: 104 MYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE-- 158

Query: 253 AVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGR 291
            VV T  Y AP+ +     + TA  D+WS G +  EM+TG+
Sbjct: 159 -VV-TLWYRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 7e-24
 Identities = 74/211 (35%), Positives = 104/211 (49%), Gaps = 26/211 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G FG V++        + T   T VA+K L + G    K ++AE Q +  L HP L
Sbjct: 13  KLGAGQFGEVWE-----GLWNNT---TPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKL 63

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           ++L   C +  E  I   +V E M   SL ++L   A   L     + +    A G+AYL
Sbjct: 64  IQLYAVCTL--EEPI--YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119

Query: 206 HEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
               E Q  I+RD  A NVL+ EN   K++DFGLAR    V    +  A  G      + 
Sbjct: 120 ----EAQNYIHRDLAARNVLVGENNICKVADFGLAR----VIKEDIYEAREGAKFPIKWT 171

Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLT-GR 291
           AP+       + KSDVWSFG++L E++T GR
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 69/240 (28%), Positives = 113/240 (47%), Gaps = 27/240 (11%)

Query: 83  RMLKI-GEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVL 140
             +K+ G G FG+VYK    P   +G      VAIK L  +   + +K+ + E   +  +
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIP---EGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN-----RAFPPLPWKTRLHII 195
           +HP++V+L+G C        Q  L+ + M    L D++ N      +   L W  ++   
Sbjct: 67  DHPHVVRLLGICL-----SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI--- 118

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G++YL E    ++++RD  A NVL+      K++DFGLA+         H     
Sbjct: 119 ---AKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGK 172

Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYP 313
           V    + A + I     T KSDVWS+GV ++E++T G +  E         LLE  ++ P
Sbjct: 173 V-PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLP 231

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 82/285 (28%), Positives = 125/285 (43%), Gaps = 37/285 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFL 137
           +D  R+  +G+G  G VYK   KP     T +  + A+KK++ DG  +  KQ + E++ L
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKP-----TGK--IYALKKIHVDGDEEFRKQLLRELKTL 53

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIIL 196
              E P +VK   Y A   E  I   +V E+M   SL D L      P          IL
Sbjct: 54  RSCESPYVVKC--YGAFYKEGEIS--IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQIL 109

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVSTAV 254
              +GL YLH      +I+RD K SN+L++     K++DFG+++  E  +      +T V
Sbjct: 110 ---KGLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC---NTFV 161

Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 314
            GT  Y +P+ I+    +  +D+WS G+ L E   G+         +   L++ +   P 
Sbjct: 162 -GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP 220

Query: 315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
                     P L  E    E R        CL K  K RP  ++
Sbjct: 221 ----------PSLPAEEFSPEFRDF---ISACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 70/217 (32%), Positives = 104/217 (47%), Gaps = 27/217 (12%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           + ++ KIGEG +G VYK     A    T E  +VAIKK+      +G  K  + E++ L 
Sbjct: 1   YQKLGKIGEGTYGVVYK-----ARDKLTGE--IVAIKKIKLRFESEGIPKTALREIKLLK 53

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
            L HPN++KL+    V   +G   L LV+EFM        L       LP       +  
Sbjct: 54  ELNHPNIIKLL---DVFRHKG--DLYLVFEFMDTDLY--KLIKDRQRGLPESLIKSYLYQ 106

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVV 255
             +GLA+ H      +++RD K  N+L++     KL+DFGLAR    P+  +TH     V
Sbjct: 107 LLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH----YV 159

Query: 256 GTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGR 291
            T  Y AP+ +      +   D+WS G +  E+L+ R
Sbjct: 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 67/211 (31%), Positives = 90/211 (42%), Gaps = 28/211 (13%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQGHKQWVAEVQFLGVLE 141
           +G GGFG V    +K        +    A+K + +      G Q H    +E + L    
Sbjct: 1   LGVGGFGRVELVKVKS-------KNRTFALKCVKKRHIVETGQQEHIF--SEKEILEECN 51

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAE 200
           HP +VKL  Y     ++ I  L+  E+ L   L   L +R  F    +  R   I     
Sbjct: 52  HPFIVKL--YRTFKDKKYIYMLM--EYCLGGELWTILRDRGLFDE--YTARF-YIACVVL 104

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
              YLH      +IYRD K  N+LLD N   KL DFG A++      T       GT  Y
Sbjct: 105 AFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEY 158

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+ I         D WS G++LYE+LTGR
Sbjct: 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 74/291 (25%), Positives = 120/291 (41%), Gaps = 33/291 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFL 137
                + ++GEG  GSV K  +K           + A+K +  D      KQ + E++  
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTG-------MIFALKTITTDPNPDLQKQILRELEIN 53

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
              + P +VK  G    +    I   +  E+    SL D ++ +       +    ++  
Sbjct: 54  KSCKSPYIVKYYGAFLDESSSSIG--IAMEYCEGGSL-DSIYKKVKK-RGGRIGEKVLGK 109

Query: 198 AAE----GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            AE    GL+YLH     ++I+RD K SN+LL    + KL DFG++  G +V    ++  
Sbjct: 110 IAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS--GELV--NSLAGT 162

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL--LEWVQQ 311
             GT  Y AP+ I+    +  SDVWS G+ L E+   R       P+ E  L  +E +  
Sbjct: 163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLGPIELL-S 218

Query: 312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
           Y  +     L  +P       I  + +       CL K    RP    ++E
Sbjct: 219 YIVNMPNPELKDEP----GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 2e-22
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 66/301 (21%)

Query: 80  DFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQ 135
           + + + ++G G FG V    ++  I             VAIK + R+G      ++ E +
Sbjct: 5   ELTFLKELGSGQFGVVHLGKWRGKID------------VAIKMI-REGAMSEDDFIEEAK 51

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            +  L HPNLV+L G C    +R I   +V E+M N  L ++L  R       K     +
Sbjct: 52  VMMKLSHPNLVQLYGVCT--KQRPI--FIVTEYMANGCLLNYLRER-----KGKLGTEWL 102

Query: 196 LGAA----EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV- 250
           L       E + YL        I+RD  A N L+ E+   K+SDFGLAR        +V 
Sbjct: 103 LDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLAR--------YVL 151

Query: 251 ---STAVVGT---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR 304
               T+  GT     +A P+  +    ++KSDVWSFGV+++E+ +  +        +E  
Sbjct: 152 DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-- 209

Query: 305 LLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 363
           ++E V          G  +  P+L          ++  +  +C  +  +DRP   +++ +
Sbjct: 210 VVESVSA--------GYRLYRPKL-------APTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254

Query: 364 L 364
           L
Sbjct: 255 L 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 77/293 (26%), Positives = 122/293 (41%), Gaps = 44/293 (15%)

Query: 87  IGEGGFGSVYK---SSIKPAAGDGTSEATVVAIKKLN-RDGLQGHKQWVAEVQFLGVLEH 142
           +G+G FG VY+     +     +       VAIK +N    ++   +++ E   +     
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETR-----VAIKTVNENASMRERIEFLNEASVMKEFNC 68

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-----NRAFPPLPWKTRLHIILG 197
            ++V+L+G  +     G   L+V E M    L+ +L          P L   T    I  
Sbjct: 69  HHVVRLLGVVS----TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124

Query: 198 AAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           AAE   G+AYL      + ++RD  A N ++ E+   K+ DFG+ R+     +       
Sbjct: 125 AAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKG 181

Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 314
           +    + AP+ ++ G  T KSDVWSFGVVL+EM T               L E  Q Y  
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAE--QPYQG 224

Query: 315 DSKK--FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
            S +     ++D     +   N   K+  L   C   + K RP   ++V  LK
Sbjct: 225 LSNEEVLKFVIDGGH-LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 94.3 bits (235), Expect = 5e-22
 Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 16/205 (7%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNL 145
           +G G FGSV K      +G    E  V A+K L ++ +   K+ ++ E   +  L+HP +
Sbjct: 3   LGHGNFGSVVKGVYLMKSG---KEVEV-AVKTLKQEHIAAGKKEFLREASVMAQLDHPCI 58

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+LIG C     +G   +LV E      L  +L  R    +P      +    A G+AYL
Sbjct: 59  VRLIGVC-----KGEPLMLVMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYL 111

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVVGTFGYAAPD 264
                   ++RD  A NVLL    + K+SDFG++R  G    +   +TA      + AP+
Sbjct: 112 ES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE 168

Query: 265 YIETGHLTAKSDVWSFGVVLYEMLT 289
            I  G  ++KSDVWS+GV L+E  +
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 94.8 bits (236), Expect = 5e-22
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 14/206 (6%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G+G FGSV      P   D T E  VVA+KKL     +  + +  E++ L  L+H N+V
Sbjct: 12  LGKGNFGSVELCRYDPL-QDNTGE--VVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKTRLHIILGAAEGLAYL 205
           K  G C   G R ++  LV E++   SL D+L  +R    L  +  L       +G+ YL
Sbjct: 69  KYKGVCYSAGRRNLR--LVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYL 124

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST--AVVGTFGYAAP 263
                 + ++RD    N+L++   R K+ DFGL +  P     +          F YA P
Sbjct: 125 GS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-P 180

Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLT 289
           + +     +  SDVWSFGVVLYE+ T
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 95.1 bits (237), Expect = 5e-22
 Identities = 80/297 (26%), Positives = 132/297 (44%), Gaps = 40/297 (13%)

Query: 86  KIGEGGFGSVY---------KSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQ 135
           K+GEG FG V+          S    A  D      +VA+K L  D     ++ ++ EV+
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLF-----NRAFPPL 186
            L  L  PN+ +L+G C VD    +    + E+M    LN+ L+ H+            L
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCM----IMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 187 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            + T L++    A G+ YL     +  ++RD    N L+ +N+  K++DFG++R      
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 247 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK---TEQ 303
           +  V         + A + +  G  T KSDVW+FGV L+E+LT    L R +P    T+Q
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT----LCREQPYEHLTDQ 240

Query: 304 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
           +++E    +  D  +   +  P        N  + I  L   C  +  +DRP   ++
Sbjct: 241 QVIENAGHFFRDDGRQIYLPRPP-------NCPKDIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 94.9 bits (237), Expect = 5e-22
 Identities = 69/242 (28%), Positives = 108/242 (44%), Gaps = 45/242 (18%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----RDGLQGHKQWVAEVQF 136
           + ++ +IGEG +G VYK      A +  +   +VA+KK+     ++G       + E++ 
Sbjct: 1   YEKIAQIGEGTYGQVYK------ARNKKTGE-LVALKKIRMENEKEGFP--ITAIREIKL 51

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLH 193
           L  L HPN+V+L       G+  I   +V+E+M   L   L+          +  K  + 
Sbjct: 52  LQKLRHPNIVRLKEIVTSKGKGSI--YMVFEYMDHDLTGLLDSPEVKFTESQI--KCYMK 107

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS-T 252
            +L   EGL YLH      +++RD K SN+L++ +   KL+DFGLAR  P         T
Sbjct: 108 QLL---EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR--PYTKRNSADYT 159

Query: 253 AVVGTFGYAAP-------DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
             V T  Y  P        Y        + D+WS G +L E+  G+      +  TE   
Sbjct: 160 NRVITLWYRPPELLLGATRY------GPEVDMWSVGCILAELFLGKPIF---QGSTELEQ 210

Query: 306 LE 307
           LE
Sbjct: 211 LE 212

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 94.8 bits (236), Expect = 6e-22
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 22/216 (10%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNL 145
           +GEG FG V+         +   +  +VA+K L         K +  E + L   +H N+
Sbjct: 13  LGEGAFGKVFLGECYHLEPEN--DKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 146 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDH--LFNRAFPPLPWKTRL------H 193
           VK  G C      G   ++V+E+M    LN+ L  H         P      L       
Sbjct: 71  VKFYGVCT----EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
           I +  A G+ YL        ++RD    N L+  +   K+ DFG++R+     +  V   
Sbjct: 127 IAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGH 183

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            +    +  P+ I     T +SDVWSFGVVL+E+ T
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 94.1 bits (234), Expect = 7e-22
 Identities = 74/228 (32%), Positives = 108/228 (47%), Gaps = 37/228 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G FG V+               T VAIK L + G    + ++AE   +  L+HP L
Sbjct: 13  KLGAGQFGEVWMGYYN--------GHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRL 63

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y  V  E      ++ E+M N SL D L       L     + +    AEG+A++
Sbjct: 64  VRL--YAVVTQE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
                   I+RD +A+N+L+ E    K++DFGLAR    +   +  TA  G      + A
Sbjct: 119 ER---KNYIHRDLRAANILVSETLCCKIADFGLAR----LIEDNEYTAREGAKFPIKWTA 171

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT-GR------------RSLERN 297
           P+ I  G  T KSDVWSFG++L E++T GR            ++LER 
Sbjct: 172 PEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG 219

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 94.2 bits (235), Expect = 8e-22
 Identities = 65/239 (27%), Positives = 99/239 (41%), Gaps = 46/239 (19%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK--QWVA-EVQ 135
           +DF     IGEG F +V  +  K             AIK L++  L   K  ++V  E +
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEK-------ETNKEYAIKILDKRQLIKEKKVKYVKIEKE 53

Query: 136 FLGVLE-HPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
            L  L  HP ++KL  Y   D E     L  V E+  N  L  ++  R +  L  K    
Sbjct: 54  VLTRLNGHPGIIKLY-YTFQDEEN----LYFVLEYAPNGELLQYI--RKYGSLDEKCTRF 106

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
                   L YLH      +I+RD K  N+LLD++   K++DFG A+   ++       +
Sbjct: 107 YAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAK---VLDPNSSPES 160

Query: 254 V---------------------VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
                                 VGT  Y +P+ +        SD+W+ G ++Y+MLTG+
Sbjct: 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.0 bits (234), Expect = 9e-22
 Identities = 82/297 (27%), Positives = 130/297 (43%), Gaps = 47/297 (15%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFL 137
           +D+  +  IG G    VY +   P      +E   VAIK+++ +  Q    +   EVQ +
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLP-----NNE--KVAIKRIDLEKCQTSVDELRKEVQAM 53

Query: 138 GVLEHPNLVKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP--LPWKTRLHI 194
               HPN+VK   Y + V G+   +  LV  ++   SL D +   ++P   L       +
Sbjct: 54  SQCNHPNVVKY--YTSFVVGD---ELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATV 107

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVST 252
           +    +GL YLH       I+RD KA N+LL E+   K++DFG++            V  
Sbjct: 108 LKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK 164

Query: 253 AVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 311
             VGT  + AP+ +E  H    K+D+WSFG+   E+ TG     +  P   + L+  +Q 
Sbjct: 165 TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTLQN 222

Query: 312 YP------ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
            P      AD KK+         K +     RK   +   CL K    RP   ++++
Sbjct: 223 DPPSLETGADYKKYS--------KSF-----RK---MISLCLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 81/218 (37%), Positives = 109/218 (50%), Gaps = 38/218 (17%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQFL 137
           F+ + +IG G FG+VY      A    T+E  VVAIKK++  G Q +++W   + EV+FL
Sbjct: 17  FTDLREIGHGSFGAVYF-----ARDVRTNE--VVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS---LEDHLFNRAFPPLPWKTRLHI 194
             L HPN ++  G C +   R     LV E+ L  +   LE H       PL       I
Sbjct: 70  QQLRHPNTIEYKG-CYL---REHTAWLVMEYCLGSASDILEVHK-----KPLQEVEIAAI 120

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA- 253
             GA +GLAYLH     + I+RD KA N+LL E    KL+DFG A        + VS A 
Sbjct: 121 CHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSA--------SLVSPAN 169

Query: 254 -VVGTFGYAAPDYI---ETGHLTAKSDVWSFGVVLYEM 287
             VGT  + AP+ I   + G    K DVWS G+   E+
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 22/207 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G +G VY+   K         +  VA+K L  D ++   +++ E   +  ++HPNL
Sbjct: 13  KLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 64

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L+G C  +    I    + EFM   +L D+L       +     L++    +  + YL
Sbjct: 65  VQLLGVCTREPPFYI----ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            +      I+RD  A N L+ EN   K++DFGL+R   M G T+  TA  G      + A
Sbjct: 121 EKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTY--TAHAGAKFPIKWTA 173

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT 289
           P+ +     + KSDVW+FGV+L+E+ T
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 93.4 bits (232), Expect = 2e-21
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 32/225 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPN 144
           IG+G FG V+++    A G       T+VA+K L  +        +  E   +   +HPN
Sbjct: 13  IGQGAFGRVFQAR---APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA--------------------FP 184
           +VKL+G CAV    G    L++E+M    L + L +R+                      
Sbjct: 70  IVKLLGVCAV----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125

Query: 185 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           PL    +L I    A G+AYL E    + ++RD    N L+ EN   K++DFGL+R    
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182

Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
             +   S        +  P+ I     T +SDVW++GVVL+E+ +
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 92.7 bits (230), Expect = 2e-21
 Identities = 83/287 (28%), Positives = 131/287 (45%), Gaps = 44/287 (15%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL---NRDGLQGHKQWVA---EVQFLGVL 140
           +G+G +G+VY           T++  ++A+K++     + L   K++     EV  L  L
Sbjct: 8   LGKGAYGTVYCGL--------TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           +H N+V+ +G C  D    I      EF+   S+   L NR F PLP            +
Sbjct: 60  KHVNIVQYLGTCLDDNTISI----FMEFVPGGSISSIL-NR-FGPLPEPVFCKYTKQILD 113

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG----HTHVSTAVVG 256
           G+AYLH      V++RD K +NV+L  N   KL DFG AR    VG    H+++  ++ G
Sbjct: 114 GVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170

Query: 257 TFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
           T  + AP+ I E+G+   KSD+WS G  ++EM TG+  L              +      
Sbjct: 171 TPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDR---------LAAMFYI 220

Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
               GL+  PRL   +S            +CL++   +RP   Q++ 
Sbjct: 221 GAHRGLM--PRLPDSFSAAAI----DFVTSCLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 70/298 (23%), Positives = 128/298 (42%), Gaps = 52/298 (17%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK--QWVAEVQFL 137
           D+  +  IG+G FG+V K   K    DG     ++  K+++   +   +  Q V+EV  L
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKS---DGK----ILVWKEIDYGNMTEKEKQQLVSEVNIL 53

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRL-LVYEF--------MLNRSLEDHLFNRAFP-PLP 187
             L+HPN+V+   Y     +R  Q L +V E+        ++ +  ++  +         
Sbjct: 54  RELKHPNIVR---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY---IEEEFI 107

Query: 188 WKTRLHIILGAAEGLAYLHEGLEV--QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 245
           W+    ++L     L   H   +    V++RD K +N+ LD N   KL DFGLA+   ++
Sbjct: 108 WRILTQLLLA----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK---IL 160

Query: 246 GHTHVSTAV-VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR 304
           GH        VGT  Y +P+ +       KSD+WS G ++YE+            + + +
Sbjct: 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQ 217

Query: 305 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
           L   +++        G     R+   YS     ++  +  + L+     RP   ++++
Sbjct: 218 LASKIKE--------GKF--RRIPYRYS----SELNEVIKSMLNVDPDKRPSTEELLQ 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 92.4 bits (230), Expect = 4e-21
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 38/218 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----RDGLQGHKQWVAEVQFLGVLE 141
           +IGEG  G V+K+  +      T E   VA+KK+       G+    Q + E++ L   +
Sbjct: 7   RIGEGAHGIVFKAKDR-----ETGE--TVALKKVALRRLEGGIP--NQALREIKALQACQ 57

Query: 142 HPNLVKLIGYCAV--DGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILG 197
           HP +VKL+    V   G   +   LV E+M    L + L +  R  P    K+ + ++L 
Sbjct: 58  HPYVVKLL---DVFPHGSGFV---LVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLL- 109

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAV 254
             +G+AY+H      +++RD K +N+L+  +   K++DFGLAR   E     ++H     
Sbjct: 110 --KGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH----Q 160

Query: 255 VGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           V T  Y AP+ +          D+W+ G +  E+L G 
Sbjct: 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 92.2 bits (229), Expect = 5e-21
 Identities = 71/231 (30%), Positives = 121/231 (52%), Gaps = 25/231 (10%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGV 139
           F ++ K+GEG + +VYK       G   +   +VA+K+++ D  +G     + E+  +  
Sbjct: 2   FKQLEKLGEGTYATVYK-------GRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKE 54

Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           L+H N+V+L  +  +  E  +  +LV+E+M   L + ++ H    A  P   K+  + +L
Sbjct: 55  LKHENIVRL--HDVIHTENKL--MLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLL 110

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
              +G+A+ HE    +V++RD K  N+L+++    KL+DFGLAR   +  +T  S  VV 
Sbjct: 111 ---KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV- 162

Query: 257 TFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 306
           T  Y APD +      + S D+WS G ++ EM+TG R L       +Q L 
Sbjct: 163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLLK 212

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 90.9 bits (225), Expect = 1e-20
 Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 23/207 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G FG V+            + +T VA+K L + G    + ++ E   +  L+H  L
Sbjct: 13  KLGAGQFGEVWMGYY--------NNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKL 63

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y  V  E  I   ++ E+M   SL D L +     +     +      AEG+AY+
Sbjct: 64  VRL--YAVVTKEEPI--YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
                   I+RD +A+NVL+ E+   K++DFGLAR    V   +  TA  G      + A
Sbjct: 120 ERK---NYIHRDLRAANVLVSESLMCKIADFGLAR----VIEDNEYTAREGAKFPIKWTA 172

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT 289
           P+ I  G  T KSDVWSFG++LYE++T
Sbjct: 173 PEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 70/223 (31%), Positives = 104/223 (46%), Gaps = 41/223 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK--KLNRDGLQGHKQWVAEVQFLGVLEHP 143
           KIG G FG VY                ++A+K  ++  +  +  K+   E++ L +L+HP
Sbjct: 7   KIGGGTFGKVY-------TAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHP 59

Query: 144 NLVKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFN-RAFPPLPWKTRLHIILGAAEG 201
           NLVK   Y  V+  R  +++ ++ E+    +LE+ L + R       +     +L   EG
Sbjct: 60  NLVK---YYGVEVHR--EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL---EG 111

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA--------REGPMVGHTHVSTA 253
           LAYLH      +++RD K +N+ LD N   KL DFG A          G  V        
Sbjct: 112 LAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL----- 163

Query: 254 VVGTFGYAAPDYI----ETGHLTAKSDVWSFGVVLYEMLTGRR 292
             GT  Y AP+ I      GH  A +D+WS G V+ EM TG+R
Sbjct: 164 -AGTPAYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 74/224 (33%), Positives = 114/224 (50%), Gaps = 35/224 (15%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQF 136
           F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+      + E+  
Sbjct: 2   FQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTA--IREISL 52

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW---KTRLH 193
           L  L HPN+VKL+    +  E  +   LV+EF L++ L+  +       +P    K+ L 
Sbjct: 53  LKELNHPNIVKLLD--VIHTENKL--YLVFEF-LHQDLKKFMDASPLSGIPLPLIKSYLF 107

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVS 251
            +L   +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH  
Sbjct: 108 QLL---QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-- 159

Query: 252 TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
              V T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 160 --EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 89.9 bits (223), Expect = 2e-20
 Identities = 81/290 (27%), Positives = 135/290 (46%), Gaps = 40/290 (13%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH--KQWVAEVQFLGVLEHPN 144
           IG G FG V +  +K     G  E  V AIK L + G      + +++E   +G  +HPN
Sbjct: 12  IGAGEFGEVCRGRLKLP---GKREIFV-AIKTL-KSGYTEKQRRDFLSEASIMGQFDHPN 66

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGL 202
           ++ L G   V   R +  +++ EFM N +L+  L      F  +     + ++ G A G+
Sbjct: 67  IIHLEG--VVTKSRPV--MIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGIAAGM 119

Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG---TFG 259
            YL E   +  ++RD  A N+L++ N   K+SDFGL+R           T+ +G      
Sbjct: 120 KYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK 318
           + AP+ I     T+ SDVWS+G+V++E+++ G R        + Q ++  ++Q       
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---WDMSNQDVINAIEQ------- 226

Query: 319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV 368
                D RL        A  + +L  +C  K    RPK  Q+V  L +++
Sbjct: 227 -----DYRLPPPMDCPTA--LHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 88.9 bits (220), Expect = 3e-20
 Identities = 81/286 (28%), Positives = 133/286 (46%), Gaps = 48/286 (16%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK-QWVAEVQFLGVLEHPNL 145
           +G+G FG V+K ++K        + T VA+K    D  Q  K ++++E + L   +HPN+
Sbjct: 3   LGKGNFGEVFKGTLK--------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNI 54

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEGLA 203
           VKLIG C        QR  +Y  M      D L    +    L  K  +   L AA G+A
Sbjct: 55  VKLIGVCT-------QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMA 107

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT-FGYAA 262
           YL        I+RD  A N L+ EN   K+SDFG++R+       + S+ +      + A
Sbjct: 108 YLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQED--DGIYSSSGLKQIPIKWTA 162

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
           P+ +  G  +++SDVWS+G++L+E      SL              V  YP  + +    
Sbjct: 163 PEALNYGRYSSESDVWSYGILLWETF----SLG-------------VCPYPGMTNQQA-- 203

Query: 323 MDPRLEKEYSINEARK----IGRLADNCLSKSSKDRPKMSQVVERL 364
              ++EK Y ++  +K    + ++   C     ++RPK S++ + L
Sbjct: 204 -REQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 88.9 bits (221), Expect = 4e-20
 Identities = 66/228 (28%), Positives = 103/228 (45%), Gaps = 49/228 (21%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
             F  + K+GEG +GSVYK+  K           VVAIK +  +     ++ + E+  L 
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETG-------QVVAIKVVPVEE--DLQEIIKEISILK 53

Query: 139 VLEHPNLVKLIG-------------YCAVDGERGIQRLLVYEFMLNRSL-EDHLFNRAFP 184
             + P +VK  G             YC       I +      + N++L E+ +   A  
Sbjct: 54  QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK------ITNKTLTEEEI---AA- 103

Query: 185 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
                    I+    +GL YLH     + I+RD KA N+LL+E  + KL+DFG++  G +
Sbjct: 104 ---------ILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVS--GQL 149

Query: 245 VGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
                    V+GT  + AP+ I E G+   K+D+WS G+   EM  G+
Sbjct: 150 TDTMAKRNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 89.4 bits (222), Expect = 5e-20
 Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 26/220 (11%)

Query: 84  MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEH 142
           + ++GEG FG VYK  +          AT VAIK L  +   +  +++  E + +  L+H
Sbjct: 10  LEELGEGAFGKVYKGELTGPNER--LSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP---------------PLP 187
           PN+V L+G C  +        +++E++ +  L + L   + P                L 
Sbjct: 68  PNIVCLLGVCTKE----QPTCMLFEYLAHGDLHEFLVRNS-PHSDVGAESGDETVKSSLD 122

Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
               LHI +  A G+ YL        ++RD  A N L+ E    K+SDFGL+R+     +
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179

Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEM 287
             V +  +    +  P+ I  G  T +SD+WSFGVVL+E+
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 89.8 bits (222), Expect = 5e-20
 Identities = 88/290 (30%), Positives = 133/290 (45%), Gaps = 44/290 (15%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQFL 137
           F+ + +IG G FG+VY      A    T+E  VVAIKK++  G Q +++W   + EV+FL
Sbjct: 27  FTDLREIGHGSFGAVYF-----ARDVRTNE--VVAIKKMSYSGKQSNEKWQDIIKEVKFL 79

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
             ++HPN ++  G C +   R     LV E+ L  + +  L      PL       I  G
Sbjct: 80  QRIKHPNSIEYKG-CYL---REHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHG 133

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
           A +GLAYLH      +I+RD KA N+LL E  + KL+DFG A           + + VGT
Sbjct: 134 ALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGT 184

Query: 258 FGYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 314
             + AP+ I   + G    K DVWS G+   E+       ER  P      +  +     
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMSALYHIAQ 238

Query: 315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 364
           +         P L+     +  R      D+CL K  +DRP   ++++ +
Sbjct: 239 NES-------PTLQSNEWSDYFRN---FVDSCLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 88.8 bits (220), Expect = 6e-20
 Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 19/214 (8%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNL 145
           +G G FG VY+ +     G G+    V A+K L +    Q  K+++ E   +    HPN+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRV-AVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 146 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPP-LPWKTRLHIILGAAE 200
           VKL+G C +  E    + ++ E M    L   L D    R  PP L  K  L I L  A+
Sbjct: 62  VKLLGVC-LLNE---PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDEN--FRP---KLSDFGLAREGPMVGHTHVSTAVV 255
           G  YL +   +  I+RD  A N L+ E         K+ DFGLAR+     +       +
Sbjct: 118 GCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
               + AP+ +  G  T +SDVWSFGV+++E+LT
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 88.5 bits (220), Expect = 7e-20
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 31/216 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH---KQWVAEVQFLGVLEHP 143
           I +G +G V+  + K + GD      + AIK + +  +       Q + E   L   + P
Sbjct: 1   ISKGAYGRVF-LAKKKSTGD------IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSP 53

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLN---RSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
            +VKL  Y +  G++ +   LV E++      SL +++ +     L        I     
Sbjct: 54  YVVKL--YYSFQGKKNL--YLVMEYLPGGDLASLLENVGS-----LDEDVARIYIAEIVL 104

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA------V 254
            L YLH      +I+RD K  N+L+D N   KL+DFGL++ G +    +++        +
Sbjct: 105 ALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161

Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           VGT  Y AP+ I     +   D WS G +LYE L G
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 88.0 bits (218), Expect = 9e-20
 Identities = 73/285 (25%), Positives = 130/285 (45%), Gaps = 39/285 (13%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA--EVQFLG 138
           + ++  +G G FG V+            ++  +V IK++  + +   ++  A  E Q L 
Sbjct: 2   YEKIRVVGRGAFGIVHLCR-------RKADQKLVIIKQIPVEQMTKDERLAAQNECQVLK 54

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
           +L HPN+++       D    I    V E+    +L +++  R    L   T LH  +  
Sbjct: 55  LLSHPNIIEYYENFLEDKALMI----VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI 110

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
              L ++H  L   +++RD K  N+LLD++    K+ DFG+++    +     +  VVGT
Sbjct: 111 LLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGT 164

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYPADS 316
             Y +P+  E      KSD+W+ G VLYE+ + +R+ E  N P    +++         S
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM---------S 215

Query: 317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 361
             F  I D      YS  + R   +L  + L+     RP++SQ++
Sbjct: 216 GTFAPISD-----RYS-PDLR---QLILSMLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 88.3 bits (219), Expect = 9e-20
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH--KQWVAEVQFLGVLEHPN 144
           +GEG FGSV +  +     DG+     VA+K +  D       +++++E   +   +HPN
Sbjct: 7   LGEGEFGSVMEGQLS--QDDGSQLK--VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62

Query: 145 LVKLIGYC--AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK----TRLHIILGA 198
           ++KLIG C  A   ++  + +++  FM +  L   L       LP K    T L  ++  
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE---GPMVGHTHVSTAVV 255
           A G+ YL        I+RD  A N +L E+    ++DFGL+++   G       ++   V
Sbjct: 123 ALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
               + A + +     T+KSDVW+FGV ++E+ T
Sbjct: 180 K---WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 69/224 (30%), Positives = 98/224 (43%), Gaps = 46/224 (20%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK--LNRDGLQGHKQWVAEVQFLG 138
           +  + KIGEG  G VYK+    A G        VAIKK  L +   +       E+  + 
Sbjct: 21  YKNLEKIGEGASGEVYKA-TDRATGK------EVAIKKMRLRKQNKELIIN---EILIMK 70

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI--- 194
             +HPN+V       V  E     L +V E+M   SL D +  + F  +       I   
Sbjct: 71  DCKHPNIVDYYDSYLVGDE-----LWVVMEYMDGGSLTD-IITQNFVRM---NEPQIAYV 121

Query: 195 ---ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA----REGPMVGH 247
              +L   +GL YLH      VI+RD K+ N+LL ++   KL+DFG A    +E      
Sbjct: 122 CREVL---QGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--- 172

Query: 248 THVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTG 290
                +VVGT  + AP+ I        K D+WS G++  EM  G
Sbjct: 173 ---RNSVVGTPYWMAPEVI-KRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 69/240 (28%), Positives = 107/240 (44%), Gaps = 31/240 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHP 143
           +G+GGFG V    +K       +   + A KKL++  L   +G +  + E + L  +   
Sbjct: 1   LGKGGFGEVCACQVK-------ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR 53

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE--- 200
            +V L    A   E      LV   M    L+ H++N   P  P       I  AA+   
Sbjct: 54  FIVSL----AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP---EARAIFYAAQIIC 106

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           GL +LH+    +++YRD K  NVLLD++   ++SD GLA E              GT GY
Sbjct: 107 GLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---GRAGTPGY 160

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR-----RSLERNRPKTEQRLLEWVQQYPAD 315
            AP+ ++        D ++ G  LYEM+ GR     R  +  + + ++R LE   +YP  
Sbjct: 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK 220

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 62/214 (28%), Positives = 89/214 (41%), Gaps = 32/214 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR---DGLQGHKQWVAEVQFLGVLEHP 143
           IG+G FG V     +           + A+K +N+         +  + E + L  L HP
Sbjct: 8   IGKGAFGKVCIVQKR-------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-----FNRAFPPLPWKTRLHIILGA 198
            LV L  Y   D E      LV + +L   L  HL     F+        + +   I   
Sbjct: 61  FLVNLW-YSFQDEE---NMYLVVDLLLGGDLRYHLSQKVKFSEE------QVKF-WICEI 109

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
              L YLH      +I+RD K  N+LLDE     ++DF +A     V    ++T+  GT 
Sbjct: 110 VLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTP 163

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           GY AP+ +     +   D WS GV  YE L G+R
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 87.7 bits (217), Expect = 1e-19
 Identities = 79/285 (27%), Positives = 121/285 (42%), Gaps = 46/285 (16%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG+G FG V           G      VA+K +  D     + ++AE   +  L H NLV
Sbjct: 14  IGKGEFGDVML---------GDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 62

Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 206
           +L+G   V+ + G+   +V E+M   SL D+L +R    L     L   L   E + YL 
Sbjct: 63  QLLG-VIVEEKGGL--YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119

Query: 207 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI 266
                  ++RD  A NVL+ E+   K+SDFGL +E      T           + AP+ +
Sbjct: 120 AN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEAL 171

Query: 267 ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPR 326
                + KSDVWSFG++L+E+ +  R      P     L + V               PR
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVV---------------PR 211

Query: 327 LEKEYSINEARK----IGRLADNCLSKSSKDRPKMSQVVERLKQI 367
           +EK Y ++        +  +   C    +  RP   Q+ E+L+ I
Sbjct: 212 VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 67/210 (31%), Positives = 106/210 (50%), Gaps = 22/210 (10%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFLGVLEHPNL 145
           IG+G FG VY  ++  + G         A+K LNR   L+  +Q++ E   +    HPN+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIH----CAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNV 58

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + L+G C      G   L+V  +M +  L + + +    P   K  +   L  A+G+ YL
Sbjct: 59  LSLLGICLPS--EGSP-LVVLPYMKHGDLRNFIRSETHNPTV-KDLIGFGLQVAKGMEYL 114

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE------GPMVGHTHVSTAVVGTFG 259
                 + ++RD  A N +LDE+F  K++DFGLAR+        +  HT     V     
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV----K 167

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           + A + ++T   T KSDVWSFGV+L+E++T
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 88/290 (30%), Positives = 132/290 (45%), Gaps = 50/290 (17%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQFL 137
           F  + +IG G FG+VY      A    T+E  VVA+KK++  G Q +++W   + EV+FL
Sbjct: 23  FVGLHEIGHGSFGAVYF-----ATNSHTNE--VVAVKKMSYSGKQTNEKWQDIIKEVKFL 75

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS---LEDHLFNRAFPPLPWKTRLHI 194
             L+HPN ++  G C +         LV E+ L  +   LE H       PL       I
Sbjct: 76  QQLKHPNTIEYKG-CYLKEHTA---WLVMEYCLGSASDLLEVHK-----KPLQEVEIAAI 126

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
             GA +GLAYLH      +I+RD KA N+LL E  + KL+DFG A +      +  + + 
Sbjct: 127 THGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSF 177

Query: 255 VGTFGYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 311
           VGT  + AP+ I   + G    K DVWS G+   E+       ER  P      +  +  
Sbjct: 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMSALYH 231

Query: 312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 361
              +         P L+     +  R      D CL K  ++RP  ++++
Sbjct: 232 IAQNDS-------PTLQSNEWTDSFR---GFVDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 80/293 (27%), Positives = 126/293 (43%), Gaps = 41/293 (13%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFLG 138
           D   +  +G G  GSV K    P         TV+A K ++        KQ + E+Q + 
Sbjct: 6   DLETISDLGAGNGGSVSKVKHIPTG-------TVMAKKVVHIGAKSSVRKQILRELQIMH 58

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
               P +V   G  A   E  I   +  EFM   SL D ++ +   P+P +    I +  
Sbjct: 59  ECRSPYIVSFYG--AFLNENNI--CMCMEFMDCGSL-DRIY-KKGGPIPVEILGKIAVAV 112

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
            EGL YL+     ++++RD K SN+L++   + KL DFG++  G ++    ++   VGT 
Sbjct: 113 VEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVS--GELI--NSIADTFVGTS 166

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR--------LLEWVQ 310
            Y +P+ I+ G  T KSDVWS G+ + E+  G+     +    + +        LL+ + 
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226

Query: 311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 363
           Q P           PRL       + R      D CL K   +RP   Q+   
Sbjct: 227 QEPP----------PRLPSSDFPEDLR---DFVDACLLKDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 67/217 (30%), Positives = 100/217 (46%), Gaps = 28/217 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----RDGLQGHKQWVAEV 134
             F+ +  IG+G FG VYK+  K      T++  VVAIK ++     D ++  +Q   E+
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDK-----RTNQ--VVAIKVIDLEEAEDEIEDIQQ---EI 50

Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           QFL     P + K  G   + G     +L ++ E+    S  D L       L       
Sbjct: 51  QFLSQCRSPYITKYYG-SFLKG----SKLWIIMEYCGGGSCLDLLKPG---KLDETYIAF 102

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
           I+     GL YLHE      I+RD KA+N+LL E    KL+DFG++  G +         
Sbjct: 103 ILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNT 157

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            VGT  + AP+ I+      K+D+WS G+   E+  G
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 86.8 bits (215), Expect = 4e-19
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 28/218 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV--------AEVQFLG 138
           IG+G +G VY      A    T E   V   +L       H            +E++ L 
Sbjct: 9   IGKGTYGRVYL-----ALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK 63

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRA-FPPLPWKTRLHIIL 196
            L+H N+V+ +G+     E   + L ++ E++   S+   L     F     +     +L
Sbjct: 64  DLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL 118

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
              EGLAYLH      +++RD KA N+L+D +   K+SDFG++++   +     + ++ G
Sbjct: 119 ---EGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG 172

Query: 257 TFGYAAPDYIETGH--LTAKSDVWSFGVVLYEMLTGRR 292
           +  + AP+ I +     +AK D+WS G V+ EM  GRR
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 86.8 bits (216), Expect = 4e-19
 Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 33/215 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW-----VAEVQFLGVL 140
           ++G+G FGSVY                +VAIKK+ +        W     + EV+ L  L
Sbjct: 6   QLGDGTFGSVYL-------ARNKETGELVAIKKMKKK----FYSWEECMNLREVKSLRKL 54

Query: 141 -EHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            EHPN+VKL      +  R    L  V+E+M   +L   + +R   P        II   
Sbjct: 55  NEHPNIVKL-----KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQI 108

Query: 199 AEGLAYLHE-GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
            +GLA++H+ G      +RD K  N+L+      K++DFGLARE   +      T  V T
Sbjct: 109 LQGLAHIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLARE---IRSRPPYTDYVST 161

Query: 258 FGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
             Y AP+ +  +   ++  D+W+ G ++ E+ T R
Sbjct: 162 RWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 86.6 bits (214), Expect = 4e-19
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 22/217 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++GEG FG V+ +       +   +  +VA+K L        + +  E + L VL+H ++
Sbjct: 12  ELGEGAFGKVFLAECHNLLPE--QDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69

Query: 146 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFN---------RAFPPLPWKTRL 192
           V+  G C  +G      L+V+E+M    LNR L  H  +          A   L     L
Sbjct: 70  VRFYGVCT-EGR---PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I    A G+ YL     +  ++RD    N L+ +    K+ DFG++R+     +  V  
Sbjct: 126 AIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 182

Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
             +    +  P+ I     T +SD+WSFGVVL+E+ T
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 75/238 (31%), Positives = 110/238 (46%), Gaps = 42/238 (17%)

Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQGHKQWVA 132
              D+  + K+GEG FG VYK+  +   G       VVA+KK+     +DG       + 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKA-RQIKTG------RVVALKKILMHNEKDGF--PITALR 56

Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-----LVYEFM---LNRSLEDHLFNRAFP 184
           E++ L  L+HPN+V LI   AV+     +R      +V  +M   L+  LE+        
Sbjct: 57  EIKILKKLKHPNVVPLIDM-AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LT 113

Query: 185 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---- 240
               K  +  +L   EG+ YLHE     +++RD KA+N+L+D     K++DFGLAR    
Sbjct: 114 ESQIKCYMLQLL---EGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDG 167

Query: 241 EGPMVGH-----THVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGR 291
             P         T   T +V T  Y  P+ +  E  + TA  D+W  G V  EM T R
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 85.8 bits (212), Expect = 6e-19
 Identities = 77/283 (27%), Positives = 125/283 (44%), Gaps = 44/283 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
            IGEG FG+V         G+ T +   V   K +       + ++ E   +  L H NL
Sbjct: 13  IIGEGEFGAVL-------QGEYTGQKVAVKNIKCDVTA----QAFLEETAVMTKLHHKNL 61

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L+G    +G       +V E M   +L + L  R    +     L   L  AEG+ YL
Sbjct: 62  VRLLGVILHNG-----LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 265
                 ++++RD  A N+L+ E+   K+SDFGLAR G M               + AP+ 
Sbjct: 117 ESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEA 168

Query: 266 IETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPK-TEQRLLEWVQQYPADSKKFGLIM 323
           ++    ++KSDVWS+GV+L+E+ + GR       PK + + + E V++        G  M
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAPY----PKMSLKEVKECVEK--------GYRM 216

Query: 324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 366
           +P       +        L  +C     K RP   ++ E+L++
Sbjct: 217 EPPEGCPADVYV------LMTSCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 9e-19
 Identities = 75/223 (33%), Positives = 111/223 (49%), Gaps = 38/223 (17%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-----EVQ 135
           + ++ KIGEG +G VYK      A D  +   +VA+KK+    L+   + V      E+ 
Sbjct: 1   YQKVEKIGEGTYGVVYK------ARDKLT-GEIVALKKIR---LETEDEGVPSTAIREIS 50

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLE---DHLFNRAFPPLPWKTR 191
            L  L HPN+V+L     V  E    +L LV+EF L+  L+   D        P   K+ 
Sbjct: 51  LLKELNHPNIVRL--LDVVHSE---NKLYLVFEF-LDLDLKKYMDSSPLTGLDPPLIKSY 104

Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-G-PMVGHTH 249
           L+ +L   +G+AY H     +V++RD K  N+L+D     KL+DFGLAR  G P+  +TH
Sbjct: 105 LYQLL---QGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158

Query: 250 VSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGR 291
               VV T  Y AP+ +      +   D+WS G +  EM+  R
Sbjct: 159 ---EVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 25/222 (11%)

Query: 86  KIGEGGFGSVY---KSSIKPAAGDGTSEAT----VVAIKKLNRDGLQ-GHKQWVAEVQFL 137
           K+GEG FG V+      +    G+G  E      +VA+K L  D  +     ++ E++ +
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAF----------PPLP 187
             L++PN+++L+G C  D        ++ E+M N  L   L  R            P + 
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPL----CMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127

Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
               L++ +  A G+ YL     +  ++RD    N L+  ++  K++DFG++R      +
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184

Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
             +    V    + A + I  G  T  SDVW+FGV L+EM T
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 85.9 bits (212), Expect = 1e-18
 Identities = 88/281 (31%), Positives = 123/281 (43%), Gaps = 44/281 (15%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQFL 137
           FS + +IG G FG+VY       A D  +   VVAIKK++  G Q +++W   + EV+FL
Sbjct: 17  FSDLREIGHGSFGAVY------FARDVRNSE-VVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
             L HPN ++  G C +   R     LV E+ L  + +  L      PL       +  G
Sbjct: 70  QKLRHPNTIQYRG-CYL---REHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHG 123

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
           A +GLAYLH      +I+RD KA N+LL E    KL DFG A           +   VGT
Sbjct: 124 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGT 174

Query: 258 FGYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 314
             + AP+ I   + G    K DVWS G+   E+       ER  P      +  +     
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMSALYHIAQ 228

Query: 315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 355
           +         P L+  +     R      D+CL K  +DRP
Sbjct: 229 NES-------PALQSGHWSEYFRN---FVDSCLQKIPQDRP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 72/213 (33%), Positives = 104/213 (48%), Gaps = 19/213 (8%)

Query: 83  RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLE 141
           R+  +GEG FG V      P  GD T E   VA+K L  +    H      E++ L  L 
Sbjct: 8   RIRDLGEGHFGKVELCRYDPE-GDNTGE--QVAVKSLKPESGGNHIADLKKEIEILRNLY 64

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           H N+VK  G C  DG  GI+  L+ EF+ + SL+++L  R    +  K +L   +   +G
Sbjct: 65  HENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKG 121

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVG 256
           + YL      Q ++RD  A NVL++   + K+ DFGL +     +        + + V  
Sbjct: 122 MDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV-- 176

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            F YA P+ +        SDVWSFGV LYE+LT
Sbjct: 177 -FWYA-PECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 20/224 (8%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQ-GHKQWVAEVQFLGVL 140
           +IGEG +G V+K      A D  +    VA+K++      +G+     + VA ++ L   
Sbjct: 8   EIGEGAYGKVFK------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61

Query: 141 EHPNLVKLIGYCAVD-GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           EHPN+V+L   C V   +R  +  LV+E  +++ L  +L     P +P +T   ++    
Sbjct: 62  EHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120

Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            GL +LH     +V++RD K  N+L+  + + KL+DFGLAR   +       T+VV T  
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLW 174

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ 303
           Y AP+ +         D+WS G +  EM   R+ L R     +Q
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 217

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 29/224 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFL 137
           +  ++   IG G FG V++  +K     G  E  V AIK L     +  +Q +++E   +
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMP---GRKEVAV-AIKTLKPGYTEKQRQDFLSEASIM 60

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHII 195
           G   H N+++L G       +    +++ E+M N +L+ +L +    F        L   
Sbjct: 61  GQFSHHNIIRLEGVVT----KFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-- 114

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR------EGPMVGHTH 249
            G A G+ YL +   +  ++RD  A N+L++ N   K+SDFGL+R      EG     T+
Sbjct: 115 -GIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG-----TY 165

Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 292
            ++       + AP+ I     T+ SDVWSFG+V++E+++ G R
Sbjct: 166 TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 20/215 (9%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++GEG FG V+ +       +   +  +VA+K L        K +  E + L  L+H ++
Sbjct: 12  ELGEGAFGKVFLAECYNLCPE--QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 146 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDH-----LFNRAFPP--LPWKTRLHI 194
           VK  G C V+G+  I   +V+E+M    LN+ L  H     L      P  L     LHI
Sbjct: 70  VKFYGVC-VEGDPLI---MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
               A G+ YL        ++RD    N L+ EN   K+ DFG++R+     +  V    
Sbjct: 126 AQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182

Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           +    +  P+ I     T +SDVWS GVVL+E+ T
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 64/210 (30%), Positives = 108/210 (51%), Gaps = 26/210 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK----LNRDGLQGHKQWVAEVQFLGVLE- 141
           IGEG +G+VYK      A D  +    VA+KK    L+ +G+      + E+  L  LE 
Sbjct: 7   IGEGAYGTVYK------ARD-LNTGRFVALKKVRVPLSEEGIP--LSTLREIALLKQLES 57

Query: 142 --HPNLVKLIGYCAV-DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
             HPN+V+L+  C     +R ++  LV+E + ++ L  +L     P LP +T   ++   
Sbjct: 58  FEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQL 116

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
             G+ +LH      +++RD K  N+L+  + + K++DFGLAR   +       T+VV T 
Sbjct: 117 LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVTL 170

Query: 259 GYAAPD-YIETGHLTAKSDVWSFGVVLYEM 287
            Y AP+  +++ + T   D+WS G +  E+
Sbjct: 171 WYRAPEVLLQSSYATP-VDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 66/223 (29%), Positives = 101/223 (45%), Gaps = 33/223 (14%)

Query: 86  KIGEGGFGSVYKS---SIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH 142
           ++GEG FG V+ +   ++ P     T +  +VA+K L    L   K +  E + L  L+H
Sbjct: 12  ELGEGAFGKVFLAECYNLSP-----TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH 66

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP----------------L 186
            ++VK  G C  DG+  I   +V+E+M +  L    F RA  P                L
Sbjct: 67  EHIVKFYGVC-GDGDPLI---MVFEYMKHGDLNK--FLRAHGPDAMILVDGQPRQAKGEL 120

Query: 187 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
                LHI    A G+ YL        ++RD    N L+  N   K+ DFG++R+     
Sbjct: 121 GLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177

Query: 247 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           +  V    +    +  P+ I     T +SDVWSFGV+L+E+ T
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 83.9 bits (207), Expect = 4e-18
 Identities = 69/248 (27%), Positives = 116/248 (46%), Gaps = 31/248 (12%)

Query: 67  RVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-NRDGLQ 125
           R+   +E+R       ++  +G G FG+V+K    P   +G S    VAIK + +R G Q
Sbjct: 2   RILKETELR-------KLKLLGSGVFGTVHKGIWIP---EGDSIKIPVAIKTIQDRSGRQ 51

Query: 126 GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--AF 183
             ++    +  +G L+H  +V+L+G C      G    LV +     SL DH+     + 
Sbjct: 52  TFQEITDHMLAMGSLDHAYIVRLLGICP-----GASLQLVTQLSPLGSLLDHVRQHRDSL 106

Query: 184 PP---LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 240
            P   L W  ++      A+G+ YL E    ++++R+  A N+LL  +   +++DFG+A 
Sbjct: 107 DPQRLLNWCVQI------AKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD 157

Query: 241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP 299
                   +  +       + A + I  G  T +SDVWS+GV ++EM++ G       RP
Sbjct: 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217

Query: 300 KTEQRLLE 307
                LLE
Sbjct: 218 HEVPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 4e-18
 Identities = 67/214 (31%), Positives = 91/214 (42%), Gaps = 30/214 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--NRDGLQGHKQWVAEVQFLGVLEHP 143
            +GEG +G V K   K      T E  +VAIKK   + D     K  + EV+ L  L H 
Sbjct: 8   VVGEGAYGVVLKCRNK-----ATGE--IVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 144 NLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLED-HLFNRAFPPLPWKTRLHIILGAAEG 201
           N+V L       G     RL LV+E++    LE         PP     R   I    + 
Sbjct: 61  NIVNLKEAFRRKG-----RLYLVFEYVERTLLELLEASPGGLPPD--AVRS-YIWQLLQA 112

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           +AY H      +I+RD K  N+L+ E+   KL DFG AR       + + T  V T  Y 
Sbjct: 113 IAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYR 168

Query: 262 APD----YIETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+        G      DVW+ G ++ E+L G 
Sbjct: 169 APELLVGDTNYG---KPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 7e-18
 Identities = 68/247 (27%), Positives = 100/247 (40%), Gaps = 45/247 (18%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL------ 140
           I +G FGSVY +  K + GD        AIK L +  +      +A+ Q   V       
Sbjct: 4   ISKGAFGSVYLAK-KRSTGD------YFAIKVLKKSDM------IAKNQVTNVKAERAIM 50

Query: 141 ----EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
               E P + KL  Y +   +  +   LV E++        +      P  W  +     
Sbjct: 51  MIQGESPYVAKL--YYSFQSKDYL--YLVMEYLNGGDCASLIKTLGGLPEDWAKQY---- 102

Query: 197 GAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
             AE   G+  LH+     +I+RD K  N+L+D+    KL+DFGL+R G        +  
Sbjct: 103 -IAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKK 152

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQY 312
            VGT  Y AP+ I        SD WS G V++E L G        P      +L     +
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212

Query: 313 PADSKKF 319
           P + K+F
Sbjct: 213 PEEVKEF 219

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 83.1 bits (205), Expect = 7e-18
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 30/224 (13%)

Query: 84  MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV---AEVQFLGVL 140
           M ++GE  FG +YK  +      G   A +VAIK L    +   +QW     E   +  L
Sbjct: 10  MEELGECAFGKIYKGHLYLP---GMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAEL 64

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA---------------FPP 185
            HPN+V L+G   V  E+ +   +++E++    L + L  R+                  
Sbjct: 65  HHPNIVCLLG--VVTQEQPV--CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120

Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 245
           L     LHI +  A G+ YL        +++D  A N+L+ E    K+SD GL+RE    
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177

Query: 246 GHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            +  V    +    +  P+ I  G  ++ SD+WSFGVVL+E+ +
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 83.9 bits (207), Expect = 8e-18
 Identities = 81/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           +DF ++ ++G G  G V+K S KP+      +   + IK   R+      Q + E+Q L 
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN------QIIRELQVLH 58

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
               P +V   G    DGE  I      E M   SL D +  +A   +P +    + +  
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPEQILGKVSIAV 112

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
            +GL YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++ + VGT 
Sbjct: 113 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANSFVGTR 166

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 318
            Y +P+ ++  H + +SD+WS G+ L EM  GR  +                  P D+K+
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP-----------------PPDAKE 209

Query: 319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD-RPKMSQVVERLKQIV 368
             L+    +E + + +E     R     LS    D RP M+ + E L  IV
Sbjct: 210 LELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMA-IFELLDYIV 259

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 82.6 bits (205), Expect = 1e-17
 Identities = 69/220 (31%), Positives = 101/220 (45%), Gaps = 34/220 (15%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ---WVAEVQ 135
           +DF  +  +G G FG V     K +           A+K L++  +   KQ    + E +
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGK-------YYALKILSKAKIVKLKQVEHVLNEKR 53

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            L  + HP LV L G    D       L LV E++    L  HL      P P   R + 
Sbjct: 54  ILQSIRHPFLVNLYG-SFQDD----SNLYLVMEYVPGGELFSHLRKSGRFPEPV-ARFY- 106

Query: 195 ILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
              AA+    L YLH    + ++YRD K  N+LLD +   K++DFG A+   + G T+  
Sbjct: 107 ---AAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTY-- 156

Query: 252 TAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTG 290
             + GT  Y AP+ I   G+  A  D W+ G+++YEML G
Sbjct: 157 -TLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 69/224 (30%), Positives = 109/224 (48%), Gaps = 37/224 (16%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-----EV 134
           D++++ KIGEG +G VYK       G       +VA+KK+    L+  ++ V      E+
Sbjct: 1   DYTKIEKIGEGTYGVVYK-------GRNKKTGQIVAMKKIR---LESEEEGVPSTAIREI 50

Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKT 190
             L  L+HPN+V L      +      RL L++EF+   L + L+     +       K+
Sbjct: 51  SLLKELQHPNIVCLQDVLMQE-----SRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS 105

Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHT 248
            L+ IL   +G+ + H     +V++RD K  N+L+D     KL+DFGLAR    P+  +T
Sbjct: 106 YLYQIL---QGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159

Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
           H    VV T  Y AP+ +      +   D+WS G +  EM T +
Sbjct: 160 H---EVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 54/292 (18%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----------RDGLQGHKQWVAEVQF 136
           +G G FG VYK   K       +   ++A+K++N          R+  +     V+EV  
Sbjct: 8   LGSGAFGCVYKVRKK------NNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 137 LG-VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN------RAFPPLP-W 188
           +   L HPN+V+      ++ +R     +V + +    L +H FN      + F     W
Sbjct: 62  IKEQLRHPNIVRYYK-TFLENDR---LYIVMDLIEGAPLGEH-FNSLKEKKQRFTEERIW 116

Query: 189 KTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 248
              + ++L     L YLH+  E ++++RD   +N++L E+ +  ++DFGLA++       
Sbjct: 117 NIFVQMVLA----LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK---QPE 167

Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW 308
              T+VVGT  Y+ P+ ++      K+DVW+FG +LY+M T         P     +L  
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSL 221

Query: 309 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
                  +K    + +P  E  YS +    I      CL+  ++ RP + QV
Sbjct: 222 A------TKIVEAVYEPLPEGMYSEDVTDVITS----CLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 70/231 (30%), Positives = 106/231 (45%), Gaps = 62/231 (26%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-------NRDGLQGHKQWVAEVQFLG 138
           K+GEG +  VYK      A D      +VAIKK+        +DG+  +   + E++ L 
Sbjct: 7   KLGEGTYAVVYK------ARD-KETGRIVAIKKIKLGERKEAKDGI--NFTALREIKLLQ 57

Query: 139 VLEHPNLVKLIGYCAVDGERG-IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
            L+HPN++ L+    V G +  I   LV+EFM    LE  + +++           I+L 
Sbjct: 58  ELKHPNIIGLL---DVFGHKSNIN--LVFEFMET-DLEKVIKDKS-----------IVLT 100

Query: 198 AAE----------GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMV 245
            A+          GL YLH      +++RD K +N+L+  +   KL+DFGLAR    P  
Sbjct: 101 PADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157

Query: 246 GHTHVSTAVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGR 291
             TH    VV T  Y AP+ +      A+      D+WS G +  E+L   
Sbjct: 158 KMTH---QVV-TRWYRAPELL----FGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 79/289 (27%), Positives = 122/289 (42%), Gaps = 36/289 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNL 145
           +G G FG VY+   +   GD       VA+K L      Q    ++ E   +    H N+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQ--VAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFP----PLPWKTRLHIILGAAE 200
           V+LIG   V  ER + R ++ E M    L+  L  NR  P     L  K  L      A+
Sbjct: 72  VRLIG---VSFER-LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK 127

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTHVSTAVVG 256
           G  YL E      I+RD  A N LL     P    K++DFG+AR+     +       + 
Sbjct: 128 GCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAML 183

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 316
              +  P+    G  T+K+DVWSFGV+L+E+ +        R   E  ++E+V       
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFV------- 234

Query: 317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
                    RL+          + R+  +C   + +DRP  + ++ER++
Sbjct: 235 -----TGGGRLDPPKGCPGP--VYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 81.5 bits (201), Expect = 3e-17
 Identities = 69/211 (32%), Positives = 102/211 (48%), Gaps = 24/211 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQGHKQWVAEVQFLGVLE 141
           +IG G +G+VYK+   P +G        VA+K +    N DGL      V EV  L  LE
Sbjct: 7   EIGVGAYGTVYKAR-DPHSGH------FVALKSVRVQTNEDGLP--LSTVREVALLKRLE 57

Query: 142 ---HPNLVKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
              HPN+V+L+  CA    +R  +  LV+E  +++ L  +L     P LP +T   ++  
Sbjct: 58  AFDHPNIVRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIKDLMRQ 116

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
              GL +LH      +++RD K  N+L+    + KL+DFGLAR   +       T VV T
Sbjct: 117 FLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVT 170

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
             Y AP+ +         D+WS G +  EM 
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 81.3 bits (201), Expect = 4e-17
 Identities = 75/226 (33%), Positives = 109/226 (48%), Gaps = 41/226 (18%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQGHKQWVAEVQ 135
           +F ++ +IGEG +G VY+      A D TS   +VA+KK+     RDG+      + E+ 
Sbjct: 8   EFEKLNRIGEGTYGIVYR------ARDTTSG-EIVALKKVRMDNERDGIPISS--LREIT 58

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRL 192
            L  L HPN+V+L     V G+      LV E+    L   L++      F     K   
Sbjct: 59  LLLNLRHPNIVELKE--VVVGKHLDSIFLVMEYCEQDLASLLDN--MPTPFSESQVKC-- 112

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGH 247
            ++L    GL YLHE     +I+RD K SN+LL +    K++DFGLAR       PM   
Sbjct: 113 -LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--- 165

Query: 248 THVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGR 291
               T  V T  Y AP+ +   T + TA  D+W+ G +L E+L  +
Sbjct: 166 ----TPKVVTLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 80.5 bits (199), Expect = 4e-17
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 39/218 (17%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT-VVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           +G G FGSVY+        DG   A   V++    + G +  KQ   E+  L  L+HPN+
Sbjct: 8   LGSGSFGSVYEGL---NLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64

Query: 146 VKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRAFPPLPWK-----TRLHIILGAA 199
           V+ +G      ER    L ++ E +   SL   L  + +   P       TR  I+LG  
Sbjct: 65  VQYLG-----TEREEDNLYIFLELVPGGSLAKLL--KKYGSFPEPVIRLYTR-QILLG-- 114

Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST-----AV 254
             L YLH+      ++RD K +N+L+D N   KL+DFG+A+         V       + 
Sbjct: 115 --LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSF 161

Query: 255 VGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
            G+  + AP+ I + G     +D+WS G  + EM TG+
Sbjct: 162 KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 83.7 bits (207), Expect = 4e-17
 Identities = 65/242 (26%), Positives = 116/242 (47%), Gaps = 20/242 (8%)

Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  +G L+HPN+VKLIG C  +        L++E++  ++L + L N     L W+ R 
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGA----YLIHEYIEGKNLSEVLRN-----LSWERRR 783

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I +G A+ L +LH      V+  +     +++D    P L    L+  G +       T
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLC----TDT 836

Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY 312
               +  Y AP+  ET  +T KSD++ FG++L E+LTG+   +         ++EW  +Y
Sbjct: 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS-IVEWA-RY 894

Query: 313 PADSKKFGLIMDPRLEKEYSIN--EARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV 370
                   + +DP +  + S+N  E  ++  LA +C +     RP  + V++ L+   + 
Sbjct: 895 CYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954

Query: 371 SN 372
           S+
Sbjct: 955 SS 956

Length = 968

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 81.1 bits (200), Expect = 4e-17
 Identities = 73/305 (23%), Positives = 131/305 (42%), Gaps = 48/305 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSE---------ATVVAIKKLNRDGLQGHKQ-WVAEVQ 135
           K+GEG FG V+   +       T +           +VA+K L  D  +  +  ++ EV+
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAF------------ 183
            L  L+ PN+++L+G C  +        ++ E+M N  L   L +               
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPL----CMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127

Query: 184 -----PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 238
                P + + + LH+ L  A G+ YL     +  ++RD    N L+ EN   K++DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGM 184

Query: 239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 298
           +R      +  +    V    + A + I  G  T  SDVW+FGV L+E+L     L + +
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL----MLCKEQ 240

Query: 299 PK---TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 355
           P    T+++++E   ++  D  +   +  P    +        +  L   C S+  ++RP
Sbjct: 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQ-------GLYELMLQCWSRDCRERP 293

Query: 356 KMSQV 360
             S +
Sbjct: 294 SFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 83/312 (26%), Positives = 135/312 (43%), Gaps = 57/312 (18%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL 137
           ND      IGEG FG V K+ IK    DG       AIK++     +  H+ +  E++ L
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKK---DGLRMDA--AIKRMKEYASKDDHRDFAGELEVL 61

Query: 138 GVL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------------FNRA 182
             L  HPN++ L+G C     RG   L + E+  + +L D L               N  
Sbjct: 62  CKLGHHPNIINLLGACE---HRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANST 117

Query: 183 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 242
              L  +  LH     A G+ YL +    Q I+RD  A N+L+ EN+  K++DFGL+R  
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQ 174

Query: 243 PM-----VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
            +     +G   V    + +  Y+          T  SDVWS+GV+L+E+++        
Sbjct: 175 EVYVKKTMGRLPVRWMAIESLNYSV--------YTTNSDVWSYGVLLWEIVS-----LGG 221

Query: 298 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 357
            P       E  ++ P            RLEK  + ++  ++  L   C  +   +RP  
Sbjct: 222 TPYCGMTCAELYEKLP---------QGYRLEKPLNCDD--EVYDLMRQCWREKPYERPSF 270

Query: 358 SQVVERLKQIVQ 369
           +Q++  L ++++
Sbjct: 271 AQILVSLNRMLE 282

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 80.5 bits (198), Expect = 5e-17
 Identities = 79/286 (27%), Positives = 124/286 (43%), Gaps = 43/286 (15%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----RDGLQGHKQWVAEVQF 136
           F+++ +IG+G FG V+K       G       VVAIK ++     D ++  +Q   E+  
Sbjct: 6   FTKLERIGKGSFGEVFK-------GIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITV 55

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           L   + P + K  G       +G +  ++ E++   S  D L    F      T L  IL
Sbjct: 56  LSQCDSPYVTKYYGSYL----KGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL 111

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
              +GL YLH     + I+RD KA+NVLL E    KL+DFG+A  G +          VG
Sbjct: 112 ---KGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVG 163

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 316
           T  + AP+ I+     +K+D+WS G+   E+  G        P    R+L  + +     
Sbjct: 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP---MRVLFLIPKNNP-- 218

Query: 317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                   P L  E+S    +      D CL+K    RP   ++++
Sbjct: 219 --------PTLTGEFS----KPFKEFIDACLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 40/230 (17%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           +GEG FG V K++     G   +  T VA+K L  +      +  ++E   L  + HP++
Sbjct: 8   LGEGEFGKVVKATAFRLKG--RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL----------------------FNRAF 183
           +KL G C+ DG      LL+ E+    SL   L                       N   
Sbjct: 66  IKLYGACSQDGPL----LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121

Query: 184 PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--- 240
             L     +      + G+ YL E   +++++RD  A NVL+ E  + K+SDFGL+R   
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178

Query: 241 -EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            E   V  +     V     + A + +     T +SDVWSFGV+L+E++T
Sbjct: 179 EEDSYVKRSKGRIPV----KWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 75/287 (26%), Positives = 128/287 (44%), Gaps = 43/287 (14%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQ-WVAEVQFL 137
           DF  + K+G+G +GSVYK           S+    A+K+++   + Q  ++  V E++ L
Sbjct: 1   DFKVLKKLGKGSYGSVYKV-------KRLSDNQFYALKEVDLGSMSQKEREDAVNEIRIL 53

Query: 138 GVLEHPNLVKLIGY--CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--PLPWKTRLH 193
             + HPN+   I Y    +DG +     +V E+     L   +  R      +P +    
Sbjct: 54  ASVNHPNI---ISYKEAFLDGNK---LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR 107

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
           I +    GL  LHE    ++++RD K++N+LL  N   K+ D G+++    V   +++  
Sbjct: 108 IFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISK----VLKKNMAKT 160

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 313
            +GT  Y AP+  +    + KSD+WS G +LYEM T     E    ++ Q L   VQ   
Sbjct: 161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE---ARSMQDLRYKVQ--- 214

Query: 314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
               K+     P +   YS    + +     + L    K RP   ++
Sbjct: 215 --RGKY-----PPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 80.3 bits (198), Expect = 5e-17
 Identities = 72/287 (25%), Positives = 131/287 (45%), Gaps = 36/287 (12%)

Query: 87  IGEGGFGSVYKSSIK-PAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPN 144
           IG G FG V    +K P   +       VAIK L     +  ++ +++E   +G  +HPN
Sbjct: 12  IGAGEFGEVCSGRLKLPGKRE-----IPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPN 66

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           ++ L G       +    ++V E+M N SL D    +          + ++ G A G+ Y
Sbjct: 67  IIHLEGVVT----KSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKY 121

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYA 261
           L +   +  ++RD  A N+L++ N   K+SDFGL+R   + P   +T     +     + 
Sbjct: 122 LSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWT 176

Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 321
           AP+ I     T+ SDVWS+G+V++E+++            E+   E   Q    + + G 
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMS----------YGERPYWEMSNQDVIKAIEEGY 226

Query: 322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV 368
            +   ++   ++++      L  +C  K   +RPK  Q+V  L +++
Sbjct: 227 RLPAPMDCPAALHQ------LMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 80.5 bits (199), Expect = 6e-17
 Identities = 82/300 (27%), Positives = 131/300 (43%), Gaps = 43/300 (14%)

Query: 72  SEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQ 129
            +   A  ND   + +IG G  G VYK   K           V+A+K++ R G  + +K+
Sbjct: 7   GQKYPADLNDLENLGEIGSGTCGQVYKMRFK-------KTGHVMAVKQMRRTGNKEENKR 59

Query: 130 WVAEVQFLGVLEH--PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
            + ++  + +  H  P +VK  GY   D +  I      E M   +  D L  R   P+P
Sbjct: 60  ILMDLDVV-LKSHDCPYIVKCYGYFITDSDVFI----CMELM--STCLDKLLKRIQGPIP 112

Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV-G 246
                 + +   + L YL E  +  VI+RD K SN+LLD +   KL DFG++  G +V  
Sbjct: 113 EDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS--GRLVDS 168

Query: 247 HTHVSTAVVGTFGYAAPDYIE----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE 302
                +A  G   Y AP+ I+          ++DVWS G+ L E+ TG+   +    KTE
Sbjct: 169 KAKTRSA--GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC--KTE 224

Query: 303 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
             +L  + Q    S            + +S +         D CL+K  + RPK  ++++
Sbjct: 225 FEVLTKILQEEPPS--------LPPNEGFSPD----FCSFVDLCLTKDHRKRPKYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 79.8 bits (197), Expect = 7e-17
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ---WVAEV 134
             +F    KIG+G F  VYK+           +  VVA+KK+    +   K     + E+
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLL-------DGRVVALKKVQIFEMMDAKARQDCLKEI 53

Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
             L  L+HPN++K +     + E  I   L     L+R ++   F +    +P +T    
Sbjct: 54  DLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKH--FKKQKRLIPERTIWKY 111

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
            +     L ++H     ++++RD K +NV +      KL D GL R       T  + ++
Sbjct: 112 FVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSL 166

Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEM 287
           VGT  Y +P+ I       KSD+WS G +LYEM
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 80.5 bits (198), Expect = 8e-17
 Identities = 81/302 (26%), Positives = 132/302 (43%), Gaps = 41/302 (13%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 190
           ++ L+G C  DG       ++ E+    +L ++L  R  P               + +K 
Sbjct: 83  IINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +   
Sbjct: 139 LVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 309
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E  +LL   
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL--- 252

Query: 310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   K G  MD         N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 253 --------KEGHRMDK------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298

Query: 370 VS 371
           ++
Sbjct: 299 LT 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 68/210 (32%), Positives = 104/210 (49%), Gaps = 22/210 (10%)

Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT+    VAIK L + G    + ++ E Q +  L H  
Sbjct: 12  VKLGQGCFGEVWMGT-----WNGTTR---VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 62

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 63  LVQLY---AVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 117

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAA 262
           +     +  ++RD +A+N+L+ EN   K++DFGLAR   ++     +      F   + A
Sbjct: 118 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTA 171

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+    G  T KSDVWSFG++L E+ T  R
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 67/236 (28%), Positives = 105/236 (44%), Gaps = 22/236 (9%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLEHP 143
           +G+GGFG V    +K       +   + A KKL++  L+   G K  + E + L  +  P
Sbjct: 1   LGKGGFGEVCAVQVK-------NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSP 53

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
            +V L    A   E      LV   M    L+ H++N     L  +  +H       G+ 
Sbjct: 54  FIVNL----AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGIL 109

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           +LH    + ++YRD K  NVLLD+    +LSD GLA E          T   GT GY AP
Sbjct: 110 HLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK---DGKTITQRAGTNGYMAP 163

Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 319
           + ++    +   D ++ G  +YEM+ GR   + ++ K  +   E  ++   D  KF
Sbjct: 164 EILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRTLEDEVKF 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 65/218 (29%), Positives = 95/218 (43%), Gaps = 27/218 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAEVQFLGVLEH 142
            IG G +G VYK     A      +    AIKK   D  Q     +    E+  L  L+H
Sbjct: 7   CIGRGTYGRVYK-----AKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 143 PNLVKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAA 199
            N+V L+       ++ +  L  Y E  L + ++ H   +    PP   K+ L  IL   
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL--- 118

Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAR--EGPMVGHTHVSTA 253
            G+ YLH      V++RD K +N+L+     E    K+ D GLAR    P+     +   
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 254 VVGTFGYAAPDYIETG--HLTAKSDVWSFGVVLYEMLT 289
           VV T  Y AP+ +  G  H T   D+W+ G +  E+LT
Sbjct: 176 VV-TIWYRAPELL-LGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 24/210 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G FG V+  +      +G    T VA+K L + G    + ++ E Q +  L H  L
Sbjct: 13  KLGNGQFGEVWMGT-----WNGN---TKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKL 63

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L    AV  E  I   +V E+M   SL D L +     L     + +    A G+AY+
Sbjct: 64  VQLY---AVVSEEPI--YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
                +  I+RD +++N+L+ +    K++DFGLAR    +   +  TA  G      + A
Sbjct: 119 ER---MNYIHRDLRSANILVGDGLVCKIADFGLAR----LIEDNEYTARQGAKFPIKWTA 171

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+    G  T KSDVWSFG++L E++T  R
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 85/301 (28%), Positives = 132/301 (43%), Gaps = 55/301 (18%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK--LNRDGLQGHKQWVAEVQF 136
            D   + +IG G FG+V K   KP+        T++A+K+     D  +  K+ + ++  
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSG-------TIMAVKRIRSTVDEKE-QKRLLMDLDV 55

Query: 137 LGVLEH-PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI- 194
           +      P +VK  G    +G+  I      E M + SL D  +   +       +  I 
Sbjct: 56  VMRSSDCPYIVKFYGALFREGDCWI----CMELM-DISL-DKFYKYVYE----VLKSVIP 105

Query: 195 --ILGA-----AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
             ILG       + L YL E  E+++I+RD K SN+LLD N   KL DFG++      G 
Sbjct: 106 EEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS------GQ 157

Query: 248 THVSTAV---VGTFGYAAPDYIETGHLTA---KSDVWSFGVVLYEMLTGRRSLERNRPKT 301
              S A     G   Y AP+ I+         +SDVWS G+ LYE+ TG+    +     
Sbjct: 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF 217

Query: 302 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 361
           +Q L + V+  P        I+    E+E+S +    I    + CL K    RPK  +++
Sbjct: 218 DQ-LTQVVKGDPP-------ILSNSEEREFSPSFVNFI----NLCLIKDESKRPKYKELL 265

Query: 362 E 362
           E
Sbjct: 266 E 266

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 22/210 (10%)

Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 12  VKLGQGCFGEVWMGT-----WNGT---TKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDK 62

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV L    AV  E  I   +V EFM   SL D L       L     + +    A+G+AY
Sbjct: 63  LVPLY---AVVSEEPI--YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAA 262
           +     +  I+RD +A+N+L+ +N   K++DFGLAR   ++     +      F   + A
Sbjct: 118 IER---MNYIHRDLRAANILVGDNLVCKIADFGLAR---LIEDNEYTARQGAKFPIKWTA 171

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+    G  T KSDVWSFG++L E++T  R
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 80/279 (28%), Positives = 120/279 (43%), Gaps = 40/279 (14%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFLGV 139
           + R+  IG G +G+VY+       G       VVA+K +N D        +  EV  L  
Sbjct: 3   YQRLELIGRGAYGAVYR-------GKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQ 55

Query: 140 LEH---PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           L     PN+ K  G   + G R     ++ E+    S+   +  +A  P+  K    II 
Sbjct: 56  LRQSQPPNITKYYG-SYLKGPR---LWIIMEYAEGGSVRTLM--KA-GPIAEKYISVIIR 108

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
                L Y+H+   V VI+RD KA+N+L+      KL DFG+A    +  ++   +  VG
Sbjct: 109 EVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVG 163

Query: 257 TFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
           T  + AP+ I  G     K+D+WS G+ +YEM TG      N P ++      +   P  
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG------NPPYSDVDAFRAMMLIP-K 216

Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR 354
           SK       PRLE        R+       CL +  K+R
Sbjct: 217 SKP------PRLEDNGYSKLLRE---FVAACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 59/187 (31%), Positives = 99/187 (52%), Gaps = 17/187 (9%)

Query: 114 VAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS 173
           VAIK + ++G     +++ E + +  L H  LV+L G C    +R I   +V E+M N  
Sbjct: 31  VAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPI--YIVTEYMSNGC 85

Query: 174 LEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL 233
           L ++L        P +  L +     EG+AYL      Q I+RD  A N L+D+    K+
Sbjct: 86  LLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKV 141

Query: 234 SDFGLAREGPMVGHTHVSTAVVGT---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT- 289
           SDFGL+R   ++   + S+  VG+     ++ P+ +     ++KSDVW+FGV+++E+ + 
Sbjct: 142 SDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSL 197

Query: 290 GRRSLER 296
           G+   ER
Sbjct: 198 GKMPYER 204

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 26/208 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           +IG G +G VYK+         T E  +VAIK +  +     +    E+  L    HPN+
Sbjct: 10  RIGSGTYGDVYKARDIA-----TGE--LVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 146 VKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           V   G           +L +V E+    SL+D ++     PL      ++     +GLAY
Sbjct: 63  VAYFG-----SYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAY 116

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS--TAVVGTFGYAA 262
           LHE      I+RD K +N+LL E+   KL+DFG++ +   +  T ++   + +GT  + A
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ---LTAT-IAKRKSFIGTPYWMA 169

Query: 263 PDYIE---TGHLTAKSDVWSFGVVLYEM 287
           P+       G    K D+W+ G+   E+
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHP 143
           +IG G FG V+   ++       ++ T VA+K   R+ L      +++ E + L    HP
Sbjct: 2   RIGRGNFGEVFSGRLR-------ADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHP 53

Query: 144 NLVKLIGYCAVDGERGIQRLLVY---EFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           N+V+LIG C        Q+  +Y   E +        L     P L  K  + ++  AA 
Sbjct: 54  NIVRLIGVCT-------QKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAA 105

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           G+ YL        I+RD  A N L+ E    K+SDFG++RE     +            +
Sbjct: 106 GMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW 162

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            AP+ +  G  +++SDVWSFG++L+E  +
Sbjct: 163 TAPEALNYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 82/310 (26%), Positives = 135/310 (43%), Gaps = 43/310 (13%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D  ++   VA+K L  D   +     V+E++ + ++ +H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP---------------LPWK 189
           ++ L+G C  DG       ++ E+    +L ++L  R  PP               L +K
Sbjct: 80  IINLLGACTQDGPL----YVLVEYASKGNLREYLRARR-PPGMDYSFDTCKLPEEQLTFK 134

Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
             +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +  
Sbjct: 135 DLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191

Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEW 308
            +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL  
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-- 249

Query: 309 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV 368
                    K G  MD         N   ++  +   C       RP   Q+VE L +++
Sbjct: 250 ---------KEGHRMDK------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294

Query: 369 QVSNEGDSFD 378
            V++  +  D
Sbjct: 295 TVTSTDEYLD 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 47/301 (15%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVL-EHPN 144
           +GEG FG V K+       D  +E + VA+K L  D   +     V+E++ + ++ +H N
Sbjct: 20  LGEGAFGQVVKAEAVGL--DNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG------- 197
           ++ L+G C  +G       +V E+  + +L D L  R  P                    
Sbjct: 78  IINLLGVCTQEGPL----YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133

Query: 198 -------AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
                   A G+ +L      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 134 LVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190

Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S                 
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS----------------- 233

Query: 311 QYP--ADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
            YP     + F L+ +  R+EK    N  +++  L  +C  +    RP   Q+VE L ++
Sbjct: 234 PYPGIPVEELFKLLKEGYRMEK--PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291

Query: 368 V 368
           +
Sbjct: 292 L 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 78.6 bits (193), Expect = 3e-16
 Identities = 67/229 (29%), Positives = 118/229 (51%), Gaps = 28/229 (12%)

Query: 66  LRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GL 124
           LR+   +E++       R+  +G G FG+VYK    P   +G +    VAIK LN   G 
Sbjct: 1   LRILKETELK-------RVKVLGSGAFGTVYKGIWVP---EGETVKIPVAIKILNETTGP 50

Query: 125 QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE--DHLFNRA 182
           + + +++ E   +  ++HP+LV+L+G C     + + +L+ +  +L+   E  D++ ++ 
Sbjct: 51  KANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQL 110

Query: 183 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 242
              L W  ++      A+G+ YL E    ++++RD  A NVL+      K++DFGLAR  
Sbjct: 111 L--LNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL- 158

Query: 243 PMVGHTHVSTAVVGTF--GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            + G      A  G     + A + I     T +SDVWS+GV ++E++T
Sbjct: 159 -LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 72/223 (32%), Positives = 104/223 (46%), Gaps = 39/223 (17%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFLGVL-EHPN 144
           IGEG FG V ++ IK    DG       AIK L     +  H+ +  E++ L  L  HPN
Sbjct: 10  IGEGNFGQVIRAMIKK---DGLKMNA--AIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 145 LVKLIGYCAVDGERGIQRLLV----YEFMLN-----RSLE-DHLFNRAF---PPLPWKTR 191
           ++ L+G C     RG   + +    Y  +L+     R LE D  F +       L  +  
Sbjct: 65  IINLLGACE---NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM-----VG 246
           L      A G+ YL E    Q I+RD  A NVL+ EN   K++DFGL+R   +     +G
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG 178

Query: 247 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              V    + +  Y+          T KSDVWSFGV+L+E+++
Sbjct: 179 RLPVRWMAIESLNYSV--------YTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 78.6 bits (193), Expect = 5e-16
 Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 18/213 (8%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           +DF R+ ++G G  G V K   KP+      +   + IK   R+      Q + E+Q L 
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN------QIIRELQVLH 58

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
               P +V   G    DGE  I      E M   SL+  L  +    +P +    + +  
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAV 112

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
             GLAYL E  + Q+++RD K SN+L++     KL DFG++  G ++    ++ + VGT 
Sbjct: 113 LRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANSFVGTR 166

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            Y +P+ ++  H + +SD+WS G+ L E+  GR
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 18/213 (8%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPN 144
           ++G+G FG VY+   K    D     T VAIK +N    ++   +++ E   +      +
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF--------NRAFPPLPWKTRLHIIL 196
           +V+L+G  +    +G   L++ E M    L+ +L         N    P   K  + +  
Sbjct: 71  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 127 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 76/296 (25%), Positives = 131/296 (44%), Gaps = 48/296 (16%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQF- 136
           +D   + ++G G +G V K    P         T++A+K++      Q  K+ + ++   
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTG-------TIMAVKRIRATVNSQEQKRLLMDLDIS 53

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM--LNRSLEDHLFNRAFPP---LPWKTR 191
           +  ++ P  V   G    +G+       V+  M  ++ SL D  + + +     +P    
Sbjct: 54  MRSVDCPYTVTFYGALFREGD-------VWICMEVMDTSL-DKFYKKVYDKGLTIPEDIL 105

Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
             I +   + L YLH  L   VI+RD K SNVL++ N + KL DFG++  G +V  +   
Sbjct: 106 GKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGIS--GYLV-DSVAK 160

Query: 252 TAVVGTFGYAAPDYI----ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 307
           T   G   Y AP+ I           KSDVWS G+ + E+ TGR   +  +   +Q  L+
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ--LK 218

Query: 308 WVQQYPADSKKFGLIMDPRLEKE-YSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
            V + P+          P+L  E +S           + CL K+ K+RP   ++++
Sbjct: 219 QVVEEPS----------PQLPAEKFSPE----FQDFVNKCLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 77.4 bits (190), Expect = 8e-16
 Identities = 78/303 (25%), Positives = 133/303 (43%), Gaps = 41/303 (13%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       +  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 190
           ++ L+G C  DG       ++ E+    +L ++L  R  P + +              K 
Sbjct: 86  IINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 142 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198

Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 309
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 255

Query: 310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   K G  MD         N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 256 --------KEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301

Query: 370 VSN 372
           +++
Sbjct: 302 LTS 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 77.0 bits (189), Expect = 8e-16
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 30/224 (13%)

Query: 84  MLKIGEGGFGSVYKSSI-KPAAGDGTSEATVVAIKKLNRDGLQG--HKQWVAEVQFLGVL 140
           M ++GE  FG VYK  +   A G+ T     VAIK L +D  +G   +++  E      L
Sbjct: 10  MEELGEDRFGKVYKGHLFGTAPGEQTQ---AVAIKTL-KDKAEGPLREEFKHEAMMRSRL 65

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVY-------EFMLNRSL--------EDHLFNRAFPP 185
           +HPN+V L+G   V  E+ +  +  Y       EF++ RS         +D        P
Sbjct: 66  QHPNIVCLLG--VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEP 123

Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 245
             +   +HI+   A G+ +L       V+++D    NVL+ +    K+SD GL RE    
Sbjct: 124 ADF---VHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177

Query: 246 GHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            +  +    +    + +P+ I  G  +  SD+WS+GVVL+E+ +
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.4 bits (188), Expect = 9e-16
 Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 28/212 (13%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-----KQWVAEVQFLGVLE 141
           +G+G FG VY         D   E   +A+K++  D               E+Q L  L+
Sbjct: 10  LGQGAFGRVYLC----YDVDTGRE---LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-TRLHI--ILGA 198
           H  +V+  G    D    I      E+M   S++D L  +A+  L    TR +   IL  
Sbjct: 63  HERIVQYYGCLRDDETLSI----FMEYMPGGSVKDQL--KAYGALTETVTRKYTRQIL-- 114

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA-REGPMVGHTHVSTAVVGT 257
            EG+ YLH      +++RD K +N+L D     KL DFG + R   +        +V GT
Sbjct: 115 -EGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
             + +P+ I       K+DVWS G  + EMLT
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 74/231 (32%), Positives = 107/231 (46%), Gaps = 59/231 (25%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-----NRDGLQGHKQWVAEVQFLGVL 140
           K+G+G +G V+K      A D  ++  VVA+KK+     N    Q   +   E+ FL  L
Sbjct: 14  KLGKGAYGIVWK------AIDRRTK-EVVALKKIFDAFRNATDAQ---RTFREIMFLQEL 63

Query: 141 -EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
            +HPN+VKL+     + ++ I   LV+E+M                   +T LH ++ A 
Sbjct: 64  GDHPNIVKLLNVIKAENDKDI--YLVFEYM-------------------ETDLHAVIRAN 102

Query: 200 ---------------EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---E 241
                          + L Y+H G    VI+RD K SN+LL+ + R KL+DFGLAR   E
Sbjct: 103 ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159

Query: 242 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
                   V T  V T  Y AP+ +       K  D+WS G +L EML G+
Sbjct: 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 69/219 (31%), Positives = 105/219 (47%), Gaps = 33/219 (15%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--NRDGLQGHKQWVAEVQFLG 138
           + ++ KIGEG +G V+K   +           +VAIKK   + D     K  + E++ L 
Sbjct: 3   YEKLSKIGEGSYGVVFKCRNR-------ETGQIVAIKKFVESEDDPVIKKIALREIRMLK 55

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL-LVYEF----MLNRSLEDHLFNRAFPPLPWKTRLH 193
            L+HPNLV LI     +  R  ++L LV+E+    +LN  LE +   R  P    K  + 
Sbjct: 56  QLKHPNLVNLI-----EVFRRKRKLHLVFEYCDHTVLN-ELEKNP--RGVPEHLIKKIIW 107

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
             L   + + + H+      I+RD K  N+L+ +  + KL DFG AR   + G     T 
Sbjct: 108 QTL---QAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFAR--ILTGPGDDYTD 159

Query: 254 VVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTG 290
            V T  Y AP+ +  +T +     DVW+ G V  E+LTG
Sbjct: 160 YVATRWYRAPELLVGDTQYGPP-VDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 77/292 (26%), Positives = 128/292 (43%), Gaps = 58/292 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           KIGEG FG +Y      A     SE  V+    L +  ++  +    EV  L  ++HPN+
Sbjct: 7   KIGEGSFGKIYL-----AKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 146 VK-------------LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           V              ++ YC  DG   ++R+     +L    ED +       L W  ++
Sbjct: 62  VTFFASFQENGRLFIVMEYC--DGGDLMKRINRQRGVLFS--EDQI-------LSWFVQI 110

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR-PKLSDFGLAREGPMVGHTHVS 251
            +      GL ++H+    ++++RD K+ N+ L +N    KL DFG+AR+  +     ++
Sbjct: 111 SL------GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELA 159

Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 311
              VGT  Y +P+  +      K+D+WS G VLYE+ T +   E N     Q +L+  Q 
Sbjct: 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN--NLHQLVLKICQG 217

Query: 312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 363
           Y A                 S N +R +  L       S +DRP ++ +++R
Sbjct: 218 YFA---------------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 77.2 bits (191), Expect = 1e-15
 Identities = 68/221 (30%), Positives = 100/221 (45%), Gaps = 40/221 (18%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLGVLEHPN 144
           IG G +G V       +A D  +    VAIKK++   D L   K+ + E++ L  L H N
Sbjct: 8   IGSGAYGVVC------SAVDKRTG-RKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 145 LVKL---IGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHI---- 194
           ++ L   +   + +    +   +V E M   L++ ++         PL   T  HI    
Sbjct: 61  IIGLLDILRPPSPEDFNDV--YIVTELMETDLHKVIKSPQ------PL---TDDHIQYFL 109

Query: 195 --ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVS 251
             IL    GL YLH      VI+RD K SN+L++ N   K+ DFGLAR   P        
Sbjct: 110 YQIL---RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163

Query: 252 TAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           T  V T  Y AP+ +  +   T   D+WS G +  E+LT +
Sbjct: 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 67/218 (30%), Positives = 97/218 (44%), Gaps = 40/218 (18%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---------GLQGHKQWVAEVQFL 137
           +G+G FG V  + +K     GT E  + A+K L +D              K+ +A     
Sbjct: 3   LGKGSFGKVLLAELK-----GTDE--LYAVKVLKKDVILQDDDVECTMTEKRVLALAG-- 53

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
              +HP L +L  +     +    RL  V E++    L  H+        P         
Sbjct: 54  ---KHPFLTQL--HSCFQTK---DRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARF 100

Query: 197 GAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            AAE   GL +LHE     +IYRD K  NVLLD     K++DFG+ +EG + G T  ++ 
Sbjct: 101 YAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TST 155

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
             GT  Y AP+ +         D W+ GV+LYEML G+
Sbjct: 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 22/214 (10%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           DF ++ ++G G  G V K   +P+      +   + IK   R       Q + E++ L  
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIR------NQIIRELKVLHE 55

Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
              P +V   G    DGE  I      E M   SL D +  +A   +P      I +   
Sbjct: 56  CNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPENILGKISIAVL 109

Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA--VVGT 257
            GL YL E  + ++++RD K SN+L++     KL DFG++      G    S A   VGT
Sbjct: 110 RGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMANSFVGT 161

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
             Y +P+ ++  H T +SD+WS G+ L EM  GR
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 43/227 (18%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDG-----LQGHKQW 130
           ++ ++ +I EG +G VY+      A D  +   +VA+KKL     ++G     L+     
Sbjct: 6   EYEKLNRIEEGTYGVVYR------ARDKKTG-EIVALKKLKMEKEKEGFPITSLR----- 53

Query: 131 VAEVQFLGVLEHPNLVKL--IGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPL 186
             E+  L  L+HPN+V +  +    V G    +  +V E++ +  +SL +    + F   
Sbjct: 54  --EINILLKLQHPNIVTVKEV----VVGSNLDKIYMVMEYVEHDLKSLMET-MKQPFLQS 106

Query: 187 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
             K  +  +L    G+A+LH+     +++RD K SN+LL+     K+ DFGLARE    G
Sbjct: 107 EVKCLMLQLL---SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLARE---YG 157

Query: 247 H-THVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
                 T +V T  Y AP+  +     +   D+WS G +  E+LT +
Sbjct: 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 75.9 bits (186), Expect = 2e-15
 Identities = 70/223 (31%), Positives = 106/223 (47%), Gaps = 39/223 (17%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFLGVL-EHPN 144
           IGEG FG V K+ IK    DG       AIK++     +  H+ +  E++ L  L  HPN
Sbjct: 3   IGEGNFGQVLKARIKK---DGLRMDA--AIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 57

Query: 145 LVKLIGYCAVDGERGIQRLLV----YEFMLN-----RSLE-DHLFNRAF---PPLPWKTR 191
           ++ L+G C     RG   L +    +  +L+     R LE D  F  A      L  +  
Sbjct: 58  IINLLGACE---HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM-----VG 246
           LH     A G+ YL +    Q I+RD  A N+L+ EN+  K++DFGL+R   +     +G
Sbjct: 115 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 171

Query: 247 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              V    + +  Y+          T  SDVWS+GV+L+E+++
Sbjct: 172 RLPVRWMAIESLNYSV--------YTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 72/217 (33%), Positives = 106/217 (48%), Gaps = 38/217 (17%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGV-LEH 142
           +G+G FG V  + +K     GT+E    AIK L +D +      +  + E + L +  EH
Sbjct: 3   LGKGSFGKVMLAELK-----GTNE--FFAIKALKKDVVLEDDDVECTMVERRVLALAWEH 55

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-----FNRAFPPLPWKTRLHIILG 197
           P L  L  +C    +  +    V E++    L  H+     F+ A      + R +    
Sbjct: 56  PFLTHL--FCTFQTKEHL--FFVMEYLNGGDLMFHIQSSGRFDEA------RARFY---- 101

Query: 198 AAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           AAE   GL +LH+     +IYRD K  NVLLD++   K++DFG+ +E  M G    ST  
Sbjct: 102 AAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN-MNGEGKAST-F 156

Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            GT  Y AP+ ++        D WSFGV+LYEML G+
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 35/222 (15%)

Query: 84  MLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           M ++G G FG V    +++ IK            VAIK +N +G    + ++ E + +  
Sbjct: 9   MKELGSGQFGVVHLGKWRAQIK------------VAIKAIN-EGAMSEEDFIEEAKVMMK 55

Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVY---EFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           L HP LV+L G C        Q+  +Y   EFM N  L ++L  R    L     L +  
Sbjct: 56  LSHPKLVQLYGVC-------TQQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQ 107

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
              EG+ YL        I+RD  A N L+      K+SDFG+ R   ++   + S++   
Sbjct: 108 DVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAK 162

Query: 257 -TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 296
               ++ P+       ++KSDVWSFGV+++E+ T G+   E+
Sbjct: 163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 61/227 (26%), Positives = 114/227 (50%), Gaps = 24/227 (10%)

Query: 66  LRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GL 124
           +R+   +E++       ++  +G G FG+VYK    P   DG +    VAIK L  +   
Sbjct: 1   MRILKETELK-------KVKVLGSGAFGTVYKGIWIP---DGENVKIPVAIKVLRENTSP 50

Query: 125 QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRA 182
           + +K+ + E   +  +  P + +L+G C     + + +L+ Y  +L+  R  +D + ++ 
Sbjct: 51  KANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQD 110

Query: 183 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 242
              L W  ++      A+G++YL E   V++++RD  A NVL+      K++DFGLAR  
Sbjct: 111 L--LNWCVQI------AKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159

Query: 243 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            +    + +        + A + I     T +SDVWS+GV ++E++T
Sbjct: 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 64/282 (22%), Positives = 123/282 (43%), Gaps = 39/282 (13%)

Query: 87  IGEGGFGS--VYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA--EVQFLGVLEH 142
           +G+G FG   +Y+          T + ++V  K++N   L   ++  A  E+  L +L+H
Sbjct: 8   LGKGAFGEATLYRR---------TEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH 58

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           PN++    +   D    I+     E+    +L D +  +       +  L  +      +
Sbjct: 59  PNIIAYYNHFMDDNTLLIE----MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAV 114

Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
           +Y+H+     +++RD K  N+ L +    KL DFG+++   +     ++  VVGT  Y +
Sbjct: 115 SYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMS 169

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
           P+  +      KSD+W+ G VLYE+LT +R+ +   P      L  V +          I
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVK----------I 213

Query: 323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 364
           +        S+  +  I  L  + L +  + RP   +V+++ 
Sbjct: 214 VQGNYTPVVSVYSSELI-SLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 25/214 (11%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQGH--KQWVAEVQFLGVL 140
           +G G F S Y       A D  +  T++A+K++    N    Q    +    E++ +  L
Sbjct: 8   LGTGAFSSCY------QARDVKT-GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
            HP++++++G    D    +      E+M   S+   L    +        ++       
Sbjct: 61  NHPHIIRMLGATCEDSHFNL----FVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLR 114

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLARE--GPMVGHTHVSTAVVGT 257
           GL+YLHE    Q+I+RD K +N+L+D   +  +++DFG A        G       ++GT
Sbjct: 115 GLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
             + AP+ +         DVWS G V+ EM T +
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 66/292 (22%), Positives = 124/292 (42%), Gaps = 39/292 (13%)

Query: 84  MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQGHKQWVAEVQFLGVLEH 142
           +  +G G FG V+ +  K    +     T+V +K L          ++  E+     L H
Sbjct: 10  ITTLGRGEFGEVFLAKAK--GIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH 67

Query: 143 PNLVKLIGYCAVDGERGIQRLLVY-------EFML-NRSLEDHLFNRAFPPLPWKTRLHI 194
            N+V+L+G C       +  +L Y       +F+   +S ++ L     PPL  K ++ +
Sbjct: 68  KNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKP---PPLSTKQKVAL 122

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
               A G+ +L      + ++RD  A N L+      K+S   L+++     +  +  A+
Sbjct: 123 CTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179

Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 314
           +    + AP+ ++    + KSDVWSFGV+++E+ T     +   P       E + +   
Sbjct: 180 I-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-----QGELPFYGLSDEEVLNR--L 231

Query: 315 DSKKFGLIMDPRLEKEYSINEA--RKIGRLADNCLSKSSKDRPKMSQVVERL 364
            + K           E  + E    ++ +L   C + + KDRP  S++V  L
Sbjct: 232 QAGKL----------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 75/235 (31%), Positives = 115/235 (48%), Gaps = 39/235 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G FG V+ ++         ++ T VA+K + + G    + ++AE   +  L+H  L
Sbjct: 13  KLGAGQFGEVWMATY--------NKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKL 63

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VKL    AV  +  I   ++ EFM   SL D L +      P    +      AEG+A++
Sbjct: 64  VKL---HAVVTKEPI--YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            +      I+RD +A+N+L+  +   K++DFGLAR    V   +  TA  G      + A
Sbjct: 119 EQR---NYIHRDLRAANILVSASLVCKIADFGLAR----VIEDNEYTAREGAKFPIKWTA 171

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT-GR------------RSLERN--RPKTE 302
           P+ I  G  T KSDVWSFG++L E++T GR            R+LER    P+ E
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE 226

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 77.6 bits (191), Expect = 4e-15
 Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 21/194 (10%)

Query: 114 VAIKKLNRDGLQGHKQWV---AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLL-VYEFM 169
           VAIK L  D  +   Q      E      L HPN+V L+      GE     L  V+E++
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD----SGEAPPGLLFAVFEYV 61

Query: 170 LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---D 226
             R+L + L       LP      ++L   + LA  H      +++RD K  N+++    
Sbjct: 62  PGRTLREVLAADG--ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTG 116

Query: 227 ENFRPKLSDFGLAREGPMVGHTHVSTA-----VVGTFGYAAPDYIETGHLTAKSDVWSFG 281
                K+ DFG+    P V    V+T      V+GT  Y AP+ +    +T  SD++++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 282 VVLYEMLTGRRSLE 295
           ++  E LTG+R ++
Sbjct: 177 LIFLECLTGQRVVQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 64/223 (28%), Positives = 96/223 (43%), Gaps = 37/223 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLGVLEHP 143
            IG G +G V        A D  S   V AIKK+    D     K+ + E++ L   +H 
Sbjct: 12  NIGSGAYGVVCS------AIDTRSGKKV-AIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFM---------LNRSLEDHLFNRAFPPLPWKTRLHI 194
           N++ +       G       +V + M          ++ L +    R F        L+ 
Sbjct: 65  NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHI-RYF--------LYQ 115

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVST 252
           +L    GL Y+H      VI+RD K SN+L++E+   ++ DFG+AR        H +  T
Sbjct: 116 LL---RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169

Query: 253 AVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSL 294
             V T  Y AP+ + +    T   D+WS G +  EML GRR L
Sbjct: 170 EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 74.2 bits (182), Expect = 7e-15
 Identities = 75/291 (25%), Positives = 129/291 (44%), Gaps = 46/291 (15%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ--WVAEVQFLGVLEHPN 144
           +G G FG + +  +K  +         VAI  L R G    ++  ++AE   LG  +H N
Sbjct: 13  LGTGRFGELCRGCLKLPS----KRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSN 67

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +V+L G       RG   ++V E+M N +L D    +    L     + ++ G A G+ Y
Sbjct: 68  IVRLEGVIT----RGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKY 122

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG----- 259
           L E   +  +++   A  VL++ +   K+S F   +E           A+  T       
Sbjct: 123 LSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS-------EAIYTTMSGKSPV 172

Query: 260 -YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK 317
            +AAP+ I+  H ++ SDVWSFG+V++E+++ G R       +   + +E   + PA   
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA--- 229

Query: 318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV 368
                  PR       N    + +L  +C  K   +RP+ SQ+   L ++V
Sbjct: 230 -------PR-------NCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 74.6 bits (183), Expect = 7e-15
 Identities = 74/301 (24%), Positives = 134/301 (44%), Gaps = 34/301 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPN 144
           ++G+G FG VY+ + +     G +E T VA+K +N    L+   +++ E   +      +
Sbjct: 13  ELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 70

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF--------NRAFPPLPWKTRLHIIL 196
           +V+L+G  +    +G   L+V E M +  L+ +L         N   PP   +  + +  
Sbjct: 71  VVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             A+G+AYL+     + ++RD  A N ++  +F  K+ DFG+ R+     +       + 
Sbjct: 127 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 316
              + AP+ ++ G  T  SD+WSFGVVL+E+ +               L E   Q  ++ 
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNE 228

Query: 317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS 376
           +    +MD     +   N   ++  L   C   + K RP   ++V  LK  +  S    S
Sbjct: 229 QVLKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287

Query: 377 F 377
           F
Sbjct: 288 F 288

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 73.8 bits (181), Expect = 8e-15
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 31/222 (13%)

Query: 83  RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH--KQWVAEVQFLGVL 140
           RML  G+G FGSV ++ +K   G        VA+K L  D       ++++ E   +   
Sbjct: 5   RML--GKGEFGSVREAQLKSEDGSFQK----VAVKMLKADIFSSSDIEEFLREAACMKEF 58

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLV-------------YEFMLNRSLEDHLFNRAFPPLP 187
           +HPN++KLIG       R   RL +             + F+L   + +  F      LP
Sbjct: 59  DHPNVIKLIGVSL--RSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT-----LP 111

Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
            +T +  ++  A G+ YL        I+RD  A N +L+EN    ++DFGL+++     +
Sbjct: 112 LQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY 168

Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                A      + A + +     T  SDVW+FGV ++E++T
Sbjct: 169 YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 74.6 bits (184), Expect = 9e-15
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 46/221 (20%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLGVLEHPN 144
           +G G +G V  +         T     VAIKKL+R        K+   E++ L  ++H N
Sbjct: 23  VGSGAYGQVCSAFDT-----KTGRK--VAIKKLSRPFQSAIHAKRTYRELRLLKHMDHEN 75

Query: 145 LVKLIG-YCAVDGERGIQRL-LVYEFM---LNRSL------EDHLFNRAFPPLPWKTRLH 193
           ++ L+  +         Q + LV   M   LN  +      +DH+          +  ++
Sbjct: 76  VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI----------QFLVY 125

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVS 251
            IL    GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  +  M G+    
Sbjct: 126 QIL---RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY---- 175

Query: 252 TAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
              V T  Y AP+ +    H     D+WS G ++ E+LTG+
Sbjct: 176 ---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 73.6 bits (180), Expect = 1e-14
 Identities = 78/283 (27%), Positives = 126/283 (44%), Gaps = 37/283 (13%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFLGV 139
           F+++ KIG+G FG V+K       G       VVAIK ++ +  +   + +  E+  L  
Sbjct: 6   FTKLEKIGKGSFGEVFK-------GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58

Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
            + P + K  G    D +  I    + E++   S  D L           T L  IL   
Sbjct: 59  CDSPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEPGPLDETQIATILREIL--- 111

Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           +GL YLH     + I+RD KA+NVLL E+   KL+DFG+A  G +          VGT  
Sbjct: 112 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPF 166

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 319
           + AP+ I+     +K+D+WS G+   E+  G        P +E   ++ +   P ++   
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKGE------PPHSELHPMKVLFLIPKNNP-- 218

Query: 320 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                P LE  YS    + +    + CL+K    RP   ++++
Sbjct: 219 -----PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 30/224 (13%)

Query: 75  RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
            ++ ++  R+ +IG G  G+VYK   +P     T     + +   N +     +Q   E+
Sbjct: 70  AKSLSELERVNRIGSGAGGTVYKVIHRP-----TGRLYALKVIYGNHED-TVRRQICREI 123

Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED-HLFNRAFPPLPWKTRLH 193
           + L  + HPN+VK       +GE  IQ LL  EFM   SLE  H+ +  F          
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGE--IQVLL--EFMDGGSLEGTHIADEQFLA-------D 172

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT-HVST 252
           +      G+AYLH      +++RD K SN+L++     K++DFG++R   ++  T     
Sbjct: 173 VARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSR---ILAQTMDPCN 226

Query: 253 AVVGTFGYAAPDYIETGHLTAK-----SDVWSFGVVLYEMLTGR 291
           + VGT  Y +P+ I T            D+WS GV + E   GR
Sbjct: 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 41/93 (44%), Positives = 57/93 (61%), Gaps = 7/93 (7%)

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           A  L +LH    + +IYRD K  N+LLDE    KL+DFGL++E   + H   + +  GT 
Sbjct: 108 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTV 162

Query: 259 GYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTG 290
            Y AP+ +   GH T  +D WSFGV+++EMLTG
Sbjct: 163 EYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 27/210 (12%)

Query: 86  KIGEGGFGSVYKS-SIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA--EVQFLGVLE- 141
           KIGEG F  V K+ S K     G       AIK + +   +  +Q     E+Q L  L  
Sbjct: 6   KIGEGTFSEVLKAQSRK----TGKY----YAIKCMKKH-FKSLEQVNNLREIQALRRLSP 56

Query: 142 HPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           HPN+++LI     D + G  RL LV+E M + +L + +  R  P LP K     +    +
Sbjct: 57  HPNILRLIE-VLFDRKTG--RLALVFELM-DMNLYELIKGRKRP-LPEKRVKSYMYQLLK 111

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L ++H      + +RD K  N+L+ ++   KL+DFG  R    +      T  + T  Y
Sbjct: 112 SLDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRG---IYSKPPYTEYISTRWY 164

Query: 261 AAPDYIET-GHLTAKSDVWSFGVVLYEMLT 289
            AP+ + T G+   K D+W+ G V +E+L+
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 72/225 (32%), Positives = 112/225 (49%), Gaps = 41/225 (18%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-----EVQ 135
           + ++ KIGEG +G VYK      A D  +  T +A+KK+    L+   + V      E+ 
Sbjct: 4   YEKVEKIGEGTYGVVYK------ARDRVTNET-IALKKIR---LEQEDEGVPSTAIREIS 53

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-----FNRAFPPLPWKT 190
            L  ++H N+V+L     V  E+ +   LV+E+ L+  L+ H+     F +   P   KT
Sbjct: 54  LLKEMQHGNIVRL--QDVVHSEKRL--YLVFEY-LDLDLKKHMDSSPDFAKN--PRLIKT 106

Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREG--PMVGH 247
            L+ IL    G+AY H     +V++RD K  N+L+D      KL+DFGLAR    P+   
Sbjct: 107 YLYQIL---RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160

Query: 248 THVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
           TH     V T  Y AP+  + + H +   D+WS G +  EM+  +
Sbjct: 161 TH----EVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 32/221 (14%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQF 136
           DF+ ++ +G+G FG V  +  K     GT E  + AIK L +D +      +  + E + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERK-----GTDE--LYAIKILKKDVIIQDDDVECTMVEKRV 53

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHL--FNRAFPPLPWKTRLH 193
           L +   P  +  +  C     + + RL  V E++    L  H+    +   P       H
Sbjct: 54  LALPGKPPFLTQLHSCF----QTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP-------H 102

Query: 194 IILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +  AAE   GL +LH      +IYRD K  NV+LD     K++DFG+ +E    G T  
Sbjct: 103 AVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT-- 157

Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           +    GT  Y AP+ I         D W+FGV+LYEML G+
Sbjct: 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 22/210 (10%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G+G +G VY       A    S    +AIK++     +  +    E+     L+H N+V
Sbjct: 16  LGKGTYGIVY-------AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIV 68

Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA--EGLAY 204
           + +G  + +G   I      E +   SL   L    + PL    +  I       EGL Y
Sbjct: 69  QYLGSDSENGFFKI----FMEQVPGGSLSA-LLRSKWGPLKDNEQTIIFYTKQILEGLKY 123

Query: 205 LHEGLEVQVIYRDFKASNVLLDE-NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           LH+    Q+++RD K  NVL++  +   K+SDFG ++   + G    +    GT  Y AP
Sbjct: 124 LHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR--LAGINPCTETFTGTLQYMAP 178

Query: 264 DYIETGH--LTAKSDVWSFGVVLYEMLTGR 291
           + I+ G     A +D+WS G  + EM TG+
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 25/217 (11%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLNRDGLQGHKQ-WVAEVQFLG 138
           F + L  G G FG V +++   A G   S+A + VA+K L        ++  ++E++ + 
Sbjct: 39  FGKTL--GAGAFGKVVEAT---AYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93

Query: 139 VL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
            L  H N+V L+G C + G      L++ E+     L + L  +    L  +  L     
Sbjct: 94  HLGNHENIVNLLGACTIGGPI----LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV-- 255
            A+G+A+L        I+RD  A NVLL      K+ DFGLAR+       + S  VV  
Sbjct: 150 VAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD-----IMNDSNYVVKG 201

Query: 256 GTF---GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                  + AP+ I     T +SDVWS+G++L+E+ +
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 78/284 (27%), Positives = 109/284 (38%), Gaps = 50/284 (17%)

Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAE 133
           +   T  F  +  IGEG +G VYK               +VAIK ++       ++   E
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYK-------ARHKKTGQLVAIKIMDIIE-DEEEEIKEE 52

Query: 134 VQFLGVL-EHPNLVKLIG--YCAVDGERGIQRLLVYEFMLNRSLED-----HLFNRAFPP 185
              L     HPN+    G            Q  LV E     S+ D         +    
Sbjct: 53  YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE 112

Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 245
             W    +I+     GLAYLHE    +VI+RD K  N+LL +N   KL DFG++ +   +
Sbjct: 113 -EWIA--YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ---L 163

Query: 246 GHT-HVSTAVVGTFGYAAPDYI-----ETGHLTAKSDVWSFGVVLYEMLTGR-------- 291
             T       +GT  + AP+ I           A+SDVWS G+   E+  G+        
Sbjct: 164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223

Query: 292 -RSL---ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEY 331
            R+L    RN P T +    W       SKKF   +   L K Y
Sbjct: 224 MRALFKIPRNPPPTLKSPENW-------SKKFNDFISECLIKNY 260

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 23/219 (10%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVL-EHPN 144
           +GEG FG V ++           +   VA+K L  +   +     ++E++ + ++ +H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 190
           ++ L+G C  +G       ++ E+    +L + L  R  P               L +K 
Sbjct: 80  IINLLGVCTQEGPL----YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR    + +   
Sbjct: 136 LVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192

Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           ++       + AP+ +     T +SDVWSFG++++E+ T
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 72/207 (34%), Positives = 93/207 (44%), Gaps = 20/207 (9%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK--LNRDGLQGHKQWVAEVQ-FLGVLEHP 143
           IG+G FG V  +  K    DG   A  V  KK  LNR   +  K  +AE    L  ++HP
Sbjct: 3   IGKGSFGKVLLAKRKL---DGKCYAVKVLQKKIVLNR---KEQKHIMAERNVLLKNVKHP 56

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
            LV L  Y     E+      V +F+    L  HL      P P + R +     A  L 
Sbjct: 57  FLVGL-HYSFQTTEK---LYFVLDFVNGGELFFHLQRERSFPEP-RARFYAA-EIASALG 110

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + ++YRD K  N+LLD      L+DFGL +EG  +  +  +T   GT  Y AP
Sbjct: 111 YLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEG--IAQSDTTTTFCGTPEYLAP 165

Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTG 290
           + I         D W  G VLYEML G
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 73/291 (25%), Positives = 121/291 (41%), Gaps = 31/291 (10%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQF 136
           +F    KIG G F  VY+++          +   VA+KK+    L   +     + E+  
Sbjct: 3   NFRIEKKIGRGQFSEVYRATC-------LLDGVPVALKKVQIFDLMDAKARADCIKEIDL 55

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           L  L HPN++K       D E  I   L     L+R ++   F +    +P KT     +
Sbjct: 56  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH--FKKQKRLIPEKTVWKYFV 113

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
                L ++H     +V++RD K +NV +      KL D GL R       T  + ++VG
Sbjct: 114 QLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVG 168

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 316
           T  Y +P+ I       KSD+WS G +LYEM   +     ++               +  
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLYSLC 217

Query: 317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
           KK      P L  ++   E R+   L + C++   + RP ++ V +  K++
Sbjct: 218 KKIEQCDYPPLPSDHYSEELRQ---LVNMCINPDPEKRPDITYVYDVAKRM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 19/206 (9%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPN 144
            IGEG FG VY+           +E   VA+K          ++ ++ E   +   +HP+
Sbjct: 13  CIGEGQFGDVYQGVYM----SPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +VKLIG    +    +  L      L   L+ + ++     L   + +      +  LAY
Sbjct: 69  IVKLIGVITENPVWIVMELAPLG-ELRSYLQVNKYS-----LDLASLILYSYQLSTALAY 122

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAA 262
           L      + ++RD  A NVL+      KL DFGL+R    +       A  G     + A
Sbjct: 123 LES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR---YLEDESYYKASKGKLPIKWMA 176

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEML 288
           P+ I     T+ SDVW FGV ++E+L
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 60/214 (28%), Positives = 110/214 (51%), Gaps = 19/214 (8%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFLG 138
           +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   + 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVMA 64

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHIIL 196
            +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++    
Sbjct: 65  SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI---- 118

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-EGPMVGHTHVSTAVV 255
             A+G+ YL E    ++++RD  A NVL+      K++DFGLA+  G      H     V
Sbjct: 119 --AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173

Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
               + A + I     T +SDVWS+GV ++E++T
Sbjct: 174 -PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 25/210 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--NRDGLQGHKQWVAEVQFLGVLEHP 143
            +GEG +G V K   K           +VAIKK   + D     K  + E++ L  L H 
Sbjct: 8   LVGEGSYGMVMKCKHK-------ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 144 NLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPP-LPWKTRLHIILGAAEG 201
           NLV LI        R  +RL LV+EF+ +  L+D      +P  L        +     G
Sbjct: 61  NLVNLIEVF-----RRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRG 112

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           + + H      +I+RD K  N+L+ ++   KL DFG AR   +     V T  V T  Y 
Sbjct: 113 IEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVATRWYR 167

Query: 262 APDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           AP+ +       ++ D+W+ G ++ EMLTG
Sbjct: 168 APELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 69/212 (32%), Positives = 102/212 (48%), Gaps = 28/212 (13%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVL-EH 142
           +G+G FG V+ + +K     GT++    AIK L +D +      +  + E + L +  EH
Sbjct: 3   LGKGSFGKVFLAELK-----GTNQ--FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 55

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE-- 200
           P L  L  YC    +  +    V E++    L  H+ +     LP  T       AAE  
Sbjct: 56  PFLTHL--YCTFQTKENL--FFVMEYLNGGDLMFHIQSCHKFDLPRAT-----FYAAEII 106

Query: 201 -GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            GL +LH      ++YRD K  N+LLD +   K++DFG+ +E  M+G     T   GT  
Sbjct: 107 CGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN-MLGDAKTCT-FCGTPD 161

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           Y AP+ +         D WSFGV+LYEML G+
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 39/221 (17%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
                +KIGEG  G V  ++ K       S    VA+KK++    Q  +    EV  +  
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDK-------STGRQVAVKKMDLRKQQRRELLFNEVVIMRD 72

Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------ 193
            +HPN+V++     V  E      +V EF+   +L D         +   TR++      
Sbjct: 73  YQHPNIVEMYSSYLVGDEL----WVVMEFLEGGALTD---------IVTHTRMNEEQIAT 119

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG----LAREGPMVGHTH 249
           + L   + L++LH      VI+RD K+ ++LL  + R KLSDFG    +++E P      
Sbjct: 120 VCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR----- 171

Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
              ++VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 67/223 (30%), Positives = 111/223 (49%), Gaps = 40/223 (17%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHK-QWVAEVQFL 137
           + ++ K+GEG + +VYK         G S+ T  +VA+K++  +  +G     + EV  L
Sbjct: 8   YIKLDKLGEGTYATVYK---------GRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLL 58

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLED-----HLFNRAFPPLPWK 189
             L+H N+V L  +  +  E+ +   LV+E++   L + L+D     ++ N        K
Sbjct: 59  KDLKHANIVTL--HDIIHTEKSLT--LVFEYLDKDLKQYLDDCGNSINMHNV-------K 107

Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
             L  +L    GL Y H     +V++RD K  N+L++E    KL+DFGLAR   +   T+
Sbjct: 108 LFLFQLL---RGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161

Query: 250 VSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            +  V  T  Y  PD  + +   + + D+W  G + YEM TGR
Sbjct: 162 SNEVV--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 76/240 (31%), Positives = 108/240 (45%), Gaps = 29/240 (12%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ---WVAEVQF 136
           DF     +G G FG V  +  K     GT E    AIK L +  +   KQ      E   
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHK-----GTGE--YYAIKCLKKREILKMKQVQHVAQEKSI 71

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHII 195
           L  L HP +V +   C+   E  +  LL  EF++   L  HL     FP    K     +
Sbjct: 72  LMELSHPFIVNM--MCSFQDENRVYFLL--EFVVGGELFTHLRKAGRFPNDVAKFYHAEL 127

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           + A E   YLH      +IYRD K  N+LLD     K++DFG A++ P    T     + 
Sbjct: 128 VLAFE---YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LC 176

Query: 256 GTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRP-KTEQRLLEWVQQYP 313
           GT  Y AP+ I++ GH  A  D W+ GV+LYE + G      + P +  +++L    ++P
Sbjct: 177 GTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP 235

Length = 329

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 71.1 bits (174), Expect = 7e-14
 Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 32/213 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK--QWVAEVQFLGVLEHP 143
           ++G+G FG+VY    K A     +E  +  +K++    L  ++  Q   E Q L  L+HP
Sbjct: 7   RLGKGSFGTVYLVKDKKA----VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 144 NLVKLIG-------YCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHI 194
            +VK          +C           ++ E+   R L+  L         L        
Sbjct: 63  AIVKFHASFLERDAFC-----------IITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
            +    G+ Y+H+    ++++RD KA N+ L  N   K+ DFG++R   ++G   ++T  
Sbjct: 112 FIQLLLGVHYMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRL--LMGSCDLATTF 165

Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEM 287
            GT  Y +P+ ++     +KSD+WS G +LYEM
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 71.2 bits (174), Expect = 7e-14
 Identities = 66/242 (27%), Positives = 104/242 (42%), Gaps = 25/242 (10%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           F +   +G+GGFG V    ++       +   + A K+L +  ++  K     +    +L
Sbjct: 2   FRQYRVLGKGGFGEVCACQVR-------ATGKMYACKRLEKKRIKKRKGESMALNEKQIL 54

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           E  N  + +   A   E      LV   M    L+ H++N   P    +     +  AAE
Sbjct: 55  EKVN-SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE---RALFYAAE 110

Query: 201 ---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
              GL  LH       +YRD K  N+LLD+    ++SD GLA + P           VGT
Sbjct: 111 ILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIP---EGESIRGRVGT 164

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR-----RSLERNRPKTEQRLLEWVQQY 312
            GY AP+ +     T   D W  G ++YEM+ G+     R  +  R + ++R+LE  + Y
Sbjct: 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY 224

Query: 313 PA 314
            A
Sbjct: 225 SA 226

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 67/212 (31%), Positives = 97/212 (45%), Gaps = 30/212 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQ-FLGVLEH 142
           IG+G FG V  +  K       ++    A+K L +  +   K+    +AE    L  ++H
Sbjct: 3   IGKGSFGKVLLAKHK-------ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH 55

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIILGAAE- 200
           P LV L  Y     ++      V +++    L  HL   R+FP    + R +    AAE 
Sbjct: 56  PFLVGL-HYSFQTADK---LYFVLDYVNGGELFFHLQRERSFPEP--RARFY----AAEI 105

Query: 201 --GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
              L YLH    + +IYRD K  N+LLD      L+DFGL +EG  + H+  ++   GT 
Sbjct: 106 ASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEG--IEHSKTTSTFCGTP 160

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            Y AP+ +         D W  G VLYEML G
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.5 bits (175), Expect = 8e-14
 Identities = 51/148 (34%), Positives = 73/148 (49%), Gaps = 23/148 (15%)

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           GL +LH      +IYRD K  NV+LD +   K++DFG+ +E  + G    ST   GT  Y
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN-VFGDNRAST-FCGTPDY 162

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ----YP--- 313
            AP+ ++    T   D WSFGV+LYEML G+     +    E  L E ++     YP   
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD---DEDELFESIRVDTPHYPRWI 219

Query: 314 -ADSKKFGLIMDPRLEKEYSINEARKIG 340
             +SK         LEK +  +  R++G
Sbjct: 220 TKESKDI-------LEKLFERDPTRRLG 240

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.9 bits (174), Expect = 8e-14
 Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 35/224 (15%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQF 136
           + ++ KIGEG +G+V+K     A    T E  +VA+K++  D    G+      + E+  
Sbjct: 2   YEKLEKIGEGTYGTVFK-----AKNRETHE--IVALKRVRLDDDDEGVPSSA--LREICL 52

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII- 195
           L  L+H N+V+L  Y  +  ++ +   LV+E+       D    + F          I+ 
Sbjct: 53  LKELKHKNIVRL--YDVLHSDKKL--TLVFEYC------DQDLKKYFDSCNGDIDPEIVK 102

Query: 196 ---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVS 251
                  +GLA+ H      V++RD K  N+L+++N   KL+DFGLAR  G  V      
Sbjct: 103 SFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---RCY 156

Query: 252 TAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSL 294
           +A V T  Y  PD +    L + S D+WS G +  E+    R L
Sbjct: 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 71.2 bits (174), Expect = 9e-14
 Identities = 67/230 (29%), Positives = 115/230 (50%), Gaps = 24/230 (10%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHK-QWVAEVQFL 137
           + ++ K+GEG + +V+K         G S+ T  +VA+K++  +  +G     + EV  L
Sbjct: 7   YVKLDKLGEGTYATVFK---------GRSKLTENLVALKEIRLEHEEGAPCTAIREVSLL 57

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
             L+H N+V L  +  +  ER +   LV+E+ L+  L+ +L N          ++  +  
Sbjct: 58  KNLKHANIVTL--HDIIHTERCLT--LVFEY-LDSDLKQYLDNCGNLMSMHNVKI-FMFQ 111

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
              GL+Y H+    ++++RD K  N+L++E    KL+DFGLAR   +   T+ +  V  T
Sbjct: 112 LLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--T 166

Query: 258 FGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 306
             Y  PD  + +   +   D+W  G +LYEM TGR     +  K E  L+
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 71.0 bits (174), Expect = 9e-14
 Identities = 73/244 (29%), Positives = 110/244 (45%), Gaps = 34/244 (13%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLEHP 143
           +G+GGFG V    ++ A G       + A KKL +  ++   G    + E Q L  +   
Sbjct: 8   LGKGGFGEVCACQVR-ATG------KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE--- 200
            +V L    A   E      LV   M    L+ H++N   P    +     +  AAE   
Sbjct: 61  FVVSL----AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEE---RAVFYAAEITC 113

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           GL  LH     +++YRD K  N+LLD+    ++SD GLA E P           VGT GY
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIP---EGETIRGRVGTVGY 167

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR-----RSLERNRPKTEQRLLEWVQQYPAD 315
            AP+ ++    T   D W  G ++YEM+ G+     R  +  R + E+R+ E  ++Y   
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY--- 224

Query: 316 SKKF 319
           S+KF
Sbjct: 225 SEKF 228

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 78/286 (27%), Positives = 126/286 (44%), Gaps = 43/286 (15%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----RDGLQGHKQWVAEVQF 136
           F+++ +IG+G FG VYK       G       VVAIK ++     D ++  +Q   E+  
Sbjct: 6   FTKLERIGKGSFGEVYK-------GIDNRTKEVVAIKIIDLEEAEDEIEDIQQ---EITV 55

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           L   + P + +  G       +G +  ++ E++   S  D L           T L  IL
Sbjct: 56  LSQCDSPYITRYYGSYL----KGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL 111

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
              +GL YLH     + I+RD KA+NVLL E    KL+DFG+A  G +          VG
Sbjct: 112 ---KGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVG 163

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 316
           T  + AP+ I+      K+D+WS G+   E+  G        P ++   +  +   P +S
Sbjct: 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE------PPNSDLHPMRVLFLIPKNS 217

Query: 317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                   P LE +YS    +      + CL+K  + RP   ++++
Sbjct: 218 P-------PTLEGQYS----KPFKEFVEACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 25/206 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNL 145
           +G G  G+VYK+              ++A+K +  D  ++  KQ ++E++ L   + P +
Sbjct: 9   LGHGNGGTVYKAYHLLTR-------RILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           +   G   V+    I      EFM   SL+       +  +P      I +   +GL YL
Sbjct: 62  IGFYGAFFVENRISI----CTEFMDGGSLD------VYRKIPEHVLGRIAVAVVKGLTYL 111

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 265
                +++++RD K SN+L++   + KL DFG++ +  +V    ++   VGT  Y AP+ 
Sbjct: 112 ---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQ--LV--NSIAKTYVGTNAYMAPER 164

Query: 266 IETGHLTAKSDVWSFGVVLYEMLTGR 291
           I        SDVWS G+   E+  GR
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 72/233 (30%), Positives = 104/233 (44%), Gaps = 41/233 (17%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGH--KQWVAEVQFLGVL-EH 142
           +G+G FG V  + +K           + A+K L +D  LQ    +  + E + L +   H
Sbjct: 3   LGKGSFGKVMLARLK-------ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 55

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-----FNRAFPPLPWKTRLHIILG 197
           P L +L   C    +R      V EF+    L  H+     F+ A      + R +    
Sbjct: 56  PFLTQLY-CCFQTPDR---LFFVMEFVNGGDLMFHIQKSRRFDEA------RARFY---- 101

Query: 198 AAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           AAE    L +LH+     +IYRD K  NVLLD     KL+DFG+ +EG   G T  ++  
Sbjct: 102 AAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTF 156

Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 307
            GT  Y AP+ ++        D W+ GV+LYEML G    E    + E  L E
Sbjct: 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE---AENEDDLFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 24/238 (10%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           F +   +G+GGFG V    ++       +   + A KKL +  ++  K     +    +L
Sbjct: 2   FRQYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGESMALNEKQIL 54

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           E  N  + +   A   E      LV   M    L+ H+++              +  AAE
Sbjct: 55  EKVN-SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG---RAVFYAAE 110

Query: 201 ---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
              GL  LH+    +++YRD K  N+LLD++   ++SD GLA   P           VGT
Sbjct: 111 ICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGT 164

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE----QRLLEWVQQ 311
            GY AP+ ++    T   D W+ G +LYEM+ G+   ++ + K +    +RL++ VQ+
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE 222

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 40/101 (39%), Positives = 55/101 (54%), Gaps = 8/101 (7%)

Query: 198 AAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           AAE    L +LH      VIYRD K  N+LLD     KL+DFG+ +EG + G T  +T  
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTF 156

Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
            GT  Y AP+ ++        D W+ GV++YEM+ G+   E
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 67/303 (22%), Positives = 137/303 (45%), Gaps = 40/303 (13%)

Query: 86  KIGEGGFGSVYKSSIKP---------AAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQ 135
           K+GEG FG V+    +          +     ++  +VA+K L  D  +  +  ++ E++
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRA-----FPPL 186
            +  L+ PN+++L+  C           ++ E+M    LN+ L  H    A        +
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPL----CMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 187 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            + T + +    A G+ YL     +  ++RD    N L+ +N+  K++DFG++R      
Sbjct: 128 SYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184

Query: 247 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK---TEQ 303
           +  +    V    + + + I  G  T  SDVW+FGV L+E+LT    L + +P    +++
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT----LCKEQPYSQLSDE 240

Query: 304 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 363
           +++E   ++  D  +   +  P L  +        + +L  +C  +++K+RP   ++   
Sbjct: 241 QVIENTGEFFRDQGRQVYLPKPALCPD-------SLYKLMLSCWRRNAKERPSFQEIHAT 293

Query: 364 LKQ 366
           L +
Sbjct: 294 LLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 69/240 (28%), Positives = 106/240 (44%), Gaps = 26/240 (10%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN-- 144
           +G+GGFG V    ++       +   + A KKL +  ++  K     +    +LE  N  
Sbjct: 8   LGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
            V  + Y     E      LV   M    L+ H++N   P    +     I  AAE    
Sbjct: 61  FVVSLAYAY---ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ---RAIFYAAELCCG 114

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 264
           L +    +++YRD K  N+LLD+    ++SD GLA + P           VGT GY AP+
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIP---EGETVRGRVGTVGYMAPE 171

Query: 265 YIETGHLTAKSDVWSFGVVLYEMLTG----RRSLER-NRPKTEQRLLEWVQQYPADSKKF 319
            I     T   D W  G ++YEM+ G    R+  ER  R + ++R+ E  ++Y   S+KF
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEY---SEKF 228

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 37/90 (41%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y 
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYL 162

Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ +E        D W  GVV+YEM+ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 73/247 (29%), Positives = 109/247 (44%), Gaps = 29/247 (11%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ---WVAEVQF 136
           DF+ ++ +G+G FG V  +  K     GT E  + AIK L +D +         + E + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERK-----GTDE--LYAIKILKKDVVIQDDDVECTMVEKRV 53

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
           L +   P  +  +  C     + + RL  V E++    L   +        P     H +
Sbjct: 54  LALSGKPPFLTQLHSCF----QTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP-----HAV 104

Query: 196 LGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             AAE   GL +LH      +IYRD K  NV+LD     K++DFG+ +E    G T  + 
Sbjct: 105 FYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TK 159

Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQ 311
              GT  Y AP+ I         D W+FGV+LYEML G+   E  +  +  Q ++E    
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 219

Query: 312 YPADSKK 318
           YP    K
Sbjct: 220 YPKSMSK 226

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 64/227 (28%), Positives = 106/227 (46%), Gaps = 47/227 (20%)

Query: 87  IGEGGFGSVY-------------KSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAE 133
           IG G FGSVY             K    P+       A+    K+   D L        E
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVS-----ASSKDRKRSMLDALAR------E 56

Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNR-AFPPLPWKTR 191
           +  L  L+H N+V+ +G  ++D +     L ++ E++   S+   L N  AF     +  
Sbjct: 57  IALLKELQHENIVQYLG-SSLDADH----LNIFLEYVPGGSVAALLNNYGAFEETLVRNF 111

Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
           +  IL   +GL YLH      +I+RD K +N+L+D     K+SDFG++++   +    +S
Sbjct: 112 VRQIL---KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK---LEANSLS 162

Query: 252 TA-------VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           T        + G+  + AP+ ++    T K+D+WS G ++ EMLTG+
Sbjct: 163 TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 69.1 bits (169), Expect = 2e-13
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 22/219 (10%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA--EVQFLG 138
           + ++ KIGEG FG   K+ +  +  DG        IK++N   +   ++  +  EV  L 
Sbjct: 2   YVKVKKIGEGSFG---KAILVKSKEDGKQ----YVIKEINISKMSPKEREESRKEVAVLS 54

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            ++HPN+V+   Y     E G    +V ++     L   +  +     P    L   +  
Sbjct: 55  NMKHPNIVQ---YQESFEENG-NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQI 110

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA--VVG 256
              L ++H+    ++++RD K+ N+ L ++   KL DFG+AR    V ++ V  A   +G
Sbjct: 111 CLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR----VLNSTVELARTCIG 163

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
           T  Y +P+  E      KSD+W+ G VLYEM T + + E
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 27/223 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA--EVQF 136
           + + ++ KIG+G FG V+K+  K           +VA+KK+  +  +      A  E++ 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHK-------KTKQIVALKKVLMENEKEGFPITALREIKI 64

Query: 137 LGVLEHPNLVKLIGYC-----AVDGERGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWK 189
           L +L+H N+V LI  C       +  +G    LV+EF     L   L N+   F     K
Sbjct: 65  LQLLKHENVVNLIEICRTKATPYNRYKG-SFYLVFEF-CEHDLAGLLSNKNVKFTLSEIK 122

Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGH 247
             + ++L    GL Y+H     ++++RD KA+N+L+ ++   KL+DFGLAR         
Sbjct: 123 KVMKMLL---NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176

Query: 248 THVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLT 289
            +  T  V T  Y  P+  +         D+W  G ++ EM T
Sbjct: 177 PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 30/213 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHK-QWVAEVQFLGVLEH 142
           K+GEG + +VYK         G S+ T  +VA+K++  +  +G     + E   L  L+H
Sbjct: 12  KLGEGSYATVYK---------GRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKH 62

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
            N+V L  +  +  ++ +   LV+E++   L + ++D            +  L  +L   
Sbjct: 63  ANIVTL--HDIIHTKKTLT--LVFEYLDTDLKQYMDDC--GGGLSMHNVRLFLFQLL--- 113

Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            GLAY H+    +V++RD K  N+L+ E    KL+DFGLAR   +   T+ S  VV T  
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEVV-TLW 168

Query: 260 YAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
           Y  PD  + +   +   D+W  G + YEM TGR
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 32/218 (14%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D  R+  +G G FG V+   ++    +      V+AI ++ R   + H     E + L  
Sbjct: 2   DLERIKTVGTGTFGRVHL--VRDRISEHYYALKVMAIPEVIRLKQEQHVH--NEKRVLKE 57

Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG-- 197
           + HP +++L  +     +R +  L+  E++    L  +L N          R     G  
Sbjct: 58  VSHPFIIRL--FWTEHDQRFLYMLM--EYVPGGELFSYLRNSG--------RFSNSTGLF 105

Query: 198 -AAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            A+E    L YLH     +++YRD K  N+LLD+    KL+DFG A++  +   T     
Sbjct: 106 YASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTW---T 157

Query: 254 VVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTG 290
           + GT  Y AP+ I+  GH  A  D W+ G+++YEML G
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 69.1 bits (169), Expect = 4e-13
 Identities = 71/247 (28%), Positives = 104/247 (42%), Gaps = 30/247 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHP 143
           +G+GGFG V    ++ A G       + A KKLN+  L   +G++  + E + L  +   
Sbjct: 1   LGKGGFGEVSACQMR-ATG------KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSR 53

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEG 201
            +V L    A   +      LV   M    L  H++N     P  P             G
Sbjct: 54  FIVSL----AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           L +LH+    ++IYRD K  NVLLD +   ++SD GLA E  +      +    GT G+ 
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVE--LKDGQSKTKGYAGTPGFM 164

Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-----QRLLEWVQQYP--- 313
           AP+ ++        D ++ GV LYEM+  R        K E     QR+L     YP   
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKF 224

Query: 314 -ADSKKF 319
              SK F
Sbjct: 225 SPASKSF 231

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 69.9 bits (171), Expect = 5e-13
 Identities = 38/110 (34%), Positives = 52/110 (47%), Gaps = 3/110 (2%)

Query: 185 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           PLP +  + I     E LAYLH      +I+RD K  N+ LDE     L DFG A +   
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237

Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
              T       GT    +P+ +      AK+D+WS G+VL+EM     +L
Sbjct: 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 44/225 (19%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH---KQWVAEVQ 135
            DF  + ++G+GG+G V+ +  K      T E  +VA+K++ +  L      +  + E  
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKK-----DTGE--IVALKRMKKSLLFKLNEVRHVLTERD 53

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEF--------MLN--RSLEDHLFNRAFPP 185
            L   +   LVKL+ Y   D E      L  E+        +LN    L +         
Sbjct: 54  ILTTTKSEWLVKLL-YAFQDDE---YLYLAMEYVPGGDFRTLLNNLGVLSED-------- 101

Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 245
                R ++    AE    +    E+  I+RD K  N L+D +   KL+DFGL++     
Sbjct: 102 ---HARFYM----AEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY 154

Query: 246 GHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            ++     VVG+  Y AP+ +         D WS G +LYE L G
Sbjct: 155 ANS-----VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 69.2 bits (169), Expect = 6e-13
 Identities = 90/349 (25%), Positives = 153/349 (43%), Gaps = 48/349 (13%)

Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW-- 130
           + +    DF+ +  +G G FG V  ++ K        +   VAIK+  +  +   KQ   
Sbjct: 24  KNKMKYEDFNFIRTLGTGSFGRVILATYK------NEDFPPVAIKRFEKSKIIKQKQVDH 77

Query: 131 -VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPW 188
             +E + L  + HP  V L G    +        LV EF++       L  N+ FP    
Sbjct: 78  VFSERKILNYINHPFCVNLYGSFKDES----YLYLVLEFVIGGEFFTFLRRNKRFPN--- 130

Query: 189 KTRLHIILGAAEGLAYLHEGLE-VQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
                +    A  +  + E L+ + ++YRD K  N+LLD++   K++DFG A+    V  
Sbjct: 131 ----DVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK----VVD 182

Query: 248 THVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP-KTEQRL 305
           T   T + GT  Y AP+  +  GH  A +D W+ G+ +YE+L G      N P    Q++
Sbjct: 183 TRTYT-LCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEPLLIYQKI 240

Query: 306 LEWVQQYPADSKKFGLIMDPR----LEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV- 360
           LE +  +P    KF   +D      ++K  S +  ++ G L     +++ K+ P    + 
Sbjct: 241 LEGIIYFP----KF---LDNNCKHLMKKLLSHDLTKRYGNLKKG--AQNVKEHPWFGNID 291

Query: 361 -VERLKQIVQVSNE---GDSFDKTFEEICEEDPVEAQTKQKQHEPSEAW 405
            V  L + V+V  +    + FD +  E  +ED   A     +++P   W
Sbjct: 292 WVSLLHKNVEVPYKPKYKNVFDSSNFERVQEDLTIADKITNENDPFFDW 340

Length = 340

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 68.9 bits (168), Expect = 7e-13
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 28/217 (12%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHK-QWVAEVQFL 137
           + ++ K+GEG + +V+K         G S+ T  +VA+K++  +  +G     + EV  L
Sbjct: 8   YIKLEKLGEGTYATVFK---------GRSKLTENLVALKEIRLEHEEGAPCTAIREVSLL 58

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHII 195
             L+H N+V L      D        LV+E+ L++ L+ ++ +          K  L+ I
Sbjct: 59  KDLKHANIVTLHDIVHTDK----SLTLVFEY-LDKDLKQYMDDCGNIMSMHNVKIFLYQI 113

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           L    GLAY H     +V++RD K  N+L++E    KL+DFGLAR   +   T+ +  V 
Sbjct: 114 L---RGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV- 166

Query: 256 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            T  Y  PD  + +   + + D+W  G + +EM +GR
Sbjct: 167 -TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 9e-13
 Identities = 39/93 (41%), Positives = 51/93 (54%), Gaps = 5/93 (5%)

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-EGPMVGHTHVSTAVVGTFG 259
           GL Y+H      V++RD K SN+LL+ N   K+ DFGLAR   P   HT   T  V T  
Sbjct: 118 GLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 260 YAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
           Y AP+ +       K+ D+WS G +L EML+ R
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 17/211 (8%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQF 136
           +F    KIG G F  VY+++          +   VA+KK+    +   +  +  V E+  
Sbjct: 3   NFQIEKKIGRGQFSEVYRATC-------LLDRKPVALKKVQIFEMMDAKARQDCVKEIDL 55

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           L  L HPN++K +     D E  I   L     L++ ++   F +    +P +T     +
Sbjct: 56  LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIK--YFKKQKRLIPERTVWKYFV 113

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
                + ++H     +V++RD K +NV +      KL D GL R       T  + ++VG
Sbjct: 114 QLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVG 168

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEM 287
           T  Y +P+ I       KSD+WS G +LYEM
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 75/280 (26%), Positives = 120/280 (42%), Gaps = 36/280 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAE--VQFLGVLEHPN 144
           +G+G +G V   S+     DG        IKKLN       ++  AE   Q L  L+HPN
Sbjct: 8   VGKGSYGEV---SLVRHRTDGKQ----YVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +V      + +GE G    +V  F     L   L  +    LP    +   +  A  L Y
Sbjct: 61  IVAYRE--SWEGEDG-LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 264
           LHE     +++RD K  NV L      K+ D G+AR   +     +++ ++GT  Y +P+
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTLIGTPYYMSPE 172

Query: 265 YIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYPADSKKFGLIM 323
                    KSDVW+ G  +YEM T + +   ++      R++E            G + 
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE------------GKL- 219

Query: 324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 363
            P + K+YS     ++G L    LSK  + RP +  ++ +
Sbjct: 220 -PPMPKDYS----PELGELIATMLSKRPEKRPSVKSILRQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 71/229 (31%), Positives = 103/229 (44%), Gaps = 28/229 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QGHKQWVAEVQFLGVL 140
           +G+GG+G V++         G     + A+K L +  +        H +  AE   L  +
Sbjct: 4   LGKGGYGKVFQVR----KVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNILEAV 57

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAA 199
           +HP +V LI      G    +  L+ E++    L  HL     F        L  I  A 
Sbjct: 58  KHPFIVDLIYAFQTGG----KLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA- 112

Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
             L +LH+     +IYRD K  N+LLD     KL+DFGL +E    G   V+    GT  
Sbjct: 113 --LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIE 165

Query: 260 YAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLL 306
           Y AP+ +  +GH  A  D WS G ++Y+MLTG       NR KT  ++L
Sbjct: 166 YMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 85/298 (28%), Positives = 126/298 (42%), Gaps = 39/298 (13%)

Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAE 133
           +R     F  +  +G G +G VYK       G       + AIK ++  G +  ++   E
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYK-------GRHVKTGQLAAIKVMDVTGDE-EEEIKQE 52

Query: 134 VQFLGVL-EHPNLVKLIGYCAVDGERGI--QRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 190
           +  L     H N+    G        G+  Q  LV EF    S+ D + N     L  + 
Sbjct: 53  INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW 112

Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL-AREGPMVGHTH 249
             +I      GL++LH+    +VI+RD K  NVLL EN   KL DFG+ A+    VG  +
Sbjct: 113 IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 169

Query: 250 VSTAVVGTFGYAAPDYI---ETGHLTA--KSDVWSFGVVLYEMLTGRRSLERNRPKTEQR 304
                +GT  + AP+ I   E    T   KSD+WS G+   EM  G   L    P    R
Sbjct: 170 ---TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MR 223

Query: 305 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
            L  + + PA          PRL+   S   ++K     ++CL K+   RP   Q+++
Sbjct: 224 ALFLIPRNPA----------PRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 36/90 (40%), Positives = 51/90 (56%), Gaps = 5/90 (5%)

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           GL YLHE    +++YRD K  N+LLD     K++DFGL +EG  +G    ++   GT  +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEG--MGFGDRTSTFCGTPEF 167

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            AP+ +     T   D W  GV++YEML G
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 5/90 (5%)

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           L +LHE     +IYRD K  NVLLD     KL+D+G+ +EG   G T  ++   GT  Y 
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYI 163

Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ +         D W+ GV+++EM+ GR
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 71/247 (28%), Positives = 111/247 (44%), Gaps = 29/247 (11%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ---WVAEVQF 136
           DF+ ++ +G+G FG V  +  K     GT E  + AIK L +D +         + E + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERK-----GTDE--LYAIKILKKDVVIQDDDVECTMVEKRV 53

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
           L + + P  +  +  C     + + RL  V E++    L  H+        P       +
Sbjct: 54  LALQDKPPFLTQLHSCF----QTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-----QAV 104

Query: 196 LGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             AAE   GL +LH      +IYRD K  NV+LD     K++DFG+ +E  + G T  + 
Sbjct: 105 FYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TR 159

Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQ 311
              GT  Y AP+ I         D W++GV+LYEML G+   +  +  +  Q ++E    
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219

Query: 312 YPADSKK 318
           YP    K
Sbjct: 220 YPKSLSK 226

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 60/304 (19%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV--VAIKKL-----NRDGLQGHKQWVAEVQFLGV 139
           +GEG FGSV +       G    + ++  VA+K +      R  ++    +++E   +  
Sbjct: 7   LGEGEFGSVME-------GQLNQDDSILKVAVKTMKIAICTRSEME---DFLSEAVCMKE 56

Query: 140 LEHPNLVKLIGYC--AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP----LPWKTRLH 193
            +HPN+++LIG C   V+ E     +++  FM +  L   L           LP +  + 
Sbjct: 57  FDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK 116

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE---GPMVGHTHV 250
            +   A G+ YL        I+RD  A N +L+EN    ++DFGL+++   G       +
Sbjct: 117 FMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI 173

Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 309
           +   V    + A + +     T KSDVWSFGV ++E+ T  ++     P  E   + +++
Sbjct: 174 AKMPVK---WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQT---PYPGVENSEIYDYL 227

Query: 310 QQ-----YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 364
           +Q      P D           L+  YS         L  +C   + KDRP    +   L
Sbjct: 228 RQGNRLKQPPDC----------LDGLYS---------LMSSCWLLNPKDRPSFETLRCEL 268

Query: 365 KQIV 368
           ++ +
Sbjct: 269 EKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 19/210 (9%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           ++R  KIG+G  G+VY ++I  A G        VAIK++N       +  + E+  +   
Sbjct: 21  YTRFEKIGQGASGTVY-TAIDVATG------QEVAIKQMNLQQQPKKELIINEILVMREN 73

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           +HPN+V  +    V    G +  +V E++   SL D +                 L A E
Sbjct: 74  KHPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 129

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
              +LH     QVI+RD K+ N+LL  +   KL+DFG   +  +       + +VGT  +
Sbjct: 130 ---FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYW 181

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            AP+ +       K D+WS G++  EM+ G
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 38/91 (41%), Positives = 50/91 (54%), Gaps = 4/91 (4%)

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH   E  V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 107 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEY 162

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           L +LH+   + +IYRD K  N+LLD      L+DFGL++E  +      + +  GT  Y 
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIEYM 173

Query: 262 APDYI---ETGHLTAKSDVWSFGVVLYEMLTG 290
           AP+ I     GH  A  D WS GV+ +E+LTG
Sbjct: 174 APEVIRGGSGGHDKA-VDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 68/247 (27%), Positives = 108/247 (43%), Gaps = 46/247 (18%)

Query: 59  YEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVV 114
           YE+ A  +      ++R    DF  +  IG G FG V    +KSS             V 
Sbjct: 28  YEKAAEKIT-----KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSS-----------KQVY 71

Query: 115 AIKKLNRDGLQGHKQWVAEVQFL----GVLEHPN---LVKLIGYCAVDGERGIQRLLVYE 167
           A+K L++  +       ++  F      ++ H N   +V+L  + A   ++ +   +V E
Sbjct: 72  AMKLLSKFEMIKR----SDSAFFWEERDIMAHANSEWIVQL--HYAFQDDKYL--YMVME 123

Query: 168 FMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE 227
           +M    L + + N   P   W  R +        L  +H    +  I+RD K  N+LLD+
Sbjct: 124 YMPGGDLVNLMSNYDIPE-KW-ARFY-TAEVVLALDAIH---SMGFIHRDVKPDNMLLDK 177

Query: 228 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET----GHLTAKSDVWSFGVV 283
           +   KL+DFG   +    G     TA VGT  Y +P+ +++    G+   + D WS GV 
Sbjct: 178 SGHLKLADFGTCMKMDANGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236

Query: 284 LYEMLTG 290
           LYEML G
Sbjct: 237 LYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 45/141 (31%), Positives = 70/141 (49%), Gaps = 20/141 (14%)

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L +LH+   + +IYRD K  N+LLD N    L+DFGL++E         + +  GT  Y
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-HEDEVERAYSFCGTIEY 172

Query: 261 AAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSL-----ERNRPKTEQRLLEWVQQY 312
            APD +   + GH  A  D WS GV++YE+LTG         + ++ +  +R+L+    Y
Sbjct: 173 MAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 231

Query: 313 PADSKKFG-------LIMDPR 326
           P +            L+ DP+
Sbjct: 232 PQEMSALAKDIIQRLLMKDPK 252

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 65.7 bits (160), Expect = 4e-12
 Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 23/215 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPN 144
           +IG G FG V           G S+A VV +K+L           ++ EVQ    L HPN
Sbjct: 2   EIGNGWFGKVLLGEAH----RGMSKARVV-VKELRASATPDEQLLFLQEVQPYRELNHPN 56

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIILG--AAEG 201
           +++ +G C       I  LLV EF     L+++L  NR       +  +   +    A G
Sbjct: 57  VLQCLGQCI----ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           L +LH+      I+ D    N  L  +   K+ D+GLA E     +            + 
Sbjct: 113 LLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169

Query: 262 APDYIETGH-------LTAKSDVWSFGVVLYEMLT 289
           AP+ +E           T KS++WS GV ++E+ T
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 35/91 (38%), Positives = 50/91 (54%), Gaps = 5/91 (5%)

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH G   +++YRD K  N++LD++   K++DFGL +EG  +          GT  Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEG--ITDAATMKTFCGTPEY 161

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 44/128 (34%), Positives = 65/128 (50%), Gaps = 12/128 (9%)

Query: 193 HIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
           H    AAE    L +LHE     +IYRD K  NVLLD +   KL+D+G+ +EG   G T 
Sbjct: 97  HARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT- 152

Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE--RNRP--KTEQRL 305
            ++   GT  Y AP+ +         D W+ GV+++EM+ GR   +   + P   TE  L
Sbjct: 153 -TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL 211

Query: 306 LEWVQQYP 313
            + + + P
Sbjct: 212 FQVILEKP 219

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 26/209 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FG VYK+  K       + A V+  K  + + L+    ++ E++ L    HP +
Sbjct: 19  ELGDGAFGKVYKAKNKETGA--LAAAKVIETK--SEEELE---DYMVEIEILATCNHPYI 71

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEGLA 203
           VKL+G    DG+  I    + EF    +++  +   +R       +     +L   E L 
Sbjct: 72  VKLLGAFYWDGKLWI----MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML---EALQ 124

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    +++I+RD KA NVLL  +   KL+DFG++ +   V       + +GT  + AP
Sbjct: 125 YLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN--VKTLQRRDSFIGTPYWMAP 179

Query: 264 DYI--ETGHLTA---KSDVWSFGVVLYEM 287
           + +  ET   T    K+D+WS G+ L EM
Sbjct: 180 EVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 30/214 (14%)

Query: 87  IGEGGFGSVY---------KSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFL 137
           +G G FG VY         + ++K    D  S+ T   +  L             E+Q L
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALE-----------CEIQLL 58

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
             L H  +V+  G C  D E   ++L ++ E+M   S++D L  +A+  L          
Sbjct: 59  KNLRHDRIVQYYG-CLRDPEE--KKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTR 113

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS-TAVV 255
              +G++YLH  +   +++RD K +N+L D     KL DFG ++    +  +     +V 
Sbjct: 114 QILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170

Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           GT  + +P+ I       K+DVWS    + EMLT
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 66/222 (29%), Positives = 98/222 (44%), Gaps = 35/222 (15%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQ 135
           TN +  +  +G G FG V       +A D  +   V AIKK+ +        K+   E++
Sbjct: 9   TNRYVDLQPVGMGAFGLVC------SARDQLTGQNV-AIKKIMKPFSTPVLAKRTYRELK 61

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRL 192
            L  L H N+   I    +          V E +   L+R L      + F     +  L
Sbjct: 62  LLKHLRHENI---ISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFI----QYFL 114

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHV 250
           + IL    GL Y+H      V++RD K SN+L++EN   K+ DFGLAR  +  M G+   
Sbjct: 115 YQIL---RGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY--- 165

Query: 251 STAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGR 291
               V T  Y AP+ + T      + D+WS G +  EML G+
Sbjct: 166 ----VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 65.5 bits (159), Expect = 7e-12
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 19/210 (9%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           ++R  KIG+G  G+V+ +          +    VAIK++N       +  + E+  +  L
Sbjct: 21  YTRYEKIGQGASGTVFTAI-------DVATGQEVAIKQINLQKQPKKELIINEILVMKEL 73

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           ++PN+V  +    V    G +  +V E++   SL D +                 L A E
Sbjct: 74  KNPNIVNFLDSFLV----GDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALE 129

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
              +LH     QVI+RD K+ NVLL  +   KL+DFG   +  +       + +VGT  +
Sbjct: 130 ---FLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYW 181

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            AP+ +       K D+WS G++  EM+ G
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 28/215 (13%)

Query: 87  IGEGGFGSVY---------KSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFL 137
           +G+G FG VY         + + K    D  S  T   +  L             E+Q L
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALE-----------CEIQLL 58

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
             L+H  +V+  G      E+ +   +  E+M   S++D L  +A+  L           
Sbjct: 59  KNLQHERIVQYYGCLRDRAEKTLT--IFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQ 114

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST-AVVG 256
             EG++YLH  +   +++RD K +N+L D     KL DFG ++    +  +     +V G
Sbjct: 115 ILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           T  + +P+ I       K+DVWS G  + EMLT +
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 66/216 (30%), Positives = 97/216 (44%), Gaps = 25/216 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLGVL-EH 142
           ++G+G +G V   S + A    TSE   VAIKK+          K+ + E++ L     H
Sbjct: 7   ELGQGAYGIV--CSARNA---ETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI---ILGAA 199
            N+  L     V        L +YE ++   L  H   R+  PL   T  H    I    
Sbjct: 62  KNITCLYDMDIVFPG-NFNELYLYEELMEADL--HQIIRSGQPL---TDAHFQSFIYQIL 115

Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVG 256
            GL Y+H      V++RD K  N+L++ +   K+ DFGLAR   E P      + T  V 
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVA 171

Query: 257 TFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
           T  Y AP+ + +     K+ DVWS G +L E+L  +
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 37/90 (41%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y 
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYL 162

Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ +E        D W  GVV+YEM+ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 37/222 (16%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH---KQWVAEVQFL 137
           ++ + ++G G +GSV  S+I    G+       VAIKKL+R   Q     K+   E+  L
Sbjct: 17  YTSLKQVGSGAYGSVC-SAIDKRTGEK------VAIKKLSRP-FQSEIFAKRAYRELTLL 68

Query: 138 GVLEHPNLVKLIG-YCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKTRL 192
             ++H N++ L+  + +       Q   LV  +M   L + +   L       L ++   
Sbjct: 69  KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM-- 126

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHV 250
                   GL Y+H      +I+RD K  N+ ++E+   K+ DFGLAR  +  M G+   
Sbjct: 127 ------LCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY--- 174

Query: 251 STAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGR 291
               V T  Y AP+ I    H     D+WS G ++ EMLTG+
Sbjct: 175 ----VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 51/170 (30%), Positives = 75/170 (44%), Gaps = 13/170 (7%)

Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E   L  ++HPN+V        DG   I    V E+     L   +  +     P  T L
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYI----VMEYCDGGDLMQKIKLQRGKLFPEDTIL 103

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHV 250
              +    G+ ++HE    +V++RD K+ N+ L +N + KL DFG AR    P       
Sbjct: 104 QWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA----Y 156

Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 300
           +   VGT  Y  P+  E      KSD+WS G +LYE+ T +   + N  K
Sbjct: 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 24/220 (10%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK--LNRDGLQGHKQWVAEVQFLG 138
           + ++ KIGEG +G VYK+  K       +   +VA+KK  L  D        + E+  L 
Sbjct: 3   YEKLEKIGEGTYGKVYKARDK-------NTGKLVALKKTRLEMDEEGIPPTALREISLLQ 55

Query: 139 VLEH-PNLVKLIGYCAVDGERG-IQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHI 194
           +L     +V+L+    V+ + G     LV+E++ +  +   D        PLP KT    
Sbjct: 56  MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREG--PMVGHTHVS 251
           +    +G+A+ H   +  V++RD K  N+L+D +    K++D GL R    P+  +TH  
Sbjct: 116 MYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH-- 170

Query: 252 TAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTG 290
             +V T  Y AP+ +    H +   D+WS G +  EM   
Sbjct: 171 -EIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 31/212 (14%)

Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +KIGEG  G V  +++K       S   +VA+KK++    Q  +    EV  +   +H N
Sbjct: 26  IKIGEGSTGIVCIATVK-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------IILGA 198
           +V++     V    G +  +V EF+   +L D + +         TR++      + L  
Sbjct: 79  VVEMYNSYLV----GDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAV 125

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
            + L+ LH      VI+RD K+ ++LL  + R KLSDFG   +  +        ++VGT 
Sbjct: 126 LKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTP 180

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            + AP+ I       + D+WS G+++ EM+ G
Sbjct: 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 75/289 (25%), Positives = 115/289 (39%), Gaps = 57/289 (19%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWV-AEVQ 135
           +DF  +  IG G FG V+        G       V A+K L +  +  +     V AE  
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVR-DKDTGQ------VYAMKVLRKSDMIKRNQIAHVRAERD 53

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L   + P +VKL  Y +   E  +   LV E+M    L + L  +   P     R +I 
Sbjct: 54  ILADADSPWIVKL--YYSFQDEEHL--YLVMEYMPGGDLMNLLIRKDVFPEET-ARFYI- 107

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA---------------- 239
              AE +  L    ++  I+RD K  N+L+D +   KL+DFGL                 
Sbjct: 108 ---AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164

Query: 240 -----REGPMVGHT------HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
                R+  +V           + + VGT  Y AP+ +       + D WS GV+LYEML
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Query: 289 TGRRSL-ERNRPKTEQRLLEWVQ--QYPAD---SKKF-----GLIMDPR 326
            G          +T  +++ W +  ++P D   S +       L+ DP 
Sbjct: 225 YGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPE 273

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 66/251 (26%), Positives = 101/251 (40%), Gaps = 62/251 (24%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH---KQWVAEVQF 136
            F ++  +G+G  G V+   +K     GT +  + A+K L++  +      K+ + E + 
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLK-----GTGK--LFALKVLDKKEMIKRNKVKRVLTEQEI 54

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRL 192
           L  L+HP L  L  Y +   E  +   LV ++     L R L+                 
Sbjct: 55  LATLDHPFLPTL--YASFQTETYL--CLVMDYCPGGELFRLLQRQPGKC-LS------EE 103

Query: 193 HIILGAAE---GLAYLH-EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 248
                AAE    L YLH  G    ++YRD K  N+LL E+    LSDF L+++  +    
Sbjct: 104 VARFYAAEVLLALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159

Query: 249 HV---------------------------STAVVGTFGYAAPDYIE-TGHLTAKSDVWSF 280
                                        S + VGT  Y AP+ I   GH  +  D W+ 
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTL 218

Query: 281 GVVLYEMLTGR 291
           G++LYEML G 
Sbjct: 219 GILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 5/95 (5%)

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLHE     +IYRD K  NVLLD     KL+D+G+ +EG   G T  ++   GT  Y
Sbjct: 108 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 162

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
            AP+ +         D W+ GV+++EM+ GR   +
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FG VYK+  K           + A K ++    +  + ++ E+  L   +HPN+
Sbjct: 12  ELGDGAFGKVYKAQNK-------ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VKL+   A   E  +  L+  EF    +++  +     P    + R+ +     E L YL
Sbjct: 65  VKLLD--AFYYENNLWILI--EFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYL 119

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 265
           HE    ++I+RD KA N+L   +   KL+DFG++ +         S   +GT  + AP+ 
Sbjct: 120 HEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEV 174

Query: 266 I--ETGH---LTAKSDVWSFGVVLYEM 287
           +  ET        K+DVWS G+ L EM
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA---EVQFLGVLEHP 143
           +G+G FG VY         D   E  V  ++  + +  +  K+  A   E+Q L  L H 
Sbjct: 10  LGQGAFGRVYLCY----DADTGRELAVKQVQ-FDPESPETSKEVNALECEIQLLKNLLHE 64

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
            +V+  G      ER +   +  E M   S++D L  +++  L             EG++
Sbjct: 65  RIVQYYGCLRDPMERTLS--IFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVS 120

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS-TAVVGTFGYAA 262
           YLH  +   +++RD K +N+L D     KL DFG ++    +  +     +V GT  + +
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           P+ I       K+D+WS G  + EMLT +
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 36/215 (16%)

Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLV--------YEFMLNRSLEDHLFNRAFP 184
           E   L  + HP+++++          G    +V        Y ++  RS           
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV----SGAITCMVLPHYSSDLYTYLTKRS----------R 152

Query: 185 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           PLP    L I     EGL YLH     ++I+RD K  N+ +++  +  + D G A+  P+
Sbjct: 153 PLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPV 208

Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT--- 301
           V    +  A  GT    AP+ +      +K+D+WS G+VL+EML    ++  + P T   
Sbjct: 209 VAPAFLGLA--GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEE 266

Query: 302 -----EQRLLEWVQQYPADSKKFGLIMDPRLEKEY 331
                   LL+ +       ++F      RL + +
Sbjct: 267 YVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGF 301

Length = 357

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 16/207 (7%)

Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFLGVLEHP 143
           +++G G FG V K   K        +   VAIK L  +  +    + + E + +  L++P
Sbjct: 1   VELGSGNFGCVKKGVYKM-----RKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
            +V++IG C  +       +LV E      L   L  +    +     + ++   + G+ 
Sbjct: 56  YIVRMIGVCEAEA-----LMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMK 109

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVVGTFGYAA 262
           YL        ++RD  A NVLL      K+SDFGL++  G    +    +A      + A
Sbjct: 110 YLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYA 166

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT 289
           P+ I     +++SDVWS+G+ ++E  +
Sbjct: 167 PECINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 63.2 bits (154), Expect = 5e-11
 Identities = 66/233 (28%), Positives = 94/233 (40%), Gaps = 62/233 (26%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLGVLEHPN 144
           IG G +G V  S+      +       VAIKK+    D     K+ + E++ L  L+H N
Sbjct: 13  IGRGAYGIVC-SAKNSETNEK------VAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65

Query: 145 LVKLIGYCAVDGERGIQR------LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
           ++ +      D      R       +VYE M                    T LH I+ +
Sbjct: 66  VIAIK-----DIMPPPHREAFNDVYIVYELM-------------------DTDLHQIIRS 101

Query: 199 AE----------------GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 242
           ++                GL Y+H      V++RD K SN+LL+ N   K+ DFGLAR  
Sbjct: 102 SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT 158

Query: 243 PMVGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
              G     T  V T  Y AP+ +      T   DVWS G +  E+L GR+ L
Sbjct: 159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 62.8 bits (152), Expect = 6e-11
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 19/210 (9%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           ++R  KIG+G  G+VY ++I  A G        VAIK++N       +  + E+  +   
Sbjct: 21  YTRFEKIGQGASGTVY-TAIDIATGQE------VAIKQMNLQQQPKKELIINEILVMREN 73

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           ++PN+V  +    V    G +  +V E++   SL D +                 L A  
Sbjct: 74  KNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA-- 127

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L +LH     QVI+RD K+ N+LL  +   KL+DFG   +  +       + +VGT  +
Sbjct: 128 -LDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYW 181

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            AP+ +       K D+WS G++  EM+ G
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 63.2 bits (153), Expect = 6e-11
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 28/218 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G +G VYK+  K    DG  E    A+K++   G+        E+  L  L+HPN+
Sbjct: 8   KVGRGTYGHVYKAKRK----DGKDEKEY-ALKQIEGTGIS--MSACREIALLRELKHPNV 60

Query: 146 VKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRA------FPPLPWKTRLHIILGA 198
           + L        +R +  L  Y E  L   ++ H  ++A       P    K+ L+ IL  
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL-- 118

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAR--EGPMVGHTHVST 252
            +G+ YLH      V++RD K +N+L+     E  R K++D G AR    P+     +  
Sbjct: 119 -DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 253 AVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLT 289
            VV TF Y AP+ +    H T   D+W+ G +  E+LT
Sbjct: 175 VVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 63.0 bits (153), Expect = 6e-11
 Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 25/218 (11%)

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           AE L  L    +  VIYRD K  N+LLD      L DFGL +    +     +    GT 
Sbjct: 100 AELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLN--MKDDDKTNTFCGTP 157

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQQYP--AD 315
            Y AP+ +     T   D W+ GV+LYEMLTG     + N  +  +++L+   ++P   D
Sbjct: 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFD 217

Query: 316 SKKFGLIM-----DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV 370
                L++     DP   +    N A++I        S+ S  +  M  +    K  V  
Sbjct: 218 RDAKDLLIGLLSRDPT--RRLGYNGAQEIKN--HPFFSQLSWKKLLMKGIQPPFKPAVSS 273

Query: 371 SNEGDSFDKTFEEICEEDPVE--------AQTKQKQHE 400
           + +  +FD   EE   E P++        ++T Q+Q  
Sbjct: 274 AIDTSNFD---EEFTREKPIDSVVDDSHLSETVQQQFG 308

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 35/92 (38%), Positives = 46/92 (50%), Gaps = 5/92 (5%)

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           A  L YLH    + ++YRD K  N+LLD      L+DFGL +E   + H   ++   GT 
Sbjct: 106 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN--IEHNGTTSTFCGTP 160

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            Y AP+ +         D W  G VLYEML G
Sbjct: 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 69/212 (32%), Positives = 95/212 (44%), Gaps = 30/212 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQ-FLGVLEH 142
           IG+G FG V  +  K       S+ +  A+K L +  +   K+    +AE    L  L+H
Sbjct: 3   IGKGSFGKVLLAKRK-------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKH 55

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIILGAAE- 200
           P LV L  Y     E+      V +++    L  HL   R F  L  + R +    AAE 
Sbjct: 56  PFLVGL-HYSFQTAEK---LYFVLDYVNGGELFFHLQRERCF--LEPRARFY----AAEV 105

Query: 201 --GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
              + YLH    + +IYRD K  N+LLD      L+DFGL +EG  V     ++   GT 
Sbjct: 106 ASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEG--VEPEETTSTFCGTP 160

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            Y AP+ +         D W  G VLYEML G
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 34/212 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG--HKQWVAEVQFLGVLEHP 143
           ++G G FG+V K   K            VA+K L  D        + + E   +  L++P
Sbjct: 2   ELGSGNFGTVKKGMYKMKKS-----EKTVAVKILKNDNNDPALKDELLREANVMQQLDNP 56

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
            +V++IG C  + E     +LV E      LN+ L+    N+    +  K    ++   +
Sbjct: 57  YIVRMIGIC--EAE---SWMLVMELAELGPLNKFLQK---NKH---VTEKNITELVHQVS 105

Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAV 254
            G+ YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V
Sbjct: 106 MGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPV 162

Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYE 286
                + AP+ +     ++KSDVWSFGV+++E
Sbjct: 163 ----KWYAPECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 62.2 bits (151), Expect = 8e-11
 Identities = 83/300 (27%), Positives = 132/300 (44%), Gaps = 65/300 (21%)

Query: 84  MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK--QWVAEVQFLGVLE 141
           + ++G+G +GSVYK   +P           +A+K++ R  L   K  Q + E+  L    
Sbjct: 6   LDELGKGNYGSVYKVLHRPTG-------VTMAMKEI-RLELDESKFNQIIMELDILHKAV 57

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVY---EFMLNRSLEDHLF--NRAFPPLPWKTRLHIIL 196
            P +V   G   ++G        VY   E+M   SL D L+    A   +P      I  
Sbjct: 58  SPYIVDFYGAFFIEGA-------VYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITY 109

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
              +GL +L E  E  +I+RD K +NVL++ N + KL DFG++  G +V    ++   +G
Sbjct: 110 AVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS--GNLV--ASLAKTNIG 163

Query: 257 TFGYAAPDYIETGHLTA------KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
              Y AP+ I++G          +SDVWS G+ + EM  GR                   
Sbjct: 164 CQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP----------------- 206

Query: 311 QYPADS-----KKFGLIMD---PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
            YP ++      +   I+D   P L   YS ++A+        CL+K    RP  +Q++E
Sbjct: 207 -YPPETYANIFAQLSAIVDGDPPTLPSGYS-DDAQD---FVAKCLNKIPNRRPTYAQLLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 62.4 bits (151), Expect = 8e-11
 Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 28/218 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G +G VYK+  K    D        A+K++   G+        E+  L  L+HPN+
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRD-----YALKQIEGTGIS--MSACREIALLRELKHPNV 60

Query: 146 VKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRA------FPPLPWKTRLHIILGA 198
           + L        +R +  L  Y E  L   ++ H  ++A       P    K+ L+ IL  
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL-- 118

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAR--EGPMVGHTHVST 252
            +G+ YLH      V++RD K +N+L+     E  R K++D G AR    P+     +  
Sbjct: 119 -DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 253 AVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLT 289
            VV TF Y AP+ +    H T   D+W+ G +  E+LT
Sbjct: 175 VVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 62.0 bits (150), Expect = 9e-11
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 19/210 (9%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           ++R  KIG+G  G+VY +++  A G        VAI+++N       +  + E+  +   
Sbjct: 22  YTRFEKIGQGASGTVY-TAMDVATGQE------VAIRQMNLQQQPKKELIINEILVMREN 74

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           ++PN+V  +    V    G +  +V E++   SL D +                 L A E
Sbjct: 75  KNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 130

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
              +LH     QVI+RD K+ N+LL  +   KL+DFG   +  +       + +VGT  +
Sbjct: 131 ---FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYW 182

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            AP+ +       K D+WS G++  EM+ G
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 30/227 (13%)

Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH 127
           V S  + R+  + F   +KIGEG  G V  ++ K            VA+KK++    Q  
Sbjct: 14  VVSPGDPREYLDSF---IKIGEGSTGIVCIATEKHTGKQ-------VAVKKMDLRKQQRR 63

Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
           +    EV  +    H N+V +     V    G +  +V EF+   +L D + +       
Sbjct: 64  ELLFNEVVIMRDYHHENVVDMYNSYLV----GDELWVVMEFLEGGALTDIVTHTRMNEEQ 119

Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG----LAREGP 243
             T   + L     L+YLH      VI+RD K+ ++LL  + R KLSDFG    +++E P
Sbjct: 120 IAT---VCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173

Query: 244 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
                    ++VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 174 K------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 34/198 (17%)

Query: 114 VAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL---------- 163
           VA+KK+     Q  K  + E++ +  L+H N+VK+       G    + +          
Sbjct: 33  VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92

Query: 164 LVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHIILGAAE---GLAYLHEGLEVQVIYRD 217
           +V E+M   L   LE         PL  +   H  L   +   GL Y+H      V++RD
Sbjct: 93  IVQEYMETDLANVLEQG-------PLSEE---HARLFMYQLLRGLKYIHSA---NVLHRD 139

Query: 218 FKASNVLLD-ENFRPKLSDFGLAR-EGPMVGHT-HVSTAVVGTFGYAAPDYI-ETGHLTA 273
            K +NV ++ E+   K+ DFGLAR   P   H  ++S  +V  + Y +P  +    + T 
Sbjct: 140 LKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTK 198

Query: 274 KSDVWSFGVVLYEMLTGR 291
             D+W+ G +  EMLTG+
Sbjct: 199 AIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 36/104 (34%), Positives = 53/104 (50%), Gaps = 7/104 (6%)

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           GL YLH      +++RD K  N+L++ N   K+ DFGLAR        H++  VV  + Y
Sbjct: 115 GLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170

Query: 261 AAPDYIETG--HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE 302
            AP+ I  G  H T+  D+WS G +  E+L  R   +   P  +
Sbjct: 171 RAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ 213

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 67/244 (27%), Positives = 107/244 (43%), Gaps = 40/244 (16%)

Query: 59  YEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVV 114
           YE+    +R     +++    D+  +  IG G FG V    +KSS K           V 
Sbjct: 28  YEKIVRKIR-----KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQK-----------VY 71

Query: 115 AIKKLNRDGLQGHKQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFML 170
           A+K L++  +         W  E   +     P +V+L  +CA   ++ +   +V E+M 
Sbjct: 72  AMKLLSKFEMIKRSDSAFFW-EERDIMAFANSPWVVQL--FCAFQDDKYL--YMVMEYMP 126

Query: 171 NRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR 230
              L + + N   P   W          AE +  L     + +I+RD K  N+LLD++  
Sbjct: 127 GGDLVNLMSNYDVPE-KWAK-----FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH 180

Query: 231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYE 286
            KL+DFG   +    G     TA VGT  Y +P+ +++    G+   + D WS GV L+E
Sbjct: 181 LKLADFGTCMKMDETGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFE 239

Query: 287 MLTG 290
           ML G
Sbjct: 240 MLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 65/226 (28%), Positives = 98/226 (43%), Gaps = 44/226 (19%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 19  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 71

Query: 139 VLEHPNLVKLIGYC--AVDGERGIQRLLVYEFM---LN------RSLEDHLFNRAFPPLP 187
            ++H N++ L+     A   E      LV   M   LN      +  +DH+         
Sbjct: 72  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 122

Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
                 +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR      H
Sbjct: 123 ----QFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR------H 169

Query: 248 THVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
           T    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 170 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 30/143 (20%)

Query: 198 AAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA----REGPMVGHTHV 250
           AAE   GL ++H      V+YRD K +N+LLDE+   ++SD GLA    ++ P     H 
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HA 154

Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVW-SFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 309
           S   VGT GY AP+ ++ G     S  W S G +L+++L G     +++ K +  +    
Sbjct: 155 S---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---- 207

Query: 310 QQYPADSKKFGLIMDPRLEKEYS 332
                   +  L M   L   +S
Sbjct: 208 -------DRMTLTMAVELPDSFS 223

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 22/210 (10%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G+G FG VYK+  K       + A ++ I+  + + L+     + E+  L   +HPN+V
Sbjct: 13  LGDGAFGKVYKAQHKET--GLFAAAKIIQIE--SEEELEDF---MVEIDILSECKHPNIV 65

Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 206
            L      + +  I    + EF    +L D +       L      ++     E L +LH
Sbjct: 66  GLYEAYFYENKLWI----LIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFLH 120

Query: 207 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI 266
                 VI+RD KA N+LL  +   KL+DFG++ +         +   +GT  + AP+ +
Sbjct: 121 SHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVV 175

Query: 267 --ETGHLTA---KSDVWSFGVVLYEMLTGR 291
             ET        K+D+WS G+ L E+    
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 51/227 (22%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLGVLEHPN 144
           IG+G +G V        +   T     VAIKK+N   + +    + + E++ L +L HP+
Sbjct: 8   IGKGSYGVV-------CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 145 LVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE--- 200
           +V++         R  + + +V+E M                   ++ LH ++ A +   
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELM-------------------ESDLHQVIKANDDLT 101

Query: 201 -------------GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
                         L Y+H      V +RD K  N+L + + + K+ DFGLAR       
Sbjct: 102 PEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158

Query: 248 THVS-TAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGR 291
           T +  T  V T  Y AP+   +     T   D+WS G +  E+LTG+
Sbjct: 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.5 bits (146), Expect = 4e-10
 Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 26/217 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK-QWVAEVQFL 137
           + + ++ K+GEG + +VYK       G       +VA+K +     +G     + E   L
Sbjct: 5   DSYEKLEKLGEGSYATVYK-------GKSKVNGKLVALKVIRLQEEEGTPFTAIREASLL 57

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHI 194
             L+H N+V L  +  +  +  +   LV+E++   L + ++ H       P   K  L  
Sbjct: 58  KGLKHANIVLL--HDIIHTKETLT--LVFEYVHTDLCQYMDKH--PGGLHPENVKLFLFQ 111

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +L    GL+Y+H+     +++RD K  N+L+ +    KL+DFGLAR   +  HT+ +  V
Sbjct: 112 LL---RGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV 165

Query: 255 VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTG 290
             T  Y  PD  + +   +   D+W  G +  EM+ G
Sbjct: 166 --TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 62/228 (27%), Positives = 92/228 (40%), Gaps = 32/228 (14%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQ 135
            DF  +  I  G +G+VY    K             A+KK+N+  L      +Q   E  
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHK-------ETRQRFAMKKINKQNLILRNQIQQVFVERD 53

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L   E+P +V +  +C+ + +R +   +V E++        L N     LP        
Sbjct: 54  ILTFAENPFVVSM--FCSFETKRHL--CMVMEYVEGGDCATLLKNIG--ALPVDMARMYF 107

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV-------GHT 248
                 L YLH      +++RD K  N+L+      KL+DFGL++ G M        GH 
Sbjct: 108 AETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164

Query: 249 HVST------AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
              T       V GT  Y AP+ I         D W+ G++LYE L G
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 83/300 (27%), Positives = 121/300 (40%), Gaps = 39/300 (13%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV 131
           S +R     F  +  +G G +G VYK       G       + AIK ++    +  ++  
Sbjct: 9   SALRDPAGIFELVEVVGNGTYGQVYK-------GRHVKTGQLAAIKVMDVTEDE-EEEIK 60

Query: 132 AEVQFLGVL-EHPNLVKLIGYCAVDGERGI--QRLLVYEFMLNRSLEDHLFNRAFPPLPW 188
            E+  L     H N+    G        G   Q  LV EF    S+ D + N     L  
Sbjct: 61  LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120

Query: 189 KTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL-AREGPMVGH 247
               +I      GLA+LH     +VI+RD K  NVLL EN   KL DFG+ A+    VG 
Sbjct: 121 DWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 177

Query: 248 THVSTAVVGTFGYAAPDYI---ETGHLT--AKSDVWSFGVVLYEMLTGRRSLERNRPKTE 302
            +     +GT  + AP+ I   E    T   +SD+WS G+   EM  G   L    P   
Sbjct: 178 RN---TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP--- 231

Query: 303 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
            R L  + + P           P+L+   S   ++K     + CL K+   RP   Q+++
Sbjct: 232 MRALFLIPRNPP----------PKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.6 bits (144), Expect = 9e-10
 Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 38/223 (17%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH---KQWVAEVQFL 137
           +  + ++G G +G+V       +A D  + A V AIKKL R   Q     K+   E++ L
Sbjct: 17  YRDLKQVGSGAYGTVC------SALDRRTGAKV-AIKKLYRP-FQSELFAKRAYRELRLL 68

Query: 138 GVLEHPNLVKLIGYCAVDG--ERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRL 192
             ++H N++ L+     D   +R     LV  FM   L + ++    +        + R+
Sbjct: 69  KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS--------EDRI 120

Query: 193 H-IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTH 249
             ++    +GL Y+H      +I+RD K  N+ ++E+   K+ DFGLAR  +  M G+  
Sbjct: 121 QFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGY-- 175

Query: 250 VSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGR 291
                V T  Y AP+ I    H T   D+WS G ++ EMLTG+
Sbjct: 176 -----VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 74/248 (29%), Positives = 113/248 (45%), Gaps = 34/248 (13%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW-----VAEVQ 135
           F  + +IGEG +G VYK     A    T E  +VA+KK+    L   K+      + E++
Sbjct: 9   FDIIGQIGEGTYGQVYK-----ARDKDTGE--LVALKKVR---LDNEKEGFPITAIREIK 58

Query: 136 FLGVLEHPNLVKLIGYC-----AVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPL 186
            L  L H N+V L         A+D ++      LV+E+M   L   LE  L +  F   
Sbjct: 59  ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH--FSED 116

Query: 187 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
             K+ +  +L   EGL Y H+      ++RD K SN+LL+   + KL+DFGLAR      
Sbjct: 117 HIKSFMKQLL---EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLY-NSE 169

Query: 247 HTHVSTAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
            +   T  V T  Y  P+ +        + DVWS G +L E+ T +   + N+   +  L
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229

Query: 306 LEWVQQYP 313
           +  +   P
Sbjct: 230 ISRLCGSP 237

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 20/217 (9%)

Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK-QWVAEVQ 135
           A   +  + K+GEG + +VYK       G       +VA+K ++    +G     + E  
Sbjct: 3   AATSYLNLEKLGEGSYATVYK-------GISRINGQLVALKVISMKTEEGVPFTAIREAS 55

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  L+H N+V L  +  +  +  +    V+E+M +  L  ++        P+  RL  +
Sbjct: 56  LLKGLKHANIVLL--HDIIHTKETLT--FVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FM 109

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
                GLAY+H      +++RD K  N+L+      KL+DFGLAR   +   T+ S  V 
Sbjct: 110 FQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV- 165

Query: 256 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            T  Y  PD  +     ++  D+W  G +  EML G+
Sbjct: 166 -TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 40/120 (33%), Positives = 66/120 (55%), Gaps = 12/120 (10%)

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           L +LH+   + ++YRD K  N+LLD      L+DFGL++E  +      + +  GT  Y 
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYM 173

Query: 262 APDYI--ETGHLTAKSDVWSFGVVLYEMLTGRRSL----ERN-RPKTEQRLLEWVQQYPA 314
           AP+ I  + GH  A  D WS G++++E+LTG        ERN + +  +R+L+    +P+
Sbjct: 174 APEIIRGKGGHGKA-VDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS 232

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 37/110 (33%), Positives = 59/110 (53%), Gaps = 16/110 (14%)

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA----REGPMVGHTHVSTAVVG 256
           GL ++H      V+YRD K +N+LLDE+   ++SD GLA    ++ P     H S   VG
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VG 157

Query: 257 TFGYAAPDYIETGHLTAKSDVW-SFGVVLYEMLTGRRSLERNRPKTEQRL 305
           T GY AP+ ++ G     S  W S G +L+++L G     +++ K +  +
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 32/216 (14%)

Query: 89  EGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKL 148
           EG FG ++   +         E  V  +K  +   +Q     + E   L  L H N++ +
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTL-LLQESCLLYGLSHQNILPI 73

Query: 149 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN----RAFPPLPWKTR--LHIILGAAEGL 202
           +  C  DGE      ++Y +M   +L+  L       A  P    T+  +H+ +  A G+
Sbjct: 74  LHVCIEDGEP---PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130

Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVVGTFG-- 259
           +YLH+     VI++D  A N ++DE  + K++D  L+R+  PM  H           G  
Sbjct: 131 SYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH---------CLGDN 178

Query: 260 ------YAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                 + A + +     ++ SDVWSFGV+L+E++T
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 73/276 (26%), Positives = 112/276 (40%), Gaps = 34/276 (12%)

Query: 58  LYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK 117
           LY    +N  +     +   T+ +  +  IG+G +G VYK + K    DG+  A  +   
Sbjct: 1   LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDP 57

Query: 118 KLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIG-YCAVDGERGIQRLLVYEFMLNRSLE 175
             + D     ++  AE   L  L  HPN+VK  G +   D   G Q  LV E     S+ 
Sbjct: 58  ISDVD-----EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVT 112

Query: 176 DHL--FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL 233
           + +         L      +I+ GA  GL +LH     ++I+RD K +N+LL      KL
Sbjct: 113 ELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKL 169

Query: 234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-----LTAKSDVWSFGVVLYEML 288
            DFG++ +  +          VGT  + AP+ I           A+ DVWS G+   E+ 
Sbjct: 170 VDFGVSAQ--LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227

Query: 289 TGRRSL------------ERNRPKTEQRLLEWVQQY 312
            G   L             RN P T     +W + +
Sbjct: 228 DGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSF 263

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 52/186 (27%), Positives = 76/186 (40%), Gaps = 71/186 (38%)

Query: 214 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH--- 270
           I+RD  A N+LL EN   K+ DFGLAR+                  Y  PDY+  G    
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARD-----------------IYKDPDYVRKGDARL 237

Query: 271 --------------LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 316
                          T +SDVWSFGV+L+E+ +   S                  YP   
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS-----------------PYP--- 277

Query: 317 KKFGLIMDP----RLEK-------EYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
              G+ +D     RL++       EY+  E   I  +  +C   + +DRP  S++VE L 
Sbjct: 278 ---GVQIDEEFCRRLKEGTRMRAPEYATPE---IYSIMLDCWHNNPEDRPTFSELVEILG 331

Query: 366 QIVQVS 371
            ++Q +
Sbjct: 332 DLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 38/122 (31%), Positives = 62/122 (50%), Gaps = 3/122 (2%)

Query: 212 QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL 271
           ++++RD K++N+ L      KL DFG +++        V+++  GT  Y AP+  E    
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248

Query: 272 TAKSDVWSFGVVLYEMLTGRRSLE--RNRPKTEQRLLEWVQQYPAD-SKKFGLIMDPRLE 328
           + K+D+WS GV+LYE+LT  R  +    R   +Q L      +P   S     ++DP L 
Sbjct: 249 SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLS 308

Query: 329 KE 330
           K 
Sbjct: 309 KN 310

Length = 478

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 92/359 (25%), Positives = 133/359 (37%), Gaps = 113/359 (31%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL-GVLEHPN 144
           +G G FG V ++S      D  S    VA+K L        HK  ++E++ L  +  H N
Sbjct: 15  LGHGAFGKVVEASA--FGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLN 72

Query: 145 LVKLIGYCAVDG-----------------------------------ERGIQRLLVYEFM 169
           +V L+G C                                       +RG  R +V +  
Sbjct: 73  VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132

Query: 170 LNRSLE----DHLFNR--------AFPPLP----WKTRLHI------ILGAAEGLAYLHE 207
           ++R +E      LF+R          PP      WK+ L +          A G+ +L  
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192

Query: 208 GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE 267
               + I+RD  A N+LL EN   K+ DFGLAR+                  Y  PDY+ 
Sbjct: 193 R---KCIHRDLAARNILLSENNVVKICDFGLARD-----------------IYKDPDYVR 232

Query: 268 TGH-----------------LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
            G                   T +SDVWSFGV+L+E+     SL  +     Q   E+ Q
Sbjct: 233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF----SLGASPYPGVQINEEFCQ 288

Query: 311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
           +      K G  M      E +  E   I R+   C     K+RP  S +VE L  ++Q
Sbjct: 289 RL-----KDGTRMRA---PENATPE---IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 57.8 bits (139), Expect = 3e-09
 Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 34/221 (15%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        +   T     VA+KKL+R    L   ++   E++ L 
Sbjct: 17  YQNLTPVGSGAYGSV-------CSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK 69

Query: 139 VLEHPNLVKLIGYC--AVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLH 193
            ++H N++ L+     A   E   +  LV   M   LN  ++          L  +    
Sbjct: 70  HMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK-------CQKLSDEHVQF 122

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVS 251
           +I     GL Y+H      +I+RD K SNV ++E+   ++ DFGLAR+    M G+    
Sbjct: 123 LIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY---- 175

Query: 252 TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
              V T  Y AP+  +   H     D+WS G ++ E+L G+
Sbjct: 176 ---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 78/286 (27%), Positives = 119/286 (41%), Gaps = 39/286 (13%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNL 145
           IG+G +G V+K   K    +G+  A  +     + D     ++  AE   L  L +HPN+
Sbjct: 26  IGKGTYGKVFKVLNKK---NGSKAAVKILDPIHDID-----EEIEAEYNILKALSDHPNV 77

Query: 146 VKLIG-YCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEGL 202
           VK  G Y   D + G Q  LV E     S+ D +  F +    +      +I+  A  GL
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
            +LH     + I+RD K +N+LL      KL DFG++ +  +          VGT  + A
Sbjct: 138 QHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTSVGTPFWMA 192

Query: 263 PDYIETGH-----LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK 317
           P+ I           A+ DVWS G+   E+  G   L    P    R L  + + P    
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP---MRALFKIPRNPP--- 246

Query: 318 KFGLIMDPRLEK-EYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                  P L + E   NE          CL+K  + RP +S +++
Sbjct: 247 -------PTLHQPELWSNE---FNDFIRKCLTKDYEKRPTVSDLLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 8/91 (8%)

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           L +LH+     ++YRD K  N+LLD      L DFGL++    +     +    GT  Y 
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163

Query: 262 APDYI--ETGHLTAKSDVWSFGVVLYEMLTG 290
           AP+ +  E G+ T   D WS GV+++EM  G
Sbjct: 164 APEVLLDEKGY-TKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 41/128 (32%), Positives = 60/128 (46%), Gaps = 10/128 (7%)

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           AE +  +H   ++  ++RD K  NVL+D     KL+DFG A           S   VGT 
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTP 167

Query: 259 GYAAPDYIETGHLTAKS------DVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQ- 310
            Y AP+ + T +   K       D WS GV+ YEM+ GR    E    KT   ++ + + 
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF 227

Query: 311 -QYPADSK 317
            ++P D K
Sbjct: 228 LKFPEDPK 235

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 32/240 (13%)

Query: 59  YEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK 118
           Y++  + +R     ++R    D+  +  IG G FG V     K       S   V A+K 
Sbjct: 28  YKDTINKIR-----DLRMKAEDYEVVKVIGRGAFGEVQLVRHK-------STRKVYAMKL 75

Query: 119 LNRDGLQGHKQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL 174
           L++  +         W  E   +     P +V+L  + A   +R +   +V E+M    L
Sbjct: 76  LSKFEMIKRSDSAFFW-EERDIMAFANSPWVVQL--FYAFQDDRYL--YMVMEYMPGGDL 130

Query: 175 EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 234
            + + N   P   W  R +     AE +  L     +  I+RD K  N+LLD++   KL+
Sbjct: 131 VNLMSNYDVPE-KW-ARFY----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLA 184

Query: 235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTG 290
           DFG   +    G     TA VGT  Y +P+ +++    G+   + D WS GV LYEML G
Sbjct: 185 DFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 19/206 (9%)

Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +KIGEG  G V  +  K +          VA+K ++    Q  +    EV  +   +H N
Sbjct: 27  IKIGEGSTGIVCIAREKHSGRQ-------VAVKMMDLRKQQRRELLFNEVVIMRDYQHQN 79

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +V++     V    G +  ++ EF+   +L D +           T    +L A   L Y
Sbjct: 80  VVEMYKSYLV----GEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQA---LCY 132

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 264
           LH      VI+RD K+ ++LL  + R KLSDFG   +  +        ++VGT  + AP+
Sbjct: 133 LHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQ--ISKDVPKRKSLVGTPYWMAPE 187

Query: 265 YIETGHLTAKSDVWSFGVVLYEMLTG 290
            I       + D+WS G+++ EM+ G
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 56/263 (21%), Positives = 112/263 (42%), Gaps = 36/263 (13%)

Query: 112 TVVAIKKLNRDGLQGHK----QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVY 166
             V I+   +   +GHK        E++ L  ++  N++K+ G+  +D    + RL L+ 
Sbjct: 44  KEVIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGF-IIDIVDDLPRLSLIL 101

Query: 167 EFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD 226
           E+     L + L       L +KT+L + +   +GL  L++       Y++  + + L+ 
Sbjct: 102 EYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVT 157

Query: 227 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVL 284
           EN++ K+   GL +        +V+  V     Y +   +       T K D++S GVVL
Sbjct: 158 ENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVL 212

Query: 285 YEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK-FGLIMDPRLEKEYSINEARKIGRLA 343
           +E+ TG+   E                    +K+ + LI++     +  ++   +I  + 
Sbjct: 213 WEIFTGKIPFEN-----------------LTTKEIYDLIINKNNSLKLPLDCPLEIKCIV 255

Query: 344 DNCLSKSSKDRPKMSQVVERLKQ 366
           + C S  S  RP + +++  L  
Sbjct: 256 EACTSHDSIKRPNIKEILYNLSL 278

Length = 283

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 22/170 (12%)

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           A+G+++L        I+RD  A N+LL      K+ DFGLAR+     +  V        
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 318
            + AP+ I     T +SDVWS+G++L+E+     SL  + P             P DSK 
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIF----SLG-SSP---------YPGMPVDSKF 326

Query: 319 FGLIMDP-RLEK-EYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 366
           + +I +  R+   E + +E   I +   +C       RP   Q+V+ ++Q
Sbjct: 327 YKMIKEGYRMLSPECAPSEMYDIMK---SCWDADPLKRPTFKQIVQLIEQ 373

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 23/217 (10%)

Query: 75  RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           R    DF  + +IG G +G VYK+          +   + AIK +  +  +       E+
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYKAR-------NVNTGELAAIKVIKLEPGEDFAVVQQEI 57

Query: 135 QFLGVLEHPNLVKLIG-YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
             +   +H N+V   G Y   D     +  +  EF    SL+D        PL      +
Sbjct: 58  IMMKDCKHSNIVAYFGSYLRRD-----KLWICMEFCGGGSLQD--IYHVTGPLSESQIAY 110

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
           +     +GL YLH   +   ++RD K +N+LL +N   KL+DFG++ +  +        +
Sbjct: 111 VSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKS 165

Query: 254 VVGTFGYAAPDYI---ETGHLTAKSDVWSFGVVLYEM 287
            +GT  + AP+       G      D+W+ G+   E+
Sbjct: 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 6/97 (6%)

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           AE +  +H   ++  ++RD K  NVLLD N   +L+DFG   +    G    S A VGT 
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA-VGTP 167

Query: 259 GYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTG 290
            Y +P+ ++      G    + D WS GV +YEML G
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 39/138 (28%), Positives = 58/138 (42%), Gaps = 44/138 (31%)

Query: 214 IYRDFKASNVLLDENFRPKLSDFGL------------------AREGPMV---------- 245
           I+RD K  N+L+D +   KL+DFGL                   R+  M           
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 246 ------------GHTHVST-AVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 291
                        H      ++VGT  Y AP+ +  TG+ T   D WS GV+LYEML G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQ 241

Query: 292 RSLERNRP-KTEQRLLEW 308
                + P +T+ +++ W
Sbjct: 242 PPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 30/81 (37%), Positives = 45/81 (55%)

Query: 212 QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL 271
            +I+RD K++N+LL  N   KL DFG ++         V     GT  Y AP+       
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222

Query: 272 TAKSDVWSFGVVLYEMLTGRR 292
           + K+D++S GV+LYE+LT +R
Sbjct: 223 SKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 14/86 (16%)

Query: 214 IYRDFKASNVLLDENFRPKLSDFG----LAREGPMVGHTHVSTAVVGTFGYAAPDYIE-- 267
           ++RD K  NVLLD+N   +L+DFG    L  +G     T  S   VGT  Y +P+ ++  
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-----TVQSNVAVGTPDYISPEILQAM 178

Query: 268 ---TGHLTAKSDVWSFGVVLYEMLTG 290
               G    + D WS GV +YEML G
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 54.1 bits (130), Expect = 6e-08
 Identities = 38/113 (33%), Positives = 56/113 (49%), Gaps = 11/113 (9%)

Query: 185 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           PL     L      A+G+ +L        I+RD  A NVLL +    K+ DFGLAR+  M
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARD-IM 263

Query: 245 VGHTHVSTAVVGT----FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS 293
               +V   V G       + AP+ I     T +SDVWS+G++L+E+ +  +S
Sbjct: 264 NDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 62/242 (25%), Positives = 98/242 (40%), Gaps = 64/242 (26%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN----RDGLQGHKQWVA---------- 132
           +GEG +G V K      A D T    +VAIKK+      + +   +Q V           
Sbjct: 17  LGEGTYGKVEK------AYD-TLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69

Query: 133 EVQFLGVLEHPNLVKLIG-YCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPW 188
           E++ +  ++H N++ L+  Y   D    I   LV + M   L + ++             
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDF---IN--LVMDIMASDLKKVVDR------------ 112

Query: 189 KTRLH------IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE- 241
           K RL       I+L    GL  LH+      ++RD   +N+ ++     K++DFGLAR  
Sbjct: 113 KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRY 169

Query: 242 -GPMVGHTHVS----------TAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLT 289
             P    T             T+ V T  Y AP+ +          D+WS G +  E+LT
Sbjct: 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Query: 290 GR 291
           G+
Sbjct: 230 GK 231

Length = 335

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.2 bits (127), Expect = 1e-07
 Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 37/222 (16%)

Query: 89  EGGFGSVYKSSIKPAAGDGTSEATVVA-----------IKKLNRDGLQGHKQWVAEVQFL 137
            G FG ++  +++ +  +  +   V +           I K  + G +   Q   E+  L
Sbjct: 158 AGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILAL 217

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR----SLEDHLFNRAFP----PLPWK 189
           G L H N++K+           I R     +M+ +     L   +++ AF     PL  +
Sbjct: 218 GRLNHENILKI---------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQ 268

Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGH 247
           TR  I+      + Y+H+     +I+RD K  N+ L+ + +  L DFG A   E      
Sbjct: 269 TR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324

Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            +     VGT    +P+ +        +D+WS G++L +ML+
Sbjct: 325 DY---GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 32/215 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY+     A    TSE   VAIKK+    LQ  +    E+  +  L H N++
Sbjct: 74  IGNGSFGVVYE-----AICIDTSEK--VAIKKV----LQDPQYKNRELLIMKNLNHINII 122

Query: 147 KLIGY----CAVDGERGIQRLLVYEFMLNRSLEDHL-----FNRAFPPLPWKTRLHIILG 197
            L  Y    C    E+ I   +V EF + +++  ++      N A P    K   + +  
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEF-IPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVG 256
           A   LAY+H      + +RD K  N+L+D N    KL DFG A+   ++      + +  
Sbjct: 182 A---LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKN--LLAGQRSVSYICS 233

Query: 257 TFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTG 290
            F Y AP+  +   + T   D+WS G ++ EM+ G
Sbjct: 234 RF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 30/214 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA---EVQFLGVLEHP 143
           +G+G F ++YK  ++    D         +  + +     H+  +A       +  L H 
Sbjct: 3   LGQGTFTNIYKGVLRVQ-SDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHK 61

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIILGAAEGL 202
           +LVKL G C  D       ++V E++    L+  L   +    L WK  L +    A  L
Sbjct: 62  HLVKLYGVCVRDEN-----IMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASAL 114

Query: 203 AYLHEGLEVQVIYRDFKASNVLL-----DENFRP--KLSDFGLAREGPMVGHTHVSTAVV 255
            YL +    ++++ +    N+L+     +E + P  KLSD G+                V
Sbjct: 115 HYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------V 165

Query: 256 GTFGYAAPDYIETGH--LTAKSDVWSFGVVLYEM 287
               + AP+ I  G   LT  +D WSFG  L E+
Sbjct: 166 ERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 40/218 (18%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGH-KQWVAEVQFLGVLEHPN 144
           IG G  G V        A   T     VAIKKL+R      H K+   E+  + ++ H N
Sbjct: 24  IGSGAQGIV-------CAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKN 76

Query: 145 LVKLIGYCAVDGERGIQRL----LVYEFM-------LNRSLEDHLFNRAFPPLPWKTRLH 193
           ++ L+       ++ ++      LV E M       +   L DH           +   +
Sbjct: 77  IIGLLN--VFTPQKSLEEFQDVYLVMELMDANLCQVIQMDL-DH-----------ERMSY 122

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
           ++     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T 
Sbjct: 123 LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTP 176

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            V T  Y AP+ I         D+WS G ++ EM+ G 
Sbjct: 177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 25/215 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
           +IG G FG V    +      G + A VV +K+L     +Q   +++ E Q    L+H N
Sbjct: 2   EIGNGWFGKVILGEVN----SGYTPAQVV-VKELRVSASVQEQMKFLEEAQPYRSLQHSN 56

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           L++ +G C          LLV EF     L   L          P P  T   +    A 
Sbjct: 57  LLQCLGQCT----EVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDP-TTLQRMACEIAL 111

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           GL +LH+      I+ D    N LL  +   K+ D+GL+       +      +     +
Sbjct: 112 GLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168

Query: 261 AAPDYIETGH-------LTAKSDVWSFGVVLYEML 288
            AP+ ++  H        T +S+VWS GV ++E+ 
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 41/127 (32%), Positives = 63/127 (49%), Gaps = 19/127 (14%)

Query: 179 FNRAFPPLPWKTRLHIILGAAEGLAYLH-EGLEVQV------------IYRDFKASNVLL 225
           +++  P  P +TR   ++  +  L+Y+   G   QV            ++RD  A NVL+
Sbjct: 213 YDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272

Query: 226 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF---GYAAPDYIETGHLTAKSDVWSFGV 282
            E    K+ DFGLAR+  M    ++S     TF    + AP+ I     T  SDVWSFG+
Sbjct: 273 CEGKLVKICDFGLARD-IMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGI 329

Query: 283 VLYEMLT 289
           +L+E+ T
Sbjct: 330 LLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 52/201 (25%), Positives = 80/201 (39%), Gaps = 74/201 (36%)

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           A+G+ +L      + I+RD  A N+LL EN   K+ DFGLAR+                 
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARD----------------- 228

Query: 259 GYAAPDYIETGH-----------------LTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 301
            Y  PDY+  G                   T +SDVWSFGV+L+E+ +   S        
Sbjct: 229 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-------- 280

Query: 302 EQRLLEWVQQYPADSKKFGLIMDP----RLEK-------EYSINEARKIGRLADNCLSKS 350
                     YP      G+ +D     RL++       +Y+  E   + +   +C    
Sbjct: 281 ---------PYP------GVKIDEEFCRRLKEGTRMRAPDYTTPE---MYQTMLDCWHGE 322

Query: 351 SKDRPKMSQVVERLKQIVQVS 371
              RP  S++VE L  ++Q +
Sbjct: 323 PSQRPTFSELVEHLGNLLQAN 343

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 30/86 (34%), Positives = 46/86 (53%), Gaps = 6/86 (6%)

Query: 210 EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET- 268
           ++  ++RD K  N+L+D N   +L+DFG   +  M   T  S+  VGT  Y +P+ ++  
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLK-LMEDGTVQSSVAVGTPDYISPEILQAM 178

Query: 269 ----GHLTAKSDVWSFGVVLYEMLTG 290
               G    + D WS GV +YEML G
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 29/220 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--NRDGLQGHKQWVAEVQF 136
           N F  +  +GEG +G V K   K      T E  +VAIKK   + +  +  +  + E++ 
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKE-----TKE--IVAIKKFKDSEENEEVKETTLRELKM 53

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE--DHLFNRAFPPLPWKTRLHI 194
           L  L+  N+V+L         R  +  LV+E++    LE  + + N   PP   ++ ++ 
Sbjct: 54  LRTLKQENIVEL----KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV-PPEKVRSYIYQ 108

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVS 251
           ++ A   + + H+     +++RD K  N+L+  N   KL DFG AR   EG    +T   
Sbjct: 109 LIKA---IHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE-- 160

Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
              V T  Y +P+ +         D+WS G +L E+  G+
Sbjct: 161 --YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 27/219 (12%)

Query: 75  RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           R   +D+  + ++G G +G VYK     A    T E   V I KL      G    + + 
Sbjct: 5   RNPQHDYELIQRVGSGTYGDVYK-----ARNLHTGELAAVKIIKLE----PGDDFSLIQQ 55

Query: 135 QFLGVLE--HPNLVKLIG-YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR 191
           +   V E  H N+V   G Y + +     +  +  E+    SL+D        PL     
Sbjct: 56  EIFMVKECKHCNIVAYFGSYLSRE-----KLWICMEYCGGGSLQD--IYHVTGPLSELQI 108

Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
            ++     +GLAYLH   +   ++RD K +N+LL +N   KL+DFG+A +  +       
Sbjct: 109 AYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKR 163

Query: 252 TAVVGTFGYAAPDYI---ETGHLTAKSDVWSFGVVLYEM 287
            + +GT  + AP+     + G      D+W+ G+   E+
Sbjct: 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 48/216 (22%), Positives = 78/216 (36%), Gaps = 37/216 (17%)

Query: 90  GGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVK 147
                + K              T+VA+KK+N D    +  K    E+     L+HPN++ 
Sbjct: 13  LMIVHLAKH---------KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 148 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHL---FNRAFPPLPWKTRLHIILGAAEGLAY 204
                 +      +  +V   M   S ED L   F    P L       I+      L Y
Sbjct: 64  -YVTSFIVDS---ELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA---FILKDVLNALDY 116

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG----- 259
           +H       I+R  KAS++LL  + +  LS    +    M+ H      V   F      
Sbjct: 117 IHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSV--SMIKHGKRQRVVHD-FPKSSVK 170

Query: 260 ---YAAPDYIETGHL--TAKSDVWSFGVVLYEMLTG 290
              + +P+ ++        KSD++S G+   E+  G
Sbjct: 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 31/79 (39%), Positives = 45/79 (56%), Gaps = 6/79 (7%)

Query: 214 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF---GYAAPDYIETGH 270
           ++RD  A NVLL +    K+ DFGLAR+  M    +VS     TF    + AP+ I    
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARD-IMHDSNYVSKG--STFLPVKWMAPESIFDNL 315

Query: 271 LTAKSDVWSFGVVLYEMLT 289
            T  SDVWS+G++L+E+ +
Sbjct: 316 YTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 49/186 (26%), Positives = 72/186 (38%), Gaps = 27/186 (14%)

Query: 114 VAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---- 169
           V IK   R G         E   L  + HP++++L G               Y       
Sbjct: 120 VVIKAGQRGGT------ATEAHILRAINHPSIIQLKG------------TFTYNKFTCLI 161

Query: 170 LNRSLED-HLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN 228
           L R   D + +  A   +     L I       + YLHE    ++I+RD KA N+ ++  
Sbjct: 162 LPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHP 218

Query: 229 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
               L DFG A   P+  + +      GT    AP+ +         D+WS G+VL+EM 
Sbjct: 219 GDVCLGDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMA 277

Query: 289 TGRRSL 294
           T   SL
Sbjct: 278 TCHDSL 283

Length = 391

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 6/91 (6%)

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  V T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+ I         D+WS G ++ EM+ G 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 77/319 (24%), Positives = 138/319 (43%), Gaps = 62/319 (19%)

Query: 71  YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK-- 128
           Y +     N++  + KIG G FG V+    K      T E      K ++  GL+  +  
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKR-----TQE--FFCWKAISYRGLKEREKS 57

Query: 129 QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFM----LNRSLEDHLFNRAF 183
           Q V EV  +  L+H N+V+ I        +  Q+L ++ EF     L+R+++     + F
Sbjct: 58  QLVIEVNVMRELKHKNIVRYIDRFL---NKANQKLYILMEFCDAGDLSRNIQKCY--KMF 112

Query: 184 PPLPWKTRLHIILGAAEGLAYLHEGLE----VQVIYRDFKASNVLLDE------------ 227
             +     + I       LAY H   +     +V++RD K  N+ L              
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172

Query: 228 ---NFRP--KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSF 280
              N RP  K+ DFGL++    +G   ++ + VGT  Y +P+ +  ET     KSD+W+ 
Sbjct: 173 NNLNGRPIAKIGDFGLSKN---IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229

Query: 281 GVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIG 340
           G ++YE+ +G+     ++     +L+  +++ P    K                +++++ 
Sbjct: 230 GCIIYELCSGKTPF--HKANNFSQLISELKRGPDLPIK---------------GKSKELN 272

Query: 341 RLADNCLSKSSKDRPKMSQ 359
            L  N L+ S+K+RP   Q
Sbjct: 273 ILIKNLLNLSAKERPSALQ 291

Length = 1021

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 36/114 (31%), Positives = 47/114 (41%), Gaps = 38/114 (33%)

Query: 214 IYRDFKASNVLLDENFRPKLSDFGL--------------------------AREGPMVGH 247
           I+RD K  N+LLD     KLSDFGL                              PM   
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 248 THVST----------AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTG 290
               T          + VGT  Y AP+ +++TG+   + D WS GV++YEML G
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 40/143 (27%), Positives = 68/143 (47%), Gaps = 22/143 (15%)

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  V T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEML------TGRRSLER-NR---------PKTEQR 304
            AP+ I         D+WS G ++ EM+       GR  +++ N+         P+  ++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 305 LLEWVQQYPADSKKFGLIMDPRL 327
           L   V+ Y  +  K+  +  P+L
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKL 267

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 50/181 (27%), Positives = 82/181 (45%), Gaps = 15/181 (8%)

Query: 114 VAIKKLNRD-GLQGH-KQWVAEVQFLGVLEHPNLVKLIG-YCAVDGERGIQRL-LVYEFM 169
           VA+KKL+R    Q H K+   E+  L  + H N++ L+  +         Q + LV E M
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108

Query: 170 LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF 229
                + +L       L  +   +++     G+ +LH      +I+RD K SN+++  + 
Sbjct: 109 -----DANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 160

Query: 230 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
             K+ DFGLAR         + T  V T  Y AP+ I         D+WS G ++ E++ 
Sbjct: 161 TLKILDFGLARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK 217

Query: 290 G 290
           G
Sbjct: 218 G 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 37/124 (29%), Positives = 54/124 (43%), Gaps = 12/124 (9%)

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
           AAE +  L       ++ RD   +N+LLD+    +L+ F    E   V  +    AV   
Sbjct: 91  AAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSE---VEDSCDGEAVENM 147

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK-----TEQRLLEWVQQY 312
             Y AP+       T   D WS G +L+E+LTG ++L    P      T   + EWV + 
Sbjct: 148 --YCAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIPEWVSE- 203

Query: 313 PADS 316
            A S
Sbjct: 204 EARS 207

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 47.9 bits (115), Expect = 4e-06
 Identities = 35/100 (35%), Positives = 47/100 (47%), Gaps = 12/100 (12%)

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPMVGHTHVS 251
            II    E L  LH+     +I+ D K  NVL D    R  L D+GL +           
Sbjct: 113 KIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTP 163

Query: 252 TAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           +   GT  Y +P+ I+ GH    S D W+ GV+ YE+LTG
Sbjct: 164 SCYDGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 46.8 bits (111), Expect = 8e-06
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 37/220 (16%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G+G F  ++K   +     G    T V +K L++      + +      +  L H +LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIILGAAEGLAY- 204
              G C    E     ++V E++   SL+ +L  N+    + WK      L  A+ LA+ 
Sbjct: 63  LNYGVCVCGDES----IMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWA 112

Query: 205 LHEGLEVQVIYRDFKASNVLL-----DENFRP---KLSDFG-----LAREGPMVGHTHVS 251
           LH   +  + + +  A NVLL      +   P   KLSD G     L +E          
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE---------- 162

Query: 252 TAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTG 290
             ++    +  P+ IE   +L+  +D WSFG  L+E+ +G
Sbjct: 163 -ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 40/131 (30%), Positives = 57/131 (43%), Gaps = 38/131 (29%)

Query: 214 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH--------TH---------------- 249
           I+RD K  N+LLD     KLSDFGL   G    H        TH                
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLC-TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181

Query: 250 ----------VSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 298
                     ++ + VGT  Y AP+ +++TG+     D WS GV++YEML G        
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 299 PK-TEQRLLEW 308
           P+ T ++++ W
Sbjct: 241 PQETYRKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 32/218 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
           +IG G FG V  S I       T  A VV +K+L  +   +   +++ +     +L+HPN
Sbjct: 2   EIGNGWFGKVLLSEIYT----DTGVARVV-VKELKANASSKEQNEFLQQGDPYRILQHPN 56

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL-------G 197
           +++ +G C       I  LLV+E+     L+ +L         W  R   +L        
Sbjct: 57  ILQCLGQCV----EAIPYLLVFEYCELGDLKSYLSQEQ-----WHRRNSQLLLLQRMACE 107

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
            A G+ ++H   +   ++ D    N  L  +   K+ D+G+        +          
Sbjct: 108 IAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164

Query: 258 FGYAAPDYIETGH---LTAK----SDVWSFGVVLYEML 288
             + AP+ +   H   +TA+    S+VW+ GV L+E+ 
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 59/236 (25%), Positives = 91/236 (38%), Gaps = 50/236 (21%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG----HKQWVAEVQFLGVLE 141
            IG+GG G VY +   P           VA+KK+  D L       K+++ E +    L 
Sbjct: 9   LIGKGGMGEVYLAY-DPVCS------RRVALKKIRED-LSENPLLKKRFLREAKIAADLI 60

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFM-------LNRSLEDHLFNRAFP-PLPWKTR-- 191
           HP +V +   C+ DG+       VY  M       L   L+      +    L  KT   
Sbjct: 61  HPGIVPVYSICS-DGD------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVG 113

Query: 192 --LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA---------- 239
             L I       + Y+H      V++RD K  N+LL       + D+G A          
Sbjct: 114 AFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170

Query: 240 ------REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                           +   +VGT  Y AP+ +     +  +D+++ GV+LY+MLT
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 37/141 (26%), Positives = 56/141 (39%), Gaps = 46/141 (32%)

Query: 214 IYRDFKASNVLLDENFRPKLSDFGLA------------------REGPM----------- 244
           I+RD K  N+L+D +   KL+DFGL                   R+  M           
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 245 -------------VGHTH---VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
                            H   ++ ++VGT  Y AP+ +     T   D WS GV+LYEML
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 289 TGRRSLERNRP-KTEQRLLEW 308
            G+       P +T+ +++ W
Sbjct: 243 VGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 44/161 (27%), Positives = 65/161 (40%), Gaps = 42/161 (26%)

Query: 214 IYRDFKASNVLLDENFRPKLSDFGLAR--------------------------------- 240
           I+RD K  N+LLD     KLSDFGL                                   
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 241 EGPMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           E        ++ + VGT  Y AP+ +++TG+     D WS GV++YEML G        P
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 300 K-TEQRLLEWVQ------QYPADSKKFGLIMDPRLEKEYSI 333
           + T ++++ W +      + P   K   LI+    E E+ I
Sbjct: 242 QETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRI 282

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 36/141 (25%), Positives = 56/141 (39%), Gaps = 46/141 (32%)

Query: 214 IYRDFKASNVLLDENFRPKLSDFGLA------------------REGPM----------- 244
           I+RD K  N+L+D +   KL+DFGL                   R+  M           
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 245 -------------VGHTH---VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
                            H   ++ ++VGT  Y AP+ +     T   D WS GV+L+EML
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 289 TGRRSLERNRP-KTEQRLLEW 308
            G+       P +T+ +++ W
Sbjct: 243 VGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 37/138 (26%), Positives = 63/138 (45%), Gaps = 19/138 (13%)

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
           I+ GA  GL YLH+      I+R+ KAS++L+  +    LS  GL+    +V +   +  
Sbjct: 106 ILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKV 160

Query: 254 V-------VGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ 303
           V            + +P+ +     G+   KSD++S G+   E+ TGR   + +  +T+ 
Sbjct: 161 VYDFPQFSTSVLPWLSPELLRQDLYGY-NVKSDIYSVGITACELATGRVPFQ-DMLRTQM 218

Query: 304 RL--LEWVQQYPADSKKF 319
            L  L+     P D   F
Sbjct: 219 LLQKLKGPPYSPLDITTF 236

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 41/149 (27%), Positives = 62/149 (41%), Gaps = 13/149 (8%)

Query: 195 ILGAAEGLAYLH-EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
           +L A +   Y+H EG    +I+RD K  NVL++      L DFG A        T     
Sbjct: 269 LLSAID---YIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-----ERNRPKTEQRLLEW 308
           + GT    AP+ +     T   D+WS G+V++E      SL        R   + ++L  
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRI 381

Query: 309 VQQYPADSKKFGLIMDPRLEKEYSINEAR 337
           ++Q      +F      RL  +Y    AR
Sbjct: 382 IRQAQVHVDEFPQHAGSRLVSQYRHRAAR 410

Length = 461

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 28/115 (24%), Positives = 48/115 (41%), Gaps = 23/115 (20%)

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD----------------ENFRPKLSDF 236
            II      L Y H   E+ +++ D K  N+L++                +  R ++ D 
Sbjct: 235 QIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292

Query: 237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           G           H  TA+V T  Y +P+ +        +D+WS G ++YE+ TG+
Sbjct: 293 G-----GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 35/151 (23%), Positives = 55/151 (36%), Gaps = 50/151 (33%)

Query: 214 IYRDFKASNVLLDENFRPKLSDFGLA---------------------------REGPMVG 246
           I+RD K  N+L+D     KLSDFGL+                           R    V 
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182

Query: 247 HTHVST------------------AVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEM 287
             +++                   + VGT  Y AP+ I        + D WS G +++E 
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSLGAIMFEC 241

Query: 288 LTGRRSL-ERNRPKTEQRLLEWVQ--QYPAD 315
           L G       N  +T ++++ W +   +P D
Sbjct: 242 LIGWPPFCSENSHETYRKIINWRETLYFPDD 272

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	436
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.82
smart00090	237	RIO RIO-like kinase.	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.7
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.58
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.57
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.44
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.39
KOG1243	690	consensus Protein kinase [General function predict	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.33
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.3
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.27
KOG3087	229	consensus Serine/threonine protein kinase [General	99.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.26
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.21
COG4248	637	Uncharacterized protein with protein kinase and he	99.17
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.08
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.99
PRK09902	216	hypothetical protein; Provisional	98.96
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.92
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.9
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.89
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.65
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.57
PF01636	239	APH: Phosphotransferase enzyme family This family	98.49
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.48
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.45
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.35
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.32
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.31
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.3
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.22
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.14
PLN02876	822	acyl-CoA dehydrogenase	98.13
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.06
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.05
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.04
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.94
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.93
PRK10593	297	hypothetical protein; Provisional	97.87
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.7
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.65
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.53
PRK05231	319	homoserine kinase; Provisional	97.5
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.45
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.39
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.33
PLN02236	344	choline kinase	97.24
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.16
KOG2270	520	consensus Serine/threonine protein kinase involved	97.11
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.8
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.65
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.65
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.62
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.56
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.49
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.48
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.43
PLN02756	418	S-methyl-5-thioribose kinase	96.36
COG2334	331	Putative homoserine kinase type II (protein kinase	96.24
PRK06148	1013	hypothetical protein; Provisional	95.85
PTZ00384	383	choline kinase; Provisional	95.81
PRK12396	409	5-methylribose kinase; Reviewed	95.76
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.73
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.55
PTZ00296	442	choline kinase; Provisional	95.43
PRK11768	325	serine/threonine protein kinase; Provisional	95.04
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	94.49

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-53  Score=410.94  Aligned_cols=291  Identities=55%  Similarity=0.925  Sum_probs=247.9

Q ss_pred             cCcccCHHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCC
Q 013790           65 NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN  144 (436)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn  144 (436)
                      ..+.|++.++..++++|...+.||+|+||.||+|...        ++..||||++.........+|.+|+.++.+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~--------~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~N  132 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS--------DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPN  132 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC--------CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcC
Confidence            5778999999999999999999999999999999986        44889999887664431455999999999999999


Q ss_pred             ceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEE
Q 013790          145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL  224 (436)
Q Consensus       145 Iv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIl  224 (436)
                      +|+++|||.+.+.   +.+|||||+++|+|.++|+.....+++|..+++||.++|+||+|||..+.+.||||||||+|||
T Consensus       133 lv~LlGyC~e~~~---~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNIL  209 (361)
T KOG1187|consen  133 LVKLLGYCLEGGE---HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNIL  209 (361)
T ss_pred             cccEEEEEecCCc---eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHee
Confidence            9999999987764   3599999999999999998765438999999999999999999999998888999999999999


Q ss_pred             EcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 013790          225 LDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR  304 (436)
Q Consensus       225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~  304 (436)
                      ||+++++||+|||+|+..+.. .........||.+|+|||++..+..+.++|||||||+|+||+||+.+.+...+.....
T Consensus       210 LD~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~  288 (361)
T KOG1187|consen  210 LDEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS  288 (361)
T ss_pred             ECCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccccc
Confidence            999999999999999764321 1111111179999999999998999999999999999999999999988765555555


Q ss_pred             HHHHHhhcccCccccccccCCccc-CcCCH-HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          305 LLEWVQQYPADSKKFGLIMDPRLE-KEYSI-NEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                      +..|........ .+..++|+.+. ..++. .....+..++.+|++.+|.+||+|.+|++.|+.+.
T Consensus       289 l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  289 LVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            788775544443 67789999987 55554 57778999999999999999999999999996654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-52  Score=383.80  Aligned_cols=255  Identities=29%  Similarity=0.426  Sum_probs=214.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++++.++.||+|..|+||++.++       .+++.+|+|.+... .....+++.+|+++++.++|||||.+||.|...+
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk-------~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~  150 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHK-------PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG  150 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEc-------CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence            346778889999999999999988       67899999999544 3445678999999999999999999999999876


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      .   .+.++||||.+|+|.+++...  +.+++.....|+.+|++||.|||+.  .+||||||||+||||+..|.+|||||
T Consensus       151 ~---~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDF  223 (364)
T KOG0581|consen  151 E---EISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDF  223 (364)
T ss_pred             c---eEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccc
Confidence            4   459999999999999999665  4699999999999999999999963  29999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chhhHHHHHHHhhccc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR--PKTEQRLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~--~~~~~~~~~~~~~~~~  314 (436)
                      |.+.....    ....+++||..|||||.+.+..|+.++||||||++++|+++|+.||....  +.....++.++..-+.
T Consensus       224 GVS~~lvn----S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp  299 (364)
T KOG0581|consen  224 GVSGILVN----SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP  299 (364)
T ss_pred             cccHHhhh----hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC
Confidence            99986322    25577899999999999999999999999999999999999999997642  2233444444332211


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                |.++..   ..++++..||..||++||.+|||+.|+++|
T Consensus       300 ----------P~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  300 ----------PRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             ----------CCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                      222221   356889999999999999999999999987

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-51  Score=393.51  Aligned_cols=260  Identities=33%  Similarity=0.525  Sum_probs=212.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceE-EEEEEeccCcchh--HHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLNRDGLQG--HKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++...+.||.|+||+||+|.|+         ++. ||||++.......  .+.|.+|+.+|.+++|||||+++|+|...
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~---------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~  111 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWR---------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP  111 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeC---------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            34555566999999999999986         444 9999998654322  45899999999999999999999999876


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc-eeeccCCCCcEEEcCCC-ceEE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENF-RPKL  233 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl  233 (436)
                      ..   .+++||||+++|+|.+++.......+++..++.|+.|||+||.|||++   + ||||||||+||||+.++ ++||
T Consensus       112 ~~---~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI  185 (362)
T KOG0192|consen  112 PG---SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKI  185 (362)
T ss_pred             CC---ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEE
Confidence            52   358999999999999999875456899999999999999999999998   7 99999999999999998 9999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE--TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      +|||+++......  ...+...||+.|||||++.  ...|+.++|||||||++|||+||..||.+..+..   ....+. 
T Consensus       186 ~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~~~~v~-  259 (362)
T KOG0192|consen  186 ADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---VASAVV-  259 (362)
T ss_pred             CCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---HHHHHH-
Confidence            9999998532211  2334478999999999999  5699999999999999999999999999876521   111111 


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                                  ....+...+..++..+..||.+||..||..||++.+|+..|+.+....
T Consensus       260 ------------~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  260 ------------VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             ------------hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence                        111112223336688999999999999999999999999999887543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-50  Score=370.60  Aligned_cols=252  Identities=29%  Similarity=0.459  Sum_probs=206.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ..+|...+.||+|+||+||+|+++       .++..||||.+.+.  .....+.+..|+.+|+.++|||||.+++++..+
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~-------~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~   81 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHK-------KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD   81 (429)
T ss_pred             cccceehhhccCcceEEEEEeEec-------cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC
Confidence            468999999999999999999987       56689999999877  444567789999999999999999999998776


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC------C
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN------F  229 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~------~  229 (436)
                      +    .+|||||||.||+|.+||++++  .+++.++..++.|||.||++||++   +||||||||+||||+..      -
T Consensus        82 ~----~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~  152 (429)
T KOG0595|consen   82 D----FIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSP  152 (429)
T ss_pred             C----eEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCc
Confidence            5    4699999999999999998765  799999999999999999999999   99999999999999764      5


Q ss_pred             ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 013790          230 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  309 (436)
Q Consensus       230 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  309 (436)
                      .+||+|||+|+..   .......+.+|++.|||||++....|+.|+|+||+|+|+|++++|+.||...++.+...   ++
T Consensus       153 ~LKIADFGfAR~L---~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~---~~  226 (429)
T KOG0595|consen  153 VLKIADFGFARFL---QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL---YI  226 (429)
T ss_pred             eEEecccchhhhC---CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH---HH
Confidence            6899999999963   34555667899999999999999999999999999999999999999998765544322   22


Q ss_pred             hhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..-..            +....+...+..+.+|+...+..+|.+|-++.+-..+
T Consensus       227 ~k~~~------------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~  268 (429)
T KOG0595|consen  227 KKGNE------------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH  268 (429)
T ss_pred             hcccc------------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence            21111            1111222223345577777888888888877665443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-51  Score=360.41  Aligned_cols=262  Identities=26%  Similarity=0.383  Sum_probs=211.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ..+|++++.||+|+||.||++.+.       .++..+|.|.+.-..  ....+....|+.+|++|+|||||+++++...+
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~-------~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~   90 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCL-------LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE   90 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeec-------cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence            347999999999999999999976       688999999987543  33446788999999999999999999954443


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-ceeeccCCCCcEEEcCCCceE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEV-QVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      +..  -++||||||.+|+|.+.|..  ...+.+++..+|+++.|++.||..+|++... .|+||||||.||+|+.+|.+|
T Consensus        91 ~~e--vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvK  168 (375)
T KOG0591|consen   91 DNE--VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVK  168 (375)
T ss_pred             cch--hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCcee
Confidence            322  25899999999999999864  3456799999999999999999999994222 389999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |+|||+++..  ........+.+|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+.+-.   .+...+.+-
T Consensus       169 LGDfGL~r~l--~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~---~L~~KI~qg  243 (375)
T KOG0591|consen  169 LGDFGLGRFL--SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL---SLCKKIEQG  243 (375)
T ss_pred             eccchhHhHh--cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH---HHHHHHHcC
Confidence            9999999863  33445556789999999999999999999999999999999999999999886332   222222221


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  366 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~  366 (436)
                                   .++.......+..+..||..|+..||+.||+...++..+..
T Consensus       244 -------------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  244 -------------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             -------------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                         11111124557889999999999999999997666555543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-50  Score=373.94  Aligned_cols=254  Identities=24%  Similarity=0.376  Sum_probs=207.9

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh-------HHHHHHHHHHHhccCCCCceeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-------HKQWVAEVQFLGVLEHPNLVKLI  149 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~~  149 (436)
                      ..+.|.+.+.||+|+||.|-+|..+       .+++.||||++++.....       ...+.+|+++|++|+|||||+++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~-------~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~  242 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEK-------KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIK  242 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEc-------ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEe
Confidence            3457888999999999999999865       789999999997653222       23467999999999999999999


Q ss_pred             eEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC-
Q 013790          150 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-  228 (436)
Q Consensus       150 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-  228 (436)
                      +++..+..    .|+||||+.||+|.+++..+.  .+.+.....++.|++.|+.|||++   ||+||||||+|||+..+ 
T Consensus       243 d~f~~~ds----~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~  313 (475)
T KOG0615|consen  243 DFFEVPDS----SYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDA  313 (475)
T ss_pred             eeeecCCc----eEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCC
Confidence            99987764    399999999999999997764  688888899999999999999999   99999999999999765 


Q ss_pred             --CceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCchh-h
Q 013790          229 --FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL---TAKSDVWSFGVVLYEMLTGRRSLERNRPKT-E  302 (436)
Q Consensus       229 --~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGvil~elltg~~pf~~~~~~~-~  302 (436)
                        ..+||+|||+|+.   .+......+.+||+.|.|||++.+..+   ..++|+|||||+||-+++|.+||.+..... .
T Consensus       314 e~~llKItDFGlAK~---~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl  390 (475)
T KOG0615|consen  314 EDCLLKITDFGLAKV---SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL  390 (475)
T ss_pred             cceEEEecccchhhc---cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH
Confidence              7799999999996   446667788999999999999976543   347899999999999999999997654332 1


Q ss_pred             HHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          303 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .+.+. -..+...             .......+.+..+||.+||..||++|||+.|+|++
T Consensus       391 ~eQI~-~G~y~f~-------------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  391 KEQIL-KGRYAFG-------------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             HHHHh-cCccccc-------------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            11111 0111111             12334556788899999999999999999999987

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-49  Score=385.23  Aligned_cols=249  Identities=26%  Similarity=0.437  Sum_probs=211.2

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC---cchhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ..|...+.||+|||+.||.++..       .++..||+|++.+.   .....+.+.+|+++.+.|+|||||+++++|.+.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~-------~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs   90 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDL-------DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS   90 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEc-------CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC
Confidence            46999999999999999999864       57899999999864   233457789999999999999999999999766


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      .    ++|+|.|+|..++|..++.++  .++++.++..++.||+.||.|||+.   +|+|||||..|+||+++.++||+|
T Consensus        91 ~----nVYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgD  161 (592)
T KOG0575|consen   91 N----NVYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGD  161 (592)
T ss_pred             C----ceEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecc
Confidence            5    469999999999999999754  4899999999999999999999999   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||||....  .......+.+||+.|.|||++.....+..+||||+||+||.|++|++||+...-.+.   ...+....  
T Consensus       162 FGLAt~le--~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket---y~~Ik~~~--  234 (592)
T KOG0575|consen  162 FGLATQLE--YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET---YNKIKLNE--  234 (592)
T ss_pred             cceeeeec--CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH---HHHHHhcC--
Confidence            99998642  233455778999999999999999999999999999999999999999986543322   22221110  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                       .            ..|...+.+..+||.++|+.||.+|||+.+|+.+
T Consensus       235 -Y------------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  235 -Y------------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -c------------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             0            1122345678899999999999999999999986

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-49  Score=378.99  Aligned_cols=257  Identities=30%  Similarity=0.462  Sum_probs=214.4

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ..+..++.||+|-||.||.|.|+        ....||+|.+.... ...+.|.+|+++|++|+|+|||+++|+|..++  
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~--------~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--  274 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWN--------GSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE--  274 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEc--------CCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCC--
Confidence            45667889999999999999997        34579999987653 34468889999999999999999999998765  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        .++|||||++.|+|.+||....+..+...+.+.++.|||+||+||+++   ++|||||..+||||+++..+||+|||+
T Consensus       275 --piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGL  349 (468)
T KOG0197|consen  275 --PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGL  349 (468)
T ss_pred             --ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccc
Confidence              359999999999999999986677899999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      |+.. ..+.........-...|.|||.+..+.++.+||||||||+||||+| |+.||.+.....   +++.+.       
T Consensus       350 Ar~~-~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---v~~~le-------  418 (468)
T KOG0197|consen  350 ARLI-GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---VLELLE-------  418 (468)
T ss_pred             cccc-CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---HHHHHh-------
Confidence            9932 2222222333344568999999999999999999999999999999 999998765433   222221       


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                             ...+-..|..||..+.+++..||..+|++|||+..+...|+++..
T Consensus       419 -------~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  419 -------RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             -------ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence                   122223456678999999999999999999999999999988764

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-48  Score=353.74  Aligned_cols=251  Identities=27%  Similarity=0.421  Sum_probs=208.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++++.||+|+||+||.++.+       .+++.||+|++++....   ..+....|..+|..++||+||.++-.|+.
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~-------dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt   96 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKK-------DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT   96 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEc-------ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc
Confidence            458999999999999999999976       67899999999876443   34568889999999999999999988876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    .+|+|+||+.||.|.-+|.+..  .+++..+.-++..|+.||.|||++   |||||||||+|||||.+|+++|+
T Consensus        97 ~~----kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~Lt  167 (357)
T KOG0598|consen   97 EE----KLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLT  167 (357)
T ss_pred             CC----eEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEe
Confidence            54    4699999999999999997654  699999999999999999999999   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||+++..  ........+++||+.|||||++.+..|+.++|.||||+++|||++|.+||...+....   .+.+...+.
T Consensus       168 DFgL~k~~--~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~---~~~I~~~k~  242 (357)
T KOG0598|consen  168 DFGLCKED--LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM---YDKILKGKL  242 (357)
T ss_pred             ccccchhc--ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH---HHHHhcCcC
Confidence            99999852  3344455668999999999999999999999999999999999999999987654322   222211110


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC----CHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP----KMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP----s~~eil~~  363 (436)
                                +    ..+...+....+++..+|..||++|.    ++.+|.+|
T Consensus       243 ----------~----~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  243 ----------P----LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             ----------C----CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence                      0    11111346788999999999999996    55665544

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-47  Score=363.83  Aligned_cols=255  Identities=26%  Similarity=0.354  Sum_probs=210.0

Q ss_pred             HHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhcc-CCCCceeeee
Q 013790           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVL-EHPNLVKLIG  150 (436)
Q Consensus        75 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hpnIv~~~~  150 (436)
                      +.-.+||..++.||.|+|++|++|+.+       .+++.||||++.+....   ..+.+.+|-.+|.+| +||.|++++-
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~-------~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~  141 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREK-------ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYF  141 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeec-------CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEE
Confidence            445679999999999999999999966       57899999999765332   224567788899999 7999999988


Q ss_pred             EeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc
Q 013790          151 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  230 (436)
Q Consensus       151 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  230 (436)
                      -|.++.    .+|+|+||+++|+|.++|..-  +.+++.....++.+|+.||+|||++   |||||||||+|||||++|+
T Consensus       142 TFQD~~----sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmh  212 (604)
T KOG0592|consen  142 TFQDEE----SLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGH  212 (604)
T ss_pred             Eeeccc----ceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCc
Confidence            887654    469999999999999999765  4799999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCCCCCCCCCCc---------ccc--cccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 013790          231 PKLSDFGLAREGPMVGHT---------HVS--TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP  299 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~  299 (436)
                      +||+|||.|+........         ...  .+++||..|.+||++.++..++.+|+|+||||||+|+.|.+||.+.+.
T Consensus       213 ikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne  292 (604)
T KOG0592|consen  213 IKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE  292 (604)
T ss_pred             EEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence            999999999854322111         122  568999999999999999999999999999999999999999987655


Q ss_pred             hhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....   +.+...           +-    .++...++...+||.++|..||.+|++.++|.+|
T Consensus       293 yliF---qkI~~l-----------~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  293 YLIF---QKIQAL-----------DY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHH---HHHHHh-----------cc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            3322   111111           11    1222223678899999999999999999999887

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-47  Score=356.05  Aligned_cols=261  Identities=27%  Similarity=0.409  Sum_probs=207.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ..++...+.||+|+||.||++...       .++...|||.+........+.+.+|+.+|++++|||||+++|.......
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~-------~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~   88 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNK-------KTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN   88 (313)
T ss_pred             cchhhhhccccCccceEEEEEEec-------CCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence            346888899999999999999976       3478899999876643346678999999999999999999997443332


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC-CCceEEeec
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-NFRPKLSDF  236 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Df  236 (436)
                        ..+++.|||+++|+|.+++.+..+ .+++..+..++.|+++||.|||++   ||+||||||+||||+. ++.+||+||
T Consensus        89 --~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDF  162 (313)
T KOG0198|consen   89 --DEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADF  162 (313)
T ss_pred             --eeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccC
Confidence              346899999999999999988765 799999999999999999999999   9999999999999999 799999999


Q ss_pred             cCCCCCCC-CCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          237 GLAREGPM-VGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |+++.... ...........||+.|||||++..+ ....++|||||||++.||+||..||....... ..+. ++..   
T Consensus       163 G~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~-~~~~-~ig~---  237 (313)
T KOG0198|consen  163 GLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA-EALL-LIGR---  237 (313)
T ss_pred             ccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH-HHHH-HHhc---
Confidence            99975322 1112233457899999999999853 33459999999999999999999998641111 1111 1110   


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  366 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~  366 (436)
                               .. ....++...+....+++..|+..||.+|||+.++|.+..-
T Consensus       238 ---------~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  238 ---------ED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             ---------cC-CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence                     00 1113344456788999999999999999999999998643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.2e-47  Score=338.45  Aligned_cols=267  Identities=25%  Similarity=0.329  Sum_probs=210.4

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      +.|+.+.++|+|+||.||+++.+       .+|+.||||++..+.  ....+-..+|+++|++|+|||+|.++.+|....
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk-------~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr   74 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNK-------DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR   74 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccC-------CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc
Confidence            46888999999999999999976       689999999996543  333456789999999999999999999997655


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          .++||+|||.. ++.+-|... ...++...+.+++.|++.|+.|+|++   ++|||||||+||||+.+|.+|||||
T Consensus        75 ----klhLVFE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDF  145 (396)
T KOG0593|consen   75 ----KLHLVFEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDF  145 (396)
T ss_pred             ----eeEEEeeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccc
Confidence                45999999966 444445443 34689999999999999999999999   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh----
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ----  311 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~----  311 (436)
                      |+|+...  ......+.++-|..|.|||++.| ..|+..+||||+||++.||++|.+.|.+..+.+....+.....    
T Consensus       146 GFAR~L~--~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p  223 (396)
T KOG0593|consen  146 GFARTLS--APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP  223 (396)
T ss_pred             hhhHhhc--CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH
Confidence            9999643  24455567788999999999987 7899999999999999999999999998776555433322211    


Q ss_pred             ----cccCccccccccCCcccCcCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 ----YPADSKKFGLIMDPRLEKEYS-----INEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 ----~~~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                          .......|..+.-|......+     +..+..+.+|+..||..||.+|++.++++.+
T Consensus       224 rhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  224 RHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             HHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence                111122222222222221111     2334468899999999999999999999876

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-46  Score=348.35  Aligned_cols=264  Identities=28%  Similarity=0.380  Sum_probs=216.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhH-HHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..+|++...||.|..+.||+|++.       ..+..||||+++.+..... +.+++|+..|+.++||||++++..|..+.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~-------p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~   97 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCI-------PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS   97 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeec-------ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence            468999999999999999999987       4568999999987765544 78999999999999999999999988765


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          .+|+||.||.+|++.+.+.......+++..+..|++++++||.|||.+   |.||||||+.||||+.+|.|||+||
T Consensus        98 ----~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadF  170 (516)
T KOG0582|consen   98 ----ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADF  170 (516)
T ss_pred             ----eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCc
Confidence                469999999999999999887767899999999999999999999999   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcc--cccccccCCCcccccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          237 GLAREGPMVGHTH--VSTAVVGTFGYAAPDYIE--TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       237 g~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |.+......+...  ....++||+.|||||++.  ...|+.|+|||||||+..||.+|..||....|...  ++..++..
T Consensus       171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~tLqn~  248 (516)
T KOG0582|consen  171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLLTLQND  248 (516)
T ss_pred             eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHHHhcCC
Confidence            9876533333221  125679999999999963  35789999999999999999999999998876532  33333333


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +....      ...+........+..+.++|..||..||.+|||+++++++
T Consensus       249 pp~~~------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  249 PPTLL------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CCCcc------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            32111      1111112222334589999999999999999999999875

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.3e-47  Score=360.06  Aligned_cols=248  Identities=29%  Similarity=0.453  Sum_probs=212.1

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|.+.+.||+|+||.||+|+.+       .+.+.||+|.+.+...  .+.+.+.+|+++++.++|||||.++++|....
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK-------~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~   74 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRK-------YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA   74 (808)
T ss_pred             cchhHHHHhcCCccceeeecccc-------cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc
Confidence            57899999999999999999866       6789999999987643  34567999999999999999999999997665


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          .+|+|+||+.| +|..+|....  .++++.+..|+.|++.||.|||+.   +|+|||+||.|||++.+|.+|+|||
T Consensus        75 ----~~~vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdF  144 (808)
T KOG0597|consen   75 ----HLWVVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDF  144 (808)
T ss_pred             ----eEEEEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechh
Confidence                45999999976 9999997664  799999999999999999999999   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      |+|+..  .......+...||+.|||||+..+.+|+..+|+||||||+||+++|++||...   ....++..+...+.  
T Consensus       145 g~Ar~m--~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv~~I~~d~v--  217 (808)
T KOG0597|consen  145 GLARAM--STNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLVKSILKDPV--  217 (808)
T ss_pred             hhhhhc--ccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHHHHHhcCCC--
Confidence            999863  33455667788999999999999999999999999999999999999999643   22233333222221  


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                   ..+...+..+..|+...|..||.+|.+..+++.|
T Consensus       218 -------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  218 -------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             -------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                         1233556789999999999999999999999886

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=361.64  Aligned_cols=251  Identities=25%  Similarity=0.390  Sum_probs=214.8

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ..|....+||+|+.|.||.|...       .+++.||||+++.......+-+.+|+.+|+..+|+|||.+++.+...+  
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~-------~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d--  343 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKI-------STKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD--  343 (550)
T ss_pred             hhhcchhhhccccccceeeeeec-------cCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc--
Confidence            56888889999999999999855       677889999998877677778999999999999999999999887764  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        .+|.||||++||+|.+.+...   .+++.++..|+.+++.||+|||.+   ||+|||||.+|||++.+|.+||+|||+
T Consensus       344 --eLWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGF  415 (550)
T KOG0578|consen  344 --ELWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGF  415 (550)
T ss_pred             --eeEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeee
Confidence              459999999999999998654   489999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  318 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  318 (436)
                      +...  ........+.+||+.|||||++....|+++.||||||++++||+-|++||-..++.-...+   +...      
T Consensus       416 caqi--~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL---Ia~n------  484 (550)
T KOG0578|consen  416 CAQI--SEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IATN------  484 (550)
T ss_pred             eecc--ccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH---Hhhc------
Confidence            9864  3334466788999999999999999999999999999999999999999986554322211   1111      


Q ss_pred             cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       319 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                            ..+....+...+..|.+|+.+||..|+++|+++.++|+|
T Consensus       485 ------g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  485 ------GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ------CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence                  111123344556889999999999999999999999987

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-47  Score=355.40  Aligned_cols=269  Identities=27%  Similarity=0.374  Sum_probs=215.5

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHH-HHHHHHHHHhccC-CCCceeeeeEee
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK-QWVAEVQFLGVLE-HPNLVKLIGYCA  153 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-hpnIv~~~~~~~  153 (436)
                      ...++|.++++||.|+||.||+|+-+       .++..||||+++..-....+ .-.+|+..|++|+ |||||++.+++.
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~-------~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~   79 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSK-------ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIR   79 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeec-------CCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhh
Confidence            35678999999999999999999865       57788999999766433322 2467999999999 999999999987


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      +...   .+++||||| ..+|++.+.++ ...+++..+..|+.||++||+|+|.+   |+.|||+||+|||+..+..+||
T Consensus        80 d~~~---~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKi  151 (538)
T KOG0661|consen   80 DNDR---ILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKI  151 (538)
T ss_pred             ccCc---eEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEe
Confidence            6553   579999999 67999999988 57999999999999999999999999   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCccccccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhh
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQ  311 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~  311 (436)
                      +|||+|+.   .......+.++.|.-|.|||++ +.+.|+.+.|+||+|||++|+.+-++.|.+.+..+.. .+.+.+..
T Consensus       152 aDFGLARe---v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGt  228 (538)
T KOG0661|consen  152 ADFGLARE---VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGT  228 (538)
T ss_pred             cccccccc---cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCC
Confidence            99999995   3344556778899999999987 5678999999999999999999999999887654432 22332222


Q ss_pred             cccCcccc----ccccCC--------cccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 YPADSKKF----GLIMDP--------RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 ~~~~~~~~----~~~~~~--------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ........    ...++-        .+..-. ...+.++.+||.+|+.+||.+|||+.+++++
T Consensus       229 P~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  229 PDKDSWPEGYNLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             CccccchhHHHHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            22111111    111111        111112 2367789999999999999999999999987

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-47  Score=363.48  Aligned_cols=266  Identities=27%  Similarity=0.456  Sum_probs=215.9

Q ss_pred             HHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCCceeee
Q 013790           72 SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLI  149 (436)
Q Consensus        72 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~  149 (436)
                      .+.....+++.+...||+|+||+||+|.|.          -.||||+++.+...  ..+.|..|+..+++-+|.||+-+.
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh----------GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFM  454 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH----------GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFM  454 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc----------cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeee
Confidence            455556678888999999999999999997          24999999876443  457899999999999999999999


Q ss_pred             eEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC
Q 013790          150 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  229 (436)
Q Consensus       150 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  229 (436)
                      |+|..++.     .||+.+|+|.+|+.+|+... ..+...+...|+.|+|+||.|||.+   +|||||||..|||+.+++
T Consensus       455 G~~~~p~~-----AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~  525 (678)
T KOG0193|consen  455 GACMNPPL-----AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDL  525 (678)
T ss_pred             hhhcCCce-----eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCC
Confidence            99987753     89999999999999998765 5789999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCCCCCCCCCCcccccccccCCCccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 013790          230 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  306 (436)
Q Consensus       230 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  306 (436)
                      .|||+|||++................|...|||||+++.   .+|+..+||||||+++|||+||..||......  ..+.
T Consensus       526 kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--qIif  603 (678)
T KOG0193|consen  526 KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--QIIF  603 (678)
T ss_pred             cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--heEE
Confidence            999999999974332223333445678899999999954   57899999999999999999999999843221  1111


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                      ...+.+          ..+.+. .....++.++.+|+..||..++++||.+.+|+..|+.++.
T Consensus       604 mVGrG~----------l~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  604 MVGRGY----------LMPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             Eecccc----------cCccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            100110          011111 2234567899999999999999999999999999988875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=357.51  Aligned_cols=251  Identities=25%  Similarity=0.398  Sum_probs=208.5

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC----cc-hhHHHHHHHHHHHhccC-CCCceeeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GL-QGHKQWVAEVQFLGVLE-HPNLVKLIG  150 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~  150 (436)
                      ..+.|.+.+.||+|+||+|+.|.+.       .++..||+|++++.    .. ...+.+.+|+.+++.+. ||||++++.
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~-------~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~e   87 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHR-------LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLE   87 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeec-------cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEE
Confidence            4578999999999999999999876       56789999988764    22 23456778999999999 999999999


Q ss_pred             EeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC-C
Q 013790          151 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-F  229 (436)
Q Consensus       151 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~  229 (436)
                      ++.....    .++||||+.||+|.+++.+.  .++.+..+..+++|++.|++|||++   ||+||||||+|||++.+ +
T Consensus        88 v~~t~~~----~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~  158 (370)
T KOG0583|consen   88 VFATPTK----IYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEG  158 (370)
T ss_pred             EEecCCe----EEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCC
Confidence            9987654    59999999999999999873  4799999999999999999999999   99999999999999999 9


Q ss_pred             ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 013790          230 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-LT-AKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       230 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  307 (436)
                      ++||+|||++....  .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+..+....   ..
T Consensus       159 ~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l---~~  233 (370)
T KOG0583|consen  159 NLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL---YR  233 (370)
T ss_pred             CEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH---HH
Confidence            99999999998632  3455667889999999999998876 75 789999999999999999999987433221   11


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHH-HHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINE-ARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .+....             +  .++... +..+..|+.+||..||.+|+++.+|+.+
T Consensus       234 ki~~~~-------------~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  234 KIRKGE-------------F--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             HHhcCC-------------c--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence            111110             0  111112 5788899999999999999999999944

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-45  Score=357.65  Aligned_cols=268  Identities=28%  Similarity=0.404  Sum_probs=207.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|++.+.||+|+||.||+|.+....  ...++..||+|++.... ......+.+|+.++..+ +||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGID--KKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccC--CcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            468999999999999999999864211  22356789999987543 23345788999999999 899999999988654


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC-----------------------------------------------------
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA-----------------------------------------------------  182 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------  182 (436)
                      +.   ..+++|||+++|+|.+++....                                                     
T Consensus        84 ~~---~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          84 NG---PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             CC---ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            32   3589999999999999986532                                                     


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccc
Q 013790          183 -------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV  255 (436)
Q Consensus       183 -------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  255 (436)
                             ..++++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...............
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  237 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR  237 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence                   13477888999999999999999998   99999999999999999999999999997532221112222344


Q ss_pred             cCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHH
Q 013790          256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSIN  334 (436)
Q Consensus       256 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  334 (436)
                      ++..|+|||++.+..++.++|||||||++|||++ |..||.+......  +...+....          ..    ..+..
T Consensus       238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~~~~~~~----------~~----~~~~~  301 (338)
T cd05102         238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQRLKDGT----------RM----RAPEN  301 (338)
T ss_pred             CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHHHHhcCC----------CC----CCCCC
Confidence            6678999999998899999999999999999997 9999976543221  111111100          00    11222


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          335 EARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       335 ~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                      .+..+.+|+.+||+.||.+|||+.+|++.|+++++
T Consensus       302 ~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         302 ATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            34678999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-46  Score=352.15  Aligned_cols=270  Identities=27%  Similarity=0.358  Sum_probs=214.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .+.|+.+++||+|+||.||+|+..       .+++.||+|++..+.  ........+|+.||++|+||||+++.++....
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~-------~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~  188 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDL-------ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK  188 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeec-------ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence            467999999999999999999854       789999999998765  33446678999999999999999999998876


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                        ....+|||+|||+. +|..++.... -.+++.++..++.||+.||.|||++   ||+|||||.+|||||.+|.+||+|
T Consensus       189 --~~~siYlVFeYMdh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaD  261 (560)
T KOG0600|consen  189 --LSGSIYLVFEYMDH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIAD  261 (560)
T ss_pred             --CCceEEEEEecccc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecc
Confidence              23457999999955 8999886643 4699999999999999999999999   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ||||+.+.. ......+..+-|+-|.|||++.|. .|+.+.|+||.||||.||++|++.|.+.+..+..+.+..+..-|.
T Consensus       262 FGLAr~y~~-~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~  340 (560)
T KOG0600|consen  262 FGLARFYTP-SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT  340 (560)
T ss_pred             ccceeeccC-CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC
Confidence            999996432 233345667789999999999774 799999999999999999999999999877666555544444433


Q ss_pred             Ccc-c---cc--cccCCc------ccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSK-K---FG--LIMDPR------LEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~-~---~~--~~~~~~------l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ... .   +.  ..+.+.      +.+. -...+....+|+..+|..||.+|.|+.++|..
T Consensus       341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  341 EDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             hhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            322 1   00  011110      0000 11124567799999999999999999998764

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.6e-46  Score=376.25  Aligned_cols=269  Identities=29%  Similarity=0.494  Sum_probs=223.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..+....+.||+|.||+||+|......  .....+.||||.++..... ...+|++|++++..|+|||||+++|+|.+..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~--p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLL--PGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCC--CCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            356777889999999999999876433  2346788999999877655 6788999999999999999999999998766


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEE
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRA------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL  224 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIl  224 (436)
                      .    +++|+|||..|+|.+||..+.            ..+++..+.+.||.|||.||.||-++   .+|||||..+|+|
T Consensus       563 P----~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCL  635 (774)
T KOG1026|consen  563 P----LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCL  635 (774)
T ss_pred             e----eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhce
Confidence            4    599999999999999997532            22388899999999999999999998   9999999999999


Q ss_pred             EcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 013790          225 LDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQ  303 (436)
Q Consensus       225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  303 (436)
                      |.++..|||+|||+++.....+.........-..+|||||.+..+.|+.+||||||||+|||+++ |..||.+....   
T Consensus       636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---  712 (774)
T KOG1026|consen  636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---  712 (774)
T ss_pred             eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---
Confidence            99999999999999996443333333333344679999999999999999999999999999999 99999876543   


Q ss_pred             HHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          304 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                      ++++.++.             .++ ...+..+|.++..|+..||+.+|.+||++.+|-..|+.+.+...
T Consensus       713 EVIe~i~~-------------g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  713 EVIECIRA-------------GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             HHHHHHHc-------------CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence            34444332             222 34567788999999999999999999999999999998876543

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-46  Score=359.39  Aligned_cols=242  Identities=27%  Similarity=0.464  Sum_probs=202.1

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcce
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  160 (436)
                      ...++-||.|+.|.||+|+++         +..||||+++...       ..+++.|++|+||||+.|.|+|....-   
T Consensus       126 IsELeWlGSGaQGAVF~Grl~---------netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPc---  186 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLH---------NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPC---  186 (904)
T ss_pred             hhhhhhhccCcccceeeeecc---------CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCce---
Confidence            344567999999999999975         6789999986433       347899999999999999999987653   


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                       .|||||||..|.|...|+..  .++.......|..+||.||.|||.+   .|||||||.-||||+.+..|||+|||-++
T Consensus       187 -yCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  187 -YCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             -eEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchH
Confidence             49999999999999999765  4788889999999999999999999   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ...   .....-.+.||..|||||++++.+.+.++|||||||+||||+||..||.+.....    +-|            
T Consensus       261 e~~---~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw------------  321 (904)
T KOG4721|consen  261 ELS---DKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW------------  321 (904)
T ss_pred             hhh---hhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE------------
Confidence            522   2233345789999999999999999999999999999999999999997543211    001            


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  366 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~  366 (436)
                      .+-.-.|....+..++..|.-||++||+..|..||++.+|+.||+-
T Consensus       322 GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  322 GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            0112223345566778899999999999999999999999999963

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-46  Score=347.92  Aligned_cols=251  Identities=25%  Similarity=0.379  Sum_probs=211.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ...|..+..||+|+||.||+|...       .+++.||+|+++.+... ..+.+.+|+.+|.+++++||.++|+.+....
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~-------~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~   84 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDN-------KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT   84 (467)
T ss_pred             ccccccchhccccccceeeeeeec-------cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc
Confidence            346777889999999999999855       78899999999876443 4578899999999999999999999887654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          .++++||||.||++.+.+....  .+.+..+.-++++++.||.|||..   +.+|||||+.|||+..+|.+||+||
T Consensus        85 ----~LwiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~Df  155 (467)
T KOG0201|consen   85 ----KLWIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADF  155 (467)
T ss_pred             ----cHHHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEec
Confidence                4599999999999999996543  458888899999999999999999   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      |++-...  .......+++||+.|||||++.+..|+.++||||||++.+||++|.+||....|....             
T Consensus       156 gVa~ql~--~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-------------  220 (467)
T KOG0201|consen  156 GVAGQLT--NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-------------  220 (467)
T ss_pred             ceeeeee--chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-------------
Confidence            9997632  3334447899999999999999989999999999999999999999999877663211             


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                          .++....+.......+..+.+||..||..||+.|||+.+++++
T Consensus       221 ----flIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  221 ----FLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ----EeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence                1122222223333556789999999999999999999999986

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-45  Score=323.83  Aligned_cols=238  Identities=27%  Similarity=0.412  Sum_probs=202.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhH---HHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH---KQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|+.++.||.|+||.|.+++.+       .++..+|+|++++......   +...+|..+|+.+.||+++++++.+.+
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k-------~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d  115 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREK-------HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD  115 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEc-------cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence            458999999999999999999977       5688999999988765544   456789999999999999999988865


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ++++||||.+||.|..++++.  +++++..+.-++.||+.||.|||+.   +|++|||||+|||||.+|.+||+
T Consensus       116 ~~----~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKit  186 (355)
T KOG0616|consen  116 NS----NLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKIT  186 (355)
T ss_pred             CC----eEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEE
Confidence            44    569999999999999999765  4799999999999999999999999   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||+|+..     .....+.+||+.|+|||++...+|+.++|.|||||++|||+.|.+||...++..   +.+.+     
T Consensus       187 DFGFAK~v-----~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~---iY~KI-----  253 (355)
T KOG0616|consen  187 DFGFAKRV-----SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ---IYEKI-----  253 (355)
T ss_pred             eccceEEe-----cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH---HHHHH-----
Confidence            99999862     233567899999999999999999999999999999999999999998876632   22221     


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCC
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR  354 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~R  354 (436)
                              +...+  .+|...+..+.+|+..+|+.|-.+|
T Consensus       254 --------~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  254 --------LEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --------HhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence                    11111  2333345678899999999999999

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-45  Score=341.65  Aligned_cols=264  Identities=27%  Similarity=0.359  Sum_probs=209.1

Q ss_pred             HHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--------------hHHHHHHHHHHH
Q 013790           72 SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--------------GHKQWVAEVQFL  137 (436)
Q Consensus        72 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l  137 (436)
                      .+-+...|+|++++.||+|.||.|-+|+.       ..+++.||||++.+....              ..+.+.+|+.+|
T Consensus        90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~-------~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIail  162 (576)
T KOG0585|consen   90 DQDRKQLNQYELIKEIGSGQYGKVKLARD-------EVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAIL  162 (576)
T ss_pred             cccceehhheehhhhhcCCccceEEEEee-------cCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHH
Confidence            33455679999999999999999999984       478899999999753211              235789999999


Q ss_pred             hccCCCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCceeec
Q 013790          138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP-LPWKTRLHIILGAAEGLAYLHEGLEVQVIYR  216 (436)
Q Consensus       138 ~~l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~  216 (436)
                      ++|.|||||+++.+..+....  .+|||+|||..|.+...-   ...+ +++.++++++.+++.||.|||.+   |||||
T Consensus       163 Kkl~H~nVV~LiEvLDDP~s~--~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHR  234 (576)
T KOG0585|consen  163 KKLHHPNVVKLIEVLDDPESD--KLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHR  234 (576)
T ss_pred             HhcCCcCeeEEEEeecCcccC--ceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---Ceecc
Confidence            999999999999988765544  679999999988776442   2224 89999999999999999999999   99999


Q ss_pred             cCCCCcEEEcCCCceEEeeccCCCCCCC---CCCcccccccccCCCcccccccccCC----CCchhhHHHHHHHHHHHHh
Q 013790          217 DFKASNVLLDENFRPKLSDFGLAREGPM---VGHTHVSTAVVGTFGYAAPDYIETGH----LTAKSDVWSFGVVLYEMLT  289 (436)
Q Consensus       217 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~ellt  289 (436)
                      ||||+|+||+.+|++||+|||.+...+.   .+.........||+.|+|||.+.++.    .+.+.||||+||+||.|+.
T Consensus       235 DIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllf  314 (576)
T KOG0585|consen  235 DIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLF  314 (576)
T ss_pred             ccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhh
Confidence            9999999999999999999999875322   12223334478999999999997632    3568999999999999999


Q ss_pred             CCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 013790          290 GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  366 (436)
Q Consensus       290 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~  366 (436)
                      |+.||.+...   ..+...             +++..+.-....+....+.+||.+||..||++|.+..+|..|..-
T Consensus       315 G~~PF~~~~~---~~l~~K-------------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  315 GQLPFFDDFE---LELFDK-------------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             ccCCcccchH---HHHHHH-------------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence            9999986532   222222             222223222233456789999999999999999999999888643

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5e-44  Score=338.26  Aligned_cols=250  Identities=21%  Similarity=0.305  Sum_probs=200.8

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh---HHHHHHHHHHHhccCCCCceeeeeEeeecCCccee
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  161 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  161 (436)
                      ..||+|++|.||+|.+         +++.||||.+.......   .+.+.+|+.+|.+++||||++++|++.........
T Consensus        26 ~~i~~g~~~~v~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~   96 (283)
T PHA02988         26 VLIKENDQNSIYKGIF---------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPR   96 (283)
T ss_pred             eEEeeCCceEEEEEEE---------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCc
Confidence            5799999999999986         47889999997653332   46788999999999999999999998762222335


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          162 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       162 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      .++||||+.+|+|.+++...  ..+++.....++.|++.||.|||+.  .+++||||||+|||++.++.+||+|||+++.
T Consensus        97 ~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~  172 (283)
T PHA02988         97 LSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKI  172 (283)
T ss_pred             eEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhh
Confidence            68999999999999999764  3689999999999999999999973  2788999999999999999999999999874


Q ss_pred             CCCCCCcccccccccCCCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccc
Q 013790          242 GPMVGHTHVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF  319 (436)
Q Consensus       242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  319 (436)
                      ...     ......|+..|+|||++.+  ..++.++|||||||++|||++|..||.......   +...+....      
T Consensus       173 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~i~~~~------  238 (283)
T PHA02988        173 LSS-----PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDLIINKN------  238 (283)
T ss_pred             hcc-----ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHhcC------
Confidence            221     1123468899999999976  688999999999999999999999998664332   222211100      


Q ss_pred             ccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          320 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       320 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                             .....+..++..+.+|+.+||+.||++|||+.+|++.|+.+-
T Consensus       239 -------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        239 -------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             -------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence                   001122234678999999999999999999999999998764

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.6e-45  Score=335.80  Aligned_cols=248  Identities=22%  Similarity=0.397  Sum_probs=208.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhH---HHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH---KQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .+|++.+.||+|+||+|-+|+..       ..++.||||.++++...+.   -.+++|++||..|+||||+.+|.+|.+.
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~-------~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk  125 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEH-------KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK  125 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhc-------cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC
Confidence            57999999999999999999854       6789999999988765544   3578999999999999999999999776


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +.    +.|||||..+|.|++|+.++.  .+++..+.++++||+.|+.|+|.+   +++|||||.+|||+|.|+++||+|
T Consensus       126 dK----IvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIAD  196 (668)
T KOG0611|consen  126 DK----IVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIAD  196 (668)
T ss_pred             ce----EEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeec
Confidence            53    599999999999999997764  799999999999999999999999   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ||++..   ........+++|++.|.+||++.|.+| ++.+|.|||||+||.|+.|..||++.+-.   .++..+..   
T Consensus       197 FGLSNl---y~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvrQIs~---  267 (668)
T KOG0611|consen  197 FGLSNL---YADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVRQISR---  267 (668)
T ss_pred             cchhhh---hccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHHHhhc---
Confidence            999964   234455678999999999999999988 47899999999999999999999986432   22221111   


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                      .  .   ...        +..+....-||++||..||++|.|+.+|..|-
T Consensus       268 G--a---YrE--------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  268 G--A---YRE--------PETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             c--c---ccC--------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            0  0   011        11234556899999999999999999998874

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.1e-44  Score=343.34  Aligned_cols=254  Identities=23%  Similarity=0.357  Sum_probs=210.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh---HHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++++.||+|+||.||+|+-+       .+|..+|+|++++.....   .+.++.|-.+|...++|+||++|-.|.+
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk-------~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD  212 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKK-------DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD  212 (550)
T ss_pred             cccchhheeeccccceeEEEEEEc-------cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC
Confidence            479999999999999999999976       689999999998774433   3567889999999999999999988876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      ..    ++||||||++||++..+|.+..  .|++..+..++.+++.|+..||..   |+|||||||+|+|||..|++||+
T Consensus       213 ~~----~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLS  283 (550)
T KOG0605|consen  213 KE----YLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLS  283 (550)
T ss_pred             CC----eeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeec
Confidence            54    5699999999999999997654  799999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCC----------------------CCCcc----c-------------------ccccccCCCcccccccccC
Q 013790          235 DFGLAREGPM----------------------VGHTH----V-------------------STAVVGTFGYAAPDYIETG  269 (436)
Q Consensus       235 Dfg~a~~~~~----------------------~~~~~----~-------------------~~~~~gt~~y~aPE~~~~~  269 (436)
                      ||||+.-...                      .....    .                   ....+|||-|||||++.+.
T Consensus       284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k  363 (550)
T KOG0605|consen  284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK  363 (550)
T ss_pred             cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence            9999851100                      00000    0                   1235899999999999999


Q ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhc
Q 013790          270 HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLS  348 (436)
Q Consensus       270 ~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~  348 (436)
                      .|+..+|.||||||+|||+.|.+||...++... ..++.|......+..               ...+.+..+||.+||.
T Consensus       364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~---------------~~~s~eA~DLI~rll~  428 (550)
T KOG0605|consen  364 GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE---------------VDLSDEAKDLITRLLC  428 (550)
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc---------------CcccHHHHHHHHHHhc
Confidence            999999999999999999999999998877644 556777655443221               1223678899999999


Q ss_pred             CCCCCCCC---HHHHHHH
Q 013790          349 KSSKDRPK---MSQVVER  363 (436)
Q Consensus       349 ~dp~~RPs---~~eil~~  363 (436)
                       ||++|.-   +.||.+|
T Consensus       429 -d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  429 -DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             -CHHHhcCcccHHHHhcC
Confidence             9999985   6777665

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.3e-44  Score=313.39  Aligned_cols=267  Identities=24%  Similarity=0.337  Sum_probs=208.7

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh--HHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG--HKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .+|..++.||+|.||.||+|+..       .+++.||||++......+  .....+|++.|+.++|+||+.++++|...+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~-------~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~   74 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDT-------ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS   74 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEec-------CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC
Confidence            46888899999999999999954       789999999997653332  345788999999999999999999997665


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      .    +.||+||++ .+|+..|++.. ..++...+..++.++++||+|||.+   .|+||||||.|+||+.+|.+||+||
T Consensus        75 ~----l~lVfEfm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADF  145 (318)
T KOG0659|consen   75 N----LSLVFEFMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADF  145 (318)
T ss_pred             c----eEEEEEecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecc
Confidence            4    489999995 49999997765 4789999999999999999999999   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |+|+.+...  .......+-|.-|.|||++.|. .|+...|+||.|||+.||+-|.+-|.+.++.+....+-..-.-|..
T Consensus       146 GLAr~f~~p--~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~  223 (318)
T KOG0659|consen  146 GLARFFGSP--NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTP  223 (318)
T ss_pred             cchhccCCC--CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCc
Confidence            999975332  2223334788999999998764 7899999999999999999999888887665544333222222221


Q ss_pred             cc--cccc--------ccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SK--KFGL--------IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~--~~~~--------~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..  .+..        .+........-..++....+|+..||..||.+|++++|++++
T Consensus       224 ~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  224 DQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11  1100        011111111223345566899999999999999999999876

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.8e-44  Score=338.24  Aligned_cols=252  Identities=26%  Similarity=0.433  Sum_probs=201.5

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .|+..+.||+|+||.||+|...       .+++.||+|.+......   ....+.+|+.++..++|+||+++++++...+
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~   73 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD   73 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEe-------cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC
Confidence            3778899999999999999875       46789999998654322   2345778999999999999999999886554


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+++|+|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        74 ----~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Df  146 (285)
T cd05631          74 ----ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDL  146 (285)
T ss_pred             ----eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeC
Confidence                459999999999999988765545789999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~  315 (436)
                      |++.....   ........||..|+|||++.+..++.++|||||||++|+|++|+.||.......... +...+....  
T Consensus       147 g~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--  221 (285)
T cd05631         147 GLAVQIPE---GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ--  221 (285)
T ss_pred             CCcEEcCC---CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc--
Confidence            99875321   112234568999999999999999999999999999999999999998654322111 111111000  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~  363 (436)
                                   ..++...+..+.+|+.+||+.||.+||+     +.+++++
T Consensus       222 -------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         222 -------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             -------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence                         0112223467889999999999999997     7888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-44  Score=358.81  Aligned_cols=270  Identities=23%  Similarity=0.299  Sum_probs=220.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCCceeeee-Eeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNLVKLIG-YCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~-~~~~~  155 (436)
                      ..++++.+.|.+|||+.||+|...       ..+..||+|++-..+....+.+.+|+.+|++|. |+|||.+++ .....
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~-------~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~  108 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDV-------KGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR  108 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEec-------CCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence            457888999999999999999865       334889999988777778889999999999997 999999999 33332


Q ss_pred             -CCc-ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          156 -GER-GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       156 -~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                       +.. ....+|+||||.||.|-+++..+....|++.++++|+.|+++|+++||.. .++|||||||-+||||+.+|.+||
T Consensus       109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEe
Confidence             222 35778999999999999999877666799999999999999999999995 678999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcc-------cccccccCCCccccccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 013790          234 SDFGLAREGPMVGHTH-------VSTAVVGTFGYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ  303 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~  303 (436)
                      ||||.|..........       ..-....|+.|.|||++   .+.+.++|+|||+|||+||-|+....||+.....   
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---  264 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---  264 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---
Confidence            9999997422111111       01123568999999987   6788999999999999999999999999864221   


Q ss_pred             HHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcCCCC
Q 013790          304 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGD  375 (436)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~~~  375 (436)
                                       .+++..+.-......+..|.+||..||+.||.+||++.+++.++..+........
T Consensus       265 -----------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~  319 (738)
T KOG1989|consen  265 -----------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP  319 (738)
T ss_pred             -----------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence                             1344444434445678899999999999999999999999999999987665433

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.7e-44  Score=322.21  Aligned_cols=272  Identities=22%  Similarity=0.318  Sum_probs=213.6

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh--HHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG--HKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      ...++|+.++.|++|+||.||+|+.+       .++..||+|+++.+....  .-.-.+|+.+|.+++|||||.+-.+..
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk-------~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVv  145 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDK-------KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVV  145 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccC-------CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEe
Confidence            34568999999999999999999855       788999999998764221  234578999999999999999998887


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ...-.  .+|+|||||+. +|...+.... .++...++..+..|++.|++|||.+   .|+||||||+|+|++..|.+||
T Consensus       146 G~~~d--~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKi  218 (419)
T KOG0663|consen  146 GSNMD--KIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKI  218 (419)
T ss_pred             ccccc--eeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEe
Confidence            65443  46999999965 8999987765 6899999999999999999999999   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      +|||+|+..  .......+..+-|.-|.|||++.|. .|+.+.|+||+|||+.||+++++.|.+.......+.+-.+...
T Consensus       219 aDFGLAR~y--gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGt  296 (419)
T KOG0663|consen  219 ADFGLAREY--GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGT  296 (419)
T ss_pred             cccchhhhh--cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCC
Confidence            999999963  2233445667789999999999774 7899999999999999999999999887665544433333333


Q ss_pred             ccCcc--cccc-----------ccCCcccCcCCHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSK--KFGL-----------IMDPRLEKEYSIN-EARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~--~~~~-----------~~~~~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      |....  .+..           .....+...+... .+..-.+|+..+|..||.+|.|+.+.|++
T Consensus       297 Pte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  297 PSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             CccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            32211  0000           0011112222211 34667799999999999999999999887

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-43  Score=348.90  Aligned_cols=265  Identities=25%  Similarity=0.383  Sum_probs=205.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|++.+.||+|+||.||+|++....  ...++..||||++.... ....+.+.+|+.++..+ +||||++++++|...
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLF--KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccc--cCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            457999999999999999999864211  22356789999987543 23446788999999999 899999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC-----------------------------------------------------
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA-----------------------------------------------------  182 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------  182 (436)
                      +.    .++||||+++|+|.+++....                                                     
T Consensus       112 ~~----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  187 (375)
T cd05104         112 GP----TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR  187 (375)
T ss_pred             Cc----ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence            54    499999999999999986432                                                     


Q ss_pred             --------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCC
Q 013790          183 --------------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG  242 (436)
Q Consensus       183 --------------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  242 (436)
                                          ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~  264 (375)
T cd05104         188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI  264 (375)
T ss_pred             ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceec
Confidence                                12478889999999999999999998   9999999999999999999999999999753


Q ss_pred             CCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 013790          243 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  321 (436)
Q Consensus       243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (436)
                      .............++..|+|||++.+..++.++|||||||++|+|++ |..||.......  .+...+.....       
T Consensus       265 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~~~-------  335 (375)
T cd05104         265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEGYR-------  335 (375)
T ss_pred             cCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhCcc-------
Confidence            22211112222345668999999999999999999999999999998 889997643321  12222211100       


Q ss_pred             ccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       322 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                         .    ..+...+.++.+||.+||+.||++|||+.+|++.|++.
T Consensus       336 ---~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 ---M----LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ---C----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence               0    01112246789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.3e-43  Score=336.18  Aligned_cols=271  Identities=25%  Similarity=0.428  Sum_probs=204.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCC---------CCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCcee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAG---------DGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVK  147 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~---------~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~  147 (436)
                      .++|.+.+.||+|+||.||+|.+.....         .....+..||+|.+..... .....+.+|+.++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3579999999999999999998753210         0123456899999876532 23457889999999999999999


Q ss_pred             eeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 013790          148 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-----------------FPPLPWKTRLHIILGAAEGLAYLHEGLE  210 (436)
Q Consensus       148 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~  210 (436)
                      +++++...+.    .++||||+.+|+|.+++....                 ...+++..++.++.||+.||.|||+.  
T Consensus        84 ~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--  157 (304)
T cd05096          84 LLGVCVDEDP----LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--  157 (304)
T ss_pred             EEEEEecCCc----eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence            9999976543    599999999999999985432                 12467888999999999999999998  


Q ss_pred             CceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-
Q 013790          211 VQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-  289 (436)
Q Consensus       211 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-  289 (436)
                       +|+||||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|+|++ 
T Consensus       158 -~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         158 -NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             -CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence             999999999999999999999999999975322222222233456788999999988899999999999999999987 


Q ss_pred             -CCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          290 -GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       290 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                       +..||.......   ..............       ......+..++..+.+|+.+||+.||.+|||+.+|.+.|+
T Consensus       237 ~~~~p~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         237 CKEQPYGELTDEQ---VIENAGEFFRDQGR-------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             cCCCCCCcCCHHH---HHHHHHHHhhhccc-------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence             567887654322   22111111000000       0000112234567899999999999999999999988875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-43  Score=327.03  Aligned_cols=257  Identities=25%  Similarity=0.362  Sum_probs=212.0

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh---HHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      ..++|++++.||.|.-|+||++..+       .++..+|+|++++.....   ..+...|-+||+.++||.++.+|..+.
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~-------~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe  147 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELR-------GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE  147 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEec-------CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee
Confidence            3468999999999999999999987       456899999998775443   345677999999999999999999997


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      .+.    ..|+|||||+||+|...++++....+++..+.-++..++.||+|||-.   |||.|||||+||||.++|++.|
T Consensus       148 t~~----~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIML  220 (459)
T KOG0610|consen  148 TDK----YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIML  220 (459)
T ss_pred             ccc----eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEe
Confidence            765    359999999999999999999888999999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCC---------------------------------C-C--------------------CcccccccccCCC
Q 013790          234 SDFGLAREGPM---------------------------------V-G--------------------HTHVSTAVVGTFG  259 (436)
Q Consensus       234 ~Dfg~a~~~~~---------------------------------~-~--------------------~~~~~~~~~gt~~  259 (436)
                      +||.|+.....                                 . .                    ...++..++||-.
T Consensus       221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE  300 (459)
T KOG0610|consen  221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE  300 (459)
T ss_pred             eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence            99998742110                                 0 0                    0122345789999


Q ss_pred             cccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHH
Q 013790          260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKI  339 (436)
Q Consensus       260 y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l  339 (436)
                      |.|||++.|...+.++|.|+|||++|||+.|..||.+.+.....  ..              ++...+.-......+..+
T Consensus       301 YlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl--~N--------------Iv~~~l~Fp~~~~vs~~a  364 (459)
T KOG0610|consen  301 YLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL--RN--------------IVGQPLKFPEEPEVSSAA  364 (459)
T ss_pred             cccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH--HH--------------HhcCCCcCCCCCcchhHH
Confidence            99999999999999999999999999999999999886544321  11              111111111222556789


Q ss_pred             HHHHHHhhcCCCCCCCC----HHHHHHH
Q 013790          340 GRLADNCLSKSSKDRPK----MSQVVER  363 (436)
Q Consensus       340 ~~li~~cl~~dp~~RPs----~~eil~~  363 (436)
                      ++||+++|.+||.+|..    +.||.+|
T Consensus       365 kDLIr~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  365 KDLIRKLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             HHHHHHHhccChhhhhccccchHHhhcC
Confidence            99999999999999998    7888776

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-44  Score=311.62  Aligned_cols=251  Identities=25%  Similarity=0.400  Sum_probs=213.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++++.||+|-||.||.|+.+       .+.-.||+|++.+...   ....++.+|+++-..|+||||+++|++|.+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarek-------ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd   93 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREK-------KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD   93 (281)
T ss_pred             hhhccccccccCCccccEeEeeec-------cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence            458999999999999999999976       6778899999976532   234679999999999999999999999976


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      +.    .+||++||..+|.|...|.......+++.....++.|+|.||.|+|.+   +++||||||+|+|++..|.+||+
T Consensus        94 ~~----riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiA  166 (281)
T KOG0580|consen   94 SK----RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIA  166 (281)
T ss_pred             cc----eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeecc
Confidence            65    359999999999999999877767899999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||.+..    .......+.+||.-|.+||...+..++..+|+|++|++.||++.|.+||......   .....+.... 
T Consensus       167 dfGwsV~----~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---etYkrI~k~~-  238 (281)
T KOG0580|consen  167 DFGWSVH----APSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---ETYKRIRKVD-  238 (281)
T ss_pred             CCCceee----cCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---HHHHHHHHcc-
Confidence            9999864    2245567789999999999999999999999999999999999999999865522   2222222111 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                                    -.++...+....++|.+|+..+|.+|.+..+++++-
T Consensus       239 --------------~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  239 --------------LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             --------------ccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence                          122334456788999999999999999999998873

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-44  Score=349.23  Aligned_cols=250  Identities=25%  Similarity=0.373  Sum_probs=212.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .+-|.+++.||.|+.|.|-+|++.       .+|+.+|||++.+..   ......+.+|+-+|+.+.|||++++|+++.+
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~-------~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~   83 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHA-------ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN   83 (786)
T ss_pred             ccceeccccccCCCCceehhhhcc-------cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc
Confidence            356889999999999999999865       789999999997652   1223568899999999999999999999976


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      ..    ++|+|.||++||-|.+++...+  ++++.++.+++.||+.|+.|+|..   +|+||||||+|+|||..+++||+
T Consensus        84 ~~----~lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIA  154 (786)
T KOG0588|consen   84 KQ----HLYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIA  154 (786)
T ss_pred             Cc----eEEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeee
Confidence            54    5699999999999999997764  799999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLT-AKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |||+|..   .-......+.+|++-|.+||++.|.+|+ .++||||.|||||.|+||..||++.+   ...++..++.-.
T Consensus       155 DFGMAsL---e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV~~G~  228 (786)
T KOG0588|consen  155 DFGMASL---EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKVQRGV  228 (786)
T ss_pred             ccceeec---ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHHHcCc
Confidence            9999974   2234455678999999999999999885 68999999999999999999998543   333444444322


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                      .               ..+...+.+.++|+.+|+..||..|.|+++|++|-
T Consensus       229 f---------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  229 F---------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             c---------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence            2               11334457888999999999999999999999984

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.1e-43  Score=348.69  Aligned_cols=266  Identities=25%  Similarity=0.388  Sum_probs=206.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|++.+.||+|+||.||+|++....  ...+...||+|.+.... ....+.+.+|+.+++.+ +||||++++++|...
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLG--KEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCC--cccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            457999999999999999999875222  12345679999997543 23345688999999999 899999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC-----------------------------------------------------
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA-----------------------------------------------------  182 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------  182 (436)
                      +.    .++||||+++|+|.+++....                                                     
T Consensus       115 ~~----~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         115 GP----VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             CC----eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence            53    599999999999999985421                                                     


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCC
Q 013790          183 ---------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH  247 (436)
Q Consensus       183 ---------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  247 (436)
                                     ..++++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                           12478889999999999999999998   999999999999999999999999999975322211


Q ss_pred             cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccccccCCc
Q 013790          248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPR  326 (436)
Q Consensus       248 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (436)
                      ........++..|+|||++.+..++.++|||||||++|+|++ |..||.......  .........              
T Consensus       268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~~~~~--------------  331 (374)
T cd05106         268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKMVKRG--------------  331 (374)
T ss_pred             eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHHHHcc--------------
Confidence            112222345668999999988899999999999999999997 999997643321  111111110              


Q ss_pred             ccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          327 LEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       327 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                      .....+...+..+.+++.+||+.||.+|||+.+|++.|++++
T Consensus       332 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         332 YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            000111112467899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-44  Score=369.37  Aligned_cols=268  Identities=28%  Similarity=0.442  Sum_probs=217.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ...+..+.||+|.||.||.|...+.+++..  ...||||.+.+. +......|.+|..+|+.++|||||+++|+|...+.
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~--~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVS--PIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCcc--ceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            456677899999999999999986554322  567999999765 44556789999999999999999999999988654


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRA-----FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      .    ++++|||++|+|..||++..     ...++....+.++.|||+|+.||+++   ++|||||..+|+||+....+|
T Consensus       770 ~----~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VK  842 (1025)
T KOG1095|consen  770 P----LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVK  842 (1025)
T ss_pred             c----EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEE
Confidence            4    99999999999999998652     34688999999999999999999999   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhh
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      |+|||+|+...............-...|||||.+..+.++.++|||||||+|||++| |..||...+.......  ++. 
T Consensus       843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~--~~~-  919 (1025)
T KOG1095|consen  843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD--VLE-  919 (1025)
T ss_pred             EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH--HHh-
Confidence            999999995322222222222233468999999999999999999999999999999 9999987654332211  111 


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                                  ..+  -..+..|+..+.++|..||+.+|++||++..|++.+..+++...
T Consensus       920 ------------ggR--L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  920 ------------GGR--LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             ------------CCc--cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence                        111  13355677889999999999999999999999999988876543

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.6e-43  Score=339.19  Aligned_cols=265  Identities=25%  Similarity=0.377  Sum_probs=205.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++++.||+|+||.||++...       .++..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHK-------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG   76 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEEC-------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            468999999999999999999875       567889999987652 233467899999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+||
T Consensus        77 ----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Df  148 (331)
T cd06649          77 ----EISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDF  148 (331)
T ss_pred             ----EEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccC
Confidence                3599999999999999996643  689999999999999999999985  16999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      |++.....    .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........   +.......
T Consensus       149 g~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~---~~~~~~~~  221 (331)
T cd06649         149 GVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI---FGRPVVDG  221 (331)
T ss_pred             cccccccc----cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---hccccccc
Confidence            99874321    122345689999999999999999999999999999999999999976543222111   11100000


Q ss_pred             -cc--------------------------------cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 -KK--------------------------------FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 -~~--------------------------------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                       ..                                +..+.............+..+.+||.+||..||++|||+.+|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         222 EEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             00                                000000000000111245679999999999999999999999987


Q ss_pred             H
Q 013790          364 L  364 (436)
Q Consensus       364 L  364 (436)
                      .
T Consensus       302 ~  302 (331)
T cd06649         302 T  302 (331)
T ss_pred             h
Confidence            4

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=346.56  Aligned_cols=252  Identities=25%  Similarity=0.431  Sum_probs=209.3

Q ss_pred             HHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhccC-CCCceeeee
Q 013790           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLE-HPNLVKLIG  150 (436)
Q Consensus        75 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-hpnIv~~~~  150 (436)
                      ....++|.+++.||+|+||+|+++..+       .+++.+|||++++....   +.+....|..|+...+ ||.++.++.
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k-------~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~  436 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELK-------GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFS  436 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEc-------CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccc
Confidence            345679999999999999999999987       56789999999887443   3466778888888775 999999999


Q ss_pred             EeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc
Q 013790          151 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  230 (436)
Q Consensus       151 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  230 (436)
                      .|....    ++|+||||+.||++..+++.   ..+++..+.-++..|+.||.|||++   |||+||||.+|||||.+|.
T Consensus       437 ~fQT~~----~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh  506 (694)
T KOG0694|consen  437 CFQTKE----HLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGH  506 (694)
T ss_pred             ccccCC----eEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCc
Confidence            987655    46999999999996655543   3699999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      +||+|||+++..  .......++++||+.|||||++.+..|+.++|.|||||+||||+.|+.||.+.+..+..+-+    
T Consensus       507 ~kiADFGlcKe~--m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI----  580 (694)
T KOG0694|consen  507 VKIADFGLCKEG--MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI----  580 (694)
T ss_pred             EEeccccccccc--CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----
Confidence            999999999974  33445678899999999999999999999999999999999999999999976544332211    


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM-----SQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~  363 (436)
                                  +...  ..+|...+.+...++.++|..+|++|.-+     .+|..+
T Consensus       581 ------------~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h  624 (694)
T KOG0694|consen  581 ------------VNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH  624 (694)
T ss_pred             ------------hcCC--CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence                        1110  13455556788899999999999999955     555544

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.5e-43  Score=330.48  Aligned_cols=262  Identities=27%  Similarity=0.488  Sum_probs=208.7

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|++.+.||+|+||.||+|......  .......||+|.+..... .....+.+|+.++..++||||+++++++.... 
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPN--ERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ-   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCC--CCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC-
Confidence            47899999999999999999876322  123457899999875432 33456889999999999999999999987554 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcE
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAF--------------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  223 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NI  223 (436)
                         ..+++|||+++++|.+++.....              ..+++..++.++.|++.||.|||+.   +++|+||||+||
T Consensus        82 ---~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Ni  155 (283)
T cd05048          82 ---PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNC  155 (283)
T ss_pred             ---ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceE
Confidence               35899999999999999975421              4578899999999999999999998   999999999999


Q ss_pred             EEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 013790          224 LLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTE  302 (436)
Q Consensus       224 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~  302 (436)
                      +++.++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+..... 
T Consensus       156 l~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-  234 (283)
T cd05048         156 LVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-  234 (283)
T ss_pred             EEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence            999999999999999875322222222334456788999999988899999999999999999998 999998755432 


Q ss_pred             HHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 013790          303 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  366 (436)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~  366 (436)
                        +...+....              ....+..++..+.+|+.+||+.||.+||++.+|+++|++
T Consensus       235 --~~~~i~~~~--------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 --VIEMIRSRQ--------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHHHcCC--------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence              222222110              011233446789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-44  Score=308.79  Aligned_cols=274  Identities=23%  Similarity=0.333  Sum_probs=218.1

Q ss_pred             HHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEe
Q 013790           73 EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYC  152 (436)
Q Consensus        73 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  152 (436)
                      ++..+.++|++.+.||+|||+-||++.       +..++..||+|++......+.+...+|++..++++|||+++++++.
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~-------~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~   87 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVK-------GLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQ   87 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeec-------ccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence            345567899999999999999999987       4468899999999888777888899999999999999999999988


Q ss_pred             eecCC-cceeEEEEEEecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC
Q 013790          153 AVDGE-RGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  229 (436)
Q Consensus       153 ~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  229 (436)
                      ..+.. .....||+++|...|+|.+.+....  +..+++.+++.|+.+|++||.+||+. .+.+.||||||.|||+++.+
T Consensus        88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~  166 (302)
T KOG2345|consen   88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSG  166 (302)
T ss_pred             HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCC
Confidence            75543 3345799999999999999997643  44689999999999999999999997 23599999999999999999


Q ss_pred             ceEEeeccCCCCCCCCCCcc-------cccccccCCCccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 013790          230 RPKLSDFGLAREGPMVGHTH-------VSTAVVGTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRP  299 (436)
Q Consensus       230 ~~kl~Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~  299 (436)
                      .++|.|||.++..+..-.+.       .......|..|.|||++.-   ...+.++|||||||+||.|+.|..||+..-.
T Consensus       167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~  246 (302)
T KOG2345|consen  167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ  246 (302)
T ss_pred             ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence            99999999997532211111       1123467999999999843   4678899999999999999999999974211


Q ss_pred             hhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                                    ......-.+.++.+........+..+.+||.+||+.||.+||++.+++.++++++
T Consensus       247 --------------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 --------------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             --------------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                          0001111122333332333336788999999999999999999999999998764

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.2e-44  Score=329.53  Aligned_cols=272  Identities=26%  Similarity=0.335  Sum_probs=209.1

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      -.|...+.+|.|+||.||+|...       .++..||||++-.+..    --.+|+++|+.+.|||||+++-+|......
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~-------e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~   92 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLR-------ETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTES   92 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEc-------CCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence            35778889999999999999986       4578899999865432    234699999999999999999888766554


Q ss_pred             -ceeEEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC-CceEEe
Q 013790          159 -GIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLS  234 (436)
Q Consensus       159 -~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~  234 (436)
                       ..+..+||||++. +|.++++.  ..+..++...+.-+..||.+||+|||+.   ||+||||||+|+|+|.+ |.+|||
T Consensus        93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKic  168 (364)
T KOG0658|consen   93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKIC  168 (364)
T ss_pred             chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEec
Confidence             4466799999965 99999874  2345688888999999999999999998   99999999999999965 999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |||.|+..   .......+...|..|.|||++.| ..|+.+.||||.||++.||+-|++.|.+.........+-.+-+.|
T Consensus       169 DFGSAK~L---~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P  245 (364)
T KOG0658|consen  169 DFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP  245 (364)
T ss_pred             cCCcceee---ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence            99999863   23334466788999999999876 579999999999999999999999999866544433322222222


Q ss_pred             cCcc-----------ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHHhh
Q 013790          314 ADSK-----------KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER--LKQIV  368 (436)
Q Consensus       314 ~~~~-----------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~~~  368 (436)
                      ....           .+..+....+..-+....++++.+|+.++|..+|.+|.++.+++.+  ++.+.
T Consensus       246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR  313 (364)
T ss_pred             CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence            2111           1111111111111333446788899999999999999999999876  44444

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.5e-43  Score=332.68  Aligned_cols=268  Identities=25%  Similarity=0.375  Sum_probs=201.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++.+.||.|+||.||+|...       .++..||+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSK-------LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER   76 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEEC-------CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            357999999999999999999865       4678899999875432 23346778999999999999999999986543


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+. ++|.+++.... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        77 ----~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  147 (288)
T cd07871          77 ----CLTLVFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADF  147 (288)
T ss_pred             ----eEEEEEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcC
Confidence                4589999996 59999886543 3578999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |+++....  .........+++.|+|||++.+ ..++.++|||||||++|+|+||..||.+................+..
T Consensus       148 G~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  225 (288)
T cd07871         148 GLARAKSV--PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE  225 (288)
T ss_pred             cceeeccC--CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            99874221  1112234567899999999865 56899999999999999999999999876544332222111111110


Q ss_pred             c--------cccccccCCcccC----cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 S--------KKFGLIMDPRLEK----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~--------~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .        ..+.....+....    ......+..+.+||.+||..||.+|||+.++++|
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             HHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0        0001111111000    0011224568899999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.3e-43  Score=341.27  Aligned_cols=249  Identities=26%  Similarity=0.386  Sum_probs=193.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|+.++.||+|+||.||+|.+.       .+++.||||++..... .....+.+|+.+++.++|+||+++++++...+ 
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-  145 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHR-------PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG-  145 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEEC-------CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC-
Confidence            46778889999999999999865       4678899999865432 23467889999999999999999999986554 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+.+|+|.+..      ...+..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus       146 ---~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG  213 (353)
T PLN00034        146 ---EIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFG  213 (353)
T ss_pred             ---eEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccc
Confidence               459999999999987542      356778889999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      +++....  .........||..|+|||++..     ...+.++|||||||++|||++|+.||..........+...+...
T Consensus       214 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  291 (353)
T PLN00034        214 VSRILAQ--TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS  291 (353)
T ss_pred             cceeccc--ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc
Confidence            9875321  1112234578999999998743     23456899999999999999999999743332222222111100


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .          .    ...+...+..+.+||.+||..||++|||+.+|+++
T Consensus       292 ~----------~----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 Q----------P----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             C----------C----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0          0    01122335678999999999999999999999987

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=337.15  Aligned_cols=246  Identities=24%  Similarity=0.334  Sum_probs=200.6

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|++.+.||+|+||.||+|...       .+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   73 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDR-------ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ   73 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEc-------CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC
Confidence            47899999999999999999865       4678899999865422   2345688899999999999999999887654


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      .    ..++||||+++|+|.+++...  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~D  144 (291)
T cd05612          74 R----FLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTD  144 (291)
T ss_pred             C----eEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEe
Confidence            3    469999999999999999764  3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||+++....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   +...+....  
T Consensus       145 fg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~--  214 (291)
T cd05612         145 FGFAKKLRD-----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IYEKILAGK--  214 (291)
T ss_pred             cCcchhccC-----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCC--
Confidence            999875311     1223568999999999998889999999999999999999999998754322   111111110  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~  363 (436)
                               .    .++...+..+.+||.+||..||.+||+     +.+++++
T Consensus       215 ---------~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 ---------L----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ---------c----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                     0    111122467889999999999999995     8888876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.2e-42  Score=325.77  Aligned_cols=260  Identities=25%  Similarity=0.389  Sum_probs=205.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++.+.||+|+||.||+|.++..    ...+..||+|.++.... .....+.+|+.++..++||||+++++++...+
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~----~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   79 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLP----SKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN   79 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecC----CCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence            35789999999999999999987522    23578899999876532 23456889999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.++++||
T Consensus        80 ----~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~df  151 (266)
T cd05064          80 ----TMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGF  151 (266)
T ss_pred             ----CcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCC
Confidence                3599999999999999997643 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |.+...... .........++..|+|||.+.+..++.++|||||||++||+++ |..||.......   ....+....  
T Consensus       152 g~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~~~--  225 (266)
T cd05064         152 RRLQEDKSE-AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAVEDGF--  225 (266)
T ss_pred             ccccccccc-chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHHCCC--
Confidence            987642111 1111112335678999999999999999999999999999875 999997654432   222221100  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                              .    ...+..++..+.+++..||+.+|.+||++.+|++.|.++
T Consensus       226 --------~----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 --------R----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --------C----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                    0    011223456789999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.5e-43  Score=334.90  Aligned_cols=264  Identities=23%  Similarity=0.359  Sum_probs=207.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|+..+.||+|+||.||+|.+...   +......||+|.+.... ....+.+.+|+.+++.++||||++++|+|....
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~   82 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPE---GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   82 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecC---CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC
Confidence            35799999999999999999987521   22234569999987543 234567889999999999999999999987542


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                           .+++++|+++|+|.+++.... ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        83 -----~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~Df  153 (316)
T cd05108          83 -----VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDF  153 (316)
T ss_pred             -----ceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccc
Confidence                 379999999999999997643 3588999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+......   ...+..... 
T Consensus       154 G~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~---~~~~~~~~~-  229 (316)
T cd05108         154 GLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSILEKGER-  229 (316)
T ss_pred             cccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHhCCCC-
Confidence            99985432222111222334668999999999999999999999999999998 9999986543322   111111100 


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                                   ...+..++..+.+++.+||..||.+||++.+++..|..+...
T Consensus       230 -------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         230 -------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence                         001112335688999999999999999999999999888643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.8e-43  Score=338.16  Aligned_cols=267  Identities=26%  Similarity=0.392  Sum_probs=207.7

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhcc-CCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  156 (436)
                      ++|++.+.||.|+||.||+|......  ...+++.||+|++..... ...+.+..|+.++.++ +||||++++++|...+
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~--~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIE--KSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccc--cccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            47999999999999999999764221  224568899999875432 2345678899999999 7999999999887543


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCC------------------------------------------------------
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRA------------------------------------------------------  182 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------  182 (436)
                      .   ..+++|||+++++|.+++....                                                      
T Consensus        85 ~---~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          85 G---PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             C---CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            3   4689999999999999986422                                                      


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccC
Q 013790          183 -----FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT  257 (436)
Q Consensus       183 -----~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt  257 (436)
                           ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.++|+|||+++...............++
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence                 12688999999999999999999998   9999999999999999999999999999753222211222334566


Q ss_pred             CCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHH
Q 013790          258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEA  336 (436)
Q Consensus       258 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  336 (436)
                      ..|+|||++.+..++.++|||||||++|+|++ |..||.+......  +...+....          ..    ..+...+
T Consensus       239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~~~~~~----------~~----~~~~~~~  302 (337)
T cd05054         239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRRLKEGT----------RM----RAPEYAT  302 (337)
T ss_pred             ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHHHhccC----------CC----CCCccCC
Confidence            78999999999999999999999999999998 9999976433221  111111100          00    1112234


Q ss_pred             HHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          337 RKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       337 ~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                      ..+.+++.+||+.+|++||++.+|+++|+.+++
T Consensus       303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            678899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.7e-43  Score=338.76  Aligned_cols=243  Identities=26%  Similarity=0.370  Sum_probs=196.7

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCccee
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  161 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  161 (436)
                      +.||+|+||.||+|...       .+++.||+|++....   ......+.+|+.+++.++||||+++++++...+    .
T Consensus         1 ~~lG~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~----~   69 (323)
T cd05571           1 KLLGKGTFGKVILVREK-------ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD----R   69 (323)
T ss_pred             CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC----E
Confidence            36999999999999865       567899999987542   223356778999999999999999999887654    4


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          162 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       162 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      .++||||+++|+|.+++...  ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        70 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~  144 (323)
T cd05571          70 LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKE  144 (323)
T ss_pred             EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcc
Confidence            69999999999999998654  3689999999999999999999998   999999999999999999999999999874


Q ss_pred             CCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 013790          242 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  321 (436)
Q Consensus       242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (436)
                      ..  ..........||+.|+|||++.+..++.++|||||||++|||++|..||.......   ....+...         
T Consensus       145 ~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~~~~~---------  210 (323)
T cd05571         145 GI--SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELILME---------  210 (323)
T ss_pred             cc--cCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHHHHcC---------
Confidence            21  11222344679999999999999999999999999999999999999997654322   11111110         


Q ss_pred             ccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       322 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                        ..    .++...+..+.+||.+||..||++||     ++.+++++
T Consensus       211 --~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         211 --EI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             --CC----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence              00    11222346788999999999999999     79998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.2e-43  Score=331.90  Aligned_cols=268  Identities=25%  Similarity=0.319  Sum_probs=201.8

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|++.+.||+|+||.||+|+++       .+++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHK-------ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG   73 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEEC-------CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC
Confidence            47999999999999999999975       467889999986542  223456788999999999999999999887654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+.++.+..+...  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+||
T Consensus        74 ----~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Df  144 (287)
T cd07848          74 ----KLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDF  144 (287)
T ss_pred             ----EEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeec
Confidence                45999999988777655432  24689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH-hhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV-QQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~  315 (436)
                      |++...... .........|++.|+|||++.+..++.++|||||||++|+|++|+.||............... ...+..
T Consensus       145 g~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  223 (287)
T cd07848         145 GFARNLSEG-SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAE  223 (287)
T ss_pred             cCccccccc-ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHH
Confidence            999753211 112223456899999999999888999999999999999999999999865443221111111 000000


Q ss_pred             -------ccccccccCCcc------cCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 -------SKKFGLIMDPRL------EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 -------~~~~~~~~~~~l------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                             ...+.....+..      ........+..+.+|+.+||..||.+|||+.++++|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         224 QMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             HHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                   000000000000      001111235679999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=323.98  Aligned_cols=274  Identities=25%  Similarity=0.341  Sum_probs=213.5

Q ss_pred             HHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEec--cCcchhHHHHHHHHHHHhccCCCCceeeeeEe
Q 013790           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN--RDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYC  152 (436)
Q Consensus        75 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  152 (436)
                      ......|..++.||.|+||.|..|..+       .++..||||++.  -......++..+|+++|+.++|+||+.+++++
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~-------~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~   90 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDK-------RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIF   90 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEc-------CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeec
Confidence            344567777899999999999999976       577999999997  34555677889999999999999999999998


Q ss_pred             ee-cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCce
Q 013790          153 AV-DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  231 (436)
Q Consensus       153 ~~-~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  231 (436)
                      .. .......+|+|+|+| +.+|.+.|+.+.  .++...+..++.|+++||.|+|+.   +|+||||||.|+|++.+..+
T Consensus        91 ~p~~~~~f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~l  164 (359)
T KOG0660|consen   91 RPPSRDKFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDL  164 (359)
T ss_pred             ccccccccceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCE
Confidence            76 223345679999999 679999996653  599999999999999999999998   99999999999999999999


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCcccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      ||+|||+|+...........+..+-|..|.|||++. ...|+.+.||||.|||+.||++|++.|.+.+......++..+.
T Consensus       165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l  244 (359)
T KOG0660|consen  165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL  244 (359)
T ss_pred             EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence            999999999643332344456678899999999884 4689999999999999999999999998876544433322222


Q ss_pred             hcccCcccccccc---------------CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          311 QYPADSKKFGLIM---------------DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~---------------~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .-|.. ..+..+.               ...+...++ ...+...+|+.+||..||.+|+|++|+++|
T Consensus       245 GtP~~-e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  245 GTPSE-EDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             CCCCH-HHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            21111 0010000               000111112 334567799999999999999999999988

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=344.09  Aligned_cols=268  Identities=28%  Similarity=0.474  Sum_probs=214.6

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC---cchhHHHHHHHHHHHhccCCCCceeeeeEe
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQGHKQWVAEVQFLGVLEHPNLVKLIGYC  152 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  152 (436)
                      ...++..+.++||+|.||.||+|.++..++.   ....||||....+   .......+.+|+++|++++|||||++||++
T Consensus       154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~---~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa  230 (474)
T KOG0194|consen  154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGF---KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA  230 (474)
T ss_pred             EeccCccccceeecccccEEEEEEEEecCCc---eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            3446677779999999999999999843211   1223999998753   234557799999999999999999999999


Q ss_pred             eecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          153 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      .....    +++|||+|.||+|.++|..... .++..+...++.+.|.||+|||++   +++||||..+|+|++.++.+|
T Consensus       231 ~~~~P----l~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK  302 (474)
T KOG0194|consen  231 VLEEP----LMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK  302 (474)
T ss_pred             cCCCc----cEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence            87654    4999999999999999987653 699999999999999999999999   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCccccc-ccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHh
Q 013790          233 LSDFGLAREGPMVGHTHVST-AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~  310 (436)
                      |+|||+++...   ...... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.....   +..++.
T Consensus       303 ISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI~  376 (474)
T KOG0194|consen  303 ISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKIV  376 (474)
T ss_pred             eCccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHHH
Confidence            99999998532   111111 2234569999999999999999999999999999999 888998765542   222221


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcCC
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE  373 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~  373 (436)
                      .             ...+...+...+..+..++.+||..||++||+|.++.+.|+.+......
T Consensus       377 ~-------------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  377 K-------------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             h-------------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            1             1111122334567888999999999999999999999999998765543

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.6e-44  Score=340.02  Aligned_cols=254  Identities=26%  Similarity=0.422  Sum_probs=215.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|..++.||+|+||.++.++++       .+...|++|.+......  .......|+.+++++.|||||.+++.|..+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk-------~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~   75 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHK-------SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED   75 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhc-------cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC
Confidence            368999999999999999999876       56678999998765433  334678899999999999999999999876


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +.   .++|||+||+||+|.+.|....+..+++..+..|+.|++.|+.|||++   .|+|||||+.|||++.++.|||+|
T Consensus        76 ~~---~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgD  149 (426)
T KOG0589|consen   76 GQ---LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGD  149 (426)
T ss_pred             Cc---eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecc
Confidence            64   369999999999999999887777899999999999999999999988   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||+|+...  .......+..||+.||+||++.+.+|+.++|||||||++|||++-+++|...+-..   ++..+...   
T Consensus       150 fGlaK~l~--~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki~~~---  221 (426)
T KOG0589|consen  150 FGLAKILN--PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKINRG---  221 (426)
T ss_pred             hhhhhhcC--CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHHhhc---
Confidence            99999632  22235677899999999999999999999999999999999999999998654322   22211110   


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                 .-...+...+.++..||..|+..+|..||++.++|.+
T Consensus       222 -----------~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 -----------LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -----------cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                       1123455566889999999999999999999999987

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.3e-43  Score=327.63  Aligned_cols=255  Identities=34%  Similarity=0.550  Sum_probs=198.5

Q ss_pred             ccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCccee
Q 013790           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  161 (436)
Q Consensus        83 ~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  161 (436)
                      +.+.||.|.||.||+|.+..   .....+..|+||.+.... ....+.+.+|++.+++++||||++++|++...+.    
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~---~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~----   75 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQ---KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP----   75 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEES---TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS----
T ss_pred             EeeEEccCCCcEEEEEEEEc---ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc----
Confidence            45789999999999999973   233568899999996543 3346789999999999999999999999984443    


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          162 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       162 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      .++||||+++|+|.++|.......+++..++.|+.|++.||.|||++   +++|+||+++|||++.++.+||+|||++..
T Consensus        76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~  152 (259)
T PF07714_consen   76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRP  152 (259)
T ss_dssp             EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            59999999999999999887556799999999999999999999998   999999999999999999999999999975


Q ss_pred             CCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          242 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ..............+...|+|||.+.+..++.++||||||+++|||++ |..||.......   +...+.....      
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~~~~~~~------  223 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEKLKQGQR------  223 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHHHHTTEE------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccc------
Confidence            422222233344556779999999998889999999999999999999 789987663322   2222211110      


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                              ...+..++..+.++|..||..||++|||+.+|++.|
T Consensus       224 --------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 --------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                    011222356788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.1e-43  Score=339.25  Aligned_cols=247  Identities=26%  Similarity=0.393  Sum_probs=201.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|.+.+.||+|+||.||+|.++       .+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++..
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   89 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHK-------GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD   89 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence            468999999999999999999976       4678899999875422   234568899999999999999999999876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||+.+|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+
T Consensus        90 ~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~  160 (329)
T PTZ00263         90 EN----RVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVT  160 (329)
T ss_pred             CC----EEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEe
Confidence            54    459999999999999999764  3689999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||+++....     ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..+..   ....+...  
T Consensus       161 Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~i~~~--  230 (329)
T PTZ00263        161 DFGFAKKVPD-----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IYEKILAG--  230 (329)
T ss_pred             eccCceEcCC-----CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HHHHHhcC--
Confidence            9999975321     1223578999999999999999999999999999999999999997654322   11111110  


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~  363 (436)
                                 .+  .++...+..+.+||.+||+.||.+||+     +.+++.|
T Consensus       231 -----------~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        231 -----------RL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             -----------Cc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                       00  011112356889999999999999997     6888766

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-43  Score=339.47  Aligned_cols=253  Identities=25%  Similarity=0.366  Sum_probs=204.1

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|++++.||+|+||.||+|.+.       .+++.||+|++.....   .....+.+|+.++..++||||+++++++...
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~   73 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKK-------DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD   73 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC
Confidence            47999999999999999999975       4578899999875422   2345678899999999999999999988765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~D  144 (333)
T cd05600          74 E----YLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTD  144 (333)
T ss_pred             C----EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEe
Confidence            4    469999999999999999654  3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHH-HHHHhhccc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL-LEWVQQYPA  314 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~~~  314 (436)
                      ||++.....     ......||+.|+|||++.+..++.++|||||||++|||++|..||........... ..+..... 
T Consensus       145 fg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-  218 (333)
T cd05600         145 FGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ-  218 (333)
T ss_pred             CcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc-
Confidence            999975321     23456799999999999999999999999999999999999999987654332211 11110000 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                               .+.. .......+..+.+||.+||..+|.+||++.+++.+
T Consensus       219 ---------~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         219 ---------RPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ---------CCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                     0000 00011235678899999999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.7e-42  Score=340.71  Aligned_cols=268  Identities=21%  Similarity=0.341  Sum_probs=207.1

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccC-CCCceeeeeEeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLE-HPNLVKLIGYCAV  154 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~  154 (436)
                      ..++|++++.||+|+||.||+|++....  .......||||++..... ...+.+.+|+.++..+. ||||+++++++..
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLS--RSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccC--CCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            3568999999999999999999864211  123356799999975432 23457889999999996 9999999999976


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCC----------------------------------------------------
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRA----------------------------------------------------  182 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------  182 (436)
                      .+    ..++||||+++|+|.++|..+.                                                    
T Consensus       113 ~~----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         113 SG----PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             CC----ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence            54    3599999999999999886421                                                    


Q ss_pred             ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCC
Q 013790          183 ------------------------------------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKA  220 (436)
Q Consensus       183 ------------------------------------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp  220 (436)
                                                                ...+++..+..++.|++.||.|||+.   +|+||||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp  265 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAA  265 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCh
Confidence                                                      12478888899999999999999998   999999999


Q ss_pred             CcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 013790          221 SNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP  299 (436)
Q Consensus       221 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~  299 (436)
                      +|||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus       266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~  345 (400)
T cd05105         266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV  345 (400)
T ss_pred             HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence            999999999999999999875322211112223456778999999998899999999999999999997 9999975432


Q ss_pred             hhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                      ..  .+...+...              .....+...+..+.+++.+||+.||++||++.+|.+.|+.++.
T Consensus       346 ~~--~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         346 DS--TFYNKIKSG--------------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             hH--HHHHHHhcC--------------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            21  111111110              0001122345678999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2e-42  Score=328.32  Aligned_cols=271  Identities=25%  Similarity=0.397  Sum_probs=199.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhcc---CCCCceeeeeEee
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVL---EHPNLVKLIGYCA  153 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~~~~~~~  153 (436)
                      ++|++.+.||+|+||.||+|...      ..++..||+|.+......  ....+.+|+.+++.+   +||||+++++++.
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~   74 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDL------KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT   74 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEc------CCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence            37899999999999999999863      124678999988654221  223456677776655   6999999999886


Q ss_pred             ecC-CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          154 VDG-ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       154 ~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      ... ......++||||+. ++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~k  150 (290)
T cd07862          75 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK  150 (290)
T ss_pred             cccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEE
Confidence            432 12335699999995 6999999766555789999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhh
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQ  311 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~  311 (436)
                      |+|||+++....   ........||+.|+|||.+.+..++.++|||||||++|+|++|.+||.+........ +.... .
T Consensus       151 l~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~-~  226 (290)
T cd07862         151 LADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI-G  226 (290)
T ss_pred             EccccceEeccC---CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh-C
Confidence            999999875321   122344568999999999988899999999999999999999999998765433221 11111 1


Q ss_pred             cccCcc-cc-----ccccCCccc---CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 YPADSK-KF-----GLIMDPRLE---KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 ~~~~~~-~~-----~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .+.... ..     .........   .......+..+.+|+.+||+.||++|||+.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            111000 00     000000000   00111234678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.8e-42  Score=325.53  Aligned_cols=265  Identities=25%  Similarity=0.427  Sum_probs=211.3

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      .+|.+.+.||+|+||.||+|.+....  ...+...+++|.+........+.+.+|+.+++.++||||+++++++....  
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLS--PTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD--   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccC--CCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC--
Confidence            46888899999999999999865221  22456779999987766655677899999999999999999999987544  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEE
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL  224 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIl  224 (436)
                        ..++||||+++++|.+++....              ...+++..++.++.||+.||+|||++   +++||||||+|||
T Consensus        81 --~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  155 (291)
T cd05094          81 --PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCL  155 (291)
T ss_pred             --ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEE
Confidence              3599999999999999996532              23488999999999999999999998   9999999999999


Q ss_pred             EcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 013790          225 LDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQ  303 (436)
Q Consensus       225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  303 (436)
                      ++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|+| |..||.......  
T Consensus       156 ~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--  233 (291)
T cd05094         156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--  233 (291)
T ss_pred             EccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence            99999999999999975322222222334456788999999998999999999999999999999 999997654432  


Q ss_pred             HHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          304 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                       ....+.....          .    ..+...+..+.+++.+||+.||.+|||+.+|++.|+++..
T Consensus       234 -~~~~~~~~~~----------~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         234 -VIECITQGRV----------L----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             -HHHHHhCCCC----------C----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence             2221111000          0    0111234678899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-42  Score=336.06  Aligned_cols=271  Identities=24%  Similarity=0.344  Sum_probs=200.4

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|++.+.||+|+||.||+|...       .++..||||.+...  .......+.+|+.+++.++||||+++++++.....
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   73 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDT-------HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR   73 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEEC-------CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCC
Confidence            4888999999999999999865       56789999998643  22334568899999999999999999998865432


Q ss_pred             -cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          158 -RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       158 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                       .....|+||||+ +++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        74 ~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Df  147 (338)
T cd07859          74 REFKDIYVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDF  147 (338)
T ss_pred             CCCceEEEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccC
Confidence             223569999999 57999998654  3689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCC-cccccccccCCCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          237 GLAREGPMVGH-THVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       237 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |+++....... ........||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~  227 (338)
T cd07859         148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP  227 (338)
T ss_pred             ccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99975321111 112234578999999999865  678999999999999999999999997654332211111111000


Q ss_pred             cCc----------cccccccCCcccCcC---CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADS----------KKFGLIMDPRLEKEY---SINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~----------~~~~~~~~~~l~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...          ..+...+........   ....+..+.+++.+||..||++|||+.+++++
T Consensus       228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000          000000000000000   01124567899999999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.2e-42  Score=324.82  Aligned_cols=268  Identities=25%  Similarity=0.416  Sum_probs=211.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|.+.+.||+|+||.||++......  ...++..+|+|.+..........+.+|+.++++++||||+++++++...+ 
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~--~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   80 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLC--PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-   80 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCC--CCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence            357899999999999999999864211  22356779999987665555677899999999999999999999987654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRA-----------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  226 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~  226 (436)
                         ..++||||+++++|.+++....           ...+++..++.++.|++.||+|||+.   +++||||||+|||++
T Consensus        81 ---~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~  154 (288)
T cd05093          81 ---PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVG  154 (288)
T ss_pred             ---ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc
Confidence               3599999999999999996432           23589999999999999999999998   999999999999999


Q ss_pred             CCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHH
Q 013790          227 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRL  305 (436)
Q Consensus       227 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~  305 (436)
                      .++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   .
T Consensus       155 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~  231 (288)
T cd05093         155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V  231 (288)
T ss_pred             cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence            999999999999875322211112223345778999999998889999999999999999998 999997654322   2


Q ss_pred             HHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          306 LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                      ...+.....          ...    +...+..+.+|+.+||+.||.+|||+.+++..|+++....
T Consensus       232 ~~~i~~~~~----------~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         232 IECITQGRV----------LQR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             HHHHHcCCc----------CCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence            222211100          000    1112357899999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.1e-42  Score=333.40  Aligned_cols=243  Identities=27%  Similarity=0.365  Sum_probs=195.5

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCccee
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  161 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  161 (436)
                      +.||+|+||.||++...       .++..||+|++.....   .....+.+|+.+++.++||||+++++++...+    .
T Consensus         1 ~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~----~   69 (323)
T cd05595           1 KLLGKGTFGKVILVREK-------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD----R   69 (323)
T ss_pred             CeeeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC----E
Confidence            36999999999999865       5678999999875422   23356778999999999999999999887654    4


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          162 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       162 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      .++||||+++|+|..++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        70 ~~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~  144 (323)
T cd05595          70 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE  144 (323)
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcc
Confidence            699999999999999886543  689999999999999999999998   999999999999999999999999999874


Q ss_pred             CCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 013790          242 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  321 (436)
Q Consensus       242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (436)
                      ...  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.........   ..+...         
T Consensus       145 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~---~~~~~~---------  210 (323)
T cd05595         145 GIS--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---ELILME---------  210 (323)
T ss_pred             ccC--CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH---HHHhcC---------
Confidence            211  112223457999999999999999999999999999999999999999765433221   111100         


Q ss_pred             ccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       322 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                        ...    ++...+..+.+||.+||..||.+||     ++.+++++
T Consensus       211 --~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         211 --EIR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             --CCC----CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence              001    1122346788999999999999998     88888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.7e-42  Score=320.17  Aligned_cols=256  Identities=26%  Similarity=0.410  Sum_probs=205.8

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      .+|.+.+.||+|+||.||+|.++       ..++.||+|.+.... .....+.+|+.+++.++||||+++++++..++. 
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-------~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   76 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-   76 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEe-------cCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC-
Confidence            46888899999999999999976       457889999987543 334678899999999999999999999876553 


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                         .+++|||+++++|.+++.......+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||+
T Consensus        77 ---~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~  150 (263)
T cd05052          77 ---FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL  150 (263)
T ss_pred             ---cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcc
Confidence               48999999999999999765555789999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      +....... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.....   ....+...     
T Consensus       151 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~-----  221 (263)
T cd05052         151 SRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEKG-----  221 (263)
T ss_pred             ccccccce-eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCC-----
Confidence            87532111 111112234567999999998999999999999999999998 999997654322   11111110     


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                               .....+...+..+.+++.+||..||++||++.++++.|+.+
T Consensus       222 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 ---------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                     00111223357789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.3e-42  Score=325.00  Aligned_cols=262  Identities=24%  Similarity=0.434  Sum_probs=207.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|.+.+.||+|+||.||+|.+....  ...+...||+|.+...... ..+.+.+|+++++.++||||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLE--PENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeecccc--CcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            357888999999999999999875221  1245678999998765444 4568899999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEE
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRA------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL  224 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIl  224 (436)
                          ..++||||+++++|.+++....            ...+++..+..++.|++.||.|||++   +++||||||+||+
T Consensus        82 ----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nil  154 (280)
T cd05049          82 ----PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCL  154 (280)
T ss_pred             ----CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEE
Confidence                3599999999999999996542            23578899999999999999999998   9999999999999


Q ss_pred             EcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 013790          225 LDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQ  303 (436)
Q Consensus       225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  303 (436)
                      ++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......  
T Consensus       155 i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--  232 (280)
T cd05049         155 VGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--  232 (280)
T ss_pred             EcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--
Confidence            99999999999999874322211122233345778999999999999999999999999999999 999997654432  


Q ss_pred             HHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          304 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                       ....+.....              ...+...+..+.+++.+||..||++||++.+|++.|+
T Consensus       233 -~~~~~~~~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         233 -VIECITQGRL--------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -HHHHHHcCCc--------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence             2222211000              0111223467899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-42  Score=348.94  Aligned_cols=255  Identities=22%  Similarity=0.291  Sum_probs=203.7

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ..|.+.+.||+|+||.||+|...      ...+..||+|.+..........+.+|+.+++.++||||+++++++...+  
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~------~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~--  138 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRG------SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD--  138 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEc------CCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC--
Confidence            34899999999999999999854      1225678888876655555567888999999999999999999987654  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                        ..|+||||+++|+|.+++...  ...++++..+..++.|++.||.|||+.   +|+||||||+||||+.++.+||+||
T Consensus       139 --~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DF  213 (478)
T PTZ00267        139 --KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDF  213 (478)
T ss_pred             --EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeC
Confidence              469999999999999988642  234689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      |+++...............||+.|+|||++.+..++.++|||||||++|+|++|..||.......   +...+.....  
T Consensus       214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~~~~~~~~--  288 (478)
T PTZ00267        214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQQVLYGKY--  288 (478)
T ss_pred             cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCC--
Confidence            99975322222223345679999999999999999999999999999999999999997654321   2221111000  


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                             .     ..+...+..+.+||.+||..||++||++.+++.+
T Consensus       289 -------~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        289 -------D-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             -------C-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                   0     1112234678999999999999999999998764

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.7e-42  Score=322.20  Aligned_cols=256  Identities=31%  Similarity=0.470  Sum_probs=209.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ..+|++.+.||.|+||.||+|.+.        .+..+++|.+..........+..|+.+++.++||||+++++++.....
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~--------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   76 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWK--------NRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP   76 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEec--------CCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCC
Confidence            457999999999999999999875        367899999987766566788999999999999999999998876543


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||
T Consensus        77 ----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g  149 (261)
T cd05148          77 ----VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFG  149 (261)
T ss_pred             ----eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEcccc
Confidence                59999999999999999876556789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      ++......  ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ....+...    
T Consensus       150 ~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~----  220 (261)
T cd05148         150 LARLIKED--VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQITAG----  220 (261)
T ss_pred             chhhcCCc--cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHHhC----
Confidence            98753211  111123345678999999988889999999999999999998 899997654322   22221110    


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                                .....+...+..+.++|.+||..||.+|||+.+|++.|+.+
T Consensus       221 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         221 ----------YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ----------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                      00011223346788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4e-42  Score=332.80  Aligned_cols=264  Identities=25%  Similarity=0.378  Sum_probs=202.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++.+.||.|+||.||++.+.       .++..+|+|.+.... ......+.+|+++++.++||||+++++++...+
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHK-------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG   76 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEEC-------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence            468999999999999999999875       467889999887542 233467889999999999999999999998754


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.  .+++|+||||+|||++.++.+||+||
T Consensus        77 ----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Df  148 (333)
T cd06650          77 ----EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDF  148 (333)
T ss_pred             ----EEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeC
Confidence                4599999999999999996543  689999999999999999999974  17999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      |++.....    .......|+..|+|||++.+..++.++|||||||++|+|++|..||...........   +.......
T Consensus       149 g~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~  221 (333)
T cd06650         149 GVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM---FGCPVEGD  221 (333)
T ss_pred             Ccchhhhh----hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHH---hcCcccCC
Confidence            99864311    122345689999999999988899999999999999999999999975443221111   10000000


Q ss_pred             cc-------------------------------cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 KK-------------------------------FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~~-------------------------------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..                               ...+.............+.++.+|+.+||+.||++|||+.+++.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         222 PAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             ccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence            00                               000000000000011134678899999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.6e-42  Score=333.45  Aligned_cols=243  Identities=26%  Similarity=0.382  Sum_probs=195.9

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCccee
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  161 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  161 (436)
                      +.||+|+||.||++...       .+++.||+|++....   ......+.+|+.+++.++||||+++++++...+    .
T Consensus         1 ~~lG~G~~g~Vy~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~   69 (328)
T cd05593           1 KLLGKGTFGKVILVREK-------ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD----R   69 (328)
T ss_pred             CeeeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC----E
Confidence            36999999999999865       567899999987542   223456788999999999999999998887654    4


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          162 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       162 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        70 ~~lv~Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~  144 (328)
T cd05593          70 LCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE  144 (328)
T ss_pred             EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCcc
Confidence            59999999999999998654  3689999999999999999999998   999999999999999999999999999874


Q ss_pred             CCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 013790          242 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  321 (436)
Q Consensus       242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (436)
                      ..  ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+...         
T Consensus       145 ~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~~~~~~---------  210 (328)
T cd05593         145 GI--TDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELILME---------  210 (328)
T ss_pred             CC--CcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHHHhccC---------
Confidence            21  11222234579999999999998899999999999999999999999997654322   11111100         


Q ss_pred             ccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       322 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                        ...    ++...+..+.+||.+||..||.+||     ++.+++++
T Consensus       211 --~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         211 --DIK----FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             --Ccc----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence              011    1122346788999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.1e-42  Score=327.81  Aligned_cols=268  Identities=24%  Similarity=0.375  Sum_probs=198.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++.+.||+|+||.||+|...       .+++.||+|++..... .....+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSK-------VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE   76 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEEC-------CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence            468999999999999999999865       4678899999875432 22345778999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        77 ----~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Df  147 (303)
T cd07869          77 ----TLTLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADF  147 (303)
T ss_pred             ----eEEEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCC
Confidence                4699999994 68888886543 4688999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhhccc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~  314 (436)
                      |+++....  .........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+....... .........+.
T Consensus       148 g~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  225 (303)
T cd07869         148 GLARAKSV--PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN  225 (303)
T ss_pred             CcceeccC--CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCC
Confidence            99864211  1122234568899999999865 45788999999999999999999999865432111 11111111110


Q ss_pred             Cc-------------cccccccCCcccCcC-CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DS-------------KKFGLIMDPRLEKEY-SINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~-------------~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..             ..+.......+.... ....+..+.+|+.+||+.||.+|||+.++++|
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            00             000000000000000 00113567899999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-42  Score=335.65  Aligned_cols=248  Identities=24%  Similarity=0.344  Sum_probs=200.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|.+.+.||+|+||.||+|.++.      ..+..||+|.+....   ....+.+.+|+.+++.++||||+++++++..
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~  102 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKN------EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD  102 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEEC------CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence            4579999999999999999998651      234689999986542   2234567889999999999999999999876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus       103 ~~----~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~  173 (340)
T PTZ00426        103 ES----YLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMT  173 (340)
T ss_pred             CC----EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEe
Confidence            54    4699999999999999997653  689999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||+++...     .......||+.|+|||++.+..++.++|||||||++|+|++|..||....+...   ...+.... 
T Consensus       174 DFG~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~~~i~~~~-  244 (340)
T PTZ00426        174 DFGFAKVVD-----TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI---YQKILEGI-  244 (340)
T ss_pred             cCCCCeecC-----CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH---HHHHhcCC-
Confidence            999997531     112345799999999999988899999999999999999999999986544321   11111100 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                                .    .++...+..+.++|.+||+.||.+|+     ++.+++++
T Consensus       245 ----------~----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 ----------I----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ----------C----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                      0    01112235678999999999999995     89988876

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.9e-42  Score=327.53  Aligned_cols=270  Identities=26%  Similarity=0.424  Sum_probs=209.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|.+.+.||+|+||.||+|.+.............+|+|.+.... ......+.+|+.++..+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3579999999999999999998753332233345689999997642 23445688899999999 799999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCC
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  221 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~  221 (436)
                      +    ..++||||+++|+|.+++....              ...+++.+++.++.|++.||+|||+.   +++||||||+
T Consensus        97 ~----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~  169 (307)
T cd05098          97 G----PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  169 (307)
T ss_pred             C----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHH
Confidence            4    3599999999999999997542              13588999999999999999999998   9999999999


Q ss_pred             cEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCch
Q 013790          222 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPK  300 (436)
Q Consensus       222 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~  300 (436)
                      |||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            99999999999999999875322111111222234568999999988889999999999999999998 88898765432


Q ss_pred             hhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                      .   +...+....              ....+...+..+.+|+.+||..+|.+|||+.++++.|+.++...
T Consensus       250 ~---~~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         250 E---LFKLLKEGH--------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             H---HHHHHHcCC--------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            2   221111110              00112233468889999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.7e-42  Score=326.35  Aligned_cols=270  Identities=27%  Similarity=0.433  Sum_probs=211.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      ..+|.+.+.||+|+||.||+|.+..........+..||+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            4678999999999999999998753333333456789999987542 23446788999999999 799999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCC
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  221 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~  221 (436)
                      .    ..+++|||+.+|+|.+++....              ...+++..+..++.|++.||.|||++   |++||||||+
T Consensus        94 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  166 (304)
T cd05101          94 G----PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR  166 (304)
T ss_pred             C----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccc
Confidence            4    3589999999999999997542              13578889999999999999999998   9999999999


Q ss_pred             cEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCch
Q 013790          222 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPK  300 (436)
Q Consensus       222 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~  300 (436)
                      |||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            99999999999999999975432222222233445678999999988889999999999999999998 78888765432


Q ss_pred             hhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                      .   +...+.....              ...+..++..+.+|+.+||..+|.+|||+.++++.|++++...
T Consensus       247 ~---~~~~~~~~~~--------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         247 E---LFKLLKEGHR--------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             H---HHHHHHcCCc--------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence            2   2222111100              0112234567889999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-42  Score=330.75  Aligned_cols=241  Identities=26%  Similarity=0.335  Sum_probs=193.3

Q ss_pred             ccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        87 ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      ||+|+||.||+|...       .+++.||+|.+....   ......+.+|+.++..++||||+++++++...+    ..+
T Consensus         1 lg~G~~g~Vy~~~~~-------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~   69 (312)
T cd05585           1 IGKGSFGKVMQVRKR-------DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE----KLY   69 (312)
T ss_pred             CCcCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC----eEE
Confidence            799999999999865       467889999986532   223456788999999999999999999887554    459


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCC
Q 013790          164 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  243 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  243 (436)
                      +||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        70 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~  144 (312)
T cd05585          70 LVLAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNM  144 (312)
T ss_pred             EEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence            999999999999999764  3689999999999999999999998   99999999999999999999999999987421


Q ss_pred             CCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccccc
Q 013790          244 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM  323 (436)
Q Consensus       244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (436)
                        ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+...+          
T Consensus       145 --~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~---~~~~~~~~~----------  209 (312)
T cd05585         145 --KDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE---MYRKILQEP----------  209 (312)
T ss_pred             --cCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH---HHHHHHcCC----------
Confidence              11222344679999999999999999999999999999999999999997654322   111111100          


Q ss_pred             CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC---HHHHHHH
Q 013790          324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPK---MSQVVER  363 (436)
Q Consensus       324 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~eil~~  363 (436)
                       .    .++...+..+.+||.+||..||.+||+   +.+++.+
T Consensus       210 -~----~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         210 -L----RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             -C----CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence             0    112223467889999999999999985   5666654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.1e-42  Score=345.06  Aligned_cols=266  Identities=24%  Similarity=0.318  Sum_probs=198.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC-
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG-  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-  156 (436)
                      ..+|.+++.||+|+||.||+|...       .+++.||||++....    ....+|+.+++.++||||+++++++.... 
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~-------~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~  133 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICI-------DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECF  133 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEEC-------CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence            467999999999999999999875       467889999886442    23457999999999999999988765432 


Q ss_pred             ---CcceeEEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC-c
Q 013790          157 ---ERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-R  230 (436)
Q Consensus       157 ---~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~  230 (436)
                         .....+++||||++ ++|.+++..  .....+++..+..++.||+.||.|||+.   +|+||||||+||||+.++ .
T Consensus       134 ~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~  209 (440)
T PTZ00036        134 KKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHT  209 (440)
T ss_pred             ccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCc
Confidence               22345679999996 578777643  2345789999999999999999999998   999999999999998654 7


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  309 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  309 (436)
                      +||+|||+++....   ........||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.......  ...+
T Consensus       210 vkL~DFGla~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~--~~i~  284 (440)
T PTZ00036        210 LKLCDFGSAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL--VRII  284 (440)
T ss_pred             eeeeccccchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHH
Confidence            99999999975321   1222345789999999998664 6899999999999999999999999876543221  1111


Q ss_pred             hhcccCcc-------------ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          310 QQYPADSK-------------KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       310 ~~~~~~~~-------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ........             .+..+....+...++...+.++.+||.+||..||.+|||+.+++.+
T Consensus       285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            11111000             0000111111112222345678999999999999999999999976

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.2e-41  Score=321.48  Aligned_cols=262  Identities=24%  Similarity=0.360  Sum_probs=203.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|++++.||+|+||.||+|.+...   +......+++|.+..... .....+..|+..+..++||||+++++++...  
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~---~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~--   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPE---GDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA--   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCC---CCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC--
Confidence            4788999999999999999997521   111234588888764422 2335677888899999999999999987432  


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++++||+++|+|.+++.... ..+++..+..++.|++.||.|||++   +++|+||||+|||++.++.+||+|||
T Consensus        82 ---~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg  154 (279)
T cd05111          82 ---SLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFG  154 (279)
T ss_pred             ---ccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCc
Confidence               2478999999999999997543 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      +++...............++..|+|||.+.++.++.++||||||+++|||++ |..||.+..+.....+   +...... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~---~~~~~~~-  230 (279)
T cd05111         155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL---LEKGERL-  230 (279)
T ss_pred             cceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HHCCCcC-
Confidence            9975432222222233456778999999988899999999999999999998 9999987654332222   2211100 


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                            ..       +..++..+.+++.+||..||.+|||+.++++.|..+..
T Consensus       231 ------~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         231 ------AQ-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ------CC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                  00       11123567889999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.5e-42  Score=348.88  Aligned_cols=262  Identities=21%  Similarity=0.268  Sum_probs=208.0

Q ss_pred             HHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEe
Q 013790           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYC  152 (436)
Q Consensus        75 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  152 (436)
                      ....++|.+.+.||+|+||.||+|...       .+++.||||.+....  ......+.+|+.++..++|+||+++++.+
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~  100 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRV-------SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDF  100 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEc-------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence            344579999999999999999999865       467899999987553  23345678899999999999999998876


Q ss_pred             eecCC----cceeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc
Q 013790          153 AVDGE----RGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  226 (436)
Q Consensus       153 ~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~  226 (436)
                      .....    ....+++||||+++|+|.+++..+  ....+++..+..++.|++.||.|||+.   +|+||||||+||||+
T Consensus       101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~  177 (496)
T PTZ00283        101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLC  177 (496)
T ss_pred             ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEe
Confidence            54322    122468999999999999999653  235789999999999999999999998   999999999999999


Q ss_pred             CCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 013790          227 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  306 (436)
Q Consensus       227 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  306 (436)
                      .++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|..||.......   +.
T Consensus       178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---~~  254 (496)
T PTZ00283        178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---VM  254 (496)
T ss_pred             CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HH
Confidence            999999999999975332222223345679999999999999999999999999999999999999997654321   11


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .......         .     ...+...+..+.+|+.+||+.||.+||++.+++.+
T Consensus       255 ~~~~~~~---------~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        255 HKTLAGR---------Y-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHhcCC---------C-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1111100         0     01122335678999999999999999999999876

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.4e-41  Score=322.59  Aligned_cols=264  Identities=27%  Similarity=0.410  Sum_probs=206.7

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      +|++.+.||+|+||.||+|......  .......+++|.+..... .....+.+|+.+++.++||||+++++.+...+. 
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLK--GRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP-   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCC--CCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC-
Confidence            5788899999999999999865222  122446799998875432 334678899999999999999999999876554 


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeec
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRA----------------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYR  216 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~  216 (436)
                         .++++||+.+++|.+++....                      ...+++..++.++.|++.||.|||+.   +++||
T Consensus        78 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~  151 (290)
T cd05045          78 ---LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHR  151 (290)
T ss_pred             ---cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehh
Confidence               499999999999999986421                      23578999999999999999999998   99999


Q ss_pred             cCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 013790          217 DFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLE  295 (436)
Q Consensus       217 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~  295 (436)
                      ||||+|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus       152 dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  231 (290)
T cd05045         152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  231 (290)
T ss_pred             hhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence            9999999999999999999999875322221112223345678999999988889999999999999999999 999997


Q ss_pred             CCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          296 RNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                      +..+..   +...+....              ....+...+..+.+++.+||+.+|.+||++.++++.|++++.
T Consensus       232 ~~~~~~---~~~~~~~~~--------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         232 GIAPER---LFNLLKTGY--------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             CCCHHH---HHHHHhCCC--------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            654432   222221110              001122234678899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.5e-42  Score=338.73  Aligned_cols=262  Identities=21%  Similarity=0.276  Sum_probs=197.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|.+++.||+|+||.||+|...       .+++.||+|....      ..+.+|+.+++.++||||+++++++.... 
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~-------~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~-  156 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDN-------KTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNK-  156 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEEC-------CCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECC-
Confidence            368999999999999999999865       5678899997542      34678999999999999999999987654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++|+|++ +++|..++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       157 ---~~~lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG  227 (391)
T PHA03212        157 ---FTCLILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG  227 (391)
T ss_pred             ---eeEEEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCC
Confidence               358999998 57898888654  3689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh-----hHHHHHHHhhc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-----EQRLLEWVQQY  312 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-----~~~~~~~~~~~  312 (436)
                      +++..... .........||+.|+|||++.+..++.++|||||||++|||++|..||.......     ...+...+...
T Consensus       228 ~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~  306 (391)
T PHA03212        228 AACFPVDI-NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRS  306 (391)
T ss_pred             cccccccc-cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHh
Confidence            99642111 1122334679999999999999999999999999999999999998875432110     11111111111


Q ss_pred             ccCcccc--------ccc---------cCCccc--CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKF--------GLI---------MDPRLE--KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~--------~~~---------~~~~l~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...+..+        ...         ..+...  .......+..+.+||.+||+.||.+|||+.+++++
T Consensus       307 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        307 GTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             cCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0000000        000         000000  00011345678999999999999999999999975

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=318.21  Aligned_cols=261  Identities=27%  Similarity=0.435  Sum_probs=206.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|.+.+.||+|+||.||+|.+...    ......||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLP----GKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR   78 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccC----CCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence            35799999999999999999998622    12356899999875432 23456888999999999999999999886544


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..+++|||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+|+||||+|||++.++.++|+||
T Consensus        79 ----~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~df  150 (266)
T cd05033          79 ----PVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF  150 (266)
T ss_pred             ----ceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECcc
Confidence                3599999999999999997644 3689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .....+......
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~~~~  227 (266)
T cd05033         151 GLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAVEDGYRL  227 (266)
T ss_pred             chhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHHcCCCC
Confidence            99986431111112222345678999999998889999999999999999998 99999654322   222222111000


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                                    ..+...+..+.+|+.+||+.+|++||++.+|+++|+++
T Consensus       228 --------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 --------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             --------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                          11122346789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.9e-42  Score=319.56  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=204.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.++||+|+||.||+|...        ++..||+|.+..... ..+.+.+|+.+++.++||||+++++.+...+.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~--------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN--------NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP   75 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec--------CCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            358999999999999999999864        346799998865432 35678899999999999999999988865443


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .+++|||+++++|.+++.......+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        76 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg  148 (261)
T cd05072          76 ----IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFG  148 (261)
T ss_pred             ----cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCc
Confidence                49999999999999999776556789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      ++....... ........++..|+|||.+.+..++.++|||||||++|+|+| |..||.......   ....+.....  
T Consensus       149 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~~--  222 (261)
T cd05072         149 LARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQRGYR--  222 (261)
T ss_pred             cceecCCCc-eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHcCCC--
Confidence            997532211 111122345678999999988889999999999999999998 999997644322   2222211100  


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                              .    ......+..+.+++.+||..+|++||++.++++.|+++
T Consensus       223 --------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         223 --------M----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             --------C----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                    0    01112346788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.4e-41  Score=324.70  Aligned_cols=265  Identities=25%  Similarity=0.381  Sum_probs=207.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|.+.+.||+|+||.||+|.+....  ....+..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLS--KSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCC--CCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            457999999999999999999864211  12356789999987543 23346788999999999 799999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +.    .+++|||+.+|+|.+++.......+++.++..++.|++.||.|||++   +++|+||||+|||++.++.++|+|
T Consensus       112 ~~----~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         112 GP----ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             Cc----eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECC
Confidence            43    59999999999999999765444589999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||........  ....+.... 
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~~~~-  261 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIKEGY-  261 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHHcCC-
Confidence            999975322221112223346778999999988889999999999999999998 9999976543322  111111100 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                                   ....+...+..+.+++.+||..+|++|||+.+++..|+++
T Consensus       262 -------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 -------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                         0001112246789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3e-42  Score=339.85  Aligned_cols=253  Identities=22%  Similarity=0.309  Sum_probs=197.6

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .|..++.||+|+||.||+|...       .+++.||+|++.....   .....+.+|+.+++.++||||+++++++...+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~-------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~   74 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKV-------DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD   74 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC
Confidence            6889999999999999999865       5678999999975432   23456888999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+++|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+||
T Consensus        75 ----~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DF  145 (381)
T cd05626          75 ----NLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDF  145 (381)
T ss_pred             ----EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeC
Confidence                4699999999999999997643  689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCC---------------------------------------------cccccccccCCCcccccccccCCC
Q 013790          237 GLAREGPMVGH---------------------------------------------THVSTAVVGTFGYAAPDYIETGHL  271 (436)
Q Consensus       237 g~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~  271 (436)
                      |+++.......                                             ........||+.|+|||++.+..+
T Consensus       146 Gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~  225 (381)
T cd05626         146 GLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY  225 (381)
T ss_pred             cCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC
Confidence            99753210000                                             000123579999999999998889


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhh--c
Q 013790          272 TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCL--S  348 (436)
Q Consensus       272 ~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl--~  348 (436)
                      +.++|||||||++|||++|..||....+..... +..+....               ........+..+.+||.+|+  .
T Consensus       226 ~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------~~~~~~~~s~~~~dli~~ll~~~  290 (381)
T cd05626         226 TQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL---------------HIPPQVKLSPEAVDLITKLCCSA  290 (381)
T ss_pred             CCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---------------CCCCCCCCCHHHHHHHHHHccCc
Confidence            999999999999999999999998765432211 11110000               00011123467788998854  5


Q ss_pred             CCCCCCCCHHHHHHH
Q 013790          349 KSSKDRPKMSQVVER  363 (436)
Q Consensus       349 ~dp~~RPs~~eil~~  363 (436)
                      .++..||++.+++.+
T Consensus       291 ~~~~~R~~~~~~l~h  305 (381)
T cd05626         291 EERLGRNGADDIKAH  305 (381)
T ss_pred             ccccCCCCHHHHhcC
Confidence            556669999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=9e-42  Score=321.78  Aligned_cols=263  Identities=25%  Similarity=0.407  Sum_probs=203.7

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ..++|++.+.||+|+||.||+|.+....  ....+..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~--~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVV--KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCC--CCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            3568999999999999999999875321  12345779999986432 23345688999999999999999999998654


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA--------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      .    ..++||||+++++|.+++....        ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.
T Consensus        82 ~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~  154 (277)
T cd05062          82 Q----PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE  154 (277)
T ss_pred             C----CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcC
Confidence            4    3599999999999999986532        12467888999999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHH
Q 013790          228 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLL  306 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  306 (436)
                      ++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....   ..
T Consensus       155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~  231 (277)
T cd05062         155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VL  231 (277)
T ss_pred             CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH
Confidence            99999999999875322221112222345778999999998899999999999999999999 788997654332   22


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                      ..+......              ..+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus       232 ~~~~~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         232 RFVMEGGLL--------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHcCCcC--------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            222111000              011123467899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-42  Score=324.95  Aligned_cols=252  Identities=27%  Similarity=0.432  Sum_probs=201.4

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .|++.+.||+|+||.||++...       .+++.||+|++......   ....+.+|+.+++.++||||+++++.+...+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD   73 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEc-------CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC
Confidence            4788899999999999999865       46789999998654322   2345678999999999999999999886544


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+.+|+|.+++.......+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+||
T Consensus        74 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Df  146 (285)
T cd05605          74 ----ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDL  146 (285)
T ss_pred             ----eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeC
Confidence                469999999999999998765555799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~  315 (436)
                      |++....   .........|+..|+|||++.+..++.++|||||||++|+|++|..||.+....... .+...+....  
T Consensus       147 g~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--  221 (285)
T cd05605         147 GLAVEIP---EGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ--  221 (285)
T ss_pred             CCceecC---CCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--
Confidence            9987532   111223356899999999999888999999999999999999999999865432221 1111111100  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                                   ...+...+..+.+||.+||..||.+||     ++.+++.+
T Consensus       222 -------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 -------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             -------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                         011223456788999999999999999     78888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=339.73  Aligned_cols=254  Identities=24%  Similarity=0.340  Sum_probs=199.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|++++.||+|+||.||+|...       .+++.||||++....   ......+.+|+.++..++||||+++++++...
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~   73 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKK-------DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE   73 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC
Confidence            47999999999999999999975       467889999997542   22335578899999999999999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|
T Consensus        74 ~----~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D  144 (364)
T cd05599          74 N----YLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSD  144 (364)
T ss_pred             C----eEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEee
Confidence            4    4599999999999999997643  689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCc------------------------------------ccccccccCCCcccccccccCCCCchhhHHH
Q 013790          236 FGLAREGPMVGHT------------------------------------HVSTAVVGTFGYAAPDYIETGHLTAKSDVWS  279 (436)
Q Consensus       236 fg~a~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS  279 (436)
                      ||+++........                                    .......||+.|+|||++.+..++.++||||
T Consensus       145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  224 (364)
T cd05599         145 FGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS  224 (364)
T ss_pred             cccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeec
Confidence            9998642111000                                    0111246999999999999889999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC---
Q 013790          280 FGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK---  356 (436)
Q Consensus       280 lGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs---  356 (436)
                      |||++|+|++|..||....+...   ...+.....           .+........+..+.+||.+|+. +|.+|++   
T Consensus       225 lG~il~el~~G~~Pf~~~~~~~~---~~~i~~~~~-----------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~  289 (364)
T cd05599         225 LGVIMYEMLVGYPPFCSDNPQET---YRKIINWKE-----------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNG  289 (364)
T ss_pred             chhHHHHhhcCCCCCCCCCHHHH---HHHHHcCCC-----------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCC
Confidence            99999999999999987654322   111111100           00000011224678899999996 9999998   


Q ss_pred             HHHHHHH
Q 013790          357 MSQVVER  363 (436)
Q Consensus       357 ~~eil~~  363 (436)
                      +.+++.+
T Consensus       290 ~~~ll~h  296 (364)
T cd05599         290 VNEIKSH  296 (364)
T ss_pred             HHHHhcC
Confidence            8888875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.6e-42  Score=336.44  Aligned_cols=254  Identities=25%  Similarity=0.336  Sum_probs=196.6

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|++++.||+|+||.||+|...       .+++.||+|++.....   .....+.+|+.++..++||||+++++.+...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~   73 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKK-------DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK   73 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            47999999999999999999865       4678999999975422   2235678899999999999999999988765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      .    ..|+||||+++|+|.+++...  ..+++..+..++.|++.||.|||++   +|+||||||+||||+.++.+||+|
T Consensus        74 ~----~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~D  144 (363)
T cd05628          74 L----NLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSD  144 (363)
T ss_pred             C----eEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEee
Confidence            4    459999999999999999764  3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCC---------------------------------cccccccccCCCcccccccccCCCCchhhHHHHHH
Q 013790          236 FGLAREGPMVGH---------------------------------THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGV  282 (436)
Q Consensus       236 fg~a~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv  282 (436)
                      ||+++.......                                 ........||+.|+|||++.+..++.++|||||||
T Consensus       145 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGv  224 (363)
T cd05628         145 FGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV  224 (363)
T ss_pred             ccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHH
Confidence            999874211100                                 00012357999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCC---CCCCHHH
Q 013790          283 VLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSK---DRPKMSQ  359 (436)
Q Consensus       283 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~---~RPs~~e  359 (436)
                      ++|||++|..||.+..+....   ..+...... .    .+.+    .  ...+..+.++|.+|+. +|.   .||++.+
T Consensus       225 il~ell~G~~Pf~~~~~~~~~---~~i~~~~~~-~----~~p~----~--~~~s~~~~~li~~l~~-~~~~r~~r~~~~e  289 (363)
T cd05628         225 IMYEMLIGYPPFCSETPQETY---KKVMNWKET-L----IFPP----E--VPISEKAKDLILRFCC-EWEHRIGAPGVEE  289 (363)
T ss_pred             HHHHHHhCCCCCCCCCHHHHH---HHHHcCcCc-c----cCCC----c--CCCCHHHHHHHHHHcC-ChhhcCCCCCHHH
Confidence            999999999999875543221   111110000 0    0011    0  1123567788888654 344   5689999


Q ss_pred             HHHH
Q 013790          360 VVER  363 (436)
Q Consensus       360 il~~  363 (436)
                      |+++
T Consensus       290 i~~h  293 (363)
T cd05628         290 IKTN  293 (363)
T ss_pred             HhCC
Confidence            9887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.8e-41  Score=318.65  Aligned_cols=262  Identities=24%  Similarity=0.373  Sum_probs=200.7

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecCC-
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE-  157 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-  157 (436)
                      |.+.+.||+|+||.||+|.+.     .......||+|.+....  ....+.+..|+.+++.++||||+++++++..... 
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~-----~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   75 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLN-----QDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES   75 (272)
T ss_pred             CccccccCcccCceEEEeEEc-----cCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcc
Confidence            356788999999999999875     11223479999886542  3345678889999999999999999998754321 


Q ss_pred             -cceeEEEEEEecCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          158 -RGIQRLLVYEFMLNRSLEDHLFNR----AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       158 -~~~~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                       .....+++|||+.+|+|.+++...    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++
T Consensus        76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k  152 (272)
T cd05075          76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVC  152 (272)
T ss_pred             cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEE
Confidence             122458999999999999987432    223589999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhh
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      |+|||+++...............++..|++||.+.+..++.++||||||+++|+|++ |..||......   .+...+..
T Consensus       153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~  229 (272)
T cd05075         153 VADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYLRQ  229 (272)
T ss_pred             ECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHc
Confidence            999999975322211111223345678999999998899999999999999999999 88999764432   22222221


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                      ...          .    ..+...+..+.++|.+||+.||++|||+.+|++.|+++
T Consensus       230 ~~~----------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         230 GNR----------L----KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC----------C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            100          0    01112346688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.2e-41  Score=321.98  Aligned_cols=261  Identities=27%  Similarity=0.464  Sum_probs=204.6

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .+|++.+.||+|+||.||+|.+...   +...+..|++|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~---~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLP---GMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecC---CCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence            5788999999999999999986421   223567899999875432 233578889999999999999999999876543


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRA---------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN  222 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~N  222 (436)
                          .++||||+.+++|.+++....               ...+++..++.++.|++.||.|||++   +++|+||||+|
T Consensus        82 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~n  154 (283)
T cd05090          82 ----VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARN  154 (283)
T ss_pred             ----eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---Ceehhccccce
Confidence                499999999999999985321               12478889999999999999999998   99999999999


Q ss_pred             EEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchh
Q 013790          223 VLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKT  301 (436)
Q Consensus       223 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~  301 (436)
                      ||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+..+..
T Consensus       155 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~  234 (283)
T cd05090         155 ILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE  234 (283)
T ss_pred             EEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            9999999999999999975322222222233445678999999988889999999999999999998 999997654322


Q ss_pred             hHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 013790          302 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  366 (436)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~  366 (436)
                         +.+.+......              ..+...+..+.+++.+||+.||.+||++.+|+++|..
T Consensus       235 ---~~~~~~~~~~~--------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 ---VIEMVRKRQLL--------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HHHHHHcCCcC--------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence               22222211100              1112234678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.8e-42  Score=313.54  Aligned_cols=272  Identities=25%  Similarity=0.333  Sum_probs=208.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCC-ceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPN-LVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~  154 (436)
                      ...|..+++||+|+||+||+|+.+       .+++.||+|++......  ......+|+.+|+.|+|+| |+.+++++..
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~-------~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~   82 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSK-------RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHT   82 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEe-------cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence            456888889999999999999976       57789999999765332  3456788999999999999 9999999987


Q ss_pred             cCC--cceeEEEEEEecCCCCHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc
Q 013790          155 DGE--RGIQRLLVYEFMLNRSLEDHLFNRAF--PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  230 (436)
Q Consensus       155 ~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  230 (436)
                      ...  ....+++|+||+ .-+|..++.....  ..++...+..++.||+.||+|||++   +|+||||||+||||+.+|.
T Consensus        83 ~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~  158 (323)
T KOG0594|consen   83 SNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGV  158 (323)
T ss_pred             cccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCc
Confidence            652  233568999999 5699999977553  3677789999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  309 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  309 (436)
                      +||+|||+|+....  .....+..++|.-|.|||++.+. .|+...||||+|||+.||+++++.|.+.........+-.+
T Consensus       159 lKlaDFGlAra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~  236 (323)
T KOG0594|consen  159 LKLADFGLARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL  236 (323)
T ss_pred             EeeeccchHHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence            99999999985321  22234567789999999999886 7999999999999999999999999887664333222222


Q ss_pred             hhcccCcccccccc---CC--ccc-----CcCCHHH---HHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          310 QQYPADSKKFGLIM---DP--RLE-----KEYSINE---ARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       310 ~~~~~~~~~~~~~~---~~--~l~-----~~~~~~~---~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..-|... .+..+.   +-  .+.     .......   .....+++.+||+.+|.+|.|+..++.|
T Consensus       237 lGtP~e~-~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  237 LGTPNEK-DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCcc-CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            2222111 111000   00  000     0111111   1367899999999999999999999887

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.8e-42  Score=324.81  Aligned_cols=267  Identities=27%  Similarity=0.433  Sum_probs=208.6

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhcc-CCCCceeeeeEee
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCA  153 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  153 (436)
                      ...++|++.+.||+|+||.||++.+....  .......+|+|.+.... ......+.+|+.++..+ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~--~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLD--NPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCC--CCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            34568999999999999999999876322  12355789999987542 23345688899999999 7999999999987


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCC
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNR--------------AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFK  219 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlk  219 (436)
                      ..+.    .+++|||+++|+|.+++...              ....+++..++.++.|++.||.|||+.   +|+|||||
T Consensus        87 ~~~~----~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlk  159 (293)
T cd05053          87 QEGP----LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLA  159 (293)
T ss_pred             CCCC----eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccc
Confidence            6543    59999999999999999642              234688999999999999999999998   99999999


Q ss_pred             CCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 013790          220 ASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR  298 (436)
Q Consensus       220 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~  298 (436)
                      |+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus       160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  239 (293)
T cd05053         160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  239 (293)
T ss_pred             eeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence            9999999999999999999975322211112222335678999999988899999999999999999998 999997654


Q ss_pred             chhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                      .....   ..+....              ....+...+..+.+|+.+||..||.+|||+.++++.|++++
T Consensus       240 ~~~~~---~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         240 VEELF---KLLKEGY--------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHH---HHHHcCC--------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            33221   1111100              00112233467889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.2e-41  Score=319.42  Aligned_cols=263  Identities=24%  Similarity=0.377  Sum_probs=205.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|+.++.||.|+||.||+|.+...   +......||+|.+.... ......+.+|+.++..++||||+++++++....
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~---~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPD---GENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTST   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecC---CCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC
Confidence            45899999999999999999997622   11223468999986543 233467888999999999999999999986432


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                           .+++++|+++|+|.+++.... ..+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+||
T Consensus        83 -----~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~df  153 (279)
T cd05109          83 -----VQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDF  153 (279)
T ss_pred             -----cEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCC
Confidence                 479999999999999997543 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   +..++......
T Consensus       154 G~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~  230 (279)
T cd05109         154 GLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEKGERL  230 (279)
T ss_pred             CceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCCcC
Confidence            99975422211111222335678999999988889999999999999999998 999997654322   22222211100


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                                    ..+...+..+.+++.+||..||++||++.++++.|..+..
T Consensus       231 --------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         231 --------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             --------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                          0112234678899999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-41  Score=330.10  Aligned_cols=269  Identities=26%  Similarity=0.382  Sum_probs=206.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|++.+.||+|+||.||+|.+....  ...+++.||||++..... .....+.+|+.++..+ +||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGID--KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCC--ccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            357999999999999999999864221  234678999999975432 2345688899999999 689999999988654


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC-----------------------------------------------------
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA-----------------------------------------------------  182 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------  182 (436)
                      +.   ..+++|||+++|+|.+++....                                                     
T Consensus        84 ~~---~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          84 GG---PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             CC---ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            33   3589999999999999986431                                                     


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCccc
Q 013790          183 ------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV  250 (436)
Q Consensus       183 ------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  250 (436)
                                  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++...........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  237 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR  237 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh
Confidence                        12367888899999999999999998   999999999999999999999999999875322111112


Q ss_pred             ccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccC
Q 013790          251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEK  329 (436)
Q Consensus       251 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  329 (436)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |..||........  +...+....          ....  
T Consensus       238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~~~----------~~~~--  303 (343)
T cd05103         238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKEGT----------RMRA--  303 (343)
T ss_pred             cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHHHHhccC----------CCCC--
Confidence            223345678999999988889999999999999999997 9999975432211  111111000          0000  


Q ss_pred             cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          330 EYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                        +...+..+.+++..||+.||.+|||+.+|+++|+.+++.
T Consensus       304 --~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         304 --PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             --CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence              111235688999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.1e-42  Score=332.61  Aligned_cols=243  Identities=26%  Similarity=0.355  Sum_probs=194.9

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCccee
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  161 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  161 (436)
                      +.||+|+||.||++...       .++..||+|++....   ......+..|+.++..++||||+++++++...+    .
T Consensus         1 ~~lG~G~~g~V~~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~----~   69 (325)
T cd05594           1 KLLGKGTFGKVILVKEK-------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD----R   69 (325)
T ss_pred             CeeeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC----E
Confidence            36999999999999865       567899999987542   223356778999999999999999998886654    4


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          162 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       162 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      .++||||+++|+|..++...  ..+++..+..++.||+.||.|||+ .   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~lv~E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~  144 (325)
T cd05594          70 LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCK  144 (325)
T ss_pred             EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCe
Confidence            69999999999999988654  368999999999999999999997 6   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||........   ...+...        
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~---~~~i~~~--------  211 (325)
T cd05594         145 EGIK--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELILME--------  211 (325)
T ss_pred             ecCC--CCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH---HHHHhcC--------
Confidence            4211  12222345699999999999999999999999999999999999999976543222   1111110        


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                         ...+    +...+..+.+|+.+||+.||.+|+     ++.+++++
T Consensus       212 ---~~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         212 ---EIRF----PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             ---CCCC----CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence               0011    112346788999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-41  Score=316.46  Aligned_cols=255  Identities=29%  Similarity=0.405  Sum_probs=203.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.+.||+|+||.||+|.+.        .++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+.
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--------~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN--------NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP   75 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec--------CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCC
Confidence            457999999999999999999864        34679999987553 234678899999999999999999998876543


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .+++|||+++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        76 ----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg  148 (261)
T cd05068          76 ----IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFG  148 (261)
T ss_pred             ----eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcc
Confidence                49999999999999999765555789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      +++...... .........+..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.....   ....+.....  
T Consensus       149 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~--  222 (261)
T cd05068         149 LARVIKEDI-YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQVDQGYR--  222 (261)
T ss_pred             eEEEccCCc-ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCC--
Confidence            987532111 111111223457999999998899999999999999999999 999997654322   1111111100  


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  366 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~  366 (436)
                                  ...+...+..+.+++.+||+.+|.+||++.+|+..|++
T Consensus       223 ------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 ------------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ------------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                        01122234678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-41  Score=320.75  Aligned_cols=276  Identities=30%  Similarity=0.424  Sum_probs=206.0

Q ss_pred             CC-cccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DF-SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~-~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +| +..+.||+|+||+||++.+...   ...++..||+|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPA---NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccc---cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            44 8889999999999998876421   224577899999876532 234678899999999999999999998865432


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                        ...+++|||+.+++|.+++...   .+++..+..++.|++.||.|||++   +++||||||+|||++.++.++|+|||
T Consensus        81 --~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  152 (283)
T cd05080          81 --KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG  152 (283)
T ss_pred             --ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence              2468999999999999999653   489999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcc-cccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTH-VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      +++......... ......++..|+|||.+.+..++.++||||||+++|+|+||..||........ ......... ...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~  230 (283)
T cd05080         153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQ-MTV  230 (283)
T ss_pred             cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccc-cch
Confidence            987532211111 11223456679999999888899999999999999999999999865432211 111000000 000


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                      ..+............+...+..+.+++.+||+.||++|||+.+|+..|+.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0011111111111223344578999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.4e-42  Score=330.78  Aligned_cols=246  Identities=25%  Similarity=0.406  Sum_probs=194.1

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHH---hccCCCCceeeeeEeee
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFL---GVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpnIv~~~~~~~~  154 (436)
                      |++++.||+|+||.||+|.+.       .+++.||||++....   ....+.+.+|+.++   +.++||||+++++++..
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~   73 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYK-------KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT   73 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc
Confidence            677899999999999999875       467899999987542   12234566665554   56789999999998875


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..|+||||+++++|..++..   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        74 ~~----~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~  143 (324)
T cd05589          74 ED----HVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIA  143 (324)
T ss_pred             CC----EEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeC
Confidence            54    46999999999999988854   3589999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||+++....  .........|++.|+|||.+.+..++.++|||||||++|+|++|..||.+......   ...+.... 
T Consensus       144 Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~~~i~~~~-  217 (324)
T cd05589         144 DFGLCKEGMG--FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---FDSIVNDE-  217 (324)
T ss_pred             cccCCccCCC--CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhCC-
Confidence            9999874211  12223456799999999999999999999999999999999999999986543221   11111100 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                                .    ..+...+..+.++|.+||..||.+||     ++.+++++
T Consensus       218 ----------~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         218 ----------V----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ----------C----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                      0    01122346788999999999999999     56777665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-42  Score=337.65  Aligned_cols=253  Identities=26%  Similarity=0.367  Sum_probs=203.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|.+.+.||+|+||.||+|...       .+++.||+|++.....   .....+.+|+.++..++||||+++++++...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   73 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDK-------DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE   73 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEEC-------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC
Confidence            47999999999999999999865       4678999999875422   2345688899999999999999999988654


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..++||||+++++|.+++...  ..+++..+..++.||+.||.|||+.   ||+||||||+||||+.++.+||+|
T Consensus        74 ~----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~D  144 (350)
T cd05573          74 E----HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLAD  144 (350)
T ss_pred             C----eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeec
Confidence            4    469999999999999999765  4689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCC---------------------------CcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHH
Q 013790          236 FGLAREGPMVG---------------------------HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML  288 (436)
Q Consensus       236 fg~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell  288 (436)
                      ||++.......                           .........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  224 (350)
T cd05573         145 FGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML  224 (350)
T ss_pred             CCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhc
Confidence            99987532221                           001223457899999999999999999999999999999999


Q ss_pred             hCCCCCCCCCchhhHH-HHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHHH
Q 013790          289 TGRRSLERNRPKTEQR-LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-MSQVVER  363 (436)
Q Consensus       289 tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~eil~~  363 (436)
                      +|..||.......... +..|.....             +  ......+..+.+||.+||. ||.+||+ +.+++.+
T Consensus       225 ~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------~--p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         225 YGFPPFYSDTLQETYNKIINWKESLR-------------F--PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             cCCCCCCCCCHHHHHHHHhccCCccc-------------C--CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            9999998765332211 111100000             0  0011135778899999997 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.8e-41  Score=313.81  Aligned_cols=249  Identities=27%  Similarity=0.450  Sum_probs=195.2

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      +.||+|+||.||+|++.       .+++.||+|.+.... ......+.+|+++++.++||||+++++++....    ..+
T Consensus         1 ~~lg~g~~g~vy~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~   69 (252)
T cd05084           1 ERIGRGNFGEVFSGRLR-------ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ----PIY   69 (252)
T ss_pred             CccCcccCccEEEEEEe-------cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC----CeE
Confidence            36999999999999875       467889999876443 233467889999999999999999999987654    359


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCC
Q 013790          164 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  243 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  243 (436)
                      +||||+++++|.+++.... ..+++..++.++.|++.||.|||++   +++|+||||+|||++.++.+||+|||++....
T Consensus        70 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  145 (252)
T cd05084          70 IVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEE  145 (252)
T ss_pred             EEEeeccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccc
Confidence            9999999999999996543 4689999999999999999999998   99999999999999999999999999987422


Q ss_pred             CCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccccc
Q 013790          244 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI  322 (436)
Q Consensus       244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (436)
                      ............++..|+|||.+.++.++.++||||||+++|+|++ |..||...........   +...          
T Consensus       146 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~---~~~~----------  212 (252)
T cd05084         146 DGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA---IEQG----------  212 (252)
T ss_pred             cccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH---HHcC----------
Confidence            1111111111123457999999998889999999999999999998 8899975543222111   1110          


Q ss_pred             cCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       323 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                          .....+...+..+.+|+.+||..+|++|||+.++++.|.
T Consensus       213 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         213 ----VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ----CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence                001112233567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.2e-41  Score=315.28  Aligned_cols=259  Identities=25%  Similarity=0.367  Sum_probs=205.6

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC---cchhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|++.+.||+|+||.||+|+..       .+++.||||.+...   .......+.+|+.+++.++||||+++++++...
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCL-------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED   74 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEe-------CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC
Confidence            57999999999999999999975       46788999987543   223345688899999999999999999988765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      +    ..++++||+++++|.+++...  ....+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|
T Consensus        75 ~----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l  147 (267)
T cd08228          75 N----ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             C----eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEE
Confidence            4    358999999999999988532  234588999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +|||++.....  .........|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... ..+...+....
T Consensus       148 ~d~g~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~  224 (267)
T cd08228         148 GDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKIEQCD  224 (267)
T ss_pred             Cccccceeccc--hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHHhcCC
Confidence            99999875321  1112233568889999999988889999999999999999999999996543221 12222221111


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                                   .........+..+.+++.+||..+|++||++.+|++.|+.+
T Consensus       225 -------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         225 -------------YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             -------------CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                         00011223456789999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.5e-41  Score=319.33  Aligned_cols=262  Identities=24%  Similarity=0.426  Sum_probs=205.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ..+|...+.||+|+||.||++......  ...++..+|+|.+..........+.+|+++++.++||||+++++++...+ 
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   80 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLL--PEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR-   80 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCC--CCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC-
Confidence            357888999999999999999764211  22456789999988766666678999999999999999999999887654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEE
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAF-------------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL  224 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIl  224 (436)
                         ..+++|||+++++|.+++.....             ..+++..++.++.|++.||+|||+.   +++||||||+|||
T Consensus        81 ---~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil  154 (280)
T cd05092          81 ---PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCL  154 (280)
T ss_pred             ---ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEE
Confidence               35999999999999999975421             3588999999999999999999998   9999999999999


Q ss_pred             EcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 013790          225 LDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQ  303 (436)
Q Consensus       225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  303 (436)
                      +++++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||........ 
T Consensus       155 ~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-  233 (280)
T cd05092         155 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-  233 (280)
T ss_pred             EcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-
Confidence            99999999999999874322111112223345678999999998899999999999999999998 9999975443222 


Q ss_pred             HHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          304 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                        ........          ..    ..+...+..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       234 --~~~~~~~~----------~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         234 --IECITQGR----------EL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             --HHHHHcCc----------cC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence              11111100          00    111223467889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.4e-42  Score=331.44  Aligned_cols=255  Identities=23%  Similarity=0.350  Sum_probs=198.6

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc----chhHHHHHHHHHHHhccC-CCCceeeeeEeee
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQGHKQWVAEVQFLGVLE-HPNLVKLIGYCAV  154 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~  154 (436)
                      +|++++.||+|+||.||++....    +..++..||+|++....    ....+.+..|+.++..++ ||||+++++++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVT----GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT   76 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcc----cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence            58899999999999999988641    23467899999986532    223356788999999994 9999999988865


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||+.+|+|.+++..+.  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        77 ~~----~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~  147 (332)
T cd05614          77 EA----KLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLT  147 (332)
T ss_pred             CC----EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEe
Confidence            54    4599999999999999997643  689999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHHHhhc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQY  312 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~  312 (436)
                      |||+++..... .........||+.|+|||++.+. .++.++|||||||++|+|+||..||........ ..+...+.. 
T Consensus       148 DfG~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-  225 (332)
T cd05614         148 DFGLSKEFLSE-EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-  225 (332)
T ss_pred             eCcCCcccccc-CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-
Confidence            99998753211 11222345799999999999765 478899999999999999999999975432211 111111111 


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                                .++.+    +...+..+.+++.+||..||++||     ++.+++++
T Consensus       226 ----------~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 ----------CDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ----------CCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                      01111    122346788999999999999999     77788776

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-41  Score=328.01  Aligned_cols=247  Identities=26%  Similarity=0.406  Sum_probs=196.1

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc----hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcc
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  159 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  159 (436)
                      ++.||+|+||.||++....    +...++.||+|++.....    .....+..|+.+++.++||||+++++++...+   
T Consensus         1 ~~~lg~G~~g~V~~~~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~---   73 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVT----GADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG---   73 (323)
T ss_pred             CceeeecCCeEEEEEEEcc----cCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC---
Confidence            3679999999999998641    224678999999875321    22345778999999999999999999987654   


Q ss_pred             eeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCC
Q 013790          160 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  239 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  239 (436)
                       ..++||||+.+++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        74 -~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  147 (323)
T cd05584          74 -KLYLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLC  147 (323)
T ss_pred             -eEEEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCC
Confidence             4599999999999999996543  688899999999999999999998   9999999999999999999999999998


Q ss_pred             CCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccc
Q 013790          240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF  319 (436)
Q Consensus       240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  319 (436)
                      +...  ..........||+.|+|||++.+..++.++|||||||++|||++|..||.......   ....+....      
T Consensus       148 ~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---~~~~~~~~~------  216 (323)
T cd05584         148 KESI--HEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---TIDKILKGK------  216 (323)
T ss_pred             eecc--cCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCC------
Confidence            6421  11222334579999999999998889999999999999999999999998654322   111111100      


Q ss_pred             ccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          320 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       320 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                           .    ..+...+..+.+||.+||..||++||     ++.+++.+
T Consensus       217 -----~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         217 -----L----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             -----C----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence                 0    11122346788999999999999999     78888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.3e-41  Score=321.33  Aligned_cols=261  Identities=30%  Similarity=0.423  Sum_probs=202.7

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhcc-CCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  156 (436)
                      ++|++.+.||+|+||.||+|...     .......+++|.+... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIK-----KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEec-----CCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence            57899999999999999999875     1122345788887643 223446788999999999 6999999999887654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCc
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN  222 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~N  222 (436)
                      .    .++++||+++++|.+++....              ...+++..+..++.|++.||+|||+.   +++||||||+|
T Consensus        77 ~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~N  149 (297)
T cd05089          77 Y----LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARN  149 (297)
T ss_pred             c----ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcce
Confidence            3    599999999999999996532              13588999999999999999999998   99999999999


Q ss_pred             EEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchh
Q 013790          223 VLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKT  301 (436)
Q Consensus       223 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~  301 (436)
                      ||++.++.+||+|||++....   ..........+..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus       150 ill~~~~~~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~  226 (297)
T cd05089         150 VLVGENLASKIADFGLSRGEE---VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE  226 (297)
T ss_pred             EEECCCCeEEECCcCCCcccc---ceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999999986321   1111111223457999999988889999999999999999998 999997654332


Q ss_pred             hHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          302 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                         ....+...          ...    ..+...+..+.+|+.+||..+|.+|||+.++++.|..+.+..
T Consensus       227 ---~~~~~~~~----------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         227 ---LYEKLPQG----------YRM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             ---HHHHHhcC----------CCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence               11111100          000    111223467889999999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.9e-41  Score=320.53  Aligned_cols=262  Identities=24%  Similarity=0.398  Sum_probs=205.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .+|.+.+.||.|+||.||+|.+....  ....+..||+|.+...... ..+.+.+|+.++..++||||+++++++.....
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   82 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTA--PGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCC--CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence            46888899999999999999875321  1235678999999755322 24568889999999999999999999876543


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcE
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  223 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NI  223 (436)
                          .++++||+.+++|.+++....              ...+++..+..++.|++.||.|||+.   +++||||||+||
T Consensus        83 ----~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Ni  155 (283)
T cd05091          83 ----LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNV  155 (283)
T ss_pred             ----eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhhe
Confidence                489999999999999985321              23578889999999999999999998   999999999999


Q ss_pred             EEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 013790          224 LLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTE  302 (436)
Q Consensus       224 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~  302 (436)
                      |+++++.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||.+....  
T Consensus       156 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--  233 (283)
T cd05091         156 LVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--  233 (283)
T ss_pred             EecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence            999999999999999875322222222233446778999999988889999999999999999998 88898765432  


Q ss_pred             HHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 013790          303 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  366 (436)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~  366 (436)
                       .+...+......              ..+..++..+.+|+..||+.+|.+||++.+|+..|+.
T Consensus       234 -~~~~~i~~~~~~--------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         234 -DVIEMIRNRQVL--------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -HHHHHHHcCCcC--------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             233322221110              1122345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-42  Score=330.07  Aligned_cols=263  Identities=25%  Similarity=0.400  Sum_probs=215.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ......+.||.|-||.||+|.+.+..   ....-.||||..+.+ .....+.|..|+-+|++++|||||+++|+|.+.. 
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~---kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-  464 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPE---KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-  464 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccc---cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-
Confidence            44555678999999999999997542   234556999999874 4556788999999999999999999999998764 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .|+|||.++.|.|..||..+. ..++..+...++.||+.||+|||+.   .+|||||..+|||+.....+||+|||
T Consensus       465 ----~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFG  536 (974)
T KOG4257|consen  465 ----MWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFG  536 (974)
T ss_pred             ----eeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccc
Confidence                499999999999999998765 4799999999999999999999999   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      +++..... .....+...-...|||||.+.-..++.++|||.|||++||++. |..||.+....+.              
T Consensus       537 LSR~~ed~-~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--------------  601 (974)
T KOG4257|consen  537 LSRYLEDD-AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--------------  601 (974)
T ss_pred             hhhhcccc-chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--------------
Confidence            99863211 1222222233458999999999999999999999999999987 9999987543211              


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                        +. .+...-+...+..||+.|..|+.+||+.+|.+||++.+|...|+++++..
T Consensus       602 --I~-~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee  653 (974)
T KOG4257|consen  602 --IG-HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE  653 (974)
T ss_pred             --EE-EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence              00 11111123456778899999999999999999999999999999998743

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.5e-41  Score=319.85  Aligned_cols=277  Identities=25%  Similarity=0.382  Sum_probs=206.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ..+|++++.||+|+||.||+|.+...   +..++..||+|.+........+.+.+|+.+++.++||||+++++++...+.
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~---~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPL---QDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCC---cCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            35789999999999999999986421   224678899999987665566788999999999999999999998765432


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                      .  ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        80 ~--~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg  153 (284)
T cd05081          80 R--NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFG  153 (284)
T ss_pred             C--ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCc
Confidence            2  4589999999999999996543 3589999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCccc-ccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC-
Q 013790          238 LAREGPMVGHTHV-STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD-  315 (436)
Q Consensus       238 ~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-  315 (436)
                      +++.......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+......    ....+...... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~  229 (284)
T cd05081         154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQ  229 (284)
T ss_pred             ccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccc
Confidence            9985432211111 11122345699999999888999999999999999999988776432211    00000000000 


Q ss_pred             --ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          316 --SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       316 --~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                        ...+...+........+...+..+.+|+.+||..+|++|||+.+|+..|+.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence              0000000010001111223356799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-42  Score=337.79  Aligned_cols=253  Identities=22%  Similarity=0.322  Sum_probs=197.4

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|.+++.||+|+||.||++...       .+++.||||++....   ....+.+.+|+.++..++||||+++++++...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~   73 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKK-------DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA   73 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEEC-------CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence            47999999999999999999865       567899999986542   22345678899999999999999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      .    ..|+||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~D  144 (377)
T cd05629          74 Q----YLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSD  144 (377)
T ss_pred             C----eeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEee
Confidence            4    459999999999999999654  4689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCC-----------cc----------------------------------cccccccCCCcccccccccCC
Q 013790          236 FGLAREGPMVGH-----------TH----------------------------------VSTAVVGTFGYAAPDYIETGH  270 (436)
Q Consensus       236 fg~a~~~~~~~~-----------~~----------------------------------~~~~~~gt~~y~aPE~~~~~~  270 (436)
                      ||+++.......           ..                                  ......||+.|+|||++.+..
T Consensus       145 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  224 (377)
T cd05629         145 FGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG  224 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC
Confidence            999863211000           00                                  001246999999999999889


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcC
Q 013790          271 LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSK  349 (436)
Q Consensus       271 ~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~  349 (436)
                      ++.++|||||||++|||++|..||.......... +..|.....             +..  ....+..+.+||.+||. 
T Consensus       225 ~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------~p~--~~~~s~~~~dli~~lL~-  288 (377)
T cd05629         225 YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLY-------------FPD--DIHLSVEAEDLIRRLIT-  288 (377)
T ss_pred             CCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccC-------------CCC--CCCCCHHHHHHHHHHhc-
Confidence            9999999999999999999999997655432111 111100000             000  11224678899999997 


Q ss_pred             CCCCC---CCHHHHHHH
Q 013790          350 SSKDR---PKMSQVVER  363 (436)
Q Consensus       350 dp~~R---Ps~~eil~~  363 (436)
                      +|.+|   +++.+++.+
T Consensus       289 ~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         289 NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             CHhhcCCCCCHHHHhcC
Confidence            77765   599999886

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.7e-41  Score=327.39  Aligned_cols=248  Identities=26%  Similarity=0.402  Sum_probs=195.9

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCC-CceeeeeEeeec
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHP-NLVKLIGYCAVD  155 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~  155 (436)
                      +|++++.||+|+||.||+|...       .+++.||+|++....   ....+.+..|..++..+.|+ +|+.+++++...
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~   73 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERK-------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM   73 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC
Confidence            5889999999999999999865       467789999987542   22345677899999999765 577888777654


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..|+||||+++|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~D  144 (324)
T cd05587          74 D----RLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIAD  144 (324)
T ss_pred             C----EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEee
Confidence            3    4699999999999999986543  689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||++.....  .........||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.....   ....+....  
T Consensus       145 fg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~~~~--  217 (324)
T cd05587         145 FGMCKENIF--GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQSIMEHN--  217 (324)
T ss_pred             cCcceecCC--CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHcCC--
Confidence            999864211  1122334579999999999999999999999999999999999999998654322   222111110  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM-----SQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~  363 (436)
                               .    .++...+..+.+++.+||..||.+|++.     .+++++
T Consensus       218 ---------~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         218 ---------V----SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             ---------C----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                     0    1111234678899999999999999986     566554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.2e-42  Score=338.42  Aligned_cols=252  Identities=23%  Similarity=0.327  Sum_probs=196.8

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .|+.++.||+|+||.||+|...       .+++.||+|++.....   .....+.+|+.+++.++||||+++++.+...+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~-------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~   74 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKV-------DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD   74 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEEC-------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC
Confidence            6889999999999999999865       5678999999875432   23456888999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.+|.+||+||
T Consensus        75 ----~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DF  145 (382)
T cd05625          75 ----NLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  145 (382)
T ss_pred             ----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeEC
Confidence                469999999999999999664  3688999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCC---------------------------------------------CcccccccccCCCcccccccccCCC
Q 013790          237 GLAREGPMVG---------------------------------------------HTHVSTAVVGTFGYAAPDYIETGHL  271 (436)
Q Consensus       237 g~a~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~  271 (436)
                      |++.......                                             .........||+.|+|||++.+..+
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~  225 (382)
T cd05625         146 GLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY  225 (382)
T ss_pred             CCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC
Confidence            9975211000                                             0000123468999999999999999


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCC
Q 013790          272 TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKS  350 (436)
Q Consensus       272 ~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~d  350 (436)
                      +.++|||||||++|||++|..||....+..... +..+...               +........+..+.++|.+|+ .+
T Consensus       226 ~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~~~~~s~~~~~li~~l~-~~  289 (382)
T cd05625         226 TQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------LHIPPQAKLSPEASDLIIKLC-RG  289 (382)
T ss_pred             CCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------cCCCCcccCCHHHHHHHHHHc-cC
Confidence            999999999999999999999998765432211 1111000               000011122456778888876 59


Q ss_pred             CCCCCC---HHHHHHH
Q 013790          351 SKDRPK---MSQVVER  363 (436)
Q Consensus       351 p~~RPs---~~eil~~  363 (436)
                      |.+|++   +.+++.|
T Consensus       290 p~~R~~~~~~~ei~~h  305 (382)
T cd05625         290 PEDRLGKNGADEIKAH  305 (382)
T ss_pred             HhHcCCCCCHHHHhcC
Confidence            999997   8888765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.5e-41  Score=313.95  Aligned_cols=251  Identities=26%  Similarity=0.433  Sum_probs=199.3

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ++|++.+.||+|+||.||++.++        ....+|+|.+.... .....+.+|+.+++.++||||+++++++...+  
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~--------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   72 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR--------AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK--   72 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec--------cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC--
Confidence            56889999999999999999875        34579999886443 23467888999999999999999999987654  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+
T Consensus        73 --~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~  146 (256)
T cd05114          73 --PLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGM  146 (256)
T ss_pred             --CEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCC
Confidence              3599999999999999987543 3589999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ++..... .........++..|+|||.+.+..++.++||||||+++|+|++ |+.||......   .....+.....   
T Consensus       147 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i~~~~~---  219 (256)
T cd05114         147 TRYVLDD-EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMISRGFR---  219 (256)
T ss_pred             ccccCCC-ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHCCCC---
Confidence            8753211 1111122335568999999988889999999999999999999 89999765432   22222221110   


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                          ...       +...+..+.+++.+||..||++||++.++++.|
T Consensus       220 ----~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 ----LYR-------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ----CCC-------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                000       111235788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.7e-42  Score=339.72  Aligned_cols=254  Identities=23%  Similarity=0.302  Sum_probs=198.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|++++.||+|+||.||+|...       .+++.||+|++.....   .....+.+|+.+++.++||||+++++.+...
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~   73 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKV-------DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK   73 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEEC-------CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence            47999999999999999999865       4678999999865422   2235678899999999999999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..++||||+++|+|.+++...  ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~D  144 (376)
T cd05598          74 D----NLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTD  144 (376)
T ss_pred             C----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEe
Confidence            4    469999999999999999664  3688999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCC-----------------------------------------CcccccccccCCCcccccccccCCCCch
Q 013790          236 FGLAREGPMVG-----------------------------------------HTHVSTAVVGTFGYAAPDYIETGHLTAK  274 (436)
Q Consensus       236 fg~a~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~  274 (436)
                      ||++.......                                         .........||+.|+|||++.+..++.+
T Consensus       145 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  224 (376)
T cd05598         145 FGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL  224 (376)
T ss_pred             CCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc
Confidence            99974211000                                         0001123579999999999999999999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCC
Q 013790          275 SDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR  354 (436)
Q Consensus       275 ~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~R  354 (436)
                      +|||||||++|+|++|..||....+......   +.....           .+........+..+.++|.+|+ .+|.+|
T Consensus       225 ~DiwSlGvilyell~G~~Pf~~~~~~~~~~~---i~~~~~-----------~~~~~~~~~~s~~~~~li~~l~-~~p~~R  289 (376)
T cd05598         225 CDWWSVGVILYEMLVGQPPFLADTPAETQLK---VINWET-----------TLHIPSQAKLSREASDLILRLC-CGAEDR  289 (376)
T ss_pred             eeeeeccceeeehhhCCCCCCCCCHHHHHHH---HhccCc-----------cccCCCCCCCCHHHHHHHHHHh-cCHhhc
Confidence            9999999999999999999987654332111   111000           0000011123456778998876 599999


Q ss_pred             C---CHHHHHHH
Q 013790          355 P---KMSQVVER  363 (436)
Q Consensus       355 P---s~~eil~~  363 (436)
                      +   ++.+++.+
T Consensus       290 ~~~~t~~ell~h  301 (376)
T cd05598         290 LGKNGADEIKAH  301 (376)
T ss_pred             CCCCCHHHHhCC
Confidence            9   89999877

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-41  Score=315.93  Aligned_cols=263  Identities=25%  Similarity=0.404  Sum_probs=204.3

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC-
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE-  157 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-  157 (436)
                      |.+.+.||+|+||.||+|.+..    +...+..||+|.+.....  .....+.+|+..++.++||||+++++++..... 
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   76 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQ----DDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL   76 (273)
T ss_pred             CccccccCcCCCceEEEEEEec----CCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc
Confidence            5678899999999999998752    112457899999875432  334678899999999999999999998865443 


Q ss_pred             -cceeEEEEEEecCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          158 -RGIQRLLVYEFMLNRSLEDHLFNR----AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       158 -~~~~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                       .....+++|||+++|+|..++...    ....+++..+..++.|++.||.|||+.   +++||||||+||++++++.+|
T Consensus        77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~k  153 (273)
T cd05035          77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVC  153 (273)
T ss_pred             ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEE
Confidence             112358999999999999998543    223689999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhh
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      |+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+....   .+...+..
T Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~~~  230 (273)
T cd05035         154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLRH  230 (273)
T ss_pred             ECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc
Confidence            999999975322221111222335678999999988889999999999999999999 88999764432   22222221


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                      ...          .    ..+...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus       231 ~~~----------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GNR----------L----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCC----------C----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110          0    11223346789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.6e-41  Score=332.51  Aligned_cols=266  Identities=24%  Similarity=0.387  Sum_probs=205.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccC-CCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  155 (436)
                      .++|.+.+.||+|+||.||+|++....  ....+..||+|++..... ...+.+.+|+.++..+. ||||+++++++...
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLS--HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCC--CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            457888999999999999999976221  223567899999976532 22356889999999997 99999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC-----------------------------------------------------
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA-----------------------------------------------------  182 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------  182 (436)
                      +.    .++||||+.+|+|.+++....                                                     
T Consensus       114 ~~----~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         114 GP----IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             CC----cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            43    599999999999999996432                                                     


Q ss_pred             -------------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCC
Q 013790          183 -------------------------------------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFK  219 (436)
Q Consensus       183 -------------------------------------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlk  219 (436)
                                                                 ...+++..++.++.|++.||.|||+.   +++|||||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlk  266 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLA  266 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCC
Confidence                                                       12467778899999999999999998   99999999


Q ss_pred             CCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 013790          220 ASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR  298 (436)
Q Consensus       220 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~  298 (436)
                      |+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999975321111111223356788999999988889999999999999999998 889987543


Q ss_pred             chhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                      ....  ....+..-              .....+...+..+.+|+.+||..+|.+||++.+|+..|+.++
T Consensus       347 ~~~~--~~~~~~~~--------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         347 MNEQ--FYNAIKRG--------------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             chHH--HHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            2221  11111110              000112223468899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-41  Score=329.69  Aligned_cols=262  Identities=22%  Similarity=0.345  Sum_probs=193.9

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ...+|.+++.||+|+||.||+|...       .++..||+|+....      ....|+.+++.++||||+++++++....
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~  130 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKP-------GQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGA  130 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEEC-------CCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCC
Confidence            3468999999999999999999975       45678999985433      2346899999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+ .++|.+++.... ..+++..+..|+.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       131 ----~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~Df  201 (357)
T PHA03209        131 ----ITCMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDL  201 (357)
T ss_pred             ----eeEEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecC
Confidence                358999999 568998886543 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh--------hHHHHHH
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT--------EQRLLEW  308 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~--------~~~~~~~  308 (436)
                      |+++...   .........||..|+|||++.+..++.++|||||||++|||+++..|+....+..        ...+...
T Consensus       202 G~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~  278 (357)
T PHA03209        202 GAAQFPV---VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI  278 (357)
T ss_pred             ccccccc---cCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHH
Confidence            9987421   1122234568999999999999999999999999999999999655553322211        1111111


Q ss_pred             HhhcccCccccc---------cccC------CcccC---cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          309 VQQYPADSKKFG---------LIMD------PRLEK---EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       309 ~~~~~~~~~~~~---------~~~~------~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +......+..+.         ..+.      .....   ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        279 ISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             HHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            111111111000         0000      00000   0001223456789999999999999999999876

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.6e-41  Score=322.32  Aligned_cols=269  Identities=24%  Similarity=0.414  Sum_probs=208.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|.+.+.||+|+||.||+|...............+|+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            3578899999999999999998643222223456789999987543 23345688899999999 599999999998754


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCC
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  221 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~  221 (436)
                      +    ..+++|||+++|+|.+++....              ...+++..+..++.|++.||.|||++   |++||||||+
T Consensus        91 ~----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~  163 (314)
T cd05099          91 G----PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR  163 (314)
T ss_pred             C----ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccce
Confidence            4    3599999999999999996532              23588999999999999999999998   9999999999


Q ss_pred             cEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCch
Q 013790          222 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPK  300 (436)
Q Consensus       222 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~  300 (436)
                      |||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999975322111111122234567999999988889999999999999999999 88999765433


Q ss_pred             hhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      .   +...+.....              ...+..++..+.+++.+||..||.+|||+.++++.|.++...
T Consensus       244 ~---~~~~~~~~~~--------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         244 E---LFKLLREGHR--------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             H---HHHHHHcCCC--------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            2   2222211100              011222346788999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.7e-41  Score=317.62  Aligned_cols=262  Identities=26%  Similarity=0.431  Sum_probs=203.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|.+.+.||+|+||.||+|.+....+  ......|++|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDG--DAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCC--CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            4679999999999999999999863221  13577899998865432 23456888999999999999999999887654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC--
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAF-----PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF--  229 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~--  229 (436)
                      .    .++||||+++++|.+++.....     ..+++..+..++.||+.||.|||++   +++|+||||+||+++.++  
T Consensus        83 ~----~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~  155 (277)
T cd05036          83 P----RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPG  155 (277)
T ss_pred             C----cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCC
Confidence            3    4899999999999999965431     2589999999999999999999998   999999999999998655  


Q ss_pred             -ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHH
Q 013790          230 -RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       230 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~  307 (436)
                       .+||+|||+++................+..|+|||++.+..++.++|||||||++|+|++ |..||.......   +..
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~  232 (277)
T cd05036         156 RVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VME  232 (277)
T ss_pred             cceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence             599999999975321111111122233568999999998899999999999999999997 999998654432   222


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                      .+.....              ...+...+..+.+++.+||+.+|++|||+.+|+++|.
T Consensus       233 ~~~~~~~--------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         233 FVTGGGR--------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHcCCc--------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            2211100              0112223467889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=314.49  Aligned_cols=251  Identities=27%  Similarity=0.411  Sum_probs=213.2

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      .-|.++.+||+|+||.||+|.++       .+|+++|||++..+  .+.+.+..|+.+++++..|++|++||.+..... 
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~-------EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-  102 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHR-------ESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-  102 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHh-------ccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-
Confidence            34777889999999999999987       68999999998766  356788999999999999999999998876543 


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                         +|+|||||-.|+..+.++-+. .++.+.++..++.+-++||+|||..   .-+|||||..|||++.+|.+||+|||.
T Consensus       103 ---LWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGV  175 (502)
T KOG0574|consen  103 ---LWIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGV  175 (502)
T ss_pred             ---eEeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccc
Confidence               599999999999999997765 5899999999999999999999998   889999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  318 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  318 (436)
                      |-..  .+.-....+..||+.|||||++..-.|+.++||||||++..||..|++||..-.|.-.      +-..|.    
T Consensus       176 AGQL--TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA------IFMIPT----  243 (502)
T KOG0574|consen  176 AGQL--TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA------IFMIPT----  243 (502)
T ss_pred             cchh--hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce------eEeccC----
Confidence            8652  3344566778999999999999999999999999999999999999999987655321      000111    


Q ss_pred             cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       319 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                           .+...-..+...+..+.++|++||..+|++|-|+.++++|
T Consensus       244 -----~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  244 -----KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             -----CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence                 1111223355667889999999999999999999999886

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=325.42  Aligned_cols=265  Identities=27%  Similarity=0.414  Sum_probs=215.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhH-HHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .+...+.++||+|-||.|.++...        .+..||||.++....... ..|..|+++|.+|+||||+.++|+|..++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeve--------g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De  608 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVE--------GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD  608 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEec--------CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence            456778899999999999999864        468999999987755544 78999999999999999999999999877


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      ..    ++++||+++|+|.+|+.....+.+......+|+.||+.||+||.+.   ++|||||.+.|||++.++++||+||
T Consensus       609 Pi----cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadf  681 (807)
T KOG1094|consen  609 PL----CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADF  681 (807)
T ss_pred             ch----HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCc
Confidence            54    9999999999999999887544445566788999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCchhhHHHHHHHhhccc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT--GRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |+++..............+-...|||||.+..+.++.++|||+||+++||+++  ...||.....   ...++....+..
T Consensus       682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~  758 (807)
T KOG1094|consen  682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFR  758 (807)
T ss_pred             ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcC
Confidence            99986543333444445566789999999999999999999999999999876  7789976543   333333333222


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                      ....-..       ...+.-++..+.+++.+||..|-.+||+++++..+|.+.
T Consensus       759 ~~~~~~~-------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  759 DQGRQVV-------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CCCccee-------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            2111111       122445678899999999999999999999999888654

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2e-41  Score=318.35  Aligned_cols=258  Identities=29%  Similarity=0.388  Sum_probs=203.2

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      +.+.|++.+.||+|+||.||+|...       .+++.||+|.+.... .....+.+|+.++..+ +||||+++++++...
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHV-------KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   75 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEc-------CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence            4678899999999999999999875       467899999986543 3345678899999988 699999999998764


Q ss_pred             CCc--ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          156 GER--GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       156 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ...  ....+++|||+.+++|.+++.......+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++|
T Consensus        76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l  152 (272)
T cd06637          76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL  152 (272)
T ss_pred             CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEE
Confidence            322  23568999999999999999765555789999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  308 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  308 (436)
                      +|||++.....  .........|+..|+|||++.     +..++.++|||||||++|+|++|..||....+......   
T Consensus       153 ~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~---  227 (272)
T cd06637         153 VDFGVSAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---  227 (272)
T ss_pred             ccCCCceeccc--ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH---
Confidence            99999874211  112234467899999999985     34678899999999999999999999975543222111   


Q ss_pred             HhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          309 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....+          ...   ......+..+.+|+.+||..||.+|||+.+++++
T Consensus       228 ~~~~~----------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         228 IPRNP----------APR---LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             HhcCC----------CCC---CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            10000          000   0111234678899999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.3e-41  Score=319.58  Aligned_cols=270  Identities=26%  Similarity=0.371  Sum_probs=198.9

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhcc---CCCCceeeeeEeee
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVL---EHPNLVKLIGYCAV  154 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~  154 (436)
                      +|++.+.||+|+||.||+|..+       .+++.||+|.+......  ....+.+|+.+++.+   +||||+++++++..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~   73 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDP-------HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCAT   73 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEEC-------CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecc
Confidence            4888999999999999999865       56789999998754221  223455677766655   79999999998865


Q ss_pred             cC-CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          155 DG-ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       155 ~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      .. ......+++|||+. ++|.+++.......+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||
T Consensus        74 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl  149 (288)
T cd07863          74 SRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKL  149 (288)
T ss_pred             ccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence            32 22345789999996 5899998765555689999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhhc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQY  312 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~  312 (436)
                      +|||+++...   .........||..|+|||++.+..++.++|||||||++|+|++|.+||......... .+.......
T Consensus       150 ~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~  226 (288)
T cd07863         150 ADFGLARIYS---CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  226 (288)
T ss_pred             CccCcccccc---CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCC
Confidence            9999987532   111223456889999999999889999999999999999999999999765443221 122111110


Q ss_pred             ccCcccc-----ccccCCcc---cCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKF-----GLIMDPRL---EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~-----~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .......     .....+..   ........+..+.+||.+||+.||.+|||+.+++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000000     00000000   001112335678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.8e-41  Score=319.20  Aligned_cols=271  Identities=27%  Similarity=0.435  Sum_probs=208.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCC---------CCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCcee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAA---------GDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVK  147 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---------~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~  147 (436)
                      .++|++.+.||+|+||.||+|......         .........||+|.+..... ...+.+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            458999999999999999999876322         12223457799999876532 34567889999999999999999


Q ss_pred             eeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccC
Q 013790          148 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA---------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDF  218 (436)
Q Consensus       148 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dl  218 (436)
                      +++++..++.    .+++|||+.+++|.+++....         ...+++..++.++.|++.||.|||+.   +++|+||
T Consensus        84 ~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dl  156 (296)
T cd05051          84 LLGVCTVDPP----LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDL  156 (296)
T ss_pred             EEEEEecCCC----cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Ccccccc
Confidence            9999876543    499999999999999996543         12689999999999999999999998   9999999


Q ss_pred             CCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 013790          219 KASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT--GRRSLER  296 (436)
Q Consensus       219 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~  296 (436)
                      ||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++  |..||..
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999875322222222334456778999999988889999999999999999998  7788865


Q ss_pred             CCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          297 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                      .....   .............       .......+...+..+.+++.+||+.||.+|||+.+|++.|+
T Consensus       237 ~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         237 LTDQQ---VIENAGHFFRDDG-------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             cChHH---HHHHHHhcccccc-------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            44322   2222221111100       00000112223467999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.3e-41  Score=322.24  Aligned_cols=262  Identities=29%  Similarity=0.452  Sum_probs=202.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|++.+.||+|+||.||+|.++     .......+++|.+.... ......+.+|+.++.++ +||||+++++++...
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~-----~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~   80 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIK-----KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   80 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEc-----cCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence            468999999999999999999875     11233457888776432 23345788899999999 899999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCC
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  221 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~  221 (436)
                      +.    .++||||+++++|.+++....              ...+++..++.++.|++.||+|||+.   +++||||||+
T Consensus        81 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~  153 (303)
T cd05088          81 GY----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAAR  153 (303)
T ss_pred             CC----ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---Cccccccchh
Confidence            43    599999999999999996432              23578999999999999999999998   9999999999


Q ss_pred             cEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCch
Q 013790          222 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPK  300 (436)
Q Consensus       222 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~  300 (436)
                      |||++.++.+||+|||++....   .........++..|+|||.+.+..++.++|||||||++|+|+| |..||......
T Consensus       154 Nili~~~~~~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  230 (303)
T cd05088         154 NILVGENYVAKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA  230 (303)
T ss_pred             eEEecCCCcEEeCccccCcccc---hhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH
Confidence            9999999999999999986311   1111112234567999999988889999999999999999998 99999755432


Q ss_pred             hhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                      .   ....+..   .           .....+...+..+.+|+.+||+.+|++||++.+++..|..++...
T Consensus       231 ~---~~~~~~~---~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         231 E---LYEKLPQ---G-----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             H---HHHHHhc---C-----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            2   1111110   0           000111223457889999999999999999999999998886543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.1e-42  Score=330.59  Aligned_cols=250  Identities=24%  Similarity=0.404  Sum_probs=193.3

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhcc-CCCCceeeeeEeeecCCcce
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  160 (436)
                      +.||+|+||.||+|.+.       .+++.||+|++.....   .....+..|..++..+ +||||+++++++...+    
T Consensus         1 ~~lG~G~~g~V~~~~~~-------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~----   69 (329)
T cd05588           1 RVIGRGSYAKVLLVELK-------KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES----   69 (329)
T ss_pred             CeEeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC----
Confidence            36999999999999876       4678899999975422   2335578899999888 6999999999887654    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~  144 (329)
T cd05588          70 RLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK  144 (329)
T ss_pred             EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccc
Confidence            459999999999999988654  3699999999999999999999998   99999999999999999999999999986


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh--hHHHHHHHhhcccCccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT--EQRLLEWVQQYPADSKK  318 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~  318 (436)
                      ...  ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ......++...      
T Consensus       145 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------  216 (329)
T cd05588         145 EGI--RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV------  216 (329)
T ss_pred             ccc--cCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH------
Confidence            421  11222344679999999999999999999999999999999999999996422111  00001111000      


Q ss_pred             cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC------HHHHHHH
Q 013790          319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK------MSQVVER  363 (436)
Q Consensus       319 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs------~~eil~~  363 (436)
                         +....+  ..+...+..+.++|.+||..||.+||+      +.+++++
T Consensus       217 ---~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         217 ---ILEKQI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             ---HHcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence               000000  111223467889999999999999997      5677655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.2e-41  Score=319.75  Aligned_cols=246  Identities=26%  Similarity=0.395  Sum_probs=193.3

Q ss_pred             ccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        87 ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      ||+|+||.||++...       .+++.||+|.+......   ..+.+..|+.+++.++||||+++.+++....    ..+
T Consensus         1 lg~G~~g~Vy~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~----~~~   69 (280)
T cd05608           1 LGKGGFGEVSACQMR-------ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT----DLC   69 (280)
T ss_pred             CCCCCceeEEEEEEc-------cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC----eEE
Confidence            799999999999865       56789999998754322   2345678999999999999999998886544    359


Q ss_pred             EEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          164 LVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      +||||+++|+|..++...  ....+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.++|+|||++..
T Consensus        70 lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  146 (280)
T cd05608          70 LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVE  146 (280)
T ss_pred             EEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcccee
Confidence            999999999999887542  234689999999999999999999998   999999999999999999999999999874


Q ss_pred             CCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHHHhhcccCccccc
Q 013790          242 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  320 (436)
                      ....  ........||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ......+.          
T Consensus       147 ~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~----------  214 (280)
T cd05608         147 LKDG--QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL----------  214 (280)
T ss_pred             cCCC--CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc----------
Confidence            3211  1122345789999999999999999999999999999999999999976433211 11111110          


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                         ...  ...+...+..+.+++.+||+.||++||     ++.+++++
T Consensus       215 ---~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         215 ---NDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             ---ccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence               000  011223456788999999999999999     66777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.2e-41  Score=312.56  Aligned_cols=250  Identities=26%  Similarity=0.409  Sum_probs=197.3

Q ss_pred             cccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        86 ~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      .||+|+||.||+|.++     ...++..+|+|++....  ....+.+.+|+.+++.++||||+++++++..+     ..+
T Consensus         2 ~lg~G~~g~v~~~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   71 (257)
T cd05116           2 ELGSGNFGTVKKGMYK-----MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE-----SWM   71 (257)
T ss_pred             cCCCcCCcceEEeEEe-----cCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CcE
Confidence            5899999999999875     33467889999986543  22346788999999999999999999987532     248


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCC
Q 013790          164 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  243 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  243 (436)
                      +||||+++|+|.+++...  ..+++..+..++.|++.||.|||++   +++||||||.||+++.++.+||+|||++....
T Consensus        72 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~  146 (257)
T cd05116          72 LVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG  146 (257)
T ss_pred             EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccC
Confidence            999999999999999654  3689999999999999999999998   99999999999999999999999999987532


Q ss_pred             CCCCcc-cccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 013790          244 MVGHTH-VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  321 (436)
Q Consensus       244 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (436)
                      ...... ......++..|+|||.+....++.++|||||||++|||++ |..||.......   +...+....        
T Consensus       147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i~~~~--------  215 (257)
T cd05116         147 ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMIESGE--------  215 (257)
T ss_pred             CCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHCCC--------
Confidence            221111 1122234578999999988889999999999999999998 999998654332   222222110        


Q ss_pred             ccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       322 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                        ..    ..+...+..+.++|.+||+.||++||++.+|...|++.
T Consensus       216 --~~----~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 --RM----ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             --CC----CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence              00    11223456789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=8.4e-41  Score=311.78  Aligned_cols=251  Identities=24%  Similarity=0.443  Sum_probs=197.5

Q ss_pred             cccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEEE
Q 013790           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLL  164 (436)
Q Consensus        86 ~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~l  164 (436)
                      .||+|+||.||+|.+.     ....+..||+|++..... ...+.+.+|+.+++.++||||+++++++...     ..++
T Consensus         2 ~ig~G~~g~v~~~~~~-----~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~-----~~~l   71 (257)
T cd05115           2 ELGSGNFGCVKKGVYK-----MRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-----ALML   71 (257)
T ss_pred             ccCCCCcccEEEEEEe-----cCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC-----CeEE
Confidence            4899999999999875     223456799999876533 2345688999999999999999999987532     3589


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCC
Q 013790          165 VYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM  244 (436)
Q Consensus       165 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  244 (436)
                      ||||+++++|.+++.... ..+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        72 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  147 (257)
T cd05115          72 VMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGA  147 (257)
T ss_pred             EEEeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccC
Confidence            999999999999986543 4689999999999999999999998   999999999999999999999999999874322


Q ss_pred             CCCccc-ccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccccc
Q 013790          245 VGHTHV-STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI  322 (436)
Q Consensus       245 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (436)
                      ...... .....++..|+|||.+.+..++.++||||||+++|++++ |..||.......   ....+....         
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~---------  215 (257)
T cd05115         148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMSFIEQGK---------  215 (257)
T ss_pred             CccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHHCCC---------
Confidence            211111 111233578999999988889999999999999999996 999998654432   222221110         


Q ss_pred             cCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       323 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                           ....+..++..+.+++.+||..||++||++.+|.+.|+.+
T Consensus       216 -----~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         216 -----RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                 0112233457888999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.9e-41  Score=326.31  Aligned_cols=243  Identities=26%  Similarity=0.401  Sum_probs=192.8

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhcc-CCCCceeeeeEeeecCCcce
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  160 (436)
                      +.||+|+||.||+|..+       .+++.||+|++....   ....+.+..|..++..+ +||||+++++++...+    
T Consensus         1 ~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~----   69 (320)
T cd05590           1 RVLGKGSFGKVMLARLK-------ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD----   69 (320)
T ss_pred             CeeeeCCCeEEEEEEEc-------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC----
Confidence            36999999999999865       467889999987542   22345567788888766 6999999999886554    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~iv~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~  144 (320)
T cd05590          70 RLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK  144 (320)
T ss_pred             EEEEEEcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCe
Confidence            459999999999999998654  3689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.......   +...+.....      
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~i~~~~~------  213 (320)
T cd05590         145 EGIF--NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAILNDEV------  213 (320)
T ss_pred             ecCc--CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHHHhcCCC------
Confidence            4211  1222344579999999999999899999999999999999999999998654322   2222211100      


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH------HHHHHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM------SQVVER  363 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~  363 (436)
                               ..+...+..+.+|+.+||+.||.+||++      .+++.+
T Consensus       214 ---------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         214 ---------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence                     0111234678899999999999999998      566554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.8e-41  Score=316.53  Aligned_cols=256  Identities=22%  Similarity=0.338  Sum_probs=201.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.+.||+|+||.||+|...       .+++.||+|++..........+.+|+.+++.++||||+++++++...+ 
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~-   79 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNL-------HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE-   79 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEEC-------CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-
Confidence            358999999999999999999865       467899999987654445567888999999999999999999987654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+++++|.+++...  .++++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||
T Consensus        80 ---~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg  151 (267)
T cd06646          80 ---KLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFG  151 (267)
T ss_pred             ---EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCc
Confidence               459999999999999998654  3689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ++.....  .........|+..|+|||.+.   ...++.++|||||||++|+|++|..||....+....  ..    ...
T Consensus       152 ~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~----~~~  223 (267)
T cd06646         152 VAAKITA--TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FL----MSK  223 (267)
T ss_pred             cceeecc--cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--ee----eec
Confidence            9875321  111223356888999999884   345788999999999999999999999654332110  00    000


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                        .   ....+.+.  .....+..+.++|.+||..||++|||+.+|+++|
T Consensus       224 --~---~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         224 --S---NFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --C---CCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              0   00011111  1122346789999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7e-41  Score=313.21  Aligned_cols=256  Identities=27%  Similarity=0.388  Sum_probs=203.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.++||+|+||.||+|.+.        ....||+|.+..... ..+.+.+|+.+++.++||||+++++++...  
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--------~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--   73 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWN--------GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE--   73 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEec--------CCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCC--
Confidence            357999999999999999999864        234599999875432 345788999999999999999999876432  


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        74 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg  147 (262)
T cd05071          74 ---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  147 (262)
T ss_pred             ---CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCC
Confidence               248999999999999999765445689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      .++...... ........++..|+|||.+.+..++.++||||||+++|+|+| |..||........   ...+...    
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~~~~~~~----  219 (262)
T cd05071         148 LARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQVERG----  219 (262)
T ss_pred             ceeeccccc-cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---HHHHhcC----
Confidence            987532111 111123346678999999988889999999999999999999 8889876543221   1111100    


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                                .....+...+..+.+++.+||+.||++||++.++++.|+..+
T Consensus       220 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         220 ----------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             ----------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence                      000112334567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=306.69  Aligned_cols=254  Identities=24%  Similarity=0.358  Sum_probs=206.8

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      +++.|++-+.||+|.|+.|+++.+.       .+|+.+|+|+++..  .....+.+.+|+.|-+.|+||||+++.+.+..
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~-------~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~   81 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHK-------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE   81 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhc-------cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc
Confidence            4567888899999999999999865       57888999988644  23356789999999999999999999988866


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc---CCCce
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRP  231 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~  231 (436)
                      .+    .+|+|+|++.|++|..-|..+.  .+++..+.+.++||+.+|.|+|.+   +|||||+||+|+|+.   ...-+
T Consensus        82 ~~----~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~v  152 (355)
T KOG0033|consen   82 ES----FHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAV  152 (355)
T ss_pred             cc----eeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCce
Confidence            55    4599999999999988876653  578899999999999999999999   999999999999994   44558


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      ||+|||+|....   .........|||.|||||+++..+|+..+|||+.|||||-|+.|.+||.+.+..   .+.+.+..
T Consensus       153 KL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~~  226 (355)
T KOG0033|consen  153 KLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIKA  226 (355)
T ss_pred             eecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHhc
Confidence            999999998632   333445578999999999999999999999999999999999999999874322   23222221


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      -..           .++.......+++..+||++||..||.+|.|+.|.|+|
T Consensus       227 g~y-----------d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  227 GAY-----------DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             ccc-----------CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            110           11122334455778899999999999999999999875

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.1e-41  Score=312.88  Aligned_cols=251  Identities=28%  Similarity=0.444  Sum_probs=202.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ..+|++.+.||+|+||.||++...         +..||+|.+....  ..+.+.+|+.+++.++|+||+++++++...+.
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   73 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc---------CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC
Confidence            357999999999999999998753         5679999986543  34578899999999999999999998754432


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..+++|||+++++|.+++.......+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||
T Consensus        74 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg  147 (256)
T cd05082          74 ---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFG  147 (256)
T ss_pred             ---ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCc
Confidence               358999999999999999876555689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      ++.....     ......++..|+|||++.+..++.++|||||||++|+|++ |..||......   .+...+....   
T Consensus       148 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~~~~---  216 (256)
T cd05082         148 LTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKGY---  216 (256)
T ss_pred             cceeccc-----cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhcCC---
Confidence            9874221     1122344568999999988889999999999999999998 99999754322   1222221110   


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                             .+    ..+...+..+.+++.+||..+|++|||+.++++.|+.+
T Consensus       217 -------~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         217 -------KM----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -------CC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                   00    11223356788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.2e-41  Score=340.22  Aligned_cols=270  Identities=21%  Similarity=0.332  Sum_probs=196.9

Q ss_pred             HHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCC------CCc
Q 013790           72 SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH------PNL  145 (436)
Q Consensus        72 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pnI  145 (436)
                      +++....++|++++.||+|+||.||+|...       ..++.||||+++... .....+..|+.+++.+.|      ++|
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~-------~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i  193 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDR-------KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPL  193 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEc-------CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcce
Confidence            334445688999999999999999999865       467889999986432 222345567777766654      458


Q ss_pred             eeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeeccCCCCcEE
Q 013790          146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVL  224 (436)
Q Consensus       146 v~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dlkp~NIl  224 (436)
                      +.+++++....   ...|+||+++ +++|.+++...  ..+++..+..|+.||+.||.|||+ .   +|+||||||+|||
T Consensus       194 ~~i~~~~~~~~---~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NIL  264 (467)
T PTZ00284        194 MKIQRYFQNET---GHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENIL  264 (467)
T ss_pred             eeeEEEEEcCC---ceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence            88888886543   2468999988 88999998654  369999999999999999999997 5   9999999999999


Q ss_pred             EcCCC----------------ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHH
Q 013790          225 LDENF----------------RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML  288 (436)
Q Consensus       225 l~~~~----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell  288 (436)
                      ++.++                .+||+|||++...     ........||+.|+|||++.+..++.++|||||||++|||+
T Consensus       265 l~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell  339 (467)
T PTZ00284        265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY  339 (467)
T ss_pred             EecCCcccccccccccCCCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH
Confidence            98765                4999999987531     12234567999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCchhhHHHHHHHh-hcccCcc------cccccc------CCccc--------C---cCCHHHHHHHHHHHH
Q 013790          289 TGRRSLERNRPKTEQRLLEWVQ-QYPADSK------KFGLIM------DPRLE--------K---EYSINEARKIGRLAD  344 (436)
Q Consensus       289 tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~------~~~~~~------~~~l~--------~---~~~~~~~~~l~~li~  344 (436)
                      +|+.||.+.........+.... ..+....      ....+.      .+...        .   .........+.+||.
T Consensus       340 tG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~  419 (467)
T PTZ00284        340 TGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIY  419 (467)
T ss_pred             hCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHH
Confidence            9999998765433322222111 1110000      000000      00000        0   000112356789999


Q ss_pred             HhhcCCCCCCCCHHHHHHH
Q 013790          345 NCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       345 ~cl~~dp~~RPs~~eil~~  363 (436)
                      +||..||.+|||+.|+++|
T Consensus       420 ~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        420 GLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             HhCCcChhhCCCHHHHhcC
Confidence            9999999999999999986

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.5e-41  Score=328.28  Aligned_cols=250  Identities=24%  Similarity=0.395  Sum_probs=192.1

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhcc-CCCCceeeeeEeeecCCcce
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  160 (436)
                      +.||+|+||.||+|...       .+++.||+|++....   ......+.+|+.++..+ +||||+++++++...+    
T Consensus         1 ~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~----   69 (329)
T cd05618           1 RVIGRGSYAKVLLVRLK-------KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----   69 (329)
T ss_pred             CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC----
Confidence            46999999999999875       567889999987542   22345577888888766 7999999999887654    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++||||+++|+|..++...  ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~lv~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~  144 (329)
T cd05618          70 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK  144 (329)
T ss_pred             EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccc
Confidence            459999999999999988654  3689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh--hHHHHHHHhhcccCccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT--EQRLLEWVQQYPADSKK  318 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~  318 (436)
                      ....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ......++...      
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------  216 (329)
T cd05618         145 EGLR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV------  216 (329)
T ss_pred             cccC--CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH------
Confidence            4211  1222334678999999999999999999999999999999999999996321110  00011111000      


Q ss_pred             cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH------HHHHHH
Q 013790          319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM------SQVVER  363 (436)
Q Consensus       319 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~  363 (436)
                         +.....  .++...+..+.+||.+||..||.+||++      .+++++
T Consensus       217 ---i~~~~~--~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         217 ---ILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             ---HhcCCC--CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence               000000  1122334678899999999999999984      677655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.1e-41  Score=332.95  Aligned_cols=263  Identities=23%  Similarity=0.327  Sum_probs=207.3

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-C-----CCceeeeeEee
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-H-----PNLVKLIGYCA  153 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~~~~~~~  153 (436)
                      +|.+++.||+|+||.|.+|...       .+++.||||+++... ....+...|+.+|..|+ |     -|+|+++++|.
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~-------~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~  258 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDH-------KTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY  258 (586)
T ss_pred             EEEEEEEecccccceeEEEEec-------CCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence            5788999999999999999865       789999999997653 34566677999999997 4     38999999998


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC--Cce
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN--FRP  231 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~  231 (436)
                      ..+.    +|||+|.+ .-+|+++|+.+...+++...+..|+.||+.||..||..   +|||+||||+||||.+-  ..+
T Consensus       259 fr~H----lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~v  330 (586)
T KOG0667|consen  259 FRNH----LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRI  330 (586)
T ss_pred             cccc----eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCce
Confidence            7664    59999988 67999999999888999999999999999999999998   99999999999999643  369


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      ||+|||+|+..     ........-+..|.|||++.|.+|+.+.||||||||+.||++|.+.|.+.+..+....+.-+..
T Consensus       331 KVIDFGSSc~~-----~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG  405 (586)
T KOG0667|consen  331 KVIDFGSSCFE-----SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG  405 (586)
T ss_pred             eEEeccccccc-----CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhC
Confidence            99999999752     2222267788999999999999999999999999999999999999988766554433322222


Q ss_pred             cccCc---------ccccc-----------------------------ccCCccc-------CcCCHHHHHHHHHHHHHh
Q 013790          312 YPADS---------KKFGL-----------------------------IMDPRLE-------KEYSINEARKIGRLADNC  346 (436)
Q Consensus       312 ~~~~~---------~~~~~-----------------------------~~~~~l~-------~~~~~~~~~~l~~li~~c  346 (436)
                      .|...         .-+..                             ......+       ..........+.+++.+|
T Consensus       406 ~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~  485 (586)
T KOG0667|consen  406 LPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC  485 (586)
T ss_pred             CCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence            22110         00000                             0000000       011123345689999999


Q ss_pred             hcCCCCCCCCHHHHHHH
Q 013790          347 LSKSSKDRPKMSQVVER  363 (436)
Q Consensus       347 l~~dp~~RPs~~eil~~  363 (436)
                      |.+||.+|+|..++++|
T Consensus       486 L~~dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  486 LEWDPAERITPAQALNH  502 (586)
T ss_pred             hccCchhcCCHHHHhcC
Confidence            99999999999999987

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.4e-42  Score=332.28  Aligned_cols=254  Identities=22%  Similarity=0.294  Sum_probs=200.4

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|.+.+.||+|+||.||+|...       .+++.||+|++.....   .....+.+|+.+++.++||||+++++++...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~   73 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREK-------ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK   73 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence            47899999999999999999865       5678999999975432   2345678899999999999999999888654


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~D  145 (330)
T cd05601          74 D----NLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLAD  145 (330)
T ss_pred             C----eEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEecc
Confidence            4    4599999999999999997652 4689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE------TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  309 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  309 (436)
                      ||++...... .........||+.|+|||++.      +..++.++|||||||++|+|++|..||........   ...+
T Consensus       146 fg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~~i  221 (330)
T cd05601         146 FGSAARLTAN-KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT---YNNI  221 (330)
T ss_pred             CCCCeECCCC-CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH---HHHH
Confidence            9999753221 111223457899999999986      45678899999999999999999999976543221   1111


Q ss_pred             hhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .....       ..  .+  ......+..+.+|+..||. +|.+||++.+++.+
T Consensus       222 ~~~~~-------~~--~~--~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         222 MNFQR-------FL--KF--PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             HcCCC-------cc--CC--CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            11100       00  00  0111234678899999998 99999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.9e-41  Score=316.65  Aligned_cols=266  Identities=23%  Similarity=0.360  Sum_probs=209.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++.+.||+|+||.||+|.+...   ....+..|++|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~---~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDE---KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecC---CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            46899999999999999999998621   12246889999886542 333566888999999999999999999887643


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAF------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  230 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  230 (436)
                      .   ..+++++|+.+++|.+++.....      ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.
T Consensus        82 ~---~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~  155 (280)
T cd05043          82 E---PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQ  155 (280)
T ss_pred             C---CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCc
Confidence            2   34899999999999999865321      4689999999999999999999998   9999999999999999999


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHH
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWV  309 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  309 (436)
                      +||+|||+++...............++..|+|||++.+..++.++||||||+++|++++ |..||....+..   +..++
T Consensus       156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~  232 (280)
T cd05043         156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYL  232 (280)
T ss_pred             EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHH
Confidence            99999999975322221112223345678999999988889999999999999999999 999997654432   22222


Q ss_pred             hhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                      ....              ....+..++..+.+++.+||..||++|||+.++++.|+.+..
T Consensus       233 ~~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         233 KDGY--------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HcCC--------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1110              001112234678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.2e-41  Score=317.35  Aligned_cols=248  Identities=27%  Similarity=0.382  Sum_probs=193.3

Q ss_pred             ccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        87 ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      ||+|+||.||++..+       .+++.||+|.+......   ....+..|+++++.++||||+++++++....    ..+
T Consensus         1 lg~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~----~~~   69 (277)
T cd05607           1 LGKGGFGEVCAVQVK-------NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT----HLC   69 (277)
T ss_pred             CCCCCceEEEEEEEc-------cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC----eEE
Confidence            799999999999875       46889999998653221   2334567999999999999999998886543    469


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCC
Q 013790          164 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  243 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  243 (436)
                      +||||+++++|.+++.......+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++....
T Consensus        70 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~  146 (277)
T cd05607          70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK  146 (277)
T ss_pred             EEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecC
Confidence            999999999999998766555789999999999999999999998   99999999999999999999999999987532


Q ss_pred             CCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccccc
Q 013790          244 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM  323 (436)
Q Consensus       244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (436)
                      .   ........|+..|+|||++.+..++.++|||||||++|+|++|..||............  ......         
T Consensus       147 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~--~~~~~~---------  212 (277)
T cd05607         147 D---GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL--KRRTLE---------  212 (277)
T ss_pred             C---CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH--HHHhhc---------
Confidence            1   11223456899999999998888999999999999999999999999764332111111  111000         


Q ss_pred             CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       324 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                       ..+.. .....+..+.+|+.+||+.||.+||++.++++.+
T Consensus       213 -~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         213 -DEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             -ccccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence             00000 0112346788999999999999999997766443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3e-41  Score=324.36  Aligned_cols=243  Identities=25%  Similarity=0.413  Sum_probs=190.0

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhc-cCCCCceeeeeEeeecCCcce
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGV-LEHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~~  160 (436)
                      +.||+|+||.||+|...       .+++.||+|.+.....   ...+.+..|..++.. .+||||+++++++...+    
T Consensus         1 ~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~----   69 (316)
T cd05592           1 KVLGKGSFGKVMLAELK-------GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE----   69 (316)
T ss_pred             CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC----
Confidence            36999999999999875       4678899999875421   223445556666654 48999999999886544    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~  144 (316)
T cd05592          70 HLFFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCK  144 (316)
T ss_pred             EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCe
Confidence            469999999999999998654  3689999999999999999999998   99999999999999999999999999997


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   +...+...        
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~~i~~~--------  211 (316)
T cd05592         145 ENMN--GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFDSILND--------  211 (316)
T ss_pred             ECCC--CCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHcC--------
Confidence            4221  1223344679999999999999899999999999999999999999998754322   11111110        


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHH-HHHHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS-QVVER  363 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~~  363 (436)
                         .+    ..+...+..+.+|+.+||..||.+||++. +++++
T Consensus       212 ---~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         212 ---RP----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             ---CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence               01    11122346788999999999999999875 55443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.9e-41  Score=329.85  Aligned_cols=270  Identities=23%  Similarity=0.293  Sum_probs=201.7

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      ...++|++++.||+|+||.||+|...       ..++.||+|.+....  ......+.+|+.+++.++||||+++++++.
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   86 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDA-------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT   86 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEec-------CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeee
Confidence            35679999999999999999999854       467889999987542  233456788999999999999999999886


Q ss_pred             ecCC--cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCce
Q 013790          154 VDGE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  231 (436)
Q Consensus       154 ~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  231 (436)
                      ....  .....++||||+. ++|.+.+..    .+++..+..++.|++.||.|||+.   ||+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~  158 (355)
T cd07874          87 PQKSLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL  158 (355)
T ss_pred             ccccccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCE
Confidence            5432  2234699999995 477777643    478899999999999999999998   99999999999999999999


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHH--
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEW--  308 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~--  308 (436)
                      ||+|||+++...   .........||..|+|||++.+..++.++|||||||++|+|++|..||.+........ ....  
T Consensus       159 kl~Dfg~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (355)
T cd07874         159 KILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG  235 (355)
T ss_pred             EEeeCcccccCC---CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999997521   2222334578999999999999899999999999999999999999998655322211 0000  


Q ss_pred             -------------HhhcccCccccccc-----cCCcc---cCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          309 -------------VQQYPADSKKFGLI-----MDPRL---EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       309 -------------~~~~~~~~~~~~~~-----~~~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                   +..+.........+     ....+   ........+..+.+||.+||..||++|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                         00000000000000     00000   001111224578899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.9e-41  Score=313.17  Aligned_cols=251  Identities=27%  Similarity=0.406  Sum_probs=199.3

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      .+|.+++.||+|+||.||+|.+.        ....+|+|.+..... ..+.+.+|+.+++.++||||+++++++..... 
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~--------~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   73 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR--------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP-   73 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec--------CCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCC-
Confidence            47889999999999999999865        234599998875432 34678899999999999999999999865543 


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                         .+++|||+.+|+|.+++.... ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        74 ---~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~  146 (256)
T cd05113          74 ---IYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGL  146 (256)
T ss_pred             ---cEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCcc
Confidence               499999999999999997643 3689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ++..... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ....+......  
T Consensus       147 ~~~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~~~--  220 (256)
T cd05113         147 SRYVLDD-EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVSQGLRL--  220 (256)
T ss_pred             ceecCCC-ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHhcCCCC--
Confidence            8743211 1111122335678999999988889999999999999999999 999997654322   11111111000  


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                                  ..+...+..+.+++.+||+.||.+||++.+|+..|
T Consensus       221 ------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         221 ------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             ------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence                        00111246789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-41  Score=326.00  Aligned_cols=252  Identities=27%  Similarity=0.334  Sum_probs=213.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhccC-CCCceeeeeEee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLE-HPNLVKLIGYCA  153 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-hpnIv~~~~~~~  153 (436)
                      ...|++.+.||.|.||.||+++.+       .+++.+|+|.+.+....   ..+.+.+|+.+|+++. |||||.+++.+.
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~-------~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e  106 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREK-------STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE  106 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEec-------CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            457899999999999999999976       56899999999876543   3458999999999998 999999999998


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC----CC
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE----NF  229 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~----~~  229 (436)
                      ...    ..++|||++.||.|.+.|...   .+++..+..++.|++.++.|||+.   ||+||||||+|+|+..    ++
T Consensus       107 ~~~----~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~  176 (382)
T KOG0032|consen  107 DPD----SVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSG  176 (382)
T ss_pred             cCC----eEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCC
Confidence            766    459999999999999999776   399999999999999999999998   9999999999999953    35


Q ss_pred             ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 013790          230 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  309 (436)
Q Consensus       230 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  309 (436)
                      .+|++|||++.....   .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+........  ...
T Consensus       177 ~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--~i~  251 (382)
T KOG0032|consen  177 RIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--AIL  251 (382)
T ss_pred             cEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--HHH
Confidence            799999999986432   456677899999999999999999999999999999999999999998765433222  111


Q ss_pred             hhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..            +..+........+..+.++|..|+..||..|+|+.++++|
T Consensus       252 ~~------------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  252 RG------------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             cC------------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            11            1122334445557889999999999999999999999997

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.5e-41  Score=329.01  Aligned_cols=267  Identities=22%  Similarity=0.287  Sum_probs=200.5

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      ..++|++.+.||+|+||.||++...       .++..||+|.+...  .......+.+|+.+++.++||||+++++++..
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   91 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDT-------VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTP   91 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEc-------CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence            4579999999999999999999865       56789999998654  22334567889999999999999999998865


Q ss_pred             cCC--cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          155 DGE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       155 ~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      ...  .....++||||+. ++|.+.+..    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        92 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~k  163 (359)
T cd07876          92 QKSLEEFQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK  163 (359)
T ss_pred             CCCccccceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEE
Confidence            432  1234699999995 467776632    478899999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |+|||+++...   .........||..|+|||++.+..++.++|||||||++|+|++|..||.+.+.....  .......
T Consensus       164 l~Dfg~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~--~~~~~~~  238 (359)
T cd07876         164 ILDFGLARTAC---TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQW--NKVIEQL  238 (359)
T ss_pred             EecCCCccccc---cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhc
Confidence            99999997421   122223457899999999999999999999999999999999999999865432211  0001100


Q ss_pred             ccC------------------cc-----ccccccCCcc---cCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PAD------------------SK-----KFGLIMDPRL---EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~------------------~~-----~~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...                  ..     .+........   ........+..+.+||.+||..||++|||+.+++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         239 GTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             CCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000                  00     0000000000   000111224578899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.4e-41  Score=324.37  Aligned_cols=243  Identities=26%  Similarity=0.409  Sum_probs=194.2

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhcc-CCCCceeeeeEeeecCCcce
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  160 (436)
                      +.||+|+||.||+|.+.       .+++.||+|++....   ......+..|..++..+ +||||+++++++...+    
T Consensus         1 ~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~----   69 (318)
T cd05570           1 KVLGKGSFGKVLLAELK-------GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD----   69 (318)
T ss_pred             CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC----
Confidence            46999999999999875       467889999987542   22345567788888877 6999999999886544    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++||||+++|+|..++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  144 (318)
T cd05570          70 RLFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK  144 (318)
T ss_pred             EEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCe
Confidence            469999999999999998654  3699999999999999999999998   99999999999999999999999999986


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ....  .........|+..|+|||++.+..++.++|||||||++|+|++|..||.......   ....+....       
T Consensus       145 ~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~~i~~~~-------  212 (318)
T cd05570         145 EGIL--GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQSILEDE-------  212 (318)
T ss_pred             ecCc--CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHHHHHcCC-------
Confidence            4211  1222234568999999999999999999999999999999999999997654322   211111110       


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM-----SQVVER  363 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~  363 (436)
                          .    ..+...+..+.+||.+||..||.+||++     .+++.+
T Consensus       213 ----~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         213 ----V----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             ----C----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence                0    1112234678899999999999999999     887765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.2e-41  Score=323.30  Aligned_cols=242  Identities=25%  Similarity=0.418  Sum_probs=191.1

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhc-cCCCCceeeeeEeeecCCcce
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGV-LEHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~~  160 (436)
                      +.||+|+||.||+|.+.       .+++.||+|.+....   ......+..|..++.. ++||||+++++++...+    
T Consensus         1 ~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~----   69 (316)
T cd05619           1 KMLGKGSFGKVFLAELK-------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE----   69 (316)
T ss_pred             CeeeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC----
Confidence            36999999999999875       467889999987542   1223455667777775 58999999999987654    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  144 (316)
T cd05619          70 NLFFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK  144 (316)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcce
Confidence            459999999999999999654  3689999999999999999999998   99999999999999999999999999986


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ....  .........||..|+|||++.+..++.++|||||||++|+|++|..||.......   +...+...        
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i~~~--------  211 (316)
T cd05619         145 ENML--GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSIRMD--------  211 (316)
T ss_pred             ECCC--CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhC--------
Confidence            4211  1122234568999999999999899999999999999999999999998654322   22222111        


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHH-HHHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS-QVVE  362 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~  362 (436)
                         .+.    .+...+..+.+++.+||..||.+||++. +++.
T Consensus       212 ---~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         212 ---NPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ---CCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence               011    1112345688999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-40  Score=330.04  Aligned_cols=266  Identities=23%  Similarity=0.303  Sum_probs=200.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ..+|.+++.||.|+||.||+|...     +...+..||+|.+...     ....+|+.+++.++||||+++++++.... 
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~-----~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~-  159 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKH-----GDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKS-  159 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEc-----CCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCC-
Confidence            457999999999999999999765     3345788999988643     23467999999999999999999887554 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++|||++ +++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||
T Consensus       160 ---~~~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG  230 (392)
T PHA03207        160 ---TVCMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG  230 (392)
T ss_pred             ---EEEEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCc
Confidence               459999998 47899988433  4799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~  316 (436)
                      +++...............||+.|+|||++.+..++.++|||||||++|||++|..||.+........ +...+.......
T Consensus       231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~  310 (392)
T PHA03207        231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP  310 (392)
T ss_pred             cccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence            9975432222223345679999999999999999999999999999999999999997654432111 111111111000


Q ss_pred             ccccc-----------ccCCcccCcCC-------HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 KKFGL-----------IMDPRLEKEYS-------INEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~~~~~-----------~~~~~l~~~~~-------~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..+..           .........+.       ...+..+.++|.+||..||++|||+.+++.+
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00000           00000000000       1124568899999999999999999999887

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.2e-41  Score=324.23  Aligned_cols=243  Identities=25%  Similarity=0.417  Sum_probs=191.4

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhc-cCCCCceeeeeEeeecCCcce
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGV-LEHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~~  160 (436)
                      +.||+|+||.||+|.++       .++..||+|.+.....   .....+..|..++.. ++||||+++++++...+    
T Consensus         1 ~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~----   69 (316)
T cd05620           1 KVLGKGSFGKVLLAELK-------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE----   69 (316)
T ss_pred             CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC----
Confidence            46999999999999976       4678899999875421   233456667777765 48999999999987654    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++||||+.+|+|..++...  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+|||+++
T Consensus        70 ~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~  144 (316)
T cd05620          70 HLFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK  144 (316)
T ss_pred             EEEEEECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCe
Confidence            469999999999999998654  3689999999999999999999998   99999999999999999999999999986


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.......   +...+...        
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~~~~--------  211 (316)
T cd05620         145 ENVF--GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESIRVD--------  211 (316)
T ss_pred             eccc--CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHhC--------
Confidence            4211  1122344678999999999999999999999999999999999999997654322   22211110        


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHH-HHHHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS-QVVER  363 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~~  363 (436)
                         .+.+    +...+..+.+||.+||..||.+||++. +++++
T Consensus       212 ---~~~~----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         212 ---TPHY----PRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             ---CCCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence               0111    111346788999999999999999984 56543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.8e-41  Score=326.95  Aligned_cols=242  Identities=26%  Similarity=0.401  Sum_probs=192.7

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      +|.+++.||+|+||.||+|...       .++..||+|++.....   .....+..|..++..+ +||+|+.+++++...
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~   73 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERK-------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM   73 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC
Confidence            5888999999999999999865       4678899999875422   2234466677777776 588999998888654


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..++||||+++|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~D  144 (323)
T cd05616          74 D----RLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIAD  144 (323)
T ss_pred             C----EEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEcc
Confidence            4    4599999999999999986543  689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||+++....  .........||+.|+|||++.+..++.++|||||||++|+|+||..||.......   +...+....  
T Consensus       145 fG~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~i~~~~--  217 (323)
T cd05616         145 FGMCKENMW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIMEHN--  217 (323)
T ss_pred             CCCceecCC--CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHHHHhCC--
Confidence            999874221  1222334678999999999999999999999999999999999999998654432   222211110  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM  357 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  357 (436)
                               .    .++...+..+.+|+.+||+.||.+|++.
T Consensus       218 ---------~----~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 ---------V----AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---------C----CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                     0    1122234678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.8e-41  Score=325.42  Aligned_cols=243  Identities=25%  Similarity=0.394  Sum_probs=193.7

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhcc-CCCCceeeeeEeeecCCcce
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  160 (436)
                      +.||+|+||.||+|...       .+++.||+|++....   ......+..|..++..+ +||||+++++++...+    
T Consensus         1 ~~lG~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~----   69 (321)
T cd05591           1 KVLGKGSFGKVMLAELK-------GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD----   69 (321)
T ss_pred             CccccCCCeEEEEEEEC-------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC----
Confidence            36999999999999875       467889999987542   22334567788888765 7999999999987654    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..|+||||+++|+|..++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus        70 ~~~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~  144 (321)
T cd05591          70 RLFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK  144 (321)
T ss_pred             eEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccce
Confidence            359999999999999998654  3689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+....       
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~~i~~~~-------  212 (321)
T cd05591         145 EGIL--NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFESILHDD-------  212 (321)
T ss_pred             eccc--CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHHHHHcCC-------
Confidence            4211  1222334578999999999999899999999999999999999999998654322   222111100       


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-------CHHHHHHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-------KMSQVVER  363 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-------s~~eil~~  363 (436)
                          .    ..+...+..+.+|+.+||..||.+||       ++.+++++
T Consensus       213 ----~----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         213 ----V----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             ----C----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence                0    01112246788999999999999999       78888766

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-41  Score=316.58  Aligned_cols=262  Identities=27%  Similarity=0.440  Sum_probs=205.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++.+.||+|+||.||+|..+....  ...+..||+|.+.... ......+.+|+.++..++||||+++++++....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVK--GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCC--CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            4689999999999999999998763221  2345789999986543 233456888999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRA--------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN  228 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  228 (436)
                          ..++||||+++|+|.+++....        ...+++..++.++.|++.||.|||+.   +++||||||+|||++.+
T Consensus        83 ----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~  155 (277)
T cd05032          83 ----PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAED  155 (277)
T ss_pred             ----CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCC
Confidence                3599999999999999996532        12468889999999999999999998   99999999999999999


Q ss_pred             CceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHH
Q 013790          229 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       229 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~  307 (436)
                      +.+||+|||+++...............++..|+|||.+.++.++.++|||||||++|+|+| |..||.......   ...
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~  232 (277)
T cd05032         156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLK  232 (277)
T ss_pred             CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHH
Confidence            9999999999875322222222233456789999999988889999999999999999998 999997654432   222


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                      .+....          ..    ..+...+..+.+++.+||+.+|++|||+.+++..|+
T Consensus       233 ~~~~~~----------~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         233 FVIDGG----------HL----DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHhcCC----------CC----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            221100          00    111222578899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=321.19  Aligned_cols=250  Identities=22%  Similarity=0.363  Sum_probs=213.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh--HHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG--HKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .+=|.+.+.||+|-|..|-+|++.       .+|..||||++++.....  ...+.+|+..|+.++|||||++|.+....
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHV-------FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ   89 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHV-------FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ   89 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhh-------cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc
Confidence            355888899999999999999865       789999999998775443  45688899999999999999999988654


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE-cCCCceEEe
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL-DENFRPKLS  234 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~  234 (436)
                      .    .+|||+|.-.+|+|.+||.... ..+.+..+.+++.||+.|+.|+|..   .+|||||||+||++ .+-|-+||+
T Consensus        90 T----KlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLT  161 (864)
T KOG4717|consen   90 T----KLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLT  161 (864)
T ss_pred             c----eEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEee
Confidence            4    4699999999999999998765 4699999999999999999999998   99999999999887 678999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLT-AKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |||++..+   .......+.+|++.|.|||++.|..|+ +++||||||||||.|++|++||+..++.+...         
T Consensus       162 DFGFSNkf---~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------  229 (864)
T KOG4717|consen  162 DFGFSNKF---QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------  229 (864)
T ss_pred             eccccccC---CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------
Confidence            99999753   345566778999999999999998886 67999999999999999999999776543321         


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                             .+++-..  ..+...+.++++||..||..||.+|.+.++|...
T Consensus       230 -------mImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  230 -------MIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             -------hhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence                   1333322  4567788999999999999999999999999765

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.1e-41  Score=311.96  Aligned_cols=251  Identities=29%  Similarity=0.448  Sum_probs=203.7

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|.+.+.||+|+||.||+|...       .++..|++|.+...  .......+.+|+.+++.++||||+++++++...+ 
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   72 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRK-------ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG-   72 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEc-------CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC-
Confidence            5788899999999999999875       46788999988644  2334567889999999999999999999987654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        73 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~  146 (256)
T cd08529          73 ---KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLG  146 (256)
T ss_pred             ---EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccc
Confidence               459999999999999999875456799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      +++.....  ........|++.|+|||++.+..++.++||||||+++|+|++|..||.......   .........    
T Consensus       147 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~----  217 (256)
T cd08529         147 VAKLLSDN--TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILKIIRGV----  217 (256)
T ss_pred             cceeccCc--cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHcCC----
Confidence            98753221  122234568889999999998889999999999999999999999997654321   111111100    


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                            .+    ..+...+..+.+++.+||+.+|++||++.+++++
T Consensus       218 ------~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         218 ------FP----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ------CC----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                  00    1112345678999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.8e-41  Score=312.35  Aligned_cols=254  Identities=27%  Similarity=0.406  Sum_probs=202.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.+.||+|+||.||+|...        .+..+|+|.+..... ..+.+.+|+.++++++||||+++++++...  
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~--------~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--   73 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN--------GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEE--   73 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec--------CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCC--
Confidence            357899999999999999999764        455699999876433 345788999999999999999999887432  


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..+++|||+.+++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        74 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg  147 (260)
T cd05070          74 ---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFG  147 (260)
T ss_pred             ---CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCce
Confidence               248999999999999999765555689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      ++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ....+....   
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~---  220 (260)
T cd05070         148 LARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQVERGY---  220 (260)
T ss_pred             eeeeccCcc-cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCC---
Confidence            987532111 111122335668999999988889999999999999999999 899997644322   222221110   


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  366 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~  366 (436)
                                 ....+...+..+.+|+.+||..+|++|||+.++.+.|++
T Consensus       221 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         221 -----------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -----------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                       001122334679999999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-41  Score=312.12  Aligned_cols=251  Identities=27%  Similarity=0.422  Sum_probs=198.6

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      .+|++.+.||+|+||.||+|.++        .+..+|+|.+..... ....+.+|+.+++.++||||+++++++...+  
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~--------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   72 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR--------GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR--   72 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec--------CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--
Confidence            46889999999999999999864        345799999865432 3356788999999999999999999886554  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        73 --~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~  146 (256)
T cd05059          73 --PIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGL  146 (256)
T ss_pred             --ceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCccc
Confidence              3599999999999999997644 3689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ++..... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||....+...   ...+....    
T Consensus       147 ~~~~~~~-~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~~~----  218 (256)
T cd05059         147 ARYVLDD-QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VESVSAGY----  218 (256)
T ss_pred             ceecccc-cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HHHHHcCC----
Confidence            8753211 1111112223457999999998899999999999999999999 8999976543321   11111110    


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                            ..    ..+...+..+.+++.+||..+|++|||+.++++.|
T Consensus       219 ------~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         219 ------RL----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ------cC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                  00    11122456899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-40  Score=323.02  Aligned_cols=270  Identities=27%  Similarity=0.427  Sum_probs=209.1

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhcc-CCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  156 (436)
                      .+|++.+.||+|+||.||+|.+.....+.......||+|.+.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            478999999999999999998754332233345679999887542 23346788999999999 7999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCc
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN  222 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~N  222 (436)
                          ..+++|||+++|+|.+++....              ...+++..++.++.|++.||.|||++   +++||||||+|
T Consensus        92 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  164 (334)
T cd05100          92 ----PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN  164 (334)
T ss_pred             ----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence                3599999999999999997532              23478889999999999999999998   99999999999


Q ss_pred             EEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchh
Q 013790          223 VLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKT  301 (436)
Q Consensus       223 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~  301 (436)
                      ||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999875322111111222334567999999999899999999999999999998 889987654322


Q ss_pred             hHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          302 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                         ....+....              ....+...+..+.+|+.+||+.+|.+|||+.+++..|+++.....
T Consensus       245 ---~~~~~~~~~--------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         245 ---LFKLLKEGH--------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             ---HHHHHHcCC--------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence               221111100              001122234678899999999999999999999999999975443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.2e-41  Score=322.42  Aligned_cols=267  Identities=25%  Similarity=0.380  Sum_probs=200.2

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|.+.+.||+|+||.||+|...       .++..||+|.+..... .....+.+|+.+++.++||||+++++++..++ 
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   77 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSK-------LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK-   77 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEec-------CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC-
Confidence            57999999999999999999865       4677899999875432 22346778999999999999999999987654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        78 ---~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  149 (309)
T cd07872          78 ---SLTLVFEYLD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFG  149 (309)
T ss_pred             ---eEEEEEeCCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccc
Confidence               3599999996 48888886543 3588999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      +++....  .........+++.|+|||.+.+ ..++.++|||||||++|+|+||..||..................+...
T Consensus       150 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  227 (309)
T cd07872         150 LARAKSV--PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE  227 (309)
T ss_pred             cceecCC--CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            9874221  1112233467899999999865 468899999999999999999999998765443322222111111100


Q ss_pred             c--------ccccccCCcccC----cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 K--------KFGLIMDPRLEK----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~--------~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .        .+...-.+....    ......+..+.+||.+||..||.+|||+.+++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             HHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            0        000000000000    0011234678899999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.8e-41  Score=332.75  Aligned_cols=255  Identities=24%  Similarity=0.274  Sum_probs=200.4

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      ..++|++.+.||+|+||.||+|...       .++..||+|++....   ......+.+|+.+++.++||||+++++++.
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~  113 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHK-------SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ  113 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            4568999999999999999999875       467889999986532   123345778999999999999999998886


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ...    ..++||||+++|+|.+++...   .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       114 ~~~----~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL  183 (370)
T cd05596         114 DDK----YLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKL  183 (370)
T ss_pred             cCC----EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEE
Confidence            544    469999999999999998653   478889999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG----HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  309 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  309 (436)
                      +|||++...... .........||+.|+|||++.+.    .++.++|||||||++|||++|..||........   ...+
T Consensus       184 ~DfG~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i  259 (370)
T cd05596         184 ADFGTCMKMDAN-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YSKI  259 (370)
T ss_pred             EeccceeeccCC-CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---HHHH
Confidence            999998753211 11122346799999999998653    478899999999999999999999986543221   1111


Q ss_pred             hhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 013790          310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD--RPKMSQVVER  363 (436)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~  363 (436)
                      .....           .+........+..+.+||.+||..+|.+  ||++.+++.+
T Consensus       260 ~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         260 MDHKN-----------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HcCCC-----------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            11000           0000011123567889999999999988  9999999887

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.4e-41  Score=319.34  Aligned_cols=252  Identities=27%  Similarity=0.440  Sum_probs=199.9

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .|+..+.||+|+||.||++.+.       .+++.||+|.+......   ....+.+|+.+++.++|+||+.+++.+...+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~   73 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD   73 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEc-------CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC
Confidence            3677889999999999999876       56789999998654222   2345678999999999999999999886544


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+||
T Consensus        74 ----~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Df  146 (285)
T cd05630          74 ----ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDL  146 (285)
T ss_pred             ----EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeec
Confidence                469999999999999998765545699999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH-HhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW-VQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~-~~~~~~~  315 (436)
                      |++.....   ........|+..|+|||++.+..++.++||||||+++|+|++|..||.............. .....  
T Consensus       147 g~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~--  221 (285)
T cd05630         147 GLAVHVPE---GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ--  221 (285)
T ss_pred             cceeecCC---CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--
Confidence            99864321   1112234689999999999998999999999999999999999999986433211111111 01000  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~  363 (436)
                               .    ..+...+..+.+|+.+||+.||.+|||     +.+++++
T Consensus       222 ---------~----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         222 ---------E----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             ---------h----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence                     0    111223456889999999999999999     7888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=310.34  Aligned_cols=251  Identities=30%  Similarity=0.486  Sum_probs=204.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.+.||.|+||.||+|..         .++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.... 
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~---------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   73 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY---------RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN-   73 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe---------cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC-
Confidence            45889999999999999999975         367899999976644 4577899999999999999999999987543 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        74 ---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g  147 (256)
T cd05039          74 ---PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFG  147 (256)
T ss_pred             ---CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccc
Confidence               359999999999999999776555799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      +++....   .  .....++..|+|||.+.+..++.++||||||+++|++++ |..||.......   +...+.....  
T Consensus       148 ~~~~~~~---~--~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~~--  217 (256)
T cd05039         148 LAKEASQ---G--QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVEKGYR--  217 (256)
T ss_pred             ccccccc---c--cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhcCCC--
Confidence            9975311   1  112334568999999988889999999999999999998 999997654322   2222211100  


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                              .    ..+...+..+.++|.+||..+|++|||+.+++..|+.+
T Consensus       218 --------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         218 --------M----EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             --------C----CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                    0    11122347788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.1e-40  Score=312.36  Aligned_cols=259  Identities=26%  Similarity=0.375  Sum_probs=205.3

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|++.+.||.|+||.||+|.+.       .++..||||.+....   ......+.+|+.+++.++||||+++++++...
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~-------~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCL-------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED   74 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeec-------CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC
Confidence            47888999999999999999865       467889999876432   22345788899999999999999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      +    ..+++|||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        75 ~----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l  147 (267)
T cd08229          75 N----ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             C----eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEE
Confidence            4    358999999999999998642  234689999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +|||++......  ........|+..|+|||.+.+..++.++||||||+++|+|++|..||.+..... ......+... 
T Consensus       148 ~dfg~~~~~~~~--~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-  223 (267)
T cd08229         148 GDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQC-  223 (267)
T ss_pred             CcchhhhccccC--CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhhhhhcC-
Confidence            999998753211  112233568889999999988889999999999999999999999997543221 1111111110 


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                               ..+   .......+..+.+++.+||..||++|||+.+|++.+.++
T Consensus       224 ---------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         224 ---------DYP---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ---------CCC---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence                     001   011123456899999999999999999999999988765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=331.27  Aligned_cols=247  Identities=34%  Similarity=0.482  Sum_probs=204.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh---HHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .-|.-++.||.|+||.||-|++.       .+..+||||++.......   ...+..|+.+|++++|||+|.+.|++..+
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~-------~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre   98 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDV-------RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE   98 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeecc-------CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc
Confidence            35777888999999999999855       688999999998664443   45678899999999999999999999876


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      ...    |||||||. |+-.|.+.-.. .++-+..+..|+.+.+.||+|||+.   +.||||||..|||+++.|.|||+|
T Consensus        99 ~Ta----WLVMEYCl-GSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaD  169 (948)
T KOG0577|consen   99 HTA----WLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLAD  169 (948)
T ss_pred             chH----HHHHHHHh-ccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeecc
Confidence            544    99999994 57777775443 5799999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCccccccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      ||.|...      ....+++|||.|||||++   ..+.|+-++|||||||+..||.-.++|+...+.......   +.+.
T Consensus       170 FGSAsi~------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH---IAQN  240 (948)
T KOG0577|consen  170 FGSASIM------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQN  240 (948)
T ss_pred             ccchhhc------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH---HHhc
Confidence            9998642      334678999999999998   457899999999999999999999999987665443221   1111


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .          .|.+.   ....+..+..|+..||+.-|.+|||..+++.|
T Consensus       241 e----------sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  241 E----------SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             C----------CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            1          11111   44567889999999999999999999999876

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=311.49  Aligned_cols=253  Identities=23%  Similarity=0.337  Sum_probs=201.2

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-----hhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      ++|.+.+.||+|++|.||+|...       .++..||+|.+.....     .....+.+|+.++++++||||+++++++.
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~-------~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   74 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDV-------DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR   74 (263)
T ss_pred             CcccccceecCCCceEEEEEEEc-------CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc
Confidence            47899999999999999999854       4678899998864321     12356888999999999999999999987


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ...    ..++|+||+++++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        75 ~~~----~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l  145 (263)
T cd06625          75 DDE----TLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKL  145 (263)
T ss_pred             cCC----eEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence            654    4699999999999999997643  688999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCc-ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          234 SDFGLAREGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      +|||+++........ .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.........   ......
T Consensus       146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~  222 (263)
T cd06625         146 GDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FKIATQ  222 (263)
T ss_pred             eecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HHHhcc
Confidence            999998743211111 1112345788999999999988999999999999999999999999764332211   111110


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .             .....+...+..+.++|.+||..+|.+|||+.+++.+
T Consensus       223 ~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 P-------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             C-------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            0             0011222345678899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.9e-40  Score=314.58  Aligned_cols=267  Identities=24%  Similarity=0.411  Sum_probs=205.5

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ..++|++.+.||+|+||.||+|..+...  ....+..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDII--KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccC--CCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            3568999999999999999999875321  112456899998865432 2334678899999999999999999988655


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA--------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      .    ..++||||+++|+|.+++....        ...+++..+..++.|++.||.|||++   +++||||||+|||++.
T Consensus        82 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~  154 (288)
T cd05061          82 Q----PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAH  154 (288)
T ss_pred             C----CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcC
Confidence            4    3499999999999999996532        23456778899999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHH
Q 013790          228 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLL  306 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  306 (436)
                      ++.++|+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.+.....   ..
T Consensus       155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~  231 (288)
T cd05061         155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VL  231 (288)
T ss_pred             CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH
Confidence            99999999999875322221112222345678999999998899999999999999999998 788997654322   22


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                      ..+.....          .    ..+...+..+.+++.+||+.||++|||+.++++.|.+.+.
T Consensus       232 ~~~~~~~~----------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         232 KFVMDGGY----------L----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             HHHHcCCC----------C----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence            22111000          0    0111224679999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-41  Score=297.84  Aligned_cols=256  Identities=23%  Similarity=0.344  Sum_probs=206.4

Q ss_pred             HHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--------hHHHHHHHHHHHhccC-CCCc
Q 013790           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--------GHKQWVAEVQFLGVLE-HPNL  145 (436)
Q Consensus        75 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~-hpnI  145 (436)
                      ..+-+.|..-+.||.|..+.|-++.++       .+++.+|+|++......        ..+.-.+|+.+|+++. ||||
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k-------~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~I   85 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHK-------ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYI   85 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhc-------ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcE
Confidence            445678888899999999999999876       56778999988543211        1245677999999885 9999


Q ss_pred             eeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE
Q 013790          146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL  225 (436)
Q Consensus       146 v~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll  225 (436)
                      +.+.+++..+.    .+++|+|.|+.|.|.|+|.+.-  .+++.....|+.|+..|+.|||.+   +||||||||+|||+
T Consensus        86 I~l~D~yes~s----F~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILl  156 (411)
T KOG0599|consen   86 IDLQDVYESDA----FVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILL  156 (411)
T ss_pred             EEeeeeccCcc----hhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheee
Confidence            99999987654    3599999999999999996653  799999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeeccCCCCCCCCCCcccccccccCCCccccccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 013790          226 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET------GHLTAKSDVWSFGVVLYEMLTGRRSLERNRP  299 (436)
Q Consensus       226 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~pf~~~~~  299 (436)
                      +++.++||+|||+++..   .........+||++|+|||.+..      ..|+...|+|++|||||.|+.|.+||-....
T Consensus       157 ddn~~i~isDFGFa~~l---~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ  233 (411)
T KOG0599|consen  157 DDNMNIKISDFGFACQL---EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ  233 (411)
T ss_pred             ccccceEEeccceeecc---CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH
Confidence            99999999999999863   34455667899999999999865      3578889999999999999999999965432


Q ss_pred             hhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ......+.- ..+.             +......+.+....+||.+||+.||.+|.|+.|+|.|
T Consensus       234 mlMLR~Ime-Gkyq-------------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  234 MLMLRMIME-GKYQ-------------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHHHHHHHh-cccc-------------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            222211110 0111             1122344556778899999999999999999999987

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2e-40  Score=315.78  Aligned_cols=270  Identities=23%  Similarity=0.397  Sum_probs=202.3

Q ss_pred             cCCcccccccccCceEEEEEEecCCCC---------CCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceee
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAG---------DGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKL  148 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~---------~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~  148 (436)
                      ++|++.+.||+|+||.||++.+.....         ....+...||+|.+.... ......+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            579999999999999999986542110         122345679999987543 2334678899999999999999999


Q ss_pred             eeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCC---------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCC
Q 013790          149 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAF---------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFK  219 (436)
Q Consensus       149 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlk  219 (436)
                      ++++...+.    .++||||+.+++|.+++.....         ..+++.++..++.|++.||+|||+.   +++|+|||
T Consensus        85 ~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlk  157 (296)
T cd05095          85 LAVCITSDP----LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLA  157 (296)
T ss_pred             EEEEecCCc----cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCC
Confidence            999876553    4999999999999999865321         2467788999999999999999998   99999999


Q ss_pred             CCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCC
Q 013790          220 ASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT--GRRSLERN  297 (436)
Q Consensus       220 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~~  297 (436)
                      |+|||++.++.++|+|||+++...............++..|++||...++.++.++|||||||++|||++  |..||...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            9999999999999999999875322211111222344678999999888889999999999999999998  77888755


Q ss_pred             CchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          298 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                      .....   ............. . ..     ...+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       238 ~~~~~---~~~~~~~~~~~~~-~-~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         238 SDEQV---IENTGEFFRDQGR-Q-VY-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             ChHHH---HHHHHHHHhhccc-c-cc-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            43221   1111000000000 0 00     0111223478899999999999999999999998885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9.6e-41  Score=311.76  Aligned_cols=254  Identities=28%  Similarity=0.420  Sum_probs=203.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|+++++||+|+||.||+|...        +++.||+|.+..... ....+.+|+.+++.++||||+++++++...  
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~--------~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--   73 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN--------GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQE--   73 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC--------CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEccC--
Confidence            468999999999999999999854        457799999875543 346788999999999999999999886432  


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..+++|||+.+++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        74 ---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg  147 (260)
T cd05067          74 ---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFG  147 (260)
T ss_pred             ---CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCc
Confidence               359999999999999999765556789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      ++...... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ....+.....  
T Consensus       148 ~~~~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~--  221 (260)
T cd05067         148 LARLIEDN-EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQNLERGYR--  221 (260)
T ss_pred             ceeecCCC-CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHHcCCC--
Confidence            98653211 1111223345678999999988889999999999999999999 999997654322   2221111100  


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  366 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~  366 (436)
                              .    ..+...+..+.+++.+||..+|++||++++++..|+.
T Consensus       222 --------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 --------M----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             --------C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                    0    1112234679999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.1e-41  Score=331.93  Aligned_cols=257  Identities=23%  Similarity=0.288  Sum_probs=199.6

Q ss_pred             HHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeE
Q 013790           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGY  151 (436)
Q Consensus        75 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~  151 (436)
                      ....++|++.+.||+|+||.||++...       .+++.||+|++....   ......+.+|+.+++.++||||++++++
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~  111 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHK-------SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA  111 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            334578999999999999999999976       467889999986432   2233457889999999999999999998


Q ss_pred             eeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCce
Q 013790          152 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  231 (436)
Q Consensus       152 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  231 (436)
                      +....    ..++||||+++|+|.+++...   .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+
T Consensus       112 ~~~~~----~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~  181 (370)
T cd05621         112 FQDDK----YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHL  181 (370)
T ss_pred             EEcCC----EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCE
Confidence            87554    469999999999999999643   488999999999999999999998   99999999999999999999


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCcccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG----HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  307 (436)
                      ||+|||++...... .........||+.|+|||++.+.    .++.++|||||||++|+|++|..||........   ..
T Consensus       182 kL~DFG~a~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~---~~  257 (370)
T cd05621         182 KLADFGTCMKMDET-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT---YS  257 (370)
T ss_pred             EEEecccceecccC-CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH---HH
Confidence            99999999753211 11122456799999999999654    378899999999999999999999986543221   11


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD--RPKMSQVVER  363 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~  363 (436)
                      .+.....           .+........+..+.+++..||..++..  |+++.+++++
T Consensus       258 ~i~~~~~-----------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         258 KIMDHKN-----------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHHhCCc-----------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            1111000           0000111223567889999999865543  8899999887

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.7e-41  Score=311.05  Aligned_cols=251  Identities=25%  Similarity=0.358  Sum_probs=202.5

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      +|++.+.||.|+||.||++...       .++..||+|.++.. .....+.+.+|+.+++.++||||+++++.+...+  
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   71 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHV-------NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG--   71 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEc-------CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--
Confidence            5888999999999999999865       46788999988643 2334567888999999999999999999886554  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..+++|||+++++|.+++.......+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+
T Consensus        72 --~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~  146 (255)
T cd08219          72 --HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGS  146 (255)
T ss_pred             --EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCc
Confidence              469999999999999998765555789999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  318 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  318 (436)
                      +.....  .........|+..|+|||++.+..++.++|+||||+++|+|++|..||........   ...+.....    
T Consensus       147 ~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~~~----  217 (255)
T cd08219         147 ARLLTS--PGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---ILKVCQGSY----  217 (255)
T ss_pred             ceeecc--cccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---HHHHhcCCC----
Confidence            875321  12222345688999999999888899999999999999999999999986543221   111111000    


Q ss_pred             cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       319 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                ...+...+..+.+||.+||..||++|||+.+|+..
T Consensus       218 ----------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 ----------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ----------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                      01122234578899999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-40  Score=316.07  Aligned_cols=271  Identities=25%  Similarity=0.414  Sum_probs=202.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCC-------CCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAA-------GDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLI  149 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-------~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~  149 (436)
                      .++|++.+.||+|+||.||++......       .........||+|.+..... .....+.+|++++++++||||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            358999999999999999998764211       00112345699999876532 2345688999999999999999999


Q ss_pred             eEeeecCCcceeEEEEEEecCCCCHHHHhhcCC----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCC
Q 013790          150 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA----------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFK  219 (436)
Q Consensus       150 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlk  219 (436)
                      +++...+.    .++||||+.+++|.+++....          ...+++..++.++.|++.||.|||+.   +++|+|||
T Consensus        84 ~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk  156 (295)
T cd05097          84 GVCVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLA  156 (295)
T ss_pred             EEEcCCCc----cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccC
Confidence            99876543    599999999999999986432          12468889999999999999999998   99999999


Q ss_pred             CCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCC
Q 013790          220 ASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT--GRRSLERN  297 (436)
Q Consensus       220 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~~  297 (436)
                      |+||+++.++.+||+|||++................++..|+|||.+.++.++.++|||||||++|+|++  |..||...
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            9999999999999999999875322221122223345678999999988889999999999999999998  66788764


Q ss_pred             CchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          298 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                      ....   .......+......   ...    ...+...+..+.+|+.+||+.||++|||+.+|++.|.
T Consensus       237 ~~~~---~~~~~~~~~~~~~~---~~~----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         237 SDEQ---VIENTGEFFRNQGR---QIY----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ChHH---HHHHHHHhhhhccc---ccc----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            4322   11111111000000   000    0011123467999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.7e-40  Score=310.36  Aligned_cols=256  Identities=23%  Similarity=0.333  Sum_probs=191.6

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      +.||+|+||.||+|.+.     +..++..+|+|.+..... .....+.+|+.+++.++||||+++++++.....    .+
T Consensus         1 ~~lg~G~~g~Vy~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~   71 (269)
T cd05087           1 KEIGNGWFGKVILGEVN-----SGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP----YL   71 (269)
T ss_pred             CcccccCCceEEEEEEc-----CCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC----cE
Confidence            36999999999999875     223567899998875532 233568889999999999999999998876543    48


Q ss_pred             EEEEecCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          164 LVYEFMLNRSLEDHLFNRA---FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      +||||+++|+|.+++....   ....++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++
T Consensus        72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~  148 (269)
T cd05087          72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSH  148 (269)
T ss_pred             EEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccc
Confidence            9999999999999997532   22456778889999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCcccccccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETG-------HLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      ...............++..|+|||++.+.       .++.++||||||+++|||++ |..||...........  .+...
T Consensus       149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~--~~~~~  226 (269)
T cd05087         149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY--TVREQ  226 (269)
T ss_pred             cccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH--Hhhcc
Confidence            43222111122334567889999998542       35789999999999999996 9999976544322111  01100


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                      ..      .+..+.+    ....+..+.+++..|| .+|++|||+.+|+..|+
T Consensus       227 ~~------~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         227 QL------KLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cC------CCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00      0111111    1123456889999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.6e-41  Score=329.86  Aligned_cols=270  Identities=24%  Similarity=0.322  Sum_probs=200.8

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|++++.||+|+||.||+|...       .+++.||+|.+...  .....+.+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   73 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDP-------RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI   73 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEEC-------CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc
Confidence            5888999999999999999864       46788999998653  22344678899999999999999999999876542


Q ss_pred             c-ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          158 R-GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       158 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      . ....++||||+. ++|.+++...  ..+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+||
T Consensus        74 ~~~~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Df  147 (372)
T cd07853          74 DPFEEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDF  147 (372)
T ss_pred             cccceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccc
Confidence            1 125699999995 6888888554  3689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |+++..... .........++..|+|||++.+. .++.++|||||||++|||++|+.||.+..+......+......+..
T Consensus       148 g~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~  226 (372)
T cd07853         148 GLARVEEPD-ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL  226 (372)
T ss_pred             cceeecccC-ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence            999753211 11222334678899999998774 5789999999999999999999999876554322221111110000


Q ss_pred             ccc------c-cccc-----CCcccC--cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKK------F-GLIM-----DPRLEK--EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~------~-~~~~-----~~~l~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...      . ..+.     .+....  ......+..+.+||.+||+.||.+|||+.+++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            000      0 0000     000000  0111224678899999999999999999999886

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.3e-41  Score=316.67  Aligned_cols=251  Identities=26%  Similarity=0.423  Sum_probs=198.7

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      |+..+.||.|+||.||+|.+.       .+++.||+|.+......   ....+.+|+.+++.++|+||+.+++.+...+ 
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-   73 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVR-------ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-   73 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEC-------CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC-
Confidence            677889999999999999875       46789999998654322   2345778999999999999999998886544 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..+++|||+.+++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        74 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg  147 (285)
T cd05632          74 ---ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLG  147 (285)
T ss_pred             ---EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCC
Confidence               469999999999999998765555799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL-EWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~~~~~~~~~  316 (436)
                      ++.....   ........|+..|+|||.+.+..++.++|+||||+++|+|++|..||............ ..+....   
T Consensus       148 ~~~~~~~---~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~---  221 (285)
T cd05632         148 LAVKIPE---GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE---  221 (285)
T ss_pred             cceecCC---CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc---
Confidence            9864221   11123456899999999998889999999999999999999999999865432221111 1111100   


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  363 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~  363 (436)
                              .    .++...+..+.+|+..||+.||.+||+     +.+++.+
T Consensus       222 --------~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         222 --------E----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             --------c----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence                    0    111223456789999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1e-40  Score=317.76  Aligned_cols=252  Identities=23%  Similarity=0.373  Sum_probs=204.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ..+|++.+.||+|+||.||+|...       .++..|++|.+........+.+.+|+.+++.+.||||+++++.+.... 
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~-   90 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDV-------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-   90 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEEC-------CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC-
Confidence            358999999999999999999854       467889999998766566678889999999999999999999887644 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+++++|.+++...   .+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.++|+|||
T Consensus        91 ---~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg  161 (296)
T cd06654          91 ---ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  161 (296)
T ss_pred             ---EEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccc
Confidence               469999999999999998543   578999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ++.....  .........+++.|+|||.+.+..++.++|||||||++|+|++|..||....+...  ..... ....   
T Consensus       162 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~-~~~~---  233 (296)
T cd06654         162 FCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIA-TNGT---  233 (296)
T ss_pred             cchhccc--cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHh-cCCC---
Confidence            9874221  11122334688999999999888889999999999999999999999976544221  11111 0000   


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                             +.  ...+...+..+.+++.+||..||++||++.+|+.+
T Consensus       234 -------~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         234 -------PE--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             -------CC--CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence                   00  01122334678899999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.3e-41  Score=326.72  Aligned_cols=250  Identities=24%  Similarity=0.394  Sum_probs=192.8

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhcc-CCCCceeeeeEeeecCCcce
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  160 (436)
                      +.||+|+||.||+|...       .+++.||+|++.....   ...+.+.+|+.++.++ +||||+.+++++...+    
T Consensus         1 ~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----   69 (327)
T cd05617           1 RVIGRGSYAKVLLVRLK-------KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS----   69 (327)
T ss_pred             CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC----
Confidence            46999999999999875       4678899999976432   2335577899998888 5999999999886554    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++||||+++|+|..++...  ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~  144 (327)
T cd05617          70 RLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCK  144 (327)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccce
Confidence            469999999999999988654  3699999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ...  ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.............++...        
T Consensus       145 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~--------  214 (327)
T cd05617         145 EGL--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV--------  214 (327)
T ss_pred             ecc--CCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH--------
Confidence            421  1122234567999999999999999999999999999999999999999643221111111111000        


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH------HHHHHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM------SQVVER  363 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~  363 (436)
                       +.....  ..+...+..+.+++.+||..||.+|+++      .+++.+
T Consensus       215 -~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         215 -ILEKPI--RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             -HHhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence             000000  1122234668899999999999999985      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.1e-40  Score=326.79  Aligned_cols=267  Identities=23%  Similarity=0.287  Sum_probs=201.2

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      ..++|.+.+.||+|+||.||+|...       ..++.||||++....  ......+.+|+.+++.++||||+++++++..
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~   94 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDA-------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP   94 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEEC-------CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecc
Confidence            4578999999999999999999865       467889999987542  2334567889999999999999999998765


Q ss_pred             cCC--cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          155 DGE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       155 ~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      ...  .....|+||||+. ++|.+++..    .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k  166 (364)
T cd07875          95 QKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK  166 (364)
T ss_pred             cccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEE
Confidence            331  2234699999995 578777742    478899999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |+|||+++...   .........||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+......  ..+...
T Consensus       167 L~DfG~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~--~~~~~~  241 (364)
T cd07875         167 ILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN--KVIEQL  241 (364)
T ss_pred             EEeCCCccccC---CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhc
Confidence            99999997521   2222334578999999999999999999999999999999999999998655432211  111111


Q ss_pred             ccCcc------------------c-----cccccCCcc---cCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSK------------------K-----FGLIMDPRL---EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~------------------~-----~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .....                  .     +..+....+   ...........+.+||.+||..||.+|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            10000                  0     000000000   000111123578899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-42  Score=328.17  Aligned_cols=268  Identities=28%  Similarity=0.429  Sum_probs=220.7

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ...+...-.+||-|-||.||.|.|+       .-...||||.++.+. -..+.|..|+.+|+.++|||+|+++|+|..+.
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWK-------kyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeee-------ccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            3445666779999999999999998       455679999997664 45678999999999999999999999998876


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      ..    |||+|||..|+|.+||++.....++....+.++.||..||.||..+   ++|||||...|+|+.++-.+|++||
T Consensus       337 PF----YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADF  409 (1157)
T KOG4278|consen  337 PF----YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADF  409 (1157)
T ss_pred             Ce----EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeecc
Confidence            54    9999999999999999988877888889999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCccccc-ccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 013790          237 GLAREGPMVGHTHVST-AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |+++.+.  +.+.... ...-...|.|||-+....++.++|||+|||+||||.| |..||.+.+-.....+++       
T Consensus       410 GLsRlMt--gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-------  480 (1157)
T KOG4278|consen  410 GLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-------  480 (1157)
T ss_pred             chhhhhc--CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-------
Confidence            9999743  2221111 1223568999999999999999999999999999999 888987654322222222       


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcCCCCCCc
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFD  378 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~~~~~~  378 (436)
                                ..++-..+..|++...+|+..||+++|.+||++.+|-+.|+.+++.....+...
T Consensus       481 ----------kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisdEV~  534 (1157)
T KOG4278|consen  481 ----------KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISDEVQ  534 (1157)
T ss_pred             ----------ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccHHHH
Confidence                      122223456677899999999999999999999999999999987766544433

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2e-40  Score=312.26  Aligned_cols=246  Identities=22%  Similarity=0.401  Sum_probs=190.6

Q ss_pred             cccccCceEEEEEEecCCC-----------------CCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceee
Q 013790           86 KIGEGGFGSVYKSSIKPAA-----------------GDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKL  148 (436)
Q Consensus        86 ~ig~G~~g~Vy~~~~~~~~-----------------~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~  148 (436)
                      .||+|+||.||+|.+....                 ..+......|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            6999999999999864211                 11223446799999876654445678889999999999999999


Q ss_pred             eeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC
Q 013790          149 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN  228 (436)
Q Consensus       149 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  228 (436)
                      ++++.....    .++||||+++|+|..++.... ..+++..+..++.|++.||+|||++   +|+||||||+|||++..
T Consensus        82 ~~~~~~~~~----~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~  153 (274)
T cd05076          82 HGVCVRGSE----NIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL  153 (274)
T ss_pred             EEEEEeCCc----eEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence            999976553    499999999999999986533 4689999999999999999999998   99999999999999764


Q ss_pred             C-------ceEEeeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCc
Q 013790          229 F-------RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEML-TGRRSLERNRP  299 (436)
Q Consensus       229 ~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell-tg~~pf~~~~~  299 (436)
                      +       .+|++|||++.....      .....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||....+
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             CcccCccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence            4       389999998864211      122347788999998865 56899999999999999985 69999976654


Q ss_pred             hhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                      ........   ...            .+...    ....+.++|.+||+.+|.+|||+.+|++.|
T Consensus       228 ~~~~~~~~---~~~------------~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         228 SEKERFYE---KKH------------RLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHHHHHH---hcc------------CCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            33222111   100            00011    124688999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.4e-40  Score=310.41  Aligned_cols=262  Identities=24%  Similarity=0.417  Sum_probs=204.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|+..+.||+|+||.||+|.....    ......+|+|.+.... ....+.+..|+.+++.++||||+++++++...+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMP----GRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK   79 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecC----CCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence            35788889999999999999987621    1234589999987553 334567889999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      .    .++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+||
T Consensus        80 ~----~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df  151 (268)
T cd05063          80 P----AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDF  151 (268)
T ss_pred             C----cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCC
Confidence            3    499999999999999996543 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCccc-ccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 013790          237 GLAREGPMVGHTHV-STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |++........... ......+..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ....+.... 
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i~~~~-  227 (268)
T cd05063         152 GLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAINDGF-  227 (268)
T ss_pred             ccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHhcCC-
Confidence            99875322111111 111223457999999988889999999999999999998 999997654322   222221100 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                                   ....+...+..+.+++.+||..+|++||++.+|++.|++++
T Consensus       228 -------------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         228 -------------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             -------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                         00111223467889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.8e-40  Score=311.47  Aligned_cols=260  Identities=27%  Similarity=0.438  Sum_probs=203.2

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|.+.+.||+|+||.||+|.+...    ...+..||+|.+... .......+..|+.+++.++||||+++++++.... 
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLP----GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR-   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecC----CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC-
Confidence            4688899999999999999997622    123467999998754 2334567899999999999999999999986554 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        79 ---~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg  151 (269)
T cd05065          79 ---PVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFG  151 (269)
T ss_pred             ---ceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCc
Confidence               3599999999999999987543 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccc-cc--cCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcc
Q 013790          238 LAREGPMVGHTHVSTA-VV--GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      ++.............. ..  .+..|+|||.+.+..++.++|||||||++||+++ |..||......   ....++....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~~  228 (269)
T cd05065         152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQDY  228 (269)
T ss_pred             cccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCC
Confidence            9864322111111111 11  2357999999998899999999999999999887 99999765433   2222222110


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                      .              ...+...+..+.+++.+||..+|++||++.+|+..|+++
T Consensus       229 ~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 R--------------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             c--------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0              011122346788999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.3e-40  Score=308.98  Aligned_cols=260  Identities=25%  Similarity=0.380  Sum_probs=206.0

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC---cchhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|++.+.||+|+||.||+|...       .+++.||+|.+...   .....+.+.+|+.++++++|+||+++++++...
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~   74 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICL-------LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN   74 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEc-------CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence            57999999999999999999875       46788999988643   222346788999999999999999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      +    ..++||||+++++|..++...  ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        75 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l  147 (267)
T cd08224          75 N----ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             C----eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEE
Confidence            4    359999999999999998642  234689999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +|||++.....  .........++..|+|||.+.+..++.++||||||+++|+|++|..||...... ........... 
T Consensus       148 ~d~~~~~~~~~--~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-  223 (267)
T cd08224         148 GDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEKC-  223 (267)
T ss_pred             eccceeeeccC--CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhhhhcC-
Confidence            99999874321  111223356888999999998888999999999999999999999999654321 11111111100 


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                              ...+    ......+..+.++|.+||..+|++|||+.+|++.|+++.
T Consensus       224 --------~~~~----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         224 --------DYPP----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             --------CCCC----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                    0000    001134567889999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-40  Score=331.20  Aligned_cols=264  Identities=23%  Similarity=0.265  Sum_probs=196.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ...|.+.+.||+|+||.||+|.+.       ..++.||||....      ..+.+|+.++++++||||+++++++...+ 
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~-------~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~-  233 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHP-------DYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGG-  233 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEEC-------CCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECC-
Confidence            457999999999999999999875       4578899996432      24567999999999999999999987654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++|||++ .++|..++.... ..+++..++.|+.||+.||.|||+.   +|+||||||+||||+.++.+||+|||
T Consensus       234 ---~~~lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFG  305 (461)
T PHA03211        234 ---LTCLVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFG  305 (461)
T ss_pred             ---EEEEEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccC
Confidence               358999999 579999886543 3699999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----hhHHHHHHHhhc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK-----TEQRLLEWVQQY  312 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-----~~~~~~~~~~~~  312 (436)
                      +++...............||..|+|||++.+..++.++|||||||++|||++|..|+......     ....+...+...
T Consensus       306 la~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~  385 (461)
T PHA03211        306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA  385 (461)
T ss_pred             CceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence            997532221122223456999999999999999999999999999999999988765432211     111222222211


Q ss_pred             ccCccccccc----------------cCCcccCcC---CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLI----------------MDPRLEKEY---SINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~----------------~~~~l~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ......+...                ..+......   .......+.+||.+||+.||.+|||+.|+|++
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        386 QVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             ccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            1100000000                000000000   00123468899999999999999999999986

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.2e-41  Score=313.75  Aligned_cols=255  Identities=23%  Similarity=0.367  Sum_probs=201.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|.+.+.||+|+||.||+|...       .+++.||+|.+..........+.+|+.+++.++||||+++++.+...+ 
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~-   79 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNV-------NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD-   79 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEc-------CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-
Confidence            357899999999999999999865       467889999987665555567888999999999999999999887654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        80 ---~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd06645          80 ---KLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFG  151 (267)
T ss_pred             ---EEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcce
Confidence               4599999999999999986543  689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ++....  ..........|+..|+|||++.   ...++.++|||||||++|+|++|..||....+......  .....  
T Consensus       152 ~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~--~~~~~--  225 (267)
T cd06645         152 VSAQIT--ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--MTKSN--  225 (267)
T ss_pred             eeeEcc--CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh--hhccC--
Confidence            986432  1122223457899999999974   45688899999999999999999999965443221111  00000  


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                             ...+.+..  ....+..+.++|.+||..||++||++.+|+++
T Consensus       226 -------~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         226 -------FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             -------CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence                   00011100  11224568899999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2e-40  Score=317.52  Aligned_cols=264  Identities=25%  Similarity=0.373  Sum_probs=202.0

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|++.+.||+|+||.||++.+.       .++..+|+|.+.... ......+.+|+++++.++||||+++++++...+ 
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   72 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHR-------PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG-   72 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEc-------CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-
Confidence            47999999999999999999865       467889999987542 223456888999999999999999999997655 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.  .+++|+||||+|||++.++.++|+|||
T Consensus        73 ---~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg  145 (308)
T cd06615          73 ---EISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFG  145 (308)
T ss_pred             ---EEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCC
Confidence               459999999999999999654  4689999999999999999999973  189999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ++.....    .......|+..|+|||.+.+..++.++||||||+++|+|++|..||........   ..+.........
T Consensus       146 ~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~  218 (308)
T cd06615         146 VSGQLID----SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVSEGE  218 (308)
T ss_pred             Ccccccc----cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCcccccc
Confidence            9864311    122345688999999999888899999999999999999999999975443221   111111100000


Q ss_pred             c-----------------------cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          318 K-----------------------FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       318 ~-----------------------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                      .                       ...+.............+..+.+|+.+||..||++||++.+|+.+.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         219 AKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             ccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            0                       0000000000000011345789999999999999999999998873

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-40  Score=310.02  Aligned_cols=252  Identities=30%  Similarity=0.474  Sum_probs=195.0

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhcc-CCCCceeeeeEeeecCCcceeE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGIQR  162 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~  162 (436)
                      +.||+|+||.||+|...     .......+++|.+.... ....+.+.+|+.++.++ +||||+++++++...+.    .
T Consensus         1 ~~lg~g~~g~v~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~----~   71 (270)
T cd05047           1 DVIGEGNFGQVLKARIK-----KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY----L   71 (270)
T ss_pred             CcCCCCCCceEEEEEEc-----CCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC----c
Confidence            36899999999999876     11223467888887432 23446788999999999 79999999999876553    4


Q ss_pred             EEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC
Q 013790          163 LLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN  228 (436)
Q Consensus       163 ~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  228 (436)
                      ++||||+++|+|.+++....              ...+++..+..++.|++.||+|||+.   +++|+||||+|||++.+
T Consensus        72 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~  148 (270)
T cd05047          72 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  148 (270)
T ss_pred             eEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCC
Confidence            99999999999999996532              12478999999999999999999998   99999999999999999


Q ss_pred             CceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHH
Q 013790          229 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       229 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~  307 (436)
                      +.+||+|||++....   ..........+..|+|||++.+..++.++||||||+++|+|++ |..||.......   ...
T Consensus       149 ~~~kl~dfgl~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~  222 (270)
T cd05047         149 YVAKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE  222 (270)
T ss_pred             CeEEECCCCCccccc---hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHH
Confidence            999999999985311   1111112233567999999988889999999999999999997 999997543322   111


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                      .+   +..           .....+...+..+.+|+.+||..||.+|||+.+++..|..++
T Consensus       223 ~~---~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         223 KL---PQG-----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HH---hCC-----------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            11   110           000111223457889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.5e-41  Score=322.67  Aligned_cols=238  Identities=29%  Similarity=0.433  Sum_probs=187.5

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHH-HHhccCCCCceeeeeEeeecCCcce
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQ-FLGVLEHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~~  160 (436)
                      +.||+|+||.||+|...       .+++.||+|++.....   .....+..|.. +++.++||||+++++++...+    
T Consensus         1 ~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~----   69 (323)
T cd05575           1 KVIGKGSFGKVLLAKHK-------ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD----   69 (323)
T ss_pred             CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC----
Confidence            46999999999999975       5678999999875422   12233444544 567899999999999887654    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++||||+.+|+|..++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~  144 (323)
T cd05575          70 KLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK  144 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCc
Confidence            459999999999999998654  3689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ...  ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+...+       
T Consensus       145 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~-------  212 (323)
T cd05575         145 EGI--EHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYDNILNKP-------  212 (323)
T ss_pred             ccc--cCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---HHHHHHcCC-------
Confidence            421  12222344578999999999999999999999999999999999999998654322   111111110       


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS  358 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  358 (436)
                          ..+    ....+..+.++|.+||+.||.+||++.
T Consensus       213 ----~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 ----LRL----KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ----CCC----CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence                001    112246788999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.5e-41  Score=325.28  Aligned_cols=243  Identities=26%  Similarity=0.392  Sum_probs=192.7

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCCceeeeeEeeecCCccee
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  161 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  161 (436)
                      ++.||+|+||.||++....    +..+++.||+|++......  ....+..|+.++++++||||+++++++...+    .
T Consensus         1 l~~lg~G~~g~Vy~~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~   72 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKIT----GPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG----K   72 (318)
T ss_pred             CceeeeCCCEEEEEEEEec----cCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC----E
Confidence            3579999999999987531    2246789999999754322  2345678999999999999999999987654    4


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          162 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       162 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      .|+||||+.+|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        73 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  147 (318)
T cd05582          73 LYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE  147 (318)
T ss_pred             EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence            59999999999999999654  3689999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 013790          242 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  321 (436)
Q Consensus       242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (436)
                      ...  .........|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......   ....+....        
T Consensus       148 ~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~i~~~~--------  214 (318)
T cd05582         148 SID--HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TMTMILKAK--------  214 (318)
T ss_pred             cCC--CCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HHHHHHcCC--------
Confidence            321  1122334678999999999998889999999999999999999999998654322   111111100        


Q ss_pred             ccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 013790          322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ  359 (436)
Q Consensus       322 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  359 (436)
                         .    ..+...+..+.+||.+||+.||.+||++.+
T Consensus       215 ---~----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 ---L----GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             ---C----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence               0    111223467889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2e-40  Score=313.44  Aligned_cols=251  Identities=25%  Similarity=0.419  Sum_probs=200.4

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcce
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  160 (436)
                      |++.+.||.|+||.||+|...       .++..+++|.+........+.+.+|+.+++.++||||+++++++...+    
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~----   75 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNK-------ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN----   75 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEEC-------CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC----
Confidence            678889999999999999865       467889999987665556677889999999999999999999987654    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++||||+++++|..++.+.. .++++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++.
T Consensus        76 ~~~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~  151 (282)
T cd06643          76 NLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSA  151 (282)
T ss_pred             EEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccc
Confidence            4599999999999999886533 4689999999999999999999998   99999999999999999999999999986


Q ss_pred             CCCCCCCcccccccccCCCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ...  ..........++..|+|||++.     +..++.++|||||||++|+|++|..||....+..  .........+. 
T Consensus       152 ~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~~~~~~-  226 (282)
T cd06643         152 KNT--RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKIAKSEPP-  226 (282)
T ss_pred             ccc--ccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHHhhcCCC-
Confidence            532  1122233456889999999983     4567789999999999999999999997654321  11111111100 


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                .+  ..+...+..+.+||.+||+.||.+||++.+++++
T Consensus       227 ----------~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         227 ----------TL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ----------CC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      00  1112234678999999999999999999998766

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.9e-40  Score=314.00  Aligned_cols=253  Identities=26%  Similarity=0.405  Sum_probs=202.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      +.|++++.||.|+||.||+|...       .++..|++|.+........+.+.+|+.+++.++||||+++++.+..++  
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   82 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNK-------ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG--   82 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEEC-------CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC--
Confidence            57999999999999999999865       467889999998776666678889999999999999999999987655  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..++||||+++++|..++.+.. ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        83 --~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~  156 (292)
T cd06644          83 --KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGV  156 (292)
T ss_pred             --eEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCcc
Confidence              3599999999999998876543 4689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +....  ..........++..|+|||++.     ...++.++|||||||++|+|++|..||....+..  ..........
T Consensus       157 ~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~  232 (292)
T cd06644         157 SAKNV--KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIAKSEP  232 (292)
T ss_pred             ceecc--ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHHHHhcCCC
Confidence            86421  1122223456888999999984     3456789999999999999999999997654321  1111111100


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                 +.  ...+...+..+.++|.+||..||++||++.+++++
T Consensus       233 -----------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         233 -----------PT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             -----------cc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                       00  01122334578899999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.3e-40  Score=307.39  Aligned_cols=253  Identities=28%  Similarity=0.393  Sum_probs=200.8

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ++|.+...||+|+||.||+|.+.        ....+|+|.+.... ...+.+.+|+.+++.++||||+++++++...   
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~--------~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   73 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWN--------GTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE---   73 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEc--------CCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCC---
Confidence            56889999999999999999865        23458999876543 2346788899999999999999999887432   


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..+++|||+.+++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||+
T Consensus        74 --~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~  148 (260)
T cd05069          74 --PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGL  148 (260)
T ss_pred             --CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCcc
Confidence              248999999999999999765555689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      +....... ........++..|+|||.+.+..++.++||||||+++|+|+| |..||.+..+..   ...+......   
T Consensus       149 ~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~---  221 (260)
T cd05069         149 ARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVERGYR---  221 (260)
T ss_pred             ceEccCCc-ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCC---
Confidence            87432111 111122345678999999988889999999999999999999 999997654322   2222211100   


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  366 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~  366 (436)
                                 ...+...+..+.+++.+||..||.+||++.+|++.|++
T Consensus       222 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 -----------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -----------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                       01122345779999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.8e-41  Score=330.60  Aligned_cols=254  Identities=25%  Similarity=0.353  Sum_probs=197.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|+.++.||+|+||.||++..+       .+++.||+|++....   ......+.+|+.++..++||||+++++.+...
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   73 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKK-------DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK   73 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            47899999999999999999875       467899999986532   22345678899999999999999999988655


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   ||+||||||+||||+.++.++|+|
T Consensus        74 ~----~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~D  144 (360)
T cd05627          74 R----NLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSD  144 (360)
T ss_pred             C----EEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEee
Confidence            4    469999999999999999654  3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCC---------------------------------cccccccccCCCcccccccccCCCCchhhHHHHHH
Q 013790          236 FGLAREGPMVGH---------------------------------THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGV  282 (436)
Q Consensus       236 fg~a~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv  282 (436)
                      ||+++.......                                 ........||+.|+|||++.+..++.++|||||||
T Consensus       145 fG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGv  224 (360)
T cd05627         145 FGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV  224 (360)
T ss_pred             ccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccc
Confidence            999864211100                                 00112347999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC---HHH
Q 013790          283 VLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK---MSQ  359 (436)
Q Consensus       283 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~e  359 (436)
                      ++|||++|..||....+.....   .+......   .  .+.+    .  ...+..+.+||.+|+ .||.+|++   +.+
T Consensus       225 ilyel~tG~~Pf~~~~~~~~~~---~i~~~~~~---~--~~p~----~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  289 (360)
T cd05627         225 IMYEMLIGYPPFCSETPQETYR---KVMNWKET---L--VFPP----E--VPISEKAKDLILRFC-TDSENRIGSNGVEE  289 (360)
T ss_pred             eeeecccCCCCCCCCCHHHHHH---HHHcCCCc---e--ecCC----C--CCCCHHHHHHHHHhc-cChhhcCCCCCHHH
Confidence            9999999999998765433211   11110000   0  0011    0  112457788998877 49999995   677


Q ss_pred             HHHH
Q 013790          360 VVER  363 (436)
Q Consensus       360 il~~  363 (436)
                      ++.|
T Consensus       290 i~~h  293 (360)
T cd05627         290 IKSH  293 (360)
T ss_pred             HhcC
Confidence            7765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.3e-40  Score=308.68  Aligned_cols=247  Identities=20%  Similarity=0.350  Sum_probs=191.6

Q ss_pred             ccccccCceEEEEEEecCCCCC-----CCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcc
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGD-----GTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  159 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  159 (436)
                      +.||+|+||.||+|++.....+     .......|++|.+..........+.+|+.+++.++||||+++++++.....  
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~--   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE--   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC--
Confidence            3689999999999987532211     123455789999876655555678889999999999999999999876554  


Q ss_pred             eeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc-------eE
Q 013790          160 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR-------PK  232 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~k  232 (436)
                        .++||||+.+|+|..++.... ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.       ++
T Consensus        79 --~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          79 --NIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             --CEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence              389999999999999886543 4689999999999999999999998   9999999999999987664       89


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCchhhHHHHHHHh
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEML-TGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell-tg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      ++|||++....      ......++..|+|||.+. +..++.++|||||||++|+|+ +|..||..........+.   .
T Consensus       153 l~d~g~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~  223 (262)
T cd05077         153 LSDPGIPITVL------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY---E  223 (262)
T ss_pred             eCCCCCCcccc------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---h
Confidence            99999986421      112345788999999986 467889999999999999998 588888754332211110   0


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                      ..              .  ......+..+.+||.+||+.||.+||++.+|++.|
T Consensus       224 ~~--------------~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         224 GQ--------------C--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             cC--------------c--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            00              0  00111235788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.6e-41  Score=329.23  Aligned_cols=262  Identities=24%  Similarity=0.284  Sum_probs=201.4

Q ss_pred             HHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCcee
Q 013790           71 YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVK  147 (436)
Q Consensus        71 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~  147 (436)
                      ..++....++|++.+.||+|+||.||+|.++       .+++.||+|++....   ......+.+|+.+++.++||||++
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~-------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~  107 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ  107 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEEC-------CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence            3444555689999999999999999999876       567899999986432   122345778999999999999999


Q ss_pred             eeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          148 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       148 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      +++.+....    ..++||||+++|+|.+++...   .+++..+..++.||+.||.|||+.   +|+||||||+|||++.
T Consensus       108 ~~~~~~~~~----~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~  177 (371)
T cd05622         108 LFYAFQDDR----YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDK  177 (371)
T ss_pred             EEEEEEcCC----EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECC
Confidence            999886543    469999999999999998653   488899999999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 013790          228 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG----HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ  303 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~  303 (436)
                      ++.+||+|||+++..... .........||+.|+|||++.+.    .++.++|||||||++|+|++|..||...+.... 
T Consensus       178 ~~~ikL~DfG~a~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-  255 (371)
T cd05622         178 SGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-  255 (371)
T ss_pred             CCCEEEEeCCceeEcCcC-CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-
Confidence            999999999999753211 11223356799999999998653    378899999999999999999999986544221 


Q ss_pred             HHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHHH
Q 013790          304 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD--RPKMSQVVERL  364 (436)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~L  364 (436)
                        ...+.....           .+........+..+.+||..||..++.+  |+++.+|+++.
T Consensus       256 --~~~i~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         256 --YSKIMNHKN-----------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             --HHHHHcCCC-----------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence              111111000           0000111223467889999999844433  77999998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.4e-40  Score=316.44  Aligned_cols=201  Identities=27%  Similarity=0.412  Sum_probs=162.0

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      .++||+|+||.||+|..+     +..+++.||+|.+.....  ...+.+|+.+++.++||||+++++++.....  ...+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~-----~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~~~   76 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRK-----DGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHAD--RKVW   76 (317)
T ss_pred             ccccccCCCeEEEEEEEc-----cCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCC--cEEE
Confidence            468999999999999875     234568899999875432  2456789999999999999999998865433  2568


Q ss_pred             EEEEecCCCCHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE----cCCCceE
Q 013790          164 LVYEFMLNRSLEDHLFNR-------AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPK  232 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~k  232 (436)
                      ++|||+ +++|.+++...       ....+++..+..++.||+.||.|||++   +|+||||||+|||+    +.++.+|
T Consensus        77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~k  152 (317)
T cd07868          77 LLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK  152 (317)
T ss_pred             EEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEE
Confidence            999998 46888887532       123589999999999999999999998   99999999999999    4668899


Q ss_pred             EeeccCCCCCCCCC-CcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 013790          233 LSDFGLAREGPMVG-HTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERN  297 (436)
Q Consensus       233 l~Dfg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~  297 (436)
                      |+|||+++...... .........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...
T Consensus       153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             EeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            99999997532111 1112234578999999999876 45899999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-40  Score=310.37  Aligned_cols=263  Identities=24%  Similarity=0.395  Sum_probs=206.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..+|++.+.||+|+||.||+|.++..   +......+|+|.+..... .....+.+|+.++..++||||+++++++.. .
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~---~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPE---GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecC---CCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            35789999999999999999997621   122345799998876543 334678899999999999999999999875 2


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+||
T Consensus        82 ----~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~df  153 (279)
T cd05057          82 ----QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDF  153 (279)
T ss_pred             ----ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCC
Confidence                3589999999999999997653 3589999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |+++...............++..|+|||.+....++.++||||||+++||+++ |..||.......   +...+..... 
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~-  229 (279)
T cd05057         154 GLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLLEKGER-  229 (279)
T ss_pred             cccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhCCCC-
Confidence            99975432211111122224568999999988889999999999999999999 999998764432   2222211100 


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                                   ...+..++..+.+++.+||..||.+||++.++++.|.++..
T Consensus       230 -------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 -------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                         01111223568899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=308.40  Aligned_cols=255  Identities=29%  Similarity=0.421  Sum_probs=203.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.+.||+|+||.||+|...        +++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.... 
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~--------~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   74 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN--------GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE-   74 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc--------CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCC-
Confidence            468999999999999999999864        346799999875433 3467889999999999999999999886544 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+++++|.+++.......+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||
T Consensus        75 ---~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g  148 (261)
T cd05034          75 ---PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFG  148 (261)
T ss_pred             ---ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccc
Confidence               359999999999999999876555789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      ++...... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.....   ....+.....  
T Consensus       149 ~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~~~~--  222 (261)
T cd05034         149 LARLIEDD-EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVERGYR--  222 (261)
T ss_pred             cceeccch-hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCC--
Confidence            98753211 1111122334568999999998889999999999999999999 999997654322   2222111100  


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  366 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~  366 (436)
                                  ...+...+..+.+++.+||..+|++||++.++++.|+.
T Consensus       223 ------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 ------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                        01111224678999999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.8e-40  Score=313.37  Aligned_cols=251  Identities=26%  Similarity=0.379  Sum_probs=196.7

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|++.+.||+|+||.||+|...       .+++.||+|.+.... ......+.+|+.++.+++||||+++++++...+.
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   73 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHL-------LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR   73 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEc-------CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE
Confidence            36888999999999999999865       567889999986542 2334568899999999999999999999977553


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .++||||+++++|..+.      .+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.++|+|||
T Consensus        74 ----~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg  140 (279)
T cd06619          74 ----ISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFG  140 (279)
T ss_pred             ----EEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCC
Confidence                48999999999997652      478889999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~  316 (436)
                      ++....    ........|+..|+|||.+.+..++.++||||||+++|+|++|..||.......... ........... 
T Consensus       141 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  215 (279)
T cd06619         141 VSTQLV----NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-  215 (279)
T ss_pred             cceecc----cccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-
Confidence            987431    112234578999999999998889999999999999999999999997533221110 00100000000 


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                            ..+.+   .....+..+.++|.+||+.||.+||++.+++++
T Consensus       216 ------~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         216 ------DPPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ------CCCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                  00111   011124578899999999999999999999876

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.8e-40  Score=307.79  Aligned_cols=252  Identities=25%  Similarity=0.377  Sum_probs=202.1

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|++++.||.|+||.||++...       .+++.||+|.+.....  ...+.+.+|+.+++.++|||++++++.+.... 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   72 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHR-------TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED-   72 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEc-------CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC-
Confidence            5889999999999999999865       4567899999865432  33456888999999999999999998765332 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                        ...+++|||+++++|.+++.......+++.++..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||
T Consensus        73 --~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~  147 (257)
T cd08223          73 --GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLG  147 (257)
T ss_pred             --CEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEeccc
Confidence              2468999999999999999775555789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ++.....  .........+++.|+|||++.+..++.++||||||+++|+|++|..||...+.....  ........    
T Consensus       148 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~--~~~~~~~~----  219 (257)
T cd08223         148 IARVLEN--QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV--YRIIEGKL----  219 (257)
T ss_pred             ceEEecc--cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHhcCC----
Confidence            9875321  122233456889999999999999999999999999999999999999754432111  11111000    


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                             +    ..+...+..+.+++.+||+.||++||++.+++.+
T Consensus       220 -------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 -------P----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -------C----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                   0    1122345678999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.6e-40  Score=313.57  Aligned_cols=262  Identities=29%  Similarity=0.462  Sum_probs=203.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++.+.||+|+||.||+|......  ...++..||+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLL--PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccC--CCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            468999999999999999999865211  123567899999875532 33466889999999999999999999887654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRA--------------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYR  216 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~  216 (436)
                      .    .+++|||+++|+|.+++....                    ...+++..++.++.|++.||.|||+.   +++||
T Consensus        82 ~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~  154 (288)
T cd05050          82 P----MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHR  154 (288)
T ss_pred             c----cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceecc
Confidence            3    499999999999999996422                    13478889999999999999999998   99999


Q ss_pred             cCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 013790          217 DFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLE  295 (436)
Q Consensus       217 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~  295 (436)
                      ||||+|||++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus       155 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             cccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999874321111111222334667999999988899999999999999999998 888987


Q ss_pred             CCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          296 RNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                      +.....   ....+....             . ...+...+..+.+|+.+||+.||.+|||+.++++.|+
T Consensus       235 ~~~~~~---~~~~~~~~~-------------~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         235 GMAHEE---VIYYVRDGN-------------V-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             CCCHHH---HHHHHhcCC-------------C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            554322   222211100             0 0111223467899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.3e-41  Score=321.97  Aligned_cols=242  Identities=25%  Similarity=0.409  Sum_probs=191.8

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccC-CCCceeeeeEeeec
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVD  155 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  155 (436)
                      +|+..+.||+|+||.||+|..+       .+++.||+|++.....   ...+.+..|..++..+. |++|+++++++...
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~   73 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERK-------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV   73 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC
Confidence            4778899999999999999865       4678999999875421   23345777888888876 56777888877654


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~D  144 (323)
T cd05615          74 D----RLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIAD  144 (323)
T ss_pred             C----EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEec
Confidence            4    459999999999999998654  3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||+++....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   ....+..... 
T Consensus       145 fg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~~~~~-  218 (323)
T cd05615         145 FGMCKEHMV--DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSIMEHNV-  218 (323)
T ss_pred             cccccccCC--CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCC-
Confidence            999874211  1122334568999999999999899999999999999999999999998754322   2221111100 


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM  357 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  357 (436)
                                    ..+...+..+.+++.+||+.||.+|++.
T Consensus       219 --------------~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 --------------SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --------------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                          1111234578899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=9e-41  Score=311.40  Aligned_cols=254  Identities=32%  Similarity=0.538  Sum_probs=202.2

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHH--HHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK--QWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      |++.+.||+|+||.||++...       .+++.||+|.+.........  ...+|+.+++.++||||+++++++....  
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--   71 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNK-------KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN--   71 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEET-------TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS--
T ss_pred             CEEeEEEEeCCCEEEEEEEEC-------CCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc--
Confidence            678899999999999999976       57789999999877544332  3456999999999999999999998744  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..++||||+.+++|.+++...  ..+++..+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||+
T Consensus        72 --~~~~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~  144 (260)
T PF00069_consen   72 --YLYIVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGS  144 (260)
T ss_dssp             --EEEEEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTT
T ss_pred             --ccccccccccccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence              458999999999999999732  3689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      +...  ...........++..|+|||++. +..++.++||||||+++|+|++|..||.......................
T Consensus       145 ~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  222 (260)
T PF00069_consen  145 SVKL--SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS  222 (260)
T ss_dssp             TEES--TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH
T ss_pred             cccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc
Confidence            8642  12233444567899999999998 78899999999999999999999999987633333322222111110000


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .           .........+.+++.+||+.||++|||+.+++++
T Consensus       223 ~-----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  223 S-----------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             T-----------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             c-----------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0           0000012689999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-40  Score=306.92  Aligned_cols=255  Identities=25%  Similarity=0.377  Sum_probs=204.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ++|++.+.||.|+||.||+|...       .++..+++|.+........+.+.+|+.+++.++||||+++++++....  
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--   73 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDI-------ATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD--   73 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEec-------CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC--
Confidence            57999999999999999999865       456789999998765556678899999999999999999999886544  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..+++|||+.+++|.+++.... ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        74 --~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~  147 (262)
T cd06613          74 --KLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGV  147 (262)
T ss_pred             --EEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECcccc
Confidence              4699999999999999986642 4689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETG---HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      +.....  .........++..|+|||.+.+.   .++.++||||||+++|+|+||..||....+.......   ......
T Consensus       148 ~~~~~~--~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~---~~~~~~  222 (262)
T cd06613         148 SAQLTA--TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI---SKSNFP  222 (262)
T ss_pred             chhhhh--hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhccCC
Confidence            875321  11122345688899999999776   7889999999999999999999999865543221111   110000


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                              ...  .......+..+.+++.+||..+|.+|||+.+|+.+
T Consensus       223 --------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         223 --------PPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             --------Ccc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                    000  01223445679999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.2e-40  Score=315.43  Aligned_cols=263  Identities=24%  Similarity=0.388  Sum_probs=203.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|+..+.||+|+||.||+|.+....   ......||+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~   82 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEG---ETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT   82 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCC---CcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC
Confidence            457889999999999999999875211   11234689998875532 22346788999999999999999999886432


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                           .++++||+++|+|.+++.... ..+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+||
T Consensus        83 -----~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Df  153 (303)
T cd05110          83 -----IQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDF  153 (303)
T ss_pred             -----ceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccc
Confidence                 378999999999999987543 3689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+......   ..++......
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~~~~  230 (303)
T cd05110         154 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---PDLLEKGERL  230 (303)
T ss_pred             cccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHCCCCC
Confidence            99975322211111222345678999999998899999999999999999998 9999976543322   2222211100


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                                    ..+..++..+.+++..||..+|++||++.+++..|+.+..
T Consensus       231 --------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         231 --------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             --------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                          0011123568899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.2e-40  Score=306.46  Aligned_cols=256  Identities=28%  Similarity=0.422  Sum_probs=195.5

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      +.||+|+||.||+|.+...    ......||+|.+... .....+.+.+|+.+++.++||||+++++++...+.   ..+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~   73 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDS----DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG---SPL   73 (262)
T ss_pred             CcccccCCceEEEEEEecC----CCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC---CcE
Confidence            4689999999999987521    234678999998543 23345678889999999999999999998764332   248


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCC
Q 013790          164 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  243 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  243 (436)
                      ++|||+.+|+|.+++.... ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++...
T Consensus        74 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          74 VVLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcccccccc
Confidence            9999999999999997543 3467788899999999999999998   99999999999999999999999999987432


Q ss_pred             CCCCc--ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          244 MVGHT--HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG-RRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       244 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      .....  .......++..|+|||.+.+..++.++|||||||++|||++| .+||.......   ....+....       
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~~~~~-------  219 (262)
T cd05058         150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYLLQGR-------  219 (262)
T ss_pred             CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHhcCC-------
Confidence            11110  111223456789999999888899999999999999999995 56665443221   222221110       


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                         ..    ..+...+..+.+++.+||..+|++||++.+|+..|++++
T Consensus       220 ---~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         220 ---RL----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ---CC----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence               00    001122457889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.7e-40  Score=307.83  Aligned_cols=260  Identities=26%  Similarity=0.427  Sum_probs=203.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .+|++.+.||+|+||.||+|.+...    ......+|+|.+..... ...+.+.+|+.+++.++||||+++++++...+ 
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLP----GKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK-   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecC----CCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence            5788999999999999999987521    12456899999875432 23457889999999999999999999987554 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+++++|.+++.... ..+++.+++.++.|++.||.|||+.   +++|+||||+|||++.++.++|+|||
T Consensus        79 ---~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd05066          79 ---PVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFG  151 (267)
T ss_pred             ---ccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCC
Confidence               3599999999999999997643 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcc-cccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          238 LAREGPMVGHTH-VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       238 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ++.......... ......++..|+|||.+.+..++.++||||||+++|++++ |..||.......   ....+..... 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~~~~-  227 (267)
T cd05066         152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIEEGYR-  227 (267)
T ss_pred             cccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHhCCCc-
Confidence            997532211111 1111223568999999998889999999999999999887 999997654322   2222211100 


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                                   ...+...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       228 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 -------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                         011122346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.5e-41  Score=323.41  Aligned_cols=241  Identities=27%  Similarity=0.383  Sum_probs=188.4

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHH-HHHhccCCCCceeeeeEeeecCCcce
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEV-QFLGVLEHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~~~~~~  160 (436)
                      +.||+|+||.||+|...       .+++.||+|++.....   .....+..|. .+++.++||||+++++++...+    
T Consensus         1 ~~lg~G~fg~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~----   69 (325)
T cd05602           1 KVIGKGSFGKVLLARHK-------AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD----   69 (325)
T ss_pred             CeeeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC----
Confidence            36999999999999875       4678899999875421   1222334443 4568899999999999887654    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   ||+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~  144 (325)
T cd05602          70 KLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK  144 (325)
T ss_pred             eEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCc
Confidence            459999999999999999654  3688889999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ...  ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+...+.      
T Consensus       145 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~------  213 (325)
T cd05602         145 ENI--EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNILNKPL------  213 (325)
T ss_pred             ccc--cCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHHHHhCCc------
Confidence            421  12222345679999999999999999999999999999999999999998654322   2222211110      


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV  361 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil  361 (436)
                               ......+..+.+++.+||+.||.+||++.+.+
T Consensus       214 ---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         214 ---------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence                     01112346788999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.6e-40  Score=315.01  Aligned_cols=251  Identities=24%  Similarity=0.392  Sum_probs=204.1

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      .+|++.+.||.|+||.||+|...       .+++.|++|.+........+.+.+|+.+++.++||||+++++++....  
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--   89 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDV-------ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD--   89 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEc-------CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc--
Confidence            46999999999999999999854       567889999987665555677889999999999999999999987544  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..++|+||+++++|..++...   .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+
T Consensus        90 --~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~  161 (296)
T cd06655          90 --ELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGF  161 (296)
T ss_pred             --eEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCcc
Confidence              459999999999999998643   589999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  318 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  318 (436)
                      +......  ........++..|+|||.+.+..++.++|||||||++|+|++|..||....+......   +.....    
T Consensus       162 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~---~~~~~~----  232 (296)
T cd06655         162 CAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IATNGT----  232 (296)
T ss_pred             chhcccc--cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCC----
Confidence            8753211  1122345688899999999888899999999999999999999999987654322111   111000    


Q ss_pred             cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       319 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                            +.+  ..+...+..+.++|.+||..||.+||++.+|+.+
T Consensus       233 ------~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         233 ------PEL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ------ccc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                  000  1122234678899999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-40  Score=306.82  Aligned_cols=252  Identities=28%  Similarity=0.450  Sum_probs=198.9

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      +.||+|+||.||+|.+...+    .....||+|.+..... ...+.+.+|+.+++.+.||||+++++++...     ..+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~   71 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKS----GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE-----PLM   71 (257)
T ss_pred             CccCccCceeEEEeEeeccC----CCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC-----ceE
Confidence            46999999999999876221    1347899999876544 2456788999999999999999999987532     358


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCC
Q 013790          164 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  243 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  243 (436)
                      +||||+.+++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.+||+|||+++...
T Consensus        72 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~  146 (257)
T cd05060          72 LVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALG  146 (257)
T ss_pred             EEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceee
Confidence            9999999999999997654  689999999999999999999998   99999999999999999999999999987532


Q ss_pred             CCCCccc-ccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 013790          244 MVGHTHV-STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  321 (436)
Q Consensus       244 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (436)
                      ....... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .+..++......      
T Consensus       147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~~~~~------  217 (257)
T cd05060         147 AGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLESGERL------  217 (257)
T ss_pred             cCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHcCCcC------
Confidence            2211111 111223567999999988899999999999999999998 99999765432   233332221100      


Q ss_pred             ccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       322 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                              ..+...+..+.++|.+||..+|.+||++.+|++.|+++
T Consensus       218 --------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         218 --------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             --------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence                    11222346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-40  Score=310.74  Aligned_cols=247  Identities=22%  Similarity=0.364  Sum_probs=192.7

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEEE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLL  164 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~l  164 (436)
                      +.||.|+||.||+|..+.....+......|++|.+........+.+.+|+.+++.++||||+++++++.....    .++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~----~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE----SIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC----cEE
Confidence            3699999999999987632222233456689998876655555678889999999999999999999986543    489


Q ss_pred             EEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc--------eEEeec
Q 013790          165 VYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR--------PKLSDF  236 (436)
Q Consensus       165 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~Df  236 (436)
                      ||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++   +|+||||||+||+++.++.        ++++||
T Consensus        77 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             EEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence            999999999999997654 3689999999999999999999998   9999999999999987765        699999


Q ss_pred             cCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCC-CCCCCCCchhhHHHHHHHhhccc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGR-RSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~-~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |++....      ......++..|+|||++.+ ..++.++||||||+++|+|++|. .||....+........   .   
T Consensus       153 g~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~---~---  220 (258)
T cd05078         153 GISITVL------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE---D---  220 (258)
T ss_pred             ccccccC------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH---c---
Confidence            9886421      1223467889999999976 45789999999999999999984 6665443322111110   0   


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                               ..    ..+......+.+|+.+||+.||++|||+.+|++.|
T Consensus       221 ---------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         221 ---------RH----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             ---------cc----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                     00    11112235688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.9e-40  Score=313.92  Aligned_cols=268  Identities=27%  Similarity=0.394  Sum_probs=203.4

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      -|++++.||+|+||.||++.+..   ....++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDP---EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEcc---CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            47889999999999999998641   123467889999987553 33346789999999999999999999988765322


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..++||||+++++|.+++.... ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||+
T Consensus        82 --~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~  155 (284)
T cd05079          82 --GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL  155 (284)
T ss_pred             --ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcc
Confidence              3589999999999999986543 3689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCc-ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh--------H-HHHHH
Q 013790          239 AREGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE--------Q-RLLEW  308 (436)
Q Consensus       239 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~--------~-~~~~~  308 (436)
                      ++........ .......++..|+|||.+.+..++.++||||||+++|+|+|+..|+........        . .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05079         156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL  235 (284)
T ss_pred             ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence            8753221111 112234567789999999888899999999999999999998776532111000        0 00000


Q ss_pred             HhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          309 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                      +...           ........+...+..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus       236 ~~~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         236 VRVL-----------EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHH-----------HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0000           00000011222457899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3e-40  Score=315.29  Aligned_cols=267  Identities=24%  Similarity=0.386  Sum_probs=200.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|.+.+.||.|+||.||+|...       .++..||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~   77 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSK-------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK   77 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEc-------CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC
Confidence            357999999999999999999865       4678899999865432 22346778999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.++|+||
T Consensus        78 ----~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  148 (301)
T cd07873          78 ----SLTLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADF  148 (301)
T ss_pred             ----eEEEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcC
Confidence                3599999996 69999886543 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |++.....  .........+++.|+|||.+.+ ..++.++|||||||++|+|+||..||...+..............+..
T Consensus       149 g~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  226 (301)
T cd07873         149 GLARAKSI--PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE  226 (301)
T ss_pred             cchhccCC--CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99874221  1112233457889999999865 45788999999999999999999999866543221111111111110


Q ss_pred             cccccccc---------CCcccC----cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKKFGLIM---------DPRLEK----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~---------~~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                       ..+..+.         .+....    ......+..+.+||.+||..||.+|||+.+++.+
T Consensus       227 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         227 -ETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             -hhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             0000000         000000    0111234578899999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5e-40  Score=308.67  Aligned_cols=260  Identities=25%  Similarity=0.361  Sum_probs=204.8

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|.+.+.||.|+||.||+|.+....    .....|++|...... ....+.+.+|+.+++.++||||+++++++...  
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPE----NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN--   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCC----CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC--
Confidence            56888999999999999999875221    234579999887654 34456789999999999999999999988643  


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        80 ---~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g  152 (270)
T cd05056          80 ---PVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFG  152 (270)
T ss_pred             ---CcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCc
Confidence               2489999999999999997643 3689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      +++..... .........++..|+|||.+.+..++.++||||||+++|++++ |..||........   ...+....   
T Consensus       153 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~~~~~---  225 (270)
T cd05056         153 LSRYLEDE-SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRIENGE---  225 (270)
T ss_pred             eeeecccc-cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHcCC---
Confidence            98753221 1111122234568999999988889999999999999999986 9999976543221   12111100   


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                             ..    ..+...+..+.++|.+||..+|.+|||+.+++..|+++..
T Consensus       226 -------~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         226 -------RL----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             -------cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                   00    1112234678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-40  Score=347.91  Aligned_cols=260  Identities=25%  Similarity=0.404  Sum_probs=201.8

Q ss_pred             HHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEe
Q 013790           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYC  152 (436)
Q Consensus        75 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  152 (436)
                      ....++|.+++.||.|+||.||+|.+.       .++..||+|.+....  ......+..|+.++..|+||||+++++++
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk-------~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f   81 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHK-------RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRF   81 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEEC-------CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence            344679999999999999999999976       467889999987542  23346788999999999999999999988


Q ss_pred             eecCCcceeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCC----CceeeccCCCCcEEEc
Q 013790          153 AVDGERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLE----VQVIYRDFKASNVLLD  226 (436)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~----~~ivH~Dlkp~NIll~  226 (436)
                      ......  .+|+||||+.+|+|.++|...  ....+++..++.|+.||+.||.|||+...    .+||||||||+||||+
T Consensus        82 ~de~~~--~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~  159 (1021)
T PTZ00266         82 LNKANQ--KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS  159 (1021)
T ss_pred             EecCCC--EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence            654332  469999999999999999653  23469999999999999999999998511    2599999999999996


Q ss_pred             C-----------------CCceEEeeccCCCCCCCCCCcccccccccCCCccccccccc--CCCCchhhHHHHHHHHHHH
Q 013790          227 E-----------------NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEM  287 (436)
Q Consensus       227 ~-----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~el  287 (436)
                      .                 .+.+||+|||++....   .........||+.|+|||++.+  ..++.++||||||||||+|
T Consensus       160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~---~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL  236 (1021)
T PTZ00266        160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL  236 (1021)
T ss_pred             cCccccccccccccccCCCCceEEccCCcccccc---ccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence            4                 3458999999997532   1222334579999999999854  4588999999999999999


Q ss_pred             HhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          288 LTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       288 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +||..||.......  .+...+...+.            +.   ....+..+.+||..||..+|.+||++.+++.+
T Consensus       237 LTGk~PF~~~~~~~--qli~~lk~~p~------------lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        237 CSGKTPFHKANNFS--QLISELKRGPD------------LP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             HHCCCCCCcCCcHH--HHHHHHhcCCC------------CC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            99999997544321  12221111110            00   01124678899999999999999999999854

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-40  Score=305.57  Aligned_cols=253  Identities=33%  Similarity=0.515  Sum_probs=203.1

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh-HHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      +.||+|+||.||+|......    ..+..|++|.+....... .+.+.+|+..+..++|+||+++++++....    ..+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~   72 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD----GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE----PLY   72 (262)
T ss_pred             CccccCCceEEEEEEEecCC----CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCC----ceE
Confidence            46999999999999976211    337889999997664433 578889999999999999999999987633    459


Q ss_pred             EEEEecCCCCHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          164 LVYEFMLNRSLEDHLFNRA-------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      +||||+++++|.+++....       ...+++..++.++.|++.||+|||++   +++|+||+|+||+++.++.++|+||
T Consensus        73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~df  149 (262)
T cd00192          73 LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDF  149 (262)
T ss_pred             EEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccc
Confidence            9999999999999997652       35789999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   +...+....  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~--  224 (262)
T cd00192         150 GLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLRKGY--  224 (262)
T ss_pred             ccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCC--
Confidence            99986433222223344567889999999988889999999999999999999 699998764322   222222100  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                                  ....+...+..+.+++.+||..+|.+|||+.+++++|+
T Consensus       225 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 ------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                        00112233578999999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.6e-40  Score=306.44  Aligned_cols=253  Identities=28%  Similarity=0.425  Sum_probs=201.0

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      +.||+|+||.||+|.+...    ......||+|.+..... ...+.+.+|+.++++++||||+++++++.. .    ..+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~----~~~   71 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS----GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H----PLM   71 (257)
T ss_pred             CcCCccCcccEEeeeEecC----CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-C----eEE
Confidence            3689999999999998621    12345799999987765 556788999999999999999999998865 2    459


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCC
Q 013790          164 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  243 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  243 (436)
                      +||||+++++|.+++.......+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus        72 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~  148 (257)
T cd05040          72 MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALP  148 (257)
T ss_pred             EEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccc
Confidence            999999999999999775435689999999999999999999998   99999999999999999999999999997542


Q ss_pred             CCCCc-ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 013790          244 MVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  321 (436)
Q Consensus       244 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (436)
                      ..... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ....+......      
T Consensus       149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~------  219 (257)
T cd05040         149 QNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDKEGER------  219 (257)
T ss_pred             ccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHhcCCc------
Confidence            21111 11123456788999999998899999999999999999999 999997654332   22222111000      


Q ss_pred             ccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       322 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                           +  ..+...+..+.+++.+||..+|.+|||+.++++.|.
T Consensus       220 -----~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         220 -----L--ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -----C--CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                 0  011223467889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=9.5e-40  Score=306.59  Aligned_cols=255  Identities=24%  Similarity=0.342  Sum_probs=189.1

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      +.||+|+||.||+|...     .......+++|.+..... .....+.+|+.+++.++||||+++++.+.....    .+
T Consensus         1 ~~lg~G~fg~v~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~----~~   71 (269)
T cd05042           1 DEIGNGWFGKVLLGEAH-----RGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP----YL   71 (269)
T ss_pred             CcCCccCCceEEEEEEe-----cCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCc----eE
Confidence            35999999999999764     223456799998765432 234567889999999999999999999876543    59


Q ss_pred             EEEEecCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          164 LVYEFMLNRSLEDHLFNRA---FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      +||||+++|+|.+++....   ....++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus        72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~  148 (269)
T cd05042          72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLAL  148 (269)
T ss_pred             EEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccccc
Confidence            9999999999999997643   12346788899999999999999998   99999999999999999999999999986


Q ss_pred             CCCCCCCcccccccccCCCccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIET-------GHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      ...............++..|+|||++..       ..++.++|||||||++|+|++ |..||....+...  +...+...
T Consensus       149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~~~  226 (269)
T cd05042         149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LKQVVREQ  226 (269)
T ss_pred             ccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HHHHhhcc
Confidence            4221111111223345678999998743       356789999999999999999 7888876543221  11111111


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                      ..      .+..+.    .+...+..+.+++..|| .||++|||+.+|++.|
T Consensus       227 ~~------~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         227 DI------KLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             Cc------cCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            00      011111    12233466778999999 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=312.46  Aligned_cols=253  Identities=24%  Similarity=0.398  Sum_probs=203.3

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ++|++.+.||.|+||.||+|.+.       .++..||+|.+........+.+.+|+.+++.++||||+++++++....  
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   75 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHK-------ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN--   75 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEc-------CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC--
Confidence            57999999999999999999875       467889999997766666678899999999999999999999987654  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||+
T Consensus        76 --~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~  149 (280)
T cd06611          76 --KLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGV  149 (280)
T ss_pred             --eEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCcc
Confidence              4599999999999999986543 4699999999999999999999998   999999999999999999999999998


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +.....  .........++..|+|||.+.     +..++.++||||||+++|+|++|..||........  .... ....
T Consensus       150 ~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~-~~~~  224 (280)
T cd06611         150 SAKNKS--TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKI-LKSE  224 (280)
T ss_pred             chhhcc--cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHH-hcCC
Confidence            864221  122223456889999999974     34567899999999999999999999976543221  1111 1110


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .          +.+  ..+...+..+.++|..||..+|.+||++.+++++
T Consensus       225 ~----------~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         225 P----------PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             C----------CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            0          000  1122234678899999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.1e-40  Score=314.57  Aligned_cols=252  Identities=23%  Similarity=0.365  Sum_probs=203.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ..+|++.+.||.|+||.||+|...       .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+ 
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-   89 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDI-------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-   89 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEEC-------CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence            368999999999999999999854       467889999997665555677889999999999999999999987654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+++++|.+++...   .+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||
T Consensus        90 ---~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg  160 (297)
T cd06656          90 ---ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  160 (297)
T ss_pred             ---EEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCc
Confidence               459999999999999998643   588999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ++......  ........+++.|+|||.+.+..++.++||||||+++|++++|..||....+......   ...      
T Consensus       161 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---~~~------  229 (297)
T cd06656         161 FCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IAT------  229 (297)
T ss_pred             cceEccCC--ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee---ecc------
Confidence            98643211  1122345688899999999988899999999999999999999999976543211000   000      


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                            ........+...+..+.+|+.+||..||++||++.+|+++
T Consensus       230 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         230 ------NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             ------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0000001122334678899999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.1e-40  Score=305.73  Aligned_cols=252  Identities=27%  Similarity=0.413  Sum_probs=203.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|+..+.||.|+||.||+|.+.       .++..|++|.+.....  .+.+.+|+.+++.++||||+++++++.... 
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-   71 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHK-------ETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT-   71 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEc-------CCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC-
Confidence            468999999999999999999976       3568899999875532  578999999999999999999999987654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++++||+.+++|.+++.... ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        72 ---~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg  144 (256)
T cd06612          72 ---DLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFG  144 (256)
T ss_pred             ---cEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccc
Confidence               4599999999999999986543 4789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ++......  ........++..|+|||.+.+..++.++||||||+++|+|++|..||....+......   ....     
T Consensus       145 ~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~---~~~~-----  214 (256)
T cd06612         145 VSGQLTDT--MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM---IPNK-----  214 (256)
T ss_pred             cchhcccC--ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh---hccC-----
Confidence            98753221  1122345578899999999888999999999999999999999999976543221100   0000     


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                           ..+.  ...+...+..+.++|.+||+.||.+|||+.+++.+
T Consensus       215 -----~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         215 -----PPPT--LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             -----CCCC--CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence                 0000  01122344678999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.1e-40  Score=344.56  Aligned_cols=263  Identities=21%  Similarity=0.272  Sum_probs=203.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|++.+.||+|+||.||+|...       .+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++...
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~-------~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~   74 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDP-------VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG   74 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEEC-------CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC
Confidence            58999999999999999999865       4678899999875422   2345788999999999999999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA---------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  226 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~  226 (436)
                      +    ..+++|||++||+|.+++....         ...+++..++.++.||+.||+|||+.   +|+||||||+|||++
T Consensus        75 ~----~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd  147 (932)
T PRK13184         75 D----PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLG  147 (932)
T ss_pred             C----EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEc
Confidence            4    4599999999999999986421         12456778899999999999999998   999999999999999


Q ss_pred             CCCceEEeeccCCCCCCCCCC----------------cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhC
Q 013790          227 ENFRPKLSDFGLAREGPMVGH----------------THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG  290 (436)
Q Consensus       227 ~~~~~kl~Dfg~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg  290 (436)
                      .++.++|+|||+++.......                ........||+.|+|||.+.+..++.++|||||||++|||+||
T Consensus       148 ~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG  227 (932)
T PRK13184        148 LFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL  227 (932)
T ss_pred             CCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHC
Confidence            999999999999975311100                0011234699999999999999999999999999999999999


Q ss_pred             CCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHhhh
Q 013790          291 RRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-KMSQVVERLKQIVQ  369 (436)
Q Consensus       291 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~eil~~L~~~~~  369 (436)
                      ..||........   .. ...... ..        ..  ......+..+.+++.+||..||++|| +++++++.|+..++
T Consensus       228 ~~PF~~~~~~ki---~~-~~~i~~-P~--------~~--~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        228 SFPYRRKKGRKI---SY-RDVILS-PI--------EV--APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             CCCCCCcchhhh---hh-hhhccC-hh--------hc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            999976332211   00 000000 00        00  00113346788999999999999996 66778888888876


Q ss_pred             h
Q 013790          370 V  370 (436)
Q Consensus       370 ~  370 (436)
                      .
T Consensus       293 ~  293 (932)
T PRK13184        293 G  293 (932)
T ss_pred             c
Confidence            4

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.3e-40  Score=309.21  Aligned_cols=261  Identities=24%  Similarity=0.406  Sum_probs=204.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|+.+..||.|+||.||+|+.+...  .....+.|++|.+...... ..+.+.+|+.++++++||||+++++++.... 
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIE--EEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE-   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCC--cCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC-
Confidence            57899999999999999999976332  2245678999998765433 4567899999999999999999999886544 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCC-------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAF-------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  230 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  230 (436)
                         ..++||||+++|+|.+++.....       ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        82 ---~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~  155 (275)
T cd05046          82 ---PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQRE  155 (275)
T ss_pred             ---cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCc
Confidence               34999999999999999975431       2589999999999999999999998   9999999999999999999


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHH
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWV  309 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  309 (436)
                      ++|+|||++...... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ......
T Consensus       156 ~~l~~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~~  231 (275)
T cd05046         156 VKVSLLSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNRL  231 (275)
T ss_pred             EEEcccccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHHH
Confidence            999999998642211 1112223345678999999988888999999999999999999 88899654332   122221


Q ss_pred             hhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                      ....             +....+...+..+.+++.+||+.+|.+|||+.+++..|.
T Consensus       232 ~~~~-------------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 QAGK-------------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HcCC-------------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1100             000111223467899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=335.32  Aligned_cols=263  Identities=26%  Similarity=0.450  Sum_probs=216.1

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +...+.+.||.|.||.|++|+++...    .....||||.++.-... ....|..|+.||.++.||||+++.|+..... 
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pg----kre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~-  703 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPG----KREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK-  703 (996)
T ss_pred             hheEEEEEEecccccceecccccCCC----CcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc-
Confidence            45667789999999999999998432    45678999999866443 3457999999999999999999999987654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         .+.||+|||++|+|+.||+.+.+ .+.+.++..+++.||.||.||-+.   ++|||||..+||||+.+..+|++|||
T Consensus       704 ---PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFG  776 (996)
T KOG0196|consen  704 ---PVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFG  776 (996)
T ss_pred             ---eeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccc
Confidence               45999999999999999988774 599999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCccccccccc--CCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 013790          238 LAREGPMVGHTHVSTAVVG--TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      +++...... ....++.-|  ...|.|||.+....++.++|||||||+|||.++ |..||-+...   ++++..+     
T Consensus       777 LSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---QdVIkaI-----  847 (996)
T KOG0196|consen  777 LSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVIKAI-----  847 (996)
T ss_pred             ceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---HHHHHHH-----
Confidence            998642222 112222222  358999999999999999999999999999998 9999865432   2333222     


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                               ...++...|.+||..|.+|+..||++|-.+||.+.+|+..|++++...
T Consensus       848 ---------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  848 ---------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             ---------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence                     122233457788899999999999999999999999999999997543

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-40  Score=322.54  Aligned_cols=268  Identities=24%  Similarity=0.310  Sum_probs=199.6

Q ss_pred             HHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEe
Q 013790           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYC  152 (436)
Q Consensus        75 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~  152 (436)
                      ....++|++++.||.|+||.||+|...       .++..||+|.+.....  .....+.+|+.+++.++||||+++++++
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDT-------RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVF   83 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEEC-------CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhh
Confidence            345678999999999999999999865       4678899999875422  2335677899999999999999999987


Q ss_pred             eecCC--cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc
Q 013790          153 AVDGE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  230 (436)
Q Consensus       153 ~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  230 (436)
                      .....  .....+++++++ +++|.+++..   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.
T Consensus        84 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~  156 (343)
T cd07878          84 TPATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCE  156 (343)
T ss_pred             cccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCC
Confidence            54321  223458999987 8899988753   3589999999999999999999998   9999999999999999999


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  309 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  309 (436)
                      +||+|||+++....     ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........  ...
T Consensus       157 ~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~  229 (343)
T cd07878         157 LRILDFGLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK--RIM  229 (343)
T ss_pred             EEEcCCccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH--HHH
Confidence            99999999975321     2234568999999999876 568899999999999999999999997654322111  111


Q ss_pred             hhcccCccc-ccccc-------CCcccCc-------CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          310 QQYPADSKK-FGLIM-------DPRLEKE-------YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       310 ~~~~~~~~~-~~~~~-------~~~l~~~-------~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ......... +..+.       ...+...       .....+..+.+||.+||..||.+|||+.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         230 EVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            100000000 00000       0000000       000123457899999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.9e-40  Score=312.24  Aligned_cols=265  Identities=28%  Similarity=0.365  Sum_probs=205.6

Q ss_pred             CHHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCceee
Q 013790           70 SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKL  148 (436)
Q Consensus        70 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~  148 (436)
                      +..++....+.|++.+.||.|+||.||+|...       .+++.+|+|.+.... .....+..|+.+++.+ +||||+++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~   78 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHV-------KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATY   78 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEc-------CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEE
Confidence            34455556789999999999999999999975       467889999986543 2345678899999988 69999999


Q ss_pred             eeEeeecC--CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc
Q 013790          149 IGYCAVDG--ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  226 (436)
Q Consensus       149 ~~~~~~~~--~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~  226 (436)
                      ++++....  ......+++|||+.+|+|.+++.......+++..+..++.|++.||.|||+.   +++|+||+|+||+++
T Consensus        79 ~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~  155 (282)
T cd06636          79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLT  155 (282)
T ss_pred             eeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEC
Confidence            99886432  1234679999999999999999765555688999999999999999999998   999999999999999


Q ss_pred             CCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q 013790          227 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT  301 (436)
Q Consensus       227 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  301 (436)
                      .++.++|+|||++.....  .........|+..|+|||.+.     +..++.++|||||||++|+|++|..||....+..
T Consensus       156 ~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~  233 (282)
T cd06636         156 ENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR  233 (282)
T ss_pred             CCCCEEEeeCcchhhhhc--cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence            999999999999864211  111223456889999999985     3467889999999999999999999997554322


Q ss_pred             hHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          302 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....   ....          ..+.+   .....+..+.+||.+||..||.+||++.+|+++
T Consensus       234 ~~~~---~~~~----------~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         234 ALFL---IPRN----------PPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hhhh---HhhC----------CCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            1111   0000          00000   111234679999999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.6e-40  Score=320.68  Aligned_cols=239  Identities=28%  Similarity=0.391  Sum_probs=187.5

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHH-HHhccCCCCceeeeeEeeecCCcce
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQ-FLGVLEHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~~  160 (436)
                      +.||+|+||.||+|...       .+++.||+|++.....   .....+..|.. +++.++||||+++++++...+    
T Consensus         1 ~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~----   69 (325)
T cd05604           1 KVIGKGSFGKVLLAKRK-------LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE----   69 (325)
T ss_pred             CceeeCCCeEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC----
Confidence            46999999999999865       5678999999865421   22234455544 567899999999999887654    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++||||+.+|+|..++...  ..+++..+..++.||+.||.|||+.   ||+||||||+|||++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~  144 (325)
T cd05604          70 KLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCK  144 (325)
T ss_pred             EEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcc
Confidence            459999999999999988654  3689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ...  ..........||+.|+|||++.+..++.++|||||||++|+|++|..||........   ...+....       
T Consensus       145 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~~~~~~~~-------  212 (325)
T cd05604         145 EGI--AQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM---YDNILHKP-------  212 (325)
T ss_pred             cCC--CCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH---HHHHHcCC-------
Confidence            421  112223446799999999999999999999999999999999999999986543221   11111100       


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ  359 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  359 (436)
                          ..+    ....+..+.+++.+||..||.+||++.+
T Consensus       213 ----~~~----~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         213 ----LVL----RPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             ----ccC----CCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence                000    1123456789999999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=327.53  Aligned_cols=253  Identities=23%  Similarity=0.401  Sum_probs=210.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      +-|.++..||.|+||.||+|..+       .++...|.|++........+.+.-|++||..+.||+||++++.|..++. 
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nk-------et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-  103 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNK-------ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-  103 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcc-------cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-
Confidence            35777888999999999999865       4566678898887777788899999999999999999999998887764 


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                         +|++.|||.||-....+..-. .++.+.++..++.|++.||.|||++   +|||||||..|||++-+|.++|+|||.
T Consensus       104 ---LwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGV  176 (1187)
T KOG0579|consen  104 ---LWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGV  176 (1187)
T ss_pred             ---eEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccc
Confidence               599999999999998887654 5799999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCccccccc-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYI-----ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +..  .........++.||+.|||||+.     ...+|+.++||||||++|.||..+.+|....++.-.   +-.++...
T Consensus       177 SAK--n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV---llKiaKSe  251 (1187)
T KOG0579|consen  177 SAK--NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLKIAKSE  251 (1187)
T ss_pred             ccc--chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH---HHHHhhcC
Confidence            854  23344556778999999999987     456899999999999999999999999887665422   11111110


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                .|.+  ..+...+..+.+++.+||..||..||++.+|++|
T Consensus       252 ----------PPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  252 ----------PPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             ----------CCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence                      0111  2244556789999999999999999999999986

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-40  Score=308.89  Aligned_cols=250  Identities=29%  Similarity=0.414  Sum_probs=202.8

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|++.+.||.|+||.||+|...       .++..||+|.+.... ......+.+|+.+++.++||||+++++++.... 
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   72 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDK-------RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS-   72 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEEC-------CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC-
Confidence            46888999999999999999875       467899999987653 334467889999999999999999999887653 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++|+||+++++|.+++...   ++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        73 ---~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g  143 (274)
T cd06609          73 ---KLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFG  143 (274)
T ss_pred             ---eEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccc
Confidence               469999999999999999654   689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      +++.....  ........++..|+|||.+.+..++.++||||||+++|+|+||..||....+...   ...+...     
T Consensus       144 ~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~-----  213 (274)
T cd06609         144 VSGQLTST--MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LFLIPKN-----  213 (274)
T ss_pred             cceeeccc--ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HHHhhhc-----
Confidence            99753221  1223345688899999999988899999999999999999999999976543211   1111100     


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                           ..+.+...   ..+..+.+++.+||..+|++|||+.+++.+
T Consensus       214 -----~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         214 -----NPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             -----CCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                 01111111   134678899999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.6e-40  Score=308.63  Aligned_cols=266  Identities=28%  Similarity=0.431  Sum_probs=207.3

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .+|+..+.||+|+||.||+|.+...   ...++..||+|.+...... ..+.+.+|+.+++.+.||||+++++++...+.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~---~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPL---GDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCC---CCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            4688889999999999999987522   1245788999999766543 45679999999999999999999998866432


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                        ...+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        81 --~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  154 (284)
T cd05038          81 --RSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFG  154 (284)
T ss_pred             --CceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccc
Confidence              24589999999999999997653 3589999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCc-ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh------------hHH
Q 013790          238 LAREGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT------------EQR  304 (436)
Q Consensus       238 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~------------~~~  304 (436)
                      ++......... .......++..|++||.+.+..++.++||||||+++|+|+||..|+.......            ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05038         155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR  234 (284)
T ss_pred             cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence            99754311111 11112334567999999988889999999999999999999999986533221            111


Q ss_pred             HHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          305 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                      +..++..              ......+..++..+.+|+.+||..+|++|||+.+|++.|+++
T Consensus       235 ~~~~~~~--------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         235 LLELLKE--------------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHc--------------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111111              111111223446799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-41  Score=326.75  Aligned_cols=256  Identities=25%  Similarity=0.373  Sum_probs=209.8

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      +..+.++||+|+||.|++|.|....    .+...||||.+...... ....|.+|+.+|.+|+|||++++||+.....  
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~ps----gk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp--  184 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPS----GKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP--  184 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCC----CcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch--
Confidence            4556778999999999999998544    34567999999877554 5678999999999999999999999987532  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                         ..+|||.++.|+|.+.|+......|.......++.|||.||.||.++   ++|||||..+|+||.....+||+|||+
T Consensus       185 ---~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGL  258 (1039)
T KOG0199|consen  185 ---AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGL  258 (1039)
T ss_pred             ---hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccc
Confidence               47999999999999999885556788889999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccc-cccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          239 AREGPMVGHTHVS-TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       239 a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      ++........... ....-...|+|||.++...++.++|||+|||++|||+| |..||-+.........++         
T Consensus       259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD---------  329 (1039)
T KOG0199|consen  259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID---------  329 (1039)
T ss_pred             eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc---------
Confidence            9864332222221 12223458999999999999999999999999999999 889998876543222211         


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                              ..-....+..|++.|.+++..||..+|.+|||+..|.+.+
T Consensus       330 --------~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 --------AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             --------ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence                    1111123556789999999999999999999999998554

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.6e-40  Score=320.11  Aligned_cols=238  Identities=27%  Similarity=0.379  Sum_probs=186.6

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHH-HHHhccCCCCceeeeeEeeecCCcce
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEV-QFLGVLEHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~~~~~~  160 (436)
                      +.||+|+||.||+|...       .++..||+|++.....   .....+..|. .+++.++||||+++++++...+    
T Consensus         1 ~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~----   69 (321)
T cd05603           1 KVIGKGSFGKVLLAKRK-------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE----   69 (321)
T ss_pred             CeeeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC----
Confidence            36999999999999875       4678999999865422   1223344454 4678899999999998886544    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++||||+++|+|..++...  ..+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  144 (321)
T cd05603          70 KLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK  144 (321)
T ss_pred             EEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCc
Confidence            459999999999999988654  3688999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ...  ..........||+.|+|||++.+..++.++|||||||++|+|++|..||...+...   ....+...+.      
T Consensus       145 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~------  213 (321)
T cd05603         145 EGV--EPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYDNILHKPL------  213 (321)
T ss_pred             cCC--CCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHHHHhcCCC------
Confidence            421  11222344578999999999998899999999999999999999999998654322   2121111100      


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS  358 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  358 (436)
                               ..+...+..+.+++.+||+.||.+||++.
T Consensus       214 ---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 ---------QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                     11222346788999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.1e-40  Score=307.26  Aligned_cols=256  Identities=24%  Similarity=0.364  Sum_probs=199.9

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ..++++.....||+|+||.||+|.+.       .++..|++|.+........+.+.+|+.+++.++|+||+++++++...
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   77 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDL-------STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN   77 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEec-------CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC
Confidence            34556666678999999999999865       46788999998877666667899999999999999999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC-CCceE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPL--PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-NFRPK  232 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~k  232 (436)
                      +    ..++|+||+++++|.+++.... ..+  ++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.++
T Consensus        78 ~----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~  149 (268)
T cd06624          78 G----FFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVK  149 (268)
T ss_pred             C----EEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEE
Confidence            4    4599999999999999997643 234  7888999999999999999998   9999999999999976 77999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH--LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      |+|||++.....  .........|+..|+|||.+.+..  ++.++||||||+++|+|++|..||..........   +..
T Consensus       150 l~dfg~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~  224 (268)
T cd06624         150 ISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKV  224 (268)
T ss_pred             Eecchhheeccc--CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhh
Confidence            999999864321  112223345789999999986643  7889999999999999999999997543221110   000


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....        ..+    ..+...+..+.+++.+||+.+|.+|||+.+++.+
T Consensus       225 ~~~~--------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         225 GMFK--------IHP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             hhhc--------cCC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            0000        011    1223345678899999999999999999999865

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.4e-39  Score=306.83  Aligned_cols=249  Identities=26%  Similarity=0.382  Sum_probs=203.2

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ..|+.++.||.|+||.||+|.+.       .++..||+|.+.... ......+.+|+.+++.++||||+++++++.... 
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   75 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDN-------RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT-   75 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEc-------cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence            46888899999999999999865       467889999987543 334567889999999999999999999987654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+.+++|.+++..   .++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        76 ---~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg  146 (277)
T cd06640          76 ---KLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFG  146 (277)
T ss_pred             ---EEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccc
Confidence               45999999999999999864   3588999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ++.....  .........++..|+|||.+.+..++.++|+||||+++|+|+||..||....+......   +.       
T Consensus       147 ~~~~~~~--~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---~~-------  214 (277)
T cd06640         147 VAGQLTD--TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL---IP-------  214 (277)
T ss_pred             cceeccC--CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh---hh-------
Confidence            9875322  11222334678899999999888899999999999999999999999976543321111   00       


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                             ...........+..+.+++.+||..+|++||++.+++.+
T Consensus       215 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         215 -------KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -------cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                   000112334456789999999999999999999999877

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.4e-40  Score=305.58  Aligned_cols=246  Identities=30%  Similarity=0.463  Sum_probs=198.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ++|++.+.||+|+||.||++..         ++..||+|.+....  ....+.+|+.+++.++||||+++++++...+  
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~---------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--   72 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY---------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG--   72 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc---------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC--
Confidence            5789999999999999998763         46679999986543  3357889999999999999999999886532  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                         .+++|||+.+++|.+++.......+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        73 ---~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~  146 (254)
T cd05083          73 ---LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGL  146 (254)
T ss_pred             ---cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCcc
Confidence               48999999999999999876555689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      +.....     .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||........   ...+....    
T Consensus       147 ~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~----  214 (254)
T cd05083         147 ARVGSM-----GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV---KECVEKGY----  214 (254)
T ss_pred             ceeccc-----cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHHhCCC----
Confidence            864211     1122234568999999988889999999999999999998 9999976544322   11111100    


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                            ..    ..+...+..+.+++.+||+.+|++||++.+|+..|+
T Consensus       215 ------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         215 ------RM----EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             ------CC----CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence                  00    111223467889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.8e-40  Score=316.16  Aligned_cols=265  Identities=19%  Similarity=0.289  Sum_probs=195.6

Q ss_pred             cccccccc--CceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           83 RMLKIGEG--GFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        83 ~~~~ig~G--~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      +++.||+|  +||+||++..+       .+++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++..++  
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--   72 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYK-------PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--   72 (327)
T ss_pred             hhhhccccccceEEEEEEeec-------ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--
Confidence            46789999  78999999865       5788999999976532  23456778999999999999999999997765  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..++||||+++|+|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.++++||+.
T Consensus        73 --~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~  147 (327)
T cd08227          73 --ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRS  147 (327)
T ss_pred             --EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccch
Confidence              359999999999999999765445689999999999999999999998   999999999999999999999999986


Q ss_pred             CCCCCCCCCc-----ccccccccCCCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          239 AREGPMVGHT-----HVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       239 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      .......+..     .......++..|+|||++.+  ..++.++|||||||++|+|++|..||.......  ........
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~  225 (327)
T cd08227         148 NLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNG  225 (327)
T ss_pred             hhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcC
Confidence            5432111110     01122356778999999976  468899999999999999999999997543211  11111110


Q ss_pred             -cccC-------cccc----------cccc------------CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 013790          312 -YPAD-------SKKF----------GLIM------------DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV  361 (436)
Q Consensus       312 -~~~~-------~~~~----------~~~~------------~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil  361 (436)
                       .+..       ...+          ..+.            ............+..+.+|+.+||+.||.+|||+.+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell  305 (327)
T cd08227         226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL  305 (327)
T ss_pred             CccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence             0000       0000          0000            00000011223356789999999999999999999998


Q ss_pred             HH
Q 013790          362 ER  363 (436)
Q Consensus       362 ~~  363 (436)
                      ++
T Consensus       306 ~~  307 (327)
T cd08227         306 NH  307 (327)
T ss_pred             cC
Confidence            75

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.7e-40  Score=306.02  Aligned_cols=251  Identities=23%  Similarity=0.396  Sum_probs=198.8

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh---------HHHHHHHHHHHhccCCCCceeeee
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---------HKQWVAEVQFLGVLEHPNLVKLIG  150 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~hpnIv~~~~  150 (436)
                      +|.+...||.|+||.||+|...       .+++.||+|.+.......         .+.+.+|+.+++.++||||+++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   73 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNA-------SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLG   73 (267)
T ss_pred             CccccceeecCCCeEEEEEEec-------CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence            4778889999999999999864       456789999886543221         246788999999999999999999


Q ss_pred             EeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc
Q 013790          151 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  230 (436)
Q Consensus       151 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  230 (436)
                      ++...+.    .+++|||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.
T Consensus        74 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~  144 (267)
T cd06628          74 SSLDADH----LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGG  144 (267)
T ss_pred             EEEeCCc----cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCC
Confidence            9876543    48999999999999999654  3689999999999999999999998   9999999999999999999


Q ss_pred             eEEeeccCCCCCCCCC----CcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 013790          231 PKLSDFGLAREGPMVG----HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  306 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  306 (436)
                      ++|+|||+++......    .........|+..|+|||.+.+..++.++||||||+++|+|++|..||.......  .+.
T Consensus       145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~  222 (267)
T cd06628         145 IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AIF  222 (267)
T ss_pred             EEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HHH
Confidence            9999999987532111    0111123457889999999998889999999999999999999999997643221  111


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      . +..          ...+    ..+...+..+.++|.+||+.||.+||++.+|+++
T Consensus       223 ~-~~~----------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         223 K-IGE----------NASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             H-Hhc----------cCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            1 100          0111    1222345678899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.4e-39  Score=304.89  Aligned_cols=254  Identities=23%  Similarity=0.362  Sum_probs=198.0

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-----hhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      .+|+..+.||+|+||.||+|...       .++..|++|.+.....     .....+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   74 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDV-------DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLR   74 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEc-------CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEE
Confidence            47899999999999999999865       4678899998864321     22356888999999999999999999886


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ....  ...++++||+++++|.+++....  .+++...+.++.|++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        75 ~~~~--~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l  147 (266)
T cd06651          75 DRAE--KTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKL  147 (266)
T ss_pred             cCCC--CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEE
Confidence            5332  24689999999999999996543  588999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCC-CcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          234 SDFGLAREGPMVG-HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       234 ~Dfg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      +|||++....... .........++..|+|||.+.+..++.++|||||||++|+|++|..||........  +.. ....
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~--~~~-~~~~  224 (266)
T cd06651         148 GDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA--IFK-IATQ  224 (266)
T ss_pred             ccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH--HHH-HhcC
Confidence            9999987432111 11111234578899999999988899999999999999999999999976432211  111 1100


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +         ..    ...+...+..+.+++ +||..+|++||++.+|+.+
T Consensus       225 ~---------~~----~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         225 P---------TN----PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             C---------CC----CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            0         01    122233446677888 6888999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.6e-40  Score=310.13  Aligned_cols=266  Identities=25%  Similarity=0.352  Sum_probs=197.2

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|++.+.||+|+||.||+|...       .++..||+|.+.....  .....+.+|+.+++.++||||+++++++..++ 
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   72 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNK-------KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES-   72 (285)
T ss_pred             CceEeeEecccCceEEEEEEEC-------CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC-
Confidence            5888999999999999999865       4678899999865422  23456788999999999999999999987654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                         ..++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.++|+||
T Consensus        73 ---~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  145 (285)
T cd07861          73 ---RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADF  145 (285)
T ss_pred             ---eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcc
Confidence               4599999996 68988886533 25689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhhccc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~  314 (436)
                      |++......  ........+++.|+|||.+.+. .++.++|||||||++|+|+||+.||.+....... ...........
T Consensus       146 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~  223 (285)
T cd07861         146 GLARAFGIP--VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTE  223 (285)
T ss_pred             cceeecCCC--cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            998743211  1122234568899999988654 5788999999999999999999999865432211 11111100000


Q ss_pred             Cc-------cccccc----cCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DS-------KKFGLI----MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~-------~~~~~~----~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..       ..+...    ....+ .......+.++.++|.+||..||.+|||+.+|+.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         224 DVWPGVTSLPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhhhcchhhHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00       000000    00000 00011235678899999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.7e-40  Score=307.43  Aligned_cols=256  Identities=31%  Similarity=0.486  Sum_probs=198.1

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      +.||+|+||.||+|.+..... ...++..+|+|.+.... ......+.+|+.+++.++||||+++++++.....    .+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~-~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILG-PGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP----QY   75 (269)
T ss_pred             CccccccceeEEeeeeccccc-CcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC----eE
Confidence            369999999999998763221 12345789999886543 2345678899999999999999999999875543    59


Q ss_pred             EEEEecCCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC-----ceEE
Q 013790          164 LVYEFMLNRSLEDHLFNRA-----FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-----RPKL  233 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl  233 (436)
                      +||||+++++|.+++....     ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++     .++|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence            9999999999999997532     23478899999999999999999998   999999999999999877     8999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      +|||++................++..|+|||.+.++.++.++|||||||++|+|+| |..||.......   ....+...
T Consensus       153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~~  229 (269)
T cd05044         153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHVTAG  229 (269)
T ss_pred             CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHHhcC
Confidence            99999875322222222223445778999999999999999999999999999998 999997544322   22221110


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                      .              ....+...+..+.++|.+||..+|.+||++.+|++.|+
T Consensus       230 ~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         230 G--------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             C--------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            0              00112234567889999999999999999999998885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.4e-39  Score=306.02  Aligned_cols=263  Identities=25%  Similarity=0.402  Sum_probs=202.7

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      |.+.+.||+|+||.||+|.+..    ...++..||||++....  ....+.+.+|+.+++.++||||+++++++......
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   76 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKS----EDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAK   76 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeec----cCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCC
Confidence            5677899999999999998752    12457899999986542  23456788999999999999999999988654322


Q ss_pred             c--eeEEEEEEecCCCCHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          159 G--IQRLLVYEFMLNRSLEDHLFNRA----FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       159 ~--~~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      +  ...+++++|+.+|+|.+++....    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        77 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~k  153 (273)
T cd05074          77 GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVC  153 (273)
T ss_pred             CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEE
Confidence            1  23478899999999998875321    22578899999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhh
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      |+|||+++...............++..|++||.+.+..++.++||||||+++|+|++ |..||......   .+..++..
T Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~  230 (273)
T cd05074         154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLIK  230 (273)
T ss_pred             ECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHHc
Confidence            999999875322221112223345678999999988889999999999999999999 88998755332   22222221


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                      ...          .    ..+...+..+.+++.+||+.+|++|||+.+++..|+++
T Consensus       231 ~~~----------~----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNR----------L----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCc----------C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            100          0    01112346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.2e-39  Score=300.60  Aligned_cols=247  Identities=29%  Similarity=0.449  Sum_probs=194.6

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      +.||+|+||.||+|...        ++..||+|.+...... ....+.+|+.+++.++||||+++++++...+.    .+
T Consensus         1 ~~ig~g~~g~vy~~~~~--------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~   68 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK--------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQP----IY   68 (250)
T ss_pred             CccCCCCCceEEEEEec--------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCc----cE
Confidence            36999999999999853        4678999998765432 23468889999999999999999999876543    49


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCC
Q 013790          164 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  243 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  243 (436)
                      +||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus        69 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  144 (250)
T cd05085          69 IVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQED  144 (250)
T ss_pred             EEEECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecc
Confidence            9999999999999986543 4688999999999999999999998   99999999999999999999999999986421


Q ss_pred             CCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccccc
Q 013790          244 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI  322 (436)
Q Consensus       244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (436)
                      .. .........++..|+|||++.+..++.++||||||+++|++++ |..||........   ...+....         
T Consensus       145 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~~~~~~~~---------  211 (250)
T cd05085         145 DG-IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---REQVEKGY---------  211 (250)
T ss_pred             cc-ccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHHcCC---------
Confidence            11 1111112234567999999988889999999999999999998 9999976543321   11111110         


Q ss_pred             cCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       323 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                       ..    ..+...+..+.+++.+||..+|++||++.++++.|.
T Consensus       212 -~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         212 -RM----SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             -CC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence             00    111223467899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.7e-40  Score=311.38  Aligned_cols=265  Identities=27%  Similarity=0.376  Sum_probs=203.6

Q ss_pred             HHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCceeeee
Q 013790           72 SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIG  150 (436)
Q Consensus        72 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~  150 (436)
                      +.+....++|++.+.||+|+||.||+|...       .+++.+|+|.+.... .....+.+|+.+++.+ +||||+++++
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~-------~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~   82 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNK-------KNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYG   82 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEEC-------CCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeee
Confidence            444556789999999999999999999865       457789999876532 2235678899999999 6999999999


Q ss_pred             EeeecC-CcceeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          151 YCAVDG-ERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       151 ~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      ++.... ..+...++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||+++.
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~  159 (286)
T cd06638          83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTT  159 (286)
T ss_pred             eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECC
Confidence            875432 2234579999999999999987532  234688999999999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCCCCCCCCCCcccccccccCCCccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 013790          228 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE  302 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  302 (436)
                      ++.++|+|||+++.....  ........|+..|+|||++..     ..++.++|||||||++|+|++|..||....+...
T Consensus       160 ~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~  237 (286)
T cd06638         160 EGGVKLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA  237 (286)
T ss_pred             CCCEEEccCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence            999999999998753211  122234568999999999853     4578899999999999999999999976543211


Q ss_pred             HHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          303 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                        +... ....          .+.+  ..+...+..+.+||.+||+.||++|||+.+|++++
T Consensus       238 --~~~~-~~~~----------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         238 --LFKI-PRNP----------PPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             --Hhhc-cccC----------CCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence              1110 0000          0000  01112245788999999999999999999998764

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=301.78  Aligned_cols=248  Identities=31%  Similarity=0.455  Sum_probs=196.7

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      +.||.|+||.||++...       . ++.||+|.+...... ....+.+|+.++++++||||+++++++.....    .+
T Consensus         1 ~~lg~g~~g~v~~~~~~-------~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~   68 (251)
T cd05041           1 EKIGKGNFGDVYKGVLK-------G-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQP----IY   68 (251)
T ss_pred             CccccCCCceEEEEEEe-------C-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCC----eE
Confidence            46999999999999865       2 788999998765443 45678999999999999999999999876553    49


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCC
Q 013790          164 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  243 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  243 (436)
                      +||||+.+++|.+++.... ..+++..+..++.+++.||.|||++   +++||||+|+|||++.++.++|+|||++....
T Consensus        69 ~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          69 IVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            9999999999999996643 3688999999999999999999998   99999999999999999999999999987532


Q ss_pred             CCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccccc
Q 013790          244 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI  322 (436)
Q Consensus       244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (436)
                      ............++..|+|||.+.++.++.++||||||+++|+|+| |..||...........   +....         
T Consensus       145 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~---~~~~~---------  212 (251)
T cd05041         145 GGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---IESGY---------  212 (251)
T ss_pred             CCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH---HhcCC---------
Confidence            1111111112233567999999988889999999999999999999 8889876543322211   11110         


Q ss_pred             cCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       323 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                           ....+...+..+.+++.+||..+|.+|||+.++++.|+
T Consensus       213 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         213 -----RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             -----CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence                 00112233567999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=294.38  Aligned_cols=257  Identities=23%  Similarity=0.263  Sum_probs=209.5

Q ss_pred             hhcCCccc-ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCceeeeeEeee
Q 013790           77 ATNDFSRM-LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAV  154 (436)
Q Consensus        77 ~~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  154 (436)
                      .+++|.+. +.||-|-.|.|-.+.++       .+++.+|+|++...     ...++|+++.-.. .|||||.+++++.+
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k-------~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeN  126 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHK-------RTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYEN  126 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEec-------cchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence            45677774 47899999999999877       67889999998533     4567888876665 49999999999987


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc---CCCce
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRP  231 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~  231 (436)
                      .-..-..+.+|||.++||.|...|.+++...+++.++..|+.||+.|+.|||+.   +|.||||||+|+|..   .|..+
T Consensus       127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~l  203 (400)
T KOG0604|consen  127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPL  203 (400)
T ss_pred             hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcce
Confidence            655556778999999999999999999888999999999999999999999998   999999999999995   46679


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      ||+|||+|+..   .......+.+.|+.|.|||++....|+...|+||+||++|-|++|.+||........         
T Consensus       204 KLtDfGFAK~t---~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---------  271 (400)
T KOG0604|consen  204 KLTDFGFAKET---QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---------  271 (400)
T ss_pred             Eeccccccccc---CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---------
Confidence            99999999863   223445667899999999999999999999999999999999999999975432111         


Q ss_pred             cccCccccccccCC--cccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 YPADSKKFGLIMDP--RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 ~~~~~~~~~~~~~~--~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                         .+.+-..+...  .++.......++...++|+.+|..+|.+|.|+.+++++
T Consensus       272 ---spgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  272 ---SPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ---ChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence               00000001111  12233456778889999999999999999999999887

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-40  Score=319.20  Aligned_cols=256  Identities=23%  Similarity=0.287  Sum_probs=196.0

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|++++.||+|+||.||++...       .+++.||+|++....   ....+.+.+|+.++..++||||+++++++...
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   73 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMK-------NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE   73 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEEC-------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence            47999999999999999999875       467889999986532   22345678899999999999999999988765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~D  145 (331)
T cd05597          74 N----NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLAD  145 (331)
T ss_pred             C----eEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEE
Confidence            4    4699999999999999996532 4689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      ||++...... .........||+.|+|||++.+     ..++.++|||||||++|+|++|..||.........   ..+.
T Consensus       146 fg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~---~~i~  221 (331)
T cd05597         146 FGSCLRLLAD-GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY---GKIM  221 (331)
T ss_pred             CCceeecCCC-CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH---HHHH
Confidence            9998643211 1112233568999999999863     45788999999999999999999999765432211   1111


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD--RPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~  363 (436)
                      ....   .+      .+.. .....+..+.++|.+||..++..  ||++.+++.+
T Consensus       222 ~~~~---~~------~~~~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         222 NHKE---HF------QFPP-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cCCC---cc------cCCC-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            1000   00      0000 01113467889999988654443  7899999887

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=309.83  Aligned_cols=268  Identities=23%  Similarity=0.342  Sum_probs=210.0

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHh--ccCCCCceeeeeEee
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG--VLEHPNLVKLIGYCA  153 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~hpnIv~~~~~~~  153 (436)
                      ....+.++.+.||+|.||.||+|.|+         |..||||++...   +...+.+|.++++  .|+|+||+.|++.-.
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr---------Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~  275 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR---------GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADN  275 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc---------CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence            34568889999999999999999997         677999999754   3456778888886  569999999999888


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCceeeccCCCCcEEEcCC
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG-----LEVQVIYRDFKASNVLLDEN  228 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-----~~~~ivH~Dlkp~NIll~~~  228 (436)
                      .+.....++|||++|.+.|||.|||.+.   .++....++++..+|.||++||..     ..+.|.|||||+.||||..+
T Consensus       276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn  352 (513)
T KOG2052|consen  276 KDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  352 (513)
T ss_pred             cCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence            8777788999999999999999999763   689999999999999999999974     36789999999999999999


Q ss_pred             CceEEeeccCCCCCCCCC--CcccccccccCCCcccccccccCC----C--CchhhHHHHHHHHHHHHhC----------
Q 013790          229 FRPKLSDFGLAREGPMVG--HTHVSTAVVGTFGYAAPDYIETGH----L--TAKSDVWSFGVVLYEMLTG----------  290 (436)
Q Consensus       229 ~~~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwSlGvil~elltg----------  290 (436)
                      |.+.|+|+|||.......  ........+||..|||||++...-    +  -..+||||||.++||++..          
T Consensus       353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey  432 (513)
T KOG2052|consen  353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY  432 (513)
T ss_pred             CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence            999999999997543221  122345578999999999996532    1  1359999999999999853          


Q ss_pred             CCCCCCCCchhhHHHHHHHhhcccCcccccccc----CCcccCc-CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          291 RRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM----DPRLEKE-YSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       291 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                      +.||.+.-+.+           |....+...+.    .|.++.. .+.+....+.+|++.||..||.-|.|+-.|.+.|.
T Consensus       433 ~~Pyyd~Vp~D-----------Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~  501 (513)
T KOG2052|consen  433 QLPYYDVVPSD-----------PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLA  501 (513)
T ss_pred             cCCcccCCCCC-----------CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHH
Confidence            35665432221           11111111122    2222222 24566778999999999999999999999999998


Q ss_pred             Hhhh
Q 013790          366 QIVQ  369 (436)
Q Consensus       366 ~~~~  369 (436)
                      ++.+
T Consensus       502 ~l~~  505 (513)
T KOG2052|consen  502 KLSN  505 (513)
T ss_pred             HHhc
Confidence            8864

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=7.4e-40  Score=308.71  Aligned_cols=248  Identities=27%  Similarity=0.403  Sum_probs=199.4

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      .|+..+.||+|+||.||+|.+.       .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++....  
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   75 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDN-------RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT--   75 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEc-------CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC--
Confidence            4677788999999999999865       457889999987543 233457889999999999999999999887654  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..++||||+++++|.+++..   ..+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||+
T Consensus        76 --~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~  147 (277)
T cd06642          76 --KLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGV  147 (277)
T ss_pred             --ceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccc
Confidence              35999999999999999854   3689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  318 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  318 (436)
                      +.....  .........++..|+|||.+.+..++.++||||||+++|+|++|..||....+...   ...+.   ..   
T Consensus       148 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~~~---~~---  216 (277)
T cd06642         148 AGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFLIP---KN---  216 (277)
T ss_pred             cccccC--cchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhhhh---cC---
Confidence            875321  12222334678899999999988899999999999999999999999975433221   11110   00   


Q ss_pred             cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       319 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                          ..+    ......+..+.++|.+||..+|++||++.+++.+
T Consensus       217 ----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         217 ----SPP----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ----CCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                011    1122335678899999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.2e-39  Score=303.44  Aligned_cols=252  Identities=22%  Similarity=0.361  Sum_probs=203.7

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|+.++.||.|+||.||.+...       .++..+++|.+....  ......+.+|+.++++++|+||+++++++...+ 
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-   72 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRT-------EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-   72 (256)
T ss_pred             CceEeeEecccCCceEEEEEEc-------CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC-
Confidence            5888999999999999998854       567889999876542  334567889999999999999999999997654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..+++|||+++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||
T Consensus        73 ---~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~  146 (256)
T cd08221          73 ---TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFG  146 (256)
T ss_pred             ---eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCc
Confidence               469999999999999999776445789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ++.......  .......+++.|+|||.+.+..++.++||||||+++|+|++|..||........   ...+...     
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~---~~~~~~~-----  216 (256)
T cd08221         147 ISKILGSEY--SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL---VVKIVQG-----  216 (256)
T ss_pred             ceEEccccc--ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHcC-----
Confidence            987532211  123345689999999999888889999999999999999999999976543221   1111100     


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                              .+. ..+...+..+.+++.+||..+|.+||++.++++++
T Consensus       217 --------~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         217 --------NYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             --------CCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                    000 01123346788999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-39  Score=309.02  Aligned_cols=254  Identities=25%  Similarity=0.412  Sum_probs=199.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|++++.||+|+||.||++.+.       .++..||+|.+... .......+.+|+.++++++||||+++++.+...+ 
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-   72 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHR-------PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG-   72 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEc-------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC-
Confidence            36889999999999999999865       46788999988654 2233467889999999999999999999887654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                         ..++||||+++++|..++.... ...+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.++|+||
T Consensus        73 ---~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~df  147 (286)
T cd06622          73 ---AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDF  147 (286)
T ss_pred             ---eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeec
Confidence               4599999999999999986532 23689999999999999999999963  28999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG------HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      |++....    ........++..|+|||.+.+.      .++.++|||||||++|+|++|..||..............+.
T Consensus       148 g~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  223 (286)
T cd06622         148 GVSGNLV----ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIV  223 (286)
T ss_pred             CCccccc----CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHh
Confidence            9986431    1122334578899999998554      34789999999999999999999997543322211111111


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...              ....+...+..+.++|.+||..+|++||++.+++.+
T Consensus       224 ~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         224 DGD--------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             hcC--------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            100              011223355778899999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.3e-39  Score=309.23  Aligned_cols=267  Identities=28%  Similarity=0.398  Sum_probs=206.0

Q ss_pred             cCHHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCcee
Q 013790           69 FSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVK  147 (436)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  147 (436)
                      +.+.++....++|.+.+.||+|+||.||++...       .+++.+|+|.+.... .....+.+|+.++..+ +||||++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~-------~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~   83 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNK-------KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVK   83 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEEC-------CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEE
Confidence            445566667889999999999999999999865       467889999986542 2335677899999988 7999999


Q ss_pred             eeeEeeecCC-cceeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEE
Q 013790          148 LIGYCAVDGE-RGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL  224 (436)
Q Consensus       148 ~~~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIl  224 (436)
                      +++++...+. .+...++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||||+||+
T Consensus        84 ~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nil  160 (291)
T cd06639          84 FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNIL  160 (291)
T ss_pred             EEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEE
Confidence            9999875432 233569999999999999988642  234689999999999999999999998   9999999999999


Q ss_pred             EcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 013790          225 LDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-----HLTAKSDVWSFGVVLYEMLTGRRSLERNRP  299 (436)
Q Consensus       225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~pf~~~~~  299 (436)
                      ++.++.+||+|||++......  ........|+..|+|||.+...     .++.++|||||||++|+|++|..||....+
T Consensus       161 i~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~  238 (291)
T cd06639         161 LTTEGGVKLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP  238 (291)
T ss_pred             EcCCCCEEEeecccchhcccc--cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence            999999999999998753211  1122335688899999998543     367899999999999999999999976543


Q ss_pred             hhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...  +..+....+           +.+  ..+......+.+||.+||+.+|++||++.+|+++
T Consensus       239 ~~~--~~~~~~~~~-----------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         239 VKT--LFKIPRNPP-----------PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHH--HHHHhcCCC-----------CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            211  111111100           000  0111233568899999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-41  Score=293.54  Aligned_cols=255  Identities=27%  Similarity=0.465  Sum_probs=198.4

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccC-CCCceeeeeEeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLE-HPNLVKLIGYCAV  154 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~  154 (436)
                      ..++.+.+..||.|+.|.||+++++       .++..+|||.+.+.. ....+++...+.++...+ +|+||+.+|+|..
T Consensus        90 dindl~~l~dlGsGtcG~V~k~~~r-------s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   90 DINDLENLGDLGSGTCGQVWKMRFR-------STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             ChHHhhhHHhhcCCCccceEEEEEc-------ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            3467777888999999999999987       678999999998764 344566777777776665 9999999999987


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      +..-    ++.||.| ..-++.++. +...++++..+-++...+++||.||..++  +|+|||+||+|||+|+.|++|||
T Consensus       163 n~dV----~IcMelM-s~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlC  234 (391)
T KOG0983|consen  163 NTDV----FICMELM-STCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLC  234 (391)
T ss_pred             CchH----HHHHHHH-HHHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEee
Confidence            6653    7889977 334444444 44468999999999999999999999874  99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      |||++-+...   ..-.+...|-+.|||||.+.-   ..|+.++||||||++++||.||+.||.+....  .+.+..+..
T Consensus       235 DFGIsGrlvd---SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvln  309 (391)
T KOG0983|consen  235 DFGISGRLVD---SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVLN  309 (391)
T ss_pred             cccccceeec---ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHHh
Confidence            9999865322   222233568999999999843   47889999999999999999999999875432  222222222


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .          ..|.++..  ...+..+.+++..||..|+.+||.+.+++++
T Consensus       310 ~----------ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  310 E----------EPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             c----------CCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            1          01122211  1145788999999999999999999999876

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.6e-39  Score=312.43  Aligned_cols=266  Identities=24%  Similarity=0.349  Sum_probs=189.5

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEEE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLL  164 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~l  164 (436)
                      .+||+|+||.||+|..+     +..++..||+|.+.....  ...+.+|+.+++.++||||+++++++......  ..++
T Consensus         7 ~~lG~G~~g~Vy~~~~~-----~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~~~l   77 (317)
T cd07867           7 CKVGRGTYGHVYKAKRK-----DGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDR--KVWL   77 (317)
T ss_pred             eEeccCCCeeEEEEEec-----CCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCC--eEEE
Confidence            57999999999999875     234568899999875532  24577899999999999999999988654332  4689


Q ss_pred             EEEecCCCCHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE----cCCCceEE
Q 013790          165 VYEFMLNRSLEDHLFNR-------AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKL  233 (436)
Q Consensus       165 v~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl  233 (436)
                      ||||+. ++|.+++...       ....+++..+..++.||+.||.|||+.   +|+||||||+|||+    +.++.+||
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl  153 (317)
T cd07867          78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI  153 (317)
T ss_pred             EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEE
Confidence            999985 5888877421       123588999999999999999999998   99999999999999    56789999


Q ss_pred             eeccCCCCCCCCC-CcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh-------hHH
Q 013790          234 SDFGLAREGPMVG-HTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-------EQR  304 (436)
Q Consensus       234 ~Dfg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-------~~~  304 (436)
                      +|||+++...... .........||..|+|||++.+ ..++.++|||||||++|||+||.+||.......       ...
T Consensus       154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~  233 (317)
T cd07867         154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ  233 (317)
T ss_pred             eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHH
Confidence            9999997532211 1112234568999999999876 457899999999999999999999997533211       011


Q ss_pred             HHHHHhhcccCc-ccccc-------------c-----cCCccc---CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 013790          305 LLEWVQQYPADS-KKFGL-------------I-----MDPRLE---KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE  362 (436)
Q Consensus       305 ~~~~~~~~~~~~-~~~~~-------------~-----~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~  362 (436)
                      +........... ..+..             .     ....+.   ..........+.+|+.+||..||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             HHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            111111110000 00000             0     000000   0001112346889999999999999999999986


Q ss_pred             H
Q 013790          363 R  363 (436)
Q Consensus       363 ~  363 (436)
                      +
T Consensus       314 h  314 (317)
T cd07867         314 D  314 (317)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.7e-39  Score=301.30  Aligned_cols=255  Identities=20%  Similarity=0.330  Sum_probs=188.8

Q ss_pred             cccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEEE
Q 013790           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLL  164 (436)
Q Consensus        86 ~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~l  164 (436)
                      .||+|+||.||+|...     .......+++|.+.... ....+.+.+|+.+++.++||||+++++.+....    ..++
T Consensus         2 ~lg~G~~g~v~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~----~~~l   72 (268)
T cd05086           2 EIGNGWFGKVLLSEIY-----TDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI----PYLL   72 (268)
T ss_pred             cCCCCcCceEEEEEEE-----cCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC----ccEE
Confidence            5999999999999764     12234567788776543 234567899999999999999999999987654    3599


Q ss_pred             EEEecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCC
Q 013790          165 VYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG  242 (436)
Q Consensus       165 v~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  242 (436)
                      ||||+++|+|.+++....  ....++..+..++.||+.||.|||+.   +++||||||+|||++.++.++|+|||++...
T Consensus        73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~  149 (268)
T cd05086          73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSR  149 (268)
T ss_pred             EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEeccccccccc
Confidence            999999999999997542  23467778889999999999999998   9999999999999999999999999998642


Q ss_pred             CCCCCcccccccccCCCccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 013790          243 PMVGHTHVSTAVVGTFGYAAPDYIET-------GHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       243 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      .............++..|+|||++..       ..++.++||||||+++|||++ |..||....+...  +...+.... 
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~~~~-  226 (268)
T cd05086         150 YKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV--LNHVIKDQQ-  226 (268)
T ss_pred             CcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHhhcc-
Confidence            11111122234567889999999743       245778999999999999997 5778865443221  111111110 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                           ....++.+...    .+..+.+++..|| .+|++||++.+|++.|.
T Consensus       227 -----~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         227 -----VKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             -----cccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence                 01122222222    3367788999999 67999999999988773

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.9e-39  Score=303.05  Aligned_cols=254  Identities=26%  Similarity=0.399  Sum_probs=201.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ..+|.+.+.||+|+||.||++.+.        .+..+|+|.+.... ...+.+.+|+.+++.++|+||+++++++.. . 
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~--------~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~-   73 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN--------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E-   73 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec--------CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C-
Confidence            468999999999999999999754        34569999886543 234678889999999999999999998765 2 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..+++|||+++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||
T Consensus        74 ---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~  147 (260)
T cd05073          74 ---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFG  147 (260)
T ss_pred             ---CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCc
Confidence               358999999999999999775555788999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      ++....... ........++..|+|||.+.+..++.++|+||||+++|+++| |..||.......   ...++.....  
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~~--  221 (260)
T cd05073         148 LARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALERGYR--  221 (260)
T ss_pred             ceeeccCCC-cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhCCCC--
Confidence            987532111 111122345677999999988889999999999999999999 999997654322   2222211100  


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  366 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~  366 (436)
                                  ...+...+..+.+++.+||..+|++||++.+++..|+.
T Consensus       222 ------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 ------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                        00112234678899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=305.34  Aligned_cols=259  Identities=30%  Similarity=0.408  Sum_probs=204.1

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      ..++|++.+.||.|+||.||+|..+       .+++.+++|++..... ..+.+.+|+.+++++ +||||+++++++...
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHK-------KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKK   75 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEEC-------CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence            4578999999999999999999875       4567899999876543 346788999999998 699999999998765


Q ss_pred             CC--cceeEEEEEEecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCce
Q 013790          156 GE--RGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  231 (436)
Q Consensus       156 ~~--~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  231 (436)
                      ..  .+...++||||+++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~  152 (275)
T cd06608          76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEV  152 (275)
T ss_pred             CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeE
Confidence            52  3456799999999999999986533  45789999999999999999999998   99999999999999999999


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  306 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  306 (436)
                      +|+|||++....  ..........|+..|+|||.+..     ..++.++||||||+++|+|++|..||....+..  ...
T Consensus       153 ~l~d~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~  228 (275)
T cd06608         153 KLVDFGVSAQLD--STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALF  228 (275)
T ss_pred             EECCCccceecc--cchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHH
Confidence            999999986422  12222344568899999998754     346788999999999999999999997543321  111


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ......           .+.+  ..+...+..+.+||.+||..||++|||+.+++.+
T Consensus       229 ~~~~~~-----------~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         229 KIPRNP-----------PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             HhhccC-----------CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            111110           0001  1122345688999999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-39  Score=308.68  Aligned_cols=258  Identities=29%  Similarity=0.417  Sum_probs=203.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++++.||+|+||.||++.+.       .+++.||+|++.... ....+.+.+|+++++.++||||+++++++...+
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   76 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHI-------PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN   76 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEc-------CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC
Confidence            357899999999999999999865       467889999876543 234567889999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+++++|.+++...  +.+++..+..++.+++.||.|||+.  .+++|+||+|+||+++.++.++|+||
T Consensus        77 ----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~  148 (284)
T cd06620          77 ----NICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDF  148 (284)
T ss_pred             ----EEEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccC
Confidence                459999999999999998654  3689999999999999999999973  28999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----hhHHHHHHHhh
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK-----TEQRLLEWVQQ  311 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-----~~~~~~~~~~~  311 (436)
                      |++.....    .......|+..|+|||++.+..++.++|||||||++|+|++|..||......     ....+..+...
T Consensus       149 gl~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  224 (284)
T cd06620         149 GVSGELIN----SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ  224 (284)
T ss_pred             Ccccchhh----hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH
Confidence            99864211    1122356899999999998888999999999999999999999999865432     11112222211


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                      .....       .+.+   .....+..+.+|+.+||..||++|||+.+++++.
T Consensus       225 ~~~~~-------~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         225 IVQEP-------PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             Hhhcc-------CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            11000       0111   0112456789999999999999999999998864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.5e-39  Score=304.41  Aligned_cols=252  Identities=28%  Similarity=0.454  Sum_probs=198.3

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc------hhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      +|+..+.||.|+||.||+|...        ++..+|+|.+.....      .....+.+|+.+++.++|+||+++++++.
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   72 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN--------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL   72 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc--------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee
Confidence            5788899999999999999753        567899998864321      12356888999999999999999999987


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ...    ..+++|||+++++|.+++.+..  .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        73 ~~~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l  143 (265)
T cd06631          73 DDN----TISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKL  143 (265)
T ss_pred             cCC----eEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEe
Confidence            653    4699999999999999996543  688999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCC----CcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 013790          234 SDFGLAREGPMVG----HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  309 (436)
Q Consensus       234 ~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  309 (436)
                      +|||++.......    .........|+..|+|||.+.+..++.++||||||+++|+|++|..||.........  .. .
T Consensus       144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~~-~  220 (265)
T cd06631         144 IDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM--FY-I  220 (265)
T ss_pred             ccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH--HH-h
Confidence            9999987432111    111223456889999999999888999999999999999999999999764332211  11 1


Q ss_pred             hhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .....        ..+.    .+...+..+.++|.+||..+|.+||++.+++.+
T Consensus       221 ~~~~~--------~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         221 GAHRG--------LMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             hhccC--------CCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00000        0011    122234678899999999999999999998753

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3e-39  Score=301.69  Aligned_cols=253  Identities=23%  Similarity=0.352  Sum_probs=203.0

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|++.+.||.|+||.||++...       .++..||+|.+....  ....+.+..|+.+++.++||||+++++++.....
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRK-------SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN   73 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeec-------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC
Confidence            5888899999999999999865       467889999986542  2334568889999999999999999998765432


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCCceeeccCCCCcEEEcCCCc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLH-----EGLEVQVIYRDFKASNVLLDENFR  230 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~  230 (436)
                        ...+++|||+++++|.+++...  ....+++..++.++.||+.||.|||     +.   +++|+||+|+||+++.++.
T Consensus        74 --~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~  148 (265)
T cd08217          74 --QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNN  148 (265)
T ss_pred             --CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCC
Confidence              3468999999999999998653  2357899999999999999999999     66   9999999999999999999


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      +||+|||++......  ........++..|+|||.+.+..++.++||||||+++|+|++|..||......   .+...+.
T Consensus       149 ~kl~d~g~~~~~~~~--~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~  223 (265)
T cd08217         149 VKLGDFGLAKILGHD--SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKIK  223 (265)
T ss_pred             EEEecccccccccCC--cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHHh
Confidence            999999998753221  11123456899999999998888999999999999999999999999865422   2222222


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....              ...+...+..+.+++.+||..+|.+||++.+|+++
T Consensus       224 ~~~~--------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         224 EGKF--------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             cCCC--------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            1110              11222345678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=312.41  Aligned_cols=255  Identities=24%  Similarity=0.349  Sum_probs=202.6

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|+..+.||+|+||.||+|...       .+++.||+|.+......   ..+.+..|+++++.++||||+++++.+...
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   73 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLK-------GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE   73 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEc-------CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC
Confidence            37899999999999999999865       46789999999765433   345688899999999999999999988654


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      .    ..++||||+.+++|.+++.......+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|
T Consensus        74 ~----~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~d  146 (316)
T cd05574          74 T----YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSD  146 (316)
T ss_pred             C----EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEee
Confidence            3    469999999999999999765556799999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCC---------------------------cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHH
Q 013790          236 FGLAREGPMVGH---------------------------THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML  288 (436)
Q Consensus       236 fg~a~~~~~~~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell  288 (436)
                      ||++........                           ........|+..|+|||++.+..++.++||||||+++|+|+
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~  226 (316)
T cd05574         147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML  226 (316)
T ss_pred             cchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHh
Confidence            999864321110                           00112346788999999999888999999999999999999


Q ss_pred             hCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC----HHHHHHH
Q 013790          289 TGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK----MSQVVER  363 (436)
Q Consensus       289 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~eil~~  363 (436)
                      +|..||........  +......              ..........+..+.+++.+||..||++||+    +.+++.+
T Consensus       227 ~g~~pf~~~~~~~~--~~~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         227 YGTTPFKGSNRDET--FSNILKK--------------EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             hCCCCCCCCchHHH--HHHHhcC--------------CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            99999976543221  1111110              0000011114578999999999999999999    7777764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.2e-39  Score=301.96  Aligned_cols=245  Identities=24%  Similarity=0.428  Sum_probs=190.7

Q ss_pred             ccccccCceEEEEEEecCCCCC---CCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCccee
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGD---GTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  161 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  161 (436)
                      +.||+|+||.||+|.+......   .......|++|.+...... ...+.+|+.+++.++||||+++++++.. ..    
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~----   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DE----   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CC----
Confidence            3699999999999998732210   0122356888887655433 5778899999999999999999999876 33    


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC-------ceEEe
Q 013790          162 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-------RPKLS  234 (436)
Q Consensus       162 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~  234 (436)
                      .++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++       .+||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence            389999999999999997643 2689999999999999999999998   999999999999999888       79999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhh
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG--HLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      |||++.....      .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||...........   ...
T Consensus       151 Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~---~~~  221 (259)
T cd05037         151 DPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF---YQD  221 (259)
T ss_pred             CCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH---Hhc
Confidence            9999875321      2234567789999999776  78999999999999999999 5778866543221111   110


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                      ..            .+    +......+.+++.+||..+|.+|||+.+|++.|
T Consensus       222 ~~------------~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         222 QH------------RL----PMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             CC------------CC----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            00            00    000116788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.5e-39  Score=302.05  Aligned_cols=254  Identities=22%  Similarity=0.314  Sum_probs=198.8

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-----chhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      ++|.+.+.||+|+||.||+|...       .++..||+|.+....     ....+.+.+|+.+++.+.||||+++++++.
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~-------~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   74 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDA-------DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLR   74 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEc-------CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEec
Confidence            47899999999999999999865       467899999875331     122356888999999999999999999876


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ....  ...+++|||+++++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        75 ~~~~--~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l  147 (265)
T cd06652          75 DPME--RTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKL  147 (265)
T ss_pred             cCCC--ceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEE
Confidence            5432  24689999999999999987543  578899999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCC-cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          234 SDFGLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      +|||++........ ........|+..|+|||.+.+..++.++||||||+++|+|++|..||........  +.. ....
T Consensus       148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~-~~~~  224 (265)
T cd06652         148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IFK-IATQ  224 (265)
T ss_pred             CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HHH-HhcC
Confidence            99999874321111 1112234588899999999888899999999999999999999999976532211  111 1111


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +             .....+...+..+.+++.+||. +|.+||++.+|+++
T Consensus       225 ~-------------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         225 P-------------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             C-------------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            0             0112233445678899999995 99999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=324.33  Aligned_cols=246  Identities=26%  Similarity=0.414  Sum_probs=204.4

Q ss_pred             cccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEEEE
Q 013790           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLV  165 (436)
Q Consensus        86 ~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~lv  165 (436)
                      .||+|+||+||-|+..       .+...+|||-+........+-+..|+.+.+.|+|.|||+++|.+...+    ++-|.
T Consensus       582 VLGKGTYG~VYA~RD~-------~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG----f~kIF  650 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDM-------DTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG----FFKIF  650 (1226)
T ss_pred             EeecCceeEEEeeccc-------cceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC----eEEEE
Confidence            5999999999999855       678889999998777677777899999999999999999999986655    45789


Q ss_pred             EEecCCCCHHHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc-CCCceEEeeccCCCCC
Q 013790          166 YEFMLNRSLEDHLFNRAFPPL--PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREG  242 (436)
Q Consensus       166 ~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~  242 (436)
                      ||.++||+|.++++... +++  .+.++-.+..||++||.|||.+   .|||||||-+||||+ -.|.+||.|||-+++.
T Consensus       651 MEqVPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL  726 (1226)
T KOG4279|consen  651 MEQVPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL  726 (1226)
T ss_pred             eecCCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhh
Confidence            99999999999997754 567  7889999999999999999999   999999999999995 6899999999999873


Q ss_pred             CCCCCcccccccccCCCcccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          243 PMVGHTHVSTAVVGTFGYAAPDYIETG--HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                        .+......++.||..|||||++..+  .|+.++|||||||++.||.||++||......-  ..+-.+..+        
T Consensus       727 --AginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkVGmy--------  794 (1226)
T KOG4279|consen  727 --AGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKVGMY--------  794 (1226)
T ss_pred             --ccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhhhcce--------
Confidence              4445556778899999999999665  58899999999999999999999996432211  011111111        


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                           ......|...+.+...+|.+|+..||.+||++.+++..
T Consensus       795 -----KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  795 -----KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             -----ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence                 11224566778899999999999999999999999864

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.4e-40  Score=317.40  Aligned_cols=256  Identities=21%  Similarity=0.281  Sum_probs=196.7

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|.+.+.||+|+||.||++.++       .+++.||+|++....   ......+..|+.++..++|+||+++++++...
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   73 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLK-------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE   73 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEEC-------CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC
Confidence            47899999999999999999876       457889999986432   12234578899999999999999999988755


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~D  145 (332)
T cd05623          74 N----NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD  145 (332)
T ss_pred             C----EEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEee
Confidence            4    4599999999999999997633 3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      ||++...... .........||+.|+|||++.     ...++.++|||||||++|||++|..||........   ...+.
T Consensus       146 fG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~---~~~i~  221 (332)
T cd05623         146 FGSCLKLMED-GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIM  221 (332)
T ss_pred             cchheecccC-CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH---HHHHh
Confidence            9998642211 112223457999999999986     34678899999999999999999999986543221   11111


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD--RPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~  363 (436)
                      .....   .      .+. ......+..+.+|+.+|+..++..  |+++.+++++
T Consensus       222 ~~~~~---~------~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         222 NHKER---F------QFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCCcc---c------cCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            11000   0      000 011223567889999998765544  6899999887

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.2e-40  Score=317.82  Aligned_cols=256  Identities=22%  Similarity=0.269  Sum_probs=196.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|.+.+.||+|+||.||++...       .+++.||+|.+....   ......+.+|..++..++|+||+++++++...
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~   73 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMK-------HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE   73 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            47999999999999999999865       467889999986532   12234578899999999999999999988765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        74 ~----~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~D  145 (331)
T cd05624          74 N----YLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLAD  145 (331)
T ss_pred             C----EEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEe
Confidence            4    4599999999999999997633 3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      ||++...... .........||+.|+|||++.+     +.++.++|||||||++|+|++|+.||........   ...+.
T Consensus       146 fG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~~i~  221 (331)
T cd05624         146 FGSCLKMNQD-GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIM  221 (331)
T ss_pred             ccceeeccCC-CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH---HHHHH
Confidence            9998753211 1112234569999999999865     4678899999999999999999999976543221   11111


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD--RPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~  363 (436)
                      .....         ..+.. .....+..+.+++.+||..++.+  |+++.+++++
T Consensus       222 ~~~~~---------~~~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         222 NHEER---------FQFPS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             cCCCc---------ccCCC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            10000         00000 01123467889999999876544  4688888766

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.7e-40  Score=310.42  Aligned_cols=250  Identities=26%  Similarity=0.395  Sum_probs=199.1

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcc
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  159 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  159 (436)
                      .|.....||.|+||.||++...       .++..||||.+........+.+.+|+.+++.++||||+++++.+...+   
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~---   92 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEK-------HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD---   92 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEEC-------CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC---
Confidence            3444567999999999999864       467889999987665555677889999999999999999999886544   


Q ss_pred             eeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCC
Q 013790          160 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  239 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  239 (436)
                       ..++||||+++++|.+++...   .+++..+..++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        93 -~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~  165 (292)
T cd06658          93 -ELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFC  165 (292)
T ss_pred             -eEEEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcch
Confidence             459999999999999988542   588999999999999999999998   9999999999999999999999999998


Q ss_pred             CCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccc
Q 013790          240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF  319 (436)
Q Consensus       240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  319 (436)
                      .....  .........|+..|+|||.+.+..++.++||||||+++|||++|..||....+......   +...       
T Consensus       166 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~-------  233 (292)
T cd06658         166 AQVSK--EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IRDN-------  233 (292)
T ss_pred             hhccc--ccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhc-------
Confidence            64221  11122345688999999999888899999999999999999999999976543322111   1110       


Q ss_pred             ccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          320 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       320 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                         ..+.+..  ....+..+.+++.+||..||.+|||+.+++++
T Consensus       234 ---~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         234 ---LPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ---CCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence               0111110  11234578899999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.4e-39  Score=301.37  Aligned_cols=251  Identities=25%  Similarity=0.414  Sum_probs=201.8

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|++.+.||+|+||.||++...       .+++.||+|.+....  ....+.+.+|+.+++.++||||+++++++...+ 
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   72 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSK-------EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG-   72 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEc-------CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC-
Confidence            5888999999999999999865       467889999986432  233457889999999999999999999886554 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+.+++|.+++.......+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        73 ---~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~  146 (256)
T cd08218          73 ---NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFG  146 (256)
T ss_pred             ---eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeecc
Confidence               459999999999999999765445689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ++.....  .........|++.|+|||++.+..++.++|+|||||++|+|++|..||........  .........    
T Consensus       147 ~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~--~~~~~~~~~----  218 (256)
T cd08218         147 IARVLNS--TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL--VLKIIRGSY----  218 (256)
T ss_pred             ceeecCc--chhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH--HHHHhcCCC----
Confidence            9874321  11122334688899999999888899999999999999999999999975433221  111111100    


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                             +    ..+...+..+.++|.+||+.+|.+||++.+|+++
T Consensus       219 -------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         219 -------P----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             -------C----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                   0    1122234678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.7e-39  Score=300.86  Aligned_cols=250  Identities=25%  Similarity=0.384  Sum_probs=200.8

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|+..+.||+|+||.||++...       .++..+|+|.+....  ......+.+|+.+++.++||||+++++.+...+ 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-   72 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRK-------ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK-   72 (256)
T ss_pred             CceEEEEecccCceEEEEEEEc-------CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC-
Confidence            5888999999999999999865       467889999987543  233467889999999999999999999886543 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC-CceEEeec
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDF  236 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df  236 (436)
                         ..++||||+++++|.+++.......+++..+..++.|++.||.|||++   +++|+||+|+||+++.+ +.++|+||
T Consensus        73 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~  146 (256)
T cd08220          73 ---ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDF  146 (256)
T ss_pred             ---EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccC
Confidence               459999999999999999776555689999999999999999999998   99999999999999854 46899999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      |++.....   ........++..|+|||.+.+..++.++||||||+++|+|++|..||...+....   .........  
T Consensus       147 ~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~--  218 (256)
T cd08220         147 GISKILSS---KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKIMSGTF--  218 (256)
T ss_pred             CCceecCC---CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHHHhcCC--
Confidence            99875321   1222335688899999999888889999999999999999999999976543221   111111000  


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                  ...+...+..+.+++.+||..||.+|||+.+++.+
T Consensus       219 ------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 ------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                        01112234678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6e-39  Score=303.60  Aligned_cols=267  Identities=26%  Similarity=0.354  Sum_probs=199.4

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|+..+.||+|+||.||+|..+       .+++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   73 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNR-------ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR   73 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEEC-------CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC
Confidence            46889999999999999999875       4678899998864422  23356788999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+++++|..++...  ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+||
T Consensus        74 ----~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~df  144 (286)
T cd07847          74 ----KLHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDF  144 (286)
T ss_pred             ----EEEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcc
Confidence                459999999998888877543  3689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHH-HHhhccc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE-WVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~-~~~~~~~  314 (436)
                      |++......  ........++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+........... .......
T Consensus       145 g~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  222 (286)
T cd07847         145 GFARILTGP--GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP  222 (286)
T ss_pred             ccceecCCC--cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            999753221  112233457889999999876 457889999999999999999999998665432221111 1000000


Q ss_pred             -------CccccccccCCcccCcCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 -------DSKKFGLIMDPRLEKEYS-----INEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 -------~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                             ..........+......+     ...+..+.+|+.+||..||++||++.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         223 RHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             HHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                   000000000010000000     1225678899999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-40  Score=319.21  Aligned_cols=242  Identities=25%  Similarity=0.343  Sum_probs=185.8

Q ss_pred             ccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhcc---CCCCceeeeeEeeecCCcce
Q 013790           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVL---EHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        87 ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~~  160 (436)
                      ||+|+||.||+|...       .++..||+|++......   ....+..|..++..+   +||||+.+++++....    
T Consensus         1 lG~G~~g~Vy~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~----   69 (330)
T cd05586           1 IGKGTFGQVYQVRKK-------DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS----   69 (330)
T ss_pred             CCCCCceEEEEEEEC-------CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC----
Confidence            799999999999865       56789999998654221   223345566666655   6999999999887654    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++||||+.+|+|..++...  ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.++|+|||++.
T Consensus        70 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~  144 (330)
T cd05586          70 DLYLVTDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK  144 (330)
T ss_pred             eEEEEEcCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCc
Confidence            359999999999999998654  3689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF  319 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  319 (436)
                      ...  ..........||..|+|||++.+. .++.++|||||||++|+|++|..||........   ...+....      
T Consensus       145 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~---~~~i~~~~------  213 (330)
T cd05586         145 ANL--TDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM---YRNIAFGK------  213 (330)
T ss_pred             CCC--CCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH---HHHHHcCC------
Confidence            421  112223456799999999998654 478999999999999999999999976543221   11111000      


Q ss_pred             ccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC----CHHHHHHH
Q 013790          320 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP----KMSQVVER  363 (436)
Q Consensus       320 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP----s~~eil~~  363 (436)
                           ..+..   ...+..+.+|+.+||..||.+||    ++.+++++
T Consensus       214 -----~~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         214 -----VRFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             -----CCCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence                 00110   11245778999999999999998    56666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-40  Score=317.36  Aligned_cols=254  Identities=25%  Similarity=0.369  Sum_probs=200.2

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccC-CCCceeeeeEee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLE-HPNLVKLIGYCA  153 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~  153 (436)
                      ....|+++++||+||.+.||++...        +.+.||+|++...  +.....-|.+|+..|.+|+ |.+||++++|-.
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s--------~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv  430 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNS--------DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV  430 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecC--------CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence            3467999999999999999998743        5577888876533  3445577999999999996 999999999987


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      .++    ++|+||||- .-+|..+|...... .+.-.+..+..|++.++.++|..   ||||.||||.|+|+- .|.+||
T Consensus       431 ~d~----~lYmvmE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKL  500 (677)
T KOG0596|consen  431 TDG----YLYMVMECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKL  500 (677)
T ss_pred             cCc----eEEEEeecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEe
Confidence            755    569999976 67999999876543 34337788999999999999999   999999999999995 578999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-----------LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE  302 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  302 (436)
                      +|||+|...............+||+.||+||.+....           .+.++||||||||||+|+.|+.||+....   
T Consensus       501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---  577 (677)
T KOG0596|consen  501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---  577 (677)
T ss_pred             eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---
Confidence            9999998766666666677889999999999985432           45789999999999999999999975321   


Q ss_pred             HHHHHHHhhcccCccccccccCCcccCcCCH-HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          303 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSI-NEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                        ...          ++..+.++.-.-.++. ....++.++++.||.+||.+||++.++|++
T Consensus       578 --~~a----------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  578 --QIA----------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             --HHH----------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence              111          1222334432222221 112238899999999999999999999987

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-39  Score=330.86  Aligned_cols=278  Identities=18%  Similarity=0.299  Sum_probs=191.6

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCC--------CcceE----EEEEEeccCcchhHHHHHHHHHHHhccCCC
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGT--------SEATV----VAIKKLNRDGLQGHKQWVAEVQFLGVLEHP  143 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~--------~~~~~----vavK~~~~~~~~~~~~~~~E~~~l~~l~hp  143 (436)
                      ...++|++++.||+|+||.||+|.++...+...        ..+..    ++.|.+. ........+.+|+.+++.++||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence            346799999999999999999987652211000        00011    1112211 1122345688999999999999


Q ss_pred             CceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCC
Q 013790          144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA---FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKA  220 (436)
Q Consensus       144 nIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp  220 (436)
                      ||+++++++...+.    .++|++++ +++|..++....   ........+..|+.||+.||.|||++   +|+||||||
T Consensus       224 nIv~l~~~~~~~~~----~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP  295 (501)
T PHA03210        224 NILKIEEILRSEAN----TYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKL  295 (501)
T ss_pred             CcCcEeEEEEECCe----eEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence            99999999876653    48999998 568888875432   12234566788999999999999998   999999999


Q ss_pred             CcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCc
Q 013790          221 SNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR-SLERNRP  299 (436)
Q Consensus       221 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~-pf~~~~~  299 (436)
                      +||||+.++.+||+|||+++..... .........||..|+|||++.+..++.++|||||||++|||++|.. ||.....
T Consensus       296 ~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~  374 (501)
T PHA03210        296 ENIFLNCDGKIVLGDFGTAMPFEKE-REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG  374 (501)
T ss_pred             HHEEECCCCCEEEEeCCCceecCcc-cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence            9999999999999999999753211 1122234679999999999999999999999999999999999875 4544333


Q ss_pred             hhhHHHHHHHhhcccCccccc-------cccC-Cccc---CcC-----CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          300 KTEQRLLEWVQQYPADSKKFG-------LIMD-PRLE---KEY-----SINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~-------~~~~-~~l~---~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .....+...+.........+.       ..+. ..+.   ...     ....+..+.++|.+||..||.+|||+.|++.+
T Consensus       375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            333333333322211111000       0000 0000   000     01123467788999999999999999999876

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.2e-39  Score=300.18  Aligned_cols=253  Identities=28%  Similarity=0.435  Sum_probs=206.4

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|++.+.||.|++|.||+|...       .+++.|++|++..... .....+.+|+..+..++||||+++++++.... 
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~-------~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   72 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHK-------PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG-   72 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEc-------CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC-
Confidence            47889999999999999999876       4678899999876644 34567899999999999999999999987654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                         ..++||||+++++|.+++...  ..+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+||
T Consensus        73 ---~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df  144 (264)
T cd06623          73 ---EISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADF  144 (264)
T ss_pred             ---eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccC
Confidence               459999999999999999765  478999999999999999999999 8   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      |++.....  .........++..|+|||.+.+..++.++||||||+++|+|+||..||..............+.....  
T Consensus       145 ~~~~~~~~--~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--  220 (264)
T cd06623         145 GISKVLEN--TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP--  220 (264)
T ss_pred             ccceeccc--CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC--
Confidence            99875321  11222345688899999999888899999999999999999999999977643222222222221100  


Q ss_pred             cccccccCCcccCcCCHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSIN-EARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                              +    ..+.. .+..+.++|.+||..+|++||++.+++++
T Consensus       221 --------~----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 --------P----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             --------C----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                    1    11122 45789999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.4e-39  Score=299.68  Aligned_cols=251  Identities=30%  Similarity=0.507  Sum_probs=198.2

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      .+|++.+.||.|+||.||+|.+.        .+..+|+|.+..... ....+.+|+++++.++||||+++++++....  
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~--------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   72 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL--------EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS--   72 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe--------CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC--
Confidence            47888999999999999999864        356799998865432 3457889999999999999999999886544  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..++||||+.+++|.+++.... ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||+
T Consensus        73 --~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~  146 (256)
T cd05112          73 --PICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGM  146 (256)
T ss_pred             --ceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcc
Confidence              3599999999999999987543 3688999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      +...... .........++..|+|||.+.++.++.++||||||+++|+|++ |..||.......   ....+..   ...
T Consensus       147 ~~~~~~~-~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~---~~~  219 (256)
T cd05112         147 TRFVLDD-QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETINA---GFR  219 (256)
T ss_pred             eeecccC-cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHhC---CCC
Confidence            8743211 1111122334568999999988889999999999999999998 999997543321   2221111   000


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                          ...+       ...+..+.+|+.+||+.+|++|||+.+++++|
T Consensus       220 ----~~~~-------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         220 ----LYKP-------RLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ----CCCC-------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                0011       11246788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.2e-39  Score=299.62  Aligned_cols=256  Identities=32%  Similarity=0.510  Sum_probs=201.3

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecCCcc
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  159 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  159 (436)
                      |++.+.||.|+||.||++.+....   ...+..||+|.+...... ..+.+..|+.++..++||||+++++++...+   
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   74 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLS---GEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE---   74 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCC---CCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC---
Confidence            456788999999999999976211   123588999999766433 4568899999999999999999999987654   


Q ss_pred             eeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCC
Q 013790          160 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  239 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  239 (436)
                       ..+++|||+++++|.+++.......+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++
T Consensus        75 -~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~  150 (258)
T smart00219       75 -PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLS  150 (258)
T ss_pred             -eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCc
Confidence             359999999999999999765433389999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccc
Q 013790          240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK  318 (436)
Q Consensus       240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  318 (436)
                      .......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   +...+.....    
T Consensus       151 ~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~~~~~----  222 (258)
T smart00219      151 RDLYDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYLKKGYR----  222 (258)
T ss_pred             eecccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcCCC----
Confidence            7533221111 112336789999999988889999999999999999998 888887643322   2222211110    


Q ss_pred             cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       319 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                            .    ..+...+..+.+++.+||..||++|||+.++++.|
T Consensus       223 ------~----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 ------L----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ------C----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                  0    11112456789999999999999999999998754

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.9e-39  Score=309.13  Aligned_cols=249  Identities=24%  Similarity=0.379  Sum_probs=198.8

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcce
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  160 (436)
                      |.....||.|+||.||+|...       .++..||+|.+........+.+.+|+.++..++||||+++++++...+    
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~----   91 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREK-------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE----   91 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEc-------CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC----
Confidence            444557999999999999864       467889999987655455567889999999999999999999887654    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..+++|||+++++|..++..   ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        92 ~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~  165 (297)
T cd06659          92 ELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCA  165 (297)
T ss_pred             eEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHh
Confidence            45999999999999998754   3589999999999999999999998   99999999999999999999999999986


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ....  .........|+..|+|||.+.+..++.++|||||||++|+|++|..||....+...   ...+...+...    
T Consensus       166 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~----  236 (297)
T cd06659         166 QISK--DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLRDSPPPK----  236 (297)
T ss_pred             hccc--ccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhccCCCC----
Confidence            4221  11222345688999999999888899999999999999999999999976543322   11111111100    


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                            .  ......+..+.++|.+||..+|.+||++.+++++
T Consensus       237 ------~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         237 ------L--KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ------c--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                  0  0011224568899999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.8e-39  Score=306.52  Aligned_cols=252  Identities=24%  Similarity=0.377  Sum_probs=202.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|.+.+.||+|+||.||++...       .++..|++|.+........+.+.+|+.+++.++||||+++++++.....
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~   90 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDV-------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDE   90 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEc-------CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence            368999999999999999999854       4567899999876555556778899999999999999999999876543


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .++|+||+++++|.+++.+.   .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        91 ----~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg  160 (293)
T cd06647          91 ----LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  160 (293)
T ss_pred             ----EEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCc
Confidence                59999999999999998653   478999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ++......  ........+++.|+|||.+.+..++.++||||||+++|++++|..||....+......   ...      
T Consensus       161 ~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~---~~~------  229 (293)
T cd06647         161 FCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IAT------  229 (293)
T ss_pred             ceeccccc--ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee---hhc------
Confidence            88643211  1122334688899999999888899999999999999999999999976543221000   000      


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                            ........+...+..+.++|.+||..+|++||++.+++.+
T Consensus       230 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         230 ------NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0000011122345678899999999999999999999877

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5.8e-39  Score=300.40  Aligned_cols=258  Identities=28%  Similarity=0.396  Sum_probs=203.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|++.+.||.|+||.||+|.+.       .++..+++|++.... ......+.+|+.+++.++|+||+++++.+.... 
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   72 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICL-------PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD-   72 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEc-------CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC-
Confidence            47999999999999999999865       357789999987543 234567899999999999999999999886654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAF-PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                         ..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+||
T Consensus        73 ---~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df  146 (267)
T cd06610          73 ---ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADF  146 (267)
T ss_pred             ---EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccc
Confidence               45999999999999999976432 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCc--ccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          237 GLAREGPMVGHT--HVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       237 g~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |++.........  .......|+..|+|||.+... .++.++|+||||+++|+|++|..||....+..  .........+
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~  224 (267)
T cd06610         147 GVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQNDP  224 (267)
T ss_pred             chHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhcCCC
Confidence            998753322221  122344688999999998776 78899999999999999999999997654321  1222111111


Q ss_pred             cCccccccccCCcccCcC-CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEY-SINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                         .        .+.... ....+..+.+++.+||..||++||++.+|+.+
T Consensus       225 ---~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         225 ---P--------SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             ---C--------CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence               0        011000 12345778899999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-38  Score=301.74  Aligned_cols=261  Identities=26%  Similarity=0.362  Sum_probs=203.7

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|...+.||.|++|.||++...       .+++.+|+|.+..... .....+.+|+++++.++||||+++++++.....
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   73 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLK-------NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS   73 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEEC-------CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence            46888999999999999999975       4678899999875432 345678899999999999999999998865432


Q ss_pred             cceeEEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                        ...++||||+++++|.+++..  .....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|
T Consensus        74 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d  148 (287)
T cd06621          74 --SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCD  148 (287)
T ss_pred             --CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEee
Confidence              246899999999999988753  2234688999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hhhHHHHHHHhhcc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP--KTEQRLLEWVQQYP  313 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~--~~~~~~~~~~~~~~  313 (436)
                      ||++......    ......++..|+|||.+.+..++.++||||||+++|+|++|..||.....  ........++....
T Consensus       149 fg~~~~~~~~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  224 (287)
T cd06621         149 FGVSGELVNS----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP  224 (287)
T ss_pred             cccccccccc----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence            9998642211    11234578899999999988999999999999999999999999976532  12222333332211


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..  .    +....  ......+..+.+++.+||..+|.+|||+.+++.+
T Consensus       225 ~~--~----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         225 NP--E----LKDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             ch--h----hccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            10  0    00000  0011235678999999999999999999999885

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.4e-39  Score=301.02  Aligned_cols=255  Identities=23%  Similarity=0.393  Sum_probs=200.2

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc------hhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      +|+..+.||+|+||.||+|...       .++..||+|.+.....      ...+.+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   73 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDV-------KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC   73 (268)
T ss_pred             CccccceecCcCceEEEEEEEc-------CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec
Confidence            4788899999999999999854       5678899999864321      12467889999999999999999999987


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC-ceE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-RPK  232 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~k  232 (436)
                      ..+    ..++||||+++++|.+++.+.  .++++..+..++.|++.||.|||++   +++|+||+|+||+++.++ .++
T Consensus        74 ~~~----~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~  144 (268)
T cd06630          74 EDS----HFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLR  144 (268)
T ss_pred             cCC----eEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence            554    359999999999999999654  3689999999999999999999998   999999999999998776 599


Q ss_pred             EeeccCCCCCCCCCC--cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          233 LSDFGLAREGPMVGH--THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      |+|||++........  ........++..|+|||.+.+..++.++||||||+++|+|++|..||................
T Consensus       145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  224 (268)
T cd06630         145 IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA  224 (268)
T ss_pred             EcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh
Confidence            999999875332211  111223467889999999988889999999999999999999999997543322111111110


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .             .......+...+..+.+++.+||..+|.+||++.+++.+
T Consensus       225 ~-------------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         225 S-------------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             c-------------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            0             000112333455788999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.6e-39  Score=303.34  Aligned_cols=267  Identities=23%  Similarity=0.334  Sum_probs=200.1

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|++.+.||.|+||.||+|.+.       .++..||+|++.....  .....+.+|+.+++.++||||+++++++.... 
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-   72 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDR-------ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS-   72 (286)
T ss_pred             CceEEeecccCCCcEEEEEEEC-------CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC-
Confidence            5888999999999999999865       4578899999876542  23467889999999999999999999987643 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+ +++|.+++.... .++++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        73 ---~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg  144 (286)
T cd07832          73 ---GFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFG  144 (286)
T ss_pred             ---eeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeee
Confidence               459999999 999999986544 5699999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHH-HHHHhhccc-
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL-LEWVQQYPA-  314 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~~~-  314 (436)
                      ++........ .......++..|+|||.+.+. .++.++||||||+++|+|++|.+||.+......... ...+..... 
T Consensus       145 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (286)
T cd07832         145 LARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEE  223 (286)
T ss_pred             ecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChH
Confidence            9875322211 122345688899999998654 468999999999999999999888866543221111 111000000 


Q ss_pred             Ccc------ccccccCCccc----CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSK------KFGLIMDPRLE----KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~------~~~~~~~~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...      ....+..+.-.    .......+..+.+||.+||..||++|||+.+++.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000      00000000000    00111234788999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-39  Score=304.84  Aligned_cols=268  Identities=27%  Similarity=0.387  Sum_probs=200.7

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|++.+.||+|+||.||+|.+.       .+++.||+|.++...  ....+.+.+|+++++.++|+||+++++++...+
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~-------~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   73 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNK-------ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG   73 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeC-------CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC
Confidence            46899999999999999999865       457889999886542  223467889999999999999999999997644


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..+++|||+.++.+..++...  ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+||
T Consensus        74 ----~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~  144 (288)
T cd07833          74 ----RLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDF  144 (288)
T ss_pred             ----EEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEee
Confidence                459999999887776665433  3589999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HHHhhccc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL-EWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~~~~~~~  314 (436)
                      |++........ .......++..|+|||++.+. .++.++||||||+++|+|++|..||............ ......+.
T Consensus       145 g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  223 (288)
T cd07833         145 GFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP  223 (288)
T ss_pred             ecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99875332211 123345678899999999887 8899999999999999999999999765432211111 11111110


Q ss_pred             Cc-------ccccc--ccCC----cccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DS-------KKFGL--IMDP----RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~-------~~~~~--~~~~----~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..       ..+..  ....    .+...++...+..+.+||.+||..+|++|||+.+++.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             HHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            00       00000  0000    00001122236789999999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.7e-39  Score=305.37  Aligned_cols=266  Identities=26%  Similarity=0.324  Sum_probs=198.4

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-----hHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----GHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      +|.+.+.||.|+||.||+|...       .+++.||+|.+......     ....+..|+.+++.++|+||+++++++..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   73 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDK-------ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH   73 (298)
T ss_pred             CceeeeeeeeccccEEEEEEEC-------CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec
Confidence            4788899999999999999865       45789999998765332     23456789999999999999999999876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.   +++|+||+|+|||++.++.++|+
T Consensus        74 ~~----~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~  144 (298)
T cd07841          74 KS----NINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLA  144 (298)
T ss_pred             CC----EEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEc
Confidence            43    459999999 999999997643 3699999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHH-HHHHhhc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL-LEWVQQY  312 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~  312 (436)
                      |||++.......  .......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||........... .......
T Consensus       145 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~  222 (298)
T cd07841         145 DFGLARSFGSPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTP  222 (298)
T ss_pred             cceeeeeccCCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCC
Confidence            999997532211  12223356788999998854 4678999999999999999999888876544322111 1110000


Q ss_pred             ccCc-c---ccccccCCccc-----CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADS-K---KFGLIMDPRLE-----KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~-~---~~~~~~~~~l~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .... .   ...........     .......+..+.++|.+||..||.+|||+.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             chhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000 0   00000000000     01112335678899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.1e-39  Score=305.42  Aligned_cols=264  Identities=23%  Similarity=0.334  Sum_probs=194.1

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|++.+.||.|+||.||+|.+.       .++..||+|.+.....  .....+.+|+.+++.++||||+++++++.... 
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~-------~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-   72 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNR-------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK-   72 (284)
T ss_pred             CceeEEEecccCCeEEEEEEEC-------CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC-
Confidence            4788899999999999999975       4677899999865422  12345778999999999999999999987554 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++++||+. ++|.+++.... ..+++..++.++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        73 ---~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg  144 (284)
T cd07839          73 ---KLTLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFG  144 (284)
T ss_pred             ---ceEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccc
Confidence               3599999996 58888876543 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh-ccc-
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ-YPA-  314 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~-~~~-  314 (436)
                      +++.....  ........++..|+|||.+.+. .++.++|||||||++|+|+||..||........  ....+.. ... 
T Consensus       145 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~  220 (284)
T cd07839         145 LARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTP  220 (284)
T ss_pred             hhhccCCC--CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCC
Confidence            98743211  1112334578899999998664 478999999999999999999988644332211  1111100 000 


Q ss_pred             Ccccc---cccc----CCccc-----CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKF---GLIM----DPRLE-----KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~---~~~~----~~~l~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....+   ....    -+...     .......+..+.+||.+||..||.+|||+.+++.+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         221 TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             ChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            00000   0000    00000     00112235678899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=305.48  Aligned_cols=279  Identities=24%  Similarity=0.369  Sum_probs=210.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhc--cCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV--LEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~~  156 (436)
                      ...+.+..||+|.||.||+|.+.         ++.||||++...   ..+.|.+|-.|++.  ++|+||+++++.-....
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~---------~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t  277 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD---------NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT  277 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc---------CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence            35666788999999999999875         688999999754   45678888887774  57999999998766544


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC------CCceeeccCCCCcEEEcCCCc
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL------EVQVIYRDFKASNVLLDENFR  230 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~------~~~ivH~Dlkp~NIll~~~~~  230 (436)
                      ......+||++|.+.|+|.+||..+   .++|....+|+..+++||+|||+..      +++|+|||||+.||||..|++
T Consensus       278 ~~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT  354 (534)
T KOG3653|consen  278 ADRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT  354 (534)
T ss_pred             ccccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc
Confidence            4455679999999999999999775   5899999999999999999999752      568999999999999999999


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCcccccccccC-CCC-----chhhHHHHHHHHHHHHhCCCCCC-CCCchhhH
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLT-----AKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQ  303 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DvwSlGvil~elltg~~pf~-~~~~~~~~  303 (436)
                      ..|+|||+|...............+||.+|||||++.+. .+.     .+.||||+|.+||||++...-+. +..+....
T Consensus       355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql  434 (534)
T KOG3653|consen  355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL  434 (534)
T ss_pred             EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence            999999999876555555555568999999999999764 222     36899999999999999776553 22222111


Q ss_pred             HHHHHHhhcccCccccccccCCcccCcCCH-----HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          304 RLLEWVQQYPADSKKFGLIMDPRLEKEYSI-----NEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                      .+-..+...|........++..+.+..++.     .....+.+.+..||..||+.|.|+.=+.+++.++....+
T Consensus       435 pfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  435 PFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             chhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            222223333333222222232222222221     234578899999999999999999999999988865443

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.3e-39  Score=304.50  Aligned_cols=264  Identities=26%  Similarity=0.392  Sum_probs=197.7

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|+.++.||.|+||.||+|...       .+++.||||.+.....  .....+.+|++++++++||||+++++++...+ 
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   72 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-   72 (284)
T ss_pred             CceeeeeecCCCceEEEEEEEC-------CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCC-
Confidence            5888999999999999999865       4678899998865432  22356888999999999999999999986544 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+. ++|..++.......+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||
T Consensus        73 ---~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg  145 (284)
T cd07860          73 ---KLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG  145 (284)
T ss_pred             ---cEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence               3599999995 6899998765556789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      ++......  ........++..|+|||.+.+.. ++.++||||||+++|+|+||..||........  ............
T Consensus       146 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~  221 (284)
T cd07860         146 LARAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPD  221 (284)
T ss_pred             chhhcccC--ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCC
Confidence            98643211  11122345678999999886644 58899999999999999999999976543221  111111111100


Q ss_pred             c--------------ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 K--------------KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~--------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .              .+.......+. ......+..+.++|.+||+.||.+|||+.+++.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         222 EVVWPGVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhhhhhhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            0              00000000000 0011234567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.2e-39  Score=301.27  Aligned_cols=254  Identities=27%  Similarity=0.431  Sum_probs=201.7

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|+..+.||.|+||.||++..+       .+++.|++|.+..... .....+.+|+++++.+.||||+++++++...+ 
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-   72 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHR-------PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG-   72 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEc-------CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC-
Confidence            46888899999999999999875       4678899999876532 34467889999999999999999999987654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                         ..++++||+.+++|.+++.... ..+++..+..++.|++.||+|||+ .   +++|+||||+||+++.++.++|+||
T Consensus        73 ---~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~  145 (265)
T cd06605          73 ---DISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDF  145 (265)
T ss_pred             ---EEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence               4599999999999999997653 578999999999999999999999 7   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      |.+....    ........++..|+|||.+.+..++.++||||||+++|+|++|..||........ ............ 
T Consensus       146 g~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~-  219 (265)
T cd06605         146 GVSGQLV----NSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNE-  219 (265)
T ss_pred             ccchhhH----HHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcC-
Confidence            9986421    1111226688899999999988999999999999999999999999975431111 111111111000 


Q ss_pred             cccccccCCcccCcCCHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSIN-EARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                            ..+    ..+.. .+..+.++|.+||..||.+|||+.+++.+
T Consensus       220 ------~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         220 ------PPP----RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ------CCC----CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence                  001    11111 45678999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.6e-39  Score=312.16  Aligned_cols=269  Identities=23%  Similarity=0.313  Sum_probs=201.3

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      ..++|+..+.||+|+||.||+|...       .++..||+|.+...  .......+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDT-------VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTP   86 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEEC-------CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeecc
Confidence            4578999999999999999999865       46788999998643  22334567789999999999999999998865


Q ss_pred             cCC--cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          155 DGE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       155 ~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      ...  .....++||||+. ++|.+.+..    .+++..+..++.|++.||.|||+.   |++||||||+||+++.++.+|
T Consensus        87 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~k  158 (353)
T cd07850          87 QKSLEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK  158 (353)
T ss_pred             CCCccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEE
Confidence            432  2234699999995 588888753    288899999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHH---
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEW---  308 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~---  308 (436)
                      |+|||+++...   .........++..|+|||.+.+..++.++|||||||++|+|++|..||...+..... .+...   
T Consensus       159 L~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  235 (353)
T cd07850         159 ILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT  235 (353)
T ss_pred             EccCccceeCC---CCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999997532   111223346788999999999999999999999999999999999999765432111 01000   


Q ss_pred             ----------------Hhhccc-CccccccccCCcc----cCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          309 ----------------VQQYPA-DSKKFGLIMDPRL----EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       309 ----------------~~~~~~-~~~~~~~~~~~~l----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                      ....+. ....+..+....+    ........+..+.++|.+||..||++|||+.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                            000000 0000101111100    001122345678899999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.8e-39  Score=300.45  Aligned_cols=256  Identities=23%  Similarity=0.396  Sum_probs=197.5

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch----------hHHHHHHHHHHHhccCCCCceeee
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----------GHKQWVAEVQFLGVLEHPNLVKLI  149 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~hpnIv~~~  149 (436)
                      +|...+.||.|+||.||+|...       .+++.||+|.+......          ..+.+..|+.+++.++||||++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   74 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNV-------TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYL   74 (272)
T ss_pred             ceeecceecccCceEEEEEeec-------CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEE
Confidence            4778889999999999999854       46788999987532111          124577899999999999999999


Q ss_pred             eEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC
Q 013790          150 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  229 (436)
Q Consensus       150 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  229 (436)
                      +++...+    ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++
T Consensus        75 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~  145 (272)
T cd06629          75 GFETTEE----YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADG  145 (272)
T ss_pred             EEeccCC----ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCC
Confidence            9886543    359999999999999999765  4689999999999999999999998   999999999999999999


Q ss_pred             ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 013790          230 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH--LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       230 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  307 (436)
                      .++|+|||+++...............|+..|+|||.+....  ++.++|+||||+++|++++|..||........  ...
T Consensus       146 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~  223 (272)
T cd06629         146 ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFK  223 (272)
T ss_pred             eEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHH
Confidence            99999999987532211112223456888999999987654  78899999999999999999999964332211  111


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....          .....+........+..+.+++.+||..+|++|||+.+|+++
T Consensus       224 ~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         224 LGNK----------RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             hhcc----------ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            1000          001111111222345788999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1e-38  Score=299.43  Aligned_cols=254  Identities=24%  Similarity=0.427  Sum_probs=197.9

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc----------chhHHHHHHHHHHHhc-cCCCCceee
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----------LQGHKQWVAEVQFLGV-LEHPNLVKL  148 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~hpnIv~~  148 (436)
                      +|++.+.||+|+||.||+|.+..      ..++.+|+|.+....          ......+.+|+.++.. ++||||+++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~   74 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKN------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRY   74 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcC------CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeE
Confidence            47888999999999999999762      246789999875332          1223456778887764 799999999


Q ss_pred             eeEeeecCCcceeEEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeeccCCCCcEEE
Q 013790          149 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVLL  225 (436)
Q Consensus       149 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dlkp~NIll  225 (436)
                      ++++...+    ..+++|||+++++|.+++..  .....+++..++.++.|++.||.|||+ .   +++|+||+|+|||+
T Consensus        75 ~~~~~~~~----~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~  147 (269)
T cd08528          75 YKTFLEND----RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIML  147 (269)
T ss_pred             EeeEccCC----eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEE
Confidence            99987654    45999999999999998853  223468999999999999999999996 5   89999999999999


Q ss_pred             cCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 013790          226 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL  305 (436)
Q Consensus       226 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  305 (436)
                      +.++.++|+|||++......   .......|+..|+|||.+.+..++.++||||||+++|+|++|..||.........  
T Consensus       148 ~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~--  222 (269)
T cd08528         148 GEDDKVTITDFGLAKQKQPE---SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA--  222 (269)
T ss_pred             CCCCcEEEecccceeecccc---cccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH--
Confidence            99999999999998753221   1234456889999999999888999999999999999999999999754332211  


Q ss_pred             HHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          306 LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                       ..+....         ..+.    .....+..+.++|.+||+.||++||++.++..++.
T Consensus       223 -~~~~~~~---------~~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         223 -TKIVEAV---------YEPL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -HHHhhcc---------CCcC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence             1111100         0000    01122467889999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.4e-39  Score=304.40  Aligned_cols=269  Identities=24%  Similarity=0.336  Sum_probs=200.3

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|++.+.||.|+||.||+|.+.       .+++.+++|.+......  ....+.+|+.++..++||||+++++++....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   77 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDK-------KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN   77 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEEC-------CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC
Confidence            57999999999999999999875       45788999998754322  2235678999999999999999999887653


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      .  ...++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+.   +++|+||||+|||++.++.++|+||
T Consensus        78 ~--~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~  150 (293)
T cd07843          78 L--DKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDF  150 (293)
T ss_pred             C--CcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeec
Confidence            1  24699999996 59999886543 3689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHH-HHHHhh---
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL-LEWVQQ---  311 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~~~---  311 (436)
                      |++.......  .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........... ......   
T Consensus       151 g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  228 (293)
T cd07843         151 GLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTE  228 (293)
T ss_pred             CceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence            9987532211  222334578899999998654 468899999999999999999999986554322111 111000   


Q ss_pred             --------cccCc-cccccccCCcccCcCCHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 --------YPADS-KKFGLIMDPRLEKEYSIN-EARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 --------~~~~~-~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                              .+... ..+.......+...++.. .+..+.++|.+||+.||++|||+.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                    00000 000000111111122222 35678899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.9e-39  Score=304.25  Aligned_cols=246  Identities=26%  Similarity=0.392  Sum_probs=199.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|++.+.||+|+||.||++.+.       .+++.||+|.+.....   ...+.+.+|++++++++||||+++++++...
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHK-------GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD   73 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEc-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC
Confidence            47899999999999999999875       4678899999865422   2345688899999999999999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      .    ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||+|+||||+.++.+||+|
T Consensus        74 ~----~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d  144 (290)
T cd05580          74 S----NLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITD  144 (290)
T ss_pred             C----eEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEee
Confidence            4    459999999999999999665  4689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||++......     .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......   ....+...   
T Consensus       145 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~---  213 (290)
T cd05580         145 FGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYEKILEG---  213 (290)
T ss_pred             CCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhcC---
Confidence            9998753211     234568899999999988888999999999999999999999997654221   11111110   


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                              ..    ..+...+..+.+++.+||..||.+||     ++.+++.+
T Consensus       214 --------~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         214 --------KV----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             --------Cc----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence                    00    11112246788999999999999999     77777755

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.4e-39  Score=306.51  Aligned_cols=267  Identities=26%  Similarity=0.374  Sum_probs=199.0

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|++.+.||+|+||.||+|.+.       .+++.||+|.+......  ..+.+.+|+.+++.++||||+++++++...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   73 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHK-------ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK   73 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEEC-------CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC
Confidence            46889999999999999999875       45788999987654222  3456788999999999999999999986544


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+.+++|..+....  ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        74 ----~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~df  144 (286)
T cd07846          74 ----RLYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDF  144 (286)
T ss_pred             ----eEEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEee
Confidence                459999999999998877543  3589999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhhccc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~  314 (436)
                      |++......  ........++..|+|||.+.+ ..++.++||||||+++|+|++|.+||......... .+.........
T Consensus       145 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  222 (286)
T cd07846         145 GFARTLAAP--GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP  222 (286)
T ss_pred             eeeeeccCC--ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCch
Confidence            998753221  122233567889999999865 45678999999999999999999999755432211 11111111100


Q ss_pred             Cccc-------cccccCCcccC-----cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKK-------FGLIMDPRLEK-----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~-------~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....       ......+....     ......+..+.+|+.+||..+|++||++.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            0000       00000000000     0112335679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.5e-39  Score=297.71  Aligned_cols=249  Identities=24%  Similarity=0.374  Sum_probs=198.2

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-----hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      +|+..+.||+|+||.||+|...       .++..|++|.+.....     ...+.+.+|+.+++.++||||+++++++..
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   73 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNL-------DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE   73 (258)
T ss_pred             CccccceeeecCCceEEEEEEc-------CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec
Confidence            4677889999999999999865       4678899998865431     234678899999999999999999998865


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      ..    ..++++||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+
T Consensus        74 ~~----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~  144 (258)
T cd06632          74 ED----NLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLA  144 (258)
T ss_pred             CC----eEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEc
Confidence            54    359999999999999999654  3688999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |||++.......   ......|+..|++||.+.... ++.++|+||||+++|+|++|..||........  ..... ...
T Consensus       145 d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~-~~~  218 (258)
T cd06632         145 DFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKIG-RSK  218 (258)
T ss_pred             cCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHHH-hcc
Confidence            999987532111   233456889999999987766 89999999999999999999999976542111  11111 000


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .         .+    ..+...+..+.+++.+||..+|.+||++.+++.+
T Consensus       219 ~---------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         219 E---------LP----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             c---------CC----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            0         00    1122234678899999999999999999999764

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-38  Score=302.26  Aligned_cols=250  Identities=25%  Similarity=0.399  Sum_probs=199.8

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcc
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  159 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  159 (436)
                      .|...+.||.|++|.||++...       .++..+++|.+........+.+.+|+.+++.++||||+++++++...+   
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~---   89 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDK-------STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD---   89 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEEC-------CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC---
Confidence            4555678999999999999865       457889999987655555567889999999999999999999887544   


Q ss_pred             eeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCC
Q 013790          160 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  239 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  239 (436)
                       ..++++||+.+++|.+++..   ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++
T Consensus        90 -~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~  162 (285)
T cd06648          90 -ELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC  162 (285)
T ss_pred             -eEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccc
Confidence             35999999999999999866   3589999999999999999999998   9999999999999999999999999987


Q ss_pred             CCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccc
Q 013790          240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF  319 (436)
Q Consensus       240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  319 (436)
                      .....  .........|+..|+|||.+.+..++.++||||||+++|+|++|..||....+....   ..+.....     
T Consensus       163 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~---~~~~~~~~-----  232 (285)
T cd06648         163 AQVSK--EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM---KRIRDNLP-----  232 (285)
T ss_pred             hhhcc--CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH---HHHHhcCC-----
Confidence            64221  111223356889999999998888999999999999999999999999765432221   11111110     


Q ss_pred             ccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          320 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       320 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                           +.+.  .....+..+.+++.+||..+|++||++.+++++
T Consensus       233 -----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         233 -----PKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             -----CCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence                 0000  011234678999999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.5e-38  Score=299.86  Aligned_cols=248  Identities=28%  Similarity=0.425  Sum_probs=199.4

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      -|+.++.||.|+||.||+|...       .++..||+|.+..... .....+.+|+.++..++||||+++++++....  
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--   75 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDN-------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT--   75 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEEC-------CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC--
Confidence            4778889999999999999864       4678999998865432 33457888999999999999999999987654  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..++||||+.+++|.+++..   ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        76 --~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~  147 (277)
T cd06641          76 --KLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV  147 (277)
T ss_pred             --eEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeeccc
Confidence              35999999999999999854   3589999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  318 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  318 (436)
                      +.....  .........++..|+|||.+.+..++.++|+|||||++|+|++|..||....+..   ....+....     
T Consensus       148 ~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~-----  217 (277)
T cd06641         148 AGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLFLIPKNN-----  217 (277)
T ss_pred             ceeccc--chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHHHHhcCC-----
Confidence            864321  1122233567889999999988888999999999999999999999997644322   111111100     


Q ss_pred             cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       319 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                           .+    ......+..+.+++.+||..+|.+||++.+++.+
T Consensus       218 -----~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         218 -----PP----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             -----CC----CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                 01    1122234678899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1e-38  Score=305.33  Aligned_cols=257  Identities=26%  Similarity=0.345  Sum_probs=199.1

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|++.+.||+|+||.||++...       ..++.|++|.+.....   .....+.+|+.+++.++||||+++++.+...
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   73 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHK-------ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK   73 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEEC-------CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC
Confidence            47899999999999999999875       4678899999875532   2335677899999999999999999988654


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|
T Consensus        74 ~----~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~d  144 (305)
T cd05609          74 R----HLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTD  144 (305)
T ss_pred             C----EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEee
Confidence            4    459999999999999999654  3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCC-------------cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 013790          236 FGLAREGPMVGH-------------THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE  302 (436)
Q Consensus       236 fg~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  302 (436)
                      ||+++.......             ........++..|+|||.+.+..++.++||||||+++|+|++|..||.+..+.. 
T Consensus       145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-  223 (305)
T cd05609         145 FGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-  223 (305)
T ss_pred             CCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            999863211000             001112457889999999988889999999999999999999999997654322 


Q ss_pred             HHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 013790          303 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  366 (436)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~  366 (436)
                        +........        ...+..    ....+..+.++|.+||+.||++||++..+.+.|+.
T Consensus       224 --~~~~~~~~~--------~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         224 --LFGQVISDD--------IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             --HHHHHHhcc--------cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence              111111100        000000    11234678899999999999999996655555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=302.49  Aligned_cols=268  Identities=25%  Similarity=0.370  Sum_probs=195.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++.+.||.|+||.||+|..+       .+++.||+|.+...... ....+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   76 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSK-------LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK   76 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEc-------CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC
Confidence            368999999999999999999865       45788999998654322 2245678999999999999999999987544


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.+||+||
T Consensus        77 ----~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  147 (291)
T cd07844          77 ----TLTLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADF  147 (291)
T ss_pred             ----eEEEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcc
Confidence                4599999997 59999887644 3689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHHHhhccc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~~  314 (436)
                      |+++......  .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........ ..........+.
T Consensus       148 g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  225 (291)
T cd07844         148 GLARAKSVPS--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPT  225 (291)
T ss_pred             ccccccCCCC--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCC
Confidence            9986422111  11122346789999999865 4578999999999999999999999976542111 111110000000


Q ss_pred             Ccc-------------ccccccCCcccCcC-CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSK-------------KFGLIMDPRLEKEY-SINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~-------------~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...             .+.......+.... .......+.+++.+||+.||.+|||+.+++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         226 EETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            000             00000000000000 01112567899999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.9e-38  Score=301.83  Aligned_cols=264  Identities=17%  Similarity=0.198  Sum_probs=190.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhH-----------HHHHHHHHHHhccCCCCce
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-----------KQWVAEVQFLGVLEHPNLV  146 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpnIv  146 (436)
                      .++|.+.+.||+|+||.||+|.+...    ...+..+|+|+.........           .....+...+..+.|+||+
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~----~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASD----HCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCC----cccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            46899999999999999999987621    11245677776443321110           1122344556677899999


Q ss_pred             eeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc
Q 013790          147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  226 (436)
Q Consensus       147 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~  226 (436)
                      ++++++..........+++++++ ..++.+.+...  ...++..+..++.|++.||.|||+.   +|+||||||+|||++
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~  160 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD  160 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence            99997765544444567888877 44677666443  2467888999999999999999998   999999999999999


Q ss_pred             CCCceEEeeccCCCCCCCCCC-----cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q 013790          227 ENFRPKLSDFGLAREGPMVGH-----THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT  301 (436)
Q Consensus       227 ~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  301 (436)
                      .++.++|+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            999999999999975321111     111223469999999999999999999999999999999999999998763322


Q ss_pred             hHH---HHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          302 EQR---LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       302 ~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                      ...   ..+++.....          ..+.   ....+..+.+++..||..+|++||++.+|++.|
T Consensus       241 ~~~~~~~~~~~~~~~~----------~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        241 NLIHAAKCDFIKRLHE----------GKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHhHHHHHHHhhh----------hhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            111   0111111111          0000   112247789999999999999999999998865

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.1e-39  Score=301.15  Aligned_cols=249  Identities=24%  Similarity=0.353  Sum_probs=201.3

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      +|++.+.||.|+||.||+|...       .++..||+|.+.....   ...+.+.+|++++++++||||+++++.+....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   73 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKR-------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE   73 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEc-------cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC
Confidence            5888999999999999999865       4678899999875432   33567889999999999999999998886543


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++|+||+.+++|.+++...  .++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        74 ----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~  144 (258)
T cd05578          74 ----NMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDF  144 (258)
T ss_pred             ----eEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeec
Confidence                469999999999999999665  4789999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      |++......   .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..........+......     
T Consensus       145 ~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----  216 (258)
T cd05578         145 NIATKVTPD---TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-----  216 (258)
T ss_pred             ccccccCCC---ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-----
Confidence            998753221   123345688899999999888899999999999999999999999987654322222221110     


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH--HHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM--SQVVE  362 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~--~eil~  362 (436)
                                .....+...+..+.++|.+||..||.+||++  .+++.
T Consensus       217 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 ----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             ----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence                      0011222334788899999999999999999  66543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.8e-38  Score=301.44  Aligned_cols=267  Identities=23%  Similarity=0.323  Sum_probs=196.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|.+.+.||+|+||.||+|...       .++..||+|.+...... ....+.+|+.+++.++|+||+++++++....
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   76 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISR-------INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE   76 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEc-------CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC
Confidence            468999999999999999999865       45778999998654322 2345678999999999999999999987543


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.++|+||
T Consensus        77 ----~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Df  147 (291)
T cd07870          77 ----TLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADF  147 (291)
T ss_pred             ----eEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecc
Confidence                4599999995 78877775443 3578888999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc--
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP--  313 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~--  313 (436)
                      |+++.....  ........++..|+|||.+.+. .++.++||||||+++|+|++|..||........ .+.......+  
T Consensus       148 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~  224 (291)
T cd07870         148 GLARAKSIP--SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVP  224 (291)
T ss_pred             ccccccCCC--CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCC
Confidence            998743211  1112334578899999998753 578899999999999999999999976543211 1111111000  


Q ss_pred             cCc---------cccccccCCcccCc-----CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADS---------KKFGLIMDPRLEKE-----YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~---------~~~~~~~~~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...         ..............     .....+..+.+++.+|+..||.+|||+.+++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         225 TEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            000         00000000000000     001124578899999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=300.04  Aligned_cols=249  Identities=27%  Similarity=0.414  Sum_probs=197.5

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccC---CCCceeeeeEeeec
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLE---HPNLVKLIGYCAVD  155 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~  155 (436)
                      .|+..+.||.|+||.||+|.+.       .++..||+|.+.... ......+.+|+.+++.+.   |||++++++++...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~   74 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHV-------PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG   74 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEc-------CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence            5788899999999999999975       467889999987542 234467888999999886   99999999988654


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      .    ..++||||+++++|.+++...   .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|
T Consensus        75 ~----~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~d  144 (277)
T cd06917          75 P----RLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCD  144 (277)
T ss_pred             C----EEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEcc
Confidence            3    459999999999999998543   689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ||++......  ........|+..|+|||.+.+ ..++.++||||||+++|+|++|..||........   ...+...  
T Consensus       145 fg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~~~--  217 (277)
T cd06917         145 FGVAALLNQN--SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MMLIPKS--  217 (277)
T ss_pred             CCceeecCCC--ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhccccC--
Confidence            9998753221  122334568899999998865 4568899999999999999999999976533211   1111000  


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                              ..+.+...   ..+..+.+++.+||..||++||++.+++.+
T Consensus       218 --------~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         218 --------KPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             --------CCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence                    01111111   134678899999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9.7e-39  Score=297.28  Aligned_cols=251  Identities=27%  Similarity=0.456  Sum_probs=199.9

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|.+.+.||.|+||.||+|..+       .++..||+|.+....  ....+.+.+|+.+++.++||||+++++.+...+ 
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-   72 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAK-------SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG-   72 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEc-------CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC-
Confidence            5788899999999999999975       456789999986542  233457889999999999999999999886554 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC-ceEEeec
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-RPKLSDF  236 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Df  236 (436)
                         ..++|+||+++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||++++++ .++|+||
T Consensus        73 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~  146 (257)
T cd08225          73 ---RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDF  146 (257)
T ss_pred             ---eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccc
Confidence               459999999999999999765555689999999999999999999998   999999999999998886 4699999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      |.+.....  .........|++.|+|||.+.+..++.++|+||||+++|+|++|..||........  ........    
T Consensus       147 ~~~~~~~~--~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~----  218 (257)
T cd08225         147 GIARQLND--SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL--VLKICQGY----  218 (257)
T ss_pred             ccchhccC--CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHhccc----
Confidence            99875321  11122334688999999999888899999999999999999999999975433211  11111100    


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                            ..     ......+..+.+++.+||..+|++|||+.+++.+
T Consensus       219 ------~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         219 ------FA-----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ------CC-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                  00     1112234678899999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.4e-38  Score=302.98  Aligned_cols=249  Identities=33%  Similarity=0.457  Sum_probs=196.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      ...|...+.||+|+||.||+|...       .+++.||+|.+.....   .....+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~   86 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDV-------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR   86 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEc-------CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe
Confidence            356889999999999999999865       4578899998864322   233568889999999999999999999986


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+.    .++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+
T Consensus        87 ~~~----~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~  157 (307)
T cd06607          87 EHT----AWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLA  157 (307)
T ss_pred             CCe----EEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEe
Confidence            553    489999996 67777775433 3689999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      |||++.....      .....++..|+|||++.   ...++.++||||||+++|+|+||..||..........   .+..
T Consensus       158 dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~---~~~~  228 (307)
T cd06607         158 DFGSASLVSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQ  228 (307)
T ss_pred             ecCcceecCC------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH---HHhc
Confidence            9999864221      12346788999999874   4568889999999999999999999997654332111   1110


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                      ..          .+.   ......+..+.++|.+||..||++||++.+|+.+.
T Consensus       229 ~~----------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         229 ND----------SPT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             CC----------CCC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            00          000   11123456789999999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.2e-38  Score=296.10  Aligned_cols=254  Identities=30%  Similarity=0.432  Sum_probs=199.5

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|+..+.||+|+||.||+|...       .++..|++|.+......  ..+.+.+|+.+++.++|+||+++++++...+ 
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-   72 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNL-------DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-   72 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEEC-------CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC-
Confidence            4788899999999999999864       46788999998766443  5677899999999999999999999876543 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++|+||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||
T Consensus        73 ---~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g  144 (264)
T cd06626          73 ---KVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFG  144 (264)
T ss_pred             ---EEEEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccc
Confidence               459999999999999999654  3588999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCccc--ccccccCCCcccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          238 LAREGPMVGHTHV--STAVVGTFGYAAPDYIETGH---LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       238 ~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      ++...........  .....++..|+|||.+.+..   ++.++||||||+++|++++|..||........  ....+.. 
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~~~~~~-  221 (264)
T cd06626         145 CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IMFHVGA-  221 (264)
T ss_pred             cccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HHHHHhc-
Confidence            9875322211110  12356788999999997765   78899999999999999999999975432211  1111111 


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..         .+.++.  ....+..+.++|.+||+.+|.+|||+.+++.+
T Consensus       222 ~~---------~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         222 GH---------KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             CC---------CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00         011111  11224677899999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.6e-38  Score=300.41  Aligned_cols=253  Identities=27%  Similarity=0.419  Sum_probs=192.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHH-HhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQF-LGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|++.+.||+|+||.||+|...       .++..||+|.+..... .....+..|+.+ ++.++||||+++++++...+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~   73 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHV-------PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG   73 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEc-------CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence            47899999999999999999865       5688999999875532 233445556654 66778999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .    .+++|||++ |+|.+++...  ....+++..++.++.|++.||.|||++  .+++||||||+||+++.++.+||+
T Consensus        74 ~----~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~  146 (283)
T cd06617          74 D----VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLC  146 (283)
T ss_pred             c----EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEe
Confidence            3    599999995 6888887542  234689999999999999999999984  289999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCccccccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      |||++.....   ........++..|+|||.+.+    ..++.++|+||||+++|+|++|..||....... ..+.....
T Consensus       147 dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~  222 (283)
T cd06617         147 DFGISGYLVD---SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQVVE  222 (283)
T ss_pred             eccccccccc---ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHHHHh
Confidence            9999875321   111223457889999999865    456889999999999999999999996532211 11111111


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...           +.+.   ....+..+.++|.+||..+|.+||++.+++.+
T Consensus       223 ~~~-----------~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         223 EPS-----------PQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             cCC-----------CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            100           0010   11234678999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.2e-38  Score=298.46  Aligned_cols=265  Identities=24%  Similarity=0.388  Sum_probs=198.2

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      +|+..+.||.|++|.||+|+..       .++..||+|.+...... ....+.+|+.+++.++||||+++++++...+. 
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-   72 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNR-------TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENK-   72 (284)
T ss_pred             CceEeeeeccCCceEEEEEEEC-------CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc-
Confidence            5888999999999999999965       46789999998765322 34567789999999999999999999987653 


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         .++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        73 ---~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g  145 (284)
T cd07836          73 ---LMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFG  145 (284)
T ss_pred             ---EEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecc
Confidence               4999999974 8988886543 24689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhhcccC
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQYPAD  315 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~  315 (436)
                      ++......  ........++..|++||.+.+. .++.++||||||+++|+|++|..||.+........ +..... .+..
T Consensus       146 ~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~  222 (284)
T cd07836         146 LARAFGIP--VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG-TPTE  222 (284)
T ss_pred             hhhhhcCC--ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCCh
Confidence            98743211  1122334578899999988654 56889999999999999999999998654432211 111100 0000


Q ss_pred             ccccccc-----cCCccc-------CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKKFGLI-----MDPRLE-------KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~-----~~~~l~-------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                       ..+..+     ......       .......+..+.+++.+||+.||.+||++.+++.+
T Consensus       223 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         223 -STWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             -hhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             000000     000000       00112335678899999999999999999998754

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=300.34  Aligned_cols=263  Identities=25%  Similarity=0.375  Sum_probs=197.0

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      |++.+.||.|++|.||+|.+.       .++..||+|++.....  .....+.+|+.+++.++||||+++++++...+  
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~--   71 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDK-------LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN--   71 (283)
T ss_pred             CchheEecCCCCeEEEEEEEc-------CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC--
Confidence            677889999999999999875       4678899999865432  22356788999999999999999999987553  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..+++|||+ +++|.+++.......+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        72 --~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~  145 (283)
T cd07835          72 --KLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGL  145 (283)
T ss_pred             --eEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccc
Confidence              459999999 56999998765544689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      +......  ........++..|+|||++.+. .++.++||||||+++|+|++|..||....+...  +............
T Consensus       146 ~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~  221 (283)
T cd07835         146 ARAFGVP--VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDE  221 (283)
T ss_pred             ccccCCC--ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCh
Confidence            8743211  1111223568899999988654 578899999999999999999999976544222  1111111000000


Q ss_pred             --------------ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          318 --------------KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       318 --------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                    .+........ .......+..+.++|.+||+.||.+|||+.+++.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         222 DVWPGVTSLPDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             HHhhhhhhchhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                          0000000000 01112234678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.9e-38  Score=300.44  Aligned_cols=266  Identities=23%  Similarity=0.334  Sum_probs=196.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|++.+.||.|++|.||+|...       .+++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDR-------VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK   74 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEec-------CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC
Confidence            57999999999999999999865       4678899999865432  22356788999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC-CCceEEee
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-NFRPKLSD  235 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~D  235 (436)
                          ..++||||+. ++|.+++.......+++..+..++.||+.||+|||++   +++|+||+|+||+++. ++.+||+|
T Consensus        75 ----~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~d  146 (294)
T PLN00009         75 ----RLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLAD  146 (294)
T ss_pred             ----eEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcc
Confidence                4599999995 5888888665544568889999999999999999998   9999999999999985 56799999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ||++......  ........+++.|+|||.+.+ ..++.++||||||+++|+|+||..||........  +.........
T Consensus       147 fg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~~~~~~~~  222 (294)
T PLN00009        147 FGLARAFGIP--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFKIFRILGT  222 (294)
T ss_pred             cccccccCCC--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCC
Confidence            9999743211  111233457889999998866 4578999999999999999999999976544322  1111111110


Q ss_pred             Cccc-cc------c---cc---CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKK-FG------L---IM---DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~-~~------~---~~---~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .... +.      .   ..   ............+..+.+++.+||+.||++||++.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        223 PNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             CChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000 00      0   00   0000000112234668899999999999999999999875

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.6e-38  Score=299.53  Aligned_cols=254  Identities=27%  Similarity=0.408  Sum_probs=204.4

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..+.|+..+.||.|+||.||+|.+.       .++..|++|++..... ..+.+.+|+.+++.++|+||+++++.+....
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   88 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDR-------ATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGD   88 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEc-------cCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC
Confidence            4567889999999999999999875       3578899999876543 4567889999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++++||+++++|.+++.... ..+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++|+||
T Consensus        89 ----~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~  160 (286)
T cd06614          89 ----ELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADF  160 (286)
T ss_pred             ----EEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECcc
Confidence                4599999999999999997654 3799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      |++.....  .........++..|+|||.+.+..++.++||||||+++|+|++|..||....+.....  . ......  
T Consensus       161 ~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~-~~~~~~--  233 (286)
T cd06614         161 GFAAQLTK--EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--L-ITTKGI--  233 (286)
T ss_pred             chhhhhcc--chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHhcCC--
Confidence            98864221  1112233457889999999988889999999999999999999999997654432211  1 111000  


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                              +.+  ......+..+.++|.+||+.+|.+||++.+++.+
T Consensus       234 --------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         234 --------PPL--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             --------CCC--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                    000  0111234678899999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.2e-38  Score=302.25  Aligned_cols=256  Identities=27%  Similarity=0.424  Sum_probs=193.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccC-CCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~  156 (436)
                      ++|...+.||+|+||.||++...       .+++.||+|.+..... .....+.+|+.++.++. ||||+++++++..++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~   76 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHK-------PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG   76 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEEC-------CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC
Confidence            35677789999999999999865       5678999999875432 33456888999999996 999999999887654


Q ss_pred             CcceeEEEEEEecCCCCHHHHh---hcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHL---FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l---~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      .    .+++|||+. ++|.++.   .......+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.++|
T Consensus        77 ~----~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl  149 (288)
T cd06616          77 D----CWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKL  149 (288)
T ss_pred             c----EEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEE
Confidence            3    489999985 4655543   223335799999999999999999999973  28999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG---HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      +|||++.....   ........|+..|+|||.+.+.   .++.++|||||||++|+|++|..||.....     ....+.
T Consensus       150 ~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~  221 (288)
T cd06616         150 CDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLT  221 (288)
T ss_pred             eecchhHHhcc---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHh
Confidence            99999864221   1112334588899999999766   688999999999999999999999975431     111111


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .....       ..+.+........+..+.+||.+||+.||.+|||+.+|+.+
T Consensus       222 ~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         222 QVVKG-------DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             hhcCC-------CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11000       00111112222345678999999999999999999999876

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.6e-38  Score=298.62  Aligned_cols=243  Identities=24%  Similarity=0.381  Sum_probs=186.6

Q ss_pred             cccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHH---HhccCCCCceeeeeEeeecCCcc
Q 013790           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQF---LGVLEHPNLVKLIGYCAVDGERG  159 (436)
Q Consensus        86 ~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~---l~~l~hpnIv~~~~~~~~~~~~~  159 (436)
                      .||+|+||.||++...       .+++.||+|.+......   ....+.+|..+   +...+||||+.+++++...+   
T Consensus         1 ~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---   70 (279)
T cd05633           1 IIGRGGFGEVYGCRKA-------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD---   70 (279)
T ss_pred             CcccCCCeEEEEEEEC-------CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC---
Confidence            4899999999999865       46789999988654221   12233444433   34457999999998887654   


Q ss_pred             eeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCC
Q 013790          160 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  239 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  239 (436)
                       ..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.++|+|||++
T Consensus        71 -~~~lv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~  144 (279)
T cd05633          71 -KLCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA  144 (279)
T ss_pred             -eEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcc
Confidence             3599999999999999986543  699999999999999999999998   9999999999999999999999999998


Q ss_pred             CCCCCCCCcccccccccCCCcccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 013790          240 REGPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  318 (436)
Q Consensus       240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  318 (436)
                      .....    .......|+..|+|||.+. +..++.++|||||||++|+|++|..||..........+......       
T Consensus       145 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-------  213 (279)
T cd05633         145 CDFSK----KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-------  213 (279)
T ss_pred             eeccc----cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc-------
Confidence            64221    1122346899999999986 45688999999999999999999999976543322222111110       


Q ss_pred             cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       319 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                          ...    ..+...+..+.++|.+||..||.+||     ++.+++++
T Consensus       214 ----~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         214 ----VNV----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ----CCc----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                011    12233456888999999999999999     58888776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=289.66  Aligned_cols=251  Identities=25%  Similarity=0.375  Sum_probs=205.3

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhH---HHHHHHHHHHhccCCCCceeeeeEee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH---KQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      ..++|..++.||+|.||+|.+++-+       .+++.||+|++++.-....   ..-..|-.+|+..+||.+..+.-.|.
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEK-------at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ  238 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREK-------ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ  238 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeec-------ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence            3578999999999999999999865       6889999999987644332   34567889999999999988866665


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ..+    .+|+||||..||.|.-+|.+.  +.+++.....+-..|+.||.|||++   +||.||||.+|+|+|.+|++||
T Consensus       239 t~d----rlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKi  309 (516)
T KOG0690|consen  239 TQD----RLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKI  309 (516)
T ss_pred             cCc----eEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEe
Confidence            443    469999999999999888654  4789999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +|||+++..  .......++++||+.|+|||++....|+.++|.|.+||++|||++|+.||...+......++-.     
T Consensus       310 tDFGLCKE~--I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~-----  382 (516)
T KOG0690|consen  310 TDFGLCKEE--IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM-----  382 (516)
T ss_pred             eecccchhc--ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-----
Confidence            999999863  3445567889999999999999999999999999999999999999999976543322222110     


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                               .+-    .++...+++...|+..+|..||.+|.     .+.||.++
T Consensus       383 ---------ed~----kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  383 ---------EDL----KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             ---------hhc----cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence                     011    22333346778999999999999997     45666654

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-38  Score=294.12  Aligned_cols=254  Identities=22%  Similarity=0.304  Sum_probs=199.7

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-----cchhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      .+|.+.+.||+|+||.||+|...       .++..||+|.+...     .......+.+|+.++++++||||+++++++.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~   74 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDA-------DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLR   74 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEc-------CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEE
Confidence            47899999999999999999865       46788999987532     1223457889999999999999999999876


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ....  ...++++||+++++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        75 ~~~~--~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l  147 (264)
T cd06653          75 DPEE--KKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKL  147 (264)
T ss_pred             cCCC--CEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEE
Confidence            5432  24689999999999999987543  588999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCC-cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          234 SDFGLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      +|||+++....... ........++..|+|||.+.+..++.++|||||||++|+|++|..||.......  .+... ...
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~-~~~  224 (264)
T cd06653         148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKI-ATQ  224 (264)
T ss_pred             CccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHHH-HcC
Confidence            99999975321111 111123568899999999988888999999999999999999999997643221  11111 111


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +             .....+...+..+.+++.+||. +|..||++.+++.+
T Consensus       225 ~-------------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         225 P-------------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             C-------------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            0             0112233445779999999999 57999999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.1e-38  Score=298.89  Aligned_cols=245  Identities=28%  Similarity=0.426  Sum_probs=192.7

Q ss_pred             ccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        87 ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      ||+|+||.||+|...       .+++.||+|.+.....   .....+..|+.+++.++||||+++++++...+    ..|
T Consensus         1 lg~g~~g~vy~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~   69 (277)
T cd05577           1 LGKGGFGEVCACQVK-------ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD----DLC   69 (277)
T ss_pred             CCCCCceeEEEEEEc-------CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC----eEE
Confidence            699999999999865       4678899999865422   22345678999999999999999999886554    359


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCC
Q 013790          164 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  243 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  243 (436)
                      +||||+++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        70 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~  146 (277)
T cd05577          70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELK  146 (277)
T ss_pred             EEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence            999999999999999776555799999999999999999999998   99999999999999999999999999987432


Q ss_pred             CCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhhcccCccccccc
Q 013790          244 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQYPADSKKFGLI  322 (436)
Q Consensus       244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  322 (436)
                      .   ........++..|+|||.+.+..++.++||||||+++|+|++|..||.......... +.......          
T Consensus       147 ~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------  213 (277)
T cd05577         147 G---GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM----------  213 (277)
T ss_pred             c---CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc----------
Confidence            1   222234567889999999988889999999999999999999999997654322111 11110000          


Q ss_pred             cCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       323 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                       .    ...+...+..+.++|.+||+.||.+||     ++.+++.+
T Consensus       214 -~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         214 -A----VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             -c----ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence             0    011222356788999999999999999     66666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.2e-38  Score=302.48  Aligned_cols=270  Identities=28%  Similarity=0.362  Sum_probs=198.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++.+.||.|+||.||+|...       .++..||+|.+......  ....+.+|+.+++.++|+||+++++++...
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDT-------TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK   78 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEEC-------CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence            568999999999999999999865       46788999998644322  123456799999999999999999998654


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      ..  ...++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|
T Consensus        79 ~~--~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~d  151 (309)
T cd07845          79 HL--DSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIAD  151 (309)
T ss_pred             CC--CeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence            32  24599999995 58988886543 4689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ||++.......  .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...++.............+.
T Consensus       152 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  229 (309)
T cd07845         152 FGLARTYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN  229 (309)
T ss_pred             cceeeecCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99987532211  11222345778999999865 5678999999999999999999999986554332221111100000


Q ss_pred             Ccc--cc------ccc-cCCcccCc---CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSK--KF------GLI-MDPRLEKE---YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~--~~------~~~-~~~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...  .+      ... ........   .....+..+.+||.+||..||++|||+.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000  00      000 00000000   001125678899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.2e-38  Score=290.76  Aligned_cols=251  Identities=29%  Similarity=0.442  Sum_probs=203.5

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcc
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  159 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  159 (436)
                      +|...+.||.|++|.||++...       .++..+++|.+..........+.+|+.+++.++||||+++++++....   
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   70 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHK-------RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD---   70 (253)
T ss_pred             CceeeeeeccCCceEEEEEEEC-------CCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC---
Confidence            5788899999999999999975       467889999997765555678899999999999999999999887654   


Q ss_pred             eeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCC
Q 013790          160 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  239 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  239 (436)
                       ..++++||+++++|.+++.... ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+
T Consensus        71 -~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~  145 (253)
T cd05122          71 -ELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLS  145 (253)
T ss_pred             -eEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccc
Confidence             3599999999999999987653 4789999999999999999999998   9999999999999999999999999998


Q ss_pred             CCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccc
Q 013790          240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF  319 (436)
Q Consensus       240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  319 (436)
                      ........   .....++..|+|||.+.+..++.++||||||+++|+|++|..||............   ...  .    
T Consensus       146 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~--~----  213 (253)
T cd05122         146 AQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI---ATN--G----  213 (253)
T ss_pred             cccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---Hhc--C----
Confidence            75322211   34456889999999998888899999999999999999999999765432221111   100  0    


Q ss_pred             ccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          320 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       320 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                          .+.+.  .....+..+.++|.+||..||.+|||+.+++.+
T Consensus       214 ----~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         214 ----PPGLR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ----CCCcC--cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                00000  011124678999999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=308.43  Aligned_cols=276  Identities=26%  Similarity=0.326  Sum_probs=201.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++.+.||+|+||.||+|...       .+++.||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHK-------PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPS   76 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEc-------CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence            468999999999999999999865       467889999986432 223456788999999999999999999876543


Q ss_pred             C-cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          157 E-RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       157 ~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      . .....++++||+. ++|.+.+..   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        77 ~~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~d  149 (336)
T cd07849          77 FESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICD  149 (336)
T ss_pred             ccccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECc
Confidence            2 2235699999995 588888754   3589999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCC-cccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          236 FGLAREGPMVGH-THVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       236 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      ||++........ ........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..............+
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~  229 (336)
T cd07849         150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP  229 (336)
T ss_pred             ccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            999875322111 111233568899999998754 568899999999999999999999997654322111110000000


Q ss_pred             cCccccccccCCc-------cc--Cc-----CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHHhh
Q 013790          314 ADSKKFGLIMDPR-------LE--KE-----YSINEARKIGRLADNCLSKSSKDRPKMSQVVER--LKQIV  368 (436)
Q Consensus       314 ~~~~~~~~~~~~~-------l~--~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~~~  368 (436)
                      .. ..+..+....       +.  ..     .....+..+.++|.+||+.||.+|||+.+++.+  ++...
T Consensus       230 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         230 SQ-EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             CH-HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            00 0000000000       00  00     001224678899999999999999999999987  54443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.7e-38  Score=301.01  Aligned_cols=275  Identities=24%  Similarity=0.361  Sum_probs=200.3

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      ..++|++.+.||+|+||.||+|...       .+++.||+|.+......  ....+.+|+.+++.++||||+++++++..
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   82 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHK-------KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT   82 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEEC-------CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence            3468999999999999999999865       46789999988644222  23356679999999999999999998875


Q ss_pred             cCC----cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc
Q 013790          155 DGE----RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  230 (436)
Q Consensus       155 ~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  230 (436)
                      ...    .....++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~  157 (310)
T cd07865          83 KATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGI  157 (310)
T ss_pred             ccccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCc
Confidence            432    1345699999995 58888886543 3689999999999999999999998   9999999999999999999


Q ss_pred             eEEeeccCCCCCCCCCCc--ccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 013790          231 PKLSDFGLAREGPMVGHT--HVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  307 (436)
                      +||+|||++.........  .......++..|+|||.+.+. .++.++||||||+++|+|++|..||....+......+.
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~  237 (310)
T cd07865         158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS  237 (310)
T ss_pred             EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999998753221111  112234577889999988664 46889999999999999999999998765544333333


Q ss_pred             HHhhc-ccCc----cccccccCCcccCcC---------CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          308 WVQQY-PADS----KKFGLIMDPRLEKEY---------SINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       308 ~~~~~-~~~~----~~~~~~~~~~l~~~~---------~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .+... +...    ..+...-...+....         +......+.+||.+||..||.+|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            22211 1000    000000000000000         00113467799999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.1e-38  Score=298.79  Aligned_cols=270  Identities=23%  Similarity=0.324  Sum_probs=198.0

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccC-CCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  155 (436)
                      ++|++.+.||+|+||.||+|.+.       .+++.||+|.+.....  .....+.+|+.+++.+. ||||+++++++...
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~-------~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   73 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDK-------NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVE   73 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEEC-------CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeec
Confidence            46899999999999999999865       4678999998765432  22356788999999995 69999999988765


Q ss_pred             CC-cceeEEEEEEecCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC-CCc
Q 013790          156 GE-RGIQRLLVYEFMLNRSLEDHLFNRA---FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-NFR  230 (436)
Q Consensus       156 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~  230 (436)
                      .. .....++||||+.+ +|.+++....   ...+++..++.++.||+.||.|||+.   +++||||+|+||+++. ++.
T Consensus        74 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~  149 (295)
T cd07837          74 EKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGL  149 (295)
T ss_pred             CCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCe
Confidence            43 22346899999975 8988886532   24689999999999999999999998   9999999999999998 899


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHH
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEW  308 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~  308 (436)
                      +||+|||++......  ........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+..+.... .+...
T Consensus       150 ~kl~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~  227 (295)
T cd07837         150 LKIADLGLGRAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL  227 (295)
T ss_pred             EEEeecccceecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            999999998743211  111223356788999998865 45789999999999999999999999765433221 11111


Q ss_pred             HhhcccCcccccccc-----------CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          309 VQQYPADSKKFGLIM-----------DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       309 ~~~~~~~~~~~~~~~-----------~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +.. +.. ..+....           .+..........+..+.++|.+||..||.+||++.+++.+
T Consensus       228 ~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         228 LGT-PTE-QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hCC-CCh-hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            110 000 0000000           0000000112245678899999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.7e-38  Score=307.79  Aligned_cols=273  Identities=22%  Similarity=0.314  Sum_probs=203.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++.+.||.|+||.||+|...       .++..||+|.+....  ......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   76 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDT-------RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPP   76 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEc-------CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcccc
Confidence            368999999999999999999865       567899999987542  23345677899999999999999999988765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      .......++||||+. ++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        77 ~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~d  150 (334)
T cd07855          77 GADFKDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGD  150 (334)
T ss_pred             CCCCceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecc
Confidence            545556799999995 6899998654  3589999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCC--cccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          236 FGLAREGPMVGH--THVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       236 fg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      ||++........  ........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||..................
T Consensus       151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~  230 (334)
T cd07855         151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS  230 (334)
T ss_pred             cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCC
Confidence            999875322111  111234568889999999865 46789999999999999999999999765443221111111000


Q ss_pred             ccCcc-------ccccc---cCCccc---CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSK-------KFGLI---MDPRLE---KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~-------~~~~~---~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +....       .....   ......   .......+..+.++|.+||+.+|++||++.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00000       00000   000000   00112235789999999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.1e-38  Score=296.13  Aligned_cols=265  Identities=24%  Similarity=0.299  Sum_probs=193.0

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccC-CCCceeeeeEeeecCCc
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVDGER  158 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~  158 (436)
                      |++.+.||+|+||.||+|...       .++..||+|.+..... .......+|+.++.++. ||||+++++++....  
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~-------~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--   71 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSR-------KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK--   71 (282)
T ss_pred             CceEeeccccccceEEEEEEc-------CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC--
Confidence            677889999999999999865       4678899999875421 22233456888888885 999999999987652  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                      ....++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++. +.+||+|||+
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~  145 (282)
T cd07831          72 TGRLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGS  145 (282)
T ss_pred             CCcEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccc
Confidence            124699999996 58888886543 4689999999999999999999998   9999999999999999 9999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HHHhhccc--
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL-EWVQQYPA--  314 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~~~~~~~--  314 (436)
                      +.....   ........++..|+|||.+. +..++.++|||||||++|+|++|..||.+.+........ ......+.  
T Consensus       146 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
T cd07831         146 CRGIYS---KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV  222 (282)
T ss_pred             cccccc---CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            975321   11122345788999999764 456788999999999999999999999775543221111 11000000  


Q ss_pred             -----CccccccccCCccc---CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 -----DSKKFGLIMDPRLE---KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 -----~~~~~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                           ..............   .......+..+.+||.+||..+|++||++.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         223 LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             HHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence                 00000000000000   00112346789999999999999999999999865

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.1e-38  Score=299.26  Aligned_cols=247  Identities=26%  Similarity=0.417  Sum_probs=197.3

Q ss_pred             ccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeE
Q 013790           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQR  162 (436)
Q Consensus        83 ~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  162 (436)
                      ....||+|+||.||++...       .++..||+|.+..........+.+|+.+++.++||||+++++++...+    ..
T Consensus        24 ~~~~lg~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~   92 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVK-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD----EL   92 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEc-------CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC----EE
Confidence            3467999999999999875       467899999987655555667889999999999999999999987654    45


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCC
Q 013790          163 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG  242 (436)
Q Consensus       163 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  242 (436)
                      ++||||+++++|.+++...   .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~  166 (292)
T cd06657          93 WVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  166 (292)
T ss_pred             EEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceec
Confidence            9999999999999987543   589999999999999999999998   9999999999999999999999999988643


Q ss_pred             CCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccc
Q 013790          243 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI  322 (436)
Q Consensus       243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (436)
                      ..  .........|+..|+|||.+.+..++.++|+||||+++|+|++|..||.............  ...+         
T Consensus       167 ~~--~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~--~~~~---------  233 (292)
T cd06657         167 SK--EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR--DNLP---------  233 (292)
T ss_pred             cc--ccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hhCC---------
Confidence            21  1112234568899999999988888999999999999999999999997654332211111  1111         


Q ss_pred             cCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       323 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                        +.+.  .....+..+.+++.+||..||.+||++.+++.+
T Consensus       234 --~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         234 --PKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             --cccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence              0000  011234568899999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.2e-38  Score=305.38  Aligned_cols=270  Identities=28%  Similarity=0.397  Sum_probs=199.7

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhcc-CCCCceeeeeEee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCA  153 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  153 (436)
                      ..++|++.+.||+|+||.||+|...       .++..+|+|.+...  .......+.+|+.+++++ +||||+++++++.
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~   77 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDR-------RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIK   77 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEc-------CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeec
Confidence            4568999999999999999999865       45788999988543  223345677899999999 9999999999886


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ....  ...++||||+. ++|..++...   .+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||
T Consensus        78 ~~~~--~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl  148 (337)
T cd07852          78 AEND--KDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKL  148 (337)
T ss_pred             cCCC--ceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEE
Confidence            5432  24699999996 5999988654   688999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCc---ccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 013790          234 SDFGLAREGPMVGHT---HVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  309 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  309 (436)
                      +|||++.........   .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+..+..........
T Consensus       149 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~  228 (337)
T cd07852         149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV  228 (337)
T ss_pred             eeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            999999754322211   12233568899999998754 56788999999999999999999999765443221111100


Q ss_pred             hhcccC-----------ccccccccC---CcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          310 QQYPAD-----------SKKFGLIMD---PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       310 ~~~~~~-----------~~~~~~~~~---~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...+..           ...+..+..   ..+. ......+..+.++|.+||+.||++|||+.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hCCCCHHHHHHHHhhhHHHhhhhcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000000           000000000   0000 0011135678999999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=9.3e-38  Score=290.25  Aligned_cols=255  Identities=26%  Similarity=0.380  Sum_probs=204.3

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|...+.||+|++|.||+|...       .++..|++|++.....  ...+.+.+|+.++++++||||+++++.+.... 
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   72 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDK-------DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE-   72 (260)
T ss_pred             CceeeeEeeecCceEEEEEEEC-------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC-
Confidence            4778899999999999999865       4678899999876543  34567889999999999999999999987652 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                       ....++++||+.+++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        73 -~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~  146 (260)
T cd06606          73 -KNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFG  146 (260)
T ss_pred             -CCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccc
Confidence             124589999999999999997654  789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      .+................++..|+|||.+.+...+.++||||||+++|+|++|..||.......  .....+.       
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~-------  217 (260)
T cd06606         147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYKIG-------  217 (260)
T ss_pred             cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHhcc-------
Confidence            9875332221111344568889999999988889999999999999999999999998655111  1111100       


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                            ........+...+..+.++|.+||..||++||++.+++.+
T Consensus       218 ------~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         218 ------SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             ------ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence                  0000111222335789999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.7e-38  Score=292.81  Aligned_cols=244  Identities=26%  Similarity=0.372  Sum_probs=194.2

Q ss_pred             ccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        87 ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      ||.|+||.||+|...       .+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++....    ..+
T Consensus         1 lg~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~   69 (262)
T cd05572           1 LGVGGFGRVELVKVK-------SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK----YIY   69 (262)
T ss_pred             CCCCCceEEEEEEEC-------CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC----ccE
Confidence            799999999999975       4678899999875432   23467889999999999999999999886554    359


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCC
Q 013790          164 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  243 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  243 (436)
                      +++||+++++|.+++.+..  .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        70 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~  144 (262)
T cd05572          70 MLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK  144 (262)
T ss_pred             EEEecCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccC
Confidence            9999999999999997643  589999999999999999999998   99999999999999999999999999997532


Q ss_pred             CCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccccc
Q 013790          244 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM  323 (436)
Q Consensus       244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (436)
                      ...   ......++..|++||.+.+..++.++|+||||+++|+|++|..||........ .....+....          
T Consensus       145 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~----------  210 (262)
T cd05572         145 SGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EIYNDILKGN----------  210 (262)
T ss_pred             ccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HHHHHHhccC----------
Confidence            211   22335688899999999888899999999999999999999999976542111 1111111000          


Q ss_pred             CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 013790          324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  363 (436)
Q Consensus       324 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~  363 (436)
                         ....++...+..+.++|.+||..||++||+     +.+++++
T Consensus       211 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         211 ---GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             ---CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence               001122222568999999999999999999     7777663

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9.2e-38  Score=300.37  Aligned_cols=251  Identities=32%  Similarity=0.457  Sum_probs=197.5

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .|...+.||+|+||.||+|...       .++..||+|.+.....   .....+.+|+.+++.++|||++++++++....
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~-------~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   98 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDV-------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH   98 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEc-------CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            4778889999999999999865       4678899999864422   23456888999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      .    .++||||+. |+|.+.+.... .++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        99 ~----~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~df  169 (317)
T cd06635          99 T----AWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADF  169 (317)
T ss_pred             e----EEEEEeCCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecC
Confidence            3    499999996 58887775433 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |++....      ......|+..|+|||.+.   .+.++.++|||||||++|+|++|..||........  ...+.....
T Consensus       170 g~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~~~~  241 (317)
T cd06635         170 GSASIAS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNES  241 (317)
T ss_pred             CCccccC------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHHhccC
Confidence            9986421      123346888999999973   45688999999999999999999999976433221  111111100


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                                    ........+..+.+++.+||+.+|.+||++.+++.++..+.
T Consensus       242 --------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         242 --------------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             --------------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                          00111223467899999999999999999999998865443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=299.13  Aligned_cols=273  Identities=22%  Similarity=0.273  Sum_probs=197.5

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .|.+.+.||+|+||.||+|....     ...+..||+|.+....   ....+.+.+|+.++..++||||+++++++....
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKN-----GKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA   75 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecC-----CCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence            47888999999999999999762     1257899999997632   233456788999999999999999999997653


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC----CC
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNR---AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE----NF  229 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~----~~  229 (436)
                      .  ...++||||+. ++|.+++...   ....+++..++.++.|++.||.|||+.   +|+||||||+||+++.    ++
T Consensus        76 ~--~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~  149 (316)
T cd07842          76 D--KSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERG  149 (316)
T ss_pred             C--ceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccc
Confidence            2  25699999996 4777776432   123689999999999999999999998   9999999999999999    99


Q ss_pred             ceEEeeccCCCCCCCCCC-cccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchh------
Q 013790          230 RPKLSDFGLAREGPMVGH-THVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT------  301 (436)
Q Consensus       230 ~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~------  301 (436)
                      .+||+|||++........ ........++..|+|||.+.+. .++.++||||||+++|+|++|..||.......      
T Consensus       150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~  229 (316)
T cd07842         150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF  229 (316)
T ss_pred             eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchh
Confidence            999999999875322111 1122334678899999988664 57899999999999999999999997654332      


Q ss_pred             -hHHHHHHHhhcccCcc----------cccc----ccCCccc-----CcCCH--HHHHHHHHHHHHhhcCCCCCCCCHHH
Q 013790          302 -EQRLLEWVQQYPADSK----------KFGL----IMDPRLE-----KEYSI--NEARKIGRLADNCLSKSSKDRPKMSQ  359 (436)
Q Consensus       302 -~~~~~~~~~~~~~~~~----------~~~~----~~~~~l~-----~~~~~--~~~~~l~~li~~cl~~dp~~RPs~~e  359 (436)
                       ...+...+........          .+..    .......     .....  ..+..+.+++.+||+.||.+|||+.+
T Consensus       230 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~e  309 (316)
T cd07842         230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEE  309 (316)
T ss_pred             HHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence             0111111111100000          0000    0000000     00000  23456889999999999999999999


Q ss_pred             HHHH
Q 013790          360 VVER  363 (436)
Q Consensus       360 il~~  363 (436)
                      ++.+
T Consensus       310 il~~  313 (316)
T cd07842         310 ALEH  313 (316)
T ss_pred             HhcC
Confidence            9864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.7e-38  Score=302.01  Aligned_cols=263  Identities=22%  Similarity=0.293  Sum_probs=194.1

Q ss_pred             cccccc--CceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcce
Q 013790           85 LKIGEG--GFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        85 ~~ig~G--~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  160 (436)
                      ..||.|  +||+||++.+.       .+++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+    
T Consensus         4 ~~ig~g~~~~~~v~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~----   72 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHT-------PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS----   72 (328)
T ss_pred             HHhCCcccCceeEEEEEEc-------CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC----
Confidence            356766  89999999865       578899999987543  223467888999999999999999999997654    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++|+||+.+++|.+++.......+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++++||+.+.
T Consensus        73 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~  149 (328)
T cd08226          73 WLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLY  149 (328)
T ss_pred             ceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHh
Confidence            359999999999999999775545689999999999999999999998   99999999999999999999999998653


Q ss_pred             CCCCCCCcc-----cccccccCCCcccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          241 EGPMVGHTH-----VSTAVVGTFGYAAPDYIETG--HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       241 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      .........     ......++..|+|||++.+.  .++.++|||||||++|+|++|..||........  ....+...+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~  227 (328)
T cd08226         150 SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPP  227 (328)
T ss_pred             hhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCC
Confidence            211110000     01112346679999999763  478999999999999999999999976543211  111111110


Q ss_pred             cCccc-------------------------------cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 013790          314 ADSKK-------------------------------FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE  362 (436)
Q Consensus       314 ~~~~~-------------------------------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~  362 (436)
                      .....                               ...+....+........+..+.+|+.+||+.||++|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         228 YSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             CCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            00000                               00011111122223445678999999999999999999999987


Q ss_pred             H
Q 013790          363 R  363 (436)
Q Consensus       363 ~  363 (436)
                      +
T Consensus       308 ~  308 (328)
T cd08226         308 H  308 (328)
T ss_pred             C
Confidence            6

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-38  Score=309.39  Aligned_cols=251  Identities=25%  Similarity=0.370  Sum_probs=208.4

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      ..+.|.+.++||+|.|+.|.+|++.       .++..||||.+++....  ....+.+|+++|..|+|||||+++.+...
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~-------~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t  126 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHI-------LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET  126 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEec-------CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence            4578999999999999999999976       56788999999876433  33558899999999999999999998876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      ..    .+|+||||+.+|.+.+++....  ...+..+..++.|++.|++|||++   +|||||||++||||+.+.++||+
T Consensus       127 ~~----~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIa  197 (596)
T KOG0586|consen  127 EA----TLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIA  197 (596)
T ss_pred             cc----eeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeee
Confidence            54    3599999999999999997765  566788999999999999999999   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |||++..+   .......+++|++.|.|||++.+..| ++.+|+||+|+++|.|++|..||++..-.....-        
T Consensus       198 DfgfS~~~---~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r--------  266 (596)
T KOG0586|consen  198 DFGFSTFF---DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR--------  266 (596)
T ss_pred             ccccceee---cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch--------
Confidence            99999853   35566778999999999999988766 5789999999999999999999987543321100        


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                              .+...+  .++...+.++.+||+++|..+|.+|+++.+|..+-
T Consensus       267 --------vl~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  267 --------VLRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             --------heeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence                    011111  11222345678999999999999999999998764

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=313.27  Aligned_cols=277  Identities=27%  Similarity=0.413  Sum_probs=206.6

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC-
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE-  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-  157 (436)
                      -+...+.||+|+||.||+|+.+       .+|..||||.++.. .....+...+|+++|++|+|||||+++++-..... 
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnk-------etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~   86 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNK-------ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG   86 (732)
T ss_pred             ceeehhhhcCCccceeeeeccc-------ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence            3455678999999999999865       78999999999864 33455788999999999999999999887544330 


Q ss_pred             -cceeEEEEEEecCCCCHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc--CCC--ce
Q 013790          158 -RGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD--ENF--RP  231 (436)
Q Consensus       158 -~~~~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~  231 (436)
                       ......+|||||.||||...+.+- +..++++.+.+.++.+++.||.|||.+   ||+||||||.||++-  .+|  ..
T Consensus        87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~Iy  163 (732)
T KOG4250|consen   87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIY  163 (732)
T ss_pred             cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEE
Confidence             123458999999999999999763 345799999999999999999999998   999999999999993  334  37


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH-
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV-  309 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~-  309 (436)
                      ||+|||.|+.   .+......+.+||..|.+||++.. ..|+..+|.|||||++|+++||..||..........-+.|. 
T Consensus       164 KLtDfG~Are---l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~  240 (732)
T KOG4250|consen  164 KLTDFGAARE---LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI  240 (732)
T ss_pred             eeeccccccc---CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh
Confidence            9999999996   334446778999999999999984 88899999999999999999999999654332111111111 


Q ss_pred             hhcccCccccccc--------cCCc--ccCcCCHHHHHHHHHHHHHhhcCCCCCCC--CHHHHHHHHHHhhh
Q 013790          310 QQYPADSKKFGLI--------MDPR--LEKEYSINEARKIGRLADNCLSKSSKDRP--KMSQVVERLKQIVQ  369 (436)
Q Consensus       310 ~~~~~~~~~~~~~--------~~~~--l~~~~~~~~~~~l~~li~~cl~~dp~~RP--s~~eil~~L~~~~~  369 (436)
                      ...+.+.......        ....  .+..........+..++..+|..+|++|-  .+.+....+..|+.
T Consensus       241 ~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  241 ITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             hccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            1111111000000        0001  12233444455677888899999999999  77777666666653

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.9e-38  Score=306.47  Aligned_cols=273  Identities=23%  Similarity=0.334  Sum_probs=203.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|.+.+.||+|+||.||+|...       .++..||||.+...  .......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   76 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNS-------ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPP   76 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEec-------CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecc
Confidence            457999999999999999999864       56789999998653  222345677899999999999999999987654


Q ss_pred             CC-cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          156 GE-RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       156 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .. .....++|+||+. ++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+
T Consensus        77 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~  150 (337)
T cd07858          77 HREAFNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKIC  150 (337)
T ss_pred             cccccCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEC
Confidence            32 2234699999994 7899988654  4699999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |||++......  ........++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..............+
T Consensus       151 Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  228 (337)
T cd07858         151 DFGLARTTSEK--GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP  228 (337)
T ss_pred             cCccccccCCC--cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999753221  122334567889999998864 468899999999999999999999997654322211111111110


Q ss_pred             cCcccccccc---------------CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHHh
Q 013790          314 ADSKKFGLIM---------------DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER--LKQI  367 (436)
Q Consensus       314 ~~~~~~~~~~---------------~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~~  367 (436)
                      ... ....+.               ...+. ......+..+.+||.+||+.||.+|||+.+++.+  +..+
T Consensus       229 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         229 SEE-DLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             ChH-HhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            000 000000               00000 0112345678899999999999999999999988  5544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-37  Score=341.97  Aligned_cols=266  Identities=26%  Similarity=0.443  Sum_probs=206.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ...|...+.||+|+||.||+|.+.       .++..||+|.+......    ...|++.+++++||||++++|+|.....
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~  757 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSI-------KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKG  757 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEEC-------CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence            356777889999999999999875       46788999998654321    2346889999999999999999977654


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .++||||+++|+|.+++.     .++|..+..|+.|++.||+|||..+..+|+||||||+||+++.++..++. ||
T Consensus       758 ----~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~  827 (968)
T PLN00113        758 ----AYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS  827 (968)
T ss_pred             ----CEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence                499999999999999994     38899999999999999999996555699999999999999999888875 66


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ......      ......+|..|+|||++.+..++.++|||||||++|||+||+.||..... ....+..|....... .
T Consensus       828 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~  899 (968)
T PLN00113        828 LPGLLC------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-C  899 (968)
T ss_pred             cccccc------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-c
Confidence            553211      11223678999999999999999999999999999999999999954322 122344444332211 1


Q ss_pred             ccccccCCcccC--cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          318 KFGLIMDPRLEK--EYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       318 ~~~~~~~~~l~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                      ....++++.+..  ........++.+++.+||+.||++|||+.++++.|+.+.....
T Consensus       900 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  956 (968)
T PLN00113        900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS  956 (968)
T ss_pred             chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence            222334444432  2344556678899999999999999999999999999876444

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.2e-37  Score=292.21  Aligned_cols=252  Identities=23%  Similarity=0.338  Sum_probs=194.0

Q ss_pred             HHHHHHhhcCCcccccc--cccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCcee
Q 013790           71 YSEMRQATNDFSRMLKI--GEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVK  147 (436)
Q Consensus        71 ~~~~~~~~~~~~~~~~i--g~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  147 (436)
                      ..+.....++|.+.+.+  |.|+||.||++..+       .++..+|+|.+........     |+.....+ +||||++
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~   73 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHK-------PTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIK   73 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEc-------CCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEE
Confidence            34555566788888877  99999999999865       5678899999875432221     22222222 7999999


Q ss_pred             eeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          148 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       148 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      +++.+...+    ..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.   +++||||||+||+++.
T Consensus        74 ~~~~~~~~~----~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~  144 (267)
T PHA03390         74 LYYSVTTLK----GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDR  144 (267)
T ss_pred             EEEEEecCC----eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeC
Confidence            999987654    4599999999999999997653  799999999999999999999998   9999999999999999


Q ss_pred             CC-ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 013790          228 NF-RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  306 (436)
Q Consensus       228 ~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  306 (436)
                      ++ .++|+|||++....      ......++..|+|||++.+..++.++||||||+++|+|++|..||....... ....
T Consensus       145 ~~~~~~l~dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~  217 (267)
T PHA03390        145 AKDRIYLCDYGLCKIIG------TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLE  217 (267)
T ss_pred             CCCeEEEecCccceecC------CCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHH
Confidence            88 99999999986421      1123468899999999998889999999999999999999999997543321 1111


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHHH
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-MSQVVER  363 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~eil~~  363 (436)
                      .+.......           .  ......+..+.++|.+||+.||.+||+ +.+++++
T Consensus       218 ~~~~~~~~~-----------~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        218 SLLKRQQKK-----------L--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             HHHHhhccc-----------C--CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            111111100           0  111134567899999999999999995 6888754

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-39  Score=313.32  Aligned_cols=247  Identities=21%  Similarity=0.339  Sum_probs=197.0

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC----cchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcc
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  159 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  159 (436)
                      ...||+|+|-+||+|..       ..++..||.-.+...    .....++|..|+.+|+.|+||||+++|.++...... 
T Consensus        45 ~evLGrGafKtVYka~D-------e~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~-  116 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFD-------EEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK-  116 (632)
T ss_pred             hhhcccccceeeeeccc-------cccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc-
Confidence            45799999999999984       367777775544322    334457899999999999999999999999877653 


Q ss_pred             eeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc-CCCceEEeeccC
Q 013790          160 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGL  238 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~  238 (436)
                       .+.+|+|.+..|+|..|+.+..  .++...+..|++||++||.|||++ .++|+|||||.+||||+ .-|.|||+|+||
T Consensus       117 -~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGL  192 (632)
T KOG0584|consen  117 -TINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGL  192 (632)
T ss_pred             -eeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhH
Confidence             4589999999999999997654  688899999999999999999996 67999999999999997 468999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  318 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  318 (436)
                      |+..    .........|||.|||||++. ..|+..+||||||++|+||+|+..||.....  ...+...+..- ..+..
T Consensus       193 Atl~----r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SG-iKP~s  264 (632)
T KOG0584|consen  193 ATLL----RKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSG-IKPAA  264 (632)
T ss_pred             HHHh----hccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcC-CCHHH
Confidence            9742    222334478999999999997 7899999999999999999999999975432  22333333221 11122


Q ss_pred             cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       319 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +..+-            .+++++||.+|+.. ..+|||+.|+|.+
T Consensus       265 l~kV~------------dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  265 LSKVK------------DPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             hhccC------------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            22222            24688999999999 9999999999875

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.3e-37  Score=289.34  Aligned_cols=251  Identities=26%  Similarity=0.447  Sum_probs=203.4

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|.+.+.||.|+||.||++.+.       .++..|++|.+.....  .....+.+|+++++.++|||++++++.+.... 
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~-   72 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRK-------SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKG-   72 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEc-------CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCC-
Confidence            5788899999999999999965       4678899999876543  44567889999999999999999999887653 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                         ..++|+||+++++|.+++....  ...+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|
T Consensus        73 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d  146 (258)
T cd08215          73 ---KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGD  146 (258)
T ss_pred             ---EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECC
Confidence               4699999999999999997643  35799999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||++......  ........|++.|+|||.+.+..++.++||||||+++|+|++|..||.......   +........  
T Consensus       147 ~~~~~~~~~~--~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~~~~--  219 (258)
T cd08215         147 FGISKVLSST--VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALKILKGQ--  219 (258)
T ss_pred             ccceeecccC--cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHHHHhcCC--
Confidence            9998753221  122334568889999999988889999999999999999999999997654221   111111100  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                              ..    ..+...+..+.+++.+||..+|++|||+.+++.+
T Consensus       220 --------~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         220 --------YP----PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             --------CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    00    1122334678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.8e-37  Score=296.07  Aligned_cols=273  Identities=26%  Similarity=0.329  Sum_probs=201.0

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      ...++|++.+.||.|+||.||+|.+.       .+++.||+|.+.....  .....+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~   76 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDK-------DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVT   76 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEEC-------CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheec
Confidence            34678999999999999999999976       4567899999865432  22346778999999999999999999886


Q ss_pred             ecC------CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          154 VDG------ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       154 ~~~------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      ...      ......++|+||+.+ +|.+++... ...+++..+..++.|++.||+|||+.   +|+|+||||+||+++.
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~  151 (302)
T cd07864          77 DKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNN  151 (302)
T ss_pred             CcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence            543      112256999999965 787777654 34689999999999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 013790          228 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  306 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  306 (436)
                      ++.+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...........+
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~  230 (302)
T cd07864         152 KGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI  230 (302)
T ss_pred             CCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99999999999875322111 11222345778999998865 45688999999999999999999999865543332222


Q ss_pred             HHHhhcccCcccccccc--------------CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          307 EWVQQYPADSKKFGLIM--------------DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~--------------~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ......+.. ..+..+.              ...+... ....+..+.+++.+||..||.+||++.+++.+
T Consensus       231 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         231 SRLCGSPCP-AVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HHHhCCCCh-hhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            221111110 0000000              0000000 11135678999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=294.36  Aligned_cols=267  Identities=26%  Similarity=0.364  Sum_probs=198.5

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      |++.+.||.|+||.||+|...       .+++.+|+|.+....  ......+.+|+.+++.++|||++++++++....  
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   71 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNK-------KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG--   71 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEEC-------CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC--
Confidence            677889999999999999875       457889999997653  223456788999999999999999999987652  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                      ....++||||+. ++|.+++.... ..+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~  146 (287)
T cd07840          72 KGSIYMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGL  146 (287)
T ss_pred             CCcEEEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccc
Confidence            224699999996 58998886553 4689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      +........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||..................+.. .
T Consensus       147 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~-~  224 (287)
T cd07840         147 ARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD-E  224 (287)
T ss_pred             eeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch-h
Confidence            875322211 11223456788999998765 46789999999999999999999999876543222111111111100 0


Q ss_pred             cccccc--------------CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          318 KFGLIM--------------DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       318 ~~~~~~--------------~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .+....              ...+...+...++..+.+++.+||..+|.+||++.+++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            000000              0000000111125678999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-39  Score=294.71  Aligned_cols=266  Identities=23%  Similarity=0.316  Sum_probs=208.2

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCC--C----Cceeee
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH--P----NLVKLI  149 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--p----nIv~~~  149 (436)
                      ...++|.+..++|+|+||.|-.+...       ..+..||||+++.-. ...+...-|+++|.++.+  |    -++.+.
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~-------~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~  157 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDR-------ETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMR  157 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeec-------CCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence            34789999999999999999999865       447899999986442 233556679999999942  2    267777


Q ss_pred             eEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC--
Q 013790          150 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE--  227 (436)
Q Consensus       150 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--  227 (436)
                      ++|...+.    .|||+|.+ |-|+.++|..++..+++...+..|+.|++.++++||+.   +++|.||||+|||+..  
T Consensus       158 ~wFdyrgh----iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~  229 (415)
T KOG0671|consen  158 DWFDYRGH----ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSE  229 (415)
T ss_pred             hhhhccCc----eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccc
Confidence            77866553    59999987 77999999998888999999999999999999999999   9999999999999931  


Q ss_pred             ------------------CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh
Q 013790          228 ------------------NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT  289 (436)
Q Consensus       228 ------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt  289 (436)
                                        +..++|+|||.|+..     ....+..+.|..|.|||++.+..++..+||||+||||+||.|
T Consensus       230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~-----~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt  304 (415)
T KOG0671|consen  230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFD-----HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT  304 (415)
T ss_pred             eEEEeccCCccceeccCCCcceEEEecCCccee-----ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence                              345899999999752     222266788999999999999999999999999999999999


Q ss_pred             CCCCCCCCCchhhHHHHHHHhhcccCccccccc------cCCccc-----------------------CcCCHHHHHHHH
Q 013790          290 GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI------MDPRLE-----------------------KEYSINEARKIG  340 (436)
Q Consensus       290 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~l~-----------------------~~~~~~~~~~l~  340 (436)
                      |...|......+....++.+.+ |.+...+...      ...++.                       -.....+...|.
T Consensus       305 G~~LFqtHen~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf  383 (415)
T KOG0671|consen  305 GETLFQTHENLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF  383 (415)
T ss_pred             cceecccCCcHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence            9999998876665555555544 2221111110      000000                       011234456799


Q ss_pred             HHHHHhhcCCCCCCCCHHHHHHH
Q 013790          341 RLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       341 ~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +|+.+||..||.+|+|+.|++.|
T Consensus       384 DLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  384 DLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             HHHHHHHccCccccccHHHHhcC
Confidence            99999999999999999999876

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4e-38  Score=323.93  Aligned_cols=259  Identities=27%  Similarity=0.403  Sum_probs=195.3

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .-.++|+.+..||+||||.||+++.+       -+|+.||||++.... ......+.+|+..|.+|+|||||+++..+.+
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNK-------lDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVE  548 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNK-------LDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVE  548 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeec-------ccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhc
Confidence            45678999999999999999999966       789999999997653 2334568899999999999999998765422


Q ss_pred             cCC-----------------------------------------------------------------------------
Q 013790          155 DGE-----------------------------------------------------------------------------  157 (436)
Q Consensus       155 ~~~-----------------------------------------------------------------------------  157 (436)
                      ...                                                                             
T Consensus       549 s~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~  628 (1351)
T KOG1035|consen  549 STAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGR  628 (1351)
T ss_pred             cCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccc
Confidence            100                                                                             


Q ss_pred             --------------------------------------cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 013790          158 --------------------------------------RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA  199 (436)
Q Consensus       158 --------------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~  199 (436)
                                                            ....+||-||||+..+|.+++.++.... .....++++++|+
T Consensus       629 ~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIl  707 (1351)
T KOG1035|consen  629 NLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREIL  707 (1351)
T ss_pred             ccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHH
Confidence                                                  0035689999999988888876654211 4578899999999


Q ss_pred             HHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCC----------------CCCCcccccccccCCCcccc
Q 013790          200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP----------------MVGHTHVSTAVVGTFGYAAP  263 (436)
Q Consensus       200 ~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~aP  263 (436)
                      +||+|+|++   |||||||||.|||++.++.|||+|||+|+...                ........+..+||..|+||
T Consensus       708 EGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP  784 (1351)
T KOG1035|consen  708 EGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP  784 (1351)
T ss_pred             HHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence            999999999   99999999999999999999999999997511                01112234567899999999


Q ss_pred             cccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCccc--CcCCHHHHHH
Q 013790          264 DYIETG---HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLE--KEYSINEARK  338 (436)
Q Consensus       264 E~~~~~---~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~~  338 (436)
                      |++.+.   .|+.|+|+||||||++||+.   ||..  ..+...++..+..             ..++  ..+..+....
T Consensus       785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~LR~-------------g~iP~~~~f~~~~~~~  846 (1351)
T KOG1035|consen  785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT--SMERASILTNLRK-------------GSIPEPADFFDPEHPE  846 (1351)
T ss_pred             HHhcccccccccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhccc-------------CCCCCCcccccccchH
Confidence            999765   49999999999999999996   4542  2222233332221             1111  1122223334


Q ss_pred             HHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          339 IGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       339 l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      -..+|.+|++.||.+|||+.|+|..
T Consensus       847 e~slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  847 EASLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHHHHHHHhcCCCccCCCHHHHhhc
Confidence            5589999999999999999999863

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1e-37  Score=298.83  Aligned_cols=274  Identities=27%  Similarity=0.320  Sum_probs=199.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++.+.||.|+||.||+|.+.       .+++.||+|.+......  ....+.+|+++++.++||||+++++++...
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQI-------KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVER   79 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEEC-------CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecc
Confidence            578999999999999999999975       45778999988644322  234567899999999999999999987654


Q ss_pred             CC----cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCce
Q 013790          156 GE----RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  231 (436)
Q Consensus       156 ~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  231 (436)
                      ..    ....+++|+||+. ++|...+.... ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+
T Consensus        80 ~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~  154 (311)
T cd07866          80 PDKSKRKRGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGIL  154 (311)
T ss_pred             cccccccCceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence            32    2345789999985 57777775432 4699999999999999999999998   99999999999999999999


Q ss_pred             EEeeccCCCCCCCCCC---------cccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q 013790          232 KLSDFGLAREGPMVGH---------THVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT  301 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  301 (436)
                      +|+|||++........         ........+++.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.....
T Consensus       155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~  234 (311)
T cd07866         155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID  234 (311)
T ss_pred             EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999874322111         1111234568889999988654 57899999999999999999999998765543


Q ss_pred             hHHHHHHHhhcccCcc--cc---ccc----cCCcccCc---CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          302 EQRLLEWVQQYPADSK--KF---GLI----MDPRLEKE---YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       302 ~~~~~~~~~~~~~~~~--~~---~~~----~~~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....+......+....  ..   ...    ........   ........+.++|.+||..||.+|||+.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            3222211111110000  00   000    00000000   001122568899999999999999999998764

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-37  Score=290.89  Aligned_cols=266  Identities=25%  Similarity=0.365  Sum_probs=197.4

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhcc---CCCCceeeeeEeeec
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVL---EHPNLVKLIGYCAVD  155 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~  155 (436)
                      |++.+.||.|+||.||+|.++       .+++.||+|.+......  ....+.+|+.+++++   +||||+++++++...
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   73 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDL-------NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGP   73 (287)
T ss_pred             CeEEEEecccCceEEEEEEEC-------CCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeec
Confidence            677889999999999999976       35788999998744222  224466677776655   699999999998765


Q ss_pred             CC-cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          156 GE-RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       156 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .. .....+++|||+. ++|.+++.......+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+
T Consensus        74 ~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~  149 (287)
T cd07838          74 RTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIA  149 (287)
T ss_pred             cCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEe
Confidence            43 2234689999996 5899988765444689999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||++......   .......++..|+|||.+.+..++.++|||||||++|+|++|.+||.........  .........
T Consensus       150 dfg~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~~~~~~~  224 (287)
T cd07838         150 DFGLARIYSFE---MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKIFDVIGL  224 (287)
T ss_pred             ccCcceeccCC---cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHHHHHcCC
Confidence            99998753221   1122335788999999999888999999999999999999999999865543221  111111100


Q ss_pred             Cc------------cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DS------------KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~------------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..            ..+........ .......+..+.++|.+||+.||.+||++.+++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         225 PSEEEWPRNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CChHhcCCCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            00            00000000000 11122345678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.2e-37  Score=292.12  Aligned_cols=243  Identities=24%  Similarity=0.368  Sum_probs=186.1

Q ss_pred             cccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh---HHHHHHHH---HHHhccCCCCceeeeeEeeecCCcc
Q 013790           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAEV---QFLGVLEHPNLVKLIGYCAVDGERG  159 (436)
Q Consensus        86 ~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~---~~l~~l~hpnIv~~~~~~~~~~~~~  159 (436)
                      .||+|+||.||+|...       .+++.||+|.+.......   ...+..|.   ..++...||||+.+++++...+   
T Consensus         1 ~ig~g~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---   70 (278)
T cd05606           1 IIGRGGFGEVYGCRKA-------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD---   70 (278)
T ss_pred             CcccCCCeEEEEEEEe-------cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC---
Confidence            4899999999999864       467899999986543221   12233343   4455568999999998887654   


Q ss_pred             eeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCC
Q 013790          160 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  239 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  239 (436)
                       ..++||||+.|++|.+++...  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        71 -~~~~v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~  144 (278)
T cd05606          71 -KLSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA  144 (278)
T ss_pred             -EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCc
Confidence             459999999999999998654  3699999999999999999999998   9999999999999999999999999998


Q ss_pred             CCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 013790          240 REGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  318 (436)
Q Consensus       240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  318 (436)
                      .....    .......|+..|+|||.+.++ .++.++||||||+++|+|++|..||.................       
T Consensus       145 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------  213 (278)
T cd05606         145 CDFSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-------  213 (278)
T ss_pred             cccCc----cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc-------
Confidence            74321    112345689999999999754 688999999999999999999999976533222211111100       


Q ss_pred             cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       319 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                          ....    .+...+..+.+++.+||..+|.+||     ++.+++++
T Consensus       214 ----~~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         214 ----MAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             ----cCCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence                0111    1122356788999999999999999     89998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.9e-38  Score=301.80  Aligned_cols=276  Identities=26%  Similarity=0.325  Sum_probs=205.7

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecC-
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG-  156 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-  156 (436)
                      +|++.+.||.|+||.||+|...       .++..||+|.+....  ....+.+.+|+.+++.++||||+++++++.... 
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDK-------RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP   73 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeC-------CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc
Confidence            5888999999999999999865       457889999987643  334567889999999999999999999887654 


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      ......+++|||+. ++|.+++....  .+++..+..++.||+.||.|||+.   |++|+||||+|||++.++.++|+||
T Consensus        74 ~~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~df  147 (330)
T cd07834          74 EDFNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDF  147 (330)
T ss_pred             ccccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccc
Confidence            22235699999996 58999986543  799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCC-cccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          237 GLAREGPMVGH-THVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |++........ ........++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+......+.
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  227 (330)
T cd07834         148 GLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS  227 (330)
T ss_pred             CceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCC
Confidence            99975322211 0122345678899999999887 789999999999999999999999987654332211111001100


Q ss_pred             Ccc-------ccccccC---Cccc---CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHHhh
Q 013790          315 DSK-------KFGLIMD---PRLE---KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER--LKQIV  368 (436)
Q Consensus       315 ~~~-------~~~~~~~---~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~~~  368 (436)
                      ...       .....+.   ....   .......+..+.++|.+||+.+|.+||++.+++.+  ++.+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence            000       0000000   0000   00011235678899999999999999999999986  55543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-37  Score=300.74  Aligned_cols=274  Identities=24%  Similarity=0.327  Sum_probs=203.5

Q ss_pred             cCHHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCce
Q 013790           69 FSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLV  146 (436)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv  146 (436)
                      ....++....++|.+.+.||+|+||.||+|...       .+++.||+|++....  ....+.+.+|+.+++.++||||+
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv   79 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDT-------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI   79 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEc-------CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCccc
Confidence            345567778899999999999999999999854       467899999987542  22345678899999999999999


Q ss_pred             eeeeEeeecCC--cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEE
Q 013790          147 KLIGYCAVDGE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL  224 (436)
Q Consensus       147 ~~~~~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIl  224 (436)
                      ++++++.....  .....+++++++ +++|.+++...   .+++..+..++.|++.||+|||+.   +|+||||||+||+
T Consensus        80 ~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl  152 (345)
T cd07877          80 GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLA  152 (345)
T ss_pred             ceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEE
Confidence            99998764322  112357888876 88999887543   589999999999999999999998   9999999999999


Q ss_pred             EcCCCceEEeeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 013790          225 LDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ  303 (436)
Q Consensus       225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~  303 (436)
                      ++.++.+||+|||++....     .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.........
T Consensus       153 l~~~~~~kl~dfg~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~  227 (345)
T cd07877         153 VNEDCELKILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL  227 (345)
T ss_pred             EcCCCCEEEeccccccccc-----ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999999999999987421     12234567889999999866 56788999999999999999999999754432221


Q ss_pred             HHHHHHhhcccCccccc---------------cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          304 RLLEWVQQYPADSKKFG---------------LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       304 ~~~~~~~~~~~~~~~~~---------------~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .........+.. ....               ......+. ......+..+.+||.+||..||.+||++.+++.+
T Consensus       228 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         228 KLILRLVGTPGA-ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHHHhCCCCH-HHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            111100000000 0000               00000000 0001134568899999999999999999999877

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=292.39  Aligned_cols=263  Identities=26%  Similarity=0.343  Sum_probs=198.9

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      |.+.+.||.|++|.||+|...       .+++.+++|.+......  ....+.+|+.+++.++||||+++++++....  
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   71 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDK-------LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG--   71 (283)
T ss_pred             CccceeeecCCCceEEEEEcC-------CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC--
Confidence            567789999999999999864       46788999998765332  3467888999999999999999999887553  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..++|+||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||.
T Consensus        72 --~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~  144 (283)
T cd05118          72 --DLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGL  144 (283)
T ss_pred             --CEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeee
Confidence              45999999965 8888886643 4789999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc-
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS-  316 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-  316 (436)
                      +.......  .......++..|+|||.+.+. .++.++||||||+++|+|+||+.||...+........  ........ 
T Consensus       145 ~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~--~~~~~~~~~  220 (283)
T cd05118         145 ARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI--FRTLGTPDP  220 (283)
T ss_pred             eEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHcCCCch
Confidence            87532221  122334578899999998776 7889999999999999999999999765543221111  11110000 


Q ss_pred             cccccccC------Ccc-------cCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 KKFGLIMD------PRL-------EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~~~~~~~~------~~l-------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..+..+..      ...       ........+..+.++|.+||..||.+||++.+++.+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         221 EVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             HhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00000000      000       001122346789999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-37  Score=288.36  Aligned_cols=242  Identities=26%  Similarity=0.314  Sum_probs=185.6

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh---HHHHHHHHHH-HhccCCCCceeeeeEeeecCCcce
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAEVQF-LGVLEHPNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~~  160 (436)
                      +.||.|+||.||+|...       .+++.||+|.+.......   ...+..|..+ ...++||||+++++++...+    
T Consensus         2 ~~l~~g~~~~v~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----   70 (260)
T cd05611           2 KPISKGAFGSVYLAKKR-------STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD----   70 (260)
T ss_pred             ccCCcCCCeeEEEEEec-------CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC----
Confidence            56999999999999865       457889999987543221   2233445444 44568999999999987544    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++|+||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        71 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  145 (260)
T cd05611          71 YLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR  145 (260)
T ss_pred             eEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccce
Confidence            459999999999999999654  3689999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ....      .....++..|+|||.+.+..++.++||||||+++|+|++|..||........   .........      
T Consensus       146 ~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~------  210 (260)
T cd05611         146 NGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---FDNILSRRI------  210 (260)
T ss_pred             eccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHhccc------
Confidence            4221      2334688899999999888889999999999999999999999976543221   111111000      


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE  362 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~  362 (436)
                           ..........+..+.+++.+||..||++||++.++.+
T Consensus       211 -----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         211 -----NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             -----CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence                 0000111123567889999999999999997654433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=9.8e-38  Score=303.35  Aligned_cols=270  Identities=23%  Similarity=0.314  Sum_probs=199.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|.+.+.||.|+||.||+|...       .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~-------~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   76 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDS-------DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS   76 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEEC-------CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence            468999999999999999999865       5678999999877665556778899999999999999999987765432


Q ss_pred             cc----------eeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc-
Q 013790          158 RG----------IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-  226 (436)
Q Consensus       158 ~~----------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~-  226 (436)
                      ..          ...++||||+. ++|.+++...   .+++..+..++.||+.||.|||+.   +++||||||+||+++ 
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~  149 (342)
T cd07854          77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINT  149 (342)
T ss_pred             ccccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcC
Confidence            21          24689999996 5898888542   589999999999999999999998   999999999999997 


Q ss_pred             CCCceEEeeccCCCCCCCCC-CcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 013790          227 ENFRPKLSDFGLAREGPMVG-HTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR  304 (436)
Q Consensus       227 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~  304 (436)
                      .++.++|+|||+++...... .........++..|+|||.+.+ ..++.++|||||||++|+|++|..||....+.....
T Consensus       150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~  229 (342)
T cd07854         150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ  229 (342)
T ss_pred             CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            56678999999987432111 1111123457889999998754 567889999999999999999999997665432211


Q ss_pred             HHHHHhhcccCcc-ccc-------ccc-----CCc-ccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          305 LLEWVQQYPADSK-KFG-------LIM-----DPR-LEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       305 ~~~~~~~~~~~~~-~~~-------~~~-----~~~-l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                        ..+...+.... ...       ...     ... .........+..+.+||.+||..||.+|||+.+++.+
T Consensus       230 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         230 --LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             --HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence              11111111100 000       000     000 0000011234678899999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-37  Score=285.83  Aligned_cols=249  Identities=31%  Similarity=0.471  Sum_probs=201.2

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|.+.+.||+|++|.||++...       ..++.|++|.+.....  ...+.+.+|++++..++|||++++++++...+ 
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   72 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNL-------ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD-   72 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEc-------CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-
Confidence            4788899999999999999865       4567899999976654  34567899999999999999999999887643 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..+++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        73 ---~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~  144 (254)
T cd06627          73 ---SLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFG  144 (254)
T ss_pred             ---EEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccc
Confidence               459999999999999999765  4789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ++.......  .......++..|+|||.+.+..++.++||||||+++|+|++|..||........  .... ..  ..  
T Consensus       145 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~~~~-~~--~~--  215 (254)
T cd06627         145 VATKLNDVS--KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--LFRI-VQ--DD--  215 (254)
T ss_pred             cceecCCCc--ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--HHHH-hc--cC--
Confidence            997532211  112345678899999999888889999999999999999999999976542211  1111 10  00  


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                            .+    ..+...+..+.+++.+||..+|++|||+.+++.+
T Consensus       216 ------~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         216 ------HP----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             ------CC----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence                  01    1122234678899999999999999999998753

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-37  Score=301.16  Aligned_cols=270  Identities=24%  Similarity=0.339  Sum_probs=199.3

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      ..++|...+.||+|+||.||+|...       .+++.||+|.+....  ......+.+|+.+++.++||||+++++++..
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~   85 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDK-------RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTS   85 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeC-------CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecc
Confidence            3478999999999999999999865       467899999986542  1223567889999999999999999998865


Q ss_pred             cCC--cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          155 DGE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       155 ~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      ...  .....++|+||+. .+|..++.    ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~k  157 (342)
T cd07879          86 AVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELK  157 (342)
T ss_pred             cccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence            432  1234589999985 47777652    2589999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      |+|||+++....     ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+...........  ..
T Consensus       158 L~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~--~~  230 (342)
T cd07879         158 ILDFGLARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL--KV  230 (342)
T ss_pred             EeeCCCCcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hh
Confidence            999999875211     1223467889999999866 468899999999999999999999998754332211111  11


Q ss_pred             cccCcccccccc-----------CCcc-cCcC---CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHHhh
Q 013790          312 YPADSKKFGLIM-----------DPRL-EKEY---SINEARKIGRLADNCLSKSSKDRPKMSQVVER--LKQIV  368 (436)
Q Consensus       312 ~~~~~~~~~~~~-----------~~~l-~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~~~  368 (436)
                      .+.....+....           .+.. ....   ....+..+.+||.+||+.||.+||++.+++.+  ++.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            100000000000           0000 0000   01234568899999999999999999999976  55553

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.1e-37  Score=287.95  Aligned_cols=249  Identities=26%  Similarity=0.375  Sum_probs=201.1

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +|++.+.||.|+||.||++...       .++..+++|.+....  ......+.+|+.+++.++||||+++++++.... 
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   72 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRL-------SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN-   72 (256)
T ss_pred             CceEeeeecCCCceeEEEEEEC-------CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC-
Confidence            5788899999999999999865       467889999987543  223456778999999999999999998886553 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                         ..++||||+++++|.+++....  ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|
T Consensus        73 ---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d  146 (256)
T cd08530          73 ---KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGD  146 (256)
T ss_pred             ---EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEee
Confidence               4699999999999999986622  34689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||++......    ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......   +...+...   
T Consensus       147 ~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~~~---  216 (256)
T cd08530         147 LGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYKVQRG---  216 (256)
T ss_pred             ccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhcC---
Confidence            9998753221    2233557889999999998889999999999999999999999997654322   11111110   


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                 .....+...+..+.+++.+||..+|++||++.+++++
T Consensus       217 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         217 -----------KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             -----------CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                       0011223445779999999999999999999999865

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=292.67  Aligned_cols=265  Identities=26%  Similarity=0.355  Sum_probs=196.2

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccC-CCCceeeeeEeeecCCc
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVDGER  158 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~  158 (436)
                      |++.+.||.|+||.||+|...       .+++.|+||.+..... .......+|+..+..++ ||||+++++++...+  
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~--   71 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNK-------ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND--   71 (283)
T ss_pred             CeeheeeccCCceEEEEEEEC-------CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC--
Confidence            677889999999999999975       4577899999865432 22234557899999999 999999999987644  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..++||||+ +|+|.+++.......+++..+..++.|++.+|.|||++   +++|+||+|+||+++.++.++|+|||+
T Consensus        72 --~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~  145 (283)
T cd07830          72 --ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGL  145 (283)
T ss_pred             --cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeeccc
Confidence              459999999 88999998776545789999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhhcccCc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQYPADS  316 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~  316 (436)
                      +....   .........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... ............
T Consensus       146 ~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (283)
T cd07830         146 AREIR---SRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD  222 (283)
T ss_pred             ceecc---CCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhh
Confidence            87532   1112233567889999998854 457899999999999999999999997654432211 111111100000


Q ss_pred             c----ccccccCCcccC-------cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 K----KFGLIMDPRLEK-------EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~----~~~~~~~~~l~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .    .........+..       ......+..+.++|.+||+.||++|||+.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0    000000000000       0001114678899999999999999999998764

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.4e-37  Score=290.45  Aligned_cols=246  Identities=26%  Similarity=0.364  Sum_probs=192.7

Q ss_pred             ccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        87 ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      ||.|+||.||++.+.       .+++.|++|.+.....   ...+.+.+|+.+++.++||||+++++.+....    ..+
T Consensus         1 lg~g~~~~vy~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~   69 (265)
T cd05579           1 ISKGAYGRVFLAKKK-------STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK----NLY   69 (265)
T ss_pred             CCCCCceEEEEEEEC-------CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc----EEE
Confidence            689999999999875       4578899999876543   34467888999999999999999998876443    459


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCC
Q 013790          164 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  243 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  243 (436)
                      ++|||+.+++|.+++.+..  .+++..+..++.||+.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        70 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~  144 (265)
T cd05579          70 LVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGL  144 (265)
T ss_pred             EEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence            9999999999999997644  689999999999999999999998   99999999999999999999999999987532


Q ss_pred             CCCC------cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          244 MVGH------THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       244 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ....      ........++..|++||.+.+..++.++||||||+++|+|++|..||....+...   ...+......  
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~--  219 (265)
T cd05579         145 VRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---FQNILNGKIE--  219 (265)
T ss_pred             cCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhcCCcC--
Confidence            2111      1122345678899999999888889999999999999999999999976543321   1111110000  


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                               .  ......+..+.+++.+||+.+|.+|||+..+.+.|
T Consensus       220 ---------~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         220 ---------W--PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             ---------C--CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence                     0  00001256788999999999999999995544433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.5e-37  Score=296.13  Aligned_cols=249  Identities=33%  Similarity=0.443  Sum_probs=195.1

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC---cchhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      +.|...+.||.|+||.||+|...       .++..+|+|.+...   .......+.+|+.+++.++|||++++++++...
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   87 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDV-------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE   87 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEc-------CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC
Confidence            45777889999999999999965       45788999988643   222345678899999999999999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      .    ..++||||+. |+|.+++.... .++++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|
T Consensus        88 ~----~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~d  158 (308)
T cd06634          88 H----TAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGD  158 (308)
T ss_pred             C----eeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECC
Confidence            4    3589999996 68888775443 4689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      ||++....      ......++..|+|||.+.   ...++.++|||||||++|+|++|..||........  ...+....
T Consensus       159 fg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~  230 (308)
T cd06634         159 FGSASIMA------PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNE  230 (308)
T ss_pred             cccceeec------CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--HHHHhhcC
Confidence            99986421      122346788999999974   35678899999999999999999999876433221  11111110


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                      .           +   .......+..+.+||.+||..+|.+||++.+++.+..
T Consensus       231 ~-----------~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         231 S-----------P---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             C-----------C---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence            0           0   0111234567889999999999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.8e-37  Score=294.82  Aligned_cols=245  Identities=33%  Similarity=0.484  Sum_probs=193.2

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      |...+.||+|+||.||+|+..       .++..|++|.+.....   .....+.+|+.+++.++|||++++++++.... 
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~-------~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   94 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNS-------HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH-   94 (313)
T ss_pred             hhcceeeccCCCeEEEEEEEC-------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-
Confidence            666778999999999999864       4678899999865422   23356788999999999999999999987654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+. |+|.+++.... .++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        95 ---~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg  166 (313)
T cd06633          95 ---TAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG  166 (313)
T ss_pred             ---EEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecC
Confidence               3599999995 68888776543 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ++....      ......|+..|+|||.+.   +..++.++||||||+++|+|++|..||...........   ......
T Consensus       167 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~~~  237 (313)
T cd06633         167 SASKSS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQNDS  237 (313)
T ss_pred             CCcccC------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhcCC
Confidence            986421      123456888999999984   45688899999999999999999999976543322111   111000


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                +.   ......+..+.+|+.+||+.+|.+||++.+++.+
T Consensus       238 ----------~~---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         238 ----------PT---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ----------CC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      00   0111223568899999999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.8e-37  Score=295.59  Aligned_cols=264  Identities=22%  Similarity=0.270  Sum_probs=192.5

Q ss_pred             cccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcc
Q 013790           82 SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  159 (436)
Q Consensus        82 ~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  159 (436)
                      .+.+.+|.|+++.||++.         .+++.||+|++...  .....+.+.+|+.+++.++||||+++++++....   
T Consensus         5 ~i~~~~~~~~~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~---   72 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHK---------PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS---   72 (314)
T ss_pred             hhhHhhcCCceEEEEEec---------CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC---
Confidence            334445555555555543         36889999998754  3344567899999999999999999999887654   


Q ss_pred             eeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCC
Q 013790          160 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  239 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  239 (436)
                       ..+++|||+++|+|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||.+
T Consensus        73 -~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~  148 (314)
T cd08216          73 -ELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYS  148 (314)
T ss_pred             -eEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccc
Confidence             359999999999999999865555689999999999999999999998   9999999999999999999999999988


Q ss_pred             CCCCCCCC-----cccccccccCCCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          240 REGPMVGH-----THVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       240 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      ........     ........++..|+|||++.+  ..++.++|||||||++|+|++|..||........  ..+.....
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~  226 (314)
T cd08216         149 VSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGT  226 (314)
T ss_pred             eeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcc
Confidence            64321111     111233457778999999865  3578999999999999999999999986543221  11111110


Q ss_pred             c----------cCcccccc----ccC----CcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 P----------ADSKKFGL----IMD----PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~----------~~~~~~~~----~~~----~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .          ........    ...    ...........+..+.+|+.+||..||++|||+.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            0          00000000    000    001111223445678899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.7e-37  Score=298.13  Aligned_cols=270  Identities=25%  Similarity=0.301  Sum_probs=195.6

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhcc-CCCCceeeeeEeeecC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  156 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  156 (436)
                      +|.+.+.||+|+||.||++...     ....+..||+|.+....  ....+.+.+|+.+++.+ +||||+++++.+....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   75 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNA-----ETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP   75 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeC-----CCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc
Confidence            4788899999999999999976     11237789999986432  22345678899999999 5999999998765432


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      ......+++++|+ +++|.+++...  ..+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+||
T Consensus        76 ~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df  149 (332)
T cd07857          76 GNFNELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF  149 (332)
T ss_pred             ccCCcEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence            3233468888988 46999998654  4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCC--cccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhhc
Q 013790          237 GLAREGPMVGH--THVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQY  312 (436)
Q Consensus       237 g~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~  312 (436)
                      |+++.......  ........|+..|+|||.+.+ ..++.++||||||+++|+|++|..||.......... ...... .
T Consensus       150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~  228 (332)
T cd07857         150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG-T  228 (332)
T ss_pred             CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC-C
Confidence            99975322111  111233568999999998765 468899999999999999999999997654322111 011000 0


Q ss_pred             ccCccccccc---------------cCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLI---------------MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~---------------~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +.. ..+..+               ....+. ......+..+.+|+.+||+.||.+|||+.+++.+
T Consensus       229 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         229 PDE-ETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             CCH-HHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000 000000               000000 0011124678899999999999999999999865

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.4e-37  Score=291.55  Aligned_cols=251  Identities=25%  Similarity=0.353  Sum_probs=200.6

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccC-CCCceeeeeEeee
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLE-HPNLVKLIGYCAV  154 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~  154 (436)
                      ++|.+.+.||.|+||.||+|...       .+++.||+|++....   ......+.+|+.+++++. ||||+++++++..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~   73 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEK-------ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD   73 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEc-------CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC
Confidence            47899999999999999999875       467899999987532   223456788999999998 9999999998865


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||+.+++|.+++....  .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+
T Consensus        74 ~~----~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~  144 (280)
T cd05581          74 EE----NLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKIT  144 (280)
T ss_pred             Cc----eEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEec
Confidence            44    4599999999999999997653  699999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCC------------------cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 013790          235 DFGLAREGPMVGH------------------THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLER  296 (436)
Q Consensus       235 Dfg~a~~~~~~~~------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~  296 (436)
                      |||++........                  ........++..|+|||.+.+..++.++||||||++++++++|..||..
T Consensus       145 df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  224 (280)
T cd05581         145 DFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG  224 (280)
T ss_pred             CCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999875322111                  1222344678899999999888889999999999999999999999986


Q ss_pred             CCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH----HHHHHH
Q 013790          297 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM----SQVVER  363 (436)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~----~eil~~  363 (436)
                      .....   ....+...           .    ...+...+..+.++|.+||..+|.+||++    .+++.+
T Consensus       225 ~~~~~---~~~~~~~~-----------~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         225 SNEYL---TFQKILKL-----------E----YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ccHHH---HHHHHHhc-----------C----CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            54211   11111100           0    01122225678899999999999999999    777654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=296.03  Aligned_cols=254  Identities=28%  Similarity=0.444  Sum_probs=206.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .+.|..-+.||+||||.||-+..+       .+|+.||.|.+.+....   ......+|-.+|.+++.+.||.+--.+..
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvr-------aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT  256 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVR-------ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET  256 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEe-------cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence            367888899999999999988866       67899999988654322   22346779999999999999998655544


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    .+|+|+..|.||+|.-+|++.+.+.+++..+..++.+|+.||.+||..   +||.|||||+|||+|+.|+++|+
T Consensus       257 kd----~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRIS  329 (591)
T KOG0986|consen  257 KD----ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRIS  329 (591)
T ss_pred             CC----ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEee
Confidence            43    369999999999999999998888999999999999999999999999   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhhcc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQYP  313 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~  313 (436)
                      |+|+|...+   ........+||.+|||||++.++.|+...|.|||||++|||+.|+.||......... ++-..+...+
T Consensus       330 DLGLAvei~---~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~  406 (591)
T KOG0986|consen  330 DLGLAVEIP---EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP  406 (591)
T ss_pred             ccceEEecC---CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch
Confidence            999998643   233334458999999999999999999999999999999999999999866544333 2222111111


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~  363 (436)
                                     ..++...+++..+|....|..||.+|.-     +.++.+|
T Consensus       407 ---------------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  407 ---------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             ---------------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence                           1234445578889999999999999984     4566554

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.1e-37  Score=292.92  Aligned_cols=253  Identities=29%  Similarity=0.470  Sum_probs=191.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccC-CCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  155 (436)
                      .++|++.+.||.|+||.||+|.+.       .+++.||||.+..... .....+..|+.++..+. ||||+++++++...
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   86 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFK-------KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD   86 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEEC-------CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence            467899999999999999999975       4578899999875432 23345666777666664 99999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .    ..+++|||+ +++|..++.... ..+++..+..++.|++.||+|||+ .   +|+||||+|+||+++.++.+||+
T Consensus        87 ~----~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~  157 (296)
T cd06618          87 S----DVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLC  157 (296)
T ss_pred             C----eEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEEC
Confidence            5    359999998 457777765533 378999999999999999999997 5   89999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH----LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      |||++.....   ........++..|+|||.+.+..    ++.++||||||+++|+|++|..||......  ........
T Consensus       158 dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~  232 (296)
T cd06618         158 DFGISGRLVD---SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKIL  232 (296)
T ss_pred             ccccchhccC---CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHh
Confidence            9999864321   11122335788999999987553    788999999999999999999999753221  11111111


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...  .        +.+..  ....+..+.+|+.+||..||.+||++.+++.+
T Consensus       233 ~~~--~--------~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         233 QEE--P--------PSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             cCC--C--------CCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            100  0        00000  01234678999999999999999999999876

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.8e-37  Score=295.62  Aligned_cols=268  Identities=25%  Similarity=0.349  Sum_probs=200.0

Q ss_pred             HHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeE
Q 013790           74 MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGY  151 (436)
Q Consensus        74 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~  151 (436)
                      +....++|++.+.||.|+||.||+|...       .++..||+|.+....  ....+.+.+|+.+++.++||||++++++
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   77 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQ-------LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI   77 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEEC-------CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeee
Confidence            3456789999999999999999999865       567889999876432  2234567889999999999999999998


Q ss_pred             eeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCce
Q 013790          152 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  231 (436)
Q Consensus       152 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  231 (436)
                      +...+.   ..++++||+ +++|..++...   ++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+
T Consensus        78 ~~~~~~---~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~  147 (328)
T cd07856          78 FISPLE---DIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDL  147 (328)
T ss_pred             EecCCC---cEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCE
Confidence            865332   358999998 67899888542   578888999999999999999998   99999999999999999999


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HHH
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL-EWV  309 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~~  309 (436)
                      +|+|||++....     .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||............ ..+
T Consensus       148 ~l~dfg~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~  222 (328)
T cd07856         148 KICDFGLARIQD-----PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLL  222 (328)
T ss_pred             EeCccccccccC-----CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999987421     11233467889999998865 56899999999999999999999999765543222111 111


Q ss_pred             hhcccC-------ccccccccCCcccCcCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          310 QQYPAD-------SKKFGLIMDPRLEKEYS-----INEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       310 ~~~~~~-------~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...+..       ......+..-......+     ...+..+.++|.+||+.+|++||++.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         223 GTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            110000       00000000000000111     1234678999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.2e-37  Score=299.00  Aligned_cols=270  Identities=26%  Similarity=0.366  Sum_probs=200.6

Q ss_pred             HHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeee
Q 013790           73 EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIG  150 (436)
Q Consensus        73 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~  150 (436)
                      .+....++|++++.||+|+||.||+|...       .++..||||.+....  ......+.+|+.+++.++||||+++++
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   81 (343)
T cd07880           9 TIWEVPDRYRDLKQVGSGAYGTVCSALDR-------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD   81 (343)
T ss_pred             hhhccccceEEEEEeeecCCeEEEEEEEC-------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceee
Confidence            34445678999999999999999999865       467889999986432  222356788999999999999999999


Q ss_pred             EeeecCCc--ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC
Q 013790          151 YCAVDGER--GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN  228 (436)
Q Consensus       151 ~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  228 (436)
                      ++......  ....++||||+ +++|.+++..   ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~  154 (343)
T cd07880          82 VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNED  154 (343)
T ss_pred             eecCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            88754322  12458999998 7899988854   3689999999999999999999998   99999999999999999


Q ss_pred             CceEEeeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 013790          229 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       229 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  307 (436)
                      +.++|+|||++....     .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||........  ...
T Consensus       155 ~~~kl~dfg~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~  227 (343)
T cd07880         155 CELKILDFGLARQTD-----SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LME  227 (343)
T ss_pred             CCEEEeecccccccc-----cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH
Confidence            999999999987521     11223457889999999866 4578999999999999999999999986543211  111


Q ss_pred             HHhhcccCccccccccC-----------Cccc----CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          308 WVQQYPADSKKFGLIMD-----------PRLE----KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~-----------~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...........+...+.           +...    .......+..+.++|.+||..||.+|||+.+++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         228 IMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            11100000000000000           0000    00111234568899999999999999999999865

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-39  Score=331.14  Aligned_cols=254  Identities=28%  Similarity=0.340  Sum_probs=201.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      +-+++....||.|.||.||.|..       ..+|...|+|-+....  ....+.+.+|+.++..++|||+|++||+-...
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN-------~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVN-------LDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR 1306 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeec-------CCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH
Confidence            45677788999999999999984       4688889999776442  23345688899999999999999999987765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      ..    ++|.||||.+|+|.+.+...  +..++.....+..|++.|++|||+.   |||||||||.|||++.+|.+|++|
T Consensus      1307 ek----v~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~D 1377 (1509)
T KOG4645|consen 1307 EK----VYIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGD 1377 (1509)
T ss_pred             HH----HHHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeec
Confidence            54    38999999999999998654  3467777788899999999999999   999999999999999999999999


Q ss_pred             ccCCCCCCCCC--CcccccccccCCCcccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          236 FGLAREGPMVG--HTHVSTAVVGTFGYAAPDYIETG---HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       236 fg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      ||.|.......  .........||+.|||||++.+.   .-..++|||||||++.||+||+.||...+..  ..++..+.
T Consensus      1378 FGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V~ 1455 (1509)
T KOG4645|consen 1378 FGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHVA 1455 (1509)
T ss_pred             ccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHHh
Confidence            99997532221  12233467899999999999764   3456899999999999999999999865432  22222222


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .--          .|    .+|...+.+-.++|..||..||.+|.++.||+++
T Consensus      1456 ~gh----------~P----q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 AGH----------KP----QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ccC----------CC----CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            110          11    2333456778899999999999999999888776

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.1e-36  Score=295.29  Aligned_cols=267  Identities=22%  Similarity=0.290  Sum_probs=195.2

Q ss_pred             cCCcc-cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh--------------HHHHHHHHHHHhccCCC
Q 013790           79 NDFSR-MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG--------------HKQWVAEVQFLGVLEHP  143 (436)
Q Consensus        79 ~~~~~-~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hp  143 (436)
                      ++|.. .+.||.|+||.||+|...       ..++.||+|.+.......              ...+.+|+.+++.++||
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   80 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDT-------LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHE   80 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEEC-------CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCc
Confidence            46654 467999999999999865       467889999886543221              12467899999999999


Q ss_pred             CceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcE
Q 013790          144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  223 (436)
Q Consensus       144 nIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NI  223 (436)
                      ||+++++++...+    ..++||||+. |+|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||+|+||
T Consensus        81 ~iv~~~~~~~~~~----~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~ni  150 (335)
T PTZ00024         81 NIMGLVDVYVEGD----FINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANI  150 (335)
T ss_pred             ceeeeeEEEecCC----cEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHe
Confidence            9999999987654    4599999996 6999998654  3689999999999999999999998   999999999999


Q ss_pred             EEcCCCceEEeeccCCCCCCCCC------------CcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhC
Q 013790          224 LLDENFRPKLSDFGLAREGPMVG------------HTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTG  290 (436)
Q Consensus       224 ll~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg  290 (436)
                      +++.++.++|+|||++.......            .........++..|+|||.+.+. .++.++|||||||++|+|++|
T Consensus       151 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg  230 (335)
T PTZ00024        151 FINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG  230 (335)
T ss_pred             EECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence            99999999999999987432100            01111223467889999998764 468899999999999999999


Q ss_pred             CCCCCCCCchhhHH-HHHHHhhcccCccc----------cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 013790          291 RRSLERNRPKTEQR-LLEWVQQYPADSKK----------FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ  359 (436)
Q Consensus       291 ~~pf~~~~~~~~~~-~~~~~~~~~~~~~~----------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  359 (436)
                      ..||.......... +.............          +.......+. ......+..+.++|.+||+.+|++|||+.+
T Consensus       231 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~  309 (335)
T PTZ00024        231 KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKE  309 (335)
T ss_pred             CCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence            99998765432211 11111111100000          0000000000 001123467889999999999999999999


Q ss_pred             HHHH
Q 013790          360 VVER  363 (436)
Q Consensus       360 il~~  363 (436)
                      ++.+
T Consensus       310 ~l~~  313 (335)
T PTZ00024        310 ALKH  313 (335)
T ss_pred             HhcC
Confidence            9875

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-38  Score=309.66  Aligned_cols=260  Identities=26%  Similarity=0.380  Sum_probs=217.7

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ....+++||+|+||+||+|.|.+.   +..-..+||||++... .......+..|+-+|..++|||+++++|+|....  
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pe---ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPE---GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecC---CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--
Confidence            345567899999999999999854   3345678999998654 3445678999999999999999999999998654  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                         +.||++|++.|+|.+|++... .++.....+.|..|||+||.|||.+   .+|||||..+||||..-..+||+|||+
T Consensus       772 ---~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgl  844 (1177)
T KOG1025|consen  772 ---LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGL  844 (1177)
T ss_pred             ---HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecch
Confidence               478999999999999998754 5788999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ++.....+...........+.|||-|.+....|+.++|||||||++||++| |..|+++....+..++++.-.+      
T Consensus       845 a~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR------  918 (1177)
T KOG1025|consen  845 AKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER------  918 (1177)
T ss_pred             hhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc------
Confidence            987544444443444445678999999999999999999999999999999 9999998876665555443221      


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                                 ...+..++.++..++.+||..|+..||+++++...+.++.
T Consensus       919 -----------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  919 -----------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             -----------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence                       1335556778889999999999999999999999988775

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=286.68  Aligned_cols=270  Identities=23%  Similarity=0.313  Sum_probs=206.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-----C---CCceeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-----H---PNLVKLI  149 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv~~~  149 (436)
                      .++|.+.++||.|-|++||+|...       ...+.||+|+.+... ...+....|+++|++++     |   .+||+++
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDt-------q~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll  148 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDT-------QNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL  148 (590)
T ss_pred             CceEEEEEeccccccceeEEEeec-------cCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence            378999999999999999999854       778999999987543 33466778999999884     2   3699999


Q ss_pred             eEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC
Q 013790          150 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  229 (436)
Q Consensus       150 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  229 (436)
                      ++|...+..|.++|+|+|++ |.+|..+|.....+.++...+.+|+.||+.||.|||..|  ||||.||||+|||+..+.
T Consensus       149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e  225 (590)
T KOG1290|consen  149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTE  225 (590)
T ss_pred             ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccc
Confidence            99999999999999999998 889999999888889999999999999999999999986  999999999999983110


Q ss_pred             --------------------------------------------------------------------------------
Q 013790          230 --------------------------------------------------------------------------------  229 (436)
Q Consensus       230 --------------------------------------------------------------------------------  229 (436)
                                                                                                      
T Consensus       226 ~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~  305 (590)
T KOG1290|consen  226 IDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNN  305 (590)
T ss_pred             cchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 013790          230 --------------------------------------------------------------------------------  229 (436)
Q Consensus       230 --------------------------------------------------------------------------------  229 (436)
                                                                                                      
T Consensus       306 ~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~  385 (590)
T KOG1290|consen  306 EPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIP  385 (590)
T ss_pred             ccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCC
Confidence                                                                                            


Q ss_pred             ------ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---
Q 013790          230 ------RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK---  300 (436)
Q Consensus       230 ------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~---  300 (436)
                            .+||+|||-|+..     ....+.-..|..|.|||++.|..|++.+||||++|++|||+||...|+.....   
T Consensus       386 ~~~~di~vKIaDlGNACW~-----~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~  460 (590)
T KOG1290|consen  386 LPECDIRVKIADLGNACWV-----HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYS  460 (590)
T ss_pred             CCccceeEEEeeccchhhh-----hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCC
Confidence                  1233333333210     11112234578899999999999999999999999999999999999643321   


Q ss_pred             ----hhHHHHHHHhhcccCc----cccccccCCc-----------------cc--CcCCHHHHHHHHHHHHHhhcCCCCC
Q 013790          301 ----TEQRLLEWVQQYPADS----KKFGLIMDPR-----------------LE--KEYSINEARKIGRLADNCLSKSSKD  353 (436)
Q Consensus       301 ----~~~~~~~~~~~~~~~~----~~~~~~~~~~-----------------l~--~~~~~~~~~~l~~li~~cl~~dp~~  353 (436)
                          ....+++.+..+|...    .....+++.+                 |.  -.++.....++.+|+.-||+.+|++
T Consensus       461 rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeK  540 (590)
T KOG1290|consen  461 RDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEK  540 (590)
T ss_pred             ccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccc
Confidence                1123344444443211    1111111110                 00  1356677889999999999999999


Q ss_pred             CCCHHHHHHH
Q 013790          354 RPKMSQVVER  363 (436)
Q Consensus       354 RPs~~eil~~  363 (436)
                      |||+.+++++
T Consensus       541 R~tA~~cl~h  550 (590)
T KOG1290|consen  541 RPTAAQCLKH  550 (590)
T ss_pred             cccHHHHhcC
Confidence            9999999986

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-36  Score=288.48  Aligned_cols=255  Identities=25%  Similarity=0.380  Sum_probs=194.5

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc----hhHHHHHHHHHHHhcc-CCCCceeeeeEeee
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QGHKQWVAEVQFLGVL-EHPNLVKLIGYCAV  154 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  154 (436)
                      +|++.+.||.|+||.||+|....    ...++..||+|.+.....    ...+.+.+|+.++..+ +||||+++++.+..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~----~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVS----GHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT   76 (290)
T ss_pred             CceeeeeeccCCcceEEEEEecc----CCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence            47888999999999999998642    123678899999875422    2235678899999999 59999999988865


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      ..    ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++||||+|+|||++.++.+||+
T Consensus        77 ~~----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~  147 (290)
T cd05613          77 DT----KLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLT  147 (290)
T ss_pred             CC----eEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEe
Confidence            43    458999999999999999764  3688999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchh-hHHHHHHHhh
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG--HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-EQRLLEWVQQ  311 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-~~~~~~~~~~  311 (436)
                      |||++...... .........|+..|+|||.+.+.  .++.++||||||+++|+|++|..||....... ...+...+..
T Consensus       148 dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~  226 (290)
T cd05613         148 DFGLSKEFHED-EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK  226 (290)
T ss_pred             eCccceecccc-cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc
Confidence            99998753211 11122345688999999998653  46789999999999999999999996433211 1112111111


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                      .           .+    ..+...+..+.+++.+||..||.+||     ++.+++.+
T Consensus       227 ~-----------~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         227 S-----------EP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             c-----------CC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            0           00    11222346788999999999999997     66666554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=287.45  Aligned_cols=264  Identities=27%  Similarity=0.388  Sum_probs=197.6

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      |+..+.||+|+||.||+|...       .+++.||+|.+....  ....+.+..|+.+++.++||||+++++++...+  
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--   71 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDK-------KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER--   71 (282)
T ss_pred             CeeehcccccCcceEEEeeec-------CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC--
Confidence            566788999999999999865       467899999987653  233466788999999999999999999987653  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||+
T Consensus        72 --~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~  144 (282)
T cd07829          72 --KLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGL  144 (282)
T ss_pred             --ceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCc
Confidence              4599999997 59999997653 3689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHHhhccc--
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWVQQYPA--  314 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~--  314 (436)
                      +......  ........++..|+|||.+.+. .++.++||||||+++|+|++|..||.......... +.........  
T Consensus       145 ~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
T cd07829         145 ARAFGIP--LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES  222 (282)
T ss_pred             ccccCCC--ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHH
Confidence            8753221  1122234467789999998766 78899999999999999999999997654322211 1111100000  


Q ss_pred             ---------CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 ---------DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ---------~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                               ....+........... ....+..+.++|.+||..||.+||++.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         223 WPGVTKLPDYKPTFPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             HHhhcccccccccccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence                     0000000000000000 11125679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.1e-36  Score=288.77  Aligned_cols=258  Identities=24%  Similarity=0.364  Sum_probs=196.6

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc----hhHHHHHHHHHHHhcc-CCCCceeeeeEeee
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QGHKQWVAEVQFLGVL-EHPNLVKLIGYCAV  154 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  154 (436)
                      +|++.+.||+|+||.||++....    ...++..||||.+.....    ...+.+.+|+.++..+ +||||+++++.+..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~----~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~   76 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVG----GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT   76 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEec----cccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence            47888999999999999998642    123567899999864322    2335678899999999 59999999988765


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      ..    ..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+
T Consensus        77 ~~----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~  147 (288)
T cd05583          77 DT----KLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLT  147 (288)
T ss_pred             CC----EEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEE
Confidence            43    458999999999999998654  3689999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchh-hHHHHHHHhh
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH--LTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-EQRLLEWVQQ  311 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~pf~~~~~~~-~~~~~~~~~~  311 (436)
                      |||++...... .........|+..|+|||.+.+..  .+.++||||||+++|+|++|..||....... ...+...+..
T Consensus       148 dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  226 (288)
T cd05583         148 DFGLSKEFLAE-EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK  226 (288)
T ss_pred             ECccccccccc-cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc
Confidence            99998753222 111223346889999999987654  6889999999999999999999996432211 1111111111


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  366 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~  366 (436)
                      .           ..    ..+...+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       227 ~-----------~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         227 S-----------KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             c-----------CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            0           01    1112234578899999999999999998877665543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=9.1e-37  Score=284.81  Aligned_cols=250  Identities=24%  Similarity=0.364  Sum_probs=191.3

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEecc---C--cchhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR---D--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~---~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      +|.+.+.||+|+||.||++.+.       ..+..+++|.+..   .  .......+..|+.+++.++||||+++++++..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDK-------KAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE   73 (260)
T ss_pred             CceeeeeecCCCCceEEEEEec-------CCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc
Confidence            4788899999999999999865       2233344444432   1  11233456778999999999999999998865


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      ..    ..++||||+++++|.+++..  .....+++..++.++.|++.||.|||+.   +++|+||+|+||+++. +.++
T Consensus        74 ~~----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~  145 (260)
T cd08222          74 RD----AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLK  145 (260)
T ss_pred             CC----ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEe
Confidence            54    35899999999999998864  2235789999999999999999999998   9999999999999975 5699


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |+|||++.....  .........|+..|+|||.+.+..++.++|+||||+++|+|++|..||......   .........
T Consensus       146 l~d~g~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~~~~~~~  220 (260)
T cd08222         146 IGDFGVSRLLMG--SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---SVVLRIVEG  220 (260)
T ss_pred             ecccCceeecCC--CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHcC
Confidence            999999875321  122223456788999999998888899999999999999999999999654321   111111110


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .          .    ...+...+..+.++|.+||..||++||++.+++++
T Consensus       221 ~----------~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         221 P----------T----PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             C----------C----CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            0          0    11233445788999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=282.23  Aligned_cols=257  Identities=28%  Similarity=0.449  Sum_probs=197.0

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHh-ccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLG-VLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~  156 (436)
                      .+.+.+..||.|+||+|++..++       ..++..|||++..... .+.+++..|.+... .-+.||||++||.+..++
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk-------~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG  136 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHK-------PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG  136 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcC-------ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence            45666778999999999999987       6789999999986644 45567888876554 556999999999999888


Q ss_pred             CcceeEEEEEEecCCCCHHHHh---hcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHL---FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l---~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ..    |+.||.| .-||..+.   +.-....+++..+-+|....+.||.||...  ..||||||||+||||+..|.+||
T Consensus       137 dc----WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKL  209 (361)
T KOG1006|consen  137 DC----WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKL  209 (361)
T ss_pred             ce----eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEee
Confidence            76    9999988 55665543   333345799999999999999999999976  49999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      ||||++-..   ..+.-.+.-.|-..|||||.+..  ..|+.++||||||++|||+.||..||...... ...+...+..
T Consensus       210 CDFGIcGqL---v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-feql~~Vv~g  285 (361)
T KOG1006|consen  210 CDFGICGQL---VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-FEQLCQVVIG  285 (361)
T ss_pred             ecccchHhH---HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-HHHHHHHHcC
Confidence            999998531   11222233468889999999943  45899999999999999999999999876542 1222222222


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .+.   .   +..    .......+..+..+|..||..|-.+||.+.+++.+
T Consensus       286 dpp---~---l~~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  286 DPP---I---LLF----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CCC---e---ecC----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            111   1   111    11123456789999999999999999999998765

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=313.59  Aligned_cols=268  Identities=30%  Similarity=0.453  Sum_probs=211.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccC-CCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  155 (436)
                      .++..+.+.||+|.||.|++|...............||||.+.... ....+.+..|+++|+.+. ||||+.++|+|...
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            3455666799999999999999774443322346789999987553 345678999999999986 99999999999874


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC------C--------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCC
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA------F--------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  221 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~------~--------~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~  221 (436)
                      +    .+++|+||+..|+|..+++...      .        ..++....+.++.|||.|+.||++.   ++|||||..+
T Consensus       375 ~----~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR  447 (609)
T KOG0200|consen  375 G----PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR  447 (609)
T ss_pred             C----ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence            4    3599999999999999997654      0        1388899999999999999999998   9999999999


Q ss_pred             cEEEcCCCceEEeeccCCCCCCCCCCccccccccc--CCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 013790          222 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG--TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR  298 (436)
Q Consensus       222 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~  298 (436)
                      ||||..+..+||+|||+|+......... .....|  ...|||||.+....|+.++|||||||+||||+| |..||.+..
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999998533222221 121222  335999999999999999999999999999999 899998743


Q ss_pred             chhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                      ....  +.+++..-              .....|..++.++.+++..||+.+|++||++.++.+.|...++
T Consensus       527 ~~~~--l~~~l~~G--------------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  527 PTEE--LLEFLKEG--------------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             cHHH--HHHHHhcC--------------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            2222  23332211              1112344556889999999999999999999999999998764

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-37  Score=306.33  Aligned_cols=261  Identities=28%  Similarity=0.389  Sum_probs=216.5

Q ss_pred             HHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCceeeeeEee
Q 013790           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCA  153 (436)
Q Consensus        75 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  153 (436)
                      ...+.-|++...||.|.+|.||+++.+       .+++..|+|+..... ...+.+..|.++|+.+ .|||++.++|++.
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~-------~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~   86 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHV-------KTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFI   86 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeee-------ecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence            334567999999999999999999866       677888999887664 3345677788899877 5999999999887


Q ss_pred             ec-CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          154 VD-GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       154 ~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      .. ...+.++|||||||.+||..|++.+..+..+.|..+..|++.++.|+.+||.+   .++|||||-.|||++.++.||
T Consensus        87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence            53 34567899999999999999999887777899999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  307 (436)
                      |+|||++.+  .........+..||+.|||||++..     ..|+..+|+||||++..||.-|.+|+.+..|.-.     
T Consensus       164 LvDFGvSaQ--ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-----  236 (953)
T KOG0587|consen  164 LVDFGVSAQ--LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-----  236 (953)
T ss_pred             Eeeeeeeee--eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-----
Confidence            999999976  3445566778899999999999954     3577889999999999999999999987665321     


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                       +-..+         -+|.....-+.....++.++|..||..|..+||++.++++|
T Consensus       237 -LF~Ip---------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  237 -LFLIP---------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             -hccCC---------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence             11111         12222333456678899999999999999999999999875

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-37  Score=280.54  Aligned_cols=272  Identities=21%  Similarity=0.288  Sum_probs=220.8

Q ss_pred             HHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeee
Q 013790           72 SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIG  150 (436)
Q Consensus        72 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~  150 (436)
                      .++.....+++....+-+|.||.||+|.|+.  .+...+.+.|.+|.++... ......+..|...+..+.|||+.++.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~e--Edt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWRE--EDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecc--cCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            4444455678888889999999999999983  2334455667788776442 233456888999999999999999999


Q ss_pred             EeeecCCcceeEEEEEEecCCCCHHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEE
Q 013790          151 YCAVDGERGIQRLLVYEFMLNRSLEDHLFN------RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL  224 (436)
Q Consensus       151 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIl  224 (436)
                      ++.++...   .+.++.++.-|+|..|+..      ...+.++-.+...++.|++.|++|||+.   ++||.||..+|++
T Consensus       355 V~ie~~~~---P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCv  428 (563)
T KOG1024|consen  355 VSIEDYAT---PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCV  428 (563)
T ss_pred             EEeeccCc---ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcce
Confidence            99876543   4889999999999999972      1234567778899999999999999998   9999999999999


Q ss_pred             EcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 013790          225 LDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQ  303 (436)
Q Consensus       225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  303 (436)
                      ||+..++||+|=.+++.....+.............||+||.+....|+.++|||||||+||||+| |+.||..-+|.+..
T Consensus       429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~  508 (563)
T KOG1024|consen  429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME  508 (563)
T ss_pred             ehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence            99999999999999997655555555555566789999999999999999999999999999999 99999888776654


Q ss_pred             HHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          304 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                      ..+..                 ..+-..|.+||+++..++..||..+|++||++++++.-|.+..
T Consensus       509 ~ylkd-----------------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  509 HYLKD-----------------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             HHHhc-----------------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            44321                 1112335667899999999999999999999999999988764

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-38  Score=320.59  Aligned_cols=260  Identities=25%  Similarity=0.295  Sum_probs=208.0

Q ss_pred             HHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC---cchhHHHHHHHHHHHhccCCCCcee
Q 013790           71 YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQGHKQWVAEVQFLGVLEHPNLVK  147 (436)
Q Consensus        71 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~  147 (436)
                      ..+++-..+||.+++.||+|+||.|..++++       .++++||+|++++-   .......|+.|-.+|...+.+=|+.
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k-------~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~  139 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHK-------STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQ  139 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEee-------ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHH
Confidence            3445556689999999999999999999987       67899999999873   2334567899999999999999999


Q ss_pred             eeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          148 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       148 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      +.-.|.++.    ++|+||||++||+|..++.+..  ++|+.-+..++..|+-||.-||+.   |+|||||||+|||||.
T Consensus       140 LhyAFQD~~----~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~  210 (1317)
T KOG0612|consen  140 LHYAFQDER----YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDK  210 (1317)
T ss_pred             HHHHhcCcc----ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecc
Confidence            987776554    5699999999999999996654  799999999999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccc----c-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-h
Q 013790          228 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE----T-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK-T  301 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-~  301 (436)
                      .|++||+|||.+-... .+....+...+|||-|.+||++.    + +.|+..+|.||+||++|||+.|..||....-. +
T Consensus       211 ~GHikLADFGsClkm~-~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT  289 (1317)
T KOG0612|consen  211 SGHIKLADFGSCLKMD-ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET  289 (1317)
T ss_pred             cCcEeeccchhHHhcC-CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH
Confidence            9999999999986532 23345667789999999999993    3 67899999999999999999999999743211 1


Q ss_pred             hHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC---HHHHHHH
Q 013790          302 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK---MSQVVER  363 (436)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~eil~~  363 (436)
                      ...++..-..               +.-+....++....+||...+. +|+.|..   ++++..|
T Consensus       290 Y~KIm~hk~~---------------l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  290 YGKIMNHKES---------------LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             HHHHhchhhh---------------cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence            1111111000               0000113356788999999876 6889988   8888776

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.4e-37  Score=297.73  Aligned_cols=267  Identities=22%  Similarity=0.317  Sum_probs=199.7

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      ...++|++.+.||+|+||.||+|...       .++..||+|.+....  ......+.+|+.+++.++||||+++++++.
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDT-------KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFT   84 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEEC-------CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhh
Confidence            34678999999999999999999875       467889999986532  223356778999999999999999998776


Q ss_pred             ecCC--cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCce
Q 013790          154 VDGE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  231 (436)
Q Consensus       154 ~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  231 (436)
                      ....  .....++|+||+ +++|.+++..   ..+++..+..++.|++.||.|||+.   ||+|+||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~  157 (343)
T cd07851          85 PASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCEL  157 (343)
T ss_pred             ccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCE
Confidence            5432  223468999998 7799999865   3689999999999999999999998   99999999999999999999


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      +|+|||++.....     ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||..........  ....
T Consensus       158 kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~--~i~~  230 (343)
T cd07851         158 KILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLK--RIMN  230 (343)
T ss_pred             EEccccccccccc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHH
Confidence            9999999975321     1233467889999999865 367889999999999999999999997654422111  1111


Q ss_pred             hcccCcccc-cc--------c---cCCcccCc---CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          311 QYPADSKKF-GL--------I---MDPRLEKE---YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~-~~--------~---~~~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ........+ ..        .   ........   .....+..+.++|.+||..||.+|||+.+|+.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         231 LVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             hcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            111000000 00        0   00000000   001125679999999999999999999999876

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-37  Score=274.00  Aligned_cols=263  Identities=23%  Similarity=0.349  Sum_probs=206.7

Q ss_pred             cCHHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCCcee
Q 013790           69 FSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNLVK  147 (436)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~  147 (436)
                      -.+.++...++     +.||+|+|+.|--+..       ..++..||||++.+...-...++.+|++++.+++ |+||++
T Consensus        73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~-------i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilq  140 (463)
T KOG0607|consen   73 GKFEDMYKLTS-----ELLGEGAYASVQTCVS-------IQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQ  140 (463)
T ss_pred             chHHHHHHhHH-----HHhcCccceeeeeeee-------eccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHH
Confidence            34666666655     3699999999998874       4688999999999886667788999999999996 999999


Q ss_pred             eeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          148 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       148 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      ++++|.++..    .|||||-+.||+|..+|..+.  .+++.++..+..+|+.||.+||.+   ||.||||||+|||-..
T Consensus       141 LiefFEdd~~----FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~  211 (463)
T KOG0607|consen  141 LIEFFEDDTR----FYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCES  211 (463)
T ss_pred             HHHHhcccce----EEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecC
Confidence            9999987765    499999999999999998765  699999999999999999999999   9999999999999965


Q ss_pred             CCc---eEEeeccCCCCCCCC-----CCcccccccccCCCccccccc-----ccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 013790          228 NFR---PKLSDFGLAREGPMV-----GHTHVSTAVVGTFGYAAPDYI-----ETGHLTAKSDVWSFGVVLYEMLTGRRSL  294 (436)
Q Consensus       228 ~~~---~kl~Dfg~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvil~elltg~~pf  294 (436)
                      ...   +|||||.+.......     .......+.+|+..|||||+.     ....|+.++|.||||||+|-|++|.+||
T Consensus       212 pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPF  291 (463)
T KOG0607|consen  212 PNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPF  291 (463)
T ss_pred             CCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCc
Confidence            444   799999987532111     112233467899999999986     2346889999999999999999999999


Q ss_pred             CCCCchh------------hHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 013790          295 ERNRPKT------------EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE  362 (436)
Q Consensus       295 ~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~  362 (436)
                      .+.-..+            ...+.+-++.-   .        -.++.......+.+..+||..+|..|+.+|.++.+++.
T Consensus       292 vG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG---k--------YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  292 VGHCGADCGWDRGEVCRVCQNKLFESIQEG---K--------YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cCccCCcCCccCCCccHHHHHHHHHHHhcc---C--------CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            7643311            11222222110   0        01122334556778889999999999999999999987


Q ss_pred             H
Q 013790          363 R  363 (436)
Q Consensus       363 ~  363 (436)
                      +
T Consensus       361 h  361 (463)
T KOG0607|consen  361 H  361 (463)
T ss_pred             C
Confidence            4

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-36  Score=277.73  Aligned_cols=236  Identities=28%  Similarity=0.380  Sum_probs=189.7

Q ss_pred             ccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        87 ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      ||.|+||.||++...       .+++.|++|.+......   ....+..|+.+++.++||||+++++.+....    ..+
T Consensus         1 lg~G~~~~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~   69 (250)
T cd05123           1 LGKGSFGKVLLVRKK-------DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE----KLY   69 (250)
T ss_pred             CCCCCceEEEEEEEC-------CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC----eeE
Confidence            799999999999865       35788999998765332   3457888999999999999999998886544    459


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCC
Q 013790          164 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP  243 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  243 (436)
                      ++|||+++++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        70 ~v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~  144 (250)
T cd05123          70 LVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELS  144 (250)
T ss_pred             EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecc
Confidence            9999999999999996653  689999999999999999999998   99999999999999999999999999987532


Q ss_pred             CCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccccc
Q 013790          244 MVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM  323 (436)
Q Consensus       244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (436)
                      ..  ........++..|++||.+.+...+.++|+||||+++|+|++|..||.....   ......+...           
T Consensus       145 ~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~-----------  208 (250)
T cd05123         145 SE--GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILKD-----------  208 (250)
T ss_pred             cC--CCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcC-----------
Confidence            11  1223445688899999999888889999999999999999999999976543   1122211110           


Q ss_pred             CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 013790          324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS  358 (436)
Q Consensus       324 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  358 (436)
                      ..    ..+...+..+.+++.+||..||++||++.
T Consensus       209 ~~----~~~~~~~~~l~~~i~~~l~~~p~~R~~~~  239 (250)
T cd05123         209 PL----RFPEFLSPEARDLISGLLQKDPTKRLGSG  239 (250)
T ss_pred             CC----CCCCCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence            00    11222246788999999999999999994

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=9.2e-38  Score=279.01  Aligned_cols=276  Identities=25%  Similarity=0.338  Sum_probs=199.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ...|+.+..||+|+||.||+|.-++.++   ...+.+|||++....  ........+|+.+++.++||||+.+..++...
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~---kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTND---KRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCc---ccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            3579999999999999999997653322   124589999997552  22235678899999999999999999988764


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC----
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNR---AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN----  228 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----  228 (436)
                      +   ..+++++||.+. +|.+.|+-.   ....++...+..|+.||+.|+.|||++   =|+||||||.||||..+    
T Consensus       100 d---~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgper  172 (438)
T KOG0666|consen  100 D---KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPER  172 (438)
T ss_pred             C---ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCcc
Confidence            2   246999999965 888888532   234688999999999999999999998   89999999999999877    


Q ss_pred             CceEEeeccCCCCCCCC-CCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh----
Q 013790          229 FRPKLSDFGLAREGPMV-GHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE----  302 (436)
Q Consensus       229 ~~~kl~Dfg~a~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~----  302 (436)
                      |.|||+|||+++.+... .........+-|.-|.|||++.|. .|+.+.|||+.|||+.||+|-.+.|.+......    
T Consensus       173 G~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~P  252 (438)
T KOG0666|consen  173 GRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNP  252 (438)
T ss_pred             CeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCC
Confidence            99999999999864221 122233445678899999999775 789999999999999999999999876433211    


Q ss_pred             ------HHHHHHHhhcccCccc--cccc-------cCC--cccCcCCHH--------HHHHHHHHHHHhhcCCCCCCCCH
Q 013790          303 ------QRLLEWVQQYPADSKK--FGLI-------MDP--RLEKEYSIN--------EARKIGRLADNCLSKSSKDRPKM  357 (436)
Q Consensus       303 ------~~~~~~~~~~~~~~~~--~~~~-------~~~--~l~~~~~~~--------~~~~l~~li~~cl~~dp~~RPs~  357 (436)
                            ..+.+ +...|.+...  +..+       .+-  ......+..        -++...+|+.++|..||-+|.|+
T Consensus       253 fq~dQl~rIf~-vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta  331 (438)
T KOG0666|consen  253 FQHDQLDRIFE-VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITA  331 (438)
T ss_pred             chHHHHHHHHH-HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccH
Confidence                  11121 1122221110  0000       000  000000000        02236799999999999999999


Q ss_pred             HHHHHHH
Q 013790          358 SQVVERL  364 (436)
Q Consensus       358 ~eil~~L  364 (436)
                      ++.+++.
T Consensus       332 ~qAleh~  338 (438)
T KOG0666|consen  332 EQALEHP  338 (438)
T ss_pred             HHHhccc
Confidence            9998873

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=293.64  Aligned_cols=246  Identities=25%  Similarity=0.380  Sum_probs=201.7

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCccee
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ  161 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  161 (436)
                      .+.||+|-||+||-|+++       .+|+.||||++++...  ....++++|+.||+++.||.||.+...|...+    .
T Consensus       569 devLGSGQFG~VYgg~hR-------ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e----r  637 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHR-------KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE----R  637 (888)
T ss_pred             HhhccCCcceeeecceec-------ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc----e
Confidence            468999999999999987       6889999999986532  33467999999999999999999987776554    3


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC---CCceEEeeccC
Q 013790          162 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPKLSDFGL  238 (436)
Q Consensus       162 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~  238 (436)
                      ++.|||-+ .|++.+.|.....+.+++..-..++.||+.||.|||.+   +|+|+||||+|||+..   -..+||||||+
T Consensus       638 vFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGf  713 (888)
T KOG4236|consen  638 VFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGF  713 (888)
T ss_pred             EEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccc
Confidence            59999998 66777777777778899999999999999999999999   9999999999999954   34699999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  318 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  318 (436)
                      |+.   .+......+.+||+.|+|||+++...|....|+||.|||+|.-++|..||....+..+     -++.-..    
T Consensus       714 ARi---IgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd-----QIQNAaF----  781 (888)
T KOG4236|consen  714 ARI---IGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND-----QIQNAAF----  781 (888)
T ss_pred             eee---cchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH-----Hhhcccc----
Confidence            996   4455566778999999999999999999999999999999999999999975543322     2221100    


Q ss_pred             cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       319 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                         +..+    ....+.+....+||..+|+..-.+|.|..+.+.+
T Consensus       782 ---MyPp----~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  782 ---MYPP----NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             ---ccCC----CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence               1111    2233445667799999999999999999888765

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1e-35  Score=311.60  Aligned_cols=147  Identities=27%  Similarity=0.379  Sum_probs=128.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|.+++.||+|+||.||+|.+.       .+++.||||++.....   .....+..|+.++..++||||+++++++..
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~   75 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKK-------NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS   75 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEEC-------CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE
Confidence            468999999999999999999875       4678899999875432   223578889999999999999999988865


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      ..    ..|+||||+.+++|.+++...  ..+++..++.|+.||+.||.|||..   +|+||||||+||||+.++.+||+
T Consensus        76 ~~----~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~  146 (669)
T cd05610          76 AN----NVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLT  146 (669)
T ss_pred             CC----EEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEE
Confidence            44    469999999999999999654  3588999999999999999999998   99999999999999999999999


Q ss_pred             eccCCC
Q 013790          235 DFGLAR  240 (436)
Q Consensus       235 Dfg~a~  240 (436)
                      |||+++
T Consensus       147 DFGls~  152 (669)
T cd05610         147 DFGLSK  152 (669)
T ss_pred             eCCCCc
Confidence            999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=249.25  Aligned_cols=267  Identities=25%  Similarity=0.352  Sum_probs=202.1

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .+|...++||+|+||+||+|+.+       .+...||+|.+..+.  ........+|+-+++.++|.|||+++++...+.
T Consensus         2 ~~ydkmekigegtygtvfkarn~-------~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdk   74 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNR-------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK   74 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccC-------CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc
Confidence            35777889999999999999854       678899999986543  223456789999999999999999999876554


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          .+-+|+||| ..+|..+...-+ +.+....+..++.|+++||.++|++   ++.||||||+|+||+.+|.+|++||
T Consensus        75 ----kltlvfe~c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladf  145 (292)
T KOG0662|consen   75 ----KLTLVFEFC-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADF  145 (292)
T ss_pred             ----eeEEeHHHh-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEeccc
Confidence                358999999 568988876544 5788999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |+++.+..  ...-.+..+-|.-|.+|.++.|. -|+...|+||.|||+.|+.. |++.|.+.+..+....+-|+...+.
T Consensus       146 glarafgi--pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~  223 (292)
T KOG0662|consen  146 GLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  223 (292)
T ss_pred             chhhhcCC--ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCc
Confidence            99985321  12233456778999999999774 57899999999999999997 6666776655544444444443333


Q ss_pred             Ccc--ccccccCCcccCcC---------CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSK--KFGLIMDPRLEKEY---------SINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~--~~~~~~~~~l~~~~---------~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...  .+..+.+-....-+         .+.....-++|+.+.|.-+|.+|.+++..+++
T Consensus       224 ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  224 EDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            221  11111111111111         11223345689999999999999999988765

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=8.4e-36  Score=274.64  Aligned_cols=220  Identities=20%  Similarity=0.210  Sum_probs=174.0

Q ss_pred             cCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEEEEEEec
Q 013790           90 GGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM  169 (436)
Q Consensus        90 G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~  169 (436)
                      |.||.||++...       .+++.||+|.+....     .+.+|...+....||||+++++++....    ..+++|||+
T Consensus         4 g~~~~v~~~~~~-------~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~   67 (237)
T cd05576           4 GVIDKVLLVMDT-------RTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSED----SVFLVLQHA   67 (237)
T ss_pred             cccceEEEEEEc-------cCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCC----eEEEEEecC
Confidence            899999999865       577889999997653     2234555555667999999999887543    459999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcc
Q 013790          170 LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH  249 (436)
Q Consensus       170 ~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  249 (436)
                      ++|+|.+++....  .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++|||.+.....     
T Consensus        68 ~~~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----  137 (237)
T cd05576          68 EGGKLWSHISKFL--NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----  137 (237)
T ss_pred             CCCCHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccc-----
Confidence            9999999986543  589999999999999999999998   999999999999999999999999998754211     


Q ss_pred             cccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccC
Q 013790          250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEK  329 (436)
Q Consensus       250 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  329 (436)
                      ......++..|+|||.+.+..++.++||||+|+++|+|++|..|+........                  .....    
T Consensus       138 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------------~~~~~----  195 (237)
T cd05576         138 SCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------------THTTL----  195 (237)
T ss_pred             ccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------------ccccc----
Confidence            12233457789999999888889999999999999999999988754221100                  00000    


Q ss_pred             cCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 013790          330 EYSINEARKIGRLADNCLSKSSKDRPKM  357 (436)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~dp~~RPs~  357 (436)
                      ..+...+..+.++|.+||+.||.+||++
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence            1122234678899999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=294.52  Aligned_cols=243  Identities=23%  Similarity=0.303  Sum_probs=195.2

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      +..+|.....+|.|+|+.|-.+...       .+++..++|++.....    +..+|+.++... +||||+++.+.+...
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~-------~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~  388 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESS-------PTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDG  388 (612)
T ss_pred             cchhhccccccCCCCccceeeeecc-------ccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCC
Confidence            4568888888999999999998866       5678899999976622    223466555544 699999999998654


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE-cCCCceEEe
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL-DENFRPKLS  234 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~  234 (436)
                      .    +.|+|||++.|+-|.+.+....   .....+..|+.+|+.++.|||++   |+|||||||+|||+ +..|+++|+
T Consensus       389 ~----~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrlt  458 (612)
T KOG0603|consen  389 K----EIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLT  458 (612)
T ss_pred             c----eeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEE
Confidence            3    5699999999999998886543   33377788999999999999999   99999999999999 699999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||.++.....     ....+-|..|.|||++....|++++|+||||++||+|++|+.||......  ..+...++.   
T Consensus       459 yFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~---  528 (612)
T KOG0603|consen  459 YFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQM---  528 (612)
T ss_pred             EechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcC---
Confidence            99999753211     33456788999999999999999999999999999999999999876544  122222111   


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                                +    .++...+...++|+.+||+.||.+||++.++..+=
T Consensus       529 ----------~----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~  564 (612)
T KOG0603|consen  529 ----------P----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP  564 (612)
T ss_pred             ----------C----ccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence                      1    22345567889999999999999999999998773

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=278.59  Aligned_cols=244  Identities=26%  Similarity=0.388  Sum_probs=197.0

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh---HHHHHHHHHHHhccC-CCCceeeeeEe
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAEVQFLGVLE-HPNLVKLIGYC  152 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-hpnIv~~~~~~  152 (436)
                      ...+|..+..||+|+||+|.+|..+       .+...||||+++++-...   .+--..|-.+|.... -|.++++..++
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerk-------gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF  419 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERK-------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF  419 (683)
T ss_pred             eecccceEEEeccCccceeeeeccc-------CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh
Confidence            3468999999999999999999865       567889999998763322   223345667777664 67888888777


Q ss_pred             eecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          153 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      ..-+    .+|+||||+.||+|.-.|..-  +.+.+..+..+|..||-||-+||++   ||+.||||.+|||+|.+|++|
T Consensus       420 QTmD----RLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiK  490 (683)
T KOG0696|consen  420 QTMD----RLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIK  490 (683)
T ss_pred             hhhh----heeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceE
Confidence            6554    359999999999999998654  3688889999999999999999999   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhh
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQ  311 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~  311 (436)
                      |+|||+++...  -......+++||+.|+|||++...+|+.++|.|||||+||||+.|++||++.+..+.. .+.+.-. 
T Consensus       491 i~DFGmcKEni--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv-  567 (683)
T KOG0696|consen  491 IADFGMCKENI--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV-  567 (683)
T ss_pred             eeecccccccc--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC-
Confidence            99999998632  2344567789999999999999999999999999999999999999999987554322 1221111 


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM  357 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  357 (436)
                                        .++...+.+...+....|...|.+|.-.
T Consensus       568 ------------------syPKslSkEAv~ickg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  568 ------------------SYPKSLSKEAVAICKGLLTKHPGKRLGC  595 (683)
T ss_pred             ------------------cCcccccHHHHHHHHHHhhcCCccccCC
Confidence                              2333445677889999999999999743

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-37  Score=267.24  Aligned_cols=275  Identities=25%  Similarity=0.355  Sum_probs=203.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .+.|....+||+|.||.||+|+.+       .+++.||+|++-.++  ........+|+.+|..|.|+|++.++.+|...
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~-------n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk   88 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSK-------NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   88 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhc-------CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence            456888889999999999999876       567889998765432  22234667899999999999999999988653


Q ss_pred             CC----cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCce
Q 013790          156 GE----RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  231 (436)
Q Consensus       156 ~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  231 (436)
                      ..    ....+++||.+|+. +|...+.+.. ..++..++.+++.++..||.|+|..   .|+|||+|+.|+||+.+|.+
T Consensus        89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgil  163 (376)
T KOG0669|consen   89 ATPTNRDRATFYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGIL  163 (376)
T ss_pred             cCCcccccceeeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceE
Confidence            22    22347999999965 8888886653 4689999999999999999999998   99999999999999999999


Q ss_pred             EEeeccCCCCCCCCCC--cccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 013790          232 KLSDFGLAREGPMVGH--THVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  308 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  308 (436)
                      ||+|||+++.+.....  ....+..+-|..|.+||.+.| ..|+++.|||..|||+.||+||.+.+++........++..
T Consensus       164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~  243 (376)
T KOG0669|consen  164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ  243 (376)
T ss_pred             EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence            9999999975432222  122344566899999999876 4789999999999999999999999988755443333332


Q ss_pred             Hhhccc-Ccc----c---cccccCCcccCc-C--------CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          309 VQQYPA-DSK----K---FGLIMDPRLEKE-Y--------SINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       309 ~~~~~~-~~~----~---~~~~~~~~l~~~-~--------~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                      +..... +.+    .   +..+-.+.+... +        +..-.+...+|+..+|..||.+|+++.+++.+-
T Consensus       244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            221111 000    0   011101111111 0        011123567999999999999999999998873

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-37  Score=289.21  Aligned_cols=250  Identities=24%  Similarity=0.375  Sum_probs=207.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      ..++..+..||-||||.|-++...       .....+|+|.+++....   ..+.+..|-.+|..++.|.||++|--|.+
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~-------~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd  491 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVN-------SQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD  491 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEec-------ccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence            457788889999999999998865       22234888888765433   34567889999999999999999988866


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      +.    ++|++||-|.||.|+..|+.++  .+.+.+...++..+++|+.|||.+   |||.|||||+|++++.+|.+||.
T Consensus       492 ~k----yvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLV  562 (732)
T KOG0614|consen  492 SK----YVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLV  562 (732)
T ss_pred             ch----hhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEe
Confidence            54    4699999999999999997765  799999999999999999999999   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHH-HHhhcc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE-WVQQYP  313 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~-~~~~~~  313 (436)
                      |||+|+.   .+......+++||+.|.|||++.+...+.++|.||||+++|||++|.+||.+.++.....++- -+..  
T Consensus       563 DFGFAKk---i~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~--  637 (732)
T KOG0614|consen  563 DFGFAKK---IGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK--  637 (732)
T ss_pred             ehhhHHH---hccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh--
Confidence            9999986   445666788999999999999999999999999999999999999999999988765433321 1111  


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~  363 (436)
                                     ..+|...+....+||++++..+|.+|.-     +.+|.+|
T Consensus       638 ---------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  638 ---------------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             ---------------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence                           1223334466779999999999999986     5666665

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-35  Score=264.87  Aligned_cols=246  Identities=26%  Similarity=0.425  Sum_probs=196.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhcc-CCCCceeeeeEee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVL-EHPNLVKLIGYCA  153 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  153 (436)
                      .++|.+++.||+|+|++|..+.++       .+.+.||+|++++....   +.+-++.|-.+..+. +||.+|-+..+|.
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~-------~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq  321 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLK-------KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ  321 (593)
T ss_pred             cccceeeeeecCcchhhhhheehc-------ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence            579999999999999999999977       67899999999865333   233456676666654 6999999998887


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      .+.    .+++|.||++||+|.-++.++.  .+++..+..+...|+.||.|||++   ||+.||||.+|+|||..|.+||
T Consensus       322 tes----rlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikl  392 (593)
T KOG0695|consen  322 TES----RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKL  392 (593)
T ss_pred             ccc----eEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceee
Confidence            654    4699999999999998886654  799999999999999999999999   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chhhHHHHHH
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR-----PKTEQRLLEW  308 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~-----~~~~~~~~~~  308 (436)
                      +|+|+++..  .......++++||+.|.|||+++|..|...+|.|+|||+++||+.|+.||+-..     ..++..+.+.
T Consensus       393 tdygmcke~--l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv  470 (593)
T KOG0695|consen  393 TDYGMCKEG--LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV  470 (593)
T ss_pred             cccchhhcC--CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH
Confidence            999999863  445556788999999999999999999999999999999999999999996321     1122222221


Q ss_pred             HhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC
Q 013790          309 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK  356 (436)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs  356 (436)
                                   ++...++  .+-..+-....+++..|..||.+|.-
T Consensus       471 -------------ilekqir--iprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  471 -------------ILEKQIR--IPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             -------------Hhhhccc--ccceeehhhHHHHHHhhcCCcHHhcC
Confidence                         1222111  11112234457888889999999863

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.3e-34  Score=296.37  Aligned_cols=272  Identities=19%  Similarity=0.255  Sum_probs=171.4

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeee-c
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV-D  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~  155 (436)
                      ..++|.+.+.||+|+||.||+|++....   ...+..||+|++......  +.+..+  .+....+.++..++..+.. .
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~---~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQ---SKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCc---cccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            4579999999999999999999976211   122788999988644321  111111  1222223333322222111 0


Q ss_pred             -CCcceeEEEEEEecCCCCHHHHhhcCCCC------------------CCCHHHHHHHHHHHHHHHHHhhcCCCCceeec
Q 013790          156 -GERGIQRLLVYEFMLNRSLEDHLFNRAFP------------------PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYR  216 (436)
Q Consensus       156 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~  216 (436)
                       .......++||||+.+++|.+++......                  ......+..++.||+.||.|||++   +|+||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHR  279 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHR  279 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence             12233569999999999999998654311                  112334668999999999999998   99999


Q ss_pred             cCCCCcEEEcC-CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccC----------------------CCCc
Q 013790          217 DFKASNVLLDE-NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG----------------------HLTA  273 (436)
Q Consensus       217 Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~  273 (436)
                      ||||+|||++. ++.+||+|||+++.... ..........+++.|+|||.+...                      .++.
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~-~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~  358 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRV-GINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD  358 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCcccccc-ccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence            99999999985 68999999999974321 122233456789999999976332                      2334


Q ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCc----C--CHHHHHHHHHHHHHhh
Q 013790          274 KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKE----Y--SINEARKIGRLADNCL  347 (436)
Q Consensus       274 ~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~----~--~~~~~~~l~~li~~cl  347 (436)
                      ++|||||||+||||+++..++...    ...+...+.....+...+.....+.....    +  .........+||.+||
T Consensus       359 k~DVwSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL  434 (566)
T PLN03225        359 RFDIYSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM  434 (566)
T ss_pred             CcccHHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence            569999999999999977665421    11111111111111111111111110000    0  0011234558999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 013790          348 SKSSKDRPKMSQVVER  363 (436)
Q Consensus       348 ~~dp~~RPs~~eil~~  363 (436)
                      +.||.+|||+.++++|
T Consensus       435 ~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        435 RFKGRQRISAKAALAH  450 (566)
T ss_pred             cCCcccCCCHHHHhCC
Confidence            9999999999999987

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-36  Score=277.19  Aligned_cols=259  Identities=27%  Similarity=0.398  Sum_probs=199.6

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-------cchhHHHHHHHHHHHhccCCCCceeeeeE
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQGHKQWVAEVQFLGVLEHPNLVKLIGY  151 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~  151 (436)
                      ++|-++.+||+|||+.||+|..       ....+.||+|+-...       .....+...+|..|.+.|.||.||++|++
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFD-------l~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy  535 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFD-------LTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY  535 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcc-------cchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence            4677889999999999999874       467889999985432       11223557889999999999999999999


Q ss_pred             eeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc---CC
Q 013790          152 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---EN  228 (436)
Q Consensus       152 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~  228 (436)
                      +..+...   .|-|+|||+|.+|.-||....  .+++..+..|+.||+.||.||... .++|||-||||.|||+-   ..
T Consensus       536 fslDtds---FCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gtac  609 (775)
T KOG1151|consen  536 FSLDTDS---FCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTAC  609 (775)
T ss_pred             eeecccc---ceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccc
Confidence            9876543   589999999999999997654  789999999999999999999985 67999999999999994   56


Q ss_pred             CceEEeeccCCCCCCCCCCc-----ccccccccCCCcccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 013790          229 FRPKLSDFGLAREGPMVGHT-----HVSTAVVGTFGYAAPDYIETG----HLTAKSDVWSFGVVLYEMLTGRRSLERNRP  299 (436)
Q Consensus       229 ~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~pf~~~~~  299 (436)
                      |.+||+|||+++.+......     ...+...||..|++||.+.-+    ..+.++||||.|||+|..+.|+.||.....
T Consensus       610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs  689 (775)
T KOG1151|consen  610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS  689 (775)
T ss_pred             ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence            88999999999875332222     123456799999999988433    568899999999999999999999986432


Q ss_pred             hhhHHHHHHHhhcccCccccccccCC-cccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          300 KTEQRLLEWVQQYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                        ..++++.-.           ++.. ...-..-+.++.+...+|++||+.--++|....++..+
T Consensus       690 --QQdILqeNT-----------IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  690 --QQDILQENT-----------ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             --HHHHHhhhc-----------hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence              233332210           0100 00001112334678899999999999999998887654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-33  Score=282.17  Aligned_cols=272  Identities=18%  Similarity=0.228  Sum_probs=183.8

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCC---------CCCCcceEEEEEEeccCcchhHHHH--------------HHH
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAG---------DGTSEATVVAIKKLNRDGLQGHKQW--------------VAE  133 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~---------~~~~~~~~vavK~~~~~~~~~~~~~--------------~~E  133 (436)
                      ..++|.+.++||+|+||.||+|.+.....         .....++.||||.+........+.|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            35789999999999999999997632211         1123457899999875533322233              346


Q ss_pred             HHHHhccCCCCc-----eeeeeEeeecCC----cceeEEEEEEecCCCCHHHHhhcCCC---------------------
Q 013790          134 VQFLGVLEHPNL-----VKLIGYCAVDGE----RGIQRLLVYEFMLNRSLEDHLFNRAF---------------------  183 (436)
Q Consensus       134 ~~~l~~l~hpnI-----v~~~~~~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------  183 (436)
                      +.++.+++|.++     ++++++|.....    .....++||||+.+++|.+++.....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            666677766544     677777754311    11246999999999999999864211                     


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCccc
Q 013790          184 -PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA  262 (436)
Q Consensus       184 -~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  262 (436)
                       ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++...... .........+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG-INFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccC-CccCccccCCCcceeC
Confidence             1245678889999999999999998   9999999999999999999999999999643211 1111122335789999


Q ss_pred             ccccccCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCCCchhh------HHHHHHHhhcc
Q 013790          263 PDYIETGH--------------------L--TAKSDVWSFGVVLYEMLTGRR-SLERNRPKTE------QRLLEWVQQYP  313 (436)
Q Consensus       263 PE~~~~~~--------------------~--~~~~DvwSlGvil~elltg~~-pf~~~~~~~~------~~~~~~~~~~~  313 (436)
                      ||.+....                    +  ....||||+||++|+|++|.. ||........      .....|..   
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~---  455 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM---  455 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh---
Confidence            99875322                    1  124699999999999999875 7654221110      01111111   


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCC---CCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSS---KDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp---~~RPs~~eil~~  363 (436)
                              .......-......+....+|+.+||..+|   .+|+|+.++++|
T Consensus       456 --------~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        456 --------YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             --------hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence                    000111111122335678899999999876   689999999987

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.7e-33  Score=258.61  Aligned_cols=239  Identities=29%  Similarity=0.413  Sum_probs=191.4

Q ss_pred             CceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh-HHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEEEEEEec
Q 013790           91 GFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM  169 (436)
Q Consensus        91 ~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~  169 (436)
                      +||.||+|.+.       .++..+++|++....... .+.+.+|+..++.++|+||+++++++....    ..++++||+
T Consensus         1 ~~g~v~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~l~~e~~   69 (244)
T smart00220        1 SFGKVYLARDK-------KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED----KLYLVMEYC   69 (244)
T ss_pred             CceEEEEEEEC-------CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC----EEEEEEeCC
Confidence            58999999975       357889999997665444 678999999999999999999999987653    459999999


Q ss_pred             CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcc
Q 013790          170 LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH  249 (436)
Q Consensus       170 ~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  249 (436)
                      .+++|..++....  .+++..++.++.+++.++.|||+.   +++|+||+|+||+++.++.++|+|||.+......   .
T Consensus        70 ~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~  141 (244)
T smart00220       70 DGGDLFDLLKKRG--RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---G  141 (244)
T ss_pred             CCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccc---c
Confidence            9999999986643  389999999999999999999998   9999999999999999999999999998753221   1


Q ss_pred             cccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccC
Q 013790          250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEK  329 (436)
Q Consensus       250 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  329 (436)
                      ......++..|++||.+.+..++.++||||||+++|+|++|..||.....  .......+........            
T Consensus       142 ~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~~~------------  207 (244)
T smart00220      142 LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGKPKPPFP------------  207 (244)
T ss_pred             ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCCCCc------------
Confidence            33445678899999999888889999999999999999999999976322  1222222221111000            


Q ss_pred             cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 013790          330 EYSINEARKIGRLADNCLSKSSKDRPKMSQVVE  362 (436)
Q Consensus       330 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~  362 (436)
                      ......+..+.+++.+||..+|++||++.++++
T Consensus       208 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      208 PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            000003467889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-34  Score=278.57  Aligned_cols=244  Identities=25%  Similarity=0.359  Sum_probs=190.1

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhH---HHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH---KQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      -|..++.||-|+||.|.+++..       .+...||+|.+.+.+....   ..+..|-.||..-+.+-||++|-.|.+.+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~Kv-------DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd  702 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKV-------DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD  702 (1034)
T ss_pred             ceEEEeeecccccceeEEEeec-------chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence            4666788999999999999854       4678899999987655433   34677889999999999999998887665


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      .    +|+||+|++||++..+|.+.+  -+++..+..++..+..|+.+.|..   |+|||||||+|||||.+|++||+||
T Consensus       703 n----LYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDF  773 (1034)
T KOG0608|consen  703 N----LYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  773 (1034)
T ss_pred             c----eEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeec
Confidence            4    599999999999999998765  689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCC--------C-Cc-------------------------------ccccccccCCCcccccccccCCCCchhh
Q 013790          237 GLAREGPMV--------G-HT-------------------------------HVSTAVVGTFGYAAPDYIETGHLTAKSD  276 (436)
Q Consensus       237 g~a~~~~~~--------~-~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D  276 (436)
                      ||++-+.+.        + ..                               ......+||+.|+|||++....|+..+|
T Consensus       774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd  853 (1034)
T KOG0608|consen  774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD  853 (1034)
T ss_pred             cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence            998621110        0 00                               0012457999999999999999999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC
Q 013790          277 VWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP  355 (436)
Q Consensus       277 vwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP  355 (436)
                      .||.|||||||+.|++||....+.... .+..|-..           ++    -.+....+.++.+||.+++. +++.|.
T Consensus       854 wws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~-----------l~----~~~~~~ls~e~~~li~kLc~-sad~RL  917 (1034)
T KOG0608|consen  854 WWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNF-----------LH----IPYQGNLSKEALDLIQKLCC-SADSRL  917 (1034)
T ss_pred             hhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhc-----------cc----cccccccCHHHHHHHHHHhc-Chhhhh
Confidence            999999999999999999877665432 23333211           11    12223334566677766443 466776

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=242.36  Aligned_cols=204  Identities=26%  Similarity=0.400  Sum_probs=164.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++...+..||+|++|.|-+.++.       .+++..|+|.+... +....++...|+.+..+. .+|.+|.+||....+
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~-------~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re  117 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHI-------QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE  117 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeec-------cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence            345666778999999999888876       68999999998755 334456677888776655 699999999987766


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      +.    .|+.||.| .-||..+-..  ..+..+++..+-+|+..++.||.|||++  ..++|||+||+||||+.+|++|+
T Consensus       118 gd----vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKi  190 (282)
T KOG0984|consen  118 GD----VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKI  190 (282)
T ss_pred             cc----EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEE
Confidence            54    59999988 5588776543  2345799999999999999999999998  59999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCccccccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTGRRSLERNR  298 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltg~~pf~~~~  298 (436)
                      ||||++-...   .+.-.+...|-..|||||.+..    ..|+.++||||||+++.||.+++.||....
T Consensus       191 CDFGIsG~L~---dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  191 CDFGISGYLV---DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             cccccceeeh---hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            9999985311   1111122457889999999843    378999999999999999999999998654

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.9e-33  Score=241.43  Aligned_cols=264  Identities=21%  Similarity=0.316  Sum_probs=197.7

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  155 (436)
                      ..++|++.+++|+|.|+.||.|...       .++..++||++++-   ..+.+.+|+.+|..|. ||||++++++..+.
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~-------~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp  105 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINI-------TNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDP  105 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhccccc-------CCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCc
Confidence            4579999999999999999999844       57788999999754   4467889999999997 99999999988765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC-CCceEEe
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-NFRPKLS  234 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~  234 (436)
                      ...  ...|++||+.+.+.....     +.++...+...+.+++.||.|+|+.   ||.|||+||.|++||. ...++|+
T Consensus       106 ~Sk--tpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlI  175 (338)
T KOG0668|consen  106 ESK--TPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLI  175 (338)
T ss_pred             ccc--CchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeee
Confidence            433  237999999887776654     3578889999999999999999999   9999999999999985 4569999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH----------
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ----------  303 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~----------  303 (436)
                      |+|+|.....   .......+-+..|..||++.. ..|+.+.|+|||||++..|+..+.||.......++          
T Consensus       176 DWGLAEFYHp---~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt  252 (338)
T KOG0668|consen  176 DWGLAEFYHP---GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGT  252 (338)
T ss_pred             ecchHhhcCC---CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhCh
Confidence            9999985322   222233345667889999865 56899999999999999999999999655444332          


Q ss_pred             -HHHHHHhhcccC-ccccccccCCccc--------CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          304 -RLLEWVQQYPAD-SKKFGLIMDPRLE--------KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       304 -~~~~~~~~~~~~-~~~~~~~~~~~l~--------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                       ++..++..+... +..+..++..-..        ..-..-.+++..+|+.+.|..|.++|||+.|.+.|
T Consensus       253 ~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  253 DELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence             222233322111 1112211111100        01111123567799999999999999999999876

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-34  Score=250.04  Aligned_cols=272  Identities=22%  Similarity=0.318  Sum_probs=201.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .+.+..+.||-|+||.||.++.       ..+++.||+|++..-  +....+.+.+|+++|..++|.|++..+++.....
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTD-------PRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph  125 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTD-------PRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPAN  125 (449)
T ss_pred             ccCCCCCcccccceeEEEeccC-------CCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCC
Confidence            4667788999999999999874       468899999988643  3445678899999999999999999988776443


Q ss_pred             Cc-ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          157 ER-GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       157 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      .. ...+|.++|.+ ..+|...|..-  ..++.+.+.-++.||++||.|||+.   +|.||||||.|+|++.|..+||||
T Consensus       126 ~dfFqEiYV~TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICD  199 (449)
T KOG0664|consen  126 PSFFQELYVLTELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICD  199 (449)
T ss_pred             chHHHHHHHHHHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecc
Confidence            22 12346788877 56888888553  4788899999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ||+++... .......+..+-|..|.|||++.|. .|+.+.||||.|||+.||+..+..|....+....+++.-+..-|.
T Consensus       200 FGLARvee-~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs  278 (449)
T KOG0664|consen  200 FGLARTWD-QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPS  278 (449)
T ss_pred             cccccccc-hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCc
Confidence            99998532 2223333445678899999999774 789999999999999999999999987776554443322221111


Q ss_pred             Cccc-------cccccC-----CcccC----cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          315 DSKK-------FGLIMD-----PRLEK----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       315 ~~~~-------~~~~~~-----~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                      ...+       -..++.     +.+..    .-+.....+...+...++..||++|.+..+.+.++
T Consensus       279 ~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  279 QEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            1000       000111     11110    01112234566888999999999999999988775

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.98  E-value=3.5e-33  Score=278.26  Aligned_cols=243  Identities=24%  Similarity=0.352  Sum_probs=179.5

Q ss_pred             cccccccCceE-EEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCCceeeeeEeeecCCccee
Q 013790           84 MLKIGEGGFGS-VYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVDGERGIQ  161 (436)
Q Consensus        84 ~~~ig~G~~g~-Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~  161 (436)
                      -+.+|.|+.|+ ||+|.+         +++.||||.+-..   ......+|+..|+..+ |||||++++.-  .+..  .
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y---------e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~q--F  577 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY---------EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQ--F  577 (903)
T ss_pred             HHHcccCCCCcEEEEEee---------CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeec--cCCc--e
Confidence            35688888764 889886         5789999998644   2345678999999885 99999996543  3322  5


Q ss_pred             EEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC---C--CceEEe
Q 013790          162 RLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---N--FRPKLS  234 (436)
Q Consensus       162 ~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~  234 (436)
                      +||+.|.| ..+|.+++...  ..........+.++.|++.||++||+.   +||||||||+||||+.   +  .+++|+
T Consensus       578 ~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iS  653 (903)
T KOG1027|consen  578 LYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKIS  653 (903)
T ss_pred             EEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEec
Confidence            69999999 67999999763  111112134578899999999999997   9999999999999975   3  568999


Q ss_pred             eccCCCCCCCCCC-cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchhhHHHHHHHhhc
Q 013790          235 DFGLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG-RRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       235 Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |||+++....... ........||.+|+|||++....-+.++|||||||++|+.++| .+||+..-... ..++      
T Consensus       654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl------  726 (903)
T KOG1027|consen  654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANIL------  726 (903)
T ss_pred             ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhh------
Confidence            9999997543322 2234567899999999999988888899999999999999995 89998542211 0110      


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                       .....+..     +   .+... ....+||.+|++.+|..||++.+|+.|
T Consensus       727 -~~~~~L~~-----L---~~~~d-~eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  727 -TGNYTLVH-----L---EPLPD-CEAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             -cCccceee-----e---ccCch-HHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence             00000000     0   01110 167799999999999999999999876

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=2.6e-33  Score=272.67  Aligned_cols=255  Identities=23%  Similarity=0.356  Sum_probs=209.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ..+|..+..+|.|+||.||+++.+       .++...|+|+++.....+..-+.+|+-+++.++||||+.++|.+.....
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~-------~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk   86 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDK-------RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK   86 (829)
T ss_pred             ccchhheeeecCCcccchhhhccc-------ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC
Confidence            468999999999999999999865       6789999999998877777788899999999999999999998876654


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          +|++||||.+|+|.+.-+..  .++++.++..+++..++||+|||+.   |-+|||||-.|||+++.|.+|++|||
T Consensus        87 ----lwicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfg  157 (829)
T KOG0576|consen   87 ----LWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFG  157 (829)
T ss_pred             ----cEEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccC
Confidence                49999999999999976544  4899999999999999999999999   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCccccccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      .+-..  ...-.+...+.||+.|||||+.   +.+.|...+|||++|+...|+---++|.....+.-...+..  .... 
T Consensus       158 vsaqi--tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT--kS~~-  232 (829)
T KOG0576|consen  158 VSAQI--TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT--KSGF-  232 (829)
T ss_pred             chhhh--hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh--ccCC-
Confidence            98653  2234456778999999999987   55778999999999999999999888877655543222211  1111 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +        .+.+.  -.......+.+|++.|+..+|.+||+++.++.+
T Consensus       233 q--------pp~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  233 Q--------PPTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             C--------CCccc--CCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence            1        11111  122234678899999999999999999988764

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-32  Score=245.12  Aligned_cols=267  Identities=23%  Similarity=0.311  Sum_probs=197.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ..+|.-++.+|.|.- .|--|-       +...+++||+|++...  +....++..+|...+..++|+||++++.++...
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~-------D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~   87 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAF-------DQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQ   87 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecc-------hhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcc
Confidence            357888889999988 554443       4467899999987544  233346778899999999999999999988754


Q ss_pred             CCc--ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          156 GER--GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       156 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ...  ....|+||||+ ..+|.+.+..    .++-.++..|+.|++.|+.|||+.   ||+||||||+||++..++.+||
T Consensus        88 ~~l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi  159 (369)
T KOG0665|consen   88 KTLEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKI  159 (369)
T ss_pred             ccHHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheee
Confidence            321  22458999999 6799999863    467789999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH-HH------
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LL------  306 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~------  306 (436)
                      .|||+|+..   +..-..+.++.|..|.|||++.+..+.+.+||||+||++.||++|...|.+....+... +.      
T Consensus       160 ~dfg~ar~e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtp  236 (369)
T KOG0665|consen  160 LDFGLARTE---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTP  236 (369)
T ss_pred             ccchhhccc---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCC
Confidence            999999852   22335566788999999999999889999999999999999999999997643321110 00      


Q ss_pred             ---------HHHhhcccCc-----ccccccc-CCcccC--cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          307 ---------EWVQQYPADS-----KKFGLIM-DPRLEK--EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       307 ---------~~~~~~~~~~-----~~~~~~~-~~~l~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                               .-...+....     ..+...+ +..+..  ..+......+.+|+.+||..||++|.|+.++|.|
T Consensus       237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                     0000000000     0011111 111100  0111224568899999999999999999999987

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-32  Score=260.22  Aligned_cols=199  Identities=27%  Similarity=0.399  Sum_probs=169.2

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhH--------HHHHHHHHHHhccC---CCCc
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH--------KQWVAEVQFLGVLE---HPNL  145 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~E~~~l~~l~---hpnI  145 (436)
                      ...+|..++.+|.|+||.|++|+++       .+...|+||.+.+...-..        -.+--|+.||..|+   |+||
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K-------~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI  631 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHK-------ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI  631 (772)
T ss_pred             ccccceeeeeccccccceEEEeeec-------ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence            3467999999999999999999987       4578899999876532211        12345999999998   9999


Q ss_pred             eeeeeEeeecCCcceeEEEEEEec-CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEE
Q 013790          146 VKLIGYCAVDGERGIQRLLVYEFM-LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL  224 (436)
Q Consensus       146 v~~~~~~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIl  224 (436)
                      ++++++|.+++..    ||+||-- ++-+|.++|...  +.+++..+..|+.|++.|+++||++   ||||||||-+||.
T Consensus       632 lKlLdfFEddd~y----yl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvi  702 (772)
T KOG1152|consen  632 LKLLDFFEDDDYY----YLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVI  702 (772)
T ss_pred             hhhhheeecCCee----EEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccccc---CceecccccccEE
Confidence            9999999877643    8999865 567899999654  5799999999999999999999999   9999999999999


Q ss_pred             EcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCC
Q 013790          225 LDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLE  295 (436)
Q Consensus       225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~  295 (436)
                      ++.+|.+||+|||.|..    -.......++||..|.|||++.|..| +..-|||+||++||.++....||.
T Consensus       703 vd~~g~~klidfgsaa~----~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  703 VDSNGFVKLIDFGSAAY----TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EecCCeEEEeeccchhh----hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999999999999853    23445567899999999999999877 466899999999999999988885

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=5.1e-30  Score=229.79  Aligned_cols=212  Identities=37%  Similarity=0.585  Sum_probs=179.8

Q ss_pred             ccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEEEE
Q 013790           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLV  165 (436)
Q Consensus        87 ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~lv  165 (436)
                      ||+|++|.||++...       .++..+++|++...... ..+.+.+|+..++.+.|++|+++++++....    ..+++
T Consensus         1 l~~g~~~~v~~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~~~   69 (215)
T cd00180           1 LGEGGFGTVYLARDK-------KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN----HLYLV   69 (215)
T ss_pred             CCcCCceEEEEEEec-------CCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC----eEEEE
Confidence            689999999999864       35788999999766432 3467889999999999999999999987653    45999


Q ss_pred             EEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC-CCceEEeeccCCCCCCC
Q 013790          166 YEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-NFRPKLSDFGLAREGPM  244 (436)
Q Consensus       166 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~  244 (436)
                      +||+.+++|.+++.... ..+++..+..++.+++.++.+||+.   +++|+||+|.||+++. ++.++|+|||.+.....
T Consensus        70 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~  145 (215)
T cd00180          70 MEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS  145 (215)
T ss_pred             EecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccC
Confidence            99999999999997642 3689999999999999999999998   9999999999999999 89999999999875322


Q ss_pred             CCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcccccccc
Q 013790          245 VGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM  323 (436)
Q Consensus       245 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (436)
                      ...  ......+...|++||.+... ..+.++|+|+||+++++|                                    
T Consensus       146 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------  187 (215)
T cd00180         146 DKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------  187 (215)
T ss_pred             Ccc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------
Confidence            111  23335578899999999776 788999999999999999                                    


Q ss_pred             CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       324 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                                   ..+.+++..|+..||.+||++.++++++
T Consensus       188 -------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                         2466899999999999999999998653

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=9.6e-32  Score=254.89  Aligned_cols=267  Identities=22%  Similarity=0.273  Sum_probs=199.3

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCC------CCceeeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH------PNLVKLIG  150 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~~~~  150 (436)
                      ..+.|.+....|+|-|++|.+|...       ..+..||||++.... ..++.=..|+++|++|+.      -|+++++-
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~-------~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQ-------ARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             hcceeEEEeccccceeeeeeecccc-------CCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            4578888899999999999999854       455689999997653 445666789999999963      37888888


Q ss_pred             EeeecCCcceeEEEEEEecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC
Q 013790          151 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  229 (436)
Q Consensus       151 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  229 (436)
                      .|...+    ++|||+|-+ ..+|.+.|..-+ .-.|....+..++.|+.-||..|-..   ||+|.||||+||||+++.
T Consensus       502 ~F~hkn----HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  502 HFKHKN----HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESK  573 (752)
T ss_pred             Hhhhcc----eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCc
Confidence            886654    469999977 679999987532 34688899999999999999999987   999999999999998755


Q ss_pred             -ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 013790          230 -RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  308 (436)
Q Consensus       230 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  308 (436)
                       .+||||||.|-...   .. ..+.+.-+..|.|||++.|.+|+...|+||.||+||||.||+..|.+.+......+..-
T Consensus       574 ~iLKLCDfGSA~~~~---en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me  649 (752)
T KOG0670|consen  574 NILKLCDFGSASFAS---EN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME  649 (752)
T ss_pred             ceeeeccCccccccc---cc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence             57999999986421   11 12223456689999999999999999999999999999999999988766544433211


Q ss_pred             Hh-hcccC--------------cccc-cc-------------c--cCC------cccC--cC---CHHHHHHHHHHHHHh
Q 013790          309 VQ-QYPAD--------------SKKF-GL-------------I--MDP------RLEK--EY---SINEARKIGRLADNC  346 (436)
Q Consensus       309 ~~-~~~~~--------------~~~~-~~-------------~--~~~------~l~~--~~---~~~~~~~l~~li~~c  346 (436)
                      +. .+|..              .-.| ..             +  +.|      .+..  .+   .......|.+|+..|
T Consensus       650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm  729 (752)
T KOG0670|consen  650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM  729 (752)
T ss_pred             hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence            11 11110              0000 00             0  000      0000  01   223356799999999


Q ss_pred             hcCCCCCCCCHHHHHHH
Q 013790          347 LSKSSKDRPKMSQVVER  363 (436)
Q Consensus       347 l~~dp~~RPs~~eil~~  363 (436)
                      |..||++|.|..+.|.|
T Consensus       730 l~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  730 LILDPEKRITVNQALKH  746 (752)
T ss_pred             hccChhhcCCHHHHhcC
Confidence            99999999999999876

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6e-31  Score=231.40  Aligned_cols=253  Identities=22%  Similarity=0.380  Sum_probs=186.4

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      ..+.|.+.+.||+|.||.+-++.++       .+++.+++|.+.... .....|.+|...--.| .|.||+.-|+.....
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr-------~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHR-------QSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeecc-------CCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            4568999999999999999999987       567889999987664 3557889998765555 489999888765543


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE--cCCCceEE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL--DENFRPKL  233 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl  233 (436)
                      ..   ..++++||++.|+|..-+...   .+.+.....++.|++.|+.|+|++   ++||||||.+||||  .+.-++||
T Consensus        94 ~d---~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKl  164 (378)
T KOG1345|consen   94 SD---AYVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKL  164 (378)
T ss_pred             Cc---eEEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEe
Confidence            32   347899999999999988553   588899999999999999999999   99999999999999  34457999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCccccccccc---C--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET---G--HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  308 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  308 (436)
                      ||||+++..     .........+..|.+||.+..   +  ...+.+|||.||+++|.++||+.||+... ..+....+|
T Consensus       165 cDFG~t~k~-----g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~  238 (378)
T KOG1345|consen  165 CDFGLTRKV-----GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEW  238 (378)
T ss_pred             eeccccccc-----CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHH
Confidence            999998742     112222335668999998733   2  34678999999999999999999998432 223333333


Q ss_pred             HhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 013790          309 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV  361 (436)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil  361 (436)
                      .+-......        .++..+. ..+..+.++.++-|..++++|=-..++.
T Consensus       239 ~~w~~rk~~--------~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  239 EQWLKRKNP--------ALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             HHHhcccCc--------cCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHH
Confidence            332222111        1111111 1135667888999999999994444433

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=5.5e-29  Score=226.36  Aligned_cols=200  Identities=33%  Similarity=0.456  Sum_probs=169.8

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecCCcc
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  159 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  159 (436)
                      |.+.+.||.|++|.||++...       .++..+++|.+...... ..+.+.+|+..++.++|+|++++++++....   
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~---   70 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDK-------GTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE---   70 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEc-------CCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC---
Confidence            566788999999999999875       35688999999876554 5678899999999999999999999887654   


Q ss_pred             eeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCC
Q 013790          160 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  239 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  239 (436)
                       ..++++||+.+++|.+++..... .+++..+..++.+++.++.+||+.   +++|+||+|.||+++.++.++|+|||++
T Consensus        71 -~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~  145 (225)
T smart00221       71 -PLYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLA  145 (225)
T ss_pred             -ceEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCcee
Confidence             34899999999999999976532 288999999999999999999998   9999999999999999999999999998


Q ss_pred             CCCCCCCCcccccccccCCCccccccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 013790          240 REGPMVGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLER  296 (436)
Q Consensus       240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~pf~~  296 (436)
                      ....... ........++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       146 ~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      146 RFIHRDL-AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eEecCcc-cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            7532221 0122345678889999998 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=5.8e-30  Score=238.38  Aligned_cols=273  Identities=25%  Similarity=0.363  Sum_probs=199.0

Q ss_pred             HHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCCceeeeeE
Q 013790           73 EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNLVKLIGY  151 (436)
Q Consensus        73 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~  151 (436)
                      .+....+.|..+++||+|+|+.||++.+...    ......||+|.+.....  ...+.+|+++|..+. +.||+++.++
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~----~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~  103 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQ----DTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGC  103 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhh----ccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhh
Confidence            3445567899999999999999999987631    23678899999976643  347889999999886 9999999998


Q ss_pred             eeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc-CCCc
Q 013790          152 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFR  230 (436)
Q Consensus       152 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~  230 (436)
                      +...+    +.++|+||++.....++..     .++...+..+++.+..||.++|.+   |||||||||+|+|.+ ..+.
T Consensus       104 ~rnnd----~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~r  171 (418)
T KOG1167|consen  104 FRNND----QVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQR  171 (418)
T ss_pred             hccCC----eeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCC
Confidence            86654    5699999999999988874     367888999999999999999999   999999999999997 4677


Q ss_pred             eEEeeccCCCCC-----------------CC-CCC------------------------cccccccccCCCccccccccc
Q 013790          231 PKLSDFGLAREG-----------------PM-VGH------------------------THVSTAVVGTFGYAAPDYIET  268 (436)
Q Consensus       231 ~kl~Dfg~a~~~-----------------~~-~~~------------------------~~~~~~~~gt~~y~aPE~~~~  268 (436)
                      -.|+|||+|...                 .. .+.                        ........||++|.|||++..
T Consensus       172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k  251 (418)
T KOG1167|consen  172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR  251 (418)
T ss_pred             ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence            899999998610                 00 000                        000123469999999999854


Q ss_pred             -CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH--HHH--------HHHhhcccC------cc---------ccccc
Q 013790          269 -GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ--RLL--------EWVQQYPAD------SK---------KFGLI  322 (436)
Q Consensus       269 -~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~--~~~--------~~~~~~~~~------~~---------~~~~~  322 (436)
                       ...++++||||.|||++.++++..||.......+.  ++.        ......+..      ..         .+..+
T Consensus       252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~  331 (418)
T KOG1167|consen  252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL  331 (418)
T ss_pred             ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence             56789999999999999999999999765443221  110        001111110      00         00111


Q ss_pred             ----cCC--c--ccC-cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          323 ----MDP--R--LEK-EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       323 ----~~~--~--l~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                          +.+  .  +.. ......+..+.+|+.+|+..||.+|.|+++.|.|
T Consensus       332 ~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  332 HIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                000  0  011 1112224578899999999999999999999886

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=6.6e-29  Score=266.25  Aligned_cols=201  Identities=17%  Similarity=0.206  Sum_probs=140.1

Q ss_pred             ccCC-CCceeeeeEeeecC---CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 013790          139 VLEH-PNLVKLIGYCAVDG---ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVI  214 (436)
Q Consensus       139 ~l~h-pnIv~~~~~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~iv  214 (436)
                      .++| +||++++++|....   .....+++++||+ +++|.++|.... ..+++..++.++.||+.||.|||++   ||+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQ---GIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            4455 58888888773322   1112356778877 779999996543 4699999999999999999999998   999


Q ss_pred             eccCCCCcEEEcCC-------------------CceEEeeccCCCCCCCCCC--------------cccccccccCCCcc
Q 013790          215 YRDFKASNVLLDEN-------------------FRPKLSDFGLAREGPMVGH--------------THVSTAVVGTFGYA  261 (436)
Q Consensus       215 H~Dlkp~NIll~~~-------------------~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~  261 (436)
                      ||||||+||||+..                   +.+||+|||+++.......              ........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            99999999999654                   4455666666543110000              00011245788999


Q ss_pred             cccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHH
Q 013790          262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGR  341 (436)
Q Consensus       262 aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~  341 (436)
                      |||++.+..++.++|||||||+||||++|..|+.....    .+.......          ..+..     .........
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~~----------~~~~~-----~~~~~~~~~  243 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHRV----------LPPQI-----LLNWPKEAS  243 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHhh----------cChhh-----hhcCHHHHH
Confidence            99999999999999999999999999999888753211    011110000          01100     111234568


Q ss_pred             HHHHhhcCCCCCCCCHHHHHHH
Q 013790          342 LADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       342 li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ++.+||..||.+||++.+|+++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhhc
Confidence            8899999999999999999886

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.8e-27  Score=208.78  Aligned_cols=169  Identities=23%  Similarity=0.261  Sum_probs=128.0

Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccc
Q 013790          172 RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS  251 (436)
Q Consensus       172 gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  251 (436)
                      |+|.+++..+. .++++..++.|+.|++.||.|||+.   +      ||+|||++.++.+|+  ||++.....       
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~-------   61 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTP-------   61 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecc-------
Confidence            68999997543 4699999999999999999999998   5      999999999999999  999875321       


Q ss_pred             cccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcC
Q 013790          252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEY  331 (436)
Q Consensus       252 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  331 (436)
                      ....||+.|||||++.+..++.++|||||||++|||+||..||........ .+............        . ....
T Consensus        62 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~--------~-~~~~  131 (176)
T smart00750       62 EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMPADDP--------R-DRSN  131 (176)
T ss_pred             ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhccCCc--------c-cccc
Confidence            122589999999999999999999999999999999999999975432211 11111111111000        0 0001


Q ss_pred             CHHHHH--HHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          332 SINEAR--KIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       332 ~~~~~~--~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                      ......  .+.++|.+||..||.+||++.++++++..+..
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            112222  68999999999999999999999999876643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-25  Score=214.84  Aligned_cols=265  Identities=24%  Similarity=0.237  Sum_probs=197.9

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCC----CCceeeeeEeeec
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH----PNLVKLIGYCAVD  155 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~~~~~~~~~  155 (436)
                      +|.+.+.||+|+||.||.+.....      ....+|+|............+..|..++..+..    +++..+++.... 
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~------~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~-   91 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSE------KNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRS-   91 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCC------CCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccC-
Confidence            899999999999999999986511      146789998876533332356778888888863    588888877741 


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC-----Cc
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-----FR  230 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~  230 (436)
                        .....|+||+.+ |.+|.++......+.++..+++.|+.|++.+|.+||+.   |++||||||+|+++...     ..
T Consensus        92 --~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~  165 (322)
T KOG1164|consen   92 --TEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRT  165 (322)
T ss_pred             --CCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccce
Confidence              122459999977 99999988665556899999999999999999999998   99999999999999765     46


Q ss_pred             eEEeeccCCCCCCC--CCC---cc--c-ccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 013790          231 PKLSDFGLAREGPM--VGH---TH--V-STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE  302 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~--~~~---~~--~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  302 (436)
                      +.|.|||+++....  ...   ..  . .....||..|+++....+...+.+.|+||++.++.+++.|..||........
T Consensus       166 ~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~  245 (322)
T KOG1164|consen  166 LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL  245 (322)
T ss_pred             EEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence            99999999983221  111   11  1 2345699999999999999999999999999999999999999976554322


Q ss_pred             HH-HHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          303 QR-LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       303 ~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                      .. +........         ...     .....+..+.++...+-..+..++|....+...|.......
T Consensus       246 ~~~~~~~~~~~~---------~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  246 KSKFEKDPRKLL---------TDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             HHHHHHHhhhhc---------ccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            11 111110000         000     11222456667777777799999999999999998887654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-25  Score=202.32  Aligned_cols=268  Identities=20%  Similarity=0.228  Sum_probs=208.2

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCCceeeeeEeeecCCc
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVDGER  158 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~  158 (436)
                      .|.++++||+|+||..+.|+       +.-++++||||.-...+  ...++..|....+.|. .++|...|-+-.    .
T Consensus        29 hyrVGkKIGeGsFG~lf~G~-------Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGq----e   95 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGK-------NLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQ----E   95 (449)
T ss_pred             cceeccccccCcceeeeccc-------ccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeecc----c
Confidence            79999999999999999987       44789999999876543  3457888998888886 788888765433    3


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC-----CceEE
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-----FRPKL  233 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl  233 (436)
                      +.+-.||+|.+ |.+|+|+..-.. +.++..+++.+|.|++.-++|+|++   .+|.|||||+|+||...     ..+.|
T Consensus        96 G~~NiLVidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ihi  170 (449)
T KOG1165|consen   96 GKYNILVIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHI  170 (449)
T ss_pred             cchhhhhhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEE
Confidence            44458999987 899999875443 5799999999999999999999999   99999999999999643     34899


Q ss_pred             eeccCCCCCCCCCC-----cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 013790          234 SDFGLAREGPMVGH-----THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  308 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  308 (436)
                      +|||+|+.......     .....+..||..||+-....|...+...|+-|||-++++.+-|..||.+....+...-.+.
T Consensus       171 iDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK  250 (449)
T KOG1165|consen  171 IDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK  250 (449)
T ss_pred             EeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH
Confidence            99999986433222     1223456899999999999999999999999999999999999999999877665544443


Q ss_pred             HhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcCCCC
Q 013790          309 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGD  375 (436)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~~~  375 (436)
                      +..-....          .........|.++...+.-.-..+-.+-|...-+...+.+++......+
T Consensus       251 IGe~Kr~T----------~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~  307 (449)
T KOG1165|consen  251 IGETKRST----------PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETD  307 (449)
T ss_pred             hccccccC----------CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcc
Confidence            32211110          0012223346778888888888899999999988888888876655433

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=7.8e-27  Score=205.61  Aligned_cols=251  Identities=19%  Similarity=0.351  Sum_probs=195.3

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++.++.+|.+...|..|+|+|.         +..++.|+++....  .....|..|.-.|+-+.||||+.++|.|....
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwq---------gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp  260 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQ---------GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP  260 (448)
T ss_pred             hhhhhhhhhccCCCccccccccc---------CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence            34556678899999999999986         33366777764432  23467899999999999999999999998765


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe--
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS--  234 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--  234 (436)
                      .    +.++..|++.|+|+..++....-..+..++.+++.++++|++|||+. .+-|.---|.+..++||++.+.+|.  
T Consensus       261 n----lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarisma  335 (448)
T KOG0195|consen  261 N----LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMA  335 (448)
T ss_pred             C----ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecc
Confidence            4    48999999999999999887766677789999999999999999996 3344455789999999999888764  


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLT---AKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      |--++.         ........+.||+||.+...+-+   .++|+|||++++|||.|...||....+.+..-.      
T Consensus       336 d~kfsf---------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk------  400 (448)
T KOG0195|consen  336 DTKFSF---------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK------  400 (448)
T ss_pred             cceeee---------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh------
Confidence            222221         11223357899999999776544   479999999999999999999998776543211      


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                                +-...++..+++..+..+.+|+.-|+..||.+||.+..|+-.|+++.
T Consensus       401 ----------ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  401 ----------IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ----------hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                      11223444566667788899999999999999999999999988764

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.1e-25  Score=216.18  Aligned_cols=171  Identities=17%  Similarity=0.126  Sum_probs=129.7

Q ss_pred             HHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-----cchhHHHHHHHHHHHhccCCCCcee
Q 013790           73 EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQGHKQWVAEVQFLGVLEHPNLVK  147 (436)
Q Consensus        73 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~  147 (436)
                      .+....++|.+.+.||+|+||+||+|.++.      .+++.||||++...     .......+.+|+++|+.++|+||+.
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~------~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~   85 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAG------DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVP   85 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcC------CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCc
Confidence            345567899999999999999999998751      24667899986532     1123456899999999999999985


Q ss_pred             eeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccC-CCCcEEEc
Q 013790          148 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDF-KASNVLLD  226 (436)
Q Consensus       148 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dl-kp~NIll~  226 (436)
                      .+..+   +    ..++||||++|++|... .     ...   ...++.|++.||.|||+.   ||+|||| ||+|||++
T Consensus        86 ~l~~~---~----~~~LVmE~~~G~~L~~~-~-----~~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~  146 (365)
T PRK09188         86 QLLAT---G----KDGLVRGWTEGVPLHLA-R-----PHG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMG  146 (365)
T ss_pred             EEEEc---C----CcEEEEEccCCCCHHHh-C-----ccc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEc
Confidence            33221   2    24999999999999732 1     111   146789999999999998   9999999 99999999


Q ss_pred             CCCceEEeeccCCCCCCCCCCccc------ccccccCCCccccccccc
Q 013790          227 ENFRPKLSDFGLAREGPMVGHTHV------STAVVGTFGYAAPDYIET  268 (436)
Q Consensus       227 ~~~~~kl~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  268 (436)
                      .++.+||+|||+|+.....+....      .....++..|+|||.+..
T Consensus       147 ~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        147 PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            999999999999985432221111      134567888999999854

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=2.1e-25  Score=193.50  Aligned_cols=272  Identities=20%  Similarity=0.238  Sum_probs=209.3

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCC-CCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH-PNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~  155 (436)
                      ..+.|.++++||.|+||.+|.|...       .++..||||+-...  ..+.++..|..+.+.|++ ..|..+..+..+.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i-------~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~   83 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISI-------TSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEK   83 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeec-------cCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence            4578999999999999999999854       67899999987544  244578889999999974 5666666555554


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC---CCceE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPK  232 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~k  232 (436)
                      ...    .+||+.+ |.+|+++..-.. +.++..+++-++-|++.-++|+|.+   +++||||||+|+|..-   ...+.
T Consensus        84 ~yn----vlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~  154 (341)
T KOG1163|consen   84 DYN----VLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLY  154 (341)
T ss_pred             ccc----eeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEE
Confidence            433    8999987 999999875443 4689999999999999999999999   9999999999999964   44589


Q ss_pred             EeeccCCCCCCCCCC-----cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 013790          233 LSDFGLAREGPMVGH-----THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  307 (436)
                      ++|||+|+.......     ........||..|.+--...+...+...|+-|+|.+|.++.-|..||++..+.+...-.+
T Consensus       155 LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE  234 (341)
T KOG1163|consen  155 LIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE  234 (341)
T ss_pred             EEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence            999999986432221     223346789999999988888888999999999999999999999999988776655554


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcCCCCC
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS  376 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~~~~  376 (436)
                      .+........          ........|.++.-.+.-|-..--++-|...-+.+.+.-++...+...+
T Consensus       235 kI~EkK~s~~----------ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d  293 (341)
T KOG1163|consen  235 KISEKKMSTP----------IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYD  293 (341)
T ss_pred             HHHHhhcCCC----------HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCC
Confidence            4433222110          0111223357788899999999999999998888877766655554433

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=6.5e-23  Score=196.14  Aligned_cols=260  Identities=33%  Similarity=0.500  Sum_probs=195.9

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhccCCC-CceeeeeEeeecC
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLEHP-NLVKLIGYCAVDG  156 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~  156 (436)
                      |.....||.|+||.||++...          ..+++|.+......   ....+.+|+.++..+.|+ +|+++++++....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~----------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   71 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR----------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG   71 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec----------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC
Confidence            677889999999999999853          67899988765433   356789999999999988 7999999884433


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC-ceEEe
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAF-PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-RPKLS  234 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~  234 (436)
                      .    .+++++|+.++++.+++..... ..+.......++.|++.++.|+|..   +++||||||+||+++..+ .++++
T Consensus        72 ~----~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~  144 (384)
T COG0515          72 S----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLI  144 (384)
T ss_pred             E----EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEe
Confidence            2    5899999999999977755432 2688999999999999999999998   999999999999999988 79999


Q ss_pred             eccCCCCCCCCCCc----ccccccccCCCccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-hhHHHH
Q 013790          235 DFGLAREGPMVGHT----HVSTAVVGTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK-TEQRLL  306 (436)
Q Consensus       235 Dfg~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-~~~~~~  306 (436)
                      |||+++........    .......|+..|++||.+.+   ..++...|+||+|++++++++|..||...... ......
T Consensus       145 dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~  224 (384)
T COG0515         145 DFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL  224 (384)
T ss_pred             ccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHH
Confidence            99998743222211    13466789999999999987   57889999999999999999999997765431 011122


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..+......      .................+.+++..|+..+|..|.+.......
T Consensus       225 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         225 KIILELPTP------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHhcCCc------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            222221111      000000000002223568899999999999999999887765

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=2.8e-25  Score=227.06  Aligned_cols=260  Identities=19%  Similarity=0.239  Sum_probs=183.5

Q ss_pred             cccccccccCceEEEEEEecCCCCCCCCcceEEEEEEe-ccCcchh-HHHHHHHHHHHhccCCCCceeeeeEeeecCCcc
Q 013790           82 SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-NRDGLQG-HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  159 (436)
Q Consensus        82 ~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~-~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  159 (436)
                      .....+|.|.+|.|+.+.......  ..-...+++| . ....... ...+..|+.+-..+.|||++..+..+...... 
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~--~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~-  396 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLK--SFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI-  396 (601)
T ss_pred             CccceeeecccCceEEEEecCCCc--cchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc-
Confidence            345678999999777766542110  0111222222 1 1111111 12256688888899999998877766554333 


Q ss_pred             eeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCC
Q 013790          160 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  239 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  239 (436)
                         ...||||++ +|..++...  ..+....+-.++.|++.|+.|||+.   ||.|||||++|+++..+|.+||+|||.+
T Consensus       397 ---~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~  467 (601)
T KOG0590|consen  397 ---LQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAA  467 (601)
T ss_pred             ---hhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcc
Confidence               344999999 999999765  2578888999999999999999999   9999999999999999999999999998


Q ss_pred             CCCCCCCCc--ccccccccCCCcccccccccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          240 REGPMVGHT--HVSTAVVGTFGYAAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       240 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      ..+......  ......+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||........... .  ..+..  
T Consensus       468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-~--~~~~~--  542 (601)
T KOG0590|consen  468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-T--NNYSD--  542 (601)
T ss_pred             eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-h--hcccc--
Confidence            754433333  5566788999999999999999986 58999999999999999999976543322110 0  00000  


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                       .......   ........+...+.+|.+||+.||.+|.|+.+|++.
T Consensus       543 -~~~~~~~---~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  543 -QRNIFEG---PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             -ccccccC---hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence             0000000   011223445678899999999999999999999763

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.91  E-value=1.4e-24  Score=212.25  Aligned_cols=273  Identities=26%  Similarity=0.379  Sum_probs=196.9

Q ss_pred             HhccCCCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCce-ee
Q 013790          137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQV-IY  215 (436)
Q Consensus       137 l~~l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~i-vH  215 (436)
                      |+.+.|.|+.+++|.+...+    ..+.|.+||..|+|.+.+.... ..+++.....++++++.||.|||+.   .| .|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~----~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGP----EMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNS---PIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecCC----ceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcC---cceee
Confidence            46789999999999998774    3589999999999999998744 4688999999999999999999997   44 99


Q ss_pred             ccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccC-------CCCchhhHHHHHHHHHHHH
Q 013790          216 RDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-------HLTAKSDVWSFGVVLYEML  288 (436)
Q Consensus       216 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ell  288 (436)
                      +.+++.|+++|..+.+||+|||+.................-...|.|||.+++.       ..+.+.||||||++++|++
T Consensus        73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~  152 (484)
T KOG1023|consen   73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL  152 (484)
T ss_pred             eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence            999999999999999999999998653211111111222245689999999763       1466799999999999999


Q ss_pred             hCCCCCCCCCchhh-HHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          289 TGRRSLERNRPKTE-QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       289 tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                      +...||........ .+++..+.....      ..+.|.+....  ..+..+..++..||..+|.+||++.+|-..++.+
T Consensus       153 ~r~~~~~~~~~~~~~~eii~~~~~~~~------~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  153 FRSGPFDLRNLVEDPDEIILRVKKGGS------NPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             hccCccccccccCChHHHHHHHHhcCC------CCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            99999976433222 344444433111      11222222111  3334788999999999999999999999999888


Q ss_pred             hhhc----CCCCCCcchhhhhcc--CCchhhhhhhccCCc-------hHHHHHHHHHHHhccccccccchh
Q 013790          368 VQVS----NEGDSFDKTFEEICE--EDPVEAQTKQKQHEP-------SEAWKRRMAHLAKLGEHVEGASRR  425 (436)
Q Consensus       368 ~~~~----~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~  425 (436)
                      ....    +..+.+...++.+..  +..+..++.....+.       .+..+...+..++.|..++|+.+.
T Consensus       225 ~~~~~~~~nl~D~m~~~le~Y~~nLe~~v~eRt~~l~~e~~k~d~LL~~mLP~~VA~~lk~G~~v~pe~~~  295 (484)
T KOG1023|consen  225 NKGGSSKGNLMDSLFRMLESYADNLEKLVDERTAELEEEKKKTDTLLGQMLPKSVAESLKLGKTVDPESFD  295 (484)
T ss_pred             cccccccchhHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHhhHhhcCCcCCccccC
Confidence            7643    334445555566643  555555555554444       344556677777888888887653

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=3.1e-23  Score=185.78  Aligned_cols=176  Identities=10%  Similarity=0.077  Sum_probs=132.8

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHH---------HHHHHHHHhccCCCCcee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ---------WVAEVQFLGVLEHPNLVK  147 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~hpnIv~  147 (436)
                      ..++|..++.||.|+||.||++..         ++..+|+|.+..........         +.+|+..+.++.||+|..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~---------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~   99 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT---------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS   99 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec---------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence            468999999999999999998542         24569999997554333222         678999999999999999


Q ss_pred             eeeEeeecCCc----ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcE
Q 013790          148 LIGYCAVDGER----GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  223 (436)
Q Consensus       148 ~~~~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NI  223 (436)
                      +.+++......    ....+++|||++|.+|.++.      .++.    ....+++.+|..||..   |++||||||+||
T Consensus       100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Ni  166 (232)
T PRK10359        100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNF  166 (232)
T ss_pred             ceEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHE
Confidence            98886643211    12458999999999998874      2332    3466999999999998   999999999999


Q ss_pred             EEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh
Q 013790          224 LLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT  289 (436)
Q Consensus       224 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt  289 (436)
                      +++.+| ++|+|||.......  ....            ..+.....|+.++|+||||+++..+..
T Consensus       167 li~~~g-i~liDfg~~~~~~e--~~a~------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTAQ--RKAK------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEeCCC-EEEEECCCcccccc--hhhH------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            999988 99999998864210  0000            013334456678999999999876653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=1.5e-22  Score=186.62  Aligned_cols=237  Identities=21%  Similarity=0.310  Sum_probs=151.8

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCC----------CCce
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEH----------PNLV  146 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------pnIv  146 (436)
                      .+.....||.|+|+.||.+++.       .+++.+|+|++....   ....+.+.+|.-....+.+          -.++
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~-------~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l   85 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDV-------ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFL   85 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEET-------TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B-
T ss_pred             EEEEccccccCCceEEEEEEEc-------cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEE
Confidence            4566788999999999999965       688999999875432   2234666766655444322          1222


Q ss_pred             eeeeEeeecC----------Ccce---eEEEEEEecCCCCHHHHhh---cCC--CCCCCHHHHHHHHHHHHHHHHHhhcC
Q 013790          147 KLIGYCAVDG----------ERGI---QRLLVYEFMLNRSLEDHLF---NRA--FPPLPWKTRLHIILGAAEGLAYLHEG  208 (436)
Q Consensus       147 ~~~~~~~~~~----------~~~~---~~~lv~e~~~~gsL~~~l~---~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~  208 (436)
                      -.++.....+          ....   ..+++|+-+ .++|.+++.   ...  ...+....++.+..|+++.+++||+.
T Consensus        86 ~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~  164 (288)
T PF14531_consen   86 VPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY  164 (288)
T ss_dssp             --SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             eeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc
Confidence            2222222111          0001   236788877 668888753   221  12344556677889999999999999


Q ss_pred             CCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCccccccccc--------CCCCchhhHHHH
Q 013790          209 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET--------GHLTAKSDVWSF  280 (436)
Q Consensus       209 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSl  280 (436)
                         |++|+||+|+|+|++.+|.+.|+||+....   .+.....  ...+..|.|||....        -.++.+.|.|+|
T Consensus       165 ---GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r---~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~L  236 (288)
T PF14531_consen  165 ---GLVHGDIKPENFLLDQDGGVFLGDFSSLVR---AGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQL  236 (288)
T ss_dssp             ---TEEEST-SGGGEEE-TTS-EEE--GGGEEE---TTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHH
T ss_pred             ---ceEecccceeeEEEcCCCCEEEcChHHHee---cCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHH
Confidence               999999999999999999999999998764   2222111  345578999998743        257889999999


Q ss_pred             HHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCC
Q 013790          281 GVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR  354 (436)
Q Consensus       281 Gvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~R  354 (436)
                      |+++|.|++|..||+...+......                    .+ ..+. +.++.++.||..+|+.||.+|
T Consensus       237 G~~ly~lWC~~lPf~~~~~~~~~~~--------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  237 GITLYSLWCGRLPFGLSSPEADPEW--------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHSS-STCCCGGGSTSGG--------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHHccCCCCCCCccccccc--------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999999999986543221100                    11 1334 778899999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1e-22  Score=180.10  Aligned_cols=138  Identities=17%  Similarity=0.137  Sum_probs=106.4

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--h-------H-----------------HHHHHHHHHH
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--G-------H-----------------KQWVAEVQFL  137 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l  137 (436)
                      ...||+|+||.||+|...        +++.||||+++.....  .       .                 .....|+.++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~--------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   73 (190)
T cd05147           2 NGCISTGKEANVYHATTA--------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNL   73 (190)
T ss_pred             CCccccccceEEEEEECC--------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHH
Confidence            467999999999999853        5789999998754221  1       0                 1223499999


Q ss_pred             hccCCCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCceeec
Q 013790          138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL-HEGLEVQVIYR  216 (436)
Q Consensus       138 ~~l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~L-H~~~~~~ivH~  216 (436)
                      ..+.++++.....+...  .    .++||||++++++...+...  .+++...+..++.|++.+|.|| |+.   ||+||
T Consensus        74 ~~l~~~~v~~p~~~~~~--~----~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHr  142 (190)
T cd05147          74 KRLVTAGIPCPEPILLK--S----HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDC---RLVHA  142 (190)
T ss_pred             HHHHHCCCCCCcEEEec--C----CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence            99988776443322211  1    28999999988776554322  3688999999999999999999 687   99999


Q ss_pred             cCCCCcEEEcCCCceEEeeccCCCC
Q 013790          217 DFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       217 Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      ||||+|||++ ++.++|+|||+|..
T Consensus       143 DlkP~NIli~-~~~v~LiDFG~a~~  166 (190)
T cd05147         143 DLSEYNLLYH-DGKLYIIDVSQSVE  166 (190)
T ss_pred             CCCHHHEEEE-CCcEEEEEcccccc
Confidence            9999999998 57899999999963

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=9.7e-23  Score=209.04  Aligned_cols=247  Identities=19%  Similarity=0.264  Sum_probs=175.1

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-ch---hHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQ---GHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      +|...+.||.+.|=+|.+|.++        +|. |+||++-+.. ..   ...+-..|++ ...++|||.+++..+...+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~--------eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~   93 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR--------EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD   93 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC--------Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh
Confidence            6777889999999999999865        444 8889886553 22   2344444555 5667899999987664433


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      ..    .|+|-+|. .-+|+|.|..+.  -+...+...|+.||+.||..+|..   ||+|||||.+||||+.-..+.|+|
T Consensus        94 kA----AylvRqyv-khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtD  163 (1431)
T KOG1240|consen   94 KA----AYLVRQYV-KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTD  163 (1431)
T ss_pred             HH----HHHHHHHH-hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhc
Confidence            32    27787887 569999996653  577788889999999999999999   999999999999999999999999


Q ss_pred             ccCCCCCCCCC-Ccc----cccccccCCCcccccccccC-----------CCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 013790          236 FGLAREGPMVG-HTH----VSTAVVGTFGYAAPDYIETG-----------HLTAKSDVWSFGVVLYEMLT-GRRSLERNR  298 (436)
Q Consensus       236 fg~a~~~~~~~-~~~----~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvil~ellt-g~~pf~~~~  298 (436)
                      |..-+...... +..    ...+...-..|.|||.+...           ..+++-||||+||++.||++ |++||.-  
T Consensus       164 FAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L--  241 (1431)
T KOG1240|consen  164 FASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL--  241 (1431)
T ss_pred             ccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--
Confidence            98765321111 111    11222334589999987331           25778999999999999999 7888852  


Q ss_pred             chhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                          ..+..+-.....+..    ..-..+.       ...++.||..|++.||.+|.++++.|+.
T Consensus       242 ----SQL~aYr~~~~~~~e----~~Le~Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  242 ----SQLLAYRSGNADDPE----QLLEKIE-------DVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ----HHHHhHhccCccCHH----HHHHhCc-------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence                122222111111110    1111111       1257899999999999999999999986

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=1.5e-21  Score=173.20  Aligned_cols=138  Identities=18%  Similarity=0.139  Sum_probs=108.1

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh--------------------------HHHHHHHHHHH
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG--------------------------HKQWVAEVQFL  137 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l  137 (436)
                      ...||+|+||.||+|...        +++.||||+++......                          ...+..|...+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~--------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   73 (190)
T cd05145           2 NGCISTGKEANVYHARTG--------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNL   73 (190)
T ss_pred             CceeecCCCcEEEEEEcC--------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHH
Confidence            568999999999999853        57899999987642110                          12245789999


Q ss_pred             hccCCCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeec
Q 013790          138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYR  216 (436)
Q Consensus       138 ~~l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~  216 (436)
                      .++.|++|.....+....      .++||||++|+++.......  ..++...+..++.|++.++.+||+ .   ||+||
T Consensus        74 ~~l~~~~i~~p~~~~~~~------~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---givHr  142 (190)
T cd05145          74 KRLYEAGVPVPEPILLKK------NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHG  142 (190)
T ss_pred             HHHHhCCCCCceEEEecC------CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecC
Confidence            999999875444333221      28999999888654432222  357788999999999999999999 8   99999


Q ss_pred             cCCCCcEEEcCCCceEEeeccCCCC
Q 013790          217 DFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       217 Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      ||||+|||++ ++.++|+|||++..
T Consensus       143 DlkP~NIll~-~~~~~liDFG~a~~  166 (190)
T cd05145         143 DLSEYNILYH-DGKPYIIDVSQAVE  166 (190)
T ss_pred             CCChhhEEEE-CCCEEEEEccccee
Confidence            9999999999 89999999999975

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=7.1e-21  Score=170.01  Aligned_cols=141  Identities=18%  Similarity=0.242  Sum_probs=109.0

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-----CCCCceeeeeEeeec
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-----EHPNLVKLIGYCAVD  155 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~  155 (436)
                      +.....||+|+||.||.  +.       .++.. +||++........+.+.+|+.+++.+     .||||++++|++..+
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp-------~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~   73 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HP-------EDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD   73 (210)
T ss_pred             cCCcceecCCCceEEEE--CC-------CCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC
Confidence            34457899999999995  32       23333 69988765444567899999999999     579999999999876


Q ss_pred             CCcceeEEEEEEe--cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCceeeccCCCCcEEEcC----C
Q 013790          156 GERGIQRLLVYEF--MLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL-AYLHEGLEVQVIYRDFKASNVLLDE----N  228 (436)
Q Consensus       156 ~~~~~~~~lv~e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l-~~LH~~~~~~ivH~Dlkp~NIll~~----~  228 (436)
                      ...+....+|+||  +.+++|.+++.+.   .+++.  ..++.+++.++ .|||++   +|+||||||+|||++.    +
T Consensus        74 ~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~  145 (210)
T PRK10345         74 CGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESE  145 (210)
T ss_pred             CCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCC
Confidence            5433334589999  5579999999653   35555  35677888777 999999   9999999999999974    3


Q ss_pred             CceEEeeccCC
Q 013790          229 FRPKLSDFGLA  239 (436)
Q Consensus       229 ~~~kl~Dfg~a  239 (436)
                      +.++|+||+.+
T Consensus       146 ~~~~LiDg~G~  156 (210)
T PRK10345        146 VIPVVCDNIGE  156 (210)
T ss_pred             CcEEEEECCCC
Confidence            47999996544

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=3.3e-21  Score=178.49  Aligned_cols=202  Identities=20%  Similarity=0.261  Sum_probs=142.5

Q ss_pred             CCCCceeeeeEeeecC-----------------------CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 013790          141 EHPNLVKLIGYCAVDG-----------------------ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG  197 (436)
Q Consensus       141 ~hpnIv~~~~~~~~~~-----------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q  197 (436)
                      .|||||++.++|.+.-                       ..+..+|+||.-+ ..+|.+++-.+.   .+.....-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence            5999999998775421                       1335678999887 569999996553   566777889999


Q ss_pred             HHHHHHHhhcCCCCceeeccCCCCcEEE--cCCC--ceEEeeccCCCCCCCCCC----cccccccccCCCcccccccccC
Q 013790          198 AAEGLAYLHEGLEVQVIYRDFKASNVLL--DENF--RPKLSDFGLAREGPMVGH----THVSTAVVGTFGYAAPDYIETG  269 (436)
Q Consensus       198 l~~~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~  269 (436)
                      +++|+.|||.+   ||.|||+|++||||  |+++  .+.|+|||.+--....+-    ....-..-|...-||||+....
T Consensus       350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            99999999999   99999999999999  3333  478999998742111111    1111223577789999998543


Q ss_pred             CC------CchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHH
Q 013790          270 HL------TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLA  343 (436)
Q Consensus       270 ~~------~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li  343 (436)
                      +-      -.++|.|+.|.+.||+++...||......... .    ..+       .+-..|    ..+..++..+++|+
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-~----r~Y-------qe~qLP----alp~~vpp~~rqlV  490 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-T----RTY-------QESQLP----ALPSRVPPVARQLV  490 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec-h----hhh-------hhhhCC----CCcccCChHHHHHH
Confidence            21      24799999999999999999999763221110 0    001       111112    23444567888999


Q ss_pred             HHhhcCCCCCCCCHHHHHHHHH
Q 013790          344 DNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       344 ~~cl~~dp~~RPs~~eil~~L~  365 (436)
                      ...|+.||.+|++..-....|+
T Consensus       491 ~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHhcCCccccCCccHHHhHHH
Confidence            9999999999999876666554

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=8.7e-21  Score=198.10  Aligned_cols=249  Identities=18%  Similarity=0.224  Sum_probs=180.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC---CCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE---HPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~  154 (436)
                      ...|.+-+.||+|+||.||+|...        +++.||+|+-+....-.   |.--.+++.+|+   -+.|..+...+..
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~--------~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHS--------NGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecC--------CCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence            456788889999999999999864        38999999987664321   111223444444   2334444443333


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc-------C
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-------E  227 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~-------~  227 (436)
                      .+..    +||+||.+.|+|.+++.  ..+.++|..+..++.|++..+..||..   +|||+||||+|+||.       +
T Consensus       766 ~~~S----~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~  836 (974)
T KOG1166|consen  766 QNAS----VLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSD  836 (974)
T ss_pred             CCcc----eeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCc
Confidence            3332    89999999999999996  345799999999999999999999998   999999999999994       3


Q ss_pred             CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 013790          228 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  307 (436)
                      +.-++|+|||.+..+............++|-.+-.+|...|.+++..+|.|.|+-+++.|+.|+.-              
T Consensus       837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~--------------  902 (974)
T KOG1166|consen  837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM--------------  902 (974)
T ss_pred             ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH--------------
Confidence            445899999999765545455566778899999999999999999999999999999999998531              


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                        +.  .++..+  .++..++....   -.-..+++..+|..|-..=|...+|...|+.++.
T Consensus       903 --q~--~~g~~~--~~~~~~~Ry~~---~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~  955 (974)
T KOG1166|consen  903 --EV--KNGSSW--MVKTNFPRYWK---RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA  955 (974)
T ss_pred             --Hh--cCCcce--eccccchhhhh---HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence              10  000000  11111111111   1235567777888777777788888888877764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.85  E-value=3.2e-22  Score=195.94  Aligned_cols=229  Identities=28%  Similarity=0.402  Sum_probs=177.9

Q ss_pred             cccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh--HHHHHHHHHHHhccC-CCCceeeeeEeeecCCcceeE
Q 013790           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG--HKQWVAEVQFLGVLE-HPNLVKLIGYCAVDGERGIQR  162 (436)
Q Consensus        86 ~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~  162 (436)
                      .+|.|+||.|+++.-.    .+...+..+|+|++.+.....  ......|..++..++ ||.++++.-.+..++.    .
T Consensus         1 vlg~g~~gkvfLvrk~----~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k----l   72 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKA----GGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK----L   72 (612)
T ss_pred             CCCcCCCcchHHHHHh----ccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc----h
Confidence            3799999999987543    233567889999887653221  113445777888887 9999999877776654    4


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCC
Q 013790          163 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG  242 (436)
Q Consensus       163 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  242 (436)
                      +++++|..||.|...+....  .+.+.....+...++-++.++|..   +|+|||+|++||+++.+|++++.|||+++..
T Consensus        73 ~l~ld~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~  147 (612)
T KOG0603|consen   73 YLILDFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEA  147 (612)
T ss_pred             hHhhhhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHh
Confidence            89999999999988876543  577788888899999999999998   9999999999999999999999999999853


Q ss_pred             CCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccc
Q 013790          243 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI  322 (436)
Q Consensus       243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (436)
                      ...      ...+||..|||||++.  ....++|.||||++++||+||..||..   .....+.    .           
T Consensus       148 v~~------~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~~~~Il----~-----------  201 (612)
T KOG0603|consen  148 VKE------KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DTMKRIL----K-----------  201 (612)
T ss_pred             Hhh------hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HHHHHHh----h-----------
Confidence            211      1228999999999998  457899999999999999999999986   1111111    1           


Q ss_pred             cCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 013790          323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM  357 (436)
Q Consensus       323 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  357 (436)
                          .....+......+.+++..++..+|..|.-.
T Consensus       202 ----~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  202 ----AELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             ----hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence                0012344556678899999999999999855

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=2.3e-20  Score=163.79  Aligned_cols=186  Identities=17%  Similarity=0.102  Sum_probs=136.4

Q ss_pred             cccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh----HHHHHHHHHHHhccC-CCCceeeeeEeeecC
Q 013790           82 SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG----HKQWVAEVQFLGVLE-HPNLVKLIGYCAVDG  156 (436)
Q Consensus        82 ~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~  156 (436)
                      .+...|++|+||+||.+.         ..+.+++.+.+.....-.    ...+.+|+++|++|. |++|++++++.    
T Consensus         5 ~~~~~l~~~~f~~v~~~~---------~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~----   71 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVR---------GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD----   71 (218)
T ss_pred             ccceeecCCCcceEEEee---------cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----
Confidence            345689999999999764         246778877776543211    125789999999995 58899998862    


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccC-CCCcEEEcCCCceEEee
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDF-KASNVLLDENFRPKLSD  235 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~D  235 (436)
                          ..+++|||+.|.+|.+.+..         ....++.|++.+|.++|..   ||+|||| ||+|||++.++.++|+|
T Consensus        72 ----~~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LID  135 (218)
T PRK12274         72 ----GRHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVID  135 (218)
T ss_pred             ----CEEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEE
Confidence                13899999999999765311         1135788999999999999   9999999 79999999999999999


Q ss_pred             ccCCCCCCCCCCc----cc-------ccccccCCCcccccccccC-CCC-chhhHHHHHHHHHHHHhCCCCCCC
Q 013790          236 FGLAREGPMVGHT----HV-------STAVVGTFGYAAPDYIETG-HLT-AKSDVWSFGVVLYEMLTGRRSLER  296 (436)
Q Consensus       236 fg~a~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGvil~elltg~~pf~~  296 (436)
                      ||++........-    ..       ......++.|++|+...-. ..+ ...+.++.|+-+|.++|+..++-+
T Consensus       136 FG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        136 FQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             CCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            9999853221110    00       0112357778888754322 223 578999999999999999887643

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.83  E-value=2.3e-21  Score=186.49  Aligned_cols=172  Identities=26%  Similarity=0.335  Sum_probs=129.1

Q ss_pred             eEEEEEEecCCCCHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  239 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  239 (436)
                      ++++.|++|...+|.+||.++ .....++...+.++.|++.|+.|   +   +.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999743 34467888999999999999999   6   9999999999999999999999999998


Q ss_pred             CCCCCCC----CcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 013790          240 REGPMVG----HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       240 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      .......    .....+...||..||+||.+.+..|+.++||||||+||+||++ -..+++....               
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t---------------  468 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT---------------  468 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh---------------
Confidence            7643332    2234456789999999999999999999999999999999998 2222221100               


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS  358 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  358 (436)
                          +..+-+..+++.+..+.+ .-..|+.+++...|.+||++.
T Consensus       469 ----~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  469 ----LTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             ----hhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHH
Confidence                000111111111111111 233899999999999999443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.82  E-value=9.1e-21  Score=194.50  Aligned_cols=210  Identities=27%  Similarity=0.408  Sum_probs=148.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|..++.|..|+||.||.++++       .+.+++|+ ++++++..     .+-  ++.....|.+            
T Consensus        82 e~df~~IklisngAygavylvrh~-------~trqrfa~-kiNkq~li-----lRn--ilt~a~npfv------------  134 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHK-------ETRQRFAM-KINKQNLI-----LRN--ILTFAGNPFV------------  134 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeecc-------ccccchhh-cccccchh-----hhc--cccccCCcce------------
Confidence            568999999999999999999876       56788998 44443211     010  2222222222            


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                             |      |+-...+....  +++...        +.+++|||+.   ||+|||+||+|++|..-|.+|++|||
T Consensus       135 -------v------gDc~tllk~~g--~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfg  188 (1205)
T KOG0606|consen  135 -------V------GDCATLLKNIG--PLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFG  188 (1205)
T ss_pred             -------e------chhhhhcccCC--CCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchh
Confidence                   2      44444443322  344322        7789999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCc-------------ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 013790          238 LAREGPMVGHT-------------HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR  304 (436)
Q Consensus       238 ~a~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~  304 (436)
                      +++.+.+....             ......+||+.|.|||++....|+..+|.|++|+|+||.+-|+.||.+..+.+...
T Consensus       189 Lsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg  268 (1205)
T KOG0606|consen  189 LSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG  268 (1205)
T ss_pred             hhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh
Confidence            98753222111             11234589999999999999999999999999999999999999999987755422


Q ss_pred             H-HHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC
Q 013790          305 L-LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK  356 (436)
Q Consensus       305 ~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs  356 (436)
                      . +......+..                ....+.+.+++|.++|..+|..|--
T Consensus       269 ~visd~i~wpE~----------------dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  269 QVISDDIEWPEE----------------DEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             hhhhhhcccccc----------------CcCCCHHHHHHHHHHHHhChHhhcc
Confidence            1 1111111110                1222467889999999999999973

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=3.6e-19  Score=162.85  Aligned_cols=142  Identities=17%  Similarity=0.113  Sum_probs=110.1

Q ss_pred             cCCcccccccccCceEEEEEE-ecCCCCCCCCcceEEEEEEeccCcch------------------------hHHHHHHH
Q 013790           79 NDFSRMLKIGEGGFGSVYKSS-IKPAAGDGTSEATVVAIKKLNRDGLQ------------------------GHKQWVAE  133 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E  133 (436)
                      ..|.+.+.||+|+||.||+|. ..       .+++.||+|++......                        ....+..|
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~-------~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E  100 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFD-------GSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKE  100 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecC-------CCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHH
Confidence            458899999999999999997 32       36789999998754211                        01235689


Q ss_pred             HHHHhccCCCC--ceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 013790          134 VQFLGVLEHPN--LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEV  211 (436)
Q Consensus       134 ~~~l~~l~hpn--Iv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~  211 (436)
                      +.++.++.+.+  +.+++++   . .    .++||||+.+++|...+...  ..+....+..++.|++.+|.+||+.   
T Consensus       101 ~~~L~~L~~~~i~~p~~~~~---~-~----~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---  167 (237)
T smart00090      101 FRNLQRLYEAGVPVPKPIAW---R-R----NVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKE---  167 (237)
T ss_pred             HHHHHHHHhcCCCCCeeeEe---c-C----ceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhc---
Confidence            99999997633  3444432   1 1    28999999998887765332  2456667789999999999999998   


Q ss_pred             c-eeeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          212 Q-VIYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       212 ~-ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      | ++||||||+||+++ ++.++|+|||.+..
T Consensus       168 g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      168 GELVHGDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             CCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence            8 99999999999999 88999999999863

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.6e-18  Score=156.63  Aligned_cols=133  Identities=19%  Similarity=0.217  Sum_probs=108.3

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--------hHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--------GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      +.||+|++|.||+|.+         .+..+++|+.......        ....+.+|+.++..+.|++|.....++....
T Consensus         2 ~~l~~G~~~~vy~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~   72 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF---------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE   72 (211)
T ss_pred             cccccCceEEEEEEee---------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC
Confidence            5799999999999975         3556888976543211        1235778999999999999877666655443


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      .    .+++|||++|++|.+++....     . .+..++.+++.+|.+||+.   +++|+|++|.|||++ ++.++|+||
T Consensus        73 ~----~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf  138 (211)
T PRK14879         73 N----FIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDF  138 (211)
T ss_pred             C----CEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEEC
Confidence            3    389999999999999985432     2 7889999999999999998   999999999999999 889999999


Q ss_pred             cCCC
Q 013790          237 GLAR  240 (436)
Q Consensus       237 g~a~  240 (436)
                      |.+.
T Consensus       139 ~~a~  142 (211)
T PRK14879        139 GLAE  142 (211)
T ss_pred             Cccc
Confidence            9885

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=2.6e-18  Score=153.66  Aligned_cols=130  Identities=17%  Similarity=0.265  Sum_probs=102.5

Q ss_pred             cccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--------hHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--------GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        86 ~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .||+|+||.||+|.+.         +..|++|........        ....+.+|+.++..+.|+++.....++.....
T Consensus         1 ~ig~G~~~~vy~~~~~---------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~   71 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL---------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN   71 (199)
T ss_pred             CCCCCceEEEEEeecC---------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC
Confidence            4899999999999853         567889886432211        12557789999999998876544444443332


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .++||||++|++|.+++....  .       .++.+++.+|.+||+.   +++|+|++|.||+++ ++.++++|||
T Consensus        72 ----~~lv~e~~~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg  134 (199)
T TIGR03724        72 ----KTIVMEYIEGKPLKDVIEEGN--D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFG  134 (199)
T ss_pred             ----CEEEEEEECCccHHHHHhhcH--H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECC
Confidence                389999999999999875421  1       7899999999999998   999999999999999 8999999999


Q ss_pred             CCCC
Q 013790          238 LARE  241 (436)
Q Consensus       238 ~a~~  241 (436)
                      ++..
T Consensus       135 ~a~~  138 (199)
T TIGR03724       135 LGKY  138 (199)
T ss_pred             CCcC
Confidence            9864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=4.1e-18  Score=152.32  Aligned_cols=142  Identities=17%  Similarity=0.105  Sum_probs=108.5

Q ss_pred             HHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch----------------------hHHHH
Q 013790           73 EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ----------------------GHKQW  130 (436)
Q Consensus        73 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~  130 (436)
                      ++.....-|.+.+.||.|+||.||++...        +++.||||++......                      ....+
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP--------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAA   80 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC--------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHH
Confidence            33333344888899999999999999753        5788999987543210                      01235


Q ss_pred             HHHHHHHhccCCCC--ceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 013790          131 VAEVQFLGVLEHPN--LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG  208 (436)
Q Consensus       131 ~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~  208 (436)
                      ..|+.++..+.|++  ++..++.    .    ..++||||++|++|......        .....++.+++.++.++|..
T Consensus        81 ~~E~~~l~~l~~~~i~v~~~~~~----~----~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~  144 (198)
T cd05144          81 QKEFAALKALYEEGFPVPKPIDW----N----RHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH  144 (198)
T ss_pred             HHHHHHHHHHHHcCCCCCceeec----C----CceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC
Confidence            67888999888774  4444432    1    23899999999999765421        24567889999999999998


Q ss_pred             CCCceeeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          209 LEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       209 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                         +++|+||||+||+++.++.++|+|||++..
T Consensus       145 ---gi~H~Dl~p~Nill~~~~~~~liDfg~~~~  174 (198)
T cd05144         145 ---GIIHGDLSEFNILVDDDEKIYIIDWPQMVS  174 (198)
T ss_pred             ---CCCcCCCCcccEEEcCCCcEEEEECCcccc
Confidence               999999999999999999999999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=8.2e-18  Score=172.61  Aligned_cols=137  Identities=21%  Similarity=0.228  Sum_probs=107.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--c------chhHHHHHHHHHHHhccCCCCceeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--G------LQGHKQWVAEVQFLGVLEHPNLVKLI  149 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~------~~~~~~~~~E~~~l~~l~hpnIv~~~  149 (436)
                      ...|...+.||+|+||.||+|.+.         +..+++|+....  .      ....+.+.+|+.++..++|++|+...
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~---------~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~  402 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYL---------GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV  402 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeec---------CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence            345567789999999999999864         112333322111  1      01235688899999999999998877


Q ss_pred             eEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC
Q 013790          150 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  229 (436)
Q Consensus       150 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  229 (436)
                      .++.....    .++||||+++++|.+++.          ....++.+++.+|.+||+.   +++||||||+|||+ .++
T Consensus       403 ~~~~~~~~----~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~  464 (535)
T PRK09605        403 IYDVDPEE----KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDD  464 (535)
T ss_pred             EEEEeCCC----CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECC
Confidence            66655433    389999999999999884          3567999999999999998   99999999999999 678


Q ss_pred             ceEEeeccCCCC
Q 013790          230 RPKLSDFGLARE  241 (436)
Q Consensus       230 ~~kl~Dfg~a~~  241 (436)
                      .++|+|||+++.
T Consensus       465 ~~~liDFGla~~  476 (535)
T PRK09605        465 RLYLIDFGLGKY  476 (535)
T ss_pred             cEEEEeCccccc
Confidence            999999999864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=1.4e-18  Score=178.05  Aligned_cols=259  Identities=24%  Similarity=0.286  Sum_probs=190.4

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccC-CCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  155 (436)
                      ..|.+.+.||+|+|+.|-.....      ......+|+|.+....  ....+....|..+-..+. |+|++.+++.....
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~------~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~   93 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNS------RDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP   93 (601)
T ss_pred             ccccccccccccccchhhhhhhc------CCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC
Confidence            36777788999999999876542      1244557777665543  223344555777777777 99999999887665


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCceeeccCCCCcEEEcCCC-ceEE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH-EGLEVQVIYRDFKASNVLLDENF-RPKL  233 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl  233 (436)
                      ...    +++.+|..++++.+.+........+......++.|+..++.|+| ..   ++.|+||||+|.+++..+ .+++
T Consensus        94 ~~~----~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~  166 (601)
T KOG0590|consen   94 RSY----LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKI  166 (601)
T ss_pred             ccc----ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccC
Confidence            543    89999999999999884333234666777889999999999999 77   999999999999999999 9999


Q ss_pred             eeccCCCCCCC-CCCccccccccc-CCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          234 SDFGLAREGPM-VGHTHVSTAVVG-TFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       234 ~Dfg~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      .|||+|..... .+.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..||........ ....|..
T Consensus       167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~  245 (601)
T KOG0590|consen  167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKS  245 (601)
T ss_pred             CCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecc
Confidence            99999987655 445555566778 9999999999874 556789999999999999999999976543321 1111111


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..    .        ...............+++.+++..+|..|.+.+++...
T Consensus       246 ~~----~--------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  246 NK----G--------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             cc----c--------ccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence            10    0        00011122223456688999999999999999887543

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=2.6e-16  Score=144.27  Aligned_cols=138  Identities=22%  Similarity=0.227  Sum_probs=104.0

Q ss_pred             cccc-ccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-------------hhHHHHHHHHHHHhccCCCCc--eee
Q 013790           85 LKIG-EGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------------QGHKQWVAEVQFLGVLEHPNL--VKL  148 (436)
Q Consensus        85 ~~ig-~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnI--v~~  148 (436)
                      ..|| .||.|+||.+..         .+..++||.......             .....+.+|+.++..|.|++|  +..
T Consensus        37 ~~lg~~~g~gtv~~v~~---------~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~p  107 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT---------PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRP  107 (239)
T ss_pred             ceeecCCCCccEEEEEe---------CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCcee
Confidence            3576 788888888764         256788887753211             123467889999999998875  667


Q ss_pred             eeEeeecCCcceeEEEEEEecCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          149 IGYCAVDGERGIQRLLVYEFMLN-RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       149 ~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      +++...........++||||++| .+|.+++...   +++..    .+.+++.+|.+||+.   ||+|+||||.|||++.
T Consensus       108 l~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~  177 (239)
T PRK01723        108 IAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDP  177 (239)
T ss_pred             EeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcC
Confidence            77654433322234699999997 6999888542   35543    357899999999998   9999999999999999


Q ss_pred             CCceEEeeccCCCC
Q 013790          228 NFRPKLSDFGLARE  241 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~  241 (436)
                      ++.++|+|||.+..
T Consensus       178 ~~~v~LIDfg~~~~  191 (239)
T PRK01723        178 DGKFWLIDFDRGEL  191 (239)
T ss_pred             CCCEEEEECCCccc
Confidence            99999999998864

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=1.8e-16  Score=134.58  Aligned_cols=135  Identities=21%  Similarity=0.181  Sum_probs=109.9

Q ss_pred             ccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCC--CCceeeeeEeeecCCcce
Q 013790           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH--PNLVKLIGYCAVDGERGI  160 (436)
Q Consensus        83 ~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~~  160 (436)
                      +++.||.|.++.||++...         +..+++|.......  ...+..|+.++..+.|  .++++++++....+    
T Consensus         2 ~~~~i~~g~~~~v~~~~~~---------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~----   66 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK---------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDG----   66 (155)
T ss_pred             cceecccccccceEEEEec---------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC----
Confidence            4567999999999999864         25799999865543  4578889999999976  58888887775443    


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..+++|||+.++.+..+         +......++.+++.+|++||.....+++|+||+|.||+++.++.++++|||.+.
T Consensus        67 ~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          67 WSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             ccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            35999999988777654         456677889999999999998633479999999999999999999999999986


Q ss_pred             C
Q 013790          241 E  241 (436)
Q Consensus       241 ~  241 (436)
                      .
T Consensus       138 ~  138 (155)
T cd05120         138 Y  138 (155)
T ss_pred             C
Confidence            4

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=2e-16  Score=139.97  Aligned_cols=135  Identities=21%  Similarity=0.157  Sum_probs=94.6

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh--HHH----------------------HHHHHHHHhc
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG--HKQ----------------------WVAEVQFLGV  139 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~  139 (436)
                      .+.||+|+||.||+|...        +++.||||++.......  ...                      ...|...+..
T Consensus         2 ~~~lg~G~~g~Vy~a~~~--------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~   73 (187)
T cd05119           2 GGPIGTGKEADVYLALDG--------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKR   73 (187)
T ss_pred             CcccccccceeEEEEECC--------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHH
Confidence            567999999999999753        57789999886542211  111                      1345555555


Q ss_pred             cCCCC--ceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeec
Q 013790          140 LEHPN--LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYR  216 (436)
Q Consensus       140 l~hpn--Iv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~  216 (436)
                      +.+..  +.+.++..        ..++||||++++++........  ... .....++.+++.++.++|. .   +|+|+
T Consensus        74 l~~~~~~~~~~~~~~--------~~~lv~e~~~g~~~~~~~l~~~--~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~  139 (187)
T cd05119          74 LYEAGVPVPKPIDLN--------RHVLVMEFIGGDGIPAPRLKDV--RLL-EDPEELYDQILELMRKLYREA---GLVHG  139 (187)
T ss_pred             HHHcCCCCCceEecC--------CCEEEEEEeCCCCccChhhhhh--hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcC
Confidence            54432  34444321        1389999999854432111111  011 5678899999999999999 7   99999


Q ss_pred             cCCCCcEEEcCCCceEEeeccCCCC
Q 013790          217 DFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       217 Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      ||||+||+++ ++.++|+|||.+..
T Consensus       140 Dl~p~Nili~-~~~~~liDfg~a~~  163 (187)
T cd05119         140 DLSEYNILVD-DGKVYIIDVPQAVE  163 (187)
T ss_pred             CCChhhEEEE-CCcEEEEECccccc
Confidence            9999999999 99999999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=6.1e-15  Score=144.98  Aligned_cols=254  Identities=21%  Similarity=0.251  Sum_probs=181.7

Q ss_pred             hcCCcccccccc--cCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccC-CCCceeeeeEe
Q 013790           78 TNDFSRMLKIGE--GGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLE-HPNLVKLIGYC  152 (436)
Q Consensus        78 ~~~~~~~~~ig~--G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~  152 (436)
                      ...|.+...+|.  |.+|.||.+.+.     .......+|+|.-+..  .......-.+|+...+.++ |+|.++.+..+
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~-----~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~  187 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCT-----NSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW  187 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCC-----cccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence            456778889999  999999998873     2356788999874322  2223333455776667775 99999977776


Q ss_pred             eecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCceeeccCCCCcEEEcCC
Q 013790          153 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE----GLAYLHEGLEVQVIYRDFKASNVLLDEN  228 (436)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~----~l~~LH~~~~~~ivH~Dlkp~NIll~~~  228 (436)
                      ...+.    .++-+|++ +.+|..+..... ..++...++.+..+...    ||.++|+.   +++|-|+||.||++..+
T Consensus       188 e~~~~----lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~  258 (524)
T KOG0601|consen  188 EGSGI----LFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSD  258 (524)
T ss_pred             ccCCc----ceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccc
Confidence            65543    48888888 689988887644 35788888999999988    99999998   99999999999999999


Q ss_pred             -CceEEeeccCCCCCCCCC---CcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 013790          229 -FRPKLSDFGLAREGPMVG---HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR  304 (436)
Q Consensus       229 -~~~kl~Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~  304 (436)
                       ...+++|||+........   .........|...|++||.+. +-++...|+|+||.++.+..+|..+....-.     
T Consensus       259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-----  332 (524)
T KOG0601|consen  259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN-----  332 (524)
T ss_pred             cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC-----
Confidence             889999999987533222   112223336788999999986 4568899999999999999998766542200     


Q ss_pred             HHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          305 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                       ..|.+           +-...+...+.......+...+..|++.+|..|++.+.+..+
T Consensus       333 -~~W~~-----------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  333 -SSWSQ-----------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             -CCccc-----------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence             00100           001111222222334456669999999999999998887653

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=2.3e-15  Score=136.93  Aligned_cols=207  Identities=20%  Similarity=0.244  Sum_probs=144.5

Q ss_pred             HHHHhccCCCCceeeeeEeeecCC-cceeEEEEEEecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 013790          134 VQFLGVLEHPNLVKLIGYCAVDGE-RGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLE  210 (436)
Q Consensus       134 ~~~l~~l~hpnIv~~~~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~  210 (436)
                      ...|-++.|.||+++..|+..... ......+++||+..|+|.++|++..  ...+......+|+.||..||.|||+ |.
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence            345556679999999999876554 3445689999999999999997632  3467888889999999999999999 67


Q ss_pred             CceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCC--CcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHH
Q 013790          211 VQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG--HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML  288 (436)
Q Consensus       211 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell  288 (436)
                      +.|+|+++..+.|++..+|-+|+.--.-....+...  .........+.++|.+||.=.....+.++|||+||+...+|.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            899999999999999999988875322111100000  111122334677899999866667778999999999999998


Q ss_pred             hCCCCCCCCCchh--hHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          289 TGRRSLERNRPKT--EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       289 tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .|..--.......  ...+...+..          +-+            ..=+.++..|+...|..||++.+++.|
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~~----------len------------~lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVIIG----------LEN------------GLQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HheeccCCCcceeehhhhhhhheee----------ccC------------ccccCcCcccccCCCCCCcchhhhhcC
Confidence            8765322111110  0001000000          000            111268889999999999999998875

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=7.1e-14  Score=139.13  Aligned_cols=139  Identities=16%  Similarity=0.091  Sum_probs=95.1

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhH-------------------------------------
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-------------------------------------  127 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------------------------------------  127 (436)
                      +.||.|++|.||+|+++        +|+.||||+.++......                                     
T Consensus       123 ~plasaSigQVh~A~l~--------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l  194 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV--------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTL  194 (437)
T ss_pred             cceeeeehhheEEEEec--------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHH
Confidence            57999999999999975        578899999865421110                                     


Q ss_pred             ---HHHHHHHHHHhccC----CCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHH
Q 013790          128 ---KQWVAEVQFLGVLE----HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE  200 (436)
Q Consensus       128 ---~~~~~E~~~l~~l~----hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~  200 (436)
                         -.+.+|+..+.++.    |.+-+.+-.++..-   ....++||||++|++|.++...... ..   ....++..++.
T Consensus       195 ~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~---~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~  267 (437)
T TIGR01982       195 RRELDLRREAANASELGENFKNDPGVYVPEVYWDR---TSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLAR  267 (437)
T ss_pred             HHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhh---cCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHH
Confidence               02444555555442    22223332233211   1124899999999999987643211 12   23456666665


Q ss_pred             -HHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          201 -GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       201 -~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                       .+..+|..   |++|+|++|.||+++.++.++++|||++..
T Consensus       268 ~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~  306 (437)
T TIGR01982       268 SFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGR  306 (437)
T ss_pred             HHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence             46788987   999999999999999999999999999864

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.44  E-value=5.9e-13  Score=115.70  Aligned_cols=130  Identities=17%  Similarity=0.124  Sum_probs=94.3

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCce-eeeeEeeecCCcceeE
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV-KLIGYCAVDGERGIQR  162 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~~~~  162 (436)
                      ++.|+.|.++.||++..         .+..|++|....... ....+..|+.+++.+.+.+++ +++.+..  ..    .
T Consensus         3 ~~~l~~G~~~~vy~~~~---------~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~----~   66 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV---------ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ET----G   66 (170)
T ss_pred             eeecCCcccCceEEEEE---------CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CC----C
Confidence            45689999999999874         256799998755431 223467899999988765544 4444332  11    2


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          163 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL--EVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       163 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ++||||++|.++...-       .   ....++.+++.+|+.||...  ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus        67 ~lv~e~i~G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          67 VLITEFIEGSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             eEEEEecCCCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            7999999998876430       1   11345788999999999972  12369999999999999 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.39  E-value=1.7e-12  Score=130.87  Aligned_cols=142  Identities=16%  Similarity=0.138  Sum_probs=90.6

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh--------------------------------
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG--------------------------------  126 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------------  126 (436)
                      .+|.. +.||+|++|.||+|+++       .+|+.||||+.++.....                                
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~-------~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~  191 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLK-------DNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVA  191 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEEC-------CCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHH
Confidence            45666 78999999999999986       247899999997542110                                


Q ss_pred             --HH------HHHHHHHHHhccC----CCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHh--hcCCC--CCCCHHH
Q 013790          127 --HK------QWVAEVQFLGVLE----HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAF--PPLPWKT  190 (436)
Q Consensus       127 --~~------~~~~E~~~l~~l~----hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~--~~l~~~~  190 (436)
                        .+      .+.+|+..+.++.    +.+.+.+-.++.+   .....+|||||+.|+.+.+.-  ...+.  ..+....
T Consensus       192 e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d---~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~  268 (537)
T PRK04750        192 EFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWD---YCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERG  268 (537)
T ss_pred             HHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecc---cCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHH
Confidence              01      1344444444442    3333332222211   122348999999999998753  22110  0133333


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC----ceEEeeccCCCC
Q 013790          191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF----RPKLSDFGLARE  241 (436)
Q Consensus       191 ~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~a~~  241 (436)
                      +..++.|+.       ..   |++|+|+||.||+++.+|    .++++|||++..
T Consensus       269 v~~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~  313 (537)
T PRK04750        269 VEVFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS  313 (537)
T ss_pred             HHHHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence            334444443       34   999999999999999888    999999999864

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.35  E-value=8.3e-12  Score=124.30  Aligned_cols=165  Identities=18%  Similarity=0.258  Sum_probs=123.8

Q ss_pred             CcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCH
Q 013790          109 SEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW  188 (436)
Q Consensus       109 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~  188 (436)
                      .++.+|.|...+...........+-++.|+.++||||++++..+..++    .+|+|+|-+  -.|..++.+.     ..
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~----~~ylvTErV--~Pl~~~lk~l-----~~  103 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG----TLYLVTERV--RPLETVLKEL-----GK  103 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC----ceEEEeecc--ccHHHHHHHh-----HH
Confidence            466778888777665544456778899999999999999999887766    359999987  4777777543     35


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCccccccccc
Q 013790          189 KTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET  268 (436)
Q Consensus       189 ~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  268 (436)
                      ..+...+.||+.||.+||+.|  +++|++|.-+.|+|+..|..||++|.++........  ......---.|..|+.+..
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCc
Confidence            667778999999999999764  999999999999999999999999998864221111  1111112224566665532


Q ss_pred             CCCCchhhHHHHHHHHHHHHhC
Q 013790          269 GHLTAKSDVWSFGVVLYEMLTG  290 (436)
Q Consensus       269 ~~~~~~~DvwSlGvil~elltg  290 (436)
                      ..  -..|.|-|||++++++.|
T Consensus       180 s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 SE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cc--cchhhhhHHHHHHHHhCc
Confidence            22  357999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.33  E-value=8.5e-13  Score=130.00  Aligned_cols=256  Identities=21%  Similarity=0.191  Sum_probs=174.8

Q ss_pred             ccCHHH-HHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHH--HHHHHHHHhccC-CC
Q 013790           68 VFSYSE-MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ--WVAEVQFLGVLE-HP  143 (436)
Q Consensus        68 ~~~~~~-~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-hp  143 (436)
                      ++.-.+ ......+|..+..||.|.|+.|+....+      ..++..|++|-+.........+  -..|+-+...+. |.
T Consensus       253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r------~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~  326 (524)
T KOG0601|consen  253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKR------PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHL  326 (524)
T ss_pred             eecccccceeecCCcceeEEccCCccccceeeeec------CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccc
Confidence            344444 3445678999999999999999987632      3467789999876553333222  234555555554 77


Q ss_pred             CceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcE
Q 013790          144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  223 (436)
Q Consensus       144 nIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NI  223 (436)
                      +++.++..+.....    .++--|||.++++...+.-  ...+.+..++.+..|++.++.++|+.   .++|+|+||+||
T Consensus       327 ~~~g~~~~W~~~r~----~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni  397 (524)
T KOG0601|consen  327 PSVGKNSSWSQLRQ----GYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNI  397 (524)
T ss_pred             ccCCCCCCcccccc----ccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccch---hhhcccccccce
Confidence            77776665554433    3788999999998887732  23577788899999999999999998   999999999999


Q ss_pred             EEcCC-CceEEeeccCCCCCCCCCCcccccccccCCCcc--cccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Q 013790          224 LLDEN-FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA--APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK  300 (436)
Q Consensus       224 ll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~  300 (436)
                      ++..+ +..++.|||..+....     ..........++  ++.......+..++|++|||..+.+.++|...-....  
T Consensus       398 ~i~~~~~~~~~~~~~~~t~~~~-----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--  470 (524)
T KOG0601|consen  398 LISNDGFFSKLGDFGCWTRLAF-----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--  470 (524)
T ss_pred             eeccchhhhhccccccccccce-----ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc--
Confidence            99876 7889999998864111     111122233333  5556666778889999999999999999865322110  


Q ss_pred             hhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                                       ....+....+. ..+. ....+..+...+...++..||.+.++..+.
T Consensus       471 -----------------~~~~i~~~~~p-~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  471 -----------------QSLTIRSGDTP-NLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             -----------------cceeeeccccc-CCCc-hHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence                             00111111111 1111 126677888999999999999998876554

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.30  E-value=3.6e-11  Score=105.67  Aligned_cols=142  Identities=16%  Similarity=0.093  Sum_probs=96.6

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc----------------------chhHHHH----HHHHHHH
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----------------------LQGHKQW----VAEVQFL  137 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l  137 (436)
                      ...||.|--+.||.|...... .....+..+|||+.+...                      ....+.+    .+|+..|
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~-~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L   80 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNE-TEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNL   80 (197)
T ss_pred             CCccccCcceEEEEEecCccc-ccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHH
Confidence            346999999999999743100 011245789999864210                      0011222    3799999


Q ss_pred             hccCC--CCceeeeeEeeecCCcceeEEEEEEecCCCCHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCce
Q 013790          138 GVLEH--PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED-HLFNRAFPPLPWKTRLHIILGAAEGLAYL-HEGLEVQV  213 (436)
Q Consensus       138 ~~l~h--pnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~ql~~~l~~L-H~~~~~~i  213 (436)
                      .++..  -++...+++.    .    .++||||+.+..+.. .+.+   ..++......+..+++.+|..| |..   ++
T Consensus        81 ~rl~~~Gv~vP~pi~~~----~----~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---gl  146 (197)
T cd05146          81 KRMQKAGIPCPEVVVLK----K----HVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NL  146 (197)
T ss_pred             HHHHHcCCCCCeEEEec----C----CEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            98863  4556666541    2    289999996643322 2221   1345566778889999999999 787   99


Q ss_pred             eeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          214 IYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       214 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      ||+||++.|||++ ++.+.|+|||.+..
T Consensus       147 VHGDLs~~NIL~~-~~~v~iIDF~qav~  173 (197)
T cd05146         147 VHADLSEYNMLWH-DGKVWFIDVSQSVE  173 (197)
T ss_pred             ecCCCCHHHEEEE-CCcEEEEECCCcee
Confidence            9999999999997 46799999998853

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.27  E-value=1.8e-12  Score=134.23  Aligned_cols=249  Identities=21%  Similarity=0.229  Sum_probs=167.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .+++.+.+-+-+|.+|.++.+.-.       ..+...++|+.....   ....+...++-.++-.-.+|.++...--+  
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa-------~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--  873 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPA-------GSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF--  873 (1205)
T ss_pred             CccceecccccCCCCcccccCCcc-------ccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC--
Confidence            457777888889999999986533       233333444332221   11122222333333333456655443321  


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                        ......+|+++|+.+++|...++...  ..+.......+..+..+++|||+.   .+.|+|++|.|+|+..+|..+++
T Consensus       874 --~~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~  946 (1205)
T KOG0606|consen  874 --PCRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLT  946 (1205)
T ss_pred             --CCCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccC
Confidence              12234589999999999999987654  456666667788888999999997   79999999999999999999999


Q ss_pred             eccCCCCCCCC----CC-------------------------cccccccccCCCcccccccccCCCCchhhHHHHHHHHH
Q 013790          235 DFGLAREGPMV----GH-------------------------THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLY  285 (436)
Q Consensus       235 Dfg~a~~~~~~----~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~  285 (436)
                      |||........    +.                         ........||+.|.+||.+.+......+|.|++|++++
T Consensus       947 ~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~ 1026 (1205)
T KOG0606|consen  947 DFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLF 1026 (1205)
T ss_pred             ccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhh
Confidence            99843211000    00                         01123457899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccC-cCCHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 013790          286 EMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEK-EYSINEARKIGRLADNCLSKSSKDRPKMS  358 (436)
Q Consensus       286 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~  358 (436)
                      |.++|.+||....+....   +             .+....... ..+...+....+++...+..+|.+|..+.
T Consensus      1027 e~l~g~pp~na~tpq~~f---~-------------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1027 EVLTGIPPFNAETPQQIF---E-------------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhcCCCCCCCcchhhhh---h-------------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            999999999876543221   1             111111111 12333445677899999999999998776

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.26  E-value=8.4e-11  Score=99.51  Aligned_cols=142  Identities=19%  Similarity=0.178  Sum_probs=102.3

Q ss_pred             ccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--------hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--------QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        83 ~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .+..|-+|+-+.|+++.+.         ++.+.||.-.....        -...+..+|+..|.++.--.|.-..-++.+
T Consensus        11 ~l~likQGAEArv~~~~~~---------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D   81 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS---------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID   81 (229)
T ss_pred             cceeeeccceeeEeeeccC---------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe
Confidence            5677889999999998864         67777775432211        123456789999998864444332223333


Q ss_pred             cCCcceeEEEEEEecCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC---c
Q 013790          155 DGERGIQRLLVYEFMLN-RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF---R  230 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~  230 (436)
                      ....    .|+|||++| .++.+++...............++..|-..+.-||.+   +|+|+||..+||+|..++   .
T Consensus        82 ~~~~----~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~  154 (229)
T KOG3087|consen   82 TYGG----QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQIT  154 (229)
T ss_pred             cCCC----eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCc
Confidence            2222    899999976 4888888765544444445578999999999999999   999999999999996444   3


Q ss_pred             eEEeeccCCC
Q 013790          231 PKLSDFGLAR  240 (436)
Q Consensus       231 ~kl~Dfg~a~  240 (436)
                      +.++|||++.
T Consensus       155 ~~lIdfgls~  164 (229)
T KOG3087|consen  155 PILIDFGLSS  164 (229)
T ss_pred             eEEEeecchh
Confidence            5899999985

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.26  E-value=9.1e-11  Score=99.80  Aligned_cols=131  Identities=19%  Similarity=0.234  Sum_probs=93.7

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--------hHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--------GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..|++|+-+.+|.+.+.         +..+++|.-.+....        ......+|+.++.++.--.|...+=+..+..
T Consensus         2 ~~i~~GAEa~i~~~~~~---------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL---------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD   72 (204)
T ss_pred             chhhCCcceeEEeeecc---------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC
Confidence            35789999999998664         334666653322111        1234677999999886544433322333333


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      ..    .|+|||++|..|.+.+...         ...++..+-.-+.-||..   ||+|+||.++||+++.++ +.++||
T Consensus        73 ~~----~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDf  135 (204)
T COG3642          73 NG----LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDF  135 (204)
T ss_pred             CC----EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEEC
Confidence            22    7999999999999888543         246777788888999998   999999999999998765 999999


Q ss_pred             cCCCC
Q 013790          237 GLARE  241 (436)
Q Consensus       237 g~a~~  241 (436)
                      |++..
T Consensus       136 GLg~~  140 (204)
T COG3642         136 GLGEF  140 (204)
T ss_pred             Ccccc
Confidence            99863

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=1.5e-10  Score=105.08  Aligned_cols=145  Identities=20%  Similarity=0.216  Sum_probs=107.7

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCC--CCceeeeeEeeecCCccee
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEH--PNLVKLIGYCAVDGERGIQ  161 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~~~  161 (436)
                      +.||.|.++.||++...        ++..+++|....... .....+..|++++..+.+  .++.+++.+...... ...
T Consensus         4 ~~l~~G~~n~~~~v~~~--------~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~-~~~   74 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG--------GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV-LGT   74 (223)
T ss_pred             eecCCCccceEEEEEec--------CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc-cCC
Confidence            56899999999998753        246799998765432 134567889999999875  345667766654321 112


Q ss_pred             EEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------
Q 013790          162 RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL--------------------------------  209 (436)
Q Consensus       162 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--------------------------------  209 (436)
                      .++||||++|.++.+.+..   ..++......++.+++.+|..||+..                                
T Consensus        75 ~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (223)
T cd05154          75 PFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT  151 (223)
T ss_pred             ceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence            4899999999988876532   24677778888889999999998531                                


Q ss_pred             ---------------------CCceeeccCCCCcEEEcC--CCceEEeeccCCCC
Q 013790          210 ---------------------EVQVIYRDFKASNVLLDE--NFRPKLSDFGLARE  241 (436)
Q Consensus       210 ---------------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~  241 (436)
                                           ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                 245799999999999998  67789999998853

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.21  E-value=1.3e-09  Score=105.82  Aligned_cols=221  Identities=16%  Similarity=0.211  Sum_probs=152.3

Q ss_pred             CceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEEEEEEecC
Q 013790           91 GFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFML  170 (436)
Q Consensus        91 ~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~  170 (436)
                      ...+.|++...       .+|..|++|+++..........-.-++.++++.|+|+|++.+++.........+++||+|++
T Consensus       288 ~~~Ttyk~~s~-------~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP  360 (655)
T KOG3741|consen  288 FSITTYKATSN-------VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP  360 (655)
T ss_pred             ccceeEeeeec-------cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence            34678888755       57888999999543222222223457889999999999999988754444456799999998


Q ss_pred             C-CCHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          171 N-RSLEDHLFNRA-------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       171 ~-gsL~~~l~~~~-------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      + ++|.++-....             +...++..+|.++.|+..||.++|+.   |+.-+-|.|.+||++.+.+++|...
T Consensus       361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C  437 (655)
T KOG3741|consen  361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGC  437 (655)
T ss_pred             CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecc
Confidence            6 68888754321             34578899999999999999999999   9999999999999999999999888


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      |.........         +       |.+.+   -.+-|.=.||.+++.|.||..--...+ ........         
T Consensus       438 ~i~Dvl~~d~---------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d-~~~~s~~~---------  488 (655)
T KOG3741|consen  438 GIMDVLQEDP---------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTD-STQSSHLT---------  488 (655)
T ss_pred             cceeeecCCC---------C-------cchhH---HhhhhHHHHHHHHHHHhhccccccccc-chHHHHHH---------
Confidence            8764321110         0       11111   236799999999999999964311110 00000000         


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                                   ......+.+++++|.-....++++ -++.+++.++
T Consensus       489 -------------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  489 -------------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             -------------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence                         112233456778888888888877 5777776653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.17  E-value=1.9e-09  Score=102.10  Aligned_cols=268  Identities=18%  Similarity=0.236  Sum_probs=160.9

Q ss_pred             cccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEee---ecCCc
Q 013790           82 SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCA---VDGER  158 (436)
Q Consensus        82 ~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~---~~~~~  158 (436)
                      ...+.||+|+-+.+|-.-          +-.-.+-|+..........+...|+  ..--.||-+..-+.+-.   ..+..
T Consensus        14 ~~gr~LgqGgea~ly~l~----------e~~d~VAKIYh~Pppa~~aqk~a~l--a~~p~~p~~~~rvaWPqa~L~G~~~   81 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG----------EVRDQVAKIYHAPPPAAQAQKVAEL--AATPDAPLLNYRVAWPQATLHGGRR   81 (637)
T ss_pred             CCCccccCCccceeeecc----------hhhchhheeecCCCchHHHHHHHHh--ccCCCCcchhhhhcccHHHhhCCCc
Confidence            345679999999999532          2222445666555444333322222  22224664433111111   11112


Q ss_pred             ceeEEEEEEecCCC-CHHHHh----hcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          159 GIQRLLVYEFMLNR-SLEDHL----FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       159 ~~~~~lv~e~~~~g-sL~~~l----~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      +...-++|..+.+. ....++    +++..+-..|...++.++.++.+.+-||..   |.+-+|+.++|+|+++++.+.|
T Consensus        82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~L  158 (637)
T COG4248          82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVL  158 (637)
T ss_pred             cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEE
Confidence            22234667766553 222222    123456688999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCc-----hhh
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTG-RRSLERNRP-----KTE  302 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~-----~~~  302 (436)
                      .|-..-..   ..........+|...|.+||.-.     +-.-+...|.|.||+++++|+.| ++||.+-..     ...
T Consensus       159 VdsDsfqi---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~  235 (637)
T COG4248         159 VDSDSFQI---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL  235 (637)
T ss_pred             Ecccceee---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc
Confidence            98654322   22333445578899999999864     23446679999999999999885 999976321     111


Q ss_pred             -HHHHHHHhhcccCccccccccCCcccCcCC-HHHHHHHHHHHHHhhcCC--CCCCCCHHHHHHHHHHhhhhc
Q 013790          303 -QRLLEWVQQYPADSKKFGLIMDPRLEKEYS-INEARKIGRLADNCLSKS--SKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       303 -~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-~~~~~~l~~li~~cl~~d--p~~RPs~~eil~~L~~~~~~~  371 (436)
                       ..+....-.+..+ ..-. ...+.  ...+ .-.+..+.-|..+|+...  +.-|||++-.+..|..+.+..
T Consensus       236 E~~Ia~g~f~ya~~-~~~g-~~p~P--~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         236 ETDIAHGRFAYASD-QRRG-LKPPP--RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             hhhhhcceeeechh-ccCC-CCCCC--CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence             1121111001000 0000 00000  0111 122456778888888753  568999999988887766543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.08  E-value=2.9e-09  Score=98.85  Aligned_cols=128  Identities=16%  Similarity=0.102  Sum_probs=90.3

Q ss_pred             cceEEEEEEeccCcchh-H----------HHHHHHHHHHhccCCCCc--eeeeeEeeec-CCcceeEEEEEEecCCC-CH
Q 013790          110 EATVVAIKKLNRDGLQG-H----------KQWVAEVQFLGVLEHPNL--VKLIGYCAVD-GERGIQRLLVYEFMLNR-SL  174 (436)
Q Consensus       110 ~~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~hpnI--v~~~~~~~~~-~~~~~~~~lv~e~~~~g-sL  174 (436)
                      +++.|.||......... .          ..+.+|...+..|..-+|  +..+++.... +......++|||++++. +|
T Consensus        44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL  123 (268)
T PRK15123         44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL  123 (268)
T ss_pred             CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence            46789999775433110 1          136788888887753333  2334444321 11123458999999875 89


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC-------CCceEEeeccCCC
Q 013790          175 EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-------NFRPKLSDFGLAR  240 (436)
Q Consensus       175 ~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~~kl~Dfg~a~  240 (436)
                      .+++......+.+......++.+++..+.-||..   ||+|+|+++.|||++.       ++.+.|+||+.+.
T Consensus       124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9998543223456677789999999999999999   9999999999999975       4679999999875

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.99  E-value=4.1e-09  Score=92.37  Aligned_cols=97  Identities=21%  Similarity=0.258  Sum_probs=64.1

Q ss_pred             HHHHHHHHHhccCCC--CceeeeeEeeecCCcceeEEEEEEecC--CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 013790          129 QWVAEVQFLGVLEHP--NLVKLIGYCAVDGERGIQRLLVYEFML--NRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY  204 (436)
Q Consensus       129 ~~~~E~~~l~~l~hp--nIv~~~~~~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~  204 (436)
                      ...+|+..|.++..-  ++.+.+++.    ..    ++||||+.  |..+..+. ...   ++......++.+++..+..
T Consensus        54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~----~ivME~I~~~G~~~~~l~-~~~---~~~~~~~~~~~~il~~~~~  121 (188)
T PF01163_consen   54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RN----VIVMEYIGEDGVPLPRLK-DVD---LSPEEPKELLEEILEEIIK  121 (188)
T ss_dssp             HHHHHHHHHHHCCCTT-SS--EEEEE----TT----EEEEE--EETTEEGGCHH-HCG---GGGSTHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHCCccCCcEEEEe----CC----EEEEEecCCCccchhhHH-hcc---ccchhHHHHHHHHHHHHHH
Confidence            467799999999765  456666443    12    89999998  54454433 221   2234556777888886655


Q ss_pred             -hhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          205 -LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       205 -LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                       +|..   ||+|+||.+.|||++++ .+.|+|||.+..
T Consensus       122 ~~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~  155 (188)
T PF01163_consen  122 MLHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVD  155 (188)
T ss_dssp             HHHCT---TEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred             HHHhc---CceecCCChhhEEeecc-eEEEEecCccee
Confidence             4677   99999999999999987 899999998853

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK09902 hypothetical protein; Provisional

Probab=98.96  E-value=2.8e-08  Score=87.69  Aligned_cols=159  Identities=18%  Similarity=0.161  Sum_probs=113.3

Q ss_pred             HHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc------chhHHHHHHHHHHHhccCCCC
Q 013790           71 YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG------LQGHKQWVAEVQFLGVLEHPN  144 (436)
Q Consensus        71 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpn  144 (436)
                      ++.+.....++...---|+||.+.|++..+.         +..+-+|.-....      +.....|.+|+..+..|..-+
T Consensus        10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~---------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~G   80 (216)
T PRK09902         10 FNHWWATEGDWVEEPNYRRNGMSGVQCVERN---------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAG   80 (216)
T ss_pred             HHHHHhCCCceecCCCcCCCCcceEEEEEeC---------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcC
Confidence            4444444455544445677999999997653         3467788754110      224467999999998886322


Q ss_pred             --ceeeeeEeeecCCcceeEEEEEEecCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCC
Q 013790          145 --LVKLIGYCAVDGERGIQRLLVYEFMLN-RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  221 (436)
Q Consensus       145 --Iv~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~  221 (436)
                        +.+.............+.+||+|-+.| -+|.+++.+....+.+......++.+++..+.-||..   |+.|+|+.+.
T Consensus        81 vPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~k  157 (216)
T PRK09902         81 VIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVR  157 (216)
T ss_pred             CCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHh
Confidence              444442222223334566899997753 6899998665545667888889999999999999999   9999999999


Q ss_pred             cEEEcCCCc--eEEeeccCCCC
Q 013790          222 NVLLDENFR--PKLSDFGLARE  241 (436)
Q Consensus       222 NIll~~~~~--~kl~Dfg~a~~  241 (436)
                      |||++.+|.  ++++||.-++.
T Consensus       158 hIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        158 HIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             heeecCCCCeeEEEEEhhccch
Confidence            999986677  99999987653

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.92  E-value=3.5e-10  Score=113.36  Aligned_cols=150  Identities=21%  Similarity=0.322  Sum_probs=103.9

Q ss_pred             HHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCC-------CcccccccccCCCcccccccccC
Q 013790          197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG-------HTHVSTAVVGTFGYAAPDYIETG  269 (436)
Q Consensus       197 ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~  269 (436)
                      +++.|+.|+|..  .++||++|.|++|.++.++..||+.|+++.......       .........-...|.|||++.+.
T Consensus       107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            344899999987  599999999999999999999999999876422100       11111223345689999999988


Q ss_pred             CCCchhhHHHHHHHHHHHH-hCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhc
Q 013790          270 HLTAKSDVWSFGVVLYEML-TGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLS  348 (436)
Q Consensus       270 ~~~~~~DvwSlGvil~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~  348 (436)
                      ..+.++|+||||+++|.+. .|+.-+............    ....+          .-....+...+.++.+=+.+++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~----~~~~~----------~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS----RNLLN----------AGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhh----hcccc----------cccccccccCcHHHHHHHHHHhc
Confidence            8889999999999999999 455554433221111110    00000          00112334556788899999999


Q ss_pred             CCCCCCCCHHHHHH
Q 013790          349 KSSKDRPKMSQVVE  362 (436)
Q Consensus       349 ~dp~~RPs~~eil~  362 (436)
                      .++.-||++..+..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998777653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.90  E-value=1e-08  Score=92.63  Aligned_cols=134  Identities=19%  Similarity=0.102  Sum_probs=94.1

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc----------------------hhHHHHHHHHHHHh
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----------------------QGHKQWVAEVQFLG  138 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~  138 (436)
                      ..++..||.|--+.||.|...        .+.++|||.-+.-..                      .......+|.++|.
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~--------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~  164 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP--------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQ  164 (304)
T ss_pred             HhhccccccCccceEEEEECC--------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHH
Confidence            456789999999999999853        678899996432100                      01234678999999


Q ss_pred             ccCCC--CceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeec
Q 013790          139 VLEHP--NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYR  216 (436)
Q Consensus       139 ~l~hp--nIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~  216 (436)
                      +|...  .+.+.+++-        ...+||||++|-.|...-       +.....-.++..|+.-+.-+-..   |+||+
T Consensus       165 ~L~~~G~~VP~P~~~n--------RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHG  226 (304)
T COG0478         165 RLYPEGVKVPKPIAWN--------RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHG  226 (304)
T ss_pred             HhhhcCCCCCCccccc--------cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---Ccccc
Confidence            98754  666666543        238999999886665442       12222334444444444444454   99999


Q ss_pred             cCCCCcEEEcCCCceEEeeccCCC
Q 013790          217 DFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       217 Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      |+++-||+++++|.+.++||--+.
T Consensus       227 DlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         227 DLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             CCchheEEEecCCCEEEEeCcccc
Confidence            999999999999999999997664

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.89  E-value=3.5e-08  Score=88.49  Aligned_cols=109  Identities=23%  Similarity=0.218  Sum_probs=83.9

Q ss_pred             HHHHHHHHHHhccCCCC--ceeeeeEeeecCCcceeEEEEEEecCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 013790          128 KQWVAEVQFLGVLEHPN--LVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY  204 (436)
Q Consensus       128 ~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~  204 (436)
                      ....+|...+..|..-+  ....+++...........++|+|++++. +|.+++....  ..+......++.+++..+.-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHH
Confidence            45677888777775332  3455555554333334568999999884 8999986533  25666778999999999999


Q ss_pred             hhcCCCCceeeccCCCCcEEEcCCC---ceEEeeccCCCC
Q 013790          205 LHEGLEVQVIYRDFKASNVLLDENF---RPKLSDFGLARE  241 (436)
Q Consensus       205 LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~  241 (436)
                      ||..   ||+|+|+++.|||++.++   .+.++||+-++.
T Consensus       134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999   999999999999998887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.65  E-value=1.2e-07  Score=95.51  Aligned_cols=138  Identities=17%  Similarity=0.176  Sum_probs=88.3

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh--------------------------------------
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG--------------------------------------  126 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------------------  126 (436)
                      ..|+.++-|.||+|+++        +|+.||||+..+.-...                                      
T Consensus       131 ~PiAsASIaQVH~A~L~--------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l  202 (517)
T COG0661         131 EPIASASIAQVHRAVLK--------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRL  202 (517)
T ss_pred             CchhhhhHhhheeEEec--------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHH
Confidence            57999999999999987        58999999986531110                                      


Q ss_pred             --HHHHHHHHHHHhccC-----CCCceeeeeEe-eecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHH
Q 013790          127 --HKQWVAEVQFLGVLE-----HPNLVKLIGYC-AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA  198 (436)
Q Consensus       127 --~~~~~~E~~~l~~l~-----hpnIv~~~~~~-~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql  198 (436)
                        .-++.+|+..+.+++     .|++. +=.++ ...+.    ..|+|||+.|-.+.+...-.. ..++...+.....++
T Consensus       203 ~~ElDy~~EA~n~~~~~~nf~~~~~v~-VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~  276 (517)
T COG0661         203 REELDYRREAANAERFRENFKDDPDVY-VPKVYWEYTTR----RVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA  276 (517)
T ss_pred             HHHhCHHHHHHHHHHHHHHcCCCCCeE-eceeehhccCC----cEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH
Confidence              012445555555552     33322 11122 11222    389999999999988843222 234433333322222


Q ss_pred             HHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       199 ~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      .-  ..+-..   |++|.|.+|.||+++.+|.+.+.|||+...
T Consensus       277 f~--~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~  314 (517)
T COG0661         277 FL--RQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGR  314 (517)
T ss_pred             HH--HHHHhc---CccccCCCccceEEecCCcEEEEcCcceec
Confidence            21  222223   899999999999999999999999999854

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.57  E-value=1.3e-06  Score=77.44  Aligned_cols=141  Identities=12%  Similarity=0.073  Sum_probs=91.6

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHH---------HHHHHHHHhccC---CCC
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ---------WVAEVQFLGVLE---HPN  144 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---hpn  144 (436)
                      ..++|...+.+-......|.+-..         ++..+++|..........+.         ..+++..+..+.   -..
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei---------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~   99 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI---------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTE   99 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE---------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccc
Confidence            457788888887777777877654         56789999887654332222         223333333332   222


Q ss_pred             ceeeeeEeeecC-CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcE
Q 013790          145 LVKLIGYCAVDG-ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  223 (436)
Q Consensus       145 Iv~~~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NI  223 (436)
                      +..++.+..... ......+++|||++|..|.+..      .+++    .++..++.++.-||..   |++|+|..|.|+
T Consensus       100 ~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~------~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNF  166 (229)
T PF06176_consen  100 PADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIE------DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNF  166 (229)
T ss_pred             cccceeeeeeeeccceeEEEEEEEEecCeecccch------hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcE
Confidence            333222222211 1223346899999998887764      1232    3456677889999998   999999999999


Q ss_pred             EEcCCCceEEeeccCCC
Q 013790          224 LLDENFRPKLSDFGLAR  240 (436)
Q Consensus       224 ll~~~~~~kl~Dfg~a~  240 (436)
                      ++++++ ++++||+..+
T Consensus       167 lv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  167 LVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             EEECCc-EEEEECcccc
Confidence            998655 9999998664

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.49  E-value=1.3e-06  Score=79.58  Aligned_cols=145  Identities=20%  Similarity=0.218  Sum_probs=83.9

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCC--CceeeeeEeeecCCccee
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHP--NLVKLIGYCAVDGERGIQ  161 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~~~~~~~~  161 (436)
                      ++.|+.|..+.||+....         +..+++|.....  .....+.+|..+++.+...  .+.+++.+..... ....
T Consensus         2 i~~l~~G~~n~~~~v~~~---------~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~-~~~~   69 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTD---------DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDE-FNGF   69 (239)
T ss_dssp             EEEEEESSSSEEEEEEET---------TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETE-ETSE
T ss_pred             CccCCCCCeeeEEEEEEC---------CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccc-cccc
Confidence            457899999999998854         247999997655  3456777888888888633  3456665443332 2233


Q ss_pred             EEEEEEecCCCCHHH----------------Hh---hcC--CCCCCCHHH---------HHHH------------HHHHH
Q 013790          162 RLLVYEFMLNRSLED----------------HL---FNR--AFPPLPWKT---------RLHI------------ILGAA  199 (436)
Q Consensus       162 ~~lv~e~~~~gsL~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~ql~  199 (436)
                      .+++|++++|..+..                .+   +..  ...+.....         ....            ...+.
T Consensus        70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (239)
T PF01636_consen   70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE  149 (239)
T ss_dssp             EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred             ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence            689999999988887                11   111  111111110         0000            11122


Q ss_pred             H-HHHHhhc----CCCCceeeccCCCCcEEEc-CCCceEEeeccCCC
Q 013790          200 E-GLAYLHE----GLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAR  240 (436)
Q Consensus       200 ~-~l~~LH~----~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~  240 (436)
                      . .+..++.    .....++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            2 2333332    1234799999999999999 66767899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.48  E-value=2.1e-06  Score=78.05  Aligned_cols=138  Identities=16%  Similarity=0.162  Sum_probs=79.5

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCC--ceeeeeEeeecCCcceeE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN--LVKLIGYCAVDGERGIQR  162 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~~~~  162 (436)
                      ..||.|..+.||+..           +..+++|......  ......+|.++++.+..-+  +.+.+++....+.    .
T Consensus         7 ~~i~~G~t~~~y~~~-----------~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~----~   69 (226)
T TIGR02172         7 TQTGEGGNGESYTHK-----------TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGR----L   69 (226)
T ss_pred             eeecCCCCcceeEec-----------CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe----e
Confidence            579999999999731           2347788876532  3345688999998886433  3555655544332    3


Q ss_pred             EEEEEecCCCC-HHHHh---------------------hcCCCCCCCHHHHH-HHHH----------HHHH-HHHHhhcC
Q 013790          163 LLVYEFMLNRS-LEDHL---------------------FNRAFPPLPWKTRL-HIIL----------GAAE-GLAYLHEG  208 (436)
Q Consensus       163 ~lv~e~~~~gs-L~~~l---------------------~~~~~~~l~~~~~~-~i~~----------ql~~-~l~~LH~~  208 (436)
                      .+|||+++|.+ +...+                     +.-.....+..... .+..          .+.. ...+|...
T Consensus        70 glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~  149 (226)
T TIGR02172        70 GLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEV  149 (226)
T ss_pred             eeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhC
Confidence            67999998863 21111                     11100011111100 0000          0000 11222211


Q ss_pred             -CCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          209 -LEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       209 -~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                       ....++|+|+.|.||++++++ +.|+||+.+.
T Consensus       150 ~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       150 PDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence             124678999999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.45  E-value=1.7e-06  Score=77.69  Aligned_cols=151  Identities=17%  Similarity=0.140  Sum_probs=98.5

Q ss_pred             cCHHHHHHhhcCCccccc---ccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhH------------------
Q 013790           69 FSYSEMRQATNDFSRMLK---IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH------------------  127 (436)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~---ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------  127 (436)
                      .+...+....+...+...   |+.|--+.||+|..        .++..+|+|+.........                  
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~--------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~  106 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAET--------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSN  106 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc--------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCC
Confidence            345556666666666554   45566678999863        3578899999864322110                  


Q ss_pred             ------HHHHHHHHHHhccC--CCCceeeeeEeeecCCcceeEEEEEEecCCCC-HHHHhhcCCCCCCCHHHHHHHHHHH
Q 013790          128 ------KQWVAEVQFLGVLE--HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS-LEDHLFNRAFPPLPWKTRLHIILGA  198 (436)
Q Consensus       128 ------~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~ql  198 (436)
                            .-...|+..|.++.  +-.+.+.+++..        -.|||||+.... -.-.|..   .++.......+..++
T Consensus       107 rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~--------nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~  175 (268)
T COG1718         107 RRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN--------NVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDV  175 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecC--------CeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHH
Confidence                  11345777777774  334455555442        289999995431 1111111   123333577788888


Q ss_pred             HHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       199 ~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      ++.+.-|-..  .++||+||+.-|||+. ++.+.|+|||-|..
T Consensus       176 v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         176 VEYMRRLYKE--AGLVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             HHHHHHHHHh--cCcccccchhhheEEE-CCeEEEEECccccc
Confidence            8888888873  2999999999999999 88999999998863

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.35  E-value=2.2e-06  Score=75.47  Aligned_cols=102  Identities=27%  Similarity=0.304  Sum_probs=80.5

Q ss_pred             HHHHHHHhccCC-CCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 013790          131 VAEVQFLGVLEH-PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN-RAFPPLPWKTRLHIILGAAEGLAYLHEG  208 (436)
Q Consensus       131 ~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~ql~~~l~~LH~~  208 (436)
                      ..|.-+++.+.+ +++++++|+|-    .    +++.||...+++...-.. ......+|..+.+||.+++..+.+|+..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----R----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----C----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence            347888888875 69999999992    2    789999987655421000 0112468999999999999999999986


Q ss_pred             CCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          209 LEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       209 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ....+.-.|++|+|+-++++|++|++|...+.
T Consensus        79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             CCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence            44468889999999999999999999998764

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.32  E-value=5.5e-06  Score=70.40  Aligned_cols=129  Identities=18%  Similarity=0.166  Sum_probs=88.6

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCcee-eeeEeeecCCcc
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVK-LIGYCAVDGERG  159 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~-~~~~~~~~~~~~  159 (436)
                      ....+.||+|++|.||++.|.         +..+|+|+-..+..  ...+..|+++|..+.--++.+ +|.+-.    . 
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~---------~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~-   87 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR---------GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----D-   87 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc---------CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----h-
Confidence            344567999999999999986         55799998776643  357888999999998766643 443321    1 


Q ss_pred             eeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCC-CCcEEEcCCCceEEeeccC
Q 013790          160 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFK-ASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~Dfg~  238 (436)
                         ++.|||+.|-.|.++-..     ..-.++.    .+++.---|-..   ||-|+.|. |...+|-.++.+.|+||..
T Consensus        88 ---~i~me~i~G~~L~~~~~~-----~~rk~l~----~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~  152 (201)
T COG2112          88 ---FIRMEYIDGRPLGKLEIG-----GDRKHLL----RVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDS  152 (201)
T ss_pred             ---hhhhhhhcCcchhhhhhc-----ccHHHHH----HHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccc
Confidence               667999998888876532     1223333    333443334343   99999987 4444444555999999998


Q ss_pred             CC
Q 013790          239 AR  240 (436)
Q Consensus       239 a~  240 (436)
                      |+
T Consensus       153 At  154 (201)
T COG2112         153 AT  154 (201)
T ss_pred             hh
Confidence            86

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.31  E-value=3.7e-06  Score=84.52  Aligned_cols=137  Identities=16%  Similarity=0.115  Sum_probs=85.4

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh-------------------------------HH-----
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-------------------------------HK-----  128 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~-----  128 (436)
                      +.||..+.|.||+|+.+        +|+.||||+-++.-...                               .+     
T Consensus       167 ~piaaASlaQVhrA~L~--------~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~E  238 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK--------NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQE  238 (538)
T ss_pred             chhhhcchhheEEEEec--------CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhh
Confidence            57999999999999987        48899999875431110                               00     


Q ss_pred             -HHHHHHHHHhc----cCCCC------ceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 013790          129 -QWVAEVQFLGV----LEHPN------LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG  197 (436)
Q Consensus       129 -~~~~E~~~l~~----l~hpn------Iv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q  197 (436)
                       +|.+|++...+    +.|-+      |.+++-.+.      ....|+|||++|..+.+.-.-.. ..++...+..-+.+
T Consensus       239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s------t~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~  311 (538)
T KOG1235|consen  239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLS------TKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVE  311 (538)
T ss_pred             cchHHHHHhHHHHHHHHHhcccccceeCCeehhhcC------cceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHH
Confidence             13444443333    23444      444433221      23489999999987776532211 23444443333333


Q ss_pred             HHHHHHHhhcCCCCceeeccCCCCcEEEc----CCCceEEeeccCCCC
Q 013790          198 AAEGLAYLHEGLEVQVIYRDFKASNVLLD----ENFRPKLSDFGLARE  241 (436)
Q Consensus       198 l~~~l~~LH~~~~~~ivH~Dlkp~NIll~----~~~~~kl~Dfg~a~~  241 (436)
                      ...-+-+ +    .|++|+|-+|.||+++    .++.+.+.|||+...
T Consensus       312 ~~~~qIf-~----~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~  354 (538)
T KOG1235|consen  312 AYLEQIF-K----TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV  354 (538)
T ss_pred             HHHHHHH-h----cCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence            2211111 2    2899999999999998    377899999999864

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.30  E-value=1.2e-05  Score=74.02  Aligned_cols=139  Identities=17%  Similarity=0.139  Sum_probs=80.6

Q ss_pred             cccccCc-eEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCCceeeeeEeeecCCcceeEE
Q 013790           86 KIGEGGF-GSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        86 ~ig~G~~-g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      .|..|.+ ..||+...         .+..+.+|+.....   ...+.+|+.+++.+. +--+.+++++....+.    .+
T Consensus         5 ~~~~g~~~~~v~~~~~---------~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~----~~   68 (244)
T cd05150           5 RVTEGQSGATVYRLDG---------KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGR----AW   68 (244)
T ss_pred             ecCCCCCcCeEEEEcC---------CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCc----cE
Confidence            3555555 78998753         23568888876543   235667888888774 3335566666544322    38


Q ss_pred             EEEEecCCCCHHHHh-------------------hcCCCC--CCCHH--HHHHH-----------------------HHH
Q 013790          164 LVYEFMLNRSLEDHL-------------------FNRAFP--PLPWK--TRLHI-----------------------ILG  197 (436)
Q Consensus       164 lv~e~~~~gsL~~~l-------------------~~~~~~--~l~~~--~~~~i-----------------------~~q  197 (436)
                      +||++++|.+|....                   +.....  ++...  .....                       +.+
T Consensus        69 lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (244)
T cd05150          69 LLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEE  148 (244)
T ss_pred             EEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHH
Confidence            999999998776432                   111000  11100  00000                       111


Q ss_pred             HHHHHHHhh-cCCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          198 AAEGLAYLH-EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       198 l~~~l~~LH-~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      +...|.... ....+.++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       149 ~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         149 LYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             HHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            111111111 1113468999999999999998888999999774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.22  E-value=1.3e-07  Score=94.27  Aligned_cols=190  Identities=18%  Similarity=0.120  Sum_probs=128.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCC-ceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN-LVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~  156 (436)
                      +.-+....-+++|++++++|.+-.       .+. ....+.+...     ....-++++|.+++||| .+..++-+..+ 
T Consensus       241 ~kws~~fh~fvK~altknpKkRpt-------aek-lL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E-  306 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPT-------AEK-LLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGE-  306 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCC-------hhh-heeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcc-
Confidence            344455566889999999986532       122 2224444332     33455789999999999 55555544333 


Q ss_pred             CcceeEEEEEEecCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          157 ERGIQRLLVYEFMLNR-SLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                         .+.+++++++.++ +-..-+. ...-.+...+...+.+.-++++++||+.   .=+|+|    ||+..+ +..+.+|
T Consensus       307 ---~~~~i~~~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~  374 (829)
T KOG0576|consen  307 ---DYLWIPMRICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLD  374 (829)
T ss_pred             ---cccchhhhhhcCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-ccccccc
Confidence               3458999999776 2221111 0111233445566777778899999986   458888    777655 7789999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLER  296 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~  296 (436)
                      |+.......   ........+++.|+|||+.....+....|+|++|+--.++.-|-+|-..
T Consensus       375 ~~v~~~L~~---~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  375 FAVPPQLTR---TMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             ccCCcccCc---ccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            998865322   2245567799999999999999999999999999877777777777543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.14  E-value=7.2e-06  Score=87.37  Aligned_cols=201  Identities=20%  Similarity=0.201  Sum_probs=139.9

Q ss_pred             HHHHHHHHhccCCCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 013790          130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL  209 (436)
Q Consensus       130 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~  209 (436)
                      ..-|+..+..+.|+|++.++.|....-..+....+..+++...++...+..-.  .++..+.+.+..++.+||.|+|+. 
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~-  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSL-  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHh-
Confidence            34567788888999999999887766555444456668888888888886543  688889999999999999999997 


Q ss_pred             CCceeeccCCCC---cEEEcCCCceEEe--eccCCCCCCCCCCcccccccccCCCcccccccccCCCCch--hhHHHHHH
Q 013790          210 EVQVIYRDFKAS---NVLLDENFRPKLS--DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAK--SDVWSFGV  282 (436)
Q Consensus       210 ~~~ivH~Dlkp~---NIll~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DvwSlGv  282 (436)
                        ...|.-+..+   +-.++..+.+.++  ||+.+.....   .........+..|.+||......+..+  .|+|.+|.
T Consensus       306 --~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d---~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  306 --SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD---NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             --ccceeEEecccccccccCccceeecchhhhcccccCCC---cccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence              5555444444   4444566777777  8888875332   222233445667888888876655544  79999999


Q ss_pred             HHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 013790          283 VLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE  362 (436)
Q Consensus       283 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~  362 (436)
                      .+..+..|..+-.....                       ...-+    +......+.++...|+..++++|+++.+++.
T Consensus       381 l~~~~~~~~~i~~~~~~-----------------------~~~~l----~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~  433 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAV-----------------------PVSLL----DVLSTSELLDALPKCLDEDSEERLSALELLT  433 (1351)
T ss_pred             HHhhhhhcCcccccccc-----------------------hhhhh----ccccchhhhhhhhhhcchhhhhccchhhhhh
Confidence            99999987654321100                       00000    0000114668889999999999999999998


Q ss_pred             HHH
Q 013790          363 RLK  365 (436)
Q Consensus       363 ~L~  365 (436)
                      +.-
T Consensus       434 ~~f  436 (1351)
T KOG1035|consen  434 HPF  436 (1351)
T ss_pred             chh
Confidence            753

>PLN02876 acyl-CoA dehydrogenase

Probab=98.13  E-value=4.6e-05  Score=82.53  Aligned_cols=152  Identities=16%  Similarity=0.191  Sum_probs=90.5

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccC-CCCc--eeeeeEeeecCCcc
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLE-HPNL--VKLIGYCAVDGERG  159 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnI--v~~~~~~~~~~~~~  159 (436)
                      ++.|+.|.++.+|+.....     ......+++|+..... ......+.+|+.+++.+. |+++  .+++.+|...... 
T Consensus        43 v~~l~gG~sn~ty~l~~~~-----~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~-  116 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGN-----GGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVI-  116 (822)
T ss_pred             EEEeCCCCcCceEEEEECC-----CCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcC-
Confidence            5678999999999987541     1112457777764432 123356889999999996 6665  7777777553221 


Q ss_pred             eeEEEEEEecCCCCHHH--------------------H---hhcCCC---------CCCC--HHHHHHHHH---------
Q 013790          160 IQRLLVYEFMLNRSLED--------------------H---LFNRAF---------PPLP--WKTRLHIIL---------  196 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~--------------------~---l~~~~~---------~~l~--~~~~~~i~~---------  196 (436)
                      ...|+||||++|..+.+                    .   |+.-..         .+..  ...+..+..         
T Consensus       117 G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~  196 (822)
T PLN02876        117 GTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEG  196 (822)
T ss_pred             CCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhccc
Confidence            23489999998764321                    1   111110         0101  111211111         


Q ss_pred             ------HHHHHHHHhhcCCC--------CceeeccCCCCcEEEcC-CC-ceEEeeccCCCC
Q 013790          197 ------GAAEGLAYLHEGLE--------VQVIYRDFKASNVLLDE-NF-RPKLSDFGLARE  241 (436)
Q Consensus       197 ------ql~~~l~~LH~~~~--------~~ivH~Dlkp~NIll~~-~~-~~kl~Dfg~a~~  241 (436)
                            .+...+.+|..+.+        ..+||+|+++.|||++. ++ ..-|.||+++..
T Consensus       197 ~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        197 KPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             CCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence                  12334566644321        35999999999999975 33 357999999875

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.06  E-value=3.4e-05  Score=70.74  Aligned_cols=30  Identities=20%  Similarity=0.263  Sum_probs=26.2

Q ss_pred             CceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          211 VQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       211 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++|+|+.+.|||+++++..-|+||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            468999999999999877667799999875

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.05  E-value=9.9e-05  Score=64.87  Aligned_cols=129  Identities=26%  Similarity=0.341  Sum_probs=90.0

Q ss_pred             cCCcccccccccCc-eEEEEEEecCCCCCCCCcceEEEEEEecc---Ccc------------------hhHHHHHHHHHH
Q 013790           79 NDFSRMLKIGEGGF-GSVYKSSIKPAAGDGTSEATVVAIKKLNR---DGL------------------QGHKQWVAEVQF  136 (436)
Q Consensus        79 ~~~~~~~~ig~G~~-g~Vy~~~~~~~~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~  136 (436)
                      .+++.++.||.|.- |.||++...         +..||+|++..   ...                  .....|..|...
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~---------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRA  107 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID---------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRA  107 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC---------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHh
Confidence            78999999999999 999999864         77999999321   110                  011347788888


Q ss_pred             HhccC---CCCc--eeeeeEeeecC--------------CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 013790          137 LGVLE---HPNL--VKLIGYCAVDG--------------ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG  197 (436)
Q Consensus       137 l~~l~---hpnI--v~~~~~~~~~~--------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q  197 (436)
                      ..+|+   +.++  ++++||..-..              .......||.||.+...           .+..    .-+.+
T Consensus       108 fgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~  172 (207)
T PF13095_consen  108 FGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQ  172 (207)
T ss_pred             hHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHH
Confidence            77775   4556  89999885442              11122357777775433           1222    33456


Q ss_pred             HHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCC
Q 013790          198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  239 (436)
Q Consensus       198 l~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  239 (436)
                      |.+-|..+|..   ||+-+|+++.|..     .-+|+|||.+
T Consensus       173 ~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  173 MLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            66667889998   9999999999985     3589999865

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.04  E-value=0.00013  Score=64.55  Aligned_cols=129  Identities=21%  Similarity=0.268  Sum_probs=87.2

Q ss_pred             ccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc----------------chhHHHHHHHHHHHhccC-----
Q 013790           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----------------LQGHKQWVAEVQFLGVLE-----  141 (436)
Q Consensus        83 ~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~-----  141 (436)
                      ....||+|+.=.||.-          ..+...+||+.....                .....+..+|+.....+.     
T Consensus         5 ~~~~i~~G~~R~cy~H----------P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~   74 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH----------PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGV   74 (199)
T ss_pred             CCcccccCCCceEEEC----------CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCC
Confidence            3457999999999962          233447889887665                122456677776666665     


Q ss_pred             -CCCceeeeeEeeecCCcceeEEEEEEecC------CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 013790          142 -HPNLVKLIGYCAVDGERGIQRLLVYEFML------NRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVI  214 (436)
Q Consensus       142 -hpnIv~~~~~~~~~~~~~~~~~lv~e~~~------~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~iv  214 (436)
                       +.+|.+++|+...+-..    -+|+|.+.      .-+|.+++...   .++. .....+.++   ..||-..   .|+
T Consensus        75 ~~~~i~r~~G~veT~~G~----Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~f---~~~l~~~---~Iv  140 (199)
T PF10707_consen   75 DWSHIPRFYGFVETNLGL----GLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDEF---KRYLLDH---HIV  140 (199)
T ss_pred             cccccccEeEEEecCCce----EEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHHH---HHHHHHc---CCe
Confidence             78899999998876554    45665542      34788888543   3554 444444444   5677776   999


Q ss_pred             eccCCCCcEEEcCC--C--ceEEee
Q 013790          215 YRDFKASNVLLDEN--F--RPKLSD  235 (436)
Q Consensus       215 H~Dlkp~NIll~~~--~--~~kl~D  235 (436)
                      .+||+|.||++...  +  .+.|+|
T Consensus       141 ~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  141 IRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCcccEEEEecCCCceEEEEEe
Confidence            99999999999532  2  467776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.94  E-value=0.00011  Score=67.28  Aligned_cols=142  Identities=21%  Similarity=0.218  Sum_probs=79.1

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCc-eeeeeEeeecCCcceeE
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL-VKLIGYCAVDGERGIQR  162 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~~~~  162 (436)
                      ++.|..|-...+|+.....      ..+..|++|+...... ..-...+|+.+++.+...++ +++++.+  .+      
T Consensus         3 i~~l~gG~tN~~~~v~~~~------~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~------   67 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKE------DNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATF--QN------   67 (235)
T ss_pred             EEEcCCcccceEEEEEcCC------CCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEe--CC------
Confidence            3567788889999886320      0245788887654321 11223468888888854333 3444332  11      


Q ss_pred             EEEEEecCCCCHHHH--------------h---hcCCC---------CCC-CHHHHHHHH--------------------
Q 013790          163 LLVYEFMLNRSLEDH--------------L---FNRAF---------PPL-PWKTRLHII--------------------  195 (436)
Q Consensus       163 ~lv~e~~~~gsL~~~--------------l---~~~~~---------~~l-~~~~~~~i~--------------------  195 (436)
                      .++|||++|.++...              +   +....         ... .+..+..+.                    
T Consensus        68 ~~l~e~i~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  147 (235)
T cd05157          68 GLIYEFIPGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAI  147 (235)
T ss_pred             cEEEEeeCCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccc
Confidence            479999988765321              0   11110         011 112211111                    


Q ss_pred             -----HHHHHHH-HHhhcC-CCCceeeccCCCCcEEEcC-CCceEEeeccCCC
Q 013790          196 -----LGAAEGL-AYLHEG-LEVQVIYRDFKASNVLLDE-NFRPKLSDFGLAR  240 (436)
Q Consensus       196 -----~ql~~~l-~~LH~~-~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~  240 (436)
                           .+.+..| ..+-.. ....++|+|+.+.|||++. ++.+.|+||..|.
T Consensus       148 ~~~~l~~~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         148 SFEQLRDEISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             cHHHHHHHHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence                 1111111 111111 2347999999999999998 5789999998875

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.93  E-value=6.8e-05  Score=69.65  Aligned_cols=137  Identities=18%  Similarity=0.110  Sum_probs=76.3

Q ss_pred             cccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCc-eeeeeEeeecCCcceeEEE
Q 013790           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL-VKLIGYCAVDGERGIQRLL  164 (436)
Q Consensus        86 ~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~~~~~l  164 (436)
                      .+..|-.+.+|+...         ++..+++|..........-...+|..+++.+...++ .+++...  .  .    ++
T Consensus         3 ~~~~G~tn~~y~~~~---------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~----~~   65 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH---------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--H----WL   65 (256)
T ss_pred             cCCCcCcCCeEEEEe---------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--C----EE
Confidence            356688889998762         345688887654322211134678888888864333 3344332  1  1    68


Q ss_pred             EEEecCCCCHHHH-----------------hhcCC--CCCCCHH-HHHHHHHHH---------HHHHHHhhcC-----CC
Q 013790          165 VYEFMLNRSLEDH-----------------LFNRA--FPPLPWK-TRLHIILGA---------AEGLAYLHEG-----LE  210 (436)
Q Consensus       165 v~e~~~~gsL~~~-----------------l~~~~--~~~l~~~-~~~~i~~ql---------~~~l~~LH~~-----~~  210 (436)
                      ||||++|..+...                 |+...  ..+++.. .+..+..++         ...+..+-..     ..
T Consensus        66 v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (256)
T TIGR02721        66 LVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLP  145 (256)
T ss_pred             EEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCC
Confidence            9999998765421                 11111  1111211 111111111         1111111111     12


Q ss_pred             CceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          211 VQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       211 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++|+|+.|.||++++++ +.|+||+.+.
T Consensus       146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            3689999999999999877 7899999885

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=97.87  E-value=0.00023  Score=67.57  Aligned_cols=82  Identities=13%  Similarity=0.040  Sum_probs=54.2

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCC---CCceeeeeEeeecCC
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH---PNLVKLIGYCAVDGE  157 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~~~~~~~~~~~  157 (436)
                      ....+.||.|..+.||+....        ++ .+++|..+..  .....+..|+..|+.|.-   -.+.++++++.....
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~--------~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~   84 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDS--------QG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS   84 (297)
T ss_pred             hheeeecCCccceeEEEEEcC--------CC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence            344567999999999987532        22 4667774321  123478889999988853   357788877754321


Q ss_pred             cceeEEEEEEecCCCCH
Q 013790          158 RGIQRLLVYEFMLNRSL  174 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL  174 (436)
                       ....++|||+++++++
T Consensus        85 -~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         85 -PGPDVLLLERLRGVSV  100 (297)
T ss_pred             -CCCeEEEEeccCCEec
Confidence             1224999999988765

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.70  E-value=0.00043  Score=65.69  Aligned_cols=145  Identities=20%  Similarity=0.161  Sum_probs=81.1

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCC--ceeeeeEeeec--CCcc
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN--LVKLIGYCAVD--GERG  159 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~--~~~~  159 (436)
                      ++.|..|....+|+....         +..+++|+....   .......|+.++..+.+-+  +.+++......  ....
T Consensus        19 i~~i~~G~~n~~y~v~~~---------~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~   86 (296)
T cd05153          19 FEGISAGIENTNYFVTTD---------SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELA   86 (296)
T ss_pred             eecccCccccceEEEEeC---------CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeC
Confidence            556777888899987532         335888987642   2345666777777775322  34443311000  0011


Q ss_pred             eeEEEEEEecCCCCHHH----H----------hhc--CC--C-----CCCCHHHHH----------HHHHHHHHHHHHhh
Q 013790          160 IQRLLVYEFMLNRSLED----H----------LFN--RA--F-----PPLPWKTRL----------HIILGAAEGLAYLH  206 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~----~----------l~~--~~--~-----~~l~~~~~~----------~i~~ql~~~l~~LH  206 (436)
                      ...++|++|++|..+..    .          ++.  ..  .     ....|....          .....+..++.++.
T Consensus        87 ~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  166 (296)
T cd05153          87 GKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQD  166 (296)
T ss_pred             CceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHH
Confidence            23489999998876532    0          011  00  0     011111110          01111223344444


Q ss_pred             c----CCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          207 E----GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       207 ~----~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      .    ....+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       167 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         167 AFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            2    123479999999999999998878999999874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.65  E-value=0.00042  Score=66.05  Aligned_cols=146  Identities=27%  Similarity=0.310  Sum_probs=81.9

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCc-eeeeeEeeecCCcceeEE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL-VKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~~~~~  163 (436)
                      +.|..|-...+|+....... .....+..+++|+..... .......+|..++..+...++ .++++++.  +      .
T Consensus         4 ~~l~gGltN~~y~v~~~~~~-~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~------~   73 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDED-ALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP--N------G   73 (302)
T ss_pred             EEecCcccceeEEEEcCCcc-cccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC--C------C
Confidence            45666777899988743110 012235778899875542 222345678888887753333 34454442  1      3


Q ss_pred             EEEEecCCCCHHHH-----------------hhcCCCC-------CCC--HHHHHH------------------------
Q 013790          164 LVYEFMLNRSLEDH-----------------LFNRAFP-------PLP--WKTRLH------------------------  193 (436)
Q Consensus       164 lv~e~~~~gsL~~~-----------------l~~~~~~-------~l~--~~~~~~------------------------  193 (436)
                      +|++|++|..+...                 ++.....       ..+  +..+..                        
T Consensus        74 ~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (302)
T cd05156          74 RIEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVEL  153 (302)
T ss_pred             chhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhH
Confidence            58999988766431                 1111110       011  111100                        


Q ss_pred             --HHHHHHHHHHHhhc------CCCCceeeccCCCCcEEEcCC----CceEEeeccCCC
Q 013790          194 --IILGAAEGLAYLHE------GLEVQVIYRDFKASNVLLDEN----FRPKLSDFGLAR  240 (436)
Q Consensus       194 --i~~ql~~~l~~LH~------~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~  240 (436)
                        +...+..-+..|-.      .....++|+|+.|.|||++.+    +.+.++||..|.
T Consensus       154 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         154 SLFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence              11122222333431      134589999999999999985    889999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.53  E-value=0.0028  Score=62.31  Aligned_cols=77  Identities=17%  Similarity=0.130  Sum_probs=51.1

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC------c-chhHHHHHHHHHHHhccC---CCCceeeeeEee
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD------G-LQGHKQWVAEVQFLGVLE---HPNLVKLIGYCA  153 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~  153 (436)
                      .+.||.|.+..||++...       ..++.|+||+-...      . ....++...|.+.|..+.   ..++++++.+..
T Consensus        31 ~~elggGn~N~VyrV~~~-------~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~  103 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDT-------EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE  103 (401)
T ss_pred             eeEcCCCceEEEEEEEeC-------CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC
Confidence            357999999999999853       12257999985421      1 123456777888888763   345677776633


Q ss_pred             ecCCcceeEEEEEEecCCCC
Q 013790          154 VDGERGIQRLLVYEFMLNRS  173 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gs  173 (436)
                      .  .    .++||||+++..
T Consensus       104 ~--~----~~lVME~L~~~~  117 (401)
T PRK09550        104 E--L----AVTVMEDLSDHK  117 (401)
T ss_pred             C--C----CEEEEecCCCcc
Confidence            2  1    389999997644

>PRK05231 homoserine kinase; Provisional

Probab=97.50  E-value=0.0029  Score=60.72  Aligned_cols=31  Identities=29%  Similarity=0.278  Sum_probs=27.0

Q ss_pred             CCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          210 EVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       210 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..+++|+|+.|.|||++.+...-|+||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            4589999999999999977666899999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.45  E-value=0.0024  Score=60.98  Aligned_cols=146  Identities=18%  Similarity=0.129  Sum_probs=78.9

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCC--ceeeeeEeeec--CCcc
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN--LVKLIGYCAVD--GERG  159 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~--~~~~  159 (436)
                      ++.++.|....+|+....         +..+++|+.....  ....+..|+.++..|...+  +.+++......  ....
T Consensus        27 i~~~~~G~~n~~y~v~t~---------~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~   95 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD---------VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA   95 (307)
T ss_pred             ccccCCccccceEEEEeC---------CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence            456777777899987532         2357788765432  1234455677776664222  33333311100  0012


Q ss_pred             eeEEEEEEecCCCCHHH-----------H---hhcCCC---CC-------CCHHHHH------------HHHHHHHHHHH
Q 013790          160 IQRLLVYEFMLNRSLED-----------H---LFNRAF---PP-------LPWKTRL------------HIILGAAEGLA  203 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~-----------~---l~~~~~---~~-------l~~~~~~------------~i~~ql~~~l~  203 (436)
                      ...+++++|++|..+..           .   ++....   .+       -.|....            .....+...+.
T Consensus        96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~  175 (307)
T TIGR00938        96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD  175 (307)
T ss_pred             CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence            24589999998854321           0   111000   00       0111100            01112233454


Q ss_pred             Hhhc----CCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          204 YLHE----GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       204 ~LH~----~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ++..    ....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            4532    124589999999999999998877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.39  E-value=0.00018  Score=67.16  Aligned_cols=134  Identities=17%  Similarity=0.092  Sum_probs=90.9

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc------------------h----hHHHHHHHHHHH
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------------------Q----GHKQWVAEVQFL  137 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~------------------~----~~~~~~~E~~~l  137 (436)
                      =+.+++.||-|--+.+|.+...        ++.+.++|.-..-..                  .    ..-...+|...|
T Consensus        93 v~svGnqIGVGKESDIY~v~d~--------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafm  164 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE--------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFM  164 (465)
T ss_pred             hhhhccccccccccceEEEecC--------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHH
Confidence            4677889999999999998753        678888885321100                  0    011245688888


Q ss_pred             hccC-CCC-ceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceee
Q 013790          138 GVLE-HPN-LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIY  215 (436)
Q Consensus       138 ~~l~-hpn-Iv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH  215 (436)
                      +.|. |.. +.+.++++        ..++|||++.|-.|.+.-.-     ....+   +...+..-+.-|-..   |+||
T Consensus       165 kaL~e~gfpVPkpiD~~--------RH~Vvmelv~g~Pl~~v~~v-----~d~~~---ly~~lm~~Iv~la~~---GlIH  225 (465)
T KOG2268|consen  165 KALYERGFPVPKPIDHN--------RHCVVMELVDGYPLRQVRHV-----EDPPT---LYDDLMGLIVRLANH---GLIH  225 (465)
T ss_pred             HHHHHcCCCCCCccccc--------ceeeHHHhhcccceeeeeec-----CChHH---HHHHHHHHHHHHHHc---Ccee
Confidence            8885 322 34444443        34899999988888765321     12223   333444445566666   9999


Q ss_pred             ccCCCCcEEEcCCCceEEeeccCCC
Q 013790          216 RDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       216 ~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      +|..-=||+|++++.++++||--..
T Consensus       226 gDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  226 GDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             cccchheeEEecCCCEEEeechHhh
Confidence            9999999999999999999998654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.33  E-value=0.0027  Score=59.55  Aligned_cols=31  Identities=26%  Similarity=0.442  Sum_probs=25.9

Q ss_pred             CceeeccCCCCcEEEcCCCc-eEEeeccCCCC
Q 013790          211 VQVIYRDFKASNVLLDENFR-PKLSDFGLARE  241 (436)
Q Consensus       211 ~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~  241 (436)
                      ..++|+|++|.|||++.++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 56999998854

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=97.24  E-value=0.0038  Score=60.60  Aligned_cols=145  Identities=14%  Similarity=0.175  Sum_probs=81.0

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCc-eeeeeEeeecCCcceeE
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL-VKLIGYCAVDGERGIQR  162 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~~~~  162 (436)
                      +..|..|-.-.+|++.+...   ....+..|++|+.......... -.+|..++..+..-++ .++++.+.  +      
T Consensus        41 i~~l~gGlTN~~y~v~~~~~---~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~--~------  108 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTK---EGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFP--N------  108 (344)
T ss_pred             EEEcCCcccceeEEEEeCCC---CCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEEC--C------
Confidence            44565688889999875311   1123467889987654322222 2568888887764333 34455442  1      


Q ss_pred             EEEEEecCCCCHHHH-----------------hhcCC----CCCCCHHHHHHHHHHH-----------------HHHHHH
Q 013790          163 LLVYEFMLNRSLEDH-----------------LFNRA----FPPLPWKTRLHIILGA-----------------AEGLAY  204 (436)
Q Consensus       163 ~lv~e~~~~gsL~~~-----------------l~~~~----~~~l~~~~~~~i~~ql-----------------~~~l~~  204 (436)
                      ..|++|+++.+|...                 ++...    ..+..+..+..+..++                 ...+..
T Consensus       109 g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~  188 (344)
T PLN02236        109 GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL  188 (344)
T ss_pred             ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence            247899877666421                 11111    0011223333332221                 111111


Q ss_pred             ----hhc-CCCCceeeccCCCCcEEEcC-CCceEEeeccCCC
Q 013790          205 ----LHE-GLEVQVIYRDFKASNVLLDE-NFRPKLSDFGLAR  240 (436)
Q Consensus       205 ----LH~-~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~  240 (436)
                          +.. .....++|+|+++.|||+++ ++.+.++||..+.
T Consensus       189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence                221 12347899999999999986 5789999998874

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.16  E-value=0.00015  Score=79.55  Aligned_cols=161  Identities=12%  Similarity=-0.031  Sum_probs=114.4

Q ss_pred             HHHHHHHHhccCCCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhc
Q 013790          130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHE  207 (436)
Q Consensus       130 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~  207 (436)
                      ...|...++...|+++...+.-..  +......+.+++|+.+|.+...|.+..  .+++...-+...-.+.+.+..-+|+
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~--ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIP--PSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCC--CCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            334455556678998877644332  222334488999999999999987543  2334433343333443666666665


Q ss_pred             CC--CCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHH
Q 013790          208 GL--EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLY  285 (436)
Q Consensus       208 ~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~  285 (436)
                      ..  ..-.+|+++|+-|.+|..+-++|++++|+.+..  ...........+++.|+.|++...-.++.++|+|..|+-+|
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk--np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK--NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCccccccccccccc--CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence            42  224689999999999999999999999999831  22233445567888999999988888888899999999999


Q ss_pred             HHHhCCCCC
Q 013790          286 EMLTGRRSL  294 (436)
Q Consensus       286 elltg~~pf  294 (436)
                      ++.-|..+|
T Consensus      1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred             HHhcccHHH
Confidence            998887766

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.11  E-value=0.0029  Score=60.26  Aligned_cols=135  Identities=17%  Similarity=0.119  Sum_probs=89.4

Q ss_pred             cccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc------------------------hh-HH-HHHHHHHHHhc
Q 013790           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------------------------QG-HK-QWVAEVQFLGV  139 (436)
Q Consensus        86 ~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~------------------------~~-~~-~~~~E~~~l~~  139 (436)
                      .|..|--+.||.|+-.        +|..+|||+.+-+-.                        .. .+ -...|+..|.+
T Consensus       151 CiSTGKEANVYHat~~--------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkR  222 (520)
T KOG2270|consen  151 CISTGKEANVYHATEE--------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKR  222 (520)
T ss_pred             ccccCccceeEeeecC--------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHH
Confidence            4666777889998743        566799998643210                        00 01 13457778888


Q ss_pred             cCCCCceeeeeEeeecCCcceeEEEEEEecCCCCHH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccC
Q 013790          140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE-DHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDF  218 (436)
Q Consensus       140 l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dl  218 (436)
                      ++...|.-.--+..      ....|||+|+.+.... -.|.   ...++...+..+-.+++.-|.-|...|  ++||.||
T Consensus       223 l~~aGIP~PePIlL------k~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADL  291 (520)
T KOG2270|consen  223 LNNAGIPCPEPILL------KNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADL  291 (520)
T ss_pred             HHhcCCCCCCceee------ecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccch
Confidence            87655442211111      1238999999432221 1121   124677778888889999999998876  9999999


Q ss_pred             CCCcEEEcCCCceEEeeccCCC
Q 013790          219 KASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       219 kp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      .--|+|+- +|.+.|+|-+-+.
T Consensus       292 SEfN~Lyh-dG~lyiIDVSQSV  312 (520)
T KOG2270|consen  292 SEFNLLYH-DGKLYIIDVSQSV  312 (520)
T ss_pred             hhhhheEE-CCEEEEEEccccc
Confidence            99999995 6789999998775

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.80  E-value=0.017  Score=54.80  Aligned_cols=31  Identities=19%  Similarity=0.355  Sum_probs=28.3

Q ss_pred             CceeeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          211 VQVIYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       211 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      ..++|+|+.+.|++|+.++-+-|+||+++..
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            4699999999999999988899999999864

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.65  E-value=0.0076  Score=57.43  Aligned_cols=73  Identities=18%  Similarity=0.163  Sum_probs=58.4

Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                      +.+.|++|++- |++|...      ....+.++..|+.+.+..+.-+..+  ...-|||+.-.||||+ +|++-|+||-+
T Consensus       298 ~~y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             ceEEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeee
Confidence            44567777765 5555422      2356788999999999988888876  4789999999999999 99999999999


Q ss_pred             CCC
Q 013790          239 ARE  241 (436)
Q Consensus       239 a~~  241 (436)
                      ++.
T Consensus       368 sRl  370 (488)
T COG5072         368 SRL  370 (488)
T ss_pred             eec
Confidence            984

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.65  E-value=0.02  Score=53.94  Aligned_cols=76  Identities=17%  Similarity=0.305  Sum_probs=45.2

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC---CCCceeeeeEeeecCC
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE---HPNLVKLIGYCAVDGE  157 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~  157 (436)
                      .+..+.|+.|....+|+..         .+++.+.||+-...   ....|..|+.-|+.|.   --.+.+.+++....+.
T Consensus        19 i~~~~~v~GG~i~~a~~~~---------~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~   86 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD---------TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD   86 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE---------TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC
T ss_pred             eeeeEecCCCChhheEEEE---------CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC
Confidence            3445678889999999876         35678999987632   2346778888888873   3456677777765544


Q ss_pred             cceeEEEEEEecCCC
Q 013790          158 RGIQRLLVYEFMLNR  172 (436)
Q Consensus       158 ~~~~~~lv~e~~~~g  172 (436)
                      .    +|||||++.+
T Consensus        87 ~----fLlle~l~~~   97 (288)
T PF03881_consen   87 A----FLLLEFLEMG   97 (288)
T ss_dssp             C----EEEEE-----
T ss_pred             c----eEEEEeecCC
Confidence            3    9999999766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.62  E-value=0.0054  Score=60.88  Aligned_cols=167  Identities=25%  Similarity=0.314  Sum_probs=95.8

Q ss_pred             HHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 013790          128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE  207 (436)
Q Consensus       128 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~  207 (436)
                      .++..-..+++.+.|+|...++++.......   ..+|||++ +-+|++.+..+.   +.....      +      -| 
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r---~IVV~e~~-~~Sled~~~~~~---l~~~s~------~------~~-   86 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHER---VIVVMEHY-TMSLEDILKTGN---LKDESL------L------AH-   86 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccce---EEEEehhh-ccchHHHHHhcc---cchhhh------c------cc-
Confidence            4556677889999999999998877654443   58999999 779999986653   111110      0      11 


Q ss_pred             CCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHH
Q 013790          208 GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEM  287 (436)
Q Consensus       208 ~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~el  287 (436)
                          ++.|-     |+       .+++| .++..      .              |-     ...+++||||+|.++.++
T Consensus        87 ----~~~~~-----~~-------~~~td-~~~t~------~--------------~~-----~~~pKsdVwsl~~i~~el  124 (725)
T KOG1093|consen   87 ----GVLHL-----NI-------IYITD-HFLTK------Y--------------PS-----PIGPKSDVWSLGFIILEL  124 (725)
T ss_pred             ----cccee-----hh-------hhccc-ccccc------C--------------CC-----CCCcchhhhhHHHHHHHH
Confidence                33332     11       23333 11110      0              10     011499999999999999


Q ss_pred             HhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 013790          288 LTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE  362 (436)
Q Consensus       288 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~  362 (436)
                      .-|..-+.....   .+....+..+...+.....+...   ..+...+...+.++...|+-..|..||...++.+
T Consensus       125 ~L~~~l~~~~~~---s~~l~~i~k~~~~d~~~~~~a~e---~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k  193 (725)
T KOG1093|consen  125 YLGISLEAELTE---SEYLEILLKYYTDDQELLSTAME---HLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK  193 (725)
T ss_pred             HHhhHHHHHHHH---HHHHHHHHHhccCchhHHHHHHH---HHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence            998776653322   22222333332222111100000   0223344567788999999999999996655543

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.56  E-value=0.044  Score=52.90  Aligned_cols=73  Identities=12%  Similarity=0.080  Sum_probs=45.0

Q ss_pred             cccccCceEEEEEEecCCCCCCCCcceEEEEEEecc-------CcchhHHHHHHHHHHHhccC--CC-CceeeeeEeeec
Q 013790           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-------DGLQGHKQWVAEVQFLGVLE--HP-NLVKLIGYCAVD  155 (436)
Q Consensus        86 ~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~~~~  155 (436)
                      .||.|....||++...       ..++.|+||+-..       +-....++...|...|+...  .| .+.++|.+-.. 
T Consensus         2 EigdGnlN~VfrV~~~-------~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e-   73 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQ-------EGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTE-   73 (370)
T ss_pred             cCCCCceEEEEEEEcC-------CCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccc-
Confidence            4799999999999842       2235689997431       11233455566777776654  34 45556544322 


Q ss_pred             CCcceeEEEEEEecCC
Q 013790          156 GERGIQRLLVYEFMLN  171 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~  171 (436)
                       .    ..+|||+++.
T Consensus        74 -~----~~~vMEdL~~   84 (370)
T TIGR01767        74 -M----AVTVMEDLSH   84 (370)
T ss_pred             -c----ceehHhhCcc
Confidence             1    2689999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.49  E-value=0.012  Score=56.86  Aligned_cols=61  Identities=16%  Similarity=0.083  Sum_probs=44.4

Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC
Q 013790          163 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN  228 (436)
Q Consensus       163 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  228 (436)
                      .++-+|..|-++..++....   .++..+.+++.-.+.|+--+---  -+++|.|+.|.||++.-+
T Consensus       321 vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             eeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEEec
Confidence            57778888999999986543   56666667776666665444322  289999999999999543

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.48  E-value=0.0063  Score=54.63  Aligned_cols=30  Identities=27%  Similarity=0.401  Sum_probs=21.5

Q ss_pred             CceeeccCCCCcEEE-cCCCceEEeeccCCC
Q 013790          211 VQVIYRDFKASNVLL-DENFRPKLSDFGLAR  240 (436)
Q Consensus       211 ~~ivH~Dlkp~NIll-~~~~~~kl~Dfg~a~  240 (436)
                      ..++|+||.|.|||+ +.++.++++||..|.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            368999999999999 889999999999874

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.43  E-value=0.029  Score=54.12  Aligned_cols=143  Identities=19%  Similarity=0.219  Sum_probs=76.8

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCc-eeeeeEeeecCCcceeEE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL-VKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~~~~~  163 (436)
                      +.|..|=...+|+......    ..+...|++|+...... ..-.-.+|..+++.+..-++ .++++++ . +      -
T Consensus        20 ~~l~gGlTN~~~~v~~~~~----~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~-~-~------G   86 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEE----NGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVF-G-N------G   86 (330)
T ss_pred             EEeCCcccceEEEEEecCC----CCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEe-C-C------c
Confidence            4455577788998865311    11234788898754322 11123468888888865444 3455444 1 1      1


Q ss_pred             EEEEecCCCCHHHH-----------------hhcCCC----CCCCHHHHHHHHHHH------------------------
Q 013790          164 LVYEFMLNRSLEDH-----------------LFNRAF----PPLPWKTRLHIILGA------------------------  198 (436)
Q Consensus       164 lv~e~~~~gsL~~~-----------------l~~~~~----~~l~~~~~~~i~~ql------------------------  198 (436)
                      +|.+|+++.+|..-                 ++....    .+-.+..+..+..++                        
T Consensus        87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~  166 (330)
T PLN02421         87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD  166 (330)
T ss_pred             EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence            48888877655321                 111110    011222222222221                        


Q ss_pred             -HHHHHHhh-cC-CCCceeeccCCCCcEEEcC-CCceEEeeccCCC
Q 013790          199 -AEGLAYLH-EG-LEVQVIYRDFKASNVLLDE-NFRPKLSDFGLAR  240 (436)
Q Consensus       199 -~~~l~~LH-~~-~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~  240 (436)
                       +..+..+. .. ...-++|+|+.+.|||+++ ++.++++||..|-
T Consensus       167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence             11111111 11 1234799999999999974 5789999999873

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.36  E-value=0.084  Score=51.94  Aligned_cols=74  Identities=14%  Similarity=0.148  Sum_probs=47.8

Q ss_pred             ccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC----cc---hhHHHHHHHHHHHhccC---CCCceeeeeEe
Q 013790           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GL---QGHKQWVAEVQFLGVLE---HPNLVKLIGYC  152 (436)
Q Consensus        83 ~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---hpnIv~~~~~~  152 (436)
                      ..+.||.|....||+....         +..++||+-..-    ..   ....+-..|+..|+.+.   ..++.+++.++
T Consensus        36 ~~~eiggGn~N~VyrV~~~---------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d  106 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS---------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD  106 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC---------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC
Confidence            3567899999999997632         345889986411    11   12334445566666554   34788888887


Q ss_pred             eecCCcceeEEEEEEecCC
Q 013790          153 AVDGERGIQRLLVYEFMLN  171 (436)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~  171 (436)
                      .+.      .+++|||+++
T Consensus       107 ed~------~vlvME~L~~  119 (418)
T PLN02756        107 RTM------ALIGMRYLEP  119 (418)
T ss_pred             CCC------CEEEEeecCC
Confidence            633      2889999976

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.24  E-value=0.066  Score=51.38  Aligned_cols=143  Identities=20%  Similarity=0.235  Sum_probs=77.4

Q ss_pred             cccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCC------ceeeeeEeeecCCcc
Q 013790           86 KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN------LVKLIGYCAVDGERG  159 (436)
Q Consensus        86 ~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~~~~~~~~~~~~  159 (436)
                      .|++ .-..+|+....         +..+++|+....  ....++.-|+..+..|.-.+      +..+-|-....-..+
T Consensus        33 ~l~s-~eN~~f~~~~~---------~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~  100 (331)
T COG2334          33 GLNS-EENSNFRVQTE---------DGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGG  100 (331)
T ss_pred             cccc-ccCceEEEEec---------CCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCC
Confidence            3444 45678887643         333488887765  33445666777777774211      222222111100000


Q ss_pred             eeEEEEEEecCCCCHHH-H--------------hhc--CC--------CCCCCHHH-------------HHHHHHHHHHH
Q 013790          160 IQRLLVYEFMLNRSLED-H--------------LFN--RA--------FPPLPWKT-------------RLHIILGAAEG  201 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~-~--------------l~~--~~--------~~~l~~~~-------------~~~i~~ql~~~  201 (436)
                      ...+-+++|++|..+.. .              |+.  +.        .....|..             -.....++...
T Consensus       101 ~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~  180 (331)
T COG2334         101 PRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAA  180 (331)
T ss_pred             ceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHH
Confidence            35588999999888772 1              010  10        01122320             01122333333


Q ss_pred             HHHhhcC----CCCc---eeeccCCCCcEEEcCCCc-eEEeeccCCC
Q 013790          202 LAYLHEG----LEVQ---VIYRDFKASNVLLDENFR-PKLSDFGLAR  240 (436)
Q Consensus       202 l~~LH~~----~~~~---ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~  240 (436)
                      +..+...    ...+   +||+|+.|.||+++.+.. ..++|||-+.
T Consensus       181 ~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         181 LDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             HHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            3333332    1223   999999999999998885 8999999875

>PRK06148 hypothetical protein; Provisional

Probab=95.85  E-value=0.15  Score=56.80  Aligned_cols=32  Identities=41%  Similarity=0.453  Sum_probs=26.8

Q ss_pred             CCceeeccCCCCcEEEcCCC--ceE-EeeccCCCC
Q 013790          210 EVQVIYRDFKASNVLLDENF--RPK-LSDFGLARE  241 (436)
Q Consensus       210 ~~~ivH~Dlkp~NIll~~~~--~~k-l~Dfg~a~~  241 (436)
                      ..++||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            45899999999999999775  554 999998854

>PTZ00384 choline kinase; Provisional

Probab=95.81  E-value=0.12  Score=50.85  Aligned_cols=83  Identities=17%  Similarity=0.188  Sum_probs=45.5

Q ss_pred             ccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCc-eeeeeEeeecCCccee
Q 013790           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL-VKLIGYCAVDGERGIQ  161 (436)
Q Consensus        83 ~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~~~  161 (436)
                      .++.|..|-...+|++......+ .....+.|.++..... ....-.-.+|+.+++.+...++ .++++.+.  +     
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~-~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~--~-----  124 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDK-DRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG--D-----  124 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCC-CccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecC--C-----
Confidence            34556668889999987541110 0011123444442211 1111122458889998875544 45555542  1     


Q ss_pred             EEEEEEecCCCCHH
Q 013790          162 RLLVYEFMLNRSLE  175 (436)
Q Consensus       162 ~~lv~e~~~~gsL~  175 (436)
                       .+++||++|.+|.
T Consensus       125 -g~l~efIeGr~l~  137 (383)
T PTZ00384        125 -FTIQEWVEGNTMG  137 (383)
T ss_pred             -EEEEEEeccccCC
Confidence             6899999987764

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.76  E-value=0.072  Score=52.13  Aligned_cols=75  Identities=19%  Similarity=0.191  Sum_probs=47.3

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEecc------CcchhHHHHHHHHHHHhccC--CC-CceeeeeEeee
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR------DGLQGHKQWVAEVQFLGVLE--HP-NLVKLIGYCAV  154 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~~~  154 (436)
                      .+.||.|.-.-||++...       ..+..|+||+-..      +-....++..-|.+.|+...  .| .+.+++.+-.+
T Consensus        34 ~~eigdGnlN~VfrV~~~-------~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDE-------QKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSV  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeC-------CCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcH
Confidence            457899999999999753       1235688987431      11233456667778887664  34 45556544322


Q ss_pred             cCCcceeEEEEEEecCC
Q 013790          155 DGERGIQRLLVYEFMLN  171 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~  171 (436)
                      .      ..+|||+++.
T Consensus       107 ~------~~~vMEdL~~  117 (409)
T PRK12396        107 M------NCCVMEDLSD  117 (409)
T ss_pred             H------hhHHHHhCcc
Confidence            1      2689998854

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.73  E-value=0.069  Score=47.61  Aligned_cols=137  Identities=15%  Similarity=0.151  Sum_probs=81.0

Q ss_pred             EEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHH
Q 013790          113 VVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR  191 (436)
Q Consensus       113 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~  191 (436)
                      +..+|++...... ....+..+..++.++.  .|+++..    +  .+...-++.|+|-..              .... 
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N----D--n~~~yGvIlE~Cy~~--------------~i~~-  143 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN----D--NNYKYGVILERCYKI--------------KINF-  143 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec----C--CCceeEEEEeeccCc--------------ccch-
Confidence            3556666544333 3455677888887664  3666651    2  233345788888321              1111 


Q ss_pred             HHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCC
Q 013790          192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL  271 (436)
Q Consensus       192 ~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  271 (436)
                      ..++..=+.+|.-.|+. ..+.+|+|..|+||+-|..|.+||.|=+.--.              .+..|.--|+   ...
T Consensus       144 ~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~Y---~~l  205 (308)
T PF07387_consen  144 SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIEY---ESL  205 (308)
T ss_pred             hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeeec---ccc
Confidence            12222224667888863 35899999999999999999999999774321              1122222111   233


Q ss_pred             CchhhHHHHHHHHHHHHhC
Q 013790          272 TAKSDVWSFGVVLYEMLTG  290 (436)
Q Consensus       272 ~~~~DvwSlGvil~elltg  290 (436)
                      ++++.+=+|=.-++++...
T Consensus       206 T~~aE~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  206 TQEAEVKVFVKSCLKLVEK  224 (308)
T ss_pred             ChHHHHHHHHHHHHHHHHH
Confidence            5677777766666666653

The function of this family is unknown.

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.55  E-value=0.13  Score=48.57  Aligned_cols=53  Identities=19%  Similarity=0.343  Sum_probs=33.5

Q ss_pred             cccCceEEEEEEecC-CCCCCCCcceEEEEEEeccCcc-----hhHHHHHHHHHHHhcc
Q 013790           88 GEGGFGSVYKSSIKP-AAGDGTSEATVVAIKKLNRDGL-----QGHKQWVAEVQFLGVL  140 (436)
Q Consensus        88 g~G~~g~Vy~~~~~~-~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l  140 (436)
                      |.|-.|.+|++.... ...++......++||.......     .....|.+|+.+...+
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~   60 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYREL   60 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHH
Confidence            778889999988764 1223344567788998762211     1224577887776654

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PTZ00296 choline kinase; Provisional

Probab=95.43  E-value=0.18  Score=50.52  Aligned_cols=83  Identities=16%  Similarity=0.182  Sum_probs=46.6

Q ss_pred             ccccccccCceEEEEEEecCCCC-CCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCce-eeeeEeeecCCcce
Q 013790           83 RMLKIGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV-KLIGYCAVDGERGI  160 (436)
Q Consensus        83 ~~~~ig~G~~g~Vy~~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~~  160 (436)
                      .++.|..|=.-.+|++....... .....++.|.+++......... .-.+|..+++.+..-+|- ++++.+  .+    
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f--~g----  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTF--SG----  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEe--CC----
Confidence            34556667778889887542110 0112246788888754432222 234577777777644443 444443  22    


Q ss_pred             eEEEEEEecCCCCH
Q 013790          161 QRLLVYEFMLNRSL  174 (436)
Q Consensus       161 ~~~lv~e~~~~gsL  174 (436)
                        ..|.+|++|.+|
T Consensus       182 --g~I~efi~g~~l  193 (442)
T PTZ00296        182 --GRIEEWLYGDPL  193 (442)
T ss_pred             --CEEEEeeCCccC
Confidence              468999988744

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.04  E-value=0.4  Score=46.12  Aligned_cols=29  Identities=24%  Similarity=0.387  Sum_probs=24.6

Q ss_pred             CCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          210 EVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       210 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..+++|+|+.+.|||++ + .+.|+||+-+.
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            34789999999999995 4 57899999875

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=94.49  E-value=0.28  Score=45.17  Aligned_cols=79  Identities=18%  Similarity=0.076  Sum_probs=52.5

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeEE
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      ...+..|..+.|+.++..        +|.+.++|+.........+  ......|+..+-...|++++.-...+      .
T Consensus         7 ~~~~~~g~~s~V~pv~~~--------dG~~avLKl~~p~~~~~~E--~~g~~~L~~w~G~GaVrll~~d~~~~------A   70 (253)
T PF04655_consen    7 DGPPAHGSSSLVVPVRRA--------DGTPAVLKLAPPHAEAEHE--ARGEAALRWWNGRGAVRLLAADPERG------A   70 (253)
T ss_pred             CCCCCCCcceEEEEEEcC--------CCCeEEEEecCCcccchhh--hhHHhHhheeCCCCceeeeccccccc------h
Confidence            345667999999999753        6789999998654322111  11224577778778899988654332      6


Q ss_pred             EEEEec-CCCCHHHHh
Q 013790          164 LVYEFM-LNRSLEDHL  178 (436)
Q Consensus       164 lv~e~~-~~gsL~~~l  178 (436)
                      +++|.+ ++.+|.+..
T Consensus        71 lLLErl~~g~~L~~~~   86 (253)
T PF04655_consen   71 LLLERLDPGRSLASLP   86 (253)
T ss_pred             hhhhhccCCCchhhcc
Confidence            788988 555776554

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	436
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-52
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		8e-52
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-50
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-48
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-38
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-38
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-37
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-35
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-21
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-21
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-20
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-20
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-20
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-18
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-18
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-18
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-17
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-17
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-17
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-17
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-17
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-17
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-17
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-17
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-17
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-17
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-17
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-17
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-17
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		9e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-16
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-16
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-16
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-16
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-16
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		9e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-14
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		9e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		9e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-13
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-13
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-13
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-12
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		9e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		9e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-11
3soa_A	444	Full-Length Human Camkii Length = 444		1e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		9e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-09
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		8e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		9e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-07
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-07
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-07
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-07
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-07
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-07
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-07
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-07
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		8e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		9e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		7e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-05

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 115/295 (38%), Positives = 174/295 (58%), Gaps = 18/295 (6%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA 132
           ++ +ATN+F     IG G FG VYK  ++  A         VA+K+   +  QG +++  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK--------VALKRRTPESSQGIEEFET 84
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP--WKT 190
           E++ L    HP+LV LIG+C    ER  + +L+Y++M N +L+ HL+    P +   W+ 
Sbjct: 85  EIETLSFCRHPHLVSLIGFC---DERN-EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
           RL I +GAA GL YLH      +I+RD K+ N+LLDENF PK++DFG++++G  +G TH+
Sbjct: 141 RLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHL 197
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
              V GT GY  P+Y   G LT KSDV+SFGVVL+E+L  R ++ ++ P+    L EW  
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
           +   ++ +   I+DP L  +      RK G  A  CL+ SS+DRP M  V+ +L+
Sbjct: 258 E-SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  201 bits (510), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 114/295 (38%), Positives = 173/295 (58%), Gaps = 18/295 (6%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA 132
           ++ +ATN+F     IG G FG VYK  ++  A         VA+K+   +  QG +++  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK--------VALKRRTPESSQGIEEFET 84
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP--WKT 190
           E++ L    HP+LV LIG+C    ER  + +L+Y++M N +L+ HL+    P +   W+ 
Sbjct: 85  EIETLSFCRHPHLVSLIGFC---DERN-EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
           RL I +GAA GL YLH      +I+RD K+ N+LLDENF PK++DFG++++G  +  TH+
Sbjct: 141 RLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
              V GT GY  P+Y   G LT KSDV+SFGVVL+E+L  R ++ ++ P+    L EW  
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
           +   ++ +   I+DP L  +      RK G  A  CL+ SS+DRP M  V+ +L+
Sbjct: 258 E-SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  195 bits (496), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 123/329 (37%), Positives = 188/329 (57%), Gaps = 27/329 (8%)
Query: 65  NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL 124
            L+ FS  E++ A+++FS    +G GGFG VYK  +        ++ T+VA+K+L  +  
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL--------ADGTLVAVKRLKEERX 75
Query: 125 QGHK-QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-- 181
           QG + Q+  EV+ + +  H NL++L G+C    ER    LLVY +M N S+   L  R  
Sbjct: 76  QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER----LLVYPYMANGSVASCLRERPE 131
Query: 182 AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE 241
           + PPL W  R  I LG+A GLAYLH+  + ++I+RD KA+N+LLDE F   + DFGLA+ 
Sbjct: 132 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 191
Query: 242 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 301
                  HV  AV GT G+ AP+Y+ TG  + K+DV+ +GV+L E++TG+R+ +  R   
Sbjct: 192 MD-YKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 250
Query: 302 EQ--RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
           +    LL+WV+    + KK   ++D  L+  Y   E  ++ ++A  C   S  +RPKMS+
Sbjct: 251 DDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 309
Query: 360 VVERLKQIVQVSNEGDSFDKTFEEICEED 388
           VV  L        EGD   + +EE  +E+
Sbjct: 310 VVRML--------EGDGLAERWEEWQKEE 330

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  189 bits (480), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 120/329 (36%), Positives = 185/329 (56%), Gaps = 27/329 (8%)
Query: 65  NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL 124
            L+ FS  E++ A+++F     +G GGFG VYK  +        ++  +VA+K+L  +  
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRL--------ADGXLVAVKRLKEERT 67
Query: 125 QGHK-QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-- 181
           QG + Q+  EV+ + +  H NL++L G+C    ER    LLVY +M N S+   L  R  
Sbjct: 68  QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER----LLVYPYMANGSVASCLRERPE 123
Query: 182 AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE 241
           + PPL W  R  I LG+A GLAYLH+  + ++I+RD KA+N+LLDE F   + DFGLA+ 
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 242 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 301
                  HV  AV G  G+ AP+Y+ TG  + K+DV+ +GV+L E++TG+R+ +  R   
Sbjct: 184 MD-YKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
Query: 302 EQ--RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
           +    LL+WV+    + KK   ++D  L+  Y   E  ++ ++A  C   S  +RPKMS+
Sbjct: 243 DDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301
Query: 360 VVERLKQIVQVSNEGDSFDKTFEEICEED 388
           VV  L        EGD   + +EE  +E+
Sbjct: 302 VVRML--------EGDGLAERWEEWQKEE 322

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 108/311 (34%), Positives = 166/311 (53%), Gaps = 31/311 (9%)
Query: 69  FSYSEMRQATNDFSRM------LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--- 119
           FS+ E++  TN+F          K+GEGGFG VYK         G    T VA+KKL   
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYK---------GYVNNTTVAVKKLAAM 65
Query: 120 -NRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 178
            +    +  +Q+  E++ +   +H NLV+L+G+ + DG+      LVY +M N SL D L
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-DGD---DLCLVYVYMPNGSLLDRL 121
Query: 179 FN-RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 237
                 PPL W  R  I  GAA G+ +LHE      I+RD K++N+LLDE F  K+SDFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFG 178
Query: 238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           LAR       T + + +VGT  Y AP+ +  G +T KSD++SFGVVL E++TG  +++ +
Sbjct: 179 LARASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH 237
Query: 298 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 357
           R    Q LL+  ++   + K     +D ++    S +    +  +A  CL +    RP +
Sbjct: 238 REP--QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDI 294
Query: 358 SQVVERLKQIV 368
            +V + L+++ 
Sbjct: 295 KKVQQLLQEMT 305

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  154 bits (390), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 108/311 (34%), Positives = 165/311 (53%), Gaps = 31/311 (9%)
Query: 69  FSYSEMRQATNDFSRM------LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--- 119
           FS+ E++  TN+F          K+GEGGFG VYK         G    T VA+KKL   
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYK---------GYVNNTTVAVKKLAAM 65
Query: 120 -NRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 178
            +    +  +Q+  E++ +   +H NLV+L+G+ + DG+      LVY +M N SL D L
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-DGD---DLCLVYVYMPNGSLLDRL 121
Query: 179 FN-RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 237
                 PPL W  R  I  GAA G+ +LHE      I+RD K++N+LLDE F  K+SDFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFG 178
Query: 238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           LAR       T +   +VGT  Y AP+ +  G +T KSD++SFGVVL E++TG  +++ +
Sbjct: 179 LARASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH 237
Query: 298 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 357
           R    Q LL+  ++   + K     +D ++    S +    +  +A  CL +    RP +
Sbjct: 238 REP--QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDI 294
Query: 358 SQVVERLKQIV 368
            +V + L+++ 
Sbjct: 295 KKVQQLLQEMT 305

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 107/311 (34%), Positives = 164/311 (52%), Gaps = 31/311 (9%)
Query: 69  FSYSEMRQATNDFSRM------LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--- 119
           FS+ E++  TN+F          K+GEGGFG VYK         G    T VA+KKL   
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYK---------GYVNNTTVAVKKLAAM 59
Query: 120 -NRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 178
            +    +  +Q+  E++ +   +H NLV+L+G+ + DG+      LVY +M N SL D L
Sbjct: 60  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-DGD---DLCLVYVYMPNGSLLDRL 115
Query: 179 FN-RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 237
                 PPL W  R  I  GAA G+ +LHE      I+RD K++N+LLDE F  K+SDFG
Sbjct: 116 SCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFG 172
Query: 238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           LAR         +   +VGT  Y AP+ +  G +T KSD++SFGVVL E++TG  +++ +
Sbjct: 173 LARASEKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH 231
Query: 298 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 357
           R    Q LL+  ++   + K     +D ++    S +    +  +A  CL +    RP +
Sbjct: 232 REP--QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDI 288
Query: 358 SQVVERLKQIV 368
            +V + L+++ 
Sbjct: 289 KKVQQLLQEMT 299

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  144 bits (364), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 106/309 (34%), Positives = 158/309 (51%), Gaps = 31/309 (10%)
Query: 69  FSYSEMRQATNDFSRM------LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--- 119
           FS+ E++  TN+F          K GEGGFG VYK         G    T VA+KKL   
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYK---------GYVNNTTVAVKKLAAM 56
Query: 120 -NRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 178
            +    +  +Q+  E++     +H NLV+L+G+ + DG+      LVY +  N SL D L
Sbjct: 57  VDITTEELKQQFDQEIKVXAKCQHENLVELLGFSS-DGD---DLCLVYVYXPNGSLLDRL 112
Query: 179 FN-RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 237
                 PPL W  R  I  GAA G+ +LHE      I+RD K++N+LLDE F  K+SDFG
Sbjct: 113 SCLDGTPPLSWHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFG 169
Query: 238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           LAR           + +VGT  Y AP+ +  G +T KSD++SFGVVL E++TG  +++ +
Sbjct: 170 LARASEKFAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH 228
Query: 298 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 357
           R    Q LL+  ++   + K     +D +     S +       +A  CL +    RP +
Sbjct: 229 REP--QLLLDIKEEIEDEEKTIEDYIDKKXNDADSTS-VEAXYSVASQCLHEKKNKRPDI 285
Query: 358 SQVVERLKQ 366
            +V + L++
Sbjct: 286 KKVQQLLQE 294

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 95/295 (32%), Positives = 133/295 (45%), Gaps = 27/295 (9%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGV 139
             ++  +GEG FG V      P   DGT E  +VA+K L  D G Q    W  E+  L  
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGE--MVAVKALKADCGPQHRSGWKQEIDILRT 72
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L H +++K  G C   GE+ +Q  LV E++   SL D+L   +   +     L       
Sbjct: 73  LYHEHIIKYKGCCEDQGEKSLQ--LVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQIC 127
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG--- 256
           EG+AYLH       I+R+  A NVLLD +   K+ DFGLA+  P  GH +      G   
Sbjct: 128 EGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSP 183
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 316
            F YA P+ ++       SDVWSFGV LYE+LT   S     P T  + LE +    A  
Sbjct: 184 VFWYA-PECLKEYKFYYASDVWSFGVTLYELLTHCDS--SQSPPT--KFLELIGI--AQG 236
Query: 317 KKFGLIMDPRLEKEYSINEARK----IGRLADNCLSKSSKDRPKMSQVVERLKQI 367
           +   L +   LE+   +    K    +  L  NC    +  RP    ++  LK +
Sbjct: 237 QMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 95/295 (32%), Positives = 133/295 (45%), Gaps = 27/295 (9%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGV 139
             ++  +GEG FG V      P   DGT E  +VA+K L  D G Q    W  E+  L  
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGE--MVAVKALKADCGPQHRSGWKQEIDILRT 72
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L H +++K  G C   GE+ +Q  LV E++   SL D+L   +   +     L       
Sbjct: 73  LYHEHIIKYKGCCEDQGEKSLQ--LVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQIC 127
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG--- 256
           EG+AYLH       I+R+  A NVLLD +   K+ DFGLA+  P  GH +      G   
Sbjct: 128 EGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSP 183
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 316
            F YA P+ ++       SDVWSFGV LYE+LT   S     P T  + LE +    A  
Sbjct: 184 VFWYA-PECLKEYKFYYASDVWSFGVTLYELLTHCDS--SQSPPT--KFLELIGI--AQG 236
Query: 317 KKFGLIMDPRLEKEYSINEARK----IGRLADNCLSKSSKDRPKMSQVVERLKQI 367
           +   L +   LE+   +    K    +  L  NC    +  RP    ++  LK +
Sbjct: 237 QMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 126/292 (43%), Gaps = 46/292 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG GGFG VY+     A   G   A   A    + D  Q  +    E +   +L+HPN++
Sbjct: 15  IGIGGFGKVYR-----AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP---LPWKTRLHIILGAAEGLA 203
            L G C     +     LV EF     L   L  +  PP   + W  ++      A G+ 
Sbjct: 70  ALRGVCL----KEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ARGMN 119
Query: 204 YLHEGLEVQVIYRDFKASNVLLDE--------NFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           YLH+   V +I+RD K+SN+L+ +        N   K++DFGLARE     H     +  
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTKMSAA 175
Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
           G + + AP+ I     +  SDVWS+GV+L+E+LTG                   +     
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF---------------RGIDGL 220
Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
           +  +G+ M+ +L             +L ++C +     RP  + ++++L  I
Sbjct: 221 AVAYGVAMN-KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 128/256 (50%), Gaps = 26/256 (10%)
Query: 114 VAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS 173
           VAIK + R+G    + ++ E + +  L HP LV+L G C           LV+EFM +  
Sbjct: 32  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA----PICLVFEFMEHGC 86
Query: 174 LEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL 233
           L D+L  +       +T L + L   EG+AYL E     VI+RD  A N L+ EN   K+
Sbjct: 87  LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 142
Query: 234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS 293
           SDFG+ R      +T  ST       +A+P+       ++KSDVWSFGV+++E+ +  + 
Sbjct: 143 SDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201
Query: 294 LERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD 353
              NR  +E  ++E +      S  F L   PRL   +       + ++ ++C  +  +D
Sbjct: 202 PYENRSNSE--VVEDI------STGFRL-YKPRLASTH-------VYQIMNHCWKERPED 245
Query: 354 RPKMSQVVERLKQIVQ 369
           RP  S+++ +L +I +
Sbjct: 246 RPAFSRLLRQLAEIAE 261

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 128/256 (50%), Gaps = 26/256 (10%)
Query: 114 VAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS 173
           VAIK + R+G    + ++ E + +  L HP LV+L G C           LV+EFM +  
Sbjct: 34  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA----PICLVFEFMEHGC 88
Query: 174 LEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL 233
           L D+L  +       +T L + L   EG+AYL E     VI+RD  A N L+ EN   K+
Sbjct: 89  LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 144
Query: 234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS 293
           SDFG+ R      +T  ST       +A+P+       ++KSDVWSFGV+++E+ +  + 
Sbjct: 145 SDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 203
Query: 294 LERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD 353
              NR  +E  ++E +      S  F L   PRL   +       + ++ ++C  +  +D
Sbjct: 204 PYENRSNSE--VVEDI------STGFRL-YKPRLASTH-------VYQIMNHCWKERPED 247
Query: 354 RPKMSQVVERLKQIVQ 369
           RP  S+++ +L +I +
Sbjct: 248 RPAFSRLLRQLAEIAE 263

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 123/256 (48%), Gaps = 26/256 (10%)
Query: 114 VAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS 173
           VAIK + R+G    + ++ E + +  L HP LV+L G C           LV+EFM +  
Sbjct: 37  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA----PICLVFEFMEHGC 91
Query: 174 LEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL 233
           L D+L  +       +T L + L   EG+AYL E     VI+RD  A N L+ EN   K+
Sbjct: 92  LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 147
Query: 234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS 293
           SDFG+ R      +T  ST       +A+P+       ++KSDVWSFGV+++E+ +  + 
Sbjct: 148 SDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 206
Query: 294 LERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD 353
              NR  +E            D      +  PRL   +       + ++ ++C  +  +D
Sbjct: 207 PYENRSNSE---------VVEDISTGFRLYKPRLASTH-------VYQIMNHCWRERPED 250
Query: 354 RPKMSQVVERLKQIVQ 369
           RP  S+++ +L +I +
Sbjct: 251 RPAFSRLLRQLAEIAE 266

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/216 (37%), Positives = 106/216 (49%), Gaps = 23/216 (10%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGV 139
             ++  +GEG FG V      P   DGT E  +VA+K L    G Q    W  E++ L  
Sbjct: 11  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGE--MVAVKALKEGCGPQLRSGWQREIEILRT 67
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA- 198
           L H ++VK  G C   GE+ +Q  LV E++   SL D+L      P        ++L A 
Sbjct: 68  LYHEHIVKYKGCCEDQGEKSVQ--LVMEYVPLGSLRDYL------PRHCVGLAQLLLFAQ 119
Query: 199 --AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
              EG+AYLH       I+R   A NVLLD +   K+ DFGLA+  P  GH +      G
Sbjct: 120 QICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDG 175
Query: 257 ---TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
               F YA P+ ++       SDVWSFGV LYE+LT
Sbjct: 176 DSPVFWYA-PECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/216 (37%), Positives = 106/216 (49%), Gaps = 23/216 (10%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGV 139
             ++  +GEG FG V      P   DGT E  +VA+K L    G Q    W  E++ L  
Sbjct: 10  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGE--MVAVKALKEGCGPQLRSGWQREIEILRT 66
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA- 198
           L H ++VK  G C   GE+ +Q  LV E++   SL D+L      P        ++L A 
Sbjct: 67  LYHEHIVKYKGCCEDQGEKSVQ--LVMEYVPLGSLRDYL------PRHCVGLAQLLLFAQ 118
Query: 199 --AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
              EG+AYLH       I+R   A NVLLD +   K+ DFGLA+  P  GH +      G
Sbjct: 119 QICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDG 174
Query: 257 ---TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
               F YA P+ ++       SDVWSFGV LYE+LT
Sbjct: 175 DSPVFWYA-PECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 126/254 (49%), Gaps = 26/254 (10%)
Query: 114 VAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS 173
           VAIK + R+G    + ++ E + +  L HP LV+L G C           LV+EFM +  
Sbjct: 34  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA----PICLVFEFMEHGC 88
Query: 174 LEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL 233
           L D+L  +       +T L + L   EG+AYL E     VI+RD  A N L+ EN   K+
Sbjct: 89  LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---SVIHRDLAARNCLVGENQVIKV 144
Query: 234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS 293
           SDFG+ R      +T  ST       +A+P+       ++KSDVWSFGV+++E+ +  + 
Sbjct: 145 SDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 203
Query: 294 LERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD 353
              NR  +E  ++E +      S  F L   PRL   +       + ++ ++C  +  +D
Sbjct: 204 PYENRSNSE--VVEDI------STGFRL-YKPRLASTH-------VYQIMNHCWKERPED 247
Query: 354 RPKMSQVVERLKQI 367
           RP  S+++ +L  I
Sbjct: 248 RPAFSRLLRQLAAI 261

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 95/295 (32%), Positives = 130/295 (44%), Gaps = 27/295 (9%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGV 139
             ++  +GEG FG V      P   DGT E  +VA+K L  D G Q    W  E+  L  
Sbjct: 33  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGE--MVAVKALKADAGPQHRSGWKQEIDILRT 89
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L H +++K  G C   G   +Q  LV E++   SL D+L   +   +     L       
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQ--LVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQIC 144
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG--- 256
           EG+AYLH       I+RD  A NVLLD +   K+ DFGLA+  P  GH        G   
Sbjct: 145 EGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEXYRVREDGDSP 200
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 316
            F YA P+ ++       SDVWSFGV LYE+LT   S     P T  + LE +    A  
Sbjct: 201 VFWYA-PECLKEYKFYYASDVWSFGVTLYELLTHCDS--SQSPPT--KFLELIGI--AQG 253
Query: 317 KKFGLIMDPRLEKEYSINEARK----IGRLADNCLSKSSKDRPKMSQVVERLKQI 367
           +   L +   LE+   +    K    +  L  NC    +  RP    ++  LK +
Sbjct: 254 QMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 122/256 (47%), Gaps = 26/256 (10%)
Query: 114 VAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS 173
           VAIK + R+G    + ++ E + +  L HP LV+L G C           LV EFM +  
Sbjct: 35  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA----PICLVTEFMEHGC 89
Query: 174 LEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL 233
           L D+L  +       +T L + L   EG+AYL E     VI+RD  A N L+ EN   K+
Sbjct: 90  LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 145
Query: 234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS 293
           SDFG+ R      +T  ST       +A+P+       ++KSDVWSFGV+++E+ +  + 
Sbjct: 146 SDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
Query: 294 LERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD 353
              NR  +E            D      +  PRL   +       + ++ ++C  +  +D
Sbjct: 205 PYENRSNSE---------VVEDISTGFRLYKPRLASTH-------VYQIMNHCWRERPED 248
Query: 354 RPKMSQVVERLKQIVQ 369
           RP  S+++ +L +I +
Sbjct: 249 RPAFSRLLRQLAEIAE 264

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 127/256 (49%), Gaps = 26/256 (10%)
Query: 114 VAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS 173
           VAIK + ++G      ++ E + +  L HP LV+L G C           LV+EFM +  
Sbjct: 54  VAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQA----PICLVFEFMEHGC 108
Query: 174 LEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL 233
           L D+L  +       +T L + L   EG+AYL E     VI+RD  A N L+ EN   K+
Sbjct: 109 LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 164
Query: 234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS 293
           SDFG+ R      +T  ST       +A+P+       ++KSDVWSFGV+++E+ +  + 
Sbjct: 165 SDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 223
Query: 294 LERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD 353
              NR  +E  ++E +      S  F L   PRL   +       + ++ ++C  +  +D
Sbjct: 224 PYENRSNSE--VVEDI------STGFRL-YKPRLASTH-------VYQIMNHCWKERPED 267
Query: 354 RPKMSQVVERLKQIVQ 369
           RP  S+++ +L +I +
Sbjct: 268 RPAFSRLLRQLAEIAE 283

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 136/305 (44%), Gaps = 40/305 (13%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
            D +   K+G G FG VY+   K         +  VA+K L  D ++  ++++ E   + 
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EEFLKEAAVMK 62
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            ++HPNLV+L+G C     R     ++ EFM   +L D+L       +     L++    
Sbjct: 63  EIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 118
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT- 257
           +  + YL +      I+RD  A N L+ EN   K++DFGL+R   M G T   TA  G  
Sbjct: 119 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDT--XTAHAGAK 171
Query: 258 --FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA 314
               + AP+ +     + KSDVW+FGV+L+E+ T G        P     LLE       
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE------- 224
Query: 315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEG 374
                    D R+E+     E  K+  L   C   +  DRP  +++ +  + + Q S+  
Sbjct: 225 --------KDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 274
Query: 375 DSFDK 379
           D  +K
Sbjct: 275 DEVEK 279

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 139/306 (45%), Gaps = 50/306 (16%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA---- 132
           A N+     +IG+GGFG V+K       G    + +VVAIK L     +G  + +     
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHK-------GRLVKDKSVVAIKSLILGDSEGETEMIEKFQE 69
Query: 133 ---EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
              EV  +  L HPN+VKL G             +V EF+    L   L ++A P + W 
Sbjct: 70  FQREVFIMSNLNHPNIVKLYGLMHNPPR------MVMEFVPCGDLYHRLLDKAHP-IKWS 122
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DEN--FRPKLSDFGLAREGPM 244
            +L ++L  A G+ Y+ +     +++RD ++ N+ L   DEN     K++DFGL+++   
Sbjct: 123 VKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-- 179
Query: 245 VGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE 302
               H  + ++G F + AP+ I  E    T K+D +SF ++LY +LTG    +       
Sbjct: 180 ---VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------- 229
Query: 303 QRLLEWVQQYPADSKKF-GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 361
                   +Y     KF  +I +  L      +   ++  + + C S   K RP  S +V
Sbjct: 230 --------EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281
Query: 362 ERLKQI 367
           + L ++
Sbjct: 282 KELSEL 287

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 136/292 (46%), Gaps = 42/292 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQGHKQWVAEVQFLGVL 140
           +IG G FG+VYK       GD       VA+K LN        LQ  K    EV  L   
Sbjct: 31  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKT 77
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
            H N++  +GY         Q  +V ++    SL  HL + +      K  + I    A 
Sbjct: 78  RHVNILLFMGYSTAP-----QLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTAR 131
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           G+ YLH      +I+RD K++N+ L E+   K+ DFGLA E      +H    + G+  +
Sbjct: 132 GMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 261 AAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK 317
            AP+ I   ++   + +SDV++FG+VLYE++TG+  L  +      +++E V +      
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGS---- 242
Query: 318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                + P L K  S N  +++ RL   CL K   +RP   +++  ++++ +
Sbjct: 243 -----LSPDLSKVRS-NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 146/317 (46%), Gaps = 46/317 (14%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 56
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLP 187
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR      
Sbjct: 57  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ----- 107
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G
Sbjct: 108 -EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTG 164
Query: 247 HTHVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
            T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S            
Sbjct: 165 DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------ 212
Query: 306 LEWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                 YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +
Sbjct: 213 -----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQ 265
Query: 363 RLKQIVQVSNEGDSFDK 379
             + + Q S+  D  +K
Sbjct: 266 AFETMFQESSISDEVEK 282

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 146/317 (46%), Gaps = 46/317 (14%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 57
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLP 187
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR      
Sbjct: 58  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ----- 108
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G
Sbjct: 109 -EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTG 165
Query: 247 HTHVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
            T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S            
Sbjct: 166 DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------ 213
Query: 306 LEWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                 YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +
Sbjct: 214 -----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQ 266
Query: 363 RLKQIVQVSNEGDSFDK 379
             + + Q S+  D  +K
Sbjct: 267 AFETMFQESSISDEVEK 283

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 135/303 (44%), Gaps = 36/303 (11%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
            D +   K+G G +G VY+   K         +  VA+K L  D ++  ++++ E   + 
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EEFLKEAAVMK 62
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            ++HPNLV+L+G C     R     ++ EFM   +L D+L       +     L++    
Sbjct: 63  EIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 118
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG-T 257
           +  + YL +      I+RD  A N L+ EN   K++DFGL+R   M G T  + A     
Sbjct: 119 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTFTAHAGAKFP 173
Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS 316
             + AP+ +     + KSDVW+FGV+L+E+ T G        P     LLE         
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE--------- 224
Query: 317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS 376
                  D R+E+     E  K+  L   C   +  DRP  +++ +  + + Q S+  D 
Sbjct: 225 ------KDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 276
Query: 377 FDK 379
            +K
Sbjct: 277 VEK 279

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 142/314 (45%), Gaps = 40/314 (12%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 55
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L       +   
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIIIEFMTYGNLLDYLRECNRQEVSAV 111
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
             L++    +  + YL +      I+RD  A N L+ EN   K++DFGL+R   M G T+
Sbjct: 112 VLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTY 166
Query: 250 VSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW 308
            + A       + AP+ +     + KSDVW+FGV+L+E+ T   S               
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS--------------- 211
Query: 309 VQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
              YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +  +
Sbjct: 212 --PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFE 267
Query: 366 QIVQVSNEGDSFDK 379
            + Q S+  D  +K
Sbjct: 268 TMFQESSISDEVEK 281

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 142/314 (45%), Gaps = 40/314 (12%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 55
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L       +   
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAV 111
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
             L++    +  + YL +      I+RD  A N L+ EN   K++DFGL+R   M G T+
Sbjct: 112 VLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTY 166
Query: 250 VSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW 308
            + A       + AP+ +     + KSDVW+FGV+L+E+ T   S               
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS--------------- 211
Query: 309 VQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
              YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +  +
Sbjct: 212 --PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFE 267
Query: 366 QIVQVSNEGDSFDK 379
            + Q S+  D  +K
Sbjct: 268 TMFQESSISDEVEK 281

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 142/314 (45%), Gaps = 40/314 (12%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 60
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L       +   
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAV 116
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
             L++    +  + YL +      I+RD  A N L+ EN   K++DFGL+R   M G T+
Sbjct: 117 VLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTY 171
Query: 250 VSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW 308
            + A       + AP+ +     + KSDVW+FGV+L+E+ T   S               
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS--------------- 216
Query: 309 VQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
              YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +  +
Sbjct: 217 --PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFE 272
Query: 366 QIVQVSNEGDSFDK 379
            + Q S+  D  +K
Sbjct: 273 TMFQESSISDEVEK 286

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 142/314 (45%), Gaps = 40/314 (12%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 55
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L       +   
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIIIEFMTYGNLLDYLRECNRQEVSAV 111
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
             L++    +  + YL +      I+RD  A N L+ EN   K++DFGL+R   M G T+
Sbjct: 112 VLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTY 166
Query: 250 VSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW 308
            + A       + AP+ +     + KSDVW+FGV+L+E+ T   S               
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS--------------- 211
Query: 309 VQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
              YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +  +
Sbjct: 212 --PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFE 267
Query: 366 QIVQVSNEGDSFDK 379
            + Q S+  D  +K
Sbjct: 268 TMFQESSISDEVEK 281

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 146/317 (46%), Gaps = 46/317 (14%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 60
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLP 187
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR      
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ----- 111
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G
Sbjct: 112 -EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTG 168
Query: 247 HTHVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
            T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S            
Sbjct: 169 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------ 216
Query: 306 LEWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                 YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +
Sbjct: 217 -----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQ 269
Query: 363 RLKQIVQVSNEGDSFDK 379
             + + Q S+  D  +K
Sbjct: 270 AFETMFQESSISDEVEK 286

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 146/317 (46%), Gaps = 46/317 (14%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 57
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLP 187
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR      
Sbjct: 58  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ----- 108
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G
Sbjct: 109 -EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTG 165
Query: 247 HTHVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
            T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S            
Sbjct: 166 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------ 213
Query: 306 LEWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                 YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +
Sbjct: 214 -----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQ 266
Query: 363 RLKQIVQVSNEGDSFDK 379
             + + Q S+  D  +K
Sbjct: 267 AFETMFQESSISDEVEK 283

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 146/317 (46%), Gaps = 46/317 (14%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 57
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLP 187
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR      
Sbjct: 58  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ----- 108
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G
Sbjct: 109 -EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTG 165
Query: 247 HTHVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
            T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S            
Sbjct: 166 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------ 213
Query: 306 LEWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                 YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +
Sbjct: 214 -----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQ 266
Query: 363 RLKQIVQVSNEGDSFDK 379
             + + Q S+  D  +K
Sbjct: 267 AFETMFQESSISDEVEK 283

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 146/317 (46%), Gaps = 46/317 (14%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 68
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLP 187
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR      
Sbjct: 69  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ----- 119
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G
Sbjct: 120 -EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTG 176
Query: 247 HTHVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
            T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S            
Sbjct: 177 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------ 224
Query: 306 LEWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                 YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +
Sbjct: 225 -----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQ 277
Query: 363 RLKQIVQVSNEGDSFDK 379
             + + Q S+  D  +K
Sbjct: 278 AFETMFQESSISDEVEK 294

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 142/314 (45%), Gaps = 40/314 (12%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 55
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L       +   
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAV 111
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
             L++    +  + YL +      I+RD  A N L+ EN   K++DFGL+R   M G T+
Sbjct: 112 VLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTY 166
Query: 250 VSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW 308
            + A       + AP+ +     + KSDVW+FGV+L+E+ T   S               
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS--------------- 211
Query: 309 VQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
              YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +  +
Sbjct: 212 --PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFE 267
Query: 366 QIVQVSNEGDSFDK 379
            + Q S+  D  +K
Sbjct: 268 TMFQESSISDEVEK 281

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 136/292 (46%), Gaps = 42/292 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQGHKQWVAEVQFLGVL 140
           +IG G FG+VYK       GD       VA+K LN        LQ  K    EV  L   
Sbjct: 31  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKT 77
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
            H N++  +GY         Q  +V ++    SL  HL + +      K  + I    A 
Sbjct: 78  RHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTAR 131
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           G+ YLH      +I+RD K++N+ L E+   K+ DFGLA E      +H    + G+  +
Sbjct: 132 GMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 261 AAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK 317
            AP+ I   ++   + +SDV++FG+VLYE++TG+  L  +      +++E V +      
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGS---- 242
Query: 318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                + P L K  S N  +++ RL   CL K   +RP   +++  ++++ +
Sbjct: 243 -----LSPDLSKVRS-NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 89/319 (27%), Positives = 146/319 (45%), Gaps = 50/319 (15%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 56
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLP 187
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR      
Sbjct: 57  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIIIEFMTYGNLLDYLRECNRQ----- 107
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G
Sbjct: 108 -EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTG 164
Query: 247 HTHVSTAVVGT---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ 303
            T   TA  G      + AP+ +     + KSDVW+FGV+L+E+ T   S          
Sbjct: 165 DT--XTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------- 212
Query: 304 RLLEWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
                   YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++
Sbjct: 213 -------PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEI 263
Query: 361 VERLKQIVQVSNEGDSFDK 379
            +  + + Q S+  D  +K
Sbjct: 264 HQAFETMFQESSISDEVEK 282

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 138/306 (45%), Gaps = 50/306 (16%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA---- 132
           A N+     +IG+GGFG V+K       G    + +VVAIK L     +G  + +     
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHK-------GRLVKDKSVVAIKSLILGDSEGETEMIEKFQE 69
Query: 133 ---EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
              EV  +  L HPN+VKL G             +V EF+    L   L ++A P + W 
Sbjct: 70  FQREVFIMSNLNHPNIVKLYGLMHNPPR------MVMEFVPCGDLYHRLLDKAHP-IKWS 122
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DEN--FRPKLSDFGLAREGPM 244
            +L ++L  A G+ Y+ +     +++RD ++ N+ L   DEN     K++DFG +++   
Sbjct: 123 VKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-- 179
Query: 245 VGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE 302
               H  + ++G F + AP+ I  E    T K+D +SF ++LY +LTG    +       
Sbjct: 180 ---VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------- 229
Query: 303 QRLLEWVQQYPADSKKF-GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 361
                   +Y     KF  +I +  L      +   ++  + + C S   K RP  S +V
Sbjct: 230 --------EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281
Query: 362 ERLKQI 367
           + L ++
Sbjct: 282 KELSEL 287

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 138/306 (45%), Gaps = 50/306 (16%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA---- 132
           A N+     +IG+GGFG V+K       G    + +VVAIK L     +G  + +     
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHK-------GRLVKDKSVVAIKSLILGDSEGETEMIEKFQE 69
Query: 133 ---EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
              EV  +  L HPN+VKL G             +V EF+    L   L ++A P + W 
Sbjct: 70  FQREVFIMSNLNHPNIVKLYGLMHNPPR------MVMEFVPCGDLYHRLLDKAHP-IKWS 122
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DEN--FRPKLSDFGLAREGPM 244
            +L ++L  A G+ Y+ +     +++RD ++ N+ L   DEN     K++DF L+++   
Sbjct: 123 VKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-- 179
Query: 245 VGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE 302
               H  + ++G F + AP+ I  E    T K+D +SF ++LY +LTG    +       
Sbjct: 180 ---VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------- 229
Query: 303 QRLLEWVQQYPADSKKF-GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 361
                   +Y     KF  +I +  L      +   ++  + + C S   K RP  S +V
Sbjct: 230 --------EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281
Query: 362 ERLKQI 367
           + L ++
Sbjct: 282 KELSEL 287

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 136/303 (44%), Gaps = 43/303 (14%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
            D +   K+G G +G VY+   K         +  VA+K L  D ++  ++++ E   + 
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EEFLKEAAVMK 62
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            ++HPNLV+L+G C     R     ++ EFM   +L D+L       +     L++    
Sbjct: 63  EIKHPNLVQLLGVCT----REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 118
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT- 257
           +  + YL +      I+RD  A N L+ EN   K++DFGL+R   M G T   TA  G  
Sbjct: 119 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDT--XTAHAGAK 171
Query: 258 --FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA 314
               + AP+ +     + KSDVW+FGV+L+E+ T G        P     LLE       
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE------- 224
Query: 315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ---VS 371
                    D R+E+     E  K+  L   C   +  DRP  +++ +  + + Q   +S
Sbjct: 225 --------KDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 274
Query: 372 NEG 374
           +EG
Sbjct: 275 DEG 277

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 146/323 (45%), Gaps = 41/323 (12%)
Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIK-PAAGDGTSEATVV 114
           PE YE+    +  F+  E+  +     R+  IG G FG V    +K P   D       V
Sbjct: 23  PETYEDPNRAVHQFA-KELDASCIKIERV--IGAGEFGEVCSGRLKLPGKRD-----VAV 74
Query: 115 AIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS 173
           AIK L     +  ++ ++ E   +G  +HPN+V L G       RG   ++V EFM N +
Sbjct: 75  AIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVT----RGKPVMIVIEFMENGA 130
Query: 174 LEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL 233
           L D    +          + ++ G A G+ YL    ++  ++RD  A N+L++ N   K+
Sbjct: 131 L-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKV 186
Query: 234 SDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT- 289
           SDFGL+R   + P   +T     +     + AP+ I+    T+ SDVWS+G+V++E+++ 
Sbjct: 187 SDFGLSRVIEDDPEAVYTTTGGKI--PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 244
Query: 290 GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSK 349
           G R       +   + +E   + PA                  ++    + +L  +C  K
Sbjct: 245 GERPYWDMSNQDVIKAIEEGYRLPA-----------------PMDCPAGLHQLMLDCWQK 287
Query: 350 SSKDRPKMSQVVERLKQIVQVSN 372
              +RPK  Q+V  L ++++  N
Sbjct: 288 ERAERPKFEQIVGILDKMIRNPN 310

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 146/317 (46%), Gaps = 46/317 (14%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 301
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLP 187
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR      
Sbjct: 302 FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ----- 352
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            +    ++L  A  ++   E LE +  I+R+  A N L+ EN   K++DFGL+R   M G
Sbjct: 353 -EVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL--MTG 409
Query: 247 HTHVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
            T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S            
Sbjct: 410 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------ 457
Query: 306 LEWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                 YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +
Sbjct: 458 -----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQ 510
Query: 363 RLKQIVQVSNEGDSFDK 379
             + + Q S+  D  +K
Sbjct: 511 AFETMFQESSISDEVEK 527

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/314 (26%), Positives = 142/314 (45%), Gaps = 40/314 (12%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 262
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L       +   
Sbjct: 263 FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAV 318
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
             L++    +  + YL +      I+R+  A N L+ EN   K++DFGL+R   M G T+
Sbjct: 319 VLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRL--MTGDTY 373
Query: 250 VSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW 308
            + A       + AP+ +     + KSDVW+FGV+L+E+ T   S               
Sbjct: 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS--------------- 418
Query: 309 VQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
              YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +  +
Sbjct: 419 --PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFE 474
Query: 366 QIVQVSNEGDSFDK 379
            + Q S+  D  +K
Sbjct: 475 TMFQESSISDEVEK 488

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/319 (26%), Positives = 145/319 (45%), Gaps = 45/319 (14%)
Query: 69  FSYSEMRQATNDFSRMLKI---------GEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL 119
           F++ +  +A  +F++ + I         G G FG V    +K            VAIK L
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG----KREIFVAIKTL 69
Query: 120 NRDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 178
                +  ++ +++E   +G  +HPN++ L G       +    +++ EFM N SL D  
Sbjct: 70  KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT----KSTPVMIITEFMENGSL-DSF 124
Query: 179 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 238
             +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   K+SDFGL
Sbjct: 125 LRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGL 181
Query: 239 AR--EGPMVGHTHVSTAVVGTFG--YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRS 293
           +R  E      T+ S A+ G     + AP+ I+    T+ SDVWS+G+V++E+++ G R 
Sbjct: 182 SRFLEDDTSDPTYTS-ALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240
Query: 294 LERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD 353
                  T Q ++  ++Q            D RL        A  + +L  +C  K    
Sbjct: 241 YWD---MTNQDVINAIEQ------------DYRLPPPMDCPSA--LHQLMLDCWQKDRNH 283
Query: 354 RPKMSQVVERLKQIVQVSN 372
           RPK  Q+V  L ++++  N
Sbjct: 284 RPKFGQIVNTLDKMIRNPN 302

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 142/309 (45%), Gaps = 46/309 (14%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 59
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLP 187
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR      
Sbjct: 60  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ----- 110
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G
Sbjct: 111 -EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTG 167
Query: 247 HTHVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
            T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S            
Sbjct: 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------ 215
Query: 306 LEWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                 YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +
Sbjct: 216 -----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQ 268
Query: 363 RLKQIVQVS 371
             + + Q S
Sbjct: 269 AFETMFQES 277

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 123/282 (43%), Gaps = 46/282 (16%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQFL 137
           FS + +IG G FG+VY +            + VVAIKK++  G Q +++W   + EV+FL
Sbjct: 17  FSDLREIGHGSFGAVYFAR-------DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
             L HPN ++  G C +   R     LV E+ L  + +  L      PL       +  G
Sbjct: 70  QKLRHPNTIQYRG-CYL---REHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHG 123
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-EGPMVGHTHVSTAVVG 256
           A +GLAYLH      +I+RD KA N+LL E    KL DFG A    P       +   VG
Sbjct: 124 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVG 173
Query: 257 TFGYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 313
           T  + AP+ I   + G    K DVWS G+   E+       ER  P      +  +    
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMSALYHIA 227
Query: 314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 355
            +         P L+  +     R      D+CL K  +DRP
Sbjct: 228 QNES-------PALQSGHWSEYFRN---FVDSCLQKIPQDRP 259

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 141/307 (45%), Gaps = 46/307 (14%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+       G     +  VA+K L  D ++  ++
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYE-------GVWKKYSLTVAVKTLKEDTMEV-EE 60
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLP 187
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR      
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIIIEFMTYGNLLDYLRECNRQ----- 111
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G
Sbjct: 112 -EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTG 168
Query: 247 HTHVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
            T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S            
Sbjct: 169 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------ 216
Query: 306 LEWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                 YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +
Sbjct: 217 -----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQ 269
Query: 363 RLKQIVQ 369
             + + Q
Sbjct: 270 AFETMFQ 276

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 142/309 (45%), Gaps = 46/309 (14%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+       G     +  VA+K L  D ++  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYE-------GVWKKYSLTVAVKTLKEDTMEV-EE 55
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLP 187
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR      
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ----- 106
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G
Sbjct: 107 -EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTG 163
Query: 247 HTHVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
            T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S            
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------ 211
Query: 306 LEWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                 YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +
Sbjct: 212 -----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQ 264
Query: 363 RLKQIVQVS 371
             + + Q S
Sbjct: 265 AFETMFQES 273

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 122/281 (43%), Gaps = 44/281 (15%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQFL 137
           FS + +IG G FG+VY +            + VVAIKK++  G Q +++W   + EV+FL
Sbjct: 56  FSDLREIGHGSFGAVYFAR-------DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 108
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
             L HPN ++  G C +   R     LV E+ L  + +  L      PL       +  G
Sbjct: 109 QKLRHPNTIQYRG-CYL---REHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHG 162
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
           A +GLAYLH      +I+RD KA N+LL E    KL DFG A           +   VGT
Sbjct: 163 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGT 213
Query: 258 FGYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 314
             + AP+ I   + G    K DVWS G+   E+       ER  P      +  +     
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMSALYHIAQ 267
Query: 315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 355
           +         P L+  +     R      D+CL K  +DRP
Sbjct: 268 NES-------PALQSGHWSEYFRN---FVDSCLQKIPQDRP 298

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 141/307 (45%), Gaps = 46/307 (14%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 60
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLP 187
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR      
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ----- 111
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G
Sbjct: 112 -EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTG 168
Query: 247 HTHVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
            T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S            
Sbjct: 169 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------ 216
Query: 306 LEWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                 YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++ +
Sbjct: 217 -----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQ 269
Query: 363 RLKQIVQ 369
             + + Q
Sbjct: 270 AFETMFQ 276

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 135/292 (46%), Gaps = 42/292 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQGHKQWVAEVQFLGVL 140
           +IG G FG+VYK       GD       VA+K LN        LQ  K    EV  L   
Sbjct: 19  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKT 65
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
            H N++  +GY         Q  +V ++    SL  HL + +      K  + I    A 
Sbjct: 66  RHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTAR 119
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           G+ YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G+  +
Sbjct: 120 GMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 176
Query: 261 AAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK 317
            AP+ I   ++   + +SDV++FG+VLYE++TG+  L  +      +++E V +      
Sbjct: 177 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGS---- 230
Query: 318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                + P L K  S N  +++ RL   CL K   +RP   +++  ++++ +
Sbjct: 231 -----LSPDLSKVRS-NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 276

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/227 (33%), Positives = 106/227 (46%), Gaps = 26/227 (11%)
Query: 74  MRQATNDFSRMLK----IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           MR  T    R LK    +G+G FGSV      P   D T E  VVA+KKL     +  + 
Sbjct: 1   MRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRD 57
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
           +  E++ L  L+H N+VK  G C   G R ++  L+ E++   SL D+L          K
Sbjct: 58  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------K 108
Query: 190 TRL-HIIL-----GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGP 243
            R+ HI L        +G+ YL      + I+RD    N+L++   R K+ DFGL +  P
Sbjct: 109 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165
Query: 244 MVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                  V         + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 166 QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 72  SEMRQATNDFSRMLK----IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH 127
           SE R  T    R LK    +G+G FGSV      P   D T E  VVA+KKL     +  
Sbjct: 2   SEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHL 58
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
           + +  E++ L  L+H N+VK  G C   G R ++  L+ E++   SL D+L         
Sbjct: 59  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH------ 110
Query: 188 WKTRL-HIIL-----GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE 241
            K R+ HI L        +G+ YL      + I+RD    N+L++   R K+ DFGL + 
Sbjct: 111 -KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 166
Query: 242 GPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            P       V         + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 167 LPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 87/311 (27%), Positives = 142/311 (45%), Gaps = 50/311 (16%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 60
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLP 187
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR      
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ----- 111
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G
Sbjct: 112 -EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTG 168
Query: 247 HTHVSTAVVGT---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ 303
            T   TA  G      + AP+ +     + KSDVW+FGV+L+E+ T   S          
Sbjct: 169 DT--XTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------- 216
Query: 304 RLLEWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
                   YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++
Sbjct: 217 -------PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEI 267
Query: 361 VERLKQIVQVS 371
            +  + + Q S
Sbjct: 268 HQAFETMFQES 278

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/318 (23%), Positives = 145/318 (45%), Gaps = 45/318 (14%)
Query: 69  FSYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL 119
           F++ +  QA  +F++ +          IG G FG V    +K            VAIK L
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPG----KREICVAIKTL 65
Query: 120 NRDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 178
                   ++ +++E   +G  +HPN++ L G       +    +++ E+M N SL D  
Sbjct: 66  KAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVT----KCKPVMIITEYMENGSL-DAF 120
Query: 179 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 238
             +          + ++ G   G+ YL +   +  ++RD  A N+L++ N   K+SDFG+
Sbjct: 121 LRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGM 177
Query: 239 AR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSL 294
           +R   + P   +T     +     + AP+ I     T+ SDVWS+G+V++E+++ G R  
Sbjct: 178 SRVLEDDPEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 235
Query: 295 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR 354
                 + Q +++ +++        G  + P ++   ++++      L  +C  K   DR
Sbjct: 236 ---WDMSNQDVIKAIEE--------GYRLPPPMDCPIALHQ------LMLDCWQKERSDR 278
Query: 355 PKMSQVVERLKQIVQVSN 372
           PK  Q+V  L ++++  N
Sbjct: 279 PKFGQIVNMLDKLIRNPN 296

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 126/285 (44%), Gaps = 32/285 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           IG G FG VY  ++     D   +    A+K LNR    G   Q++ E   +    HPN+
Sbjct: 37  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 146 VKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           + L+G C   +G      L+V  +M +  L + + N    P   K  +   L  A+G+ Y
Sbjct: 93  LSLLGICLRSEGSP----LVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 147
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAA 262
           L      + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A
Sbjct: 148 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
            + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++    
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL--- 255
Query: 323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
               L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 256 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 115/234 (49%), Gaps = 20/234 (8%)
Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQGHK----QW 130
           +A   +  + +IGEG +G V+K      A D  +    VA+K++  + G +G      + 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFK------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61
Query: 131 VAEVQFLGVLEHPNLVKLIGYCAVD-GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
           VA ++ L   EHPN+V+L   C V   +R  +  LV+E + ++ L  +L     P +P +
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTE 120
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
           T   ++     GL +LH     +V++RD K  N+L+  + + KL+DFGLAR   +     
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQM 174
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ 303
             T+VV T  Y AP+ +         D+WS G +  EM   R+ L R     +Q
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 227

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 115/234 (49%), Gaps = 20/234 (8%)
Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQGHK----QW 130
           +A   +  + +IGEG +G V+K      A D  +    VA+K++  + G +G      + 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFK------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61
Query: 131 VAEVQFLGVLEHPNLVKLIGYCAVD-GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
           VA ++ L   EHPN+V+L   C V   +R  +  LV+E + ++ L  +L     P +P +
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTE 120
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
           T   ++     GL +LH     +V++RD K  N+L+  + + KL+DFGLAR   +     
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQM 174
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ 303
             T+VV T  Y AP+ +         D+WS G +  EM   R+ L R     +Q
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 227

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P   D T E  VVA+KKL     +  + +  E++ L  L+H N+
Sbjct: 16  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 199
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 73  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 123
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH-THVSTAVVGTF 258
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 124 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 180
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 181 FWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 10/205 (4%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P   D T E  VVA+KKL     +  + +  E++ L  L+H N+
Sbjct: 20  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VK  G C   G R ++  L+ E++   SL D+L   A   +     L       +G+ YL
Sbjct: 77  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQAHA-ERIDHIKLLQYTSQICKGMEYL 133
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH-THVSTAVVGTFGYAAPD 264
                 + I+RD    N+L++   R K+ DFGL +  P       V         + AP+
Sbjct: 134 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 265 YIETGHLTAKSDVWSFGVVLYEMLT 289
            +     +  SDVWSFGVVLYE+ T
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 115/234 (49%), Gaps = 20/234 (8%)
Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQGHK----QW 130
           +A   +  + +IGEG +G V+K      A D  +    VA+K++  + G +G      + 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFK------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61
Query: 131 VAEVQFLGVLEHPNLVKLIGYCAVD-GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
           VA ++ L   EHPN+V+L   C V   +R  +  LV+E + ++ L  +L     P +P +
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTE 120
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
           T   ++     GL +LH     +V++RD K  N+L+  + + KL+DFGLAR   +     
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQM 174
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ 303
             T+VV T  Y AP+ +         D+WS G +  EM   R+ L R     +Q
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 227

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P   D T E  VVA+KKL     +  + +  E++ L  L+H N+
Sbjct: 21  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 199
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 78  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 128
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH-THVSTAVVGTF 258
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 129 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 185
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 186 FWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 137/298 (45%), Gaps = 46/298 (15%)
Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +Y +      D +   K+G G +G VY+   K         +  VA+K L  D ++  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDTMEV-EE 55
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLP 187
           ++ E   +  ++HPNLV+L+G C     R     ++ EFM   +L D+L   NR      
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQ----- 106
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQ-VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            +    ++L  A  ++   E LE +  I+RD  A N L+ EN   K++DFGL+R   M G
Sbjct: 107 -EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTG 163
Query: 247 HTHVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
            T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S            
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------ 211
Query: 306 LEWVQQYPAD--SKKFGLI-MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
                 YP    S+ + L+  D R+E+     E  K+  L   C   +  DRP  +++
Sbjct: 212 -----PYPGIDLSQVYELLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEI 262

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P   D T E  VVA+KKL     +  + +  E++ L  L+H N+
Sbjct: 15  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 199
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 72  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 122
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH-THVSTAVVGTF 258
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 123 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 179
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 180 FWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G FG V+            + +T VA+K L + G    + ++ E   +  L+H  L
Sbjct: 19  KLGAGQFGEVWMGYY--------NNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKL 69
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y  V  E  I   ++ EFM   SL D L +     +     +      AEG+AY+
Sbjct: 70  VRL--YAVVTKEEPI--YIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 125
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
                   I+RD +A+NVL+ E+   K++DFGLAR    V   +  TA  G      + A
Sbjct: 126 ERK---NYIHRDLRAANVLVSESLMCKIADFGLAR----VIEDNEYTAREGAKFPIKWTA 178
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT 289
           P+ I  G  T KS+VWSFG++LYE++T
Sbjct: 179 PEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 124/284 (43%), Gaps = 30/284 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           IG G FG VY  ++     D   +    A+K LNR    G   Q++ E   +    HPN+
Sbjct: 33  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ YL
Sbjct: 89  LSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKYL 144
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAAP 263
                 + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A 
Sbjct: 145 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 323
           + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++     
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL---- 251
Query: 324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
              L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 252 ---LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P   D T E  VVA+KKL     +  + +  E++ L  L+H N+
Sbjct: 22  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 199
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 79  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 129
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH-THVSTAVVGTF 258
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 130 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 186
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 187 FWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 126/285 (44%), Gaps = 32/285 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           IG G FG VY  ++     D   +    A+K LNR    G   Q++ E   +    HPN+
Sbjct: 38  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 146 VKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           + L+G C   +G      L+V  +M +  L + + N    P   K  +   L  A+G+ Y
Sbjct: 94  LSLLGICLRSEGSP----LVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 148
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAA 262
           L      + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
            + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++    
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL--- 256
Query: 323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
               L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 257 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 124/284 (43%), Gaps = 30/284 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           IG G FG VY  ++     D   +    A+K LNR    G   Q++ E   +    HPN+
Sbjct: 36  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ YL
Sbjct: 92  LSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKYL 147
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAAP 263
                 + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A 
Sbjct: 148 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 204
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 323
           + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++     
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL---- 254
Query: 324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
              L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 255 ---LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 124/284 (43%), Gaps = 30/284 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           IG G FG VY  ++     D   +    A+K LNR    G   Q++ E   +    HPN+
Sbjct: 30  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ YL
Sbjct: 86  LSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKYL 141
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAAP 263
                 + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A 
Sbjct: 142 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 198
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 323
           + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++     
Sbjct: 199 ESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL---- 248
Query: 324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
              L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 249 ---LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 115/221 (52%), Gaps = 23/221 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW-VAEVQ 135
           +++ F ++ K+G G + +VYK       G   +    VA+K++  D  +G     + E+ 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYK-------GLNKTTGVYVALKEVKLDSEEGTPSTAIREIS 55
Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            +  L+H N+V+L  Y  +  E  +   LV+EFM N  L+ ++ +R     P    L+++
Sbjct: 56  LMKELKHENIVRL--YDVIHTENKLT--LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLV 110
Query: 196 ----LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
                   +GLA+ HE    ++++RD K  N+L+++  + KL DFGLAR   +  +T  S
Sbjct: 111 KYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167
Query: 252 TAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
             V  T  Y APD +      + S D+WS G +L EM+TG+
Sbjct: 168 EVV--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P   D T E  VVA+KKL     +  + +  E++ L  L+H N+
Sbjct: 23  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 199
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 80  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 130
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH-THVSTAVVGTF 258
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 131 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 187
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 188 FWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 126/285 (44%), Gaps = 32/285 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           IG G FG VY  ++     D   +    A+K LNR    G   Q++ E   +    HPN+
Sbjct: 57  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 146 VKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           + L+G C   +G      L+V  +M +  L + + N    P   K  +   L  A+G+ Y
Sbjct: 113 LSLLGICLRSEGSP----LVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 167
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAA 262
           L      + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A
Sbjct: 168 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
            + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++    
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL--- 275
Query: 323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
               L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 276 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 124/284 (43%), Gaps = 30/284 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           IG G FG VY  ++     D   +    A+K LNR    G   Q++ E   +    HPN+
Sbjct: 35  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ YL
Sbjct: 91  LSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKYL 146
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAAP 263
                 + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A 
Sbjct: 147 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 203
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 323
           + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++     
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL---- 253
Query: 324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
              L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 254 ---LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P   D T E  VVA+KKL     +  + +  E++ L  L+H N+
Sbjct: 48  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 199
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 105 VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 155
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH-THVSTAVVGTF 258
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 156 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 212
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P   D T E  VVA+KKL     +  + +  E++ L  L+H N+
Sbjct: 17  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 199
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 74  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 124
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH-THVSTAVVGTF 258
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 125 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 181
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 124/284 (43%), Gaps = 30/284 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           IG G FG VY  ++     D   +    A+K LNR    G   Q++ E   +    HPN+
Sbjct: 56  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ YL
Sbjct: 112 LSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKYL 167
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAAP 263
                 + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A 
Sbjct: 168 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 224
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 323
           + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++     
Sbjct: 225 ESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL---- 274
Query: 324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
              L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 275 ---LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 126/285 (44%), Gaps = 32/285 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           IG G FG VY  ++     D   +    A+K LNR    G   Q++ E   +    HPN+
Sbjct: 38  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 146 VKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           + L+G C   +G      L+V  +M +  L + + N    P   K  +   L  A+G+ Y
Sbjct: 94  LSLLGICLRSEGSP----LVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 148
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAA 262
           L      + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
            + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++    
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL--- 256
Query: 323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
               L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 257 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 126/285 (44%), Gaps = 32/285 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           IG G FG VY  ++     D   +    A+K LNR    G   Q++ E   +    HPN+
Sbjct: 37  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 146 VKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           + L+G C   +G      L+V  +M +  L + + N    P   K  +   L  A+G+ Y
Sbjct: 93  LSLLGICLRSEGSP----LVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 147
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAA 262
           L      + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A
Sbjct: 148 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
            + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++    
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL--- 255
Query: 323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
               L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 256 ----LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P   D T E  VVA+KKL     +  + +  E++ L  L+H N+
Sbjct: 24  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 199
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 81  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 131
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH-THVSTAVVGTF 258
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 132 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 188
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 189 FWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P   D T E  VVA+KKL     +  + +  E++ L  L+H N+
Sbjct: 20  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 199
           VK  G C   G R ++  L+ EF+   SL ++L          K R+ HI L        
Sbjct: 77  VKYKGVCYSAGRRNLK--LIMEFLPYGSLREYLQKH-------KERIDHIKLLQYTSQIC 127
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH-THVSTAVVGTF 258
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 128 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 184
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 185 FWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P   D T E  VVA+KKL     +  + +  E++ L  L+H N+
Sbjct: 35  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 199
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 92  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 142
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH-THVSTAVVGTF 258
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 143 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 199
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 200 FWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 111/237 (46%), Gaps = 38/237 (16%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEA-TVVAIKKLNRDG---LQGHKQWVAEV 134
           N+   +  IGEG FG V+++    A G    E  T+VA+K L  +    +Q   Q   E 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQAR---APGLLPYEPFTMVAVKMLKEEASADMQADFQ--REA 101
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LN---RSLEDH---------L 178
             +   ++PN+VKL+G CAV    G    L++E+M    LN   RS+  H         L
Sbjct: 102 ALMAEFDNPNIVKLLGVCAV----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 179 FNRA------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK 232
             RA       PPL    +L I    A G+AYL E    + ++RD    N L+ EN   K
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 214
Query: 233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           ++DFGL+R      +            +  P+ I     T +SDVW++GVVL+E+ +
Sbjct: 215 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 134/309 (43%), Gaps = 41/309 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 190
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 103 IINLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   +     
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 311 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 269 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 370 VSNEGDSFD 378
           ++   +  D
Sbjct: 319 LTTNEEYLD 327

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 30/284 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           IG G FG VY  ++     D   +    A+K LNR    G   Q++ E   +    HPN+
Sbjct: 97  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ +L
Sbjct: 153 LSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL 208
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAAP 263
                 + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A 
Sbjct: 209 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 323
           + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++     
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL---- 315
Query: 324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
              L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 316 ---LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 30/284 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           IG G FG VY  ++     D   +    A+K LNR    G   Q++ E   +    HPN+
Sbjct: 39  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ +L
Sbjct: 95  LSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKFL 150
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAAP 263
                 + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A 
Sbjct: 151 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 207
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 323
           + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++     
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL---- 257
Query: 324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
              L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 258 ---LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 30/284 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           IG G FG VY  ++     D   +    A+K LNR    G   Q++ E   +    HPN+
Sbjct: 36  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ +L
Sbjct: 92  LSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKFL 147
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAAP 263
                 + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A 
Sbjct: 148 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 204
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 323
           + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++     
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL---- 254
Query: 324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
              L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 255 ---LQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRISAI 292

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V+            + +T VA+K L + G    + ++ E   +  L+H  L
Sbjct: 20  RLGAGQFGEVWMGYY--------NNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKL 70
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y  V  E  I   ++ E+M   SL D L +     +     +      AEG+AY+
Sbjct: 71  VRL--YAVVTREEPI--YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 126
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
                   I+RD +A+NVL+ E+   K++DFGLAR    V   +  TA  G      + A
Sbjct: 127 ERK---NYIHRDLRAANVLVSESLMCKIADFGLAR----VIEDNEYTAREGAKFPIKWTA 179
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT 289
           P+ I  G  T KSDVWSFG++LYE++T
Sbjct: 180 PEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 30/284 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           IG G FG VY  ++     D   +    A+K LNR    G   Q++ E   +    HPN+
Sbjct: 38  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ +L
Sbjct: 94  LSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKFL 149
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAAP 263
                 + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A 
Sbjct: 150 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 323
           + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++     
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL---- 256
Query: 324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
              L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 257 ---LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 30/284 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           IG G FG VY  ++     D   +    A+K LNR    G   Q++ E   +    HPN+
Sbjct: 43  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ +L
Sbjct: 99  LSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKFL 154
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAAP 263
                 + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A 
Sbjct: 155 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 211
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 323
           + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++     
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL---- 261
Query: 324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
              L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 262 ---LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P   D T E  VVA+KKL     +  + +  E++ L  L+H N+
Sbjct: 35  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 199
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 92  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 142
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH-THVSTAVVGTF 258
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 143 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 199
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 200 FWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 30/284 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           IG G FG VY  ++     D   +    A+K LNR    G   Q++ E   +    HPN+
Sbjct: 39  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ +L
Sbjct: 95  LSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKFL 150
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAAP 263
                 + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A 
Sbjct: 151 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMAL 207
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 323
           + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++     
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL---- 257
Query: 324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
              L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 258 ---LQPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/326 (24%), Positives = 149/326 (45%), Gaps = 49/326 (15%)
Query: 62  KAHNLRVF----SYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIKPAAGDGT 108
           K   LR F    +Y +  Q  ++F++ L          +G G FG V    +K  +    
Sbjct: 15  KLPGLRTFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74
Query: 109 SEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYE 167
           S    VAIK L     +  ++ ++ E   +G  +HPN+++L G       +    ++V E
Sbjct: 75  S----VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTE 126
Query: 168 FMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE 227
           +M N SL D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ 
Sbjct: 127 YMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINS 182
Query: 228 NFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVL 284
           N   K+SDFGL+R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 285 YEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLA 343
           +E+++ G R        + Q +++ V +        G  + P ++   ++ +      L 
Sbjct: 241 WEVMSYGERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LM 283
Query: 344 DNCLSKSSKDRPKMSQVVERLKQIVQ 369
            +C  K   +RPK  Q+V  L ++++
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 30/284 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHPNL 145
           IG G FG VY  ++     D   +    A+K LNR    G   Q++ E   +    HPN+
Sbjct: 38  IGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + L+G C          L+V  +M +  L + + N    P   K  +   L  A+G+ +L
Sbjct: 94  LSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKFL 149
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAAP 263
                 + ++RD  A N +LDE F  K++DFGLAR+         H  T       + A 
Sbjct: 150 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 323
           + ++T   T KSDVWSFGV+L+E++T      R  P         +  Y    ++     
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL---- 256
Query: 324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
              L+ EY  +   ++      C    ++ RP  S++V R+  I
Sbjct: 257 ---LQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRISAI 294

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P   D T E  VVA+KKL     +  + +  E++ L  L+H N+
Sbjct: 17  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 199
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 74  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 124
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH-THVSTAVVGTF 258
           +G+ YL      + I+RD    N+L++   R K+ DFGL +  P       V        
Sbjct: 125 KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 134/309 (43%), Gaps = 41/309 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 190
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 103 IINLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   +     
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 311 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 269 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 370 VSNEGDSFD 378
           ++   +  D
Sbjct: 319 LTTNEEYLD 327

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++GEG FG V+ +       +   +  +VA+K L        K +  E + L  L+H ++
Sbjct: 20  ELGEGAFGKVFLAECYNLCPE--QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 146 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDH-----LFNRAFPP--LPWKTRLHI 194
           VK  G C V+G+  I   +V+E+M    LN+ L  H     L     PP  L     LHI
Sbjct: 78  VKFYGVC-VEGDPLI---MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
               A G+ YL        ++RD    N L+ EN   K+ DFG++R+     +  V    
Sbjct: 134 AQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 190
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           +    +  P+ I     T +SDVWS GVVL+E+ T
Sbjct: 191 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P   D T E  VVA+KKL     +  + +  E++ L  L+H N+
Sbjct: 18  QLGKGNFGSVEMCRYDPLQ-DNTGE--VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL-HIIL-----GAA 199
           VK  G C   G R ++  L+ E++   SL D+L          K R+ HI L        
Sbjct: 75  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-------KERIDHIKLLQYTSQIC 125
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH-VSTAVVGTF 258
           +G+ YL      + I+R+    N+L++   R K+ DFGL +  P     + V        
Sbjct: 126 KGMEYLGTK---RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 182
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            + AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 183 FWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/319 (25%), Positives = 147/319 (46%), Gaps = 39/319 (12%)
Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVA 115
           P  YE+      V  +++   ATN  S    +G G FG V    +K  +    S    VA
Sbjct: 25  PHTYEDPTQT--VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEIS----VA 77
Query: 116 IKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL 174
           IK L     +  ++ ++ E   +G  +HPN+++L G       +    ++V E+M N SL
Sbjct: 78  IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSL 133
Query: 175 EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 234
            D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   K+S
Sbjct: 134 -DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVS 189
Query: 235 DFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-G 290
           DFGL+R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL+E+++ G
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 291 RRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKS 350
            R        + Q +++ V +        G  + P ++   ++ +      L  +C  K 
Sbjct: 248 ERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LMLDCWQKD 290
Query: 351 SKDRPKMSQVVERLKQIVQ 369
             +RPK  Q+V  L ++++
Sbjct: 291 RNNRPKFEQIVSILDKLIR 309

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/319 (25%), Positives = 147/319 (46%), Gaps = 39/319 (12%)
Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVA 115
           P  YE+      V  +++   ATN  S    +G G FG V    +K  +    S    VA
Sbjct: 23  PHTYEDPTQT--VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEIS----VA 75
Query: 116 IKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL 174
           IK L     +  ++ ++ E   +G  +HPN+++L G       +    ++V E+M N SL
Sbjct: 76  IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSL 131
Query: 175 EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 234
            D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   K+S
Sbjct: 132 -DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVS 187
Query: 235 DFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-G 290
           DFGL+R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL+E+++ G
Sbjct: 188 DFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 245
Query: 291 RRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKS 350
            R        + Q +++ V +        G  + P ++   ++ +      L  +C  K 
Sbjct: 246 ERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LMLDCWQKD 288
Query: 351 SKDRPKMSQVVERLKQIVQ 369
             +RPK  Q+V  L ++++
Sbjct: 289 RNNRPKFEQIVSILDKLIR 307

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/326 (24%), Positives = 149/326 (45%), Gaps = 49/326 (15%)
Query: 62  KAHNLRVF----SYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIKPAAGDGT 108
           K   LR F    ++ +  Q  ++F++ L          +G G FG V    +K  +    
Sbjct: 15  KLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74
Query: 109 SEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYE 167
           S    VAIK L     +  ++ ++ E   +G  +HPN+++L G       +    ++V E
Sbjct: 75  S----VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTE 126
Query: 168 FMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE 227
           +M N SL D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ 
Sbjct: 127 YMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINS 182
Query: 228 NFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVL 284
           N   K+SDFGLAR   + P   +T     +     + +P+ I     T+ SDVWS+G+VL
Sbjct: 183 NLVCKVSDFGLARVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 285 YEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLA 343
           +E+++ G R        + Q +++ V +        G  + P ++   ++ +      L 
Sbjct: 241 WEVMSYGERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LM 283
Query: 344 DNCLSKSSKDRPKMSQVVERLKQIVQ 369
            +C  K   +RPK  Q+V  L ++++
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQGHKQWVAEVQFLGVL 140
           +IG G FG+VYK       GD       VA+K LN        LQ  K    EV  L   
Sbjct: 15  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKT 61
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGA 198
            H N++  +GY         Q  +V ++    SL  HL      F  +     + I    
Sbjct: 62  RHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQT 113
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           A+G+ YLH      +I+RD K++N+ L E+   K+ DFGLA E      +H    + G+ 
Sbjct: 114 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 170
Query: 259 GYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
            + AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y   
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY--- 226
Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
                  + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 227 -------LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQGHKQWVAEVQFLGVL 140
           +IG G FG+VYK       GD       VA+K LN        LQ  K    EV  L   
Sbjct: 35  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKT 81
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGA 198
            H N++  +GY         Q  +V ++    SL  HL      F  +     + I    
Sbjct: 82  RHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQT 133
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           A+G+ YLH      +I+RD K++N+ L E+   K+ DFGLA E      +H    + G+ 
Sbjct: 134 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 190
Query: 259 GYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
            + AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y   
Sbjct: 191 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY--- 246
Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
                  + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 247 -------LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 288

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQGHKQWVAEVQFLGVL 140
           +IG G FG+VYK       GD       VA+K LN        LQ  K    EV  L   
Sbjct: 43  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKT 89
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGA 198
            H N++  +GY         Q  +V ++    SL  HL      F  +     + I    
Sbjct: 90  RHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQT 141
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           A+G+ YLH      +I+RD K++N+ L E+   K+ DFGLA E      +H    + G+ 
Sbjct: 142 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSI 198
Query: 259 GYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
            + AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y   
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY--- 254
Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
                  + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 255 -------LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 136/295 (46%), Gaps = 38/295 (12%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAE 133
           M    +DF ++ ++G G  G V+K S KP+      +   + IK   R+      Q + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN------QIIRE 54
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           +Q L     P +V   G    DGE  I      E M   SL D +  +A   +P +    
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPEQILGK 108
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
           + +   +GL YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++ +
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANS 162
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-------LL 306
            VGT  Y +P+ ++  H + +SD+WS G+ L EM  GR  +     K + R       LL
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELL 222
Query: 307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 361
           +++   P      G+     LE +  +N+          CL K+  +R  + Q++
Sbjct: 223 DYIVNEPPPKLPSGVF---SLEFQDFVNK----------CLIKNPAERADLKQLM 264

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 112/223 (50%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IR 51
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L++ L+D +   A   +P     
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKDFMDASALTGIPLPLIK 106
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 107 SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE 163
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 164 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 41/303 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 190
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 103 IINLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +   
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 311 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 269 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 370 VSN 372
           ++ 
Sbjct: 319 LTT 321

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 134/304 (44%), Gaps = 43/304 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP---------------LPWK 189
           ++ L+G C  DG   +    + E+    +L ++L  R  PP               + +K
Sbjct: 103 IITLLGACTQDGPLYV----IVEYASKGNLREYLRARR-PPGMEYSYDINRVPEEQMTFK 157
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
             +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +  
Sbjct: 158 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 309
            +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E       
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------ 268
Query: 310 QQYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV 368
                    F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+
Sbjct: 269 ---------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317
Query: 369 QVSN 372
            ++ 
Sbjct: 318 TLTT 321

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 41/303 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 190
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 103 IINLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +   
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKN 215
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 311 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 269 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 370 VSN 372
           ++ 
Sbjct: 319 LTT 321

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 41/303 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 190
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 103 IIHLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +   
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 311 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 269 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 370 VSN 372
           ++ 
Sbjct: 319 LTT 321

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 134/304 (44%), Gaps = 43/304 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP---------------LPWK 189
           ++ L+G C  DG   +    + E+    +L ++L  R  PP               + +K
Sbjct: 90  IINLLGACTQDGPLYV----IVEYASKGNLREYLRARR-PPGMEYSYDINRVPEEQMTFK 144
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
             +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +  
Sbjct: 145 DLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYK 201
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 309
            +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E       
Sbjct: 202 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------ 255
Query: 310 QQYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV 368
                    F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+
Sbjct: 256 ---------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 304
Query: 369 QVSN 372
            ++ 
Sbjct: 305 TLTT 308

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 45/288 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G G FG V K+  +         A  VAIK++  +  +  K ++ E++ L  + HPN+V
Sbjct: 16  VGRGAFGVVCKAKWR---------AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 64
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII---LGAAEGLA 203
           KL G C           LV E+    SL + L      PLP+ T  H +   L  ++G+A
Sbjct: 65  KLYGACLNP------VCLVMEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVA 116
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
           YLH      +I+RD K  N+LL       K+ DFG A +      TH+ T   G+  + A
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHM-TNNKGSAAWMA 171
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQQYPADSKKFGL 321
           P+  E  + + K DV+S+G++L+E++T R+   E   P    R++  V            
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNG--------- 220
Query: 322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
              P L K    N  + I  L   C SK    RP M ++V+ +  +++
Sbjct: 221 -TRPPLIK----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 45/288 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G G FG V K+  +         A  VAIK++  +  +  K ++ E++ L  + HPN+V
Sbjct: 17  VGRGAFGVVCKAKWR---------AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 65
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII---LGAAEGLA 203
           KL G C           LV E+    SL + L      PLP+ T  H +   L  ++G+A
Sbjct: 66  KLYGACLNP------VCLVMEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVA 117
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
           YLH      +I+RD K  N+LL       K+ DFG A +      TH+ T   G+  + A
Sbjct: 118 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHM-TNNKGSAAWMA 172
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQQYPADSKKFGL 321
           P+  E  + + K DV+S+G++L+E++T R+   E   P    R++  V            
Sbjct: 173 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNG--------- 221
Query: 322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
              P L K    N  + I  L   C SK    RP M ++V+ +  +++
Sbjct: 222 -TRPPLIK----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 41/303 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 190
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 149 IINLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +   
Sbjct: 205 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 314
Query: 311 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 315 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364
Query: 370 VSN 372
           ++ 
Sbjct: 365 LTT 367

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 134/304 (44%), Gaps = 43/304 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP---------------LPWK 189
           ++ L+G C  DG   +    + E+    +L ++L  R  PP               + +K
Sbjct: 95  IINLLGACTQDGPLYV----IVEYASKGNLREYLRARR-PPGMEYSYDINRVPEEQMTFK 149
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
             +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +  
Sbjct: 150 DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 206
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 309
            +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E       
Sbjct: 207 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------ 260
Query: 310 QQYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV 368
                    F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+
Sbjct: 261 ---------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 309
Query: 369 QVSN 372
            ++ 
Sbjct: 310 TLTT 313

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 41/303 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 190
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 92  IINLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +   
Sbjct: 148 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 204
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 205 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 257
Query: 311 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 258 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 307
Query: 370 VSN 372
           ++ 
Sbjct: 308 LTT 310

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/326 (24%), Positives = 149/326 (45%), Gaps = 49/326 (15%)
Query: 62  KAHNLRVF----SYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIKPAAGDGT 108
           K   LR F    ++ +  Q  ++F++ L          +G G FG V    +K  +    
Sbjct: 15  KLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74
Query: 109 SEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYE 167
           S    VAIK L     +  ++ ++ E   +G  +HPN+++L G       +    ++V E
Sbjct: 75  S----VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTE 126
Query: 168 FMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE 227
           +M N SL D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ 
Sbjct: 127 YMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGFVHRDLAARNILINS 182
Query: 228 NFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVL 284
           N   K+SDFGL+R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 285 YEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLA 343
           +E+++ G R        + Q +++ V +        G  + P ++   ++ +      L 
Sbjct: 241 WEVMSYGERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LM 283
Query: 344 DNCLSKSSKDRPKMSQVVERLKQIVQ 369
            +C  K   +RPK  Q+V  L ++++
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 110/223 (49%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+      + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTA--IR 53
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L+  L+D +   A   +P     
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LSMDLKDFMDASALTGIPLPLIK 108
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 109 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 165
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 166 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 84/309 (27%), Positives = 136/309 (44%), Gaps = 41/309 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 190
           ++ L+G C  DG   +    + E+    +L ++L  R  P L +              K 
Sbjct: 96  IINLLGACTQDGPLYV----IVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 152 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 309
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 265
Query: 310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 266 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 311
Query: 370 VSNEGDSFD 378
           +++  +  D
Sbjct: 312 LTSNQEYLD 320

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 110/223 (49%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+      + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTA--IR 54
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L+  L+D +   A   +P     
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LSMDLKDFMDASALTGIPLPLIK 109
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 110 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 166
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 167 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 133/303 (43%), Gaps = 41/303 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 190
           ++ L+G C  DG   +    + E+    +L ++L  R  P               + +K 
Sbjct: 103 IINLLGACTQDGPLYV----IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ EN   +++DFGLAR+   + +   
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKK 215
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
           +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E        
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------- 268
Query: 311 QYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   F L+ +  R++K    N   ++  +  +C       RP   Q+VE L +I+ 
Sbjct: 269 --------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 370 VSN 372
           ++ 
Sbjct: 319 LTT 321

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 102/212 (48%), Gaps = 13/212 (6%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGV 139
             R+  +GEG FG V      P  GD T E   VA+K L  +    H      E++ L  
Sbjct: 23  LKRIRDLGEGHFGKVELCRYDPE-GDNTGEQ--VAVKSLKPESGGNHIADLKKEIEILRN 79
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L H N+VK  G C  DG  GI+  L+ EF+ + SL+++L  +    +  K +L   +   
Sbjct: 80  LYHENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQIC 136
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVSTAVVGT 257
           +G+ YL      Q ++RD  A NVL++   + K+ DFGL +  E      T         
Sbjct: 137 KGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPV 193
Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           F YA P+ +        SDVWSFGV L+E+LT
Sbjct: 194 FWYA-PECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/326 (24%), Positives = 149/326 (45%), Gaps = 49/326 (15%)
Query: 62  KAHNLRVF----SYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIKPAAGDGT 108
           K   LR F    ++ +  Q  ++F++ L          +G G FG V    +K  +    
Sbjct: 15  KLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74
Query: 109 SEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYE 167
           S    VAIK L     +  ++ ++ E   +G  +HPN+++L G       +    ++V E
Sbjct: 75  S----VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTE 126
Query: 168 FMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE 227
           +M N SL D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ 
Sbjct: 127 YMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINS 182
Query: 228 NFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVL 284
           N   K+SDFGL+R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 285 YEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLA 343
           +E+++ G R        + Q +++ V +        G  + P ++   ++ +      L 
Sbjct: 241 WEVMSYGERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LM 283
Query: 344 DNCLSKSSKDRPKMSQVVERLKQIVQ 369
            +C  K   +RPK  Q+V  L ++++
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 136/309 (44%), Gaps = 41/309 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-----------FNRAFPP---LPWKT 190
           ++ L+G C  DG   +    + E+    +L ++L           FN +  P   L  K 
Sbjct: 96  IINLLGACTQDGPLYV----IVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   +     
Sbjct: 152 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 309
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 265
Query: 310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 266 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 311
Query: 370 VSNEGDSFD 378
           +++  +  D
Sbjct: 312 LTSNQEXLD 320

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 133/292 (45%), Gaps = 36/292 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNL 145
           IG G FG V    +K            VAIK L     +  ++ +++E   +G  +HPN+
Sbjct: 15  IGAGEFGEVCSGHLKLPG----KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + L G       +    +++ EFM N SL D    +          + ++ G A G+ YL
Sbjct: 71  IHLEGVVT----KSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 125
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVSTAVVGTFG--YA 261
            +   +  ++R   A N+L++ N   K+SDFGL+R  E      T+ S A+ G     + 
Sbjct: 126 AD---MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS-ALGGKIPIRWT 181
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFG 320
           AP+ I+    T+ SDVWS+G+V++E+++ G R        T Q ++  ++Q         
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD---MTNQDVINAIEQ--------- 229
Query: 321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN 372
              D RL        A  + +L  +C  K    RPK  Q+V  L ++++  N
Sbjct: 230 ---DYRLPPPMDCPSA--LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 276

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 102/212 (48%), Gaps = 13/212 (6%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGV 139
             R+  +GEG FG V      P  GD T E   VA+K L  +    H      E++ L  
Sbjct: 11  LKRIRDLGEGHFGKVELCRYDPE-GDNTGEQ--VAVKSLKPESGGNHIADLKKEIEILRN 67
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L H N+VK  G C  DG  GI+  L+ EF+ + SL+++L  +    +  K +L   +   
Sbjct: 68  LYHENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQIC 124
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVSTAVVGT 257
           +G+ YL      Q ++RD  A NVL++   + K+ DFGL +  E      T         
Sbjct: 125 KGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPV 181
Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           F YA P+ +        SDVWSFGV L+E+LT
Sbjct: 182 FWYA-PECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 124/287 (43%), Gaps = 50/287 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG+G FG V           G      VA+K +  D     + ++AE   +  L H NLV
Sbjct: 201 IGKGEFGDVML---------GDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 206
           +L+G   V+ + G+   +V E+M   SL D+L +R    L     L   L   E + YL 
Sbjct: 250 QLLG-VIVEEKGGL--YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306
Query: 207 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPD 264
                  ++RD  A NVL+ E+   K+SDFGL +E         ST   G     + AP+
Sbjct: 307 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPE 356
Query: 265 YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD 324
            +     + KSDVWSFG++L+E+ +  R                   YP    K    + 
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRV-----------------PYPRIPLK---DVV 396
Query: 325 PRLEKEYSINEAR----KIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
           PR+EK Y ++        +  +  NC    +  RP   Q+ E+L+ I
Sbjct: 397 PRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 80/319 (25%), Positives = 147/319 (46%), Gaps = 39/319 (12%)
Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVA 115
           P  +E+      V  +++   ATN  S    +G G FG V    +K  +    S    VA
Sbjct: 25  PHTFEDPTQT--VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEIS----VA 77
Query: 116 IKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL 174
           IK L     +  ++ ++ E   +G  +HPN+++L G       +    ++V E+M N SL
Sbjct: 78  IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSL 133
Query: 175 EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 234
            D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   K+S
Sbjct: 134 -DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVS 189
Query: 235 DFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-G 290
           DFGL+R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL+E+++ G
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 291 RRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKS 350
            R        + Q +++ V +        G  + P ++   ++ +      L  +C  K 
Sbjct: 248 ERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LMLDCWQKD 290
Query: 351 SKDRPKMSQVVERLKQIVQ 369
             +RPK  Q+V  L ++++
Sbjct: 291 RNNRPKFEQIVSILDKLIR 309

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 134/291 (46%), Gaps = 36/291 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNL 145
           IG G FG V    +K            VAIK L        ++ +++E   +G  +HPN+
Sbjct: 22  IGVGEFGEVCSGRLKVPG----KREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 77
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + L G       +    +++ E+M N SL D    +          + ++ G   G+ YL
Sbjct: 78  IHLEGVVT----KCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL 132
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAA 262
            +   +  ++RD  A N+L++ N   K+SDFG++R   + P   +T     +     + A
Sbjct: 133 SD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTA 187
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 321
           P+ I     T+ SDVWS+G+V++E+++ G R        + Q +++ +++        G 
Sbjct: 188 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---WDMSNQDVIKAIEE--------GY 236
Query: 322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN 372
            + P ++   ++++      L  +C  K   DRPK  Q+V  L ++++  N
Sbjct: 237 RLPPPMDCPIALHQ------LMLDCWQKERSDRPKFGQIVNMLDKLIRNPN 281

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 80/326 (24%), Positives = 148/326 (45%), Gaps = 49/326 (15%)
Query: 62  KAHNLRVF----SYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIKPAAGDGT 108
           K   LR F    ++ +  Q  ++F++ L          +G G FG V    +K  +    
Sbjct: 15  KLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74
Query: 109 SEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYE 167
           S    VAIK L     +  ++ ++ E   +G  +HPN+++L G       +    ++V E
Sbjct: 75  S----VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTE 126
Query: 168 FMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE 227
           +M N SL D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ 
Sbjct: 127 YMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINS 182
Query: 228 NFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVL 284
           N   K+SDFGL R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL
Sbjct: 183 NLVCKVSDFGLGRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 285 YEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLA 343
           +E+++ G R        + Q +++ V +        G  + P ++   ++ +      L 
Sbjct: 241 WEVMSYGERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LM 283
Query: 344 DNCLSKSSKDRPKMSQVVERLKQIVQ 369
            +C  K   +RPK  Q+V  L ++++
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 134/291 (46%), Gaps = 36/291 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNL 145
           IG G FG V    +K            VAIK L        ++ +++E   +G  +HPN+
Sbjct: 16  IGVGEFGEVCSGRLKVPG----KREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 71
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + L G       +    +++ E+M N SL D    +          + ++ G   G+ YL
Sbjct: 72  IHLEGVVT----KCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL 126
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAA 262
            +   +  ++RD  A N+L++ N   K+SDFG++R   + P   +T     +     + A
Sbjct: 127 SD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTA 181
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 321
           P+ I     T+ SDVWS+G+V++E+++ G R        + Q +++ +++        G 
Sbjct: 182 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---WDMSNQDVIKAIEE--------GY 230
Query: 322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN 372
            + P ++   ++++      L  +C  K   DRPK  Q+V  L ++++  N
Sbjct: 231 RLPPPMDCPIALHQ------LMLDCWQKERSDRPKFGQIVNMLDKLIRNPN 275

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 86/331 (25%), Positives = 144/331 (43%), Gaps = 57/331 (17%)
Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIK-PAAG 105
           P+ Y E        +Y E  +A   F+R ++         IG G  G V    ++ P   
Sbjct: 23  PQFYAEP------HTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQR 76
Query: 106 DGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLL 164
           D       VAIK L     +  ++ +++E   +G  +HPN+++L G       RG   ++
Sbjct: 77  D-----VPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT----RGRLAMI 127
Query: 165 VYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN 222
           V E+M N SL+  L   +  F  +     + ++ G   G+ YL +   +  ++RD  A N
Sbjct: 128 VTEYMENGSLDTFLRTHDGQFTIM---QLVGMLRGVGAGMRYLSD---LGYVHRDLAARN 181
Query: 223 VLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWS 279
           VL+D N   K+SDFGL+R   + P   +T     +     + AP+ I     ++ SDVWS
Sbjct: 182 VLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI--PIRWTAPEAIAFRTFSSASDVWS 239
Query: 280 FGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARK 338
           FGVV++E+L  G R       +     +E   + PA                  +     
Sbjct: 240 FGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA-----------------PMGCPHA 282
Query: 339 IGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
           + +L  +C  K    RP+ SQ+V  L  +++
Sbjct: 283 LHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 86  KIGEGGFGSVYKS---SIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH 142
           ++GEG FG V+ +   ++ P     T +  +VA+K L    L   K +  E + L  L+H
Sbjct: 22  ELGEGAFGKVFLAECYNLSP-----TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH 76
Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP----------------L 186
            ++VK  G C  DG+  I   +V+E+M +  L    F RA  P                L
Sbjct: 77  EHIVKFYGVCG-DGDPLI---MVFEYMKHGDLNK--FLRAHGPDAMILVDGQPRQAKGEL 130
Query: 187 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
                LHI    A G+ YL        ++RD    N L+  N   K+ DFG++R+     
Sbjct: 131 GLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
Query: 247 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           +  V    +    +  P+ I     T +SDVWSFGV+L+E+ T
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 81/319 (25%), Positives = 146/319 (45%), Gaps = 39/319 (12%)
Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVA 115
           P  YE+      V  +++   ATN  S    +G G FG V    +K  +    S    VA
Sbjct: 25  PHTYEDPTQT--VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEIS----VA 77
Query: 116 IKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL 174
           IK L     +  ++ ++ E   +G  +HPN+++L G       +    ++V E M N SL
Sbjct: 78  IKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEXMENGSL 133
Query: 175 EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 234
            D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   K+S
Sbjct: 134 -DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVS 189
Query: 235 DFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-G 290
           DFGL+R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL+E+++ G
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 291 RRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKS 350
            R        + Q +++ V +        G  + P ++   ++ +      L  +C  K 
Sbjct: 248 ERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LMLDCWQKD 290
Query: 351 SKDRPKMSQVVERLKQIVQ 369
             +RPK  Q+V  L ++++
Sbjct: 291 RNNRPKFEQIVSILDKLIR 309

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 136/290 (46%), Gaps = 38/290 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK-QWVAEVQFLGVLEHPNL 145
           IG G FG V +  +K     G  E + VAIK L     +  + ++++E   +G  EHPN+
Sbjct: 24  IGAGEFGEVCRGRLK---APGKKE-SCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 79
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLED--HLFNRAFPPLPWKTRLHIILGAAEGLA 203
           ++L G         +  +++ EFM N +L+    L +  F  +     + ++ G A G+ 
Sbjct: 80  IRLEGVVT----NSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMR 132
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG---TFGY 260
           YL E   +  ++RD  A N+L++ N   K+SDFGL+R           T+ +G      +
Sbjct: 133 YLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRW 189
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKF 319
            AP+ I     T+ SD WS+G+V++E+++ G R        + Q ++  ++Q        
Sbjct: 190 TAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD---MSNQDVINAIEQ-------- 238
Query: 320 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
               D RL        +  + +L  +C  K    RP+  QVV  L ++++
Sbjct: 239 ----DYRLPPPPDCPTS--LHQLMLDCWQKDRNARPRFPQVVSALDKMIR 282

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQGHKQWVAEVQFLGVL 140
           +IG G FG+VYK       GD       VA+K LN        LQ  K    EV  L   
Sbjct: 15  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKT 61
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGA 198
            H N++  +GY         Q  +V ++    SL  HL      F  +     + I    
Sbjct: 62  RHVNILLFMGYSTAP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQT 113
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           A+G+ YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G+ 
Sbjct: 114 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 259 GYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
            + AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y   
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY--- 226
Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
                  + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 227 -------LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 124/287 (43%), Gaps = 50/287 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG+G FG V           G      VA+K +  D     + ++AE   +  L H NLV
Sbjct: 20  IGKGEFGDVML---------GDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 68
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 206
           +L+G   V+ + G+   +V E+M   SL D+L +R    L     L   L   E + YL 
Sbjct: 69  QLLG-VIVEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 125
Query: 207 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPD 264
                  ++RD  A NVL+ E+   K+SDFGL +E         ST   G     + AP+
Sbjct: 126 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPE 175
Query: 265 YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD 324
            +     + KSDVWSFG++L+E+ +  R                   YP    K    + 
Sbjct: 176 ALREAAFSTKSDVWSFGILLWEIYSFGRV-----------------PYPRIPLK---DVV 215
Query: 325 PRLEKEYSINEAR----KIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
           PR+EK Y ++        +  +  NC    +  RP   Q+ E+L+ I
Sbjct: 216 PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 262

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 124/287 (43%), Gaps = 50/287 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG+G FG V           G      VA+K +  D     + ++AE   +  L H NLV
Sbjct: 29  IGKGEFGDVML---------GDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 206
           +L+G   V+ + G+   +V E+M   SL D+L +R    L     L   L   E + YL 
Sbjct: 78  QLLG-VIVEEKGGL--YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 207 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPD 264
                  ++RD  A NVL+ E+   K+SDFGL +E         ST   G     + AP+
Sbjct: 135 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPE 184
Query: 265 YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD 324
            +     + KSDVWSFG++L+E+ +  R                   YP    K    + 
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRV-----------------PYPRIPLK---DVV 224
Query: 325 PRLEKEYSINEAR----KIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
           PR+EK Y ++        +  +  NC    +  RP   Q+ E+L+ I
Sbjct: 225 PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 112/219 (51%), Gaps = 22/219 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQGHK----QWV 131
           AT+ +  + +IG G +G+VYK+   P +G        VA+K +   +G +G      + V
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKAR-DPHSGH------FVALKSVRVPNGEEGLPISTVREV 54
Query: 132 AEVQFLGVLEHPNLVKLIGYCAVD-GERGIQRLLVYEFMLNRSLEDHLFNRAFPP-LPWK 189
           A ++ L   EHPN+V+L+  CA    +R I+  LV+E  +++ L  +L ++A PP LP +
Sbjct: 55  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYL-DKAPPPGLPAE 112
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
           T   ++     GL +LH      +++RD K  N+L+      KL+DFGLAR   +  +  
Sbjct: 113 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQM 166
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
               VV T  Y AP+ +         D+WS G +  EM 
Sbjct: 167 ALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 29/225 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IR 52
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P     
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIK 107
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHV 250
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH 
Sbjct: 108 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH- 163
Query: 251 STAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
               V T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 164 ---EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 112/222 (50%), Gaps = 29/222 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQ 135
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + E+ 
Sbjct: 4   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IREIS 54
Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +
Sbjct: 55  LLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTA 253
               +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH    
Sbjct: 110 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---- 162
Query: 254 VVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 112/222 (50%), Gaps = 29/222 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQ 135
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + E+ 
Sbjct: 3   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IREIS 53
Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +
Sbjct: 54  LLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTA 253
               +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH    
Sbjct: 109 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---- 161
Query: 254 VVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 135/288 (46%), Gaps = 36/288 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNL 145
           +G G FG V    +K  +    S    VAIK L     +  ++ ++ E   +G  +HPN+
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEIS----VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 79
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           ++L G       +    ++V E+M N SL D    +          + ++ G A G+ YL
Sbjct: 80  IRLEGVVT----KSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 134
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAA 262
            +   +  ++RD  A N+L++ N   K+SDFGL+R   + P   +T     +     + +
Sbjct: 135 SD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTS 189
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 321
           P+ I     T+ SDVWS+G+VL+E+++ G R        + Q +++ V +        G 
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE---MSNQDVIKAVDE--------GY 238
Query: 322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
            + P ++   ++ +      L  +C  K   +RPK  Q+V  L ++++
Sbjct: 239 RLPPPMDCPAALYQ------LMLDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 111/222 (50%), Gaps = 29/222 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQ 135
           +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+      + E+ 
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTA--IREIS 58
Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +
Sbjct: 59  LLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYL 113
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTA 253
               +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH    
Sbjct: 114 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---- 166
Query: 254 VVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 167 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 112/222 (50%), Gaps = 29/222 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQ 135
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + E+ 
Sbjct: 3   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IREIS 53
Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +
Sbjct: 54  LLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTA 253
               +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH    
Sbjct: 109 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---- 161
Query: 254 VVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 129/301 (42%), Gaps = 42/301 (13%)
Query: 65  NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL 124
           NL   S  +      D +   K+G G +G VY        G     +  VA+K L  D +
Sbjct: 18  NLYFQSMDKWEMERTDITMKHKLGGGQYGEVY-------VGVWKKYSLTVAVKTLKEDTM 70
Query: 125 QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP 184
           +  ++++ E   +  ++HPNLV+L+G C ++    I    V E+M   +L D+L      
Sbjct: 71  EV-EEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYI----VTEYMPYGNLLDYLRECNRE 125
Query: 185 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
            +     L++    +  + YL +      I+RD  A N L+ EN   K++DFGL+R   M
Sbjct: 126 EVTAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRL--M 180
Query: 245 VGHTHVSTAVVG-TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ 303
            G T+ + A       + AP+ +     + KSDVW+FGV+L+E+ T   S          
Sbjct: 181 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMS---------- 230
Query: 304 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEAR----KIGRLADNCLSKSSKDRPKMSQ 359
                    P        + D  LEK Y + +      K+  L   C   S  DRP  ++
Sbjct: 231 ---------PYPGIDLSQVYD-LLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAE 280
Query: 360 V 360
Sbjct: 281 T 281

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/323 (25%), Positives = 146/323 (45%), Gaps = 46/323 (14%)
Query: 52  PRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEA 111
           PRG  +   E A  L          ATN  S    +G G FG V    +K  +    S  
Sbjct: 16  PRGSTQTVHEFAKEL---------DATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEIS-- 63
Query: 112 TVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFML 170
             VAIK L     +  ++ ++ E   +G  +HPN+++L G       +    ++V E+M 
Sbjct: 64  --VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYME 117
Query: 171 NRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR 230
           N SL D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ N  
Sbjct: 118 NGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLV 173
Query: 231 PKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEM 287
            K+SDFGL+R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL+E+
Sbjct: 174 CKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 231
Query: 288 LT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNC 346
           ++ G R        + Q +++ V +        G  + P ++   ++ +      L  +C
Sbjct: 232 MSYGERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LMLDC 274
Query: 347 LSKSSKDRPKMSQVVERLKQIVQ 369
             K   +RPK  Q+V  L ++++
Sbjct: 275 WQKDRNNRPKFEQIVSILDKLIR 297

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 41/303 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 190
           ++ L+G C  DG   +    + E+    +L ++L  R  P L +              K 
Sbjct: 81  IINLLGACTQDGPLYV----IVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 137 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 309
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 250
Query: 310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 251 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 296
Query: 370 VSN 372
           +++
Sbjct: 297 LTS 299

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 124/287 (43%), Gaps = 50/287 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG+G FG V           G      VA+K +  D     + ++AE   +  L H NLV
Sbjct: 14  IGKGEFGDVML---------GDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 62
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 206
           +L+G   V+ + G+   +V E+M   SL D+L +R    L     L   L   E + YL 
Sbjct: 63  QLLG-VIVEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119
Query: 207 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPD 264
                  ++RD  A NVL+ E+   K+SDFGL +E         ST   G     + AP+
Sbjct: 120 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPE 169
Query: 265 YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD 324
            +     + KSDVWSFG++L+E+ +  R                   YP    K    + 
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRV-----------------PYPRIPLK---DVV 209
Query: 325 PRLEKEYSINEAR----KIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
           PR+EK Y ++        +  +  NC    +  RP   Q+ E+L+ I
Sbjct: 210 PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 256

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 136/290 (46%), Gaps = 38/290 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK-QWVAEVQFLGVLEHPNL 145
           IG G FG V +  +K     G  E + VAIK L     +  + ++++E   +G  EHPN+
Sbjct: 22  IGAGEFGEVCRGRLK---APGKKE-SCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLED--HLFNRAFPPLPWKTRLHIILGAAEGLA 203
           ++L G         +  +++ EFM N +L+    L +  F  +     + ++ G A G+ 
Sbjct: 78  IRLEGVVT----NSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMR 130
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG---TFGY 260
           YL E   +  ++RD  A N+L++ N   K+SDFGL+R           T+ +G      +
Sbjct: 131 YLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRW 187
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKF 319
            AP+ I     T+ SD WS+G+V++E+++ G R        + Q ++  ++Q        
Sbjct: 188 TAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD---MSNQDVINAIEQ-------- 236
Query: 320 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
               D RL        +  + +L  +C  K    RP+  QVV  L ++++
Sbjct: 237 ----DYRLPPPPDCPTS--LHQLMLDCWQKDRNARPRFPQVVSALDKMIR 280

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 133/307 (43%), Gaps = 49/307 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 145 LVKLIGYCAVDG---------ERGIQRLLV---------YEFMLNRSLEDHLFNRAFPPL 186
           ++ L+G C  DG          +G  R  +         Y + +NR  E+ +        
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM-------- 154
Query: 187 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            +K  +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 247 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 306
           +   +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E    
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--- 268
Query: 307 EWVQQYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
                       F L+ +  R++K    N   ++  +  +C       RP   Q+VE L 
Sbjct: 269 ------------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
Query: 366 QIVQVSN 372
           +I+ ++ 
Sbjct: 315 RILTLTT 321

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G FG V+ ++         ++ T VA+K + + G    + ++AE   +  L+H  L
Sbjct: 22  KLGAGQFGEVWMATY--------NKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKL 72
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VKL    AV  +  I   ++ EFM   SL D L +      P    +      AEG+A++
Sbjct: 73  VKL---HAVVTKEPI--YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 127
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            +      I+RD +A+N+L+  +   K++DFGLAR    V   +  TA  G      + A
Sbjct: 128 EQR---NYIHRDLRAANILVSASLVCKIADFGLAR----VIEDNEYTAREGAKFPIKWTA 180
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+ I  G  T KSDVWSFG++L E++T  R
Sbjct: 181 PEAINFGSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 112/222 (50%), Gaps = 29/222 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQ 135
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + E+ 
Sbjct: 4   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IREIS 54
Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +
Sbjct: 55  LLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTA 253
               +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH    
Sbjct: 110 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---- 162
Query: 254 VVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 135/297 (45%), Gaps = 37/297 (12%)
Query: 82  SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK-QWVAEVQFLGVL 140
           +R   IG G FG VYK  +K ++G    +   VAIK L     +  +  ++ E   +G  
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSG---KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGA 198
            H N+++L G  +    +    +++ E+M N +L+  L  +   F  L     + ++ G 
Sbjct: 104 SHHNIIRLEGVIS----KYKPMMIITEYMENGALDKFLREKDGEFSVL---QLVGMLRGI 156
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVV 255
           A G+ YL     +  ++RD  A N+L++ N   K+SDFGL+R   + P   +T     + 
Sbjct: 157 AAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI- 212
Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
               + AP+ I     T+ SDVWSFG+V++E++T        RP  E    E V +   D
Sbjct: 213 -PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT-----YGERPYWELSNHE-VMKAIND 265
Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN 372
             +    MD              I +L   C  +    RPK + +V  L ++++  +
Sbjct: 266 GFRLPTPMDC----------PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 41/303 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 190
           ++ L+G C  DG   +    + E+    +L ++L  R  P L +              K 
Sbjct: 85  IINLLGACTQDGPLYV----IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 141 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 197
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 309
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 198 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 254
Query: 310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 255 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 300
Query: 370 VSN 372
           +++
Sbjct: 301 LTS 303

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 41/303 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 190
           ++ L+G C  DG   +    + E+    +L ++L  R  P L +              K 
Sbjct: 96  IINLLGACTQDGPLYV----IVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 152 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 309
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 265
Query: 310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 266 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 311
Query: 370 VSN 372
           +++
Sbjct: 312 LTS 314

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 112/222 (50%), Gaps = 29/222 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQ 135
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + E+ 
Sbjct: 4   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IREIS 54
Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +
Sbjct: 55  LLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTA 253
               +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH    
Sbjct: 110 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---- 162
Query: 254 VVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 163 EVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/326 (24%), Positives = 148/326 (45%), Gaps = 49/326 (15%)
Query: 62  KAHNLRVF----SYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIKPAAGDGT 108
           K   LR F    ++ +  Q  ++F++ L          +G G FG V    +K  +    
Sbjct: 15  KLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74
Query: 109 SEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYE 167
           S    VAIK L     +  ++ ++ E   +G  +HPN+++L G       +    ++V E
Sbjct: 75  S----VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTE 126
Query: 168 FMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE 227
            M N SL D    +          + ++ G A G+ YL +   +  ++RD  A N+L++ 
Sbjct: 127 XMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGAVHRDLAARNILINS 182
Query: 228 NFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVL 284
           N   K+SDFGL+R   + P   +T     +     + +P+ I     T+ SDVWS+G+VL
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 285 YEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLA 343
           +E+++ G R        + Q +++ V +        G  + P ++   ++ +      L 
Sbjct: 241 WEVMSYGERPYWE---MSNQDVIKAVDE--------GYRLPPPMDCPAALYQ------LM 283
Query: 344 DNCLSKSSKDRPKMSQVVERLKQIVQ 369
            +C  K   +RPK  Q+V  L ++++
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 133/307 (43%), Gaps = 49/307 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 145 LVKLIGYCAVDG---------ERGIQRLLV---------YEFMLNRSLEDHLFNRAFPPL 186
           ++ L+G C  DG          +G  R  +         Y + +NR  E+ +        
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM-------- 154
Query: 187 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            +K  +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 247 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 306
           +   +T       + AP+ +     T +SDVWSFGV+++E+ T   S     P  E    
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--- 268
Query: 307 EWVQQYPADSKKFGLIMDP-RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
                       F L+ +  R++K    N   ++  +  +C       RP   Q+VE L 
Sbjct: 269 ------------FKLLKEGHRMDK--PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
Query: 366 QIVQVSN 372
           +I+ ++ 
Sbjct: 315 RILTLTT 321

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 112/219 (51%), Gaps = 22/219 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQGHK----QWV 131
           AT+ +  + +IG G +G+VYK+   P +G        VA+K +   +G +G      + V
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKAR-DPHSGH------FVALKSVRVPNGEEGLPISTVREV 54
Query: 132 AEVQFLGVLEHPNLVKLIGYCAVD-GERGIQRLLVYEFMLNRSLEDHLFNRAFPP-LPWK 189
           A ++ L   EHPN+V+L+  CA    +R I+  LV+E  +++ L  +L ++A PP LP +
Sbjct: 55  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYL-DKAPPPGLPAE 112
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
           T   ++     GL +LH      +++RD K  N+L+      KL+DFGLAR   +  +  
Sbjct: 113 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQM 166
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
               VV T  Y AP+ +         D+WS G +  EM 
Sbjct: 167 ALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 28/207 (13%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G FG V+ ++         ++ T VA+K + + G    + ++AE   +  L+H  L
Sbjct: 189 KLGAGQFGEVWMATY--------NKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKL 239
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VKL    AV  +  I   ++ EFM   SL D L +      P    +      AEG+A++
Sbjct: 240 VKL---HAVVTKEPI--YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 294
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 265
            +      I+RD +A+N+L+  +   K++DFGLAR G                 + AP+ 
Sbjct: 295 EQR---NYIHRDLRAANILVSASLVCKIADFGLARVGAKF-----------PIKWTAPEA 340
Query: 266 IETGHLTAKSDVWSFGVVLYEMLTGRR 292
           I  G  T KSDVWSFG++L E++T  R
Sbjct: 341 INFGSFTIKSDVWSFGILLMEIVTYGR 367

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V+            +  T VA+K L + G      ++AE   +  L+H  L
Sbjct: 28  RLGAGQFGEVWMGYY--------NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 78
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++
Sbjct: 79  VRL--YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 133
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            E      I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + A
Sbjct: 134 EER---NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTA 186
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+ I  G  T KSDVWSFG++L E++T  R
Sbjct: 187 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 216

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 41/303 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 190
           ++ L+G C  DG   +    + E+    +L ++L  R  P L +              K 
Sbjct: 89  IINLLGACTQDGPLYV----IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 145 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 201
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 309
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 202 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 258
Query: 310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 259 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 304
Query: 370 VSN 372
           +++
Sbjct: 305 LTS 307

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 116/238 (48%), Gaps = 21/238 (8%)
Query: 57  ELYEEKAHNLRVFSYSEMRQA---TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATV 113
           EL E++   L  F   + +      +DF ++ ++G G  G V+K S KP+      +   
Sbjct: 8   ELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH 67
Query: 114 VAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS 173
           + IK   R+      Q + E+Q L     P +V   G    DGE  I      E M   S
Sbjct: 68  LEIKPAIRN------QIIRELQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGS 117
Query: 174 LEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL 233
           L D +  +A   +P +    + +   +GL YL E  + ++++RD K SN+L++     KL
Sbjct: 118 L-DQVLKKA-GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKL 173
Query: 234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            DFG++  G ++    ++ + VGT  Y +P+ ++  H + +SD+WS G+ L EM  GR
Sbjct: 174 CDFGVS--GQLI--DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V+            +  T VA+K L + G      ++AE   +  L+H  L
Sbjct: 26  RLGAGQFGEVWMGYY--------NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 76
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++
Sbjct: 77  VRL--YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 131
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            E      I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + A
Sbjct: 132 EER---NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTA 184
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+ I  G  T KSDVWSFG++L E++T  R
Sbjct: 185 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 111/222 (50%), Gaps = 29/222 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQ 135
           +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+      + E+ 
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTA--IREIS 61
Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +
Sbjct: 62  LLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYL 116
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTA 253
               +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH    
Sbjct: 117 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---- 169
Query: 254 VVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 170 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G FG V+ ++         ++ T VA+K + + G    + ++AE   +  L+H  L
Sbjct: 195 KLGAGQFGEVWMATY--------NKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKL 245
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VKL    AV  +  I   ++ EFM   SL D L +      P    +      AEG+A++
Sbjct: 246 VKL---HAVVTKEPI--YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            +      I+RD +A+N+L+  +   K++DFGLAR    V   +  TA  G      + A
Sbjct: 301 EQR---NYIHRDLRAANILVSASLVCKIADFGLAR----VIEDNEYTAREGAKFPIKWTA 353
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+ I  G  T KSDVWSFG++L E++T  R
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGR 383

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 41/303 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 190
           ++ L+G C  DG   +    + E+    +L ++L  R  P L +              K 
Sbjct: 96  IINLLGACTQDGPLYV----IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 152 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 309
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 265
Query: 310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 266 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 311
Query: 370 VSN 372
           +++
Sbjct: 312 LTS 314

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQGHKQWVAEVQFLGVL 140
           +IG G FG+VYK       GD       VA+K LN        LQ  K    EV  L   
Sbjct: 20  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKT 66
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGA 198
            H N++  +GY         Q  +V ++    SL  HL      F  +     + I    
Sbjct: 67  RHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQT 118
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           A+G+ YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G+ 
Sbjct: 119 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 259 GYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
            + AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y   
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY--- 231
Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
                  + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 232 -------LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 41/303 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 190
           ++ L+G C  DG   +    + E+    +L ++L  R  P L +              K 
Sbjct: 88  IINLLGACTQDGPLYV----IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 144 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 200
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 309
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 201 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 257
Query: 310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 258 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 303
Query: 370 VSN 372
           +++
Sbjct: 304 LTS 306

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 86/331 (25%), Positives = 143/331 (43%), Gaps = 57/331 (17%)
Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIK-PAAG 105
           P+ Y E        +Y E  +A   F+R ++         IG G  G V    ++ P   
Sbjct: 23  PQFYAEP------HTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQR 76
Query: 106 DGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLL 164
           D       VAIK L     +  ++ +++E   +G  +HPN+++L G       RG   ++
Sbjct: 77  D-----VPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT----RGRLAMI 127
Query: 165 VYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN 222
           V E+M N SL+  L   +  F  +     + ++ G   G+ YL +   +  ++RD  A N
Sbjct: 128 VTEYMENGSLDTFLRTHDGQFTIM---QLVGMLRGVGAGMRYLSD---LGYVHRDLAARN 181
Query: 223 VLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWS 279
           VL+D N   K+SDFGL+R   + P    T     +     + AP+ I     ++ SDVWS
Sbjct: 182 VLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRWTAPEAIAFRTFSSASDVWS 239
Query: 280 FGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARK 338
           FGVV++E+L  G R       +     +E   + PA                  +     
Sbjct: 240 FGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA-----------------PMGCPHA 282
Query: 339 IGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
           + +L  +C  K    RP+ SQ+V  L  +++
Sbjct: 283 LHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQGHKQWVAEVQFLGVL 140
           +IG G FG+VYK       GD       VA+K LN        LQ  K    EV  L   
Sbjct: 17  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKT 63
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGA 198
            H N++  +GY         Q  +V ++    SL  HL      F  +     + I    
Sbjct: 64  RHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQT 115
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           A+G+ YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G+ 
Sbjct: 116 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 172
Query: 259 GYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
            + AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y   
Sbjct: 173 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY--- 228
Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
                  + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 229 -------LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 270

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 111/222 (50%), Gaps = 29/222 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQ 135
           +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+      + E+ 
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTA--IREIS 61
Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +
Sbjct: 62  LLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYL 116
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTA 253
               +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH    
Sbjct: 117 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---- 169
Query: 254 VVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 170 EVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V+            +  T VA+K L + G      ++AE   +  L+H  L
Sbjct: 21  RLGAGQFGEVWMGYY--------NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 71
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++
Sbjct: 72  VRL--YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 126
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            E      I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + A
Sbjct: 127 EER---NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTA 179
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+ I  G  T KSDVWSFG++L E++T  R
Sbjct: 180 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 209

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 111/223 (49%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IR 51
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P     
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIK 106
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 107 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 163
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 164 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V+            +  T VA+K L + G      ++AE   +  L+H  L
Sbjct: 29  RLGAGQFGEVWMGYY--------NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 79
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++
Sbjct: 80  VRL--YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 134
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            E      I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + A
Sbjct: 135 EER---NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTA 187
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+ I  G  T KSDVWSFG++L E++T  R
Sbjct: 188 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 217

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V+            +  T VA+K L + G      ++AE   +  L+H  L
Sbjct: 20  RLGAGQFGEVWMGYY--------NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++
Sbjct: 71  VRL--YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            E      I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + A
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTA 178
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+ I  G  T KSDVWSFG++L E++T  R
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V+            +  T VA+K L + G      ++AE   +  L+H  L
Sbjct: 22  RLGAGQFGEVWMGYY--------NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 72
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++
Sbjct: 73  VRL--YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 127
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            E      I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + A
Sbjct: 128 EER---NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTA 180
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+ I  G  T KSDVWSFG++L E++T  R
Sbjct: 181 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 210

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 111/223 (49%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IR 51
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P     
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIK 106
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 107 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 163
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 164 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 111/223 (49%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IR 51
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P     
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIK 106
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 107 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 163
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 164 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQGHKQWVAEVQFLGVL 140
           +IG G FG+VYK       GD       VA+K LN        LQ  K    EV  L   
Sbjct: 20  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKT 66
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGA 198
            H N++  +GY         Q  +V ++    SL  HL      F  +     + I    
Sbjct: 67  RHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQT 118
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           A+G+ YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G+ 
Sbjct: 119 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 259 GYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
            + AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y   
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY--- 231
Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
                  + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 232 -------LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 14  VKLGQGCFGEVWMGT-----WNGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 64
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 65  LVQLY---AVVSEEPIX--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 119
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           +     +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + 
Sbjct: 120 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEXTARQGAKFPIKWT 172
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           AP+    G  T KSDVWSFG++L E+ T  R
Sbjct: 173 APEAALYGRFTIKSDVWSFGILLTELTTKGR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 111/223 (49%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IR 51
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P     
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIK 106
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 107 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 163
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 164 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 112/219 (51%), Gaps = 22/219 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQGHK----QWV 131
           AT+ +  + +IG G +G+VYK+   P +G        VA+K +   +G +G      + V
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKAR-DPHSGH------FVALKSVRVPNGEEGLPISTVREV 54
Query: 132 AEVQFLGVLEHPNLVKLIGYCAVD-GERGIQRLLVYEFMLNRSLEDHLFNRAFPP-LPWK 189
           A ++ L   EHPN+V+L+  CA    +R I+  LV+E  +++ L  +L ++A PP LP +
Sbjct: 55  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYL-DKAPPPGLPAE 112
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
           T   ++     GL +LH      +++RD K  N+L+      KL+DFGLAR   +  +  
Sbjct: 113 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQM 166
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
               VV T  Y AP+ +         D+WS G +  EM 
Sbjct: 167 ALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 111/223 (49%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IR 54
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P     
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIK 109
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 110 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 166
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 167 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 111/223 (49%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IR 53
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P     
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIK 108
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 109 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 165
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 166 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 110/220 (50%), Gaps = 25/220 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQ 135
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + E+ 
Sbjct: 3   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IREIS 53
Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +
Sbjct: 54  LLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
               +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V 
Sbjct: 109 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 164
Query: 256 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 165 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQGHKQWVAEVQFLGVL 140
           +IG G FG+VYK       GD       VA+K LN        LQ  K    EV  L   
Sbjct: 43  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKT 89
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGA 198
            H N++  +GY         Q  +V ++    SL  HL      F  +     + I    
Sbjct: 90  RHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQT 141
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           A+G+ YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G+ 
Sbjct: 142 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 198
Query: 259 GYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
            + AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y   
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY--- 254
Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
                  + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 255 -------LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 110/220 (50%), Gaps = 25/220 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQ 135
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + E+ 
Sbjct: 3   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IREIS 53
Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +
Sbjct: 54  LLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
               +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V 
Sbjct: 109 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 164
Query: 256 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 165 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQGHKQWVAEVQFLGVL 140
           +IG G FG+VYK       GD       VA+K LN        LQ  K    EV  L   
Sbjct: 42  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKT 88
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGA 198
            H N++  +GY         Q  +V ++    SL  HL      F  +     + I    
Sbjct: 89  RHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQT 140
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           A+G+ YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G+ 
Sbjct: 141 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 197
Query: 259 GYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
            + AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y   
Sbjct: 198 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY--- 253
Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
                  + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 254 -------LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 295

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-----LQGHKQWVAEVQFLGVL 140
           +IG G FG+VYK       GD       VA+K LN        LQ  K    EV  L   
Sbjct: 15  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKT 61
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGA 198
            H N++  +GY         Q  +V ++    SL  HL      F  +     + I    
Sbjct: 62  RHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQT 113
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           A+G+ YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G+ 
Sbjct: 114 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 259 GYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
            + AP+ I   +    + +SDV++FG+VLYE++TG+     N    +Q +    + Y   
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGY--- 226
Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
                  + P L K  S N  + + RL   CL K   +RP   Q++  ++
Sbjct: 227 -------LSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 18/213 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           +DF ++ ++G G  G V+K S KP+      +   + IK   R+      Q + E+Q L 
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN------QIIRELQVLH 121
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
               P +V   G    DGE  I      E M   SL D +  +A   +P +    + +  
Sbjct: 122 ECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKAGR-IPEQILGKVSIAV 175
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
            +GL YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++ + VGT 
Sbjct: 176 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANSFVGTR 229
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            Y +P+ ++  H + +SD+WS G+ L EM  GR
Sbjct: 230 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 111/223 (49%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IR 52
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P     
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIK 107
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 108 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 164
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 165 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 273 VKLGQGCFGEVWMGTW-----NGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 324 LVQLY---AVVSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAA 262
           +     +  ++RD +A+N+L+ EN   K++DFGLAR   ++     +      F   + A
Sbjct: 379 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTA 432
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+    G  T KSDVWSFG++L E+ T  R
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGR 462

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V+            +  T VA+K L + G      ++AE   +  L+H  L
Sbjct: 26  RLGAGQFGEVWMGYY--------NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 76
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++
Sbjct: 77  VRL--YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 131
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            E      I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + A
Sbjct: 132 EER---NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEYTAREGAKFPIKWTA 184
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+ I  G  T KSDVWSFG++L E++T  R
Sbjct: 185 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V+            +  T VA+K L + G      ++AE   +  L+H  L
Sbjct: 25  RLGAGQFGEVWMGYY--------NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 75
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++
Sbjct: 76  VRL--YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 130
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            E      I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + A
Sbjct: 131 EER---NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEYTAREGAKFPIKWTA 183
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+ I  G  T KSDVWSFG++L E++T  R
Sbjct: 184 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 213

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 111/223 (49%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IR 52
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P     
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIK 107
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 108 SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE 164
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 165 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 110/223 (49%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+      + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTA--IR 54
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P     
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIK 109
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 110 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 166
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 167 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V+            +  T VA+K L + G      ++AE   +  L+H  L
Sbjct: 20  RLGAGQFGEVWMGYY--------NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++
Sbjct: 71  VRL--YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            E      I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + A
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEXTAREGAKFPIKWTA 178
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+ I  G  T KSDVWSFG++L E++T  R
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 110/222 (49%), Gaps = 25/222 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK-------- 128
           AT+ +  + +IG G +G+VYK+   P +G        VA+K +      G          
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKAR-DPHSGH------FVALKSVRVPNGGGGGGGLPISTV 59
Query: 129 QWVAEVQFLGVLEHPNLVKLIGYCAVD-GERGIQRLLVYEFMLNRSLEDHLFNRAFPP-L 186
           + VA ++ L   EHPN+V+L+  CA    +R I+  LV+E  +++ L  +L ++A PP L
Sbjct: 60  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYL-DKAPPPGL 117
Query: 187 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
           P +T   ++     GL +LH      +++RD K  N+L+      KL+DFGLAR   +  
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---IYS 171
Query: 247 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
           +    T VV T  Y AP+ +         D+WS G +  EM 
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 110/223 (49%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+      + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTA--IR 53
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P     
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIK 108
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 109 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 165
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 166 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQ 135
           +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+      + E+ 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTA--IREIS 55
Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +
Sbjct: 56  LLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
               +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+    V 
Sbjct: 111 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 166
Query: 256 GTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 167 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V+            +  T VA+K L + G      ++AE   +  L+H  L
Sbjct: 30  RLGAGQFGEVWMGYY--------NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 80
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++
Sbjct: 81  VRL--YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 135
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            E      I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + A
Sbjct: 136 EER---NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEYTAREGAKFPIKWTA 188
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+ I  G  T KSDVWSFG++L E++T  R
Sbjct: 189 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 218

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V+            +  T VA+K L + G      ++AE   +  L+H  L
Sbjct: 15  RLGAGQFGEVWMGYY--------NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 65
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++
Sbjct: 66  VRL--YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 120
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            E      I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + A
Sbjct: 121 EER---NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEYTAREGAKFPIKWTA 173
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+ I  G  T KSDVWSFG++L E++T  R
Sbjct: 174 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 203

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 113/221 (51%), Gaps = 36/221 (16%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQF 136
           + ++ K+GEG +G VYK+          S+  +VA+K++  D    G+      + E+  
Sbjct: 23  YQKLEKVGEGTYGVVYKAK--------DSQGRIVALKRIRLDAEDEGIPSTA--IREISL 72
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLH 193
           L  L HPN+V LI    +  ER +   LV+EFM   L + L+++           K  L+
Sbjct: 73  LKELHHPNIVSLID--VIHSERCLT--LVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLY 126
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVS 251
            +L    G+A+ H+    ++++RD K  N+L++ +   KL+DFGLAR    P+  +TH  
Sbjct: 127 QLL---RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH-- 178
Query: 252 TAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 291
              V T  Y APD +  +   +   D+WS G +  EM+TG+
Sbjct: 179 --EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 113/221 (51%), Gaps = 36/221 (16%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQF 136
           + ++ K+GEG +G VYK+          S+  +VA+K++  D    G+      + E+  
Sbjct: 23  YQKLEKVGEGTYGVVYKAK--------DSQGRIVALKRIRLDAEDEGIPSTA--IREISL 72
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLH 193
           L  L HPN+V LI    +  ER +   LV+EFM   L + L+++           K  L+
Sbjct: 73  LKELHHPNIVSLID--VIHSERCLT--LVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLY 126
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVS 251
            +L    G+A+ H+    ++++RD K  N+L++ +   KL+DFGLAR    P+  +TH  
Sbjct: 127 QLL---RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH-- 178
Query: 252 TAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 291
              V T  Y APD +  +   +   D+WS G +  EM+TG+
Sbjct: 179 --EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 111/223 (49%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IR 53
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P     
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIK 108
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 109 SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE 165
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 166 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 110/223 (49%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+      + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTA--IR 54
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P     
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKTFMDASALTGIPLPLIK 109
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 110 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 166
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 167 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 110/223 (49%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+      + 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTA--IR 55
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P     
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIK 110
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 111 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 167
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 168 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 112/222 (50%), Gaps = 29/222 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQ 135
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + E+ 
Sbjct: 4   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IREIS 54
Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +
Sbjct: 55  LLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTA 253
               +GL++ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH    
Sbjct: 110 FQLLQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---- 162
Query: 254 VVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 17  VKLGQGCFGEVWMGT-----WNGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 67
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 68  LVQLY---AVVSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 122
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           +     +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + 
Sbjct: 123 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWT 175
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           AP+    G  T KSDVWSFG++L E+ T  R
Sbjct: 176 APEAALYGRFTIKSDVWSFGILLTELTTKGR 206

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 190 VKLGQGCFGEVWMGTW-----NGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 241 LVQLY---AVVSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAA 262
           +     +  ++RD +A+N+L+ EN   K++DFGLAR   ++     +      F   + A
Sbjct: 296 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTA 349
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+    G  T KSDVWSFG++L E+ T  R
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 24  VKLGQGCFGEVWMGT-----WNGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 75  LVQLY---AVVSEEPI--YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           +     +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + 
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEXTARQGAKFPIKWT 182
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           AP+    G  T KSDVWSFG++L E+ T  R
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V+            +  T VA+K L + G      ++AE   +  L+H  L
Sbjct: 20  RLGAGQFGEVWMGYY--------NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++
Sbjct: 71  VRL--YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            E      I+RD +A+N+L+ +    K++DFGLAR    +   +  TA  G      + A
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEYTAREGAKFPIKWTA 178
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+ I  G  T KSDVWSFG++L E++T  R
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 18/213 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           +DF ++ ++G G  G V+K S KP+      +   + IK   R+      Q + E+Q L 
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN------QIIRELQVLH 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
               P +V   G    DGE  I      E M   SL D +  +A   +P +    + +  
Sbjct: 79  ECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPEQILGKVSIAV 132
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
            +GL YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++ + VGT 
Sbjct: 133 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANSFVGTR 186
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            Y +P+ ++  H + +SD+WS G+ L EM  GR
Sbjct: 187 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 18/218 (8%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAE 133
           M    +DF ++ ++G G  G V+K S KP+      +   + IK   R+      Q + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN------QIIRE 54
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           +Q L     P +V   G    DGE  I      E M   SL D +  +A   +P +    
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPEQILGK 108
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
           + +   +GL YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++ +
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANS 162
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            VGT  Y +P+ ++  H + +SD+WS G+ L EM  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 18/218 (8%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAE 133
           M    +DF ++ ++G G  G V+K S KP+      +   + IK   R+      Q + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN------QIIRE 54
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           +Q L     P +V   G    DGE  I      E M   SL D +  +A   +P +    
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPEQILGK 108
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
           + +   +GL YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++ +
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANS 162
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            VGT  Y +P+ ++  H + +SD+WS G+ L EM  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 190 VKLGQGCFGEVWMGTW-----NGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 241 LVQLY---AVVSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           +     +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + 
Sbjct: 296 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWT 348
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           AP+    G  T KSDVWSFG++L E+ T  R
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 18/218 (8%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAE 133
           M    +DF ++ ++G G  G V+K S KP+      +   + IK   R+      Q + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN------QIIRE 54
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           +Q L     P +V   G    DGE  I      E M   SL D +  +A   +P +    
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPEQILGK 108
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
           + +   +GL YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++ +
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANS 162
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            VGT  Y +P+ ++  H + +SD+WS G+ L EM  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 18/218 (8%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAE 133
           M    +DF ++ ++G G  G V+K S KP+      +   + IK   R+      Q + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN------QIIRE 54
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           +Q L     P +V   G    DGE  I      E M   SL D +  +A   +P +    
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPEQILGK 108
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
           + +   +GL YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++ +
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANS 162
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            VGT  Y +P+ ++  H + +SD+WS G+ L EM  GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 110/223 (49%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IR 52
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L+  L+  +   A   +P     
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LSMDLKKFMDASALTGIPLPLIK 107
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 108 SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE 164
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 165 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 117/230 (50%), Gaps = 28/230 (12%)
Query: 65  NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-G 123
            LR+   +E++       R+  +G G FG+VYK    P   +G +    VAIK LN   G
Sbjct: 31  QLRILKETELK-------RVKVLGSGAFGTVYKGIWVP---EGETVKIPVAIKILNETTG 80
Query: 124 LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE--DHLFNR 181
            + + +++ E   +  ++HP+LV+L+G C     + + +L+ +  +L    E  D++ ++
Sbjct: 81  PKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQ 140
Query: 182 AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE 241
               L W  ++      A+G+ YL E    ++++RD  A NVL+      K++DFGLAR 
Sbjct: 141 LL--LNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 189
Query: 242 GPMVGHTHVSTAVVG--TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
             + G      A  G     + A + I     T +SDVWS+GV ++E++T
Sbjct: 190 --LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 15  VKLGQGCFGEVWMGT-----WNGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 65
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 66  LVQLY---AVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 120
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           +     +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + 
Sbjct: 121 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWT 173
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           AP+    G  T KSDVWSFG++L E+ T  R
Sbjct: 174 APEAALYGRFTIKSDVWSFGILLTELTTKGR 204

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 41/303 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVL-EHPN 144
           +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ + ++ +H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW--------------KT 190
           ++ L+G C  DG   +    + E+    +L ++L  R  P L +              K 
Sbjct: 137 IINLLGACTQDGPLYV----IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + +   
Sbjct: 193 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWV 309
           +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P  E  +LL   
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 306
Query: 310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   K G  MD   +     NE   + R   +C       RP   Q+VE L +IV 
Sbjct: 307 --------KEGHRMD---KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVA 352
Query: 370 VSN 372
           +++
Sbjct: 353 LTS 355

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 21/218 (9%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           +F ++ KIGEG +G VYK     A    T E   +   +L+ +        + E+  L  
Sbjct: 4   NFQKVEKIGEGTYGVVYK-----ARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKE 58
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +    
Sbjct: 59  LNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVVGT 257
           +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH     V T
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH----EVVT 166
Query: 258 FGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
             Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 21/218 (9%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           +F ++ KIGEG +G VYK     A    T E   +   +L+ +        + E+  L  
Sbjct: 3   NFQKVEKIGEGTYGVVYK-----ARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKE 57
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L HPN+VKL+     +     +  LV+EF L++ L+  +   A   +P       +    
Sbjct: 58  LNHPNIVKLLDVIHTEN----KLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVVGT 257
           +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH     V T
Sbjct: 113 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH----EVVT 165
Query: 258 FGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
             Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 24  VKLGQGCFGEVWMGT-----WNGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 75  LVQLY---AVVSEEPI--YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           +     +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + 
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWT 182
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           AP+    G  T KSDVWSFG++L E+ T  R
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 110/223 (49%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IR 54
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+EF L+  L+  +   A   +P     
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEF-LSMDLKKFMDASALTGIPLPLIK 109
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 110 SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE 166
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 167 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 24  VKLGQGCFGEVWMGT-----WNGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 75  LVQLY---AVVSEEPI--YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           +     +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + 
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWT 182
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           AP+    G  T KSDVWSFG++L E+ T  R
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 134/288 (46%), Gaps = 36/288 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPNL 145
           +G G FG V    +K  +    S    VAIK L     +  ++ ++ E   +G  +HPN+
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEIS----VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 79
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           ++L G       +    ++V E M N SL D    +          + ++ G A G+ YL
Sbjct: 80  IRLEGVVT----KSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYL 134
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAA 262
            +   +  ++RD  A N+L++ N   K+SDFGL+R   + P   +T     +     + +
Sbjct: 135 SD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTS 189
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 321
           P+ I     T+ SDVWS+G+VL+E+++ G R        + Q +++ V +        G 
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE---MSNQDVIKAVDE--------GY 238
Query: 322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
            + P ++   ++ +      L  +C  K   +RPK  Q+V  L ++++
Sbjct: 239 RLPPPMDCPAALYQ------LMLDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 13  VKLGQGCFGEVWMGT-----WNGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 63
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 64  LVQLY---AVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 118
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           +     +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + 
Sbjct: 119 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWT 171
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           AP+    G  T KSDVWSFG++L E+ T  R
Sbjct: 172 APEAALYGRFTIKSDVWSFGILLTELTTKGR 202

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 117/229 (51%), Gaps = 28/229 (12%)
Query: 66  LRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GL 124
           LR+   +E++       R+  +G G FG+VYK    P   +G +    VAIK LN   G 
Sbjct: 9   LRILKETELK-------RVKVLGSGAFGTVYKGIWVP---EGETVKIPVAIKILNETTGP 58
Query: 125 QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE--DHLFNRA 182
           + + +++ E   +  ++HP+LV+L+G C     + + +L+ +  +L    E  D++ ++ 
Sbjct: 59  KANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQL 118
Query: 183 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 242
              L W  ++      A+G+ YL E    ++++RD  A NVL+      K++DFGLAR  
Sbjct: 119 L--LNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL- 166
Query: 243 PMVGHTHVSTAVVG--TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            + G      A  G     + A + I     T +SDVWS+GV ++E++T
Sbjct: 167 -LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 21  VKLGQGCFGEVWMGT-----WNGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 71
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 72  LVQLY---AVVSEEPI--YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           +     +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + 
Sbjct: 127 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWT 179
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           AP+    G  T KSDVWSFG++L E+ T  R
Sbjct: 180 APEAALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 84/312 (26%), Positives = 135/312 (43%), Gaps = 57/312 (18%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL 137
           ND      IGEG FG V K+ IK    DG       AIK++     +  H+ +  E++ L
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKK---DGLR--MDAAIKRMKEYASKDDHRDFAGELEVL 79
Query: 138 GVL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------------FNRA 182
             L  HPN++ L+G C     RG   L + E+  + +L D L               N  
Sbjct: 80  CKLGHHPNIINLLGACE---HRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANST 135
Query: 183 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 242
              L  +  LH     A G+ YL +    Q I+RD  A N+L+ EN+  K++DFGL+R  
Sbjct: 136 ASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQ 192
Query: 243 PM-----VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
            +     +G   V    + +  Y+          T  SDVWS+GV+L+E+++   +    
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSV--------YTTNSDVWSYGVLLWEIVSLGGT---- 240
Query: 298 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 357
            P       E  ++ P            RLEK   +N   ++  L   C  +   +RP  
Sbjct: 241 -PYCGMTCAELYEKLPQGY---------RLEK--PLNCDDEVYDLMRQCWREKPYERPSF 288
Query: 358 SQVVERLKQIVQ 369
           +Q++  L ++++
Sbjct: 289 AQILVSLNRMLE 300

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 129/283 (45%), Gaps = 34/283 (12%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           +DF ++ ++G G  G V+K S KP+      +   + IK   R+      Q + E+Q L 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN------QIIRELQVLH 62
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
               P +V   G    DGE  I      E M   SL D +  +A   +P +    + +  
Sbjct: 63  ECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKA-GRIPEQILGKVSIAV 116
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
            +GL YL E  + ++++RD K SN+L++     KL DFG++  G ++    ++   VGT 
Sbjct: 117 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DEMANEFVGTR 170
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 318
            Y +P+ ++  H + +SD+WS G+ L EM  GR       P     LL+++   P     
Sbjct: 171 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP---RPPMAIFELLDYIVNEPP---- 223
Query: 319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 361
                 P+L       E +      + CL K+  +R  + Q++
Sbjct: 224 ------PKLPSAVFSLEFQD---FVNKCLIKNPAERADLKQLM 257

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 190 VKLGQGCFGEVWMGTW-----NGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 241 LVQLY---AVVSEEPI--YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           +     +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + 
Sbjct: 296 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWT 348
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           AP+    G  T KSDVWSFG++L E+ T  R
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 84/312 (26%), Positives = 135/312 (43%), Gaps = 57/312 (18%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL 137
           ND      IGEG FG V K+ IK    DG       AIK++     +  H+ +  E++ L
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKK---DGLRMDA--AIKRMKEYASKDDHRDFAGELEVL 69
Query: 138 GVL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------------FNRA 182
             L  HPN++ L+G C     RG   L + E+  + +L D L               N  
Sbjct: 70  CKLGHHPNIINLLGACE---HRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANST 125
Query: 183 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 242
              L  +  LH     A G+ YL +    Q I+RD  A N+L+ EN+  K++DFGL+R  
Sbjct: 126 ASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQ 182
Query: 243 PM-----VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
            +     +G   V    + +  Y+          T  SDVWS+GV+L+E+++   +    
Sbjct: 183 EVYVKKTMGRLPVRWMAIESLNYSV--------YTTNSDVWSYGVLLWEIVSLGGT---- 230
Query: 298 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 357
            P       E  ++ P            RLEK   +N   ++  L   C  +   +RP  
Sbjct: 231 -PYCGMTCAELYEKLPQGY---------RLEK--PLNCDDEVYDLMRQCWREKPYERPSF 278
Query: 358 SQVVERLKQIVQ 369
           +Q++  L ++++
Sbjct: 279 AQILVSLNRMLE 290

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 24  VKLGQGCFGEVWMGT-----WNGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 75  LVQLY---AVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           +     +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + 
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWT 182
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           AP+    G  T KSDVWSFG++L E+ T  R
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 21  VKLGQGCFGEVWMGT-----WNGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 71
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 72  LVQLY---AVVSEEPI--YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           +     +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + 
Sbjct: 127 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEWTARQGAKFPIKWT 179
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           AP+    G  T KSDVWSFG++L E+ T  R
Sbjct: 180 APEAALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 128/286 (44%), Gaps = 38/286 (13%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG--HKQWVAEVQFLGVLEHP 143
           +IG G FG V+   ++       ++ T+VA+K   R+ L      +++ E + L    HP
Sbjct: 121 QIGRGNFGEVFSGRLR-------ADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHP 172
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRA-FPPLPWKTRLHIILGAAEG 201
           N+V+LIG C        Q+  +Y  M      D L F R     L  KT L ++  AA G
Sbjct: 173 NIVRLIGVCT-------QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           + YL        I+RD  A N L+ E    K+SDFG++RE     +            + 
Sbjct: 226 MEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT 282
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 321
           AP+ +  G  +++SDVWSFG++L+E  +   S   N    + R  E+V+       K G 
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR--EFVE-------KGGR 333
Query: 322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
           +  P L  +        + RL + C +     RP  S + + L+ I
Sbjct: 334 LPCPELCPD-------AVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 143/314 (45%), Gaps = 45/314 (14%)
Query: 70  SYSEMRQATNDFSRMLK---------IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           +Y +  QA ++F++ ++         IG G FG V    +K     G  E  V AIK L 
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLP---GKRELPV-AIKTLK 59
Query: 121 RDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF 179
               +  ++ ++ E   +G  +HPN++ L G       +    ++V E+M N SL D   
Sbjct: 60  VGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVT----KSKPVMIVTEYMENGSL-DTFL 114
Query: 180 NRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA 239
            +          + ++ G + G+ YL +   +  ++RD  A N+L++ N   K+SDFGL+
Sbjct: 115 KKNDGQFTVIQLVGMLRGISAGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLS 171
Query: 240 R---EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLE 295
           R   + P   +T     +     + AP+ I     T+ SDVWS+G+V++E+++ G R   
Sbjct: 172 RVLEDDPEAAYTTRGGKI--PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYW 229
Query: 296 RNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 355
                T Q +++ V++              RL        A  + +L  +C  K    RP
Sbjct: 230 E---MTNQDVIKAVEE------------GYRLPSPMDCPAA--LYQLMLDCWQKERNSRP 272
Query: 356 KMSQVVERLKQIVQ 369
           K  ++V  L ++++
Sbjct: 273 KFDEIVNMLDKLIR 286

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 134/288 (46%), Gaps = 37/288 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK--QWVAEVQFLGVLEHP 143
           KIG G FG+V+++             + VA+K L        +  +++ EV  +  L HP
Sbjct: 44  KIGAGSFGTVHRAEW---------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGL 202
           N+V  +G  AV     +   +V E++   SL   L    A   L  + RL +    A+G+
Sbjct: 95  NIVLFMG--AVTQPPNLS--IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST-AVVGTFGYA 261
            YLH      +++R+ K+ N+L+D+ +  K+ DFGL+R   +   T +S+ +  GT  + 
Sbjct: 151 NYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR---LKASTFLSSKSAAGTPEWM 206
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 321
           AP+ +       KSDV+SFGV+L+E+ T ++               W    PA       
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQP--------------WGNLNPAQVVAAVG 252
Query: 322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
               RLE   ++N   ++  + + C +     RP  + +++ L+ +++
Sbjct: 253 FKCKRLEIPRNLNP--QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 130/289 (44%), Gaps = 44/289 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG--HKQWVAEVQFLGVLEHP 143
           +IG G FG V+   ++       ++ T+VA+K   R+ L      +++ E + L    HP
Sbjct: 121 QIGRGNFGEVFSGRLR-------ADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHP 172
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRA-FPPLPWKTRLHIILGAAEG 201
           N+V+LIG C        Q+  +Y  M      D L F R     L  KT L ++  AA G
Sbjct: 173 NIVRLIGVCT-------QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE---GPMVGHTHVSTAVVGTF 258
           + YL        I+RD  A N L+ E    K+SDFG++RE   G       +    V   
Sbjct: 226 MEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVK-- 280
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 318
            + AP+ +  G  +++SDVWSFG++L+E  +   S   N    + R  E+V+       K
Sbjct: 281 -WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR--EFVE-------K 330
Query: 319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
            G +  P L  +        + RL + C +     RP  S + + L+ I
Sbjct: 331 GGRLPCPELCPD-------AVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  + H  
Sbjct: 24  VKLGQGCFGEVWMGT-----WNGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEK 74
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 75  LVQLY---AVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           +     +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + 
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWT 182
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           AP+    G  T KSDVWSFG++L E+ T  R
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 112/236 (47%), Gaps = 22/236 (9%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           +DF R+ ++G G  G V K   +P+      +   + IK   R+      Q + E+Q L 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRN------QIIRELQVLH 69
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
               P +V   G    DGE  I      E M   SL D +   A   +P +    + +  
Sbjct: 70  ECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKEA-KRIPEEILGKVSIAV 123
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
             GLAYL E  + Q+++RD K SN+L++     KL DFG++  G ++    ++ + VGT 
Sbjct: 124 LRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI--DSMANSFVGTR 177
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 314
            Y AP+ ++  H + +SD+WS G+ L E+  GR  +    P  + + LE +   P 
Sbjct: 178 SYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI----PPPDAKELEAIFGRPV 229

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V+            +  T VA+K L + G      ++AE   +  L+H  L
Sbjct: 16  RLGAGQFGEVWMGYY--------NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 66
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L  Y  V  E      ++ E+M N SL D L   +   L     L +    AEG+A++
Sbjct: 67  VRL--YAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 121
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            E      I+R+ +A+N+L+ +    K++DFGLAR    +   +  TA  G      + A
Sbjct: 122 EER---NYIHRNLRAANILVSDTLSCKIADFGLAR----LIEDNEYTAREGAKFPIKWTA 174
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+ I  G  T KSDVWSFG++L E++T  R
Sbjct: 175 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 204

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 104/211 (49%), Gaps = 24/211 (11%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 24  VKLGQGCFGEVWMGT-----WNGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 75  LVQLY---AVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           +     +  ++RD  A+N+L+ EN   K++DFGLAR    +   +  TA  G      + 
Sbjct: 130 VER---MNYVHRDLAAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWT 182
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           AP+    G  T KSDVWSFG++L E+ T  R
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 104/211 (49%), Gaps = 24/211 (11%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 24  VKLGQGCFGEVWMGT-----WNGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M    L D L       L     + +    A G+AY
Sbjct: 75  LVQLY---AVVSEEPI--YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           +     +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + 
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWT 182
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           AP+    G  T KSDVWSFG++L E+ T  R
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 104/211 (49%), Gaps = 24/211 (11%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 24  VKLGQGCFGEVWMGT-----WNGT---TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M    L D L       L     + +    A G+AY
Sbjct: 75  LVQLY---AVVSEEPI--YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           +     +  ++RD +A+N+L+ EN   K++DFGLAR    +   +  TA  G      + 
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLAR----LIEDNEYTARQGAKFPIKWT 182
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           AP+    G  T KSDVWSFG++L E+ T  R
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/183 (33%), Positives = 93/183 (50%), Gaps = 14/183 (7%)
Query: 112 TVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN 171
           T VA+K L + G      ++AE   +  L+H  LV+L  Y  V  E      ++ E+M N
Sbjct: 38  TKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVTQE---PIYIITEYMEN 91
Query: 172 RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP 231
            SL D L   +   L     L +    AEG+A++ E      I+RD +A+N+L+ +    
Sbjct: 92  GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSC 148
Query: 232 KLSDFGLAREGPMVGHTHVSTAVVGTF--GYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           K++DFGLAR   ++     +      F   + AP+ I  G  T KSDVWSFG++L E++T
Sbjct: 149 KIADFGLAR---LIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
Query: 290 GRR 292
             R
Sbjct: 206 HGR 208

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 10/208 (4%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +GEG FGSV + ++K    DGTS    V   KL+    +  +++++E   +    HPN++
Sbjct: 42  LGEGEFGSVMEGNLKQE--DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 147 KLIGYCAVDGERGIQR-LLVYEFMLNRSLEDHLFNRAFPP----LPWKTRLHIILGAAEG 201
           +L+G C     +GI + +++  FM    L  +L           +P +T L  ++  A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           + YL        ++RD  A N +L ++    ++DFGL+++     +            + 
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLT 289
           A + +     T+KSDVW+FGV ++E+ T
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 129/287 (44%), Gaps = 35/287 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK--QWVAEVQFLGVLEHP 143
           KIG G FG+V+++             + VA+K L        +  +++ EV  +  L HP
Sbjct: 44  KIGAGSFGTVHRAEW---------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGL 202
           N+V  +G  AV     +   +V E++   SL   L    A   L  + RL +    A+G+
Sbjct: 95  NIVLFMG--AVTQPPNLS--IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
            YLH      +++RD K+ N+L+D+ +  K+ DFGL+R          S    GT  + A
Sbjct: 151 NYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ASXFLXSKXAAGTPEWMA 207
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
           P+ +       KSDV+SFGV+L+E+ T ++               W    PA        
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQP--------------WGNLNPAQVVAAVGF 253
Query: 323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
              RLE   ++N   ++  + + C +     RP  + +++ L+ +++
Sbjct: 254 KCKRLEIPRNLNP--QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 127/310 (40%), Gaps = 35/310 (11%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGH 127
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      Q  
Sbjct: 38  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 95
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 186
             ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 96  LDFLMEALIISKFNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQ 151
Query: 187 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 239
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 152 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 208
Query: 240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           R+    G+       +    +  P+    G  T+K+D WSFGV+L+E+ +          
Sbjct: 209 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPS 266
Query: 300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
           K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  + 
Sbjct: 267 KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAI 312
Query: 360 VVERLKQIVQ 369
           ++ER++   Q
Sbjct: 313 ILERIEYCTQ 322

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 135/312 (43%), Gaps = 57/312 (18%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL 137
           ND      IGEG FG V K+ IK    DG       AIK++     +  H+ +  E++ L
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKK---DGLRMDA--AIKRMKEYASKDDHRDFAGELEVL 76
Query: 138 GVL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------------FNRA 182
             L  HPN++ L+G C     RG   L + E+  + +L D L               N  
Sbjct: 77  CKLGHHPNIINLLGACE---HRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANST 132
Query: 183 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 242
              L  +  LH     A G+ YL +    Q I+R+  A N+L+ EN+  K++DFGL+R  
Sbjct: 133 ASTLSSQQLLHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSRGQ 189
Query: 243 PM-----VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
            +     +G   V    + +  Y+          T  SDVWS+GV+L+E+++   +    
Sbjct: 190 EVYVKKTMGRLPVRWMAIESLNYSV--------YTTNSDVWSYGVLLWEIVSLGGT---- 237
Query: 298 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 357
            P       E  ++ P            RLEK   +N   ++  L   C  +   +RP  
Sbjct: 238 -PYCGMTCAELYEKLPQGY---------RLEK--PLNCDDEVYDLMRQCWREKPYERPSF 285
Query: 358 SQVVERLKQIVQ 369
           +Q++  L ++++
Sbjct: 286 AQILVSLNRMLE 297

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D     ++GEG FG V+ +       +   +  +VA+K L        + +  E + L +
Sbjct: 19  DIVLKWELGEGAFGKVFLAECHNLLPE--QDKMLVAVKALKEASESARQDFQREAELLTM 76
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDH-----LF----NRAFPPL 186
           L+H ++V+  G C      G   L+V+E+M    LNR L  H     L     + A  PL
Sbjct: 77  LQHQHIVRFFGVCT----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 132
Query: 187 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
                L +    A G+ YL  GL    ++RD    N L+ +    K+ DFG++R+     
Sbjct: 133 GLGQLLAVASQVAAGMVYL-AGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 189
Query: 247 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           +  V    +    +  P+ I     T +SDVWSFGVVL+E+ T
Sbjct: 190 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 127/310 (40%), Gaps = 35/310 (11%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGH 127
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      Q  
Sbjct: 61  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 118
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 186
             ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 119 LDFLMEALIISKFNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQ 174
Query: 187 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 239
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 175 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
Query: 240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           R+    G+       +    +  P+    G  T+K+D WSFGV+L+E+ +          
Sbjct: 232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPS 289
Query: 300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
           K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  + 
Sbjct: 290 KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAI 335
Query: 360 VVERLKQIVQ 369
           ++ER++   Q
Sbjct: 336 ILERIEYCTQ 345

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 111/222 (50%), Gaps = 29/222 (13%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVAEVQ 135
           +F ++ KIGEG +G VYK     A    T E  VVA+KK+  D    G+      + E+ 
Sbjct: 3   NFQKVEKIGEGTYGVVYK-----ARNKLTGE--VVALKKIRLDTETEGVPSTA--IREIS 53
Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  L HPN+VKL+     +     +  LV+E + ++ L+  +   A   +P       +
Sbjct: 54  LLKELNHPNIVKLLDVIHTEN----KLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYL 108
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTA 253
               +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    P+  +TH    
Sbjct: 109 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---- 161
Query: 254 VVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D     ++GEG FG V+ +       +   +  +VA+K L        + +  E + L +
Sbjct: 13  DIVLKWELGEGAFGKVFLAECHNLLPE--QDKMLVAVKALKEASESARQDFQREAELLTM 70
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDH-----LF----NRAFPPL 186
           L+H ++V+  G C      G   L+V+E+M    LNR L  H     L     + A  PL
Sbjct: 71  LQHQHIVRFFGVCT----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 126
Query: 187 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
                L +    A G+ YL  GL    ++RD    N L+ +    K+ DFG++R+     
Sbjct: 127 GLGQLLAVASQVAAGMVYL-AGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 183
Query: 247 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           +  V    +    +  P+ I     T +SDVWSFGVVL+E+ T
Sbjct: 184 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +K+G+G FG V+  +      +GT   T VAIK L + G    + ++ E Q +  L H  
Sbjct: 191 VKLGQGCFGEVWMGTW-----NGT---TRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEK 241
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           LV+L    AV  E  I   +V E+M   SL D L       L     + +    A G+AY
Sbjct: 242 LVQLY---AVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 296
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAA 262
           +     +  ++RD +A+N+L+ EN   K++DFGL R   ++     +      F   + A
Sbjct: 297 VER---MNYVHRDLRAANILVGENLVCKVADFGLGR---LIEDNEYTARQGAKFPIKWTA 350
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+    G  T KSDVWSFG++L E+ T  R
Sbjct: 351 PEAALYGRFTIKSDVWSFGILLTELTTKGR 380

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D     ++GEG FG V+ +       +   +  +VA+K L        + +  E + L +
Sbjct: 42  DIVLKWELGEGAFGKVFLAECHNLLPE--QDKMLVAVKALKEASESARQDFQREAELLTM 99
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDH-----LF----NRAFPPL 186
           L+H ++V+  G C      G   L+V+E+M    LNR L  H     L     + A  PL
Sbjct: 100 LQHQHIVRFFGVCT----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 155
Query: 187 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
                L +    A G+ YL  GL    ++RD    N L+ +    K+ DFG++R+     
Sbjct: 156 GLGQLLAVASQVAAGMVYL-AGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212
Query: 247 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           +  V    +    +  P+ I     T +SDVWSFGVVL+E+ T
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P  GD T    +VA+K+L   G    + +  E+Q L  L    +
Sbjct: 17  QLGKGNFGSVELCRYDPL-GDNT--GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 73
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY- 204
           VK  G     G + ++  LV E++ +  L D L            R    L A+  L Y 
Sbjct: 74  VKYRGVSYGPGRQSLR--LVMEYLPSGCLRDFL-----------QRHRARLDASRLLLYS 120
Query: 205 --LHEGLEV----QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV--STAVVG 256
             + +G+E     + ++RD  A N+L++     K++DFGLA+  P+    +V        
Sbjct: 121 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 180
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            F YA P+ +     + +SDVWSFGVVLYE+ T
Sbjct: 181 IFWYA-PESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 117/253 (46%), Gaps = 37/253 (14%)
Query: 55  IPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSI-KPAAGDGTSEATV 113
           +P + + K   L+  S S +R        M ++GE  FG VYK  +  PA G+ T     
Sbjct: 9   MPLINQHKQAKLKEISLSAVR-------FMEELGEDRFGKVYKGHLFGPAPGEQTQ---A 58
Query: 114 VAIKKLNRDGLQG--HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVY----- 166
           VAIK L +D  +G   +++  E      L+HPN+V L+G   V  ++ +  +  Y     
Sbjct: 59  VAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNVVCLLG--VVTKDQPLSMIFSYCSHGD 115
Query: 167 --EFMLNRSL--------EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYR 216
             EF++ RS         +D     A  P      +H++   A G+ YL       V+++
Sbjct: 116 LHEFLVMRSPHSDVGSTDDDRTVKSALEP---PDFVHLVAQIAAGMEYLSSH---HVVHK 169
Query: 217 DFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD 276
           D    NVL+ +    K+SD GL RE     +  +    +    + AP+ I  G  +  SD
Sbjct: 170 DLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSD 229
Query: 277 VWSFGVVLYEMLT 289
           +WS+GVVL+E+ +
Sbjct: 230 IWSYGVVLWEVFS 242

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 25/223 (11%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD----GLQGHKQWVA 132
           +  +F ++ KIGEG +G VYK+  K           VVA+KK+  D    G+      + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTA--IR 54
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  L HPN+VKL+     +     +  LV+E + ++ L+  +   A   +P     
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTEN----KLYLVFEHV-DQDLKKFMDASALTGIPLPLIK 109
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +    +GLA+ H     +V++RD K  N+L++     KL+DFGLAR   +   T+   
Sbjct: 110 SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 166
Query: 253 AVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSL 294
            V  T  Y AP+  +   + +   D+WS G +  EM+T RR+L
Sbjct: 167 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           +IG G FG+VYK       GD       V I K+     +  + +  EV  L    H N+
Sbjct: 43  RIGSGSFGTVYKGKWH---GD-----VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNI 94
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           +  +GY   D        +V ++    SL  HL  +          + I    A+G+ YL
Sbjct: 95  LLFMGYMTKDN-----LAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYL 148
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 265
           H      +I+RD K++N+ L E    K+ DFGLA        +       G+  + AP+ 
Sbjct: 149 HAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEV 205
Query: 266 I---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
           I   +    + +SDV+S+G+VLYE++TG   L  +      +++  V +  A        
Sbjct: 206 IRMQDNNPFSFQSDVYSYGIVLYELMTGE--LPYSHINNRDQIIFMVGRGYA-------- 255
Query: 323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
             P L K Y  N  + + RL  +C+ K  ++RP   Q++  ++
Sbjct: 256 -SPDLSKLYK-NCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 44/299 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P  GD T    +VA+K+L   G    + +  E+Q L  L    +
Sbjct: 30  QLGKGNFGSVELCRYDPL-GDNT--GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY- 204
           VK  G     G + ++  LV E++ +  L D L            R    L A+  L Y 
Sbjct: 87  VKYRGVSYGPGRQSLR--LVMEYLPSGCLRDFL-----------QRHRARLDASRLLLYS 133
Query: 205 --LHEGLEV----QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV--STAVVG 256
             + +G+E     + ++RD  A N+L++     K++DFGLA+  P+    +V        
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQYPAD 315
            F YA P+ +     + +SDVWSFGVVLYE+ T     +   P  E  R++   +  PA 
Sbjct: 194 IFWYA-PESLSDNIFSRQSDVWSFGVVLYELFT--YCDKSCSPSAEFLRMMGCERDVPAL 250
Query: 316 SKKFG-------LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
           S+          L   P    E  ++E  K+      C + S +DRP  S +  +L  +
Sbjct: 251 SRLLELLEEGQRLPAPPACPAE--VHELMKL------CWAPSPQDRPSFSALGPQLDML 301

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 37/311 (11%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGH 127
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      Q  
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 78
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 186
             ++ E   +  L H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 79  LDFLMEALIISKLNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQ 134
Query: 187 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 239
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 135 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 191
Query: 240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR 298
           R+     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G        
Sbjct: 192 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-- 249
Query: 299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 358
            K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  +
Sbjct: 250 -KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFA 294
Query: 359 QVVERLKQIVQ 369
            ++ER++   Q
Sbjct: 295 IILERIEYCTQ 305

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 6/170 (3%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E Q    L HP +V +      +   G    +V E++   +L D +      P+  K  +
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAI 119
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            +I  A + L + H+     +I+RD K +N+++      K+ DFG+AR     G++   T
Sbjct: 120 EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 253 A-VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 301
           A V+GT  Y +P+      + A+SDV+S G VLYE+LTG      + P +
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDS 226

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P  GD T    +VA+K+L   G    + +  E+Q L  L    +
Sbjct: 18  QLGKGNFGSVELCRYDPL-GDNT--GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 74
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY- 204
           VK  G     G + ++  LV E++ +  L D L            R    L A+  L Y 
Sbjct: 75  VKYRGVSYGPGRQSLR--LVMEYLPSGCLRDFL-----------QRHRARLDASRLLLYS 121
Query: 205 --LHEGLEV----QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV--STAVVG 256
             + +G+E     + ++RD  A N+L++     K++DFGLA+  P+    +V        
Sbjct: 122 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 181
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            F YA P+ +     + +SDVWSFGVVLYE+ T
Sbjct: 182 IFWYA-PESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 20/225 (8%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVA-EVQF 136
           DF     +G+G F  VY++       +       VAIK +++  +   G  Q V  EV+ 
Sbjct: 12  DFKVGNLLGKGSFAGVYRA-------ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
              L+HP++++L  Y     E      LV E   N  +  +L NR  P    + R H + 
Sbjct: 65  HCQLKHPSILELYNYF----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMH 119
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
               G+ YLH      +++RD   SN+LL  N   K++DFGLA +  M    H +  + G
Sbjct: 120 QIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCG 174
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 301
           T  Y +P+         +SDVWS G + Y +L GR   + +  K 
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 37/311 (11%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGH 127
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      Q  
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 92
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 186
             ++ E   +  L H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 93  LDFLMEALIISKLNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQ 148
Query: 187 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 239
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 149 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 205
Query: 240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR 298
           R+     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G        
Sbjct: 206 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-- 263
Query: 299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 358
            K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  +
Sbjct: 264 -KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFA 308
Query: 359 QVVERLKQIVQ 369
            ++ER++   Q
Sbjct: 309 IILERIEYCTQ 319

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 6/168 (3%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E Q    L HP +V +      +   G    +V E++   +L D +      P+  K  +
Sbjct: 62  EAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAI 119
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            +I  A + L + H+     +I+RD K +N+++      K+ DFG+AR     G++   T
Sbjct: 120 EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 253 A-VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           A V+GT  Y +P+      + A+SDV+S G VLYE+LTG      + P
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 140/319 (43%), Gaps = 34/319 (10%)
Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQG 126
           VF   E   +    + + ++G+G FG VY+ + +     G +E T VA+K +N    L+ 
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRE 63
Query: 127 HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------- 178
             +++ E   +      ++V+L+G  +    +G   L+V E M +  L+ +L        
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 179 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 238
            N   PP   +  + +    A+G+AYL+     + ++RD  A N ++  +F  K+ DFG+
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM 176
Query: 239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 298
            R+     +       +    + AP+ ++ G  T  SD+WSFGVVL+E+ +         
Sbjct: 177 TRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------- 227
Query: 299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 358
                 L E   Q  ++ +    +MD     +   N   ++  L   C   + K RP   
Sbjct: 228 ------LAEQPYQGLSNEQVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFL 280
Query: 359 QVVERLKQIVQVSNEGDSF 377
           ++V  LK  +  S    SF
Sbjct: 281 EIVNLLKDDLHPSFPEVSF 299

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 82/168 (48%), Gaps = 6/168 (3%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E Q    L HP +V +      +   G    +V E++   +L D +      P+  K  +
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAI 119
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            +I  A + L + H+     +I+RD K +N+L+      K+ DFG+AR     G++   T
Sbjct: 120 EVIADACQALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 253 A-VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           A V+GT  Y +P+      + A+SDV+S G VLYE+LTG      + P
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 139/319 (43%), Gaps = 34/319 (10%)
Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQG 126
           VF   E   +    + + ++G+G FG VY+ + +     G +E T VA+K +N    L+ 
Sbjct: 3   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRE 60
Query: 127 HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------- 178
             +++ E   +      ++V+L+G  +    +G   L+V E M +  L+ +L        
Sbjct: 61  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAE 116
Query: 179 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 238
            N   PP   +  + +    A+G+AYL+     + ++RD  A N ++  +F  K+ DFG+
Sbjct: 117 NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM 173
Query: 239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 298
            R+             +    + AP+ ++ G  T  SD+WSFGVVL+E+ +         
Sbjct: 174 TRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------- 224
Query: 299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 358
                 L E   Q  ++ +    +MD     +   N   ++  L   C   + K RP   
Sbjct: 225 ------LAEQPYQGLSNEQVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFL 277
Query: 359 QVVERLKQIVQVSNEGDSF 377
           ++V  LK  +  S    SF
Sbjct: 278 EIVNLLKDDLHPSFPEVSF 296

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 6/168 (3%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E Q    L HP +V +      +   G    +V E++   +L D +      P+  K  +
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAI 119
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            +I  A + L + H+     +I+RD K +N+++      K+ DFG+AR     G++   T
Sbjct: 120 EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 253 A-VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           A V+GT  Y +P+      + A+SDV+S G VLYE+LTG      + P
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 140/319 (43%), Gaps = 34/319 (10%)
Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQG 126
           VF   E   +    + + ++G+G FG VY+ + +     G +E T VA+K +N    L+ 
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRE 63
Query: 127 HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------- 178
             +++ E   +      ++V+L+G  +    +G   L+V E M +  L+ +L        
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 179 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 238
            N   PP   +  + +    A+G+AYL+     + ++RD  A N ++  +F  K+ DFG+
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM 176
Query: 239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 298
            R+     +       +    + AP+ ++ G  T  SD+WSFGVVL+E+ +         
Sbjct: 177 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------- 227
Query: 299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 358
                 L E   Q  ++ +    +MD     +   N   ++  L   C   + K RP   
Sbjct: 228 ------LAEQPYQGLSNEQVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFL 280
Query: 359 QVVERLKQIVQVSNEGDSF 377
           ++V  LK  +  S    SF
Sbjct: 281 EIVNLLKDDLHPSFPEVSF 299

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFLGVLEHPNL 145
           IG+G FG VY         D        AIK L+R   +Q  + ++ E   +  L HPN+
Sbjct: 29  IGKGHFGVVYHGEYI----DQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + LIG        G+  +L+  +M +  L   + +    P   K  +   L  A G+ YL
Sbjct: 85  LALIGIML--PPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTV-KDLISFGLQVARGMEYL 140
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE------GPMVGHTHVSTAVVGTFG 259
            E    + ++RD  A N +LDE+F  K++DFGLAR+        +  H H    V     
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV----K 193
Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           + A + ++T   T KSDVWSFGV+L+E+LT
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 139/319 (43%), Gaps = 34/319 (10%)
Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQG 126
           VF   E   +    + + ++G+G FG VY+ + +     G +E T VA+K +N    L+ 
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRE 63
Query: 127 HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------- 178
             +++ E   +      ++V+L+G  +    +G   L+V E M +  L+ +L        
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 179 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 238
            N   PP   +  + +    A+G+AYL+     + ++RD  A N ++  +F  K+ DFG+
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM 176
Query: 239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 298
            R+             +    + AP+ ++ G  T  SD+WSFGVVL+E+ +         
Sbjct: 177 TRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------- 227
Query: 299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 358
                 L E   Q  ++ +    +MD     +   N   ++  L   C   + K RP   
Sbjct: 228 ------LAEQPYQGLSNEQVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFL 280
Query: 359 QVVERLKQIVQVSNEGDSF 377
           ++V  LK  +  S    SF
Sbjct: 281 EIVNLLKDDLHPSFPEVSF 299

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 6/168 (3%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E Q    L HP +V +      +   G    +V E++   +L D +      P+  K  +
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAI 119
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            +I  A + L + H+     +I+RD K +N+++      K+ DFG+AR     G++   T
Sbjct: 120 EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 253 A-VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           A V+GT  Y +P+      + A+SDV+S G VLYE+LTG      + P
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 141/316 (44%), Gaps = 34/316 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPN 144
           ++G+G FG VY+   K    D     T VAIK +N    ++   +++ E   +      +
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 82
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 196
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 83  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 138
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 139 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 195
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 316
              + +P+ ++ G  T  SDVWSFGVVL+E+ T   + +  +  + +++L +V +     
Sbjct: 196 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFVME----- 248
Query: 317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS 376
              GL+  P        N    +  L   C   + K RP   +++  +K+ ++      S
Sbjct: 249 --GGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 299
Query: 377 FDKTFEEICEEDPVEA 392
           F  + E   E +PV A
Sbjct: 300 FYYSEENKMENNPVLA 315

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 106/231 (45%), Gaps = 18/231 (7%)
Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQG 126
           VF   E   A    +   ++G+G FG VY+   K    D     T VAIK +N    ++ 
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRE 62
Query: 127 HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------- 178
             +++ E   +      ++V+L+G  +    +G   L++ E M    L+ +L        
Sbjct: 63  RIEFLNEASVMKEFNCHHVVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEME 118
Query: 179 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 238
            N    P      + +    A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+
Sbjct: 119 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 175
Query: 239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            R+     +       +    + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 176 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 118/293 (40%), Gaps = 36/293 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFLGVLEHPNL 145
           +G G FG VY+  +     D +     VA+K L      Q    ++ E   +    H N+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 122
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKTR----LHIILGAAE 200
           V+ IG       + + R ++ E M    L+  L   R  P  P        LH+    A 
Sbjct: 123 VRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 178
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
           G  YL E      I+RD  A N LL         K+ DFG+AR+     +       +  
Sbjct: 179 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 235
Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS 316
             +  P+    G  T+K+D WSFGV+L+E+ + G         K+ Q +LE+V       
Sbjct: 236 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSNQEVLEFVTS----- 287
Query: 317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
              G  MDP        N    + R+   C     +DRP  + ++ER++   Q
Sbjct: 288 ---GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 331

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 127/311 (40%), Gaps = 37/311 (11%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGH 127
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      Q  
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 77
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 186
             ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 78  LDFLMEALIISKFNHQNIVRCIGV----SLQSLPRFILMELMAGGDLKSFLRETRPRPSQ 133
Query: 187 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 239
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 134 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
Query: 240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR 298
           R+     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G        
Sbjct: 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-- 248
Query: 299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 358
            K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  +
Sbjct: 249 -KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFA 293
Query: 359 QVVERLKQIVQ 369
            ++ER++   Q
Sbjct: 294 IILERIEYCTQ 304

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 127/311 (40%), Gaps = 37/311 (11%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGH 127
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      Q  
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 77
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 186
             ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 78  LDFLMEALIISKFNHQNIVRCIGV----SLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 133
Query: 187 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 239
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 134 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
Query: 240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR 298
           R+     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G        
Sbjct: 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-- 248
Query: 299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 358
            K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  +
Sbjct: 249 -KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFA 293
Query: 359 QVVERLKQIVQ 369
            ++ER++   Q
Sbjct: 294 IILERIEYCTQ 304

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 127/311 (40%), Gaps = 37/311 (11%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGH 127
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      Q  
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 78
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 186
             ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 79  LDFLMEALIISKFNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQ 134
Query: 187 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 239
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 135 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 191
Query: 240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR 298
           R+     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G        
Sbjct: 192 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-- 249
Query: 299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 358
            K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  +
Sbjct: 250 -KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFA 294
Query: 359 QVVERLKQIVQ 369
            ++ER++   Q
Sbjct: 295 IILERIEYCTQ 305

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 30/224 (13%)
Query: 84  MLKIGEGGFGSVYKSSI-KPAAGDGTSEATVVAIKKLNRDGLQG--HKQWVAEVQFLGVL 140
           M ++GE  FG VYK  +  PA G+ T     VAIK L +D  +G   +++  E      L
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQ---AVAIKTL-KDKAEGPLREEFRHEAMLRARL 69
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVY-------EFMLNRSL--------EDHLFNRAFPP 185
           +HPN+V L+G   V  ++ +  +  Y       EF++ RS         +D     A  P
Sbjct: 70  QHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 245
                 +H++   A G+ YL       V+++D    NVL+ +    K+SD GL RE    
Sbjct: 128 ---PDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 246 GHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            +  +    +    + AP+ I  G  +  SD+WS+GVVL+E+ +
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 127/311 (40%), Gaps = 37/311 (11%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGH 127
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      Q  
Sbjct: 37  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 94
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 186
             ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 95  LDFLMEALIISKFNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQ 150
Query: 187 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 239
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 151 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 207
Query: 240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR 298
           R+     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G        
Sbjct: 208 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-- 265
Query: 299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 358
            K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  +
Sbjct: 266 -KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFA 310
Query: 359 QVVERLKQIVQ 369
            ++ER++   Q
Sbjct: 311 IILERIEYCTQ 321

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 111/225 (49%), Gaps = 20/225 (8%)
Query: 66  LRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GL 124
           LR+   +E+R+          +G G FG+VYK    P   DG +    VAIK L  +   
Sbjct: 11  LRILKETELRKVK-------VLGSGAFGTVYKGIWIP---DGENVKIPVAIKVLRENTSP 60
Query: 125 QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP 184
           + +K+ + E   +  +  P + +L+G C     + + +L+ Y  +L+   E    NR   
Sbjct: 61  KANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRE----NRGR- 115
Query: 185 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
            L  +  L+  +  A+G++YL +   V++++RD  A NVL+      K++DFGLAR   +
Sbjct: 116 -LGSQDLLNWCMQIAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 171
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
               + +        + A + I     T +SDVWS+GV ++E++T
Sbjct: 172 DETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 127/311 (40%), Gaps = 37/311 (11%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGH 127
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      Q  
Sbjct: 27  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 84
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 186
             ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 85  LDFLMEALIISKFNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQ 140
Query: 187 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 239
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 141 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 197
Query: 240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR 298
           R+     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G        
Sbjct: 198 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-- 255
Query: 299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 358
            K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  +
Sbjct: 256 -KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFA 300
Query: 359 QVVERLKQIVQ 369
            ++ER++   Q
Sbjct: 301 IILERIEYCTQ 311

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 127/311 (40%), Gaps = 37/311 (11%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGH 127
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      Q  
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 92
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 186
             ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 93  LDFLMEALIISKFNHQNIVRCIGVSL----QSLPRFILMELMAGGDLKSFLRETRPRPSQ 148
Query: 187 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 239
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 149 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 205
Query: 240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR 298
           R+     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G        
Sbjct: 206 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-- 263
Query: 299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 358
            K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  +
Sbjct: 264 -KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFA 308
Query: 359 QVVERLKQIVQ 369
            ++ER++   Q
Sbjct: 309 IILERIEYCTQ 319

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 6/168 (3%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E Q    L HP +V +      +   G    +V E++   +L D +      P+  K  +
Sbjct: 79  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAI 136
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            +I  A + L + H+     +I+RD K +N+++      K+ DFG+AR     G++   T
Sbjct: 137 EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 253 A-VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           A V+GT  Y +P+      + A+SDV+S G VLYE+LTG      + P
Sbjct: 194 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 241

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 126/310 (40%), Gaps = 35/310 (11%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGH 127
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      Q  
Sbjct: 12  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 69
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 186
             ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 70  LDFLMEALIISKFNHQNIVRCIGV----SLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 125
Query: 187 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 239
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 126 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 182
Query: 240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           R+     +       +    +  P+    G  T+K+D WSFGV+L+E+ +          
Sbjct: 183 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPS 240
Query: 300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
           K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  + 
Sbjct: 241 KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAI 286
Query: 360 VVERLKQIVQ 369
           ++ER++   Q
Sbjct: 287 ILERIEYCTQ 296

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 36/227 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
           ++G GGFG V +  I    G+       VAIK+  ++   +  ++W  E+Q +  L HPN
Sbjct: 21  RLGTGGFGYVLRW-IHQDTGEQ------VAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 145 LVKLIGYCAVDGERGIQRL-------LVYEFMLNRSLEDHL--FNRA--FPPLPWKTRLH 193
           +V      A +   G+Q+L       L  E+     L  +L  F         P +T L 
Sbjct: 74  VVS-----AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHTHV 250
            I  A   L YLHE    ++I+RD K  N++L    +    K+ D G A+E   +    +
Sbjct: 129 DISSA---LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGEL 179
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
            T  VGT  Y AP+ +E    T   D WSFG + +E +TG R    N
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 36/227 (15%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
           ++G GGFG V +  I    G+       VAIK+  ++   +  ++W  E+Q +  L HPN
Sbjct: 22  RLGTGGFGYVLRW-IHQDTGEQ------VAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 74
Query: 145 LVKLIGYCAVDGERGIQRL-------LVYEFMLNRSLEDHL--FNRA--FPPLPWKTRLH 193
           +V      A +   G+Q+L       L  E+     L  +L  F         P +T L 
Sbjct: 75  VVS-----AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 129
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHTHV 250
            I  A   L YLHE    ++I+RD K  N++L    +    K+ D G A+E   +    +
Sbjct: 130 DISSA---LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGEL 180
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
            T  VGT  Y AP+ +E    T   D WSFG + +E +TG R    N
Sbjct: 181 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 227

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 127/311 (40%), Gaps = 37/311 (11%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGH 127
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      Q  
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVYSEQDE 92
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 186
             ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 93  LDFLMEALIISKFNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQ 148
Query: 187 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 239
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 149 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 205
Query: 240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR 298
           R+     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G        
Sbjct: 206 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-- 263
Query: 299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 358
            K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  +
Sbjct: 264 -KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFA 308
Query: 359 QVVERLKQIVQ 369
            ++ER++   Q
Sbjct: 309 IILERIEYCTQ 319

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 18/213 (8%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPN 144
           ++G+G FG VY+   K    D     T VAIK +N    ++   +++ E   +      +
Sbjct: 17  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 74
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 196
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 75  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 130
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+             + 
Sbjct: 131 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLL 187
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 188 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 134/301 (44%), Gaps = 34/301 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPN 144
           ++G+G FG VY+ + +     G +E T VA+K +N    L+   +++ E   +      +
Sbjct: 23  ELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 80
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 196
           +V+L+G  +    +G   L+V E M +  L+ +L         N   PP   +  + +  
Sbjct: 81  VVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 136
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             A+G+AYL+     + ++RD  A N ++  +F  K+ DFG+ R+     +       + 
Sbjct: 137 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 193
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 316
              + AP+ ++ G  T  SD+WSFGVVL+E+ +               L E   Q  ++ 
Sbjct: 194 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNE 238
Query: 317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS 376
           +    +MD     +   N   ++  L   C   + K RP   ++V  LK  +  S    S
Sbjct: 239 QVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 297
Query: 377 F 377
           F
Sbjct: 298 F 298

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 18/213 (8%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPN 144
           ++G+G FG VY+   K    D     T VAIK +N    ++   +++ E   +      +
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 76
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 196
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 77  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 132
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 133 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 189
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 190 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 18/213 (8%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPN 144
           ++G+G FG VY+   K    D     T VAIK +N    ++   +++ E   +      +
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 196
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 90  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 145
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 146 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P  GD T    +VA+K+L   G    + +  E+Q L  L    +
Sbjct: 14  QLGKGNFGSVELCRYDPL-GDNT--GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 70
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY- 204
           VK  G     G   ++  LV E++ +  L D L            R    L A+  L Y 
Sbjct: 71  VKYRGVSYGPGRPELR--LVMEYLPSGCLRDFL-----------QRHRARLDASRLLLYS 117
Query: 205 --LHEGLEV----QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV--STAVVG 256
             + +G+E     + ++RD  A N+L++     K++DFGLA+  P+     V        
Sbjct: 118 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSP 177
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            F YA P+ +     + +SDVWSFGVVLYE+ T
Sbjct: 178 IFWYA-PESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 20/233 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           + F  +  +G+G FG V+   +K  +G    +   + + K     ++   +   E   L 
Sbjct: 24  SQFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            + HP +VKL      +G    +  L+ +F+    L    F R    + + T   +    
Sbjct: 82  EVNHPFIVKLHYAFQTEG----KLYLILDFLRGGDL----FTRLSKEVMF-TEEDVKFYL 132
Query: 199 AE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           AE    L +LH    + +IYRD K  N+LLDE    KL+DFGL++E   + H   + +  
Sbjct: 133 AELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFC 187
Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLE 307
           GT  Y AP+ +     T  +D WSFGV+++EMLTG    + ++R +T   +L+
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 18/213 (8%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPN 144
           ++G+G FG VY+   K    D     T VAIK +N    ++   +++ E   +      +
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 83
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 196
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 84  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 139
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 140 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 196
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 197 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 18/213 (8%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPN 144
           ++G+G FG VY+   K    D     T VAIK +N    ++   +++ E   +      +
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 196
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 90  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 146 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 117/237 (49%), Gaps = 32/237 (13%)
Query: 61  EKAHNL--RVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK 118
           EKA+ +  R+F  +E+R       ++  +G G FG+V+K    P   +G S    V IK 
Sbjct: 18  EKANKVLARIFKETELR-------KLKVLGSGVFGTVHKGVWIP---EGESIKIPVCIKV 67
Query: 119 L-NRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDH 177
           + ++ G Q  +     +  +G L+H ++V+L+G C      G    LV +++   SL DH
Sbjct: 68  IEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----GSSLQLVTQYLPLGSLLDH 122
Query: 178 LFNR--AFPP---LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK 232
           +     A  P   L W  ++      A+G+ YL E     +++R+  A NVLL    + +
Sbjct: 123 VRQHRGALGPQLLLNWGVQI------AKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQ 173
Query: 233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           ++DFG+A   P      + +       + A + I  G  T +SDVWS+GV ++E++T
Sbjct: 174 VADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 18/213 (8%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPN 144
           ++G+G FG VY+   K    D     T VAIK +N    ++   +++ E   +      +
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 83
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 196
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 84  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 139
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+             + 
Sbjct: 140 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLL 196
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 197 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 18/213 (8%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPN 144
           ++G+G FG VY+   K    D     T VAIK +N    ++   +++ E   +      +
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 82
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 196
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 83  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 138
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 139 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 195
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 196 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V+  +         +  T VAIK L + G    + ++ E Q +  L+H  L
Sbjct: 16  RLGNGQFGEVWMGT--------WNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKL 66
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L    AV  E  I   +V E+M   SL D L +     L     + +    A G+AY+
Sbjct: 67  VQLY---AVVSEEPI--YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 121
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
                +  I+RD +++N+L+      K++DFGLAR    +   +  TA  G      + A
Sbjct: 122 ER---MNYIHRDLRSANILVGNGLICKIADFGLAR----LIEDNEXTARQGAKFPIKWTA 174
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           P+    G  T KSDVWSFG++L E++T  R
Sbjct: 175 PEAALYGRFTIKSDVWSFGILLTELVTKGR 204

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 20/233 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           + F  +  +G+G FG V+   +K  +G    +   + + K     ++   +   E   L 
Sbjct: 25  SQFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 82
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            + HP +VKL      +G    +  L+ +F+    L    F R    + + T   +    
Sbjct: 83  EVNHPFIVKLHYAFQTEG----KLYLILDFLRGGDL----FTRLSKEVMF-TEEDVKFYL 133
Query: 199 AE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           AE    L +LH    + +IYRD K  N+LLDE    KL+DFGL++E   + H   + +  
Sbjct: 134 AELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFC 188
Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLE 307
           GT  Y AP+ +     T  +D WSFGV+++EMLTG    + ++R +T   +L+
Sbjct: 189 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 241

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 20/233 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           + F  +  +G+G FG V+   +K  +G    +   + + K     ++   +   E   L 
Sbjct: 24  SQFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            + HP +VKL      +G    +  L+ +F+    L    F R    + + T   +    
Sbjct: 82  EVNHPFIVKLHYAFQTEG----KLYLILDFLRGGDL----FTRLSKEVMF-TEEDVKFYL 132
Query: 199 AE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           AE    L +LH    + +IYRD K  N+LLDE    KL+DFGL++E   + H   + +  
Sbjct: 133 AELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFC 187
Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLE 307
           GT  Y AP+ +     T  +D WSFGV+++EMLTG    + ++R +T   +L+
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 24/219 (10%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAE 133
           M     + + + ++G G FG V     K     G  +  V    K+ ++G     ++  E
Sbjct: 3   MELKREEITLLKELGSGQFGVV-----KLGKWKGQYDVAV----KMIKEGSMSEDEFFQE 53
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
            Q +  L HP LVK  G C+    +     +V E++ N  L ++L +      P    L 
Sbjct: 54  AQTMMKLSHPKLVKFYGVCS----KEYPIYIVTEYISNGCLLNYLRSHGKGLEP-SQLLE 108
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
           +     EG+A+L      Q I+RD  A N L+D +   K+SDFG+ R   ++   +VS+ 
Sbjct: 109 MCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSS- 162
Query: 254 VVGT---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            VGT     ++AP+       ++KSDVW+FG++++E+ +
Sbjct: 163 -VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 18/213 (8%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPN 144
           ++G+G FG VY+   K    D     T VAIK +N    ++   +++ E   +      +
Sbjct: 22  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 79
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 196
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 80  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 135
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 136 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 192
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 193 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 18/213 (8%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPN 144
           ++G+G FG VY+   K    D     T VAIK +N    ++   +++ E   +      +
Sbjct: 54  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 111
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 196
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 112 VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 167
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +       + 
Sbjct: 168 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 224
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 225 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 116/235 (49%), Gaps = 28/235 (11%)
Query: 81  FSRMLKIGEGGFGSVY--KSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQ--F 136
           F  +  +G+G FG V+  +   +P +G       + A+K L +  L+   +   +++   
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGH------LYAMKVLKKATLKVRDRVRTKMERDI 83
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           L  + HP +VKL      +G    +  L+ +F+    L    F R    + + T   +  
Sbjct: 84  LADVNHPFVVKLHYAFQTEG----KLYLILDFLRGGDL----FTRLSKEVMF-TEEDVKF 134
Query: 197 GAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
             AE   GL +LH    + +IYRD K  N+LLDE    KL+DFGL++E   + H   + +
Sbjct: 135 YLAELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEA--IDHEKKAYS 189
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLE 307
             GT  Y AP+ +     +  +D WS+GV+++EMLTG    + ++R +T   +L+
Sbjct: 190 FCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILK 244

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 13/210 (6%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLNRDGLQGHKQ-WVAEVQFLGVL-EHP 143
           +G G FG V +++   A G G  +A + VA+K L        K+  ++E++ +  L +H 
Sbjct: 54  LGAGAFGKVVEAT---AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 144 NLVKLIGYCAVDGE-RGIQRLLVYEFMLN---RSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           N+V L+G C   G    I     Y  +LN   R  E  L      PL  +  LH     A
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 170
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           +G+A+L        I+RD  A NVLL      K+ DFGLAR+     +  V         
Sbjct: 171 QGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 227
Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           + AP+ I     T +SDVWS+G++L+E+ +
Sbjct: 228 WMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 127/311 (40%), Gaps = 37/311 (11%)
Query: 70  SYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGH 127
           S S++++    + + +  +G G FG VY+  +     D +     VA+K L      Q  
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS--PLQVAVKTLPEVCSEQDE 78
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPL 186
             ++ E   +    H N+V+ IG       + + R ++ E M    L+  L   R  P  
Sbjct: 79  LDFLMEALIISKFNHQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQ 134
Query: 187 PWKTR----LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLA 239
           P        LH+    A G  YL E      I+RD  A N LL         K+ DFG+A
Sbjct: 135 PSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 191
Query: 240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR 298
           ++     +       +    +  P+    G  T+K+D WSFGV+L+E+ + G        
Sbjct: 192 QDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-- 249
Query: 299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 358
            K+ Q +LE+V          G  MDP        N    + R+   C     +DRP  +
Sbjct: 250 -KSNQEVLEFVTS--------GGRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFA 294
Query: 359 QVVERLKQIVQ 369
            ++ER++   Q
Sbjct: 295 IILERIEYCTQ 305

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 115/252 (45%), Gaps = 29/252 (11%)
Query: 75  RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWV 131
           R    DF+ ++ +G+G FG V  +  K     GT E  + AIK L +D +      +  +
Sbjct: 15  RVKLTDFNFLMVLGKGSFGKVMLADRK-----GTEE--LYAIKILKKDVVIQDDDVECTM 67
Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKT 190
            E + L +L+ P  +  +  C     + + RL  V E++    L  H+        P   
Sbjct: 68  VEKRVLALLDKPPFLTQLHSCF----QTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP--- 120
Query: 191 RLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
               +  AAE   GL +LH+     +IYRD K  NV+LD     K++DFG+ +E  M G 
Sbjct: 121 --QAVFYAAEISIGLFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV 175
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLL 306
           T  +    GT  Y AP+ I         D W++GV+LYEML G+   +  +  +  Q ++
Sbjct: 176 T--TREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 233
Query: 307 EWVQQYPADSKK 318
           E    YP    K
Sbjct: 234 EHNVSYPKSLSK 245

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 111/231 (48%), Gaps = 18/231 (7%)
Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQG 126
           V+   E   +    + + ++G+G FG VY+ + +     G +E T VA+K +N    L+ 
Sbjct: 6   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRE 63
Query: 127 HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------- 178
             +++ E   +      ++V+L+G  +    +G   L+V E M +  L+ +L        
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 179 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 238
            N   PP   +  + +    A+G+AYL+     + ++RD  A N ++  +F  K+ DFG+
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM 176
Query: 239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            R+             +    + AP+ ++ G  T  SD+WSFGVVL+E+ +
Sbjct: 177 TRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 126/293 (43%), Gaps = 34/293 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLNRDGLQGHKQ-WVAEVQFLGVL-EHP 143
           +G G FG V +++   A G G  +A + VA+K L        K+  ++E++ +  L +H 
Sbjct: 46  LGAGAFGKVVEAT---AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 102
Query: 144 NLVKLIGYCAVDGE-RGIQRLLVYEFMLN---RSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           N+V L+G C   G    I     Y  +LN   R  E  L      PL  +  LH     A
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 162
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           +G+A+L        I+RD  A NVLL      K+ DFGLAR+     +  V         
Sbjct: 163 QGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 219
Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA---DS 316
           + AP+ I     T +SDVWS+G++L+E+     SL  N              YP    +S
Sbjct: 220 WMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-------------PYPGILVNS 262
Query: 317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
           K + L+ D     + +    + I  +   C +     RP   Q+   L++  Q
Sbjct: 263 KFYKLVKDGYQMAQPAF-APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 314

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G+G FG   K + +           V+ +K+L R   +  + ++ EV+ +  LEHPN++
Sbjct: 18  LGKGCFGQAIKVTHR-------ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVL 70
Query: 147 KLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           K IG    D     +RL  + E++   +L   +        PW  R+      A G+AYL
Sbjct: 71  KFIGVLYKD-----KRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA------------ 253
           H    + +I+RD  + N L+ EN    ++DFGLAR   MV                    
Sbjct: 125 H---SMNIIHRDLNSHNCLVRENKNVVVADFGLARL--MVDEKTQPEGLRSLKKPDRKKR 179
Query: 254 --VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
             VVG   + AP+ I       K DV+SFG+VL E++
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 112/229 (48%), Gaps = 30/229 (13%)
Query: 67  RVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL-NRDGLQ 125
           R+F  +E+R       ++  +G G FG+V+K    P   +G S    V IK + ++ G Q
Sbjct: 8   RIFKETELR-------KLKVLGSGVFGTVHKGVWIP---EGESIKIPVCIKVIEDKSGRQ 57
Query: 126 GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--AF 183
             +     +  +G L+H ++V+L+G C      G    LV +++   SL DH+     A 
Sbjct: 58  SFQAVTDHMLAIGSLDHAHIVRLLGLCP-----GSSLQLVTQYLPLGSLLDHVRQHRGAL 112
Query: 184 PP---LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 240
            P   L W  ++      A+G+ YL E     +++R+  A NVLL    + +++DFG+A 
Sbjct: 113 GPQLLLNWGVQI------AKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD 163
Query: 241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
             P      + +       + A + I  G  T +SDVWS+GV ++E++T
Sbjct: 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 18/213 (8%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPN 144
           ++G+G FG VY+   K    D     T VAIK +N    ++   +++ E   +      +
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKD--EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 76
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 196
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 77  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 132
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             A+G+AYL+     + ++RD  A N  + E+F  K+ DFG+ R+     +       + 
Sbjct: 133 EIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 189
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + +P+ ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 190 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 20/213 (9%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK-QWVAEVQFLGV 139
           + ++ K+GEG + +VYK       G       +VA+K++  +  +G     + EV  L  
Sbjct: 4   YIKLDKLGEGTYATVYK-------GKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKD 56
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L+H N+V L  +  +  E+ +   LV+E+ L++ L+ +L +          +L  +    
Sbjct: 57  LKHANIVTL--HDIIHTEKSLT--LVFEY-LDKDLKQYLDDCGNIINMHNVKL-FLFQLL 110
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            GLAY H     +V++RD K  N+L++E    KL+DFGLAR   +   T+ +  V  T  
Sbjct: 111 RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLW 165
Query: 260 YAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
           Y  PD  + +   + + D+W  G + YEM TGR
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK---QWVAEVQFLGVLEH 142
           KIG G F  VY+++      DG      VA+KK+    L   K     + E+  L  L H
Sbjct: 39  KIGRGQFSEVYRAA---CLLDGVP----VALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           PN++K       D E  I   L     L+R ++   F +    +P +T     +     L
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKH--FKKQKRLIPERTVWKYFVQLCSAL 149
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
            ++H     +V++RD K +NV +      KL D GL R       T  + ++VGT  Y +
Sbjct: 150 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMS 204
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEM 287
           P+ I       KSD+WS G +LYEM
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 130/295 (44%), Gaps = 38/295 (12%)
Query: 75  RQATNDFSRMLKIGEGGFGSVY----KSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW 130
           + +  DF  +  +G G FG V+    + + +  A     +  VV +K++           
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN------- 54
Query: 131 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 190
             E   L ++ HP ++++ G      +   Q  ++ +++    L   L      P P   
Sbjct: 55  -DERLMLSIVTHPFIIRMWGTF----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK 109
Query: 191 RLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
                  AAE    L YLH      +IYRD K  N+LLD+N   K++DFG A+  P    
Sbjct: 110 -----FYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP---- 157
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLL 306
             V+  + GT  Y AP+ + T       D WSFG+++YEML G     + N  KT +++L
Sbjct: 158 -DVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 216
Query: 307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 361
               ++P     F   +   L +  + + ++++G L +   ++  K+ P   +VV
Sbjct: 217 NAELRFPP---FFNEDVKDLLSRLITRDLSQRLGNLQNG--TEDVKNHPWFKEVV 266

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 109/251 (43%), Gaps = 25/251 (9%)
Query: 50  TSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTS 109
           ++P   PE  EE A   +     + + A  DF     +G+G FG+VY +  K        
Sbjct: 7   SAPENNPE--EELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREK-------Q 57
Query: 110 EATVVAIKKLNRDGLQG---HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVY 166
              ++A+K L +  L+      Q   EV+    L HPN+++L GY   D  R     L+ 
Sbjct: 58  SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LIL 113
Query: 167 EFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD 226
           E+    ++   L  +       +     I   A  L+Y H     +VI+RD K  N+LL 
Sbjct: 114 EYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLG 168
Query: 227 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYE 286
                K++DFG +   P    +   T + GT  Y  P+ IE      K D+WS GV+ YE
Sbjct: 169 SAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 224
Query: 287 MLTGRRSLERN 297
            L G+   E N
Sbjct: 225 FLVGKPPFEAN 235

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 102/230 (44%), Gaps = 24/230 (10%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---H 127
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L+     
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 57
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
            Q   EV+    L HPN+++L GY   D  R     L+ E+     +   L  +      
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPRGEVYKEL--QKLSKFD 111
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 112 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 164
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 165 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQF 136
           D   + K+G+G FG V +      +G   S    VA+K L  D L   +    ++ EV  
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVS----VAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           +  L+H NL++L G       + +  L     +L+R L  H             + H +L
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKH-------------QGHFLL 110
Query: 197 GA--------AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG-H 247
           G         AEG+ YL      + I+RD  A N+LL      K+ DFGL R  P    H
Sbjct: 111 GTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
             +       F + AP+ ++T   +  SD W FGV L+EM T
Sbjct: 168 XVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 103/230 (44%), Gaps = 24/230 (10%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---H 127
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L+     
Sbjct: 17  SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 69
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 70  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 123
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 124 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 176
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 177 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 226

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 47/234 (20%)
Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV 131
           S  +Q    F  + K+GEG +GSVYK+  K           +VAIK++  +     ++ +
Sbjct: 22  SLTKQPEEVFDVLEKLGEGSYGSVYKAIHK-------ETGQIVAIKQVPVES--DLQEII 72
Query: 132 AEVQFLGVLEHPNLVKLIG-------------YCAVDGERGIQRLLVYEFMLNRSL-EDH 177
            E+  +   + P++VK  G             YC       I RL       N++L ED 
Sbjct: 73  KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR------NKTLTEDE 126
Query: 178 LFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 237
           +               I+    +GL YLH    ++ I+RD KA N+LL+     KL+DFG
Sbjct: 127 IAT-------------ILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFG 170
Query: 238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           +A  G +         V+GT  + AP+ I+       +D+WS G+   EM  G+
Sbjct: 171 VA--GQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 126/283 (44%), Gaps = 37/283 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFLGV 139
           F+++ KIG+G FG V+K       G       VVAIK ++ +  +   + +  E+  L  
Sbjct: 9   FTKLEKIGKGSFGEVFK-------GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 61
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
            + P + K  G    D +  I    + E++   S  D L           T L  IL   
Sbjct: 62  CDSPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEPGPLDETQIATILREIL--- 114
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           +GL YLH     + I+RD KA+NVLL E+   KL+DFG+A  G +          VGT  
Sbjct: 115 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPF 169
Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 319
           + AP+ I+     +K+D+WS G+   E+  G        P +E   ++ +   P ++   
Sbjct: 170 WMAPEVIKQSAYDSKADIWSLGITAIELARGE------PPHSELHPMKVLFLIPKNNP-- 221
Query: 320 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                P LE  YS    + +    + CL+K    RP   ++++
Sbjct: 222 -----PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQF 136
           D   + K+G+G FG V +      +G   S    VA+K L  D L   +    ++ EV  
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVS----VAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           +  L+H NL++L G       + +  L     +L+R L  H             + H +L
Sbjct: 69  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKH-------------QGHFLL 114
Query: 197 GA--------AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 248
           G         AEG+ YL      + I+RD  A N+LL      K+ DFGL R  P     
Sbjct: 115 GTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171
Query: 249 HVSTAVVGT-FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           +V        F + AP+ ++T   +  SD W FGV L+EM T
Sbjct: 172 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 128/297 (43%), Gaps = 38/297 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLNRDGLQGHKQ-WVAEVQFLGVL-EHP 143
           +G G FG V +++   A G G  +A + VA+K L        K+  ++E++ +  L +H 
Sbjct: 54  LGAGAFGKVVEAT---AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 144 NLVKLIGYCAVDGE-RGIQRLLVYEFMLN------RSLE-DHLFNRAFPPLPWKTRLHII 195
           N+V L+G C   G    I     Y  +LN      R LE D  F  A   L  +  LH  
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFS 170
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
              A+G+A+L        I+RD  A NVLL      K+ DFGLAR+     +  V     
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA- 314
               + AP+ I     T +SDVWS+G++L+E+     SL  N              YP  
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-------------PYPGI 270
Query: 315 --DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
             +SK + L+ D     + +    + I  +   C +     RP   Q+   L++  Q
Sbjct: 271 LVNSKFYKLVKDGYQMAQPAF-APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQF 136
           D   + K+G+G FG V +      +G   S    VA+K L  D L   +    ++ EV  
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVS----VAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           +  L+H NL++L G       + +  L     +L+R L  H             + H +L
Sbjct: 75  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKH-------------QGHFLL 120
Query: 197 GA--------AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG-H 247
           G         AEG+ YL      + I+RD  A N+LL      K+ DFGL R  P    H
Sbjct: 121 GTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
             +       F + AP+ ++T   +  SD W FGV L+EM T
Sbjct: 178 XVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQF 136
           D   + K+G+G FG V +      +G   S    VA+K L  D L   +    ++ EV  
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVS----VAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           +  L+H NL++L G       + +  L     +L+R L  H             + H +L
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKH-------------QGHFLL 110
Query: 197 GA--------AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 248
           G         AEG+ YL      + I+RD  A N+LL      K+ DFGL R  P     
Sbjct: 111 GTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 249 HVSTAVVGT-FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           +V        F + AP+ ++T   +  SD W FGV L+EM T
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 126/283 (44%), Gaps = 37/283 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFLGV 139
           F+++ KIG+G FG V+K       G       VVAIK ++ +  +   + +  E+  L  
Sbjct: 24  FTKLEKIGKGSFGEVFK-------GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 76
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
            + P + K  G    D +  I    + E++   S  D L           T L  IL   
Sbjct: 77  CDSPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEPGPLDETQIATILREIL--- 129
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           +GL YLH     + I+RD KA+NVLL E+   KL+DFG+A  G +          VGT  
Sbjct: 130 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPF 184
Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 319
           + AP+ I+     +K+D+WS G+   E+  G        P +E   ++ +   P ++   
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGE------PPHSELHPMKVLFLIPKNNP-- 236
Query: 320 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                P LE  YS    + +    + CL+K    RP   ++++
Sbjct: 237 -----PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 270

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 126/283 (44%), Gaps = 37/283 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFLGV 139
           F+++ KIG+G FG V+K       G       VVAIK ++ +  +   + +  E+  L  
Sbjct: 29  FTKLEKIGKGSFGEVFK-------GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 81
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
            + P + K  G    D +  I    + E++   S  D L           T L  IL   
Sbjct: 82  CDSPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEPGPLDETQIATILREIL--- 134
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           +GL YLH     + I+RD KA+NVLL E+   KL+DFG+A  G +          VGT  
Sbjct: 135 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPF 189
Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 319
           + AP+ I+     +K+D+WS G+   E+  G        P +E   ++ +   P ++   
Sbjct: 190 WMAPEVIKQSAYDSKADIWSLGITAIELARGE------PPHSELHPMKVLFLIPKNNP-- 241
Query: 320 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                P LE  YS    + +    + CL+K    RP   ++++
Sbjct: 242 -----PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 275

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQF 136
           D   + K+G+G FG V +      +G   S    VA+K L  D L   +    ++ EV  
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVS----VAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           +  L+H NL++L G       + +  L     +L+R L  H             + H +L
Sbjct: 69  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKH-------------QGHFLL 114
Query: 197 GA--------AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 248
           G         AEG+ YL      + I+RD  A N+LL      K+ DFGL R  P     
Sbjct: 115 GTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171
Query: 249 HVSTAVVGT-FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           +V        F + AP+ ++T   +  SD W FGV L+EM T
Sbjct: 172 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQF 136
           D   + K+G+G FG V +      +G   S    VA+K L  D L   +    ++ EV  
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVS----VAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           +  L+H NL++L G       + +  L     +L+R L  H             + H +L
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKH-------------QGHFLL 110
Query: 197 GA--------AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 248
           G         AEG+ YL      + I+RD  A N+LL      K+ DFGL R  P     
Sbjct: 111 GTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 249 HVSTAVVGT-FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           +V        F + AP+ ++T   +  SD W FGV L+EM T
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 68
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 69  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 123
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              AEG+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 124 ---AEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 177
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 178 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 126/283 (44%), Gaps = 37/283 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFLGV 139
           F+++ KIG+G FG V+K       G       VVAIK ++ +  +   + +  E+  L  
Sbjct: 9   FTKLEKIGKGSFGEVFK-------GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 61
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
            + P + K  G    D +  I    + E++   S  D L           T L  IL   
Sbjct: 62  CDSPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEPGPLDETQIATILREIL--- 114
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           +GL YLH     + I+RD KA+NVLL E+   KL+DFG+A  G +          VGT  
Sbjct: 115 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPF 169
Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 319
           + AP+ I+     +K+D+WS G+   E+  G        P +E   ++ +   P ++   
Sbjct: 170 WMAPEVIKQSAYDSKADIWSLGITAIELARGE------PPHSELHPMKVLFLIPKNNP-- 221
Query: 320 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                P LE  YS    + +    + CL+K    RP   ++++
Sbjct: 222 -----PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 103/230 (44%), Gaps = 24/230 (10%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---H 127
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L+     
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 55
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 109
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 110 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 162
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 163 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 32/212 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-------RDGLQGHKQWVAEVQFLGV 139
           +GEG F +VYK+  K       +   +VAIKK+        +DG+  ++  + E++ L  
Sbjct: 18  LGEGQFATVYKARDK-------NTNQIVAIKKIKLGHRSEAKDGI--NRTALREIKLLQE 68
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L HPN++ L+   A   +  I   LV++FM    LE  + + +    P   + ++++   
Sbjct: 69  LSHPNIIGLLD--AFGHKSNIS--LVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM-TL 122
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHVSTAVVGT 257
           +GL YLH+     +++RD K +N+LLDEN   KL+DFGLA+    P   + H     V T
Sbjct: 123 QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXH----QVVT 175
Query: 258 FGYAAPDYIETGHLTAKS-DVWSFGVVLYEML 288
             Y AP+ +    +     D+W+ G +L E+L
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQF 136
           D   + K+G+G FG V +      +G   S    VA+K L  D L   +    ++ EV  
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVS----VAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           +  L+H NL++L G       + +  L     +L+R L  H             + H +L
Sbjct: 75  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKH-------------QGHFLL 120
Query: 197 GA--------AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 248
           G         AEG+ YL      + I+RD  A N+LL      K+ DFGL R  P     
Sbjct: 121 GTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
Query: 249 HVSTAVVGT-FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           +V        F + AP+ ++T   +  SD W FGV L+EM T
Sbjct: 178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 103/230 (44%), Gaps = 24/230 (10%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---H 127
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L+     
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 57
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 111
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 112 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 164
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 165 SSRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 103/230 (44%), Gaps = 24/230 (10%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---H 127
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L+     
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 57
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 111
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 112 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 164
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 165 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 109/251 (43%), Gaps = 27/251 (10%)
Query: 75  RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWV 131
           R    DF+ ++ +G+G FG V  S  K     GT E  + A+K L +D +      +  +
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDE--LYAVKILKKDVVIQDDDVECTM 389
Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR 191
            E + L +   P  +  +  C    +R      V E++    L  H+        P    
Sbjct: 390 VEKRVLALPGKPPFLTQLHSCFQTMDR---LYFVMEYVNGGDLMYHIQQVGRFKEP---- 442
Query: 192 LHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 248
            H +  AAE   GL +L       +IYRD K  NV+LD     K++DFG+ +E    G T
Sbjct: 443 -HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLE 307
             +    GT  Y AP+ I         D W+FGV+LYEML G+   E  +  +  Q ++E
Sbjct: 499 --TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556
Query: 308 WVQQYPADSKK 318
               YP    K
Sbjct: 557 HNVAYPKSMSK 567

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 110/253 (43%), Gaps = 31/253 (12%)
Query: 75  RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWV 131
           R    DF+ ++ +G+G FG V  S  K     GT E  + A+K L +D +      +  +
Sbjct: 16  RMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDE--LYAVKILKKDVVIQDDDVECTM 68
Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWK 189
            E + L +   P  +  +  C    +R      V E++    L  H+    R   P    
Sbjct: 69  VEKRVLALPGKPPFLTQLHSCFQTMDR---LYFVMEYVNGGDLMYHIQQVGRFKEP---- 121
Query: 190 TRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
              H +  AAE   GL +L       +IYRD K  NV+LD     K++DFG+ +E    G
Sbjct: 122 ---HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175
Query: 247 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRL 305
            T  +    GT  Y AP+ I         D W+FGV+LYEML G+   E  +  +  Q +
Sbjct: 176 VT--TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 233
Query: 306 LEWVQQYPADSKK 318
           +E    YP    K
Sbjct: 234 MEHNVAYPKSMSK 246

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEIXINKM 60
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHII 195
           L H N+VK  G+     E  IQ L      L       LF+R  P    P P   R    
Sbjct: 61  LNHENVVKFYGH---RREGNIQYLF-----LEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           L A  G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + 
Sbjct: 113 LMA--GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 256 GTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           GT  Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 8   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINAM 61
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHII 195
           L H N+VK  G+     E  IQ L      L       LF+R  P    P P   R    
Sbjct: 62  LNHENVVKFYGH---RREGNIQYLF-----LEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           L A  G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + 
Sbjct: 114 LMA--GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 256 GTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           GT  Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 112/231 (48%), Gaps = 18/231 (7%)
Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQG 126
           V+   E   +    + + ++G+G FG VY+ + +     G +E T VA+K +N    L+ 
Sbjct: 7   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRE 64
Query: 127 HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------- 178
             +++ E   +      ++V+L+G  +    +G   L+V E M +  L+ +L        
Sbjct: 65  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAE 120
Query: 179 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 238
            N   PP   +  + +    A+G+AYL+     + ++R+  A N ++  +F  K+ DFG+
Sbjct: 121 NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGM 177
Query: 239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            R+     +       +    + AP+ ++ G  T  SD+WSFGVVL+E+ +
Sbjct: 178 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL---NRDGLQGHKQWVAEVQFLGVLEH 142
           K+G GG  +VY         + T     VAIK +    R+  +  K++  EV     L H
Sbjct: 18  KLGGGGMSTVY-------LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
            N+V +I    VD E      LV E++   +L +++   +  PL   T ++      +G+
Sbjct: 71  QNIVSMID---VDEEDDC-YYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGI 124
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
            + H+   +++++RD K  N+L+D N   K+ DFG+A+       T  +  V+GT  Y +
Sbjct: 125 KHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFS 180
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           P+  +       +D++S G+VLYEML G
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVG 208

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 112/231 (48%), Gaps = 18/231 (7%)
Query: 68  VFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQG 126
           V+   E   +    + + ++G+G FG VY+ + +     G +E T VA+K +N    L+ 
Sbjct: 6   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGEAE-TRVAVKTVNESASLRE 63
Query: 127 HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------- 178
             +++ E   +      ++V+L+G  +    +G   L+V E M +  L+ +L        
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 179 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 238
            N   PP   +  + +    A+G+AYL+     + ++R+  A N ++  +F  K+ DFG+
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGM 176
Query: 239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            R+     +       +    + AP+ ++ G  T  SD+WSFGVVL+E+ +
Sbjct: 177 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 6   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKM 59
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A 
Sbjct: 60  LNHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 114
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  
Sbjct: 115 -GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 260 YAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKM 60
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A 
Sbjct: 61  LNHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 115
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  
Sbjct: 116 -GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 260 YAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 103/230 (44%), Gaps = 24/230 (10%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---H 127
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L+     
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 55
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 109
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 110 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 162
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 163 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 103/230 (44%), Gaps = 24/230 (10%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---H 127
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L+     
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 53
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 54  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 107
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 108 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 160
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 161 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 81
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 82  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 136
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 137 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 190
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 191 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAE 133
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L+      Q   E
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 58
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 59  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 112
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T 
Sbjct: 113 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTT 165
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 103/230 (44%), Gaps = 24/230 (10%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---H 127
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L+     
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 57
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 111
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 112 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 164
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 165 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 8   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKM 61
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A 
Sbjct: 62  LNHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 116
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  
Sbjct: 117 -GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 260 YAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 130
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 131 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 184
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 185 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 136/303 (44%), Gaps = 61/303 (20%)
Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN--RDGLQGHKQWVAE 133
           Q+   + R+ KIGEG FG       K      T +     IK++N  R   +  ++   E
Sbjct: 21  QSMEKYVRLQKIGEGSFG-------KAILVKSTEDGRQYVIKEINISRMSSKEREESRRE 73
Query: 134 VQFLGVLEHPNLVK-------------LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN 180
           V  L  ++HPN+V+             ++ YC  +G    +R+   + +L +  ED +  
Sbjct: 74  VAVLANMKHPNIVQYRESFEENGSLYIVMDYC--EGGDLFKRINAQKGVLFQ--EDQI-- 127
Query: 181 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 240
                L W  ++ +       L ++H+    ++++RD K+ N+ L ++   +L DFG+AR
Sbjct: 128 -----LDWFVQICL------ALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIAR 173
Query: 241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 300
              +     ++ A +GT  Y +P+  E      KSD+W+ G VLYE+ T + + E    K
Sbjct: 174 --VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK 231
Query: 301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
               +L+ +      S  F     P +   YS +    +  L      ++ +DRP ++ +
Sbjct: 232 N--LVLKII------SGSF-----PPVSLHYSYD----LRSLVSQLFKRNPRDRPSVNSI 274
Query: 361 VER 363
           +E+
Sbjct: 275 LEK 277

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKM 60
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHII 195
           L H N+VK  G+     E  IQ L      L       LF+R  P    P P   R    
Sbjct: 61  LNHENVVKFYGH---RREGNIQYLF-----LEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           L A  G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + 
Sbjct: 113 LMA--GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 256 GTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           GT  Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 102/229 (44%), Gaps = 23/229 (10%)
Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HK 128
           S+ + A  DF     +G+G FG+VY +  K +         ++A+K L +  L+      
Sbjct: 5   SKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEH 57
Query: 129 QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW 188
           Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +       
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDE 111
Query: 189 KTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 248
           +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +
Sbjct: 112 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----S 164
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
              T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 165 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 213

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKM 60
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHII 195
           L H N+VK  G+     E  IQ L      L       LF+R  P    P P   R    
Sbjct: 61  LNHENVVKFYGH---RREGNIQYLF-----LEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           L A  G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + 
Sbjct: 113 LMA--GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 256 GTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           GT  Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEIXINKM 60
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHII 195
           L H N+VK  G+     E  IQ L      L       LF+R  P    P P   R    
Sbjct: 61  LNHENVVKFYGH---RREGNIQYLF-----LEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           L A  G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + 
Sbjct: 113 LMA--GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 256 GTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           GT  Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 126
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 181 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 127
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 128 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 182 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAE 133
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L+      Q   E
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 58
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 59  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 112
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T 
Sbjct: 113 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTE 165
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKM 60
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A 
Sbjct: 61  LNHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 115
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  
Sbjct: 116 -GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 260 YAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 8   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKM 61
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A 
Sbjct: 62  LNHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 116
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  
Sbjct: 117 -GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 260 YAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 8   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKM 61
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A 
Sbjct: 62  LNHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 116
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  
Sbjct: 117 -GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 260 YAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 8   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKM 61
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A 
Sbjct: 62  LNHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 116
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  
Sbjct: 117 -GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 260 YAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 106/236 (44%), Gaps = 38/236 (16%)
Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-- 129
           S  R   ++F  +  +G+G FG V  + +K   GD      + A+K L +D +       
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVK-ETGD------LYAVKVLKKDVILQDDDVE 68
Query: 130 -WVAEVQFLGVL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-----FNRA 182
             + E + L +   HP L +L  +C    +   +   V EF+    L  H+     F+ A
Sbjct: 69  CTMTEKRILSLARNHPFLTQL--FCCF--QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA 124
Query: 183 FPPLPWKTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA 239
                 + R +    AAE    L +LH+     +IYRD K  NVLLD     KL+DFG+ 
Sbjct: 125 ------RARFY----AAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMC 171
Query: 240 REGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
           +EG   G T  +    GT  Y AP+ ++        D W+ GV+LYEML G    E
Sbjct: 172 KEGICNGVT--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 128/309 (41%), Gaps = 39/309 (12%)
Query: 63  AHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD 122
           A +L     S +R     F  +  +G G +G VYK       G       + AIK ++  
Sbjct: 8   ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYK-------GRHVKTGQLAAIKVMDVT 60
Query: 123 GLQGHKQWVAEVQFLGVLEHP-NLVKLIGYCAVDGERGI--QRLLVYEFMLNRSLEDHLF 179
           G +  ++   E+  L    H  N+    G        G+  Q  LV EF    S+ D + 
Sbjct: 61  GDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 180 NRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL- 238
           N     L  +   +I      GL++LH+    +VI+RD K  NVLL EN   KL DFG+ 
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 176
Query: 239 AREGPMVGHTHVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTGRRS 293
           A+    VG  +     +GT  + AP+ I            KSD+WS G+   EM  G   
Sbjct: 177 AQLDRTVGRRNT---FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
Query: 294 LERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD 353
           L    P    R L  + + PA          PRL+   S   ++K     ++CL K+   
Sbjct: 234 LCDMHP---MRALFLIPRNPA----------PRLK---SKKWSKKFQSFIESCLVKNHSQ 277
Query: 354 RPKMSQVVE 362
           RP   Q+++
Sbjct: 278 RPATEQLMK 286

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKM 60
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHII 195
           L H N+VK  G+     E  IQ L      L       LF+R  P    P P   R    
Sbjct: 61  LNHENVVKFYGH---RREGNIQYLF-----LEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           L A  G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + 
Sbjct: 113 LMA--GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 256 GTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           GT  Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 8   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKM 61
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHII 195
           L H N+VK  G+     E  IQ L      L       LF+R  P    P P   R    
Sbjct: 62  LNHENVVKFYGH---RREGNIQYLF-----LEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           L A  G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + 
Sbjct: 114 LMA--GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 256 GTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           GT  Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 8   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKM 61
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A 
Sbjct: 62  LNHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 116
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  
Sbjct: 117 -GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 260 YAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 129
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 130 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 184 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 128
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 129 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 183 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 128
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 129 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 183 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 129
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 130 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 184 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAE 133
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L+      Q   E
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 59
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 60  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 113
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    T +S  
Sbjct: 114 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS-- 168
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
             GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 169 --GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKM 60
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A 
Sbjct: 61  LNHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 115
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  
Sbjct: 116 -GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 260 YAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 77
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 78  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 132
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 133 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 186
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 187 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 129
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 130 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 184 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYL--LNWCVQI--- 127
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 128 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 182 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 126
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 181 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 129
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 130 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 184 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 126
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 181 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 133
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 134 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 188 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAE 133
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L+      Q   E
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 61
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 62  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 115
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +    A
Sbjct: 116 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAA 168
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKM 60
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHII 195
           L H N+VK  G+     E  IQ L      L       LF+R  P    P P   R    
Sbjct: 61  LNHENVVKFYGH---RREGNIQYLF-----LEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           L A  G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + 
Sbjct: 113 LMA--GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 256 GTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           GT  Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 8   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEIXINKM 61
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A 
Sbjct: 62  LNHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 116
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  
Sbjct: 117 -GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLP 172
Query: 260 YAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAE 133
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L+      Q   E
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 57
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 58  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 111
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T 
Sbjct: 112 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTT 164
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 165 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 208

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAE 133
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L+      Q   E
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 58
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 59  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 112
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T 
Sbjct: 113 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTD 165
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 120
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 121 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 175 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYL--LNWCVQI--- 126
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 181 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAE 133
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L+      Q   E
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 58
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 59  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 112
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T 
Sbjct: 113 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTD 165
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 96
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 97  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 151
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 152 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 205
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 206 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 127/297 (42%), Gaps = 38/297 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLNRDGLQGHKQ-WVAEVQFLGVL-EHP 143
           +G G FG V +++   A G G  +A + VA+K L        K+  ++E++ +  L +H 
Sbjct: 54  LGAGAFGKVVEAT---AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 144 NLVKLIGYCAVDGE-RGIQRLLVYEFMLN------RSLE-DHLFNRAFPPLPWKTRLHII 195
           N+V L+G C   G    I     Y  +LN      R LE D  F  A      +  LH  
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
              A+G+A+L        I+RD  A NVLL      K+ DFGLAR+     +  V     
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA- 314
               + AP+ I     T +SDVWS+G++L+E+     SL  N              YP  
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-------------PYPGI 270
Query: 315 --DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
             +SK + L+ D     + +    + I  +   C +     RP   Q+   L++  Q
Sbjct: 271 LVNSKFYKLVKDGYQMAQPAF-APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 102/235 (43%), Gaps = 14/235 (5%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           F  +  +G+GG+G V++      A  G   A  V  K +     +      AE   L  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           +HP +V LI      G    +  L+ E++    L   L           T    +   + 
Sbjct: 79  KHPFIVDLIYAFQTGG----KLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISM 132
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L +LH+     +IYRD K  N++L+     KL+DFGL +E    G   V+    GT  Y
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEY 187
Query: 261 AAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP 313
            AP+ +  +GH  A  D WS G ++Y+MLTG       NR KT  ++L+     P
Sbjct: 188 MAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP 241

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKM 60
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHII 195
           L H N+VK  G+     E  IQ L      L       LF+R  P    P P   R    
Sbjct: 61  LNHENVVKFYGH---RREGNIQYLF-----LEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           L A  G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + 
Sbjct: 113 LMA--GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 256 GTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           GT  Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAE 133
           A  DF     +G+G FG+VY +  K       +   ++A+K L +  L+      Q   E
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREK-------NSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 59  VEIQSHLRHPNILRLYGYFH-DSTRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 112
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +    A
Sbjct: 113 YITELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAA 165
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 103/230 (44%), Gaps = 24/230 (10%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---H 127
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L+     
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 54
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 55  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 108
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
            +     I   A  L+Y H     +VI+RD K  N+LL      K+++FG +   P    
Sbjct: 109 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAP---- 161
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 162 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 211

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG +G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 7   DWDLVQTLGEGAYGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKM 60
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHII 195
           L H N+VK  G+     E  IQ L      L       LF+R  P    P P   R    
Sbjct: 61  LNHENVVKFYGH---RREGNIQYLF-----LEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           L A  G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + 
Sbjct: 113 LMA--GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 256 GTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           GT  Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAE 133
           A  DF     +G+G FG+VY +  K           ++A+K L +  L+      Q   E
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREK-------QSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 59  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 112
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +    A
Sbjct: 113 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAA 165
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 26/210 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAEVQFLGVLEHP 143
           +GEG FG V     K A    T +   VA+K ++R  L+    H +   E+ +L +L HP
Sbjct: 17  LGEGSFGKV-----KLATHYKTQQK--VALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
           +++KL  Y  +     I  ++V E+      +  +  +       +     I+ A E   
Sbjct: 70  HIIKL--YDVITTPTDI--VMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE--- 122
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           Y H     ++++RD K  N+LLD+N   K++DFGL+    M     + T+  G+  YAAP
Sbjct: 123 YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLS--NIMTDGNFLKTS-CGSPNYAAP 176
Query: 264 DYIETGHLTA--KSDVWSFGVVLYEMLTGR 291
           + I  G L A  + DVWS G+VLY ML GR
Sbjct: 177 EVI-NGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 30/293 (10%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFLGV 139
           F+++ +IG+G FG V+K       G       VVAIK ++ +  +   + +  E+  L  
Sbjct: 25  FTKLERIGKGSFGEVFK-------GIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ 77
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
            +   + K  G       +G +  ++ E++   S  D L    F      T L  IL   
Sbjct: 78  CDSSYVTKYYGSYL----KGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL--- 130
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           +GL YLH     + I+RD KA+NVLL E    KL+DFG+A  G +          VGT  
Sbjct: 131 KGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPF 185
Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV-QQYPAD--- 315
           + AP+ I+     +K+D+WS G+   E+  G        P    R+L  + +  P     
Sbjct: 186 WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP---MRVLFLIPKNNPPTLVG 242
Query: 316 --SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 366
             +K F   +D  L K+ S     K   L    + K+SK    ++++++R K+
Sbjct: 243 DFTKSFKEFIDACLNKDPSFRPTAK-ELLKHKFIVKNSKKTSYLTELIDRFKR 294

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAE 133
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L+      Q   E
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 58
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 59  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 112
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T 
Sbjct: 113 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTX 165
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 102/235 (43%), Gaps = 14/235 (5%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           F  +  +G+GG+G V++      A  G   A  V  K +     +      AE   L  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           +HP +V LI      G    +  L+ E++    L   L           T    +   + 
Sbjct: 79  KHPFIVDLIYAFQTGG----KLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISM 132
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L +LH+     +IYRD K  N++L+     KL+DFGL +E    G   V+    GT  Y
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHXFCGTIEY 187
Query: 261 AAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP 313
            AP+ +  +GH  A  D WS G ++Y+MLTG       NR KT  ++L+     P
Sbjct: 188 MAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP 241

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 115/250 (46%), Gaps = 28/250 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFLG 138
           DF  +L  G G F  V  +  K           +VAIK + ++ L+G +  +  E+  L 
Sbjct: 21  DFRDVL--GTGAFSEVILAEDK-------RTQKLVAIKCIAKEALEGKEGSMENEIAVLH 71
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            ++HPN+V L        E G    L+ + +    L D +  + F      +RL  I   
Sbjct: 72  KIKHPNIVALDDIY----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQV 125
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVL---LDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
            + + YLH+   + +++RD K  N+L   LDE+ +  +SDFGL++   M     V +   
Sbjct: 126 LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTAC 179
Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQQYPA 314
           GT GY AP+ +     +   D WS GV+ Y +L G     + N  K  +++L+   +Y  
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK--AEYEF 237
Query: 315 DSKKFGLIMD 324
           DS  +  I D
Sbjct: 238 DSPYWDDISD 247

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 115/250 (46%), Gaps = 28/250 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFLG 138
           DF  +L  G G F  V  +  K           +VAIK + ++ L+G +  +  E+  L 
Sbjct: 21  DFRDVL--GTGAFSEVILAEDK-------RTQKLVAIKCIAKEALEGKEGSMENEIAVLH 71
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            ++HPN+V L        E G    L+ + +    L D +  + F      +RL  I   
Sbjct: 72  KIKHPNIVALDDIY----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQV 125
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVL---LDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
            + + YLH+   + +++RD K  N+L   LDE+ +  +SDFGL++   M     V +   
Sbjct: 126 LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTAC 179
Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQQYPA 314
           GT GY AP+ +     +   D WS GV+ Y +L G     + N  K  +++L+   +Y  
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK--AEYEF 237
Query: 315 DSKKFGLIMD 324
           DS  +  I D
Sbjct: 238 DSPYWDDISD 247

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFL 137
           +D+     IG G    V  +   P       +   VAIK++N +  Q    + + E+Q +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAP-------KKEKVAIKRINLEKCQTSMDELLKEIQAM 67
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED---HLFNRA---FPPLPWKTR 191
               HPN+V       V  E      LV + +   S+ D   H+  +       L   T 
Sbjct: 68  SQCHHPNIVSYYTSFVVKDEL----WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA---REGPMVGHT 248
             I+    EGL YLH+  +   I+RD KA N+LL E+   +++DFG++     G  +   
Sbjct: 124 ATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 249 HVSTAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 307
            V    VGT  + AP+ +E       K+D+WSFG+   E+ TG     +  P    ++L 
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP---MKVLM 237
Query: 308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 361
              Q    S + G + D  + K+Y     +   ++   CL K  + RP  ++++
Sbjct: 238 LTLQNDPPSLETG-VQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAE 133
           A  DF     +G+G FG+VY +  K           ++A+K L +  L+      Q   E
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREK-------QRKFILALKVLFKAQLEKAGVEHQLRRE 55
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 56  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 109
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T 
Sbjct: 110 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTT 162
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 163 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 206

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 109/251 (43%), Gaps = 25/251 (9%)
Query: 50  TSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTS 109
           ++P   PE  EE A   +     + + A  DF     +G+G FG+VY +  K +      
Sbjct: 7   SAPENNPE--EELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK----- 59
Query: 110 EATVVAIKKLNRDGLQG---HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVY 166
              ++A+K L +  L+      Q   EV+    L HPN+++L GY   D  R     L+ 
Sbjct: 60  --FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LIL 113
Query: 167 EFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD 226
           E+    ++   L  +       +     I   A  L+Y H     +VI+RD K  N+LL 
Sbjct: 114 EYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLG 168
Query: 227 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYE 286
                K++DFG +   P    +     + GT  Y  P+ IE      K D+WS GV+ YE
Sbjct: 169 SAGELKIADFGWSVHAP----SSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 224
Query: 287 MLTGRRSLERN 297
            L G+   E N
Sbjct: 225 FLVGKPPFEAN 235

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 101/230 (43%), Gaps = 24/230 (10%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---H 127
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L+     
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 57
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
            Q   EV+    L HPN+++L GY   D  R     L+ E+     +   L  +      
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPRGEVYKEL--QKLSKFD 111
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 112 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 164
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           +     + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 165 SSRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 115/250 (46%), Gaps = 28/250 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFLG 138
           DF  +L  G G F  V  +  K           +VAIK + ++ L+G +  +  E+  L 
Sbjct: 21  DFRDVL--GTGAFSEVILAEDK-------RTQKLVAIKCIAKEALEGKEGSMENEIAVLH 71
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            ++HPN+V L        E G    L+ + +    L D +  + F      +RL  I   
Sbjct: 72  KIKHPNIVALDDIY----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQV 125
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVL---LDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
            + + YLH+   + +++RD K  N+L   LDE+ +  +SDFGL++   M     V +   
Sbjct: 126 LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTAC 179
Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQQYPA 314
           GT GY AP+ +     +   D WS GV+ Y +L G     + N  K  +++L+   +Y  
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK--AEYEF 237
Query: 315 DSKKFGLIMD 324
           DS  +  I D
Sbjct: 238 DSPYWDDISD 247

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 102/230 (44%), Gaps = 24/230 (10%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---H 127
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L+     
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 54
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 55  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 108
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 109 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 161
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           +     + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 162 SSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 211

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 102/230 (44%), Gaps = 24/230 (10%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---H 127
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L+     
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 53
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 54  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 107
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 108 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 160
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           +     + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 161 SSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 103/230 (44%), Gaps = 24/230 (10%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---H 127
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L+     
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 55
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 109
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
            +     I   A  L+Y H     +VI+RD K  N+LL      K+++FG +   P    
Sbjct: 110 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAP---- 162
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           +   T + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 163 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 22/208 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +GEG FG V K +     G   +   ++  K L +  +QG  +   E+ +L +L HP+++
Sbjct: 22  LGEGSFGKV-KLAYHTTTGQKVA-LKIINKKVLAKSDMQGRIE--REISYLRLLRHPHII 77
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGLAYL 205
           KL  Y  +  +  I  ++V E+  N  L D++  R        +     I+ A E   Y 
Sbjct: 78  KL--YDVIKSKDEI--IMVIEYAGNE-LFDYIVQRDKMSEQEARRFFQQIISAVE---YC 129
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 265
           H     ++++RD K  N+LLDE+   K++DFGL+    M     + T+  G+  YAAP+ 
Sbjct: 130 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLS--NIMTDGNFLKTS-CGSPNYAAPEV 183
Query: 266 IETGHLTA--KSDVWSFGVVLYEMLTGR 291
           I +G L A  + DVWS GV+LY ML  R
Sbjct: 184 I-SGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFL 137
           +D+     IG G    V  +   P       +   VAIK++N +  Q    + + E+Q +
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAP-------KKEKVAIKRINLEKCQTSMDELLKEIQAM 62
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED---HLFNRA---FPPLPWKTR 191
               HPN+V       V  E      LV + +   S+ D   H+  +       L   T 
Sbjct: 63  SQCHHPNIVSYYTSFVVKDEL----WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 118
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA---REGPMVGHT 248
             I+    EGL YLH+  +   I+RD KA N+LL E+   +++DFG++     G  +   
Sbjct: 119 ATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 175
Query: 249 HVSTAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 307
            V    VGT  + AP+ +E       K+D+WSFG+   E+ TG     +  P    ++L 
Sbjct: 176 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP---MKVLM 232
Query: 308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 361
              Q    S + G + D  + K+Y     +   ++   CL K  + RP  ++++
Sbjct: 233 LTLQNDPPSLETG-VQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 109/243 (44%), Gaps = 16/243 (6%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           N F +   +G+GGFG V    ++ A G   +      ++K      +G    + E Q L 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVR-ATGKMYA---CKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            +    +V L    A   E      LV   M    L+ H+++      P       +  A
Sbjct: 240 KVNSRFVVSL----AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARAVFYA 292
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           AE    L +    +++YRD K  N+LLD++   ++SD GLA   P           VGT 
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTV 349
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE-WVQQYPAD-S 316
           GY AP+ ++    T   D W+ G +LYEM+ G+   ++ + K ++  +E  V++ P + S
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS 409
Query: 317 KKF 319
           ++F
Sbjct: 410 ERF 412

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK---QWVAEVQFLGVLEHP 143
           +G G FG V         G        VA+K LNR  ++      +   E+Q L +  HP
Sbjct: 24  LGVGTFGKV-------KVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
           +++KL  Y  +     I   +V E++    L D++       L  K    +      G+ 
Sbjct: 77  HIIKL--YQVISTPSDI--FMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVD 130
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           Y H  +   V++RD K  NVLLD +   K++DFGL+    M+          G+  YAAP
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSN---MMSDGEFLRXSCGSPNYAAP 184
Query: 264 DYIETGHLTA--KSDVWSFGVVLYEMLTG 290
           + I +G L A  + D+WS GV+LY +L G
Sbjct: 185 EVI-SGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 22/208 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +GEG FG V K +     G   +   ++  K L +  +QG  +   E+ +L +L HP+++
Sbjct: 21  LGEGSFGKV-KLAYHTTTGQKVA-LKIINKKVLAKSDMQGRIE--REISYLRLLRHPHII 76
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGLAYL 205
           KL  Y  +  +  I  ++V E+  N  L D++  R        +     I+ A E   Y 
Sbjct: 77  KL--YDVIKSKDEI--IMVIEYAGNE-LFDYIVQRDKMSEQEARRFFQQIISAVE---YC 128
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 265
           H     ++++RD K  N+LLDE+   K++DFGL+    M     + T+  G+  YAAP+ 
Sbjct: 129 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLS--NIMTDGNFLKTS-CGSPNYAAPEV 182
Query: 266 IETGHLTA--KSDVWSFGVVLYEMLTGR 291
           I +G L A  + DVWS GV+LY ML  R
Sbjct: 183 I-SGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 22/208 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +GEG FG V K +     G   +   ++  K L +  +QG  +   E+ +L +L HP+++
Sbjct: 12  LGEGSFGKV-KLAYHTTTGQKVA-LKIINKKVLAKSDMQGRIE--REISYLRLLRHPHII 67
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGLAYL 205
           KL  Y  +  +  I  ++V E+  N  L D++  R        +     I+ A E   Y 
Sbjct: 68  KL--YDVIKSKDEI--IMVIEYAGNE-LFDYIVQRDKMSEQEARRFFQQIISAVE---YC 119
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 265
           H     ++++RD K  N+LLDE+   K++DFGL+    M     + T+  G+  YAAP+ 
Sbjct: 120 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLS--NIMTDGNFLKTS-CGSPNYAAPEV 173
Query: 266 IETGHLTA--KSDVWSFGVVLYEMLTGR 291
           I +G L A  + DVWS GV+LY ML  R
Sbjct: 174 I-SGKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 88  GEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVK 147
           G+G FG+V         G   S    VAIKK+ +D    +++ +  +Q L VL HPN+V+
Sbjct: 32  GQGTFGTV-------QLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQ 83
Query: 148 LIGYCAVDGE---RGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           L  Y    GE   R I   +V E++   L+R   ++ + R   P P   ++  +      
Sbjct: 84  LQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY-YRRQVAPPPILIKV-FLFQLIRS 141
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDE-NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           +  LH    V V +RD K  NVL++E +   KL DFG A++   +  +  + A + +  Y
Sbjct: 142 IGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK---LSPSEPNVAYICSRYY 197
Query: 261 AAPDYI-ETGHLTAKSDVWSFGVVLYEMLTG 290
            AP+ I    H T   D+WS G +  EM+ G
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 109/243 (44%), Gaps = 16/243 (6%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           N F +   +G+GGFG V    ++ A G   +      ++K      +G    + E Q L 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVR-ATGKMYA---CKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            +    +V L    A   E      LV   M    L+ H+++      P       +  A
Sbjct: 240 KVNSRFVVSL----AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARAVFYA 292
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           AE    L +    +++YRD K  N+LLD++   ++SD GLA   P           VGT 
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTV 349
Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE-WVQQYPAD-S 316
           GY AP+ ++    T   D W+ G +LYEM+ G+   ++ + K ++  +E  V++ P + S
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS 409
Query: 317 KKF 319
           ++F
Sbjct: 410 ERF 412

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 94/212 (44%), Gaps = 16/212 (7%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D+  +  +GEG  G V     + A    T EA  V I  + R  +   +    E+    +
Sbjct: 7   DWDLVQTLGEGAAGEV-----QLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKM 60
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L H N+VK  G+     E  IQ L + E+     L D +      P P   R    L A 
Sbjct: 61  LNHENVVKFYGH---RREGNIQYLFL-EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 115
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT  
Sbjct: 116 -GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 260 YAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
           Y AP+ ++     A+  DVWS G+VL  ML G
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAI +L      + +K+ + E   +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIMELREATSPKANKEILDEAYVM 105
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 106 ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 160
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 161 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 214
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 215 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 19/217 (8%)
Query: 113 VVAIKKLNRDGLQGHKQWVA-EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN 171
           +VAIK + +  L+G +  +  E+  L  ++HPN+V L        E G    L+ + +  
Sbjct: 45  LVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY----ESGGHLYLIMQLVSG 100
Query: 172 RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL---LDEN 228
             L D +  + F      +RL  I    + + YLH+   + +++RD K  N+L   LDE+
Sbjct: 101 GELFDRIVEKGFYTERDASRL--IFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDED 155
Query: 229 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
            +  +SDFGL++   M     V +   GT GY AP+ +     +   D WS GV+ Y +L
Sbjct: 156 SKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 212
Query: 289 TGRRSL-ERNRPKTEQRLLEWVQQYPADSKKFGLIMD 324
            G     + N  K  +++L+   +Y  DS  +  I D
Sbjct: 213 CGYPPFYDENDAKLFEQILK--AEYEFDSPYWDDISD 247

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 75  RQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQW 130
           RQ T  DF     +G+G FG+VY +  + +         ++A+K L +  L+      Q 
Sbjct: 7   RQWTLEDFDIGRPLGKGKFGNVYLARERQSK-------FILALKVLFKTQLEKAGVEHQL 59
Query: 131 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 190
             EV+    L HPN+++L GY   D  R +  +L Y  +     E    +R       + 
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFH-DATR-VYLILEYAPLGTVYRELQKLSR----FDEQR 113
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
               I   A  L+Y H     +VI+RD K  N+LL  N   K++DFG +   P    +  
Sbjct: 114 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSR 166
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
            T + GT  Y  P+ IE      K D+WS GV+ YE L G    E
Sbjct: 167 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 97/220 (44%), Gaps = 28/220 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++++  IGEG +G V       ++       T VAIKK++    Q + Q  + E+Q L  
Sbjct: 45  YTQLQYIGEGAYGMV-------SSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLR 97
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL------H 193
             H N++         G R I R    E M +  +   L       L    +L      +
Sbjct: 98  FRHENVI---------GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY 148
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-EGPMVGHTHVST 252
            +     GL Y+H      V++RD K SN+L++     K+ DFGLAR   P   HT   T
Sbjct: 149 FLYQILRGLKYIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLT 205
Query: 253 AVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
             V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 206 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 102/230 (44%), Gaps = 24/230 (10%)
Query: 72  SEMRQ-ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---H 127
           S+ RQ A  DF     +G+G FG+VY +  K +         ++A+K L +  L+     
Sbjct: 3   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVE 55
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
            Q   EV+    L HPN+++L GY   D  R     L+ E+    ++   L  +      
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFD 109
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
            +     I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    
Sbjct: 110 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 162
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           +     + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 163 SSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 22/208 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +GEG FG V K +     G   +   ++  K L +  +QG  +   E+ +L +L HP+++
Sbjct: 16  LGEGSFGKV-KLAYHTTTGQKVA-LKIINKKVLAKSDMQGRIE--REISYLRLLRHPHII 71
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGLAYL 205
           KL  Y  +  +  I  ++V E+  N  L D++  R        +     I+ A E   Y 
Sbjct: 72  KL--YDVIKSKDEI--IMVIEYAGNE-LFDYIVQRDKMSEQEARRFFQQIISAVE---YC 123
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 265
           H     ++++RD K  N+LLDE+   K++DFGL+    M     + T+  G+  YAAP+ 
Sbjct: 124 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLS--NIMTDGNFLKTS-CGSPNYAAPEV 177
Query: 266 IETGHLTA--KSDVWSFGVVLYEMLTGR 291
           I +G L A  + DVWS GV+LY ML  R
Sbjct: 178 I-SGKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 114/238 (47%), Gaps = 28/238 (11%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQGHKQWVAEVQFLG 138
           R+LK IG+G F  V     K A    T     + I    +LN   LQ   +   EV+ + 
Sbjct: 18  RLLKTIGKGNFAKV-----KLARHILTGREVAIKIIDKTQLNPTSLQ---KLFREVRIMK 69
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILG 197
           +L HPN+VKL  +  ++ E+ +   L+ E+     + D+L           +++   I+ 
Sbjct: 70  ILNHPNIVKL--FEVIETEKTL--YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 125
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
           A +   Y H+    ++++RD KA N+LLD +   K++DFG + E  + G      A  G 
Sbjct: 126 AVQ---YCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGA 176
Query: 258 FGYAAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP 313
             YAAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L    + P
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP 234

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ--- 129
           +++    DF     +G+G FG V+ +  K             AIK L +D +        
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTN-------QFFAIKALKKDVVLMDDDVEC 64
Query: 130 WVAEVQFLGV-LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW 188
            + E + L +  EHP L  +  +C    +  +    V E++    L  H+ +     L  
Sbjct: 65  TMVEKRVLSLAWEHPFLTHM--FCTFQTKENL--FFVMEYLNGGDLMYHIQSCHKFDLSR 120
Query: 189 KTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 245
            T       AAE   GL +LH      ++YRD K  N+LLD++   K++DFG+ +E  M+
Sbjct: 121 AT-----FYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN-ML 171
Query: 246 GHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           G    +    GT  Y AP+ +         D WSFGV+LYEML G+
Sbjct: 172 GDAK-TNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +  G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 126
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 181 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +  G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 133
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 134 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 188 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +  G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 133
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFGLA+  G      H     
Sbjct: 134 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 188 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 130
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFG A+  G      H     
Sbjct: 131 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 184
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 185 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 128
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFG A+  G      H     
Sbjct: 129 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 183 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 128/304 (42%), Gaps = 50/304 (16%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLNRDGLQGHKQ-WVAEVQFLGVL-EHP 143
           +G G FG V +++   A G G  +A + VA+K L        K+  ++E++ +  L +H 
Sbjct: 54  LGAGAFGKVVEAT---AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP---------------LPW 188
           N+V L+G C      G   L++ E+     L + L  R  PP               L  
Sbjct: 111 NIVNLLGACT----HGGPVLVITEYCCYGDLLNFL-RRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 189 KTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 248
           +  LH     A+G+A+L        I+RD  A NVLL      K+ DFGLAR+     + 
Sbjct: 166 RDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW 308
            V         + AP+ I     T +SDVWS+G++L+E+     SL  N           
Sbjct: 223 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN----------- 267
Query: 309 VQQYPA---DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK 365
              YP    +SK + L+ D     + +    + I  +   C +     RP   Q+   L+
Sbjct: 268 --PYPGILVNSKFYKLVKDGYQMAQPAF-APKNIYSIMQACWALEPTHRPTFQQICSFLQ 324
Query: 366 QIVQ 369
           +  Q
Sbjct: 325 EQAQ 328

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 128
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFG A+  G      H     
Sbjct: 129 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 183 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 126
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFG A+  G      H     
Sbjct: 127 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 180
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 181 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 128
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFG A+  G      H     
Sbjct: 129 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 183 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ--- 129
           +++    DF     +G+G FG V+ +  K             AIK L +D +        
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTN-------QFFAIKALKKDVVLMDDDVEC 63
Query: 130 WVAEVQFLGV-LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW 188
            + E + L +  EHP L  +  +C    +  +    V E++    L  H+ +     L  
Sbjct: 64  TMVEKRVLSLAWEHPFLTHM--FCTFQTKENL--FFVMEYLNGGDLMYHIQSCHKFDLSR 119
Query: 189 KTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 245
            T       AAE   GL +LH      ++YRD K  N+LLD++   K++DFG+ +E  M+
Sbjct: 120 AT-----FYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN-ML 170
Query: 246 GHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           G    +    GT  Y AP+ +         D WSFGV+LYEML G+
Sbjct: 171 GDAK-TNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAE 133
           A  DF     +G+G FG+VY +  K +         ++A+K L +  L+      Q   E
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSK-------FILALKVLFKAQLEKAGVEHQLRRE 58
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 59  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 112
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +     
Sbjct: 113 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXX 165
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 97/220 (44%), Gaps = 28/220 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 45  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 97
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL------H 193
             H N++         G   I R    E M +  L  HL       L     L      +
Sbjct: 98  FRHENII---------GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICY 148
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVST 252
            +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T
Sbjct: 149 FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 205
Query: 253 AVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
             V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 206 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN--RSLEDHLFNRAFPPLPWKTRLHII 195
             +++P++ +L+G C     + I +L+ +  +L+  R  +D++ ++    L W  ++   
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI--- 133
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAV 254
              A+G+ YL +    ++++RD  A NVL+      K++DFG A+  G      H     
Sbjct: 134 ---AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 187
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           V    + A + I     T +SDVWS+GV ++E++T
Sbjct: 188 V-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 121/258 (46%), Gaps = 37/258 (14%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQGHKQWVAEVQFLG 138
           R+LK IG+G F  V     K A    T +   V I    +LN   LQ   +   EV+ + 
Sbjct: 17  RLLKTIGKGNFAKV-----KLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMK 68
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILG 197
           VL HPN+VKL  +  ++ E+ +   LV E+     + D+L           + +   I+ 
Sbjct: 69  VLNHPNIVKL--FEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
           A +   Y H+     +++RD KA N+LLD +   K++DFG + E       +   A  G 
Sbjct: 125 AVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE---FTFGNKLDAFCGA 175
Query: 258 FGYAAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP-- 313
             YAAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L    + P  
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 235
Query: 314 --ADS----KKFGLIMDP 325
              D     KKF LI++P
Sbjct: 236 MSTDCENLLKKF-LILNP 252

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 124/290 (42%), Gaps = 34/290 (11%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQF-L 137
           D   + +IG G +GSV K   KP+         ++A+K++      +  KQ + ++   +
Sbjct: 23  DLKDLGEIGRGAYGSVNKMVHKPSG-------QIMAVKRIRSTVDEKEQKQLLMDLDVVM 75
Query: 138 GVLEHPNLVKLIGYCAVDGERGI-QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
              + P +V+  G    +G+  I   L+   F        ++++     +P +    I L
Sbjct: 76  RSSDCPYIVQFYGALFREGDCWICMELMSTSF---DKFYKYVYSVLDDVIPEEILGKITL 132
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
              + L +L E L  ++I+RD K SN+LLD +   KL DFG++  G +V      T   G
Sbjct: 133 ATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVDSI-AKTRDAG 187
Query: 257 TFGYAAPDYIETGH----LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY 312
              Y AP+ I+          +SDVWS G+ LYE+ TGR       PK      +  Q  
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY----PKWNSVFDQLTQVV 243
Query: 313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
             D         P+L        +       + CL+K    RPK  ++++
Sbjct: 244 KGDP--------PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 114/238 (47%), Gaps = 28/238 (11%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQGHKQWVAEVQFLG 138
           R+LK IG+G F  V     K A    T     + I    +LN   LQ   +   EV+ + 
Sbjct: 15  RLLKTIGKGNFAKV-----KLARHILTGREVAIKIIDKTQLNPTSLQ---KLFREVRIMK 66
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILG 197
           +L HPN+VKL  +  ++ E+ +   L+ E+     + D+L           +++   I+ 
Sbjct: 67  ILNHPNIVKL--FEVIETEKTL--YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 122
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
           A +   Y H+    ++++RD KA N+LLD +   K++DFG + E  + G         G+
Sbjct: 123 AVQ---YCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD---TFCGS 173
Query: 258 FGYAAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP 313
             YAAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L    + P
Sbjct: 174 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP 231

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 127/306 (41%), Gaps = 47/306 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLNRDGLQGHKQ-WVAEVQFLGVL-EHP 143
           +G G FG V +++   A G G  +A + VA+K L        K+  ++E++ +  L +H 
Sbjct: 39  LGAGAFGKVVEAT---AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 95
Query: 144 NLVKLIGYCAVDGE-RGIQRLLVYEFMLN---RSLEDHLFNRAFP-------------PL 186
           N+V L+G C   G    I     Y  +LN   R  E  L     P             PL
Sbjct: 96  NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPL 155
Query: 187 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
             +  LH     A+G+A+L        I+RD  A NVLL      K+ DFGLAR+     
Sbjct: 156 ELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 212
Query: 247 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 306
           +  V         + AP+ I     T +SDVWS+G++L+E+     SL  N         
Sbjct: 213 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN--------- 259
Query: 307 EWVQQYPA---DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 363
                YP    +SK + L+ D     + +    + I  +   C +     RP   Q+   
Sbjct: 260 ----PYPGILVNSKFYKLVKDGYQMAQPAF-APKNIYSIMQACWALEPTHRPTFQQICSF 314
Query: 364 LKQIVQ 369
           L++  Q
Sbjct: 315 LQEQAQ 320

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL-GVLEHP 143
           +G G FG V ++    A G D T+    VA+K L        H+  ++E++ L  +  H 
Sbjct: 36  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 92
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT----------RLH 193
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+KT            H
Sbjct: 93  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEH 149
Query: 194 II---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
           +I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+         
Sbjct: 150 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                    + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 124/283 (43%), Gaps = 37/283 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFLGV 139
           F+++ +IG+G FG VYK       G       VVAIK ++ +  +   + +  E+  L  
Sbjct: 21  FTKLDRIGKGSFGEVYK-------GIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 73
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
            + P + +  G       +  +  ++ E++   S  D L           T L  IL   
Sbjct: 74  CDSPYITRYFGSYL----KSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL--- 126
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           +GL YLH     + I+RD KA+NVLL E    KL+DFG+A  G +          VGT  
Sbjct: 127 KGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNXFVGTPF 181
Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 319
           + AP+ I+      K+D+WS G+   E+  G        P ++   +  +   P +S   
Sbjct: 182 WMAPEVIKQSAYDFKADIWSLGITAIELAKG------EPPNSDLHPMRVLFLIPKNSP-- 233
Query: 320 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                P LE ++S    +      + CL+K  + RP   ++++
Sbjct: 234 -----PTLEGQHS----KPFKEFVEACLNKDPRFRPTAKELLK 267

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH   E  V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 263 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEY 318
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 319 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH   E  V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 260 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEY 315
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL-GVLEHP 143
           +G G FG V ++    A G D T+    VA+K L        H+  ++E++ L  +  H 
Sbjct: 26  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 192
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 83  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 193 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 140 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 196
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                     + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL-GVLEHP 143
           +G G FG V ++    A G D T+    VA+K L        H+  ++E++ L  +  H 
Sbjct: 35  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 192
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 92  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 193 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                     + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 107/236 (45%), Gaps = 52/236 (22%)
Query: 87  IGEGGFGSVYKSS---IKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEH 142
           +GEG FG V K++   +K  AG      T VA+K L  +      +  ++E   L  + H
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAG-----YTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE-------------------------DH 177
           P+++KL G C+ DG      LL+ E+    SL                          DH
Sbjct: 86  PHVIKLYGACSQDGPL----LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 178 LFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 237
              RA   L     +      ++G+ YL E   +++++RD  A N+L+ E  + K+SDFG
Sbjct: 142 PDERA---LTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 238 LAR----EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           L+R    E   V  +     V      +  D+I     T +SDVWSFGV+L+E++T
Sbjct: 196 LSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHI----YTTQSDVWSFGVLLWEIVT 247

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
               +KIGEG  G V  ++++       S   +VA+KK++    Q  +    EV  +   
Sbjct: 153 LDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 205
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------I 194
           +H N+V++     V    G +  +V EF+   +L D + +         TR++      +
Sbjct: 206 QHENVVEMYNSYLV----GDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAV 252
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
            L   + L+ LH      VI+RD K+ ++LL  + R KLSDFG   +  +         +
Sbjct: 253 CLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXL 307
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 27  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLA 79
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 131
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 132 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 188
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 189 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL-GVLEHP 143
           +G G FG V ++    A G D T+    VA+K L        H+  ++E++ L  +  H 
Sbjct: 26  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 192
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 83  NVVNLLGACT---KPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 193 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 140 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 196
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                     + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAE 133
           A  DF     +G+G FG+VY +  K           ++A+K L +  L+      Q   E
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREK-------QSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           V+    L HPN+++L GY   D  R     L+ E+    ++   L  +       +    
Sbjct: 62  VEIQSHLRHPNILRLYGYFH-DATRVY---LILEYAPLGTVYREL--QKLSKFDEQRTAT 115
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +     
Sbjct: 116 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRDD 168
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           + GT  Y  P+ IE      K D+WS GV+ YE L G+   E N
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 32/224 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----------NRDGLQGHKQW 130
           + ++ K+G G +G V     K    +G SE  +  IKK           N++  + H++ 
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEK----NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 131 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWK 189
             E+  L  L+HPN++KL        E      LV EF     L + + NR  F      
Sbjct: 94  YNEISLLKSLDHPNIIKLFDVF----EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA 149
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN---FRPKLSDFGLAREGPMVG 246
             +  IL    G+ YLH+     +++RD K  N+LL+        K+ DFGL+       
Sbjct: 150 NIMKQILS---GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLS---SFFS 200
Query: 247 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
             +     +GT  Y AP+ ++  +   K DVWS GV++Y +L G
Sbjct: 201 KDYKLRDRLGTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCG 243

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 107/236 (45%), Gaps = 52/236 (22%)
Query: 87  IGEGGFGSVYKSS---IKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEH 142
           +GEG FG V K++   +K  AG      T VA+K L  +      +  ++E   L  + H
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAG-----YTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE-------------------------DH 177
           P+++KL G C+ DG      LL+ E+    SL                          DH
Sbjct: 86  PHVIKLYGACSQDGPL----LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 178 LFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 237
              RA   L     +      ++G+ YL E   +++++RD  A N+L+ E  + K+SDFG
Sbjct: 142 PDERA---LTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 238 LAR----EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           L+R    E   V  +     V      +  D+I     T +SDVWSFGV+L+E++T
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI----YTTQSDVWSFGVLLWEIVT 247

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 24/218 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL-GVLEHP 143
           +G G FG V ++    A G D T+    VA+K L        H+  ++E++ L  +  H 
Sbjct: 37  LGRGAFGQVIEAD---AFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK---------TRLHI 194
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K         T  H+
Sbjct: 94  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHL 150
Query: 195 I---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
           I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+          
Sbjct: 151 IXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                   + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 99/225 (44%), Gaps = 24/225 (10%)
Query: 75  RQAT-NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQW 130
           RQ T  DF     +G+G FG+VY +  + +         ++A+K L +  L+      Q 
Sbjct: 7   RQWTLEDFDIGRPLGKGKFGNVYLARERQSK-------FILALKVLFKTQLEKAGVEHQL 59
Query: 131 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 190
             EV+    L HPN+++L GY   D  R +  +L Y  +     E    +R       + 
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFH-DATR-VYLILEYAPLGTVYRELQKLSR----FDEQR 113
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
               I   A  L+Y H     +VI+RD K  N+LL  N   K++DFG +   P    +  
Sbjct: 114 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSR 166
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
              + GT  Y  P+ IE      K D+WS GV+ YE L G    E
Sbjct: 167 RDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 106/236 (44%), Gaps = 52/236 (22%)
Query: 87  IGEGGFGSVYKSS---IKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEH 142
           +GEG FG V K++   +K  AG      T VA+K L  +      +  ++E   L  + H
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAG-----YTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE-------------------------DH 177
           P+++KL G C+ DG      LL+ E+    SL                          DH
Sbjct: 86  PHVIKLYGACSQDGPL----LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 178 LFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 237
              RA   L     +      ++G+ YL E   + +++RD  A N+L+ E  + K+SDFG
Sbjct: 142 PDERA---LTMGDLISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFG 195
Query: 238 LAR----EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           L+R    E   V  +     V      +  D+I     T +SDVWSFGV+L+E++T
Sbjct: 196 LSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHI----YTTQSDVWSFGVLLWEIVT 247

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 80  DFSRML-KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           DF  ++ ++G+G FG VYK+  K  +        + A K ++    +  + ++ E+  L 
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETS-------VLAAAKVIDTKSEEELEDYMVEIDILA 89
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
             +HPN+VKL+   A   E  +  L+  EF    +++  +     P    ++++ ++   
Sbjct: 90  SCDHPNIVKLLD--AFYYENNLWILI--EFCAGGAVDAVMLELERPLT--ESQIQVVCKQ 143
Query: 199 A-EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
             + L YLH+    ++I+RD KA N+L   +   KL+DFG++ +         S   +GT
Sbjct: 144 TLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGT 198
Query: 258 FGYAAPDYI--ETGH---LTAKSDVWSFGVVLYEM 287
             + AP+ +  ET        K+DVWS G+ L EM
Sbjct: 199 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 121/258 (46%), Gaps = 37/258 (14%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQGHKQWVAEVQFLG 138
           R+LK IG+G F  V     K A    T +   V I    +LN   LQ   +   EV+ + 
Sbjct: 17  RLLKTIGKGNFAKV-----KLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMK 68
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILG 197
           VL HPN+VKL  +  ++ E+ +   LV E+     + D+L           + +   I+ 
Sbjct: 69  VLNHPNIVKL--FEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
           A +   Y H+     +++RD KA N+LLD +   K++DFG + E       +      G+
Sbjct: 125 AVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE---FTFGNKLDTFCGS 175
Query: 258 FGYAAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP-- 313
             YAAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L    + P  
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 235
Query: 314 --ADS----KKFGLIMDP 325
              D     KKF LI++P
Sbjct: 236 MSTDCENLLKKF-LILNP 252

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH   E  V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 120 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEY 175
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 176 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL-GVLEHP 143
           +G G FG V ++    A G D T+    VA+K L        H+  ++E++ L  +  H 
Sbjct: 35  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 192
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 92  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 193 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXV 205
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                     + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH   E  V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 121 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEY 176
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 121/258 (46%), Gaps = 37/258 (14%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQGHKQWVAEVQFLG 138
           R+LK IG+G F  V     K A    T +   V I    +LN   LQ   +   EV+ + 
Sbjct: 17  RLLKTIGKGNFAKV-----KLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMK 68
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILG 197
           VL HPN+VKL  +  ++ E+ +   LV E+     + D+L           + +   I+ 
Sbjct: 69  VLNHPNIVKL--FEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
           A +   Y H+     +++RD KA N+LLD +   K++DFG + E       +      G+
Sbjct: 125 AVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE---FTFGNKLDTFCGS 175
Query: 258 FGYAAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP-- 313
             YAAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L    + P  
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 235
Query: 314 --ADS----KKFGLIMDP 325
              D     KKF LI++P
Sbjct: 236 MSTDCENLLKKF-LILNP 252

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH   E  V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 122 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEY 177
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL-GVLEHP 143
           +G G FG V ++    A G D T+    VA+K L        H+  ++E++ L  +  H 
Sbjct: 35  LGRGAFGQVIEAD---AFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K      L     + 
Sbjct: 92  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIC 148
Query: 204 Y---LHEGLEV----QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
           Y   + +G+E     + I+RD  A N+LL E    K+ DFGLAR+               
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 27  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLA 79
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 131
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 132 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTE 188
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 189 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 25  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 77
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 129
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 130 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 186
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 80  DFSRML-KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           DF  ++ ++G+G FG VYK+  K  +        + A K ++    +  + ++ E+  L 
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETS-------VLAAAKVIDTKSEEELEDYMVEIDILA 89
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
             +HPN+VKL+   A   E  +  L+  EF    +++  +     P    ++++ ++   
Sbjct: 90  SCDHPNIVKLLD--AFYYENNLWILI--EFCAGGAVDAVMLELERPLT--ESQIQVVCKQ 143
Query: 199 A-EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
             + L YLH+    ++I+RD KA N+L   +   KL+DFG++ +           + +GT
Sbjct: 144 TLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN--TRXIQRRDSFIGT 198
Query: 258 FGYAAPDYI--ETGH---LTAKSDVWSFGVVLYEM 287
             + AP+ +  ET        K+DVWS G+ L EM
Sbjct: 199 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 121/258 (46%), Gaps = 37/258 (14%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQGHKQWVAEVQFLG 138
           R+LK IG+G F  V     K A    T +   V I    +LN   LQ   +   EV+ + 
Sbjct: 17  RLLKTIGKGNFAKV-----KLARHILTGKEVAVRIIDKTQLNSSSLQ---KLFREVRIMK 68
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILG 197
           VL HPN+VKL  +  ++ E+ +   LV E+     + D+L           + +   I+ 
Sbjct: 69  VLNHPNIVKL--FEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
           A +   Y H+     +++RD KA N+LLD +   K++DFG + E       +      G+
Sbjct: 125 AVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE---FTFGNKLDTFCGS 175
Query: 258 FGYAAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP-- 313
             YAAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L    + P  
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 235
Query: 314 --ADS----KKFGLIMDP 325
              D     KKF LI++P
Sbjct: 236 MSTDCENLLKKF-LILNP 252

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 25  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 77
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 129
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 130 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 186
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 136/285 (47%), Gaps = 42/285 (14%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
            DF  +  +G GGFG V+++  K    D  + A +  I+  NR+     ++ + EV+ L 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNK---VDDCNYA-IKRIRLPNRE--LAREKVMREVKALA 58
Query: 139 VLEHPNLVKLI-GYCAVDGERGIQ----RLLVY-EFMLNR--SLEDHLFNRAFPPLPWKT 190
            LEHP +V+    +   +    +Q    ++ +Y +  L R  +L+D +  R    +  + 
Sbjct: 59  KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC--TIEERE 116
Query: 191 R---LHIILGAAEGLAYLH-EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE----- 241
           R   LHI L  AE + +LH +GL    ++RD K SN+    +   K+ DFGL        
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGL----MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 242 ------GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS-L 294
                  PM  +    T  VGT  Y +P+ I     + K D++S G++L+E+L    + +
Sbjct: 173 EEQTVLTPMPAYAR-HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQM 231
Query: 295 ERNRPKTEQRLLE----WVQQYPADSKKFGLIMDPR-LEKEYSIN 334
           ER R  T+ R L+    + Q+YP +      ++ P  +E+  +IN
Sbjct: 232 ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAIN 276

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL-GVLEHP 143
           +G G FG V ++    A G D T+    VA+K L        H+  ++E++ L  +  H 
Sbjct: 26  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 192
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 83  NVVNLLGACT---KPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 193 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 140 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 196
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                     + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 111/231 (48%), Gaps = 28/231 (12%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQGHKQWVAEVQFLG 138
           R+LK IG+G F  V     K A    T +   V I    +LN   LQ   +   EV+ + 
Sbjct: 10  RLLKTIGKGNFAKV-----KLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMK 61
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAF-PPLPWKTRLHIILG 197
           VL HPN+VKL  +  ++ E+ +   LV E+     + D+L    +      + +   I+ 
Sbjct: 62  VLNHPNIVKL--FEVIETEKTLY--LVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVS 117
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
           A +   Y H+     +++RD KA N+LLD +   K++DFG + E       +      G+
Sbjct: 118 AVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE---FTFGNKLDTFCGS 168
Query: 258 FGYAAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLL 306
             YAAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L
Sbjct: 169 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 219

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 25  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 77
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 129
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 130 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 186
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 27  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 79
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 131
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 132 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 188
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 189 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 29  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYXQRTLREIKILLR 81
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 133
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 134 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 190
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D + + ++G G FG V     K     G  +   VAIK + ++G     +++ E + +  
Sbjct: 9   DLTFLKELGTGQFGVV-----KYGKWRGQYD---VAIKMI-KEGSMSEDEFIEEAKVMMN 59
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILG 197
           L H  LV+L G C    +R I   ++ E+M N  L ++L      F     +  L +   
Sbjct: 60  LSHEKLVQLYGVCT--KQRPI--FIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKD 112
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
             E + YL      Q ++RD  A N L+++    K+SDFGL+R    V     +++V   
Sbjct: 113 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSK 166
Query: 258 FG--YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 296
           F   ++ P+ +     ++KSD+W+FGV+++E+ + G+   ER
Sbjct: 167 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 208

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--NRDGLQGHKQWVAE 133
           Q+   +  +  +GEG +G V K   K           +VAIKK   + D     K  + E
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNK-------DTGRIVAIKKFLESDDDKMVKKIAMRE 74
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP-LPWKTRL 192
           ++ L  L H NLV L+  C    ++  +  LV+EF+ +  L+D      FP  L ++   
Sbjct: 75  IKLLKQLRHENLVNLLEVC----KKKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQ 127
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             +     G+ + H      +I+RD K  N+L+ ++   KL DFG AR     G  +   
Sbjct: 128 KYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE 184
Query: 253 AVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG 290
             V T  Y AP+ +       K+ DVW+ G ++ EM  G
Sbjct: 185 --VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 106/222 (47%), Gaps = 27/222 (12%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D + + ++G G FG V     K     G  +  +    K+ ++G     +++ E + +  
Sbjct: 5   DLTFLKELGTGQFGVV-----KYGKWRGQYDVAI----KMIKEGSMSEDEFIEEAKVMMN 55
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILG 197
           L H  LV+L G C    +R I   ++ E+M N  L ++L      F     +  L +   
Sbjct: 56  LSHEKLVQLYGVCT--KQRPI--FIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKD 108
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
             E + YL      Q ++RD  A N L+++    K+SDFGL+R    V     +++V   
Sbjct: 109 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSK 162
Query: 258 FG--YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 296
           F   ++ P+ +     ++KSD+W+FGV+++E+ + G+   ER
Sbjct: 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 204

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL-GVLEHP 143
           +G G FG V ++    A G D T+    VA+K L        H+  ++E++ L  +  H 
Sbjct: 35  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 192
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 92  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 193 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                     + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 33  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 85
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 86  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 137
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-EGPMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 138 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 194
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 195 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 25  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 77
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 129
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-EGPMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 130 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 186
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQ 135
           +DF  +  IG+G FG V  +  K       +E    A+K L +  +   +  K  ++E  
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHK-------AEEVFYAVKVLQKKAILKKKEEKHIMSERN 90
Query: 136 -FLGVLEHPNLVKL-IGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRL 192
             L  ++HP LV L   +   D     +   V +++    L  HL   R F  L  + R 
Sbjct: 91  VLLKNVKHPFLVGLHFSFQTAD-----KLYFVLDYINGGELFYHLQRERCF--LEPRARF 143
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
           +     A  L YLH    + ++YRD K  N+LLD      L+DFGL +E   + H   ++
Sbjct: 144 YAA-EIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN--IEHNSTTS 197
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
              GT  Y AP+ +         D W  G VLYEML G
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL-GVLEHP 143
           +G G FG V ++    A G D T+    VA+K L        H+  ++E++ L  +  H 
Sbjct: 26  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 192
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 83  NVVNLLGACT---KPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 193 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 140 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 196
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                     + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 130/304 (42%), Gaps = 41/304 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHP 143
           +G G FG V +++   A G   S+A + VA+K L     L   +  ++E++ L  L  H 
Sbjct: 47  LGAGAFGKVVEAT---AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 103
Query: 144 NLVKLIGYCAVDGER-GIQRLLVYEFMLN---RSLEDHLFNRAFPPL--------PWKTR 191
           N+V L+G C + G    I     Y  +LN   R  +  + ++  P +          +  
Sbjct: 104 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 163
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
           L      A+G+A+L        I+RD  A N+LL      K+ DFGLAR+     +  V 
Sbjct: 164 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 220
Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 311
                   + AP+ I     T +SDVWS+G+ L+E+ +   S                  
Sbjct: 221 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM------------- 267
Query: 312 YPADSKKFGLIMDP--RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL-KQIV 368
            P DSK + +I +    L  E++  E   I +    C       RP   Q+V+ + KQI 
Sbjct: 268 -PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQIS 323
Query: 369 QVSN 372
           + +N
Sbjct: 324 ESTN 327

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL-GVLEHP 143
           +G G FG V ++    A G D T+    VA+K L        H+  ++E++ L  +  H 
Sbjct: 37  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 192
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 94  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLE 150
Query: 193 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 151 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 207
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                     + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 208 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 121/258 (46%), Gaps = 37/258 (14%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQGHKQWVAEVQFLG 138
           R+LK IG+G F  V     K A    T +   V I    +LN   LQ   +   EV+ + 
Sbjct: 17  RLLKTIGKGNFAKV-----KLARHILTGKEVAVRIIDKTQLNSSSLQ---KLFREVRIMK 68
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILG 197
           VL HPN+VKL  +  ++ E+ +   LV E+     + D+L           + +   I+ 
Sbjct: 69  VLNHPNIVKL--FEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
           A +   Y H+     +++RD KA N+LLD +   K++DFG + E       +      G+
Sbjct: 125 AVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE---FTFGNKLDEFCGS 175
Query: 258 FGYAAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP-- 313
             YAAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L    + P  
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 235
Query: 314 --ADS----KKFGLIMDP 325
              D     KKF LI++P
Sbjct: 236 MSTDCENLLKKF-LILNP 252

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 90  GGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV--LEHPNLVK 147
           G FG V+K+ +             VA+K      LQ  + W +E +      ++H NL++
Sbjct: 26  GRFGCVWKAQLM---------NDFVAVKIFP---LQDKQSWQSEREIFSTPGMKHENLLQ 73
Query: 148 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE 207
            I          ++  L+  F    SL D+L       + W    H+    + GL+YLHE
Sbjct: 74  FIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI---ITWNELCHVAETMSRGLSYLHE 130
Query: 208 --------GLEVQVIYRDFKASNVLLDENFRPKLSDFGLA---REGPMVGHTHVSTAVVG 256
                   G +  + +RDFK+ NVLL  +    L+DFGLA     G   G TH     VG
Sbjct: 131 DVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTH---GQVG 187
Query: 257 TFGYAAPDYIETG-----HLTAKSDVWSFGVVLYEMLT 289
           T  Y AP+ +E           + D+++ G+VL+E+++
Sbjct: 188 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 130/304 (42%), Gaps = 41/304 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHP 143
           +G G FG V +++   A G   S+A + VA+K L     L   +  ++E++ L  L  H 
Sbjct: 49  LGAGAFGKVVEAT---AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 105
Query: 144 NLVKLIGYCAVDGER-GIQRLLVYEFMLN---RSLEDHLFNRAFPPL--------PWKTR 191
           N+V L+G C + G    I     Y  +LN   R  +  + ++  P +          +  
Sbjct: 106 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 165
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
           L      A+G+A+L        I+RD  A N+LL      K+ DFGLAR+     +  V 
Sbjct: 166 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 222
Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 311
                   + AP+ I     T +SDVWS+G+ L+E+ +   S                  
Sbjct: 223 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM------------- 269
Query: 312 YPADSKKFGLIMDP--RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL-KQIV 368
            P DSK + +I +    L  E++  E   I +    C       RP   Q+V+ + KQI 
Sbjct: 270 -PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQIS 325
Query: 369 QVSN 372
           + +N
Sbjct: 326 ESTN 329

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D + + ++G G FG V     K     G  +   VAIK + ++G     +++ E + +  
Sbjct: 10  DLTFLKELGTGQFGVV-----KYGKWRGQYD---VAIKMI-KEGSMSEDEFIEEAKVMMN 60
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILG 197
           L H  LV+L G C    +R I   ++ E+M N  L ++L      F     +  L +   
Sbjct: 61  LSHEKLVQLYGVCT--KQRPI--FIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKD 113
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
             E + YL      Q ++RD  A N L+++    K+SDFGL+R    V     +++V   
Sbjct: 114 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSK 167
Query: 258 FG--YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 296
           F   ++ P+ +     ++KSD+W+FGV+++E+ + G+   ER
Sbjct: 168 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 209

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 45  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 97
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 149
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 150 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 206
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 207 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 19/221 (8%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQW-V 131
           M     D+  +  IG G +G   K   K       S+  ++  K+L+   + +  KQ  V
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRK-------SDGKILVWKELDYGSMTEAEKQMLV 53
Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLP 187
           +EV  L  L+HPN+V+   Y  +         +V E+     L   +      R +    
Sbjct: 54  SEVNLLRELKHPNIVRY--YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
           +  R+   L  A    +        V++RD K +NV LD     KL DFGLAR   ++ H
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---ILNH 168
Query: 248 -THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEM 287
            T  + A VGT  Y +P+ +       KSD+WS G +LYE+
Sbjct: 169 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 25  YTNLSYIGEGAYGMVC------SAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 77
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 129
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 130 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTE 186
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 30  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 82
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 134
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 135 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 191
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 192 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 31  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 83
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 84  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 135
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 136 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 192
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 193 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 22  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 74
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 75  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 126
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 127 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 183
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 184 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 29  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 81
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 133
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 134 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 23  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 75
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 127
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 128 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 184
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 185 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 23  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 75
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 127
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 128 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 184
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 185 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQF- 136
           ND   + ++G G  G V+K   +           V+A+K++ R G  + +K+ + ++   
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFR-------KTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           L   + P +V+  G    + +      +  E M   +  + L  R   P+P +    + +
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDV----FIAMELM--GTCAEKLKKRMQGPIPERILGKMTV 131
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
              + L YL E  +  VI+RD K SN+LLDE  + KL DFG++  G +V          G
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGIS--GRLV-DDKAKDRSAG 186
Query: 257 TFGYAAPDYIETGHLT-----AKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 311
              Y AP+ I+    T      ++DVWS G+ L E+ TG+   +  +   E  L + +Q+
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LTKVLQE 245
Query: 312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
            P           P L        +        +CL+K  + RPK ++++E
Sbjct: 246 EP-----------PLLPGHMGF--SGDFQSFVKDCLTKDHRKRPKYNKLLE 283

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
               +KIGEG  G V  ++++       S   +VA+KK++    Q  +    EV  +   
Sbjct: 76  LDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 128
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------I 194
           +H N+V++     V    G +  +V EF+   +L D + +         TR++      +
Sbjct: 129 QHENVVEMYNSYLV----GDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAV 175
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
            L   + L+ LH      VI+RD K+ ++LL  + R KLSDFG   +  +         +
Sbjct: 176 CLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXL 230
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 266

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 29  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 81
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 133
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 134 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 190
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           KIGEG +G VYK      A +   E   +   +L ++        + E+  L  L+H N+
Sbjct: 9   KIGEGTYGVVYK------AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VKL  Y  +  ++ +  +LV+E  L++ L+  L +     L   T    +L    G+AY 
Sbjct: 63  VKL--YDVIHTKKRL--VLVFEH-LDQDLKK-LLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVVGTFGYAAP 263
           H+    +V++RD K  N+L++     K++DFGLAR    P+  +TH     V T  Y AP
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH----EVVTLWYRAP 169
Query: 264 DYIE-TGHLTAKSDVWSFGVVLYEMLTG 290
           D +  +   +   D+WS G +  EM+ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 33/289 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNL 145
           +GEG FG VY+       G+  +    VA+K   +D  L   +++++E   +  L+HP++
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKIN----VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 71
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VKLIG    +    I  L  Y  +       H   R    L   T +   L   + +AYL
Sbjct: 72  VKLIGIIEEEPTWIIMELYPYGEL------GHYLERNKNSLKVLTLVLYSLQICKAMAYL 125
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 265
                +  ++RD    N+L+      KL DFGL+R      +   S   +    + +P+ 
Sbjct: 126 ES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPES 181
Query: 266 IETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD 324
           I     T  SDVW F V ++E+L+ G++       K    +LE   + P        +  
Sbjct: 182 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD-----LCP 236
Query: 325 PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE 373
           P L   Y+         L   C      DRP+ +++V  L  + Q+  +
Sbjct: 237 PVL---YT---------LMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 273

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 130/304 (42%), Gaps = 41/304 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHP 143
           +G G FG V +++   A G   S+A + VA+K L     L   +  ++E++ L  L  H 
Sbjct: 54  LGAGAFGKVVEAT---AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 110
Query: 144 NLVKLIGYCAVDGER-GIQRLLVYEFMLN---RSLEDHLFNRAFPPL--------PWKTR 191
           N+V L+G C + G    I     Y  +LN   R  +  + ++  P +          +  
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
           L      A+G+A+L        I+RD  A N+LL      K+ DFGLAR+     +  V 
Sbjct: 171 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 227
Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 311
                   + AP+ I     T +SDVWS+G+ L+E+ +   S                  
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM------------- 274
Query: 312 YPADSKKFGLIMDP--RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL-KQIV 368
            P DSK + +I +    L  E++  E   I +    C       RP   Q+V+ + KQI 
Sbjct: 275 -PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQIS 330
Query: 369 QVSN 372
           + +N
Sbjct: 331 ESTN 334

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHP 143
           +++G G FGSV +   +        +   VAIK L +   +   ++ + E Q +  L++P
Sbjct: 16  IELGCGNFGSVRQGVYRM-----RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 70
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
            +V+LIG C  +       +LV E      L   L  +    +P      ++   + G+ 
Sbjct: 71  YIVRLIGVCQAEA-----LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMK 124
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVVGTFGYAA 262
           YL E      ++RD  A NVLL      K+SDFGL++  G    +    +A      + A
Sbjct: 125 YLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 181
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT 289
           P+ I     +++SDVWS+GV ++E L+
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL-GVLEHP 143
           +G G FG V ++    A G D T+    VA+K L        H+  ++E++ L  +  H 
Sbjct: 72  LGRGAFGQVIEAD---AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 128
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-----------TRL 192
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K           T  
Sbjct: 129 NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 185
Query: 193 HII---LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
           H+I      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+        
Sbjct: 186 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 242
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                     + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 243 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           KIGEG +G VYK      A +   E   +   +L ++        + E+  L  L+H N+
Sbjct: 9   KIGEGTYGVVYK------AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VKL  Y  +  ++ +  +LV+E  L++ L+  L +     L   T    +L    G+AY 
Sbjct: 63  VKL--YDVIHTKKRL--VLVFEH-LDQDLKK-LLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVVGTFGYAAP 263
           H+    +V++RD K  N+L++     K++DFGLAR    P+  +TH     V T  Y AP
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH----EVVTLWYRAP 169
Query: 264 DYIE-TGHLTAKSDVWSFGVVLYEMLTG 290
           D +  +   +   D+WS G +  EM+ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 31/216 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
               +KIGEG  G V  ++++       S   +VA+KK++    Q  +    EV  +   
Sbjct: 31  LDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 83
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------I 194
           +H N+V++     V  E  +    V EF+   +L D + +         TR++      +
Sbjct: 84  QHENVVEMYNSYLVGDELWV----VMEFLEGGALTDIVTH---------TRMNEEQIAAV 130
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
            L   + L+ LH      VI+RD K+ ++LL  + R KLSDFG   +  +         +
Sbjct: 131 CLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXL 185
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 186 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 221

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 131/304 (43%), Gaps = 41/304 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHP 143
           +G G FG V +++   A G   S+A + VA+K L     L   +  ++E++ L  L  H 
Sbjct: 31  LGAGAFGKVVEAT---AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 144 NLVKLIGYCAVDGER-GIQRLLVYEFMLN---RSLEDHLFNRAFPPL--------PWKTR 191
           N+V L+G C + G    I     Y  +LN   R  +  + ++  P +          +  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
           L      A+G+A+L        I+RD  A N+LL      K+ DFGLAR+     +  V 
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 311
                   + AP+ I     T +SDVWS+G+ L+E+ +   S     P            
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGM-------- 251
Query: 312 YPADSKKFGLIMDP--RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL-KQIV 368
            P DSK + +I +    L  E++  E   I +    C       RP   Q+V+ + KQI 
Sbjct: 252 -PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQIS 307
Query: 369 QVSN 372
           + +N
Sbjct: 308 ESTN 311

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 80  DFSRML-KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           DF  ++ ++G+G FG VYK+  K  +        + A K ++    +  + ++ E+  L 
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETS-------VLAAAKVIDTKSEEELEDYMVEIDILA 89
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
             +HPN+VKL+   A   E  +  L+  EF    +++  +     P    ++++ ++   
Sbjct: 90  SCDHPNIVKLLD--AFYYENNLWILI--EFCAGGAVDAVMLELERPLT--ESQIQVVCKQ 143
Query: 199 A-EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
             + L YLH+    ++I+RD KA N+L   +   KL+DFG++ +             +GT
Sbjct: 144 TLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN--TRXIQRRDXFIGT 198
Query: 258 FGYAAPDYI--ETGH---LTAKSDVWSFGVVLYEM 287
             + AP+ +  ET        K+DVWS G+ L EM
Sbjct: 199 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           ++R  KIG+G  G+VY +++  A G        VAI+++N       +  + E+  +   
Sbjct: 22  YTRFEKIGQGASGTVY-TAMDVATGQE------VAIRQMNLQQQPKKELIINEILVMREN 74
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           ++PN+V  +    V    G +  +V E++   SL D +                 L A E
Sbjct: 75  KNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
              +LH     QVI+RD K+ N+LL  +   KL+DFG   +  +       + +VGT  +
Sbjct: 131 ---FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYW 182
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            AP+ +       K D+WS G++  EM+ G
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQGHKQWVAEVQFLGVLEHPN 144
           ++G+G F SV +  +K  AG   + A ++  KKL+ RD    H++   E +   +L+HPN
Sbjct: 29  ELGKGAF-SVVRRCVKVLAGQEYA-AKIINTKKLSARD----HQKLEREARICRLLKHPN 82
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +V+L    + +G       L+++ +    L + +  R +         H I    E + +
Sbjct: 83  IVRLHDSISEEG----HHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLH 136
Query: 205 LHEGLEVQVIYRDFKASNVLLDENFR---PKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
            H+   + V++RD K  N+LL    +    KL+DFGLA E  + G         GT GY 
Sbjct: 137 CHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGTPGYL 191
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +P+ +         D+W+ GV+LY +L G
Sbjct: 192 SPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           + ++ KIGEG +G+V+K     A    T E   +   +L+ D        + E+  L  L
Sbjct: 4   YEKLEKIGEGTYGTVFK-----AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL 58
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGA 198
           +H N+V+L      D     +  LV+EF  ++ L+ +    N    P   K+ L  +L  
Sbjct: 59  KHKNIVRLHDVLHSDK----KLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLL-- 111
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
            +GL + H      V++RD K  N+L++ N   KL+DFGLAR   +    +  +A V T 
Sbjct: 112 -KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY--SAEVVTL 165
Query: 259 GYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSL 294
            Y  PD +    L + S D+WS G +  E+    R L
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 31/216 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
               +KIGEG  G V  ++++       S   +VA+KK++    Q  +    EV  +   
Sbjct: 33  LDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 85
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------I 194
           +H N+V++     V  E  +    V EF+   +L D + +         TR++      +
Sbjct: 86  QHENVVEMYNSYLVGDELWV----VMEFLEGGALTDIVTH---------TRMNEEQIAAV 132
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
            L   + L+ LH      VI+RD K+ ++LL  + R KLSDFG   +  +         +
Sbjct: 133 CLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXL 187
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 188 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 223

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           ++R  KIG+G  G+VY +++  A G        VAI+++N       +  + E+  +   
Sbjct: 22  YTRFEKIGQGASGTVY-TAMDVATGQE------VAIRQMNLQQQPKKELIINEILVMREN 74
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           ++PN+V  +    V    G +  +V E++   SL D +                 L A E
Sbjct: 75  KNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
              +LH     QVI+RD K+ N+LL  +   KL+DFG   +  +       + +VGT  +
Sbjct: 131 ---FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSXMVGTPYW 182
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            AP+ +       K D+WS G++  EM+ G
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNL 145
           +GEG FG VY+       G+  +    VA+K   +D  L   +++++E   +  L+HP++
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKIN----VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 87
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VKLIG    +    I  L  Y  +       H   R    L   T +   L   + +AYL
Sbjct: 88  VKLIGIIEEEPTWIIMELYPYGEL------GHYLERNKNSLKVLTLVLYSLQICKAMAYL 141
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 265
                +  ++RD    N+L+      KL DFGL+R      +   S   +    + +P+ 
Sbjct: 142 ES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPES 197
Query: 266 IETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD 324
           I     T  SDVW F V ++E+L+ G++       K    +LE   + P        +  
Sbjct: 198 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD-----LCP 252
Query: 325 PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE 373
           P L              L   C      DRP+ +++V  L  + Q+  +
Sbjct: 253 PVLYT------------LMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 289

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 22/216 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL-GVLEHP 143
           +G G FG V ++    A G D T+    VA+K L        H+  ++E++ L  +  H 
Sbjct: 35  LGRGAFGQVIEAD---AFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK-------TRLHII- 195
           N+V L+G C    + G   +++ EF    +L  +L ++    +P+K       T  H+I 
Sbjct: 92  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIX 148
Query: 196 --LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
                A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+            
Sbjct: 149 YSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGD 205
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                 + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 119/289 (41%), Gaps = 33/289 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNL 145
           +GEG FG VY+       G    E   VA+K   +D  L   +++++E   +  L+HP++
Sbjct: 20  LGEGFFGEVYEGVYTNHKG----EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VKLIG    +    I  L  Y  +       H   R    L   T +   L   + +AYL
Sbjct: 76  VKLIGIIEEEPTWIIMELYPYGEL------GHYLERNKNSLKVLTLVLYSLQICKAMAYL 129
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDY 265
                +  ++RD    N+L+      KL DFGL+R      +   S   +    + +P+ 
Sbjct: 130 ES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPES 185
Query: 266 IETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD 324
           I     T  SDVW F V ++E+L+ G++       K    +LE   + P        +  
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD-----LCP 240
Query: 325 PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE 373
           P L   Y+         L   C      DRP+ +++V  L  + Q+  +
Sbjct: 241 PVL---YT---------LMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 27/222 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH--KQWVAEVQFLG 138
             RML  G+G FGSV ++ +K   G        VA+K L  D +     ++++ E   + 
Sbjct: 27  LGRML--GKGEFGSVREAQLKQEDGSFVK----VAVKMLKADIIASSDIEEFLREAACMK 80
Query: 139 VLEHPNLVKLIGYCAVDGERG---IQRLLV--------YEFMLNRSLEDHLFNRAFPPLP 187
             +HP++ KL+G       +G   I  +++        + F+L   + ++ FN     LP
Sbjct: 81  EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN-----LP 135
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
            +T +  ++  A G+ YL        I+RD  A N +L E+    ++DFGL+R+     +
Sbjct: 136 LQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                A      + A + +     T  SDVW+FGV ++E++T
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 29  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 81
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE-----DHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHI--------CYF 133
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 134 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQGHKQWVAEVQF 136
           T ++    ++G+G F SV +  +K  AG   + A ++  KKL+ RD    H++   E + 
Sbjct: 10  TEEYQLFEELGKGAF-SVVRRCVKVLAGQEYA-AMIINTKKLSARD----HQKLEREARI 63
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
             +L+HPN+V+L    + +G       L+++ +    L + +  R +         H I 
Sbjct: 64  CRLLKHPNIVRLHDSISEEG----HHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQ 117
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---PKLSDFGLAREGPMVGHTHVSTA 253
              E + + H+   + V++R+ K  N+LL    +    KL+DFGLA E  + G       
Sbjct: 118 QILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFG 172
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
             GT GY +P+ +         D+W+ GV+LY +L G
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D + + ++G G FG V     K     G  +   VAIK + ++G     +++ E + +  
Sbjct: 25  DLTFLKELGTGQFGVV-----KYGKWRGQYD---VAIKMI-KEGSMSEDEFIEEAKVMMN 75
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILG 197
           L H  LV+L G C    +R I   ++ E+M N  L ++L      F     +  L +   
Sbjct: 76  LSHEKLVQLYGVCT--KQRPI--FIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKD 128
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
             E + YL      Q ++RD  A N L+++    K+SDFGL+R    V     +++V   
Sbjct: 129 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSK 182
Query: 258 FG--YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 296
           F   ++ P+ +     ++KSD+W+FGV+++E+ + G+   ER
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           ++R  KIG+G  G+VY +++  A G        VAI+++N       +  + E+  +   
Sbjct: 23  YTRFEKIGQGASGTVY-TAMDVATGQE------VAIRQMNLQQQPKKELIINEILVMREN 75
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           ++PN+V  +    V    G +  +V E++   SL D +                 L A E
Sbjct: 76  KNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 131
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
              +LH     QVI+RD K+ N+LL  +   KL+DFG   +  +       + +VGT  +
Sbjct: 132 ---FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSXMVGTPYW 183
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            AP+ +       K D+WS G++  EM+ G
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D + + ++G G FG V     K     G  +   VAIK + ++G     +++ E + +  
Sbjct: 16  DLTFLKELGTGQFGVV-----KYGKWRGQYD---VAIKMI-KEGSMSEDEFIEEAKVMMN 66
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILG 197
           L H  LV+L G C    +R I   ++ E+M N  L ++L      F     +  L +   
Sbjct: 67  LSHEKLVQLYGVCT--KQRPI--FIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKD 119
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
             E + YL      Q ++RD  A N L+++    K+SDFGL+R    V     +++V   
Sbjct: 120 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSK 173
Query: 258 FG--YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 296
           F   ++ P+ +     ++KSD+W+FGV+++E+ + G+   ER
Sbjct: 174 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 215

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 20/234 (8%)
Query: 66  LRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DG 123
           L+  S+       +++  +  IG G +G V  S+ +   G        VAIKK+    D 
Sbjct: 41  LKARSFDVTFDVGDEYEIIETIGNGAYG-VVSSARRRLTGQQ------VAIKKIPNAFDV 93
Query: 124 LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG-IQRLLVYEFMLNRSLEDHLFNRA 182
           +   K+ + E++ L   +H N++ +          G  + + V   ++   L  H    +
Sbjct: 94  VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDL--HQIIHS 151
Query: 183 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-- 240
             PL  +   + +     GL Y+H     QVI+RD K SN+L++EN   K+ DFG+AR  
Sbjct: 152 SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL 208
Query: 241 -EGPMVGHTHVSTAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRR 292
              P   H +  T  V T  Y AP+ + + H  T   D+WS G +  EML  R+
Sbjct: 209 CTSP-AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           ++R  KIG+G  G+VY +++  A G        VAI+++N       +  + E+  +   
Sbjct: 22  YTRFEKIGQGASGTVY-TAMDVATGQE------VAIRQMNLQQQPKKELIINEILVMREN 74
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           ++PN+V  +    V    G +  +V E++   SL D +                 L A E
Sbjct: 75  KNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
              +LH     QVI+RD K+ N+LL  +   KL+DFG   +  +       + +VGT  +
Sbjct: 131 ---FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSEMVGTPYW 182
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            AP+ +       K D+WS G++  EM+ G
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 129/304 (42%), Gaps = 41/304 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATV-VAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHP 143
           +G G FG V +++   A G   S+A + VA+K L     L   +  ++E++ L  L  H 
Sbjct: 54  LGAGAFGKVVEAT---AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 110
Query: 144 NLVKLIGYCAVDGER-GIQRLLVYEFMLN---RSLEDHLFNRAFPPL--------PWKTR 191
           N+V L+G C + G    I     Y  +LN   R  +  + ++  P +          +  
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
           L      A+G+A+L        I+RD  A N+LL      K+ DFGLAR      +  V 
Sbjct: 171 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVK 227
Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 311
                   + AP+ I     T +SDVWS+G+ L+E+ +   S                  
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM------------- 274
Query: 312 YPADSKKFGLIMDP--RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL-KQIV 368
            P DSK + +I +    L  E++  E   I +    C       RP   Q+V+ + KQI 
Sbjct: 275 -PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQIS 330
Query: 369 QVSN 372
           + +N
Sbjct: 331 ESTN 334

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 107/230 (46%), Gaps = 21/230 (9%)
Query: 65  NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDG 123
           NL     +   + T+D+    ++G+G F SV +  +K       + A ++  KKL+ RD 
Sbjct: 17  NLYFQXMATCTRFTDDYQLFEELGKGAF-SVVRRCVKKTPTQEYA-AKIINTKKLSARD- 73
Query: 124 LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAF 183
              H++   E +   +L+HPN+V+L    + +G       LV++ +    L + +  R +
Sbjct: 74  ---HQKLEREARICRLLKHPNIVRLHDSISEEGFH----YLVFDLVTGGELFEDIVAREY 126
Query: 184 PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---PKLSDFGLAR 240
                    H I    E + ++H+     +++RD K  N+LL    +    KL+DFGLA 
Sbjct: 127 --YSEADASHCIHQILESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAI 181
Query: 241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           E  + G         GT GY +P+ +         D+W+ GV+LY +L G
Sbjct: 182 E--VQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 31/216 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
               +KIGEG  G V  ++++       S   +VA+KK++    Q  +    EV  +   
Sbjct: 22  LDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 74
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------I 194
           +H N+V++     V  E  +    V EF+   +L D + +         TR++      +
Sbjct: 75  QHENVVEMYNSYLVGDELWV----VMEFLEGGALTDIVTH---------TRMNEEQIAAV 121
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
            L   + L+ LH      VI+RD K+ ++LL  + R KLSDFG   +  +         +
Sbjct: 122 CLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXL 176
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           KIGEG +G VYK      A +   E   +   +L ++        + E+  L  L+H N+
Sbjct: 9   KIGEGTYGVVYK------AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VKL  Y  +  ++ +  +LV+E  L++ L+  L +     L   T    +L    G+AY 
Sbjct: 63  VKL--YDVIHTKKRL--VLVFEH-LDQDLKK-LLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG--PMVGHTHVSTAVVGTFGYAAP 263
           H+    +V++RD K  N+L++     K++DFGLAR    P+  +TH     + T  Y AP
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH----EIVTLWYRAP 169
Query: 264 DYIE-TGHLTAKSDVWSFGVVLYEMLTG 290
           D +  +   +   D+WS G +  EM+ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 20/234 (8%)
Query: 66  LRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DG 123
           L+  S+       +++  +  IG G +G V  S+ +   G        VAIKK+    D 
Sbjct: 42  LKARSFDVTFDVGDEYEIIETIGNGAYG-VVSSARRRLTGQQ------VAIKKIPNAFDV 94
Query: 124 LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG-IQRLLVYEFMLNRSLEDHLFNRA 182
           +   K+ + E++ L   +H N++ +          G  + + V   ++   L  H    +
Sbjct: 95  VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDL--HQIIHS 152
Query: 183 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-- 240
             PL  +   + +     GL Y+H     QVI+RD K SN+L++EN   K+ DFG+AR  
Sbjct: 153 SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL 209
Query: 241 -EGPMVGHTHVSTAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRR 292
              P   H +  T  V T  Y AP+ + + H  T   D+WS G +  EML  R+
Sbjct: 210 CTSP-AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 120/258 (46%), Gaps = 37/258 (14%)
Query: 83  RMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQGHKQWVAEVQFLG 138
           R+LK IG+G F  V     K A    T +   V I    +LN   LQ   +   EV+   
Sbjct: 17  RLLKTIGKGNFAKV-----KLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIXK 68
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILG 197
           VL HPN+VKL  +  ++ E+ +   LV E+     + D+L           + +   I+ 
Sbjct: 69  VLNHPNIVKL--FEVIETEKTL--YLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVS 124
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
           A +   Y H+     +++RD KA N+LLD +   K++DFG + E       +   A  G 
Sbjct: 125 AVQ---YCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNE---FTFGNKLDAFCGA 175
Query: 258 FGYAAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP-- 313
             YAAP+  +       + DVWS GV+LY +++G    + +N  +  +R+L    + P  
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 235
Query: 314 --ADS----KKFGLIMDP 325
              D     KKF LI++P
Sbjct: 236 XSTDCENLLKKF-LILNP 252

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AI+K++    Q + Q  + E++ L  
Sbjct: 29  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIRKISPFEHQTYCQRTLREIKILLR 81
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 133
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T 
Sbjct: 134 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 98/237 (41%), Gaps = 26/237 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAEVQFLGVLEHP 143
           +G GGFG V+   +K A G   +   +   +   R G QG    K+ +A+V       H 
Sbjct: 193 LGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEG 201
             +  + Y     E      LV   M    +  H++N     P       +        G
Sbjct: 245 RFIVSLAYAF---ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           L +LH+     +IYRD K  NVLLD++   ++SD GLA E    G T  +    GT G+ 
Sbjct: 302 LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKAGQTK-TKGYAGTPGFM 356
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-----QRLLEWVQQYP 313
           AP+ +         D ++ GV LYEM+  R        K E     QR+LE    YP
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D + + ++G G FG V     K     G  +   VAIK + ++G     +++ E + +  
Sbjct: 25  DLTFLKELGTGQFGVV-----KYGKWRGQYD---VAIKMI-KEGSMSEDEFIEEAKVMMN 75
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILG 197
           L H  LV+L G C    +R I   ++ E+M N  L ++L      F     +  L +   
Sbjct: 76  LSHEKLVQLYGVCT--KQRPI--FIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKD 128
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
             E + YL      Q ++RD  A N L+++    K+SDFGL+R    V     +++V   
Sbjct: 129 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEETSSVGSK 182
Query: 258 FG--YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 296
           F   ++ P+ +     ++KSD+W+FGV+++E+ + G+   ER
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 98/237 (41%), Gaps = 26/237 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAEVQFLGVLEHP 143
           +G GGFG V+   +K A G   +   +   +   R G QG    K+ +A+V       H 
Sbjct: 193 LGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEG 201
             +  + Y     E      LV   M    +  H++N     P       +        G
Sbjct: 245 RFIVSLAYAF---ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           L +LH+     +IYRD K  NVLLD++   ++SD GLA E    G T  +    GT G+ 
Sbjct: 302 LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKAGQTK-TKGYAGTPGFM 356
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-----QRLLEWVQQYP 313
           AP+ +         D ++ GV LYEM+  R        K E     QR+LE    YP
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 31/216 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
               +KIGEG  G V  ++++       S   +VA+KK++    Q  +    EV  +   
Sbjct: 26  LDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 78
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------I 194
           +H N+V++     V  E  +    V EF+   +L D + +         TR++      +
Sbjct: 79  QHENVVEMYNSYLVGDELWV----VMEFLEGGALTDIVTH---------TRMNEEQIAAV 125
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
            L   + L+ LH      VI+RD K+ ++LL  + R KLSDFG   +  +         +
Sbjct: 126 CLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXL 180
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 181 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 216

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 98/237 (41%), Gaps = 26/237 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAEVQFLGVLEHP 143
           +G GGFG V+   +K A G   +   +   +   R G QG    K+ +A+V       H 
Sbjct: 193 LGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEG 201
             +  + Y     E      LV   M    +  H++N     P       +        G
Sbjct: 245 RFIVSLAYAF---ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           L +LH+     +IYRD K  NVLLD++   ++SD GLA E    G T  +    GT G+ 
Sbjct: 302 LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKAGQTK-TKGYAGTPGFM 356
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-----QRLLEWVQQYP 313
           AP+ +         D ++ GV LYEM+  R        K E     QR+LE    YP
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLHE     +IYRD K  NVLLD     KL+D+G+ +EG   G T  ++   GT  Y
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 219
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
            AP+ +         D W+ GV+++EM+ GR   +
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 44/237 (18%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           +DF  +  +G+G FG V K+           ++   AIKK+ R   +     ++EV  L 
Sbjct: 6   SDFEEIAVLGQGAFGQVVKAR-------NALDSRYYAIKKI-RHTEEKLSTILSEVMLLA 57
Query: 139 VLEHPNLVKLIGYCAVDGERGIQR-----------LLVYEFMLNRSLEDHLFNRAFPPLP 187
            L H  +V+   Y A    R   +            +  E+  NR+L D + +       
Sbjct: 58  SLNHQYVVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQR 115
Query: 188 ---WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--- 241
              W+    I+    E L+Y+H      +I+RD K  N+ +DE+   K+ DFGLA+    
Sbjct: 116 DEYWRLFRQIL----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 242 ---------GPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEML 288
                      + G +   T+ +GT  Y A + ++ TGH   K D++S G++ +EM+
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 98/237 (41%), Gaps = 26/237 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAEVQFLGVLEHP 143
           +G GGFG V+   +K A G   +   +   +   R G QG    K+ +A+V       H 
Sbjct: 193 LGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEG 201
             +  + Y     E      LV   M    +  H++N     P       +        G
Sbjct: 245 RFIVSLAYAF---ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           L +LH+     +IYRD K  NVLLD++   ++SD GLA E    G T  +    GT G+ 
Sbjct: 302 LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKAGQTK-TKGYAGTPGFM 356
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-----QRLLEWVQQYP 313
           AP+ +         D ++ GV LYEM+  R        K E     QR+LE    YP
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLHE     +IYRD K  NVLLD     KL+D+G+ +EG   G T  ++   GT  Y
Sbjct: 133 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNY 187
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
            AP+ +         D W+ GV+++EM+ GR   +
Sbjct: 188 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/121 (37%), Positives = 64/121 (52%), Gaps = 13/121 (10%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L +LH+   + +IYRD K  N+LLD N    L+DFGL++E  +   T  +    GT  Y
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTIEY 226
Query: 261 AAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-----RLLEWVQQY 312
            APD +   ++GH  A  D WS GV++YE+LTG      +  K  Q     R+L+    Y
Sbjct: 227 MAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 285
Query: 313 P 313
           P
Sbjct: 286 P 286

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 130/307 (42%), Gaps = 44/307 (14%)
Query: 90  GGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV--LEHPNLVK 147
           G FG V+K+ +        +E   V I  +     Q  + W  E +   +  ++H N+++
Sbjct: 35  GRFGCVWKAQL-------LNEYVAVKIFPI-----QDKQSWQNEYEVYSLPGMKHENILQ 82
Query: 148 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE 207
            IG         +   L+  F    SL D L       + W    HI    A GLAYLHE
Sbjct: 83  FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHE 139
Query: 208 -------GLEVQVIYRDFKASNVLLDENFRPKLSDFGLA---REGPMVGHTHVSTAVVGT 257
                  G +  + +RD K+ NVLL  N    ++DFGLA     G   G TH     VGT
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH---GQVGT 196
Query: 258 FGYAAPDYIETG-----HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL--EWVQ 310
             Y AP+ +E           + D+++ G+VL+E+ +  R    + P  E  L   E + 
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS--RCTAADGPVDEYMLPFEEEIG 254
Query: 311 QYPADSKKFGLIMDPR---LEKEYSINEA--RKIGRLADNCLSKSSKDRPKMSQVVERLK 365
           Q+P+      +++  +   + ++Y    A    +    + C    ++ R     V ER+ 
Sbjct: 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314
Query: 366 QIVQVSN 372
           Q+ +++N
Sbjct: 315 QMQRLTN 321

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG+V K   +      T    ++   + N   L+   + +AE   +  L++P +
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALK--DELLAEANVMQQLDNPYI 90
Query: 146 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           V++IG C  +       +LV E      LN+ L+    NR       K  + ++   + G
Sbjct: 91  VRMIGICEAES-----WMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMG 139
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVG 256
           + YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V  
Sbjct: 140 MKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV-- 194
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 195 --KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG+V K   +      T    ++   + N   L+   + +AE   +  L++P +
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALK--DELLAEANVMQQLDNPYI 90
Query: 146 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           V++IG C  +       +LV E      LN+ L+    NR       K  + ++   + G
Sbjct: 91  VRMIGICEAES-----WMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMG 139
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVG 256
           + YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V  
Sbjct: 140 MKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV-- 194
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 195 --KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLHE     +IYRD K  NVLLD     KL+D+G+ +EG   G T  ++   GT  Y
Sbjct: 118 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNY 172
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
            AP+ +         D W+ GV+++EM+ GR   +
Sbjct: 173 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 120 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEY 174
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 175 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 32/213 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G+G FG V     K        E  V  I K         +  + EVQ L  L+HPN++
Sbjct: 34  LGKGSFGEVILCKDKITG----QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYL 205
           KL  +    G       LV E      L D + +R  F  +       II     G+ Y+
Sbjct: 90  KLYEFFEDKG----YFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYM 142
Query: 206 HEGLEVQVIYRDFKASNVLL-----DENFRPKLSDFGLAREGPMVGHTHVSTAV---VGT 257
           H+    ++++RD K  N+LL     D N R  + DFGL+       H   S  +   +GT
Sbjct: 143 HKN---KIVHRDLKPENLLLESKSKDANIR--IIDFGLST------HFEASKKMKDKIGT 191
Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
             Y AP+ +  G    K DVWS GV+LY +L+G
Sbjct: 192 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 19/221 (8%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQW-V 131
           M     D+  +  IG G +G   K   K       S+  ++  K+L+   + +  KQ  V
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRK-------SDGKILVWKELDYGSMTEAEKQMLV 53
Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLP 187
           +EV  L  L+HPN+V+   Y  +         +V E+     L   +      R +    
Sbjct: 54  SEVNLLRELKHPNIVRY--YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
           +  R+   L  A    +        V++RD K +NV LD     KL DFGLAR   ++ H
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---ILNH 168
Query: 248 -THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEM 287
            T  +   VGT  Y +P+ +       KSD+WS G +LYE+
Sbjct: 169 DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLHE     +IYRD K  NVLLD     KL+D+G+ +EG   G T  ++   GT  Y
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNY 176
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
            AP+ +         D W+ GV+++EM+ GR   +
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG+V K   +      T    ++   + N   L+   + +AE   +  L++P +
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALK--DELLAEANVMQQLDNPYI 74
Query: 146 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           V++IG C  +       +LV E      LN+ L+    NR       K  + ++   + G
Sbjct: 75  VRMIGICEAES-----WMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMG 123
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVG 256
           + YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V  
Sbjct: 124 MKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPV-- 178
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 179 --KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG+V K   +      T    ++   + N   L+   + +AE   +  L++P +
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALK--DELLAEANVMQQLDNPYI 88
Query: 146 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           V++IG C  +       +LV E      LN+ L+    NR       K  + ++   + G
Sbjct: 89  VRMIGICEAES-----WMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMG 137
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVG 256
           + YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V  
Sbjct: 138 MKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV-- 192
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 193 --KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV 131
           S  R    D + +  +G+G +G V++         G+ +   VA+K  +    +  K W 
Sbjct: 1   SMQRTVARDITLLECVGKGRYGEVWR---------GSWQGENVAVKIFSS---RDEKSWF 48
Query: 132 AEVQFLG--VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
            E +     +L H N++  I           Q  L+  +    SL D+L       L   
Sbjct: 49  RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTV 105
Query: 190 TRLHIILGAAEGLAYLH-EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           + L I+L  A GLA+LH E    Q    + +RD K+ N+L+ +N +  ++D GLA     
Sbjct: 106 SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA----- 160
Query: 245 VGHTHVSTAV-------VGTFGYAAPDYI-ETGHLTA-----KSDVWSFGVVLYEM 287
           V H+  +  +       VGT  Y AP+ + ET  +       + D+W+FG+VL+E+
Sbjct: 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG+V K   +      T    ++   + N   L+   + +AE   +  L++P +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALK--DELLAEANVMQQLDNPYI 80
Query: 146 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           V++IG C  +       +LV E      LN+ L+    NR       K  + ++   + G
Sbjct: 81  VRMIGICEAES-----WMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMG 129
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVG 256
           + YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V  
Sbjct: 130 MKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV-- 184
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 185 --KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEY 171
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 28/210 (13%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FG VYK+  K           + A K +     +  + ++ E++ L   +HP +
Sbjct: 26  ELGDGAFGKVYKAKNKETGA-------LAAAKVIETKSEEELEDYIVEIEILATCDHPYI 78
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL-GAAEGL 202
           VKL+G    DG+  I    + EF    +++  +   +R       + ++ ++     E L
Sbjct: 79  VKLLGAYYHDGKLWI----MIEFCPGGAVDAIMLELDRGLT----EPQIQVVCRQMLEAL 130
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
            +LH     ++I+RD KA NVL+      +L+DFG++ +   +       + +GT  + A
Sbjct: 131 NFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDSFIGTPYWMA 185
Query: 263 PDYI--ETGHLTA---KSDVWSFGVVLYEM 287
           P+ +  ET   T    K+D+WS G+ L EM
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEY 171
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEY 171
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 122 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEY 176
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 32/213 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G+G FG V     K        E  V  I K         +  + EVQ L  L+HPN++
Sbjct: 40  LGKGSFGEVILCKDKITG----QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 95
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYL 205
           KL  +    G       LV E      L D + +R  F  +       II     G+ Y+
Sbjct: 96  KLYEFFEDKG----YFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYM 148
Query: 206 HEGLEVQVIYRDFKASNVLL-----DENFRPKLSDFGLAREGPMVGHTHVSTAV---VGT 257
           H+    ++++RD K  N+LL     D N R  + DFGL+       H   S  +   +GT
Sbjct: 149 HKN---KIVHRDLKPENLLLESKSKDANIR--IIDFGLST------HFEASKKMKDKIGT 197
Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
             Y AP+ +  G    K DVWS GV+LY +L+G
Sbjct: 198 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 229

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG+V K   +      T    ++   + N   L+   + +AE   +  L++P +
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALK--DELLAEANVMQQLDNPYI 70
Query: 146 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           V++IG C  +       +LV E      LN+ L+    NR       K  + ++   + G
Sbjct: 71  VRMIGICEAES-----WMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMG 119
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVG 256
           + YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V  
Sbjct: 120 MKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV-- 174
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 175 --KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 32/213 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G+G FG V     K        E  V  I K         +  + EVQ L  L+HPN++
Sbjct: 58  LGKGSFGEVILCKDKITG----QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 113
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYL 205
           KL  +    G       LV E      L D + +R  F  +       II     G+ Y+
Sbjct: 114 KLYEFFEDKG----YFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYM 166
Query: 206 HEGLEVQVIYRDFKASNVLL-----DENFRPKLSDFGLAREGPMVGHTHVSTAV---VGT 257
           H+    ++++RD K  N+LL     D N R  + DFGL+       H   S  +   +GT
Sbjct: 167 HKN---KIVHRDLKPENLLLESKSKDANIR--IIDFGLST------HFEASKKMKDKIGT 215
Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
             Y AP+ +  G    K DVWS GV+LY +L+G
Sbjct: 216 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG+V K   +      T    ++   + N   L+   + +AE   +  L++P +
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALK--DELLAEANVMQQLDNPYI 68
Query: 146 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           V++IG C  +       +LV E      LN+ L+    NR       K  + ++   + G
Sbjct: 69  VRMIGICEAE-----SWMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMG 117
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVG 256
           + YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V  
Sbjct: 118 MKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV-- 172
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 173 --KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 32/213 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G+G FG V     K        E  V  I K         +  + EVQ L  L+HPN++
Sbjct: 57  LGKGSFGEVILCKDKITG----QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 112
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYL 205
           KL  +    G       LV E      L D + +R  F  +       II     G+ Y+
Sbjct: 113 KLYEFFEDKG----YFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYM 165
Query: 206 HEGLEVQVIYRDFKASNVLL-----DENFRPKLSDFGLAREGPMVGHTHVSTAV---VGT 257
           H+    ++++RD K  N+LL     D N R  + DFGL+       H   S  +   +GT
Sbjct: 166 HKN---KIVHRDLKPENLLLESKSKDANIR--IIDFGLST------HFEASKKMKDKIGT 214
Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
             Y AP+ +  G    K DVWS GV+LY +L+G
Sbjct: 215 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  IG G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 29  YQNLSPIGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 82  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDD 182
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 183 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEY 171
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           ++R  KIG+G  G+VY +++  A G        VAI+++N       +  + E+  +   
Sbjct: 23  YTRFEKIGQGASGTVY-TAMDVATGQE------VAIRQMNLQQQPKKELIINEILVMREN 75
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           ++PN+V  +    V    G +  +V E++   SL D +                 L A E
Sbjct: 76  KNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 131
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
              +LH     QVI+R+ K+ N+LL  +   KL+DFG   +  +       + +VGT  +
Sbjct: 132 ---FLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYW 183
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            AP+ +       K D+WS G++  EM+ G
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       GT  Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEY 171
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+ +E        D W  GVV+YEM+ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 29  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 81
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 133
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT     
Sbjct: 134 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXE 190
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 191 XVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGV 139
           ++ +  IGEG +G V       +A D  ++  V AIKK++    Q + Q  + E++ L  
Sbjct: 30  YTNLSYIGEGAYGMVC------SAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLR 82
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHI 194
             H N++ +           ++ + + + ++   L       HL N            + 
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--------CYF 134
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG-PMVGHTHVSTA 253
           +     GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT     
Sbjct: 135 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXE 191
Query: 254 VVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGR 291
            V T  Y AP+ +       KS D+WS G +L EML+ R
Sbjct: 192 XVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG+V K   +      T    ++   + N   L+   + +AE   +  L++P +
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALK--DELLAEANVMQQLDNPYI 74
Query: 146 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           V++IG C  +       +LV E      LN+ L+    NR       K  + ++   + G
Sbjct: 75  VRMIGICEAES-----WMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMG 123
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVG 256
           + YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V  
Sbjct: 124 MKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV-- 178
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 179 --KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK---QWVAEVQFLGVLEHP 143
           +G G FG V         G+       VA+K LNR  ++      +   E+Q L +  HP
Sbjct: 19  LGVGTFGKV-------KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGL 202
           +++KL    +   +      +V E++    L D++        +  +     IL A +  
Sbjct: 72  HIIKLYQVISTPTDF----FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD-- 125
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
            Y H  +   V++RD K  NVLLD +   K++DFGL+    M+          G+  YAA
Sbjct: 126 -YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSN---MMSDGEFLRTSCGSPNYAA 178
Query: 263 PDYIETGHLTA--KSDVWSFGVVLYEMLTG 290
           P+ I +G L A  + D+WS GV+LY +L G
Sbjct: 179 PEVI-SGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDD 177
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 34  YQNLAPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 86
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 87  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 130
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 131 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 187
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 188 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 28/210 (13%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FG VYK+  K           + A K +     +  + ++ E++ L   +HP +
Sbjct: 18  ELGDGAFGKVYKAKNKETGA-------LAAAKVIETKSEEELEDYIVEIEILATCDHPYI 70
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIIL-GAAEGL 202
           VKL+G    DG+  I    + EF    +++  +   +R       + ++ ++     E L
Sbjct: 71  VKLLGAYYHDGKLWI----MIEFCPGGAVDAIMLELDRGLT----EPQIQVVCRQMLEAL 122
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
            +LH     ++I+RD KA NVL+      +L+DFG++ +   +       + +GT  + A
Sbjct: 123 NFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDSFIGTPYWMA 177
Query: 263 PDYI--ETGHLTA---KSDVWSFGVVLYEM 287
           P+ +  ET   T    K+D+WS G+ L EM
Sbjct: 178 PEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHP 143
           +++G G FGSV +   +        +   VAIK L +   +   ++ + E Q +  L++P
Sbjct: 342 IELGCGNFGSVRQGVYR-----MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 396
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
            +V+LIG C  +       +LV E      L   L  +    +P      ++   + G+ 
Sbjct: 397 YIVRLIGVCQAEA-----LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMK 450
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVVGTFGYAA 262
           YL E      ++R+  A NVLL      K+SDFGL++  G    +    +A      + A
Sbjct: 451 YLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 507
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT 289
           P+ I     +++SDVWS+GV ++E L+
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG+V K   +      T    ++   + N   L+   + +AE   +  L++P +
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALK--DELLAEANVMQQLDNPYI 432
Query: 146 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           V++IG C  +       +LV E      LN+ L+    NR       K  + ++   + G
Sbjct: 433 VRMIGICEAE-----SWMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMG 481
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVG 256
           + YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V  
Sbjct: 482 MKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV-- 536
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 537 --KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG+V K   +      T    ++   + N   L+   + +AE   +  L++P +
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALK--DELLAEANVMQQLDNPYI 433
Query: 146 VKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           V++IG C  +       +LV E      LN+ L+    NR       K  + ++   + G
Sbjct: 434 VRMIGICEAE-----SWMLVMEMAELGPLNKYLQQ---NRHVKD---KNIIELVHQVSMG 482
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVG 256
           + YL E      ++RD  A NVLL      K+SDFGL++     E      TH    V  
Sbjct: 483 MKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV-- 537
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
              + AP+ I     ++KSDVWSFGV+++E  +
Sbjct: 538 --KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 27/233 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAI---KKLNRDGLQGHKQWVAEVQFLGVLEHP 143
           IG+G F  V     K A    T     V I    +LN   LQ   +   EV+ + +L HP
Sbjct: 23  IGKGNFAKV-----KLARHVLTGREVAVKIIDKTQLNPTSLQ---KLFREVRIMKILNHP 74
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGL 202
           N+VKL  +  ++ E+ +   LV E+     + D+L           + +   I+ A +  
Sbjct: 75  NIVKL--FEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ-- 128
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
            Y H+     +++RD KA N+LLD +   K++DFG + E   VG+        G+  YAA
Sbjct: 129 -YCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEF-TVGNK--LDTFCGSPPYAA 181
Query: 263 PDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLE-RNRPKTEQRLLEWVQQYP 313
           P+  +       + DVWS GV+LY +++G    + +N  +  +R+L    + P
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP 234

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 31  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 84  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 245 VGHT-HVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 181 --HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 29  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 82  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 182
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 183 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 23  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 75
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 76  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 119
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 120 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 176
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 177 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 31  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 84  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 184
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 185 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           + ++ KIGEG +G+V+K     A    T E   +   +L+ D        + E+  L  L
Sbjct: 4   YEKLEKIGEGTYGTVFK-----AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL 58
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGA 198
           +H N+V+L      D     +  LV+EF  ++ L+ +    N    P   K+ L  +L  
Sbjct: 59  KHKNIVRLHDVLHSDK----KLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLL-- 111
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
            +GL + H      V++RD K  N+L++ N   KL++FGLAR   +    +  +A V T 
Sbjct: 112 -KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTL 165
Query: 259 GYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSL 294
            Y  PD +    L + S D+WS G +  E+    R L
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 31  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 84  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 245 VGHT-HVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 181 --HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 26  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 79  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 179
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 180 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 26  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 79  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 175
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 176 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 36  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 89  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 185
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 186 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 36  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 89  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 185
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 186 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 29  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 82  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDD 182
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 183 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 30  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 83  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 183
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 184 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 35  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 88  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 131
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 132 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 184
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 185 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG+G F SV +  I    G   +   V   K  +  GL   +    E     +L+HP++V
Sbjct: 32  IGKGAF-SVVRRCINRETGQQFAVKIVDVAKFTSSPGLST-EDLKREASICHMLKHPHIV 89
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL--HIILGAAEGLAY 204
           +L+   + DG       +V+EFM    L   +  RA     +   +  H +    E L Y
Sbjct: 90  ELLETYSSDG----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 205 LHEGLEVQVIYRDFKASNVLL--DENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
            H+     +I+RD K  NVLL   EN  P KL DFG+A +    G   V+   VGT  + 
Sbjct: 146 CHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL--VAGGRVGTPHFM 200
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           AP+ ++        DVW  GV+L+ +L+G
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 105/222 (47%), Gaps = 27/222 (12%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           D + + ++G G FG V     K     G  +  +    K+ ++G     +++ E + +  
Sbjct: 10  DLTFLKELGTGQFGVV-----KYGKWRGQYDVAI----KMIKEGSMSEDEFIEEAKVMMN 60
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILG 197
           L H  LV+L G C    +R I   ++ E+M N  L ++L      F     +  L +   
Sbjct: 61  LSHEKLVQLYGVCT--KQRPI--FIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKD 113
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
             E + YL      Q ++RD  A N L+++    K+SDFGL+R    V     +++    
Sbjct: 114 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSRGSK 167
Query: 258 FG--YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 296
           F   ++ P+ +     ++KSD+W+FGV+++E+ + G+   ER
Sbjct: 168 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 209

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 30  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 83  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 179
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 180 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--NRDGLQGHKQWVAEVQFLG 138
           + ++ KIGEG +G V+K               +VAIKK   + D     K  + E++ L 
Sbjct: 5   YEKIGKIGEGSYGVVFKCR-------NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLK 57
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
            L+HPNLV L+     +  R  +RL LV+E+  +  L  H  +R    +P      I   
Sbjct: 58  QLKHPNLVNLL-----EVFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVKSITWQ 110
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
             + + + H+      I+RD K  N+L+ ++   KL DFG AR   + G +      V T
Sbjct: 111 TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARL--LTGPSDYYDDEVAT 165
Query: 258 FGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTG 290
             Y +P+  +         DVW+ G V  E+L+G
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IGEG FG V++  I  +  +      +   K    D ++  ++++ E   +   +HP++V
Sbjct: 18  IGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIV 74
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 206
           KLIG   V  E  +   ++ E      L   L  R F  L   + +      +  LAYL 
Sbjct: 75  KLIG---VITENPV--WIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLE 128
Query: 207 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG-----YA 261
                + ++RD  A NVL+  N   KL DFGL+R      +   ST    + G     + 
Sbjct: 129 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTXXKASKGKLPIKWM 179
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEML 288
           AP+ I     T+ SDVW FGV ++E+L
Sbjct: 180 APESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK---QWVAEVQFLGVLEHP 143
           +G G FG V         G+       VA+K LNR  ++      +   E+Q L +  HP
Sbjct: 19  LGVGTFGKV-------KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGL 202
           +++KL    +   +      +V E++    L D++        +  +     IL A +  
Sbjct: 72  HIIKLYQVISTPTDF----FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD-- 125
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
            Y H  +   V++RD K  NVLLD +   K++DFGL+    M+          G+  YAA
Sbjct: 126 -YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSN---MMSDGEFLRDSCGSPNYAA 178
Query: 263 PDYIETGHLTA--KSDVWSFGVVLYEMLTG 290
           P+ I +G L A  + D+WS GV+LY +L G
Sbjct: 179 PEVI-SGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 35  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 88  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 131
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 132 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR---- 184
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 185 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 26  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 79  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 175
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 176 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 87  IGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH 142
           IGEG FG V    Y S   PA         +   K    D ++  ++++ E   +   +H
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMA-----VAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 450
Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           P++VKLIG   V  E  +   ++ E      L   L  R F  L   + +      +  L
Sbjct: 451 PHIVKLIG---VITENPV--WIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTAL 504
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
           AYL      + ++RD  A NVL+  N   KL DFGL+R      +   S   +    + A
Sbjct: 505 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMA 560
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEML 288
           P+ I     T+ SDVW FGV ++E+L
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 47  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 100 HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 143
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 144 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 196
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 197 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 29  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 82  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 182
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 183 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 43  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 96  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 139
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 140 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 192
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 193 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 31  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 84  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 245 VGHT-HVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 181 --HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 127/288 (44%), Gaps = 39/288 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G+G +G VY       AG   S    +AIK++     +  +    E+     L+H N+V
Sbjct: 30  LGKGTYGIVY-------AGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 82
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP--WKTRLHIILGAAEGLAY 204
           + +G  +   E G  ++ + E +   SL   L    + PL    +T         EGL Y
Sbjct: 83  QYLGSFS---ENGFIKIFM-EQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 205 LHEGLEVQVIYRDFKASNVLLDE-NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           LH+    Q+++RD K  NVL++  +   K+SDFG ++   + G    +    GT  Y AP
Sbjct: 138 LHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAP 192
Query: 264 DYIETG--HLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQQYP------- 313
           + I+ G       +D+WS G  + EM TG+    E   P+     +   + +P       
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS 252
Query: 314 ADSKKFGL-IMDPRLEKEYSINEARKIGRLADNCL---SKSSKDRPKM 357
           A++K F L   +P  +K    N+      L D  L   SK  K +PK+
Sbjct: 253 AEAKAFILKCFEPDPDKRACANDL-----LVDEFLKVSSKKKKTQPKL 295

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 21  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 74  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 117
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 118 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 174
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 175 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 44  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 97  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 193
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 194 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQGHKQWVAEVQF 136
           T+++     IG+G F SV +  +K   G   + A ++  KKL+ RD    H++   E + 
Sbjct: 3   TDEYQLYEDIGKGAF-SVVRRCVKLCTGHEYA-AKIINTKKLSARD----HQKLEREARI 56
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
             +L+H N+V+L    + +G       LV++ +    L + +  R +         H I 
Sbjct: 57  CRLLKHSNIVRLHDSISEEGFH----YLVFDLVTGGELFEDIVAREY--YSEADASHCIQ 110
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---PKLSDFGLAREGPMVGHTHVSTA 253
              E + + H+   + V++RD K  N+LL    +    KL+DFGLA E  + G       
Sbjct: 111 QILEAVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIE--VQGDQQAWFG 165
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
             GT GY +P+ +         D+W+ GV+LY +L G
Sbjct: 166 FAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 30  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 83  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 183
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 184 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 21  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 74  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 117
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 118 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 174
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 175 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 20  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 73  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 26  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 79  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDD 179
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 180 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 111/241 (46%), Gaps = 41/241 (17%)
Query: 75  RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH---KQWV 131
           R     +  + K+G+G +G V+KS I    G+      VVA+KK+  D  Q     ++  
Sbjct: 5   RHVLRKYELVKKLGKGAYGIVWKS-IDRRTGE------VVAVKKI-FDAFQNSTDAQRTF 56
Query: 132 AEVQFLGVLE-HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 190
            E+  L  L  H N+V L+     D +R +   LV+++M     + H   RA    P   
Sbjct: 57  REIMILTELSGHENIVNLLNVLRADNDRDV--YLVFDYM---ETDLHAVIRANILEPVHK 111
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---------- 240
           + +++    + + YLH G    +++RD K SN+LL+     K++DFGL+R          
Sbjct: 112 Q-YVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 241 EGPMVGHTH---------VSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTG 290
             P+  + +         + T  V T  Y AP+  + +   T   D+WS G +L E+L G
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227
Query: 291 R 291
           +
Sbjct: 228 K 228

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 44  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 97  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 193
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 194 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 20  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 73  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCA 116
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 245 VGHTHVSTA-VVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    A  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 43  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 96  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 139
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 140 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 192
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 193 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQF 136
             +DF  +  +G+G FG+VY +  K           V+   +L ++G++   Q   E++ 
Sbjct: 12  TIDDFDIVRPLGKGKFGNVYLAREK--QNKFIMALKVLFKSQLEKEGVE--HQLRREIEI 67
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDH-LFNRAFPPLPWKTR 191
              L HPN++++  Y   D +R     L+ EF     L + L+ H  F+        +  
Sbjct: 68  QSHLRHPNILRMYNYFH-DRKRIY---LMLEFAPRGELYKELQKHGRFDE-------QRS 116
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
              +   A+ L Y HE    +VI+RD K  N+L+      K++DFG +   P +      
Sbjct: 117 ATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----R 169
Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
             + GT  Y  P+ IE      K D+W  GV+ YE L G
Sbjct: 170 RXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 30  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 83  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR---- 179
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 180 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 47  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 100 HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 143
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 144 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 200
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 201 EMXGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 245 VGHTHVSTA-VVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    A  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 22  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 74
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 75  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 118
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 119 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 175
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 176 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 20  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 73  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ D+GLAR  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLARHTDD 177
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGL R  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDD 177
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 19/221 (8%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQW-V 131
           M     D+  +  IG G +G   K   K       S+  ++  K+L+   + +  KQ  V
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRK-------SDGKILVWKELDYGSMTEAEKQMLV 53
Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDHLFNRAFPPLP 187
           +EV  L  L+HPN+V+   Y  +         +V E+     L   +      R +    
Sbjct: 54  SEVNLLRELKHPNIVRY--YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
           +  R+   L  A    +        V++RD K +NV LD     KL DFGLAR   ++ H
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---ILNH 168
Query: 248 TH-VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEM 287
               +   VGT  Y +P+ +       KSD+WS G +LYE+
Sbjct: 169 DEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV 131
           S  R   +  + +  +G+G +G V++         G+ +   VA+K  +    +  K W 
Sbjct: 1   SMQRTVAHQITLLECVGKGRYGEVWR---------GSWQGENVAVKIFSS---RDEKSWF 48
Query: 132 AEVQFLG--VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
            E +     +L H N++  I           Q  L+  +    SL D+L       L   
Sbjct: 49  RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTV 105
Query: 190 TRLHIILGAAEGLAYLH-EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           + L I+L  A GLA+LH E    Q    + +RD K+ N+L+ +N +  ++D GLA     
Sbjct: 106 SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA----- 160
Query: 245 VGHTHVSTAV-------VGTFGYAAPDYI-ETGHLTA-----KSDVWSFGVVLYEM 287
           V H+  +  +       VGT  Y AP+ + ET  +       + D+W+FG+VL+E+
Sbjct: 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 44/226 (19%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV  S               +A+KKL+R    +   K+   E++ L 
Sbjct: 53  YQTLSPVGSGAYGSVCSSY-------DVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLK 105
Query: 139 VLEHPNLVKLIGYC--AVDGERGIQRLLVYEFM---LNRSL------EDHLFNRAFPPLP 187
            ++H N++ L+     A   E      LV   M   LN  +      +DH+         
Sbjct: 106 HMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 156
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
                 +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR      H
Sbjct: 157 ----QFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR------H 203
Query: 248 THVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
           T    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 204 TDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFL 137
           ++ + R+ K+G G +G V     K       +E  +  IKK +          + EV  L
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTG----AERAIKIIKKSSVTTTSNSGALLDEVAVL 58
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIIL 196
             L+HPN++KL  Y   + +R     LV E      L D +  R  F  +     +  +L
Sbjct: 59  KQLDHPNIMKL--YEFFEDKRNY--YLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVL 114
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP---KLSDFGLAREGPMVGHTHVSTA 253
               G  YLH+     +++RD K  N+LL+   R    K+ DFGL+       H  V   
Sbjct: 115 S---GTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLS------AHFEVGGK 162
Query: 254 V---VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +   +GT  Y AP+ +   +   K DVWS GV+LY +L G
Sbjct: 163 MKERLGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCG 201

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL++    +   K+   E++ L 
Sbjct: 36  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLK 88
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 89  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 185
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 186 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 20  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 73  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 169
Query: 245 VGHTHVSTA-VVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    A  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 170 --HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 91/218 (41%), Gaps = 25/218 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFL 137
           F  +  IG+G FG V                 + A+K +N+         +    E+Q +
Sbjct: 17  FEILRAIGKGSFGKV-------CIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIM 69
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
             LEHP LV L  Y   D E      +V + +L   L  HL          +T    I  
Sbjct: 70  QGLEHPFLVNL-WYSFQDEE---DMFMVVDLLLGGDLRYHLQQNVH--FKEETVKLFICE 123
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
               L YL      ++I+RD K  N+LLDE+    ++DF +A   P    T ++T + GT
Sbjct: 124 LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RETQITT-MAGT 177
Query: 258 FGYAAPDYIETGHLTAKS---DVWSFGVVLYEMLTGRR 292
             Y AP+   +      S   D WS GV  YE+L GRR
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 91/215 (42%), Gaps = 36/215 (16%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G+G FG V     K        E  V  I K         +  + EVQ L  L+HPN+ 
Sbjct: 34  LGKGSFGEVILCKDKITG----QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIX 89
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYL 205
           KL  +    G       LV E      L D + +R  F  +       II     G+ Y 
Sbjct: 90  KLYEFFEDKG----YFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYX 142
Query: 206 HEGLEVQVIYRDFKASNVLL-----DENFRPKLSDFGLAREGPMVGHTHVSTAV-----V 255
           H+    ++++RD K  N+LL     D N R  + DFGL+        TH   +      +
Sbjct: 143 HKN---KIVHRDLKPENLLLESKSKDANIR--IIDFGLS--------THFEASKKXKDKI 189
Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           GT  Y AP+ +  G    K DVWS GV+LY +L+G
Sbjct: 190 GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQGHKQWVAEVQF 136
           T+++    ++G+G F SV +  +K   G   + A ++  KKL+ RD    H++   E + 
Sbjct: 3   TDEYQLFEELGKGAF-SVVRRCMKIPTGQEYA-AKIINTKKLSARD----HQKLEREARI 56
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
             +L+HPN+V+L    + +G       LV++ +    L + +  R +         H I 
Sbjct: 57  CRLLKHPNIVRLHDSISEEG----FHYLVFDLVTGGELFEDIVAREY--YSEADASHCIQ 110
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---PKLSDFGLAREGPMVGHTHVSTA 253
              E + + H      +++RD K  N+LL    +    KL+DFGLA E  + G       
Sbjct: 111 QILESVNHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIE--VQGDQQAWFG 165
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
             GT GY +P+ +         D+W+ GV+LY +L G
Sbjct: 166 FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 39/220 (17%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
            +  +KIGEG  G V  ++ K            VA+KK++    Q  +    EV  +   
Sbjct: 47  LANFIKIGEGSTGIVCIATEKHTGKQ-------VAVKKMDLRKQQRRELLFNEVVIMRDY 99
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH------I 194
            H N+V +     V  E  +    V EF+   +L D + +         TR++      +
Sbjct: 100 HHDNVVDMYSSYLVGDELWV----VMEFLEGGALTDIVTH---------TRMNEEQIATV 146
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG----LAREGPMVGHTHV 250
            L     L+YLH      VI+RD K+ ++LL  + R KLSDFG    +++E P       
Sbjct: 147 CLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK------ 197
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
              +VGT  + AP+ I       + D+WS G+++ EM+ G
Sbjct: 198 RKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 106/219 (48%), Gaps = 23/219 (10%)
Query: 77  ATNDFSRMLK---IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAE 133
           A N F  + K   +G G FG V+K        + T+    +A K +   G++  ++   E
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKC-------EETATGLKLAAKIIKTRGMKDKEEVKNE 136
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           +  +  L+H NL++L  Y A + +  I  +LV E++    L D + + ++      T L 
Sbjct: 137 ISVMNQLDHANLIQL--YDAFESKNDI--VLVMEYVDGGELFDRIIDESYNLTELDTIL- 191
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLL--DENFRPKLSDFGLAREGPMVGHTHVS 251
            +    EG+ ++H+   + +++ D K  N+L    +  + K+ DFGLAR         V+
Sbjct: 192 FMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN 248
Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
               GT  + AP+ +    ++  +D+WS GV+ Y +L+G
Sbjct: 249 ---FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IGEG FG V++  I  +  +      +   K    D ++  ++++ E   +   +HP++V
Sbjct: 18  IGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIV 74
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 206
           KLIG   V  E  +   ++ E      L   L  R +  L   + +      +  LAYL 
Sbjct: 75  KLIG---VITENPV--WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE 128
Query: 207 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI 266
                + ++RD  A NVL+  N   KL DFGL+R      +   S   +    + AP+ I
Sbjct: 129 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 184
Query: 267 ETGHLTAKSDVWSFGVVLYEML 288
                T+ SDVW FGV ++E+L
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL 206

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 42/228 (18%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG--VLEHPN 144
           +G+G +G V++         G      VA+K  +    +  + W  E +     +L H N
Sbjct: 16  VGKGRYGEVWR---------GLWHGESVAVKIFSS---RDEQSWFRETEIYNTVLLRHDN 63
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           ++  I           Q  L+  +  + SL D L  +   P      L + + AA GLA+
Sbjct: 64  ILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEP---HLALRLAVSAACGLAH 120
Query: 205 LH-EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV----- 254
           LH E    Q    + +RDFK+ NVL+  N +  ++D GLA     V H+  S  +     
Sbjct: 121 LHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-----VMHSQGSDYLDIGNN 175
Query: 255 --VGTFGYAAPDYIETGHLT------AKSDVWSFGVVLYEMLTGRRSL 294
             VGT  Y AP+ ++    T        +D+W+FG+VL+E+   RR++
Sbjct: 176 PRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI 221

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 87  IGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH 142
           IGEG FG V    Y S   PA         +   K    D ++  ++++ E   +   +H
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALA-----VAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 73
Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           P++VKLIG   V  E  +   ++ E      L   L  R +  L   + +      +  L
Sbjct: 74  PHIVKLIG---VITENPV--WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTAL 127
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
           AYL      + ++RD  A NVL+  N   KL DFGL+R      +   S   +    + A
Sbjct: 128 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMA 183
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEML 288
           P+ I     T+ SDVW FGV ++E+L
Sbjct: 184 PESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 87  IGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH 142
           IGEG FG V    Y S   PA         +   K    D ++  ++++ E   +   +H
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALA-----VAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 67
Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           P++VKLIG   V  E  +   ++ E      L   L  R +  L   + +      +  L
Sbjct: 68  PHIVKLIG---VITENPV--WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTAL 121
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
           AYL      + ++RD  A NVL+  N   KL DFGL+R      +   S   +    + A
Sbjct: 122 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMA 177
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEML 288
           P+ I     T+ SDVW FGV ++E+L
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 87  IGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH 142
           IGEG FG V    Y S   PA         +   K    D ++  ++++ E   +   +H
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALA-----VAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 72
Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           P++VKLIG   V  E  +   ++ E      L   L  R +  L   + +      +  L
Sbjct: 73  PHIVKLIG---VITENPV--WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTAL 126
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
           AYL      + ++RD  A NVL+  N   KL DFGL+R      +   S   +    + A
Sbjct: 127 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMA 182
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEML 288
           P+ I     T+ SDVW FGV ++E+L
Sbjct: 183 PESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 87  IGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH 142
           IGEG FG V    Y S   PA         +   K    D ++  ++++ E   +   +H
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALA-----VAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 70
Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           P++VKLIG   V  E  +   ++ E      L   L  R +  L   + +      +  L
Sbjct: 71  PHIVKLIG---VITENPV--WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTAL 124
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
           AYL      + ++RD  A NVL+  N   KL DFGL+R      +   S   +    + A
Sbjct: 125 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMA 180
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEML 288
           P+ I     T+ SDVW FGV ++E+L
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFL 137
           ++ + R+ K+G G +G V     K       +E  +  IKK +          + EV  L
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTG----AERAIKIIKKSSVTTTSNSGALLDEVAVL 75
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIIL 196
             L+HPN++KL  Y   + +R     LV E      L D +  R  F  +     +  +L
Sbjct: 76  KQLDHPNIMKL--YEFFEDKRNY--YLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVL 131
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP---KLSDFGLAREGPMVGHTHVSTA 253
               G  YLH+     +++RD K  N+LL+   R    K+ DFGL+       H  V   
Sbjct: 132 S---GTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLS------AHFEVGGK 179
Query: 254 V---VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +   +GT  Y AP+ +   +   K DVWS GV+LY +L G
Sbjct: 180 MKERLGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCG 218

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN-RDGLQGHKQWVAEVQF 136
           T+++    ++G+G F SV +  +K   G   + A ++  KKL+ RD    H++   E + 
Sbjct: 3   TDEYQLFEELGKGAF-SVVRRCMKIPTGQEYA-AKIINTKKLSARD----HQKLEREARI 56
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
             +L+HPN+V+L    + +G       LV++ +    L + +  R +         H I 
Sbjct: 57  CRLLKHPNIVRLHDSISEEG----FHYLVFDLVTGGELFEDIVAREY--YSEADASHCIQ 110
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---PKLSDFGLAREGPMVGHTHVSTA 253
              E + + H      +++RD K  N+LL    +    KL+DFGLA E  + G       
Sbjct: 111 QILESVNHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIE--VQGDQQAWFG 165
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
             GT GY +P+ +         D+W+ GV+LY +L G
Sbjct: 166 FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 44/237 (18%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           +DF  +  +G+G FG V K+           ++   AIKK+ R   +     ++EV  L 
Sbjct: 6   SDFEEIAVLGQGAFGQVVKAR-------NALDSRYYAIKKI-RHTEEKLSTILSEVMLLA 57
Query: 139 VLEHPNLVKLIGYCAVDGERGIQR-----------LLVYEFMLNRSLEDHLFNRAFPPLP 187
            L H  +V+   Y A    R   +            +  E+  N +L D + +       
Sbjct: 58  SLNHQYVVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 188 ---WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--- 241
              W+    I+    E L+Y+H      +I+RD K  N+ +DE+   K+ DFGLA+    
Sbjct: 116 DEYWRLFRQIL----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 242 ---------GPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEML 288
                      + G +   T+ +GT  Y A + ++ TGH   K D++S G++ +EM+
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 97/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 44  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 97  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR  + 
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 197
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G        V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 198 EMXG-------XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 29/213 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG V+++ +         E+  VAIKK+    LQ  +    E+Q + +++HPN+V
Sbjct: 48  IGNGSFGVVFQAKL--------VESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVV 95
Query: 147 KLIGYCAVDGERGIQRLL------VYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
            L  +   +G++  +  L      V E +   S       +  P L  K  ++ +L    
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL---R 152
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            LAY+H    + + +RD K  N+LLD  +   KL DFG A+   + G  +VS   + +  
Sbjct: 153 SLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNVSX--ICSRY 206
Query: 260 YAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           Y AP+ I    + T   D+WS G V+ E++ G+
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 32/228 (14%)
Query: 74  MRQATNDFSRMLKI----GEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           M  A+  FS    +    G+G F SV +  +    G   + A ++  KKL+    Q  ++
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAF-SVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLER 77
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ----RLLVYEFMLNRSLEDHLFNRAFPP 185
              E +    L+HPN+V+L           IQ      LV++ +    L + +  R F  
Sbjct: 78  ---EARICRKLQHPNIVRL--------HDSIQEESFHYLVFDLVTGGELFEDIVAREF-- 124
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP---KLSDFGLAREG 242
                  H I    E +AY H      +++R+ K  N+LL    +    KL+DFGLA E 
Sbjct: 125 YSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE- 180
Query: 243 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
             V  +       GT GY +P+ ++    +   D+W+ GV+LY +L G
Sbjct: 181 --VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFL 137
           ++++    ++G+G F SV +  +    G   + A ++  KKL+    Q  ++   E +  
Sbjct: 4   SDNYDVKEELGKGAF-SVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLER---EARIC 58
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQ----RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
             L+HPN+V+L           IQ      LV++ +    L + +  R F         H
Sbjct: 59  RKLQHPNIVRL--------HDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASH 108
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---PKLSDFGLAREGPMVGHTHV 250
            I    E +AY H      +++R+ K  N+LL    +    KL+DFGLA E   V  +  
Sbjct: 109 CIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEA 162
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
                GT GY +P+ ++    +   D+W+ GV+LY +L G
Sbjct: 163 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 87  IGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH 142
           IGEG FG V    Y S   PA         +   K    D ++  ++++ E   +   +H
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALA-----VAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 75
Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           P++VKLIG   V  E  +   ++ E      L   L  R +  L   + +      +  L
Sbjct: 76  PHIVKLIG---VITENPV--WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTAL 129
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
           AYL      + ++RD  A NVL+  N   KL DFGL+R      +   S   +    + A
Sbjct: 130 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMA 185
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEML 288
           P+ I     T+ SDVW FGV ++E+L
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 87  IGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH 142
           IGEG FG V    Y S   PA         +   K    D ++  ++++ E   +   +H
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALA-----VAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 98
Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           P++VKLIG   V  E  +   ++ E      L   L  R +  L   + +      +  L
Sbjct: 99  PHIVKLIG---VITENPV--WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTAL 152
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
           AYL      + ++RD  A NVL+  N   KL DFGL+R      +   S   +    + A
Sbjct: 153 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMA 208
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEML 288
           P+ I     T+ SDVW FGV ++E+L
Sbjct: 209 PESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 27/219 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQF 136
             +DF     +G+G FG+VY +  K           V+   +L ++G++   Q   E++ 
Sbjct: 13  TIDDFDIGRPLGKGKFGNVYLAREK--QNKFIMALKVLFKSQLEKEGVE--HQLRREIEI 68
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM----LNRSLEDH-LFNRAFPPLPWKTR 191
              L HPN++++  Y   D +R     L+ EF     L + L+ H  F+        +  
Sbjct: 69  QSHLRHPNILRMYNYFH-DRKRIY---LMLEFAPRGELYKELQKHGRFDE-------QRS 117
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
              +   A+ L Y HE    +VI+RD K  N+L+      K++DFG +   P +      
Sbjct: 118 ATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----R 170
Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
             + GT  Y  P+ IE      K D+W  GV+ YE L G
Sbjct: 171 RXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFL 137
           ++++    ++G+G F SV +  +    G   + A ++  KKL+    Q  ++   E +  
Sbjct: 5   SDNYDVKEELGKGAF-SVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLER---EARIC 59
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQ----RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
             L+HPN+V+L           IQ      LV++ +    L + +  R F         H
Sbjct: 60  RKLQHPNIVRL--------HDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASH 109
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---PKLSDFGLAREGPMVGHTHV 250
            I    E +AY H      +++R+ K  N+LL    +    KL+DFGLA E   V  +  
Sbjct: 110 CIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEA 163
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
                GT GY +P+ ++    +   D+W+ GV+LY +L G
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 40/221 (18%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG--VLEHPN 144
           +G+G +G V++         G+ +   VA+K  +    +  K W  E +     +L H N
Sbjct: 45  VGKGRYGEVWR---------GSWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHEN 92
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           ++  I           Q  L+  +    SL D+L       L   + L I+L  A GLA+
Sbjct: 93  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAH 149
Query: 205 LH-EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV----- 254
           LH E    Q    + +RD K+ N+L+ +N +  ++D GLA     V H+  +  +     
Sbjct: 150 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-----VMHSQSTNQLDVGNN 204
Query: 255 --VGTFGYAAPDYI-ETGHLTA-----KSDVWSFGVVLYEM 287
             VGT  Y AP+ + ET  +       + D+W+FG+VL+E+
Sbjct: 205 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFL 137
           ++++    ++G+G F SV +  +    G   + A ++  KKL+    Q  ++   E +  
Sbjct: 5   SDNYDVKEELGKGAF-SVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLER---EARIC 59
Query: 138 GVLEHPNLVKLIGYCAVDGERGIQ----RLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
             L+HPN+V+L           IQ      LV++ +    L + +  R F         H
Sbjct: 60  RKLQHPNIVRL--------HDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASH 109
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---PKLSDFGLAREGPMVGHTHV 250
            I    E +AY H      +++R+ K  N+LL    +    KL+DFGLA E   V  +  
Sbjct: 110 CIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEA 163
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
                GT GY +P+ ++    +   D+W+ GV+LY +L G
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 71/133 (53%), Gaps = 14/133 (10%)
Query: 164 LVYEFMLNRSL---EDHLF--NRAFPP-LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRD 217
           ++YE+M N S+   +++ F  ++ +   +P +    II       +Y+H   E  + +RD
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRD 177
Query: 218 FKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKS 275
            K SN+L+D+N R KLSDFG   E   +    +  +  GT+ +  P++   E+ +  AK 
Sbjct: 178 VKPSNILMDKNGRVKLSDFG---ESEYMVDKKIKGS-RGTYEFMPPEFFSNESSYNGAKV 233
Query: 276 DVWSFGVVLYEML 288
           D+WS G+ LY M 
Sbjct: 234 DIWSLGICLYVMF 246

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 21/206 (10%)
Query: 87  IGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH 142
           IGEG FG V    Y S   PA         +   K    D ++  ++++ E   +   +H
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMA-----VAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 450
Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           P++VKLIG   V  E  +   ++ E      L   L  R F  L   + +      +  L
Sbjct: 451 PHIVKLIG---VITENPV--WIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTAL 504
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
           AYL      + ++RD  A NVL+      KL DFGL+R      +   S   +    + A
Sbjct: 505 AYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMA 560
Query: 263 PDYIETGHLTAKSDVWSFGVVLYEML 288
           P+ I     T+ SDVW FGV ++E+L
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 113/264 (42%), Gaps = 30/264 (11%)
Query: 70  SYSEMRQATNDFSRMLK----IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ 125
           S S  ++   D  ++ +    +G G F  V          +  +   + A+K + +  L+
Sbjct: 9   SSSSWKKQAEDIKKIFEFKETLGTGAFSEV-------VLAEEKATGKLFAVKCIPKKALK 61
Query: 126 GHKQWVA-EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP 184
           G +  +  E+  L  ++H N+V L        E      LV + +    L D +  + F 
Sbjct: 62  GKESSIENEIAVLRKIKHENIVALEDIY----ESPNHLYLVMQLVSGGELFDRIVEKGF- 116
Query: 185 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLARE 241
               K    +I    + + YLH    + +++RD K  N+L    DE  +  +SDFGL++ 
Sbjct: 117 -YTEKDASTLIRQVLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK- 171
Query: 242 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPK 300
             M G   V +   GT GY AP+ +     +   D WS GV+ Y +L G     + N  K
Sbjct: 172 --MEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSK 229
Query: 301 TEQRLLEWVQQYPADSKKFGLIMD 324
             +++L+   +Y  DS  +  I D
Sbjct: 230 LFEQILK--AEYEFDSPYWDDISD 251

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G+G +G VY       AG   S    +AIK++     +  +    E+     L+H N+V
Sbjct: 16  LGKGTYGIVY-------AGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 68
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP--WKTRLHIILGAAEGLAY 204
           + +G  +   E G  ++ + E +   SL   L    + PL    +T         EGL Y
Sbjct: 69  QYLGSFS---ENGFIKIFM-EQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQILEGLKY 123
Query: 205 LHEGLEVQVIYRDFKASNVLLDE-NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           LH+    Q+++RD K  NVL++  +   K+SDFG ++   + G    +    GT  Y AP
Sbjct: 124 LHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAP 178
Query: 264 DYIETG--HLTAKSDVWSFGVVLYEMLTGR 291
           + I+ G       +D+WS G  + EM TG+
Sbjct: 179 EIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH---KQWVAEVQFLGVLEHP 143
           +G G +GSV  S+I   +G+       VAIKKL+R   Q     K+   E+  L  ++H 
Sbjct: 32  VGSGAYGSVC-SAIDKRSGEK------VAIKKLSR-PFQSEIFAKRAYRELLLLKHMQHE 83
Query: 144 NLVKLIG-YCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           N++ L+  +      R      LV  FM  ++    +    F     +   +++    +G
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFM--QTDLQKIMGLKFSE---EKIQYLVYQMLKG 138
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVSTAVVGTFG 259
           L Y+H      V++RD K  N+ ++E+   K+ DFGLAR  +  M G+       V T  
Sbjct: 139 LKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY-------VVTRW 188
Query: 260 YAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGR 291
           Y AP+ I +  H     D+WS G ++ EMLTG+
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 45/242 (18%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAE 133
           +R A+ DF  +  +G+G FG V K+           ++   AIKK+ R   +     ++E
Sbjct: 2   LRYAS-DFEEIAVLGQGAFGQVVKAR-------NALDSRYYAIKKI-RHTEEKLSTILSE 52
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQR-----------LLVYEFMLNRSLEDHLFNRA 182
           V  L  L H  +V+   Y A    R   +            +  E+  NR+L D + +  
Sbjct: 53  VXLLASLNHQYVVRY--YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSEN 110
Query: 183 FPPLP---WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA 239
                   W+    I+    E L+Y+H      +I+R+ K  N+ +DE+   K+ DFGLA
Sbjct: 111 LNQQRDEYWRLFRQIL----EALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLA 163
Query: 240 RE------------GPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYE 286
           +               + G +   T+ +GT  Y A + ++ TGH   K D +S G++ +E
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223
Query: 287 ML 288
            +
Sbjct: 224 XI 225

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IGEG FG V++  I  +  +      +   K    D ++  ++++ E   +   +HP++V
Sbjct: 18  IGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIV 74
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH 206
           KLIG   V  E  +   ++ E      L   L  R F  L   + +      +  LAYL 
Sbjct: 75  KLIG---VITENPV--WIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLE 128
Query: 207 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI 266
                + ++RD  A NVL+      KL DFGL+R      +   S   +    + AP+ I
Sbjct: 129 SK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 184
Query: 267 ETGHLTAKSDVWSFGVVLYEML 288
                T+ SDVW FGV ++E+L
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL 206

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 96/229 (41%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+  FGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLAR---- 173
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ D GLAR  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLARHTDD 177
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH---KQWVAEVQFLGVLEHP 143
           +G G +GSV  S+I   +G+       VAIKKL+R   Q     K+   E+  L  ++H 
Sbjct: 50  VGSGAYGSVC-SAIDKRSGEK------VAIKKLSRP-FQSEIFAKRAYRELLLLKHMQHE 101
Query: 144 NLVKLIG-YCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           N++ L+  +      R      LV  FM  ++    +    F     +   +++    +G
Sbjct: 102 NVIGLLDVFTPASSLRNFYDFYLVMPFM--QTDLQKIMGMEFSE---EKIQYLVYQMLKG 156
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVSTAVVGTFG 259
           L Y+H      V++RD K  N+ ++E+   K+ DFGLAR  +  M G+       V T  
Sbjct: 157 LKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY-------VVTRW 206
Query: 260 YAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGR 291
           Y AP+ I +  H     D+WS G ++ EMLTG+
Sbjct: 207 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQG      E+Q +  L+H N+V
Sbjct: 28  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIV 76
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYR 189
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 75  RQATNDFSRM-LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAE 133
           R A +DF  +  ++G G    VY+   K     GT +   + + K   D     K    E
Sbjct: 48  RDALSDFFEVESELGRGATSIVYRCKQK-----GTQKPYALKVLKKTVD----KKIVRTE 98
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           +  L  L HPN++KL        E      LV E +    L D +  + +     +    
Sbjct: 99  IGVLLRLSHPNIIKLKEIFETPTEIS----LVLELVTGGELFDRIVEKGY--YSERDAAD 152
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPKLSDFGLAREGPMVGHTHV 250
            +    E +AYLHE     +++RD K  N+L      +   K++DFGL++   +V H  +
Sbjct: 153 AVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVL 206
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
              V GT GY AP+ +       + D+WS G++ Y +L G
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ DF LAR  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDD 177
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 52/230 (22%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EG 242
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ D GLAR  + 
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLARHTDD 177
Query: 243 PMVGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            M G+       V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 178 EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 24/242 (9%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH---KQWVAE 133
             +DF     +G+G FG+VY +  K +         +VA+K L +  ++      Q   E
Sbjct: 21  TIDDFEIGRPLGKGKFGNVYLAREKKSH-------FIVALKVLFKSQIEKEGVEHQLRRE 73
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           ++    L HPN+++L  Y   D  R     L+ E+     L   L          +    
Sbjct: 74  IEIQAHLHHPNILRLYNY-FYDRRRI---YLILEYAPRGELYKELQKSC--TFDEQRTAT 127
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
           I+   A+ L Y H     +VI+RD K  N+LL      K++DFG +   P +        
Sbjct: 128 IMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLR----RKT 180
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLER-NRPKTEQRLLEWVQQY 312
           + GT  Y  P+ IE      K D+W  GV+ YE+L G    E  +  +T +R+++   ++
Sbjct: 181 MCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKF 240
Query: 313 PA 314
           PA
Sbjct: 241 PA 242

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 30/225 (13%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNL 145
           +G G FG V  ++    +  G S    V + K   D  +  +  ++E++ +  L  H N+
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-REALMSELKMMTQLGSHENI 111
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR---------------------AFP 184
           V L+G C + G       L++E+     L ++L ++                        
Sbjct: 112 VNLLGACTLSG----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 185 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
            L ++  L      A+G+ +L        ++RD  A NVL+      K+ DFGLAR+   
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
             +  V         + AP+ +  G  T KSDVWS+G++L+E+ +
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 25/209 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH--KQWVAEVQFLGVLEHPN 144
           +G+G FG V K   +    +        A+K +N+   +       + EV+ L  L+HPN
Sbjct: 30  LGKGSFGEVLKCKDRITQQE-------YAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           ++KL        E      +V E      L D +  R            II     G+ Y
Sbjct: 83  IMKLFEIL----EDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITY 136
Query: 205 LHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           +H+     +++RD K  N+LL+   ++   K+ DFGL+               +GT  Y 
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYI 190
Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           AP+ +  G    K DVWS GV+LY +L+G
Sbjct: 191 APEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 36/217 (16%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPN 144
           K+G G FG V+         +  S      IK +N+D  Q   +Q  AE++ L  L+HPN
Sbjct: 29  KLGSGAFGDVHLV-------EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 145 LVKLI--------GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           ++K+          Y  ++   G +       +L R +      +A         +  ++
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGE-------LLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN--FRP-KLSDFGLAREGPMVGHTHVSTA 253
            A   LAY H      V+++D K  N+L  +     P K+ DFGLA    +      ST 
Sbjct: 135 NA---LAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHSTN 185
Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
             GT  Y AP+  +   +T K D+WS GVV+Y +LTG
Sbjct: 186 AAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTG 221

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 96/229 (41%), Gaps = 50/229 (21%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLG 138
           +  +  +G G +GSV        A   T     VA+KKL+R    +   K+   E++ L 
Sbjct: 24  YQNLSPVGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLED--------HLFNRAFPPLPWKT 190
            ++H N++ L+                  F   RSLE+        HL       +    
Sbjct: 77  HMKHENVIGLLDV----------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 191 RL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           +L       +I     GL Y+H      +I+RD K SN+ ++E+   K+ D GLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLAR---- 173
Query: 245 VGHTHVS-TAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
             HT    T  V T  Y AP+  +   H     D+WS G ++ E+LTGR
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/123 (36%), Positives = 61/123 (49%), Gaps = 14/123 (11%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRP--KLSDFGLAREGPMVGHTHVSTAVVGTF 258
           G++Y H    +Q+ +RD K  N LLD +  P  K+ DFG ++    V H+    + VGT 
Sbjct: 128 GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VLHSQ-PKSTVGTP 181
Query: 259 GYAAPDYIETGHLTAK-SDVWSFGVVLYEMLTGRRSLE-----RNRPKTEQRLLEWVQQY 312
            Y AP+ +       K +DVWS GV LY ML G    E     R+  KT QR+L      
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI 241
Query: 313 PAD 315
           P D
Sbjct: 242 PDD 244

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 100/239 (41%), Gaps = 24/239 (10%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQF 136
           ++DF     +GEG +G V  ++ KP          +VAIKK+   D      + + E++ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTG-------EIVAIKKIEPFDKPLFALRTLREIKI 62
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           L   +H N++ +      D       + + + ++   L   +  +    L      + I 
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM---LSDDHIQYFIY 119
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--------EGPMVGHT 248
                +  LH      VI+RD K SN+L++ N   K+ DFGLAR             G  
Sbjct: 120 QTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 306
              T  V T  Y AP+ + T    +++ DVWS G +L E+   RR +   R    Q LL
Sbjct: 177 SGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLL 234

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 100/239 (41%), Gaps = 24/239 (10%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQF 136
           ++DF     +GEG +G V  ++ KP          +VAIKK+   D      + + E++ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTG-------EIVAIKKIEPFDKPLFALRTLREIKI 62
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           L   +H N++ +      D       + + + ++   L   +  +    L      + I 
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM---LSDDHIQYFIY 119
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--------EGPMVGHT 248
                +  LH      VI+RD K SN+L++ N   K+ DFGLAR             G  
Sbjct: 120 QTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 306
              T  V T  Y AP+ + T    +++ DVWS G +L E+   RR +   R    Q LL
Sbjct: 177 SGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLL 234

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 21/174 (12%)
Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKT 190
            E++ L  L HP ++K+  +   D E      +V E M    L D +  N+       K 
Sbjct: 64  TEIEILKKLNHPCIIKIKNF--FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGH 247
             + +L A +   YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G 
Sbjct: 119 YFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGE 169
Query: 248 THVSTAVVGTFGYAAPDY---IETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 298
           T +   + GT  Y AP+    + T       D WS GV+L+  L+G      +R
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 21/177 (11%)
Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKT 190
            E++ L  L HP ++K+  +   D E      +V E M    L D +  N+       K 
Sbjct: 63  TEIEILKKLNHPCIIKIKNF--FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKL 117
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGH 247
             + +L A +   YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G 
Sbjct: 118 YFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGE 168
Query: 248 THVSTAVVGTFGYAAPDY---IETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 301
           T +   + GT  Y AP+    + T       D WS GV+L+  L+G      +R + 
Sbjct: 169 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 225

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQG      E+Q +  L+H N+V
Sbjct: 28  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIV 76
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYR 189
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQG      E+Q +  L+H N+V
Sbjct: 28  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIV 76
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYR 189
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 62  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 110
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 170 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYR 223
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 21/177 (11%)
Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKT 190
            E++ L  L HP ++K+  +   D E      +V E M    L D +  N+       K 
Sbjct: 64  TEIEILKKLNHPCIIKIKNF--FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGH 247
             + +L A +   YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G 
Sbjct: 119 YFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGE 169
Query: 248 THVSTAVVGTFGYAAPDY---IETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 301
           T +   + GT  Y AP+    + T       D WS GV+L+  L+G      +R + 
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 21/177 (11%)
Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKT 190
            E++ L  L HP ++K+  +   D E      +V E M    L D +  N+       K 
Sbjct: 64  TEIEILKKLNHPCIIKIKNF--FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGH 247
             + +L A +   YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G 
Sbjct: 119 YFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGE 169
Query: 248 THVSTAVVGTFGYAAPDY---IETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 301
           T +   + GT  Y AP+    + T       D WS GV+L+  L+G      +R + 
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           G  YLH     +VI+RD K  N+ L+E+   K+ DFGLA +    G       + GT  Y
Sbjct: 151 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNY 205
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
            AP+ +     + + DVWS G ++Y +L G+   E
Sbjct: 206 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           G  YLH     +VI+RD K  N+ L+E+   K+ DFGLA +    G       + GT  Y
Sbjct: 153 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNY 207
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
            AP+ +     + + DVWS G ++Y +L G+   E
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 21/174 (12%)
Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKT 190
            E++ L  L HP ++K+  +   D E      +V E M    L D +  N+       K 
Sbjct: 70  TEIEILKKLNHPCIIKIKNF--FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKL 124
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGH 247
             + +L A +   YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G 
Sbjct: 125 YFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGE 175
Query: 248 THVSTAVVGTFGYAAPDY---IETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 298
           T +   + GT  Y AP+    + T       D WS GV+L+  L+G      +R
Sbjct: 176 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 229

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           G  YLH     +VI+RD K  N+ L+E+   K+ DFGLA +    G       + GT  Y
Sbjct: 133 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNY 187
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
            AP+ +     + + DVWS G ++Y +L G+   E
Sbjct: 188 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           G  YLH     +VI+RD K  N+ L+E+   K+ DFGLA +    G       + GT  Y
Sbjct: 129 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNY 183
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
            AP+ +     + + DVWS G ++Y +L G+   E
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           G  YLH     +VI+RD K  N+ L+E+   K+ DFGLA +    G       + GT  Y
Sbjct: 129 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNY 183
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
            AP+ +     + + DVWS G ++Y +L G+   E
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 33/228 (14%)
Query: 74  MRQATNDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           ++    D+  +  IG G FG V    +K+S K           V A+K L++  +     
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQK-----------VYAMKLLSKFEMIKRSD 118
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPL 186
              +  E   +     P +V+L  +CA   ++ +   +V E+M    L + + N   P  
Sbjct: 119 SAFFWEERDIMAFANSPWVVQL--FCAFQDDKYL--YMVMEYMPGGDLVNLMSNYDVPE- 173
Query: 187 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
            W          AE +  L     + +I+RD K  N+LLD++   KL+DFG   +    G
Sbjct: 174 KWAK-----FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 228
Query: 247 HTHVSTAVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTG 290
             H  TA VGT  Y +P+ +++    G+   + D WS GV L+EML G
Sbjct: 229 MVHCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 40  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 88
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 148 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYR 201
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 28/242 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           + R+ K+G G +G V     K      T     + I +        + + + EV  L +L
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKV-----THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAA 199
           +HPN++KL  +     E      LV E      L D + +R  F  +       II    
Sbjct: 94  DHPNIMKLYDFF----EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---IIKQVL 146
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRP---KLSDFGLAREGPMVGHTHVSTAVVG 256
            G+ YLH+     +++RD K  N+LL+   +    K+ DFGL+    +  +       +G
Sbjct: 147 SGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLS---AVFENQKKMKERLG 200
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ--QYPA 314
           T  Y AP+ +   +   K DVWS GV+L+ +L G         +T+Q +L  V+  +Y  
Sbjct: 201 TAYYIAPEVLRKKY-DEKCDVWSIGVILFILLAGYPPF---GGQTDQEILRKVEKGKYTF 256
Query: 315 DS 316
           DS
Sbjct: 257 DS 258

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           G  YLH     +VI+RD K  N+ L+E+   K+ DFGLA +    G       + GT  Y
Sbjct: 127 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNY 181
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
            AP+ +     + + DVWS G ++Y +L G+   E
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 47  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 95
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 154
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 155 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYR 208
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 209 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 62  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 110
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 170 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYR 223
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 102/237 (43%), Gaps = 29/237 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAE 133
             NDFS    IG GGFG VY                + A+K L++  +   QG    + E
Sbjct: 186 TMNDFSVHRIIGRGGFGEVYGCR-------KADTGKMYAMKCLDKKRIKMKQGETLALNE 238
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
              L ++   +   ++  C         +L  + + M    L  HL           +  
Sbjct: 239 RIMLSLVSTGDCPFIV--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-----FSEA 291
Query: 193 HIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
            +   AAE   GL ++H      V+YRD K +N+LLDE+   ++SD GLA +        
Sbjct: 292 DMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS----KK 344
Query: 250 VSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
              A VGT GY AP+ ++ G    + +D +S G +L+++L G     +++ K +  +
Sbjct: 345 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 401

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 36  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 84
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 143
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 144 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYR 197
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 198 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 102/237 (43%), Gaps = 29/237 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAE 133
             NDFS    IG GGFG VY                + A+K L++  +   QG    + E
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCR-------KADTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
              L ++   +   ++  C         +L  + + M    L  HL           +  
Sbjct: 240 RIMLSLVSTGDCPFIV--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-----FSEA 292
Query: 193 HIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
            +   AAE   GL ++H      V+YRD K +N+LLDE+   ++SD GLA +        
Sbjct: 293 DMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS----KK 345
Query: 250 VSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
              A VGT GY AP+ ++ G    + +D +S G +L+++L G     +++ K +  +
Sbjct: 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 84/192 (43%), Gaps = 30/192 (15%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRP--KLSDFGLAREGPMVGHTHVSTAVVGTF 258
           G++Y H    +QV +RD K  N LLD +  P  K++DFG ++    V H+   +AV GT 
Sbjct: 127 GVSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKAS--VLHSQPKSAV-GTP 180
Query: 259 GYAAPDYIETGHLTAK-SDVWSFGVVLYEMLTGRRSLE-----RNRPKTEQRLL------ 306
            Y AP+ +       K +DVWS GV LY ML G    E     +N  KT  R+L      
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAI 240
Query: 307 -EWVQQYPADSKKFGLIMDPRLEKEYSINEARK---------IGRLADNCLSKSSKDRPK 356
            ++V   P        I      K  SI E R             + DN ++    +  +
Sbjct: 241 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQ 300
Query: 357 MSQVVERLKQIV 368
             Q +E + QI+
Sbjct: 301 PGQSIEEIMQII 312

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 28/160 (17%)
Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           HP+++ LI       E      LV++ M    L D+L  +    L  K    I+    E 
Sbjct: 159 HPHIITLID----SYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEA 212
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA-----VVG 256
           +++LH      +++RD K  N+LLD+N + +LSDFG +         H+        + G
Sbjct: 213 VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFS--------CHLEPGEKLRELCG 261
Query: 257 TFGYAAPDYIETGH------LTAKSDVWSFGVVLYEMLTG 290
           T GY AP+ ++            + D+W+ GV+L+ +L G
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 56  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 104
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 163
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 164 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYR 217
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 218 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 112/244 (45%), Gaps = 32/244 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK-LNRDGLQGHK-QWVAEVQFLG 138
           + ++ KIG+G FG V+K+  +            VA+KK L  +  +G     + E++ L 
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQK-------VALKKVLMENEKEGFPITALREIKILQ 72
Query: 139 VLEHPNLVKLIGYCAVDGE-----RGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKT 190
           +L+H N+V LI  C          +G    LV++F    L   L + L       +  K 
Sbjct: 73  LLKHENVVNLIEICRTKASPYNRCKG-SIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KR 129
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            + ++L    GL Y+H     ++++RD KA+NVL+  +   KL+DFGLAR   +  ++  
Sbjct: 130 VMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 251 STAV--VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 307
           +     V T  Y  P+  +         D+W  G ++ EM T    ++ N   TEQ  L 
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN---TEQHQLA 240
Query: 308 WVQQ 311
            + Q
Sbjct: 241 LISQ 244

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 102/237 (43%), Gaps = 29/237 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAE 133
             NDFS    IG GGFG VY                + A+K L++  +   QG    + E
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCR-------KADTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
              L ++   +   ++  C         +L  + + M    L  HL           +  
Sbjct: 240 RIMLSLVSTGDCPFIV--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-----FSEA 292
Query: 193 HIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
            +   AAE   GL ++H      V+YRD K +N+LLDE+   ++SD GLA +        
Sbjct: 293 DMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS----KK 345
Query: 250 VSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
              A VGT GY AP+ ++ G    + +D +S G +L+++L G     +++ K +  +
Sbjct: 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 102/237 (43%), Gaps = 29/237 (12%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAE 133
             NDFS    IG GGFG VY                + A+K L++  +   QG    + E
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCR-------KADTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
              L ++   +   ++  C         +L  + + M    L  HL           +  
Sbjct: 240 RIMLSLVSTGDCPFIV--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-----FSEA 292
Query: 193 HIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
            +   AAE   GL ++H      V+YRD K +N+LLDE+   ++SD GLA +        
Sbjct: 293 DMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS----KK 345
Query: 250 VSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL 305
              A VGT GY AP+ ++ G    + +D +S G +L+++L G     +++ K +  +
Sbjct: 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 64  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 112
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 171
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 172 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYR 225
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 226 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 40  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 88
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 148 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYR 201
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 41  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 89
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 148
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 149 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYR 202
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 203 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 66  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 114
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 173
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 174 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYR 227
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 228 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           +G+ YLH     +VI+RD K  N+ L+++   K+ DFGLA +    G       + GT  
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKTLCGTPN 207
Query: 260 YAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
           Y AP+ + + GH + + D+WS G +LY +L G+   E
Sbjct: 208 YIAPEVLCKKGH-SFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 87  IGEGGFGSV---YKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLGVLE 141
           +G G +GSV   Y + ++            VA+KKL+R    L   ++   E++ L  L+
Sbjct: 36  VGSGAYGSVCSAYDARLRQK----------VAVKKLSRPFQSLIHARRTYRELRLLKHLK 85
Query: 142 HPNLVKLIG-YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           H N++ L+  +           + +   ++   L + + ++A      +  ++ +L    
Sbjct: 86  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLL---R 142
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           GL Y+H      +I+RD K SNV ++E+   ++ DFGLAR+          T  V T  Y
Sbjct: 143 GLKYIHSA---GIIHRDLKPSNVAVNEDSELRILDFGLARQA-----DEEMTGYVATRWY 194
Query: 261 AAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+  +   H     D+WS G ++ E+L G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 82/192 (42%), Gaps = 30/192 (15%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRP--KLSDFGLAREGPMVGHTHVSTAVVGTF 258
           G++Y H    +QV +RD K  N LLD +  P  K+ DFG ++    V H+    + VGT 
Sbjct: 127 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VLHSQ-PKSTVGTP 180
Query: 259 GYAAPDYIETGHLTAK-SDVWSFGVVLYEMLTGRRSLE-----RNRPKTEQRLL------ 306
            Y AP+ +       K +DVWS GV LY ML G    E     +N  KT  R+L      
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAI 240
Query: 307 -EWVQQYPADSKKFGLIMDPRLEKEYSINEARK---------IGRLADNCLSKSSKDRPK 356
            ++V   P        I      K  SI E R             + DN ++    +  +
Sbjct: 241 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQ 300
Query: 357 MSQVVERLKQIV 368
             Q +E + QI+
Sbjct: 301 PGQSIEEIMQII 312

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 48/235 (20%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLGVLEHPN 144
           IG G +G V ++  K        E  VVAIKK+ R  + L   K+ + E+  L  L H +
Sbjct: 61  IGTGSYGHVCEAYDK-------LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 145 LVKLIGYCAV-DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI---ILGAAE 200
           +VK++      D E+  +  +V E      + D  F + F    + T LHI   +     
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLE------IADSDFKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--EGPMVGHTHVS------- 251
           G+ Y+H      +++RD K +N L++++   K+ DFGLAR  + P  G++ +        
Sbjct: 168 GVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 252 ----------------TAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLT 289
                           T  V T  Y AP+ I    + T   DVWS G +  E+L 
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 25/215 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH--KQWVAEVQFLG 138
           ++ +  +G+G FG V K   +    +        A+K +N+   +       + EV+ L 
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQE-------YAVKVINKASAKNKDTSTILREVELLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            L+HPN++KL        E      +V E      L D +  R            II   
Sbjct: 77  KLDHPNIMKLFEIL----EDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQV 130
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
             G+ Y+H+     +++RD K  N+LL+   ++   K+ DFGL+               +
Sbjct: 131 FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRI 184
Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           GT  Y AP+ +  G    K DVWS GV+LY +L+G
Sbjct: 185 GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G +G VYK+  K        +    A+K++   G+        E+  L  L+HPN+
Sbjct: 28  KVGRGTYGHVYKAKRK-----DGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNV 80
Query: 146 VKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRA------FPPLPWKTRLHIILGA 198
           + L        +R +  L  Y E  L   ++ H  ++A       P    K+ L+ IL  
Sbjct: 81  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL-- 138
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAR--EGPMVGHTHVST 252
            +G+ YLH      V++RD K +N+L+     E  R K++D G AR    P+     +  
Sbjct: 139 -DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 253 AVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTG 290
            VV TF Y AP+ +    H T   D+W+ G +  E+LT 
Sbjct: 195 VVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 124/298 (41%), Gaps = 53/298 (17%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           DF  +  IG GGFG V+K+  +    DG +      IK++  +  +  +    EV+ L  
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRI---DGKT----YVIKRVKYNNEKAER----EVKALAK 60
Query: 140 LEHPNLVKLIG----------YCAVDGERGIQRLLV--YEFMLNRSLEDHLFNRAFPPLP 187
           L+H N+V   G            + +  R   + L    EF    +LE  +  R    L 
Sbjct: 61  LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
               L +     +G+ Y+H     ++I RD K SN+ L +  + K+ DFGL       G 
Sbjct: 121 KVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML-TGRRSLERNRPKTEQRLL 306
              S    GT  Y +P+ I +     + D+++ G++L E+L     + E ++  T+ R  
Sbjct: 178 RXRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR-- 232
Query: 307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 364
                        G+I D   +KE +         L    LSK  +DRP  S+++  L
Sbjct: 233 ------------DGIISDIFDKKEKT---------LLQKLLSKKPEDRPNTSEILRTL 269

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 112/244 (45%), Gaps = 32/244 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK-LNRDGLQGHK-QWVAEVQFLG 138
           + ++ KIG+G FG V+K+  +            VA+KK L  +  +G     + E++ L 
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQK-------VALKKVLMENEKEGFPITALREIKILQ 71
Query: 139 VLEHPNLVKLIGYCAVDGE-----RGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKT 190
           +L+H N+V LI  C          +G    LV++F    L   L + L       +  K 
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCKG-SIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KR 128
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            + ++L    GL Y+H     ++++RD KA+NVL+  +   KL+DFGLAR   +  ++  
Sbjct: 129 VMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 251 STAV--VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 307
           +     V T  Y  P+  +         D+W  G ++ EM T    ++ N   TEQ  L 
Sbjct: 183 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN---TEQHQLA 239
Query: 308 WVQQ 311
            + Q
Sbjct: 240 LISQ 243

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 107 IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 155
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 214
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 215 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYR 268
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 269 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 28  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-----FNRAFPPLPWKTRLHIILGAAEG 201
           +L  +    GE+  + ++    +L+   E        ++RA   LP       +      
Sbjct: 77  RLRYFFYSSGEK--KDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           LAY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYY 188
Query: 261 AAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+ I      T+  DVWS G VL E+L G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 87  IGEGGFGSV---YKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLGVLE 141
           +G G +GSV   Y + ++            VA+KKL+R    L   ++   E++ L  L+
Sbjct: 28  VGSGAYGSVCSAYDARLRQK----------VAVKKLSRPFQSLIHARRTYRELRLLKHLK 77
Query: 142 HPNLVKLIG-YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           H N++ L+  +           + +   ++   L + +  +A      +  ++ +L    
Sbjct: 78  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL---R 134
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           GL Y+H      +I+RD K SNV ++E+   ++ DFGLAR+          T  V T  Y
Sbjct: 135 GLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQA-----DEEMTGYVATRWY 186
Query: 261 AAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+  +   H     D+WS G ++ E+L G+
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 28  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYR 189
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 25/215 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH--KQWVAEVQFLG 138
           ++ +  +G+G FG V K   +    +        A+K +N+   +       + EV+ L 
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQE-------YAVKVINKASAKNKDTSTILREVELLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            L+HPN++KL        E      +V E      L D +  R            II   
Sbjct: 77  KLDHPNIMKLFEIL----EDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQV 130
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
             G+ Y+H+     +++RD K  N+LL+   ++   K+ DFGL+               +
Sbjct: 131 FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRI 184
Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           GT  Y AP+ +  G    K DVWS GV+LY +L+G
Sbjct: 185 GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 29  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 77
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 136
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 137 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYR 190
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 33  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 81
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 140
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 141 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYR 194
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 195 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 28  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYR 189
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 21/177 (11%)
Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKT 190
            E++ L  L HP ++K+  +   D E      +V E M    L D +  N+       K 
Sbjct: 189 TEIEILKKLNHPCIIKIKNF--FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKL 243
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGH 247
             + +L A +   YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G 
Sbjct: 244 YFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGE 294
Query: 248 THVSTAVVGTFGYAAPDY---IETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 301
           T +   + GT  Y AP+    + T       D WS GV+L+  L+G      +R + 
Sbjct: 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 112/244 (45%), Gaps = 32/244 (13%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK-LNRDGLQGHK-QWVAEVQFLG 138
           + ++ KIG+G FG V+K+  +            VA+KK L  +  +G     + E++ L 
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQK-------VALKKVLMENEKEGFPITALREIKILQ 72
Query: 139 VLEHPNLVKLIGYCAVDGE-----RGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKT 190
           +L+H N+V LI  C          +G    LV++F    L   L + L       +  K 
Sbjct: 73  LLKHENVVNLIEICRTKASPYNRCKG-SIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KR 129
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            + ++L    GL Y+H     ++++RD KA+NVL+  +   KL+DFGLAR   +  ++  
Sbjct: 130 VMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 251 STAV--VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 307
           +     V T  Y  P+  +         D+W  G ++ EM T    ++ N   TEQ  L 
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN---TEQHQLA 240
Query: 308 WVQQ 311
            + Q
Sbjct: 241 LISQ 244

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           +G+ YLH     +VI+RD K  N+ L+++   K+ DFGLA +    G       + GT  
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPN 207
Query: 260 YAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
           Y AP+ + + GH + + D+WS G +LY +L G+   E
Sbjct: 208 YIAPEVLCKKGH-SFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 21/177 (11%)
Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKT 190
            E++ L  L HP ++K+  +   D E      +V E M    L D +  N+       K 
Sbjct: 203 TEIEILKKLNHPCIIKIKNF--FDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCKL 257
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGH 247
             + +L A +   YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G 
Sbjct: 258 YFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGE 308
Query: 248 THVSTAVVGTFGYAAPDY---IETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 301
           T +   + GT  Y AP+    + T       D WS GV+L+  L+G      +R + 
Sbjct: 309 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 365

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 30/243 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK-LNRDGLQGHK-QWVAEVQFLG 138
           + ++ KIG+G FG V+K+  +            VA+KK L  +  +G     + E++ L 
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQK-------VALKKVLMENEKEGFPITALREIKILQ 72
Query: 139 VLEHPNLVKLIGYCAVDGER----GIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTR 191
           +L+H N+V LI  C               LV++F    L   L + L       +  K  
Sbjct: 73  LLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRV 130
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
           + ++L    GL Y+H     ++++RD KA+NVL+  +   KL+DFGLAR   +  ++  +
Sbjct: 131 MQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 252 TAV--VGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW 308
                V T  Y  P+  +         D+W  G ++ EM T    ++ N   TEQ  L  
Sbjct: 185 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN---TEQHQLAL 241
Query: 309 VQQ 311
           + Q
Sbjct: 242 ISQ 244

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 32  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 80
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 139
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 140 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYR 193
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 194 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 32/219 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   E  V AIKKL+R    Q H K+   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVV------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFM---LNRSLEDHLFNRAFPPLPWKTR 191
           V+ H N++ L+       ++ ++      +V E M   L++ ++  L +     L ++  
Sbjct: 79  VVNHKNIIGLLNVFT--PQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
           +        G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + 
Sbjct: 137 V--------GIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMM 182
Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           T  V T  Y AP+ I         D+WS GV++ EM+ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G FG VY++ +            +VAIKK+    LQ  +    E+Q +  L+H N+V
Sbjct: 28  IGNGSFGVVYQAKL-------CDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 147 KLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           +L  +    GE+     +  +L Y       +  H ++RA   LP       +      L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           AY+H      + +RD K  N+LLD +    KL DFG A++  + G  +VS   + +  Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVS--YICSRYYR 189
Query: 262 APDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ I      T+  DVWS G VL E+L G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 100/236 (42%), Gaps = 27/236 (11%)
Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQ 135
           Q T+ +     IG G + SV K  I  A      E  V  I K  RD  +       E++
Sbjct: 19  QFTDGYEVKEDIGVGSY-SVCKRCIHKAT---NMEFAVKIIDKSKRDPTE-------EIE 67
Query: 136 -FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
             L   +HPN++ L        + G    +V E M    L D +  + F     +    +
Sbjct: 68  ILLRYGQHPNIITLKDVY----DDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAV 121
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVL-LDENFRP---KLSDFGLAREGPMVGHTHV 250
           +    + + YLH      V++RD K SN+L +DE+  P   ++ DFG A++  +     +
Sbjct: 122 LFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAENGL 176
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 306
                 T  + AP+ +E     A  D+WS GV+LY MLTG          T + +L
Sbjct: 177 LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 18/155 (11%)
Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           HPN+++L        E      LV++ M    L D+L  +    L  K    I+    E 
Sbjct: 83  HPNIIQLKD----TYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEV 136
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           +  LH+   + +++RD K  N+LLD++   KL+DFG + +   +       +V GT  Y 
Sbjct: 137 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLRSVCGTPSYL 190
Query: 262 APDYIETGH------LTAKSDVWSFGVVLYEMLTG 290
           AP+ IE            + D+WS GV++Y +L G
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 99/239 (41%), Gaps = 24/239 (10%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQF 136
           ++DF     +GEG +G V  ++ KP          +VAIKK+   D      + + E++ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTG-------EIVAIKKIEPFDKPLFALRTLREIKI 62
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           L   +H N++ +      D       + + + ++   L   +  +    L      + I 
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM---LSDDHIQYFIY 119
Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--------EGPMVGHT 248
                +  LH      VI+RD K SN+L++ N   K+ DFGLAR             G  
Sbjct: 120 QTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 306
                 V T  Y AP+ + T    +++ DVWS G +L E+   RR +   R    Q LL
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLL 234

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           +G+ YLH     +VI+RD K  N+ L+++   K+ DFGLA +    G       + GT  
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPN 207
Query: 260 YAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
           Y AP+ + + GH + + D+WS G +LY +L G+   E
Sbjct: 208 YIAPEVLCKKGH-SFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 32/219 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   E  V AIKKL+R    Q H K+   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFM---LNRSLEDHLFNRAFPPLPWKTR 191
           V+ H N++ L+       ++ ++      +V E M   L++ ++  L +     L ++  
Sbjct: 79  VVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
           +        G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + 
Sbjct: 137 V--------GIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMM 182
Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           T  V T  Y AP+ I         D+WS GV++ EM+ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           +G+ YLH     +VI+RD K  N+ L+++   K+ DFGLA +    G       + GT  
Sbjct: 137 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPN 191
Query: 260 YAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
           Y AP+ + + GH + + D+WS G +LY +L G+   E
Sbjct: 192 YIAPEVLCKKGH-SFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 40/185 (21%)
Query: 192 LHIILGAAEGLAYLH-EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--------- 241
           LHI +  AE + +LH +GL    ++RD K SN+    +   K+ DFGL            
Sbjct: 167 LHIFIQIAEAVEFLHSKGL----MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 242 --GPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML-TGRRSLERN 297
              PM  + TH     VGT  Y +P+ I   + + K D++S G++L+E+L +    +ER 
Sbjct: 223 VLTPMPAYATHXGQ--VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV 280
Query: 298 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 357
           R  T+ R L           KF L+   +  +E+          +  + LS S  +RP+ 
Sbjct: 281 RIITDVRNL-----------KFPLLFTQKYPQEH---------MMVQDMLSPSPTERPEA 320
Query: 358 SQVVE 362
           + ++E
Sbjct: 321 TDIIE 325

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 87  IGEGGFGSV---YKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLGVLE 141
           +G G +GSV   Y + ++            VA+KKL+R    L   ++   E++ L  L+
Sbjct: 36  VGSGAYGSVCSAYDARLRQK----------VAVKKLSRPFQSLIHARRTYRELRLLKHLK 85
Query: 142 HPNLVKLIG-YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           H N++ L+  +           + +   ++   L + +  +A      +  ++ +L    
Sbjct: 86  HENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL---R 142
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           GL Y+H      +I+RD K SNV ++E+   ++ DFGLAR+          T  V T  Y
Sbjct: 143 GLKYIHSA---GIIHRDLKPSNVAVNEDSELRILDFGLARQA-----DEEMTGYVATRWY 194
Query: 261 AAPD-YIETGHLTAKSDVWSFGVVLYEMLTGR 291
            AP+  +   H     D+WS G ++ E+L G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G GG G V+      +A D   +  V AIKK+     Q  K  + E++ +  L+H N+V
Sbjct: 19  LGCGGNGLVF------SAVDNDCDKRV-AIKKIVLTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 147 KLIGYCAVDGER-----GIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAA 199
           K+       G +     G    L   +++   +E  L N     P L    RL  +    
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-FMYQLL 130
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAR-EGPMVGHT-HVSTAVVG 256
            GL Y+H      V++RD K +N+ ++ E+   K+ DFGLAR   P   H  H+S  +V 
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            +  +    +   + T   D+W+ G +  EMLTG+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 18/155 (11%)
Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           HPN+++L        E      LV++ M    L D+L  +    L  K    I+    E 
Sbjct: 70  HPNIIQL----KDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEV 123
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           +  LH+   + +++RD K  N+LLD++   KL+DFG + +   +        V GT  Y 
Sbjct: 124 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSYL 177
Query: 262 APDYIETGH------LTAKSDVWSFGVVLYEMLTG 290
           AP+ IE            + D+WS GV++Y +L G
Sbjct: 178 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 85/194 (43%), Gaps = 34/194 (17%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRP--KLSDFGLAREGPMVGHTHVSTAVVGTF 258
           G++Y H    +QV +RD K  N LLD +  P  K+ DFG ++    V H+    + VGT 
Sbjct: 126 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VLHSQ-PKSTVGTP 179
Query: 259 GYAAPDYIETGHLTAK-SDVWSFGVVLYEMLTGRRSLE-----RNRPKTEQRLL------ 306
            Y AP+ +       K +DVWS GV LY ML G    E     +N  KT  R+L      
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAI 239
Query: 307 -EWVQQYPADSKKFGLIMDPRLEKEYSINEARK---------IGRLADNCLSK--SSKDR 354
            ++V   P        I      K  SI E R             + DN ++   ++ D+
Sbjct: 240 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFAASDQ 299
Query: 355 PKMSQVVERLKQIV 368
           P   Q +E + QI+
Sbjct: 300 P--GQSIEEIMQII 311

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +KIGEG  G V  +  K +          VA+K ++    Q  +    EV  +   +H N
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQ-------VAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +V++     V    G +  ++ EF+   +L D +           T    +L A   LAY
Sbjct: 104 VVEMYKSYLV----GEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQA---LAY 156
Query: 205 LH-EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           LH +G    VI+RD K+ ++LL  + R KLSDFG   +  +         +VGT  + AP
Sbjct: 157 LHAQG----VIHRDIKSDSILLTLDGRVKLSDFGFCAQ--ISKDVPKRKXLVGTPYWMAP 210
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTG 290
           + I       + D+WS G+++ EM+ G
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 18/155 (11%)
Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           HPN+++L        E      LV++ M    L D+L  +    L  K    I+    E 
Sbjct: 83  HPNIIQL----KDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEV 136
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           +  LH+   + +++RD K  N+LLD++   KL+DFG + +   +        V GT  Y 
Sbjct: 137 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSYL 190
Query: 262 APDYIETGH------LTAKSDVWSFGVVLYEMLTG 290
           AP+ IE            + D+WS GV++Y +L G
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V++ + + A G+  +   V+   + +++ ++       E+Q + VL HP L
Sbjct: 58  ELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVR------KEIQTMSVLRHPTL 110
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V L      D E     +++YEFM    L + + +     +     +  +    +GL ++
Sbjct: 111 VNLHDAFEDDNEM----VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHM 165
Query: 206 HEGLEVQVIYRDFKASNVLLD--ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           HE      ++ D K  N++     +   KL DFGL           V+T   GT  +AAP
Sbjct: 166 HEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAP 219
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +  E   +   +D+WS GV+ Y +L+G
Sbjct: 220 EVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 22/229 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG+G F SV +  I    G   +   V   K  +  GL   +    E     +L+HP++V
Sbjct: 32  IGKGPF-SVVRRCINRETGQQFAVKIVDVAKFTSSPGLST-EDLKREASICHMLKHPHIV 89
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL--HIILGAAEGLAY 204
           +L+   + DG       +V+EFM    L   +  RA     +   +  H +    E L Y
Sbjct: 90  ELLETYSSDG----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 205 LHEGLEVQVIYRDFKASNVLL--DENFRP-KLSDFGLAREGPMVGHTH-VSTAVVGTFGY 260
            H+     +I+RD K   VLL   EN  P KL  FG+A +   +G +  V+   VGT  +
Sbjct: 146 CHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ---LGESGLVAGGRVGTPHF 199
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 309
            AP+ ++        DVW  GV+L+ +L+G          T++RL E +
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY----GTKERLFEGI 244

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 22/229 (9%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG+G F SV +  I    G   +   V   K  +  GL   +    E     +L+HP++V
Sbjct: 34  IGKGPF-SVVRRCINRETGQQFAVKIVDVAKFTSSPGLST-EDLKREASICHMLKHPHIV 91
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL--HIILGAAEGLAY 204
           +L+   + DG       +V+EFM    L   +  RA     +   +  H +    E L Y
Sbjct: 92  ELLETYSSDG----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 205 LHEGLEVQVIYRDFKASNVLL--DENFRP-KLSDFGLAREGPMVGHTH-VSTAVVGTFGY 260
            H+     +I+RD K   VLL   EN  P KL  FG+A +   +G +  V+   VGT  +
Sbjct: 148 CHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ---LGESGLVAGGRVGTPHF 201
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 309
            AP+ ++        DVW  GV+L+ +L+G          T++RL E +
Sbjct: 202 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY----GTKERLFEGI 246

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLP 187
           +Q   E+  L  L+HPN+VKL+    +D        +V+E +    + +        PL 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVE--VLDDPNEDHLYMVFELVNQGPVME---VPTLKPLS 135
Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
                       +G+ YLH     ++I+RD K SN+L+ E+   K++DFG++ E    G 
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE--FKGS 190
Query: 248 THVSTAVVGTFGYAAPDYI-ETGHLTAKS--DVWSFGVVLYEMLTGR 291
             + +  VGT  + AP+ + ET  + +    DVW+ GV LY  + G+
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 123/282 (43%), Gaps = 43/282 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH---KQWVAEVQFLGVLEHP 143
           +G G +G+V       +A DG + A V AIKKL R   Q     K+   E++ L  + H 
Sbjct: 33  VGSGAYGAVC------SAVDGRTGAKV-AIKKLYR-PFQSELFAKRAYRELRLLKHMRHE 84
Query: 144 NLVKLIGYCAVDG--ERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLH-IILG 197
           N++ L+     D   +      LV  FM   L + ++             + R+  ++  
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG--------EDRIQFLVYQ 136
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
             +GL Y+H      +I+RD K  N+ ++E+   K+ DFGLAR+      + +   VV T
Sbjct: 137 MLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ----ADSEMXGXVV-T 188
Query: 258 FGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRR---------SLERNRPKTEQRLLE 307
             Y AP+ I      T   D+WS G ++ EM+TG+           L+     T     E
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248
Query: 308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSK 349
           +VQ+  +D  K  +   P LEK+   +       LA N L K
Sbjct: 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 290

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 32/219 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   E  V AIKKL+R    Q H K+   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFM---LNRSLEDHLFNRAFPPLPWKTR 191
           V+ H N++ L+       ++ ++      +V E M   L++ ++  L +     L ++  
Sbjct: 79  VVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
           +        G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + 
Sbjct: 137 V--------GIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMM 182
Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           T  V T  Y AP+ I         D+WS G ++ EM+ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 41/226 (18%)
Query: 87  IGEGGFGSVYKSSI--KPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           IG G +G+VYK S+  +P A        V      NR      K     +  + ++EH N
Sbjct: 21  IGRGRYGAVYKGSLDERPVA--------VKVFSFANRQNFINEKN----IYRVPLMEHDN 68
Query: 145 LVKLI-GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
           + + I G   V  +  ++ LLV E+  N SL  +L   +     W +   +      GLA
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLA 125
Query: 204 YLHEGL------EVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV------- 250
           YLH  L      +  + +RD  + NVL+  +    +SDFGL+    + G+  V       
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR--LTGNRLVRPGEEDN 183
Query: 251 -STAVVGTFGYAAPDYIETG-------HLTAKSDVWSFGVVLYEML 288
            + + VGT  Y AP+ +E             + D+++ G++ +E+ 
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 96/233 (41%), Gaps = 41/233 (17%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLGVLEHPN 144
           IG G +G VY       A D  +E  V AIKK+NR  + L   K+ + E+  L  L+   
Sbjct: 34  IGRGSYGYVY------LAYDKNTEKNV-AIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI---ILGAAEG 201
           +++L      D       L +        + D    + F    + T  HI   +     G
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIV-----LEIADSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS---------- 251
             ++HE     +I+RD K +N LL+++   K+ DFGLAR       T++           
Sbjct: 142 ENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 252 ----------TAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRS 293
                     T+ V T  Y AP+ I       KS D+WS G +  E+L   +S
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V++ + + A G+  +   V+   + +++ ++       E+Q + VL HP L
Sbjct: 164 ELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVR------KEIQTMSVLRHPTL 216
Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V L      D E     +++YEFM    L + + +     +     +  +    +GL ++
Sbjct: 217 VNLHDAFEDDNEM----VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHM 271
Query: 206 HEGLEVQVIYRDFKASNVLLD--ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           HE      ++ D K  N++     +   KL DFGL           V+T   GT  +AAP
Sbjct: 272 HEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAP 325
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +  E   +   +D+WS GV+ Y +L+G
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 77/190 (40%), Gaps = 26/190 (13%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           G++Y H    +QV +RD K  N LLD +  P+L           V H+    + VGT  Y
Sbjct: 127 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ-PKSTVGTPAY 182
Query: 261 AAPDYIETGHLTAK-SDVWSFGVVLYEMLTGRRSLE-----RNRPKTEQRLL-------E 307
            AP+ +       K +DVWS GV LY ML G    E     +N  KT  R+L       +
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD 242
Query: 308 WVQQYPADSKKFGLIMDPRLEKEYSINEARK---------IGRLADNCLSKSSKDRPKMS 358
           +V   P        I      K  SI E R             + DN ++    +  +  
Sbjct: 243 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPG 302
Query: 359 QVVERLKQIV 368
           Q +E + QI+
Sbjct: 303 QSIEEIMQII 312

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ--- 129
           ++R    D+  +  IG G FG V     K       S   V A+K L++  +        
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHK-------STRKVYAMKLLSKFEMIKRSDSAF 115
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
           +  E   +     P +V+L  + A   +R +   +V E+M    L + + N   P   W 
Sbjct: 116 FWEERDIMAFANSPWVVQL--FYAFQDDRYL--YMVMEYMPGGDLVNLMSNYDVPE-KW- 169
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
            R +     AE +  L     +  I+RD K  N+LLD++   KL+DFG   +    G   
Sbjct: 170 ARFY----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 250 VSTAVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTG 290
             TA VGT  Y +P+ +++    G+   + D WS GV LYEML G
Sbjct: 226 CDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 55/101 (54%), Gaps = 9/101 (8%)
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF---RPKLSDFGLAREGPMVGHT 248
           + +I    EG+ YLH+     +++ D K  N+LL   +     K+ DFG++R+   +GH 
Sbjct: 134 IRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHA 187
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
                ++GT  Y AP+ +    +T  +D+W+ G++ Y +LT
Sbjct: 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   E  V AIKKL+R    Q H K+   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFM---LNRSLEDHLFNRAFPPLPWKTR 191
           V+ H N++ L+       ++ ++      +V E M   L++ ++  L +     L ++  
Sbjct: 79  VVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
                    G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + 
Sbjct: 137 C--------GIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMM 182
Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           T  V T  Y AP+ I         D+WS G ++ EM+ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ--- 129
           ++R    D+  +  IG G FG V     K       S   V A+K L++  +        
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHK-------STRKVYAMKLLSKFEMIKRSDSAF 120
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
           +  E   +     P +V+L  + A   +R +   +V E+M    L + + N   P   W 
Sbjct: 121 FWEERDIMAFANSPWVVQL--FYAFQDDRYL--YMVMEYMPGGDLVNLMSNYDVPE-KW- 174
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
            R +     AE +  L     +  I+RD K  N+LLD++   KL+DFG   +    G   
Sbjct: 175 ARFY----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 230
Query: 250 VSTAVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTG 290
             TA VGT  Y +P+ +++    G+   + D WS GV LYEML G
Sbjct: 231 CDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ--- 129
           ++R    D+  +  IG G FG V     K       S   V A+K L++  +        
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHK-------STRKVYAMKLLSKFEMIKRSDSAF 120
Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
           +  E   +     P +V+L  + A   +R +   +V E+M    L + + N   P   W 
Sbjct: 121 FWEERDIMAFANSPWVVQL--FYAFQDDRYL--YMVMEYMPGGDLVNLMSNYDVPE-KW- 174
Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
            R +     AE +  L     +  I+RD K  N+LLD++   KL+DFG   +    G   
Sbjct: 175 ARFY----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 230
Query: 250 VSTAVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTG 290
             TA VGT  Y +P+ +++    G+   + D WS GV LYEML G
Sbjct: 231 CDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 79
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 80  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 135
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+DE    +++DFG A+   + G T    
Sbjct: 136 QIVLT----FEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKR--VKGRT---W 183
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 184 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 230

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   E  V AIKKL+R    Q H K+   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      +V E M     + +L       L  +   ++
Sbjct: 79  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYL 131
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 185
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           V T  Y AP+ I         D+WS G ++ EM+ G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          + A VGT  Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQY 198
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   E  V AIKKL+R    Q H K+   E+  + 
Sbjct: 27  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 79
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      +V E M     + +L       L  +   ++
Sbjct: 80  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYL 132
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 133 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 186
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           V T  Y AP+ I         D+WS G ++ EM+ G
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTH 249
           +I+      ++++H+   V V++RD K  N+L    ++N   K+ DFG AR  P      
Sbjct: 110 YIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            +     T  YAAP+ +         D+WS GV+LY ML+G+
Sbjct: 167 KTPCF--TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 113
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 114 RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 169
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 170 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 217
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 218 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 87
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 88  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA 143
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 144 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 191
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 192 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 238

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   E  V AIKKL+R    Q H K+   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      +V E M     + +L       L  +   ++
Sbjct: 79  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYL 131
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 185
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           V T  Y AP+ I         D+WS G ++ EM+ G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 76/190 (40%), Gaps = 26/190 (13%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           G++Y H    +QV +RD K  N LLD +  P+L           V H+      VGT  Y
Sbjct: 127 GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ-PKDTVGTPAY 182
Query: 261 AAPDYIETGHLTAK-SDVWSFGVVLYEMLTGRRSLE-----RNRPKTEQRLL-------E 307
            AP+ +       K +DVWS GV LY ML G    E     +N  KT  R+L       +
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD 242
Query: 308 WVQQYPADSKKFGLIMDPRLEKEYSINEARK---------IGRLADNCLSKSSKDRPKMS 358
           +V   P        I      K  SI E R             + DN ++    +  +  
Sbjct: 243 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPG 302
Query: 359 QVVERLKQIV 368
           Q +E + QI+
Sbjct: 303 QSIEEIMQII 312

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 94/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  IG G FG V    +  +    A     +  VV +K++           + E 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E+M    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    K++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT---W 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 97/240 (40%), Gaps = 52/240 (21%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------------ 120
           +MR    DF  +  IG G FG V    +K A         V A+K LN            
Sbjct: 68  QMRLHREDFEILKVIGRGAFGEVAVVKLKNAD-------KVFAMKILNKWEMLKRAETAC 120
Query: 121 ----RDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE 175
               RD L  G  +W+  + +    +  NL  ++ Y  V G+            L    E
Sbjct: 121 FREERDVLVNGDSKWITTLHY-AFQDDNNLYLVMDY-YVGGDL---------LTLLSKFE 169
Query: 176 DHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD 235
           D L     P    +  L  ++ A + +  LH       ++RD K  N+L+D N   +L+D
Sbjct: 170 DRL-----PEEMARFYLAEMVIAIDSVHQLH------YVHRDIKPDNILMDMNGHIRLAD 218
Query: 236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTG 290
           FG   +  M   T  S+  VGT  Y +P+ ++      G    + D WS GV +YEML G
Sbjct: 219 FGSCLK-LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 94/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  IG G FG V    +  +    A     +  VV +K++           + E 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E+M    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    K++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT---W 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTW--- 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTW--- 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   E  V AIKKL+R    Q H K+   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      +V E M     + +L       L  +   ++
Sbjct: 79  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYL 131
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPE 185
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           V T  Y AP+ I         D+WS G ++ EM+ G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTW--- 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   E  V AIKKL+R    Q H K+   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFM---LNRSLEDHLFNRAFPPLPWKTR 191
            + H N++ L+       ++ ++      +V E M   L++ ++  L +     L ++  
Sbjct: 79  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
                    G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + 
Sbjct: 137 C--------GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMM 182
Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           T  V T  Y AP+ I         D+WS G ++ EM+ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 93
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 94  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 150 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTW--- 197
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          + + VGT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +     +  SD+W+ G ++Y+++ G
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 113
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 114 RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 169
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 170 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGAT---W 217
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 218 TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL  +   D        +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 248
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 75/312 (24%), Positives = 126/312 (40%), Gaps = 68/312 (21%)
Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV 139
           DF  +  IG GGFG V+K+  +    DG +      I+++  +  +  +    EV+ L  
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRI---DGKT----YVIRRVKYNNEKAER----EVKALAK 61
Query: 140 LEHPNLVKLIGYC------------------------AVDGERGIQRLLV--YEFMLNRS 173
           L+H N+V   G C                        + +  R   + L    EF    +
Sbjct: 62  LDHVNIVHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGT 120
Query: 174 LEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL 233
           LE  +  R    L     L +     +G+ Y+H     ++I+RD K SN+ L +  + K+
Sbjct: 121 LEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKI 177
Query: 234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML-TGRR 292
            DFGL       G     T   GT  Y +P+ I +     + D+++ G++L E+L     
Sbjct: 178 GDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 234
Query: 293 SLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSK 352
           + E ++  T+ R               G+I D   +KE +         L    LSK  +
Sbjct: 235 AFETSKFFTDLR--------------DGIISDIFDKKEKT---------LLQKLLSKKPE 271
Query: 353 DRPKMSQVVERL 364
           DRP  S+++  L
Sbjct: 272 DRPNTSEILRTL 283

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K +    A     +  VV +K++           + E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL  Y   D        +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL-EYSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K +    A     +  VV +K++           + E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL  Y   D        +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL-EYSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K +    A     +  VV +K++           + E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL  Y   D        +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL-EYSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 26/216 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           + ++  IG G  G V        A   T     VA+KKL+R    Q H K+   E+  L 
Sbjct: 26  YQQLKPIGSGAQGIV-------CAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 79  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIHMELDHERMSYL 131
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR         + T  
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPY 185
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           V T  Y AP+ I      A  D+WS G ++ E++ G
Sbjct: 186 VVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 66/151 (43%), Gaps = 9/151 (5%)
Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           L+HP  VKL  +C  D E+     L +     ++ E   + R                  
Sbjct: 94  LDHPFFVKLY-FCFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 147
Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
             L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  
Sbjct: 148 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           Y +P+ +        SD+W+ G ++Y+++ G
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 52/201 (25%)
Query: 185 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--- 241
           P+  +  +      A G+ +L      + I+RD  A N+LL EN   K+ DFGLAR+   
Sbjct: 195 PITMEDLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 242 GPMV---GHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 298
            P     G T +         + AP+ I     + KSDVWS+GV+L+E+ +   S     
Sbjct: 252 NPDYVRKGDTRL------PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGS----- 300
Query: 299 PKTEQRLLEWVQQYPADSKKFGLIMD----PRLEK-------EYSINEARKIGRLADNCL 347
                        YP      G+ MD     RL +       EYS  E   I ++  +C 
Sbjct: 301 ------------PYP------GVQMDEDFCSRLREGMRMRAPEYSTPE---IYQIMLDCW 339
Query: 348 SKSSKDRPKMSQVVERLKQIV 368
            +  K+RP+ +++VE+L  ++
Sbjct: 340 HRDPKERPRFAELVEKLGDLL 360

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   E  V AIKKL+R    Q H K+   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFM---LNRSLEDHLFNRAFPPLPWKTR 191
            + H N++ L+       ++ ++      +V E M   L++ ++  L +     L ++  
Sbjct: 79  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
                    G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + 
Sbjct: 137 C--------GIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMM 182
Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           T  V T  Y AP+ I         D+WS G ++ EM+ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      + P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEP 243

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          + + VGT  Y
Sbjct: 145 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 201
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 122 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 91/221 (41%), Gaps = 30/221 (13%)
Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+GEGGF  V          +G  +    A+K++     Q  ++   E     +  HPN+
Sbjct: 36  KLGEGGFSYV-------DLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 146 VKLIGYCAVDGERGIQR--LLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEG 201
           ++L+ YC    ERG +    L+  F    +L + +         L     L ++LG   G
Sbjct: 89  LRLVAYCL--RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS---------T 252
           L  +H        +RD K +N+LL +  +P L D G   +  +  H   S          
Sbjct: 147 LEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI--HVEGSRQALTLQDWA 201
Query: 253 AVVGTFGYAAPDYIETGH---LTAKSDVWSFGVVLYEMLTG 290
           A   T  Y AP+         +  ++DVWS G VLY M+ G
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 120 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 176
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 121 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 177
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          + + VGT  Y
Sbjct: 141 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 119 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   E  V AIKKL+R    Q H K+   E+  + 
Sbjct: 28  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 80
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      +V E M     + +L       L  +   ++
Sbjct: 81  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYL 133
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + +    
Sbjct: 134 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMVPF 187
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           V T  Y AP+ I         D+WS G ++ EM+ G
Sbjct: 188 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 40/221 (18%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV--AEVQFLGVLEHPN 144
           IG+G FG V++         G      VA+K  +    +  + W   AE+    +L H N
Sbjct: 12  IGKGRFGEVWR---------GKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHEN 59
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           ++  I     D     Q  LV ++  + SL D+L NR    +  +  + + L  A GLA+
Sbjct: 60  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAH 116
Query: 205 LH-EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV----- 254
           LH E +  Q    + +RD K+ N+L+ +N    ++D GLA     V H   +  +     
Sbjct: 117 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPN 171
Query: 255 --VGTFGYAAP----DYIETGHLTA--KSDVWSFGVVLYEM 287
             VGT  Y AP    D I   H  +  ++D+++ G+V +E+
Sbjct: 172 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 19/182 (10%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+  L  ++H N+V L        E      LV + +    L D +  R       K   
Sbjct: 56  EIAVLKKIKHENIVTLEDI----YESTTHYYLVMQLVSGGELFDRILERGV--YTEKDAS 109
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTH 249
            +I      + YLHE     +++RD K  N+L    +EN +  ++DFGL++   M  +  
Sbjct: 110 LVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGI 163
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 309
           +STA  GT GY AP+ +     +   D WS GV+ Y +L G         +TE +L E +
Sbjct: 164 MSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE---ETESKLFEKI 219
Query: 310 QQ 311
           ++
Sbjct: 220 KE 221

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+++D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKR--VKGRTW--- 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 40/221 (18%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV--AEVQFLGVLEHPN 144
           IG+G FG V++         G      VA+K  +    +  + W   AE+    +L H N
Sbjct: 11  IGKGRFGEVWR---------GKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHEN 58
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           ++  I     D     Q  LV ++  + SL D+L NR    +  +  + + L  A GLA+
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAH 115
Query: 205 LH-EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV----- 254
           LH E +  Q    + +RD K+ N+L+ +N    ++D GLA     V H   +  +     
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPN 170
Query: 255 --VGTFGYAAP----DYIETGHLTA--KSDVWSFGVVLYEM 287
             VGT  Y AP    D I   H  +  ++D+++ G+V +E+
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 248
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   +  V AIKKL+R    Q H K+   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 79  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHERMSYL 131
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 132 LYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPY 185
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTW--- 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++Y+M  G      ++P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQP 243

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 248
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   +  V AIKKL+R    Q H K+   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 79  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 131
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 185
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 126 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 98/236 (41%), Gaps = 27/236 (11%)
Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQ 135
           Q T+ +     IG G + SV K  I  A      E  V  I K  RD  +       E++
Sbjct: 19  QFTDGYEVKEDIGVGSY-SVCKRCIHKAT---NXEFAVKIIDKSKRDPTE-------EIE 67
Query: 136 -FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
             L   +HPN++ L        + G    +V E      L D +  + F     +    +
Sbjct: 68  ILLRYGQHPNIITLKDVY----DDGKYVYVVTELXKGGELLDKILRQKF--FSEREASAV 121
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVL-LDENFRP---KLSDFGLAREGPMVGHTHV 250
           +    + + YLH      V++RD K SN+L +DE+  P   ++ DFG A++  +     +
Sbjct: 122 LFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAENGL 176
Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 306
                 T  + AP+ +E     A  D+WS GV+LY  LTG          T + +L
Sbjct: 177 LXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEIL 232

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 40/221 (18%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV--AEVQFLGVLEHPN 144
           IG+G FG V++         G      VA+K  +    +  + W   AE+    +L H N
Sbjct: 17  IGKGRFGEVWR---------GKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHEN 64
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           ++  I     D     Q  LV ++  + SL D+L NR    +  +  + + L  A GLA+
Sbjct: 65  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAH 121
Query: 205 LH-EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV----- 254
           LH E +  Q    + +RD K+ N+L+ +N    ++D GLA     V H   +  +     
Sbjct: 122 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPN 176
Query: 255 --VGTFGYAAP----DYIETGHLTA--KSDVWSFGVVLYEM 287
             VGT  Y AP    D I   H  +  ++D+++ G+V +E+
Sbjct: 177 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 40/221 (18%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV--AEVQFLGVLEHPN 144
           IG+G FG V++         G      VA+K  +    +  + W   AE+    +L H N
Sbjct: 14  IGKGRFGEVWR---------GKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHEN 61
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           ++  I     D     Q  LV ++  + SL D+L NR    +  +  + + L  A GLA+
Sbjct: 62  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAH 118
Query: 205 LH-EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV----- 254
           LH E +  Q    + +RD K+ N+L+ +N    ++D GLA     V H   +  +     
Sbjct: 119 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPN 173
Query: 255 --VGTFGYAAP----DYIETGHLTA--KSDVWSFGVVLYEM 287
             VGT  Y AP    D I   H  +  ++D+++ G+V +E+
Sbjct: 174 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 40/221 (18%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV--AEVQFLGVLEHPN 144
           IG+G FG V++         G      VA+K  +    +  + W   AE+    +L H N
Sbjct: 50  IGKGRFGEVWR---------GKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHEN 97
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           ++  I     D     Q  LV ++  + SL D+L NR    +  +  + + L  A GLA+
Sbjct: 98  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAH 154
Query: 205 LH-EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV----- 254
           LH E +  Q    + +RD K+ N+L+ +N    ++D GLA     V H   +  +     
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPN 209
Query: 255 --VGTFGYAAP----DYIETGHLTA--KSDVWSFGVVLYEM 287
             VGT  Y AP    D I   H  +  ++D+++ G+V +E+
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   +  V AIKKL+R    Q H K+   E+  + 
Sbjct: 64  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 116
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 117 CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 169
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 170 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 223
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K +    A     +  VV +K++           + E 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT--------LNEK 85
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 86  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA 141
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 142 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 189
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 190 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTW--- 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP  I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 145 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   +  V AIKKL+R    Q H K+   E+  + 
Sbjct: 27  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 79
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 80  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 132
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 133 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 186
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 56/115 (48%), Gaps = 4/115 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 147 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLER-NRPKTEQRLLEWVQQYPA 314
            +P+ +        SD+W+ G ++Y+++ G       N     Q++++    +PA
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPA 258

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   +  V AIKKL+R    Q H K+   E+  + 
Sbjct: 25  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 77
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 78  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 130
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 131 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 184
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 185 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   +  V AIKKL+R    Q H K+   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 79  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 131
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 185
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 40/221 (18%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV--AEVQFLGVLEHPN 144
           IG+G FG V++         G      VA+K  +    +  + W   AE+    +L H N
Sbjct: 37  IGKGRFGEVWR---------GKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHEN 84
Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           ++  I     D     Q  LV ++  + SL D+L NR    +  +  + + L  A GLA+
Sbjct: 85  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTV--EGMIKLALSTASGLAH 141
Query: 205 LH-EGLEVQ----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV----- 254
           LH E +  Q    + +RD K+ N+L+ +N    ++D GLA     V H   +  +     
Sbjct: 142 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-----VRHDSATDTIDIAPN 196
Query: 255 --VGTFGYAAP----DYIETGHLTA--KSDVWSFGVVLYEM 287
             VGT  Y AP    D I   H  +  ++D+++ G+V +E+
Sbjct: 197 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 141 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   +  V AIKKL+R    Q H K+   E+  + 
Sbjct: 19  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 71
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 72  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHERMSYL 124
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 125 LYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPY 178
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   +  V AIKKL+R    Q H K+   E+  + 
Sbjct: 27  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 79
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 80  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 132
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 133 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 186
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K +    A     +  VV +K++           + E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT--------LNEK 93
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 94  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 150 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 197
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 248
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+++D+    K++DFGLA+   + G T     + GT  Y AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKR--VKGRT---WXLCGTPEYLAP 207
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   +  V AIKKL+R    Q H K+   E+  + 
Sbjct: 64  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 116
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 117 CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 169
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 170 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 223
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 248
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 63  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 116
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 248
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 117 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 170
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 129/297 (43%), Gaps = 50/297 (16%)
Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQF- 136
           +D   ++++G G +G V K    P+         ++A+K++      Q  K+ + ++   
Sbjct: 51  DDLEPIMELGRGAYGVVEKMRHVPSG-------QIMAVKRIRATVNSQEQKRLLMDLDIS 103
Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP---PLPWKTRLH 193
           +  ++ P  V   G    +G+  I   L     ++ SL D  + +       +P      
Sbjct: 104 MRTVDCPFTVTFYGALFREGDVWICMEL-----MDTSL-DKFYKQVIDKGQTIPEDILGK 157
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
           I +   + L +LH  L V  I+RD K SNVL++   + K+ DFG++  G +V      T 
Sbjct: 158 IAVSIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKMCDFGIS--GYLVDSV-AKTI 212
Query: 254 VVGTFGYAAPDYI-----ETGHLTAKSDVWSFGVVLYEMLTGRRSLER-NRP--KTEQRL 305
             G   Y AP+ I     + G+ + KSD+WS G+ + E+   R   +    P  + +Q +
Sbjct: 213 DAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 271
Query: 306 LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
            E   Q PAD  KF                + +       CL K+SK+RP   ++++
Sbjct: 272 EEPSPQLPAD--KF----------------SAEFVDFTSQCLKKNSKERPTYPELMQ 310

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 248
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K +    A     +  VV +K++           + E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT--------LNEK 93
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 94  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 150 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 197
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K +    A     +  VV +K++           + E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT--------LNEK 93
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 94  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 150 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 197
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 248
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   +  V AIKKL+R    Q H K+   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 79  XVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHERMSYL 131
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 132 LYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPY 185
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   +  V AIKKL+R    Q H K+   E+  + 
Sbjct: 19  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 71
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 72  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 124
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 125 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 178
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 248
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L YLH      +I+RD K  N+LL+E+   +++DFG A+          +   VGT  Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +P+ +        SD+W+ G ++Y+++ G
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 63  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 116
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 248
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 117 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 170
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K +    A     +  VV +K++           + E 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT--------LNEK 93
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E+     +  HL    R   P       
Sbjct: 94  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA 149
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+++D+    K++DFG A+   + G T    
Sbjct: 150 QIVLT----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---W 197
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   +  V AIKKL+R    Q H K+   E+  + 
Sbjct: 20  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 72
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 73  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 125
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 126 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 179
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   +  V AIKKL+R    Q H K+   E+  + 
Sbjct: 20  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 72
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 73  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 125
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 126 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 179
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 248
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 248
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K +    A     +  VV +K++           + E 
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT--------LNEK 113
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 114 RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 169
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 170 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 217
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 218 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  IG G FG V    +  +    A     +  VV +K++           + E 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    K++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT---W 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K +    A     +  VV +K++           + E 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT--------LNEK 85
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 86  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 141
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 142 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 189
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 190 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 248
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 15/170 (8%)
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           +HPN++ L        + G    LV E M    L D +  + F     +    ++    +
Sbjct: 79  QHPNIITLKDVY----DDGKHVYLVTELMRGGELLDKILRQKF--FSEREASFVLHTIGK 132
Query: 201 GLAYLHEGLEVQVIYRDFKASNVL-LDENFRP---KLSDFGLAREGPMVGHTHVSTAVVG 256
            + YLH      V++RD K SN+L +DE+  P   ++ DFG A++  +     +      
Sbjct: 133 TVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ--LRAENGLLMTPCY 187
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 306
           T  + AP+ ++        D+WS G++LY ML G          T + +L
Sbjct: 188 TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEIL 237

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 95/240 (39%), Gaps = 52/240 (21%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------------ 120
           EM+    DF  +  IG G FG V    +K       +   + A+K LN            
Sbjct: 68  EMQLHREDFEIIKVIGRGAFGEVAVVKMK-------NTERIYAMKILNKWEMLKRAETAC 120
Query: 121 ----RDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE 175
               RD L  G  QW+  + +    +  N + L+    V G+            L    E
Sbjct: 121 FREERDVLVNGDCQWITALHY--AFQDENHLYLVMDYYVGGDL---------LTLLSKFE 169
Query: 176 DHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD 235
           D L     P    +  +  ++ A + +  LH       ++RD K  NVLLD N   +L+D
Sbjct: 170 DKL-----PEDMARFYIGEMVLAIDSIHQLH------YVHRDIKPDNVLLDVNGHIRLAD 218
Query: 236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTG 290
           FG   +    G    S A VGT  Y +P+ ++      G    + D WS GV +YEML G
Sbjct: 219 FGSCLKMNDDGTVQSSVA-VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 277

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   E  V AIKKL+R    Q H K+   E+  + 
Sbjct: 20  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 72
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLL-VYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
            + H N++ L+       ++ ++    VY  M    ++ +L       L  +   +++  
Sbjct: 73  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVM--ELMDANLCQVIQMELDHERMSYLLYQ 128
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
              G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  V T
Sbjct: 129 MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 182
Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
             Y AP+ I         D+WS G ++ EM+  +
Sbjct: 183 RYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+L+D+    K++DFG A+   + G T     + GT  Y AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT---WXLCGTPEYLAP 208
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 98/237 (41%), Gaps = 46/237 (19%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLGVLEHPN 144
           IG G +G VY +  K A  +       VAIKK+NR  + L   K+ + E+  L  L+   
Sbjct: 36  IGRGSYGYVYLAYDKNANKN-------VAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 145 LVKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRAFPPLPWKTRLH---IILGAAE 200
           +++L      +       LL + E  +   + D    + F    + T  H   I+     
Sbjct: 89  IIRLHDLIIPED------LLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLL 142
Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS--------- 251
           G  ++HE     +I+RD K +N LL+++   K+ DFGLAR        H+          
Sbjct: 143 GEKFIHES---GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEEN 199
Query: 252 --------------TAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRS 293
                         T+ V T  Y AP+ I    + T   D+WS G +  E+L   +S
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKS 256

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 26/217 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   E  V AIKKL+R    Q H K+   E+  + 
Sbjct: 31  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 83
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      +V E M     + +L       L  +   ++
Sbjct: 84  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYL 136
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 137 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY 190
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           V T  Y AP+ I         D+WS G ++ EM+  +
Sbjct: 191 VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 15/170 (8%)
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           +HPN++ L        + G    LV E M    L D +  + F     +    ++    +
Sbjct: 79  QHPNIITLKDVY----DDGKHVYLVTELMRGGELLDKILRQKF--FSEREASFVLHTIGK 132
Query: 201 GLAYLHEGLEVQVIYRDFKASNVL-LDENFRP---KLSDFGLAREGPMVGHTHVSTAVVG 256
            + YLH      V++RD K SN+L +DE+  P   ++ DFG A++  +     +      
Sbjct: 133 TVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ--LRAENGLLMTPCY 187
Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL 306
           T  + AP+ ++        D+WS G++LY ML G          T + +L
Sbjct: 188 TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEIL 237

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   +  V AIKKL+R    Q H K+   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 79  XVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYL 131
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPY 185
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 95/240 (39%), Gaps = 52/240 (21%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN------------ 120
           EM+    DF  +  IG G FG V    +K       +   + A+K LN            
Sbjct: 84  EMQLHREDFEIIKVIGRGAFGEVAVVKMK-------NTERIYAMKILNKWEMLKRAETAC 136
Query: 121 ----RDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE 175
               RD L  G  QW+  + +    +  N + L+    V G+            L    E
Sbjct: 137 FREERDVLVNGDCQWITALHY--AFQDENHLYLVMDYYVGGDL---------LTLLSKFE 185
Query: 176 DHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD 235
           D L     P    +  +  ++ A + +  LH       ++RD K  NVLLD N   +L+D
Sbjct: 186 DKL-----PEDMARFYIGEMVLAIDSIHQLH------YVHRDIKPDNVLLDVNGHIRLAD 234
Query: 236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTG 290
           FG   +    G    S A VGT  Y +P+ ++      G    + D WS GV +YEML G
Sbjct: 235 FGSCLKMNDDGTVQSSVA-VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 293

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           EV  L  ++HPN++ L        E     +L+ E +    L D L  +    L  +   
Sbjct: 64  EVSILKEIQHPNVITLHEVY----ENKTDVILIGELVAGGELFDFLAEKE--SLTEEEAT 117
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 248
             +     G+ YLH    +Q+ + D K  N+ LLD N    R K+ DFGLA +   +   
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFG 171
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   +  V AIKKL+R    Q H K+   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 79  XVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHERMSYL 131
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPY 185
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEML 288
           V T  Y AP+ I         D+WS G ++ EM+
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+++D+    K++DFG A+   + G T     + GT  Y AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLAP 208
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+++D+    K++DFG A+   + G T     + GT  Y AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLAP 208
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+++D+    +++DFGLA+   + G T     + GT  Y AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKR--VKGRT---WXLCGTPEYLAP 207
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+++D+    K++DFG A+   + G T     + GT  Y AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLAP 208
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+++D+    K++DFG A+   + G T     + GT  Y AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLAP 207
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQGHKQWVA 132
           + + + R+ K+GEG +G VYK      A D  +  T VAIK++      +G+ G    + 
Sbjct: 32  SIDRYRRITKLGEGTYGEVYK------AIDTVTNET-VAIKRIRLEHEEEGVPGTA--IR 82
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTR 191
           EV  L  L+H N+++L      +      RL L++E+  N  L+ ++     P +  +  
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHN-----HRLHLIFEYAEN-DLKKYMDKN--PDVSMRVI 134
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRP--KLSDFGLAREG--PM 244
              +     G+ + H     + ++RD K  N+LL   D +  P  K+ DFGLAR    P+
Sbjct: 135 KSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191
Query: 245 VGHTHVSTAVVGTFGYAAPD-YIETGHLTAKSDVWSFGVVLYEML 288
              TH     + T  Y  P+  + + H +   D+WS   +  EML
Sbjct: 192 RQFTH----EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+++D+    K++DFG A+   + G T     + GT  Y AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLAP 207
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 249
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 166 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKET--TSHNS 219
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 220 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 249
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 172 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKET--TSHNS 225
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 226 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 265

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + GT  Y AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WTLCGTPEYLAP 208
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           + ++  IG G  G V        A   T     VA+KKL+R    Q H K+   E+  L 
Sbjct: 24  YQQLKPIGSGAQGIV-------CAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK 76
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      LV E M     + +L       L  +   ++
Sbjct: 77  CVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELM-----DANLCQVIHMELDHERMSYL 129
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR         + T  
Sbjct: 130 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---STNFMMTPY 183
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           V T  Y AP+ I         D+WS G ++ E++ G
Sbjct: 184 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 249
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 122 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKE--TTSHNS 175
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 176 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 249
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 126 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKET--TSHNS 179
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 180 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 219

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 249
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 128 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKE--TTSHNS 181
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 182 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 221

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 249
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 127 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKET--TSHNS 180
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 181 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 220

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + GT  Y AP
Sbjct: 142 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WTLCGTPEYLAP 193
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 194 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 229

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + GT  Y AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAP 208
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 249
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 122 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKET--TSHNS 175
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 176 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +  +    A     +  VV +K++           + E 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---W 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT  Y AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + GT  Y AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAP 207
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 249
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 121 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKET--TSHNS 174
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 175 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 214

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 249
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 120 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKET--TSHNS 173
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 174 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + GT  Y AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAP 207
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 30/227 (13%)
Query: 79  NDFSRMLKIGEGGFGSV----YKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           + F R+  +G G FG V    +K S    A     +  VV +K++           + E 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEK 92
Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
           + L  +  P LVKL        +      +V E++    +  HL    R   P       
Sbjct: 93  RILQAVNFPFLVKL----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            I+L       YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T    
Sbjct: 149 QIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTW--- 196
Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
            + GT    AP+ I +       D W+ GV++YEM  G      ++P
Sbjct: 197 XLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + GT  Y AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAP 207
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + GT  Y AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAP 208
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + GT  Y AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAP 207
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+L+D+    +++DFG A+   + G T     + GT  Y AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAP 207
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 249
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 136 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKE--TTSHNS 189
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           ++T     + Y AP+ +         D+WS GV++Y +L G
Sbjct: 190 LTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 229

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 129/302 (42%), Gaps = 50/302 (16%)
Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVA 132
           M    +D   ++++G G +G V K    P+         ++A+K++      Q  K+ + 
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSG-------QIMAVKRIRATVNSQEQKRLLM 54
Query: 133 EVQF-LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP---PLPW 188
           ++   +  ++ P  V   G    +G+  I   L     ++ SL D  + +       +P 
Sbjct: 55  DLDISMRTVDCPFTVTFYGALFREGDVWICMEL-----MDTSL-DKFYKQVIDKGQTIPE 108
Query: 189 KTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT 248
                I +   + L +LH  L   VI+RD K SNVL++   + K+ DFG++  G +V   
Sbjct: 109 DILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDDV 164
Query: 249 HVSTAVVGTFGYAAPDYI-----ETGHLTAKSDVWSFGVVLYEMLTGRRSLER-NRP--K 300
                  G   Y AP+ I     + G+ + KSD+WS G+ + E+   R   +    P  +
Sbjct: 165 -AKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQ 222
Query: 301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
            +Q + E   Q PAD  KF                + +       CL K+SK+RP   ++
Sbjct: 223 LKQVVEEPSPQLPAD--KF----------------SAEFVDFTSQCLKKNSKERPTYPEL 264
Query: 361 VE 362
           ++
Sbjct: 265 MQ 266

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   E  V AIKKL+R    Q H K+   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      +V E M     + +L       L  +   ++
Sbjct: 79  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYL 131
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + +    
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMEPE 185
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           V T  Y AP+ I         D+WS G ++ EM+  +
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + +IYRD K  N+++D+    +++DFG A+   + G T     + GT  Y AP
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAP 207
Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP 299
           + I +       D W+ GV++YEM  G      ++P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 44  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 148
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 149 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 192
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 193 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 251
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R  +E Q L+ W     P+D   F
Sbjct: 252 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 281

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 31  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 135
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 136 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 179
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 180 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 238
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R  +E Q L+ W     P+D   F
Sbjct: 239 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 268

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 101/222 (45%), Gaps = 22/222 (9%)
Query: 73  EMRQAT-NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW 130
           E++Q +  D+  +L+ +G G FG V++  ++ A G       V   K +N          
Sbjct: 43  EVKQGSVYDYYDILEELGSGAFGVVHRC-VEKATG------RVFVAKFINTPYPLDKYTV 95
Query: 131 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 190
             E+  +  L HP L+ L        E   + +L+ EF+    L D +    +  +    
Sbjct: 96  KNEISIMNQLHHPKLINLHDAF----EDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAE 150
Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD--ENFRPKLSDFGLAREGPMVGHT 248
            ++ +  A EGL ++HE     +++ D K  N++ +  +    K+ DFGLA +   +   
Sbjct: 151 VINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPD 204
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            +      T  +AAP+ ++   +   +D+W+ GV+ Y +L+G
Sbjct: 205 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 45  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 149
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 150 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 193
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 194 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 252
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R  +E Q L+ W     P+D   F
Sbjct: 253 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 282

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 44  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 148
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 149 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 192
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 193 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 251
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R  +E Q L+ W     P+D   F
Sbjct: 252 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 281

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 44  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 148
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 149 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 192
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 193 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 251
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R  +E Q L+ W     P+D   F
Sbjct: 252 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 281

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 45  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 149
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 150 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 193
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 194 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 252
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R  +E Q L+ W     P+D   F
Sbjct: 253 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 282

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGH-KQWVAEVQFLG 138
           +  +  IG G  G V       AA D   E  V AIKKL+R    Q H K+   E+  + 
Sbjct: 26  YQNLKPIGSGAQGIVC------AAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL----LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            + H N++ L+       ++ ++      +V E M     + +L       L  +   ++
Sbjct: 79  CVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYL 131
Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + +    
Sbjct: 132 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMEPE 185
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           V T  Y AP+ I         D+WS G ++ EM+  +
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 32  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 136
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 137 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 180
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 181 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 239
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R  +E Q L+ W     P+D   F
Sbjct: 240 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 269

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 17  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 121
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 122 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 165
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 166 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 224
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R  +E Q L+ W     P+D   F
Sbjct: 225 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 254

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 59  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 163
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 164 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 207
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 208 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 266
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R  +E Q L+ W     P+D   F
Sbjct: 267 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 296

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 51  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 155
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 156 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 199
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 200 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 258
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R  +E Q L+ W     P+D   F
Sbjct: 259 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 288

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 17  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 121
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 122 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 165
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 166 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 224
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R  +E Q L+ W     P+D   F
Sbjct: 225 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 254

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 16  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 120
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 121 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 164
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 165 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 223
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R  +E Q L+ W     P+D   F
Sbjct: 224 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 253

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 116/287 (40%), Gaps = 35/287 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G+G F  ++K   +     G    T V +K L++      + +      +  L H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIILGAAEGLAYL 205
              G C      G + +LV EF+   SL+ +L  N+    + WK  +   L AA     +
Sbjct: 76  LNYGVCVC----GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA-----M 126
Query: 206 HEGLEVQVIYRDFKASNVLL--DENFRPKLSDFGLAREGPMVGHTHVSTAVVGT-FGYAA 262
           H   E  +I+ +  A N+LL  +E+ +     F +    P +  T +   ++     +  
Sbjct: 127 HFLEENTLIHGNVCAKNILLIREEDRKTGNPPF-IKLSDPGISITVLPKDILQERIPWVP 185
Query: 263 PDYIET-GHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFG 320
           P+ IE   +L   +D WSFG  L+E+ + G + L     + + +  E   Q PA      
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAP----- 240
Query: 321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
                         +A ++  L +NC+      RP    ++  L  +
Sbjct: 241 --------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 22/223 (9%)
Query: 75  RQATNDFSRM-LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG--HKQWV 131
           +Q   DF  +  ++G G F  V K   K     G   A     K+ +R   +G   ++  
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKST---GLEYAAKFIKKRQSRASRRGVCREEIE 63
Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR 191
            EV  L  + HPN++ L        E     +L+ E +    L D L  +    L  +  
Sbjct: 64  REVSILRQVLHPNIITLHDVY----ENRTDVVLILELVSGGELFDFLAQKE--SLSEEEA 117
Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGH 247
              I    +G+ YLH     ++ + D K  N+ LLD+N      KL DFGLA E   +  
Sbjct: 118 TSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IED 171
Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
                 + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 17  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 121
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 122 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 165
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 166 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 224
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R  +E Q L+ W     P+D   F
Sbjct: 225 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 254

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 55/234 (23%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 31  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 135
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 136 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 179
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLERN 297
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E +
Sbjct: 180 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 232

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 15  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 119
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 120 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 163
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 164 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 222
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R  +E Q L+ W     P+D   F
Sbjct: 223 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 252

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 110/270 (40%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 59  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 163
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 164 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 207
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 208 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 266
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R   E Q L+ W     P+D   F
Sbjct: 267 QVFFRQRVSXECQHLIRWCLALRPSDRPTF 296

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 16/162 (9%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           EV  L  + HPN++ L        E     +L+ E +    L D L  +    L      
Sbjct: 58  EVNILREIRHPNIITLHDIF----ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEAT 111
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 248
             +    +G+ YLH     ++ + D K  N+ LLD+N    R KL DFG+A +   +   
Sbjct: 112 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAG 165
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 110/270 (40%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 45  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 149
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 150 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 193
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 194 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 252
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R   E Q L+ W     P+D   F
Sbjct: 253 QVFFRQRVSXECQHLIRWCLALRPSDRPTF 282

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 16  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLI----LERMEPVQDL--FDFITERGALQEELARSFF-- 120
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 121 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 164
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 165 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 223
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R  +E Q L+ W     P+D   F
Sbjct: 224 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 253

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 110/270 (40%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 45  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 149
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 150 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 193
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 194 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 252
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R   E Q L+ W     P+D   F
Sbjct: 253 QVFFRQRVSXECQHLIRWCLALRPSDRPTF 282

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 12  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 116
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 117 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 160
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 161 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 219
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R  +E Q L+ W     P+D   F
Sbjct: 220 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 249

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 110/270 (40%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 44  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 148
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 149 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 192
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 193 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 251
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R   E Q L+ W     P+D   F
Sbjct: 252 QVFFRQRVSXECQHLIRWCLALRPSDRPTF 281

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 34/225 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-----------KQWVAEVQ 135
           I  G +G+V        AG   SE   VAIK++      G            K+ + E++
Sbjct: 30  ISSGSYGAV-------CAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL--- 192
            L    HPN++ L        E  + +L +   ++   L   + ++     P   +    
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
           HI+LG    L  LHE     V++RD    N+LL +N    + DF LARE     +    T
Sbjct: 142 HILLG----LHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KT 191
Query: 253 AVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLER 296
             V    Y AP+ + +    T   D+WS G V+ EM   R++L R
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFR 235

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 55/234 (23%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 32  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 136
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 137 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 180
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLERN 297
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E +
Sbjct: 181 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 55/234 (23%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 32  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 136
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 137 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 180
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLERN 297
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E +
Sbjct: 181 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 16/162 (9%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           EV  L  + HPN++ L        E     +L+ E +    L D L  +    L      
Sbjct: 65  EVNILREIRHPNIITLHDIF----ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEAT 118
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 248
             +    +G+ YLH     ++ + D K  N+ LLD+N    R KL DFG+A +   +   
Sbjct: 119 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAG 172
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 173 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 111/270 (41%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 12  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 116
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 117 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 160
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 161 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 219
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R  +E Q L+ W     P+D   F
Sbjct: 220 QVFFRQRVSSECQHLIRWCLALRPSDRPTF 249

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 110/270 (40%), Gaps = 69/270 (25%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 64  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 168
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 169 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 212
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLE-------- 295
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E        
Sbjct: 213 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 271
Query: 296 ----RNRPKTE-QRLLEWVQQY-PADSKKF 319
               R R   E Q L+ W     P+D   F
Sbjct: 272 QVFFRQRVSXECQHLIRWCLALRPSDRPTF 301

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 105/247 (42%), Gaps = 50/247 (20%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G+GGFG+V+       AG   ++   VAIK + R+ + G   W      +       L+
Sbjct: 39  LGKGGFGTVF-------AGHRLTDRLQVAIKVIPRNRVLG---WSPLSDSVTCPLEVALL 88
Query: 147 KLIGYCAVDGERGIQRLLVY-----EFMLNRSLEDHLFNRAFPPLPWKTRLHII-----L 196
             +G  A  G  G+ RLL +      FML       +  R   PLP +     I     L
Sbjct: 89  WKVG--AGGGHPGVIRLLDWFETQEGFML-------VLER---PLPAQDLFDYITEKGPL 136
Query: 197 GAAEGLAYLHEGLEV-------QVIYRDFKASNVLLD-ENFRPKLSDFGLAREGPMVGHT 248
           G      +  + +          V++RD K  N+L+D      KL DFG    G ++ H 
Sbjct: 137 GEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG---SGALL-HD 192
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTA-KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 307
              T   GT  Y+ P++I      A  + VWS G++LY+M+ G    ER+     Q +LE
Sbjct: 193 EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----QEILE 247
Query: 308 WVQQYPA 314
               +PA
Sbjct: 248 AELHFPA 254

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 93/225 (41%), Gaps = 34/225 (15%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-----------KQWVAEVQ 135
           I  G +G+V        AG   SE   VAIK++      G            K+ + E++
Sbjct: 30  ISSGSYGAV-------CAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL--- 192
            L    HPN++ L        E  + +L +   ++   L   + ++     P   +    
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
           HI+LG       LH   E  V++RD    N+LL +N    + DF LARE     +    T
Sbjct: 142 HILLG-------LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KT 191
Query: 253 AVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRSLER 296
             V    Y AP+ + +    T   D+WS G V+ EM   R++L R
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFR 235

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 26/217 (11%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNL 145
           + EGGF  VY++      G G       A+K+L  +  + ++  + EV F+  L  HPN+
Sbjct: 36  LAEGGFAFVYEAQ---DVGSGRE----YALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 146 VKLIGYCAVDGERG----IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           V+     ++  E       + LL+ E    + +E      +  PL   T L I       
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA---REGPMVGHTHVSTAVV--- 255
           + ++H   +  +I+RD K  N+LL      KL DFG A      P    +    A+V   
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 256 ----GTFGYAAPDYIE---TGHLTAKSDVWSFGVVLY 285
                T  Y  P+ I+      +  K D+W+ G +LY
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY 244

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 16/162 (9%)
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           EV  L  + HPN++ L        E     +L+ E +    L D L  +    L      
Sbjct: 79  EVNILREIRHPNIITLHDIF----ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEAT 132
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNV-LLDENF---RPKLSDFGLAREGPMVGHT 248
             +    +G+ YLH     ++ + D K  N+ LLD+N    R KL DFG+A +   +   
Sbjct: 133 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAG 186
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +    + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 187 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA 132
           E R+  +  +   ++G G FG V++   K             A+KK+  +  +     V 
Sbjct: 52  EYREEVHWMTHQPRVGRGSFGEVHRMKDK-------QTGFQCAVKKVRLEVFR-----VE 99
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+     L  P +V L G  AV    G    +  E +   SL   +  +    LP    L
Sbjct: 100 ELVACAGLSSPRIVPLYG--AV--REGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRAL 153
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFG--LAREGPMVGHTH 249
           + +  A EGL YLH     ++++ D KA NVLL  +  R  L DFG  L  +   +G + 
Sbjct: 154 YYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210
Query: 250 VSTAVV-GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           ++   + GT  + AP+ +      AK D+WS   ++  ML G
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA 132
           E R+  +  +   ++G G FG V++   K             A+KK+  +  +     V 
Sbjct: 68  EYREEVHWMTHQPRVGRGSFGEVHRMKDK-------QTGFQCAVKKVRLEVFR-----VE 115
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+     L  P +V L G  AV    G    +  E +   SL   +  +    LP    L
Sbjct: 116 ELVACAGLSSPRIVPLYG--AV--REGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRAL 169
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFG--LAREGPMVGHTH 249
           + +  A EGL YLH     ++++ D KA NVLL  +  R  L DFG  L  +   +G + 
Sbjct: 170 YYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 226
Query: 250 VSTAVV-GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           ++   + GT  + AP+ +      AK D+WS   ++  ML G
Sbjct: 227 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 45/96 (46%), Gaps = 11/96 (11%)
Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTHVSTAV 254
            E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  ++T  
Sbjct: 171 GEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKE--TTSHNSLTTPC 224
Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
              + Y AP+ +         D WS GV+ Y +L G
Sbjct: 225 YTPY-YVAPEVLGPEKYDKSCDXWSLGVIXYILLCG 259

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 118/288 (40%), Gaps = 37/288 (12%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           +G+G F  ++K   +     G    T V +K L++      + +      +  L H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTRLHIILGAAEGLAY- 204
              G C      G + +LV EF+   SL+ +L  N+    + WK      L  A+ LA+ 
Sbjct: 76  LNYGVCFC----GDENILVQEFVKFGSLDTYLKKNKNCINILWK------LEVAKQLAWA 125
Query: 205 LHEGLEVQVIYRDFKASNVLL--DENFRPKLSDFGLAREGPMVGHTHVSTAVVGT-FGYA 261
           +H   E  +I+ +  A N+LL  +E+ +     F +    P +  T +   ++     + 
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF-IKLSDPGISITVLPKDILQERIPWV 184
Query: 262 APDYIET-GHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKF 319
            P+ IE   +L   +D WSFG  L+E+ + G + L     + + +  E   Q PA     
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAP---- 240
Query: 320 GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
                          +A ++  L +NC+      RP    ++  L  +
Sbjct: 241 ---------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 11/101 (10%)
Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLAREGPMVGHTH 249
           I+    E + YLH    + + +RD K  N+L     RP    KL+DFG A+E     H  
Sbjct: 120 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKET--TSHNS 173
Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           ++      + Y AP+ +         D+WS GV++Y +L G
Sbjct: 174 LTEPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 55/234 (23%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 39  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 143
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 144 --WQV--------LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 187
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLERN 297
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E +
Sbjct: 188 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 240

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA 132
           E R+  +  +   ++G G FG V++   K             A+KK+  +  +     V 
Sbjct: 66  EYREEVHWMTHQPRLGRGSFGEVHRMKDK-------QTGFQCAVKKVRLEVFR-----VE 113
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+     L  P +V L G  AV    G    +  E +   SL   +  +    LP    L
Sbjct: 114 ELVACAGLSSPRIVPLYG--AV--REGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRAL 167
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFG--LAREGPMVGHTH 249
           + +  A EGL YLH     ++++ D KA NVLL  +  R  L DFG  L  +   +G + 
Sbjct: 168 YYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 224
Query: 250 VSTAVV-GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           ++   + GT  + AP+ +      AK D+WS   ++  ML G
Sbjct: 225 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 39/215 (18%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G +G V     K A   GT      A KK+ +  ++   ++  E++ +  L+HPN++
Sbjct: 17  IGRGSWGEV-----KIAVQKGTRIRR--AAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 147 KLIGYCAVDGERGIQRLLVYEF-----MLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           +L  Y   +    I   LV E      +  R +   +F  +           I+      
Sbjct: 70  RL--YETFEDNTDI--YLVMELCTGGELFERVVHKRVFRES-------DAARIMKDVLSA 118
Query: 202 LAYLHEGLEVQVIYRDFKASNVLL--DENFRP-KLSDFGLA---REGPMVGHTHVSTAVV 255
           +AY H   ++ V +RD K  N L   D    P KL DFGLA   + G M+         V
Sbjct: 119 VAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM------RTKV 169
Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           GT  Y +P  +E G    + D WS GV++Y +L G
Sbjct: 170 GTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 83/173 (47%), Gaps = 33/173 (19%)
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR-----LHII 195
           +HPN+++   YC+   +R    L +   + N +L+D + ++       K +     + ++
Sbjct: 85  DHPNVIRY--YCSETTDRF---LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 139
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-------------ENFRPKLSDFGLARE- 241
              A G+A+LH    +++I+RD K  N+L+              EN R  +SDFGL ++ 
Sbjct: 140 RQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 196
Query: 242 --GPMVGHTHVSTAVVGTFGYAAPDYIETG---HLTAKSDVWSFGVVLYEMLT 289
             G      +++    GT G+ AP+ +E      LT   D++S G V Y +L+
Sbjct: 197 DSGQXXFRXNLNNP-SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 39/215 (18%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV 146
           IG G +G V     K A   GT      A KK+ +  ++   ++  E++ +  L+HPN++
Sbjct: 34  IGRGSWGEV-----KIAVQKGTR--IRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 147 KLIGYCAVDGERGIQRLLVYEF-----MLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           +L  Y   +    I   LV E      +  R +   +F  +           I+      
Sbjct: 87  RL--YETFEDNTDI--YLVMELCTGGELFERVVHKRVFRES-------DAARIMKDVLSA 135
Query: 202 LAYLHEGLEVQVIYRDFKASNVLL--DENFRP-KLSDFGLA---REGPMVGHTHVSTAVV 255
           +AY H   ++ V +RD K  N L   D    P KL DFGLA   + G M+         V
Sbjct: 136 VAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM------RTKV 186
Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           GT  Y +P  +E G    + D WS GV++Y +L G
Sbjct: 187 GTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 220

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 85/177 (48%), Gaps = 37/177 (20%)
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR-----LHII 195
           +HPN+++   YC+   +R    L +   + N +L+D + ++       K +     + ++
Sbjct: 67  DHPNVIRY--YCSETTDRF---LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-------------ENFRPKLSDFGLARE- 241
              A G+A+LH    +++I+RD K  N+L+              EN R  +SDFGL ++ 
Sbjct: 122 RQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 242 --GPMVGHTHVSTAVVGTFGYAAPDYIETGH-------LTAKSDVWSFGVVLYEMLT 289
             G     T+++    GT G+ AP+ +E  +       LT   D++S G V Y +L+
Sbjct: 179 DSGQSSFRTNLNNP-SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
            A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+                
Sbjct: 207 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
             + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 83/173 (47%), Gaps = 33/173 (19%)
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR-----LHII 195
           +HPN+++   YC+   +R    L +   + N +L+D + ++       K +     + ++
Sbjct: 85  DHPNVIRY--YCSETTDRF---LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 139
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-------------ENFRPKLSDFGLARE- 241
              A G+A+LH    +++I+RD K  N+L+              EN R  +SDFGL ++ 
Sbjct: 140 RQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 196
Query: 242 --GPMVGHTHVSTAVVGTFGYAAPDYIETG---HLTAKSDVWSFGVVLYEMLT 289
             G      +++    GT G+ AP+ +E      LT   D++S G V Y +L+
Sbjct: 197 DSGQXXFRXNLNNP-SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
            A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+                
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
             + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
            A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+                
Sbjct: 209 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
             + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
            A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+                
Sbjct: 200 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
             + AP+ I     T +SDVWSFGV+L+E+ +
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 55/234 (23%)
Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ----------------- 129
           +G GGFGSVY       +G   S+   VAIK + +D +    +                 
Sbjct: 12  LGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 130 ---WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPP 185
              +   ++ L   E P+   LI    ++    +Q L  ++F+  R +L++ L    F  
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLI----LERPEPVQDL--FDFITERGALQEELARSFF-- 116
Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPM 244
             W+          E + + H      V++RD K  N+L+D N    KL DFG    G +
Sbjct: 117 --WQV--------LEAVRHCHN---XGVLHRDIKDENILIDLNRGELKLIDFG---SGAL 160
Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSD-VWSFGVVLYEMLTGRRSLERN 297
           +  T V T   GT  Y+ P++I       +S  VWS G++LY+M+ G    E +
Sbjct: 161 LKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 43/228 (18%)
Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK---LNRDGLQGHK--QWVA 132
           +  +S M  +G G FG V+ +  K    +   E  V  IKK   L    ++  K  +   
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDK----EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL 78
Query: 133 EVQFLGVLEHPNLVKLI------GYCAVDGERGIQRLLVYEFM-----LNRSLEDHLFNR 181
           E+  L  +EH N++K++      G+  +  E+    L ++ F+     L+  L  ++F +
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 182 AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE 241
                         L +A G   L +     +I+RD K  N+++ E+F  KL DFG A  
Sbjct: 139 --------------LVSAVGYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDFGSAA- 178
Query: 242 GPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEML 288
              +    +     GT  Y AP+ +    +   + ++WS GV LY ++
Sbjct: 179 --YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 25/222 (11%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA 132
           E R+  +  +  L++G G FG V++   K             A+KK+  +  +       
Sbjct: 87  EYREEVHWATHQLRLGRGSFGEVHRMEDK-------QTGFQCAVKKVRLEVFRAE----- 134
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+     L  P +V L G  AV    G    +  E +   SL   +  +    LP    L
Sbjct: 135 ELMACAGLTSPRIVPLYG--AV--REGPWVNIFMELLEGGSLGQLVKEQGC--LPEDRAL 188
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFG--LAREGPMVGHTH 249
           + +  A EGL YLH     ++++ D KA NVLL  +     L DFG  +  +   +G + 
Sbjct: 189 YYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSL 245
Query: 250 VSTAVV-GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           ++   + GT  + AP+ +      AK DVWS   ++  ML G
Sbjct: 246 LTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 39/76 (51%), Gaps = 1/76 (1%)
Query: 215 YRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAK 274
           +RD K  N+L+  +    L DFG+A        T +    VGT  Y AP+     H T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYXAPERFSESHATYR 215
Query: 275 SDVWSFGVVLYEMLTG 290
           +D+++   VLYE LTG
Sbjct: 216 ADIYALTCVLYECLTG 231

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 84/177 (47%), Gaps = 37/177 (20%)
Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR-----LHII 195
           +HPN+++   YC+   +R    L +   + N +L+D + ++       K +     + ++
Sbjct: 67  DHPNVIRY--YCSETTDRF---LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-------------ENFRPKLSDFGLARE- 241
              A G+A+LH    +++I+RD K  N+L+              EN R  +SDFGL ++ 
Sbjct: 122 RQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 242 --GPMVGHTHVSTAVVGTFGYAAPDYIETGH-------LTAKSDVWSFGVVLYEMLT 289
             G      +++    GT G+ AP+ +E  +       LT   D++S G V Y +L+
Sbjct: 179 DSGQXXFRXNLNNP-SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 58/123 (47%), Gaps = 20/123 (16%)
Query: 213 VIYRDFKASNVLLDENF-RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL 271
           V++RD K  N+L+D N    KL DFG    G ++  T V T   GT  Y+ P++I     
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEWIRYHRY 233
Query: 272 TAKSD-VWSFGVVLYEMLTGRRSLE------------RNRPKTE-QRLLEWVQQY-PADS 316
             +S  VWS G++LY+M+ G    E            R R  +E Q L+ W     P+D 
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDR 293
Query: 317 KKF 319
             F
Sbjct: 294 PTF 296

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 65/160 (40%), Gaps = 27/160 (16%)
Query: 213 VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI------ 266
           +++ D K +N L+ +    KL DFG+A +      + V  + VGT  Y  P+ I      
Sbjct: 132 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 190
Query: 267 -ETGHLTAKS----DVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 321
            E G   +K     DVWS G +LY M  G+                  QQ      K   
Sbjct: 191 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQISKLHA 235
Query: 322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 361
           I+DP  E E+     + +  +   CL +  K R  + +++
Sbjct: 236 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 275

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 65/160 (40%), Gaps = 27/160 (16%)
Query: 213 VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI------ 266
           +++ D K +N L+ +    KL DFG+A +      + V  + VGT  Y  P+ I      
Sbjct: 128 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 186
Query: 267 -ETGHLTAKS----DVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGL 321
            E G   +K     DVWS G +LY M  G+                  QQ      K   
Sbjct: 187 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQISKLHA 231
Query: 322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 361
           I+DP  E E+     + +  +   CL +  K R  + +++
Sbjct: 232 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 271

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 91/222 (40%), Gaps = 25/222 (11%)
Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA 132
           E R+  +  +  L++G G FG V++   K             A+KK+  +  +       
Sbjct: 68  EYREEVHWATHQLRLGRGSFGEVHRMEDK-------QTGFQCAVKKVRLEVFRAE----- 115
Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+     L  P +V L G  AV    G    +  E +   SL   +  +    LP    L
Sbjct: 116 ELMACAGLTSPRIVPLYG--AV--REGPWVNIFMELLEGGSLGQLVKEQGC--LPEDRAL 169
Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLA---REGPMVGHT 248
           + +  A EGL YLH     ++++ D KA NVLL  +     L DFG A   +   +    
Sbjct: 170 YYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDL 226
Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
                + GT  + AP+ +      AK DVWS   ++  ML G
Sbjct: 227 LTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	436
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-162
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-153
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-135
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-84
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-57
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-55
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-55
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-54
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-54
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-53
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-52
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-52
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-50
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-47
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-40
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-40
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-40
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-40
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-40
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-39
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-39
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-38
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-37
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-36
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-36
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-36
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-36
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	9e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-35
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-35
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-35
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-34
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-34
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-34
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-34
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-34
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-33
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-33
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-33
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-33
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-32
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-31
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-30
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-30
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-29
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-29
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-28
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-28
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-28
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-28
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-27
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-27
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-26
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-26
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-25
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-25
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-25
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-25
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-25
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-25
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-24
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-24
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-23
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-23
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-23
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-21
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-20
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-20
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-20
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-20
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-20
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-19
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-19
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-19
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-19
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-18
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-18
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-18
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-18
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-18
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-18
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-18
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-17
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-17
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-17
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-17
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-17
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-15
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	9e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-07

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  459 bits (1183), Expect = e-162
 Identities = 108/323 (33%), Positives = 168/323 (52%), Gaps = 31/323 (9%)

Query: 57  ELYEEKAHNLRVFSYSEMRQATNDFSRML------KIGEGGFGSVYKSSIKPAAGDGTSE 110
           +  E        FS+ E++  TN+F          K+GEGGFG VYK         G   
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYK---------GYVN 53

Query: 111 ATVVAIKKL----NRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVY 166
            T VA+KKL    +    +  +Q+  E++ +   +H NLV+L+G+ + DG+      LVY
Sbjct: 54  NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-DGD---DLCLVY 109

Query: 167 EFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL 225
            +M N SL D L      PPL W  R  I  GAA G+ +LHE      I+RD K++N+LL
Sbjct: 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166

Query: 226 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLY 285
           DE F  K+SDFGLAR       T +++ +VGT  Y AP+ +  G +T KSD++SFGVVL 
Sbjct: 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLL 225

Query: 286 EMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADN 345
           E++TG  +++ +R    Q LL+  ++   + K     +D ++  +        +  +A  
Sbjct: 226 EIITGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQ 282

Query: 346 CLSKSSKDRPKMSQVVERLKQIV 368
           CL +    RP + +V + L+++ 
Sbjct: 283 CLHEKKNKRPDIKKVQQLLQEMT 305

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  435 bits (1121), Expect = e-153
 Identities = 118/334 (35%), Positives = 182/334 (54%), Gaps = 18/334 (5%)

Query: 41  VKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSI 100
           + S  S +  S                     ++ +ATN+F     IG G FG VYK  +
Sbjct: 1   MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60

Query: 101 KPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGI 160
           +    DG      VA+K+   +  QG +++  E++ L    HP+LV LIG+C        
Sbjct: 61  R----DGA----KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN---- 108

Query: 161 QRLLVYEFMLNRSLEDHLFNRAFP--PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDF 218
           + +L+Y++M N +L+ HL+    P   + W+ RL I +GAA GL YLH      +I+RD 
Sbjct: 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDV 165

Query: 219 KASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVW 278
           K+ N+LLDENF PK++DFG++++G  +  TH+ST V GT GY  P+Y   G LT KSDV+
Sbjct: 166 KSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVY 225

Query: 279 SFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARK 338
           SFGVVL+E+L  R ++ ++ P+    L EW  +   ++ +   I+DP L  +      RK
Sbjct: 226 SFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQLEQIVDPNLADKIRPESLRK 284

Query: 339 IGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN 372
            G  A  CL+ SS+DRP M  V+ +L+  +++  
Sbjct: 285 FGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  391 bits (1008), Expect = e-135
 Identities = 128/338 (37%), Positives = 193/338 (57%), Gaps = 27/338 (7%)

Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVA 115
            E  E     L+ FS  E++ A+++FS    +G GGFG VYK  +     DGT    +VA
Sbjct: 7   EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----DGT----LVA 58

Query: 116 IKKLNRDGLQGHK-QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL 174
           +K+L  +  QG + Q+  EV+ + +  H NL++L G+C        +RLLVY +M N S+
Sbjct: 59  VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM----TPTERLLVYPYMANGSV 114

Query: 175 EDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK 232
              L  R  + PPL W  R  I LG+A GLAYLH+  + ++I+RD KA+N+LLDE F   
Sbjct: 115 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174

Query: 233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           + DFGLA+       THV+TAV GT G+ AP+Y+ TG  + K+DV+ +GV+L E++TG+R
Sbjct: 175 VGDFGLAKLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233

Query: 293 SLERNRPKTEQR--LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKS 350
           + +  R   +    LL+WV+    + KK   ++D  L+  Y   E  ++ ++A  C   S
Sbjct: 234 AFDLARLANDDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS 292

Query: 351 SKDRPKMSQVVERLKQIVQVSNEGDSFDKTFEEICEED 388
             +RPKMS+VV  L        EGD   + +EE  +E+
Sbjct: 293 PMERPKMSEVVRML--------EGDGLAERWEEWQKEE 322

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  261 bits (669), Expect = 1e-84
 Identities = 70/321 (21%), Positives = 121/321 (37%), Gaps = 30/321 (9%)

Query: 69  FSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK 128
                +   +     +     G FG V+K                VA+K       Q  +
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWK---------AQLLNEYVAVKIFPIQDKQSWQ 64

Query: 129 QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPW 188
               EV  L  ++H N+++ IG         +   L+  F    SL D L       + W
Sbjct: 65  N-EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSW 120

Query: 189 KTRLHIILGAAEGLAYLHEGLEVQ-------VIYRDFKASNVLLDENFRPKLSDFGLARE 241
               HI    A GLAYLHE +          + +RD K+ NVLL  N    ++DFGLA +
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180

Query: 242 GPMVGHTHVSTAVVGTFGYAAPDYIETGHL-----TAKSDVWSFGVVLYEMLTGRRSLER 296
                    +   VGT  Y AP+ +E           + D+++ G+VL+E+ +   + + 
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

Query: 297 NRPKTEQRLLEWVQQYPADSKKFGLI----MDPRLEKEYSINEA-RKIGRLADNCLSKSS 351
              +      E + Q+P+      ++      P L   +  +     +    + C    +
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300

Query: 352 KDRPKMSQVVERLKQIVQVSN 372
           + R     V ER+ Q+ +++N
Sbjct: 301 EARLSAGCVGERITQMQRLTN 321

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  205 bits (524), Expect = 5e-63
 Identities = 67/335 (20%), Positives = 131/335 (39%), Gaps = 45/335 (13%)

Query: 69  FSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK 128
            + SE     ++   +  IG G +G+VYK         G+ +   VA+K  +       +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYK---------GSLDERPVAVKVFSF---ANRQ 50

Query: 129 QWVAE--VQFLGVLEHPNLVKLIGYCA-VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP 185
            ++ E  +  + ++EH N+ + I     V  +  ++ LLV E+  N SL  +L       
Sbjct: 51  NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---T 107

Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEV------QVIYRDFKASNVLLDENFRPKLSDFGLA 239
             W +   +      GLAYLH  L         + +RD  + NVL+  +    +SDFGL+
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

Query: 240 R------EGPMVGHTHVSTAVVGTFGYAAPDYIE-------TGHLTAKSDVWSFGVVLYE 286
                          + + + VGT  Y AP+ +E             + D+++ G++ +E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227

Query: 287 MLTGRRSLERNRPKTEQRL--LEWVQQYPADSKKFGLI----MDPRLEKEYSINEA--RK 338
           +      L       E ++     V  +P       L+      P+  + +  N    R 
Sbjct: 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287

Query: 339 IGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE 373
           +    ++C  + ++ R       ER+ +++ +   
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  188 bits (480), Expect = 8e-57
 Identities = 77/331 (23%), Positives = 127/331 (38%), Gaps = 54/331 (16%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
            +      +G G FG V K             A  VAIK++  +  +  K ++ E++ L 
Sbjct: 8   KEIEVEEVVGRGAFGVVCK---------AKWRAKDVAIKQIESESER--KAFIVELRQLS 56

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFN-RAFPPLPWKTRLHIIL 196
            + HPN+VKL G C       +  + LV E+    SL + L      P       +   L
Sbjct: 57  RVNHPNIVKLYGAC-------LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR-PKLSDFGLAREGPMVGHTHVSTAVV 255
             ++G+AYLH      +I+RD K  N+LL       K+ DFG A +          T   
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNK 164

Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
           G+  + AP+  E  + + K DV+S+G++L+E++T R+      P  E  +     +    
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK------PFDE--IGGPAFRIMWA 216

Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGD 375
                     R     ++ +   I  L   C SK    RP M ++V+ +  ++       
Sbjct: 217 VHN-----GTRPPLIKNLPKP--IESLMTRCWSKDPSQRPSMEEIVKIMTHLM------- 262

Query: 376 SFDKTFEEICEEDPVEAQTKQKQHEPSEAWK 406
                       D       Q    P E  +
Sbjct: 263 ------RYFPGADEPLQYPCQHSLPPGEDGR 287

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  185 bits (471), Expect = 2e-55
 Identities = 73/287 (25%), Positives = 127/287 (44%), Gaps = 35/287 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH--KQWVAEVQFLGVLEHP 143
           KIG G FG+V++              + VA+K L           +++ EV  +  L HP
Sbjct: 44  KIGAGSFGTVHR---------AEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGL 202
           N+V  +G       +     +V E++   SL   L    A   L  + RL +    A+G+
Sbjct: 95  NIVLFMGAVT----QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150

Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
            YLH      +++R+ K+ N+L+D+ +  K+ DFGL+R          S +  GT  + A
Sbjct: 151 NYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMA 207

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
           P+ +       KSDV+SFGV+L+E+ T +      +P      L   Q   A   K    
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQ------QPWGN---LNPAQVVAAVGFK-CK- 256

Query: 323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
              RLE   ++N    +  + + C +     RP  + +++ L+ +++
Sbjct: 257 ---RLEIPRNLNPQ--VAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  183 bits (466), Expect = 9e-55
 Identities = 73/335 (21%), Positives = 125/335 (37%), Gaps = 55/335 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
            +G+G FG   K + +      T E  V+ +K+L R   +  + ++ EV+ +  LEHPN+
Sbjct: 17  VLGKGCFGQAIKVTHR-----ETGE--VMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           +K IG    D     +   + E++   +L   + +      PW  R+      A G+AYL
Sbjct: 70  LKFIGVLYKDK----RLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYL 124

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR------------EGPMVGHTHVSTA 253
           H    + +I+RD  + N L+ EN    ++DFGLAR                         
Sbjct: 125 HS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 313
           VVG   + AP+ I       K DV+SFG+VL E++    +     P+T    L       
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL- 240

Query: 314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE 373
                             +   +     +   C     + RP   ++   L+ +      
Sbjct: 241 ------------DRYCPPNCPPS--FFPITVRCCDLDPEKRPSFVKLEHWLETL------ 280

Query: 374 GDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRR 408
                     +    P+  Q +Q      E ++R 
Sbjct: 281 -------RMHLAGHLPLGPQLEQLDRGFWETYRRG 308

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  182 bits (463), Expect = 1e-54
 Identities = 77/298 (25%), Positives = 132/298 (44%), Gaps = 52/298 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-------EVQFLG 138
           +IG+GGFG V+K       G    + +VVAIK L     +G  + +        EV  + 
Sbjct: 26  QIGKGGFGLVHK-------GRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
            L HPN+VKL G              +V EF+    L   L ++A  P+ W  +L ++L 
Sbjct: 79  NLNHPNIVKLYGLM-------HNPPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLD 130

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDE-----NFRPKLSDFGLAREGPMVGHTHVST 252
            A G+ Y+       +++RD ++ N+ L           K++DFGL+++       H  +
Sbjct: 131 IALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVS 184

Query: 253 AVVGTFGYAAPDYIETGHL--TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
            ++G F + AP+ I       T K+D +SF ++LY +LTG        P  E     + +
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE------GPFDE---YSYGK 235

Query: 311 -QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
            ++    ++ GL    R           ++  + + C S   K RP  S +V+ L ++
Sbjct: 236 IKFINMIREEGL----RPTIPEDCPP--RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  180 bits (458), Expect = 6e-54
 Identities = 75/297 (25%), Positives = 122/297 (41%), Gaps = 54/297 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA----EVQFLGVLE 141
            IG GGFG VY+                VA+K    D  +   Q +     E +   +L+
Sbjct: 14  IIGIGGFGKVYR---------AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           HPN++ L G C  +    +    V EF     L   L  +    +P    ++  +  A G
Sbjct: 65  HPNIIALRGVCLKEPNLCL----VMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARG 117

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRP--------KLSDFGLAREGPMVGHTHVSTA 253
           + YLH+   V +I+RD K+SN+L+ +            K++DFGLARE     H     +
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTKMS 173

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQ 310
             G + + AP+ I     +  SDVWS+GV+L+E+LTG        P        +   V 
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVAYGV- 226

Query: 311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
                      +    L    +  E     +L ++C +     RP  + ++++L  I
Sbjct: 227 ----------AMNKLALPIPSTCPEP--FAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  181 bits (461), Expect = 1e-53
 Identities = 63/307 (20%), Positives = 123/307 (40%), Gaps = 36/307 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV--AEVQFLGVLEHP 143
           +IG+G +G V+          G      VA+K            W    E+    ++ H 
Sbjct: 44  QIGKGRYGEVWM---------GKWRGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHE 91

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
           N++  I           Q  L+ ++  N SL D+L +     L  K+ L +   +  GL 
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLC 148

Query: 204 YLHEGLEVQ-----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH--VSTAVVG 256
           +LH  +        + +RD K+ N+L+ +N    ++D GLA +     +         VG
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208

Query: 257 TFGYAAP----DYIETGHLTA--KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
           T  Y  P    + +   H  +   +D++SFG++L+E+   R        + +    + V 
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVP 267

Query: 311 QYPADSKKFGLI----MDPRLEKEYSINEA-RKIGRLADNCLSKSSKDRPKMSQVVERLK 365
             P+      ++    + P     +S +E  R++G+L   C + +   R    +V + L 
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

Query: 366 QIVQVSN 372
           ++ +  +
Sbjct: 328 KMSESQD 334

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  181 bits (461), Expect = 1e-53
 Identities = 79/370 (21%), Positives = 142/370 (38%), Gaps = 57/370 (15%)

Query: 21  PELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPEL-YEEKAHNLRVFSYSEMRQATN 79
           P L  P  S   +  +    + +S S S     G+P L     A  + +           
Sbjct: 3   PSLDRPFISEGTTLKDLIYDMTTSGSGS-----GLPLLVQRTIARTIVLQE--------- 48

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAE--VQFL 137
                  IG+G FG V++         G      VA+K  +    +  + W  E  +   
Sbjct: 49  ------SIGKGRFGEVWR---------GKWRGEEVAVKIFSS---REERSWFREAEIYQT 90

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
            +L H N++  I     D     Q  LV ++  + SL D+L       +  +  + + L 
Sbjct: 91  VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALS 147

Query: 198 AAEGLAYLHEGLEVQ-----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH--V 250
            A GLA+LH  +        + +RD K+ N+L+ +N    ++D GLA        T    
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207

Query: 251 STAVVGTFGYAAP----DYIETGHLTA--KSDVWSFGVVLYEMLTGRRSLERNRPKTEQR 304
               VGT  Y AP    D I   H  +  ++D+++ G+V +E+   R S+       +  
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLP 266

Query: 305 LLEWVQQYPADSKKFGLIMD----PRLEKEYSINEA-RKIGRLADNCLSKSSKDRPKMSQ 359
             + V   P+  +   ++ +    P +   +   EA R + ++   C   +   R    +
Sbjct: 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326

Query: 360 VVERLKQIVQ 369
           + + L Q+ Q
Sbjct: 327 IKKTLSQLSQ 336

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  177 bits (451), Expect = 6e-53
 Identities = 53/287 (18%), Positives = 107/287 (37%), Gaps = 40/287 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH--KQWVAEVQFLGVLEHP 143
           K+ E   G ++K         G  +   + +K L          + +  E   L +  HP
Sbjct: 17  KLNENHSGELWK---------GRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
           N++ ++G C           L+  +M   SL + L       +     +   L  A G+A
Sbjct: 68  NVLPVLGAC--QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           +LH  LE  +      + +V++DE+   ++S   +            S   +    + AP
Sbjct: 126 FLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMYAPAWVAP 177

Query: 264 DYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG 320
           + ++          +D+WSF V+L+E++T         P  +   +E   +         
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTRE------VPFADLSNMEIGMKV-------- 223

Query: 321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
            +   R      I+    + +L   C+++    RPK   +V  L+++
Sbjct: 224 ALEGLRPTIPPGISPH--VSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  177 bits (450), Expect = 2e-52
 Identities = 63/302 (20%), Positives = 119/302 (39%), Gaps = 36/302 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAE--VQFLGVLEHP 143
            +G+G +G V++         G+ +   VA+K  +    +  K W  E  +    +L H 
Sbjct: 15  CVGKGRYGEVWR---------GSWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHE 62

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
           N++  I           Q  L+  +    SL D+L       L   + L I+L  A GLA
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLA 119

Query: 204 YLHEGLEVQ-----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV--STAVVG 256
           +LH  +        + +RD K+ N+L+ +N +  ++D GLA       +     +   VG
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179

Query: 257 TFGYAAP------DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
           T  Y AP        ++      + D+W+FG+VL+E+   R          +    + V 
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVP 238

Query: 311 QYPADSKKFGLIMD----PRLEKEYSINEA-RKIGRLADNCLSKSSKDRPKMSQVVERLK 365
             P+      ++      P +   +  +     + +L   C  ++   R    ++ + L 
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

Query: 366 QI 367
           +I
Sbjct: 299 KI 300

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  176 bits (448), Expect = 3e-52
 Identities = 75/289 (25%), Positives = 128/289 (44%), Gaps = 36/289 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH--KQWVAEVQFLGVLEHP 143
           +IG G FG+VYK       GD       VA+K LN         + +  EV  L    H 
Sbjct: 31  RIGSGSFGTVYKGKWH---GD-------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
           N++  +GY         Q  +V ++    SL  HL          K  + I    A G+ 
Sbjct: 81  NILLFMGYS-----TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMD 134

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH      +I+RD K++N+ L E+   K+ DFGLA E      +H    + G+  + AP
Sbjct: 135 YLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

Query: 264 DYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG 320
           + I   ++   + +SDV++FG+VLYE++TG+        +   +++E V          G
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVG--------RG 241

Query: 321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
            +     +   +  +   + RL   CL K   +RP   +++  ++++ +
Sbjct: 242 SLSPDLSKVRSNCPKR--MKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  164 bits (416), Expect = 3e-47
 Identities = 53/296 (17%), Positives = 106/296 (35%), Gaps = 49/296 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH--KQWVAEVQFLGVLEHP 143
            IG+G FG VY        G+       VAI+ ++ +       K +  EV       H 
Sbjct: 40  LIGKGRFGQVYHGRWH---GE-------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
           N+V  +G C       I    +      R+L   + +     L       I     +G+ 
Sbjct: 90  NVVLFMGACMSPPHLAI----ITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMG 144

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE---GPMVGHTHVSTAVVGTFGY 260
           YLH      ++++D K+ NV  D   +  ++DFGL                    G   +
Sbjct: 145 YLHA---KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200

Query: 261 AAPDYI---------ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 311
            AP+ I         +    +  SDV++ G + YE+       +       + ++  +  
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQMGT 257

Query: 312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
                   G+  +     +  + +   I  +   C +   ++RP  +++++ L+++
Sbjct: 258 --------GMKPNLS---QIGMGKE--ISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  146 bits (370), Expect = 1e-40
 Identities = 77/301 (25%), Positives = 128/301 (42%), Gaps = 38/301 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P    G +   +VA+K+L   G    + +  E+Q L  L    +
Sbjct: 30  QLGKGNFGSVELCRYDP---LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VK  G     G + ++  LV E++ +  L D L       L     L       +G+ YL
Sbjct: 87  VKYRGVSYGPGRQSLR--LVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYL 143

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG-----Y 260
                 + ++RD  A N+L++     K++DFGLA+    +        VV   G     +
Sbjct: 144 G---SRRCVHRDLAARNILVESEAHVKIADFGLAK----LLPLDKDYYVVREPGQSPIFW 196

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKF 319
            AP+ +     + +SDVWSFGVVLYE+ T   +S   +      R++   +  PA S+  
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLL 254

Query: 320 GLIMD-PRLEK-------EYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS 371
            L+ +  RL          + + +          C + S +DRP  S +  +L  +   S
Sbjct: 255 ELLEEGQRLPAPPACPAEVHELMK---------LCWAPSPQDRPSFSALGPQLDMLWSGS 305

Query: 372 N 372
            
Sbjct: 306 R 306

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  145 bits (367), Expect = 3e-40
 Identities = 73/305 (23%), Positives = 121/305 (39%), Gaps = 51/305 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
            +GEG FG V      P   +G +    VA+K L  + G         E++ L  L H N
Sbjct: 28  DLGEGHFGKVELCRYDP---EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +VK  G C  DG  GI+  L+ EF+ + SL+++L       +  K +L   +   +G+ Y
Sbjct: 85  IVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDY 141

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG----- 259
           L      Q ++RD  A NVL++   + K+ DFGL +       T      V         
Sbjct: 142 LGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK----AIETDKEYYTVKDDRDSPVF 194

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTE-----------QRLLE 307
           + AP+ +        SDVWSFGV L+E+LT             +            RL+ 
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254

Query: 308 WVQQYPADSKKFGLIMD-PRL--EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 364
            +++        G  +  P    ++ Y +            C      +R     ++E  
Sbjct: 255 TLKE--------GKRLPCPPNCPDEVYQLMR---------KCWEFQPSNRTSFQNLIEGF 297

Query: 365 KQIVQ 369
           + +++
Sbjct: 298 EALLK 302

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  146 bits (370), Expect = 4e-40
 Identities = 75/292 (25%), Positives = 124/292 (42%), Gaps = 46/292 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
           +IG G FG V+        G   ++ T+VA+K            +++ E + L    HPN
Sbjct: 121 QIGRGNFGEVFS-------GRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +V+LIG C     +     +V E +        L       L  KT L ++  AA G+ Y
Sbjct: 174 IVRLIGVCT----QKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEY 228

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY--AA 262
           L        I+RD  A N L+ E    K+SDFG++RE       + ++  +        A
Sbjct: 229 LES---KCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTA 283

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLEWVQQ-YPADSK 317
           P+ +  G  +++SDVWSFG++L+E  + G        P    + Q+  E+V++       
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGA------SPYPNLSNQQTREFVEKGG----- 332

Query: 318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                   RL       +A  + RL + C +     RP  S + + L+ I +
Sbjct: 333 --------RLPCPELCPDA--VFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  144 bits (365), Expect = 7e-40
 Identities = 85/298 (28%), Positives = 118/298 (39%), Gaps = 39/298 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
            +GEG FG V      P          +VA+K L  D G Q    W  E+  L  L H +
Sbjct: 38  DLGEGHFGKVSLYCYDP---TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           ++K  G C   G   +Q  LV E++   SL D+L   +   +     L       EG+AY
Sbjct: 95  IIKYKGCCEDAGAASLQ--LVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAY 149

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG----- 259
           LH       I+RD  A NVLLD +   K+ DFGLA+    V   H     V   G     
Sbjct: 150 LHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA---VPEGH-EYYRVREDGDSPVF 202

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKK 318
           + AP+ ++       SDVWSFGV LYE+LT    S        E   +   Q       +
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262

Query: 319 FGLIMDPRLEK-------EYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
             L    RL +        Y + +         NC    +  RP    ++  LK + +
Sbjct: 263 L-LERGERLPRPDKCPAEVYHLMK---------NCWETEASFRPTFENLIPILKTVHE 310

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  143 bits (363), Expect = 7e-40
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 14/207 (6%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P   +      VVA+KKL     +  + +  E++ L  L+H N+
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDN---TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VK  G C   G R ++  L+ E++   SL D+L       +     L       +G+ YL
Sbjct: 74  VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL 130

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
                 + I+RD    N+L++   R K+ DFGL +   +                  + A
Sbjct: 131 G---TKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEFFKVKEPGESPIFWYA 185

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT 289
           P+ +     +  SDVWSFGVVLYE+ T
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  143 bits (362), Expect = 2e-39
 Identities = 62/296 (20%), Positives = 112/296 (37%), Gaps = 41/296 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+GEGGF  V          +G  +    A+K++     Q  ++   E     +  HPN+
Sbjct: 36  KLGEGGFSYVDL-------VEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHIILGAAEGLA 203
           ++L+ YC  +     +  L+  F    +L + +         L     L ++LG   GL 
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS-------TAVVG 256
            +H        +RD K +N+LL +  +P L D G   +  +               A   
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205

Query: 257 TFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY- 312
           T  Y AP+         +  ++DVWS G VLY M+ G    +    K +   L    Q  
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265

Query: 313 -PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
            P   +             +S +   +   L ++ ++     RP +  ++ +L+ +
Sbjct: 266 IPQSPR-------------HS-SALWQ---LLNSMMTVDPHQRPHIPLLLSQLEAL 304

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  143 bits (362), Expect = 2e-39
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G+G FGSV      P   +      VVA+KKL     +  + +  E++ L  L+H N+
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDN---TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VK  G C   G R ++  L+ E++   SL D+L       +     L       +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL 161

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG-----Y 260
                 + I+RD    N+L++   R K+ DFGL +   ++         V   G     +
Sbjct: 162 G---TKRYIHRDLATRNILVENENRVKIGDFGLTK---VLPQDK-EYYKVKEPGESPIFW 214

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
            AP+ +     +  SDVWSFGVVLYE+ T
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFT 243

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  142 bits (361), Expect = 6e-38
 Identities = 75/303 (24%), Positives = 135/303 (44%), Gaps = 42/303 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G +G VY+       G     +  VA+K L ++     ++++ E   +  ++HPNL
Sbjct: 227 KLGGGQYGEVYE-------GVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L+G C  +        ++ EFM   +L D+L       +     L++    +  + YL
Sbjct: 279 VQLLGVCTREP----PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY--AAP 263
            +      I+R+  A N L+ EN   K++DFGL+R   M G T+ + A    F     AP
Sbjct: 335 EK---KNFIHRNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAG-AKFPIKWTAP 388

Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 323
           + +     + KSDVW+FGV+L+E+ T   S       ++  + E +++           M
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEK--------DYRM 438

Query: 324 D-PRL--EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDKT 380
           + P    EK Y +            C   +  DRP  +++ +  + + Q S+  D  +K 
Sbjct: 439 ERPEGCPEKVYELMR---------ACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 489

Query: 381 FEE 383
             +
Sbjct: 490 LGK 492

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  138 bits (350), Expect = 1e-37
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 20/219 (9%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L         +  + E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 71

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
             +++P++ +L+G C           L+ + M    L D++       +  +  L+  + 
Sbjct: 72  ASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQ 125

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
            A+G+ YL +    ++++RD  A NVL+      K++DFGLA+   ++G         G 
Sbjct: 126 IAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK---LLGAEEKEYHAEGG 179

Query: 258 ---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 292
                + A + I     T +SDVWS+GV ++E++T G +
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  139 bits (351), Expect = 1e-37
 Identities = 66/353 (18%), Positives = 130/353 (36%), Gaps = 47/353 (13%)

Query: 65  NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL 124
                 +  M      + R+ KIGEG FG                +     IK++N   +
Sbjct: 14  GTENLYFQSM----EKYVRLQKIGEGSFGKAILVKST-------EDGRQYVIKEINISRM 62

Query: 125 QGH--KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA 182
                ++   EV  L  ++HPN+V+       +G   I    V ++     L   +  + 
Sbjct: 63  SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI----VMDYCEGGDLFKRINAQK 118

Query: 183 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 242
                    L   +     L ++H+    ++++RD K+ N+ L ++   +L DFG+AR  
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARV- 174

Query: 243 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE-RNRPKT 301
            +     ++ A +GT  Y +P+  E      KSD+W+ G VLYE+ T + + E  +    
Sbjct: 175 -LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233

Query: 302 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP------ 355
             +++     +            P +   YS  + R    L      ++ +DRP      
Sbjct: 234 VLKIIS--GSF------------PPVSLHYS-YDLRS---LVSQLFKRNPRDRPSVNSIL 275

Query: 356 KMSQVVERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRR 408
           +   + +R+++ +      + F           P+ A+              +
Sbjct: 276 EKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQ 328

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  137 bits (346), Expect = 2e-37
 Identities = 65/303 (21%), Positives = 120/303 (39%), Gaps = 51/303 (16%)

Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ 129
           +++  ++   DF  +  IG GGFG V+K+  +        +     IK++  +  +  + 
Sbjct: 2   AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHR-------IDGKTYVIKRVKYNNEKAER- 53

Query: 130 WVAEVQFLGVLEHPNLVKLIGY---------CAVDGERGIQRLLVY---EFMLNRSLEDH 177
              EV+ L  L+H N+V   G           +       +   ++   EF    +LE  
Sbjct: 54  ---EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQW 110

Query: 178 LFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 237
           +  R    L     L +     +G+ Y+H     ++I RD K SN+ L +  + K+ DFG
Sbjct: 111 IEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFG 167

Query: 238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           L      + +    T   GT  Y +P+ I +     + D+++ G++L E+L    +    
Sbjct: 168 LVT---SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT---- 220

Query: 298 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM 357
                             SK F  + D  +   +   + +    L    LSK  +DRP  
Sbjct: 221 --------------AFETSKFFTDLRDGIISDIFD-KKEKT---LLQKLLSKKPEDRPNT 262

Query: 358 SQV 360
           S++
Sbjct: 263 SEI 265

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  139 bits (353), Expect = 4e-37
 Identities = 75/302 (24%), Positives = 120/302 (39%), Gaps = 46/302 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G+G FG V+  +            T VAIK L + G    + ++ E Q +  L H  L
Sbjct: 191 KLGQGCFGEVWMGTWNGT--------TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 241

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L    + +        +V E+M   SL D L       L     + +    A G+AY+
Sbjct: 242 VQLYAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAA 262
                +  ++RD +A+N+L+ EN   K++DFGLAR   +            +  T    A
Sbjct: 297 ER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----A 349

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
           P+    G  T KSDVWSFG++L E+ T  R         E  +L+ V++        G  
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVER--------GYR 399

Query: 323 MD-PRL--EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDK 379
           M  P    E  + +            C  K  ++RP    +   L+     +       +
Sbjct: 400 MPCPPECPESLHDLMC---------QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 450

Query: 380 TF 381
             
Sbjct: 451 NL 452

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  139 bits (351), Expect = 9e-37
 Identities = 65/237 (27%), Positives = 99/237 (41%), Gaps = 28/237 (11%)

Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVA 115
           P++ E        F  S       +   +  IG+G FG V           G      VA
Sbjct: 170 PKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVML---------GDYRGNKVA 220

Query: 116 IKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE 175
           +K +  D     + ++AE   +  L H NLV+L+G    +        +V E+M   SL 
Sbjct: 221 VKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKG---GLYIVTEYMAKGSLV 275

Query: 176 DHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD 235
           D+L +R    L     L   L   E + YL        ++RD  A NVL+ E+   K+SD
Sbjct: 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSD 332

Query: 236 FGLAREGPMVGHTHVSTAVVGT-FGY--AAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           FGL +E         S+            AP+ +     + KSDVWSFG++L+E+ +
Sbjct: 333 FGLTKE--------ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  135 bits (341), Expect = 1e-36
 Identities = 63/221 (28%), Positives = 92/221 (41%), Gaps = 22/221 (9%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA---EVQ 135
            D   + K+G+G FG V +      +G   S    VA+K L  D L   +       EV 
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS----VAVKCLKPDVLSQPEAMDDFIREVN 73

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            +  L+H NL++L G         ++  +V E     SL D L           T     
Sbjct: 74  AMHSLDHRNLIRLYGVVL---TPPMK--MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYA 127

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
           +  AEG+ YL      + I+RD  A N+LL      K+ DFGL R   +  +        
Sbjct: 128 VQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR--ALPQNDDHYVMQE 182

Query: 256 GT---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 292
                F + AP+ ++T   +  SD W FGV L+EM T G+ 
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  139 bits (352), Expect = 2e-36
 Identities = 75/302 (24%), Positives = 120/302 (39%), Gaps = 46/302 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G+G FG V+  +            T VAIK L + G    + ++ E Q +  L H  L
Sbjct: 274 KLGQGCFGEVWMGTWNGT--------TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 324

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L    + +        +V E+M   SL D L       L     + +    A G+AY+
Sbjct: 325 VQLYAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR---EGPMVGHTHVSTAVVGTFGYAA 262
                +  ++RD +A+N+L+ EN   K++DFGLAR   +            +  T    A
Sbjct: 380 ER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----A 432

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
           P+    G  T KSDVWSFG++L E+ T  R         E  +L+ V++        G  
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVER--------GYR 482

Query: 323 MD-PRL--EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFDK 379
           M  P    E  + +            C  K  ++RP    +   L+     +       +
Sbjct: 483 MPCPPECPESLHDLMC---------QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 533

Query: 380 TF 381
             
Sbjct: 534 NL 535

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  135 bits (342), Expect = 4e-36
 Identities = 88/389 (22%), Positives = 143/389 (36%), Gaps = 56/389 (14%)

Query: 10  KKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVF 69
               RR    A  +  PR S    G  S   + +S      S     +       +L   
Sbjct: 12  HHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSAL 71

Query: 70  SYSEMRQATNDFSRML---------KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN 120
           +  E+ QA                  IG G FG VY  ++     D   +    A+K LN
Sbjct: 72  N-PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLL----DNDGKKIHCAVKSLN 126

Query: 121 RD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF 179
           R   +    Q++ E   +    HPN++ L+G C          L+V  +M +  L + + 
Sbjct: 127 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIR 183

Query: 180 NRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA 239
           N        K  +   L  A+G+ +L      + ++RD  A N +LDE F  K++DFGLA
Sbjct: 184 NET-HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLA 239

Query: 240 REGPMVGHTHVSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRS 293
           R+   +      +    T       + A + ++T   T KSDVWSFGV+L+E++T G   
Sbjct: 240 RD---MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-- 294

Query: 294 LERNRP---KTEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSK 349
                P        +  ++ Q        G  +  P             +  +   C   
Sbjct: 295 ----PPYPDVNTFDITVYLLQ--------GRRLLQPE-------YCPDPLYEVMLKCWHP 335

Query: 350 SSKDRPKMSQVVERLKQIVQVSNEGDSFD 378
            ++ RP  S++V R+  I           
Sbjct: 336 KAEMRPSFSELVSRISAIFSTFIGEHYVH 364

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  133 bits (336), Expect = 5e-36
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 29/211 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
            IG+G FG V           G      VA+K +  D     + ++AE   +  L H NL
Sbjct: 28  TIGKGEFGDVML---------GDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 76

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L+G   V+ + G+   +V E+M   SL D+L +R    L     L   L   E + YL
Sbjct: 77  VQLLGVI-VEEKGGL--YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
                   ++RD  A NVL+ E+   K+SDFGL +E         S+          + A
Sbjct: 134 EG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--------ASSTQDTGKLPVKWTA 182

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 292
           P+ +     + KSDVWSFG++L+E+ + GR 
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRV 213

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  133 bits (337), Expect = 5e-36
 Identities = 75/295 (25%), Positives = 122/295 (41%), Gaps = 46/295 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
            IG G FG VY  ++     D   +    A+K LNR   +    Q++ E   +    HPN
Sbjct: 32  VIGRGHFGCVYHGTLL----DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           ++ L+G C          L+V  +M +  L + + N        K  +   L  A+G+ Y
Sbjct: 88  VLSLLGICL---RSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKY 143

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG----- 259
           L      + ++RD  A N +LDE F  K++DFGLAR+   +      +    T       
Sbjct: 144 LAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD---MYDKEYYSVHNKTGAKLPVK 197

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLEWVQQYPAD 315
           + A + ++T   T KSDVWSFGV+L+E++T G        P        +  ++ Q    
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGA------PPYPDVNTFDITVYLLQ---- 247

Query: 316 SKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
               G  +  P             +  +   C    ++ RP  S++V R+  I  
Sbjct: 248 ----GRRLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  132 bits (335), Expect = 6e-36
 Identities = 72/300 (24%), Positives = 120/300 (40%), Gaps = 42/300 (14%)

Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWV 131
           M     D+  +  IG G +G   K   K       S+  ++  K+L+   +     +  V
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRK-------SDGKILVWKELDYGSMTEAEKQMLV 53

Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHL--FNRAFPPLPW 188
           +EV  L  L+HPN+V+   Y     +R    L +V E+     L   +    +    L  
Sbjct: 54  SEVNLLRELKHPNIVR---YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 110

Query: 189 KTRLHIILGAAEGLAYLHE--GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
           +  L ++      L   H        V++RD K +NV LD     KL DFGLAR   +  
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNH 168

Query: 247 HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQ 303
            T  +   VGT  Y +P+ +       KSD+WS G +LYE+           P    +++
Sbjct: 169 DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQK 222

Query: 304 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 363
            L   +++        G     R+   YS +E  +   +    L+     RP + +++E 
Sbjct: 223 ELAGKIRE--------GKF--RRIPYRYS-DELNE---IITRMLNLKDYHRPSVEEILEN 268

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  136 bits (345), Expect = 7e-36
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 23/210 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G FG V+ ++            T VA+K + + G    + ++AE   +  L+H  L
Sbjct: 195 KLGAGQFGEVWMATYNKH--------TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKL 245

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VKL      +        ++ EFM   SL D L +      P    +      AEG+A++
Sbjct: 246 VKLHAVVTKEP-----IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY--AAP 263
            +      I+RD +A+N+L+  +   K++DFGLAR    +     +      F     AP
Sbjct: 301 EQ---RNYIHRDLRAANILVSASLVCKIADFGLARV---IEDNEYTAREGAKFPIKWTAP 354

Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLT-GRR 292
           + I  G  T KSDVWSFG++L E++T GR 
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRI 384

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  132 bits (335), Expect = 7e-36
 Identities = 75/308 (24%), Positives = 133/308 (43%), Gaps = 52/308 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G +G VY+       G     +  VA+K L ++     ++++ E   +  ++HPNL
Sbjct: 20  KLGGGQYGEVYE-------GVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L+G C  +        ++ EFM   +L D+L       +     L++    +  + YL
Sbjct: 72  VQLLGVCTREP----PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            +      I+RD  A N L+ EN   K++DFGL+R    +      TA  G      + A
Sbjct: 128 EK---KNFIHRDLAARNCLVGENHLVKVADFGLSR----LMTGDTYTAHAGAKFPIKWTA 180

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLEWVQQYPADSKK 318
           P+ +     + KSDVW+FGV+L+E+ T G        P       ++ E +++       
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGM------SPYPGIDLSQVYELLEK------- 227

Query: 319 FGLIMD-PRL--EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGD 375
               M+ P    EK Y +            C   +  DRP  +++ +  + + Q S+  D
Sbjct: 228 -DYRMERPEGCPEKVYELMR---------ACWQWNPSDRPSFAEIHQAFETMFQESSISD 277

Query: 376 SFDKTFEE 383
             +K   +
Sbjct: 278 EVEKELGK 285

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  133 bits (336), Expect = 9e-36
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 20/212 (9%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
            +G G FG+V+K    P   +G S    V IK +    G Q  +     +  +G L+H +
Sbjct: 20  VLGSGVFGTVHKGVWIP---EGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +V+L+G C           LV +++   SL DH+       L  +  L+  +  A+G+ Y
Sbjct: 77  IVRLLGLCPGS-----SLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYY 130

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           L E     +++R+  A NVLL    + +++DFG+A    ++                 + 
Sbjct: 131 LEE---HGMVHRNLAARNVLLKSPSQVQVADFGVAD---LLPPDDKQLLYSEAKTPIKWM 184

Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 292
           A + I  G  T +SDVWS+GV ++E++T G  
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  132 bits (335), Expect = 2e-35
 Identities = 57/219 (26%), Positives = 106/219 (48%), Gaps = 20/219 (9%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFL 137
            +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVM 71

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
             +++P++ +L+G C           L+ + M    L D++       +  +  L+  + 
Sbjct: 72  ASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQ 125

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
            A+G+ YL +    ++++RD  A NVL+      K++DFGLA+   ++G         G 
Sbjct: 126 IAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK---LLGAEEKEYHAEGG 179

Query: 258 ---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 292
                + A + I     T +SDVWS+GV ++E++T G +
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  131 bits (331), Expect = 2e-35
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 20/211 (9%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPN 144
            +GEG FG VY+       G+  +    VA+K   +D    +K+ +++E   +  L+HP+
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKIN----VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +VKLIG    +        ++ E      L  +L       L   T +   L   + +AY
Sbjct: 75  IVKLIGIIEEE-----PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAY 128

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAA 262
           L     +  ++RD    N+L+      KL DFGL+R    +       A V      + +
Sbjct: 129 LES---INCVHRDIAVRNILVASPECVKLGDFGLSRY---IEDEDYYKASVTRLPIKWMS 182

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 292
           P+ I     T  SDVW F V ++E+L+ G++
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  131 bits (331), Expect = 3e-35
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 21/213 (9%)

Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHP 143
           +++G G FGSV +   +            VAIK L +   +   +  + E Q +  L++P
Sbjct: 16  IELGCGNFGSVRQGVYRMRKKQ-----IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 70

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
            +V+LIG C  +       +LV E      L   L  +    +P      ++   + G+ 
Sbjct: 71  YIVRLIGVCQAE-----ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMK 124

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGY 260
           YL E      ++RD  A NVLL      K+SDFGL++   +       TA         +
Sbjct: 125 YLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA--LGADDSYYTARSAGKWPLKW 179

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 292
            AP+ I     +++SDVWS+GV ++E L+ G++
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  130 bits (330), Expect = 4e-35
 Identities = 50/223 (22%), Positives = 86/223 (38%), Gaps = 36/223 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
            +G+G F  ++K   +     G    T V +K L++      + +      +  L H +L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V   G C      G + +LV EF+   SL+ +L       +    +L +    A  + +L
Sbjct: 75  VLNYGVCV----CGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFL 129

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRP--------KLSDFGLAREGPMVGHTHVSTAVVGT 257
               E  +I+ +  A N+LL              KLSD G++              V+  
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPK 174

Query: 258 FGY------AAPDYIETG-HLTAKSDVWSFGVVLYEMLT-GRR 292
                      P+ IE   +L   +D WSFG  L+E+ + G +
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  130 bits (328), Expect = 5e-35
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 23/210 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V+               T VA+K L + G      ++AE   +  L+H  L
Sbjct: 20  RLGAGQFGEVWMGYYNGH--------TKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 70

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L        +  I   ++ E+M N SL D L   +   L     L +    AEG+A++
Sbjct: 71  VRLYAVVT---QEPI--YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY--AAP 263
            E      I+RD +A+N+L+ +    K++DFGLAR    +     +      F     AP
Sbjct: 126 EE---RNYIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEYTAREGAKFPIKWTAP 179

Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLT-GRR 292
           + I  G  T KSDVWSFG++L E++T GR 
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRI 209

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  130 bits (328), Expect = 7e-35
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 23/213 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHP 143
           ++G G FG+V K   +            VA+K L  +        + +AE   +  L++P
Sbjct: 24  ELGSGNFGTVKKGYYQ-----MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 78

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
            +V++IG C  +       +LV E      L  +L  +    +  K  + ++   + G+ 
Sbjct: 79  YIVRMIGICEAE-----SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMK 131

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGY 260
           YL E      ++RD  A NVLL      K+SDFGL++   +    +   A         +
Sbjct: 132 YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKA--LRADENYYKAQTHGKWPVKW 186

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 292
            AP+ I     ++KSDVWSFGV+++E  + G++
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  130 bits (328), Expect = 7e-35
 Identities = 69/305 (22%), Positives = 119/305 (39%), Gaps = 49/305 (16%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFL 137
            DF  +  +G GGFG V+++  K    D        AIK++     +  ++ V  EV+ L
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKV---DDC----NYAIKRIRLPNRELAREKVMREVKAL 57

Query: 138 GVLEHPNLVKLIGY-----CAVDGERGIQRLLVY---EFMLNRSLEDHLFNR-AFPPLPW 188
             LEHP +V+              +    ++ +Y   +     +L+D +  R        
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117

Query: 189 KTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE------- 241
              LHI L  AE + +LH      +++RD K SN+    +   K+ DFGL          
Sbjct: 118 SVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174

Query: 242 ---GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNR 298
                 +      T  VGT  Y +P+ I     + K D++S G++L+E+L    S +  R
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-PFSTQMER 233

Query: 299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS 358
            +T   +     ++P    +                E   +       LS S  +RP+  
Sbjct: 234 VRTLTDVRN--LKFPPLFTQ------------KYPCEYVMVQD----MLSPSPMERPEAI 275

Query: 359 QVVER 363
            ++E 
Sbjct: 276 NIIEN 280

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  130 bits (330), Expect = 8e-35
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 23/214 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPN 144
            IG G  G V    ++            VAIK L     +  ++ +++E   +G  +HPN
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVP----VAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +++L G       RG   ++V E+M N SL+  L             + ++ G   G+ Y
Sbjct: 112 IIRLEGVVT----RGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRY 166

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG----- 259
           L +   +  ++RD  A NVL+D N   K+SDFGL+R    V       A   T G     
Sbjct: 167 LSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR----VLEDDPDAAYTTTGGKIPIR 219

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 292
           + AP+ I     ++ SDVWSFGVV++E+L  G R
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  128 bits (325), Expect = 2e-34
 Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 20/211 (9%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPN 144
            IGEG FG V++             A  VAIK          ++ ++ E   +   +HP+
Sbjct: 22  CIGEGQFGDVHQGIYMSPEN----PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 77

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +VKLIG    +        ++ E      L   L  R    L   + +      +  LAY
Sbjct: 78  IVKLIGVITEN-----PVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAY 131

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAA 262
           L      + ++RD  A NVL+  N   KL DFGL+R    +  +    A  G     + A
Sbjct: 132 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMA 185

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 292
           P+ I     T+ SDVW FGV ++E+L  G +
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVK 216

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  129 bits (327), Expect = 2e-34
 Identities = 68/303 (22%), Positives = 129/303 (42%), Gaps = 54/303 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHP 143
            +GEG FGSV + ++K         +  VA+K +  D    +  +++++E   +    HP
Sbjct: 41  ILGEGEFGSVMEGNLK----QEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 144 NLVKLIGYCAVDGERGIQRLLV-YEFMLNRSLEDHLFNRAFP----PLPWKTRLHIILGA 198
           N+++L+G C     +GI + +V   FM    L  +L           +P +T L  ++  
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           A G+ YL        ++RD  A N +L ++    ++DFGL+++   +          G  
Sbjct: 157 ALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKK---IYSGDYYRQ--GRI 208

Query: 259 G-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLEWV 309
                 + A + +     T+KSDVW+FGV ++E+ T G        P        + +++
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM------TPYPGVQNHEMYDYL 262

Query: 310 QQYPADSKKFGLIMD-PR--LEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 366
                     G  +  P   L++ Y I           +C      DRP  S +  +L++
Sbjct: 263 LH--------GHRLKQPEDCLDELYEIMY---------SCWRTDPLDRPTFSVLRLQLEK 305

Query: 367 IVQ 369
           +++
Sbjct: 306 LLE 308

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  129 bits (326), Expect = 2e-34
 Identities = 76/304 (25%), Positives = 120/304 (39%), Gaps = 41/304 (13%)

Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK- 128
            Y+ +     +F    KIG G F  VY+            +   VA+KK+    L   K 
Sbjct: 27  GYNTL----ANFRIEKKIGRGQFSEVYR-------AACLLDGVPVALKKVQIFDLMDAKA 75

Query: 129 --QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFP 184
               + E+  L  L HPN++K       D E  I    V E      L   +  F +   
Sbjct: 76  RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI----VLELADAGDLSRMIKHFKKQKR 131

Query: 185 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
            +P +T     +     L ++H     +V++RD K +NV +      KL D GL R    
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF--F 186

Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR 304
              T  + ++VGT  Y +P+ I       KSD+WS G +LYEM   +     ++      
Sbjct: 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 246

Query: 305 LLEWVQ-QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER 363
             +  Q  YP           P     YS  E R+   L + C++   + RP ++ V + 
Sbjct: 247 CKKIEQCDYP-----------PLPSDHYS-EELRQ---LVNMCINPDPEKRPDVTYVYDV 291

Query: 364 LKQI 367
            K++
Sbjct: 292 AKRM 295

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  130 bits (329), Expect = 2e-34
 Identities = 62/238 (26%), Positives = 111/238 (46%), Gaps = 28/238 (11%)

Query: 69  FSYSEMRQATNDFSRML---------KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL 119
            ++ +  Q  ++F++ L          +G G FG V    +K  +    S    VAIK L
Sbjct: 26  HTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS----VAIKTL 81

Query: 120 NRDGLQGHKQ-WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 178
                +  ++ ++ E   +G  +HPN+++L G       +    ++V E+M N SL+  L
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSLDSFL 137

Query: 179 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 238
                        + ++ G A G+ YL +   +  ++RD  A N+L++ N   K+SDFGL
Sbjct: 138 RKHD-AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGL 193

Query: 239 AREGPMVGHTHVSTAVVGT---FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 292
            R   +      +    G      + +P+ I     T+ SDVWS+G+VL+E+++ G R
Sbjct: 194 GRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  128 bits (324), Expect = 3e-34
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
            IG+G FG VY         D        AIK L+R   +Q  + ++ E   +  L HPN
Sbjct: 28  VIGKGHFGVVYHGEYI----DQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           ++ LIG             ++  +M +  L   + +        K  +   L  A G+ Y
Sbjct: 84  VLALIGIMLPPEGL---PHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEY 139

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG----- 259
           L E    + ++RD  A N +LDE+F  K++DFGLAR+   +      +            
Sbjct: 140 LAE---QKFVHRDLAARNCMLDESFTVKVADFGLARD---ILDREYYSVQQHRHARLPVK 193

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLT 289
           + A + ++T   T KSDVWSFGV+L+E+LT
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  128 bits (323), Expect = 4e-34
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 20/210 (9%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHP 143
           +IG G F +VYK       G  T     VA  +L    L     +++  E + L  L+HP
Sbjct: 33  EIGRGSFKTVYK-------GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 85

Query: 144 NLVKLIGYCAVDGERGIQRLLVY-EFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           N+V+          +G + +++  E M + +L+ +L  + F  +  K          +GL
Sbjct: 86  NIVRFYDSW-ESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGL 142

Query: 203 AYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
            +LH      +I+RD K  N+ +       K+ D GLA     +     + AV+GT  + 
Sbjct: 143 QFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFM 197

Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+  E  +     DV++FG+ + EM T  
Sbjct: 198 APEMYEEKY-DESVDVYAFGMCMLEMATSE 226

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  128 bits (325), Expect = 4e-34
 Identities = 77/323 (23%), Positives = 138/323 (42%), Gaps = 54/323 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
           ++G+G FG VY+   K    D     T VAIK +N    ++   +++ E   +      +
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDE--PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------FNRAFPPLPWKTRLHIIL 196
           +V+L+G  +    +G   L++ E M    L+ +L         N    P      + +  
Sbjct: 90  VVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+   +  T       G
Sbjct: 146 EIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRD---IYET--DYYRKG 197

Query: 257 TFGY-----AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLE 307
             G       +P+ ++ G  T  SDVWSFGVVL+E+ T         +P    + +++L 
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE------QPYQGLSNEQVLR 251

Query: 308 WVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ 366
           +V +        G ++D P        N    +  L   C   + K RP   +++  +K+
Sbjct: 252 FVME--------GGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296

Query: 367 IVQVSNEGDSFDKTFEEICEEDP 389
            ++      SF  + E    E  
Sbjct: 297 EMEPGFREVSFYYSEENKLPEPE 319

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  127 bits (322), Expect = 8e-34
 Identities = 59/305 (19%), Positives = 112/305 (36%), Gaps = 50/305 (16%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFL 137
            +DF  +  +G+G FG V K+           ++   AIKK+     +     ++EV  L
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNA-------LDSRYYAIKKIRHTEEK-LSTILSEVMLL 56

Query: 138 GVLEHPNLVKLIG-YCAVDGERGIQRL--------LVYEFMLNRSLEDHLFNRAFPPLPW 188
             L H  +V+    +                    +  E+  N +L D + +        
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQR 115

Query: 189 KTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-------- 240
                +     E L+Y+H      +I+RD K  N+ +DE+   K+ DFGLA+        
Sbjct: 116 DEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172

Query: 241 ----EGPMVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
                  + G +   T+ +GT  Y A + ++ TGH   K D++S G++ +EM+       
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP----- 227

Query: 296 RNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 355
            +       +L+ ++          +   P  +        +K   +    +      RP
Sbjct: 228 FSTGMERVNILKKLRSVS-------IEFPPDFDDNKM-KVEKK---IIRLLIDHDPNKRP 276

Query: 356 KMSQV 360
               +
Sbjct: 277 GARTL 281

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  128 bits (323), Expect = 9e-34
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 16/211 (7%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPN 144
            IG G FG VYK  +K        +   VAIK L     +  +  ++ E   +G   H N
Sbjct: 51  VIGAGEFGEVYKGMLK---TSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +++L G  +    +    +++ E+M N +L+  L  +          + ++ G A G+ Y
Sbjct: 108 IIRLEGVIS----KYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKY 162

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY--AA 262
           L     +  ++RD  A N+L++ N   K+SDFGL+R           T   G       A
Sbjct: 163 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEATYTTSGGKIPIRWTA 218

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 292
           P+ I     T+ SDVWSFG+V++E++T G R
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  126 bits (319), Expect = 9e-34
 Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 25/211 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           +IG G FG V+                 VAIK + R+G    + ++ E + +  L HP L
Sbjct: 15  EIGSGQFGLVHLGYWLNK--------DKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 65

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L G C           LV EFM +  L D+L  +       +T L + L   EG+AYL
Sbjct: 66  VQLYGVCL----EQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYL 120

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
            E     VI+RD  A N L+ EN   K+SDFG+ R           T+  GT     +A+
Sbjct: 121 EE---ACVIHRDLAARNCLVGENQVIKVSDFGMTR----FVLDDQYTSSTGTKFPVKWAS 173

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 292
           P+       ++KSDVWSFGV+++E+ + G+ 
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  126 bits (318), Expect = 1e-33
 Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 46/290 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V     K            VA+K + ++G     ++  E Q +  L HP L
Sbjct: 15  ELGSGQFGVVKLGKWK--------GQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKL 65

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           VK  G C+    +     +V E++ N  L ++L +     L     L +     EG+A+L
Sbjct: 66  VKFYGVCS----KEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFL 120

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY--AAP 263
                 Q I+RD  A N L+D +   K+SDFG+ R    V      ++V   F    +AP
Sbjct: 121 ES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY---VLDDQYVSSVGTKFPVKWSAP 174

Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
           +       ++KSDVW+FG++++E+ + G+   +     T   ++  V Q        G  
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL---YTNSEVVLKVSQ--------GHR 223

Query: 323 MD-PRL--EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
           +  P L  +  Y I           +C  +  + RP   Q++  ++ + +
Sbjct: 224 LYRPHLASDTIYQIMY---------SCWHELPEKRPTFQQLLSSIEPLRE 264

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  126 bits (319), Expect = 1e-33
 Identities = 68/297 (22%), Positives = 125/297 (42%), Gaps = 54/297 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G FG V     +            VAIK + ++G     +++ E + +  L H  L
Sbjct: 31  ELGTGQFGVVKYGKWR--------GQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKL 81

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+L G C     +     ++ E+M N  L ++L          +  L +     E + YL
Sbjct: 82  VQLYGVCT----KQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYL 136

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYAA 262
                 Q ++RD  A N L+++    K+SDFGL+R           T+ VG+     ++ 
Sbjct: 137 ES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSR----YVLDDEYTSSVGSKFPVRWSP 189

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLEWVQQYPADSKK 318
           P+ +     ++KSD+W+FGV+++E+ + G+       P    T     E + Q       
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGK------MPYERFTNSETAEHIAQ------- 236

Query: 319 FGLIMD-PRL--EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN 372
            GL +  P L  EK Y+I           +C  + + +RP    ++  +  ++   +
Sbjct: 237 -GLRLYRPHLASEKVYTIMY---------SCWHEKADERPTFKILLSNILDVMDEES 283

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  127 bits (321), Expect = 2e-33
 Identities = 68/306 (22%), Positives = 123/306 (40%), Gaps = 48/306 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++GEG FG V+ +       +   +  +VA+K L        + +  E + L +L+H ++
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-------------FNRAFPPLPWKTRL 192
           V+  G C          L+V+E+M +  L   L              + A  PL     L
Sbjct: 106 VRFFGVCTEGR----PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            +    A G+ YL     +  ++RD    N L+ +    K+ DFG++R+     +  V  
Sbjct: 162 AVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 218

Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLEW 308
             +    +  P+ I     T +SDVWSFGVVL+E+ T G+      +P    +    ++ 
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK------QPWYQLSNTEAIDC 272

Query: 309 VQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
           + Q        G  ++ PR           ++  +   C  +  + R  +  V  RL+ +
Sbjct: 273 ITQ--------GRELERPR-------ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317

Query: 368 VQVSNE 373
            Q    
Sbjct: 318 AQAPPV 323

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  127 bits (320), Expect = 2e-33
 Identities = 66/313 (21%), Positives = 121/313 (38%), Gaps = 51/313 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHP 143
            +G+G FGSV ++ +K            VA+K L  D +     ++++ E   +   +HP
Sbjct: 30  MLGKGEFGSVREAQLK----QEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 144 NLVKLIGYCAVDGERGIQR--LLVYEFMLNRSLEDHLFNRAFP----PLPWKTRLHIILG 197
           ++ KL+G       +G     +++  FM +  L   L           LP +T +  ++ 
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
            A G+ YL        I+RD  A N +L E+    ++DFGL+R+   +          G 
Sbjct: 146 IACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRK---IYSGDYYRQ--GC 197

Query: 258 FG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLEW 308
                  + A + +     T  SDVW+FGV ++E++T G+       P        +  +
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ------TPYAGIENAEIYNY 251

Query: 309 VQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
           +          G  +  P            ++  L   C S   K RP  + +   L+ I
Sbjct: 252 LIG--------GNRLKQPP-------ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

Query: 368 VQVSNEGDSFDKT 380
           +   +   +    
Sbjct: 297 LGHLSVLSTSQDP 309

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  131 bits (332), Expect = 2e-33
 Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 23/209 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFLGVLEHPN 144
            I  GG G +Y       A D       V +K L   G        +AE QFL  + HP+
Sbjct: 87  CIAHGGLGWIYL------ALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPS 140

Query: 145 LVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
           +V++  +       G     +V E++  +SL+          LP    +  +L     L+
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALS 196

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           YLH    + ++Y D K  N++L E  + KL D G       +        + GT G+ AP
Sbjct: 197 YLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR---INSF---GYLYGTPGFQAP 246

Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           + I     T  +D+++ G  L  +     
Sbjct: 247 E-IVRTGPTVATDIYTVGRTLAALTLDLP 274

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  125 bits (316), Expect = 6e-33
 Identities = 61/276 (22%), Positives = 103/276 (37%), Gaps = 35/276 (12%)

Query: 75  RQATNDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQG-HKQW 130
           +  +N    +   +G+G   +V++         G  + T  + AIK  N           
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFR---------GRHKKTGDLFAIKVFNNISFLRPVDVQ 54

Query: 131 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWK 189
           + E + L  L H N+VKL  +   +      ++L+ EF    SL   L   +    LP  
Sbjct: 55  MREFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112

Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAREGPMV 245
             L ++     G+ +L E     +++R+ K  N++     D     KL+DFG ARE   +
Sbjct: 113 EFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---L 166

Query: 246 GHTHVSTAVVGTFGYAAPDYIETGHL--------TAKSDVWSFGVVLYEMLTGRRS-LER 296
                  ++ GT  Y  PD  E   L         A  D+WS GV  Y   TG       
Sbjct: 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226

Query: 297 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYS 332
             P+  + ++  +          G+        ++S
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWS 262

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  124 bits (314), Expect = 8e-33
 Identities = 70/318 (22%), Positives = 124/318 (38%), Gaps = 75/318 (23%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++GEG FG V+ +     +     +  +VA+K L    L   K +  E + L  L+H ++
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--------------AFPPLPWKTR 191
           VK  G C          ++V+E+M +  L   L                 A   L     
Sbjct: 80  VKFYGVCGDGD----PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135

Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
           LHI    A G+ YL        ++RD    N L+  N   K+ DFG++R+          
Sbjct: 136 LHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRD---------- 182

Query: 252 TAVVGTFGY-------------AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERN 297
              V +  Y               P+ I     T +SDVWSFGV+L+E+ T G+      
Sbjct: 183 ---VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------ 233

Query: 298 RP---KTEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKD 353
           +P    +   ++E + Q        G +++ PR          +++  +   C  +  + 
Sbjct: 234 QPWFQLSNTEVIECITQ--------GRVLERPR-------VCPKEVYDVMLGCWQREPQQ 278

Query: 354 RPKMSQVVERLKQIVQVS 371
           R  + ++ + L  + + +
Sbjct: 279 RLNIKEIYKILHALGKAT 296

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  129 bits (327), Expect = 9e-33
 Identities = 68/291 (23%), Positives = 112/291 (38%), Gaps = 43/291 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPN 144
            IGEG FG V++             A  VAIK          ++ ++ E   +   +HP+
Sbjct: 397 CIGEGQFGDVHQGIYMSPEN----PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +VKLIG    +        ++ E      L   L  R    L   + +      +  LAY
Sbjct: 453 IVKLIGVITEN-----PVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAY 506

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF--GYAA 262
           L      + ++RD  A NVL+  N   KL DFGL+R    +  +    A  G     + A
Sbjct: 507 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMA 560

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLEWVQQYPADSKK 318
           P+ I     T+ SDVW FGV ++E+L  G       +P        ++  ++        
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGV------KPFQGVKNNDVIGRIEN------- 607

Query: 319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
            G  +          N    +  L   C +     RP+ +++  +L  I++
Sbjct: 608 -GERLPM------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  124 bits (313), Expect = 1e-32
 Identities = 67/323 (20%), Positives = 108/323 (33%), Gaps = 46/323 (14%)

Query: 46  SASVTSPRGIPE-LYEEKAHNLRVFSYSEMRQAT-NDFSRMLKIGEGGFGSVYKSSIKPA 103
           S     PR +       +      +  S         F R+ ++G G +G V+K   K  
Sbjct: 22  SMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSK-- 79

Query: 104 AGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVDGERGI 160
             DG     + A+K+      G +   + +AEV     + +HP  V+L       G    
Sbjct: 80  -EDGR----LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG---- 130

Query: 161 QRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFK 219
             L L  E     SL+ H        LP       +      LA+LH      +++ D K
Sbjct: 131 -ILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVK 184

Query: 220 ASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWS 279
            +N+ L    R KL DFGL  E   +G         G   Y AP+ ++  +    +DV+S
Sbjct: 185 PANIFLGPRGRCKLGDFGLLVE---LGTAGAGEVQEGDPRYMAPELLQGSY-GTAADVFS 240

Query: 280 FGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKI 339
            G+ + E+           P                 +     + P      S +E R  
Sbjct: 241 LGLTILEVACNME-----LPH----------GGEGWQQLRQGYLPPEFTAGLS-SELRS- 283

Query: 340 GRLADNCLSKSSKDRPKMSQVVE 362
             +    L    K R     ++ 
Sbjct: 284 --VLVMMLEPDPKLRATAEALLA 304

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  124 bits (313), Expect = 1e-32
 Identities = 56/211 (26%), Positives = 85/211 (40%), Gaps = 22/211 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA----EVQFLGVLE 141
            +G GG G VY+      A D T    +VA+K ++   L     +      E +  G L+
Sbjct: 41  LVGRGGMGDVYE------AED-TVRERIVALKLMSET-LSSDPVFRTRMQREARTAGRLQ 92

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
            P++V +  +    GE   Q  +    +    L   L  R   PL     + I+      
Sbjct: 93  EPHVVPIHDF----GEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSA 146

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           L   H        +RD K  N+L+  +    L DFG+A        T +    VGT  Y 
Sbjct: 147 LDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYM 202

Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           AP+     H T ++D+++   VLYE LTG  
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSP 233

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  128 bits (324), Expect = 2e-32
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 21/212 (9%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPN 144
           ++G G FGSV +   +            VAIK L +   +   +  + E Q +  L++P 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQ-----IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY 397

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +V+LIG C  +       +LV E      L   L  +    +P      ++   + G+ Y
Sbjct: 398 IVRLIGVCQAE-----ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKY 451

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT---FGYA 261
           L E      ++R+  A NVLL      K+SDFGL++   +       TA         + 
Sbjct: 452 LEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKA--LGADDSYYTARSAGKWPLKWY 506

Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLT-GRR 292
           AP+ I     +++SDVWS+GV ++E L+ G++
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQK 538

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  123 bits (312), Expect = 2e-32
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA----EVQFLGVLE 141
           K+G GG  +VY       A D T     VAIK +     +  ++ +     EV     L 
Sbjct: 18  KLGGGGMSTVYL------AED-TILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLS 69

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           H N+V +I       E      LV E++   +L +++ +    PL   T ++      +G
Sbjct: 70  HQNIVSMIDV----DEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDG 123

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           + + H+   +++++RD K  N+L+D N   K+ DFG+A+       T  +  V+GT  Y 
Sbjct: 124 IKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYF 179

Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           +P+  +       +D++S G+VLYEML G  
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  123 bits (312), Expect = 3e-32
 Identities = 81/314 (25%), Positives = 127/314 (40%), Gaps = 67/314 (21%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVL-EHP 143
            IGEG FG V K+ IK             AIK++        H+ +  E++ L  L  HP
Sbjct: 32  VIGEGNFGQVLKARIK-----KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 86

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------------FNRAFPPLPWK 189
           N++ L+G C   G       L  E+  + +L D L               N     L  +
Sbjct: 87  NIINLLGACEHRG----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
             LH     A G+ YL +    Q I+RD  A N+L+ EN+  K++DFGL+R         
Sbjct: 143 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ------- 192

Query: 250 VSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---K 300
               V  T G     + A + +     T  SDVWS+GV+L+E+++ G        P    
Sbjct: 193 -EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG------TPYCGM 245

Query: 301 TEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
           T   L E + Q        G  ++ P        N   ++  L   C  +   +RP  +Q
Sbjct: 246 TCAELYEKLPQ--------GYRLEKPL-------NCDDEVYDLMRQCWREKPYERPSFAQ 290

Query: 360 VVERLKQIVQVSNE 373
           ++  L ++++    
Sbjct: 291 ILVSLNRMLEERKT 304

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  125 bits (316), Expect = 3e-32
 Identities = 65/323 (20%), Positives = 112/323 (34%), Gaps = 45/323 (13%)

Query: 75  RQATNDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQG-HKQW 130
           +  +N    +   +G+G   +V++         G  + T  + AIK  N           
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFR---------GRHKKTGDLFAIKVFNNISFLRPVDVQ 54

Query: 131 VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWK 189
           + E + L  L H N+VKL  +   +      ++L+ EF    SL   L   +    LP  
Sbjct: 55  MREFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112

Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAREGPMV 245
             L ++     G+ +L E     +++R+ K  N++     D     KL+DFG ARE   +
Sbjct: 113 EFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---L 166

Query: 246 GHTHVSTAVVGTFGYAAPDYIETGHL--------TAKSDVWSFGVVLYEMLTGRRS-LER 296
                  ++ GT  Y  PD  E   L         A  D+WS GV  Y   TG       
Sbjct: 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226

Query: 297 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINE----------ARKIGRLADNC 346
             P+  + ++  +          G+        ++S +              +  +  N 
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286

Query: 347 LSKSSKDRPKMSQVVERLKQIVQ 369
           L    +      Q       I+ 
Sbjct: 287 LEADQEKCWGFDQFFAETSDILH 309

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  123 bits (311), Expect = 3e-32
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 18/212 (8%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA----EVQFLGVLE 141
            +G GG   V+       A D   +   VA+K L R  L     +      E Q    L 
Sbjct: 19  ILGFGGMSEVHL------ARD-LRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALN 70

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           HP +V +      +   G    +V E++   +L D +      P+  K  + +I  A + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 128

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST-AVVGTFGY 260
           L + H+     +I+RD K +N+++      K+ DFG+AR     G++   T AV+GT  Y
Sbjct: 129 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
            +P+      + A+SDV+S G VLYE+LTG  
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  123 bits (311), Expect = 4e-32
 Identities = 65/305 (21%), Positives = 111/305 (36%), Gaps = 46/305 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPN 144
            + EGGF  VY+                 A+K+L  +  + ++  + EV F+  L  HPN
Sbjct: 35  VLAEGGFAFVYE-------AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87

Query: 145 LVKLIGYCAVDGER---GIQRLLVYEFMLNRSLEDHLFNRAFP-PLPWKTRLHIILGAAE 200
           +V+     ++  E    G    L+   +    L + L       PL   T L I      
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE---GPMVGHTHVSTAVV-- 255
            + ++H   +  +I+RD K  N+LL      KL DFG A      P    +    A+V  
Sbjct: 148 AVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 256 -----GTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE 307
                 T  Y  P+ I+      +  K D+W+ G +LY +   +   E      + R++ 
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG---AKLRIVN 263

Query: 308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
                P                            L    L  + ++R  +++VV +L++I
Sbjct: 264 GKYSIPPHDT-------------QY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306

Query: 368 VQVSN 372
               N
Sbjct: 307 AAARN 311

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  122 bits (309), Expect = 6e-32
 Identities = 52/230 (22%), Positives = 91/230 (39%), Gaps = 38/230 (16%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH--KQWVAEVQF 136
             +S + +IG GG   V++        +   +  + AIK +N +         +  E+ +
Sbjct: 28  RIYSILKQIGSGGSSKVFQ------VLNEKKQ--IYAIKYVNLEEADNQTLDSYRNEIAY 79

Query: 137 LGVLEHPNL--VKLIGYCAVDGERGIQRLLVYEFM--LNRSLEDHLFNRAFPPLPWKTRL 192
           L  L+  +   ++L  Y   D         +Y  M   N  L   L  +    +    R 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQY-------IYMVMECGNIDLNSWL--KKKKSIDPWERK 130

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
                  E +  +H+     +++ D K +N L+ +    KL DFG+A +      + V  
Sbjct: 131 SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 186

Query: 253 AVVGTFGYAAPDYIE-----------TGHLTAKSDVWSFGVVLYEMLTGR 291
           + VGT  Y  P+ I+              ++ KSDVWS G +LY M  G+
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  123 bits (310), Expect = 6e-32
 Identities = 79/328 (24%), Positives = 125/328 (38%), Gaps = 65/328 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEHPN 144
            +G G FG VY+  +     D +     VA+K L     +  +  ++ E   +    H N
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSP--LQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-----AFPPLPWKTRLHIILGAA 199
           +V+ IG       + + R ++ E M    L+  L            L     LH+    A
Sbjct: 95  IVRCIGVSL----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHTHVSTA--- 253
            G  YL E      I+RD  A N LL         K+ DFG+AR+        +  A   
Sbjct: 151 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--------IYRASYY 199

Query: 254 VVGTFGY-----AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQR 304
             G           P+    G  T+K+D WSFGV+L+E+ + G        P   K+ Q 
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------MPYPSKSNQE 253

Query: 305 LLEWVQQYPADSKKFGLIMD-PR--LEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 361
           +LE+V          G  MD P+      Y I            C     +DRP  + ++
Sbjct: 254 VLEFVTS--------GGRMDPPKNCPGPVYRIMTQ---------CWQHQPEDRPNFAIIL 296

Query: 362 ERLKQIVQVSNEGD-SFDKTFEEICEED 388
           ER++   Q  +  + +    +  + EE+
Sbjct: 297 ERIEYCTQDPDVINTALPIEYGPLVEEE 324

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  122 bits (308), Expect = 1e-31
 Identities = 52/230 (22%), Positives = 91/230 (39%), Gaps = 38/230 (16%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH--KQWVAEVQF 136
             +S + +IG GG   V++        +   +  + AIK +N +         +  E+ +
Sbjct: 9   RIYSILKQIGSGGSSKVFQ------VLNEKKQ--IYAIKYVNLEEADNQTLDSYRNEIAY 60

Query: 137 LGVLEHPNL--VKLIGYCAVDGERGIQRLLVYEFM--LNRSLEDHLFNRAFPPLPWKTRL 192
           L  L+  +   ++L  Y   D         +Y  M   N  L   L  +    +    R 
Sbjct: 61  LNKLQQHSDKIIRLYDYEITDQY-------IYMVMECGNIDLNSWL--KKKKSIDPWERK 111

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
                  E +  +H+     +++ D K +N L+ +    KL DFG+A +      + V  
Sbjct: 112 SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 167

Query: 253 AVVGTFGYAAPDYIE-----------TGHLTAKSDVWSFGVVLYEMLTGR 291
           + VGT  Y  P+ I+              ++ KSDVWS G +LY M  G+
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  121 bits (306), Expect = 2e-31
 Identities = 57/226 (25%), Positives = 88/226 (38%), Gaps = 27/226 (11%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV 131
            E R+  +  +   ++G G FG V++          T      A+KK+    L+  +   
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHR-----MKDKQTGF--QCAVKKVR---LEVFRV-- 98

Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR 191
            E+     L  P +V L G         I      E +   SL   +  +    LP    
Sbjct: 99  EELVACAGLSSPRIVPLYGAVREGPWVNI----FMELLEGGSLGQLI--KQMGCLPEDRA 152

Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAR---EGPMVGH 247
           L+ +  A EGL YLH     ++++ D KA NVLL  +  R  L DFG A       +   
Sbjct: 153 LYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209

Query: 248 THVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRR 292
                 + GT  + AP+ +       AK D+WS   ++  ML G  
Sbjct: 210 LLTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCH 254

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  121 bits (305), Expect = 3e-31
 Identities = 80/319 (25%), Positives = 134/319 (42%), Gaps = 59/319 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFL-GVLEHP 143
            +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ +  + +H 
Sbjct: 42  PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--------------AFPPLPWK 189
           N++ L+G C  DG       ++ E+    +L ++L  R                  + +K
Sbjct: 102 NIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
             +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +  
Sbjct: 158 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD---INNID 211

Query: 250 VSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---K 300
                  T G     + AP+ +     T +SDVWSFGV+++E+ T G        P    
Sbjct: 212 YYKK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG------SPYPGI 263

Query: 301 TEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
             + L + +++        G  MD P        N   ++  +  +C       RP   Q
Sbjct: 264 PVEELFKLLKE--------GHRMDKPA-------NCTNELYMMMRDCWHAVPSQRPTFKQ 308

Query: 360 VVERLKQIVQVSNEGDSFD 378
           +VE L +I+ ++   +  D
Sbjct: 309 LVEDLDRILTLTTNEEYLD 327

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  121 bits (305), Expect = 5e-31
 Identities = 79/325 (24%), Positives = 121/325 (37%), Gaps = 59/325 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
            +G G FG VY+  +     D       VA+K L      Q    ++ E   +    H N
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDP--SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-----AFPPLPWKTRLHIILGAA 199
           +V+ IG       + + R ++ E M    L+  L            L     LH+    A
Sbjct: 136 IVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
            G  YL E      I+RD  A N LL         K+ DFG+AR+              G
Sbjct: 192 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-----RAGYYRKG 243

Query: 257 TFGY-----AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KTEQRLLE 307
                      P+    G  T+K+D WSFGV+L+E+ + G        P   K+ Q +LE
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------MPYPSKSNQEVLE 297

Query: 308 WVQQYPADSKKFGLIMD-PRL--EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL 364
           +V          G  MD P+      Y I            C     +DRP  + ++ER+
Sbjct: 298 FVTS--------GGRMDPPKNCPGPVYRIMTQ---------CWQHQPEDRPNFAIILERI 340

Query: 365 KQIVQVSNEGD-SFDKTFEEICEED 388
           +   Q  +  + +    +  + EE+
Sbjct: 341 EYCTQDPDVINTALPIEYGPLVEEE 365

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  124 bits (312), Expect = 7e-31
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 28/218 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQ-WVAEVQFLGVLEH 142
           ++G GGFG V +            + T   VAIK+  ++    +++ W  E+Q +  L H
Sbjct: 21  RLGTGGFGYVLR---------WIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH 71

Query: 143 PNLVKLIGYCAVDGERGIQR----LLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILG 197
           PN+V        DG + +      LL  E+     L  +L        L       ++  
Sbjct: 72  PNVVSA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP---KLSDFGLAREGPMVGHTHVSTAV 254
            +  L YLHE    ++I+RD K  N++L    +    K+ D G A+E   +    + T  
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGELCTEF 183

Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           VGT  Y AP+ +E    T   D WSFG + +E +TG R
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  118 bits (298), Expect = 1e-30
 Identities = 68/305 (22%), Positives = 119/305 (39%), Gaps = 60/305 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
           ++GE  FG VYK  +   A     +   VAIK L         +++  E      L+HPN
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGE--QTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP--------------PLPWKT 190
           +V L+G    D        +++ +  +  L + L  R+                 L    
Sbjct: 74  VVCLLGVVTKDQ----PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
            +H++   A G+ YL       V+++D    NVL+ +    K+SD GL RE   V     
Sbjct: 130 FVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFRE---VYAA-- 181

Query: 251 STAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---KT 301
               +         + AP+ I  G  +  SD+WS+GVVL+E+ + G       +P    +
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL------QPYCGYS 235

Query: 302 EQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
            Q ++E ++           ++  P        +    +  L   C ++    RP+   +
Sbjct: 236 NQDVVEMIRN--------RQVLPCPD-------DCPAWVYALMIECWNEFPSRRPRFKDI 280

Query: 361 VERLK 365
             RL+
Sbjct: 281 HSRLR 285

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  120 bits (303), Expect = 1e-30
 Identities = 52/230 (22%), Positives = 91/230 (39%), Gaps = 38/230 (16%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQF 136
             +S + +IG GG   V++        +   +  + AIK +N +    Q    +  E+ +
Sbjct: 56  RIYSILKQIGSGGSSKVFQ------VLNEKKQ--IYAIKYVNLEEADNQTLDSYRNEIAY 107

Query: 137 LGVLEHPNL--VKLIGYCAVDGERGIQRLLVYEFM--LNRSLEDHLFNRAFPPLPWKTRL 192
           L  L+  +   ++L  Y   D         +Y  M   N  L   L  +    +    R 
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQY-------IYMVMECGNIDLNSWL--KKKKSIDPWERK 158

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
                  E +  +H+     +++ D K +N L+ +    KL DFG+A +      + V  
Sbjct: 159 SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 214

Query: 253 AVVGTFGYAAPDYIE-----------TGHLTAKSDVWSFGVVLYEMLTGR 291
           + VG   Y  P+ I+              ++ KSDVWS G +LY M  G+
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  116 bits (294), Expect = 8e-30
 Identities = 71/316 (22%), Positives = 126/316 (39%), Gaps = 59/316 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVL-EHP 143
            +G G FG V ++       D T+    VA+K L        H+  ++E++ L  +  H 
Sbjct: 34  PLGRGAFGQVIEADAFGI--DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------------FNRAFPPLPWK 189
           N+V L+G C    + G   +++ EF    +L  +L               +     L  +
Sbjct: 92  NVVNLLGACT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
             +      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+   +    
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD---IYKDP 202

Query: 250 VSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR---SLERNRPK 300
                          + AP+ I     T +SDVWSFGV+L+E+ + G      ++ +   
Sbjct: 203 DYVR--KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--- 257

Query: 301 TEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
             +     +++        G  M  P            ++ +   +C       RP  S+
Sbjct: 258 --EEFCRRLKE--------GTRMRAPD-------YTTPEMYQTMLDCWHGEPSQRPTFSE 300

Query: 360 VVERLKQIVQVSNEGD 375
           +VE L  ++Q + + D
Sbjct: 301 LVEHLGNLLQANAQQD 316

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  118 bits (297), Expect = 8e-30
 Identities = 79/314 (25%), Positives = 133/314 (42%), Gaps = 59/314 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVL-EHP 143
            +GEG FG V  +       D   EA  VA+K L  D  +      V+E++ + ++ +H 
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--------------AFPPLPWK 189
           N++ L+G C  DG       ++ E+    +L ++L  R                  + +K
Sbjct: 148 NIINLLGACTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
             +      A G+ YL      + I+RD  A NVL+ EN   K++DFGLAR+   + +  
Sbjct: 204 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD---INNID 257

Query: 250 VSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---K 300
                  T G     + AP+ +     T +SDVWSFGV+++E+ T G        P    
Sbjct: 258 YYKK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG------SPYPGI 309

Query: 301 TEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
             + L + +++        G  MD P        N   ++  +  +C       RP   Q
Sbjct: 310 PVEELFKLLKE--------GHRMDKPA-------NCTNELYMMMRDCWHAVPSQRPTFKQ 354

Query: 360 VVERLKQIVQVSNE 373
           +VE L +I+ ++  
Sbjct: 355 LVEDLDRILTLTTN 368

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  117 bits (295), Expect = 9e-30
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 20/214 (9%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFL 137
           +DF ++ ++G G  G V+K S KP     +    V+A K ++ +       Q + E+Q L
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKP-----SG--LVMARKLIHLEIKPAIRNQIIRELQVL 85

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
                P +V   G    DGE  I      E M   SL+  L  +    +P +    + + 
Sbjct: 86  HECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSLDQVL--KKAGRIPEQILGKVSIA 139

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
             +GL YL E  + ++++RD K SN+L++     KL DFG++ +   +  +  ++  VGT
Sbjct: 140 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ---LIDSMANS-FVGT 193

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
             Y +P+ ++  H + +SD+WS G+ L EM  GR
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  116 bits (293), Expect = 9e-30
 Identities = 67/317 (21%), Positives = 120/317 (37%), Gaps = 64/317 (20%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-WVAEVQFLGVL-EHP 143
            +G G FG V +++           A  VA+K L        ++  ++E++ L  L  H 
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSD--AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR----------------AFPPLP 187
           N+V L+G C + G      L++ E+     L + L  +                    L 
Sbjct: 88  NIVNLLGACTIGGPT----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
            +  L      A+G+A+L        I+RD  A N+LL      K+ DFGLAR+   + +
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARD---IKN 197

Query: 248 THVSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP-- 299
                            + AP+ I     T +SDVWS+G+ L+E+ + G        P  
Sbjct: 198 DSNYVV--KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS------SPYP 249

Query: 300 --KTEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPK 356
               + +  + +++        G  M  P        +   ++  +   C       RP 
Sbjct: 250 GMPVDSKFYKMIKE--------GFRMLSPE-------HAPAEMYDIMKTCWDADPLKRPT 294

Query: 357 MSQVVERLKQIVQVSNE 373
             Q+V+ +++ +  S  
Sbjct: 295 FKQIVQLIEKQISESTN 311

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  117 bits (294), Expect = 1e-29
 Identities = 77/321 (23%), Positives = 126/321 (39%), Gaps = 68/321 (21%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
            IGEG FG V+++             T+VA+K L  +        +  E   +   ++PN
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYE--PFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR----------------------A 182
           +VKL+G CAV         L++E+M    L + L +                        
Sbjct: 112 IVKLLGVCAVGK----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 183 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 242
            PPL    +L I    A G+AYL E    + ++RD    N L+ EN   K++DFGL+R  
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN- 223

Query: 243 PMVGHTHVSTAVVGTFGY-----AAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 296
             +                      P+ I     T +SDVW++GVVL+E+ + G      
Sbjct: 224 --IYSA--DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL----- 274

Query: 297 NRP---KTEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSK 352
            +P      + ++ +V+         G I+  P        N   ++  L   C SK   
Sbjct: 275 -QPYYGMAHEEVIYYVRD--------GNILACPE-------NCPLELYNLMRLCWSKLPA 318

Query: 353 DRPKMSQVVERLKQIVQVSNE 373
           DRP    +   L+++ + +  
Sbjct: 319 DRPSFCSIHRILQRMCERAEG 339

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  117 bits (296), Expect = 1e-29
 Identities = 82/331 (24%), Positives = 135/331 (40%), Gaps = 60/331 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFL-GVLEHP 143
            +GEG FG V  +       D  +  T VA+K L  D   +     ++E++ +  + +H 
Sbjct: 76  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--------------FNRAFPPLPWK 189
           N++ L+G C  DG       ++ E+    +L ++L               +     L  K
Sbjct: 136 NIINLLGACTQDGP----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
             +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+   + H  
Sbjct: 192 DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD---IHHID 245

Query: 250 VSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP---K 300
                  T G     + AP+ +     T +SDVWSFGV+L+E+ T G        P    
Sbjct: 246 YYKK--TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG------SPYPGV 297

Query: 301 TEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
             + L + +++        G  MD P        N   ++  +  +C       RP   Q
Sbjct: 298 PVEELFKLLKE--------GHRMDKPS-------NCTNELYMMMRDCWHAVPSQRPTFKQ 342

Query: 360 VVERLKQIVQ-VSNEGDSFDKTFEEICEEDP 389
           +VE L +IV   SN+   +         + P
Sbjct: 343 LVEDLDRIVALTSNQEMGYYHHHHHHDYDIP 373

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  115 bits (290), Expect = 2e-29
 Identities = 65/289 (22%), Positives = 118/289 (40%), Gaps = 40/289 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQF- 136
           +D   ++++G G +G V K    P     +    ++A+K++      Q  K+ + ++   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVP-----SG--QIMAVKRIRATVNSQEQKRLLMDLDIS 59

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRLHI 194
           +  ++ P  V   G    +G+  I      E M + SL+            +P      I
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVWI----CMELM-DTSLDKFYKQVIDKGQTIPEDILGKI 114

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
            +   + L +LH   ++ VI+RD K SNVL++   + K+ DFG++     +         
Sbjct: 115 AVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGY---LVDDVAKDID 169

Query: 255 VGTFGYAAPDYIETGHL----TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
            G   Y AP+ I         + KSD+WS G+ + E+   R   +     T  + L+ V 
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD--SWGTPFQQLKQVV 227

Query: 311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
           + P+          P+L  +    E          CL K+SK+RP   +
Sbjct: 228 EEPS----------PQLPADKFSAEFV---DFTSQCLKKNSKERPTYPE 263

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  117 bits (293), Expect = 2e-29
 Identities = 35/326 (10%), Positives = 72/326 (22%), Gaps = 63/326 (19%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQG--- 126
           S + Q       +  +  G    V+                    A+K            
Sbjct: 55  SLLSQGERKLKLVEPLRVGDRSVVFL---------VRDVERLEDFALKVFTMGAENSRSE 105

Query: 127 HKQWVAEVQFLGVLEHPNLVKLIGYC---------AVDGERGIQRL-------------L 164
            ++          L   +  +              AV  +    +L             L
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165

Query: 165 VYEFM------LNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDF 218
           +          L  +L+     R            +        A L       +++  F
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRG--DEGILALHILTAQLIRLAANLQS---KGLVHGHF 220

Query: 219 KASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL--TAKSD 276
              N+ +  + R  L D     +           A      YA  +++       T   +
Sbjct: 221 TPDNLFIMPDGRLMLGDVSALWK-----VGTRGPASSVPVTYAPREFLNASTATFTHALN 275

Query: 277 VWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEA 336
            W  G+ +Y +           P  +        + P                   + + 
Sbjct: 276 AWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD-------SLAFGSCTPLPDF 328

Query: 337 RKIGRLADNCLSKSSKDRPKMSQVVE 362
            K   L    L+   + R    + +E
Sbjct: 329 VK--TLIGRFLNFDRRRRLLPLEAME 352

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  116 bits (292), Expect = 2e-29
 Identities = 78/358 (21%), Positives = 140/358 (39%), Gaps = 45/358 (12%)

Query: 58  LYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK 117
           +  E +  L++           D   + +IG G +GSV K   KP     +    ++A+K
Sbjct: 1   MSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKP-----SG--QIMAVK 53

Query: 118 KLNRDG-LQGHKQWVAEVQF-LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE 175
           ++      +  KQ + ++   +   + P +V+  G    +G+  I      E M + S +
Sbjct: 54  RIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI----CMELM-STSFD 108

Query: 176 D---HLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK 232
               ++++     +P +    I L   + L +L E   +++I+RD K SN+LLD +   K
Sbjct: 109 KFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIK 166

Query: 233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL----TAKSDVWSFGVVLYEML 288
           L DFG++  G +V  +   T   G   Y AP+ I+          +SDVWS G+ LYE+ 
Sbjct: 167 LCDFGIS--GQLV-DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223

Query: 289 TGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLS 348
           TGR      +  +    L  V +             P+L        +       + CL+
Sbjct: 224 TGRFPYP--KWNSVFDQLTQVVKGDP----------PQLSNSEEREFSPSFINFVNLCLT 271

Query: 349 KSSKDRPKMSQVVERLKQ---IVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSE 403
           K    RPK  +    L +   I+              +I ++ P    +         
Sbjct: 272 KDESKRPKYKE----LLKHPFILMYEERAVEVACYVCKILDQMPATPSSPMYVDHHHH 325

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  114 bits (289), Expect = 2e-29
 Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 26/226 (11%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHK- 128
           + + +   DF     +G+G F  VY+           S  T   VAIK +++  +     
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYR---------AESIHTGLEVAIKMIDKKAMYKAGM 54

Query: 129 --QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPL 186
             +   EV+    L+HP++++L  Y   D        LV E   N  +  +L NR  P  
Sbjct: 55  VQRVQNEVKIHCQLKHPSILELYNYFE-DSNYVY---LVLEMCHNGEMNRYLKNRVKPFS 110

Query: 187 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
             + R H +     G+ YLH      +++RD   SN+LL  N   K++DFGLA +  M  
Sbjct: 111 ENEAR-HFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166

Query: 247 HTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 291
             H +    GT  Y +P+    + H   +SDVWS G + Y +L GR
Sbjct: 167 EKHYTLC--GTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR 209

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  114 bits (288), Expect = 5e-29
 Identities = 73/290 (25%), Positives = 125/290 (43%), Gaps = 43/290 (14%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFL 137
           ND   + ++G G  G V+K   +      T    V+A+K++ R G  + +K+ + ++  +
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRK-----TGH--VIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 138 -GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
               + P +V+  G    + +  I      E M     E  L  R   P+P +    + +
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFI----AMELM-GTCAEK-LKKRMQGPIPERILGKMTV 131

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
              + L YL E  +  VI+RD K SN+LLDE  + KL DFG++  G +V          G
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGIS--GRLV-DDKAKDRSAG 186

Query: 257 TFGYAAPDYIETGHL-----TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 311
              Y AP+ I+           ++DVWS G+ L E+ TG+   +  +   +  +L  V Q
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQ 244

Query: 312 YPADSKKFGLIMDPRLEKE--YSINEARKIGRLADNCLSKSSKDRPKMSQ 359
                        P L     +S +    +     +CL+K  + RPK ++
Sbjct: 245 EEP----------PLLPGHMGFSGDFQSFV----KDCLTKDHRKRPKYNK 280

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  113 bits (285), Expect = 1e-28
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 32/216 (14%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
           +G+G +G VY          G   +    +AIK++     +  +    E+     L+H N
Sbjct: 30  LGKGTYGIVYA---------GRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 80

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHI--ILGAAE 200
           +V+ +G  + +G   I      E +   SL   L ++             +   IL   E
Sbjct: 81  IVQYLGSFSENGFIKI----FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL---E 133

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           GL YLH+    Q+++RD K  NVL++  +   K+SDFG ++   + G    +    GT  
Sbjct: 134 GLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQ 188

Query: 260 YAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRR 292
           Y AP+ I+    G+    +D+WS G  + EM TG+ 
Sbjct: 189 YMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKP 223

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  112 bits (283), Expect = 1e-28
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 25/217 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK---QWVAEVQ 135
            DF     +G+G FG+VY +  K      +    ++A+K L +  L+      Q   EV+
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQ-----SKF--ILALKVLFKAQLEKAGVEHQLRREVE 61

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
               L HPN+++L GY          R+ L+ E+    ++   L  +       +     
Sbjct: 62  IQSHLRHPNILRLYGYFHDA-----TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 114

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           I   A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T +
Sbjct: 115 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDL 167

Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            GT  Y  P+ IE      K D+WS GV+ YE L G+
Sbjct: 168 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  113 bits (286), Expect = 2e-28
 Identities = 68/327 (20%), Positives = 122/327 (37%), Gaps = 69/327 (21%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVL-EHP 143
            +G G FG V  ++    +  G   +  VA+K L         +  ++E++ +  L  H 
Sbjct: 52  VLGSGAFGKVMNATAYGISKTG--VSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR---------------------A 182
           N+V L+G C + G       L++E+     L ++L ++                      
Sbjct: 110 NIVNLLGACTLSGPI----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 183 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 242
              L ++  L      A+G+ +L        ++RD  A NVL+      K+ DFGLAR+ 
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD- 221

Query: 243 PMVGHTHVSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 296
             +                   + AP+ +  G  T KSDVWS+G++L+E+ + G      
Sbjct: 222 --IMSDSNYVV--RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV----- 272

Query: 297 NRP----KTEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSS 351
             P      +    + +Q         G  MD P            +I  +  +C +  S
Sbjct: 273 -NPYPGIPVDANFYKLIQN--------GFKMDQPF-------YATEEIYIIMQSCWAFDS 316

Query: 352 KDRPKMSQVVERLKQIVQVSNEGDSFD 378
           + RP    +   L   +  + E    +
Sbjct: 317 RKRPSFPNLTSFLGCQLADAEEAMYQN 343

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  113 bits (284), Expect = 2e-28
 Identities = 76/317 (23%), Positives = 131/317 (41%), Gaps = 68/317 (21%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPN 144
            +GEG FG V K++     G   +  T VA+K L  +      +  ++E   L  + HP+
Sbjct: 30  TLGEGEFGKVVKATAFHLKGR--AGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR----------------------A 182
           ++KL G C+ DG      LL+ E+    SL   L                          
Sbjct: 88  VIKLYGACSQDGPL----LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143

Query: 183 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 242
              L     +      ++G+ YL E   +++++RD  A N+L+ E  + K+SDFGL+R+ 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRD- 199

Query: 243 PMVGHTHVSTAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLER 296
             V           + G     + A + +     T +SDVWSFGV+L+E++T G      
Sbjct: 200 --VYEEDSYVK--RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG----- 250

Query: 297 NRP---KTEQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSK 352
             P      +RL   ++         G  M+ P        N + ++ RL   C  +   
Sbjct: 251 -NPYPGIPPERLFNLLKT--------GHRMERPD-------NCSEEMYRLMLQCWKQEPD 294

Query: 353 DRPKMSQVVERLKQIVQ 369
            RP  + + + L++++ 
Sbjct: 295 KRPVFADISKDLEKMMV 311

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  112 bits (283), Expect = 2e-28
 Identities = 80/298 (26%), Positives = 126/298 (42%), Gaps = 41/298 (13%)

Query: 63  AHNLRVFSYSEMRQATND----FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKK 118
           AH+        M+    D    F+++ KIG+G FG V+K          T +  VVAIK 
Sbjct: 2   AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNR-----TQK--VVAIKI 54

Query: 119 LNRDGLQGHKQWV-AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDH 177
           ++ +  +   + +  E+  L   + P + K  G    D +  I    + E++   S  D 
Sbjct: 55  IDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDL 110

Query: 178 LFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG 237
           L      PL       I+    +GL YLH     + I+RD KA+NVLL E+   KL+DFG
Sbjct: 111 LEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG 164

Query: 238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN 297
           +A  G +          VGT  + AP+ I+     +K+D+WS G+   E+  G       
Sbjct: 165 VA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

Query: 298 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 355
            P    ++L  + +             P LE  YS    + +    + CL+K    RP
Sbjct: 223 HP---MKVLFLIPKNNP----------PTLEGNYS----KPLKEFVEACLNKEPSFRP 263

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  113 bits (284), Expect = 3e-28
 Identities = 58/316 (18%), Positives = 112/316 (35%), Gaps = 56/316 (17%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA------ 132
           ND+  +  + +G F  +              +    A+KK  +  L+  + +        
Sbjct: 31  NDYRIIRTLNQGKFNKIIL---------CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKI 81

Query: 133 -----------EVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFN 180
                      E+Q +  +++   +   G            + ++YE+M N S+      
Sbjct: 82  SIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEY 136

Query: 181 RAFPPLPWKTRL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 234
                  +   +       II       +Y+H      + +RD K SN+L+D+N R KLS
Sbjct: 137 FFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLS 194

Query: 235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRR 292
           DFG +          +  +  GT+ +  P++      +  AK D+WS G+ LY M     
Sbjct: 195 DFGESEYMV---DKKIKGS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250

Query: 293 --SLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSI---NEARK-IGRLADNC 346
             SL+ +  +    +     +YP D   F   +  +     +    NE    +       
Sbjct: 251 PFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF---- 306

Query: 347 LSKSSKDRPKMSQVVE 362
           L K+  +R      ++
Sbjct: 307 LRKNPAERITSEDALK 322

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  112 bits (281), Expect = 5e-28
 Identities = 65/349 (18%), Positives = 118/349 (33%), Gaps = 94/349 (26%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFL 137
            DF  +  +G GGFG V+++  K    D        AIK++     +  ++ V  EV+ L
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKV---DD----CNYAIKRIRLPNRELAREKVMREVKAL 58

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVY------------------------------- 166
             LEHP +V+             Q  +                                 
Sbjct: 59  AKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPF 118

Query: 167 ------EFMLNRSLEDHLF-----------------NRAFPPLPWKTRLHIILGAAEGLA 203
                   +   S + +L+                   +         LHI +  AE + 
Sbjct: 119 STKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVE 178

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE----------GPMVGHTHVSTA 253
           +LH      +++RD K SN+    +   K+ DFGL                +      T 
Sbjct: 179 FLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 313
            VGT  Y +P+ I   + + K D++S G++L+E+L    + +  R +    +     ++P
Sbjct: 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-QMERVRIITDVRN--LKFP 292

Query: 314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
               +                E   +     + LS S  +RP+ + ++E
Sbjct: 293 LLFTQ------------KYPQEHMMV----QDMLSPSPTERPEATDIIE 325

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  112 bits (282), Expect = 6e-28
 Identities = 40/250 (16%), Positives = 80/250 (32%), Gaps = 23/250 (9%)

Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVA 115
           P  +E +     +   +E +  +        +GEG F  VY+++          +     
Sbjct: 42  PNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQ--KFV 99

Query: 116 IKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE 175
           +K                ++ L        +K   Y A   + G   +LV E     +L 
Sbjct: 100 LKVQKPANPWEFYIGTQLMERLKPSMQHMFMKF--YSAHLFQNGS--VLVGELYSYGTLL 155

Query: 176 DHL---FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP- 231
           + +    N     +P    +   +     +  +H+    ++I+ D K  N +L   F   
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQ 212

Query: 232 ----------KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFG 281
                      L D G + +  +     + TA   T G+   + +       + D +   
Sbjct: 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVA 272

Query: 282 VVLYEMLTGR 291
             +Y ML G 
Sbjct: 273 ATVYCMLFGT 282

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (282), Expect = 6e-28
 Identities = 45/328 (13%), Positives = 98/328 (29%), Gaps = 71/328 (21%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVY-----------------KSSIKPAAGDGTSEATVV 114
           SE+ +      R   +G+    +                    +   P+      +  V+
Sbjct: 66  SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 125

Query: 115 AIKKL----NRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFML 170
            ++ L    N+   + H +++     +   +   ++++           + R  +Y  M 
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD--ERDMWVLSRFFLYPRMQ 183

Query: 171 NRSLE--DHLFNRAF--PPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVLL 225
           +      + L + +     L    RL + L     LA LH  G    +++   +  +++L
Sbjct: 184 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVL 239

Query: 226 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI-----------ETGHLTAK 274
           D+     L+ F         G   VS     + G+  P+                 +T  
Sbjct: 240 DQRGGVFLTGFEHLVRD---GARVVS---SVSRGFEPPELEARRATISYHRDRRTLMTFS 293

Query: 275 SDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSIN 334
            D W+ G+V+Y +                         P          +       +I 
Sbjct: 294 FDAWALGLVIYWIWCAD--------------------LPITKDAALGGSEWIFRSCKNIP 333

Query: 335 EARKIGRLADNCLSKSSKDRPKMSQVVE 362
           +  +   L +  L    +DR    Q +E
Sbjct: 334 QPVR--ALLEGFLRYPKEDRLLPLQAME 359

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  111 bits (281), Expect = 7e-28
 Identities = 72/309 (23%), Positives = 119/309 (38%), Gaps = 60/309 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVL-EHP 143
            +G G FG V +++      +       VA+K L         +  ++E++ +  L +H 
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAV--LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL------------FNRAFPPLPWKTR 191
           N+V L+G C   G      L++ E+     L + L            F  A      +  
Sbjct: 111 NIVNLLGACTHGGPV----LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166

Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
           LH     A+G+A+L        I+RD  A NVLL      K+ DFGLAR+   + +   S
Sbjct: 167 LHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARD---IMND--S 218

Query: 252 TAVVGTFG-----YAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP----KT 301
             +V         + AP+ I     T +SDVWS+G++L+E+ + G        P      
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL------NPYPGILV 272

Query: 302 EQRLLEWVQQYPADSKKFGLIMD-PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
             +  + V+         G  M  P           + I  +   C +     RP   Q+
Sbjct: 273 NSKFYKLVKD--------GYQMAQPA-------FAPKNIYSIMQACWALEPTHRPTFQQI 317

Query: 361 VERLKQIVQ 369
              L++  Q
Sbjct: 318 CSFLQEQAQ 326

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  110 bits (278), Expect = 1e-27
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 27/211 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHK---QWVAEVQFLGVLE 141
           +G+GGF   ++          +   T  V A K + +  L       +   E+     L 
Sbjct: 23  LGKGGFAKCFE---------ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           H ++V   G+   D +      +V E    RSL +    R     P + R + +     G
Sbjct: 74  HQHVVGFHGFFE-DNDFVF---VVLELCRRRSLLELHKRRKALTEP-EAR-YYLRQIVLG 127

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
             YLH     +VI+RD K  N+ L+E+   K+ DFGLA +    G         GT  Y 
Sbjct: 128 CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYI 182

Query: 262 APDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ +   GH + + DVWS G ++Y +L G+
Sbjct: 183 APEVLSKKGH-SFEVDVWSIGCIMYTLLVGK 212

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  112 bits (282), Expect = 1e-27
 Identities = 33/258 (12%), Positives = 73/258 (28%), Gaps = 52/258 (20%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRD------- 122
           SE+ +      R   +G+    +  +          T + T     +             
Sbjct: 71  SELGERPRTLVRGTVLGQEDPYAYLE---------ATDQETGESFEVHVPYFTERPPSNA 121

Query: 123 ---------------GLQGHKQWVAEVQFLG---VLEHPNLVKLIGYCAVDGERGIQRLL 164
                          G++  KQ    ++F+    +++ P   K+I     + +  +    
Sbjct: 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRF 181

Query: 165 VYEFMLNRSLEDHL-----FNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDF 218
                +  +L+         +     L    RL + L     LA LH  G    +++   
Sbjct: 182 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYL 237

Query: 219 KASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP-----DYIETGHLTA 273
           +  +++LD+     L+ F           +             A             +T 
Sbjct: 238 RPVDIVLDQRGGVFLTGFEHLVRDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTF 296

Query: 274 KSDVWSFGVVLYEMLTGR 291
             D W+ G+ +Y +    
Sbjct: 297 AFDTWTLGLAIYWIWCAD 314

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  112 bits (283), Expect = 1e-27
 Identities = 57/288 (19%), Positives = 109/288 (37%), Gaps = 50/288 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFL-GVLEHPN 144
            +G G  G++           G  +   VA+K++  +      +   EVQ L    EHPN
Sbjct: 31  VLGHGAEGTIVYR--------GMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPN 79

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +++   +C     +     +  E     +L++++  + F  L  +    ++     GLA+
Sbjct: 80  VIRY--FCTEKDRQFQ--YIAIELC-AATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAH 133

Query: 205 LHEGLEVQVIYRDFKASNVLLDE-----NFRPKLSDFGLAR-EGPMVGHTHVSTAVVGTF 258
           LH    + +++RD K  N+L+         +  +SDFGL +            + V GT 
Sbjct: 134 LHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190

Query: 259 GYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQQY 312
           G+ AP+ +      + T   D++S G V Y +++         P     +++    +   
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-----HPFGKSLQRQANILLGAC 245

Query: 313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
             D            EK      AR    L +  ++   + RP    V
Sbjct: 246 SLDC--------LHPEKHED-VIAR---ELIEKMIAMDPQKRPSAKHV 281

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  111 bits (279), Expect = 1e-27
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 27/211 (12%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHK---QWVAEVQFLGVLE 141
           +G+GGF   ++          +   T  V A K + +  L       +   E+     L 
Sbjct: 49  LGKGGFAKCFE---------ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           H ++V   G+   D +      +V E    RSL +    R     P + R + +     G
Sbjct: 100 HQHVVGFHGFFE-DNDFVF---VVLELCRRRSLLELHKRRKALTEP-EAR-YYLRQIVLG 153

Query: 202 LAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
             YLH     +VI+RD K  N+ L+E+   K+ DFGLA +    G         GT  Y 
Sbjct: 154 CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYI 208

Query: 262 APDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 291
           AP+ +   GH + + DVWS G ++Y +L G+
Sbjct: 209 APEVLSKKGH-SFEVDVWSIGCIMYTLLVGK 238

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (273), Expect = 4e-27
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 27/218 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK---QWVAEVQ 135
           +DF     +G+G FG+VY +  K           ++A+K L +  L+      Q   E++
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREK-----QNKF--IMALKVLFKSQLEKEGVEHQLRREIE 66

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
               L HPN++++  Y         +R+ L+ EF     L   L  +       +     
Sbjct: 67  IQSHLRHPNILRMYNYFHDR-----KRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATF 119

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG-HTHVSTA 253
           +   A+ L Y HE    +VI+RD K  N+L+      K++DFG +   P +   T     
Sbjct: 120 MEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT----- 171

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           + GT  Y  P+ IE      K D+W  GV+ YE L G 
Sbjct: 172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  107 bits (270), Expect = 1e-26
 Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 27/225 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFL 137
           +D+     IG G    V  +   P       E   VAIK++N +  Q     +  E+Q +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAP-----KKE--KVAIKRINLEKCQTSMDELLKEIQAM 67

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRL---- 192
               HPN+V       V  E     L LV + +   S+ D + +           L    
Sbjct: 68  SQCHHPNIVSYYTSFVVKDE-----LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122

Query: 193 --HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA---REGPMVGH 247
              I+    EGL YLH+      I+RD KA N+LL E+   +++DFG++     G  +  
Sbjct: 123 IATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179

Query: 248 THVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGR 291
             V    VGT  + AP+ +E       K+D+WSFG+   E+ TG 
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  107 bits (269), Expect = 2e-26
 Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 47/229 (20%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-----E 133
             + ++ KIGEG +G V+K   +      T +  +VAIKK            +      E
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRD-----TGQ--IVAIKKFL---ESEDDPVIKKIALRE 52

Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWK 189
           ++ L  L+HPNLV L+     +  R  +RL LV+E+    +   L+ +   R  P    K
Sbjct: 53  IRMLKQLKHPNLVNLL-----EVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVK 105

Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGH 247
           +     L   + + + H+      I+RD K  N+L+ ++   KL DFG AR   GP   +
Sbjct: 106 SITWQTL---QAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159

Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGR 291
                  V T  Y +P+ +    +         DVW+ G V  E+L+G 
Sbjct: 160 DD----EVATRWYRSPELL----VGDTQYGPPVDVWAIGCVFAELLSGV 200

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  108 bits (271), Expect = 3e-26
 Identities = 50/246 (20%), Positives = 90/246 (36%), Gaps = 27/246 (10%)

Query: 58  LYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEG--GFGSVYKSSIKPAAGDGTSEATVVA 115
            +     NL     S        +  +  IG+G     +V  +  KP     T E   V 
Sbjct: 4   HHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKP-----TGE--YVT 56

Query: 116 IKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNR 172
           ++++N +            E+    +  HPN+V        D E     L +V  FM   
Sbjct: 57  VRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE-----LWVVTSFMAYG 111

Query: 173 SLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK 232
           S +D +       +      +I+ G  + L Y+H    +  ++R  KAS++L+  + +  
Sbjct: 112 SAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVY 168

Query: 233 LSDFG----LAREGPMVGHTHV-STAVVGTFGYAAPDYIETGHL--TAKSDVWSFGVVLY 285
           LS       +   G      H      V    + +P+ ++       AKSD++S G+   
Sbjct: 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 228

Query: 286 EMLTGR 291
           E+  G 
Sbjct: 229 ELANGH 234

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  108 bits (271), Expect = 4e-26
 Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 32/223 (14%)

Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN 144
            K+G G +G VYK+  K        +    A+K++   G+        E+  L  L+HPN
Sbjct: 27  CKVGRGTYGHVYKAKRKD---GKDDK--DYALKQIEGTGI--SMSACREIALLRELKHPN 79

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRA------FPPLPWKTRLHII 195
           ++ L        +R +   L++++    L   ++ H  ++A       P    K+ L+ I
Sbjct: 80  VISLQKVFLSHADRKV--WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP----KLSDFGLARE--GPMVGHTH 249
           L   +G+ YLH      V++RD K +N+L+          K++D G AR    P+     
Sbjct: 138 L---DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191

Query: 250 VSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           +   VV TF Y AP+ +    H T   D+W+ G +  E+LT  
Sbjct: 192 LDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (263), Expect = 1e-25
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 27/217 (12%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFL 137
              ++R  KIG+G  G+VY +         T +   VAI+++N       +  + E+  +
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDV-----ATGQ--EVAIRQMNLQQQPKKELIINEILVM 71

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI-- 194
              ++PN+V  +    V  E     L +V E++   SL D +               I  
Sbjct: 72  RENKNPNIVNYLDSYLVGDE-----LWVVMEYLAGGSLTDVVTETCM------DEGQIAA 120

Query: 195 -ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
                 + L +LH     QVI+RD K+ N+LL  +   KL+DFG      +       + 
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRST 175

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +VGT  + AP+ +       K D+WS G++  EM+ G
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  104 bits (263), Expect = 1e-25
 Identities = 69/227 (30%), Positives = 113/227 (49%), Gaps = 44/227 (19%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDGLQGHKQWVAEV 134
             + ++ K+GEG +G VYK      A D      +VA+K++      +G+      + E+
Sbjct: 21  EKYQKLEKVGEGTYGVVYK------AKDSQGR--IVALKRIRLDAEDEGI--PSTAIREI 70

Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTR 191
             L  L HPN+V L     +  ER +   LV+EFM   L + L+++           K  
Sbjct: 71  SLLKELHHPNIVSL--IDVIHSERCL--TLVFEFMEKDLKKVLDEN--KTGLQDSQIKIY 124

Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTH 249
           L+ +L    G+A+ H+    ++++RD K  N+L++ +   KL+DFGLAR    P+  +TH
Sbjct: 125 LYQLL---RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178

Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGR 291
               VV T  Y APD +    + +K      D+WS G +  EM+TG+
Sbjct: 179 E---VV-TLWYRAPDVL----MGSKKYSTSVDIWSIGCIFAEMITGK 217

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  104 bits (261), Expect = 1e-25
 Identities = 52/240 (21%), Positives = 87/240 (36%), Gaps = 47/240 (19%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQ 135
           T +F  + KIG G FGSV+K   +    DG     + AIK+  +   G    +  + EV 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRL---DGC----IYAIKRSKKPLAGSVDEQNALREVY 62

Query: 136 FLGVL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL--FNRAFPPLPWKTRL 192
              VL +H ++V+     A D    IQ     E+    SL D +    R           
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQ----NEYCNGGSLADAISENYRIMSYFKEAELK 118

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP-------------------KL 233
            ++L    GL Y+H    + +++ D K SN+ +     P                   K+
Sbjct: 119 DLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175

Query: 234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGR 291
            D G       +    V     G   + A + +     HL  K+D+++  + +       
Sbjct: 176 GDLGHVT---RISSPQV---EEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAE 228

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  105 bits (263), Expect = 2e-25
 Identities = 65/239 (27%), Positives = 100/239 (41%), Gaps = 21/239 (8%)

Query: 60  EEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL 119
           +  A +L     S +R     F  +  +G G +G VYK          T +  + AIK +
Sbjct: 5   DSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVK-----TGQ--LAAIKVM 57

Query: 120 NRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIG-YCAVDGERGIQRL-LVYEFMLNRSLED 176
           +  G    ++   E+  L     H N+    G +   +      +L LV EF    S+ D
Sbjct: 58  DVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116

Query: 177 HLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF 236
            + N     L  +   +I      GL++LH+    +VI+RD K  NVLL EN   KL DF
Sbjct: 117 LIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 173

Query: 237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLT-----AKSDVWSFGVVLYEMLTG 290
           G++ +  +          +GT  + AP+ I            KSD+WS G+   EM  G
Sbjct: 174 GVSAQ--LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  104 bits (261), Expect = 2e-25
 Identities = 66/232 (28%), Positives = 109/232 (46%), Gaps = 54/232 (23%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDG-----LQGHKQ 129
             +  + KIGEG +G VYK      A +   E    A+KK+      +G     ++    
Sbjct: 2   EKYHGLEKIGEGTYGVVYK------AQNNYGE--TFALKKIRLEKEDEGIPSTTIR---- 49

Query: 130 WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPL 186
              E+  L  L+H N+VKL  Y  +  ++ +  +LV+E +   L + L+          +
Sbjct: 50  ---EISILKELKHSNIVKL--YDVIHTKKRL--VLVFEHLDQDLKKLLDVC--EGGLESV 100

Query: 187 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPM 244
             K+ L  +L    G+AY H+    +V++RD K  N+L++     K++DFGLAR    P+
Sbjct: 101 TAKSFLLQLL---NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154

Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGR 291
             +TH    +V T  Y APD +    + +K      D+WS G +  EM+ G 
Sbjct: 155 RKYTHE---IV-TLWYRAPDVL----MGSKKYSTTIDIWSVGCIFAEMVNGT 198

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  104 bits (261), Expect = 2e-25
 Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 31/222 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQ 135
            DF     +GEG F +V  +         TS     AIK L +  +    +      E  
Sbjct: 30  EDFKFGKILGEGSFSTVVLAREL-----ATSR--EYAIKILEKRHIIKENKVPYVTRERD 82

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFN-RAFPPLPWKTRLH 193
            +  L+HP  VKL  +   D E+    L     +  N  L  ++    +F      TR +
Sbjct: 83  VMSRLDHPFFVKLY-FTFQDDEK----LYFGLSYAKNGELLKYIRKIGSFDE--TCTRFY 135

Query: 194 IILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
                AE    L YLH      +I+RD K  N+LL+E+   +++DFG A+          
Sbjct: 136 ----TAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188

Query: 251 STAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGR 291
           + + VGT  Y +P+ +       + SD+W+ G ++Y+++ G 
Sbjct: 189 ANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGL 229

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  104 bits (261), Expect = 3e-25
 Identities = 64/230 (27%), Positives = 96/230 (41%), Gaps = 33/230 (14%)

Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVA- 132
            AT+ +  + +IG G +G+VYK              +   VA+K +      G    +  
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYK---------ARDPHSGHFVALKSVRVPNGGGGGGGLPI 56

Query: 133 ----EVQFLGVL---EHPNLVKLIGYCAVDGERGIQRL-LVYEFMLN--RSLEDHLFNRA 182
               EV  L  L   EHPN+V+L+  CA        ++ LV+E +    R+  D      
Sbjct: 57  STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG 116

Query: 183 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE- 241
            P    K  +   L    GL +LH      +++RD K  N+L+      KL+DFGLAR  
Sbjct: 117 LPAETIKDLMRQFL---RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY 170

Query: 242 GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
              +  T V   VV T  Y AP+ +         D+WS G +  EM   +
Sbjct: 171 SYQMALTPV---VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  104 bits (261), Expect = 3e-25
 Identities = 58/227 (25%), Positives = 91/227 (40%), Gaps = 43/227 (18%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVA---- 132
             +  +  +GEG +G V K           ++ T  +VAIKK          + V     
Sbjct: 25  EKYENLGLVGEGSYGMVMK---------CRNKDTGRIVAIKKFL---ESDDDKMVKKIAM 72

Query: 133 -EVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLP 187
            E++ L  L H NLV L+     +  +  +R  LV+EF+   +   LE            
Sbjct: 73  REIKLLKQLRHENLVNLL-----EVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQV 125

Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMV 245
            +  L  I+    G+ + H      +I+RD K  N+L+ ++   KL DFG AR    P  
Sbjct: 126 VQKYLFQII---NGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179

Query: 246 GHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
            +       V T  Y AP+ +          DVW+ G ++ EM  G 
Sbjct: 180 VYDD----EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  105 bits (264), Expect = 4e-25
 Identities = 67/274 (24%), Positives = 119/274 (43%), Gaps = 32/274 (11%)

Query: 26  PRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRML 85
           PR ++     +  +   +  S  V+  +   ++    A           R     ++   
Sbjct: 5   PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATP----GQGPDRPQEVSYTDTK 60

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
            IG G FG VY++ +       + E  +VAIKK+    LQ  +    E+Q +  L+H N+
Sbjct: 61  VIGNGSFGVVYQAKLCD-----SGE--LVAIKKV----LQDKRFKNRELQIMRKLDHCNI 109

Query: 146 VKLIGYCAVDGERGIQRLL--VYEFM---LNRSLEDHLFNR-AFPPLPWKTRLHIILGAA 199
           V+L  +    GE+  +  L  V +++   + R    +   +   P +  K  ++ +    
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF--- 166

Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTF 258
             LAY+H      + +RD K  N+LLD +    KL DFG A++   +     + + + + 
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEPNVSYICSR 220

Query: 259 GYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGR 291
            Y AP+ I      T+  DVWS G VL E+L G+
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  103 bits (259), Expect = 4e-25
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 47/232 (20%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKL----NRDGLQGHKQWVA 132
             + ++ KIGEG +G+V+K           +  T  +VA+K++    + +G+      + 
Sbjct: 2   QKYEKLEKIGEGTYGTVFK---------AKNRETHEIVALKRVRLDDDDEGV--PSSALR 50

Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWK 189
           E+  L  L+H N+V+L  +  +  ++ +   LV+EF    L +  +    N    P   K
Sbjct: 51  EICLLKELKHKNIVRL--HDVLHSDKKL--TLVFEFCDQDLKKYFDSC--NGDLDPEIVK 104

Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGH 247
           + L  +L   +GL + H      V++RD K  N+L++ N   KL++FGLAR    P+  +
Sbjct: 105 SFLFQLL---KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158

Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGRRSL 294
           +     VV T  Y  PD +      AK      D+WS G +  E+    R L
Sbjct: 159 SAE---VV-TLWYRPPDVL----FGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  104 bits (261), Expect = 6e-25
 Identities = 69/236 (29%), Positives = 111/236 (47%), Gaps = 46/236 (19%)

Query: 73  EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQW 130
           +++     + ++  +GEG F +VYK            + T  +VAIKK+        K  
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYK---------ARDKNTNQIVAIKKIKLGHRSEAKDG 54

Query: 131 VA-----EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRA 182
           +      E++ L  L HPN++ L    A   +  I   LV++FM   L   ++D+  +  
Sbjct: 55  INRTALREIKLLQELSHPNIIGL--LDAFGHKSNIS--LVFDFMETDLEVIIKDN--SLV 108

Query: 183 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE- 241
             P   K  + + L   +GL YLH+     +++RD K +N+LLDEN   KL+DFGLA+  
Sbjct: 109 LTPSHIKAYMLMTL---QGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162

Query: 242 -GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGR 291
             P   +TH    VV T  Y AP+ +      A+      D+W+ G +L E+L   
Sbjct: 163 GSPNRAYTHQ---VV-TRWYRAPELL----FGARMYGVGVDMWAVGCILAELLLRV 210

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  103 bits (258), Expect = 7e-25
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 19/210 (9%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           F  + K+GEG +GSVYK+  K      T +  +VAIK++  +     ++ + E+  +   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHK-----ETGQ--IVAIKQVPVE--SDLQEIIKEISIMQQC 81

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           + P++VK  G    + +  I    V E+    S+ D +       L       I+    +
Sbjct: 82  DSPHVVKYYGSYFKNTDLWI----VMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLK 136

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           GL YLH     + I+RD KA N+LL+     KL+DFG+A  G +         V+GT  +
Sbjct: 137 GLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDTMAKRNTVIGTPFW 191

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            AP+ I+       +D+WS G+   EM  G
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  103 bits (258), Expect = 9e-25
 Identities = 63/236 (26%), Positives = 114/236 (48%), Gaps = 51/236 (21%)

Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKL---NRDG-----LQ 125
            +++ F ++ K+G G + +VYK         G ++ T   VA+K++   + +G     ++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYK---------GLNKTTGVYVALKEVKLDSEEGTPSTAIR 52

Query: 126 GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRA 182
                  E+  +  L+H N+V+L  Y  +  E  +   LV+EFM   L + ++       
Sbjct: 53  -------EISLMKELKHENIVRL--YDVIHTENKL--TLVFEFMDNDLKKYMDSRTVGNT 101

Query: 183 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE- 241
              L      +      +GLA+ HE    ++++RD K  N+L+++  + KL DFGLAR  
Sbjct: 102 PRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158

Query: 242 -GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGR 291
             P+   +     VV T  Y APD +    + +++     D+WS G +L EM+TG+
Sbjct: 159 GIPVNTFSSE---VV-TLWYRAPDVL----MGSRTYSTSIDIWSCGCILAEMITGK 206

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  105 bits (263), Expect = 1e-24
 Identities = 70/307 (22%), Positives = 120/307 (39%), Gaps = 56/307 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVA---EVQFLGVL 140
            +G+G FG V              + T    A+K +++  ++      +   EVQ L  L
Sbjct: 33  VLGKGSFGEVIL---------CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           +HPN++KL  +     E      LV E      L D + +R            II     
Sbjct: 84  DHPNIMKLYEFF----EDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLS 137

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
           G+ Y+H+    ++++RD K  N+LL    ++   ++ DFGL+        +      +GT
Sbjct: 138 GITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGT 191

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQQ--Y 312
             Y AP+ +  G    K DVWS GV+LY +L+G        P     E  +L+ V++  Y
Sbjct: 192 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGC------PPFNGANEYDILKKVEKGKY 244

Query: 313 PADSKKFG-------------LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
             +  ++              L   P      S  +A     +      + S D P +  
Sbjct: 245 TFELPQWKKVSESAKDLIRKMLTYVPS--MRISARDALDHEWIQTYTKEQISVDVPSLDN 302

Query: 360 VVERLKQ 366
            +  ++Q
Sbjct: 303 AILNIRQ 309

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  104 bits (260), Expect = 1e-24
 Identities = 67/304 (22%), Positives = 119/304 (39%), Gaps = 61/304 (20%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG-VLEHPN 144
            +G G  G+V           G+ +   VA+K++  D          E++ L    +HPN
Sbjct: 22  ILGYGSSGTVVFQ--------GSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPN 70

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLED-----HLFNRAFPPLPWKTRLHIILGAA 199
           +++   YC+   +R +   +  E   N +L+D     ++ +           + ++   A
Sbjct: 71  VIRY--YCSETTDRFL--YIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125

Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLD-------------ENFRPKLSDFGLAR---EGP 243
            G+A+LH    +++I+RD K  N+L+              EN R  +SDFGL +    G 
Sbjct: 126 SGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

Query: 244 MVGHTHVSTAVVGTFGYAAPDYIE-------TGHLTAKSDVWSFGVVLYEMLTGRRSLER 296
               T+++    GT G+ AP+ +E          LT   D++S G V Y +L+  +    
Sbjct: 183 SSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241

Query: 297 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK 356
           ++   E  ++            F L     L     I EA     L    +      RP 
Sbjct: 242 DKYSRESNII---------RGIFSLDEMKCLHDRSLIAEATD---LISQMIDHDPLKRPT 289

Query: 357 MSQV 360
             +V
Sbjct: 290 AMKV 293

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  103 bits (259), Expect = 1e-24
 Identities = 63/258 (24%), Positives = 116/258 (44%), Gaps = 29/258 (11%)

Query: 42  KSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIK 101
            +  +A +   +  P     K   +         Q    ++    IG G FG V+++ + 
Sbjct: 3   FTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLV 62

Query: 102 PAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQ 161
                 + E   VAIKK+    LQ  +    E+Q + +++HPN+V L  +   +G++  +
Sbjct: 63  E-----SDE---VAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110

Query: 162 RL--LVYEFM---LNRSLEDHL-FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIY 215
               LV E++   + R+   +    +  P L  K  ++ +L     LAY+H    + + +
Sbjct: 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL---RSLAYIHS---IGICH 164

Query: 216 RDFKASNVLLDENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTA 273
           RD K  N+LLD      KL DFG A+   ++     + + + +  Y AP+ I    + T 
Sbjct: 165 RDIKPQNLLLDPPSGVLKLIDFGSAK---ILIAGEPNVSYICSRYYRAPELIFGATNYTT 221

Query: 274 KSDVWSFGVVLYEMLTGR 291
             D+WS G V+ E++ G+
Sbjct: 222 NIDIWSTGCVMAELMQGQ 239

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  102 bits (256), Expect = 2e-24
 Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 39/232 (16%)

Query: 76  QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL----NRDG-----LQG 126
           +A   +  + +IGEG +G V+K      A D  +    VA+K++      +G     ++ 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFK------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIR- 60

Query: 127 HKQWVAEVQFLGVL---EHPNLVKLIGYCAVDGERGIQRL-LVYEFMLN--RSLEDHLFN 180
                 EV  L  L   EHPN+V+L   C V       +L LV+E +     +  D +  
Sbjct: 61  ------EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE 114

Query: 181 RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 240
              P    K  +  +L    GL +LH     +V++RD K  N+L+  + + KL+DFGLAR
Sbjct: 115 PGVPTETIKDMMFQLL---RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168

Query: 241 E-GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
                +  T V   VV T  Y AP+ +         D+WS G +  EM   +
Sbjct: 169 IYSFQMALTSV---VV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  101 bits (254), Expect = 2e-24
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 22/215 (10%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
           +  + ++G+G FG VYK+  K      T    + A K +     +  + ++ E++ L   
Sbjct: 21  WEIVGELGDGAFGKVYKAKNK-----ETGA--LAAAKVIETKSEEELEDYIVEIEILATC 73

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           +HP +VKL+G    DG+  I    + EF    +++  +       L       +     E
Sbjct: 74  DHPYIVKLLGAYYHDGKLWI----MIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLE 128

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            L +LH     ++I+RD KA NVL+      +L+DFG++     +       + +GT  +
Sbjct: 129 ALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYW 183

Query: 261 AAPDYIETGHLT-----AKSDVWSFGVVLYEMLTG 290
            AP+ +    +       K+D+WS G+ L EM   
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  101 bits (254), Expect = 2e-24
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 19/210 (9%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL 140
               +KIGEG  G V  +  K      +     VA+K ++    Q  +    EV  +   
Sbjct: 47  LDSYVKIGEGSTGIVCLAREK-----HSGR--QVAVKMMDLRKQQRRELLFNEVVIMRDY 99

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
           +H N+V++     V  E  +    + EF+   +L D +           T    +L   +
Sbjct: 100 QHFNVVEMYKSYLVGEELWV----LMEFLQGGALTDIVSQVRLNEEQIATVCEAVL---Q 152

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
            LAYLH      VI+RD K+ ++LL  + R KLSDFG      +        ++VGT  +
Sbjct: 153 ALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYW 207

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            AP+ I       + D+WS G+++ EM+ G
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  101 bits (253), Expect = 4e-24
 Identities = 68/226 (30%), Positives = 106/226 (46%), Gaps = 42/226 (18%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL---NRDGLQGHKQWVAEVQ 135
             + ++ K+GEG + +VYK   K      T    +VA+K++   + +G       + EV 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKL-----TDN--LVALKEIRLEHEEGA--PCTAIREVS 52

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRL 192
            L  L+H N+V L  +  +  E+ +   LV+E++   L + L+D            K  L
Sbjct: 53  LLKDLKHANIVTL--HDIIHTEKSL--TLVFEYLDKDLKQYLDDC--GNIINMHNVKLFL 106

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE--GPMVGHTHV 250
             +L    GLAY H     +V++RD K  N+L++E    KL+DFGLAR    P   + + 
Sbjct: 107 FQLL---RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160

Query: 251 STAVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGR 291
              VV T  Y  PD +    L +       D+W  G + YEM TGR
Sbjct: 161 ---VV-TLWYRPPDIL----LGSTDYSTQIDMWGVGCIFYEMATGR 198

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  101 bits (254), Expect = 4e-24
 Identities = 64/245 (26%), Positives = 105/245 (42%), Gaps = 36/245 (14%)

Query: 63  AHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD 122
           A            +  + + ++ KIG+G FG V+K     A    T +   VA+KK+   
Sbjct: 2   AKQYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFK-----ARHRKTGQ--KVALKKVL-- 51

Query: 123 GLQGHKQWVA-----EVQFLGVLEHPNLVKLIGYCAVDGERGIQRL----LVYEFM---L 170
            ++  K+        E++ L +L+H N+V LI  C        +      LV++F    L
Sbjct: 52  -MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL 110

Query: 171 NRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR 230
              L +      F     K  + ++L    GL Y+H     ++++RD KA+NVL+  +  
Sbjct: 111 AGLLSNV--LVKFTLSEIKRVMQMLL---NGLYYIHRN---KILHRDMKAANVLITRDGV 162

Query: 231 PKLSDFGLARE--GPMVGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYE 286
            KL+DFGLAR          +  T  V T  Y  P+ +  E  +     D+W  G ++ E
Sbjct: 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP-IDLWGAGCIMAE 221

Query: 287 MLTGR 291
           M T  
Sbjct: 222 MWTRS 226

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  102 bits (256), Expect = 9e-24
 Identities = 71/312 (22%), Positives = 129/312 (41%), Gaps = 66/312 (21%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQG--HKQWVAEVQFLGVLE 141
           K+G G +G V              + T    AIK + +  +    + + + EV  L +L+
Sbjct: 44  KLGSGAYGEVLL---------CRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           HPN++KL  +     E      LV E      L D + +R            II     G
Sbjct: 95  HPNIMKLYDFF----EDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSG 148

Query: 202 LAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           + YLH+     +++RD K  N+LL   +++   K+ DFGL+    +  +       +GT 
Sbjct: 149 VTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKMKERLGTA 202

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQQ--YP 313
            Y AP+ +       K DVWS GV+L+ +L G        P   +T+Q +L  V++  Y 
Sbjct: 203 YYIAPEVLR-KKYDEKCDVWSIGVILFILLAGY------PPFGGQTDQEILRKVEKGKYT 255

Query: 314 ADSKKFG-------------LIMDPRLEKEYSINEA------RKIGRLADNCLSKSSKDR 354
            DS ++              L  D +  +  S  +A      +++    ++ +     + 
Sbjct: 256 FDSPEWKNVSEGAKDLIKQMLQFDSQ--RRISAQQALEHPWIKEMCSKKESGI-----EL 308

Query: 355 PKMSQVVERLKQ 366
           P ++  +E +++
Sbjct: 309 PSLANAIENMRK 320

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  102 bits (256), Expect = 1e-23
 Identities = 72/273 (26%), Positives = 117/273 (42%), Gaps = 35/273 (12%)

Query: 57  ELYEEKAHNLRV--FSYSEMRQAT-NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEAT 112
           + + +  + LR   + + E +    + F    + +G GGFG V+   +K      T +  
Sbjct: 160 QEFLDSLYFLRFLQWKWLEAQPMGEDWF-LDFRVLGRGGFGEVFACQMK-----ATGK-- 211

Query: 113 VVAIKKLNRDGLQGHKQW---VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEF 168
           + A KKLN+  L+  K +   + E + L  +    +V L  Y           L LV   
Sbjct: 212 LYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKT----DLCLVMTI 266

Query: 169 MLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLL 225
           M    +  H++N       ++     I   A+   GL +LH   +  +IYRD K  NVLL
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEP-RAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLL 322

Query: 226 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLY 285
           D++   ++SD GLA E         +    GT G+ AP+ +         D ++ GV LY
Sbjct: 323 DDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLY 380

Query: 286 EMLTGR-----RSLERNRPKTEQRLLEWVQQYP 313
           EM+  R     R  +    + +QR+LE    YP
Sbjct: 381 EMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  100 bits (250), Expect = 2e-23
 Identities = 71/245 (28%), Positives = 109/245 (44%), Gaps = 38/245 (15%)

Query: 63  AHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL--- 119
           + N    +    R+  + F      G+G FG+V     K      T     VAIKK+   
Sbjct: 7   SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKS-----TGM--SVAIKKVIQD 59

Query: 120 ----NRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL---LVYEFM--- 169
               NR+ LQ        +Q L VL HPN+V+L  Y    GER  + +   +V E++   
Sbjct: 60  PRFRNRE-LQ-------IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT 111

Query: 170 LNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-E 227
           L+R   ++   + A PP+  K  L  ++     +  LH    V V +RD K  NVL++  
Sbjct: 112 LHRCCRNYYRRQVAPPPILIKVFLFQLI---RSIGCLHLP-SVNVCHRDIKPHNVLVNEA 167

Query: 228 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYE 286
           +   KL DFG A+    +  +  + A + +  Y AP+ I    H T   D+WS G +  E
Sbjct: 168 DGTLKLCDFGSAK---KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAE 224

Query: 287 MLTGR 291
           M+ G 
Sbjct: 225 MMLGE 229

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  100 bits (250), Expect = 2e-23
 Identities = 91/372 (24%), Positives = 146/372 (39%), Gaps = 69/372 (18%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQ 135
           + F  +  IG+G FG V            T +  + A+K +N+       +      E+Q
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKN-----DTKK--MYAMKYMNKQKCVERNEVRNVFKELQ 67

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLF-NRAFPPLPWKTRLH 193
            +  LEHP LV L  Y   D E     + +V + +L   L  HL  N  F       +L 
Sbjct: 68  IMQGLEHPFLVNLW-YSFQDEED----MFMVVDLLLGGDLRYHLQQNVHFKE--ETVKLF 120

Query: 194 IILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
                 E    L YL      ++I+RD K  N+LLDE+    ++DF +A     +     
Sbjct: 121 ----ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAM---LPRETQ 170

Query: 251 STAVVGTFGYAAP----DYIETGHLTAKSDVWSFGVVLYEMLTGRR----SLERNRPKTE 302
            T + GT  Y AP         G+  A  D WS GV  YE+L GRR        +  +  
Sbjct: 171 ITTMAGTKPYMAPEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

Query: 303 QRLLEWVQQYPAD-SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV 361
                 V  YP+  S++   ++   LE     N  ++  +L+D       ++ P M+ + 
Sbjct: 230 HTFETTVVTYPSAWSQEMVSLLKKLLEP----NPDQRFSQLSD------VQNFPYMNDIN 279

Query: 362 -ERL--KQI-------VQVSNEGDSFDKTF---EEICEEDPVEAQTKQKQHEPSEAWKRR 408
            + +  K++           N     D TF   E I E  P+  + K+   +  +  K  
Sbjct: 280 WDAVFQKRLIPGFIPNKGRLN----CDPTFELEEMILESKPLHKKKKRLAKKEKDMRKCD 335

Query: 409 MAHLAKLGEHVE 420
            +    L EH++
Sbjct: 336 SSQTCLLQEHLD 347

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  101 bits (252), Expect = 4e-23
 Identities = 71/258 (27%), Positives = 114/258 (44%), Gaps = 34/258 (13%)

Query: 69  FSYSEMRQAT-NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG 126
           + + E +  T N F R  + +G+GGFG V    ++      T +  + A KKL +  ++ 
Sbjct: 173 WKWLERQPVTKNTF-RQYRVLGKGGFGEVCACQVR-----ATGK--MYACKKLEKKRIKK 224

Query: 127 HKQW---VAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAF 183
            K     + E Q L  +    +V L  Y     +      LV   M    L+ H+++   
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDA---LCLVLTLMNGGDLKFHIYHMGQ 280

Query: 184 PPLPWKTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 240
              P       +  AAE   GL  LH     +++YRD K  N+LLD++   ++SD GLA 
Sbjct: 281 AGFPEA---RAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAV 334

Query: 241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR-----RSLE 295
               V         VGT GY AP+ ++    T   D W+ G +LYEM+ G+     R  +
Sbjct: 335 H---VPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391

Query: 296 RNRPKTEQRLLEWVQQYP 313
             R + E+ + E  ++Y 
Sbjct: 392 IKREEVERLVKEVPEEYS 409

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 98.6 bits (246), Expect = 5e-23
 Identities = 79/269 (29%), Positives = 115/269 (42%), Gaps = 31/269 (11%)

Query: 31  DYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATN---DFSRMLKI 87
            Y       +   +           P     +A +L+    +E+    +    FS + +I
Sbjct: 3   YYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREI 62

Query: 88  GEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQFLGVLEHPN 144
           G G FG+VY +          SE  VVAIKK++  G Q +++W   + EV+FL  L HPN
Sbjct: 63  GHGSFGAVYFARDV-----RNSE--VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
            ++  G    +    +    V E+ L  S  D L      PL       +  GA +GLAY
Sbjct: 116 TIQYRGCYLREHTAWL----VMEYCLG-SASDLLEVHK-KPLQEVEIAAVTHGALQGLAY 169

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 264
           LH      +I+RD KA N+LL E    KL DFG A           + + VGT  + AP+
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGTPYWMAPE 220

Query: 265 YI---ETGHLTAKSDVWSFGVVLYEMLTG 290
            I   + G    K DVWS G+   E+   
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAER 249

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 99.8 bits (249), Expect = 7e-23
 Identities = 66/317 (20%), Positives = 115/317 (36%), Gaps = 66/317 (20%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVA----------- 132
           K+G G +G V              +      AIK + +      +               
Sbjct: 43  KLGSGAYGEVLL---------CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93

Query: 133 --EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKT 190
             E+  L  L+HPN++KL        E      LV EF     L + + NR         
Sbjct: 94  YNEISLLKSLDHPNIIKLFDVF----EDKKYFYLVTEFYEGGELFEQIINRHK--FDECD 147

Query: 191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGH 247
             +I+     G+ YLH+     +++RD K  N+LL   +     K+ DFGL+        
Sbjct: 148 AANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSK 201

Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQR 304
            +     +GT  Y AP+ ++      K DVWS GV++Y +L G        P   + +Q 
Sbjct: 202 DYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYP------PFGGQNDQD 254

Query: 305 LLEWVQQ--YPADSKKFG-------------LIMDPRLEKEYSINEARKIGRLADNCLSK 349
           +++ V++  Y  D   +              L  D    K  +  EA     +     + 
Sbjct: 255 IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYN--KRCTAEEALNSRWIKKYANNI 312

Query: 350 SSKDRPKMSQVVERLKQ 366
           +  D+  +   +  +++
Sbjct: 313 NKSDQKTLCGALSNMRK 329

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 52/218 (23%), Positives = 85/218 (38%), Gaps = 33/218 (15%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVA----EVQFLGVL 140
           +GEG +G V +              T    A+K L +  L+      A    E+Q L  L
Sbjct: 13  LGEGSYGKVKE---------VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE--DHLFNRAFPPLPWKTRLH---II 195
            H N+++L     +  E   +  +V E+ +    E  D +  + FP    +   +   +I
Sbjct: 64  RHKNVIQL--VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFP--VCQAHGYFCQLI 119

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
               +GL YLH      ++++D K  N+LL      K+S  G+A                
Sbjct: 120 ----DGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172

Query: 256 GTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGR 291
           G+  +  P+           K D+WS GV LY + TG 
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 42/218 (19%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH--KQWVAEVQFLGVLEHPN 144
           IG+G F  V     K A    T     VAIK +++  L     ++   EV+ + +L HPN
Sbjct: 23  IGKGNFAKV-----KLARHILTGRE--VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH----------I 194
           +VKL  +  ++ E+ +   L+ E+     + D+L            R+           I
Sbjct: 76  IVKL--FEVIETEKTL--YLIMEYASGGEVFDYLVA--------HGRMKEKEARSKFRQI 123

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +      + Y H+    ++++RD KA N+LLD +   K++DFG + E        +    
Sbjct: 124 V----SAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAF- 173

Query: 255 VGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 291
            G   YAAP+  +   +   + DVWS GV+LY +++G 
Sbjct: 174 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 98.8 bits (246), Expect = 2e-22
 Identities = 68/251 (27%), Positives = 112/251 (44%), Gaps = 41/251 (16%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQ 135
           NDFS    IG GGFG VY           T +  + A+K L++  ++  +     + E  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKA-----DTGK--MYAMKCLDKKRIKMKQGETLALNERI 241

Query: 136 FLGVL---EHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFN-RAFPPLPWKT 190
            L ++   + P +V +  Y     ++    L  + + M    L  HL     F       
Sbjct: 242 MLSLVSTGDCPFIVCMS-YAFHTPDK----LSFILDLMNGGDLHYHLSQHGVFSEA---- 292

Query: 191 RLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
              +   AAE   GL ++H      V+YRD K +N+LLDE+   ++SD GLA +      
Sbjct: 293 --DMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KK 346

Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTG----RRSLERNRPKTE 302
            H   A VGT GY AP+ ++ G     S D +S G +L+++L G    R+   +++ + +
Sbjct: 347 PH---ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

Query: 303 QRLLEWVQQYP 313
           +  L    + P
Sbjct: 404 RMTLTMAVELP 414

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 55/236 (23%), Positives = 99/236 (41%), Gaps = 57/236 (24%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKL----NRDG-----LQGH 127
           + + R+ K+GEG +G VYK              T   VAIK++      +G     ++  
Sbjct: 34  DRYRRITKLGEGTYGEVYK---------AIDTVTNETVAIKRIRLEHEEEGVPGTAIR-- 82

Query: 128 KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFP 184
                EV  L  L+H N+++L     +     +   L++E+    L + ++ +       
Sbjct: 83  -----EVSLLKELQHRNIIEL--KSVIHHNHRL--HLIFEYAENDLKKYMDKN---PDVS 130

Query: 185 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP-----KLSDFGLA 239
               K+ L+ ++    G+ + H     + ++RD K  N+LL  +        K+ DFGLA
Sbjct: 131 MRVIKSFLYQLI---NGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184

Query: 240 RE--GPMVGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGR 291
           R    P+   TH    ++ T  Y  P+ +     + T+  D+WS   +  EML   
Sbjct: 185 RAFGIPIRQFTHE---II-TLWYRPPEILLGSRHYSTS-VDIWSIACIWAEMLMKT 235

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 70/312 (22%), Positives = 116/312 (37%), Gaps = 66/312 (21%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQG--HKQWVAEVQFLGVLE 141
            +G+G FG V K              T    A+K +N+   +       + EV+ L  L+
Sbjct: 29  MLGKGSFGEVLK---------CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           HPN++KL      +        +V E      L D +  R            II     G
Sbjct: 80  HPNIMKLFEIL--EDSSSFY--IVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSG 133

Query: 202 LAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           + Y+H+     +++RD K  N+LL   +++   K+ DFGL+               +GT 
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTA 187

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQQ--YP 313
            Y AP+ +  G    K DVWS GV+LY +L+G        P   K E  +L+ V+   Y 
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT------PPFYGKNEYDILKRVETGKYA 240

Query: 314 ADSKKFG-------------LIMDPRLEKEYSINEARKIGRLAD------NCLSKSSKDR 354
            D  ++              L   P      +  +      L        +  + +  D 
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLTFHPS--LRITATQC-----LEHPWIQKYSSETPTISDL 293

Query: 355 PKMSQVVERLKQ 366
           P +   +  ++Q
Sbjct: 294 PSLESAMTNIRQ 305

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 94.6 bits (236), Expect = 4e-22
 Identities = 59/226 (26%), Positives = 86/226 (38%), Gaps = 56/226 (24%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFLGVLEHPNL 145
           +GEG +G V       A    T EA  VA+K ++        + +  E+    +L H N+
Sbjct: 15  LGEGAYGEVQL-----AVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRS-----LE----DHLFNRAFPPLPWKTRLH--- 193
           VK                  Y      +     LE      LF+R  P       +    
Sbjct: 68  VKF-----------------YGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPD 106

Query: 194 -------IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVG 246
                  ++     G+ YLH    + + +RD K  N+LLDE    K+SDFGLA       
Sbjct: 107 AQRFFHQLM----AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159

Query: 247 HTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 291
              +   + GT  Y AP+ ++         DVWS G+VL  ML G 
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 94.6 bits (236), Expect = 4e-22
 Identities = 53/232 (22%), Positives = 92/232 (39%), Gaps = 32/232 (13%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
            IG G +G V  +  K             A KK+ +  ++   ++  E++ +  L+HPN+
Sbjct: 16  TIGRGSWGEVKIAVQK-------GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 68

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           ++L        E      LV E      L + + ++            I+      +AY 
Sbjct: 69  IRLYETF----EDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYC 122

Query: 206 HEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
           H+   + V +RD K  N L      +   KL DFGLA          +    VGT  Y +
Sbjct: 123 HK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVS 176

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQQ 311
           P  +E  +   + D WS GV++Y +L G        P    T+  ++  +++
Sbjct: 177 PQVLEGLY-GPECDEWSAGVMMYVLLCGY------PPFSAPTDSEVMLKIRE 221

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 94.3 bits (235), Expect = 8e-22
 Identities = 56/246 (22%), Positives = 92/246 (37%), Gaps = 70/246 (28%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVA------------ 132
           IG+G +G V             +E      A+K L++  L     +              
Sbjct: 21  IGKGSYGVVKL---------AYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71

Query: 133 --------------EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 178
                         E+  L  L+HPN+VKL     +D        +V+E +    + +  
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVME-- 127

Query: 179 FNRAFPPLPWKTRLH----------IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN 228
                  +P    L           +I G    + YLH     ++I+RD K SN+L+ E+
Sbjct: 128 -------VPTLKPLSEDQARFYFQDLIKG----IEYLHY---QKIIHRDIKPSNLLVGED 173

Query: 229 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLT---AKSDVWSFGVVLY 285
              K++DFG++ E        +S   VGT  + AP+ +            DVW+ GV LY
Sbjct: 174 GHIKIADFGVSNE-FKGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

Query: 286 EMLTGR 291
             + G+
Sbjct: 232 CFVFGQ 237

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 95.9 bits (239), Expect = 9e-22
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 38/221 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVA--------EVQ 135
            +G G  G V                T   VAI+ +++          A        E++
Sbjct: 142 TLGSGACGEVKL---------AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  L HP ++K+  +   +        +V E M    L D +       L   T     
Sbjct: 193 ILKKLNHPCIIKIKNFFDAE-----DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYF 245

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVST 252
                 + YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G T +  
Sbjct: 246 YQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMR 299

Query: 253 AVVGTFGYAAPDYIETGHL---TAKSDVWSFGVVLYEMLTG 290
            + GT  Y AP+ + +          D WS GV+L+  L+G
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 66/231 (28%), Positives = 99/231 (42%), Gaps = 33/231 (14%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-- 129
            ++R    D+  +  IG G FG V     K      T +  V A+K L++  +       
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-----STRK--VYAMKLLSKFEMIKRSDSA 114

Query: 130 -WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLP 187
            +  E   +     P +V+L  Y   D       L +V E+M    L + + N   P   
Sbjct: 115 FFWEERDIMAFANSPWVVQLF-YAFQDDRY----LYMVMEYMPGGDLVNLMSNYDVPE-K 168

Query: 188 WKTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
           W  R +     AE    L  +H    +  I+RD K  N+LLD++   KL+DFG   +   
Sbjct: 169 W-ARFY----TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220

Query: 245 VGHTHVSTAVVGTFGYAAPDYIET----GHLTAKSDVWSFGVVLYEMLTGR 291
            G     TAV GT  Y +P+ +++    G+   + D WS GV LYEML G 
Sbjct: 221 EGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 23/209 (11%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA---EVQFLGVLEHP 143
           +G G FG V     K      T     VA+K LNR  ++          E+Q L +  HP
Sbjct: 19  LGVGTFGKV-----KIGEHQLTGHK--VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
           +++KL  Y  +         +V E++    L D++       +       +       + 
Sbjct: 72  HIIKL--YQVISTPTDF--FMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVD 125

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           Y H      V++RD K  NVLLD +   K++DFGL+    M     + T+  G+  YAAP
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTS-CGSPNYAAP 179

Query: 264 DYIE-TGHLTAKSDVWSFGVVLYEMLTGR 291
           + I    +   + D+WS GV+LY +L G 
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGT 208

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 60/229 (26%), Positives = 86/229 (37%), Gaps = 62/229 (27%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFLGVLEHPNL 145
           +GEG +G V       A    T EA  VA+K ++        + +  E+    +L H N+
Sbjct: 15  LGEGAYGEVQL-----AVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRS-----LE----DHLFNRAFPPLPWKTRLH--- 193
           VK                  Y      +     LE      LF+R  P       +    
Sbjct: 68  VKF-----------------YGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPD 106

Query: 194 -------IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA---REGP 243
                  ++     G+ YLH    + + +RD K  N+LLDE    K+SDFGLA   R   
Sbjct: 107 AQRFFHQLM----AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159

Query: 244 MVGHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 291
                +      GT  Y AP+ ++         DVWS G+VL  ML G 
Sbjct: 160 RERLLNKM---CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 60/247 (24%), Positives = 95/247 (38%), Gaps = 57/247 (23%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFLGVLEHPN 144
           K+G G FG V+    +      +       IK +N+D  Q   + +  E++ L  L+HPN
Sbjct: 29  KLGSGAFGDVHLVEER-----SSGLE--RVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSL--------EDHLFNRAFPPLPWKTRL---- 192
           ++K+                V+E   N  +        E  L  R          L    
Sbjct: 82  IIKIFE--------------VFEDYHNMYIVMETCEGGE--LLERIVSAQARGKALSEGY 125

Query: 193 --HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGH 247
              ++      LAY H      V+++D K  N+L      +   K+ DFGLA    +   
Sbjct: 126 VAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKS 179

Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQR 304
              ST   GT  Y AP+  +   +T K D+WS GVV+Y +LTG        P    + + 
Sbjct: 180 DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGC------LPFTGTSLEE 232

Query: 305 LLEWVQQ 311
           + +    
Sbjct: 233 VQQKATY 239

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 49/227 (21%), Positives = 83/227 (36%), Gaps = 53/227 (23%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA---------EVQFL 137
           +G G FG V       A     ++   V +K + ++ +     W+          E+  L
Sbjct: 32  LGSGAFGFV-----WTAVDKEKNKE--VVVKFIKKEKVLEDC-WIEDPKLGKVTLEIAIL 83

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRS-----LEDH-----LFNR--AFPP 185
             +EH N++K+                  +   N+      +E H     LF      P 
Sbjct: 84  SRVEHANIIKV-----------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR 126

Query: 186 LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 245
           L      +I       + YL       +I+RD K  N+++ E+F  KL DFG A      
Sbjct: 127 LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183

Query: 246 GHTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 291
              +      GT  Y AP+ +    +   + ++WS GV LY ++   
Sbjct: 184 KLFYTF---CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 93.2 bits (232), Expect = 4e-21
 Identities = 58/227 (25%), Positives = 91/227 (40%), Gaps = 40/227 (17%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQ 135
              +  +  IG G  G V       AA D   E   VAIKKL+R        K+   E+ 
Sbjct: 24  LKRYQNLKPIGSGAQGIVC------AAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELV 76

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQR--LLVYEFM---LNRSLEDHLFNRAFPPLPWKT 190
            +  + H N++ L+            +   +V E M   L + ++  L            
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL-----------D 125

Query: 191 RLHI------ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
              +      +L    G+ +LH      +I+RD K SN+++  +   K+ DFGLAR    
Sbjct: 126 HERMSYLLYQML---CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---T 176

Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            G + + T  V T  Y AP+ I         D+WS G ++ EM+ G 
Sbjct: 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 91.9 bits (229), Expect = 5e-21
 Identities = 50/210 (23%), Positives = 83/210 (39%), Gaps = 27/210 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVAEVQFLGVLEHP 143
            +G G F  V+               T  + A+K + +           E+  L  ++H 
Sbjct: 16  VLGSGAFSEVFL---------VKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
           N+V L        E      LV + +    L D +  R       K    +I      + 
Sbjct: 67  NIVTLEDIY----ESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVK 120

Query: 204 YLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           YLHE     +++RD K  N+L    +EN +  ++DFGL++    +    + +   GT GY
Sbjct: 121 YLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK----MEQNGIMSTACGTPGY 173

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            AP+ +     +   D WS GV+ Y +L G
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 58/236 (24%), Positives = 92/236 (38%), Gaps = 38/236 (16%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-- 129
            E+R   +DF  +  IG G F  V    +K      T +  V A+K +N+  +    +  
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMK-----QTGQ--VYAMKIMNKWDMLKRGEVS 106

Query: 130 -WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHL--FNRAFPP 185
            +  E   L   +   + +L  + A   E     L LV E+ +   L   L  F     P
Sbjct: 107 CFREERDVLVNGDRRWITQL--HFAFQDEN---YLYLVMEYYVGGDLLTLLSKFGERI-P 160

Query: 186 LPWKTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 242
                R +     AE    +  +H    +  ++RD K  N+LLD     +L+DFG   + 
Sbjct: 161 AEM-ARFY----LAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212

Query: 243 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKS-------DVWSFGVVLYEMLTGR 291
              G      A VGT  Y +P+ ++       +       D W+ GV  YEM  G+
Sbjct: 213 RADGTVRSLVA-VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 90.4 bits (225), Expect = 4e-20
 Identities = 59/228 (25%), Positives = 86/228 (37%), Gaps = 47/228 (20%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-----------EV 134
            I  G +G+V       A  D       VAIK++      G    +            E+
Sbjct: 29  FISSGSYGAVC------AGVDSEGI--PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKT 190
           + L    HPN++ L        E  + +L LV E M   L +     + +     +   +
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ-----VIHDQRIVI---S 132

Query: 191 RLHI------ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
             HI      IL    GL  LHE     V++RD    N+LL +N    + DF LARE   
Sbjct: 133 PQHIQYFMYHIL---LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLARE--- 183

Query: 245 VGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
                  T  V    Y AP+ + +    T   D+WS G V+ EM   +
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 90.5 bits (225), Expect = 4e-20
 Identities = 57/219 (26%), Positives = 87/219 (39%), Gaps = 45/219 (20%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFLGVLEHPNL 145
           IG G FG       +      T E   VA+K + R         V  E+     L HPN+
Sbjct: 28  IGSGNFGVA-----RLMRDKLTKEL--VAVKYIERGAAIDEN--VQREIINHRSLRHPNI 78

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH----------II 195
           V+      +     +   ++ E+     L + + N          R            ++
Sbjct: 79  VRF--KEVILTPTHL--AIIMEYASGGELYERICN--------AGRFSEDEARFFFQQLL 126

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP--KLSDFGLAREGPMVGHTHVSTA 253
            G    ++Y H    +Q+ +RD K  N LLD +  P  K+ DFG ++    V H+   + 
Sbjct: 127 SG----VSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKST 177

Query: 254 VVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 291
           V GT  Y AP+ +    +    +DVWS GV LY ML G 
Sbjct: 178 V-GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 90.6 bits (225), Expect = 5e-20
 Identities = 61/234 (26%), Positives = 92/234 (39%), Gaps = 36/234 (15%)

Query: 72  SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ-- 129
            +MR    DF  +  IG G FG V    +K        +  V A+K LN+  +    +  
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLK-----NADK--VFAMKILNKWEMLKRAETA 119

Query: 130 -WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHL--FNRAFPP 185
            +  E   L   +   +  L  Y   D       L LV ++ +   L   L  F    P 
Sbjct: 120 CFREERDVLVNGDSKWITTLH-YAFQDDN----NLYLVMDYYVGGDLLTLLSKFEDRLPE 174

Query: 186 LPWKTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 242
                R +     AE    +  +H   ++  ++RD K  N+L+D N   +L+DFG   + 
Sbjct: 175 -EM-ARFY----LAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225

Query: 243 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTGR 291
              G    S A VGT  Y +P+ ++             D WS GV +YEML G 
Sbjct: 226 MEDGTVQSSVA-VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 89.1 bits (222), Expect = 7e-20
 Identities = 69/221 (31%), Positives = 106/221 (47%), Gaps = 29/221 (13%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW--VAEVQ 135
           + F  +LK +G+G FG V+   +K  +G    +  + A+K L +  L+   +     E  
Sbjct: 24  SQF-ELLKVLGQGSFGKVFL--VKKISGSDARQ--LYAMKVLKKATLKVRDRVRTKMERD 78

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            L  + HP +VKL  Y      +    L L+ +F+    L   L            + + 
Sbjct: 79  ILVEVNHPFIVKLH-YAFQTEGK----LYLILDFLRGGDLFTRLSKEVMFTEED-VKFY- 131

Query: 195 ILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
               AE    L +LH    + +IYRD K  N+LLDE    KL+DFGL++E   + H   +
Sbjct: 132 ---LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKA 183

Query: 252 TAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
            +  GT  Y AP+ +   GH T  +D WSFGV+++EMLTG 
Sbjct: 184 YSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGT 223

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 89.3 bits (222), Expect = 7e-20
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA---EVQFLGVLEHP 143
           +GEG FG V     K A    T +   VA+K ++R  L+     +    E+ +L +L HP
Sbjct: 17  LGEGSFGKV-----KLATHYKTQQK--VALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
           +++KL  Y  +     I  ++V E+     L D++  +    +               + 
Sbjct: 70  HIIKL--YDVITTPTDI--VMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIE 122

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           Y H     ++++RD K  N+LLD+N   K++DFGL+    M     + T+  G+  YAAP
Sbjct: 123 YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKTS-CGSPNYAAP 176

Query: 264 DYIE-TGHLTAKSDVWSFGVVLYEMLTGR 291
           + I    +   + DVWS G+VLY ML GR
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 89.3 bits (222), Expect = 8e-20
 Identities = 67/276 (24%), Positives = 111/276 (40%), Gaps = 34/276 (12%)

Query: 30  ADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQAT-NDFSRMLK-I 87
             +   E       +   S     G  +L   K             +    +F  +LK +
Sbjct: 4   HHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENF-ELLKVL 62

Query: 88  GEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQ-----FLGVLEH 142
           G G +G V+   ++  +G  T +  + A+K L +  +    +     +        + + 
Sbjct: 63  GTGAYGKVFL--VRKISGHDTGK--LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 118

Query: 143 PNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE- 200
           P LV L  Y      +    L L+ +++    L  HL  R         +++      E 
Sbjct: 119 PFLVTLH-YAFQTETK----LHLILDYINGGELFTHLSQRERFTEHE-VQIY----VGEI 168

Query: 201 --GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
              L +LH+   + +IYRD K  N+LLD N    L+DFGL++E  +   T  +    GT 
Sbjct: 169 VLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTI 224

Query: 259 GYAAP---DYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            Y AP      ++GH  A  D WS GV++YE+LTG 
Sbjct: 225 EYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGA 259

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 89.1 bits (221), Expect = 8e-20
 Identities = 54/253 (21%), Positives = 86/253 (33%), Gaps = 59/253 (23%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVA-----EVQFLG 138
            IG+G +G V                T  + AIK +N++ ++            EV+ + 
Sbjct: 33  AIGQGSYGVVRV---------AIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83

Query: 139 VLEHPNLVKLIG-------------YCA---------VDGERGIQRLLVYEFMLNRSLED 176
            L HPN+ +L                C          V  +    +  +           
Sbjct: 84  KLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143

Query: 177 HLFNRAFPPLPWKTRL------------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVL 224
                A        R             +I+      L YLH      + +RD K  N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200

Query: 225 L--DENFRPKLSDFGLAR--EGPMVGHTHVSTAVVGTFGYAAPDYIETGHL--TAKSDVW 278
              +++F  KL DFGL++       G  +  T   GT  + AP+ + T +     K D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260

Query: 279 SFGVVLYEMLTGR 291
           S GV+L+ +L G 
Sbjct: 261 SAGVLLHLLLMGA 273

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 88.1 bits (219), Expect = 9e-20
 Identities = 63/236 (26%), Positives = 97/236 (41%), Gaps = 38/236 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQG--HKQWVAEVQFLGVLE 141
            +G+G FG V K              T    A+K +N+   +       + EV+ L  L+
Sbjct: 29  MLGKGSFGEVLK---------CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           HPN++KL        E      +V E      L D +  R            II     G
Sbjct: 80  HPNIMKLFEIL----EDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSG 133

Query: 202 LAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           + Y+H+     +++RD K  N+LL   +++   K+ DFGL+               +GT 
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTA 187

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQQ 311
            Y AP+ +  G    K DVWS GV+LY +L+G        P   K E  +L+ V+ 
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT------PPFYGKNEYDILKRVET 236

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 31/223 (13%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV----AE 133
             F  +L+ +G+GG+G V++  ++   G  T +  + A+K L +  +  + +      AE
Sbjct: 17  ECF-ELLRVLGKGGYGKVFQ--VRKVTGANTGK--IFAMKVLKKAMIVRNAKDTAHTKAE 71

Query: 134 VQFLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
              L  ++HP +V LI Y    G +    L L+ E++    L   L              
Sbjct: 72  RNILEEVKHPFIVDLI-YAFQTGGK----LYLILEYLSGGELFMQLEREGIFMED-TACF 125

Query: 193 HIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
           +     AE    L +LH+     +IYRD K  N++L+     KL+DFGL +E   +    
Sbjct: 126 Y----LAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKES--IHDGT 176

Query: 250 VSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           V+    GT  Y AP+ +  +GH     D WS G ++Y+MLTG 
Sbjct: 177 VTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGA 218

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 45/211 (21%), Positives = 74/211 (35%), Gaps = 27/211 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVAEVQFLG-VLEH 142
            +G G  G V +              T    A+K L             EV         
Sbjct: 36  VLGLGVNGKVLE---------CFHRRTGQKCALKLLYDSPKARQ-----EVDHHWQASGG 81

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           P++V ++             L++ E M    L   +  R       +    I+      +
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141

Query: 203 AYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            +LH      + +RD K  N+L    +++   KL+DFG A+E        + T    T  
Sbjct: 142 QFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE---TTQNALQT-PCYTPY 194

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           Y AP+ +         D+WS GV++Y +L G
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 47/221 (21%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVA---EVQFLGVLE 141
           +G G FG V           G  E T   VA+K LNR  ++          E+Q L +  
Sbjct: 24  LGVGTFGKVKV---------GKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH-------- 193
           HP+++KL  Y  +     I   +V E++    L D++            RL         
Sbjct: 75  HPHIIKL--YQVISTPSDI--FMVMEYVSGGELFDYICK--------NGRLDEKESRRLF 122

Query: 194 --IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
             I+     G+ Y H      V++RD K  NVLLD +   K++DFGL+    M     + 
Sbjct: 123 QQIL----SGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLR 173

Query: 252 TAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGR 291
           T+  G+  YAAP+ I    +   + D+WS GV+LY +L G 
Sbjct: 174 TS-CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 89.5 bits (222), Expect = 2e-19
 Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 40/218 (18%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLGVLEHPN 144
           IG G  G V       AA D   +   VAIKKL+R        K+   E+  +  + H N
Sbjct: 70  IGSGAQGIVC------AAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122

Query: 145 LVKLIG-YCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHI----- 194
           ++ L+  +         Q + LV E M   L + ++  L               +     
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----------DHERMSYLLY 171

Query: 195 -ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            +L    G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T 
Sbjct: 172 QML---CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTP 222

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
            V T  Y AP+ I         D+WS G ++ EM+  +
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 63/283 (22%), Positives = 115/283 (40%), Gaps = 37/283 (13%)

Query: 14  RREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSE 73
           R     A E+       +    +S R    +             +   K   +  F Y  
Sbjct: 33  RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSF-Y-- 89

Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWV 131
                   S+   +G G FG V+K             AT   +A K +   G++  ++  
Sbjct: 90  ------TVSKTEILGGGRFGQVHK---------CEETATGLKLAAKIIKTRGMKDKEEVK 134

Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR 191
            E+  +  L+H NL++L  Y A + +  I  +LV E++    L D + + ++      T 
Sbjct: 135 NEISVMNQLDHANLIQL--YDAFESKNDI--VLVMEYVDGGELFDRIIDESYNLTELDTI 190

Query: 192 LHI--ILGAAEGLAYLHEGLEVQVIYRDFKASNVLL--DENFRPKLSDFGLAREGPMVGH 247
           L +  I    EG+ ++H+   + +++ D K  N+L    +  + K+ DFGLAR       
Sbjct: 191 LFMKQIC---EGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLAR---RYKP 241

Query: 248 THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
                   GT  + AP+ +    ++  +D+WS GV+ Y +L+G
Sbjct: 242 REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 36/222 (16%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQ 135
           + F R+  +G G FG V     K             A+K L++  +   KQ    + E +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-------ESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFN-RAFPPLPWKTRLH 193
            L  +  P LVKL  +   D       L +V E++    +  HL     F       R +
Sbjct: 94  ILQAVNFPFLVKLE-FSFKDNSN----LYMVMEYVAGGEMFSHLRRIGRFSEP--HARFY 146

Query: 194 IILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
               AA+      YLH    + +IYRD K  N+L+D+    +++DFG A+       T  
Sbjct: 147 ----AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-- 197

Query: 251 STAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGR 291
              + GT    AP+ I + G+  A  D W+ GV++YEM  G 
Sbjct: 198 ---LCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGY 235

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 48/209 (22%), Positives = 89/209 (42%), Gaps = 24/209 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVAEVQFLGVLEHP 143
           ++G G FG V++            +AT  V   K +N            E+  +  L HP
Sbjct: 58  ELGSGAFGVVHR---------CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 108

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
            L+ L        E   + +L+ EF+    L D +    +  +     ++ +  A EGL 
Sbjct: 109 KLINLHDAF----EDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLK 163

Query: 204 YLHEGLEVQVIYRDFKASNVLL--DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA 261
           ++HE     +++ D K  N++    +    K+ DFGLA     +    +      T  +A
Sbjct: 164 HMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFA 217

Query: 262 APDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           AP+ ++   +   +D+W+ GV+ Y +L+G
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 58/227 (25%), Positives = 91/227 (40%), Gaps = 50/227 (22%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVA--------EVQ 135
            +G G  G V                T   VAIK +++          A        E++
Sbjct: 17  TLGSGACGEVKL---------AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL--- 192
            L  L HP ++K+  +   D E      +V E M     E  LF++    +    RL   
Sbjct: 68  ILKKLNHPCIIKIKNF--FDAEDYY---IVLELM--EGGE--LFDK----VVGNKRLKEA 114

Query: 193 ---HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVG 246
                       + YLHE     +I+RD K  NVLL   +E+   K++DFG ++   ++G
Sbjct: 115 TCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILG 168

Query: 247 HTHVSTAVVGTFGYAAPDYIETGHL---TAKSDVWSFGVVLYEMLTG 290
            T +   + GT  Y AP+ + +          D WS GV+L+  L+G
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 55/223 (24%), Positives = 87/223 (39%), Gaps = 43/223 (19%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVA------EVQFL- 137
           +G+GGFG+V+          G        VAIK + R+ + G            EV  L 
Sbjct: 39  LGKGGFGTVFA---------GHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89

Query: 138 ---GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLN-RSLEDHLFNRAFPPLPWKTRLH 193
                  HP +++L      + + G   +LV E  L  + L D++  +   PL       
Sbjct: 90  KVGAGGGHPGVIRL--LDWFETQEGF--MLVLERPLPAQDLFDYITEKG--PLGEGPSRC 143

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLA---REGPMVGHTH 249
                   + + H      V++RD K  N+L+D      KL DFG      + P      
Sbjct: 144 FFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDF 198

Query: 250 VSTAVVGTFGYAAPDYIETGHLT-AKSDVWSFGVVLYEMLTGR 291
                 GT  Y+ P++I         + VWS G++LY+M+ G 
Sbjct: 199 D-----GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 53/222 (23%), Positives = 84/222 (37%), Gaps = 43/222 (19%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVA------EVQFLG 138
           +G GGFGSVY          G   +    VAIK + +D +    +         EV  L 
Sbjct: 51  LGSGGFGSVYS---------GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 101

Query: 139 VLEH--PNLVKLIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPPLPWKTRLHII 195
            +      +++L      +       +L+ E       L D +  R    L  +      
Sbjct: 102 KVSSGFSGVIRL--LDWFERPDSF--VLILERPEPVQDLFDFITERG--ALQEELARSFF 155

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLA---REGPMVGHTHVS 251
               E + + H      V++RD K  N+L+D N    KL DFG     ++          
Sbjct: 156 WQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFD- 209

Query: 252 TAVVGTFGYAAPDYIETGHL--TAKSDVWSFGVVLYEMLTGR 291
               GT  Y+ P++I   H      + VWS G++LY+M+ G 
Sbjct: 210 ----GTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGD 246

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 67/312 (21%), Positives = 121/312 (38%), Gaps = 62/312 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVA-----EVQFLG 138
            IG+G F  V +           +  T    A+K ++                 E     
Sbjct: 31  VIGKGPFSVVRR---------CINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 81

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL--HIIL 196
           +L+HP++V+L+              +V+EFM    L   +  RA     +   +  H + 
Sbjct: 82  MLKHPHIVELLETY----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTA 253
              E L Y H+     +I+RD K   VLL   + +   KL  FG+A +  +     V+  
Sbjct: 138 QILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGG 192

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP--KTEQRLLEWVQ- 310
            VGT  + AP+ ++        DVW  GV+L+ +L+G        P   T++RL E +  
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGC------LPFYGTKERLFEGIIK 246

Query: 311 -QYPADSKKFG-------------LIMDPRLEKEYSINEARKIGRLADN--CLSKSSKDR 354
            +Y  + +++              L++DP   +  ++ EA     L             +
Sbjct: 247 GKYKMNPRQWSHISESAKDLVRRMLMLDPA--ERITVYEA-----LNHPWLKERDRYAYK 299

Query: 355 PKMSQVVERLKQ 366
             + + VE+L++
Sbjct: 300 IHLPETVEQLRK 311

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 87.9 bits (218), Expect = 6e-19
 Identities = 74/260 (28%), Positives = 106/260 (40%), Gaps = 32/260 (12%)

Query: 41  VKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLK-IGEGGFGSVYKSS 99
           +K   +A +    G P             +  + R   N+F   LK +G+G FG V    
Sbjct: 110 LKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEF-EYLKLLGKGTFGKVILVK 168

Query: 100 IKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQFLGVLEHPNLVKLIGYCAVDG 156
            K      T      A+K L ++ +    +    + E + L    HP L  L  Y     
Sbjct: 169 EK-----ATGR--YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTH 220

Query: 157 ERGIQRL-LVYEFMLNRSLEDHLFN-RAFPPLPWKTRLHIILGAAE---GLAYLHEGLEV 211
           +R    L  V E+     L  HL   R F     + R +     AE    L YLH   E 
Sbjct: 221 DR----LCFVMEYANGGELFFHLSRERVFSE--DRARFY----GAEIVSALDYLHS--EK 268

Query: 212 QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL 271
            V+YRD K  N++LD++   K++DFGL +EG  +          GT  Y AP+ +E    
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKTFCGTPEYLAPEVLEDNDY 326

Query: 272 TAKSDVWSFGVVLYEMLTGR 291
               D W  GVV+YEM+ GR
Sbjct: 327 GRAVDWWGLGVVMYEMMCGR 346

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 63/307 (20%), Positives = 110/307 (35%), Gaps = 51/307 (16%)

Query: 8   KEKKLRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLR 67
             +++R     +  + +   +S     ++S   +  +   +   P+G   LY +      
Sbjct: 22  ARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPED 81

Query: 68  VFSYSEMRQATNDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGL 124
                   +           IG G    V +             AT    A+K +     
Sbjct: 82  ELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR---------CVHRATGHEFAVKIMEVTAE 132

Query: 125 QGHKQWVA--------EVQFL-GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLE 175
           +   + +         E   L  V  HP+++ LI       E      LV++ M  R  E
Sbjct: 133 RLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY----ESSSFMFLVFDLM--RKGE 186

Query: 176 DHLFNRAFPPLPWKTRL------HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF 229
             LF+     L  K  L       I+    E +++LH      +++RD K  N+LLD+N 
Sbjct: 187 --LFDY----LTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNM 237

Query: 230 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP------DYIETGHLTAKSDVWSFGVV 283
           + +LSDFG +     +        + GT GY AP                + D+W+ GV+
Sbjct: 238 QIRLSDFGFSC---HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294

Query: 284 LYEMLTG 290
           L+ +L G
Sbjct: 295 LFTLLAG 301

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 86.0 bits (214), Expect = 6e-19
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 36/222 (16%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQ 135
            DF  +  +G G FG V+    +             A+K L ++ +   KQ      E  
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSR-----HNGR--YYAMKVLKKEIVVRLKQVEHTNDERL 58

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFN-RAFPPLPWKTRLH 193
            L ++ HP ++++      D ++    + ++ +++    L   L   + FP      + +
Sbjct: 59  MLSIVTHPFIIRMW-GTFQDAQQ----IFMIMDYIEGGELFSLLRKSQRFPNP--VAKFY 111

Query: 194 IILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV 250
               AAE    L YLH      +IYRD K  N+LLD+N   K++DFG A+  P V +T  
Sbjct: 112 ----AAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-- 162

Query: 251 STAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGR 291
              + GT  Y AP+ + T  +  +  D WSFG+++YEML G 
Sbjct: 163 ---LCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGY 200

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 88.0 bits (218), Expect = 7e-19
 Identities = 58/286 (20%), Positives = 109/286 (38%), Gaps = 33/286 (11%)

Query: 15  REERSAPEL------KEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRV 68
           + +   P         E ++   Y   E  + V+   + S      + +++++       
Sbjct: 90  QSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149

Query: 69  FSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQG 126
             +  +      +    ++G G FG V++          T  AT    A K +       
Sbjct: 150 IKHDHVLD---HYDIHEELGTGAFGVVHR---------VTERATGNNFAAKFVMTPHESD 197

Query: 127 HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPL 186
            +    E+Q + VL HP LV L        E   + +++YEFM    L + + +     +
Sbjct: 198 KETVRKEIQTMSVLRHPTLVNLHDAF----EDDNEMVMIYEFMSGGELFEKVADEHNK-M 252

Query: 187 PWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL--DENFRPKLSDFGLAREGPM 244
                +  +    +GL ++HE      ++ D K  N++     +   KL DFGL      
Sbjct: 253 SEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---H 306

Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           +          GT  +AAP+  E   +   +D+WS GV+ Y +L+G
Sbjct: 307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 33/217 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVA------EVQFL 137
           ++G G F  V K            + T    A K + +  L   ++ V+      EV  L
Sbjct: 12  ELGSGQFAIVRK---------CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
             + HPN++ L        E     +L+ E +    L D L  +    L        +  
Sbjct: 63  REIRHPNIITLHDIF----ENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQ 116

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAREGPMVGHTHVSTA 253
             +G+ YLH     ++ + D K  N++L      N R KL DFG+A     +   +    
Sbjct: 117 ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH---KIEAGNEFKN 170

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 84.1 bits (209), Expect = 2e-18
 Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 40/218 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQG--HKQWVAEVQFLGVLE 141
           ++G+G F  V +            + T    A K +N   L     ++   E +    L+
Sbjct: 13  ELGKGAFSVVRR---------CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL------HII 195
           HPN+V+L        +      LV++ +     E  LF      +  +         H I
Sbjct: 64  HPNIVRLHDSI----QEESFHYLVFDLV--TGGE--LFED----IVAREFYSEADASHCI 111

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVST 252
               E +AY H      +++R+ K  N+LL    +    KL+DFGLA E   V  +    
Sbjct: 112 QQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWH 165

Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
              GT GY +P+ ++    +   D+W+ GV+LY +L G
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 53/223 (23%), Positives = 85/223 (38%), Gaps = 39/223 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVA---------EV 134
            +G G    V +            + T    A+K ++  G                  EV
Sbjct: 24  ILGRGVSSVVRR---------CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74

Query: 135 QFL-GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
             L  V  HPN+++L      +        LV++ M    L D+L  +    L  K    
Sbjct: 75  DILRKVSGHPNIIQLKDTY--ETNTFF--FLVFDLMKKGELFDYLTEKVT--LSEKETRK 128

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
           I+    E +  LH+   + +++RD K  N+LLD++   KL+DFG +     +        
Sbjct: 129 IMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLRE 182

Query: 254 VVGTFGYAAP------DYIETGHLTAKSDVWSFGVVLYEMLTG 290
           V GT  Y AP                + D+WS GV++Y +L G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 48/246 (19%), Positives = 98/246 (39%), Gaps = 60/246 (24%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
            +G G FG V +          + +    A+KK+ +D     +    E+  + VL+H N+
Sbjct: 14  TLGTGSFGIVCEVFDIE-----SGK--RFALKKVLQDP----RYKNRELDIMKVLDHVNI 62

Query: 146 VKLIGYCAVDGERGIQRL----------------------------------LVYEFM-- 169
           +KL+ Y    G+   +                                    ++ E++  
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122

Query: 170 -LNRSLEDHL-FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD- 226
            L++ L+  +   R+ P       ++ +      + ++H    + + +RD K  N+L++ 
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLF---RAVGFIHS---LGICHRDIKPQNLLVNS 176

Query: 227 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLY 285
           ++   KL DFG A+    +  +  S A + +  Y AP+ +      T   D+WS G V  
Sbjct: 177 KDNTLKLCDFGSAK---KLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233

Query: 286 EMLTGR 291
           E++ G+
Sbjct: 234 ELILGK 239

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 38/215 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           ++G G    VY+   K   G     A  V  K +++  ++       E+  L  L HPN+
Sbjct: 60  ELGRGATSIVYRCKQK---GTQKPYALKVLKKTVDKKIVR------TEIGVLLRLSHPNI 110

Query: 146 VKLIGYCAVDGERGIQRLLVYEFM-LNRSLEDHLFNRAFPPLPWKTRL------HIILGA 198
           +KL        E       +   + L    E  LF+R    +  K           +   
Sbjct: 111 IKLKEIFETPTE-------ISLVLELVTGGE--LFDR----IVEKGYYSERDAADAVKQI 157

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
            E +AYLHE     +++RD K  N+L      +   K++DFGL++   +V H  +   V 
Sbjct: 158 LEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKTVC 211

Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           GT GY AP+ +       + D+WS G++ Y +L G
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 36/227 (15%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQF 136
              ++ +  IGEG +G V       +A D  ++   VAIKK++  +     ++ + E++ 
Sbjct: 26  GPRYTNLSYIGEGAYGMVC------SAYDNLNK-VRVAIKKISPFEHQTYCQRTLREIKI 78

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKTRL 192
           L    H N++ +           ++ + +V + M   L + L+          L   +  
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-------HL---SND 128

Query: 193 HI------ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMV 245
           HI      IL    GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P  
Sbjct: 129 HICYFLYQIL---RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

Query: 246 GHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
            HT   T  V T  Y AP+ +  +   T   D+WS G +L EML+ R
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 70/315 (22%), Positives = 120/315 (38%), Gaps = 75/315 (23%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQG--HKQWVAEVQFLGVLE 141
           ++G+G F  V +            + T    A K +N   L     ++   E +    L+
Sbjct: 36  ELGKGAFSVVRR---------CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 86

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL------HII 195
           HPN+V+L        E      LV++ +     E  LF      +  +         H I
Sbjct: 87  HPNIVRLHDSI--QEESFHY--LVFDLV--TGGE--LFED----IVAREFYSEADASHCI 134

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVST 252
               E +AY H      +++R+ K  N+LL    +    KL+DFGLA E   V  +    
Sbjct: 135 QQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWH 188

Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWV 309
              GT GY +P+ ++    +   D+W+ GV+LY +L G        P   + + RL   +
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY------PPFWDEDQHRLYAQI 242

Query: 310 Q--QYPADSKKFG-------------LIMDPRLEKEYSINEARK---IGRLADNCLSKSS 351
           +   Y   S ++              L ++P+  K  + ++A K   I      C  +  
Sbjct: 243 KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPK--KRITADQALKVPWI------CNRERV 294

Query: 352 KDRPKMSQVVERLKQ 366
                    V+ LK+
Sbjct: 295 ASAIHRQDTVDCLKK 309

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 64/227 (28%), Positives = 96/227 (42%), Gaps = 42/227 (18%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQ-- 135
            DF  + K +G+G FG V+ +  K      T++    AIK L +D +      V      
Sbjct: 17  EDF-ILHKMLGKGSFGKVFLAEFK-----KTNQ--FFAIKALKKDVVLMDDD-VECTMVE 67

Query: 136 ---FLGVLEHPNLVKLIGYCAVDGERGIQ---RL-LVYEFMLNRSLEDHLFN-RAFPPLP 187
                   EHP L  +            Q    L  V E++    L  H+ +   F    
Sbjct: 68  KRVLSLAWEHPFLTHMF-CT-------FQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS- 118

Query: 188 WKTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
            +   +    AAE   GL +LH      ++YRD K  N+LLD++   K++DFG+ +E   
Sbjct: 119 -RATFY----AAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN-- 168

Query: 245 VGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           +     +    GT  Y AP+ +         D WSFGV+LYEML G+
Sbjct: 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 51/214 (23%), Positives = 86/214 (40%), Gaps = 27/214 (12%)

Query: 86  KIGEGGFGSVY----KSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV-AEVQFLGVL 140
           ++G G F  V     KS+    A      A  +  ++         ++ +  EV  L  +
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYA------AKFIKKRQSRASRRGVCREEIEREVSILRQV 72

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
            HPN++ L        E     +L+ E +    L D L  +    L  +     I    +
Sbjct: 73  LHPNIITLHDVY----ENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILD 126

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
           G+ YLH     ++ + D K  N++L          KL DFGLA     +        + G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFG 180

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           T  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 63/228 (27%), Positives = 93/228 (40%), Gaps = 43/228 (18%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQ 135
              +     +G G +GSV        A D  S    VAIKKL+R        K+   E+ 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCS------AIDKRSG-EKVAIKKLSRPFQSEIFAKRAYRELL 75

Query: 136 FLGVLEHPNLVKLIG-YCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKT 190
            L  ++H N++ L+  +      R      LV  FM   L + +               +
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKF-----------S 124

Query: 191 RLHI------ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
              I      +L   +GL Y+H      V++RD K  N+ ++E+   K+ DFGLAR    
Sbjct: 125 EEKIQYLVYQML---KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR---- 174

Query: 245 VGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
                  T  V T  Y AP+ I    H     D+WS G ++ EMLTG+
Sbjct: 175 -HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 68/225 (30%), Positives = 94/225 (41%), Gaps = 39/225 (17%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEV 134
           NDF   LK +G+G FG V     K      T      A+K L ++ +    +    V E 
Sbjct: 5   NDF-DYLKLLGKGTFGKVILVREK-----ATGR--YYAMKILRKEVIIAKDEVAHTVTES 56

Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQ---RL-LVYEFMLNRSLEDHLFNRAFPPLPWKT 190
           + L    HP L  L  Y         Q   RL  V E+     L  HL          + 
Sbjct: 57  RVLQNTRHPFLTALK-YA-------FQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RA 107

Query: 191 RLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
           R +     AE    L YLH      V+YRD K  N++LD++   K++DFGL +EG  +  
Sbjct: 108 RFY----GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISD 158

Query: 248 THVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
                   GT  Y AP+ + +  +     D W  GVV+YEM+ GR
Sbjct: 159 GATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGR 202

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 50/214 (23%), Positives = 85/214 (39%), Gaps = 27/214 (12%)

Query: 86  KIGEGGFGSVY----KSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-EVQFLGVL 140
           ++G G F  V     KS+    A      A  +  ++         ++ +  EV  L  +
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYA------AKFIKKRQSRASRRGVSREEIEREVSILRQV 72

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
            H N++ L        E     +L+ E +    L D L  +    L  +     I    +
Sbjct: 73  LHHNVITLHDVY----ENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILD 126

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
           G+ YLH     ++ + D K  N++L          KL DFGLA     +        + G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFG 180

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           T  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 42/227 (18%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQ-- 135
            DF  +L+ IG G +  V    +K      T    + A+K + ++ +   +  +  VQ  
Sbjct: 9   QDF-DLLRVIGRGSYAKVLLVRLK-----KTDR--IYAMKVVKKELVNDDED-IDWVQTE 59

Query: 136 ---FLGVLEHPNLVKLIGYCAVDGERGIQ---RL-LVYEFMLNRSLEDHLFNRAFPPLPW 188
              F     HP LV L   C        Q   RL  V E++    L  H+  +   P   
Sbjct: 60  KHVFEQASNHPFLVGLH-SC-------FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 111

Query: 189 KTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 245
             R +    +AE    L YLHE     +IYRD K  NVLLD     KL+D+G+ +EG  +
Sbjct: 112 -ARFY----SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--L 161

Query: 246 GHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
                ++   GT  Y AP+ +    +     D W+ GV+++EM+ GR
Sbjct: 162 RPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 207

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 59/312 (18%), Positives = 113/312 (36%), Gaps = 56/312 (17%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVAEVQFLGVL-EH 142
            +GEG F    K            + +    A+K +++      ++   E+  L +   H
Sbjct: 18  PLGEGSFSICRK---------CVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGH 65

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           PN+VKL           +   LV E +    L + +  +           +I+      +
Sbjct: 66  PNIVKLHEVF----HDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAV 119

Query: 203 AYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           +++H   +V V++RD K  N+L    ++N   K+ DFG AR                T  
Sbjct: 120 SHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTLH 174

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTG----RRSLERNRPKTEQRLLEWVQ--QYP 313
           YAAP+ +         D+WS GV+LY ML+G    +         +   +++ ++   + 
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234

Query: 314 ADSKKFG-------------LIMDPRLEKEYSINEA------RKIGRLADNCLSKSSKDR 354
            + + +              L +DP   K   ++        +   +L+ N L       
Sbjct: 235 FEGEAWKNVSQEAKDLIQGLLTVDP--NKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILG 292

Query: 355 PKMSQVVERLKQ 366
              + V   +K 
Sbjct: 293 SSGAAVHTCVKA 304

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 45/228 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
            +G GG G V+       A D   +   VAIKK+     Q  K  + E++ +  L+H N+
Sbjct: 18  PLGCGGNGLVFS------AVDNDCD-KRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70

Query: 146 VKLIGYCAVDGERGIQRL----------LVYEFM---LNRSLEDHLFNRAFPPLPWKTRL 192
           VK+       G +    +          +V E+M   L   LE         PL      
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG-------PL---LEE 120

Query: 193 HI------ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAR-EGPM 244
           H       +L    GL Y+H      V++RD K +N+ ++ E+   K+ DFGLAR   P 
Sbjct: 121 HARLFMYQLL---RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174

Query: 245 VGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
             H    +  + T  Y +P  +    + T   D+W+ G +  EMLTG+
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 83.8 bits (208), Expect = 6e-18
 Identities = 68/228 (29%), Positives = 100/228 (43%), Gaps = 44/228 (19%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQ-- 135
           ++F   ++ +G+G FG V  + +K      T +  + A+K L +D +      V      
Sbjct: 23  DNF-EFIRVLGKGSFGKVMLARVK-----ETGD--LYAVKVLKKDVILQDDD-VECTMTE 73

Query: 136 ---FLGVLEHPNLVKLIGYCAVDGERGIQ---RL-LVYEFMLNRSLEDHLFN-RAFPPLP 187
                    HP L +L   C        Q   RL  V EF+    L  H+   R F    
Sbjct: 74  KRILSLARNHPFLTQLF-CC-------FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA- 124

Query: 188 WKTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
            + R +    AAE    L +LH+     +IYRD K  NVLLD     KL+DFG+ +EG  
Sbjct: 125 -RARFY----AAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG-- 174

Query: 245 VGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
           + +   +    GT  Y AP+ + E  +     D W+ GV+LYEML G 
Sbjct: 175 ICNGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGH 221

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 83.4 bits (207), Expect = 7e-18
 Identities = 67/227 (29%), Positives = 93/227 (40%), Gaps = 42/227 (18%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQ-- 135
            DF   L  +G+G FG V  S  K     GT E  + A+K L +D +      V      
Sbjct: 20  TDF-NFLMVLGKGSFGKVMLSERK-----GTDE--LYAVKILKKDVVIQDDD-VECTMVE 70

Query: 136 ---FLGVLEHPNLVKLIGYCAVDGERGIQ---RL-LVYEFMLNRSLEDHLFNRAFPPLPW 188
                   + P L +L   C        Q   RL  V E++    L  H+        P 
Sbjct: 71  KRVLALPGKPPFLTQLH-SC-------FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP- 121

Query: 189 KTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 245
               +    AAE   GL +L       +IYRD K  NV+LD     K++DFG+ +E   +
Sbjct: 122 HAVFY----AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN--I 172

Query: 246 GHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
                +    GT  Y AP+ I    +     D W+FGV+LYEML G+
Sbjct: 173 WDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 218

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 84.0 bits (208), Expect = 9e-18
 Identities = 59/247 (23%), Positives = 92/247 (37%), Gaps = 55/247 (22%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLGVLEHP 143
            IG G +G VY       A D  +E   VAIKK+NR  + L   K+ + E+  L  L+  
Sbjct: 33  LIGRGSYGYVYL------AYDKNTE-KNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85

Query: 144 NLVKLIGYCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHI----- 194
            +++L      D       L +V E     L +        +    L   T  HI     
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF------KTPIFL---TEEHIKTILY 136

Query: 195 -ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            +L    G  ++HE     +I+RD K +N LL+++   K+ DFGLAR       T++   
Sbjct: 137 NLL---LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190

Query: 254 VVGTFGYAAPDYIETGHLT---------------------AKSDVWSFGVVLYEMLTGRR 292
           +         +      LT                        D+WS G +  E+L   +
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250

Query: 293 SLERNRP 299
           S   +  
Sbjct: 251 SHINDPT 257

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 65/306 (21%), Positives = 118/306 (38%), Gaps = 56/306 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG--HKQWVAEVQFLGVLEHP 143
           ++G+G F  V +                 A   +N   L    H++   E +   +L+HP
Sbjct: 18  ELGKGAFSVVRRCVKV-------LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
           N+V+L    + +G       L+++ +    L + +  R +         H I    E + 
Sbjct: 71  NIVRLHDSISEEGHH----YLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVL 124

Query: 204 YLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           + H+   + V++R+ K  N+LL    +    KL+DFGLA E  + G         GT GY
Sbjct: 125 HCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGTPGY 179

Query: 261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP---KTEQRLLEWVQ--QYPAD 315
            +P+ +         D+W+ GV+LY +L G        P   + + RL + ++   Y   
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGY------PPFWDEDQHRLYQQIKAGAYDFP 233

Query: 316 SKKFG-------------LIMDPRLEKEYSINEARKIGRLADN--CLSKSSKDRPKMSQV 360
           S ++              L ++P   K  +  EA     L         +        + 
Sbjct: 234 SPEWDTVTPEAKDLINKMLTINPS--KRITAAEA-----LKHPWISHRSTVASCMHRQET 286

Query: 361 VERLKQ 366
           V+ LK+
Sbjct: 287 VDCLKK 292

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 30/219 (13%), Positives = 60/219 (27%), Gaps = 50/219 (22%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQFLGVLEH 142
             G       ++      A D T+    VA+  ++  G+         ++    L  ++ 
Sbjct: 38  FHGGVPPLQFWQ------ALD-TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           P + +++             L+V E++   SL++        P P    +  +   A   
Sbjct: 91  PGVARVLDV----VHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGA-IRAMQSLAAAA 142

Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
              H      V       S V +  +                 G       V+       
Sbjct: 143 DAAHR---AGVALSIDHPSRVRVSID-----------------GD-----VVLAYPATMP 177

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT 301
                      + D+   G  LY +L  R  L     ++
Sbjct: 178 DA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRS 209

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 31/212 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVAEVQFLG-VLEH 142
            IG G +    +            +AT    A+K +++      +    E++ L    +H
Sbjct: 29  DIGVGSYSVCKR---------CIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQH 75

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           PN++ L        + G    +V E M    L D +  + F     +    ++    + +
Sbjct: 76  PNIITLKDVY----DDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTV 129

Query: 203 AYLHEGLEVQVIYRDFKASNVLL---DENFRP-KLSDFGLAREGPMVGHTHVSTAVVGTF 258
            YLH      V++RD K SN+L      N    ++ DFG A++  +     +      T 
Sbjct: 130 EYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAENGLLMTPCYTA 184

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
            + AP+ +E     A  D+WS GV+LY MLTG
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 33/217 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVA------EVQFL 137
           ++G G F  V K            ++T    A K + +   +  ++ V+      EV  L
Sbjct: 18  ELGSGQFAVVKK---------CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
             ++HPN++ L        E     +L+ E +    L D L  +    L  +     +  
Sbjct: 69  KEIQHPNVITLHEVY----ENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQ 122

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRPKLSDFGLAREGPMVGHTHVSTA 253
              G+ YLH    +Q+ + D K  N++L        R K+ DFGLA     +   +    
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKN 176

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           + GT  + AP+ +    L  ++D+WS GV+ Y +L+G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 46/213 (21%), Positives = 89/213 (41%), Gaps = 27/213 (12%)

Query: 86  KIGEGGFGSVY----KSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE 141
           ++G G F  V     KS+ +  A      A  +  ++  +D          E+  L + +
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYA------AKFLKKRRRGQDCRAEILH---EIAVLELAK 86

Query: 142 H-PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
             P ++ L  +   +    I  +L+ E+     +           +     + +I    E
Sbjct: 87  SCPRVINL--HEVYENTSEI--ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE 142

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
           G+ YLH+     +++ D K  N+LL         K+ DFG++R    +GH      ++GT
Sbjct: 143 GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR---KIGHACELREIMGT 196

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
             Y AP+ +    +T  +D+W+ G++ Y +LT 
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 42/227 (18%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQ-- 135
            DF  +L+ IG G +  V    +K      T    + A++ + ++ +   +  +  VQ  
Sbjct: 52  QDF-DLLRVIGRGSYAKVLLVRLK-----KTDR--IYAMRVVKKELVNDDED-IDWVQTE 102

Query: 136 ---FLGVLEHPNLVKLIGYCAVDGERGIQ---RL-LVYEFMLNRSLEDHLFNRAFPPLPW 188
              F     HP LV L   C        Q   RL  V E++    L  H+  +   P   
Sbjct: 103 KHVFEQASNHPFLVGLH-SC-------FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 154

Query: 189 KTRLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMV 245
             R +    +AE    L YLHE     +IYRD K  NVLLD     KL+D+G+ +EG  +
Sbjct: 155 -ARFY----SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--L 204

Query: 246 GHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
                ++   GT  Y AP+ +    +     D W+ GV+++EM+ GR
Sbjct: 205 RPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 250

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 67/225 (29%), Positives = 97/225 (43%), Gaps = 38/225 (16%)

Query: 79  NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQ-- 135
           +DF   LK IG+G FG V  +  K             A+K L +  +   K+    +   
Sbjct: 38  SDF-HFLKVIGKGSFGKVLLARHK-----AEEV--FYAVKVLQKKAILKKKE-EKHIMSE 88

Query: 136 ---FLGVLEHPNLVKLIGYCAVDGERGIQRL-LVYEFMLNRSLEDHLFN-RAFPPLPWKT 190
               L  ++HP LV L  +     ++    L  V +++    L  HL   R F   P   
Sbjct: 89  RNVLLKNVKHPFLVGLH-FSFQTADK----LYFVLDYINGGELFYHLQRERCFL-EPR-A 141

Query: 191 RLHIILGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH 247
           R +    AAE    L YLH    + ++YRD K  N+LLD      L+DFGL +E   + H
Sbjct: 142 RFY----AAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN--IEH 192

Query: 248 THVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
              ++   GT  Y AP+ + +  +     D W  G VLYEML G 
Sbjct: 193 NSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGL 236

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 83.5 bits (206), Expect = 2e-17
 Identities = 74/280 (26%), Positives = 110/280 (39%), Gaps = 46/280 (16%)

Query: 26  PRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRML 85
           P + ++ +     +F ++       +P         K  N    + +  R    DF   L
Sbjct: 292 PPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDN----NGNRDRMKLTDF-NFL 346

Query: 86  K-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQ-----FLGV 139
             +G+G FG V  S  K     GT E  + A+K L +D +      V             
Sbjct: 347 MVLGKGSFGKVMLSERK-----GTDE--LYAVKILKKDVVIQDDD-VECTMVEKRVLALP 398

Query: 140 LEHPNLVKLIGYCAVDGERGIQ---RL-LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            + P L +L   C        Q   RL  V E++    L  H+        P     H +
Sbjct: 399 GKPPFLTQLH-SC-------FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----HAV 445

Query: 196 LGAAE---GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
             AAE   GL +L       +IYRD K  NV+LD     K++DFG+ +E   +     + 
Sbjct: 446 FYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTK 500

Query: 253 AVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
              GT  Y AP+ I    +     D W+FGV+LYEML G+
Sbjct: 501 TFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 539

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 43/211 (20%), Positives = 87/211 (41%), Gaps = 29/211 (13%)

Query: 86  KIGEGGFGSVY----KSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE 141
            +G G FG V+     SS K         A  V +K  ++  ++       E+  L +  
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYM------AKFVKVKGTDQVLVK------KEISILNIAR 59

Query: 142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEG 201
           H N++ L        E   + ++++EF+    + + +   AF  L  +  +  +    E 
Sbjct: 60  HRNILHLHESF----ESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEA 114

Query: 202 LAYLHEGLEVQVIYRDFKASNVLL--DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
           L +LH      + + D +  N++     +   K+ +FG AR    +        +     
Sbjct: 115 LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPE 168

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           Y AP+  +   ++  +D+WS G ++Y +L+G
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 42/228 (18%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQ 135
              +  +  +G G +G+V       +A DG +    VAIKKL R        K+   E++
Sbjct: 24  RAVYRDLQPVGSGAYGAVC------SAVDGRTG-AKVAIKKLYRPFQSELFAKRAYRELR 76

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQR--LLVYEFM---LNRSLEDHLFNRAFPPLPWKT 190
            L  + H N++ L+     D          LV  FM   L + ++          L    
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-------KL---G 126

Query: 191 RLHI------ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
              I      +L   +GL Y+H      +I+RD K  N+ ++E+   K+ DFGLAR    
Sbjct: 127 EDRIQFLVYQML---KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---- 176

Query: 245 VGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
                  T  V T  Y AP+ I      T   D+WS G ++ EM+TG+
Sbjct: 177 -QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 57/226 (25%), Positives = 88/226 (38%), Gaps = 43/226 (19%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR-DGLQGHKQWVAEVQFLGVLEHPN 144
            +GEG +G V        A    +   +VAIKK+   D      + + E++ L   +H N
Sbjct: 18  LLGEGAYGVVCS------ATHKPTG-EIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70

Query: 145 LVKLIGYCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHI------ 194
           ++ +      D       + ++ E M   L+R +           L   +  HI      
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ-------ML---SDDHIQYFIYQ 120

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR--------EGPMVG 246
            L     +  LH      VI+RD K SN+L++ N   K+ DFGLAR             G
Sbjct: 121 TL---RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174

Query: 247 HTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
                   V T  Y AP+ +  +   +   DVWS G +L E+   R
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 40/227 (17%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFL 137
            +D+  + K+G G +  V+++          +E   V +K L        K+   E++ L
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINIT-----NNE--KVVVKILKPVK---KKKIKREIKIL 84

Query: 138 GVL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI-- 194
             L   PN++ L     V         LV+E      + +  F + +  L   T   I  
Sbjct: 85  ENLRGGPNIITL--ADIVKDPVSRTPALVFEH-----VNNTDFKQLYQTL---TDYDIRF 134

Query: 195 ----ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREG-PMVGHT 248
               IL   + L Y H      +++RD K  NV++D E+ + +L D+GLA    P   + 
Sbjct: 135 YMYEIL---KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 188

Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKS-DVWSFGVVLYEMLTGRRSL 294
                 V +  +  P+ +    +   S D+WS G +L  M+  +   
Sbjct: 189 VR----VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 53/221 (23%), Positives = 84/221 (38%), Gaps = 36/221 (16%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVAEVQFLG-VLEHP 143
           +GEG    V             +  T    A+K + +       +   EV+ L     H 
Sbjct: 21  LGEGAHARVQT---------CINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR-AFPPLPWKTRLHIILGAAEGL 202
           N+++LI +     E   +  LV+E M   S+  H+  R  F  L     +  +  A   L
Sbjct: 72  NVLELIEFF----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA---L 124

Query: 203 AYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAR-----EGPMVGHTHVSTAV 254
            +LH      + +RD K  N+L    ++    K+ DF L              T      
Sbjct: 125 DFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181

Query: 255 VGTFGYAAPDYIETGHLTAKS-----DVWSFGVVLYEMLTG 290
            G+  Y AP+ +E     A       D+WS GV+LY +L+G
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 81.4 bits (201), Expect = 7e-17
 Identities = 59/313 (18%), Positives = 93/313 (29%), Gaps = 66/313 (21%)

Query: 29  SADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNLRVFSYSEMRQATNDFSRMLKIG 88
           S + + A+          +         + +        +       Q  + +     IG
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62

Query: 89  EGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA-----EVQFLGVLEHP 143
            G +G V +      A D   E  VVAIKK+ R                E+  L  L H 
Sbjct: 63  TGSYGHVCE------AYD-KLEKRVVAIKKILRVF---EDLIDCKRILREIAILNRLNHD 112

Query: 144 NLVKLIGYCAVDGERGIQRL-LVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHI----- 194
           ++VK++             L +V E       +        R    L   T LHI     
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF------RTPVYL---TELHIKTLLY 163

Query: 195 -ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR-----EGPMVGHT 248
            +L    G+ Y+H      +++RD K +N L++++   K+ DFGLAR     E       
Sbjct: 164 NLL---VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217

Query: 249 HVSTAVVGTFGYAAPDYIETGHLT---------------------AKSDVWSFGVVLYEM 287
                                 LT                        DVWS G +  E+
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277

Query: 288 LTGRRSLERNRPK 300
           L   +        
Sbjct: 278 LNMIKENVAYHAD 290

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 80.5 bits (199), Expect = 9e-17
 Identities = 48/211 (22%), Positives = 81/211 (38%), Gaps = 26/211 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVAEVQFLG-VLEH 142
            +G G  G V +           ++ T    A+K L         +   EV+      + 
Sbjct: 69  VLGLGINGKVLQ---------IFNKRTQEKFALKMLQD-----CPKARREVELHWRASQC 114

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           P++V+++             L+V E +    L   + +R       +    I+    E +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 203 AYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            YLH    + + +RD K  N+L      N   KL+DFG A+E       +  T    T  
Sbjct: 175 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCYTPY 228

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTG 290
           Y AP+ +         D+WS GV++Y +L G
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 76/361 (21%), Positives = 124/361 (34%), Gaps = 103/361 (28%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAE----------- 133
            +G G FG V ++       D T+    VA+K L        H+  ++E           
Sbjct: 29  PLGRGAFGQVIEADAF--GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 134 --VQFLGV--------------LEHPNLVK------------------------LIGYCA 153
             V  LG                +  NL                           +G   
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146

Query: 154 VDGERGIQRL------LVYEFMLNRSL-----EDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           VD +R +  +          F+  +SL     E+   +     L  +  +      A+G+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206

Query: 203 AYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYA- 261
            +L      + I+RD  A N+LL E    K+ DFGLAR+            V        
Sbjct: 207 EFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARD-----IYKDPDYVRKGDARLP 258

Query: 262 ----APDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP---A 314
               AP+ I     T +SDVWSFGV+L+E+ +   S     P            YP    
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----P------------YPGVKI 301

Query: 315 DSKKFGLIMD-PRLEK-EYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN 372
           D +    + +  R+   +Y+  E   + +   +C       RP  S++VE L  ++Q + 
Sbjct: 302 DEEFCRRLKEGTRMRAPDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 358

Query: 373 E 373
           +
Sbjct: 359 Q 359

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 77.8 bits (192), Expect = 6e-16
 Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 42/228 (18%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQ 135
              +  +  +G G +GSV  +               VA+KKL+R    +   K+   E++
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTG-------LRVAVKKLSRPFQSIIHAKRTYRELR 80

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQR--LLVYEFM---LNRSL------EDHLFNRAFP 184
            L  ++H N++ L+                LV   M   LN  +      +DH+  +   
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--QFL- 137

Query: 185 PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPM 244
                  ++ IL    GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR    
Sbjct: 138 -------IYQIL---RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---- 180

Query: 245 VGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGR 291
                  T  V T  Y AP+ +    H     D+WS G ++ E+LTGR
Sbjct: 181 -HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 48/223 (21%), Positives = 90/223 (40%), Gaps = 33/223 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL----- 140
           K+G G F +V+       A D     T VA+K + R      +    E++ L  +     
Sbjct: 26  KLGWGHFSTVWL------AKD-MVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADN 77

Query: 141 ------EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
                    +++KL+ +    G  G+  ++V+E +L  +L   +       +P      I
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQI 136

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP------KLSDFGLAREGPMVGHT 248
                 GL Y+H      +I+ D K  NVL++    P      K++D G A         
Sbjct: 137 SKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDE 190

Query: 249 HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           H + ++     Y +P+ +        +D+WS   +++E++TG 
Sbjct: 191 HYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 57/238 (23%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNR--DGLQGHKQWVAEVQFLGVL-EH 142
           K+G+G +G V+K      + D      VVA+KK+          ++   E+  L  L  H
Sbjct: 16  KLGKGAYGIVWK------SID-RRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFM---LNRSLEDHLFNRAFPPLPWKTRLHI----- 194
            N+V L+     D +R +   LV+++M   L+  +      RA   L     +H      
Sbjct: 69  ENIVNLLNVLRADNDRDV--YLVFDYMETDLHAVI------RA-NIL---EPVHKQYVVY 116

Query: 195 -ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
            ++   + + YLH G    +++RD K SN+LL+     K++DFGL+R    +     +  
Sbjct: 117 QLI---KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

Query: 254 VVGTFGYAAP--------DYIET------------GHLTAKSDVWSFGVVLYEMLTGR 291
           +                 DY+ T               T   D+WS G +L E+L G+
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 48/231 (20%), Positives = 83/231 (35%), Gaps = 39/231 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
            IG+GGFG +Y + +   + +         +K    D    +     E++F      P  
Sbjct: 42  PIGQGGFGCIYLADMN--SSESVGSDAPCVVKVEPSD----NGPLFTELKFYQRAAKPEQ 95

Query: 146 VKLIGYCAVDGERGIQRLL----------VYEFM----LNRSLEDHLFNRAFPPLPWKTR 191
           ++           G+ +             Y FM        L+  ++         KT 
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANAKRFSRKTV 154

Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK--LSDFGLARE-GPMVGHT 248
           L + L   + L Y+H   E + ++ D KASN+LL+     +  L D+GLA    P   H 
Sbjct: 155 LQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211

Query: 249 HVS----TAVVGTFGYAAPDYIETGHL----TAKSDVWSFGVVLYEMLTGR 291
             +        GT  + + D     H     + + D+   G  + + LTG 
Sbjct: 212 AYAADPKRCHDGTIEFTSID----AHNGVAPSRRGDLEILGYCMIQWLTGH 258

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 45/233 (19%), Positives = 79/233 (33%), Gaps = 48/233 (20%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRDGLQGHKQWVAEVQFLG-VLEH 142
            +G G  G V +           ++ T    A+K L         +   EV+      + 
Sbjct: 25  VLGLGINGKVLQ---------IFNKRTQEKFALKMLQD-----CPKARREVELHWRASQC 70

Query: 143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGL 202
           P++V+++             L+V E +    L   + +R       +    I+    E +
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130

Query: 203 AYLHEGLEVQVIYRDFKASNVLL---DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFG 259
            YLH    + + +RD K  N+L      N   KL+DFG A+E              G   
Sbjct: 131 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------TTGE-K 174

Query: 260 YAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS-LERNRPKTEQRLLEWVQQ 311
           Y               D+WS GV++Y +L G       +       +   ++ 
Sbjct: 175 Y-----------DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 216

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.7 bits (159), Expect = 6e-12
 Identities = 51/333 (15%), Positives = 89/333 (26%), Gaps = 84/333 (25%)

Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH--------K 128
            T    R  KIGEG FG V++           ++ T VAIK +  +G            +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQ---------TIADHTPVAIKIIAIEGPDLVNGSHQKTFE 68

Query: 129 QWVAEVQFLGVLE---------HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF 179
           + + E+     L              + L     V G      L  ++   +     +  
Sbjct: 69  EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128

Query: 180 NRAFPP-----------------------LPWKTRLHIILGAAEGLAYLHEGLEVQVIYR 216
              F                             T   I+      LA       ++  +R
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHR 186

Query: 217 DFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP--DYIETGHLTAK 274
           D    NVLL +    KL      +           ++ + + G      DY  +      
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYTLSRLERDG 235

Query: 275 SDVWSFGVVLYEMLTGRRSLERN----------------RPKTEQRLLEWVQQYPADSKK 318
             V+    +  ++ TG    + +                 P +    L ++         
Sbjct: 236 IVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT 295

Query: 319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSS 351
           F    +    K+      RKI       L+ SS
Sbjct: 296 FKTKCNTPAMKQI----KRKIQEFHRTMLNFSS 324

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 64.7 bits (158), Expect = 8e-12
 Identities = 57/218 (26%), Positives = 83/218 (38%), Gaps = 33/218 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH-PN 144
           KIG G FG +Y        G   +    VAIK         H Q   E +   +++    
Sbjct: 16  KIGSGSFGDIYL-------GTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVG 66

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +  +       G  G   ++V E +L  SLED LFN        KT L +       + Y
Sbjct: 67  IPTIRWC----GAEGDYNVMVME-LLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEY 120

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPK---LSDFGLARE-GPMVGHTHV----STAVVG 256
           +H       I+RD K  N L+    +     + DFGLA++      H H+    +  + G
Sbjct: 121 IH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177

Query: 257 TFGYA---APDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           T  YA       IE    + + D+ S G VL     G 
Sbjct: 178 TARYASINTHLGIE---QSRRDDLESLGYVLMYFNLGS 212

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 61/219 (27%), Positives = 90/219 (41%), Gaps = 35/219 (15%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPN 144
           KIG G FG +Y        G        VAIK  N      H Q + E +   +L+    
Sbjct: 14  KIGSGSFGEIYL-------GTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTG 64

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +  +  +    G  G   +LV + +L  SLED LFN     L  KT L +       + +
Sbjct: 65  IPNVRWF----GVEGDYNVLVMD-LLGPSLED-LFNFCSRKLSLKTVLMLADQMINRVEF 118

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPK---LSDFGLARE-GPMVGHTHV----STAVVG 256
           +H       ++RD K  N L+    R     + DFGLA++      H H+    +  + G
Sbjct: 119 VH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175

Query: 257 TFGYAAPDYIETGHL----TAKSDVWSFGVVLYEMLTGR 291
           T  YA+   + T HL    + + D+ S G VL   L G 
Sbjct: 176 TARYAS---VNT-HLGIEQSRRDDLESLGYVLMYFLRGS 210

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 40/238 (16%), Positives = 79/238 (33%), Gaps = 53/238 (22%)

Query: 86  KIGEGGFGSVYK-SSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV----AEVQFLGVL 140
                  G +Y+ +       D   +    ++K   +DG   ++Q      A+   +   
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 141 EHPNLVKLIG-----YCAVDGERGIQRLLVYEFMLNRSLEDHLFN----RAFPPLPWKTR 191
           +      L+         V  ++   R LV    L RSL+    +            ++ 
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDK--YRFLVLP-SLGRSLQS-ALDVSPKHVLSE---RSV 161

Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK--LSDFGLA---------- 239
           L +     + L +LH   E + ++ +  A N+ +D   + +  L+ +G A          
Sbjct: 162 LQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218

Query: 240 --REGPMVGHTHVSTAVVGTFGYAAPDYIETGHL----TAKSDVWSFGVVLYEMLTGR 291
              EG    H        G   + + D     H     + +SD+ S G  + + L G 
Sbjct: 219 AYVEGSRSPHE-------GDLEFISMD----LHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 52/221 (23%), Positives = 82/221 (37%), Gaps = 37/221 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH-PN 144
           +IGEG FG +++       G        VAIK   R       Q   E +   +L     
Sbjct: 17  RIGEGSFGVIFE-------GTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 67

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +  +  +    G+ G+  +LV + +L  SLED L +        KT           +  
Sbjct: 68  IPNVYYF----GQEGLHNVLVID-LLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQS 121

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPK-----LSDFGLARE-GPMVGHTHV----STAV 254
           +H   E  ++YRD K  N L+            + DFG+ +     V   H+       +
Sbjct: 122 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 178

Query: 255 VGTFGYAAPDYIETGHL----TAKSDVWSFGVVLYEMLTGR 291
            GT  Y +   I T HL    + + D+ + G V    L G 
Sbjct: 179 SGTARYMS---INT-HLGREQSRRDDLEALGHVFMYFLRGS 215

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 43/220 (19%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL------ 140
           IG+G FG V K      A D       VA+K + R+  + H+Q   E++ L  L      
Sbjct: 105 IGKGSFGQVVK------AYDHKVH-QHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKD 156

Query: 141 EHPNLVKLIGY-------CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
              N++ ++         C           + +E +L+ +L + +    F          
Sbjct: 157 NTMNVIHMLENFTFRNHIC-----------MTFE-LLSMNLYELIKKNKFQGFSLPLVRK 204

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP--KLSDFGLAREGPMVGHTHVS 251
                 + L  LH+    ++I+ D K  N+LL +  R   K+ DFG +       H  V 
Sbjct: 205 FAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVY 257

Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
           T +   F Y AP+ I         D+WS G +L E+LTG 
Sbjct: 258 TYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 56/221 (25%), Positives = 84/221 (38%), Gaps = 41/221 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL----- 140
            IG+G FG V K      A D   +   VAIK + ++      Q   EV+ L ++     
Sbjct: 61  LIGKGSFGQVVK------AYDRVEQ-EWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDT 112

Query: 141 -EHPNLVKLIGY-------CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
                +V L  +       C           LV+E ML+ +L D L N  F  +      
Sbjct: 113 EMKYYIVHLKRHFMFRNHLC-----------LVFE-MLSYNLYDLLRNTNFRGVSLNLTR 160

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP--KLSDFGLAREGPMVGHTHV 250
                    L +L    E+ +I+ D K  N+LL    R   K+ DFG +          +
Sbjct: 161 KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRI 215

Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR 291
              +   F Y +P+ +         D+WS G +L EM TG 
Sbjct: 216 YQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 49/235 (20%), Positives = 85/235 (36%), Gaps = 50/235 (21%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIK--KLNRDGLQGHKQWVAEVQFLGVLEHP 143
           KIG GGFG +Y           T++    A    K+     Q +    +E++F   +   
Sbjct: 44  KIGSGGFGLIYL-------AFPTNKPEKDARHVVKVEY---QENGPLFSELKFYQRVAKK 93

Query: 144 NLV---------------KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL-FNRAFPPLP 187
           + +                  G    + +    R +V E  L   L+     N  F    
Sbjct: 94  DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVME-RLGIDLQKISGQNGTFKK-- 150

Query: 188 WKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK--LSDFGLARE-GPM 244
             T L + +   + L Y+H   E + ++ D KA+N+LL      +  L+D+GL+    P 
Sbjct: 151 -STVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206

Query: 245 VGHTHVS----TAVVGTFGYAAPDYIETGHL----TAKSDVWSFGVVLYEMLTGR 291
             H            GT  + +   ++  H     + +SDV   G  +   L G+
Sbjct: 207 GNHKQYQENPRKGHNGTIEFTS---LDA-HKGVALSRRSDVEILGYCMLRWLCGK 257

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 50/264 (18%), Positives = 88/264 (33%), Gaps = 73/264 (27%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL----- 140
           K+G G F +V+       + D       VA+K +        +  + E++ L  +     
Sbjct: 44  KLGWGHFSTVWL------SWD-IQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDP 95

Query: 141 EHPN---LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
             PN   +V+L+    + G  G    +V+E +L   L   +    +  LP      II  
Sbjct: 96  NDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLL-------------------------------- 225
             +GL YLH   + ++I+ D K  N+LL                                
Sbjct: 155 VLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212

Query: 226 -----------------DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET 268
                             E  + K++D G A            T  + T  Y + + +  
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH-----KHFTEDIQTRQYRSLEVLIG 267

Query: 269 GHLTAKSDVWSFGVVLYEMLTGRR 292
                 +D+WS   + +E+ TG  
Sbjct: 268 SGYNTPADIWSTACMAFELATGDY 291

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 56/221 (25%), Positives = 81/221 (36%), Gaps = 37/221 (16%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH-PN 144
           KIG G FG +         G        VAIK           Q   E +F   L     
Sbjct: 16  KIGCGNFGELRL-------GKNLYTNEYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDG 66

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           + ++  +    G  G    +V E +L  SLED LF+        KT L I +     + Y
Sbjct: 67  IPQVYYF----GPCGKYNAMVLE-LLGPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEY 120

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPK-----LSDFGLARE-GPMVGHTHV----STAV 254
           +H      +IYRD K  N L+            + DF LA+E        H+      ++
Sbjct: 121 VH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL 177

Query: 255 VGTFGYAAPDYIETGHL----TAKSDVWSFGVVLYEMLTGR 291
            GT  Y +   I T HL    + + D+ + G +    L G 
Sbjct: 178 TGTARYMS---INT-HLGKEQSRRDDLEALGHMFMYFLRGS 214

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.5 bits (143), Expect = 1e-09
 Identities = 55/422 (13%), Positives = 111/422 (26%), Gaps = 140/422 (33%)

Query: 12  LRRREERSAPELKEPRKSADYSGAESDRFVKSSCSASVTSPRGIPELYEEKAHNL----R 67
           L  ++E    +  E     +Y       F+ S        P  +  +Y E+   L    +
Sbjct: 71  LLSKQEEMVQKFVEEVLRINYK------FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQ 124

Query: 68  VFS---------YSEMRQATNDFSRMLKI---GEGGFGSVYKSSIKPAAGDGTSEATVVA 115
           VF+         Y ++RQA  +      +   G  G G   K+               VA
Sbjct: 125 VFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KT--------------WVA 167

Query: 116 IKKLNRDGLQGHKQ----WVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRL--LVYEFM 169
           +       +Q        W+                 +  C       ++ L  L+Y+  
Sbjct: 168 LDVCLSYKVQCKMDFKIFWLN----------------LKNCNSPETV-LEMLQKLLYQID 210

Query: 170 LN-RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN 228
            N  S  DH  N        +  L  +L +          L   ++  + + +       
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP----YENCL---LVLLNVQNAKAW--NA 261

Query: 229 FRPKLSDFG-----LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVV 283
           F     +         R         V+  +             T H++      +    
Sbjct: 262 F-----NLSCKILLTTRF------KQVTDFLSAA---------TTTHISLDHHSMTL--- 298

Query: 284 LYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLA 343
                           + +  LL+++     D +   L   PR        E        
Sbjct: 299 -------------TPDEVKSLLLKYL-----DCRPQDL---PR--------EVLTTNPRR 329

Query: 344 DNCLSKSSKDRPKMSQ-----VVERLKQIVQVSNEG---DSFDKTFEE--ICEED-PVEA 392
            + +++S +D             ++L  I++ S        + K F+   +      +  
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT 389

Query: 393 QT 394
             
Sbjct: 390 IL 391

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 52/238 (21%), Positives = 83/238 (34%), Gaps = 61/238 (25%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL----- 140
            +GEG FG V +        D     + VA+K + R+  +  +    E+  L  +     
Sbjct: 26  NLGEGTFGKVVE------CLDHARGKSQVALKII-RNVGKYREAARLEINVLKKIKEKDK 78

Query: 141 -EHPNLVKLIGY-------CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
                 V +  +       C           + +E +L ++  + L    F P P     
Sbjct: 79  ENKFLCVLMSDWFNFHGHMC-----------IAFE-LLGKNTFEFLKENNFQPYPLPHVR 126

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP-------------------KL 233
           H+       L +LHE    Q+ + D K  N+L   +                      ++
Sbjct: 127 HMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183

Query: 234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTG 290
           +DFG A       H H +T V     Y  P+ I E G      DVWS G +L+E   G
Sbjct: 184 ADFGSA----TFDHEHHTTIVATRH-YRPPEVILELGWAQP-CDVWSIGCILFEYYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 53.4 bits (129), Expect = 6e-08
 Identities = 51/238 (21%), Positives = 83/238 (34%), Gaps = 61/238 (25%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL----- 140
            +GEG FG V +        D  +    VA+K + ++  +  +   +E+Q L  L     
Sbjct: 21  TLGEGAFGKVVE------CIDHKAGGRHVAVKIV-KNVDRYCEAARSEIQVLEHLNTTDP 73

Query: 141 -EHPNLVKLIGY-------CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
                 V+++ +       C           +V+E +L  S  D +    F P       
Sbjct: 74  NSTFRCVQMLEWFEHHGHIC-----------IVFE-LLGLSTYDFIKENGFLPFRLDHIR 121

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP-------------------KL 233
            +     + + +LH     ++ + D K  N+L  ++                      K+
Sbjct: 122 KMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178

Query: 234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTG 290
            DFG A         H ST V     Y AP+ I   G      DVWS G +L E   G
Sbjct: 179 VDFGSA----TYDDEHHSTLVSTRH-YRAPEVILALGWSQP-CDVWSIGCILIEYYLG 230

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 52/243 (21%), Positives = 86/243 (35%), Gaps = 67/243 (27%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL----- 140
           K+G+G FG V             ++    A+K + R+  +  +    E   L  +     
Sbjct: 42  KMGDGTFGRVLL------CQHIDNK-KYYAVKVV-RNIKKYTRSAKIEADILKKIQNDDI 93

Query: 141 EHPNLVKLIGY-------CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
            + N+VK  G        C           L++E  L  SL + +    +     +    
Sbjct: 94  NNNNIVKYHGKFMYYDHMC-----------LIFE-PLGPSLYEIITRNNYNGFHIEDIKL 141

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP---------------------- 231
             +   + L YL +   + + + D K  N+LLD+ +                        
Sbjct: 142 YCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198

Query: 232 ---KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEM 287
              KL DFG A         +  + +     Y AP+ I   G   + SD+WSFG VL E+
Sbjct: 199 TGIKLIDFGCA----TFKSDYHGSIINTRQ-YRAPEVILNLGWDVS-SDMWSFGCVLAEL 252

Query: 288 LTG 290
            TG
Sbjct: 253 YTG 255

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	436
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.46
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.25
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.17
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.16
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.71
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.58
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.56
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.5
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.45
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.4
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.3
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.97
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.94
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.91
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.72
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.64
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.62
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.61
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.51
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.46
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.38
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.3
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.24
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.2
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.92
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.64
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.35
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.63
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.31
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.41
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.74

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.8e-60  Score=445.56  Aligned_cols=268  Identities=25%  Similarity=0.413  Sum_probs=217.6

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ++|.+.+.||+|+||.||+|.+....  ...++..||||+++.......+.|.+|+.+|++++|||||+++|+|...+. 
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~--~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~-   89 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLC--PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP-   89 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC------CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS-
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcc--cCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE-
Confidence            57899999999999999999986322  224678999999987766667889999999999999999999999986553 


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRA-----------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                         .++|||||++|+|.++|....           ...+++..++.|+.||+.||.|||++   +|+||||||+||||+.
T Consensus        90 ---~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~  163 (299)
T 4asz_A           90 ---LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGE  163 (299)
T ss_dssp             ---EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred             ---EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECC
Confidence               599999999999999997532           34799999999999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHH
Q 013790          228 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLL  306 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  306 (436)
                      ++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+...   +.
T Consensus       164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~  240 (299)
T 4asz_A          164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI  240 (299)
T ss_dssp             GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH
T ss_pred             CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH
Confidence            99999999999975322222223344579999999999999999999999999999999999 899998765432   33


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                      ..+..-..          +    ..+..++..+.+||.+||+.||++|||+.+|+..|+++.+...
T Consensus       241 ~~i~~~~~----------~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p  292 (299)
T 4asz_A          241 ECITQGRV----------L----QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP  292 (299)
T ss_dssp             HHHHHTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             HHHHcCCC----------C----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence            33222110          0    1123345789999999999999999999999999999876543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.8e-59  Score=446.40  Aligned_cols=266  Identities=24%  Similarity=0.427  Sum_probs=211.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ++|.+.+.||+|+||.||+|.++...  ...+++.||||+++.......+.|.+|+.+|++++|||||+++|+|...+. 
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~--~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~-  117 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLL--PEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP-  117 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSC--C---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS-
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcc--cCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-
Confidence            57888899999999999999986321  224678999999987776677889999999999999999999999976553 


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRA-------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL  225 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll  225 (436)
                         .+||||||++|+|.++|....             ..++++..++.|+.||+.||+|||++   +||||||||+||||
T Consensus       118 ---~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl  191 (329)
T 4aoj_A          118 ---LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLV  191 (329)
T ss_dssp             ---EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             ---EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEE
Confidence               599999999999999997542             24699999999999999999999998   99999999999999


Q ss_pred             cCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 013790          226 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQR  304 (436)
Q Consensus       226 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  304 (436)
                      +.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.....   
T Consensus       192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---  268 (329)
T 4aoj_A          192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---  268 (329)
T ss_dssp             ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---
T ss_pred             CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999986433333334455679999999999999999999999999999999999 899998765432   


Q ss_pred             HHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          305 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      +...+..-..          .    ..+..++..+.+||.+||+.||++|||+.+|+++|+.+.+.
T Consensus       269 ~~~~i~~g~~----------~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          269 AIDCITQGRE----------L----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHHHHTCC----------C----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHcCCC----------C----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            2222221100          1    11223457899999999999999999999999999998764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-58  Score=434.29  Aligned_cols=261  Identities=27%  Similarity=0.454  Sum_probs=205.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .+++.+.+.||+|+||+||+|+++          ..||||+++...  ....+.|.+|+.++++++|||||+++|++..+
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~----------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  104 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH----------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD  104 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS----------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC----------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC
Confidence            457889999999999999999864          248999987543  33457799999999999999999999988543


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                           .++||||||++|+|.++|.... ..+++..++.|+.|||.||+|||++   +||||||||+||||++++++||+|
T Consensus       105 -----~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~D  175 (307)
T 3omv_A          105 -----NLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGD  175 (307)
T ss_dssp             -----SCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECC
T ss_pred             -----eEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEee
Confidence                 2489999999999999997654 4699999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      ||+|+...............||+.|||||++.+   +.|+.++|||||||+||||+||+.||.+......  +...+...
T Consensus       176 FGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~~~~~~~~  253 (307)
T 3omv_A          176 FGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--IIFMVGRG  253 (307)
T ss_dssp             CSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHHHTT
T ss_pred             ccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--HHHHHhcC
Confidence            999986433333334456789999999999964   4689999999999999999999999987554322  11111111


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                      .         ..+.+ ...+..++..+.+||.+||+.||++|||+.+|+++|+.+..
T Consensus       254 ~---------~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          254 Y---------ASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             C---------CCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             C---------CCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            0         01111 12233445789999999999999999999999999987743

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-58  Score=439.97  Aligned_cols=263  Identities=25%  Similarity=0.398  Sum_probs=212.2

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +++++++.||+|+||.||+|.+....  ...+++.||||+++... ....+.|.+|+.++++++|||||+++|+|...+.
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~--~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~  103 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPA--PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP  103 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC---------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCc--cCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence            46778899999999999999985221  22467899999997543 2345789999999999999999999999987654


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcE
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  223 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NI  223 (436)
                          .++|||||++|+|.++|..+.              ...+++..++.|+.|||.||+|||++   +||||||||+||
T Consensus       104 ----~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NI  176 (308)
T 4gt4_A          104 ----LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNV  176 (308)
T ss_dssp             ----CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             ----EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccce
Confidence                499999999999999996532              23689999999999999999999998   999999999999


Q ss_pred             EEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 013790          224 LLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTE  302 (436)
Q Consensus       224 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~  302 (436)
                      ||++++++||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |..||.+....  
T Consensus       177 Ll~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--  254 (308)
T 4gt4_A          177 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--  254 (308)
T ss_dssp             EECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--
T ss_pred             EECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--
Confidence            999999999999999985322222233445679999999999999999999999999999999999 89999876543  


Q ss_pred             HHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          303 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                       .+...+.....              ...+..++..+.+||.+||+.||.+|||+.+|+++|+.+
T Consensus       255 -~~~~~i~~~~~--------------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          255 -DVVEMIRNRQV--------------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -HHHHHHHTTCC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -HHHHHHHcCCC--------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence             23333322110              012334557899999999999999999999999999865

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2e-58  Score=442.77  Aligned_cols=253  Identities=24%  Similarity=0.396  Sum_probs=206.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|+++       .+++.||||++....  ....+.+.+|+.+|++|+|||||++++++...
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   95 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKST-------EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN   95 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEET-------TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             ccceEEeEEEecCCCeEEEEEEEC-------CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence            368999999999999999999976       578899999997653  23456799999999999999999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    .+|||||||+||+|.++|..+....+++..++.|+.||+.||.|||++   +|+||||||+||||+.+|.+||+|
T Consensus        96 ~----~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D  168 (350)
T 4b9d_A           96 G----SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGD  168 (350)
T ss_dssp             T----EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECS
T ss_pred             C----EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcc
Confidence            5    469999999999999999876666789999999999999999999999   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||+|+..  ..........+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+...   +...+..... 
T Consensus       169 FGla~~~--~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~~~~-  242 (350)
T 4b9d_A          169 FGIARVL--NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---LVLKIISGSF-  242 (350)
T ss_dssp             TTEESCC--CHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHTCC-
T ss_pred             cccceee--cCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHcCCC-
Confidence            9999853  112223455789999999999999999999999999999999999999998764432   2222221110 


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                               +    ..+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       243 ---------~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          243 ---------P----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ---------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---------C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                     0    1122234678999999999999999999999876

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6e-58  Score=438.72  Aligned_cols=251  Identities=25%  Similarity=0.397  Sum_probs=211.2

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ..|++++.||+|+||.||+|.++       .+++.||||+++.......+.+.+|+.+|+.++|||||++++++...+  
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~-------~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--  144 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--  144 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred             HhcEEeEEeecCcCeEEEEEEEC-------CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence            56999999999999999999976       578899999997665556677899999999999999999999998765  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        .+|||||||+||+|.+++...   .+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+||+|||+
T Consensus       145 --~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl  216 (346)
T 4fih_A          145 --ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGF  216 (346)
T ss_dssp             --EEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             --EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcC
Confidence              469999999999999999753   599999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  318 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  318 (436)
                      |+...  .........+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+...   ....+.....    
T Consensus       217 a~~~~--~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~~~~----  287 (346)
T 4fih_A          217 CAQVS--KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIRDNLP----  287 (346)
T ss_dssp             CEECC--SSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSSC----
T ss_pred             ceecC--CCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHcCCC----
Confidence            98532  22334456789999999999999999999999999999999999999998765433   2222222110    


Q ss_pred             cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       319 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                            +.+  ......+..+.+||.+||..||.+|||+.|+++|
T Consensus       288 ------~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          288 ------PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             ------CCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------CCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                  000  1112234678999999999999999999999876

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.8e-58  Score=441.54  Aligned_cols=278  Identities=24%  Similarity=0.348  Sum_probs=223.7

Q ss_pred             HHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCC-CCceee
Q 013790           71 YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEH-PNLVKL  148 (436)
Q Consensus        71 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-pnIv~~  148 (436)
                      ..++....++|++++.||+|+||.||+|.+....  .....+.||||.+..... ...+.|.+|+.+|.++.| ||||++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~--~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID--KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSS--STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCC--cccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3444445678999999999999999999987332  234568899999976543 345679999999999975 999999


Q ss_pred             eeEeeecCCcceeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 013790          149 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVI  214 (436)
Q Consensus       149 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~iv  214 (436)
                      +|+|..++.   .+++|||||++|+|.++|....              ...+++..++.++.|||.||.|||++   +||
T Consensus       134 ~g~~~~~~~---~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~ii  207 (353)
T 4ase_A          134 LGACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI  207 (353)
T ss_dssp             EEEECCTTS---CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             EEEEEecCC---EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---Cee
Confidence            999976543   3589999999999999997532              24589999999999999999999999   999


Q ss_pred             eccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCC
Q 013790          215 YRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRS  293 (436)
Q Consensus       215 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p  293 (436)
                      ||||||+||||+.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |..|
T Consensus       208 HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P  287 (353)
T 4ase_A          208 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP  287 (353)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence            999999999999999999999999986443333344456789999999999999999999999999999999998 9999


Q ss_pred             CCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          294 LERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       294 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                      |.+.....  .+...+..-.          .+    ..+..++..+.+||.+||+.||.+|||+.+|+++|+++++...
T Consensus       288 f~~~~~~~--~~~~~i~~g~----------~~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~  350 (353)
T 4ase_A          288 YPGVKIDE--EFCRRLKEGT----------RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  350 (353)
T ss_dssp             STTCCCSH--HHHHHHHHTC----------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             CCCCCHHH--HHHHHHHcCC----------CC----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence            98754332  1222222110          01    1122335788999999999999999999999999999987543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.3e-57  Score=423.71  Aligned_cols=250  Identities=22%  Similarity=0.337  Sum_probs=201.7

Q ss_pred             cccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcc
Q 013790           82 SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  159 (436)
Q Consensus        82 ~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  159 (436)
                      .+.+.||+|+||.||+|.++       .++..||+|++....  ....+.|.+|+.+|++|+|||||++++++.......
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~  101 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDT-------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred             EeeeEEecCcCcEEEEEEEC-------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence            56678999999999999976       568899999986542  234567999999999999999999999987643334


Q ss_pred             eeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc--eeeccCCCCcEEEc-CCCceEEeec
Q 013790          160 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQ--VIYRDFKASNVLLD-ENFRPKLSDF  236 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~Df  236 (436)
                      ..+|||||||+||+|.+++.+.  ..+++..+..|+.||+.||+|||++   +  |+||||||+||||+ .+|.+||+||
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DF  176 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred             cEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeC
Confidence            4679999999999999999764  3799999999999999999999997   6  99999999999997 4899999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      |+|+...    .......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.....  .+...+...... 
T Consensus       177 Gla~~~~----~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~~i~~~~~~-  248 (290)
T 3fpq_A          177 GLATLKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSGVKP-  248 (290)
T ss_dssp             TGGGGCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHTTTCCC-
T ss_pred             cCCEeCC----CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHHHHHcCCCC-
Confidence            9997521    223456789999999999865 69999999999999999999999997654322  222222211110 


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                              +.+    +...++.+.+||.+||..||.+|||+.++++|
T Consensus       249 --------~~~----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          249 --------ASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             --------GGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --------CCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    011    11123568899999999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3e-57  Score=427.65  Aligned_cols=251  Identities=21%  Similarity=0.288  Sum_probs=210.4

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|++++.||+|+||+||+|+++       .+++.||||++.+..   ....+.+.+|+.+|+.++|||||++++++..+
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~-------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  104 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLAREL-------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD  104 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccEEEEEEecccCeEEEEEEEC-------CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            57999999999999999999976       578899999997542   23356789999999999999999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    .+|+|||||+||+|.++|....  .+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+||+|
T Consensus       105 ~----~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~D  175 (311)
T 4aw0_A          105 E----KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITD  175 (311)
T ss_dssp             S----EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred             C----EEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEE
Confidence            4    4699999999999999997653  699999999999999999999999   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||+|+............+.+||+.|||||++.+..|+.++|||||||++|+|+||..||.+.+...   +...+..... 
T Consensus       176 FGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~~~~-  251 (311)
T 4aw0_A          176 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFAKIIKLEY-  251 (311)
T ss_dssp             CTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCC-
T ss_pred             cCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHcCCC-
Confidence            999986433333445567789999999999999999999999999999999999999998654332   2222222111 


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                .+    +...+..+.+||.+||..||.+|||+.|++.+
T Consensus       252 ----------~~----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          252 ----------DF----PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             ----------CC----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             ----------CC----CcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence                      11    11234678899999999999999999987544

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6e-57  Score=430.54  Aligned_cols=259  Identities=24%  Similarity=0.262  Sum_probs=210.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .+.|.+.++||+|+||.||+|+++       .+++.||||+++....     ..+|+.+++.++|||||++++++...+ 
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~-------~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~-  123 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDK-------QTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGP-  123 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETT-
T ss_pred             hhheEeCcEeccCCCeEEEEEEEC-------CCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence            457888999999999999999976       5788999999976532     246999999999999999999997654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC-ceEEeec
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-RPKLSDF  236 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Df  236 (436)
                         .+|||||||+||+|.++|....  .+++..+..++.||+.||+|||++   +||||||||+||||+.+| .+||+||
T Consensus       124 ---~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DF  195 (336)
T 4g3f_A          124 ---WVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDF  195 (336)
T ss_dssp             ---EEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCC
T ss_pred             ---EEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeC
Confidence               4699999999999999997653  699999999999999999999999   999999999999999988 6999999


Q ss_pred             cCCCCCCCCCCc---ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          237 GLAREGPMVGHT---HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       237 g~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |+|+........   ......+||+.|||||++.+..|+.++|||||||++|||+||..||.+.......   ..+...+
T Consensus       196 Gla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i~~~~  272 (336)
T 4g3f_A          196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---LKIASEP  272 (336)
T ss_dssp             TTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---HHHHHSC
T ss_pred             CCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHHHcCC
Confidence            999853222111   1223467999999999999999999999999999999999999999875543321   1111111


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                      ..   +         ...+...+..+.+||.+||+.||.+|||+.||+++|...++...
T Consensus       273 ~~---~---------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          273 PP---I---------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             CG---G---------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             CC---c---------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence            10   0         11233345788999999999999999999999999998876543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1e-56  Score=440.50  Aligned_cols=251  Identities=25%  Similarity=0.398  Sum_probs=211.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      +.|++++.||+|+||.||+|.++       .+++.||||++........+.+.+|+.+|+.++|||||++++++...+  
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~-------~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--  221 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVR-------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--  221 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred             HhcEeeeEeccCcCcEEEEEEEC-------CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC--
Confidence            56999999999999999999976       578999999998766566677899999999999999999999998765  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        .+|||||||+||+|.+++...   .+++..+..|+.||+.||+|||++   +||||||||+||||+.+|.+||+|||+
T Consensus       222 --~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGl  293 (423)
T 4fie_A          222 --ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGF  293 (423)
T ss_dssp             --EEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTT
T ss_pred             --EEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCcc
Confidence              469999999999999999653   599999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  318 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  318 (436)
                      |+...  .........+||+.|||||++.+..|+.++|||||||++|||++|..||.+.++...   ...+.....    
T Consensus       294 a~~~~--~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i~~~~~----  364 (423)
T 4fie_A          294 CAQVS--KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDNLP----  364 (423)
T ss_dssp             CEECC--SSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHSCC----
T ss_pred             ceECC--CCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHHcCCC----
Confidence            98532  223344567899999999999999999999999999999999999999987654332   222222110    


Q ss_pred             cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       319 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                            +.+  ......+..+.+||.+||..||.+|||+.|+++|
T Consensus       365 ------~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          365 ------PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             ------CCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------CCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                  001  1111234678999999999999999999999876

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9e-56  Score=411.85  Aligned_cols=248  Identities=24%  Similarity=0.396  Sum_probs=192.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++++.||+|+||.||+|..+       .+++.||||++++...   ...+.+.+|+.+++.++|||||++++++..
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   84 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHT-------TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS   84 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECT-------TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             eeCeEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            368999999999999999999865       5789999999975532   234678999999999999999999999876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      ++    ..|+||||+ +|+|.+++..+.  .+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+
T Consensus        85 ~~----~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~  154 (275)
T 3hyh_A           85 KD----EIIMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIA  154 (275)
T ss_dssp             SS----EEEEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEEC
T ss_pred             CC----EEEEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEe
Confidence            54    469999999 789999997654  799999999999999999999999   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |||+|+...   ........+||+.|||||++.+..+ +.++|||||||++|+|+||+.||.+.+...   +...+....
T Consensus       155 DFGla~~~~---~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~~i~~~~  228 (275)
T 3hyh_A          155 DFGLSNIMT---DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFKNISNGV  228 (275)
T ss_dssp             CSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTC
T ss_pred             ecCCCeecC---CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHcCC
Confidence            999997532   2233455789999999999988876 579999999999999999999998654322   222222211


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .           .+    +...+..+.+||.+||+.||.+|||+.|+++|
T Consensus       229 ~-----------~~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          229 Y-----------TL----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             C-----------CC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             C-----------CC----CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            1           11    11234678899999999999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1e-55  Score=420.04  Aligned_cols=270  Identities=22%  Similarity=0.295  Sum_probs=205.6

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      .+|.+.+.||+|+||.||+|++.         ++.||||+++..... ...+..|+..+.+++|||||+++|+|..++..
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~---------g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~   72 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR---------GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET---------TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC---------CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCC
Confidence            46888899999999999999864         678999999755322 22334566667789999999999999887665


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCceeeccCCCCcEEEcCCCceEE
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL-----EVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ...+||||||+++|+|.++|...   ++++..+..++.|++.||+|||+++     .++|+||||||+||||+.++++||
T Consensus        73 ~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki  149 (303)
T 3hmm_A           73 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             ceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEE
Confidence            56789999999999999999764   5899999999999999999999752     358999999999999999999999


Q ss_pred             eeccCCCCCCCCCCc--ccccccccCCCcccccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCchh----
Q 013790          234 SDFGLAREGPMVGHT--HVSTAVVGTFGYAAPDYIETG------HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT----  301 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~pf~~~~~~~----  301 (436)
                      +|||+|+........  .......||+.|||||++.+.      .++.++|||||||+||||+||.+||.......    
T Consensus       150 ~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~  229 (303)
T 3hmm_A          150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             CCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             EeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence            999999753222111  122345799999999999764      36789999999999999999988775432210    


Q ss_pred             --------hHHHHHHHhhcccCccccccccCCcccCc-CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          302 --------EQRLLEWVQQYPADSKKFGLIMDPRLEKE-YSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       302 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                              ...+...+..         ...++.++.. .+...+..+.+|+.+||+.||.+|||+.+|++.|+++.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~---------~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          230 DLVPSDPSVEEMRKVVCE---------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTT---------SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hcccccchHHHHHHHHhc---------ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence                    0111111100         0112222221 2345677899999999999999999999999999998754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.8e-56  Score=420.88  Aligned_cols=252  Identities=26%  Similarity=0.394  Sum_probs=200.3

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|++++.||+|+||.||+|+...    +..+++.||||+++....  .....+.+|+.+|++++|||||++++++..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKIS----GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECS----STTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred             cccEEEEEEecCCCeEEEEEEEcc----CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            579999999999999999998642    224678999999975432  22346788999999999999999999998765


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          .+|+|||||+||+|.++|.+..  .+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+||
T Consensus       100 ----~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DF  170 (304)
T 3ubd_A          100 ----KLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDF  170 (304)
T ss_dssp             ----EEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESS
T ss_pred             ----EEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccc
Confidence                4599999999999999997653  699999999999999999999999   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      |+|+...  .........+||+.|||||++.+..|+.++|||||||++|||+||..||.+.+...   +...+.....  
T Consensus       171 Gla~~~~--~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~~~~--  243 (304)
T 3ubd_A          171 GLSKESI--DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMTMILKAKL--  243 (304)
T ss_dssp             EEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCC--
T ss_pred             ccceecc--CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHHHHHcCCC--
Confidence            9997532  22233456789999999999999999999999999999999999999998765432   2222222110  


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM-----SQVVER  363 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~  363 (436)
                                   .++...+..+.+||.+||+.||.+|||+     +|+++|
T Consensus       244 -------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          244 -------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             -------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             -------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                         1122234678999999999999999985     566654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.5e-54  Score=406.46  Aligned_cols=257  Identities=25%  Similarity=0.363  Sum_probs=193.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++++.||+|+||.||+|+++       .+++.||||++..... ...+.+.+|+.+|++|+|||||++++++...+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   76 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNK-------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKN   76 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEET-------TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC
T ss_pred             chhCEEeeEEecCCCeEEEEEEEC-------CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecC
Confidence            457999999999999999999976       5688999999975533 33467899999999999999999999987654


Q ss_pred             C--------cceeEEEEEEecCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          157 E--------RGIQRLLVYEFMLNRSLEDHLFNRAF-PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       157 ~--------~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      .        ...++|+|||||.+|+|.+++..+.. ...++..++.|+.||+.||+|||++   +|+||||||+||||+.
T Consensus        77 ~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~  153 (299)
T 4g31_A           77 TTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTM  153 (299)
T ss_dssp             ----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred             ccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECC
Confidence            2        22357999999999999999976542 2356677899999999999999999   9999999999999999


Q ss_pred             CCceEEeeccCCCCCCCCCC----------cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 013790          228 NFRPKLSDFGLAREGPMVGH----------THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN  297 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~  297 (436)
                      +|.+||+|||+|+.......          .......+||+.|||||++.+..|+.++|||||||++|||++   ||...
T Consensus       154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~  230 (299)
T 4g31_A          154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ  230 (299)
T ss_dssp             TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence            99999999999985322111          112234679999999999999999999999999999999996   77532


Q ss_pred             CchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          298 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .  ........+.....             + ......++.+.+||.+||+.||.+|||+.+++++
T Consensus       231 ~--~~~~~~~~~~~~~~-------------p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          231 M--ERVRTLTDVRNLKF-------------P-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             H--HHHHHHHHHHTTCC-------------C-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             c--HHHHHHHHHhcCCC-------------C-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1  11112221111110             0 1112233457789999999999999999999875

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.6e-53  Score=413.45  Aligned_cols=271  Identities=24%  Similarity=0.332  Sum_probs=208.2

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|++++.||+|+||.||+|.++       .+++.||||++....  ....+.+.+|+.+|+.++|||||++++++....
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~-------~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  126 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRR-------LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV  126 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred             CCeEEEEEEecccCeEEEEEEEC-------CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence            57999999999999999999976       578999999997543  233467889999999999999999999886542


Q ss_pred             C--cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          157 E--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       157 ~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .  ....+|+|||||. |+|.+++...  .++++..+..++.||+.||.|||++   |||||||||+|||++.+|.+||+
T Consensus       127 ~~~~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~  200 (398)
T 4b99_A          127 PYGEFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIG  200 (398)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEEC
T ss_pred             ccccCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEe
Confidence            1  2346799999995 7899999664  4799999999999999999999999   99999999999999999999999


Q ss_pred             eccCCCCCCCC--CCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          235 DFGLAREGPMV--GHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       235 Dfg~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      |||+|+.....  .........+||+.|||||++.+. .++.++||||+||++|||++|.+||.+.+.......+.....
T Consensus       201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g  280 (398)
T 4b99_A          201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG  280 (398)
T ss_dssp             CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence            99999854221  122334567899999999998775 569999999999999999999999987665443332222221


Q ss_pred             cccCcccccc-----------ccCCcccC---cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 YPADSKKFGL-----------IMDPRLEK---EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 ~~~~~~~~~~-----------~~~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .+.... ...           .+.+....   ......+..+.+||.+||..||.+|||+.|+++|
T Consensus       281 ~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          281 TPSPAV-IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CCCGGG-TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CCChHH-hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            111100 000           00000000   0011224678899999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-50  Score=393.70  Aligned_cols=269  Identities=22%  Similarity=0.310  Sum_probs=199.4

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      ..++|++.+.||+|+||.||+|+.+.    ...+++.||+|.+....  ....+.+|+.+|+.+ +||||+++++++...
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~----~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQL----QVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEB----TTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcc----cCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            45789999999999999999998652    22467899999987653  335678899999988 699999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC-CceEEe
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLS  234 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~  234 (436)
                      +    ++|+||||+++|+|.+++.     .+++..+..++.||+.||+|||++   ||+||||||+||||+.+ +.+||+
T Consensus        93 ~----~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~  160 (361)
T 4f9c_A           93 D----HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALV  160 (361)
T ss_dssp             T----EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEEC
T ss_pred             C----EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEEC
Confidence            4    4699999999999999982     489999999999999999999999   99999999999999876 899999


Q ss_pred             eccCCCCCCCCCC--------------------------cccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHH
Q 013790          235 DFGLAREGPMVGH--------------------------THVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEM  287 (436)
Q Consensus       235 Dfg~a~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~el  287 (436)
                      |||+|+.......                          .......+||+.|||||++.+. .|+.++||||+||++|||
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~el  240 (361)
T 4f9c_A          161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL  240 (361)
T ss_dssp             CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred             cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHH
Confidence            9999974321110                          1122345799999999999775 589999999999999999


Q ss_pred             HhCCCCCCCCCchhhH--HHHHH---------HhhcccC--------ccccccc---------cCCcc---------cCc
Q 013790          288 LTGRRSLERNRPKTEQ--RLLEW---------VQQYPAD--------SKKFGLI---------MDPRL---------EKE  330 (436)
Q Consensus       288 ltg~~pf~~~~~~~~~--~~~~~---------~~~~~~~--------~~~~~~~---------~~~~l---------~~~  330 (436)
                      +||+.||.........  .+...         ...+...        .......         ..+.+         ...
T Consensus       241 l~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  320 (361)
T 4f9c_A          241 LSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLE  320 (361)
T ss_dssp             HHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------------------
T ss_pred             HHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccc
Confidence            9999999755432211  11110         0000000        0000000         00000         000


Q ss_pred             CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          331 YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       331 ~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .....+.++.+||.+||..||.+|||+.|+++|
T Consensus       321 ~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          321 GWNEVPDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             -CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            112234678899999999999999999999876

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.6e-51  Score=417.16  Aligned_cols=254  Identities=22%  Similarity=0.326  Sum_probs=211.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++++.||+|+||.||+|..+       .+++.||+|++........+.+.+|+.+|+.|+|||||++++++...+ 
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~-------~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-  227 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTER-------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-  227 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS-
T ss_pred             ccccEEEEEEeeccCeEEEEEEEC-------CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-
Confidence            468999999999999999999976       578899999998776666778999999999999999999999997654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC--CCceEEee
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE--NFRPKLSD  235 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~D  235 (436)
                         .+|+|||||.||+|.++|.... ..+++..+..++.||+.||.|||++   +|+||||||+|||++.  .+.+||+|
T Consensus       228 ---~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~D  300 (573)
T 3uto_A          228 ---EMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLID  300 (573)
T ss_dssp             ---EEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             ---EEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEee
Confidence               4699999999999999996543 4699999999999999999999999   9999999999999985  48999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||+|+...   ........+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.....   ....+......
T Consensus       301 FG~a~~~~---~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~---~~~~i~~~~~~  374 (573)
T 3uto_A          301 FGLTAHLD---PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRNVKSCDWN  374 (573)
T ss_dssp             CSSCEECC---TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHTTCCC
T ss_pred             ccceeEcc---CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHhCCCC
Confidence            99998632   2333455689999999999999999999999999999999999999998765432   22222221110


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                 +........+..+.+||.+||..||.+|||+.|+++|
T Consensus       375 -----------~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          375 -----------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             -----------CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                       0111112234678899999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.9e-51  Score=415.54  Aligned_cols=251  Identities=24%  Similarity=0.372  Sum_probs=203.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHH---HHHHHHHHHhccCCCCceeeeeE
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHK---QWVAEVQFLGVLEHPNLVKLIGY  151 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~---~~~~E~~~l~~l~hpnIv~~~~~  151 (436)
                      .++|++++.||+|+||.||+|+.+       .+++.||||++.+....   ...   ....++.+++.++|||||+++++
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~-------~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~  260 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKA-------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA  260 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEEC-------CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE
Confidence            478999999999999999999976       57899999999754221   112   23345677888899999999999


Q ss_pred             eeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCce
Q 013790          152 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  231 (436)
Q Consensus       152 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  231 (436)
                      +...+    .+|+||||++||+|.++|....  .+++..+..++.||+.||.|||++   |||||||||+||||+.+|.+
T Consensus       261 f~~~~----~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~v  331 (689)
T 3v5w_A          261 FHTPD----KLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHV  331 (689)
T ss_dssp             EECSS----EEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCE
T ss_pred             EEECC----EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCE
Confidence            97655    4699999999999999997653  699999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      ||+|||+|+...    .....+.+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+........+...+.
T Consensus       332 KL~DFGlA~~~~----~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~  407 (689)
T 3v5w_A          332 RISDLGLACDFS----KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL  407 (689)
T ss_dssp             EECCCTTCEECS----SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH
T ss_pred             EecccceeeecC----CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Confidence            999999998532    122345789999999999964 579999999999999999999999997654433333333222


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~  363 (436)
                      ....               .++...+..+.+||.+||..||.+|++     +.+|++|
T Consensus       408 ~~~~---------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          408 TMAV---------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             HCCC---------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             CCCC---------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            2111               112223467899999999999999998     6888876

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.4e-50  Score=384.59  Aligned_cols=284  Identities=40%  Similarity=0.736  Sum_probs=235.3

Q ss_pred             HHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeee
Q 013790           71 YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIG  150 (436)
Q Consensus        71 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~  150 (436)
                      +.++...+++|++.+.||+|+||.||+|.+.        ++..||||++........+.+.+|+.+++.++||||+++++
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~  102 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLR--------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG  102 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECT--------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEE
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEEC--------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            3344556789999999999999999999854        47789999988776666778999999999999999999999


Q ss_pred             EeeecCCcceeEEEEEEecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC
Q 013790          151 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN  228 (436)
Q Consensus       151 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  228 (436)
                      ++...+.    .++||||+++|+|.+++....  ...+++..++.++.|++.||.|||++   +|+||||||+|||++.+
T Consensus       103 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~  175 (321)
T 2qkw_B          103 FCDERNE----MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDEN  175 (321)
T ss_dssp             ECCCTTC----CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTT
T ss_pred             EEcCCCe----EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCC
Confidence            9876554    499999999999999997643  23589999999999999999999998   99999999999999999


Q ss_pred             CceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 013790          229 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  308 (436)
Q Consensus       229 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  308 (436)
                      +.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|+||+.||....+........|
T Consensus       176 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~  255 (321)
T 2qkw_B          176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW  255 (321)
T ss_dssp             CCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred             CCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence            99999999999753322223333455689999999999989999999999999999999999999987665544444444


Q ss_pred             HhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          309 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      ...... ...+...+++.+........+..+.+++.+||+.||.+|||+.+++++|+.++..
T Consensus       256 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          256 AVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             THHHHT-TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hhhccc-cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            322111 1223345566666677888899999999999999999999999999999998754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.7e-48  Score=381.41  Aligned_cols=271  Identities=27%  Similarity=0.425  Sum_probs=219.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|.+.+.||+|+||.||+|.+.........++..||||++..... ...+.+.+|+.+++.+ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            46899999999999999999998644444445788999999976532 3456789999999999 899999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCC
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  221 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~  221 (436)
                      +.    .++||||+.+|+|.+++....              ...+++..++.++.||+.||.|||++   +|+||||||+
T Consensus       160 ~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~  232 (370)
T 2psq_A          160 GP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR  232 (370)
T ss_dssp             SS----CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred             CC----EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchh
Confidence            54    499999999999999997643              13588999999999999999999998   9999999999


Q ss_pred             cEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCch
Q 013790          222 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPK  300 (436)
Q Consensus       222 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~  300 (436)
                      ||||+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |..||.+....
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999999975433222223344567889999999999999999999999999999999 99999876543


Q ss_pred             hhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                      ..   ...+....          .    ...+..++..+.+||.+||+.||.+|||+.++++.|+.++....
T Consensus       313 ~~---~~~~~~~~----------~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          313 EL---FKLLKEGH----------R----MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             GH---HHHHHTTC----------C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HH---HHHHhcCC----------C----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            32   22111110          0    01122345679999999999999999999999999999986543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.8e-48  Score=372.40  Aligned_cols=289  Identities=41%  Similarity=0.707  Sum_probs=234.6

Q ss_pred             cCcccCHHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCC
Q 013790           65 NLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHP  143 (436)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp  143 (436)
                      ....+++.++....++|.+.+.||+|+||.||+|.+.        +++.||||++...... ....+.+|+.+++.++||
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~   87 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA--------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHR   87 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS--------SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCT
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec--------CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCC
Confidence            4567889999999999999999999999999999753        5778999998765322 233688999999999999


Q ss_pred             CceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCC
Q 013790          144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  221 (436)
Q Consensus       144 nIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~  221 (436)
                      ||+++++++...+..    ++||||+.+|+|.+++....  ..++++..+..++.|++.||.|||+.+..+|+||||||+
T Consensus        88 ~iv~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~  163 (326)
T 3uim_A           88 NLLRLRGFCMTPTER----LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA  163 (326)
T ss_dssp             TBCCCCEEECCSSCC----EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred             CccceEEEEecCCce----EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence            999999999766543    89999999999999997653  345999999999999999999999976669999999999


Q ss_pred             cEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--
Q 013790          222 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP--  299 (436)
Q Consensus       222 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~--  299 (436)
                      |||++.++.+||+|||+++..... .........||+.|+|||++.+..++.++||||||+++|+|++|..||.....  
T Consensus       164 Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  242 (326)
T 3uim_A          164 NILLDEEFEAVVGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN  242 (326)
T ss_dssp             GEEECTTCCEEECCCSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred             hEEECCCCCEEeccCccccccCcc-cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence            999999999999999999753221 22233445699999999999988999999999999999999999999963111  


Q ss_pred             hhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                      ........|+..... ......+.+..+....+...+..+.+++.+||+.||.+|||+.+|+++|+..
T Consensus       243 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          243 DDDVMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TSCSBHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             ccchhHHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            111223344433322 2334445566666677888899999999999999999999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.1e-48  Score=365.49  Aligned_cols=252  Identities=23%  Similarity=0.367  Sum_probs=209.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.+.||+|+||.||+|...       .+++.||+|++........+.+.+|+.+++.++||||+++++++...+ 
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDV-------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-   90 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBT-------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred             hhceeeeeeeccCCCeEEEEEEEC-------CCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-
Confidence            468999999999999999999864       568899999997766666678899999999999999999999997655 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+.+|+|.+++...   .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        91 ---~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  161 (297)
T 3fxz_A           91 ---ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  161 (297)
T ss_dssp             ---EEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             ---EEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCC
Confidence               359999999999999999764   589999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ++.....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||....+........  .....   
T Consensus       162 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~~---  234 (297)
T 3fxz_A          162 FCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--TNGTP---  234 (297)
T ss_dssp             TCEECCS--TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--HHCSC---
T ss_pred             CceecCC--cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCC---
Confidence            9875322  2223345679999999999999999999999999999999999999998765433221111  11000   


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                              .  ...+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       235 --------~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          235 --------E--LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             --------C--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --------C--CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                    0  01122234678899999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.5e-48  Score=372.21  Aligned_cols=280  Identities=25%  Similarity=0.320  Sum_probs=213.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.+.||+|+||.||+|.+.         ++.||||++.... .......+|+.+++.++||||+++++++.....
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL---------NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS   92 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET---------TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             hhhchhhheecccCceEEEEEEEC---------CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence            568999999999999999999863         6889999997553 233456678999999999999999999987665


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------CCceeeccCCCCcEEEcCCCc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL-------EVQVIYRDFKASNVLLDENFR  230 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-------~~~ivH~Dlkp~NIll~~~~~  230 (436)
                      .....++||||+++|+|.+++...   .+++..++.++.|++.||.|||+.+       ..+|+||||||+|||++.++.
T Consensus        93 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~  169 (322)
T 3soc_A           93 VDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT  169 (322)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred             CCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence            455679999999999999999764   4899999999999999999999851       238999999999999999999


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCcccccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-----HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL  305 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  305 (436)
                      +||+|||+++...............||+.|+|||++.+.     .++.++|||||||++|||+||..||.+.........
T Consensus       170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~  249 (322)
T 3soc_A          170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF  249 (322)
T ss_dssp             EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred             EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence            999999999753322222233446799999999999763     456789999999999999999999976543211111


Q ss_pred             HHHHhhcccCcccccc----ccCCcccCc-CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          306 LEWVQQYPADSKKFGL----IMDPRLEKE-YSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       306 ~~~~~~~~~~~~~~~~----~~~~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      .......+........    ...+.+... .....+..+.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            1111110000000000    011111111 1234567799999999999999999999999999988654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.2e-48  Score=367.16  Aligned_cols=260  Identities=26%  Similarity=0.397  Sum_probs=212.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|.+.+.||+|+||.||+|.+.       .++..||+|.+........+.+.+|+.+++.++||||+++++++...+ 
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~-------~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   80 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHR-------ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK-   80 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEET-------TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-
T ss_pred             hhHeeccceecCCCCEEEEEEEEC-------CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC-
Confidence            458999999999999999999976       467899999987766667788999999999999999999999998654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        81 ---~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  153 (310)
T 3s95_A           81 ---RLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFG  153 (310)
T ss_dssp             ---EEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCT
T ss_pred             ---eeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecc
Confidence               3599999999999999997643 4699999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCc------------ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH--
Q 013790          238 LAREGPMVGHT------------HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ--  303 (436)
Q Consensus       238 ~a~~~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~--  303 (436)
                      +++........            .......||+.|+|||++.+..++.++||||||+++|+|++|..||....+....  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~  233 (310)
T 3s95_A          154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG  233 (310)
T ss_dssp             TCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS
T ss_pred             cceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh
Confidence            99753221111            0112457999999999999999999999999999999999999998754332211  


Q ss_pred             -HHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          304 -RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       304 -~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                       .......              .    ..+..++..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       234 ~~~~~~~~--------------~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          234 LNVRGFLD--------------R----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             BCHHHHHH--------------H----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhhcccc--------------c----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence             0000000              0    11122335688999999999999999999999999988654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.2e-47  Score=362.62  Aligned_cols=261  Identities=26%  Similarity=0.428  Sum_probs=203.8

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      ..++|++.+.||+|+||.||+|.+         .+..||||++.....  ...+.+.+|+.++++++||||+++++++..
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW---------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ  105 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE---------TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE---------CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            356899999999999999999975         367899999876532  334678899999999999999999999976


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCc--eeeccCCCCcEEEcCCCce
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQ--VIYRDFKASNVLLDENFRP  231 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~  231 (436)
                      .+.    .++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+.   +  |+||||||+|||++.++.+
T Consensus       106 ~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~  178 (309)
T 3p86_A          106 PPN----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTV  178 (309)
T ss_dssp             TTC----CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCE
T ss_pred             CCc----eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcE
Confidence            654    499999999999999997643 12389999999999999999999998   8  9999999999999999999


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      ||+|||+++...  ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.........   ..+..
T Consensus       179 kL~Dfg~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~---~~~~~  253 (309)
T 3p86_A          179 KVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV---AAVGF  253 (309)
T ss_dssp             EECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH---HHHHH
T ss_pred             EECCCCCCcccc--ccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh
Confidence            999999997421  1222234567999999999999999999999999999999999999999876543322   11111


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                      ...         ..    ..+...+..+.+||.+||..||.+|||+.+|++.|+.++...
T Consensus       254 ~~~---------~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          254 KCK---------RL----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             SCC---------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             cCC---------CC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            100         01    112233467899999999999999999999999999998643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.1e-47  Score=372.12  Aligned_cols=278  Identities=24%  Similarity=0.359  Sum_probs=221.0

Q ss_pred             cCHHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhcc-CCCCce
Q 013790           69 FSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVL-EHPNLV  146 (436)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv  146 (436)
                      +...++....++|.+.+.||+|+||.||+|.+....  ...+++.||||++..... ...+.+.+|+.++..+ +||||+
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID--KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS--STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEecccc--ccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            444555556789999999999999999999875321  335778999999976533 3346789999999999 799999


Q ss_pred             eeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCC-------------------------------------------
Q 013790          147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAF-------------------------------------------  183 (436)
Q Consensus       147 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------  183 (436)
                      ++++++...+.   ..++||||+.+|+|.+++.....                                           
T Consensus        90 ~~~~~~~~~~~---~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (359)
T 3vhe_A           90 NLLGACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG  166 (359)
T ss_dssp             CEEEEECSTTS---CCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred             eeeeeeecCCC---ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence            99999876543   25899999999999999976432                                           


Q ss_pred             ---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCC
Q 013790          184 ---------------------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG  242 (436)
Q Consensus       184 ---------------------~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  242 (436)
                                           ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  243 (359)
T 3vhe_A          167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI  243 (359)
T ss_dssp             -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred             cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence                                 1289999999999999999999999   9999999999999999999999999999854


Q ss_pred             CCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcccccc
Q 013790          243 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFGL  321 (436)
Q Consensus       243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (436)
                      .............||+.|+|||++.+..++.++|||||||++|+|+| |..||.+......  +...+....        
T Consensus       244 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~~~~--------  313 (359)
T 3vhe_A          244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKEGT--------  313 (359)
T ss_dssp             TSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHHHTC--------
T ss_pred             cccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHHHHcCC--------
Confidence            33333334455678999999999999999999999999999999998 9999987553322  111111110        


Q ss_pred             ccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          322 IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       322 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                        ..    ..+...+..+.++|.+||+.||.+|||+.+|+++|+.+++.
T Consensus       314 --~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          314 --RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             --CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence              00    11122346789999999999999999999999999998864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=369.52  Aligned_cols=271  Identities=27%  Similarity=0.421  Sum_probs=220.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|.+.+.||+|+||.||+|.+..........+..||||++..... .....+.+|+.+++.+ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            46899999999999999999998654444445678899999976533 3446789999999999 899999999999766


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCC
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  221 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~  221 (436)
                      +.    .++||||+.+|+|.+++....              ...+++..++.++.||+.||.|||+.   +|+||||||+
T Consensus       148 ~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~  220 (382)
T 3tt0_A          148 GP----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  220 (382)
T ss_dssp             SS----CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             Cc----eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence            54    499999999999999997654              23589999999999999999999998   9999999999


Q ss_pred             cEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCch
Q 013790          222 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPK  300 (436)
Q Consensus       222 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~  300 (436)
                      ||||+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999985433322233444567889999999999999999999999999999999 99999876543


Q ss_pred             hhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                      .   +...+.....          .    ..+...+..+.+||.+||+.||.+|||+.+|+++|+.++....
T Consensus       301 ~---~~~~~~~~~~----------~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          301 E---LFKLLKEGHR----------M----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             H---HHHHHHTTCC----------C----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             H---HHHHHHcCCC----------C----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            2   2222221110          0    1112234678999999999999999999999999999986654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.3e-47  Score=367.23  Aligned_cols=250  Identities=24%  Similarity=0.374  Sum_probs=207.2

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      ..++|++++.||+|+||.||+|.+.       .+++.||||++...  .....+.+.+|+.+++.++||||+++++++..
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~   85 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHI-------LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET   85 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            4578999999999999999999975       57889999998754  23345678899999999999999999999876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        86 ~~----~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~  156 (328)
T 3fe3_A           86 EK----TLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIA  156 (328)
T ss_dssp             SS----EEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred             CC----EEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEe
Confidence            54    4599999999999999997653  699999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLT-AKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |||++....   .........||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....   ...+....
T Consensus       157 DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~  230 (328)
T 3fe3_A          157 DFGFSNEFT---VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL---RERVLRGK  230 (328)
T ss_dssp             STTCCGGGS---SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHCC
T ss_pred             eccCceecC---CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHHhCC
Confidence            999997532   22334567899999999999888765 799999999999999999999987654322   22111110


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .               ..+...+..+.+|+.+||..||.+|||+.+++++
T Consensus       231 ~---------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 Y---------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             C---------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             C---------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0               0111234678899999999999999999999886

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=361.21  Aligned_cols=265  Identities=26%  Similarity=0.413  Sum_probs=211.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|.+.+.||+|+||.||+|.+...    ...+..||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVP----GQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR  123 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCT----TSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecC----CCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            46899999999999999999998621    235677999999765 3334567899999999999999999999997654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      .    .++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+||
T Consensus       124 ~----~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  195 (325)
T 3kul_A          124 L----AMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDF  195 (325)
T ss_dssp             C----CEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             c----cEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCC
Confidence            3    499999999999999996543 4699999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCC-cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 013790          237 GLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |+++....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||........   ...+.... 
T Consensus       196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~~~~~~~-  271 (325)
T 3kul_A          196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV---ISSVEEGY-  271 (325)
T ss_dssp             SSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---HHHHHTTC-
T ss_pred             CcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHHcCC-
Confidence            99975322111 112223446778999999998999999999999999999999 9999976544322   22111110 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                                   ....+..++..+.+||.+||..||.+|||+.+|++.|+.++...
T Consensus       272 -------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          272 -------------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             -------------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence                         00112233578899999999999999999999999999997643

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.9e-46  Score=354.52  Aligned_cols=283  Identities=36%  Similarity=0.615  Sum_probs=225.8

Q ss_pred             cCcccCHHHHHHhhcCCccc------ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc----chhHHHHHHHH
Q 013790           65 NLRVFSYSEMRQATNDFSRM------LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQGHKQWVAEV  134 (436)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~------~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~  134 (436)
                      ....|++.++...+++|...      +.||+|+||.||+|.+         +++.||+|++....    ....+.+.+|+
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~E~   81 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV---------NNTTVAVKKLAAMVDITTEELKQQFDQEI   81 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES---------SSCEEEEEEECCCTTSCTTTHHHHHHHHH
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE---------CCceEEEEEEecccCcchHHHHHHHHHHH
Confidence            45678999999999988877      8899999999999984         36789999986532    23356789999


Q ss_pred             HHHhccCCCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCce
Q 013790          135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQV  213 (436)
Q Consensus       135 ~~l~~l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~i  213 (436)
                      .+++.++||||+++++++...+.    .++||||+++++|.+++.... ..++++..++.++.|++.||.|||+.   +|
T Consensus        82 ~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i  154 (307)
T 2nru_A           82 KVMAKCQHENLVELLGFSSDGDD----LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HH  154 (307)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSS----CEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             HHHHhcCCCCeEEEEEEEecCCc----eEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---Ce
Confidence            99999999999999999976554    499999999999999996432 34699999999999999999999998   99


Q ss_pred             eeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 013790          214 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS  293 (436)
Q Consensus       214 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p  293 (436)
                      +||||||+|||++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..|
T Consensus       155 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p  233 (307)
T 2nru_A          155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA  233 (307)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCS
T ss_pred             ecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCC
Confidence            9999999999999999999999999875432222333345679999999999865 478999999999999999999999


Q ss_pred             CCCCCchhh-HHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          294 LERNRPKTE-QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       294 f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                      |........ ..+...+.   .....+...++..+ ...+...+..+.+++.+||+.||.+|||+.+|+++|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          234 VDEHREPQLLLDIKEEIE---DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             BCTTBSSSBTTHHHHHHH---TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             cccCcchHHHHHHHHHhh---hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            976543221 11211111   11112222233333 2346677889999999999999999999999999999875

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.7e-46  Score=358.98  Aligned_cols=262  Identities=24%  Similarity=0.368  Sum_probs=213.6

Q ss_pred             ccCHHHHHHhhcC----------CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHH
Q 013790           68 VFSYSEMRQATND----------FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFL  137 (436)
Q Consensus        68 ~~~~~~~~~~~~~----------~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l  137 (436)
                      .++++++..+++.          |...+.||+|+||.||+|...       .+++.||||++........+.+.+|+.++
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~-------~~g~~vavK~~~~~~~~~~~~~~~E~~~l   96 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK-------HSGRQVAVKMMDLRKQQRRELLFNEVVIM   96 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEETTTCCSHHHHHHHHHHH
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC-------CCCcEEEEEEEeccchhHHHHHHHHHHHH
Confidence            4667777766653          777789999999999999875       46789999999876666667899999999


Q ss_pred             hccCCCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecc
Q 013790          138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRD  217 (436)
Q Consensus       138 ~~l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~D  217 (436)
                      +.++||||+++++++...+    ..++||||+++++|.+++...   .+++..+..++.|++.||.|||+.   +|+|||
T Consensus        97 ~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~D  166 (321)
T 2c30_A           97 RDYQHFNVVEMYKSYLVGE----ELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQ---GVIHRD  166 (321)
T ss_dssp             TTCCCTTBCCEEEEEEETT----EEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HhCCCCCcceEEEEEEECC----EEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            9999999999999998754    359999999999999998643   599999999999999999999998   999999


Q ss_pred             CCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 013790          218 FKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERN  297 (436)
Q Consensus       218 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~  297 (436)
                      |||+|||++.++.+||+|||++.....  .........||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus       167 lkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~  244 (321)
T 2c30_A          167 IKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD  244 (321)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECCS--SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             CCHHHEEECCCCcEEEeeeeeeeeccc--CccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999875321  122234567999999999999999999999999999999999999999865


Q ss_pred             CchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          298 RPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....   ....+...+..          .+  ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       245 ~~~~---~~~~~~~~~~~----------~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          245 SPVQ---AMKRLRDSPPP----------KL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             CHHH---HHHHHHHSSCC----------CC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CHHH---HHHHHhcCCCC----------Cc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            4432   22222221111          00  0111234678899999999999999999999876

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.1e-46  Score=366.85  Aligned_cols=254  Identities=23%  Similarity=0.334  Sum_probs=206.6

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch------hHHHHHHHHHHHhccCCCCceeeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ------GHKQWVAEVQFLGVLEHPNLVKLIG  150 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~  150 (436)
                      ..++|.+++.||+|+||.||+|..+       .+++.||+|++......      ..+.+.+|+.+++.++||||+++++
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~   82 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREK-------STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD   82 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEEC-------CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEE
Confidence            3468999999999999999999976       56889999999765332      2467899999999999999999999


Q ss_pred             EeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC-
Q 013790          151 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-  229 (436)
Q Consensus       151 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-  229 (436)
                      ++....    ..++||||+.+|+|.+++...  ..+++..+..++.||+.||.|||+.   ||+||||||+|||++.++ 
T Consensus        83 ~~~~~~----~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~  153 (361)
T 2yab_A           83 VYENRT----DVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNI  153 (361)
T ss_dssp             EEECSS----EEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTS
T ss_pred             EEEeCC----EEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCC
Confidence            987654    469999999999999999654  4799999999999999999999998   999999999999998877 


Q ss_pred             ---ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 013790          230 ---RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  306 (436)
Q Consensus       230 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  306 (436)
                         .+||+|||+++....   ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   ..
T Consensus       154 ~~~~vkl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~  227 (361)
T 2yab_A          154 PIPHIKLIDFGLAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL  227 (361)
T ss_dssp             SSCCEEECCCSSCEECCT---TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH
T ss_pred             CccCEEEEecCCceEcCC---CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HH
Confidence               799999999975322   222345679999999999999999999999999999999999999998754332   22


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..+......       +++    ......+..+.+||.+||..||.+|||+.+++++
T Consensus       228 ~~i~~~~~~-------~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          228 ANITAVSYD-------FDE----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             HHHHTTCCC-------CCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHhcCCC-------CCc----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            222111100       000    0111224678899999999999999999999875

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.2e-46  Score=360.38  Aligned_cols=250  Identities=28%  Similarity=0.383  Sum_probs=206.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++++.||+|+||.||+|..+       .+++.||+|++....   ......+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~   76 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREK-------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence            468999999999999999999875       567899999997542   2234678899999999999999999999976


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+
T Consensus        77 ~~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~  147 (337)
T 1o6l_A           77 HD----RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKIT  147 (337)
T ss_dssp             SS----EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             CC----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEe
Confidence            54    469999999999999999764  3689999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||+++...  ..........||+.|+|||++.+..++.++|||||||++|||++|..||.......   +...+.... 
T Consensus       148 DFG~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~~~~-  221 (337)
T 1o6l_A          148 DFGLCKEGI--SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELILMEE-  221 (337)
T ss_dssp             CCTTCBCSC--CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCC-
T ss_pred             eccchhhcc--cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---HHHHHHcCC-
Confidence            999997522  12223455789999999999999999999999999999999999999998654332   222221110 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                                ..    ++...+..+.+||.+||..||.+||     ++.+|++|
T Consensus       222 ----------~~----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 ----------IR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ----------CC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----------CC----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                      01    1122346788999999999999999     89999886

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.8e-47  Score=373.00  Aligned_cols=261  Identities=27%  Similarity=0.426  Sum_probs=209.9

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ..++|.+.+.||+|+||.||+|.+.       .+++.||||.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLR-------ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEe-------cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            3468999999999999999999976       4678999999875432 2335688999999999999999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +.    .++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++   +|+||||||+||||+.++.+||+|
T Consensus       185 ~~----~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~D  256 (377)
T 3cbl_A          185 QP----IYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISD  256 (377)
T ss_dssp             SS----CEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             CC----cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECc
Confidence            54    499999999999999997543 3589999999999999999999999   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ||+++...............++..|+|||++.++.++.++|||||||++|||+| |..||........   ...+.....
T Consensus       257 fG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~---~~~~~~~~~  333 (377)
T 3cbl_A          257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT---REFVEKGGR  333 (377)
T ss_dssp             GGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH---HHHHHTTCC
T ss_pred             CCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCC
Confidence            999975221111111122335678999999998899999999999999999998 9999987654322   222221100


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                                    ...+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       334 --------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          334 --------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence                          01122234678999999999999999999999999998864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.8e-47  Score=361.15  Aligned_cols=280  Identities=25%  Similarity=0.385  Sum_probs=212.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++++.||+|+||.||+|.+...   +..+++.||||++........+.+.+|+.+++.++||||+++++++...+.
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPL---QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTT---CSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecc---cCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            46899999999999999999986421   235789999999987766666789999999999999999999999865432


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                      .  ..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        86 ~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           86 R--NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             T--SCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             C--ceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence            2  3489999999999999997654 3589999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCC-cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      +++....... ........++..|+|||++.+..++.++||||||+++|+|+||..||......    ........+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~  235 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQ  235 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccc
Confidence            9975322211 12223345677899999999999999999999999999999999998643211    111111000000


Q ss_pred             cc---cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          317 KK---FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       317 ~~---~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      ..   ....+........+..++..+.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            00   0000000111122334457899999999999999999999999999998753

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-46  Score=359.96  Aligned_cols=268  Identities=26%  Similarity=0.389  Sum_probs=216.4

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ..++|.+.+.||+|+||.||+|.+....  +..++..||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLK--GRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGG--GCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccC--cccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            3578999999999999999999874221  12456899999997643 33456789999999999999999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCce
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAF----------------------PPLPWKTRLHIILGAAEGLAYLHEGLEVQV  213 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~ql~~~l~~LH~~~~~~i  213 (436)
                      +.    .++||||+.+++|.+++.....                      ..+++..++.++.||+.||.|||++   +|
T Consensus        99 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i  171 (314)
T 2ivs_A           99 GP----LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KL  171 (314)
T ss_dssp             SS----CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             Cc----eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CC
Confidence            54    4999999999999999976432                      3488999999999999999999998   99


Q ss_pred             eeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCC
Q 013790          214 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR  292 (436)
Q Consensus       214 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~  292 (436)
                      +||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus       172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999975433222233344567889999999999889999999999999999999 999


Q ss_pred             CCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          293 SLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       293 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      ||.+.......   ..+.....          .    ..+...+..+.+||.+||+.||.+|||+.+|+++|++++..
T Consensus       252 p~~~~~~~~~~---~~~~~~~~----------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          252 PYPGIPPERLF---NLLKTGHR----------M----ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             SSTTCCGGGHH---HHHHTTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCCHHHHH---HHhhcCCc----------C----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            99876554322   22211110          0    11223346789999999999999999999999999998753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2e-46  Score=355.34  Aligned_cols=265  Identities=23%  Similarity=0.362  Sum_probs=208.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++++.||+|+||.||+|...       .++..||+|.+....   ....+.+.+|+.+++.++||||+++++++..
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~   82 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDT-------ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE   82 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEET-------TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred             hccEEEEEEEccCCCEEEEEEEEC-------CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence            468999999999999999999865       567889999985432   2334678999999999999999999999875


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||+++++|.+++....  ++++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        83 ~~----~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~  153 (294)
T 4eqm_A           83 DD----CYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIF  153 (294)
T ss_dssp             SS----EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEEC
T ss_pred             CC----eEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEE
Confidence            54    4599999999999999997653  699999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||+++..... .........||+.|+|||++.+..++.++||||||+++|+|+||..||.+......  ....+.... 
T Consensus       154 Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~~~-  229 (294)
T 4eqm_A          154 DFGIAKALSET-SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDSV-  229 (294)
T ss_dssp             CCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--HHHHHSSCC-
T ss_pred             eCCCccccccc-cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhhccC-
Confidence            99999753211 11223345799999999999999999999999999999999999999987654321  111111110 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHhhhhcC
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-KMSQVVERLKQIVQVSN  372 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~eil~~L~~~~~~~~  372 (436)
                                +.+........+..+.++|.+||+.||.+|| ++.++.+.|+.++....
T Consensus       230 ----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          230 ----------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             ----------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             ----------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence                      0011112223357789999999999999999 89999999988875443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.2e-46  Score=354.80  Aligned_cols=276  Identities=23%  Similarity=0.281  Sum_probs=216.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|.+.+.||+|+||.||+|.+.       .+++.||||++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHK-------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT   80 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred             CCCEEEEEEecCCCCeEEEEEEEC-------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence            467999999999999999999976       467899999997543 233567889999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE----cCCCce
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRP  231 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~  231 (436)
                      ..  ..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.   +|+||||||+||||    +.++.+
T Consensus        81 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~  155 (319)
T 4euu_A           81 TR--HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVY  155 (319)
T ss_dssp             TC--CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEE
T ss_pred             Cc--eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceE
Confidence            32  4599999999999999997643 23499999999999999999999999   99999999999999    888889


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCcccccccc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh-h
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE--------TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-E  302 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-~  302 (436)
                      ||+|||+++....   ........||+.|+|||++.        +..++.++|||||||++|+|++|..||....... .
T Consensus       156 kL~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  232 (319)
T 4euu_A          156 KLTDFGAARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (319)
T ss_dssp             EECCCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred             EEccCCCceecCC---CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence            9999999975322   22234467999999999986        5788999999999999999999999997544322 2


Q ss_pred             HHH-HHHHhhcccCcc-ccccc------c--CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          303 QRL-LEWVQQYPADSK-KFGLI------M--DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       303 ~~~-~~~~~~~~~~~~-~~~~~------~--~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                      ... ...+...+.... .....      .  ........+...+..+.+|+.+||+.||.+|||+.+++++..+..
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            222 222222221110 00000      0  111122456778889999999999999999999999999987654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.6e-46  Score=358.06  Aligned_cols=270  Identities=18%  Similarity=0.178  Sum_probs=214.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  156 (436)
                      .++|++.+.||+|+||.||+|...       .+++.||||++.....  .+.+.+|+.+++.+ +||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   78 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNL-------YTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK   78 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEET-------TTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred             cCCeEEEEEeeccCCceEEEEEEC-------CCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence            468999999999999999999865       5689999999875532  24678899999999 8999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc-----e
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR-----P  231 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~  231 (436)
                          ..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.     +
T Consensus        79 ----~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~  149 (330)
T 2izr_A           79 ----YNAMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVI  149 (330)
T ss_dssp             ----EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSE
T ss_pred             ----ccEEEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceE
Confidence                459999999 999999997643 4799999999999999999999998   9999999999999998887     9


Q ss_pred             EEeeccCCCCCCCCCCc-----ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 013790          232 KLSDFGLAREGPMVGHT-----HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  306 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  306 (436)
                      ||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..........
T Consensus       150 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~  229 (330)
T 2izr_A          150 HIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY  229 (330)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHH
T ss_pred             EEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHH
Confidence            99999999753221111     1124567999999999999999999999999999999999999999876554433333


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcCCCCC
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS  376 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~~~~  376 (436)
                      ..+........       .   .......+ .+.+|+..||+.||.+||++.+|++.|+++........+
T Consensus       230 ~~i~~~~~~~~-------~---~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~  288 (330)
T 2izr_A          230 QKIGDTKRATP-------I---EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFD  288 (330)
T ss_dssp             HHHHHHHHHSC-------H---HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHhhhccCC-------H---HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Confidence            22211100000       0   00001123 789999999999999999999999999999877654433

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-46  Score=361.83  Aligned_cols=268  Identities=24%  Similarity=0.373  Sum_probs=211.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|.+.+.||+|+||.||+|.+....  ...++..||+|++.... ....+.+.+|+.++.++ +||||+++++++...
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGIS--KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCS--SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccc--cCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            468999999999999999999975221  23467889999997542 23456789999999999 899999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAF---------------------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVI  214 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~ql~~~l~~LH~~~~~~iv  214 (436)
                      +.    .++||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||+.   ||+
T Consensus       122 ~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  194 (344)
T 1rjb_A          122 GP----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV  194 (344)
T ss_dssp             SS----CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             Cc----cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence            54    4999999999999999976532                     2479999999999999999999998   999


Q ss_pred             eccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCC
Q 013790          215 YRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRS  293 (436)
Q Consensus       215 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p  293 (436)
                      ||||||+||||+.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|+| |..|
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999975322222223344567889999999999999999999999999999998 9999


Q ss_pred             CCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          294 LERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       294 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      |.+......  +...+....              ....+...+..+.+||.+||..||.+|||+.+|+++|+.++..
T Consensus       275 ~~~~~~~~~--~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          275 YPGIPVDAN--FYKLIQNGF--------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             STTCCCSHH--HHHHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             cccCCcHHH--HHHHHhcCC--------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            987654322  112111110              0111222347789999999999999999999999999988754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.2e-46  Score=353.09  Aligned_cols=263  Identities=24%  Similarity=0.387  Sum_probs=204.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhc--cCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV--LEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~  155 (436)
                      .++|++.+.||+|+||.||+|.+         +++.||||++...   ....+..|.+++..  ++||||+++++++...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW---------QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS   74 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE---------TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE---------CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence            56899999999999999999985         3788999998754   23455566666665  8999999999998776


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCceeeccCCCCcEEEcC
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH--------EGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH--------~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      .......++||||+++|+|.+++..   ..+++..++.++.|++.||.|||        +.   +|+||||||+|||++.
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~  148 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKK  148 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECT
T ss_pred             cCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcC
Confidence            5555667999999999999999954   36999999999999999999999        77   9999999999999999


Q ss_pred             CCceEEeeccCCCCCCCCCCc--ccccccccCCCcccccccccC------CCCchhhHHHHHHHHHHHHhC---------
Q 013790          228 NFRPKLSDFGLAREGPMVGHT--HVSTAVVGTFGYAAPDYIETG------HLTAKSDVWSFGVVLYEMLTG---------  290 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg---------  290 (436)
                      ++.+||+|||+++........  .......||+.|+|||++.+.      .++.++|||||||++|||+||         
T Consensus       149 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~  228 (301)
T 3q4u_A          149 NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED  228 (301)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccc
Confidence            999999999998642211111  112334799999999999776      455799999999999999999         


Q ss_pred             -CCCCCCCCchhh--HHHHHHHhhcccCccccccccCCccc-CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 013790          291 -RRSLERNRPKTE--QRLLEWVQQYPADSKKFGLIMDPRLE-KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  366 (436)
Q Consensus       291 -~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~  366 (436)
                       ..||....+...  ...........         ..+.+. ...+...+..+.+|+.+||+.||.+|||+.+|++.|++
T Consensus       229 ~~~pf~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          229 YKPPFYDVVPNDPSFEDMRKVVCVDQ---------QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHHHTTSC---------CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccccccCCCCcchhhhhHHHhccC---------CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence             888865433211  11111111100         011111 12334567889999999999999999999999999987


Q ss_pred             h
Q 013790          367 I  367 (436)
Q Consensus       367 ~  367 (436)
                      +
T Consensus       300 i  300 (301)
T 3q4u_A          300 I  300 (301)
T ss_dssp             H
T ss_pred             c
Confidence            5

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.4e-46  Score=355.61  Aligned_cols=269  Identities=25%  Similarity=0.378  Sum_probs=216.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|.+.+.||+|+||.||+|.+....  ...+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLI--KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSS--STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeecc--ccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            468999999999999999999864211  235678999999976543 3456789999999999 899999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCC
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAF----------------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFK  219 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlk  219 (436)
                      +.    .++||||+++|+|.+++.....                ..+++..++.++.||+.||.|||++   +|+|||||
T Consensus       100 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk  172 (313)
T 1t46_A          100 GP----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA  172 (313)
T ss_dssp             SS----CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             CC----cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence            54    4999999999999999976542                2589999999999999999999998   99999999


Q ss_pred             CCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 013790          220 ASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR  298 (436)
Q Consensus       220 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~  298 (436)
                      |+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|+| |..||....
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            9999999999999999999986433332233344567889999999999999999999999999999999 999998754


Q ss_pred             chhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                      ....  ....+.....          .    ..+...+..+.+||.+||..||.+|||+.+++++|++++...
T Consensus       253 ~~~~--~~~~~~~~~~----------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          253 VDSK--FYKMIKEGFR----------M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             SSHH--HHHHHHHTCC----------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             chhH--HHHHhccCCC----------C----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            4322  1111111100          0    111223467899999999999999999999999999988654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.3e-47  Score=368.83  Aligned_cols=267  Identities=26%  Similarity=0.412  Sum_probs=210.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|.+++.||+|+||.||+|.+....  +..++..||||++... .......+.+|+.+++.++||||+++++++....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMP--NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCC--CCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            468999999999999999999975321  2346789999999754 2334457889999999999999999999997655


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC--
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRA-----FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF--  229 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~--  229 (436)
                      ..    ++||||+++|+|.+++....     ...+++..++.++.||+.||.|||++   +|+||||||+||||+.++  
T Consensus       148 ~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~  220 (367)
T 3l9p_A          148 PR----FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPG  220 (367)
T ss_dssp             SC----EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTT
T ss_pred             CC----EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCC
Confidence            43    99999999999999997632     23589999999999999999999999   999999999999999554  


Q ss_pred             -ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHH
Q 013790          230 -RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       230 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~  307 (436)
                       .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.......   +..
T Consensus       221 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~  297 (367)
T 3l9p_A          221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLE  297 (367)
T ss_dssp             CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH
T ss_pred             ceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence             599999999863211112222334567899999999999999999999999999999998 999998765432   222


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      .+.....          .    ..+..++..+.+||.+||+.||.+|||+.+|+++|+.+.+.
T Consensus       298 ~i~~~~~----------~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          298 FVTSGGR----------M----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HHHTTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHcCCC----------C----CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            2221110          0    11222346788999999999999999999999999988653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2e-46  Score=366.23  Aligned_cols=286  Identities=20%  Similarity=0.226  Sum_probs=213.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh-----------HHHHHHHHHHHhccCCCCce
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-----------HKQWVAEVQFLGVLEHPNLV  146 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpnIv  146 (436)
                      .++|++.+.||+|+||.||+|.+....  ....++.||||++.......           ...+..|+..+..++||||+
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSE--SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSS--CCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCcc--ccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            468999999999999999999876221  22346789999987654211           12244566677888999999


Q ss_pred             eeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc
Q 013790          147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  226 (436)
Q Consensus       147 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~  226 (436)
                      ++++++..........++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+.   +|+||||||+||||+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            99999987654445679999999 999999997653 4799999999999999999999999   999999999999999


Q ss_pred             --CCCceEEeeccCCCCCCCCCC-----cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 013790          227 --ENFRPKLSDFGLAREGPMVGH-----THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP  299 (436)
Q Consensus       227 --~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~  299 (436)
                        .++.+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|+|+||..||.+...
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              899999999999975321111     1112345599999999999999999999999999999999999999986433


Q ss_pred             hhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcCCCCCC
Q 013790          300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSF  377 (436)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~~~~~  377 (436)
                      ......... ......   ...++++.+.   ....+..+.+|+..||..||.+||++.+|++.|++++.......+.
T Consensus       267 ~~~~~~~~~-~~~~~~---~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~  337 (364)
T 3op5_A          267 DPKYVRDSK-IRYREN---IASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDG  337 (364)
T ss_dssp             CHHHHHHHH-HHHHHC---HHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             CHHHHHHHH-HHhhhh---HHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCC
Confidence            221111000 000000   1111111111   0122467899999999999999999999999999998876554433

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.8e-46  Score=348.58  Aligned_cols=257  Identities=29%  Similarity=0.452  Sum_probs=209.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.+.||+|+||.||+|.+.        ++..||+|++..... ..+.+.+|+.++++++||||+++++++...+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL--------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   79 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             hhhceeeheecCCCccEEEEEEec--------CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence            468999999999999999999875        466799999976543 34678999999999999999999999876543


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        80 ----~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  151 (269)
T 4hcu_A           80 ----ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFG  151 (269)
T ss_dssp             ----EEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTT
T ss_pred             ----eEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccc
Confidence                599999999999999997644 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      +++.... ..........+|+.|+|||++.+..++.++||||||+++|+|++ |..||........   ...+....   
T Consensus       152 ~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~---~~~~~~~~---  224 (269)
T 4hcu_A          152 MTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VEDISTGF---  224 (269)
T ss_dssp             GGGGBCC-HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHTTC---
T ss_pred             ccccccc-cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHhcCc---
Confidence            9974221 11122233456778999999999999999999999999999999 9999987554322   22111110   


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                             ..    ..+...+..+.+++.+||+.||.+|||+.+++++|+++.+
T Consensus       225 -------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          225 -------RL----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             -------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------cC----CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence                   00    1111224678899999999999999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.7e-46  Score=361.34  Aligned_cols=263  Identities=23%  Similarity=0.378  Sum_probs=206.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++++.||+|+||.||+|.+...   +......||+|.+.... ....+.+.+|+.+++.++||||+++++++....
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPE---GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC-------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCC---CceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            45899999999999999999997521   11234567999886442 234567999999999999999999999997543


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                           .++|++|+.+|+|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        91 -----~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Df  161 (327)
T 3poz_A           91 -----VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF  161 (327)
T ss_dssp             -----EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCT
T ss_pred             -----eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccC
Confidence                 489999999999999997754 4699999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |+++...............+|..|+|||++.+..++.++|||||||++|+|+| |..||.+.........+.   .... 
T Consensus       162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~~~~-  237 (327)
T 3poz_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGER-  237 (327)
T ss_dssp             THHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TTCC-
T ss_pred             cceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH---cCCC-
Confidence            99975332222233334557889999999999999999999999999999999 999998765543322221   1100 


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                                   ...+...+..+.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus       238 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          238 -------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             -------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                         01122234678899999999999999999999999998864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.7e-46  Score=350.65  Aligned_cols=254  Identities=29%  Similarity=0.550  Sum_probs=205.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh-------HHHHHHHHHHHhccCCCCceeeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-------HKQWVAEVQFLGVLEHPNLVKLIG  150 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~~~  150 (436)
                      .++|++.+.||+|+||.||+|.+.       .+++.||+|++.......       .+.+.+|+.+++.++||||+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   90 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLV-------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG   90 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEET-------TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             hccceehhccccCCceeEEEEEEc-------CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhe
Confidence            368999999999999999999975       467899999986543221       167889999999999999999999


Q ss_pred             EeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc--eeeccCCCCcEEEcCC
Q 013790          151 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQ--VIYRDFKASNVLLDEN  228 (436)
Q Consensus       151 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~--ivH~Dlkp~NIll~~~  228 (436)
                      ++....      ++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.   +  |+||||||+|||++.+
T Consensus        91 ~~~~~~------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~  160 (287)
T 4f0f_A           91 LMHNPP------RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSL  160 (287)
T ss_dssp             EETTTT------EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCC
T ss_pred             eecCCC------eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEecc
Confidence            985433      79999999999999987654 4799999999999999999999998   8  9999999999999887


Q ss_pred             Cc-----eEEeeccCCCCCCCCCCcccccccccCCCccccccc--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q 013790          229 FR-----PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI--ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT  301 (436)
Q Consensus       229 ~~-----~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  301 (436)
                      +.     +||+|||+++...     .......||+.|+|||++  ....++.++|||||||++|+|++|..||.......
T Consensus       161 ~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  235 (287)
T 4f0f_A          161 DENAPVCAKVADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK  235 (287)
T ss_dssp             CTTCSCCEEECCCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred             CCCCceeEEeCCCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence            76     9999999997421     123446799999999998  44567899999999999999999999998765433


Q ss_pred             hHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          302 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                      .... ........         .+    ..+...+..+.+||.+||+.||.+|||+.++++.|+++
T Consensus       236 ~~~~-~~~~~~~~---------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          236 IKFI-NMIREEGL---------RP----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHH-HHHHHSCC---------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHH-HHHhccCC---------CC----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            2212 11111110         11    12223357899999999999999999999999999764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.6e-46  Score=371.98  Aligned_cols=254  Identities=28%  Similarity=0.440  Sum_probs=209.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.+.||+|+||.||+|.+.         ++.||||+++...  ..+.+.+|+.++++++||||+++++++.....
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~---------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  260 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG  260 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET---------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec---------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence            468999999999999999999864         5689999997654  45689999999999999999999999876542


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+++|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       261 ---~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  334 (450)
T 1k9a_A          261 ---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFG  334 (450)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             ---ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCC
Confidence               359999999999999999876555689999999999999999999999   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      +++....     ......++..|+|||++.+..++.++|||||||++|||+| |..||........   ...+...    
T Consensus       335 ~a~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i~~~----  402 (450)
T 1k9a_A          335 LTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEKG----  402 (450)
T ss_dssp             TCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HHHHHTT----
T ss_pred             Ccccccc-----cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcC----
Confidence            9974211     1123357889999999999999999999999999999998 9999987554322   1211110    


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                                .....+..++..+.+||.+||..||.+|||+.+|++.|+.+...
T Consensus       403 ----------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          403 ----------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                      00112233457899999999999999999999999999988753

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.3e-46  Score=357.85  Aligned_cols=271  Identities=27%  Similarity=0.433  Sum_probs=216.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|++.+.||+|+||.||+|.+.........++..||+|++.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            4689999999999999999999864443344577899999997653 23456788999999999 899999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCC
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAF--------------PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  221 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~  221 (436)
                      +.    .++||||+.+|+|.+++.....              ..+++..++.++.||+.||.|||+.   +|+||||||+
T Consensus       114 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~  186 (334)
T 2pvf_A          114 GP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR  186 (334)
T ss_dssp             SC----CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             Cc----eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence            53    4999999999999999976432              2489999999999999999999998   9999999999


Q ss_pred             cEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCch
Q 013790          222 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPK  300 (436)
Q Consensus       222 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~  300 (436)
                      |||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            99999999999999999975433222223344567889999999998889999999999999999999 99999876443


Q ss_pred             hhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                      .   +...+.....          .    ..+...+..+.+||.+||+.||.+|||+.+++++|+.++....
T Consensus       267 ~---~~~~~~~~~~----------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          267 E---LFKLLKEGHR----------M----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             H---HHHHHHHTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             H---HHHHHhcCCC----------C----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            2   2222211110          0    1112234678999999999999999999999999999987544

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-46  Score=358.91  Aligned_cols=253  Identities=24%  Similarity=0.357  Sum_probs=205.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch------hHHHHHHHHHHHhccCCCCceeeeeE
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ------GHKQWVAEVQFLGVLEHPNLVKLIGY  151 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~  151 (436)
                      .+.|.+.+.||+|+||.||+|...       .++..||+|++......      ..+.+.+|+.+++.++||||++++++
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   82 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREK-------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV   82 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEET-------TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEEC-------CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            357999999999999999999975       56789999998754322      35678999999999999999999999


Q ss_pred             eeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC--
Q 013790          152 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF--  229 (436)
Q Consensus       152 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~--  229 (436)
                      +....    ..++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++  
T Consensus        83 ~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~  153 (326)
T 2y0a_A           83 YENKT----DVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVP  153 (326)
T ss_dssp             EECSS----EEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSS
T ss_pred             EEeCC----EEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCC
Confidence            87654    459999999999999999654  4799999999999999999999998   999999999999999887  


Q ss_pred             --ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 013790          230 --RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       230 --~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  307 (436)
                        .+||+|||+++....   ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+......   ..
T Consensus       154 ~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~  227 (326)
T 2y0a_A          154 KPRIKIIDFGLAHKIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LA  227 (326)
T ss_dssp             SCCEEECCCTTCEECCT---TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HH
T ss_pred             CCCEEEEECCCCeECCC---CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HH
Confidence              899999999975321   1223446799999999999999999999999999999999999999976543322   11


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .+......           +........+..+.+||.+||..||.+|||+.+++++
T Consensus       228 ~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          228 NVSAVNYE-----------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HHHHTCCC-----------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHhcCCC-----------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11111100           0000011224678899999999999999999999886

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.9e-46  Score=370.61  Aligned_cols=256  Identities=22%  Similarity=0.352  Sum_probs=206.5

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      ...++|++++.||+|+||.||+|...       .+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~-------~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~   80 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKV-------LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS   80 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEET-------TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEEC-------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence            34578999999999999999999865       5788999999876543  33467889999999999999999999997


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc---CCCc
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFR  230 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~  230 (436)
                      ..+    ..++||||+.+|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++   .++.
T Consensus        81 ~~~----~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~  151 (444)
T 3soa_A           81 EEG----HHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAA  151 (444)
T ss_dssp             CSS----EEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCC
T ss_pred             ECC----EEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCc
Confidence            654    4599999999999999997754  699999999999999999999999   999999999999998   5688


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      +||+|||++....  ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   +...+.
T Consensus       152 vkL~DFG~a~~~~--~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~~~~i~  226 (444)
T 3soa_A          152 VKLADFGLAIEVE--GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---LYQQIK  226 (444)
T ss_dssp             EEECCCSSCBCCC--TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHH
T ss_pred             EEEccCceeEEec--CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---HHHHHH
Confidence            9999999997532  22223345679999999999999999999999999999999999999997654332   222222


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .....           +........+..+.+||.+||+.||.+|||+.+++++
T Consensus       227 ~~~~~-----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          227 AGAYD-----------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             HTCCC-----------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hCCCC-----------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11100           0001111234678899999999999999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-46  Score=360.11  Aligned_cols=269  Identities=28%  Similarity=0.448  Sum_probs=213.5

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ..++|++++.||+|+||.||+|.+....  ...+++.||||++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLL--PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSS--TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcC--CCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            4578999999999999999999986221  124568999999976533 3356789999999999999999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCce
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA----------------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQV  213 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~i  213 (436)
                      +.    .++||||+++|+|.+++....                      ...+++..++.++.||+.||.|||++   +|
T Consensus       123 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~i  195 (343)
T 1luf_A          123 KP----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF  195 (343)
T ss_dssp             SS----CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             Cc----eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            54    499999999999999997642                      15789999999999999999999998   99


Q ss_pred             eeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCC
Q 013790          214 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR  292 (436)
Q Consensus       214 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~  292 (436)
                      +||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|+| |..
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999864221111122334567889999999999999999999999999999999 999


Q ss_pred             CCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          293 SLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       293 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                      ||.+.....   +...+.....          .    ..+...+..+.+||.+||+.||.+|||+.+|+++|+++.+..
T Consensus       276 p~~~~~~~~---~~~~~~~~~~----------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          276 PYYGMAHEE---VIYYVRDGNI----------L----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             TTTTSCHHH---HHHHHHTTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             cCCCCChHH---HHHHHhCCCc----------C----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            998654332   2222211100          0    112233467899999999999999999999999999987543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-46  Score=358.53  Aligned_cols=254  Identities=19%  Similarity=0.270  Sum_probs=207.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|.+.+.||+|+||.||+|...       .++..||+|.+.... .....+.+|+.+++.++||||+++++++...+ 
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-   74 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVET-------SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESME-   74 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-
T ss_pred             hhceEeeeEEecCCCeEEEEEEEC-------CCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC-
Confidence            468999999999999999999875       568899999987553 34567889999999999999999999997654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC--CCceEEee
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE--NFRPKLSD  235 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~D  235 (436)
                         ..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.   ||+||||||+|||++.  ++.+||+|
T Consensus        75 ---~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~D  147 (321)
T 1tki_A           75 ---ELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIE  147 (321)
T ss_dssp             ---EEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             ---EEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEE
Confidence               4599999999999999996543 4699999999999999999999998   9999999999999987  88999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||+++...   .........||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+......
T Consensus       148 fg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~  221 (321)
T 1tki_A          148 FGQARQLK---PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIMNAEYT  221 (321)
T ss_dssp             CTTCEECC---TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHHTCCC
T ss_pred             CCCCeECC---CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HHHHHHcCCCC
Confidence            99997532   2223345679999999999998889999999999999999999999998654332   22222111100


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                      .       ..    ......+..+.+||.+||..||.+|||+.+++++-
T Consensus       222 ~-------~~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          222 F-------DE----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             C-------CH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             C-------Ch----hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence            0       00    00012246788999999999999999999999863

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.5e-46  Score=364.92  Aligned_cols=252  Identities=26%  Similarity=0.379  Sum_probs=206.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++++.||+|+||.||+|...       .+++.||+|++....   ......+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~-------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   86 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKN-------DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD   86 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            468999999999999999999976       567899999986542   2234678899999999999999999999976


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||+.+|+|.+++...  ..+++..+..++.||+.||.|||+.   ||+||||||+||||+.+|.+||+
T Consensus        87 ~~----~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~  157 (384)
T 4fr4_A           87 EE----DMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHIT  157 (384)
T ss_dssp             SS----EEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             CC----EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEe
Confidence            54    459999999999999999764  3699999999999999999999999   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      |||+++...   .........||+.|+|||++.+   ..++.++|||||||++|+|++|..||..........+...+..
T Consensus       158 DFG~a~~~~---~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~  234 (384)
T 4fr4_A          158 DFNIAAMLP---RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET  234 (384)
T ss_dssp             CCTTCEECC---TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH
T ss_pred             ccceeeecc---CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh
Confidence            999997532   2233456789999999999963   4689999999999999999999999986554444333333222


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHHH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-MSQVVER  363 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~eil~~  363 (436)
                      ...               .++...+..+.+||.+||..||.+||+ +.+|+.+
T Consensus       235 ~~~---------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          235 TVV---------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             CCC---------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             ccc---------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence            111               112223467899999999999999998 7777653

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-46  Score=364.57  Aligned_cols=254  Identities=21%  Similarity=0.327  Sum_probs=208.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++++.||+|+||.||+|..+       .+++.||+|++..........+.+|+.+++.++||||+++++++.... 
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-  121 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEK-------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-  121 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-
T ss_pred             ccceEEEEEEecCCCEEEEEEEEC-------CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC-
Confidence            468999999999999999999875       567899999998766556677899999999999999999999987654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc--CCCceEEee
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD--ENFRPKLSD  235 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~D  235 (436)
                         ..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++  .++.+||+|
T Consensus       122 ---~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~D  194 (387)
T 1kob_A          122 ---EMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIID  194 (387)
T ss_dssp             ---EEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECC
T ss_pred             ---EEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEe
Confidence               4699999999999999997543 4689999999999999999999998   999999999999997  457899999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||+++....   ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   ....+......
T Consensus       195 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~i~~~~~~  268 (387)
T 1kob_A          195 FGLATKLNP---DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVKRCDWE  268 (387)
T ss_dssp             CTTCEECCT---TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHHCCCC
T ss_pred             cccceecCC---CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCC
Confidence            999975322   222334579999999999999999999999999999999999999998754322   22222211100


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                             ...    ......+..+.+||.+||..||.+|||+.+++++
T Consensus       269 -------~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          269 -------FDE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             -------CCS----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -------CCc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                   011    1112234678999999999999999999999876

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7.3e-46  Score=363.14  Aligned_cols=264  Identities=26%  Similarity=0.432  Sum_probs=201.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|.+.+.||+|+||.||+|++...    ...+..||||.+.... ....+.+.+|+.++++++||||+++++++...+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLP----SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCT----TSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecC----CCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            35899999999999999999986521    2356789999997653 334567999999999999999999999997654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      .    .++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       120 ~----~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  191 (373)
T 2qol_A          120 P----VMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDF  191 (373)
T ss_dssp             S----CEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             c----eEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcC
Confidence            3    499999999999999997643 4699999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCC-cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 013790          237 GLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||.......   +...+.... 
T Consensus       192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~~i~~~~-  267 (373)
T 2qol_A          192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIKAVDEGY-  267 (373)
T ss_dssp             ----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHHHHHTTE-
T ss_pred             ccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC-
Confidence            99975322111 111122345678999999999999999999999999999998 999997654332   222221110 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                                   ....+..++..+.+||.+||+.||.+||++.+|++.|+.++..
T Consensus       268 -------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          268 -------------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             -------------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -------------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence                         0011223457789999999999999999999999999998754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.9e-46  Score=365.28  Aligned_cols=253  Identities=24%  Similarity=0.391  Sum_probs=203.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhcc-CCCCceeeeeEee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVL-EHPNLVKLIGYCA  153 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  153 (436)
                      .++|++++.||+|+||.||+|+++       .+++.||+|++......   ..+.+.+|..++.++ +||||+++++++.
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~-------~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~  123 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLK-------KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ  123 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence            468999999999999999999976       56889999999765322   234578899999877 8999999999987


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ..+    ..++||||+++|+|..++....  .+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+||
T Consensus       124 ~~~----~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL  194 (396)
T 4dc2_A          124 TES----RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKL  194 (396)
T ss_dssp             CSS----EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             ECC----EEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEE
Confidence            654    4699999999999999997643  699999999999999999999999   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh------hHHHHH
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT------EQRLLE  307 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~------~~~~~~  307 (436)
                      +|||+++...  .........+||+.|+|||++.+..++.++|||||||++|||++|..||.......      ...+..
T Consensus       195 ~DFGla~~~~--~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~  272 (396)
T 4dc2_A          195 TDYGMCKEGL--RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ  272 (396)
T ss_dssp             CCCTTCBCCC--CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH
T ss_pred             eecceeeecc--cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH
Confidence            9999997522  22333456789999999999999999999999999999999999999996432211      111112


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH------HHHHHH
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM------SQVVER  363 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~  363 (436)
                      .+....           .    .++...+..+.+||.+||+.||.+||++      .+|++|
T Consensus       273 ~i~~~~-----------~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          273 VILEKQ-----------I----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             HHHHCC-----------C----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             HHhccc-----------c----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            111111           0    1122234678899999999999999985      677765

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4e-46  Score=356.33  Aligned_cols=279  Identities=24%  Similarity=0.352  Sum_probs=220.9

Q ss_pred             CHHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhcc-CCCCcee
Q 013790           70 SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVL-EHPNLVK  147 (436)
Q Consensus        70 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~  147 (436)
                      ...+.....++|++.+.||+|+||.||+|.+....  ...+++.||||++..... ...+.+.+|+.++..+ +||||++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID--KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS--STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCC--ccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            34444455689999999999999999999875221  235778999999976533 3346788999999999 6999999


Q ss_pred             eeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCce
Q 013790          148 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAF--------------PPLPWKTRLHIILGAAEGLAYLHEGLEVQV  213 (436)
Q Consensus       148 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~ql~~~l~~LH~~~~~~i  213 (436)
                      +++++...+.   ..++||||+++|+|.+++.....              ..+++..++.++.|++.||.|||+.   +|
T Consensus        96 ~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i  169 (316)
T 2xir_A           96 LLGACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KC  169 (316)
T ss_dssp             EEEEECCTTS---CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             EEEEEecCCC---ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence            9999876543   35999999999999999976542              1288999999999999999999998   99


Q ss_pred             eeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCC
Q 013790          214 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRR  292 (436)
Q Consensus       214 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~  292 (436)
                      +||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|+| |..
T Consensus       170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~  249 (316)
T 2xir_A          170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  249 (316)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999986433333333445668889999999999999999999999999999998 999


Q ss_pred             CCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          293 SLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       293 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                      ||........  +...+.....          .    ..+...+..+.++|.+||+.||.+|||+.+|+++|+.+++...
T Consensus       250 p~~~~~~~~~--~~~~~~~~~~----------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          250 PYPGVKIDEE--FCRRLKEGTR----------M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             SSTTCCCSHH--HHHHHHHTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CCcccchhHH--HHHHhccCcc----------C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            9976543321  1111111100          0    1111234678899999999999999999999999999986543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.9e-46  Score=360.25  Aligned_cols=256  Identities=23%  Similarity=0.328  Sum_probs=204.2

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      +.++|++++.||+|+||.||+|...       .+++.||||++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   77 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNR-------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG   77 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhhhceeeeEEecCCCEEEEEEEEC-------CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            3578999999999999999999875       5678999999865432 2235688999999999999999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        78 ~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~D  148 (323)
T 3tki_A           78 N----IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISD  148 (323)
T ss_dssp             S----EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             C----eEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEE
Confidence            4    459999999999999999654  3699999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ||+++...............||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ....+......
T Consensus       149 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~  227 (323)
T 3tki_A          149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTY  227 (323)
T ss_dssp             CTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTTCTT
T ss_pred             eeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhccccc
Confidence            999975322222333345679999999999987765 7789999999999999999999986544321 12222111110


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .              ......+..+.+||.+||..||.+|||+.+++++
T Consensus       228 ~--------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          228 L--------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             S--------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             C--------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            0              0011234678899999999999999999999876

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.8e-45  Score=348.93  Aligned_cols=269  Identities=17%  Similarity=0.194  Sum_probs=213.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  156 (436)
                      .++|++.+.||+|+||.||+|...       .+++.||+|++....  ..+.+.+|+.++..+ +|+||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNL-------LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   79 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEET-------TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             ccceEEEEEEeecCCEEEEEEEEC-------CCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence            468999999999999999999865       568899999986543  234578899999999 7999999999986554


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc-----e
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR-----P  231 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~  231 (436)
                          ..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.     +
T Consensus        80 ----~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~  150 (298)
T 1csn_A           80 ----HNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMI  150 (298)
T ss_dssp             ----EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCE
T ss_pred             ----eeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeE
Confidence                459999999 999999997653 4699999999999999999999998   9999999999999987776     9


Q ss_pred             EEeeccCCCCCCCCCCc-----ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 013790          232 KLSDFGLAREGPMVGHT-----HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  306 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  306 (436)
                      ||+|||+++........     .......||+.|+|||++.+..++.++||||||+++|+|++|..||............
T Consensus       151 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  230 (298)
T 1csn_A          151 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY  230 (298)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred             EEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH
Confidence            99999999753222111     1234567999999999999999999999999999999999999999876544333332


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEG  374 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~~  374 (436)
                      ..+........ .     +    ......+..+.+|+.+||+.||.+|||+.+|++.|++++...+..
T Consensus       231 ~~~~~~~~~~~-~-----~----~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~  288 (298)
T 1csn_A          231 ERIGEKKQSTP-L-----R----ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  288 (298)
T ss_dssp             HHHHHHHHHSC-H-----H----HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHhhccCcc-H-----H----HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence            22211100000 0     0    001123467899999999999999999999999999998765543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.3e-46  Score=376.75  Aligned_cols=260  Identities=26%  Similarity=0.405  Sum_probs=214.7

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..++|.+.+.||+|+||.||+|.++       .++..||||.+.... ...+.+.+|+.++++++||||+++++++...+
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  289 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP  289 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEG-------GGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEc-------CCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            3567999999999999999999986       457899999997653 34578999999999999999999999997655


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      .    .++||||+.+|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+||
T Consensus       290 ~----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DF  362 (495)
T 1opk_A          290 P----FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADF  362 (495)
T ss_dssp             S----CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCT
T ss_pred             c----EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeec
Confidence            4    49999999999999999876656799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |+++..... .........++..|+|||++.+..++.++|||||||++|||+| |..||.+......   ...+...   
T Consensus       363 G~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~---  435 (495)
T 1opk_A          363 GLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEKD---  435 (495)
T ss_dssp             TCEECCTTC-CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHHTT---
T ss_pred             ccceeccCC-ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcC---
Confidence            999853211 1122233456778999999999999999999999999999999 9999987654332   2222111   


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                                 .....+..++..+.+||.+||+.||.+|||+.+|++.|+.+++
T Consensus       436 -----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          436 -----------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                       0011223345788999999999999999999999999998764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.4e-46  Score=361.66  Aligned_cols=251  Identities=25%  Similarity=0.400  Sum_probs=200.9

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhcc-CCCCceeeeeEe
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVL-EHPNLVKLIGYC  152 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  152 (436)
                      ..++|++++.||+|+||.||+|..+       .+++.||||++....   ....+.+.+|..++..+ +||||+++++++
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~   93 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVK-------ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF   93 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEc-------CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence            3579999999999999999999976       567899999997542   22345678899999988 699999999998


Q ss_pred             eecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          153 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      ...+    ..|+||||+.+|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+|
T Consensus        94 ~~~~----~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ik  164 (353)
T 3txo_A           94 QTPD----RLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCK  164 (353)
T ss_dssp             ECSS----EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred             EeCC----EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEE
Confidence            7654    4699999999999999997653  699999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |+|||+++..  ..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...   +...+...
T Consensus       165 L~DFG~a~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i~~~  239 (353)
T 3txo_A          165 LADFGMCKEG--ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAILND  239 (353)
T ss_dssp             ECCCTTCBCS--CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHC
T ss_pred             Eccccceeec--ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---HHHHHHcC
Confidence            9999999752  222333455789999999999999899999999999999999999999998765432   22222111


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH------HHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM------SQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~  363 (436)
                      ..               .++...+..+.+||.+||..||.+||++      .+|++|
T Consensus       240 ~~---------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          240 EV---------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             CC---------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             CC---------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            10               1111234678899999999999999998      778775

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.5e-46  Score=361.59  Aligned_cols=254  Identities=23%  Similarity=0.353  Sum_probs=205.9

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      ..++|++.+.||+|+||.||+|..+       .++..||+|++....  ....+.+.+|+.+++.++||||+++++++..
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   99 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHK-------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE   99 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cccCeEEeeEEecCCCeEEEEEEEC-------CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            4568999999999999999999875       567899999997553  2344678899999999999999999999876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC---Cce
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN---FRP  231 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~  231 (436)
                      .+    ..++||||+.+|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.+   +.+
T Consensus       100 ~~----~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~  170 (362)
T 2bdw_A          100 ES----FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAV  170 (362)
T ss_dssp             SS----EEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCE
T ss_pred             CC----EEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCE
Confidence            54    459999999999999999654  3689999999999999999999999   99999999999999764   459


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      ||+|||++....   .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   +...+..
T Consensus       171 kl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i~~  244 (362)
T 2bdw_A          171 KLADFGLAIEVN---DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQIKA  244 (362)
T ss_dssp             EECCCTTCBCCT---TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH
T ss_pred             EEeecCcceEec---CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHh
Confidence            999999997532   2222345679999999999999899999999999999999999999998654322   2222211


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....           +........+..+.+||.+||..||.+|||+.+++++
T Consensus       245 ~~~~-----------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          245 GAYD-----------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             TCCC-----------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCCC-----------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1100           0000111234678899999999999999999999887

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=9.6e-46  Score=348.38  Aligned_cols=258  Identities=22%  Similarity=0.382  Sum_probs=207.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++++.||+|+||.||+|.+.        ++..||+|++..... ..+.+.+|+.++..++||||+++++++...+.
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR--------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET--------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc--------CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence            468999999999999999999875        567799999976543 34678899999999999999999999876543


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        94 ----~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  165 (283)
T 3gen_A           94 ----IFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFG  165 (283)
T ss_dssp             ----EEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred             ----eEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccc
Confidence                599999999999999997633 3699999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      +++.... ..........+|+.|+|||++.+..++.++||||||+++|+|+| |..||...........   +....   
T Consensus       166 ~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~---~~~~~---  238 (283)
T 3gen_A          166 LSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---IAQGL---  238 (283)
T ss_dssp             GGGGBCC-HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH---HHTTC---
T ss_pred             ccccccc-cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH---Hhccc---
Confidence            9975321 11122233456778999999999999999999999999999998 9999987654322211   11110   


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                             ..    ..+...+..+.+|+.+||+.||.+|||+.+++++|++++..
T Consensus       239 -------~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          239 -------RL----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             -------CC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CC----CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                   00    11112246788999999999999999999999999998754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=8.2e-46  Score=346.03  Aligned_cols=257  Identities=25%  Similarity=0.377  Sum_probs=209.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.+.||+|+||.||+|.+.        ++..||+|++..... ..+.+.+|+.++..++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   77 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK--------GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP   77 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhheeeeeeeccCCCceEEEEEec--------CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence            468999999999999999999875        466799999976543 34678999999999999999999999865543


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        78 ----~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg  149 (268)
T 3sxs_A           78 ----IYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFG  149 (268)
T ss_dssp             ----EEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTT
T ss_pred             ----eEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCc
Confidence                599999999999999997643 3589999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      ++...... .........+|+.|+|||++.+..++.++||||||+++|+|+| |..||.........   ..+.....  
T Consensus       150 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~~~~--  223 (268)
T 3sxs_A          150 MTRYVLDD-QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV---LKVSQGHR--  223 (268)
T ss_dssp             CEEECCTT-CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HHHHTTCC--
T ss_pred             cceecchh-hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH---HHHHcCCC--
Confidence            99753222 2222334456778999999999899999999999999999999 99999866543221   11111100  


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                              .    ..+...+..+.+++.+||+.||.+|||+.+++++|+.+.+
T Consensus       224 --------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          224 --------L----YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             --------C----CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             --------C----CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence                    0    0111124678899999999999999999999999988864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.4e-46  Score=352.92  Aligned_cols=253  Identities=25%  Similarity=0.356  Sum_probs=198.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--------------------------hHHHHH
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--------------------------GHKQWV  131 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~  131 (436)
                      .++|++.+.||+|+||.||+|...       .+++.||||++......                          ..+.+.
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNE-------NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVY   84 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEET-------TTTEEEEEEEEECC-------------------------------CHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEEC-------CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHH
Confidence            468999999999999999999865       56889999998654321                          124688


Q ss_pred             HHHHHHhccCCCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 013790          132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEV  211 (436)
Q Consensus       132 ~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~  211 (436)
                      +|+.+++.++||||+++++++.....  ...++||||+++++|.+++..   ..+++..+..++.||+.||.|||+.   
T Consensus        85 ~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---  156 (298)
T 2zv2_A           85 QEIAILKKLDHPNVVKLVEVLDDPNE--DHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---  156 (298)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEECSSS--SEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHHHHHhCCCCCCCeEEEEEEcCCC--CEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            99999999999999999999876432  356999999999999887633   3699999999999999999999998   


Q ss_pred             ceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCC---CCchhhHHHHHHHHHHHH
Q 013790          212 QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH---LTAKSDVWSFGVVLYEML  288 (436)
Q Consensus       212 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~ell  288 (436)
                      +|+||||||+|||++.++.+||+|||+++....  .........||+.|+|||++.+..   ++.++|||||||++|+|+
T Consensus       157 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~  234 (298)
T 2zv2_A          157 KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV  234 (298)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred             CeeccCCCHHHEEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence            999999999999999999999999999975321  222234567999999999997765   478899999999999999


Q ss_pred             hCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          289 TGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       289 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +|..||.......   +...+......           +  ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       235 ~g~~pf~~~~~~~---~~~~~~~~~~~-----------~--~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          235 FGQCPFMDERIMC---LHSKIKSQALE-----------F--PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             HSSCSSCCSSHHH---HHHHHHHCCCC-----------C--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             HCCCCCCCccHHH---HHHHHhcccCC-----------C--CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            9999998654322   11111111100           0  0011224678899999999999999999999865

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.2e-46  Score=355.64  Aligned_cols=271  Identities=24%  Similarity=0.363  Sum_probs=199.4

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      ..++|++.+.||+|+||.||+|.+....    .....||||++...  .....+.+.+|+.+++.++||||+++++++..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQED----GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-----------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccC----CcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            3568999999999999999999875211    12247999999765  33445779999999999999999999999876


Q ss_pred             cCCcc--eeEEEEEEecCCCCHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC
Q 013790          155 DGERG--IQRLLVYEFMLNRSLEDHLFNRA----FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN  228 (436)
Q Consensus       155 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  228 (436)
                      ....+  ...++||||+.+|+|.+++....    ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED  173 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence            54321  12389999999999999996432    22589999999999999999999999   99999999999999999


Q ss_pred             CceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHH
Q 013790          229 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       229 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~  307 (436)
                      +.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.......   .
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~  250 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY---N  250 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH---H
Confidence            9999999999975432222223334557789999999999999999999999999999999 99999876543322   1


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                      .+.....              ...+...+..+.+|+.+||+.||.+|||+.++++.|++++...
T Consensus       251 ~~~~~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          251 YLIGGNR--------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             HHHTTCC--------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHhcCCC--------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            1111100              0112223467899999999999999999999999999998654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.9e-46  Score=357.04  Aligned_cols=263  Identities=23%  Similarity=0.383  Sum_probs=205.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++++.||+|+||.||+|.+...   +......||+|.+... .....+.+.+|+.+++.++||||+++++++....
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPE---GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCT---TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCC---CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            46899999999999999999997622   2223456788888644 3344578899999999999999999999987543


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                           .++|++|+.+|+|.+++.... ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        91 -----~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~Df  161 (327)
T 3lzb_A           91 -----VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF  161 (327)
T ss_dssp             -----EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCT
T ss_pred             -----ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccC
Confidence                 489999999999999997654 4699999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.   .... 
T Consensus       162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~---~~~~-  237 (327)
T 3lzb_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGER-  237 (327)
T ss_dssp             TC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TTCC-
T ss_pred             cceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---cCCC-
Confidence            99975432222233334556789999999999999999999999999999999 999998765543322221   1100 


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                                   ...+...+..+.+||.+||..||.+|||+.++++.|+.+..
T Consensus       238 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          238 -------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             -------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                         01122234678899999999999999999999999998874

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.4e-45  Score=352.39  Aligned_cols=266  Identities=24%  Similarity=0.350  Sum_probs=201.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|...        +++.||+|++......  ....+.+|+.+++.++||||+++++++...
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   91 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS--------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE   91 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET--------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC--------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence            468999999999999999999864        4788999998754322  246788999999999999999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      .    ..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        92 ~----~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D  162 (311)
T 3niz_A           92 R----CLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLAD  162 (311)
T ss_dssp             S----CEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             C----EEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEcc
Confidence            4    3599999997 58888886644 4699999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ||+++....  .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......+.
T Consensus       163 fg~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  240 (311)
T 3niz_A          163 FGLARAFGI--PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN  240 (311)
T ss_dssp             CTTCEETTS--CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCC
T ss_pred             CcCceecCC--CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCC
Confidence            999975321  1222344578999999999876 5689999999999999999999999987655433222211111111


Q ss_pred             Cccccccc-------------cCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKFGLI-------------MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~-------------~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .. .+...             .............+..+.+||.+||+.||.+|||+.+++++
T Consensus       241 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          241 PR-EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             TT-TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hH-HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            10 00000             00000000111234678899999999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.2e-45  Score=344.88  Aligned_cols=254  Identities=19%  Similarity=0.321  Sum_probs=206.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++.+.||+|+||.||+|.+.         +..||+|++....  ....+.+.+|+.+++.++||||+++++++...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   79 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ---------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP   79 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET---------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC---------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence            468999999999999999999863         6789999997653  23446789999999999999999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc--eeeccCCCCcEEEcCCCceEE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQ--VIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ..  ...++||||+++|+|.+++.......+++..++.++.|++.||.|||+.   +  ++||||||+|||++.++.++|
T Consensus        80 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l  154 (271)
T 3kmu_A           80 PA--PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARI  154 (271)
T ss_dssp             TS--SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEE
T ss_pred             CC--CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeE
Confidence            32  2459999999999999999876655799999999999999999999998   7  999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTA---KSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      +|||++...       ......||+.|+|||++.+..++.   ++||||||+++|+|++|..||...........   ..
T Consensus       155 ~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~  224 (271)
T 3kmu_A          155 SMADVKFSF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK---VA  224 (271)
T ss_dssp             EGGGSCCTT-------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH---HH
T ss_pred             Eeccceeee-------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH---HH
Confidence            999987531       123356899999999998765444   89999999999999999999986554322111   11


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                      ...         ..+    ..+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       225 ~~~---------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          225 LEG---------LRP----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HSC---------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             hcC---------CCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            110         011    112233467899999999999999999999999999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.6e-45  Score=346.70  Aligned_cols=262  Identities=24%  Similarity=0.341  Sum_probs=201.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++.+.||+|+||.||+|.+...    ...+..||+|.+.... ....+.+.+|+.+++.++||||+++++++... 
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-   88 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSP----ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-   88 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecC----CCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccC-
Confidence            46899999999999999999987621    2346789999987643 33456789999999999999999999997432 


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        89 ----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  160 (281)
T 1mp8_A           89 ----PVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF  160 (281)
T ss_dssp             ----SCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             ----ccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcc
Confidence                2489999999999999997653 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |+++..... .........+++.|+|||++.+..++.++||||||+++|+|++ |..||.+......   ...+..... 
T Consensus       161 g~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i~~~~~-  235 (281)
T 1mp8_A          161 GLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENGER-  235 (281)
T ss_dssp             -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTTCC-
T ss_pred             ccccccCcc-cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHHHcCCC-
Confidence            999753211 1112233456788999999999999999999999999999997 9999987654332   222211100 


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                               .    ..+...+..+.+++.+||+.||.+|||+.++++.|+.++..
T Consensus       236 ---------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          236 ---------L----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             ---------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                     0    11223347789999999999999999999999999998753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-45  Score=365.18  Aligned_cols=258  Identities=21%  Similarity=0.257  Sum_probs=196.1

Q ss_pred             hcCCccc-ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHh-ccCCCCceeeeeEeeec
Q 013790           78 TNDFSRM-LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG-VLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~  155 (436)
                      .++|.+. +.||+|+||.||+|.++       .+++.||||++...     ..+.+|+.++. ..+||||+++++++...
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~-------~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~  127 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNK-------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL  127 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEEC-------CCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence            4678776 68999999999999975       56789999998633     35677888874 45899999999998653


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC---CCceE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPK  232 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~k  232 (436)
                      ......+|+||||+.+|+|.+++.......+++..+..|+.||+.||.|||+.   +|+||||||+||||+.   ++.+|
T Consensus       128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~k  204 (400)
T 1nxk_A          128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILK  204 (400)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEE
T ss_pred             ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEE
Confidence            33334679999999999999999876556799999999999999999999998   9999999999999987   78999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHHHhh
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQ  311 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~~~  311 (436)
                      |+|||+++...   .........||+.|+|||++.+..++.++|||||||++|+|++|..||........ ......+..
T Consensus       205 l~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~  281 (400)
T 1nxk_A          205 LTDFGFAKETT---SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM  281 (400)
T ss_dssp             ECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH
T ss_pred             EEecccccccC---CCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc
Confidence            99999997532   22233456789999999999999999999999999999999999999976543221 001111111


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                      ...           .+........+..+.+||.+||..||.+|||+.+|+++-
T Consensus       282 ~~~-----------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          282 GQY-----------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             TCC-----------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             Ccc-----------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            000           000011122346789999999999999999999999874

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.6e-46  Score=358.64  Aligned_cols=263  Identities=25%  Similarity=0.370  Sum_probs=206.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++++.||+|+||.||+|.+...   +......||+|.+.... ......+.+|+.+++.++||||+++++++... 
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-   87 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPE---GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS-   87 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCT---TCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBS-
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCC---CceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-
Confidence            35899999999999999999997621   22234568899875442 22335677899999999999999999988532 


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        88 ----~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Df  159 (325)
T 3kex_A           88 ----SLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADF  159 (325)
T ss_dssp             ----SEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSC
T ss_pred             ----ccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCC
Confidence                3589999999999999997653 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |+++...............||..|+|||++.+..++.++|||||||++|+|+| |..||.+.........+.   .....
T Consensus       160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~~~  236 (325)
T 3kex_A          160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE---KGERL  236 (325)
T ss_dssp             SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH---TTCBC
T ss_pred             CcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH---cCCCC
Confidence            99986443333333455678889999999999999999999999999999999 999998765443322221   11000


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                                    ..+...+..+.+||.+||..||.+|||+.+++++|+.+..
T Consensus       237 --------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          237 --------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             --------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             --------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                          0011122456799999999999999999999999998864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=350.92  Aligned_cols=273  Identities=27%  Similarity=0.360  Sum_probs=205.9

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-----hhHHHHHHHHHHHhccC---CCCceee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QGHKQWVAEVQFLGVLE---HPNLVKL  148 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---hpnIv~~  148 (436)
                      ..++|++.+.||+|+||.||+|...       .+++.||||++.....     .....+.+|+.+++.+.   ||||+++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~   79 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDP-------HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL   79 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECT-------TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCE
T ss_pred             cccceEEEEEEecCCCeEEEEEEEC-------CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEe
Confidence            4679999999999999999999854       5688999999864321     12345667777777664   9999999


Q ss_pred             eeEeeecCC-cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          149 IGYCAVDGE-RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       149 ~~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      ++++..... .....++||||+. ++|.+++.......+++..+..++.||+.||.|||++   +|+||||||+|||++.
T Consensus        80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~  155 (308)
T 3g33_A           80 MDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTS  155 (308)
T ss_dssp             EEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECT
T ss_pred             eeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcC
Confidence            999876543 2335689999996 6999999877656699999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHH-H
Q 013790          228 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL-L  306 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~  306 (436)
                      ++.+||+|||+++...   .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+......... .
T Consensus       156 ~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  232 (308)
T 3g33_A          156 GGTVKLADFGLARIYS---YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF  232 (308)
T ss_dssp             TSCEEECSCSCTTTST---TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH
T ss_pred             CCCEEEeeCccccccC---CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999997532   22233456789999999999999999999999999999999999999987654433222 2


Q ss_pred             HHHhhcccCccccc-----cccCCccc---CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          307 EWVQQYPADSKKFG-----LIMDPRLE---KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       307 ~~~~~~~~~~~~~~-----~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ......+.......     ..+.+...   .......+..+.+||.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            21111111110000     00000000   00111234678899999999999999999999876

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5e-46  Score=355.45  Aligned_cols=265  Identities=24%  Similarity=0.367  Sum_probs=204.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++.+.||+|+||.||+|.+.       .+++.||||++.....   .....+.+|+.+++.++||||+++++++..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   83 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDL-------RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA   83 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEEC-------CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence            468999999999999999999965       5688999999976532   234578899999999999999999999987


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      ....+...++||||+++++|.+++....  .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~  158 (311)
T 3ork_A           84 ETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVM  158 (311)
T ss_dssp             EETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEEC
T ss_pred             cCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEe
Confidence            7665556799999999999999997643  699999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCC-cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          235 DFGLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       235 Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |||+++....... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+......  .........
T Consensus       159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~~~  236 (311)
T 3ork_A          159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVREDP  236 (311)
T ss_dssp             CCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHCCC
T ss_pred             eccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhcCCC
Confidence            9999975322211 1223345689999999999999999999999999999999999999987554322  111111111


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH-HHHHhh
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE-RLKQIV  368 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~-~L~~~~  368 (436)
                      ....            ......+..+.+||.+||+.||.+||++.+++. .+..+.
T Consensus       237 ~~~~------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          237 IPPS------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             CCHH------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCcc------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            1000            001123467889999999999999997766554 454443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.6e-45  Score=344.60  Aligned_cols=254  Identities=29%  Similarity=0.478  Sum_probs=195.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc----hhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      .++|++.+.||+|+||.||+|.+.         +..||||++.....    ...+.+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   76 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI---------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL   76 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET---------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc---------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            468999999999999999999863         67899999875432    22467889999999999999999999997


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC------
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE------  227 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~------  227 (436)
                      ..+.    .++||||+.+++|.+++..   ..+++..++.++.|++.||.|||++...+|+||||||+|||++.      
T Consensus        77 ~~~~----~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~  149 (271)
T 3dtc_A           77 KEPN----LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD  149 (271)
T ss_dssp             CC------CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred             cCCc----eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccc
Confidence            6553    4999999999999999854   36999999999999999999999981112999999999999986      


Q ss_pred             --CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 013790          228 --NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL  305 (436)
Q Consensus       228 --~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  305 (436)
                        ++.+||+|||++.....    .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+........ 
T Consensus       150 ~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-  224 (271)
T 3dtc_A          150 LSNKILKITDFGLAREWHR----TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY-  224 (271)
T ss_dssp             CSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-
T ss_pred             ccCcceEEccCCccccccc----ccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence              78899999999974321    12234578999999999999999999999999999999999999998754332211 


Q ss_pred             HHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          306 LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                        .....             ......+...+..+.++|.+||+.||.+|||+.+++++|+.+
T Consensus       225 --~~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          225 --GVAMN-------------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             --HHHTS-------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             --hhhcC-------------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence              11110             011112223346799999999999999999999999999754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9e-46  Score=358.25  Aligned_cols=253  Identities=24%  Similarity=0.394  Sum_probs=205.2

Q ss_pred             HHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhcc-CCCCceeeee
Q 013790           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVL-EHPNLVKLIG  150 (436)
Q Consensus        75 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~  150 (436)
                      ....++|.+.+.||+|+||.||+|.++       .+++.||||++....   ....+.+..|..++..+ +||||+++++
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~   85 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFK-------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFC   85 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEE
Confidence            345679999999999999999999976       568899999997542   22345677899999877 8999999999


Q ss_pred             EeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc
Q 013790          151 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  230 (436)
Q Consensus       151 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  230 (436)
                      ++....    ..|+||||+++|+|.+++....  .+++..+..++.||+.||.|||++   ||+||||||+||||+.+|.
T Consensus        86 ~~~~~~----~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~  156 (345)
T 1xjd_A           86 TFQTKE----NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGH  156 (345)
T ss_dssp             EEECSS----EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred             EEEeCC----EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCC
Confidence            987654    4699999999999999997643  689999999999999999999998   9999999999999999999


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      +||+|||+++....  .........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...   +...+.
T Consensus       157 vkL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~  231 (345)
T 1xjd_A          157 IKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIR  231 (345)
T ss_dssp             EEECCCTTCBCCCC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred             EEEeEChhhhhccc--CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH
Confidence            99999999975321  2223455789999999999999999999999999999999999999998654432   222221


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHH-HHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS-QVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~~  363 (436)
                      ...           ..+    +...+..+.+||.+||..||.+||++. +|++|
T Consensus       232 ~~~-----------~~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          232 MDN-----------PFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             HCC-----------CCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             hCC-----------CCC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence            110           111    112346788999999999999999997 77654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.9e-45  Score=346.35  Aligned_cols=261  Identities=29%  Similarity=0.505  Sum_probs=197.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++.+.||+|+||.||+|.+.          ..||+|++....  ....+.+.+|+.+++.++||||+++++++...
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~----------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH----------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP   92 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS----------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc----------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC
Confidence            468999999999999999999853          249999987543  33456789999999999999999999976432


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                           ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        93 -----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~D  163 (289)
T 3og7_A           93 -----QLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGD  163 (289)
T ss_dssp             -----SCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECC
T ss_pred             -----ccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEcc
Confidence                 2489999999999999996543 4699999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      ||+++...............||+.|+|||++.   +..++.++||||||+++|+|++|..||........  +...+...
T Consensus       164 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~  241 (289)
T 3og7_A          164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRG  241 (289)
T ss_dssp             CC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHHT
T ss_pred             ceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhccc
Confidence            99997533222233334567999999999986   66788999999999999999999999987544322  22222221


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                      ...         +.+ ......++..+.+||.+||+.||.+|||+.++++.|+++.+
T Consensus       242 ~~~---------~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          242 SLS---------PDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             SCC---------CCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ccC---------cch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            110         000 01122335789999999999999999999999999998753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.6e-46  Score=360.64  Aligned_cols=255  Identities=24%  Similarity=0.334  Sum_probs=203.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-----hhHHHHHHHHHHHhccCCCCceeeeeEe
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-----QGHKQWVAEVQFLGVLEHPNLVKLIGYC  152 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~  152 (436)
                      .++|++.+.||+|+||.||+|..+       .+++.||||++.....     ...+.+.+|+.+++.++||||+++++++
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   95 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINR-------ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY   95 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            457999999999999999999875       5678999999864321     2356789999999999999999999999


Q ss_pred             eecCCcceeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc
Q 013790          153 AVDGERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  230 (436)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  230 (436)
                      ...+    ..++||||+++++|.+++...  ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus        96 ~~~~----~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~  168 (351)
T 3c0i_A           96 SSDG----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKEN  168 (351)
T ss_dssp             EETT----EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSST
T ss_pred             EeCC----EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCC
Confidence            7654    459999999999999888643  234589999999999999999999998   9999999999999986655


Q ss_pred             ---eEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 013790          231 ---PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       231 ---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  307 (436)
                         +||+|||+++....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+...    .+..
T Consensus       169 ~~~vkl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~  242 (351)
T 3c0i_A          169 SAPVKLGGFGVAIQLGE--SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE  242 (351)
T ss_dssp             TCCEEECCCTTCEECCT--TSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH
T ss_pred             CCcEEEecCcceeEecC--CCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH
Confidence               99999999975322  22223456799999999999999999999999999999999999999986422    1222


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .+......       ..+.    .....+..+.+||.+||..||.+|||+.+++++
T Consensus       243 ~i~~~~~~-------~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          243 GIIKGKYK-------MNPR----QWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HHHHTCCC-------CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHcCCCC-------CCcc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11111000       0000    001124678899999999999999999999976

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.1e-45  Score=350.05  Aligned_cols=272  Identities=22%  Similarity=0.365  Sum_probs=205.4

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      ...++|.+.+.||+|+||.||+|.+..    ...++..||+|.+....  ....+.+.+|+.+++.++||||+++++++.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQ----EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEEC----TTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEec----cCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            345789999999999999999998762    22357789999987553  233467899999999999999999999987


Q ss_pred             ecCCcc-eeEEEEEEecCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC
Q 013790          154 VDGERG-IQRLLVYEFMLNRSLEDHLFNR----AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN  228 (436)
Q Consensus       154 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  228 (436)
                      .....+ ...++||||+++|+|.+++...    ....+++..++.++.||+.||.|||++   +|+||||||+|||++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence            654322 2458999999999999998532    235799999999999999999999998   99999999999999999


Q ss_pred             CceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHH
Q 013790          229 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       229 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~  307 (436)
                      +.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||..........   
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~---  260 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD---  260 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH---
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH---
Confidence            9999999999975332222223334567889999999999999999999999999999999 899998765433221   


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                      .+....          ..    ..+...+..+.+||.+||..||.+|||+.+++++|+++++..
T Consensus       261 ~~~~~~----------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          261 YLLHGH----------RL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             HHHTTC----------CC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHcCC----------CC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            111110          00    111223467899999999999999999999999999998654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.5e-46  Score=372.96  Aligned_cols=260  Identities=25%  Similarity=0.397  Sum_probs=211.1

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ...++|.+.+.||+|+||.||+|.+.        .+..||||++.... ...+.+.+|+.+++.++||||+++++++...
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~  255 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN--------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKE  255 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET--------TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC--------CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCC
Confidence            34578999999999999999999875        46789999997654 3467899999999999999999999998632


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                           ..++||||+.+|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|
T Consensus       256 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D  327 (454)
T 1qcf_A          256 -----PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIAD  327 (454)
T ss_dssp             -----SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECS
T ss_pred             -----ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEee
Confidence                 249999999999999999765434689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ||+++.... ..........++..|+|||++.+..++.++|||||||++|||+| |..||.+.....   +...+.....
T Consensus       328 FG~a~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~~~~  403 (454)
T 1qcf_A          328 FGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALERGYR  403 (454)
T ss_dssp             TTGGGGBCC-HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHHTCC
T ss_pred             CCCceEcCC-CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCC
Confidence            999975321 11111223446778999999999999999999999999999999 999998765432   2222221100


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                                    ...+..++..+.+||.+||..||.+|||+.+|++.|+.+...
T Consensus       404 --------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          404 --------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             --------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                          011223457899999999999999999999999999988653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.2e-45  Score=346.71  Aligned_cols=261  Identities=26%  Similarity=0.399  Sum_probs=216.6

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..++|++.+.||+|+||.||+|.+.       .++..||+|.+.... ...+.+.+|+.+++.++||||+++++++...+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   82 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEG-------GGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cccceeEEeecCCCCceeEEEeEec-------CCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            4578999999999999999999976       568899999997553 34577899999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      .    .++||||+.+++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        83 ~----~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Df  155 (288)
T 3kfa_A           83 P----FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADF  155 (288)
T ss_dssp             S----EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             C----EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccC
Confidence            3    59999999999999999876666799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |++...... .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........   +....  
T Consensus       156 g~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~---~~~~~--  229 (288)
T 3kfa_A          156 GLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKDY--  229 (288)
T ss_dssp             CGGGTSCSS-SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---HHTTC--
T ss_pred             ccceeccCC-ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HhccC--
Confidence            999753221 2223334567889999999999999999999999999999999 9999987654432222   11110  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                              .    ...+...+..+.+|+.+||..||.+|||+.++++.|+.+++.
T Consensus       230 --------~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          230 --------R----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             --------C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------C----CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence                    0    011222346789999999999999999999999999998754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.2e-45  Score=355.85  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=203.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhcc-CCCCceeeeeEee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVL-EHPNLVKLIGYCA  153 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  153 (436)
                      .++|++++.||+|+||.||+|.++       .+++.||+|++.....   ...+.+.+|..++..+ +||||+++++++.
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   80 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLK-------KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ   80 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEEC-------CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence            468999999999999999999976       5688999999976532   2345678899999887 8999999999987


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ..+    ..++||||+++|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+||
T Consensus        81 ~~~----~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL  151 (345)
T 3a8x_A           81 TES----RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKL  151 (345)
T ss_dssp             CSS----EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             eCC----EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEE
Confidence            654    4699999999999999997643  699999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch------hhHHHHH
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK------TEQRLLE  307 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~------~~~~~~~  307 (436)
                      +|||+++...  ..........||+.|+|||++.+..++.++|||||||++|||++|..||......      ....+..
T Consensus       152 ~DFG~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  229 (345)
T 3a8x_A          152 TDYGMCKEGL--RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ  229 (345)
T ss_dssp             CCGGGCBCSC--CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH
T ss_pred             Eecccccccc--CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH
Confidence            9999997522  1222345568999999999999999999999999999999999999999753211      1111111


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH------HHHHHH
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM------SQVVER  363 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~  363 (436)
                      .+....           .    .++...+..+.+||.+||..||.+||++      .++++|
T Consensus       230 ~i~~~~-----------~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          230 VILEKQ-----------I----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             HHHHCC-----------C----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             HHHcCC-----------C----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            111110           0    1122234678899999999999999995      677665

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.8e-46  Score=350.37  Aligned_cols=260  Identities=23%  Similarity=0.378  Sum_probs=205.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|.+.+.||+|+||.||+|.+..........+..||+|++........+.+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            46899999999999999999987622111112246799999987766667889999999999999999999999987554


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc-------
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR-------  230 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------  230 (436)
                      .    ++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.       
T Consensus        87 ~----~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           87 N----ILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             C----EEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             C----EEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence            3    89999999999999997653 3489999999999999999999999   9999999999999998887       


Q ss_pred             -eEEeeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCC-CCCCCCCchhhHHHHH
Q 013790          231 -PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGR-RSLERNRPKTEQRLLE  307 (436)
Q Consensus       231 -~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~-~pf~~~~~~~~~~~~~  307 (436)
                       +||+|||++....      ......||+.|+|||++.+ ..++.++||||||+++|+|++|. +||........   ..
T Consensus       159 ~~kl~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~---~~  229 (289)
T 4fvq_A          159 FIKLSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK---LQ  229 (289)
T ss_dssp             EEEECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HH
T ss_pred             eeeeccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH---HH
Confidence             9999999986421      1233458899999999987 67899999999999999999955 45544332221   11


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      .......            +...    .+..+.+|+.+||+.||.+|||+.+++++|+.++..
T Consensus       230 ~~~~~~~------------~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          230 FYEDRHQ------------LPAP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HHHTTCC------------CCCC----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             HhhccCC------------CCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            1111110            0011    124577999999999999999999999999998753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-45  Score=350.59  Aligned_cols=247  Identities=25%  Similarity=0.406  Sum_probs=204.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++++.||+|+||.||+|..+       .+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~   77 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSR-------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD   77 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence            468999999999999999999875       5688999999975422   234668889999999999999999999876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      ..    ..++||||+++|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+
T Consensus        78 ~~----~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~  148 (318)
T 1fot_A           78 AQ----QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKIT  148 (318)
T ss_dssp             SS----EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             CC----EEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEe
Confidence            54    4699999999999999997653  689999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||+++...     .......||+.|+|||++.+..++.++|||||||++|+|++|..||........   ...+.... 
T Consensus       149 Dfg~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~-  219 (318)
T 1fot_A          149 DFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---YEKILNAE-  219 (318)
T ss_dssp             CCSSCEECS-----SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHHCC-
T ss_pred             ecCcceecC-----CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHHhCC-
Confidence            999997532     123456799999999999999999999999999999999999999976543322   11111110 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                                ..    ++...+..+.+||.+||..||.+||     ++.+|++|
T Consensus       220 ----------~~----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          220 ----------LR----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             ----------CC----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----------CC----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                      01    1112346788999999999999999     88999876

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3e-45  Score=346.74  Aligned_cols=266  Identities=23%  Similarity=0.320  Sum_probs=201.0

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|++++.||+|+||.||+|...       .+++.||+|++.....  .....+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   74 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNR-------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK   74 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCceeeeEecCCCCeEEEEEEEC-------CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence            57999999999999999999975       5678999999875432  23467889999999999999999999997654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||++   ||+||||||+|||++.++.+||+||
T Consensus        75 ----~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Df  145 (292)
T 3o0g_A           75 ----KLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANF  145 (292)
T ss_dssp             ----EEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             ----EEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence                45999999965 6666665433 4699999999999999999999999   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh--cc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ--YP  313 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~--~~  313 (436)
                      |+++...  ..........||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ .+......  .+
T Consensus       146 g~~~~~~--~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~  222 (292)
T 3o0g_A          146 GLARAFG--IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTP  222 (292)
T ss_dssp             TTCEECC--SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             ccceecC--CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCC
Confidence            9997532  1222334567899999999997765 79999999999999999998888644333221 11111111  11


Q ss_pred             cCcc--cccccc---------CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSK--KFGLIM---------DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~--~~~~~~---------~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....  ......         ............+..+.+||.+||+.||.+|||+.+++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            1000  000000         0000011122345778899999999999999999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.9e-45  Score=352.39  Aligned_cols=269  Identities=25%  Similarity=0.374  Sum_probs=191.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++++.||+|+||.||+|..+       .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   76 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNK-------TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN   76 (317)
T ss_dssp             ---------------CEEEEEECS-------SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT
T ss_pred             ccceeEeeEECCCCCEEEEEEEEC-------CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC
Confidence            468999999999999999999865       5688999999875432 23467889999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRA----FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                          ..++||||+. |+|.+++....    ...+++..+..++.||+.||.|||+.   ||+||||||+|||++.++.+|
T Consensus        77 ----~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~k  148 (317)
T 2pmi_A           77 ----KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLK  148 (317)
T ss_dssp             ----EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred             ----eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEE
Confidence                4599999997 69999986432    24589999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      |+|||+++....  .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus       149 l~Dfg~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  226 (317)
T 2pmi_A          149 LGDFGLARAFGI--PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMG  226 (317)
T ss_dssp             ECCCSSCEETTS--CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ECcCccceecCC--CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999999975321  1122334578999999999976 4689999999999999999999999987655433222211111


Q ss_pred             cccCc-c-ccccc--cCCcc------------cCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 YPADS-K-KFGLI--MDPRL------------EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 ~~~~~-~-~~~~~--~~~~l------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .+... . .....  ..+.+            ........+..+.+||.+||+.||.+|||+.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             SCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            11100 0 00000  00000            000111234678999999999999999999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.4e-45  Score=346.79  Aligned_cols=266  Identities=24%  Similarity=0.339  Sum_probs=198.8

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|++++.||+|+||.||+|...        +++.||+|++......  ....+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN--------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK   73 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET--------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS
T ss_pred             ccchhhhhcccCCCEEEEEEEcC--------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC
Confidence            57999999999999999999863        5778999998655322  2467889999999999999999999997654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        74 ----~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  144 (288)
T 1ob3_A           74 ----RLVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADF  144 (288)
T ss_dssp             ----CEEEEEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCT
T ss_pred             ----eEEEEEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeEC
Confidence                35999999965 9999987643 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHH-HHHHhhccc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL-LEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~~~  314 (436)
                      |+++....  .........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+......... .........
T Consensus       145 g~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  222 (288)
T 1ob3_A          145 GLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS  222 (288)
T ss_dssp             THHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             ccccccCc--cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCCh
Confidence            99864211  11223345689999999999764 589999999999999999999999987654332211 111111100


Q ss_pred             Cc-ccccc--ccCCccc-------CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DS-KKFGL--IMDPRLE-------KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~-~~~~~--~~~~~l~-------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .. .....  ..++.+.       .......+..+.+||.+||+.||.+|||+.+++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00 00000  0000000       01112235678899999999999999999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.1e-46  Score=358.13  Aligned_cols=248  Identities=24%  Similarity=0.357  Sum_probs=203.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|.+.+.||+|+||.||+|.+.       .+++.||+|++.....   .....+.+|+.+++.++||||+++++++..
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~   80 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHY-------KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT   80 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             cCCEEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            468999999999999999999975       5678999999865422   223578899999999999999999999976


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||+ +|+|.+++....  .+++..+..++.|++.||.|||+.   ||+||||||+|||++.++.+||+
T Consensus        81 ~~----~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~  150 (336)
T 3h4j_B           81 PT----DIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIA  150 (336)
T ss_dssp             SS----EEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEEC
T ss_pred             CC----EEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEE
Confidence            54    459999999 789999987653  699999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |||++....   .........||+.|+|||++.+..+ +.++|||||||++|+|++|..||........           
T Consensus       151 DFG~s~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----------  216 (336)
T 3h4j_B          151 DFGLSNIMT---DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----------  216 (336)
T ss_dssp             CSSCTBTTT---TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------
T ss_pred             Eeccceecc---CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------
Confidence            999997532   2233345679999999999988776 6899999999999999999999976432210           


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                           +..+....  ...+...+..+.+||.+||..||.+|||+.+++++
T Consensus       217 -----~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          217 -----FKKVNSCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             -----BCCCCSSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             -----HHHHHcCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                 00000000  01222335678899999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.3e-45  Score=344.46  Aligned_cols=262  Identities=25%  Similarity=0.354  Sum_probs=209.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|.+.+.||+|+||.||+|.+...    ..++..||+|.+... .....+.+.+|+.+++.++||||+++++++....
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   86 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNH----KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECT----TCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSS
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCC----CCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC
Confidence            46899999999999999999987622    235678999999765 3344577899999999999999999999976432


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                           .++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        87 -----~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  157 (281)
T 3cc6_A           87 -----TWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDF  157 (281)
T ss_dssp             -----CEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCC
T ss_pred             -----CEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCcc
Confidence                 389999999999999997643 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |++...... .........+++.|+|||++.+..++.++||||||+++|+|+| |..||.............   .... 
T Consensus       158 g~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~---~~~~-  232 (281)
T 3cc6_A          158 GLSRYIEDE-DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE---KGDR-  232 (281)
T ss_dssp             CGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH---HTCC-
T ss_pred             CCCcccccc-cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh---cCCC-
Confidence            999753221 1112234457889999999999999999999999999999998 999997655443222211   1100 


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                               .    ..+...+..+.+||.+||..||.+|||+.+++++|+.+.+.
T Consensus       233 ---------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          233 ---------L----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             ---------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------C----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence                     0    01112346788999999999999999999999999998753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=357.68  Aligned_cols=253  Identities=23%  Similarity=0.338  Sum_probs=190.7

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..++|.+.+.||+|+||.||+|.+.       .+++.||||++....  ..+.+.+|+.+++.++||||+++++++....
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  121 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQK-------GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT  121 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEEC-------CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence            4568999999999999999999976       467889999997553  3456888999999999999999999997654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC---CCceEE
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPKL  233 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl  233 (436)
                          ..++||||+++|+|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.   ++.+||
T Consensus       122 ----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl  192 (349)
T 2w4o_A          122 ----EISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKI  192 (349)
T ss_dssp             ----EEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEE
T ss_pred             ----eEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEE
Confidence                459999999999999999654  3689999999999999999999998   9999999999999975   899999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +|||+++...   .........||+.|+|||++.+..++.++|||||||++|+|++|..||........  ....+....
T Consensus       193 ~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~i~~~~  267 (349)
T 2w4o_A          193 ADFGLSKIVE---HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFRRILNCE  267 (349)
T ss_dssp             CCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHHHHHTTC
T ss_pred             ccCccccccC---cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHHHHHhCC
Confidence            9999997532   22233456799999999999999999999999999999999999999976543321  111111110


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .           ..........+..+.+||.+||..||.+|||+.+++++
T Consensus       268 ~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          268 Y-----------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             C-----------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             C-----------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0           00001112234678899999999999999999999876

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1e-45  Score=356.52  Aligned_cols=267  Identities=25%  Similarity=0.377  Sum_probs=212.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|.+.+.||+|+||.||+|.+....  .......||+|.+..... ...+.+.+|+.+++.+ +||||+++++++...
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLG--KEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCS--SSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCC--cccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            468999999999999999999976322  123446899999976532 3456789999999999 899999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  223 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NI  223 (436)
                      +.    .++||||+++|+|.+++....            ...+++..++.++.|++.||.|||+.   +|+||||||+||
T Consensus       123 ~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI  195 (333)
T 2i1m_A          123 GP----VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNV  195 (333)
T ss_dssp             SS----CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGC
T ss_pred             Cc----eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceE
Confidence            54    499999999999999996531            24689999999999999999999998   999999999999


Q ss_pred             EEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 013790          224 LLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTE  302 (436)
Q Consensus       224 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~  302 (436)
                      |++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|+| |..||.+......
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence            999999999999999975322222223334567889999999999999999999999999999999 9999986544322


Q ss_pred             HHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          303 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                        ....+.....          .    ..+...+..+.+||.+||+.||.+|||+.+|+++|+.+.+
T Consensus       276 --~~~~~~~~~~----------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          276 --FYKLVKDGYQ----------M----AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             --HHHHHHHTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHhcCCC----------C----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence              1111111100          0    1111224678899999999999999999999999998865

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.4e-46  Score=361.44  Aligned_cols=277  Identities=22%  Similarity=0.285  Sum_probs=211.9

Q ss_pred             CcccCHHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC----
Q 013790           66 LRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE----  141 (436)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~----  141 (436)
                      ...+++.+.....++|.+++.||+|+||.||+|.+.       .+++.||||++.... .....+..|+.+++.+.    
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~   93 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHI-------DNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDI   93 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCST
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEEC-------CCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCC
Confidence            344555555566789999999999999999999975       467899999997532 33456778999999886    


Q ss_pred             -CCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCC
Q 013790          142 -HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKA  220 (436)
Q Consensus       142 -hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp  220 (436)
                       ||||+++++++...+    ..++||||+ +++|.+++.......+++..+..++.||+.||.|||+.   +|+||||||
T Consensus        94 ~h~~iv~~~~~~~~~~----~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp  165 (360)
T 3llt_A           94 NNNNIVKYHGKFMYYD----HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKP  165 (360)
T ss_dssp             TGGGBCCEEEEEEETT----EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             CCCCeecccceeeECC----eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCc
Confidence             999999999997754    459999999 99999999887666799999999999999999999998   999999999


Q ss_pred             CcEEEcC-------------------------CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchh
Q 013790          221 SNVLLDE-------------------------NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKS  275 (436)
Q Consensus       221 ~NIll~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  275 (436)
                      +||||+.                         ++.+||+|||+++...     .......||+.|+|||++.+..++.++
T Consensus       166 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~  240 (360)
T 3llt_A          166 ENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS-----DYHGSIINTRQYRAPEVILNLGWDVSS  240 (360)
T ss_dssp             GGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT-----SCCCSCCSCGGGCCHHHHTTCCCCTTH
T ss_pred             ccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecC-----CCCcCccCcccccCcHHHcCCCCCCcc
Confidence            9999975                         8899999999997522     122346789999999999999999999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh-cccCc-------cccccccCCc----ccCcC------------
Q 013790          276 DVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ-YPADS-------KKFGLIMDPR----LEKEY------------  331 (436)
Q Consensus       276 DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~-------~~~~~~~~~~----l~~~~------------  331 (436)
                      |||||||++|+|++|..||...........+..... .+...       ..........    +....            
T Consensus       241 DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  320 (360)
T 3llt_A          241 DMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC  320 (360)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTC
T ss_pred             chHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhc
Confidence            999999999999999999987654433222221111 10000       0000000000    00000            


Q ss_pred             ----CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          332 ----SINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       332 ----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                          .......+.+||.+||+.||.+|||+.+++++
T Consensus       321 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             CCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                00112568899999999999999999999865

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.2e-45  Score=347.24  Aligned_cols=259  Identities=29%  Similarity=0.435  Sum_probs=202.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.+.||+|+||.||+|.+.         ++.||+|.+...  ...+.+.+|+.++++++||||+++++++...  
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--   73 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR---------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNP--   73 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET---------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC---------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--
Confidence            357999999999999999999864         577999998654  3456789999999999999999999988632  


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc-eEEee
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAF-PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR-PKLSD  235 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~D  235 (436)
                          .++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+..+|+||||||+|||++.++. +||+|
T Consensus        74 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~D  149 (307)
T 2eva_A           74 ----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD  149 (307)
T ss_dssp             ----TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECC
T ss_pred             ----cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcc
Confidence                3899999999999999976542 24788999999999999999999932229999999999999998886 79999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||++....     .......||+.|+|||++.+..++.++||||||+++|+|++|..||......... .........  
T Consensus       150 fg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~--  221 (307)
T 2eva_A          150 FGTACDIQ-----THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAVHNGT--  221 (307)
T ss_dssp             CCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHHHHHTTC--
T ss_pred             cccccccc-----cccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHHHHhcCC--
Confidence            99986421     1123346899999999999999999999999999999999999999764432211 111111100  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcCC
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE  373 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~  373 (436)
                              .+.+    ....+..+.+||.+||+.||.+|||+.++++.|+.+.+....
T Consensus       222 --------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          222 --------RPPL----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             --------CCCC----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             --------CCCc----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence                    0111    112346788999999999999999999999999998765543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.4e-45  Score=353.92  Aligned_cols=251  Identities=25%  Similarity=0.388  Sum_probs=205.2

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhcc-CCCCceeeeeEe
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVL-EHPNLVKLIGYC  152 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  152 (436)
                      ..++|++++.||+|+||.||+|..+       .+++.||+|++.....   ...+.+..|..++..+ +||||+++++++
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   90 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERK-------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF   90 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEET-------TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence            4579999999999999999999976       5688999999975422   2346678899999988 799999999998


Q ss_pred             eecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          153 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      ...+    ..|+||||++||+|.+++....  .+++..++.++.||+.||.|||++   ||+||||||+||||+.+|.+|
T Consensus        91 ~~~~----~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vk  161 (353)
T 2i0e_A           91 QTMD----RLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIK  161 (353)
T ss_dssp             ECSS----EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred             EcCC----EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEE
Confidence            7654    4699999999999999997643  699999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |+|||+++...  ..........||+.|+|||++.+..++.++|||||||++|||++|..||.+.....   +...+...
T Consensus       162 L~DFG~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i~~~  236 (353)
T 2i0e_A          162 IADFGMCKENI--WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIMEH  236 (353)
T ss_dssp             ECCCTTCBCCC--CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHC
T ss_pred             EEeCCcccccc--cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HHHHHHhC
Confidence            99999997522  12223455789999999999999999999999999999999999999998654332   22222211


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~  363 (436)
                      .           .    .++...+..+.+||.+||..||.+||+     +.+|++|
T Consensus       237 ~-----------~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          237 N-----------V----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             C-----------C----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             C-----------C----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            1           0    111223467889999999999999995     5777765

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-45  Score=354.94  Aligned_cols=281  Identities=25%  Similarity=0.359  Sum_probs=215.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++++.||+|+||.||+|.+...   +..++..||||++........+.+.+|+.+++.++||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPL---GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTT---SSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccC---CCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            36899999999999999999986421   235789999999988776667789999999999999999999998875433


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                        ...++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        99 --~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  172 (327)
T 3lxl_A           99 --QSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFG  172 (327)
T ss_dssp             --CEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGG
T ss_pred             --ceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccc
Confidence              24689999999999999997643 3589999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCC-cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc--
Q 013790          238 LAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA--  314 (436)
Q Consensus       238 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~--  314 (436)
                      ++........ ........||..|+|||++.+..++.++||||||+++|+|++|..||.......    .........  
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~----~~~~~~~~~~~  248 (327)
T 3lxl_A          173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF----LRMMGCERDVP  248 (327)
T ss_dssp             GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH----HHHCC----CC
T ss_pred             cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh----hhhcccccccc
Confidence            9975432221 122334567888999999999999999999999999999999999987532211    000000000  


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                      ........+........+...+..+.+||.+||+.||.+|||+.+++++|+.+....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             cHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            000000001111111223344578999999999999999999999999999886543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.8e-45  Score=346.16  Aligned_cols=277  Identities=25%  Similarity=0.372  Sum_probs=208.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +.|++++.||+|+||.||+|.+..   .+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~---~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDP---EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECT---TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhccCCCCceEEEEEEEcc---ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            468999999999999999998642   234578999999997543 2344678999999999999999999999986543


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                      .  ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        98 ~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           98 N--GIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             C--CEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             c--eEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccc
Confidence            2  3589999999999999996543 4699999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCC-cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      ++........ ........||..|+|||++.+..++.++||||||+++|+|+||..|+......    ............
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~  247 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHGQM  247 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCGGG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCccccc
Confidence            9975432221 12234456888899999999999999999999999999999999987532110    000000000000


Q ss_pred             c--ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          317 K--KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       317 ~--~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                      .  .....+........+...+..+.+||.+||+.||.+|||+.++++.|+.++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            0  000000011111223334578999999999999999999999999999886

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=9.5e-45  Score=364.89  Aligned_cols=268  Identities=22%  Similarity=0.258  Sum_probs=201.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|...       .+++.||||++...  .....+.+.+|+.+++.++||||+++++++...
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDA-------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ  133 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEET-------TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEEC-------CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence            478999999999999999999865       56889999999754  333456788999999999999999999998755


Q ss_pred             CC--cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          156 GE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       156 ~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ..  .....|+||||+.+ +|.+.+..    .+++..+..++.||+.||.|||+.   ||+||||||+||||+.++.+||
T Consensus       134 ~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl  205 (464)
T 3ttj_A          134 KTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI  205 (464)
T ss_dssp             CSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred             CccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEE
Confidence            32  23457999999965 57777643    489999999999999999999999   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +|||+++...   .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus       206 ~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p  282 (464)
T 3ttj_A          206 LDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  282 (464)
T ss_dssp             CCCCCC--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred             EEEEeeeecC---CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999997532   2223455789999999999999999999999999999999999999998765433221111100000


Q ss_pred             cC---------------------ccccccccCCcccC---cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 AD---------------------SKKFGLIMDPRLEK---EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~---------------------~~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..                     ...+...+...+..   ......+..+.+||.+||..||.+|||+.++++|
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00                     00000000000000   0111225678999999999999999999999987

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.8e-45  Score=350.46  Aligned_cols=258  Identities=24%  Similarity=0.370  Sum_probs=200.8

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ..++|++++.||+|+||.||+|.++       .+++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   76 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNK-------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLET   76 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEET-------TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEEC
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEc-------CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEe
Confidence            4568999999999999999999975       467899999987543 23457799999999999999999999998654


Q ss_pred             CC-----------------------------------------------------cceeEEEEEEecCCCCHHHHhhcCC
Q 013790          156 GE-----------------------------------------------------RGIQRLLVYEFMLNRSLEDHLFNRA  182 (436)
Q Consensus       156 ~~-----------------------------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~  182 (436)
                      ..                                                     .....++||||+++++|.+++....
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  156 (332)
T 3qd2_B           77 PPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC  156 (332)
T ss_dssp             CSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC
T ss_pred             ccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc
Confidence            32                                                     1124699999999999999997654


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCC----------cccc
Q 013790          183 -FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGH----------THVS  251 (436)
Q Consensus       183 -~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~----------~~~~  251 (436)
                       ....++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+++.......          ....
T Consensus       157 ~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T 3qd2_B          157 SLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH  233 (332)
T ss_dssp             SGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred             CccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence             23456677899999999999999998   999999999999999999999999999975332211          1122


Q ss_pred             cccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcC
Q 013790          252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEY  331 (436)
Q Consensus       252 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  331 (436)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..|+..     .............              ...
T Consensus       234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~--------------~~~  294 (332)
T 3qd2_B          234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKF--------------PLL  294 (332)
T ss_dssp             CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCC--------------CHH
T ss_pred             cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCC--------------Ccc
Confidence            345799999999999999999999999999999999998776531     1111111111100              011


Q ss_pred             CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          332 SINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       332 ~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....+..+.+||.+||+.||.+|||+.+++++
T Consensus       295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             cccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            22334677899999999999999999999875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.2e-45  Score=353.87  Aligned_cols=247  Identities=23%  Similarity=0.338  Sum_probs=205.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++++.||+|+||.||+|..+       .+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++..
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  112 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHK-------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD  112 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             HHHCEEEEEeecCcCcEEEEEEEC-------CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            468999999999999999999976       4678999999865432   234678899999999999999999999876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      ..    ..++||||+++|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||+
T Consensus       113 ~~----~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~  183 (350)
T 1rdq_E          113 NS----NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVT  183 (350)
T ss_dssp             SS----EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             CC----EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEc
Confidence            54    4699999999999999997643  699999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||+++...     .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   +...+.... 
T Consensus       184 DFg~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~~~~-  254 (350)
T 1rdq_E          184 DFGFAKRVK-----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKIVSGK-  254 (350)
T ss_dssp             CCTTCEECS-----SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCC-
T ss_pred             ccccceecc-----CCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---HHHHHHcCC-
Confidence            999997532     12345679999999999999999999999999999999999999998654332   222221110 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~  363 (436)
                                ..    ++...+..+.+||.+||+.||.+||+     +.+|+++
T Consensus       255 ----------~~----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          255 ----------VR----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ----------CC----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----------CC----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                      01    11223467889999999999999998     8888876

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.7e-45  Score=359.82  Aligned_cols=278  Identities=23%  Similarity=0.278  Sum_probs=217.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|.+.+.||+|+||.||+|.+.       .+++.||||++..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   80 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHK-------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT   80 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred             CCceEEEEEEEcCCCeEEEEEEEC-------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence            467999999999999999999976       4678999999975432 33567889999999999999999999987654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE----cCCCce
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL----DENFRP  231 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~  231 (436)
                      ..  ..++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||+.   +|+||||||+|||+    +.++.+
T Consensus        81 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~  155 (396)
T 4eut_A           81 TR--HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVY  155 (396)
T ss_dssp             TC--CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEE
T ss_pred             CC--eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeE
Confidence            32  4599999999999999997643 22499999999999999999999998   99999999999999    788889


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCccccccccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-hh
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET--------GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK-TE  302 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-~~  302 (436)
                      ||+|||+++...   .........||+.|+|||++.+        ..++.++|||||||++|+|++|..||...... ..
T Consensus       156 kL~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~  232 (396)
T 4eut_A          156 KLTDFGAARELE---DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (396)
T ss_dssp             EECCGGGCEECC---CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred             EEecCCCceEcc---CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence            999999997532   2233345679999999999865        56788999999999999999999999754332 11


Q ss_pred             HHH-HHHHhhcccCcc-cccccc--------CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          303 QRL-LEWVQQYPADSK-KFGLIM--------DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       303 ~~~-~~~~~~~~~~~~-~~~~~~--------~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      ... ...+...+.... ......        ........+...+..+.+++.+||..||++||++.++++.+++++..
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            222 222222221110 000000        11112244577888999999999999999999999999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.6e-45  Score=368.28  Aligned_cols=259  Identities=27%  Similarity=0.377  Sum_probs=206.6

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..++|++.+.||+|+||.||+|.+.        .+..||||++.... ...+.+.+|+.+++.++||||+++++++.. +
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~  251 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWN--------GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  251 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--------TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ChhHceeeeeecCCCCeEEEEEEEC--------CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence            3567999999999999999999975        34679999997654 235679999999999999999999999864 2


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+.+|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       252 ----~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~Df  324 (452)
T 1fmk_A          252 ----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF  324 (452)
T ss_dssp             ----SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             ----ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCC
Confidence                248999999999999999754334689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |+++..... .........++..|+|||++.+..++.++|||||||++|||+| |..||.+.....   +...+....  
T Consensus       325 G~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~~~--  398 (452)
T 1fmk_A          325 GLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVERGY--  398 (452)
T ss_dssp             CTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTC--
T ss_pred             ccceecCCC-ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC--
Confidence            999753211 1112233456788999999999999999999999999999999 999998765432   222221110  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                                  ....+..++..+.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus       399 ------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          399 ------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             ------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                        0011223457889999999999999999999999999988754

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-45  Score=342.74  Aligned_cols=264  Identities=25%  Similarity=0.411  Sum_probs=211.1

Q ss_pred             hcCCcccc-cccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRML-KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~-~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|.+.. .||+|+||.||+|.+.     ...++..||+|++.... ....+.+.+|+.+++.++||||+++++++.. 
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   81 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYR-----MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-   81 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC--------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             HHHhhhhhccccccCceeEEEeEec-----cCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-
Confidence            35677776 8999999999999875     23467889999997653 3345678999999999999999999999843 


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        82 ~----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~D  153 (287)
T 1u59_A           82 E----ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISD  153 (287)
T ss_dssp             S----SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECC
T ss_pred             C----CcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECc
Confidence            2    2599999999999999996543 4699999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCC-cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcc
Q 013790          236 FGLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       236 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      ||++........ ........+|+.|+|||++.+..++.++||||||+++|+|+| |..||.......   +...+....
T Consensus       154 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i~~~~  230 (287)
T 1u59_A          154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQGK  230 (287)
T ss_dssp             CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHTTC
T ss_pred             ccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHhcCC
Confidence            999975322211 112233456889999999998889999999999999999999 999998765432   222222111


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                      .          +    ..+...+..+.+||.+||..||.+||++.+++++|+.+.....
T Consensus       231 ~----------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          231 R----------M----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             C----------C----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             c----------C----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            0          1    1122345789999999999999999999999999999986544

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.1e-45  Score=351.07  Aligned_cols=276  Identities=28%  Similarity=0.400  Sum_probs=210.6

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcc
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  159 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  159 (436)
                      |++++.||+|+||.||++.+..   .+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++...+.. 
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~---~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-  108 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDP---TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA-  108 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECS---CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT-
T ss_pred             HhhhheecCCCCeEEEEEEEcc---CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc-
Confidence            4999999999999999997752   2345789999999986532 3456789999999999999999999999875433 


Q ss_pred             eeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCC
Q 013790          160 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLA  239 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  239 (436)
                       ..++||||+++|+|.+++...   .+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       109 -~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          109 -SLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA  181 (318)
T ss_dssp             -EEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             -eEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccc
Confidence             568999999999999999764   489999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCc-ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc--Cc
Q 013790          240 REGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA--DS  316 (436)
Q Consensus       240 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~  316 (436)
                      ......... .......+|..|+|||++.+..++.++||||||+++|+|+||..||........    ........  ..
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~----~~~~~~~~~~~~  257 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL----ELIGIAQGQMTV  257 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH----HHHCSCCHHHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh----hhhcccccchhH
Confidence            764322211 223345678889999999998999999999999999999999999975321100    00000000  00


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                      ......+........+...+..+.+||.+||+.||.+|||+.++++.|+.+....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            0000001111111223334578999999999999999999999999999887543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.3e-45  Score=339.17  Aligned_cols=257  Identities=29%  Similarity=0.447  Sum_probs=209.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.+.||+|+||.||+|.+.        ++..||+|++..... ..+.+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   77 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL--------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   77 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             hhheeeeeEecCCCceeEEEEEec--------CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            468999999999999999999875        467899999976543 34678999999999999999999999976554


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        78 ----~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg  149 (267)
T 3t9t_A           78 ----ICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFG  149 (267)
T ss_dssp             ----CEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTT
T ss_pred             ----eEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccc
Confidence                499999999999999997653 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      ++..... ..........++..|+|||++.+..++.++||||||+++|+|++ |..||.......   ....+.....  
T Consensus       150 ~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~i~~~~~--  223 (267)
T 3t9t_A          150 MTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTGFR--  223 (267)
T ss_dssp             GGGGBCC-HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTTCC--
T ss_pred             ccccccc-ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HHHHHhcCCc--
Confidence            9875321 11112233456788999999998999999999999999999999 899998654332   2222211100  


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                              .    ..+...+..+.+++.+||+.||.+|||+.+++++|+++.+
T Consensus       224 --------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          224 --------L----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             --------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------C----CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                    0    1111224678899999999999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.7e-44  Score=341.78  Aligned_cols=272  Identities=21%  Similarity=0.257  Sum_probs=209.0

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..++|++.+.||+|+||.||+|...       .+++.||||++.....  ...+.+|+.+++.++|++++..++.+...+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDI-------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG   77 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEET-------TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEc-------CCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence            4578999999999999999999865       5688999998755432  235788999999999999888887776543


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE---cCCCceEE
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKL  233 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl  233 (436)
                      .   ..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||+   +.++.+||
T Consensus        78 ~---~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL  149 (296)
T 4hgt_A           78 D---YNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYI  149 (296)
T ss_dssp             T---EEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEE
T ss_pred             C---ceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEE
Confidence            3   468999999 999999997543 4699999999999999999999999   99999999999999   78999999


Q ss_pred             eeccCCCCCCCCCCc-----ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 013790          234 SDFGLAREGPMVGHT-----HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  308 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  308 (436)
                      +|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|..||..............
T Consensus       150 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  229 (296)
T 4hgt_A          150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  229 (296)
T ss_dssp             CCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred             ecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhh
Confidence            999999753222111     122356799999999999999999999999999999999999999987544322222111


Q ss_pred             HhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcCCCC
Q 013790          309 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGD  375 (436)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~~~  375 (436)
                      +........      .+    ......+..+.+||.+||+.||.+|||+.+|++.|++++.......
T Consensus       230 ~~~~~~~~~------~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~  286 (296)
T 4hgt_A          230 ISEKKMSTP------IE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY  286 (296)
T ss_dssp             HHHHHHHSC------HH----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred             hhcccccch------hh----hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence            111000000      00    0011124678999999999999999999999999999987765433

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.6e-45  Score=353.43  Aligned_cols=269  Identities=24%  Similarity=0.397  Sum_probs=212.9

Q ss_pred             HHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        75 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      ....++|++.+.||+|+||.||+|.+....  ....++.||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVV--KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEE--TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCcc--CCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            344678999999999999999999875211  113578899999975532 33456889999999999999999999987


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRA--------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL  225 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll  225 (436)
                      ..+.    .++||||+.+|+|.+++....        ...+++..++.++.|++.||.|||++   +|+||||||+|||+
T Consensus        99 ~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli  171 (322)
T 1p4o_A           99 QGQP----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV  171 (322)
T ss_dssp             SSSS----CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred             cCCc----cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence            6543    499999999999999986521        24679999999999999999999998   99999999999999


Q ss_pred             cCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 013790          226 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQR  304 (436)
Q Consensus       226 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  304 (436)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......   
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  248 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---  248 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---
Confidence            9999999999999974322212222334567889999999999999999999999999999999 899998754332   


Q ss_pred             HHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          305 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                      ....+.....          .    ..+...+..+.+||.+||+.||.+|||+.+++++|++++.
T Consensus       249 ~~~~~~~~~~----------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          249 VLRFVMEGGL----------L----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHHTTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHHcCCc----------C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            2222211100          0    1122234678999999999999999999999999988764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.8e-45  Score=357.50  Aligned_cols=253  Identities=22%  Similarity=0.337  Sum_probs=194.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++++.||+|+||.||+|...       .+++.||||++..... ..+.+.+|+.+++.++||||+++++++...+ 
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-   89 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDK-------LTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPT-   89 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEET-------TTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred             CCcEEEEEEeccCCCEEEEEEEEC-------CCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC-
Confidence            468999999999999999999975       5688999999975432 3467889999999999999999999997654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc--eEEee
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR--PKLSD  235 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~D  235 (436)
                         ..++||||+.+|+|.+++....  .+++..+..++.||+.||.|||++   ||+||||||+||||+.++.  +||+|
T Consensus        90 ---~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~D  161 (361)
T 3uc3_A           90 ---HLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICD  161 (361)
T ss_dssp             ---EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECC
T ss_pred             ---EEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEee
Confidence               4599999999999999996643  699999999999999999999998   9999999999999987765  99999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHHHhhcc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAK-SDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWVQQYP  313 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~  313 (436)
                      ||+++...   .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+...... ......+....
T Consensus       162 fg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~  238 (361)
T 3uc3_A          162 FGYSKSSV---LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK  238 (361)
T ss_dssp             CCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC
T ss_pred             cCcccccc---ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC
Confidence            99997421   2223345679999999999988877655 8999999999999999999976543221 12222211111


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..           +  ......+..+.+||.+||..||.+|||+.++++|
T Consensus       239 ~~-----------~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          239 YS-----------I--PDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CC-----------C--CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CC-----------C--CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            00           0  0011124678899999999999999999999987

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=358.50  Aligned_cols=249  Identities=21%  Similarity=0.310  Sum_probs=198.0

Q ss_pred             ccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeE
Q 013790           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQR  162 (436)
Q Consensus        83 ~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  162 (436)
                      ..+.||+|+||.||+|...       .++..||+|++........+.+.+|+.+++.++||||+++++++...+    ..
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~-------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~  161 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEET-------ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN----DI  161 (373)
T ss_dssp             EEEECC-----CEEEEEET-------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EE
T ss_pred             cceEEecCcCEEEEEEEEc-------CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC----EE
Confidence            3568999999999999865       467899999998776666778999999999999999999999997654    45


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE--cCCCceEEeeccCCC
Q 013790          163 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL--DENFRPKLSDFGLAR  240 (436)
Q Consensus       163 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~  240 (436)
                      ++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||+  +.++.+||+|||+++
T Consensus       162 ~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~  237 (373)
T 2x4f_A          162 VLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLAR  237 (373)
T ss_dssp             EEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred             EEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence            99999999999999987543 3689999999999999999999998   99999999999999  677899999999997


Q ss_pred             CCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ...   .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  +..........     
T Consensus       238 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~i~~~~~~~-----  307 (373)
T 2x4f_A          238 RYK---PREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LNNILACRWDL-----  307 (373)
T ss_dssp             ECC---TTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHHTCCCS-----
T ss_pred             ecC---CccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCCC-----
Confidence            532   22223345699999999999988999999999999999999999999987654322  11111111100     


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                         ..    ......+..+.+||.+||..||.+|||+.+++++
T Consensus       308 ---~~----~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          308 ---ED----EEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             ---CS----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---Ch----hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               00    0011224678999999999999999999999985

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.6e-45  Score=359.10  Aligned_cols=271  Identities=18%  Similarity=0.277  Sum_probs=206.1

Q ss_pred             hhcCCccccccccc--CceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEe
Q 013790           77 ATNDFSRMLKIGEG--GFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYC  152 (436)
Q Consensus        77 ~~~~~~~~~~ig~G--~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  152 (436)
                      ..++|++++.||+|  +||.||+|..+       .+++.||||++....  ....+.+.+|+.+++.++||||+++++++
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   95 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYK-------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF   95 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEET-------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEc-------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence            35689999999999  99999999976       468899999997553  23346788899999999999999999999


Q ss_pred             eecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          153 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      ...+    ..++||||+++|+|.+++.......+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+|
T Consensus        96 ~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~k  168 (389)
T 3gni_B           96 IADN----ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVY  168 (389)
T ss_dssp             EETT----EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEE
T ss_pred             EECC----EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence            8655    459999999999999999876556799999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCCC-----CcccccccccCCCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 013790          233 LSDFGLAREGPMVG-----HTHVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL  305 (436)
Q Consensus       233 l~Dfg~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  305 (436)
                      |+|||++.......     .........||+.|+|||++.+  ..++.++|||||||++|+|++|..||.+.......  
T Consensus       169 l~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--  246 (389)
T 3gni_B          169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--  246 (389)
T ss_dssp             ECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--
T ss_pred             EcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--
Confidence            99999875321111     1112233478999999999987  67899999999999999999999999765443221  


Q ss_pred             HHHHhh-ccc-------Ccccc-------------cccc---------CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC
Q 013790          306 LEWVQQ-YPA-------DSKKF-------------GLIM---------DPRLEKEYSINEARKIGRLADNCLSKSSKDRP  355 (436)
Q Consensus       306 ~~~~~~-~~~-------~~~~~-------------~~~~---------~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP  355 (436)
                      ...+.. .+.       ....+             ....         ........+...+..+.+||.+||+.||.+||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp  326 (389)
T 3gni_B          247 LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP  326 (389)
T ss_dssp             HHC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSC
T ss_pred             HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCC
Confidence            100000 000       00000             0000         00000012233456799999999999999999


Q ss_pred             CHHHHHHH
Q 013790          356 KMSQVVER  363 (436)
Q Consensus       356 s~~eil~~  363 (436)
                      |+.+++++
T Consensus       327 ta~ell~h  334 (389)
T 3gni_B          327 SASTLLNH  334 (389)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999876

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.5e-45  Score=366.93  Aligned_cols=250  Identities=26%  Similarity=0.369  Sum_probs=197.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC---cchhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++++.||+|+||.||+|...       .+++.||||++...   .......+.+|+.+++.++||||+++++++..
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~  219 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEK-------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT  219 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEc-------CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee
Confidence            468999999999999999999865       56889999998754   22234567889999999999999999999976


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeeccCCCCcEEEcCCCceEE
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      .+    ..++||||+++|+|.+++....  .+++..+..++.||+.||.|||+ .   ||+||||||+||||+.++.+||
T Consensus       220 ~~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl  290 (446)
T 4ejn_A          220 HD----RLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKI  290 (446)
T ss_dssp             TT----EEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEE
T ss_pred             CC----EEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEE
Confidence            55    3599999999999999997643  69999999999999999999998 7   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +|||+++...  ..........||+.|+|||++.+..++.++|||||||++|||++|..||.+......   ...+....
T Consensus       291 ~DFG~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i~~~~  365 (446)
T 4ejn_A          291 TDFGLCKEGI--KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELILMEE  365 (446)
T ss_dssp             CCCCCCCTTC--C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHCC
T ss_pred             ccCCCceecc--CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHHHHhCC
Confidence            9999997522  222334557899999999999999999999999999999999999999986544322   22221111


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                                 ..    ++...+..+.+||.+||+.||.+||     ++.++++|
T Consensus       366 -----------~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          366 -----------IR----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             -----------CC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----------CC----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                       01    1122346788999999999999999     99999876

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.3e-45  Score=355.38  Aligned_cols=254  Identities=22%  Similarity=0.334  Sum_probs=203.6

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      ..++|++.+.||+|+||.||+|..+       .+++.||+|++.....    ...+|++++.++ +||||+++++++...
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~   88 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHK-------ATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDG   88 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence            4568999999999999999999976       5688999999976532    234688888887 799999999998754


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC----Cce
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN----FRP  231 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~  231 (436)
                      .    ..|+||||+.+|+|.+++....  .+++..+..++.||+.||.|||++   ||+||||||+|||+..+    +.+
T Consensus        89 ~----~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~  159 (342)
T 2qr7_A           89 K----YVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESI  159 (342)
T ss_dssp             S----EEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGE
T ss_pred             C----EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeE
Confidence            4    4699999999999999997653  699999999999999999999999   99999999999998432    359


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      ||+|||+++....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||..........+...+..
T Consensus       160 kl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~  237 (342)
T 2qr7_A          160 RICDFGFAKQLRA--ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS  237 (342)
T ss_dssp             EECCCTTCEECBC--TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH
T ss_pred             EEEECCCcccCcC--CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc
Confidence            9999999975321  12233456789999999999888899999999999999999999999986544444444443332


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....           +........+..+.+||.+||..||.+|||+.+++++
T Consensus       238 ~~~~-----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          238 GKFS-----------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             CCCC-----------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CCcc-----------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1111           1111122334678999999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.2e-44  Score=341.10  Aligned_cols=270  Identities=21%  Similarity=0.262  Sum_probs=211.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.+.||+|+||.||+|...       .+++.||||++.....  .+.+.+|+.+++.+.|++++..+.++...+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDI-------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET-------TTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEc-------CCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCC
Confidence            578999999999999999999865       5688999999865532  2468899999999999998888777755432


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE---cCCCceEEe
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLS  234 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~  234 (436)
                         ..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++   +|+||||||+|||+   +.++.+||+
T Consensus        79 ---~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~  150 (296)
T 3uzp_A           79 ---YNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             ---EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred             ---ceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEe
Confidence               469999999 999999997443 4699999999999999999999999   99999999999999   488999999


Q ss_pred             eccCCCCCCCCCCc-----ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 013790          235 DFGLAREGPMVGHT-----HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  309 (436)
Q Consensus       235 Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  309 (436)
                      |||++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|..||..............+
T Consensus       151 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 3uzp_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             eCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh
Confidence            99999753222111     1224567999999999999999999999999999999999999999875433222221111


Q ss_pred             hhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 013790          310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEG  374 (436)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~~  374 (436)
                      ........      .+    ......+..+.+|+.+||+.||.+|||+.+|++.|+++.......
T Consensus       231 ~~~~~~~~------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  285 (296)
T 3uzp_A          231 SEKKMSTP------IE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             HHHHHHSC------HH----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             cccccCCc------hH----HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence            11000000      00    001122467899999999999999999999999999998776543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.5e-45  Score=341.17  Aligned_cols=260  Identities=27%  Similarity=0.407  Sum_probs=210.4

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..++|++++.||+|+||.||+|.+.        ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++... 
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   80 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN--------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-   80 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc--------CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCC-
Confidence            3468999999999999999999864        45789999997653 3456789999999999999999999988633 


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        81 ----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df  153 (279)
T 1qpc_A           81 ----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF  153 (279)
T ss_dssp             ----SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ----CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCC
Confidence                248999999999999999654333689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |++...... .........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.....   ....+....  
T Consensus       154 g~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~~~--  227 (279)
T 1qpc_A          154 GLARLIEDN-EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNLERGY--  227 (279)
T ss_dssp             TTCEECSSS-CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTC--
T ss_pred             cccccccCc-ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHHHHhccc--
Confidence            999753211 1122233456789999999998889999999999999999999 999998654432   222221110  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                              ..    ..+...+..+.+|+.+||..||.+|||+.++++.|+++....
T Consensus       228 --------~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          228 --------RM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             --------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --------CC----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence                    00    111223468899999999999999999999999999987643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.3e-44  Score=348.04  Aligned_cols=253  Identities=24%  Similarity=0.395  Sum_probs=196.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc----hhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      .++|++++.||+|+||.||+|....    +..+++.||+|++.....    .....+.+|+.+++.++||||+++++++.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVT----GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECS----STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEec----cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            4689999999999999999998641    224688999999976532    23456788999999999999999999997


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ..+    ..++||||+.+++|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||
T Consensus        92 ~~~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl  162 (327)
T 3a62_A           92 TGG----KLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKL  162 (327)
T ss_dssp             CSS----CEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEE
T ss_pred             cCC----EEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEE
Confidence            654    3599999999999999997643  689999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +|||+++...  ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   ....+....
T Consensus       163 ~Dfg~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~  237 (327)
T 3a62_A          163 TDFGLCKESI--HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---TIDKILKCK  237 (327)
T ss_dssp             CCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHTC
T ss_pred             EeCCcccccc--cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHhCC
Confidence            9999987421  12223345679999999999999999999999999999999999999998654332   222111110


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                                 .    ..+...+..+.+||.+||..||.+||     ++.++++|
T Consensus       238 -----------~----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          238 -----------L----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             -----------C----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             -----------C----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                       0    11112346788999999999999999     77888876

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-45  Score=356.50  Aligned_cols=266  Identities=27%  Similarity=0.381  Sum_probs=201.8

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ..|.+.+.||+|+||.||+|.+...    ......||+|.+... .....+.+.+|+.++++++||||+++++++.....
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDN----DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEET----TTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECC----CCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence            3577788999999999999987521    124567999998754 33445789999999999999999999998765432


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus       165 ---~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG  237 (373)
T 3c1x_A          165 ---SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG  237 (373)
T ss_dssp             ---CCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             ---CeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecc
Confidence               2489999999999999997643 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCC--cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 013790          238 LAREGPMVGH--THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       238 ~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      +++.......  ........+|+.|+|||++.+..++.++|||||||++|||+| |.+||..........   .+.....
T Consensus       238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~---~~~~~~~  314 (373)
T 3c1x_A          238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQGRR  314 (373)
T ss_dssp             --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH---HHHTTCC
T ss_pred             ccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH---HHHcCCC
Confidence            9975321111  112233457788999999999999999999999999999999 778887654432211   1111100


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                                .    ..+..++..+.++|.+||..||.+|||+.++++.|+.++....
T Consensus       315 ----------~----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          315 ----------L----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             ----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             ----------C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence                      0    1112234678999999999999999999999999999986554

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.5e-44  Score=341.24  Aligned_cols=266  Identities=27%  Similarity=0.388  Sum_probs=206.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..+|++.+.||+|+||.||+|.+...    ......||+|.+.... ....+.+.+|+.++++++||||+++++++....
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDN----DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC---------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             ceehhhcceeeecCCceEEEEEEecC----CCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence            45799999999999999999987521    2345679999987643 334567899999999999999999999876543


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      .   ..++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       100 ~---~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df  172 (298)
T 3f66_A          100 G---SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADF  172 (298)
T ss_dssp             S---CCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSC
T ss_pred             C---ceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcc
Confidence            2   3489999999999999997643 4689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCC--CcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcc
Q 013790          237 GLAREGPMVG--HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       237 g~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |+++......  .........+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.........   ..+....
T Consensus       173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~---~~~~~~~  249 (298)
T 3f66_A          173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYLLQGR  249 (298)
T ss_dssp             GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH---HHHHTTC
T ss_pred             cccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH---HHHhcCC
Confidence            9997532211  1112234567789999999999999999999999999999999 66677654433221   1111110


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                      .          .    ..+...+..+.+++.+||+.||.+|||+.++++.|+.++...
T Consensus       250 ~----------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          250 R----------L----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             C----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             C----------C----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            0          0    011122467899999999999999999999999999998643

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.1e-45  Score=341.78  Aligned_cols=253  Identities=23%  Similarity=0.312  Sum_probs=205.6

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..++|++.+.||+|+||.||+|...       .++..||+|++........+.+.+|+.+++.++||||+++++++...+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQK-------GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT   79 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeC-------CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            3568999999999999999999875       467889999998766566778999999999999999999999997654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE---cCCCceEE
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKL  233 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl  233 (436)
                          ..++||||+++++|.+++....  .+++..++.++.|++.||.|||++   +|+||||||+|||+   +.++.+||
T Consensus        80 ----~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l  150 (277)
T 3f3z_A           80 ----DIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKL  150 (277)
T ss_dssp             ----EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEE
T ss_pred             ----eEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEE
Confidence                4599999999999999987643  689999999999999999999998   99999999999999   88899999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +|||++....   .........||+.|+|||++.+. ++.++||||||+++|+|++|..||........   ...+....
T Consensus       151 ~Dfg~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~  223 (277)
T 3f3z_A          151 IDFGLAARFK---PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV---MLKIREGT  223 (277)
T ss_dssp             CCCTTCEECC---TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHCC
T ss_pred             Eecccceecc---CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHhCC
Confidence            9999997532   22233456799999999998654 89999999999999999999999987543322   11111110


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..           +........+..+.+||.+||+.||.+|||+.+++++
T Consensus       224 ~~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          224 FT-----------FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             CC-----------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CC-----------CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00           0000001124678899999999999999999999875

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.3e-45  Score=349.35  Aligned_cols=253  Identities=23%  Similarity=0.327  Sum_probs=205.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch------hHHHHHHHHHHHhccCCCCceeeeeE
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ------GHKQWVAEVQFLGVLEHPNLVKLIGY  151 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~  151 (436)
                      .++|++.+.||+|+||.||+|...       .+++.||+|.+......      ..+.+.+|+.+++.++||||++++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   83 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREK-------STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV   83 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEEC-------CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            457999999999999999999975       46789999998754322      35678999999999999999999999


Q ss_pred             eeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC--
Q 013790          152 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF--  229 (436)
Q Consensus       152 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~--  229 (436)
                      +....    ..++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++  
T Consensus        84 ~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~  154 (321)
T 2a2a_A           84 YENRT----DVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIP  154 (321)
T ss_dssp             EECSS----EEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSS
T ss_pred             EecCC----EEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCC
Confidence            87654    459999999999999999764  3689999999999999999999998   999999999999999888  


Q ss_pred             --ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 013790          230 --RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       230 --~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  307 (436)
                        .+||+|||++.....   ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.....   ...
T Consensus       155 ~~~~kl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~  228 (321)
T 2a2a_A          155 IPHIKLIDFGLAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA  228 (321)
T ss_dssp             SCCEEECCCTTCEECCT---TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH
T ss_pred             cCCEEEccCccceecCc---cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HHH
Confidence              799999999975321   222344569999999999999999999999999999999999999997654322   222


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .+......       ..+    ......+..+.+||.+||..||.+|||+.+++++
T Consensus       229 ~i~~~~~~-------~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          229 NITSVSYD-------FDE----EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HHHTTCCC-------CCH----HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             HHHhcccc-------cCh----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11111100       000    0011224678899999999999999999999876

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.7e-45  Score=358.94  Aligned_cols=271  Identities=24%  Similarity=0.369  Sum_probs=196.9

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccC-CCCceeeeeEe
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLE-HPNLVKLIGYC  152 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~  152 (436)
                      ...++|++++.||+|+||.||+|.+.       .+++.||||++...  .......+.+|+.++..+. ||||+++++++
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~   78 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDR-------RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVL   78 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEET-------TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEEC-------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEE
Confidence            35679999999999999999999865       56889999998643  3344567889999999997 99999999998


Q ss_pred             eecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          153 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      ...+.  ...|+||||+. ++|.+++...   .+++..+..++.||+.||.|||+.   ||+||||||+||||+.++.+|
T Consensus        79 ~~~~~--~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~k  149 (388)
T 3oz6_A           79 RADND--RDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVK  149 (388)
T ss_dssp             ECTTS--SCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred             ecCCC--CEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEE
Confidence            76443  24699999996 6999999763   589999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCC-------------------CCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCC
Q 013790          233 LSDFGLAREGPMV-------------------GHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRR  292 (436)
Q Consensus       233 l~Dfg~a~~~~~~-------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~  292 (436)
                      |+|||+++.....                   ..........||+.|+|||++.+ ..++.++|||||||++|||++|.+
T Consensus       150 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~  229 (388)
T 3oz6_A          150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP  229 (388)
T ss_dssp             ECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCC
Confidence            9999999743211                   01122344679999999999976 678999999999999999999999


Q ss_pred             CCCCCCchhhHHHHHHHhhcccCcccccccc------------------CCcccCcC------------CHHHHHHHHHH
Q 013790          293 SLERNRPKTEQRLLEWVQQYPADSKKFGLIM------------------DPRLEKEY------------SINEARKIGRL  342 (436)
Q Consensus       293 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~l~~~~------------~~~~~~~l~~l  342 (436)
                      ||.+.........+......+... .+..+.                  .......+            ....+..+.+|
T Consensus       230 pf~~~~~~~~~~~i~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  308 (388)
T 3oz6_A          230 IFPGSSTMNQLERIIGVIDFPSNE-DVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDL  308 (388)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCHH-HHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHhcCCCCHH-HHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHH
Confidence            998765443322221111111100 000000                  00000000            00224678899


Q ss_pred             HHHhhcCCCCCCCCHHHHHHH
Q 013790          343 ADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       343 i~~cl~~dp~~RPs~~eil~~  363 (436)
                      +.+||..||.+|||+.++++|
T Consensus       309 l~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          309 LDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHhhccCcccCCCHHHHhCC
Confidence            999999999999999999987

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.2e-45  Score=364.67  Aligned_cols=263  Identities=22%  Similarity=0.303  Sum_probs=208.8

Q ss_pred             HHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhccCCCCcee
Q 013790           71 YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLEHPNLVK  147 (436)
Q Consensus        71 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~  147 (436)
                      +.++....++|++++.||+|+||.||+|.++       .+++.||+|++......   ....+.+|..++..++||||++
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~  138 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLK-------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT  138 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEc-------CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            3444556789999999999999999999976       46789999999753221   1234788999999999999999


Q ss_pred             eeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          148 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       148 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      +++++...+    ..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.   +|+||||||+||||+.
T Consensus       139 l~~~~~~~~----~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~  210 (437)
T 4aw2_A          139 LHYAFQDDN----NLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDM  210 (437)
T ss_dssp             EEEEEECSS----EEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred             EEEEEeeCC----EEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcC
Confidence            999997654    4699999999999999997633 4699999999999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 013790          228 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE  302 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  302 (436)
                      +|.+||+|||+++.... ..........||+.|+|||++.     ...++.++|||||||++|||++|..||.+......
T Consensus       211 ~g~vkL~DFGla~~~~~-~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~  289 (437)
T 4aw2_A          211 NGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  289 (437)
T ss_dssp             TSCEEECCCTTCEECCT-TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             CCCEEEcchhhhhhccc-CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH
Confidence            99999999999975322 1222334468999999999996     45789999999999999999999999987654332


Q ss_pred             HH-HHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 013790          303 QR-LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD--RPKMSQVVER  363 (436)
Q Consensus       303 ~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~  363 (436)
                      .. +..+......          +..    ....+..+.+||.+||..+|++  ||++.++++|
T Consensus       290 ~~~i~~~~~~~~~----------p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          290 YGKIMNHKERFQF----------PTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHHHHTHHHHCCC----------CSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             HHhhhhccccccC----------Ccc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            21 1111111111          000    0112467889999999998888  9999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.2e-44  Score=340.89  Aligned_cols=254  Identities=23%  Similarity=0.347  Sum_probs=205.1

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      ..++|++.+.||+|+||.||+|...       .++..||+|++....  ....+.+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHK-------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE   76 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEc-------CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc
Confidence            3578999999999999999999875       567889999986543  2344678899999999999999999999875


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc---e
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---P  231 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~  231 (436)
                      .+    ..++||||+.+++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.   +
T Consensus        77 ~~----~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~  147 (284)
T 3kk8_A           77 ES----FHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAV  147 (284)
T ss_dssp             SS----EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCE
T ss_pred             CC----EEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcE
Confidence            54    3599999999999999987653  689999999999999999999998   9999999999999976655   9


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      ||+|||++....   .........||+.|+|||++.+..++.++||||||+++|+|++|..||.........   ..+..
T Consensus       148 kl~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~  221 (284)
T 3kk8_A          148 KLADFGLAIEVN---DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY---AQIKA  221 (284)
T ss_dssp             EECCCTTCEECC---SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHH
T ss_pred             EEeeceeeEEcc---cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH---HHHHh
Confidence            999999997532   222234467999999999999999999999999999999999999999765443222   11111


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....           .........+..+.+||.+||+.||.+|||+.+++++
T Consensus       222 ~~~~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          222 GAYD-----------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             TCCC-----------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             cccc-----------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            1100           0000111234678899999999999999999999886

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.8e-44  Score=341.23  Aligned_cols=261  Identities=25%  Similarity=0.376  Sum_probs=207.8

Q ss_pred             hcCCcccc-cccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRML-KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~-~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|.+.+ .||+|+||.||+|.+.     ....+..||||++.....  ...+.+.+|+.+++.++||||+++++++..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   89 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQ-----MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA   89 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEE-----CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES
T ss_pred             chhhhhccCccccccCeeeEeeeec-----CCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC
Confidence            46788888 9999999999999765     335678999999976532  235678999999999999999999999832


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                       +    ..++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        90 -~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~  159 (291)
T 1xbb_A           90 -E----SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKIS  159 (291)
T ss_dssp             -S----SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred             -C----CcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEc
Confidence             2    358999999999999999765  3699999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCc-ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhc
Q 013790          235 DFGLAREGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       235 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   +...+...
T Consensus       160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~  236 (291)
T 1xbb_A          160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEKG  236 (291)
T ss_dssp             CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTT
T ss_pred             cCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcC
Confidence            99999753222211 12223446788999999998889999999999999999999 999998765432   22222211


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      ..          .    ..+...+..+.++|.+||+.||.+|||+.++++.|++++..
T Consensus       237 ~~----------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          237 ER----------M----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             CC----------C----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CC----------C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            10          1    11223357899999999999999999999999999998753

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=350.39  Aligned_cols=267  Identities=23%  Similarity=0.359  Sum_probs=208.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.+.||+|+||.||+|...       .+++.||||++........+.+.+|+.+++.++||||+++++++.....
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGL-------HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERG  100 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEET-------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred             CeEEEEEEEecCCCCeEEEEEEec-------CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence            468999999999999999999865       4678999999877666667789999999999999999999999875544


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      .....++||||+.+|+|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~d  177 (317)
T 2buj_A          101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMD  177 (317)
T ss_dssp             TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred             CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEe
Confidence            445679999999999999998752  235799999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCc-------ccccccccCCCcccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 013790          236 FGLAREGPMVGHT-------HVSTAVVGTFGYAAPDYIETGH---LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL  305 (436)
Q Consensus       236 fg~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  305 (436)
                      ||++.........       .......||+.|+|||++.+..   ++.++||||||+++|+|++|..||........ ..
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~  256 (317)
T 2buj_A          178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SV  256 (317)
T ss_dssp             CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CH
T ss_pred             cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hh
Confidence            9998642111000       0112345799999999987554   68899999999999999999999963211100 01


Q ss_pred             HHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          306 LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                      .......              .........+..+.+||.+||+.||.+|||+.+++++|+.+..
T Consensus       257 ~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          257 ALAVQNQ--------------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             HHHHHCC----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             hHHhhcc--------------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            1111110              0001112234679999999999999999999999999998754

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-44  Score=347.07  Aligned_cols=266  Identities=26%  Similarity=0.423  Sum_probs=206.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|.+.+.||+|+||.||+|.+....   ...+..||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSS---GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCC---CCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            357888999999999999999876221   22456799999976532 33457889999999999999999999987644


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       120 ----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df  191 (333)
T 1mqb_A          120 ----PMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDF  191 (333)
T ss_dssp             ----SEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             ----CcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCC
Confidence                3599999999999999997643 4699999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCC-cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 013790          237 GLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |+++....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......   +...+.....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~~~~~~~~  268 (333)
T 1mqb_A          192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKAINDGFR  268 (333)
T ss_dssp             CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTTCC
T ss_pred             CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHCCCc
Confidence            99975322111 111223346778999999999999999999999999999999 999997654332   2222211100


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                                    ...+...+..+.+||.+||+.||.+||++.+|++.|+.++...
T Consensus       269 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          269 --------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             --------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             --------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                          0112233467899999999999999999999999999987643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.1e-45  Score=365.15  Aligned_cols=258  Identities=23%  Similarity=0.297  Sum_probs=206.4

Q ss_pred             HHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeee
Q 013790           73 EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLI  149 (436)
Q Consensus        73 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~  149 (436)
                      ++....++|.+++.||+|+||.||+|.++       .+++.||+|++.....   ...+.+.+|+.++..++||||++++
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~-------~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~  135 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHK-------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF  135 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEE
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEEC-------CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            34445689999999999999999999976       5678999999865321   1223578899999999999999999


Q ss_pred             eEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC
Q 013790          150 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  229 (436)
Q Consensus       150 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  229 (436)
                      +++....    ..|+||||++||+|.+++...   .+++..+..++.||+.||.|||+.   +|+||||||+||||+.+|
T Consensus       136 ~~~~~~~----~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g  205 (410)
T 3v8s_A          136 YAFQDDR----YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSG  205 (410)
T ss_dssp             EEEECSS----EEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred             EEEEECC----EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCC
Confidence            9997654    469999999999999999754   589999999999999999999998   999999999999999999


Q ss_pred             ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH-
Q 013790          230 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH----LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-  304 (436)
Q Consensus       230 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-  304 (436)
                      .+||+|||+++..... .........||+.|+|||++.+..    ++.++|||||||++|||++|..||.+........ 
T Consensus       206 ~ikL~DFG~a~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~  284 (410)
T 3v8s_A          206 HLKLADFGTCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK  284 (410)
T ss_dssp             CEEECCCTTCEECCTT-SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             CEEEeccceeEeeccC-CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHH
Confidence            9999999999753211 122334678999999999997655    7899999999999999999999998765432211 


Q ss_pred             HHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 013790          305 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKD--RPKMSQVVER  363 (436)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~  363 (436)
                      +..........               .....+..+.+||.+||..+|.+  ||++.+|++|
T Consensus       285 i~~~~~~~~~p---------------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          285 IMNHKNSLTFP---------------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHTHHHHCCCC---------------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             HHhccccccCC---------------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            11111111100               00112467889999999999988  9999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.7e-45  Score=342.83  Aligned_cols=254  Identities=28%  Similarity=0.437  Sum_probs=202.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.+.||+|+||.||+|.+.         +..||+|.+....  ..+.+.+|+.+++.++||||+++++++.....
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   88 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET---------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             hhhceEEeEEecCCCceEEEEEEc---------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence            468999999999999999999853         6789999997653  45678999999999999999999998765432


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        89 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg  162 (278)
T 1byg_A           89 ---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFG  162 (278)
T ss_dssp             ---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             ---ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecc
Confidence               359999999999999999765433488999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      ++.....     ......+++.|+|||++.+..++.++||||||+++|+|+| |..||........   ...+...    
T Consensus       163 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~~~~----  230 (278)
T 1byg_A          163 LTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEKG----  230 (278)
T ss_dssp             C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHHTTT----
T ss_pred             ccccccc-----cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhcC----
Confidence            9874221     1223457889999999999999999999999999999998 9999986543322   1111110    


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                                .....+...+..+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus       231 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          231 ----------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence                      00111223357889999999999999999999999999988653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.2e-45  Score=352.24  Aligned_cols=253  Identities=25%  Similarity=0.388  Sum_probs=195.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCC--CCceeeeeEee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEH--PNLVKLIGYCA  153 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~  153 (436)
                      .++|++++.||+|+||.||+|...        +++.||||++....  ....+.+.+|+.++..++|  |||+++++++.
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   79 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE--------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   79 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT--------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC--------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence            457999999999999999999853        47789999987543  2334678999999999986  99999999987


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ...    ..++||| +.+++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+||||+ ++.+||
T Consensus        80 ~~~----~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl  148 (343)
T 3dbq_A           80 TDQ----YIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKL  148 (343)
T ss_dssp             CSS----EEEEEEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEE
T ss_pred             eCC----EEEEEEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEE
Confidence            654    4699999 4588999999775  3689999999999999999999998   999999999999997 678999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----------GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE  302 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  302 (436)
                      +|||+++...............||+.|+|||++.+           ..++.++|||||||++|+|++|..||........
T Consensus       149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  228 (343)
T 3dbq_A          149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS  228 (343)
T ss_dssp             CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred             eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH
Confidence            99999986432222223345679999999999865           6788999999999999999999999976433211


Q ss_pred             HHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          303 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                       .+...+              ++.....++...+..+.+||.+||..||.+|||+.+++++.
T Consensus       229 -~~~~~~--------------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          229 -KLHAII--------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             -HHHHHH--------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -HHHHHh--------------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence             111111              11111112222246788999999999999999999999874

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=348.79  Aligned_cols=247  Identities=23%  Similarity=0.305  Sum_probs=192.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhcc-CCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVL-EHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  154 (436)
                      .++|++++.||+|+||+||+|.+.       .+++.||||++.....  .....+..|+..+..+ +||||+++++++..
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~  128 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSK-------EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE  128 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEET-------TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEEC-------CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence            468999999999999999999975       4688999999865422  2333455566555555 89999999999976


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+
T Consensus       129 ~~----~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~  199 (311)
T 3p1a_A          129 GG----ILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLG  199 (311)
T ss_dssp             TT----EEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEEC
T ss_pred             CC----EEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEc
Confidence            54    459999999 779999987654 4699999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||++....   .........||+.|+|||++.+ .++.++|||||||++|||++|..|+.....     ........  
T Consensus       200 DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~~~~~~--  268 (311)
T 3p1a_A          200 DFGLLVELG---TAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----WQQLRQGY--  268 (311)
T ss_dssp             CCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----HHHHTTTC--
T ss_pred             cceeeeecc---cCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHhccC--
Confidence            999987532   2223345569999999999876 789999999999999999999776653211     11111000  


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                              ..+    ..+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       269 --------~~~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          269 --------LPP----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             --------CCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --------CCc----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence                    011    1111234678999999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-44  Score=348.32  Aligned_cols=260  Identities=30%  Similarity=0.459  Sum_probs=206.7

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcce--EEEEEEeccC-cchhHHHHHHHHHHHhcc-CCCCceeeeeEeee
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEAT--VVAIKKLNRD-GLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAV  154 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  154 (436)
                      ++|++.+.||+|+||.||+|.+.       .++.  .+|+|.+... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   97 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   97 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEE-------ETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEc-------cCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence            58999999999999999999976       3344  4599988653 223445688999999999 89999999999976


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCC
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKA  220 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp  220 (436)
                      .+    ..++||||+++|+|.+++....              ...+++..++.++.||+.||.|||+.   +|+||||||
T Consensus        98 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp  170 (327)
T 1fvr_A           98 RG----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAA  170 (327)
T ss_dssp             TT----EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             CC----ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCcc
Confidence            54    4599999999999999997643              24689999999999999999999998   999999999


Q ss_pred             CcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 013790          221 SNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRP  299 (436)
Q Consensus       221 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~  299 (436)
                      +|||++.++.+||+|||+++..   ..........+++.|+|||++.+..++.++||||||+++|+|+| |..||.+...
T Consensus       171 ~NIl~~~~~~~kL~Dfg~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~  247 (327)
T 1fvr_A          171 RNILVGENYVAKIADFGLSRGQ---EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  247 (327)
T ss_dssp             GGEEECGGGCEEECCTTCEESS---CEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             ceEEEcCCCeEEEcccCcCccc---cccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence            9999999999999999998742   11222234457889999999998889999999999999999998 9999987643


Q ss_pred             hhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                      ..   +...+....          ..    ..+...+..+.+||.+||..||.+|||+.+++++|+.++....
T Consensus       248 ~~---~~~~~~~~~----------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          248 AE---LYEKLPQGY----------RL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             HH---HHHHGGGTC----------CC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             HH---HHHHhhcCC----------CC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            32   222111110          00    1122234678999999999999999999999999999987654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=345.28  Aligned_cols=268  Identities=25%  Similarity=0.329  Sum_probs=200.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|.+.       .+++.||+|++......  ..+.+.+|+.+++.++||||+++++++...
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   74 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNR-------DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK   74 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cccceEeeEEeecCCeEEEEEEeC-------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC
Confidence            468999999999999999999975       46789999998655332  246688999999999999999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||+.   ||+||||||+|||++.++.+||+|
T Consensus        75 ~----~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D  145 (311)
T 4agu_A           75 R----RLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCD  145 (311)
T ss_dssp             T----EEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             C----eEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEee
Confidence            4    359999999999999988654  3699999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc-c
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY-P  313 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~-~  313 (436)
                      ||++....  ..........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+................ .
T Consensus       146 fg~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  223 (311)
T 4agu_A          146 FGFARLLT--GPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLI  223 (311)
T ss_dssp             CTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             CCCchhcc--CcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccc
Confidence            99997532  12222345578999999999976 67899999999999999999999999876554332222111100 0


Q ss_pred             c-------CccccccccCCcccCcC-----CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 A-------DSKKFGLIMDPRLEKEY-----SINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~-------~~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .       ....+.....+......     ....+..+.+||.+||+.||.+|||+.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0       00000000000000000     01234678899999999999999999999876

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-44  Score=339.56  Aligned_cols=265  Identities=26%  Similarity=0.341  Sum_probs=208.2

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      .|...+.||+|+||.||+|.+..    ...++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-   96 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYID----QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG-   96 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEEC----SSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS-
T ss_pred             EEccCceeccCCCceEEEEEEec----CCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC-
Confidence            56667899999999999998762    223456899999876433 345678999999999999999999999875443 


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        97 --~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~  170 (298)
T 3pls_A           97 --LPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGL  170 (298)
T ss_dssp             --CCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred             --CcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCC
Confidence              2389999999999999997643 4689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCC--CcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCchhhHHHHHHHhhcccC
Q 013790          239 AREGPMVG--HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRS-LERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       239 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ++......  .........+++.|+|||.+.+..++.++||||||+++|+|++|..| |........   ...+..... 
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~---~~~~~~~~~-  246 (298)
T 3pls_A          171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL---THFLAQGRR-  246 (298)
T ss_dssp             SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH---HHHHHTTCC-
T ss_pred             cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH---HHHhhcCCC-
Confidence            97532111  11222345678899999999999999999999999999999995554 544433322   222211110 


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                               .    ..+...+..+.+|+.+||+.||.+|||+.++++.|++++....
T Consensus       247 ---------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          247 ---------L----PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             ---------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             ---------C----CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence                     0    1112234678999999999999999999999999999986543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.3e-44  Score=343.49  Aligned_cols=264  Identities=25%  Similarity=0.377  Sum_probs=200.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC---cchhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++.+.||+|+||.||+|...       .+++.||+|++...   .......+.+|+.+++.++||||+++++++..
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~  103 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACL-------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE  103 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEET-------TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEc-------CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            458999999999999999999865       46789999998753   23345678899999999999999999999987


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      .+    ..++||||+.+++|.+++..  .....+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+|
T Consensus       104 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~k  176 (310)
T 2wqm_A          104 DN----ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVK  176 (310)
T ss_dssp             TT----EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred             CC----cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEE
Confidence            55    35999999999999999864  1234689999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |+|||++.....  .........|++.|+|||++.+..++.++||||||+++|+|++|..||.+..... ..+...+...
T Consensus       177 l~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~  253 (310)
T 2wqm_A          177 LGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQC  253 (310)
T ss_dssp             ECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHHHHHTT
T ss_pred             EEeccceeeecC--CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHHHhhcc
Confidence            999999875321  1222334568999999999999999999999999999999999999997643321 1222222211


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                      ...         +    ......+..+.+||.+||..||.+|||+.+|++.|+++....
T Consensus       254 ~~~---------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          254 DYP---------P----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             CSC---------C----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCC---------C----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            100         0    001123467899999999999999999999999999987543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-44  Score=343.03  Aligned_cols=272  Identities=22%  Similarity=0.338  Sum_probs=205.2

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc--CCCCceeeeeEee
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL--EHPNLVKLIGYCA  153 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~~~~~~~  153 (436)
                      ...++|++.+.||+|+||.||+|.+.         ++.||||++....   ...+..|.+++..+  +||||+++++++.
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~  101 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR---------GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADI  101 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET---------TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC---------CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence            34578999999999999999999863         7889999986442   23445556665544  8999999999998


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCceeeccCCCCcEEEcCC
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL-----EVQVIYRDFKASNVLLDEN  228 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-----~~~ivH~Dlkp~NIll~~~  228 (436)
                      .........++||||+++|+|.+++...   .+++..++.++.|++.||.|||+.+     ..+|+||||||+|||++.+
T Consensus       102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~  178 (337)
T 3mdy_A          102 KGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN  178 (337)
T ss_dssp             ESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred             cCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence            7654445679999999999999999664   5899999999999999999999751     3389999999999999999


Q ss_pred             CceEEeeccCCCCCCCCCCc--ccccccccCCCcccccccccCCCCch------hhHHHHHHHHHHHHhC----------
Q 013790          229 FRPKLSDFGLAREGPMVGHT--HVSTAVVGTFGYAAPDYIETGHLTAK------SDVWSFGVVLYEMLTG----------  290 (436)
Q Consensus       229 ~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvil~elltg----------  290 (436)
                      +.+||+|||+++........  .......||+.|+|||++.+..++..      +|||||||++|||+||          
T Consensus       179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            99999999999753221111  11234579999999999987766654      9999999999999999          


Q ss_pred             CCCCCCCCchhh--HHHHHHHhhcccCccccccccCCcccCc-CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          291 RRSLERNRPKTE--QRLLEWVQQYPADSKKFGLIMDPRLEKE-YSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       291 ~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                      ..||....+...  ......+...         ...+.+... ....++..+.+||.+||+.||.+|||+.+|+++|+.+
T Consensus       259 ~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  329 (337)
T 3mdy_A          259 QLPYHDLVPSDPSYEDMREIVCIK---------KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM  329 (337)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTS---------CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccHhhhcCCCCchhhhHHHHhhh---------ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence            666654322211  1111111100         011111111 1236778899999999999999999999999999999


Q ss_pred             hhhc
Q 013790          368 VQVS  371 (436)
Q Consensus       368 ~~~~  371 (436)
                      .+..
T Consensus       330 ~~~~  333 (337)
T 3mdy_A          330 SESQ  333 (337)
T ss_dssp             HHTT
T ss_pred             Hhhc
Confidence            7643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1e-44  Score=340.68  Aligned_cols=249  Identities=28%  Similarity=0.428  Sum_probs=202.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++.+.||+|+||.||+|...       .++..||+|++.....   .....+.+|+.+++.++||||+++++++..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREK-------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD   80 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             cccEEEeeEEecCCCeEEEEEEEc-------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence            568999999999999999999876       5678899999865422   224568899999999999999999999976


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        81 ~~----~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~  151 (279)
T 3fdn_A           81 AT----RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA  151 (279)
T ss_dssp             SS----EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEEC
T ss_pred             CC----EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEE
Confidence            54    4599999999999999997643  689999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||++....    ........||+.|+|||++.+..++.++||||||+++|+|++|..||...........   +.....
T Consensus       152 Dfg~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~  224 (279)
T 3fdn_A          152 DFGWSVHAP----SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR---ISRVEF  224 (279)
T ss_dssp             SCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHHTCC
T ss_pred             eccccccCC----cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH---HHhCCC
Confidence            999986422    2223446789999999999999999999999999999999999999986544322211   111110


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                                     ..+...+..+.+||.+||+.||.+|||+.+|+++-
T Consensus       225 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          225 ---------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             ---------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             ---------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                           11112346788999999999999999999999873

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=372.65  Aligned_cols=263  Identities=25%  Similarity=0.417  Sum_probs=207.6

Q ss_pred             cCCcccc-cccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRML-KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~-~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      +++.+.. .||+|+||.||+|.++     ...++..||||+++... ....+.+.+|+.+|+.++||||+++++++..+ 
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-  408 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYR-----MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-  408 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEE-----CSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS-
T ss_pred             cceeEcCcEEecCCCcEEEEEEEe-----cCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC-
Confidence            3444444 7999999999999886     23457789999997653 23457899999999999999999999998642 


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+||
T Consensus       409 ----~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DF  480 (613)
T 2ozo_A          409 ----ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDF  480 (613)
T ss_dssp             ----SEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred             ----CeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeec
Confidence                2599999999999999997543 4699999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCC-cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 013790          237 GLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |+++....... ........+++.|+|||++.+..++.++|||||||++|||+| |..||.+.....   +...+.... 
T Consensus       481 Gla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~~~~-  556 (613)
T 2ozo_A          481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQGK-  556 (613)
T ss_dssp             STTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHHHHTTC-
T ss_pred             cCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcCC-
Confidence            99985322111 111223345689999999999999999999999999999998 999998765433   222222110 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                                   ....+..++..+.+||.+||..||.+||++.+|++.|+.+.....
T Consensus       557 -------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~  601 (613)
T 2ozo_A          557 -------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  601 (613)
T ss_dssp             -------------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred             -------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence                         001223345789999999999999999999999999999876544

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.7e-44  Score=360.80  Aligned_cols=272  Identities=23%  Similarity=0.296  Sum_probs=189.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|.++       .+++.||||++...  .....+.+.+|+.+|+.++||||+++++++...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  124 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDK-------LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK  124 (458)
T ss_dssp             CTTEEECCC-------CEEEEEEC-------C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             CCCeEEeeEeeecCCeEEEEEEEC-------CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence            368999999999999999999865       56889999998654  333456789999999999999999999998654


Q ss_pred             C-CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          156 G-ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       156 ~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      . .....+|+||||+ +++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+
T Consensus       125 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~  198 (458)
T 3rp9_A          125 DVEKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVC  198 (458)
T ss_dssp             CTTTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEEC
T ss_pred             CcccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeec
Confidence            3 2234579999998 67999999664  3699999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCC-------------------------cccccccccCCCccccccc-ccCCCCchhhHHHHHHHHHHHH
Q 013790          235 DFGLAREGPMVGH-------------------------THVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEML  288 (436)
Q Consensus       235 Dfg~a~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~ell  288 (436)
                      |||+++.......                         .......+||+.|+|||++ .+..++.++|||||||++|||+
T Consensus       199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell  278 (458)
T 3rp9_A          199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL  278 (458)
T ss_dssp             CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence            9999985321111                         0123446789999999986 5667999999999999999999


Q ss_pred             h-----------CCCCCCCCCchh-----------------hHHHHHHH-hhcccCccc-c-----------cccc----
Q 013790          289 T-----------GRRSLERNRPKT-----------------EQRLLEWV-QQYPADSKK-F-----------GLIM----  323 (436)
Q Consensus       289 t-----------g~~pf~~~~~~~-----------------~~~~~~~~-~~~~~~~~~-~-----------~~~~----  323 (436)
                      +           |.++|.+.....                 ....+..+ ......... +           ...+    
T Consensus       279 tg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~  358 (458)
T 3rp9_A          279 NMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKRE  358 (458)
T ss_dssp             TTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCC
T ss_pred             HhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCC
Confidence            9           666665533110                 00000000 000000000 0           0000    


Q ss_pred             CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       324 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...+.. .....+..+.+||.+||..||.+|||+.++++|
T Consensus       359 ~~~~~~-~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          359 GTDLAE-RFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             CCCGGG-GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCHHH-HCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            000000 111235678899999999999999999999987

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6.1e-45  Score=371.57  Aligned_cols=254  Identities=28%  Similarity=0.461  Sum_probs=209.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|.+++.||+|+||.||+|..+       .+++.||+|++.....   .....+.+|+.+|+.++||||+++++++..
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~-------~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  255 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVR-------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET  255 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             ccceEEEEEEeeCCCEEEEEEEEC-------CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee
Confidence            467999999999999999999976       4688999999965422   234568899999999999999999999876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||++||+|.+++.......+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+||+
T Consensus       256 ~~----~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~  328 (576)
T 2acx_A          256 KD----ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRIS  328 (576)
T ss_dssp             SS----EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             CC----EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEE
Confidence            54    469999999999999999876655699999999999999999999999   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh-hHHHHHHHhhcc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-EQRLLEWVQQYP  313 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-~~~~~~~~~~~~  313 (436)
                      |||+++....   ........||+.|+|||++.+..++.++|||||||++|||++|..||....... ...+...+...+
T Consensus       329 DFGla~~~~~---~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~  405 (576)
T 2acx_A          329 DLGLAVHVPE---GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP  405 (576)
T ss_dssp             CCTTCEECCT---TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC
T ss_pred             ecccceeccc---CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc
Confidence            9999975321   222344689999999999999899999999999999999999999998754321 122222222221


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                      .               .++...+..+.+||.+||..||.+||     ++.+|++|
T Consensus       406 ~---------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          406 E---------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             C---------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             c---------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            1               11122346788999999999999999     78999876

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3e-44  Score=361.17  Aligned_cols=249  Identities=25%  Similarity=0.357  Sum_probs=205.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|.+.+.||+|+||.||+|.+.       .+++.||||++.....   .....+.+|+.+++.++||||+++++++..
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~   87 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHE-------LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST   87 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEET-------TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            468999999999999999999975       5688999999975432   234678899999999999999999999876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        88 ~~----~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~  158 (476)
T 2y94_A           88 PS----DIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIA  158 (476)
T ss_dssp             SS----EEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             CC----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEE
Confidence            54    459999999999999999654  4699999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |||++....   .........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.....   +...+....
T Consensus       159 DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~~i~~~~  232 (476)
T 2y94_A          159 DFGLSNMMS---DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LFKKICDGI  232 (476)
T ss_dssp             CCSSCEECC---TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HHHHHHTTC
T ss_pred             eccchhhcc---ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HHHHHhcCC
Confidence            999997532   2223345679999999999988765 689999999999999999999998654432   222111110


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .               ..+...+..+.+||.+||..||.+|||+.+|+++
T Consensus       233 ~---------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          233 F---------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             C---------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             c---------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            0               0111223678899999999999999999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.4e-45  Score=351.86  Aligned_cols=253  Identities=24%  Similarity=0.342  Sum_probs=180.9

Q ss_pred             cCCccc---ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCCceeeeeEeee
Q 013790           79 NDFSRM---LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNLVKLIGYCAV  154 (436)
Q Consensus        79 ~~~~~~---~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~  154 (436)
                      ++|.+.   +.||+|+||.||+|.++       .+++.||||++...   ....+.+|+.+++.+. ||||+++++++..
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~   77 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHK-------KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD   77 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEET-------TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hccccccCCCccccCCCeEEEEEEEC-------CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence            345553   78999999999999976       56789999999654   3456778999999997 9999999999976


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC---ce
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF---RP  231 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~  231 (436)
                      ..    ..++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++   .+
T Consensus        78 ~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~  148 (325)
T 3kn6_A           78 QL----HTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEI  148 (325)
T ss_dssp             SS----EEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEE
T ss_pred             CC----EEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccE
Confidence            54    459999999999999999765  3799999999999999999999998   999999999999997665   89


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh----hHHHHH
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT----EQRLLE  307 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~----~~~~~~  307 (436)
                      ||+|||+++....  .........||+.|+|||++.+..++.++|||||||++|+|++|..||.......    ...+..
T Consensus       149 kl~Dfg~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~  226 (325)
T 3kn6_A          149 KIIDFGFARLKPP--DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK  226 (325)
T ss_dssp             EECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH
T ss_pred             EEeccccceecCC--CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH
Confidence            9999999975321  2223345678999999999999999999999999999999999999997644321    112222


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .+.....           .+........+..+.+||.+||..||.+|||+.+++++
T Consensus       227 ~i~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          227 KIKKGDF-----------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             HHTTTCC-----------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             HHHcCCC-----------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            2111100           00111112235678999999999999999999999865

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=350.40  Aligned_cols=273  Identities=19%  Similarity=0.180  Sum_probs=202.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-----------hHHHHHHHHHHHhccCCCCce
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----------GHKQWVAEVQFLGVLEHPNLV  146 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnIv  146 (436)
                      .++|.+.+.||+|+||.||+|.+...    ...+..||+|++......           ....+.+|+..+..++||||+
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~  111 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNK----PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP  111 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSS----CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCC----CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence            36899999999999999999997621    136788999998765322           113466788999999999999


Q ss_pred             eeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc
Q 013790          147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  226 (436)
Q Consensus       147 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~  226 (436)
                      ++++++..........++||||+ +++|.+++....  .+++..++.++.||+.||.|||+.   +|+||||||+||||+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~  185 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLG  185 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEc
Confidence            99999987544455679999999 999999997654  799999999999999999999998   999999999999998


Q ss_pred             CCC--ceEEeeccCCCCCCCCC-----CcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 013790          227 ENF--RPKLSDFGLAREGPMVG-----HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP  299 (436)
Q Consensus       227 ~~~--~~kl~Dfg~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~  299 (436)
                      .++  .+||+|||+++......     .........||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus       186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~  265 (345)
T 2v62_A          186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK  265 (345)
T ss_dssp             SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred             cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            877  99999999997532111     11122456799999999999999999999999999999999999999965322


Q ss_pred             hhhHHHHHHHhhc-ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          300 KTEQRLLEWVQQY-PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       300 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                      .... ........ ............       ....+..+.+||.+||..||.+|||+.+|++.|+.+.
T Consensus       266 ~~~~-~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          266 DPVA-VQTAKTNLLDELPQSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             CHHH-HHHHHHHHHHTTTHHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             ccHH-HHHHHHhhcccccHHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            2111 11111110 000000000000       0123467999999999999999999999999998764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.4e-45  Score=352.13  Aligned_cols=262  Identities=24%  Similarity=0.269  Sum_probs=200.9

Q ss_pred             HHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-----cchhHHHHHHHHHHHhccCCCCceee
Q 013790           74 MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-----GLQGHKQWVAEVQFLGVLEHPNLVKL  148 (436)
Q Consensus        74 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~  148 (436)
                      +....++|++.+.||+|+||.||+|...       .++..||+|++...     .....+.+.+|+.+++.++||||+++
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~   93 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIEN-------QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL   93 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEEC-------CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCccee
Confidence            3456679999999999999999999865       56789999998654     22345678999999999999999999


Q ss_pred             eeEeeecCCcceeEEEEEEecCCCCHHHHhhcCC--------------------------------------CCCCCHHH
Q 013790          149 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRA--------------------------------------FPPLPWKT  190 (436)
Q Consensus       149 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~  190 (436)
                      ++++...+    ..++||||+++|+|.+++....                                      ...+++..
T Consensus        94 ~~~~~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (345)
T 3hko_A           94 YEVYEDEQ----YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKL  169 (345)
T ss_dssp             EEEEECSS----EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHH
T ss_pred             ehhhccCC----eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHH
Confidence            99997654    4699999999999999985210                                      11235778


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC--ceEEeeccCCCCCCCC--CCcccccccccCCCccccccc
Q 013790          191 RLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF--RPKLSDFGLAREGPMV--GHTHVSTAVVGTFGYAAPDYI  266 (436)
Q Consensus       191 ~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~  266 (436)
                      ++.++.||+.||.|||+.   +|+||||||+||||+.++  .+||+|||+++.....  ..........||+.|+|||++
T Consensus       170 ~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  246 (345)
T 3hko_A          170 ISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL  246 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhh
Confidence            889999999999999999   999999999999998776  8999999999742111  111223456799999999999


Q ss_pred             cc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHH
Q 013790          267 ET--GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLAD  344 (436)
Q Consensus       267 ~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~  344 (436)
                      .+  ..++.++|||||||++|+|++|..||.+.......  .........            +........+..+.+||.
T Consensus       247 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~------------~~~~~~~~~~~~~~~li~  312 (345)
T 3hko_A          247 NTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI--SQVLNKKLC------------FENPNYNVLSPLARDLLS  312 (345)
T ss_dssp             TCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHCCCC------------TTSGGGGGSCHHHHHHHH
T ss_pred             ccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHH--HHHHhcccc------------cCCcccccCCHHHHHHHH
Confidence            65  67899999999999999999999999876543221  111111100            000111123467889999


Q ss_pred             HhhcCCCCCCCCHHHHHHH
Q 013790          345 NCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       345 ~cl~~dp~~RPs~~eil~~  363 (436)
                      +||..||.+|||+.+++++
T Consensus       313 ~~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          313 NLLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HHSCSCTTTSCCHHHHHHS
T ss_pred             HHcCCChhHCCCHHHHhcC
Confidence            9999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.9e-44  Score=338.69  Aligned_cols=253  Identities=22%  Similarity=0.335  Sum_probs=203.0

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..|.+.+.||+|+||.||+|.+.       .++..||+|.+....  ....+.+.+|+.+++.++||||+++++++....
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   98 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDT-------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   98 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             eeEEeeeeccCCCCeEEEEeEec-------CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence            34788889999999999999865       567889999986543  334567899999999999999999999987655


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc--eeeccCCCCcEEEc-CCCceEE
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQ--VIYRDFKASNVLLD-ENFRPKL  233 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl  233 (436)
                      ......++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.   +  |+||||||+|||++ .++.+||
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl  173 (290)
T 1t4h_A           99 KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKI  173 (290)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred             CCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEE
Confidence            5556679999999999999999764  3689999999999999999999998   7  99999999999997 8899999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +|||++....    ........||+.|+|||++.+ .++.++||||||+++|+|++|..||........  ....+....
T Consensus       174 ~Dfg~~~~~~----~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~  246 (290)
T 1t4h_A          174 GDLGLATLKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGV  246 (290)
T ss_dssp             CCTTGGGGCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHTTTC
T ss_pred             eeCCCccccc----ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--HHHHHhccC
Confidence            9999996422    122344579999999998864 589999999999999999999999976543221  221111110


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .         ..    ..+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       247 ~---------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          247 K---------PA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             C---------CG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             C---------cc----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            0         00    1111123578899999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.5e-44  Score=347.60  Aligned_cols=267  Identities=25%  Similarity=0.408  Sum_probs=205.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|.+++.||+|+||.||+|.+....  +..++..||||.+... .......+.+|+.+++.++||||+++++++....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMP--NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC----------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCC--CCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            358999999999999999999864211  2246788999999754 2334567889999999999999999999997655


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC---C
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAF-----PPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---N  228 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~  228 (436)
                      .    .++||||+++++|.+++.....     ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.   +
T Consensus       107 ~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~  179 (327)
T 2yfx_A          107 P----RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPG  179 (327)
T ss_dssp             S----CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTT
T ss_pred             C----cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCc
Confidence            4    3999999999999999976532     3589999999999999999999998   9999999999999984   4


Q ss_pred             CceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHH
Q 013790          229 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       229 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~  307 (436)
                      +.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|+| |..||.......   +..
T Consensus       180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~  256 (327)
T 2yfx_A          180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLE  256 (327)
T ss_dssp             CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH
T ss_pred             ceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHH
Confidence            5699999999863211222222334567889999999999999999999999999999998 999998654332   222


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      .+.....          .    ..+...+..+.+||.+||+.||.+|||+.+|+++|+.+.+.
T Consensus       257 ~~~~~~~----------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          257 FVTSGGR----------M----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             HHHTTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHhcCCC----------C----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            2221110          0    11122346788999999999999999999999999988653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9.5e-45  Score=351.93  Aligned_cols=248  Identities=34%  Similarity=0.469  Sum_probs=200.7

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      +.|..++.||+|+||.||+|...       .+++.||||++.....   ...+.+.+|+.+++.++||||+++++++...
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  126 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDV-------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE  126 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hheeeeeEEccCCCEEEEEEEEc-------cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            46999999999999999999865       5788999999875432   2345788999999999999999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..++||||+. |+|.+++.... .++++..+..++.|++.||.|||+.   +|+||||||+||||+.++.+||+|
T Consensus       127 ~----~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D  197 (348)
T 1u5q_A          127 H----TAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGD  197 (348)
T ss_dssp             T----EEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECC
T ss_pred             C----eEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEee
Confidence            4    4599999996 68888885433 4799999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      ||++....      ......||+.|+|||++.   +..++.++|||||||++|||++|..||........  +.......
T Consensus       198 fG~a~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~~~~~~~  269 (348)
T 1u5q_A          198 FGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNE  269 (348)
T ss_dssp             CTTCBSSS------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSC
T ss_pred             ccCceecC------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhcC
Confidence            99997532      123457999999999984   56789999999999999999999999976543322  11111111


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                      .           +.+   .....+..+.+||.+||+.||.+|||+.+++++.
T Consensus       270 ~-----------~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          270 S-----------PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             C-----------CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             C-----------CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            0           000   0112246788999999999999999999998874

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.2e-44  Score=348.78  Aligned_cols=267  Identities=22%  Similarity=0.299  Sum_probs=195.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|...       .+++.||||++......  ....+.+|+.+++.++||||+++++++...
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDT-------VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN  105 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred             hhhEEEEEEEEecCCeEEEEEEEC-------CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            468999999999999999999865       57889999999755332  235677899999999999999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE-----cCCCc
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL-----DENFR  230 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~  230 (436)
                      .    ..++||||+. |+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+||||     +.++.
T Consensus       106 ~----~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~  175 (329)
T 3gbz_A          106 H----RLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPV  175 (329)
T ss_dssp             T----EEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCE
T ss_pred             C----EEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccce
Confidence            4    4599999996 59999997654  699999999999999999999998   99999999999999     45566


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  309 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  309 (436)
                      +||+|||+++...  ..........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.............
T Consensus       176 ~kl~Dfg~a~~~~--~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  253 (329)
T 3gbz_A          176 LKIGDFGLARAFG--IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV  253 (329)
T ss_dssp             EEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEECcCCCccccC--CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHH
Confidence            9999999987421  112223445689999999999774 5899999999999999999999999876543322211111


Q ss_pred             hhcccCccc------------cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          310 QQYPADSKK------------FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       310 ~~~~~~~~~------------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...+.....            +.......+........+..+.+||.+||+.||.+|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             HCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            111111100            000000000001111134678899999999999999999999875

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.4e-45  Score=353.30  Aligned_cols=244  Identities=22%  Similarity=0.328  Sum_probs=201.0

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--------hHHHHHHHHHHHhccCCCCceee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--------GHKQWVAEVQFLGVLEHPNLVKL  148 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~  148 (436)
                      ..++|++++.||+|+||.||+|...       .+++.||||++......        ....+.+|+.+++.++||||+++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~   94 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDK-------EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV   94 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEET-------TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCE
T ss_pred             cccceEEEeEEEecCCEEEEEEEEC-------CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            4578999999999999999999865       57889999998765321        22356779999999999999999


Q ss_pred             eeEeeecCCcceeEEEEEEecCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          149 IGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       149 ~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      ++++...+    ..++||||+.+| +|.+++....  .+++..++.++.||+.||.|||++   +|+||||||+|||++.
T Consensus        95 ~~~~~~~~----~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~  165 (335)
T 3dls_A           95 LDIFENQG----FFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAE  165 (335)
T ss_dssp             EEEEECSS----EEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred             EEEEeeCC----EEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcC
Confidence            99997654    458999999776 9999997653  699999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 013790          228 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  306 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  306 (436)
                      ++.+||+|||+++...   .........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......     
T Consensus       166 ~~~~kL~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----  237 (335)
T 3dls_A          166 DFTIKLIDFGSAAYLE---RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-----  237 (335)
T ss_dssp             TSCEEECCCTTCEECC---TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----
T ss_pred             CCcEEEeecccceECC---CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----
Confidence            9999999999997532   2222344679999999999988877 789999999999999999999997522110     


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                       ....  ..+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       238 -----------------~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 -----------------EAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----------------TTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----------------hhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                             0000  0011134678999999999999999999999886

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.2e-44  Score=356.67  Aligned_cols=252  Identities=24%  Similarity=0.386  Sum_probs=195.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccC--CCCceeeeeEeee
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLE--HPNLVKLIGYCAV  154 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~  154 (436)
                      .+|.+++.||+|+||.||+|...        .++.||||++....  ....+.+.+|+.+++.+.  ||||+++++++..
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~  127 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE--------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT  127 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT--------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             CceEEEEEEccCCCeEEEEEEcC--------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence            46999999999999999999854        37889999986543  334567899999999996  5999999999876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||| +.+++|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+||||+ ++.+||+
T Consensus       128 ~~----~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~  196 (390)
T 2zmd_A          128 DQ----YIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLI  196 (390)
T ss_dssp             SS----EEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEEC
T ss_pred             CC----EEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEE
Confidence            54    3699999 56889999997654  689999999999999999999998   999999999999995 5899999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----------GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ  303 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~  303 (436)
                      |||+++...............||+.|+|||++.+           ..++.++|||||||++|+|++|..||........ 
T Consensus       197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-  275 (390)
T 2zmd_A          197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-  275 (390)
T ss_dssp             CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-
T ss_pred             ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-
Confidence            9999986432222223345679999999999865           4688999999999999999999999976533211 


Q ss_pred             HHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          304 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                      .+...+              ++.....++...+..+.+||.+||..||.+|||+.+++++-
T Consensus       276 ~~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          276 KLHAII--------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             HHHHHH--------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHHHh--------------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence            111111              11111111111246788999999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.5e-44  Score=343.34  Aligned_cols=263  Identities=21%  Similarity=0.289  Sum_probs=201.4

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      ..++|++.+.||+|+||.||+|...       .+++.||+|++......   ..+.+.+|+.+++.++||||+++++++.
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~  104 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDT-------VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE  104 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEc-------CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence            3579999999999999999999865       46789999999755322   2467889999999999999999999997


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ..+    ..++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       105 ~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl  175 (309)
T 2h34_A          105 IDG----QLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYL  175 (309)
T ss_dssp             ETT----EEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             eCC----eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEE
Confidence            654    459999999999999999764  3689999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +|||++...... .........|++.|+|||++.+..++.++||||||+++|+|++|..||......   .+...+....
T Consensus       176 ~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~  251 (309)
T 2h34_A          176 VDFGIASATTDE-KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHINQAI  251 (309)
T ss_dssp             CSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHHSCC
T ss_pred             ecCccCcccccc-ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhccCC
Confidence            999998753211 112233457899999999999999999999999999999999999999865332   1222221111


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHhhhhc
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-KMSQVVERLKQIVQVS  371 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~eil~~L~~~~~~~  371 (436)
                      ...            ...+...+..+.+||.+||..||.+|| ++.++++.|+.++...
T Consensus       252 ~~~------------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          252 PRP------------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             CCG------------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             CCc------------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            100            011222346788999999999999999 9999999999887543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.6e-44  Score=342.26  Aligned_cols=252  Identities=22%  Similarity=0.365  Sum_probs=203.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|.+.+.||+|+||.||+|...       .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+ 
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   79 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQR-------LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT-   79 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred             hccceeeeeccCCCCceEEEEEEC-------CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC-
Confidence            468999999999999999999865       467899999998665445567889999999999999999999987654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE---cCCCceEEe
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLS  234 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~  234 (436)
                         ..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+|||+   +.++.+||+
T Consensus        80 ---~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~  151 (304)
T 2jam_A           80 ---HYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMIT  151 (304)
T ss_dssp             ---EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBC
T ss_pred             ---EEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEc
Confidence               4599999999999999986643  689999999999999999999998   99999999999999   788999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||++....    ........||+.|+|||++.+..++.++||||||+++|+|++|..||.......   +...+.....
T Consensus       152 Dfg~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~  224 (304)
T 2jam_A          152 DFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LFEKIKEGYY  224 (304)
T ss_dssp             SCSTTCCCC----CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHCCC
T ss_pred             cCCcceecC----CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHcCCC
Confidence            999987421    122344568999999999999999999999999999999999999998654322   2222221110


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .       ..    .......+..+.+||.+||..||.+|||+.+++++
T Consensus       225 ~-------~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          225 E-------FE----SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             C-------CC----TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             C-------CC----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0       00    11112234678999999999999999999999886

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.9e-44  Score=352.58  Aligned_cols=246  Identities=27%  Similarity=0.398  Sum_probs=193.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHHHHHHHH-HhccCCCCceeeeeEee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQWVAEVQF-LGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~hpnIv~~~~~~~  153 (436)
                      .++|++++.||+|+||.||+|+.+       .+++.||+|++......   ....+.+|..+ ++.++||||+++++++.
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~  109 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHK-------AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ  109 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEET-------TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEc-------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence            468999999999999999999976       56789999999765322   23445667666 57789999999999987


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ..+    ..|+||||++||+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+||
T Consensus       110 ~~~----~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL  180 (373)
T 2r5t_A          110 TAD----KLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVL  180 (373)
T ss_dssp             CSS----EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred             eCC----EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEE
Confidence            654    4699999999999999997643  689999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +|||+++...  ..........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...   +...+...+
T Consensus       181 ~DFG~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i~~~~  255 (373)
T 2r5t_A          181 TDFGLCKENI--EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNILNKP  255 (373)
T ss_dssp             CCCCBCGGGB--CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---HHHHHHHSC
T ss_pred             eeCccccccc--cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHhcc
Confidence            9999997421  12223456789999999999999999999999999999999999999998654322   222221111


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ  359 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  359 (436)
                      .           .+    +...+..+.+||.+||+.||.+||++.+
T Consensus       256 ~-----------~~----~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          256 L-----------QL----KPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             C-----------CC----CSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             c-----------CC----CCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence            0           01    1122467889999999999999999853

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=345.64  Aligned_cols=279  Identities=25%  Similarity=0.393  Sum_probs=212.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++++.||+|+||.||+|.+...   ...+++.||+|++........+.+.+|+.+++.++||||+++++++...+.
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPL---QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTT---SSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccc---cCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            45799999999999999999986421   234689999999987766667789999999999999999999999876542


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                      .  ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       117 ~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          117 R--NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             C--ceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCc
Confidence            2  3589999999999999997653 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCc-ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      ++......... .......++..|+|||++.+..++.++||||||+++|+|+||..||......    ............
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~~  266 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQ  266 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCTH
T ss_pred             chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccchh
Confidence            99754322211 1123345677899999999888999999999999999999999998642110    110000000000


Q ss_pred             c---ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          317 K---KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       317 ~---~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                      .   .+...+........+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            0   0000000000011223345789999999999999999999999999998864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=371.00  Aligned_cols=259  Identities=27%  Similarity=0.380  Sum_probs=209.9

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..++|++.+.||+|+||.||+|.+.        .+..||||++.... ...+.|.+|+.+|+.++||||+++++++.. .
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWN--------GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  334 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             chhhhhhheecccCCCeEEEEEEEC--------CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence            3567899999999999999999975        34679999997654 235679999999999999999999999864 2


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+.+|+|.+++.......+++..++.|+.||+.||.|||++   +|+||||||+||||+.++.+||+||
T Consensus       335 ----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DF  407 (535)
T 2h8h_A          335 ----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF  407 (535)
T ss_dssp             ----SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCT
T ss_pred             ----cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccc
Confidence                249999999999999999754334689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |+++.... ..........++..|+|||++.+..++.++|||||||++|||++ |..||.+.....   +...+....  
T Consensus       408 G~a~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~~~i~~~~--  481 (535)
T 2h8h_A          408 GLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVERGY--  481 (535)
T ss_dssp             TSTTTCCC-HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HHHHHHTTC--
T ss_pred             ccceecCC-CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC--
Confidence            99975321 11111223456788999999999999999999999999999999 999998754332   222221110  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                                  ....+..++..+.+||.+||..||++|||+.+|++.|+.++..
T Consensus       482 ------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          482 ------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             ------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                        0011223456789999999999999999999999999988653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.1e-44  Score=344.65  Aligned_cols=259  Identities=22%  Similarity=0.317  Sum_probs=198.8

Q ss_pred             hcCCccc-ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRM-LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .+.|++. +.||+|+||.||+|...       .+++.||||++..........+.+|+.++.++ +||||+++++++...
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINL-------ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECS-------SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ceeEEecCceecCCceEEEEEEEEc-------CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            4578885 78999999999999854       56789999999776555567889999999885 799999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc---eE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---PK  232 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~k  232 (436)
                      +    ..++||||+.+|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.   +|
T Consensus        84 ~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~k  154 (316)
T 2ac3_A           84 D----RFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVK  154 (316)
T ss_dssp             T----EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEE
T ss_pred             C----EEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceE
Confidence            4    4599999999999999997653  689999999999999999999999   9999999999999988776   99


Q ss_pred             EeeccCCCCCCCCCC-----cccccccccCCCccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh-
Q 013790          233 LSDFGLAREGPMVGH-----THVSTAVVGTFGYAAPDYIET-----GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT-  301 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~-  301 (436)
                      |+|||++........     ........||+.|+|||++.+     ..++.++|||||||++|+|++|..||....... 
T Consensus       155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  234 (316)
T 2ac3_A          155 ICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC  234 (316)
T ss_dssp             ECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS
T ss_pred             EEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc
Confidence            999999874321111     111234569999999999975     567899999999999999999999997654321 


Q ss_pred             -----------hHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          302 -----------EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       302 -----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                 ...+...+......           +........+..+.+||.+||..||.+|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~i~~~~~~-----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          235 GWDRGEACPACQNMLFESIQEGKYE-----------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             CC----CCHHHHHHHHHHHHHCCCC-----------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cccccccchhHHHHHHHHHhccCcc-----------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                       11122211111100           0000001124678999999999999999999999886

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=361.66  Aligned_cols=262  Identities=21%  Similarity=0.285  Sum_probs=206.5

Q ss_pred             HHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCcee
Q 013790           71 YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVK  147 (436)
Q Consensus        71 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~  147 (436)
                      +.++....++|++++.||+|+||.||+|..+       .+++.||+|++.+...   ...+.+.+|..++..++||||++
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~-------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~  125 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMK-------QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ  125 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeee
Confidence            3444455689999999999999999999976       5688999999975322   12345788999999999999999


Q ss_pred             eeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          148 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       148 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      +++++...+    .+|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.   +|+||||||+||||+.
T Consensus       126 l~~~~~~~~----~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~  197 (412)
T 2vd5_A          126 LHFAFQDEN----YLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDR  197 (412)
T ss_dssp             EEEEEECSS----EEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred             EEEEEeeCC----EEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecC
Confidence            999987654    4699999999999999997643 3699999999999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Q 013790          228 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-------TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK  300 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~  300 (436)
                      +|.+||+|||+++..... .........||+.|+|||++.       +..++.++|||||||++|||++|..||......
T Consensus       198 ~g~vkL~DFGla~~~~~~-~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~  276 (412)
T 2vd5_A          198 CGHIRLADFGSCLKLRAD-GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA  276 (412)
T ss_dssp             TSCEEECCCTTCEECCTT-SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             CCCEEEeechhheeccCC-CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH
Confidence            999999999999753221 122234468999999999997       356899999999999999999999999876543


Q ss_pred             hhH-HHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCC---CCHHHHHHH
Q 013790          301 TEQ-RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR---PKMSQVVER  363 (436)
Q Consensus       301 ~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps~~eil~~  363 (436)
                      ... .+..+......          +.+    ....+..+.+||.+||. +|.+|   |++.+|++|
T Consensus       277 ~~~~~i~~~~~~~~~----------p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          277 ETYGKIVHYKEHLSL----------PLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHHHHHHTHHHHCCC----------C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHHHHHHhcccCcCC----------Ccc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            221 11111111100          101    11234678899999999 99998   589999876

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.1e-44  Score=337.66  Aligned_cols=256  Identities=23%  Similarity=0.341  Sum_probs=205.4

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ..++|++.+.||+|+||.||+|...       .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNR-------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG   77 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             eecceEEEEEeecCCCcEEEEEEEC-------CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC
Confidence            4578999999999999999999875       467899999986543 23456788999999999999999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|
T Consensus        78 ~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d  148 (276)
T 2yex_A           78 N----IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISD  148 (276)
T ss_dssp             T----EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             C----EEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEee
Confidence            4    359999999999999998654  3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ||++................||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ ....+......
T Consensus       149 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~  227 (276)
T 2yex_A          149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTY  227 (276)
T ss_dssp             CTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTTCTT
T ss_pred             CCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhcccc
Confidence            999875322222223345678999999999987765 7789999999999999999999986543221 12222211100


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                              .      ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       228 --------~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          228 --------L------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             --------S------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --------c------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                    0      0011234678899999999999999999999865

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.7e-44  Score=339.55  Aligned_cols=254  Identities=25%  Similarity=0.365  Sum_probs=207.1

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..++|++.+.||+|+||.||+|.+.       .+++.||+|.+....    +.+.+|+.+++.++||||+++++++....
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   77 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHR-------IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFD   77 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEET-------TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred             hccccceeeeeccCCceEEEEEEEc-------CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccc
Confidence            4568999999999999999999975       467899999997553    34678999999999999999999875421


Q ss_pred             ------------CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEE
Q 013790          157 ------------ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVL  224 (436)
Q Consensus       157 ------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIl  224 (436)
                                  ......++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +|+|+||||+|||
T Consensus        78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil  154 (284)
T 2a19_B           78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIF  154 (284)
T ss_dssp             EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEE
Confidence                        1133469999999999999999765555799999999999999999999998   9999999999999


Q ss_pred             EcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 013790          225 LDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR  304 (436)
Q Consensus       225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~  304 (436)
                      ++.++.+||+|||++.....   ........||+.|+|||++.+..++.++||||||+++|+|++|..|+...     ..
T Consensus       155 ~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~  226 (284)
T 2a19_B          155 LVDTKQVKIGDFGLVTSLKN---DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SK  226 (284)
T ss_dssp             EEETTEEEECCCTTCEESSC---CSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HH
T ss_pred             EcCCCCEEECcchhheeccc---cccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HH
Confidence            99999999999999875322   12233456899999999999999999999999999999999999887421     11


Q ss_pred             HHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          305 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                      ....+..             ..+...    .+..+.+||.+||..||.+|||+.+++++|+.+..
T Consensus       227 ~~~~~~~-------------~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          227 FFTDLRD-------------GIISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             HHHHHHT-------------TCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             HHHHhhc-------------cccccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            1111111             111111    23568899999999999999999999999988864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.1e-45  Score=349.99  Aligned_cols=266  Identities=25%  Similarity=0.390  Sum_probs=197.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh-HHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|.+++.||+|+||.||+|...       .+++.||+|++....... ...+.+|+.+++.++||||+++++++...+.
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSK-------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS   74 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC
T ss_pred             CceEEEEEEcCCCCEEEEEEEEC-------CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE
Confidence            57999999999999999999875       467899999987543221 1234579999999999999999999976543


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .++||||+. |+|.+++.... ..+++..+..++.||+.||.|||+.   ||+||||||+|||++.++.+||+|||
T Consensus        75 ----~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  145 (324)
T 3mtl_A           75 ----LTLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFG  145 (324)
T ss_dssp             ----EEEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSS
T ss_pred             ----EEEEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCc
Confidence                599999996 69999987654 4689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      +++...  ..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......+...
T Consensus       146 ~a~~~~--~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  223 (324)
T 3mtl_A          146 LARAKS--IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE  223 (324)
T ss_dssp             EEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             cccccc--CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChH
Confidence            987422  12223344578999999999876 568999999999999999999999998765544332222222111111


Q ss_pred             cccccccC---------Cccc----CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 KKFGLIMD---------PRLE----KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~~~~~~~~---------~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      . +.....         +...    .......+..+.+||.+||+.||.+|||+.+++++
T Consensus       224 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          224 T-WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             T-STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             h-chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0 000000         0000    00111234678899999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.6e-44  Score=339.19  Aligned_cols=253  Identities=27%  Similarity=0.344  Sum_probs=198.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|.+.+.||+|+||.||+|...       .++..||+|++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   93 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEER-------SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH   93 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhheeecceeccCCCeEEEEEEEc-------cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC
Confidence            357999999999999999999865       467889999987653 234578899999999999999999999997544


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE---cCCCce
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRP  231 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~  231 (436)
                          ..++||||+++|+|.+++...  ....+++..++.++.|++.||.|||+.   +|+||||||+|||+   +.++.+
T Consensus        94 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~  166 (285)
T 3is5_A           94 ----NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPI  166 (285)
T ss_dssp             ----EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCE
T ss_pred             ----eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCE
Confidence                459999999999999998643  235799999999999999999999998   99999999999999   556889


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      ||+|||++....   .........||+.|+|||++. ..++.++||||||+++|+|++|..||.+...........   .
T Consensus       167 kl~Dfg~a~~~~---~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~---~  239 (285)
T 3is5_A          167 KIIDFGLAELFK---SDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT---Y  239 (285)
T ss_dssp             EECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H
T ss_pred             EEEeeecceecC---CcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc---c
Confidence            999999997532   222334567899999999986 568999999999999999999999998765433221111   1


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....           .... ....+..+.+||.+||+.||.+|||+.+++++
T Consensus       240 ~~~~-----------~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          240 KEPN-----------YAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CCCC-----------CCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             CCcc-----------cccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1100           0000 00123678899999999999999999999865

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.2e-43  Score=343.02  Aligned_cols=270  Identities=23%  Similarity=0.353  Sum_probs=210.8

Q ss_pred             HHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhc--cCCCCceeeeeEe
Q 013790           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGV--LEHPNLVKLIGYC  152 (436)
Q Consensus        75 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~  152 (436)
                      ....++|.+.+.||+|+||.||+|.+         +++.||||++...   ....+.+|++++..  ++||||+++++++
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~  105 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW---------RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD  105 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE---------TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE---------cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence            44567899999999999999999985         3788999999654   33567788888877  7899999999999


Q ss_pred             eecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCceeeccCCCCcEE
Q 013790          153 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH--------EGLEVQVIYRDFKASNVL  224 (436)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH--------~~~~~~ivH~Dlkp~NIl  224 (436)
                      ..........++||||+++|+|.+++...   .+++..++.++.|++.||.|||        +.   +|+||||||+|||
T Consensus       106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl  179 (342)
T 1b6c_B          106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL  179 (342)
T ss_dssp             ECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred             cccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence            87664444679999999999999999764   5899999999999999999999        76   9999999999999


Q ss_pred             EcCCCceEEeeccCCCCCCCCCCc--ccccccccCCCcccccccccC------CCCchhhHHHHHHHHHHHHhC------
Q 013790          225 LDENFRPKLSDFGLAREGPMVGHT--HVSTAVVGTFGYAAPDYIETG------HLTAKSDVWSFGVVLYEMLTG------  290 (436)
Q Consensus       225 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg------  290 (436)
                      |+.++.+||+|||++.........  .......||+.|+|||++.+.      .++.++|||||||++|+|+||      
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence            999999999999999743221111  123445799999999999765      234689999999999999999      


Q ss_pred             ----CCCCCCCCchh--hHHHHHHHhhcccCccccccccCCcccCc-CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          291 ----RRSLERNRPKT--EQRLLEWVQQYPADSKKFGLIMDPRLEKE-YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       291 ----~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                          ..||.......  ...+...+...         ...+.+... .....+..+.+||.+||+.||.+|||+.+|+++
T Consensus       260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQ---------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CCCCCCTTTTTSCSSCCHHHHHHHHTTS---------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccccccCccccCcCcccHHHHHHHHHHH---------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                77886543321  11121111110         111112111 234667889999999999999999999999999


Q ss_pred             HHHhhhhc
Q 013790          364 LKQIVQVS  371 (436)
Q Consensus       364 L~~~~~~~  371 (436)
                      |+.+.+..
T Consensus       331 L~~i~~~~  338 (342)
T 1b6c_B          331 LSQLSQQE  338 (342)
T ss_dssp             HHHHHHTT
T ss_pred             HHHHHHHh
Confidence            99997654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-44  Score=353.63  Aligned_cols=268  Identities=21%  Similarity=0.289  Sum_probs=201.2

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ...++|++++.||+|+||.||+|...       .+++.||||++.....    ...+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~   72 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDI-------ESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTT   72 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEET-------TTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEEEeccCEEEEEEEEC-------CCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeec
Confidence            45678999999999999999999865       5688999999865432    234699999999999999999998654


Q ss_pred             CC----------------------------------cceeEEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHH
Q 013790          156 GE----------------------------------RGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAA  199 (436)
Q Consensus       156 ~~----------------------------------~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~ql~  199 (436)
                      +.                                  ...+.++||||++ |+|.+.+..  .....+++..+..++.||+
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence            32                                  2335789999997 588877753  2335799999999999999


Q ss_pred             HHHHHhhcCCCCceeeccCCCCcEEEc-CCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhH
Q 013790          200 EGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDV  277 (436)
Q Consensus       200 ~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv  277 (436)
                      .||.|||+.   ||+||||||+|||++ .++.+||+|||+++...   .........||+.|+|||++.+. .++.++||
T Consensus       152 ~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  225 (383)
T 3eb0_A          152 RAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI---PSEPSVAYICSRFYRAPELMLGATEYTPSIDL  225 (383)
T ss_dssp             HHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECC---TTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred             HHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccC---CCCCCcCcccCCCccCHHHhcCCCCCCcchhh
Confidence            999999998   999999999999997 68999999999997532   22233456789999999998764 58999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc-------------ccccccCCcccCcCCHHHHHHHHHHHH
Q 013790          278 WSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK-------------KFGLIMDPRLEKEYSINEARKIGRLAD  344 (436)
Q Consensus       278 wSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~l~~~~~~~~~~~l~~li~  344 (436)
                      |||||++|+|++|..||.+........  ..+........             .+..+....+...++...+..+.+||.
T Consensus       226 wslG~il~ell~g~~pf~~~~~~~~~~--~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  303 (383)
T 3eb0_A          226 WSIGCVFGELILGKPLFSGETSIDQLV--RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE  303 (383)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHH
T ss_pred             hhHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHH
Confidence            999999999999999998765433221  11111111000             000111111111223334577899999


Q ss_pred             HhhcCCCCCCCCHHHHHHH
Q 013790          345 NCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       345 ~cl~~dp~~RPs~~eil~~  363 (436)
                      +||..||.+|||+.+++++
T Consensus       304 ~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          304 QILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             HHCCSSGGGSCCHHHHHTS
T ss_pred             HHccCChhhCCCHHHHhcC
Confidence            9999999999999999976

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=347.02  Aligned_cols=280  Identities=22%  Similarity=0.358  Sum_probs=200.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHH--HhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQF--LGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|.+         +++.||||++....   ...+..|.++  +..++||||+++++.+...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~   79 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL---------DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERV   79 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE---------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE---------CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence            46899999999999999999975         46889999997543   2334444444  5568999999999866542


Q ss_pred             C-CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC------CCceeeccCCCCcEEEcCC
Q 013790          156 G-ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL------EVQVIYRDFKASNVLLDEN  228 (436)
Q Consensus       156 ~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~------~~~ivH~Dlkp~NIll~~~  228 (436)
                      . ......++||||+++|+|.+++...   ..++..++.++.||+.||.|||+.+      ..+|+||||||+||||+.+
T Consensus        80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~  156 (336)
T 3g2f_A           80 TADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND  156 (336)
T ss_dssp             CTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred             ccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence            2 2233568999999999999999765   3588999999999999999999852      2389999999999999999


Q ss_pred             CceEEeeccCCCCCCCCC------CcccccccccCCCccccccccc-------CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 013790          229 FRPKLSDFGLAREGPMVG------HTHVSTAVVGTFGYAAPDYIET-------GHLTAKSDVWSFGVVLYEMLTGRRSLE  295 (436)
Q Consensus       229 ~~~kl~Dfg~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~elltg~~pf~  295 (436)
                      +.+||+|||+++......      .........||+.|+|||++.+       ..++.++|||||||++|||++|..||.
T Consensus       157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            999999999997532111      1122234579999999999976       456678999999999999999987764


Q ss_pred             CCCchhhH--HHHHHHhhcccCccc----cccccCCcccCc--CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          296 RNRPKTEQ--RLLEWVQQYPADSKK----FGLIMDPRLEKE--YSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       296 ~~~~~~~~--~~~~~~~~~~~~~~~----~~~~~~~~l~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                      ........  .+.......+.....    ......+.+...  .....+..+.+||.+||..||.+|||+.++++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            43221110  000000000000000    000011111111  1234677899999999999999999999999999999


Q ss_pred             hhhcC
Q 013790          368 VQVSN  372 (436)
Q Consensus       368 ~~~~~  372 (436)
                      +....
T Consensus       317 l~~~~  321 (336)
T 3g2f_A          317 MMIWE  321 (336)
T ss_dssp             HHCCC
T ss_pred             HHHHH
Confidence            86543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=346.69  Aligned_cols=264  Identities=23%  Similarity=0.330  Sum_probs=192.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~  156 (436)
                      ..+|++.+.||+|+||.||+|.+.       .+++.||||++........+.+.+|+.++..+. ||||+++++++....
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~   99 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDV-------GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK   99 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEET-------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred             CceEEEEEEEccCCceEEEEEEEC-------CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence            458999999999999999999975       467899999987766666678899999999996 999999999985322


Q ss_pred             ----CcceeEEEEEEecCCCCHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc--eeeccCCCCcEEEcCCC
Q 013790          157 ----ERGIQRLLVYEFMLNRSLEDHLFN-RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQ--VIYRDFKASNVLLDENF  229 (436)
Q Consensus       157 ----~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~--ivH~Dlkp~NIll~~~~  229 (436)
                          ......++||||+. |+|.+++.. .....+++..++.++.||+.||.|||+.   +  |+||||||+||||+.++
T Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~  175 (337)
T 3ll6_A          100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQG  175 (337)
T ss_dssp             TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTS
T ss_pred             cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCC
Confidence                22345699999995 799998865 2234699999999999999999999998   8  99999999999999999


Q ss_pred             ceEEeeccCCCCCCCCCCc----------ccccccccCCCccccccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 013790          230 RPKLSDFGLAREGPMVGHT----------HVSTAVVGTFGYAAPDYI---ETGHLTAKSDVWSFGVVLYEMLTGRRSLER  296 (436)
Q Consensus       230 ~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~pf~~  296 (436)
                      .+||+|||+++........          .......||+.|+|||++   .+..++.++|||||||++|+|++|..||..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            9999999999753322111          111245689999999998   567789999999999999999999999975


Q ss_pred             CCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcC
Q 013790          297 NRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSN  372 (436)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~  372 (436)
                      .....   +...  ..           ..    ......+..+.+||.+||+.||.+|||+.+++++|+.+.....
T Consensus       256 ~~~~~---~~~~--~~-----------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          256 GAKLR---IVNG--KY-----------SI----PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             ---------------C-----------CC----CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             hhHHH---hhcC--cc-----------cC----CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence            33211   1100  00           00    0011112457799999999999999999999999999976543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=350.04  Aligned_cols=277  Identities=17%  Similarity=0.233  Sum_probs=208.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCC-CCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCcee---------
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAG-DGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVK---------  147 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~---------  147 (436)
                      .++|++.+.||+|+||.||+|....... .....++.||+|.+...     +.+.+|+.+++.++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999999762110 00014788999998754     35778999999999999988         


Q ss_pred             ------eeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCC
Q 013790          148 ------LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  221 (436)
Q Consensus       148 ------~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~  221 (436)
                            +++++...+   ...++||||+ +++|.+++.......+++..++.++.||+.||.|||++   +|+||||||+
T Consensus       116 ~~~i~~~~~~~~~~~---~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~  188 (352)
T 2jii_A          116 LLAIPTCMGFGVHQD---KYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE  188 (352)
T ss_dssp             TCSCCCCCEEEEETT---TEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred             ccCccchhhccccCC---cEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence                  455655422   2569999999 99999999876445799999999999999999999999   9999999999


Q ss_pred             cEEEcCCC--ceEEeeccCCCCCCCCC-----CcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 013790          222 NVLLDENF--RPKLSDFGLAREGPMVG-----HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL  294 (436)
Q Consensus       222 NIll~~~~--~~kl~Dfg~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf  294 (436)
                      |||++.++  .+||+|||+++......     .........||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999998  99999999997532111     111223457999999999999999999999999999999999999999


Q ss_pred             CCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcCC
Q 013790          295 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE  373 (436)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~  373 (436)
                      ........ .+.............   +......   ....+..+.+||.+||..||.+|||+.+|++.|+.++.....
T Consensus       269 ~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  340 (352)
T 2jii_A          269 TNCLPNTE-DIMKQKQKFVDKPGP---FVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV  340 (352)
T ss_dssp             GGGTTCHH-HHHHHHHHHHHSCCC---EECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             ccCCcCHH-HHHHHHHhccCChhh---hhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence            87543221 122222211111111   0110000   011236789999999999999999999999999999876553

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-44  Score=346.93  Aligned_cols=270  Identities=24%  Similarity=0.318  Sum_probs=198.1

Q ss_pred             HHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh-----HHHHHHHHHHHhccCCCCceeee
Q 013790           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-----HKQWVAEVQFLGVLEHPNLVKLI  149 (436)
Q Consensus        75 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~  149 (436)
                      ....++|++++.||+|+||.||+|.+.       .+++.||||++.......     ...+.+|+.+++.++||||++++
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   78 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDK-------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL   78 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECS-------SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEEC-------CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence            344678999999999999999999865       467899999987542221     24678899999999999999999


Q ss_pred             eEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC
Q 013790          150 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  229 (436)
Q Consensus       150 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  229 (436)
                      +++...+.    .++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++
T Consensus        79 ~~~~~~~~----~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~  149 (346)
T 1ua2_A           79 DAFGHKSN----ISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENG  149 (346)
T ss_dssp             EEECCTTC----CEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred             EEEeeCCc----eEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCC
Confidence            99876554    4999999975 8999886543 4688999999999999999999998   999999999999999999


Q ss_pred             ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 013790          230 RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  308 (436)
Q Consensus       230 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  308 (436)
                      .+||+|||+++...  ..........||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.........+..
T Consensus       150 ~~kl~Dfg~a~~~~--~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~  227 (346)
T 1ua2_A          150 VLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE  227 (346)
T ss_dssp             CEEECCCGGGSTTT--SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CEEEEecccceecc--CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            99999999997532  122233456789999999999654 589999999999999999999999987654332211111


Q ss_pred             HhhcccCccccccc------cCCcccCc-----CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          309 VQQYPADSKKFGLI------MDPRLEKE-----YSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       309 ~~~~~~~~~~~~~~------~~~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....+... .+...      ........     .....+..+.+||.+||..||.+|||+.+++++
T Consensus       228 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          228 TLGTPTEE-QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHCCCCTT-TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HcCCCChh-hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            11111110 00000      00000000     012234679999999999999999999999886

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.6e-44  Score=347.55  Aligned_cols=259  Identities=20%  Similarity=0.313  Sum_probs=205.0

Q ss_pred             HHHhhcCCccc-ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccC-CCCceeee
Q 013790           74 MRQATNDFSRM-LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLE-HPNLVKLI  149 (436)
Q Consensus        74 ~~~~~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~  149 (436)
                      ...+.+.|.+. +.||+|+||.||+|...       .+++.||+|++....  ......+.+|+.++..+. ||||++++
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISK-------STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEEC-------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            34556778887 88999999999999875       567899999987543  223567889999999985 69999999


Q ss_pred             eEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC--
Q 013790          150 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE--  227 (436)
Q Consensus       150 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--  227 (436)
                      +++...+    ..++||||+.+|+|.+++.......+++..++.++.||+.||.|||+.   +|+||||||+|||++.  
T Consensus        96 ~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~  168 (327)
T 3lm5_A           96 EVYENTS----EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIY  168 (327)
T ss_dssp             EEEECSS----EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBT
T ss_pred             EEEEeCC----eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCC
Confidence            9987654    459999999999999999776556899999999999999999999998   9999999999999987  


Q ss_pred             -CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 013790          228 -NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  306 (436)
Q Consensus       228 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  306 (436)
                       ++.+||+|||+++...   .........||+.|+|||++.+..++.++||||||+++|+|++|..||........... 
T Consensus       169 ~~~~~kL~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-  244 (327)
T 3lm5_A          169 PLGDIKIVDFGMSRKIG---HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN-  244 (327)
T ss_dssp             TBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-
T ss_pred             CCCcEEEeeCccccccC---CccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH-
Confidence             7899999999997532   22223446799999999999999999999999999999999999999987554322111 


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                        +......           .........+..+.+||.+||..||.+|||+.+++++
T Consensus       245 --i~~~~~~-----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          245 --ISQVNVD-----------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             --HHHTCCC-----------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             --HHhcccc-----------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence              1111100           0111112234678899999999999999999999876

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3e-44  Score=365.46  Aligned_cols=255  Identities=25%  Similarity=0.382  Sum_probs=206.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|.+++.||+|+||.||+|..+       .+++.||+|++.....   .....+.+|+.+++.++||||+++++++..
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~-------~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  256 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMK-------ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET  256 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEC-------CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee
Confidence            378999999999999999999976       4688999999975432   234578899999999999999999999876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      ..    ..|+||||++||+|.+++....  ...+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+|
T Consensus       257 ~~----~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vk  329 (543)
T 3c4z_A          257 KT----DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVR  329 (543)
T ss_dssp             SS----EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred             CC----EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEE
Confidence            54    4699999999999999997643  45699999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-hhHHHHHHHhh
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK-TEQRLLEWVQQ  311 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-~~~~~~~~~~~  311 (436)
                      |+|||+++....  .........||+.|+|||++.+..++.++|||||||++|||++|..||...... ....+...+..
T Consensus       330 L~DFGla~~~~~--~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~  407 (543)
T 3c4z_A          330 ISDLGLAVELKA--GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE  407 (543)
T ss_dssp             ECCCTTCEECCT--TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH
T ss_pred             EeecceeeeccC--CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh
Confidence            999999975321  122234458999999999999999999999999999999999999999865332 11222222211


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHHH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM-----SQVVER  363 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~  363 (436)
                      ...               .++...+..+.+||.+||..||.+||++     .+|+.|
T Consensus       408 ~~~---------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          408 QAV---------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             CCC---------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             ccc---------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence            110               1122234678899999999999999965     677764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.1e-45  Score=356.29  Aligned_cols=260  Identities=15%  Similarity=0.185  Sum_probs=204.6

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC---CCCceeeeeEee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE---HPNLVKLIGYCA  153 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~  153 (436)
                      ..++|.+.+.||+|+||.||+|.+...  ....+++.||||++....   ...+..|+.++..++   |+||+.+++++.
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDL--NDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC---------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCC--cccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            457899999999999999999975321  123578889999997654   345666777777665   999999999997


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC---
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNR---AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---  227 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---  227 (436)
                      ..+.    .++||||+++|+|.+++...   ....+++..++.|+.||+.||.|||+.   +|+||||||+||||+.   
T Consensus       138 ~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          138 FQNG----SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             CSSC----EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGT
T ss_pred             cCCC----cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEeccccc
Confidence            7654    49999999999999999642   235799999999999999999999998   9999999999999998   


Q ss_pred             --------CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 013790          228 --------NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP  299 (436)
Q Consensus       228 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~  299 (436)
                              ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                    899999999999643222333444567899999999999999999999999999999999999999964322


Q ss_pred             hhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCC-CCHHHHHHHHHHhhhh
Q 013790          300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDR-PKMSQVVERLKQIVQV  370 (436)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~R-Ps~~eil~~L~~~~~~  370 (436)
                      ..               ..    ....+...   ..+..+.+++..||+.+|.+| |++.++.+.|+++++.
T Consensus       291 ~~---------------~~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          291 GE---------------CK----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             TE---------------EE----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             Cc---------------ee----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            10               00    01111111   124678899999999999999 5788888889888764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.6e-44  Score=338.50  Aligned_cols=258  Identities=24%  Similarity=0.378  Sum_probs=204.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch------hHHHHHHHHHHHhccCCCCceeeeeE
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ------GHKQWVAEVQFLGVLEHPNLVKLIGY  151 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~  151 (436)
                      .++|++.+.||+|+||.||+|...       .+++.||+|.+......      ..+.+.+|+.+++.++||||++++++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   76 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQK-------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDI   76 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEc-------CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhe
Confidence            357999999999999999999975       46789999998654322      35678999999999999999999999


Q ss_pred             eeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC--
Q 013790          152 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF--  229 (436)
Q Consensus       152 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~--  229 (436)
                      +....    ..++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++  
T Consensus        77 ~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  147 (283)
T 3bhy_A           77 FENKT----DVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVP  147 (283)
T ss_dssp             EECSS----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSS
T ss_pred             ecCCC----eEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCC
Confidence            87654    459999999999999999754  3689999999999999999999998   999999999999998877  


Q ss_pred             --ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 013790          230 --RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       230 --~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  307 (436)
                        .+||+|||++....   .........|++.|+|||++.+..++.++||||||+++|+|++|..||........   ..
T Consensus       148 ~~~~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~  221 (283)
T 3bhy_A          148 NPRIKLIDFGIAHKIE---AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET---LT  221 (283)
T ss_dssp             SCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH
T ss_pred             CCceEEEecccceecc---CCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH---HH
Confidence              89999999997532   12223345689999999999999999999999999999999999999987543322   11


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHHhh
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER--LKQIV  368 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~~~  368 (436)
                      .+......           .........+..+.+|+.+||..||.+|||+.+++++  ++.+.
T Consensus       222 ~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          222 NISAVNYD-----------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HHHTTCCC-----------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             HhHhcccC-----------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            11111100           0000011224678899999999999999999999985  44443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=338.14  Aligned_cols=252  Identities=27%  Similarity=0.431  Sum_probs=183.8

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      ..++|.+.+.||+|+||.||+|...       .+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++.
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   81 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESI-------HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE   81 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEc-------cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc
Confidence            3568999999999999999999865       4678999999865422   22367889999999999999999999987


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ..+    ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||
T Consensus        82 ~~~----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl  153 (278)
T 3cok_A           82 DSN----YVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKI  153 (278)
T ss_dssp             CSS----EEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEE
T ss_pred             cCC----eEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEE
Confidence            654    4599999999999999997653 4789999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +|||++......  ........||+.|+|||++.+..++.++||||||+++|+|++|..||........   .   ..  
T Consensus       154 ~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~~--  223 (278)
T 3cok_A          154 ADFGLATQLKMP--HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---L---NK--  223 (278)
T ss_dssp             CCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------
T ss_pred             EeecceeeccCC--CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---H---HH--
Confidence            999999753211  1222345789999999999988899999999999999999999999976443211   0   00  


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                              +.....  ..+...+..+.+||.+||..||.+|||+.+++++
T Consensus       224 --------~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          224 --------VVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             --------CCSSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             --------Hhhccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence                    000000  1122234678899999999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.6e-44  Score=350.23  Aligned_cols=260  Identities=22%  Similarity=0.347  Sum_probs=205.4

Q ss_pred             HHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--------hhHHHHHHHHHHHhcc-C
Q 013790           71 YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--------QGHKQWVAEVQFLGVL-E  141 (436)
Q Consensus        71 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~  141 (436)
                      ......+.++|.+.+.||+|+||.||+|.+.       .+++.||||++.....        ...+.+.+|+.+++.+ +
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~  158 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR-------ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG  158 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEEC-------CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcC
Confidence            3344556688999999999999999999975       4678999999865431        1135678899999999 7


Q ss_pred             CCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCC
Q 013790          142 HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  221 (436)
Q Consensus       142 hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~  221 (436)
                      ||||+++++++...+    ..++||||+.+++|.+++...  ..+++..+..++.||+.||.|||+.   ||+|+||||+
T Consensus       159 hp~iv~~~~~~~~~~----~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~  229 (365)
T 2y7j_A          159 HPHIITLIDSYESSS----FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPE  229 (365)
T ss_dssp             CTTBCCEEEEEEBSS----EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             CCCEeEEEEEEeeCC----EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence            999999999987644    469999999999999999754  3699999999999999999999998   9999999999


Q ss_pred             cEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCccccccccc------CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 013790          222 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET------GHLTAKSDVWSFGVVLYEMLTGRRSLE  295 (436)
Q Consensus       222 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~pf~  295 (436)
                      |||++.++.+||+|||++....   .........||+.|+|||++.+      ..++.++|||||||++|+|++|..||.
T Consensus       230 NIl~~~~~~ikl~DfG~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~  306 (365)
T 2y7j_A          230 NILLDDNMQIRLSDFGFSCHLE---PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW  306 (365)
T ss_dssp             GEEECTTCCEEECCCTTCEECC---TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             HEEECCCCCEEEEecCcccccC---CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence            9999999999999999987532   1223345679999999999864      357889999999999999999999997


Q ss_pred             CCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          296 RNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .......   ...+........      .+     .....+..+.+||.+||..||.+|||+.+++++
T Consensus       307 ~~~~~~~---~~~i~~~~~~~~------~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          307 HRRQILM---LRMIMEGQYQFS------SP-----EWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             CSSHHHH---HHHHHHTCCCCC------HH-----HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCHHHH---HHHHHhCCCCCC------Cc-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            6543222   221111100000      00     000123568899999999999999999999875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.4e-44  Score=346.83  Aligned_cols=268  Identities=24%  Similarity=0.373  Sum_probs=201.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|...       .+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++...
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   96 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNK-------DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK   96 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEET-------TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hhhheeeeEEeecCCEEEEEEEEC-------CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence            468999999999999999999975       5678999999865432  2345678999999999999999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..++||||+.+++|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+|
T Consensus        97 ~----~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~D  167 (331)
T 4aaa_A           97 K----RWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCD  167 (331)
T ss_dssp             T----EEEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             C----EEEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEe
Confidence            4    3599999999999988875443  699999999999999999999999   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHH-HHhhcc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE-WVQQYP  313 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~-~~~~~~  313 (436)
                      ||+++....  .........||+.|+|||++.+. .++.++|||||||++|+|++|..||............. ......
T Consensus       168 fg~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (331)
T 4aaa_A          168 FGFARTLAA--PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLI  245 (331)
T ss_dssp             CTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             CCCceeecC--CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Confidence            999975321  12233445789999999999775 78999999999999999999999998765433221111 100000


Q ss_pred             cC-------ccccccccCCcccCcC-----CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 AD-------SKKFGLIMDPRLEKEY-----SINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~-------~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..       ...+.....+.+....     ....+..+.+||.+||+.||.+|||+.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00       0000001111111111     12335789999999999999999999999876

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=334.87  Aligned_cols=256  Identities=21%  Similarity=0.282  Sum_probs=203.6

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc----chhHHHHHHHHHHHhccCCCCceeeeeEe
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQGHKQWVAEVQFLGVLEHPNLVKLIGYC  152 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  152 (436)
                      ..++|.+.+.||+|+||.||+|...       .+++.||+|++....    ......+.+|+.+++.++||||+++++++
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   75 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDS-------ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVL   75 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBT-------TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccceeEeeEEecCCCeEEEEEEEC-------CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEE
Confidence            3578999999999999999999865       567899999997543    23356789999999999999999999998


Q ss_pred             eecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          153 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      .....  ...++||||+.++ |.+++.......+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+|
T Consensus        76 ~~~~~--~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~k  149 (305)
T 2wtk_C           76 YNEEK--QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLK  149 (305)
T ss_dssp             ECC-----CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred             EcCCC--CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEE
Confidence            64332  2469999999776 88887765556799999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH--LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      |+|||++................||+.|+|||++.+..  ++.++||||||+++|+|++|..||.......   ....+.
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~i~  226 (305)
T 2wtk_C          150 ISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK---LFENIG  226 (305)
T ss_dssp             ECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHH
T ss_pred             eeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH---HHHHHh
Confidence            99999997543222333344567999999999997643  3779999999999999999999998654322   222221


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....           .+    +...+..+.+||.+||..||.+|||+.+++++
T Consensus       227 ~~~~-----------~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          227 KGSY-----------AI----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HCCC-----------CC----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             cCCC-----------CC----CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1110           11    11234678899999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5e-44  Score=362.41  Aligned_cols=252  Identities=25%  Similarity=0.368  Sum_probs=202.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|..+       .+++.||||++....  ......+.+|+.+++.++||||+++++++...
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   93 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDR-------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS   93 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEET-------TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hcceEEeEEEeecCCEEEEEEEEC-------CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence            468999999999999999999975       567899999986432  23456789999999999999999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc---CCCceE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPK  232 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~k  232 (436)
                      .    ..++||||+.+|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++   .++.+|
T Consensus        94 ~----~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k  164 (486)
T 3mwu_A           94 S----SFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK  164 (486)
T ss_dssp             S----EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEE
T ss_pred             C----EEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEE
Confidence            4    4599999999999999987653  699999999999999999999998   999999999999994   566799


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |+|||+++...   .........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.....   +...+...
T Consensus       165 l~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~  237 (486)
T 3mwu_A          165 IIDFGLSTCFQ---QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRVETG  237 (486)
T ss_dssp             ECSCSCTTTBC---CC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHT
T ss_pred             EEECCcCeECC---CCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhC
Confidence            99999997532   2223345679999999999975 58999999999999999999999998765432   22222211


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....           ........+..+.+||.+||..||.+|||+.+++++
T Consensus       238 ~~~~-----------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          238 KYAF-----------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CCCS-----------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCCC-----------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1000           001112234678899999999999999999999987

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.8e-44  Score=356.00  Aligned_cols=265  Identities=21%  Similarity=0.289  Sum_probs=203.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc------CCCCceeeeeE
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL------EHPNLVKLIGY  151 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~~  151 (436)
                      ..+|++++.||+|+||.||+|...       .+++.||||++.... .....+.+|+.+++.+      +|+||++++++
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~-------~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~  167 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDH-------KVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN  167 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEET-------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEEC-------CCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence            467999999999999999999865       568899999997542 3345677788888777      57899999999


Q ss_pred             eeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc-
Q 013790          152 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR-  230 (436)
Q Consensus       152 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-  230 (436)
                      +....    ..++||||+. ++|.+++.......+++..+..++.||+.||.|||+.   +|+||||||+||||+.++. 
T Consensus       168 ~~~~~----~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~  239 (429)
T 3kvw_A          168 FTFRN----HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRS  239 (429)
T ss_dssp             EEETT----EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSC
T ss_pred             cccCC----eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCc
Confidence            87654    4599999995 6999999887666799999999999999999999998   9999999999999999887 


Q ss_pred             -eEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 013790          231 -PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  309 (436)
Q Consensus       231 -~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  309 (436)
                       +||+|||+++...     .......||+.|+|||++.+..++.++|||||||++|||+||.+||.+.........+...
T Consensus       240 ~vkL~DFG~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~  314 (429)
T 3kvw_A          240 GIKVIDFGSSCYEH-----QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL  314 (429)
T ss_dssp             CEEECCCTTCEETT-----CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             ceEEeecccceecC-----CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence             9999999996421     1233467899999999999999999999999999999999999999876543322211111


Q ss_pred             hhcccCc--------------cccc------cccC-----------------C----cccCcCCHHHHHHHHHHHHHhhc
Q 013790          310 QQYPADS--------------KKFG------LIMD-----------------P----RLEKEYSINEARKIGRLADNCLS  348 (436)
Q Consensus       310 ~~~~~~~--------------~~~~------~~~~-----------------~----~l~~~~~~~~~~~l~~li~~cl~  348 (436)
                      ...+...              ..+.      .+.+                 +    .+........+..+.+||.+||+
T Consensus       315 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~  394 (429)
T 3kvw_A          315 LGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLE  394 (429)
T ss_dssp             HCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTC
T ss_pred             cCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCC
Confidence            1111000              0000      0000                 0    00000111124678899999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 013790          349 KSSKDRPKMSQVVER  363 (436)
Q Consensus       349 ~dp~~RPs~~eil~~  363 (436)
                      .||.+|||+.+++++
T Consensus       395 ~dP~~Rpta~e~L~H  409 (429)
T 3kvw_A          395 WDPAVRMTPGQALRH  409 (429)
T ss_dssp             SSTTTSCCHHHHHTS
T ss_pred             CChhhCCCHHHHhCC
Confidence            999999999999886

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.6e-44  Score=355.78  Aligned_cols=255  Identities=23%  Similarity=0.343  Sum_probs=193.5

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--------hHHHHHHHHHHHhccCCCCcee
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--------GHKQWVAEVQFLGVLEHPNLVK  147 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~  147 (436)
                      ...++|.+.+.||+|+||.||+|...       .+++.||||++......        ....+.+|+.++++++||||++
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  204 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFER-------KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK  204 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCC
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEEC-------CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEee
Confidence            35689999999999999999999876       56789999998654211        1224788999999999999999


Q ss_pred             eeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          148 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       148 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      +++++...     ..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||++   +|+||||||+|||++.
T Consensus       205 l~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~  274 (419)
T 3i6u_A          205 IKNFFDAE-----DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSS  274 (419)
T ss_dssp             CCEEEESS-----EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESS
T ss_pred             EEEEEecC-----ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEec
Confidence            99997532     258999999999999998654  4799999999999999999999998   9999999999999965


Q ss_pred             C---CceEEeeccCCCCCCCCCCcccccccccCCCccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q 013790          228 N---FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT  301 (436)
Q Consensus       228 ~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  301 (436)
                      +   +.+||+|||+++...   .........||+.|+|||++.+   ..++.++|||||||++|+|++|..||.......
T Consensus       275 ~~~~~~~kl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  351 (419)
T 3i6u_A          275 QEEDCLIKITDFGHSKILG---ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV  351 (419)
T ss_dssp             SSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC
T ss_pred             CCCcceEEEeecccceecC---CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH
Confidence            4   459999999998532   2333345679999999999853   678889999999999999999999997643321


Q ss_pred             hHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          302 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .  +...+......       ..+    ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       352 ~--~~~~i~~~~~~-------~~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          352 S--LKDQITSGKYN-------FIP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             C--HHHHHHTTCCC-------CCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             H--HHHHHhcCCCC-------CCc----hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            1  11111111000       000    0011224678899999999999999999999876

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6e-44  Score=348.21  Aligned_cols=277  Identities=22%  Similarity=0.230  Sum_probs=203.5

Q ss_pred             HHHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-----------hHHHHHHHHHHHhc
Q 013790           71 YSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-----------GHKQWVAEVQFLGV  139 (436)
Q Consensus        71 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~  139 (436)
                      ..++....++|.+.+.||+|+||.||+|...        ++..||||++......           ..+.+.+|+.+++.
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   85 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS--------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH   85 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECT--------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECC--------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHh
Confidence            5577788899999999999999999999854        4788999998643221           23678999999999


Q ss_pred             cCCCCceeeeeEeeecC-CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccC
Q 013790          140 LEHPNLVKLIGYCAVDG-ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDF  218 (436)
Q Consensus       140 l~hpnIv~~~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dl  218 (436)
                      ++||||+++++++.... ......++||||+. |+|.+++.... ..+++..+..++.||+.||.|||+.   +|+||||
T Consensus        86 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl  160 (362)
T 3pg1_A           86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDL  160 (362)
T ss_dssp             CCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCC
T ss_pred             CCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCC
Confidence            99999999999986543 23346799999996 68888887543 4699999999999999999999999   9999999


Q ss_pred             CCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 013790          219 KASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERN  297 (436)
Q Consensus       219 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~  297 (436)
                      ||+|||++.++.+||+|||+++...   .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus       161 kp~NIl~~~~~~~kl~Dfg~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  237 (362)
T 3pg1_A          161 HPGNILLADNNDITICDFNLAREDT---ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS  237 (362)
T ss_dssp             CGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ChHHEEEcCCCCEEEEecCcccccc---cccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999997422   2223344678999999999876 67899999999999999999999999876


Q ss_pred             CchhhHHHHHHHhhcccCc-------cccccccCC-------cccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          298 RPKTEQRLLEWVQQYPADS-------KKFGLIMDP-------RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~-------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ........+......+...       .........       ..........+..+.+||.+||+.||.+|||+.+++++
T Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            5433221111111110000       000000000       00001112234678899999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.5e-44  Score=371.47  Aligned_cols=254  Identities=25%  Similarity=0.400  Sum_probs=202.3

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQR  162 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  162 (436)
                      +.||+|+||.||+|.+.     ....++.||||+++....  ...+.+.+|+.+++.++||||+++++++...     ..
T Consensus       375 ~~LG~G~fG~Vy~~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~  444 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQ-----MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-----SW  444 (635)
T ss_dssp             EEEEECSSEEEEEEEEE-----CSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----SE
T ss_pred             CEeccCCCEEEEEEEEc-----CCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CE
Confidence            47999999999999775     334678999999976432  3357899999999999999999999998533     24


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCC
Q 013790          163 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG  242 (436)
Q Consensus       163 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  242 (436)
                      ++||||+.+|+|.+++...  ..+++..++.|+.||+.||.|||++   +|+||||||+||||+.++.+||+|||+++..
T Consensus       445 ~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          445 MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             EEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             EEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence            8999999999999999764  3699999999999999999999998   9999999999999999999999999999753


Q ss_pred             CCCCC-cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          243 PMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       243 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ..... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.....   +...+.....      
T Consensus       520 ~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~~~~~------  590 (635)
T 4fl3_A          520 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEKGER------  590 (635)
T ss_dssp             TC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTCC------
T ss_pred             ccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCC------
Confidence            22211 122233456788999999999999999999999999999998 999998765433   2222221110      


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                              ...+..++..+.+||..||+.||++||++.+|++.|+++...
T Consensus       591 --------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          591 --------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                    112223457899999999999999999999999999988643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.4e-44  Score=336.98  Aligned_cols=257  Identities=25%  Similarity=0.355  Sum_probs=205.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|...       .+++.||+|.+....  ....+.+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRK-------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR   77 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG
T ss_pred             hhheeeehhccCCCCcEEEEEEEC-------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC
Confidence            468999999999999999999875       467899999997543  23456789999999999999999999988654


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc-----eeeccCCCCcEEEcCC
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQ-----VIYRDFKASNVLLDEN  228 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~-----ivH~Dlkp~NIll~~~  228 (436)
                      ..  ...++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +     |+||||||+|||++.+
T Consensus        78 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~  152 (279)
T 2w5a_A           78 TN--TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGK  152 (279)
T ss_dssp             GG--TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSS
T ss_pred             CC--ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCC
Confidence            32  2469999999999999999753  234589999999999999999999998   7     9999999999999999


Q ss_pred             CceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 013790          229 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  308 (436)
Q Consensus       229 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  308 (436)
                      +.+||+|||+++....  .........||+.|+|||++.+..++.++||||||+++|+|++|..||.......   +...
T Consensus       153 ~~~kl~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~  227 (279)
T 2w5a_A          153 QNVKLGDFGLARILNH--DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGK  227 (279)
T ss_dssp             SCEEECCCCHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH
T ss_pred             CCEEEecCchheeecc--ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHHH
Confidence            9999999999875321  1222334578999999999999899999999999999999999999998764322   2222


Q ss_pred             HhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          309 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                      +.....          +.    .+...+..+.+||.+||+.||.+|||+.+|++++.
T Consensus       228 i~~~~~----------~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          228 IREGKF----------RR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             HHHTCC----------CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             Hhhccc----------cc----CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            221110          01    11223467899999999999999999999988753

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-44  Score=348.12  Aligned_cols=264  Identities=24%  Similarity=0.339  Sum_probs=199.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|...       .+++.||||++...  .....+.+.+|+.+++.++||||+++++++...
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   96 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDG-------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   96 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEET-------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             cceEEEeEEeeecCCeEEEEEEEC-------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence            468999999999999999999865       56889999998654  223346788999999999999999999998765


Q ss_pred             CCc--ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          156 GER--GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       156 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ...  ....|+||||+ +++|.+++...   .+++..+..++.||+.||.|||+.   ||+||||||+|||++.++.+||
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl  169 (367)
T 1cm8_A           97 ETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKI  169 (367)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred             CccccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEE
Confidence            321  23459999999 88999999763   589999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      +|||+++...     .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......
T Consensus       170 ~Dfg~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  244 (367)
T 1cm8_A          170 LDFGLARQAD-----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT  244 (367)
T ss_dssp             CCCTTCEECC-----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             Eeeecccccc-----cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999997532     12344678999999999977 67899999999999999999999999876543322111111110


Q ss_pred             ccCcccc----------------ccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKF----------------GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~----------------~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +  ...+                .......+. ......+..+.+|+.+||..||.+|||+.++++|
T Consensus       245 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          245 P--PAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             C--CHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             C--CHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0  0000                000000110 1112335678899999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=336.27  Aligned_cols=254  Identities=23%  Similarity=0.353  Sum_probs=199.4

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ++|.....||+|+||.||+|.+.       .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+  
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--   92 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDL-------SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG--   92 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEET-------TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT--
T ss_pred             cCCCCcEEEeecCcEEEEEEEEC-------CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC--
Confidence            34555668999999999999865       467899999998766556678999999999999999999999997654  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC-CCceEEeec
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-NFRPKLSDF  236 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Df  236 (436)
                        ..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.   +|+|+||||+|||++. ++.+||+||
T Consensus        93 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Df  167 (295)
T 2clq_A           93 --FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDF  167 (295)
T ss_dssp             --EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCT
T ss_pred             --cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeec
Confidence              4599999999999999997653 23567899999999999999999998   9999999999999987 899999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH--LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |++.....  .........||+.|+|||++.+..  ++.++||||||+++|+|++|..||......... ... ..... 
T Consensus       168 g~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~-~~~~~-  242 (295)
T 2clq_A          168 GTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFK-VGMFK-  242 (295)
T ss_dssp             TTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHH-HHHHC-
T ss_pred             ccccccCC--CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHh-hcccc-
Confidence            99975321  122234457899999999997653  789999999999999999999999754332211 111 00000 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                              ..+.+    +...+..+.+||.+||+.||.+|||+.+++++
T Consensus       243 --------~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          243 --------VHPEI----PESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             --------CCCCC----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             --------ccccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                    11111    22234678899999999999999999999865

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.2e-44  Score=362.43  Aligned_cols=256  Identities=27%  Similarity=0.402  Sum_probs=201.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|..+       .++..||+|++....  ......+.+|+.+++.++||||+++++++...
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  108 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDK-------VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK  108 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEET-------TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             hcCeEEeeEEecCCCEEEEEEEEC-------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            457999999999999999999975       567889999987543  23356789999999999999999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC---CCceE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPK  232 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~k  232 (436)
                      .    ..++||||+.+|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+|||++.   ++.+|
T Consensus       109 ~----~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k  179 (494)
T 3lij_A          109 R----NYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIK  179 (494)
T ss_dssp             S----EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEE
T ss_pred             C----EEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEE
Confidence            4    4599999999999999987653  689999999999999999999998   9999999999999976   45599


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |+|||++....   .........||+.|+|||++. ..++.++|||||||++|+|++|..||.+.....   +...+...
T Consensus       180 l~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~  252 (494)
T 3lij_A          180 IVDFGLSAVFE---NQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---ILRKVEKG  252 (494)
T ss_dssp             ECCCTTCEECB---TTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHT
T ss_pred             EEECCCCeECC---CCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhC
Confidence            99999997532   222334567999999999986 568999999999999999999999998765432   22222211


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHHh
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER--LKQI  367 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~~  367 (436)
                      ...       ...    ......+..+.+||.+||+.||.+|||+.+++++  |...
T Consensus       253 ~~~-------~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          253 KYT-------FDS----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             CCC-------CCS----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             CCC-------CCc----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            110       000    0011234678899999999999999999999976  4444

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.8e-44  Score=338.61  Aligned_cols=264  Identities=26%  Similarity=0.379  Sum_probs=200.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++.+.||+|+||.||+|.+...    ......||+|++....   ....+.+.+|+.+++.++||||+++++++..
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAP----SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECT----TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccC----CCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            45899999999999999999987521    1244579999987542   2345678999999999999999999999875


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      ..     .++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.+||+
T Consensus        93 ~~-----~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~  163 (291)
T 1u46_A           93 PP-----MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG  163 (291)
T ss_dssp             SS-----CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred             CC-----ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEc
Confidence            43     489999999999999997643 3689999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCc-ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhc
Q 013790          235 DFGLAREGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       235 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |||++......... .......+|..|+|||++.+..++.++||||||+++|+|++ |..||.......   ....+...
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~  240 (291)
T 1u46_A          164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDKE  240 (291)
T ss_dssp             CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTS
T ss_pred             cccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---HHHHHHcc
Confidence            99999754322211 12234457788999999998889999999999999999999 999998764432   22222111


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      ...             ...+...+..+.++|.+||..||.+|||+.+++++|+++...
T Consensus       241 ~~~-------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          241 GER-------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             CCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CCC-------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            100             011122347799999999999999999999999999888643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=347.23  Aligned_cols=260  Identities=29%  Similarity=0.387  Sum_probs=201.6

Q ss_pred             HHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCceeeeeEee
Q 013790           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCA  153 (436)
Q Consensus        75 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  153 (436)
                      ....++|++.+.||+|+||.||+|.+.       .+++.||||++.... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHV-------KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEEC-------CCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            345679999999999999999999975       467899999986543 3446788999999999 7999999999997


Q ss_pred             ecCCc--ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCce
Q 013790          154 VDGER--GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  231 (436)
Q Consensus       154 ~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  231 (436)
                      .....  ....++||||+.+++|.+++.......+++..++.++.||+.||.|||+.   +|+|+||||+|||++.++.+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCE
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCE
Confidence            64321  23579999999999999999876555799999999999999999999998   99999999999999999999


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  306 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  306 (436)
                      ||+|||++....  ..........||+.|+|||++.     +..++.++|||||||++|+|++|..||.........   
T Consensus       169 kl~Dfg~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---  243 (326)
T 2x7f_A          169 KLVDFGVSAQLD--RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---  243 (326)
T ss_dssp             EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---
T ss_pred             EEeeCcCceecC--cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH---
Confidence            999999987532  1112234457899999999986     567889999999999999999999999765543221   


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..+...+..          .+   .....+..+.+||.+||..||.+|||+.+++++
T Consensus       244 ~~~~~~~~~----------~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          244 FLIPRNPAP----------RL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             HHHHHSCCC----------CC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHhhcCccc----------cC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            111111110          00   011124678899999999999999999999886

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.8e-44  Score=351.76  Aligned_cols=267  Identities=26%  Similarity=0.386  Sum_probs=204.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++++.||+|+||.||+|.+.       .++..||+|++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  104 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHK-------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG  104 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred             cccceeeeeecCCCCeEEEEEEEC-------CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence            468999999999999999999975       567899999987653 334567899999999999999999999998654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.  .+|+||||||+||||+.++.+||+||
T Consensus       105 ----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Df  176 (360)
T 3eqc_A          105 ----EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDF  176 (360)
T ss_dssp             ----EEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred             ----EEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEEC
Confidence                3599999999999999997653  689999999999999999999983  18999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh-hccc-
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ-QYPA-  314 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~-~~~~-  314 (436)
                      |++...    .........||+.|+|||++.+..++.++|||||||++|+|++|..||................ .... 
T Consensus       177 g~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3eqc_A          177 GVSGQL----IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE  252 (360)
T ss_dssp             CCCHHH----HHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred             CCCccc----ccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence            998632    1122334578999999999999999999999999999999999999998755433211110000 0000 


Q ss_pred             -----------------C---cc----ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 -----------------D---SK----KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 -----------------~---~~----~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                       .   ..    ....+.............+..+.+||.+||..||.+|||+.+++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                             0   00    0000000000001111234678999999999999999999999987

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.2e-43  Score=352.28  Aligned_cols=204  Identities=29%  Similarity=0.357  Sum_probs=167.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|.+.       .+++.||||++...  .....+.+.+|+.+++.++||||+++++++...
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~   97 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDK-------NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD   97 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEET-------TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             cCCEEEEEEEeecCCEEEEEEEEC-------CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            468999999999999999999976       56889999999754  333456789999999999999999999998765


Q ss_pred             CC-cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          156 GE-RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       156 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .. .....|+||||+. ++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+
T Consensus        98 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~  171 (432)
T 3n9x_A           98 DLLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVC  171 (432)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEc
Confidence            32 1235699999985 6999999764  3699999999999999999999999   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCc--------------------ccccccccCCCccccccc-ccCCCCchhhHHHHHHHHHHHHhCCCC
Q 013790          235 DFGLAREGPMVGHT--------------------HVSTAVVGTFGYAAPDYI-ETGHLTAKSDVWSFGVVLYEMLTGRRS  293 (436)
Q Consensus       235 Dfg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~p  293 (436)
                      |||+++........                    .......||+.|+|||++ .+..++.++|||||||++|||++|..|
T Consensus       172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  251 (432)
T 3n9x_A          172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS  251 (432)
T ss_dssp             CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred             cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence            99999853221111                    123567899999999986 566799999999999999999985444


Q ss_pred             C
Q 013790          294 L  294 (436)
Q Consensus       294 f  294 (436)
                      |
T Consensus       252 ~  252 (432)
T 3n9x_A          252 H  252 (432)
T ss_dssp             T
T ss_pred             c
Confidence            4

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.9e-44  Score=364.11  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=205.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++.+.||+|+||.||+|...       .+++.||||++....   ....+.+.+|+.+++.++||||+++++++..
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   97 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDK-------ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED   97 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             cCceEEeeEEecCCCEEEEEEEEC-------CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            457999999999999999999975       567899999986542   2345778999999999999999999999976


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE---cCCCce
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRP  231 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~  231 (436)
                      .+    ..++||||+.+|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||+   +.++.+
T Consensus        98 ~~----~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~  168 (484)
T 3nyv_A           98 KG----YFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANI  168 (484)
T ss_dssp             SS----EEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCE
T ss_pred             CC----EEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcE
Confidence            54    4599999999999999997653  699999999999999999999999   99999999999999   568899


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      ||+|||+++...   .........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.....   +...+..
T Consensus       169 kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~  241 (484)
T 3nyv_A          169 RIIDFGLSTHFE---ASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILKKVEK  241 (484)
T ss_dssp             EECCTTHHHHBC---CCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH
T ss_pred             EEEeeeeeEEcc---cccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHc
Confidence            999999987532   1223345679999999999976 68999999999999999999999998765432   2222222


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....           +........+..+.+||.+||..||.+|||+.+++++
T Consensus       242 ~~~~-----------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          242 GKYT-----------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             CCCC-----------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCC-----------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            1110           0001112234678899999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.2e-43  Score=334.38  Aligned_cols=248  Identities=25%  Similarity=0.389  Sum_probs=204.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|.+.+.||+|+||.||+|...       .++..||+|++.....   .....+.+|+.+++.++||||+++++++..
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   85 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREK-------QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD   85 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhceeeheecCCCCeEEEEEEEc-------CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence            468999999999999999999865       4678999999865422   224678899999999999999999999876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        86 ~~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  156 (284)
T 2vgo_A           86 RK----RIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIA  156 (284)
T ss_dssp             SS----EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred             CC----EEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEe
Confidence            44    4599999999999999997653  689999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||++.....    .......|++.|+|||++.+..++.++||||||+++|+|++|..||........   ...+...  
T Consensus       157 Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~--  227 (284)
T 2vgo_A          157 DFGWSVHAPS----LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET---HRRIVNV--  227 (284)
T ss_dssp             CCTTCEECSS----SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTT--
T ss_pred             cccccccCcc----cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH---HHHHhcc--
Confidence            9999864321    122346789999999999999999999999999999999999999986543322   1111111  


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                               ...    ++...+..+.+||.+||..||.+|||+.+++++
T Consensus       228 ---------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          228 ---------DLK----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             ---------CCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ---------ccC----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                     011    112234678899999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.4e-43  Score=335.39  Aligned_cols=251  Identities=28%  Similarity=0.421  Sum_probs=206.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .+.|.+++.||+|+||.||+|...       .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   93 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDN-------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT   93 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HHHHHHhhhhcccCCeEEEEEEEC-------CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            357999999999999999999865       467899999987553 234577899999999999999999999997654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+++++|.+++..   .++++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.+||+||
T Consensus        94 ----~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df  163 (303)
T 3a7i_A           94 ----KLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADF  163 (303)
T ss_dssp             ----EEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             ----eEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeec
Confidence                35999999999999999864   3689999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      |++.....  .........||+.|+|||++.+..++.++||||||+++|+|++|..||........   ...+....   
T Consensus       164 g~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~---  235 (303)
T 3a7i_A          164 GVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV---LFLIPKNN---  235 (303)
T ss_dssp             TTCEECBT--TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHSC---
T ss_pred             ccceecCc--cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH---HHHhhcCC---
Confidence            99975321  12223456789999999999999999999999999999999999999986544322   11111110   


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                             .+.+...    .+..+.+||.+||..||.+|||+.+++++.
T Consensus       236 -------~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          236 -------PPTLEGN----YSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             -------CCCCCSS----CCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             -------CCCCccc----cCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence                   1111112    236788999999999999999999999874

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.6e-43  Score=343.74  Aligned_cols=273  Identities=23%  Similarity=0.335  Sum_probs=205.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|...       .+++.||+|++......  ....+.+|+.+++.++||||+++++++...
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   88 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHR-------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   88 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEET-------TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred             ccceeEEEEEecCCCcEEEEEEEC-------CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecc
Confidence            468999999999999999999975       56789999998654322  245778999999999999999999998764


Q ss_pred             CC----cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCce
Q 013790          156 GE----RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  231 (436)
Q Consensus       156 ~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  231 (436)
                      ..    .....++||||+. ++|.+.+.... ..+++..+..++.||+.||.|||+.   ||+||||||+||||+.++.+
T Consensus        89 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~  163 (351)
T 3mi9_A           89 ASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVL  163 (351)
T ss_dssp             --------CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred             ccccccCCceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCE
Confidence            32    1335699999996 48888876543 4699999999999999999999998   99999999999999999999


Q ss_pred             EEeeccCCCCCCCCC--CcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 013790          232 KLSDFGLAREGPMVG--HTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  308 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  308 (436)
                      ||+|||+++......  .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..
T Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  243 (351)
T 3mi9_A          164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ  243 (351)
T ss_dssp             EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            999999997532211  1223345678999999999876 4579999999999999999999999987655443333222


Q ss_pred             HhhcccCccccccccCC------ccc--CcCCH-------HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          309 VQQYPADSKKFGLIMDP------RLE--KEYSI-------NEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       309 ~~~~~~~~~~~~~~~~~------~l~--~~~~~-------~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ........ .+......      ...  .....       ..+..+.+||.+||+.||.+|||+.+++++
T Consensus       244 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          244 LCGSITPE-VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHCCCCTT-TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhCCCChh-hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            22111110 00000000      000  00000       013568899999999999999999999987

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.8e-43  Score=334.70  Aligned_cols=250  Identities=23%  Similarity=0.358  Sum_probs=205.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|.+.+.||+|+||.||+|...       .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   86 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDA-------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED   86 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             ccceEEEEEEeecCCEEEEEEEEC-------CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence            468999999999999999999875       467889999986542   2344678899999999999999999999876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||+.+++|.+++....  .+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+
T Consensus        87 ~~----~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  157 (294)
T 2rku_A           87 ND----FVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIG  157 (294)
T ss_dssp             SS----EEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             CC----EEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEE
Confidence            54    4599999999999999986643  689999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||++......  ........||+.|+|||++.+..++.++||||||+++|+|++|..||........   ...+.... 
T Consensus       158 dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~-  231 (294)
T 2rku_A          158 DFGLATKVEYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET---YLRIKKNE-  231 (294)
T ss_dssp             CCTTCEECCST--TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTTC-
T ss_pred             eccCceecccC--ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhhcc-
Confidence            99999753211  2223446789999999999998999999999999999999999999986543221   11111100 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                ..+    +...+..+.+||.+||+.||.+|||+.+++++
T Consensus       232 ----------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 ----------YSI----PKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ----------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----------CCC----ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                      001    11223678899999999999999999999886

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.1e-44  Score=341.17  Aligned_cols=255  Identities=24%  Similarity=0.395  Sum_probs=200.3

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..++|++++.||+|+||.||+|.+.       .++..||+|++........+.+.+|+.+++.++||||+++++++...+
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNK-------ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG   89 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEET-------TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred             CccceeecceeccCCCeEEEEEEEc-------CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence            3468999999999999999999975       467899999998776666788999999999999999999999997654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+||
T Consensus        90 ----~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  161 (302)
T 2j7t_A           90 ----KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADF  161 (302)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCC
T ss_pred             ----eEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEEC
Confidence                3599999999999999986533 4699999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCccccccc-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYI-----ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      |++...  ...........||+.|+|||++     .+..++.++||||||+++|+|++|..||........  .......
T Consensus       162 g~~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~  237 (302)
T 2j7t_A          162 GVSAKN--LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKS  237 (302)
T ss_dssp             HHHHHH--HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHS
T ss_pred             CCCccc--cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHHhcc
Confidence            987421  0011122345689999999998     366789999999999999999999999987654322  1111111


Q ss_pred             cccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....             ...+...+..+.+||.+||..||.+|||+.+++++
T Consensus       238 ~~~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          238 DPPT-------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             CCCC-------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             CCcc-------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            1000             01112234678899999999999999999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.4e-43  Score=342.06  Aligned_cols=250  Identities=23%  Similarity=0.358  Sum_probs=205.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|.+.+.||+|+||.||++...       .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++..
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  112 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDA-------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED  112 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            468999999999999999999875       467899999986542   2345678899999999999999999999876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||+.+++|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus       113 ~~----~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~  183 (335)
T 2owb_A          113 ND----FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIG  183 (335)
T ss_dssp             SS----EEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEEC
T ss_pred             CC----eEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEe
Confidence            54    469999999999999998764  3689999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||++......  ........||+.|+|||++.+..++.++||||||+++|+|++|..||........   ...+.... 
T Consensus       184 Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~-  257 (335)
T 2owb_A          184 DFGLATKVEYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET---YLRIKKNE-  257 (335)
T ss_dssp             CCTTCEECCST--TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHHTC-
T ss_pred             eccCceecccC--cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHHhcCC-
Confidence            99999753211  2223446789999999999999999999999999999999999999986543221   11111110 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                ..+    +...+..+.+||.+||+.||.+|||+.+++++
T Consensus       258 ----------~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          258 ----------YSI----PKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ----------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----------CCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                      001    11223578899999999999999999999886

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.7e-43  Score=348.76  Aligned_cols=270  Identities=21%  Similarity=0.308  Sum_probs=208.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC--------CCCceeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE--------HPNLVKLI  149 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~~~  149 (436)
                      .++|++.+.||+|+||.||+|...       .+++.||||++... ....+.+.+|+.+++.+.        ||||++++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDI-------QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEec-------CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            468999999999999999999865       56899999999754 234567889999999885        78899999


Q ss_pred             eEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC
Q 013790          150 GYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  229 (436)
Q Consensus       150 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  229 (436)
                      +++...+......++||||+ +++|.+++.......+++..++.++.||+.||.|||+++  ||+||||||+||||+.++
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~  184 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCH
T ss_pred             cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccc
Confidence            99886554556789999999 778888777665567999999999999999999999852  899999999999999775


Q ss_pred             -------------------------------------------------ceEEeeccCCCCCCCCCCcccccccccCCCc
Q 013790          230 -------------------------------------------------RPKLSDFGLAREGPMVGHTHVSTAVVGTFGY  260 (436)
Q Consensus       230 -------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y  260 (436)
                                                                       .+||+|||+++...     .......||+.|
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~-----~~~~~~~gt~~y  259 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH-----KHFTEDIQTRQY  259 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT-----BCSCSCCSCGGG
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc-----ccCccCCCCCcc
Confidence                                                             79999999997532     123445789999


Q ss_pred             ccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh----HH---HHHHHhhcccC--------------cccc
Q 013790          261 AAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE----QR---LLEWVQQYPAD--------------SKKF  319 (436)
Q Consensus       261 ~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~----~~---~~~~~~~~~~~--------------~~~~  319 (436)
                      +|||++.+..++.++|||||||++|+|+||..||........    ..   +.......+..              ....
T Consensus       260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  339 (397)
T 1wak_A          260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL  339 (397)
T ss_dssp             CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred             cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence            999999999999999999999999999999999976543211    11   11111111100              0000


Q ss_pred             ccccCCcc---------cCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          320 GLIMDPRL---------EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       320 ~~~~~~~l---------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..+.....         ....+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            00000000         012356677889999999999999999999999875

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.2e-43  Score=344.31  Aligned_cols=266  Identities=23%  Similarity=0.281  Sum_probs=197.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|...       .+++.||||++...  .....+.+.+|+.+++.++||||+++++++...
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   96 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDA-------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ   96 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSC
T ss_pred             hhheeEeeeeEecCCEEEEEEEEC-------CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccc
Confidence            468999999999999999999865       56789999998754  233446788999999999999999999998765


Q ss_pred             CC--cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          156 GE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       156 ~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      +.  .....++||||+. ++|.+++..    .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||
T Consensus        97 ~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl  168 (371)
T 2xrw_A           97 KSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI  168 (371)
T ss_dssp             CSTTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             cccccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEE
Confidence            42  2235799999996 578888853    489999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +|||+++...   .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  +...+....
T Consensus       169 ~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~  243 (371)
T 2xrw_A          169 LDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLG  243 (371)
T ss_dssp             CCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHC-CC
T ss_pred             EEeecccccc---cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhC
Confidence            9999997532   22233456799999999999999999999999999999999999999987544321  111111111


Q ss_pred             cCcc-----------------------ccccccCCcccC---cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSK-----------------------KFGLIMDPRLEK---EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~-----------------------~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....                       .+..........   ......+..+.+||.+||..||.+|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            0000                       000000000000   0112346789999999999999999999999987

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=338.00  Aligned_cols=253  Identities=26%  Similarity=0.405  Sum_probs=200.6

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..++|++++.||+|+||.||+|.+.       .+++.||+|.+....  ..+.+.+|+.+++.++||||+++++++...+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   97 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHK-------ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT   97 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEET-------TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             chhhhhhheeeccCCCeEEEEEEEC-------CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence            4578999999999999999999875       467899999997653  3467889999999999999999999997654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+||
T Consensus        98 ----~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  169 (314)
T 3com_A           98 ----DLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADF  169 (314)
T ss_dssp             ----EEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             ----EEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeec
Confidence                3599999999999999986432 4699999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      |++....  ..........||+.|+|||++.+..++.++||||||+++|+|++|..||.........   ..+...... 
T Consensus       170 g~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~-  243 (314)
T 3com_A          170 GVAGQLT--DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI---FMIPTNPPP-  243 (314)
T ss_dssp             TTCEECB--TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHHSCCC-
T ss_pred             ccchhhh--hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHhcCCCc-
Confidence            9997532  1122234457899999999999999999999999999999999999999865443221   111111110 


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                               .+  ..+...+..+.+||.+||..||.+|||+.+++++
T Consensus       244 ---------~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          244 ---------TF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             ---------CC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ---------cc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                     00  0112234678899999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-43  Score=361.60  Aligned_cols=253  Identities=25%  Similarity=0.364  Sum_probs=201.6

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-------------hhHHHHHHHHHHHhccCCC
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------------QGHKQWVAEVQFLGVLEHP  143 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hp  143 (436)
                      ..++|.+++.||+|+||.||+|..+       .++..||+|++.....             ...+.+.+|+.+++.++||
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  106 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEK-------NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHP  106 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEET-------TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCT
T ss_pred             cccceEEEeEecccCCeEEEEEEEC-------CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCC
Confidence            3578999999999999999999976       5678999999875432             2346788999999999999


Q ss_pred             CceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcE
Q 013790          144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  223 (436)
Q Consensus       144 nIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NI  223 (436)
                      ||+++++++....    ..++||||+++|+|.+++....  .+++..+..++.||+.||.|||+.   +|+||||||+||
T Consensus       107 niv~~~~~~~~~~----~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Ni  177 (504)
T 3q5i_A          107 NIIKLFDVFEDKK----YFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENI  177 (504)
T ss_dssp             TBCCEEEEEECSS----EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             CCCeEEEEEEcCC----EEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHE
Confidence            9999999997654    4699999999999999997653  699999999999999999999998   999999999999


Q ss_pred             EEcCCC---ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Q 013790          224 LLDENF---RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK  300 (436)
Q Consensus       224 ll~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~  300 (436)
                      |++.++   .+||+|||+++...   .........||+.|+|||++. +.++.++|||||||++|+|++|..||.+....
T Consensus       178 l~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  253 (504)
T 3q5i_A          178 LLENKNSLLNIKIVDFGLSSFFS---KDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ  253 (504)
T ss_dssp             EESSTTCCSSEEECCCTTCEECC---TTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EEecCCCCccEEEEECCCCEEcC---CCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            998776   69999999997532   222334567999999999987 46899999999999999999999999876543


Q ss_pred             hhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .   +...+.......       ..    ......+..+.+||.+||..||.+|||+.+++++
T Consensus       254 ~---~~~~i~~~~~~~-------~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          254 D---IIKKVEKGKYYF-------DF----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             H---HHHHHHHCCCCC-------CH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             H---HHHHHHcCCCCC-------Cc----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            2   222222111000       00    0001124678999999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.8e-45  Score=358.08  Aligned_cols=247  Identities=17%  Similarity=0.199  Sum_probs=189.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC---cchhHHHHHHHH---HHHhccCCCCceeee--
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD---GLQGHKQWVAEV---QFLGVLEHPNLVKLI--  149 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~hpnIv~~~--  149 (436)
                      .++|.+.+.||+|+||.||+|.+.       .+++.||||++...   .....+.+.+|+   .+++.++||||++++  
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~  144 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQ-------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR  144 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC--------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHC
T ss_pred             CceEEEcceeecCCCEEEEEEEEC-------CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhh
Confidence            467999999999999999999965       46789999998743   333457788999   555566899999998  


Q ss_pred             -----eEeeecCC----------cc---eeEEEEEEecCCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhh
Q 013790          150 -----GYCAVDGE----------RG---IQRLLVYEFMLNRSLEDHLFNRA-----FPPLPWKTRLHIILGAAEGLAYLH  206 (436)
Q Consensus       150 -----~~~~~~~~----------~~---~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~ql~~~l~~LH  206 (436)
                           +++...+.          ..   ...++||||+ +|+|.+++....     ...+++..++.|+.||+.||+|||
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  223 (377)
T 3byv_A          145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH  223 (377)
T ss_dssp             BCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence                 44443321          00   1258999999 689999997532     112345888899999999999999


Q ss_pred             cCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccC-----------CCCchh
Q 013790          207 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-----------HLTAKS  275 (436)
Q Consensus       207 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~  275 (436)
                      ++   +|+||||||+||||+.++.+||+|||+++..     ........| +.|+|||++.+.           .++.++
T Consensus       224 ~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~-----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~  294 (377)
T 3byv_A          224 HY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD-----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSF  294 (377)
T ss_dssp             HT---TEECSCCCGGGEEECTTCCEEECCGGGCEET-----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHH
T ss_pred             hC---CeecCCCCHHHEEEcCCCCEEEEechhheec-----CCcccCCCC-cCccChhhhcccccccccccccccCChhh
Confidence            99   9999999999999999999999999999752     123345567 999999999887           899999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC
Q 013790          276 DVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP  355 (436)
Q Consensus       276 DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP  355 (436)
                      |||||||++|||++|..||........                ...+...      ....+..+.+||.+||..||.+||
T Consensus       295 DvwSlG~il~elltg~~Pf~~~~~~~~----------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rp  352 (377)
T 3byv_A          295 DAWALGLVIYWIWCADLPITKDAALGG----------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRL  352 (377)
T ss_dssp             HHHHHHHHHHHHHHSSCCC------CC----------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCC
T ss_pred             hHHHHHHHHHHHHHCCCCCcccccccc----------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCC
Confidence            999999999999999999975432110                0001110      012246788999999999999999


Q ss_pred             CHHHHHHH
Q 013790          356 KMSQVVER  363 (436)
Q Consensus       356 s~~eil~~  363 (436)
                      |+.+++++
T Consensus       353 t~~e~l~h  360 (377)
T 3byv_A          353 LPLQAMET  360 (377)
T ss_dssp             CHHHHHTS
T ss_pred             CHHHHhhC
Confidence            99999874

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3e-43  Score=354.60  Aligned_cols=272  Identities=22%  Similarity=0.265  Sum_probs=210.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|.+++.||+|+||.||+|.+.       .+++.||||++.....  ...+.+|+.+++.+.|++++..+.++.... 
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~-   75 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEG-   75 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEET-------TTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEET-
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEEC-------CCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeC-
Confidence            468999999999999999999865       4678999998865432  235788999999998865555544443332 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE---cCCCceEEe
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL---DENFRPKLS  234 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~  234 (436)
                        ...++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++   +|+||||||+||||   +.++.+||+
T Consensus        76 --~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~  148 (483)
T 3sv0_A           76 --DYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYII  148 (483)
T ss_dssp             --TEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEEC
T ss_pred             --CEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEE
Confidence              2459999999 999999997543 4699999999999999999999998   99999999999999   689999999


Q ss_pred             eccCCCCCCCCCCc-----ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 013790          235 DFGLAREGPMVGHT-----HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  309 (436)
Q Consensus       235 Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  309 (436)
                      |||+++........     .......||+.|+|||++.+..++.++|||||||+||+|++|..||.+............+
T Consensus       149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i  228 (483)
T 3sv0_A          149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI  228 (483)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH
T ss_pred             eCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH
Confidence            99999753222111     1223567999999999999999999999999999999999999999876654433333222


Q ss_pred             hhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcCCCCC
Q 013790          310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDS  376 (436)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~~~~  376 (436)
                      ....... ...     .+    ....+..+.+||..||..||.+||++.+|++.|+.++........
T Consensus       229 ~~~~~~~-~~~-----~l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~  285 (483)
T 3sv0_A          229 SEKKVAT-SIE-----AL----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFD  285 (483)
T ss_dssp             HHHHHHS-CHH-----HH----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred             hhccccc-cHH-----HH----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCcc
Confidence            2111000 000     00    011246789999999999999999999999999999876654433

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.9e-44  Score=351.76  Aligned_cols=260  Identities=13%  Similarity=0.079  Sum_probs=185.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhcc--CCCCceeee---
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVL--EHPNLVKLI---  149 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~hpnIv~~~---  149 (436)
                      ..+|.+.+.||+|+||.||+|.+.       .+++.||||++.....   ...+.+.+|+.+++.|  +||||++++   
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~  133 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDV-------ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRL  133 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CB
T ss_pred             ceeeeeeeeccCCCCEEEEEEEEC-------CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeE
Confidence            346999999999999999999975       5688999999987543   2345677785544444  699988755   


Q ss_pred             ----eEeeecCCc-------------ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHhh
Q 013790          150 ----GYCAVDGER-------------GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR------LHIILGAAEGLAYLH  206 (436)
Q Consensus       150 ----~~~~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~ql~~~l~~LH  206 (436)
                          +++...+..             ....++||||+. |+|.+++.... ..+++..+      +.++.||+.||+|||
T Consensus       134 ~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH  211 (371)
T 3q60_A          134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQ  211 (371)
T ss_dssp             CCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence                444333221             134799999998 89999997642 23455566      788899999999999


Q ss_pred             cCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCccccccccc--CCCCchhhHHHHHHHH
Q 013790          207 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVL  284 (436)
Q Consensus       207 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil  284 (436)
                      ++   +|+||||||+||||+.++.+||+|||+++...     .......+|+.|+|||++.+  ..++.++|||||||++
T Consensus       212 ~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il  283 (371)
T 3q60_A          212 SK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI  283 (371)
T ss_dssp             HT---TEEETTCSGGGEEECTTSCEEECCGGGEEETT-----CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred             HC---CCccCcCCHHHEEECCCCCEEEEecceeeecC-----CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence            98   99999999999999999999999999997531     11224557799999999987  6789999999999999


Q ss_pred             HHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          285 YEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       285 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      |+|+||..||....+.....       +..  ..........+........+..+.+||.+||+.||.+|||+.+++++
T Consensus       284 ~elltg~~Pf~~~~~~~~~~-------~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          284 YRVWCLFLPFGLVTPGIKGS-------WKR--PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             HHHHHSSCSTTBCCTTCTTC-------CCB--CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             HHHHhCCCCCCCcCcccccc-------hhh--hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            99999999998764321110       000  00000001111111112345789999999999999999999999875

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.3e-43  Score=352.72  Aligned_cols=266  Identities=25%  Similarity=0.333  Sum_probs=199.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ..+|.+.+.||+|+||.||+|.+.       .+++.||||++.....    .+.+|+.+++.++||||+++++++...+.
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~  121 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLC-------DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGE  121 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred             cceEEeeeEEeeCCCEEEEEEEEC-------CCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCC
Confidence            357999999999999999999976       4678999999865421    23469999999999999999999865432


Q ss_pred             --cceeEEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC-CceE
Q 013790          158 --RGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPK  232 (436)
Q Consensus       158 --~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~k  232 (436)
                        ...++++||||+++ +|.+.+..  .....+++..+..++.||+.||.|||+.   +|+||||||+||||+.+ +.+|
T Consensus       122 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~k  197 (420)
T 1j1b_A          122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLK  197 (420)
T ss_dssp             TTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEE
T ss_pred             CCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEE
Confidence              23456899999965 67666543  2235799999999999999999999998   99999999999999954 6789


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      |+|||+++....   ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+......  +...+..
T Consensus       198 l~DFG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~  272 (420)
T 1j1b_A          198 LCDFGSAKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKV  272 (420)
T ss_dssp             ECCCTTCEECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHH
T ss_pred             eccchhhhhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHH
Confidence            999999985321   2223446789999999999764 789999999999999999999999987654322  2222211


Q ss_pred             cccCcc--------ccccccCCcc-----cCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 YPADSK--------KFGLIMDPRL-----EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 ~~~~~~--------~~~~~~~~~l-----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ......        .+....-+.+     ...+....+..+.+||.+||..||.+|||+.++++|
T Consensus       273 lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            111000        0000000111     011222335788999999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.1e-43  Score=344.79  Aligned_cols=271  Identities=25%  Similarity=0.319  Sum_probs=205.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++++.||+|+||.||+|...       .++..||||++.... ....+.+.+|+.++..++||||+++++++....
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   98 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDN-------LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   98 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             cccEEEEEEeecCCCeEEEEEEEC-------CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence            468999999999999999999865       568899999997543 233467889999999999999999999987643


Q ss_pred             -CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          157 -ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       157 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                       ......++||||+. |+|.+++...   .+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+|
T Consensus        99 ~~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D  171 (364)
T 3qyz_A           99 IEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICD  171 (364)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             ccccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEe
Confidence             22235699999996 6999998654   599999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCC-CcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          236 FGLAREGPMVG-HTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       236 fg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      ||+++...... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......+
T Consensus       172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  251 (364)
T 3qyz_A          172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP  251 (364)
T ss_dssp             CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC
T ss_pred             CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99997532111 1112244579999999998754 458999999999999999999999998765543322221111111


Q ss_pred             cCccccccc-----------c-CC-ccc-CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLI-----------M-DP-RLE-KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~-----------~-~~-~l~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ... .+...           . .. ... .......+..+.+||.+||..||.+|||+.+++++
T Consensus       252 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          252 SQE-DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CHH-HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CHH-HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000 00000           0 00 000 00111234678899999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.9e-43  Score=368.99  Aligned_cols=251  Identities=25%  Similarity=0.386  Sum_probs=205.8

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhcc-CCCCceeeeeEe
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVL-EHPNLVKLIGYC  152 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  152 (436)
                      ..++|++++.||+|+||.||+|.++       .+++.||||++....   ....+.+..|..++..+ +||||+.+++++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~-------~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~  411 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERK-------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF  411 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEES-------SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred             cccceEEEEEEccCCCEEEEEEEEC-------CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence            4578999999999999999999976       567899999997542   22345678899999987 699999999988


Q ss_pred             eecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          153 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      ...+    .+|+||||+++|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+|
T Consensus       412 ~~~~----~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ik  482 (674)
T 3pfq_A          412 QTMD----RLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIK  482 (674)
T ss_dssp             BCSS----EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEE
T ss_pred             EeCC----EEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEE
Confidence            6544    4699999999999999997653  699999999999999999999999   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |+|||+++....  .........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...   +...+...
T Consensus       483 L~DFGla~~~~~--~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~~  557 (674)
T 3pfq_A          483 IADFGMCKENIW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIMEH  557 (674)
T ss_dssp             ECCCTTCEECCC--TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHSS
T ss_pred             Eeecceeecccc--CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---HHHHHHhC
Confidence            999999985321  2233456789999999999999999999999999999999999999998754432   22222111


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKM-----SQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~  363 (436)
                      .           .    .++...+..+.+||.+||..||.+||++     .+|++|
T Consensus       558 ~-----------~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          558 N-----------V----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             C-----------C----CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             C-----------C----CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            0           0    1122234678999999999999999997     777765

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.7e-43  Score=339.01  Aligned_cols=263  Identities=20%  Similarity=0.303  Sum_probs=201.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~  156 (436)
                      .++|++++.||+|+||.||+|...       .+++.||||++....   .+.+.+|+.+++.+. ||||+++++++....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~  104 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINI-------TNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPV  104 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred             CCceEEEEEecccCCeEEEEEEEC-------CCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence            368999999999999999999865       467899999997543   467889999999997 999999999987643


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC-ceEEee
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-RPKLSD  235 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~D  235 (436)
                      .  ...++||||+.+++|.+++.     .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++ .+||+|
T Consensus       105 ~--~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~D  174 (330)
T 3nsz_A          105 S--RTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLID  174 (330)
T ss_dssp             T--CCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred             C--CceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEe
Confidence            2  24599999999999999984     388999999999999999999998   999999999999999776 899999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH-----------
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-----------  303 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-----------  303 (436)
                      ||+++....   ........||..|+|||++.+ ..++.++|||||||++|+|++|..||.........           
T Consensus       175 fg~a~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~  251 (330)
T 3nsz_A          175 WGLAEFYHP---GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  251 (330)
T ss_dssp             CTTCEECCT---TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred             CCCceEcCC---CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCc
Confidence            999975321   222344578999999999977 67899999999999999999999999654332111           


Q ss_pred             HHHHHHhhcccC-cccccccc--------CCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          304 RLLEWVQQYPAD-SKKFGLIM--------DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       304 ~~~~~~~~~~~~-~~~~~~~~--------~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....++...... ...+....        ............+..+.+||.+||+.||.+|||+.+++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            011111111000 00000000        0000111112235788999999999999999999999886

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.7e-44  Score=336.37  Aligned_cols=247  Identities=21%  Similarity=0.302  Sum_probs=197.0

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhcc-CCCCceeeeeEee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCA  153 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  153 (436)
                      ..++|++++.||+|+||.||+|.+.       .+++.||+|++....  ......+.+|+..+..+ +||||+++++++.
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~   81 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKR-------LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA   81 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEc-------CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence            3578999999999999999999975       467899999987542  23456788899999988 8999999999997


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC---
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRA--FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN---  228 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---  228 (436)
                      ..+    ..++||||+++++|.+++....  ...+++..++.++.||+.||.|||++   +|+||||||+|||++.+   
T Consensus        82 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~  154 (289)
T 1x8b_A           82 EDD----HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIP  154 (289)
T ss_dssp             ETT----EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----
T ss_pred             cCC----eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCC
Confidence            655    4599999999999999997532  24689999999999999999999998   99999999999999844   


Q ss_pred             ----------------CceEEeeccCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCC
Q 013790          229 ----------------FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGR  291 (436)
Q Consensus       229 ----------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~  291 (436)
                                      ..+||+|||++.....      .....||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~  228 (289)
T 1x8b_A          155 NAASEEGDEDDWASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE  228 (289)
T ss_dssp             ---------------CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCC
T ss_pred             cccccccccccccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCC
Confidence                            4799999999875321      1234589999999999766 5668999999999999999998


Q ss_pred             CCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          292 RSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       292 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +|+.....     ... +....          .+.+    +...+..+.+||.+||+.||.+|||+.+++++
T Consensus       229 ~~~~~~~~-----~~~-~~~~~----------~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          229 PLPRNGDQ-----WHE-IRQGR----------LPRI----PQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             CCCSSSHH-----HHH-HHTTC----------CCCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             CCCcchhH-----HHH-HHcCC----------CCCC----CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            87653311     111 11100          0111    11234678999999999999999999999876

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.7e-43  Score=333.08  Aligned_cols=255  Identities=23%  Similarity=0.315  Sum_probs=203.5

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---------hhHHHHHHHHHHHhccC-CCCc
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---------QGHKQWVAEVQFLGVLE-HPNL  145 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpnI  145 (436)
                      ...++|++.+.||+|+||.||+|.++       .+++.||||++.....         ...+.+.+|+.+++++. ||||
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i   86 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHK-------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI   86 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred             chhhccceeeeecCCCceEEEEEEEc-------CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence            34579999999999999999999975       5678999999865431         12356788999999996 9999


Q ss_pred             eeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE
Q 013790          146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL  225 (436)
Q Consensus       146 v~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll  225 (436)
                      +++++++...+    ..++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.   +++|+||||+||++
T Consensus        87 ~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~  157 (298)
T 1phk_A           87 IQLKDTYETNT----FFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILL  157 (298)
T ss_dssp             CCEEEEEECSS----EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             eeeeeeeccCC----eEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEE
Confidence            99999986544    459999999999999999764  3689999999999999999999998   99999999999999


Q ss_pred             cCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 013790          226 DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE------TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP  299 (436)
Q Consensus       226 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~  299 (436)
                      +.++.+||+|||++....   .........|++.|+|||++.      ...++.++||||||+++|+|++|..||.....
T Consensus       158 ~~~~~~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  234 (298)
T 1phk_A          158 DDDMNIKLTDFGFSCQLD---PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ  234 (298)
T ss_dssp             CTTCCEEECCCTTCEECC---TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cCCCcEEEecccchhhcC---CCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH
Confidence            999999999999997532   122234467899999999985      45688999999999999999999999976543


Q ss_pred             hhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...   ...+......           .........+..+.+||.+||+.||.+|||+.+++++
T Consensus       235 ~~~---~~~~~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          235 MLM---LRMIMSGNYQ-----------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HHH---HHHHHHTCCC-----------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHH---HHHHhcCCcc-----------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            322   1111111100           0001112234678999999999999999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.8e-43  Score=329.26  Aligned_cols=249  Identities=24%  Similarity=0.361  Sum_probs=195.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|.+.+.||+|+||.||+|.+.       .+++.||||++.....   ...+.+.+|+.+++.++||||+++++++..
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   82 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQ-------LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST   82 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             eccEEEEeeecCCCCeEEEEEEEC-------CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            468999999999999999999875       4678999999865422   234578899999999999999999999876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..++||||+.+++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.+||+
T Consensus        83 ~~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~  153 (276)
T 2h6d_A           83 PT----DFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIA  153 (276)
T ss_dssp             SS----EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEEC
T ss_pred             CC----eEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEe
Confidence            54    4599999999999999997643  689999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |||++....   .........|++.|+|||.+.+..+ +.++||||||+++|+|++|..||.......   ....+....
T Consensus       154 dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~  227 (276)
T 2h6d_A          154 DFGLSNMMS---DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFKKIRGGV  227 (276)
T ss_dssp             CCCGGGCCC---C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCC
T ss_pred             ecccccccC---CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHhhcCc
Confidence            999997532   1222334568999999999987765 689999999999999999999997654322   222221110


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .           .+    +...+..+.++|.+||+.||.+|||+.+++++
T Consensus       228 ~-----------~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 F-----------YI----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             C-----------CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             c-----------cC----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0           01    11223678899999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.4e-43  Score=335.30  Aligned_cols=273  Identities=25%  Similarity=0.385  Sum_probs=205.8

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhcc---CCCCceeeeeE
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVL---EHPNLVKLIGY  151 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~~~~~  151 (436)
                      ..++|++++.||+|+||.||+|.+.      ..+++.||+|++......  ....+.+|+.+++.+   +||||++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~   82 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDL------KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV   82 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEET------TTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEec------CCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeee
Confidence            4578999999999999999999863      135788999998644221  123466777777766   89999999999


Q ss_pred             eeecC-CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc
Q 013790          152 CAVDG-ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  230 (436)
Q Consensus       152 ~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  230 (436)
                      +.... ......++||||+. |+|.+++.......+++..++.++.|++.||.|||+.   ||+||||||+|||++.++.
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~  158 (326)
T 1blx_A           83 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQ  158 (326)
T ss_dssp             EEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred             eeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCC
Confidence            86321 23346799999997 6999999876656799999999999999999999998   9999999999999999999


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHHH
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR-LLEWV  309 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~  309 (436)
                      +||+|||+++..   ..........||+.|+|||++.+..++.++||||||+++|+|++|..||.+........ +....
T Consensus       159 ~kl~Dfg~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  235 (326)
T 1blx_A          159 IKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI  235 (326)
T ss_dssp             EEECSCCSCCCC---CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEEecCcccccc---cCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHc
Confidence            999999999753   22233445678999999999999999999999999999999999999998765433221 11111


Q ss_pred             hhcccCcccc------ccccC---CcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          310 QQYPADSKKF------GLIMD---PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       310 ~~~~~~~~~~------~~~~~---~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                       ..+......      .....   ...........+..+.+||.+||..||.+|||+.+++++
T Consensus       236 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          236 -GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             -CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             111100000      00000   000011222345778899999999999999999999865

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-44  Score=346.49  Aligned_cols=258  Identities=26%  Similarity=0.380  Sum_probs=202.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc----chhHHHHHHHHHHHhcc-CCCCceeeeeEe
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQGHKQWVAEVQFLGVL-EHPNLVKLIGYC  152 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  152 (436)
                      .++|.+++.||+|+||.||+|....    +..+++.||||++....    ....+.+.+|+.+++.+ +||||+++++++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKIS----GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECS----STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcc----cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            4689999999999999999998742    22468899999987542    12335567899999999 699999999998


Q ss_pred             eecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          153 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      ...+    ..++||||+.+|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+|
T Consensus       129 ~~~~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k  199 (355)
T 1vzo_A          129 QTET----KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV  199 (355)
T ss_dssp             EETT----EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred             eeCc----eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEE
Confidence            7654    3599999999999999997653  689999999999999999999998   999999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHHH
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE-QRLLEWV  309 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~~  309 (436)
                      |+|||+++.... ..........||+.|+|||++.+  ..++.++|||||||++|+|++|..||........ ..+...+
T Consensus       200 l~DfG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  278 (355)
T 1vzo_A          200 LTDFGLSKEFVA-DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI  278 (355)
T ss_dssp             ESCSSEEEECCG-GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred             EeeCCCCeeccc-CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence            999999975321 12223344679999999999976  3478999999999999999999999975433221 1222211


Q ss_pred             hhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHHH
Q 013790          310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVERL  364 (436)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~L  364 (436)
                      ...           .+    ..+...+..+.+||.+||..||.+||     ++.+++++.
T Consensus       279 ~~~-----------~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          279 LKS-----------EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHC-----------CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             hcc-----------CC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            111           01    11222346788999999999999999     999998874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.5e-43  Score=336.39  Aligned_cols=265  Identities=26%  Similarity=0.382  Sum_probs=187.1

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ..++|.+.+.||+|+||.||+|...       .+++.||||.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   85 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCA-------PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK   85 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC-----------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS
T ss_pred             chhhhhhhheeccccceEEEEEEEC-------CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence            4578999999999999999999864       467889999987543 23346788999999999999999999999766


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFN------RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF  229 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  229 (436)
                      +.    .++||||+++++|.+++..      .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++
T Consensus        86 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~  158 (303)
T 2vwi_A           86 DE----LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDG  158 (303)
T ss_dssp             SC----EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTC
T ss_pred             CC----cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCC
Confidence            53    5999999999999999864      1234689999999999999999999998   999999999999999999


Q ss_pred             ceEEeeccCCCCCCCCC---CcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 013790          230 RPKLSDFGLAREGPMVG---HTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL  305 (436)
Q Consensus       230 ~~kl~Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  305 (436)
                      .+||+|||++.......   .........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.........  
T Consensus       159 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--  236 (303)
T 2vwi_A          159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--  236 (303)
T ss_dssp             CEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--
T ss_pred             CEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--
Confidence            99999999986432211   1112234578999999999876 56899999999999999999999999876543321  


Q ss_pred             HHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          306 LEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .......+...  ............    .+..+.+||.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~~--~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          237 MLTLQNDPPSL--ETGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             HHHHTSSCCCT--TC-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHhccCCCcc--ccccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            11111111100  000111111112    23678899999999999999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.8e-43  Score=337.05  Aligned_cols=254  Identities=24%  Similarity=0.347  Sum_probs=197.9

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--------hhHHHHHHHHHHHhccCCCCceee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--------QGHKQWVAEVQFLGVLEHPNLVKL  148 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~  148 (436)
                      ..++|.+.+.||+|+||.||+|...       .+++.||||++.....        .....+.+|+.+++.++||||+++
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   80 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFER-------KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI   80 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEc-------CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceE
Confidence            3468999999999999999999875       5678999999875422        122357889999999999999999


Q ss_pred             eeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC
Q 013790          149 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN  228 (436)
Q Consensus       149 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  228 (436)
                      ++++....     .++||||+++++|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.+
T Consensus        81 ~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~  150 (322)
T 2ycf_A           81 KNFFDAED-----YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ  150 (322)
T ss_dssp             EEEEESSS-----EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSS
T ss_pred             eeEEcCCc-----eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecC
Confidence            99986432     49999999999999998654  4799999999999999999999998   99999999999999876


Q ss_pred             Cc---eEEeeccCCCCCCCCCCcccccccccCCCcccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 013790          229 FR---PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE  302 (436)
Q Consensus       229 ~~---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  302 (436)
                      +.   +||+|||+++...   .........||+.|+|||++.   ...++.++|||||||++|+|++|..||........
T Consensus       151 ~~~~~~kl~Dfg~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  227 (322)
T 2ycf_A          151 EEDCLIKITDFGHSKILG---ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS  227 (322)
T ss_dssp             SSSCCEEECCCTTCEECC---CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC
T ss_pred             CCCCeEEEccCccceecc---cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH
Confidence            64   9999999997532   222334467999999999974   46788999999999999999999999976543221


Q ss_pred             HHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          303 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                        +...+......       ..+    ......+..+.+||.+||..||.+|||+.+++++
T Consensus       228 --~~~~~~~~~~~-------~~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          228 --LKDQITSGKYN-------FIP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             --HHHHHHHTCCC-------CCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --HHHHHHhCccc-------cCc----hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence              11111111000       000    0011124678899999999999999999999865

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.1e-43  Score=348.23  Aligned_cols=267  Identities=24%  Similarity=0.305  Sum_probs=196.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ..+|.+.+.||+|+||.||+|.+.        .+..||+|++.....    ...+|+.+++.++||||+++++++...+.
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~--------~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~  106 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLV--------ESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGD  106 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred             cceEEEeEEEeeCCCeEEEEEEEC--------CCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence            457999999999999999999875        233488887754322    22369999999999999999999876543


Q ss_pred             --cceeEEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc-CCCceE
Q 013790          158 --RGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPK  232 (436)
Q Consensus       158 --~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k  232 (436)
                        .....++||||+.++ +...+..  .....+++..+..++.||+.||.|||+.   +|+||||||+||||+ .++.+|
T Consensus       107 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~k  182 (394)
T 4e7w_A          107 KKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLK  182 (394)
T ss_dssp             SSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEE
T ss_pred             CCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEE
Confidence              334568999999764 4443321  2234799999999999999999999998   999999999999999 899999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhh
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ  311 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  311 (436)
                      |+|||+++....   ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+.....
T Consensus       183 L~DFG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g  259 (394)
T 4e7w_A          183 LIDFGSAKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG  259 (394)
T ss_dssp             ECCCTTCEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EeeCCCcccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999975321   2223456789999999998764 589999999999999999999999987654332211111110


Q ss_pred             cccC-----------ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          312 YPAD-----------SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       312 ~~~~-----------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .+..           ...+..+....+...+....+..+.+||.+||..||.+|||+.++++|
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            0000           000000011111111222345689999999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.3e-43  Score=346.30  Aligned_cols=266  Identities=25%  Similarity=0.351  Sum_probs=188.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|...       .+++.||||++...  .....+.+.+|+.+++.++||||+++++++...
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  100 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDT-------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA  100 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEET-------TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CCceEEeeEEeecCCeEEEEEEEC-------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            468999999999999999999865       57889999998654  233456788999999999999999999998654


Q ss_pred             CC--cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          156 GE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       156 ~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ..  .....++|+||+ +++|.+++..   ..+++..+..++.||+.||.|||+.   ||+||||||+||||+.++.+||
T Consensus       101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL  173 (367)
T 2fst_X          101 RSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI  173 (367)
T ss_dssp             SSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             CccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEE
Confidence            21  123459999998 7899998865   3699999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      +|||+++...     .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus       174 ~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  248 (367)
T 2fst_X          174 LDFGLARHTA-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  248 (367)
T ss_dssp             CC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred             eecccccccc-----ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999997522     12344679999999999977 67899999999999999999999999876543322221111111


Q ss_pred             ccCccccccc-----------cCCcccC---cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLI-----------MDPRLEK---EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~-----------~~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +.. ..+..+           +......   ......+..+.+||.+||..||.+|||+.+++++
T Consensus       249 p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          249 PGA-ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CCH-HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCH-HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            100 000000           0000000   0011224678899999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.4e-43  Score=336.56  Aligned_cols=266  Identities=21%  Similarity=0.311  Sum_probs=206.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCC------ceeeeeE
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN------LVKLIGY  151 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~~~~  151 (436)
                      .++|++.+.||+|+||.||+|...      ..+++.||||++.... ...+.+.+|+.+++.++|++      |++++++
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~   85 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDH------KAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW   85 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET------TTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEec------CCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence            468999999999999999999863      2467899999997542 34567888999999887654      9999999


Q ss_pred             eeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC----
Q 013790          152 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE----  227 (436)
Q Consensus       152 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~----  227 (436)
                      +...+    ..++||||+ +++|.+++......++++..+..++.||+.||.|||++   +|+||||||+|||++.    
T Consensus        86 ~~~~~----~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~  157 (339)
T 1z57_A           86 FEHHG----HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYT  157 (339)
T ss_dssp             EEETT----EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEE
T ss_pred             cccCC----cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccc
Confidence            87655    459999999 89999999877666799999999999999999999998   9999999999999987    


Q ss_pred             ---------------CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 013790          228 ---------------NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR  292 (436)
Q Consensus       228 ---------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~  292 (436)
                                     ++.+||+|||+++...     .......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  232 (339)
T 1z57_A          158 EAYNPKIKRDERTLINPDIKVVDFGSATYDD-----EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT  232 (339)
T ss_dssp             EEEC----CEEEEESCCCEEECCCSSCEETT-----SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cccCCccccccccccCCCceEeeCcccccCc-----cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCC
Confidence                           6789999999997522     12234578999999999999999999999999999999999999


Q ss_pred             CCCCCCchhhHHHHHHHhh-cccCc-------ccc-------c----------cccCCc-ccCcCCHHHHHHHHHHHHHh
Q 013790          293 SLERNRPKTEQRLLEWVQQ-YPADS-------KKF-------G----------LIMDPR-LEKEYSINEARKIGRLADNC  346 (436)
Q Consensus       293 pf~~~~~~~~~~~~~~~~~-~~~~~-------~~~-------~----------~~~~~~-l~~~~~~~~~~~l~~li~~c  346 (436)
                      ||..............+.. .+...       ..+       .          ....+. -........+..+.+||.+|
T Consensus       233 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  312 (339)
T 1z57_A          233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM  312 (339)
T ss_dssp             SCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence            9987655433322222111 11000       000       0          000000 00112345578899999999


Q ss_pred             hcCCCCCCCCHHHHHHH
Q 013790          347 LSKSSKDRPKMSQVVER  363 (436)
Q Consensus       347 l~~dp~~RPs~~eil~~  363 (436)
                      |..||.+|||+.+++++
T Consensus       313 L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          313 LEYDPAKRITLREALKH  329 (339)
T ss_dssp             TCSSTTTSCCHHHHTTS
T ss_pred             hCcCcccccCHHHHhcC
Confidence            99999999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.5e-43  Score=367.24  Aligned_cols=262  Identities=24%  Similarity=0.348  Sum_probs=208.2

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ..++|++.+.||+|+||.||+|.+...    ...+..||+|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  463 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSP----ENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN  463 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCS----SSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecC----CCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            356899999999999999999998622    1346789999987543 23346789999999999999999999998432


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                           ..++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus       464 -----~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~D  534 (656)
T 2j0j_A          464 -----PVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD  534 (656)
T ss_dssp             -----SCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred             -----ceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEe
Confidence                 2489999999999999997653 3689999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ||+++..... .........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.....   ....+.....
T Consensus       535 FG~a~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i~~~~~  610 (656)
T 2j0j_A          535 FGLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGER  610 (656)
T ss_dssp             CCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHHTCC
T ss_pred             cCCCeecCCC-cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHcCCC
Confidence            9999853221 1122233456789999999999999999999999999999997 999998765432   2222211110


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                                .    ..+..++..+.+||.+||..||.+|||+.+|++.|+.++.
T Consensus       611 ----------~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          611 ----------L----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             ----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------C----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                      0    1122334788999999999999999999999999999874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=7.8e-43  Score=339.90  Aligned_cols=274  Identities=27%  Similarity=0.338  Sum_probs=194.3

Q ss_pred             HHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEe
Q 013790           73 EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYC  152 (436)
Q Consensus        73 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  152 (436)
                      ......++|++.+.||+|+||.||+|.+.       .+++.||||++.... .....+.+++..+..++||||+++++++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~   88 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEK-------STGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYF   88 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEET-------TTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhh
Confidence            34556789999999999999999999975       467899999886542 2234567788888999999999999998


Q ss_pred             eecCC---cceeEEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhh--cCCCCceeeccCCCCcEEE
Q 013790          153 AVDGE---RGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLH--EGLEVQVIYRDFKASNVLL  225 (436)
Q Consensus       153 ~~~~~---~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH--~~~~~~ivH~Dlkp~NIll  225 (436)
                      ...+.   .....++||||+.+ +|...+..  .....+++..+..++.|++.||.|||  +.   +|+||||||+||||
T Consensus        89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll  164 (360)
T 3e3p_A           89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLV  164 (360)
T ss_dssp             EEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEE
T ss_pred             hccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEE
Confidence            76432   23446899999975 55554432  23457899999999999999999999  77   99999999999999


Q ss_pred             cC-CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 013790          226 DE-NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ  303 (436)
Q Consensus       226 ~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~  303 (436)
                      +. ++.+||+|||+++...   .........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.......
T Consensus       165 ~~~~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  241 (360)
T 3e3p_A          165 NEADGTLKLCDFGSAKKLS---PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL  241 (360)
T ss_dssp             ETTTTEEEECCCTTCBCCC---TTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             eCCCCcEEEeeCCCceecC---CCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH
Confidence            96 8999999999997532   22233456789999999998664 4899999999999999999999999876543322


Q ss_pred             HHHHHHhhcccCccc-----------cccccCCc-----ccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          304 RLLEWVQQYPADSKK-----------FGLIMDPR-----LEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       304 ~~~~~~~~~~~~~~~-----------~~~~~~~~-----l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..+  ..........           ........     .........+..+.+||.+||+.||.+|||+.+++++
T Consensus       242 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          242 HEI--VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHH--HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHH--HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            211  1111111000           00000000     0011122246789999999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.3e-43  Score=330.06  Aligned_cols=254  Identities=22%  Similarity=0.329  Sum_probs=187.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++.+.||+|+||.||+|...       .+++.||+|++......  ..+.+.++...++.++||||+++++++...
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~   78 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHV-------PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE   78 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEec-------CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc
Confidence            468999999999999999999975       57899999999765322  223345556668889999999999999865


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      +.    .++||||+. |+|.+++..  .....+++..++.++.|++.||.|||++  .+|+||||||+|||++.++.+||
T Consensus        79 ~~----~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl  151 (290)
T 3fme_A           79 GD----VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKM  151 (290)
T ss_dssp             SS----EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEB
T ss_pred             CC----EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEE
Confidence            43    599999996 588887754  1235799999999999999999999984  28999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCccccccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI----ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  309 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  309 (436)
                      +|||+++...   .........||+.|+|||++    .+..++.++||||||+++|+|++|..||........ .+....
T Consensus       152 ~Dfg~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~  227 (290)
T 3fme_A          152 CDFGISGYLV---DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQVV  227 (290)
T ss_dssp             CCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHHHH
T ss_pred             eecCCccccc---ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHHHh
Confidence            9999997532   22223345699999999996    556789999999999999999999999976433221 122211


Q ss_pred             hhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .....           .   ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       228 ~~~~~-----------~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          228 EEPSP-----------Q---LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             HSCCC-----------C---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ccCCC-----------C---cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            11110           0   0011224678999999999999999999999885

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-42  Score=329.77  Aligned_cols=259  Identities=21%  Similarity=0.360  Sum_probs=197.2

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..++|++++.||+|+||.||+|...       .+++.||||.+... ....+.+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   75 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNA-------LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERR   75 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECC
T ss_pred             ccccchhhheeccCCcEEEEEEEEc-------CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhc
Confidence            3568999999999999999999865       46789999998643 234567889999999999999999999886532


Q ss_pred             C---------cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          157 E---------RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       157 ~---------~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      .         .....++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++   +|+||||||+|||++.
T Consensus        76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~  151 (303)
T 1zy4_A           76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDE  151 (303)
T ss_dssp             CCCC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred             chhhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcC
Confidence            1         2346799999999999999997643 4678899999999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCCCCCCCCC------------CcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 013790          228 NFRPKLSDFGLAREGPMVG------------HTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSL  294 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf  294 (436)
                      ++.+||+|||++.......            .........||+.|+|||++.+. .++.++|||||||++|+|++   ||
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~  228 (303)
T 1zy4_A          152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF  228 (303)
T ss_dssp             TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred             CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence            9999999999997532110            01223345789999999999764 78999999999999999998   55


Q ss_pred             CCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          295 ERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...  .........+...           ...+...++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       229 ~~~--~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          229 STG--MERVNILKKLRSV-----------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             SSH--HHHHHHHHHHHST-----------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CCc--hhHHHHHHhcccc-----------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            421  1112222222211           1111122333445678899999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.8e-43  Score=342.81  Aligned_cols=264  Identities=20%  Similarity=0.292  Sum_probs=204.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh-----------------HHHHHHHHHHHhcc
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-----------------HKQWVAEVQFLGVL  140 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l  140 (436)
                      .++|.+.+.||+|+||.||+|..         +++.||+|.+.......                 .+.+.+|+.+++.+
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  100 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK---------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI  100 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE---------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc---------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence            46899999999999999999985         57899999986542221                 17899999999999


Q ss_pred             CCCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHH------hhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCce
Q 013790          141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDH------LFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQV  213 (436)
Q Consensus       141 ~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~i  213 (436)
                      +||||+++++++...+    ..++||||+++++|.++      +.......+++..++.++.|++.||.|||+ .   ||
T Consensus       101 ~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i  173 (348)
T 2pml_X          101 KNEYCLTCEGIITNYD----EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NI  173 (348)
T ss_dssp             CCTTBCCCSEEEESSS----EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CE
T ss_pred             CCCCcceEEEEEeeCC----eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CE
Confidence            9999999999987654    45999999999999999      655445689999999999999999999998 8   99


Q ss_pred             eeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccC-CCCc-hhhHHHHHHHHHHHHhCC
Q 013790          214 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTA-KSDVWSFGVVLYEMLTGR  291 (436)
Q Consensus       214 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvil~elltg~  291 (436)
                      +||||||+|||++.++.+||+|||++.....    .......||..|+|||++.+. .++. ++||||||+++|+|++|.
T Consensus       174 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~  249 (348)
T 2pml_X          174 CHRDVKPSNILMDKNGRVKLSDFGESEYMVD----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV  249 (348)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECBT----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSS
T ss_pred             eecCCChHhEEEcCCCcEEEecccccccccc----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999975321    133456799999999999877 6666 999999999999999999


Q ss_pred             CCCCCCCchhhHHHHHHHhhcccCcc-ccccccCCcc---cCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          292 RSLERNRPKTEQRLLEWVQQYPADSK-KFGLIMDPRL---EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       292 ~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .||......  ......+........ .......+..   ........+..+.+||.+||+.||.+|||+.+++++
T Consensus       250 ~pf~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          250 VPFSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             CSSCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            999865442  122222221111000 0000000000   000112335688999999999999999999999875

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.6e-43  Score=334.84  Aligned_cols=270  Identities=23%  Similarity=0.322  Sum_probs=199.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC-
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG-  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-  156 (436)
                      .++|.+++.||+|+||.||+|...       .+++.||+|++........+.+.+|+.+++.++||||+++++++...+ 
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDN-------DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEET-------TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             CCceeEEEEeccCCCeEEEEEEEC-------CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            468999999999999999999975       468899999998776666778999999999999999999999875432 


Q ss_pred             ---------CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc-
Q 013790          157 ---------ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-  226 (436)
Q Consensus       157 ---------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~-  226 (436)
                               ......++||||+. |+|.+++..   .++++..++.++.|++.||.|||+.   +|+||||||+|||++ 
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  155 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINT  155 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEET
T ss_pred             ccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcC
Confidence                     12345799999997 699999854   3689999999999999999999998   999999999999997 


Q ss_pred             CCCceEEeeccCCCCCCCC-CCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 013790          227 ENFRPKLSDFGLAREGPMV-GHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQR  304 (436)
Q Consensus       227 ~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~  304 (436)
                      .++.+||+|||+++..... ..........+|..|+|||.+.+ ..++.++||||||+++|+|++|..||.+....... 
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-  234 (320)
T 2i6l_A          156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM-  234 (320)
T ss_dssp             TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-
T ss_pred             CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH-
Confidence            5779999999999753211 11122334567899999998865 67899999999999999999999999876543221 


Q ss_pred             HHHHHhhcccCcccc-cc------------ccCCcc-cCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          305 LLEWVQQYPADSKKF-GL------------IMDPRL-EKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       305 ~~~~~~~~~~~~~~~-~~------------~~~~~l-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                       .......+...... ..            ...+.. ........+..+.+||.+||+.||.+|||+.+++++
T Consensus       235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          235 -QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             -HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence             11111111110000 00            000000 000111235779999999999999999999999886

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.7e-43  Score=338.55  Aligned_cols=257  Identities=19%  Similarity=0.235  Sum_probs=178.3

Q ss_pred             hcCCcccc-cccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRML-KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~-~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|.+.+ .||+|+||.||+|.++       .+++.||||++....    ....+....++.++||||+++++++....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHR-------RTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEEC-------CCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence            46899965 5999999999999976       567899999986532    12222334466779999999999987644


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC---CCceEE
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPKL  233 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl  233 (436)
                      ......++||||+.+|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.   ++.+||
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl  172 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKL  172 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEE
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEE
Confidence            4445679999999999999999877666799999999999999999999999   9999999999999976   455999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHH-HHHHhhc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL-LEWVQQY  312 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~  312 (436)
                      +|||+++...    ........||+.|+|||++.+..++.++||||||+++|+|++|..||........... ...+.. 
T Consensus       173 ~Dfg~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-  247 (336)
T 3fhr_A          173 TDFGFAKETT----QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL-  247 (336)
T ss_dssp             CCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred             eccccceecc----ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-
Confidence            9999997532    1223445789999999999888899999999999999999999999976543221100 000000 


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                ....+........+..+.+||.+||..||.+|||+.+++++
T Consensus       248 ----------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          248 ----------GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             -------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ----------cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                      00000111112335678999999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.4e-43  Score=339.57  Aligned_cols=272  Identities=24%  Similarity=0.286  Sum_probs=203.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|.+.+.||+|+||.||+|.+.       .+++.||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHK-------PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDS   82 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEEC-------CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence            468999999999999999999875       568899999997543 233456889999999999999999999886542


Q ss_pred             -CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          157 -ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       157 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                       ......++||||+. ++|.+++...   .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        83 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~D  155 (353)
T 2b9h_A           83 FENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCD  155 (353)
T ss_dssp             STTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECC
T ss_pred             cCccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEe
Confidence             12235699999996 6999998763   589999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCc--------ccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 013790          236 FGLAREGPMVGHT--------HVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  306 (436)
Q Consensus       236 fg~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  306 (436)
                      ||+++........        .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..........
T Consensus       156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  235 (353)
T 2b9h_A          156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI  235 (353)
T ss_dssp             CTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence            9999753211110        11223578999999998754 67899999999999999999999999876543322221


Q ss_pred             HHHhhcccCccccccccC----------Cccc----CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          307 EWVQQYPADSKKFGLIMD----------PRLE----KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~----------~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ......+........+..          +...    .......+..+.+||.+||..||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            111111111100000000          0000    00112335678899999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9e-43  Score=345.16  Aligned_cols=272  Identities=24%  Similarity=0.338  Sum_probs=186.5

Q ss_pred             cCCcc-cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSR-MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~-~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      +.|.+ .++||+|+||.||+|.++     +..+++.||||++.....  ...+.+|+.+++.++||||+++++++.....
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~-----~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRK-----DGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHAD   92 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEES-----SSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEc-----cCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence            45666 458999999999999976     334678899999976532  3468899999999999999999999975433


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE----c
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNR-------AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL----D  226 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll----~  226 (436)
                      .  ..++||||+. ++|.+++...       ....+++..++.|+.||+.||.|||+.   +|+||||||+||||    +
T Consensus        93 ~--~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~  166 (405)
T 3rgf_A           93 R--KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGP  166 (405)
T ss_dssp             T--EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSST
T ss_pred             C--eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCC
Confidence            2  5699999995 5888887531       123589999999999999999999998   99999999999999    7


Q ss_pred             CCCceEEeeccCCCCCCCC-CCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchh---
Q 013790          227 ENFRPKLSDFGLAREGPMV-GHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT---  301 (436)
Q Consensus       227 ~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~---  301 (436)
                      .++.+||+|||+++..... ..........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.....   
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  246 (405)
T 3rgf_A          167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS  246 (405)
T ss_dssp             TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred             CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence            7899999999999753211 111233456789999999999874 58999999999999999999999997654321   


Q ss_pred             ----hHHHHHHHhhcccCcc-ccccc------------cCCcccCcCC---------HHHHHHHHHHHHHhhcCCCCCCC
Q 013790          302 ----EQRLLEWVQQYPADSK-KFGLI------------MDPRLEKEYS---------INEARKIGRLADNCLSKSSKDRP  355 (436)
Q Consensus       302 ----~~~~~~~~~~~~~~~~-~~~~~------------~~~~l~~~~~---------~~~~~~l~~li~~cl~~dp~~RP  355 (436)
                          ...+...+........ .+..+            +.........         ...+..+.+||.+||..||.+||
T Consensus       247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~  326 (405)
T 3rgf_A          247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI  326 (405)
T ss_dssp             CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred             ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence                1111111111111000 00000            0000000000         01135688999999999999999


Q ss_pred             CHHHHHHH
Q 013790          356 KMSQVVER  363 (436)
Q Consensus       356 s~~eil~~  363 (436)
                      |+.++++|
T Consensus       327 ta~e~L~h  334 (405)
T 3rgf_A          327 TSEQAMQD  334 (405)
T ss_dssp             CHHHHHTS
T ss_pred             CHHHHhcC
Confidence            99999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4e-42  Score=337.87  Aligned_cols=270  Identities=23%  Similarity=0.253  Sum_probs=203.9

Q ss_pred             HHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CC-----Cceee
Q 013790           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HP-----NLVKL  148 (436)
Q Consensus        75 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~~  148 (436)
                      ....++|++.+.||+|+||.||+|...       .+++.||||++.... .....+..|+.++..+. |+     +|+++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~  121 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDR-------VEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHL  121 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEET-------TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEc-------CCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence            345679999999999999999999865       567899999997542 33456778888888875 55     49999


Q ss_pred             eeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc--
Q 013790          149 IGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD--  226 (436)
Q Consensus       149 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~--  226 (436)
                      ++++...+    ..++||||+. ++|.+++.......+++..+..++.|++.||.|||+. ..+|+||||||+||||+  
T Consensus       122 ~~~~~~~~----~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~  195 (382)
T 2vx3_A          122 KRHFMFRN----HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNP  195 (382)
T ss_dssp             EEEEEETT----EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESST
T ss_pred             eeeeccCC----ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecC
Confidence            99887654    4599999995 6999999877656799999999999999999999952 23999999999999994  


Q ss_pred             CCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 013790          227 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  306 (436)
Q Consensus       227 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  306 (436)
                      .++.+||+|||+++...     .......||+.|+|||++.+..++.++|||||||++|+|+||..||.+.........+
T Consensus       196 ~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i  270 (382)
T 2vx3_A          196 KRSAIKIVDFGSSCQLG-----QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI  270 (382)
T ss_dssp             TSCCEEECCCTTCEETT-----CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCcEEEEeccCceecc-----cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            57889999999997532     1223467899999999999999999999999999999999999999876543322111


Q ss_pred             HHHhhcccCc---------cccccccCC-----------------c--------------------ccCcCCHHHHHHHH
Q 013790          307 EWVQQYPADS---------KKFGLIMDP-----------------R--------------------LEKEYSINEARKIG  340 (436)
Q Consensus       307 ~~~~~~~~~~---------~~~~~~~~~-----------------~--------------------l~~~~~~~~~~~l~  340 (436)
                      ......+...         ..+..+.+.                 .                    -...........+.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (382)
T 2vx3_A          271 VEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK  350 (382)
T ss_dssp             HHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHH
T ss_pred             HHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHH
Confidence            1111110000         000000000                 0                    00011233456899


Q ss_pred             HHHHHhhcCCCCCCCCHHHHHHH
Q 013790          341 RLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       341 ~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +||.+||+.||.+|||+.+++++
T Consensus       351 dli~~mL~~dP~~Rpta~e~L~h  373 (382)
T 2vx3_A          351 DLILRMLDYDPKTRIQPYYALQH  373 (382)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             HHHHHhcCCChhhCCCHHHHhcC
Confidence            99999999999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.6e-43  Score=343.09  Aligned_cols=270  Identities=20%  Similarity=0.303  Sum_probs=206.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-----------CCCce
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-----------HPNLV  146 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv  146 (436)
                      .++|++.+.||+|+||.||+|...       .+++.||||++.... ...+.+.+|+.+++.+.           ||||+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~   89 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDM-------VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL   89 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEec-------CCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence            468999999999999999999865       568899999997543 34466788999998886           89999


Q ss_pred             eeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc
Q 013790          147 KLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD  226 (436)
Q Consensus       147 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~  226 (436)
                      ++++++...+..+...++||||+ +++|.+++.......+++..+..++.||+.||.|||+++  +|+||||||+||||+
T Consensus        90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~  166 (373)
T 1q8y_A           90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLME  166 (373)
T ss_dssp             CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEE
T ss_pred             HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEe
Confidence            99999987665556789999999 999999998766567999999999999999999999942  899999999999994


Q ss_pred             ------CCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Q 013790          227 ------ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK  300 (436)
Q Consensus       227 ------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~  300 (436)
                            ..+.+||+|||+++...     .......||+.|+|||++.+..++.++|||||||++|+|+||..||......
T Consensus       167 ~~~~~~~~~~~kl~Dfg~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  241 (373)
T 1q8y_A          167 IVDSPENLIQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH  241 (373)
T ss_dssp             EEETTTTEEEEEECCCTTCEETT-----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ccCCCcCcceEEEcccccccccC-----CCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence                  44589999999997532     1223457899999999999999999999999999999999999999865422


Q ss_pred             h----hHHHHHHHhhcccCcc-----------------ccccccCCc---------ccCcCCHHHHHHHHHHHHHhhcCC
Q 013790          301 T----EQRLLEWVQQYPADSK-----------------KFGLIMDPR---------LEKEYSINEARKIGRLADNCLSKS  350 (436)
Q Consensus       301 ~----~~~~~~~~~~~~~~~~-----------------~~~~~~~~~---------l~~~~~~~~~~~l~~li~~cl~~d  350 (436)
                      .    ...+..........+.                 .+..+....         -...++...+..+.+||.+||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  321 (373)
T 1q8y_A          242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD  321 (373)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred             ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC
Confidence            1    1111111111110000                 000000000         011245677889999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 013790          351 SKDRPKMSQVVER  363 (436)
Q Consensus       351 p~~RPs~~eil~~  363 (436)
                      |.+|||+.+++++
T Consensus       322 P~~Rpt~~ell~h  334 (373)
T 1q8y_A          322 PRKRADAGGLVNH  334 (373)
T ss_dssp             TTTCBCHHHHHTC
T ss_pred             ccccCCHHHHhhC
Confidence            9999999999886

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.7e-42  Score=339.27  Aligned_cols=264  Identities=25%  Similarity=0.324  Sum_probs=200.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|.+.+.||+|+||.||+|...       .+++.||||++....  ....+.+.+|+.+++.++||||+++++++...
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  113 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDK-------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA  113 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             cccEEEEeEEecCCCeEEEEEEEC-------CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence            468999999999999999999865       578899999997643  22346788999999999999999999999765


Q ss_pred             CCc--ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          156 GER--GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       156 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      +..  ....++||||+. ++|.+++.    ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       114 ~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL  185 (371)
T 4exu_A          114 SSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKI  185 (371)
T ss_dssp             SSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred             CCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEE
Confidence            432  123489999996 68988873    2489999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      +|||+++...     .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+................
T Consensus       186 ~Dfg~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~  260 (371)
T 4exu_A          186 LDFGLARHAD-----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV  260 (371)
T ss_dssp             CSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EecCcccccc-----cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999997521     22344678999999999977 68899999999999999999999999876543322111111111


Q ss_pred             ccCccccccc------------cCCcccC---cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLI------------MDPRLEK---EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~------------~~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +  ...+...            +......   ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       261 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          261 P--GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             C--CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             C--cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            1  0000000            0000000   0111235678999999999999999999999886

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.6e-42  Score=327.10  Aligned_cols=254  Identities=25%  Similarity=0.370  Sum_probs=202.1

Q ss_pred             HhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           76 QATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        76 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      ...++|++++.||+|+||.||+|...       .+++.||+|++....  ....+.+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDR-------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE   91 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEc-------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence            34578999999999999999999865       467899999986543  234567899999999999999999999987


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC---Cc
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN---FR  230 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~  230 (436)
                      ..+    ..++||||+.+++|.+++....  .+++..++.++.||+.||.|||+.   +++||||||+||+++.+   +.
T Consensus        92 ~~~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~  162 (287)
T 2wei_A           92 DSS----SFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCD  162 (287)
T ss_dssp             CSS----EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCC----eEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCccc
Confidence            654    4599999999999999986543  689999999999999999999998   99999999999999754   47


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      +||+|||++....   .........||+.|+|||++.+ .++.++||||||+++|+|++|..||.......   +...+.
T Consensus       163 ~kL~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~  235 (287)
T 2wei_A          163 IKIIDFGLSTCFQ---QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRVE  235 (287)
T ss_dssp             EEECSTTGGGTBC---CCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred             EEEeccCcceeec---CCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence            9999999987532   1122234468899999999875 48999999999999999999999998754332   222222


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ......       .  +  ......+..+.+||.+||..||.+|||+.+++++
T Consensus       236 ~~~~~~-------~--~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          236 TGKYAF-------D--L--PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             HCCCCC-------C--S--GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             cCCCCC-------C--c--hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            111000       0  0  0001224678899999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.4e-42  Score=333.45  Aligned_cols=266  Identities=23%  Similarity=0.359  Sum_probs=203.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCC------ceeeeeE
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN------LVKLIGY  151 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~~~~  151 (436)
                      .++|++.+.||+|+||.||+|....      ..+..||+|++.... ...+.+.+|+.+++.+.|++      ++.++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~   90 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHA------RGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDW   90 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecC------CCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence            4689999999999999999998751      234789999997542 34567888999999997766      8888888


Q ss_pred             eeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEE------
Q 013790          152 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLL------  225 (436)
Q Consensus       152 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll------  225 (436)
                      +...+    ..++||||+ +++|.+++.......+++..++.++.||+.||.|||++   +|+||||||+||||      
T Consensus        91 ~~~~~----~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~  162 (355)
T 2eu9_A           91 FNFHG----HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFE  162 (355)
T ss_dssp             EEETT----EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEE
T ss_pred             eeeCC----eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccc
Confidence            87654    459999999 77888888776656799999999999999999999998   99999999999999      


Q ss_pred             -------------cCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 013790          226 -------------DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR  292 (436)
Q Consensus       226 -------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~  292 (436)
                                   +.++.+||+|||+++...     .......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  237 (355)
T 2eu9_A          163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDH-----EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT  237 (355)
T ss_dssp             EEECCC-CCCEEEESCCCEEECCCTTCEETT-----SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccccccccccccccCCCcEEEeecCcccccc-----ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCC
Confidence                         678899999999997521     12234579999999999999999999999999999999999999


Q ss_pred             CCCCCCchhhHHHHHHHhh-cccCc-------ccc---ccccC--------------C-cccCcCCHHHHHHHHHHHHHh
Q 013790          293 SLERNRPKTEQRLLEWVQQ-YPADS-------KKF---GLIMD--------------P-RLEKEYSINEARKIGRLADNC  346 (436)
Q Consensus       293 pf~~~~~~~~~~~~~~~~~-~~~~~-------~~~---~~~~~--------------~-~l~~~~~~~~~~~l~~li~~c  346 (436)
                      ||...........+..... .+...       ..+   ....+              + ..........+..+.+||.+|
T Consensus       238 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  317 (355)
T 2eu9_A          238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM  317 (355)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHH
Confidence            9987654333222222111 11000       000   00000              0 000012234467899999999


Q ss_pred             hcCCCCCCCCHHHHHHH
Q 013790          347 LSKSSKDRPKMSQVVER  363 (436)
Q Consensus       347 l~~dp~~RPs~~eil~~  363 (436)
                      |..||.+|||+.+++++
T Consensus       318 L~~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          318 LEFDPAQRITLAEALLH  334 (355)
T ss_dssp             TCSSTTTSCCHHHHTTS
T ss_pred             hcCChhhCcCHHHHhcC
Confidence            99999999999999865

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.8e-42  Score=330.96  Aligned_cols=256  Identities=24%  Similarity=0.374  Sum_probs=195.7

Q ss_pred             HHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccC--CCCceeeee
Q 013790           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLE--HPNLVKLIG  150 (436)
Q Consensus        75 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--hpnIv~~~~  150 (436)
                      ....++|.+++.||+|+||.||+|...        +++.||+|++....  ....+.+.+|+.++..+.  ||||+++++
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNE--------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECT--------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcC--------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence            334578999999999999999999854        47789999986543  334567899999999997  599999999


Q ss_pred             EeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc
Q 013790          151 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  230 (436)
Q Consensus       151 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  230 (436)
                      ++...+    ..++||| +.+++|.+++....  .+++..++.++.|++.||.|||+.   +|+||||||+|||+++ +.
T Consensus        96 ~~~~~~----~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~  164 (313)
T 3cek_A           96 YEITDQ----YIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GM  164 (313)
T ss_dssp             EEECSS----EEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TE
T ss_pred             EeecCC----EEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-Ce
Confidence            987654    4699999 55889999997653  689999999999999999999998   9999999999999964 89


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-----------GHLTAKSDVWSFGVVLYEMLTGRRSLERNRP  299 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~pf~~~~~  299 (436)
                      +||+|||+++...............||+.|+|||++.+           ..++.++||||||+++|+|++|..||.....
T Consensus       165 ~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (313)
T 3cek_A          165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN  244 (313)
T ss_dssp             EEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             EEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence            99999999975432222222345578999999999865           4688899999999999999999999976543


Q ss_pred             hhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 013790          300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERL  364 (436)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L  364 (436)
                      ... .+.....              +......+...+..+.+||.+||..||.+|||+.+++++-
T Consensus       245 ~~~-~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          245 QIS-KLHAIID--------------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             HHH-HHHHHHC--------------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHH-HHHHHHh--------------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            221 1111111              1111111112246788999999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.1e-42  Score=333.52  Aligned_cols=263  Identities=25%  Similarity=0.323  Sum_probs=200.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|.+.+.||+|+||.||+|...       .+++.||||++....  ....+.+.+|+.+++.++||||+++++++...
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   95 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDK-------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA   95 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CceEEEeeeEecCCCeEEEEEEEC-------CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecc
Confidence            368999999999999999999875       568899999997543  22346788999999999999999999998765


Q ss_pred             CCc--ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          156 GER--GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       156 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      +..  ....++||||+. ++|.+++..    .+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl  167 (353)
T 3coi_A           96 SSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKI  167 (353)
T ss_dssp             SSGGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEE
T ss_pred             cccccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEE
Confidence            432  123489999996 688887732    489999999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      +|||+++...     .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus       168 ~Dfg~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~  242 (353)
T 3coi_A          168 LDFGLARHAD-----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV  242 (353)
T ss_dssp             CSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCB
T ss_pred             eecccccCCC-----CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999997521     12334578999999999877 67899999999999999999999999876543221111111000


Q ss_pred             ccCcccc----------------ccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKF----------------GLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~----------------~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +  ...+                .......+. ......+..+.+||.+||..||.+|||+.+++++
T Consensus       243 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          243 P--GTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             C--CHHHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             C--CHHHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0  0000                000000010 1122345789999999999999999999999876

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.1e-43  Score=336.05  Aligned_cols=259  Identities=21%  Similarity=0.323  Sum_probs=198.6

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      ..++|++.+.||+|+||.||+|.+.          ..||+|++....  ....+.+.+|+.+++.++||||+++++++..
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~----------~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWH----------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEES----------SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEc----------CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            3578999999999999999999864          138999986542  2223457789999999999999999999986


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+.    .++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++ ++.+||+
T Consensus       101 ~~~----~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~  171 (319)
T 2y4i_B          101 PPH----LAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVIT  171 (319)
T ss_dssp             SSC----EEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEEC
T ss_pred             CCc----eEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEe
Confidence            553    599999999999999997643 4689999999999999999999998   999999999999998 6899999


Q ss_pred             eccCCCCCCCCC---CcccccccccCCCccccccccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 013790          235 DFGLAREGPMVG---HTHVSTAVVGTFGYAAPDYIET---------GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE  302 (436)
Q Consensus       235 Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  302 (436)
                      |||+++......   .........||+.|+|||++.+         ..++.++||||||+++|+|++|..||........
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  251 (319)
T 2y4i_B          172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI  251 (319)
T ss_dssp             CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH
T ss_pred             ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999986432111   1122234568999999999864         4578899999999999999999999987544322


Q ss_pred             HHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          303 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                         ...+.....          +.+.   ....+..+.+|+.+||..||.+|||+.++++.|+.+...
T Consensus       252 ---~~~~~~~~~----------~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          252 ---IWQMGTGMK----------PNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             ---HHHHHTTCC----------CCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             ---HHHhccCCC----------CCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence               111111100          0000   011235688999999999999999999999999888654

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.2e-42  Score=329.27  Aligned_cols=257  Identities=26%  Similarity=0.395  Sum_probs=178.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHH-HHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQ-FLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|.+++.||+|+||.||+|...       .+++.||||++..... .....+..|+. +++.++||||+++++++...
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~   93 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHK-------PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE   93 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEET-------TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred             HHHhhehheeccCCCEEEEEEEEc-------CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence            468999999999999999999975       4688999999976532 23345555655 77888999999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFN---RAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      +    ..++||||+.+ +|.+++..   .....+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+|
T Consensus        94 ~----~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~k  166 (327)
T 3aln_A           94 G----DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIK  166 (327)
T ss_dssp             S----EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEE
T ss_pred             C----ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEE
Confidence            4    45999999975 88887753   2235799999999999999999999984  3899999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCccccccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI----ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  308 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  308 (436)
                      |+|||+++...   .........||+.|+|||++    .+..++.++||||||+++|+|++|..||.......     ..
T Consensus       167 l~Dfg~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~  238 (327)
T 3aln_A          167 LCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQ  238 (327)
T ss_dssp             ECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------
T ss_pred             EccCCCceecc---cccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HH
Confidence            99999997532   12222334689999999998    45678999999999999999999999997643211     00


Q ss_pred             HhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          309 VQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +.....       ...+.+........+..+.+||.+||..||.+|||+.+|+++
T Consensus       239 ~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          239 LTQVVK-------GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             -CCCCC-------SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHhc-------CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            111000       001111111112234679999999999999999999999886

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=331.92  Aligned_cols=245  Identities=24%  Similarity=0.397  Sum_probs=191.6

Q ss_pred             HHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch------hHHHHHHHHHHHhcc----CCCC
Q 013790           75 RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ------GHKQWVAEVQFLGVL----EHPN  144 (436)
Q Consensus        75 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~hpn  144 (436)
                      ....++|++.+.||+|+||.||+|...       .+++.||||++......      ....+.+|+.++..+    +|||
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~   99 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRL-------TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG   99 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECT-------TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSS
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEc-------cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCC
Confidence            445678999999999999999999864       56789999999765332      123356789999888    8999


Q ss_pred             ceeeeeEeeecCCcceeEEEEEEe-cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcE
Q 013790          145 LVKLIGYCAVDGERGIQRLLVYEF-MLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  223 (436)
Q Consensus       145 Iv~~~~~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NI  223 (436)
                      |+++++++...+.    .++|||| +.+++|.+++....  .+++..++.++.||+.||.|||+.   +|+||||||+||
T Consensus       100 i~~~~~~~~~~~~----~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  170 (312)
T 2iwi_A          100 VIRLLDWFETQEG----FMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENI  170 (312)
T ss_dssp             BCCEEEEC---------CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGE
T ss_pred             eeeEEEEEecCCe----EEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhE
Confidence            9999999876543    4899999 78999999997643  699999999999999999999998   999999999999


Q ss_pred             EEc-CCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchh
Q 013790          224 LLD-ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLT-AKSDVWSFGVVLYEMLTGRRSLERNRPKT  301 (436)
Q Consensus       224 ll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~pf~~~~~~~  301 (436)
                      |++ .++.+||+|||++.....    .......||..|+|||++.+..+. .++||||||+++|+|++|..||....   
T Consensus       171 l~~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---  243 (312)
T 2iwi_A          171 LIDLRRGCAKLIDFGSGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---  243 (312)
T ss_dssp             EEETTTTEEEECCCSSCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---
T ss_pred             EEeCCCCeEEEEEcchhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---
Confidence            999 899999999999875321    123445689999999999877664 58999999999999999999997421   


Q ss_pred             hHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          302 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                        ...   ...            .    .++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       244 --~~~---~~~------------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          244 --EIL---EAE------------L----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             --HHH---HTC------------C----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --HHh---hhc------------c----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              111   100            0    0112234678899999999999999999999876

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.8e-43  Score=335.60  Aligned_cols=247  Identities=25%  Similarity=0.379  Sum_probs=198.0

Q ss_pred             HHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch------hHHHHHHHHHHHhccC--CCC
Q 013790           73 EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ------GHKQWVAEVQFLGVLE--HPN  144 (436)
Q Consensus        73 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpn  144 (436)
                      +.....++|++.+.||+|+||.||+|...       .+++.||||++......      ....+.+|+.+++.+.  |||
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~  109 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRV-------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG  109 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEET-------TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEEC-------CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCC
Confidence            34445678999999999999999999865       56799999998754322      2245667999999996  599


Q ss_pred             ceeeeeEeeecCCcceeEEEEEEecCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcE
Q 013790          145 LVKLIGYCAVDGERGIQRLLVYEFMLN-RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNV  223 (436)
Q Consensus       145 Iv~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NI  223 (436)
                      |+++++++...+    ..++||||+.+ ++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+||
T Consensus       110 i~~~~~~~~~~~----~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI  180 (320)
T 3a99_A          110 VIRLLDWFERPD----SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENI  180 (320)
T ss_dssp             BCCEEEEEECSS----EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             ceEEEEEEecCC----cEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHE
Confidence            999999997654    35999999976 8999999764  3689999999999999999999998   999999999999


Q ss_pred             EEc-CCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q 013790          224 LLD-ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKT  301 (436)
Q Consensus       224 ll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~  301 (436)
                      ||+ .++.+||+|||+++....    .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....  
T Consensus       181 ll~~~~~~~kL~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--  254 (320)
T 3a99_A          181 LIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--  254 (320)
T ss_dssp             EEETTTTEEEECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--
T ss_pred             EEeCCCCCEEEeeCcccccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--
Confidence            999 789999999999975321    12234568999999999987766 6789999999999999999999964211  


Q ss_pred             hHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          302 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                         .   .....            .+...    .+..+.+||.+||+.||.+|||+.+|+++
T Consensus       255 ---~---~~~~~------------~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          255 ---I---IRGQV------------FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ---H---HHCCC------------CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---h---hcccc------------ccccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               1   11000            01111    23678899999999999999999999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=324.35  Aligned_cols=253  Identities=26%  Similarity=0.438  Sum_probs=180.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh--HHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG--HKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|.+.       .+++.||||++.......  .+.+.++..+++.++||||+++++++...
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~   96 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFR-------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN   96 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEET-------TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hccccccceeeecCCeeEEEEEEe-------cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence            568999999999999999999975       467899999997653322  23344555678888999999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      +    ..++||||+ ++.+..+.... ...+++..++.++.|++.||.|||+ .   +|+|+||||+|||++.++.+||+
T Consensus        97 ~----~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~  167 (318)
T 2dyl_A           97 T----DVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLC  167 (318)
T ss_dssp             S----EEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEEC
T ss_pred             C----cEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEE
Confidence            4    459999999 55565555432 3479999999999999999999998 5   89999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHH
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV  309 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  309 (436)
                      |||++....   .........||+.|+|||++.     +..++.++||||||+++|+|++|..||........ .+....
T Consensus       168 dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~  243 (318)
T 2dyl_A          168 DFGISGRLV---DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VLTKVL  243 (318)
T ss_dssp             CCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHHHH
T ss_pred             ECCCchhcc---CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-HHHHHh
Confidence            999987532   122233456899999999994     45788999999999999999999999986433211 111111


Q ss_pred             hhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ...+.           .+..  ....+..+.+||.+||..||.+|||+.+|+++
T Consensus       244 ~~~~~-----------~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          244 QEEPP-----------LLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             HSCCC-----------CCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccCCC-----------CCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11110           0000  11124678899999999999999999999876

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.9e-41  Score=336.22  Aligned_cols=253  Identities=21%  Similarity=0.299  Sum_probs=185.1

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  157 (436)
                      +.|...+.||+|+||+||.+..        .+++.||||++....   .+.+.+|+.++..+ +||||+++++++.... 
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~--------~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-   82 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGS--------FQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDR-   82 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEE--------SSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS-
T ss_pred             heeeccCeEeeCCCeEEEEEEE--------ECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCC-
Confidence            3455678899999999986543        357899999986542   34678899999876 8999999999886543 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCC-----CCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC----
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPP-----LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN----  228 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----  228 (436)
                         ..++||||+. |+|.+++.......     .++..++.++.||+.||.|||+.   +|+||||||+||||+.+    
T Consensus        83 ---~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~  155 (434)
T 2rio_A           83 ---FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFT  155 (434)
T ss_dssp             ---EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHH
T ss_pred             ---eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccc
Confidence               4699999995 69999997654211     13345678999999999999998   99999999999999754    


Q ss_pred             ---------CceEEeeccCCCCCCCCCCc--ccccccccCCCccccccccc-------CCCCchhhHHHHHHHHHHHHh-
Q 013790          229 ---------FRPKLSDFGLAREGPMVGHT--HVSTAVVGTFGYAAPDYIET-------GHLTAKSDVWSFGVVLYEMLT-  289 (436)
Q Consensus       229 ---------~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-  289 (436)
                               +.+||+|||+++........  .......||+.|+|||++.+       ..++.++|||||||++|||+| 
T Consensus       156 ~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~  235 (434)
T 2rio_A          156 ADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK  235 (434)
T ss_dssp             SCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhC
Confidence                     48999999999854222111  12234579999999999965       578999999999999999999 


Q ss_pred             CCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          290 GRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       290 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      |..||....... ..+   +.....         .+.+........+..+.+||.+||+.||.+|||+.+|+++
T Consensus       236 g~~Pf~~~~~~~-~~i---~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          236 GKHPFGDKYSRE-SNI---IRGIFS---------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             SCCTTCSTTTHH-HHH---HHTCCC---------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCCchhhH-HHH---hcCCCC---------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            999997654322 111   111110         0111112245667889999999999999999999999874

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.3e-41  Score=347.55  Aligned_cols=274  Identities=25%  Similarity=0.345  Sum_probs=204.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++.+.||+|+||.||+|.+.       .++..||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~-------~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~   85 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQ-------DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ   85 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCT-------TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEEC-------CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence            368999999999999999998854       56788999998764 3334567899999999999999999999875421


Q ss_pred             C--cceeEEEEEEecCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc---
Q 013790          157 E--RGIQRLLVYEFMLNRSLEDHLFNRA-FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR---  230 (436)
Q Consensus       157 ~--~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---  230 (436)
                      .  .....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.   ||+||||||+|||++.++.   
T Consensus        86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~  162 (676)
T 3qa8_A           86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLI  162 (676)
T ss_dssp             CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCE
T ss_pred             cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCcee
Confidence            1  1234589999999999999997643 33689999999999999999999998   9999999999999997665   


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      +||+|||++....   .........||+.|+|||++.+..++.++||||||+++|+|++|..||.......     .|..
T Consensus       163 vKL~DFG~a~~~~---~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~  234 (676)
T 3qa8_A          163 HKIIDLGYAKELD---QGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHG  234 (676)
T ss_dssp             EEECSCCCCCBTT---SCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSST
T ss_pred             EEEcccccccccc---cccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhh
Confidence            9999999997532   2223345679999999999999999999999999999999999999997542211     1111


Q ss_pred             hccc-----------CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHH-----HHHHHHhhh
Q 013790          311 QYPA-----------DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV-----VERLKQIVQ  369 (436)
Q Consensus       311 ~~~~-----------~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei-----l~~L~~~~~  369 (436)
                      ....           .....................+..+.+||.+||..||.+|||+.++     .+.++.++.
T Consensus       235 ~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          235 KVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             TCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            0000           0000000000011223445577899999999999999999999884     455665553

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=331.24  Aligned_cols=251  Identities=20%  Similarity=0.309  Sum_probs=185.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  156 (436)
                      ..+|...+.||+|+||+||....        .+++.||||++......   .+.+|+.+++.+ +||||+++++++....
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~--------~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~   91 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGM--------FDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQ   91 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEE--------SSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred             cEEEecCCeeecCcCEEEEEEEE--------eCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            34699999999999999654322        35788999999765432   355799999998 7999999999887654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC-----CCce
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-----NFRP  231 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~  231 (436)
                          ..++||||+. |+|.+++.... ..+.+..++.++.||+.||.|||+.   +|+||||||+||||+.     ...+
T Consensus        92 ----~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~  162 (432)
T 3p23_A           92 ----FQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKA  162 (432)
T ss_dssp             ----EEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCE
T ss_pred             ----EEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeE
Confidence                4599999995 69999997654 2455567789999999999999998   9999999999999943     3357


Q ss_pred             EEeeccCCCCCCCCCC-cccccccccCCCcccccccc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHH
Q 013790          232 KLSDFGLAREGPMVGH-THVSTAVVGTFGYAAPDYIE---TGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLL  306 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  306 (436)
                      ||+|||+++....... ........||+.|+|||++.   ...++.++|||||||++|+|+| |..||..........  
T Consensus       163 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--  240 (432)
T 3p23_A          163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--  240 (432)
T ss_dssp             EECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--
T ss_pred             EEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--
Confidence            8999999975322111 12334567999999999997   4567889999999999999999 999996543322111  


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                       .......          ..  .......+..+.+||.+||+.||.+|||+.+|+++
T Consensus       241 -~~~~~~~----------~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          241 -LLGACSL----------DC--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             -HTTCCCC----------TT--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -HhccCCc----------cc--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence             1110000          00  01123445678899999999999999999999964

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.4e-40  Score=312.45  Aligned_cols=233  Identities=22%  Similarity=0.287  Sum_probs=182.9

Q ss_pred             hcCCccc-ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHH-hccCCCCceeeeeEeeec
Q 013790           78 TNDFSRM-LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFL-GVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|.+. +.||+|+||.||+|...       .+++.||+|++...     ..+.+|+.++ +.++||||+++++++...
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNK-------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEc-------CCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            4678887 77999999999999875       46789999998643     4567788887 566899999999998763


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC---CCceE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPK  232 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~k  232 (436)
                      .......++||||+++|+|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++.   ++.+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~k  160 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILK  160 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEE
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEE
Confidence            33344579999999999999999887666799999999999999999999998   9999999999999998   88999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |+|||++...                        .+..++.++|||||||++|+|++|..||.........      ...
T Consensus       161 l~Dfg~a~~~------------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------~~~  210 (299)
T 3m2w_A          161 LTDFGFAKET------------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------PGM  210 (299)
T ss_dssp             ECCCTTCEEC------------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------CCS
T ss_pred             Eecccccccc------------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------HHH
Confidence            9999998631                        1244678999999999999999999999754322100      000


Q ss_pred             ccCccccccccCCcccCcCC----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYS----INEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                            ...+.....  ..+    ...+..+.+||.+||+.||.+|||+.+++++
T Consensus       211 ------~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          211 ------KTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             ------CCSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ------HHHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                  000000000  111    1235789999999999999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.2e-40  Score=347.50  Aligned_cols=246  Identities=23%  Similarity=0.381  Sum_probs=194.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++.+.||+|+||.||+|.+..      .+++.||||++.... ......+.+|+.++..++||||+++++++...+
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRN------VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD  152 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGG------GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcC------CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence            4789999999999999999998751      257899999986543 334467889999999999999999999998765


Q ss_pred             Ccce-eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          157 ERGI-QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       157 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      ..+. ..|+||||+++++|.+++..    .+++..++.|+.||+.||.|||++   +|+||||||+||||+.+ .+||+|
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~D  224 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLID  224 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECC
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEe
Confidence            4322 25999999999999988743    699999999999999999999998   99999999999999875 899999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||+++....      .....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+....          ..+  
T Consensus       225 FG~a~~~~~------~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~--  285 (681)
T 2pzi_A          225 LGAVSRINS------FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLP--  285 (681)
T ss_dssp             CTTCEETTC------CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCC--
T ss_pred             cccchhccc------CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc----------ccc--
Confidence            999975321      14457999999999997654 88999999999999999999888642110          000  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHHHHHHhh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-MSQVVERLKQIV  368 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~eil~~L~~~~  368 (436)
                                  ........+..+.+||.+||+.||.+||+ +.++...|..++
T Consensus       286 ------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          286 ------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                        00111223467889999999999999995 555666665553

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=8.7e-40  Score=308.41  Aligned_cols=232  Identities=13%  Similarity=0.110  Sum_probs=184.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++.+.||+|+||.||+|.+.       .+++.||||++.....   ...+.+.+|+.++..++||||+++++++..
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~  102 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDT-------ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT  102 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEET-------TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEec-------CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence            357999999999999999999975       5688999999976533   234678999999999999999999999977


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..|+||||++|++|.+++...    .....+..|+.|++.||.|||++   ||+||||||+||||+.+|.+||+
T Consensus       103 ~~----~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~  171 (286)
T 3uqc_A          103 RA----GGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLA  171 (286)
T ss_dssp             TT----EEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEEC
T ss_pred             CC----cEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEE
Confidence            54    359999999999999999532    35557889999999999999999   99999999999999999999998


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ++|.                      ++       .++.++|||||||++|+|+||+.||.+.......           
T Consensus       172 ~~~~----------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-----------  211 (286)
T 3uqc_A          172 YPAT----------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-----------  211 (286)
T ss_dssp             SCCC----------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-----------
T ss_pred             eccc----------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-----------
Confidence            5542                      22       3688999999999999999999999865432100           


Q ss_pred             CccccccccCCccc--CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          315 DSKKFGLIMDPRLE--KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       315 ~~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                        ............  .......+..+.+||.+||+.||.+| |+.++++.|+.+...
T Consensus       212 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          212 --APAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             --EECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             --HHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence              000000000000  01122345679999999999999999 999999999988643

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3e-40  Score=327.66  Aligned_cols=247  Identities=17%  Similarity=0.185  Sum_probs=183.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCC-CCceee-----
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEH-PNLVKL-----  148 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-pnIv~~-----  148 (436)
                      ..+|...+.||+|+||.||+|.+.       .+++.||||++.....   ...+.+.+|+.+++.+.| +|+...     
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~-------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~  149 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQ-------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR  149 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred             ceeEEEecccccCCCEEEEEEEec-------CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence            346888899999999999999965       5678999999874322   235778999999999987 322111     


Q ss_pred             ----eeEeee------------c-CCcceeEEEEEEecCCCCHHHHhh-----cCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 013790          149 ----IGYCAV------------D-GERGIQRLLVYEFMLNRSLEDHLF-----NRAFPPLPWKTRLHIILGAAEGLAYLH  206 (436)
Q Consensus       149 ----~~~~~~------------~-~~~~~~~~lv~e~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~ql~~~l~~LH  206 (436)
                          .+.+..            . .......+++|+++ +++|.+++.     ......+++..++.++.||+.||.|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  228 (413)
T 3dzo_A          150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH  228 (413)
T ss_dssp             BCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                111111            0 01122346777765 789999984     223346888899999999999999999


Q ss_pred             cCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCccccccc----------ccCCCCchhh
Q 013790          207 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYI----------ETGHLTAKSD  276 (436)
Q Consensus       207 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~D  276 (436)
                      ++   +|+||||||+||||+.++.+||+|||+++...     .......| +.|+|||++          .+..++.++|
T Consensus       229 ~~---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~D  299 (413)
T 3dzo_A          229 HY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFD  299 (413)
T ss_dssp             HT---TEECSCCCGGGEEECTTCCEEECCGGGCEETT-----EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHH
T ss_pred             hC---CcccCCcccceEEEecCCeEEEEeccceeecC-----CccccCCC-CceeCchhhhccccccccccCcCCCchhh
Confidence            98   99999999999999999999999999987521     12345567 999999999          5556888999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC
Q 013790          277 VWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK  356 (436)
Q Consensus       277 vwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs  356 (436)
                      ||||||++|+|+||+.||........                ...++...      ...+..+.+||.+||..||.+||+
T Consensus       300 vwSlGvil~elltg~~Pf~~~~~~~~----------------~~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt  357 (413)
T 3dzo_A          300 TWTLGLAIYWIWCADLPNTDDAALGG----------------SEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLL  357 (413)
T ss_dssp             HHHHHHHHHHHHHSSCCCCTTGGGSC----------------SGGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHHHHHHHHCCCCCCCcchhhh----------------HHHHHhhc------ccCCHHHHHHHHHHccCChhhCcC
Confidence            99999999999999999976432211                00011100      012367999999999999999999


Q ss_pred             HHHHHHH
Q 013790          357 MSQVVER  363 (436)
Q Consensus       357 ~~eil~~  363 (436)
                      +.+++++
T Consensus       358 ~~~~l~~  364 (413)
T 3dzo_A          358 PLQAMET  364 (413)
T ss_dssp             HHHHTTS
T ss_pred             HHHHHhC
Confidence            9888664

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2e-38  Score=306.04  Aligned_cols=248  Identities=19%  Similarity=0.179  Sum_probs=185.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--------hhHHHHHHHHHHHhccC--------
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--------QGHKQWVAEVQFLGVLE--------  141 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~--------  141 (436)
                      .++|++++.||+|+||.||+|++         +++.||||++.....        ...+.+.+|+.+++.++        
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~   89 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA---------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCN   89 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE---------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSS
T ss_pred             cccchheeeecccCceEEEEEEe---------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccc
Confidence            46899999999999999999985         368999999976532        22367888999988885        


Q ss_pred             -CCCceeeeeEeeecCC--------------------------cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHH
Q 013790          142 -HPNLVKLIGYCAVDGE--------------------------RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI  194 (436)
Q Consensus       142 -hpnIv~~~~~~~~~~~--------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i  194 (436)
                       ||||+++.+++...+.                          .....++||||+++|++.+.+.+   ..+++..+..+
T Consensus        90 ~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i  166 (336)
T 2vuw_A           90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSI  166 (336)
T ss_dssp             BCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHH
T ss_pred             cCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHH
Confidence             7777777665432110                          13357999999999987777644   36899999999


Q ss_pred             HHHHHHHHHHhh-cCCCCceeeccCCCCcEEEcCCC--------------------ceEEeeccCCCCCCCCCCcccccc
Q 013790          195 ILGAAEGLAYLH-EGLEVQVIYRDFKASNVLLDENF--------------------RPKLSDFGLAREGPMVGHTHVSTA  253 (436)
Q Consensus       195 ~~ql~~~l~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~  253 (436)
                      +.||+.||.||| +.   +|+||||||+||||+.++                    .+||+|||+|+...       ...
T Consensus       167 ~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~-------~~~  236 (336)
T 2vuw_A          167 LHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER-------DGI  236 (336)
T ss_dssp             HHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE-------TTE
T ss_pred             HHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC-------CCc
Confidence            999999999999 88   999999999999999887                    89999999997521       124


Q ss_pred             cccCCCcccccccccCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCC
Q 013790          254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVV-LYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYS  332 (436)
Q Consensus       254 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvi-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  332 (436)
                      ..||+.|+|||++.+.. +.++||||||++ .+++++|..||.....  .......+....        ...........
T Consensus       237 ~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~~--------~~~~~~~~~~~  305 (336)
T 2vuw_A          237 VVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQM--------TFKTKCNTPAM  305 (336)
T ss_dssp             EECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHTC--------CCSSCCCSHHH
T ss_pred             EEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhhh--------ccCcccchhhh
Confidence            57999999999998766 899999998777 7788889999853100  011111111000        00111111233


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCHHHHH-HH
Q 013790          333 INEARKIGRLADNCLSKSSKDRPKMSQVV-ER  363 (436)
Q Consensus       333 ~~~~~~l~~li~~cl~~dp~~RPs~~eil-~~  363 (436)
                      ...+..+.+||.+||+.|     |+.+++ +|
T Consensus       306 ~~~s~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          306 KQIKRKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             hhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence            467789999999999976     999988 54

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=9e-33  Score=283.66  Aligned_cols=186  Identities=17%  Similarity=0.079  Sum_probs=128.3

Q ss_pred             ccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc----------chhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           87 IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----------LQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        87 ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      ++.|++|.+..++..       ..+..|++|++....          ....+.|.+|+++|+++ .|+||+++++++.++
T Consensus       242 ~~~~~~~~h~~~rr~-------~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~  314 (569)
T 4azs_A          242 PYAGAGLAHKRSRRY-------FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA  314 (569)
T ss_dssp             -C--------CCEEE-------EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS
T ss_pred             cccCCcccccccccc-------cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC
Confidence            455555555544332       457779999986542          12235699999999999 699999999999766


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..||||||++|++|.++|....  +++..   .|+.||+.||+|||++   |||||||||+||||+.+|.+||+|
T Consensus       315 ~----~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~D  382 (569)
T 4azs_A          315 Q----SGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLID  382 (569)
T ss_dssp             S----EEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECC
T ss_pred             C----EEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEee
Confidence            5    4599999999999999997653  56654   5899999999999999   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL  294 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf  294 (436)
                      ||+|+...  .......+.+||+.|||||++.+. +..++|+||+|++++++.++..++
T Consensus       383 FGlAr~~~--~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          383 FGSIVTTP--QDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             CTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             cccCeeCC--CCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence            99998632  222334557899999999999764 577899999999988887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.1e-28  Score=251.94  Aligned_cols=186  Identities=18%  Similarity=0.227  Sum_probs=141.2

Q ss_pred             cccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--------hHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           82 SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--------GHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        82 ~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      ...+.||+|+||.||+|.+         .+..+++|........        ..+.+.+|+.++++++||||+++..++.
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~  409 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY---------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV  409 (540)
T ss_dssp             ---------CCEEEEEEEC---------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE---------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE
Confidence            4456899999999999964         3567888876443211        1345889999999999999995555555


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      .....    ++||||+++++|.+++..          +..++.|++.||.|||++   +|+||||||+|||++.  .+||
T Consensus       410 ~~~~~----~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL  470 (540)
T 3en9_A          410 DLDNK----RIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYI  470 (540)
T ss_dssp             ETTTT----EEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEE
T ss_pred             eCCcc----EEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEE
Confidence            44433    999999999999999854          568999999999999998   9999999999999998  9999


Q ss_pred             eeccCCCCCCCCCCcc-----cccccccCCCccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 013790          234 SDFGLAREGPMVGHTH-----VSTAVVGTFGYAAPDYIET--GHLTAKSDVWSFGVVLYEMLTGRRSLE  295 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~  295 (436)
                      +|||+++.........     ......||+.|||||++.+  ..|+..+|+||..+-..+-+.++.+|.
T Consensus       471 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          471 IDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             EECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            9999998642211111     1245689999999999976  567888999999999888888776653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=3.4e-25  Score=207.85  Aligned_cols=151  Identities=13%  Similarity=0.049  Sum_probs=118.9

Q ss_pred             HHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc------------------hhHHHHHHHH
Q 013790           73 EMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------------------QGHKQWVAEV  134 (436)
Q Consensus        73 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~  134 (436)
                      .+......|.+.+.||+|+||.||+|.+.        +++.||+|.+.....                  .....+.+|+
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~  155 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSE--------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF  155 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEET--------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHH
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeC--------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHH
Confidence            33444556777899999999999999863        578999999864322                  1245688999


Q ss_pred             HHHhccCCCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 013790          135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVI  214 (436)
Q Consensus       135 ~~l~~l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~iv  214 (436)
                      .+++.++  | +++.+++.. +    ..++||||++|++|.+ +..        .....++.|++.||.|||+.   ||+
T Consensus       156 ~~l~~l~--~-~~v~~~~~~-~----~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---gii  215 (282)
T 1zar_A          156 RALQKLQ--G-LAVPKVYAW-E----GNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIV  215 (282)
T ss_dssp             HHHHHTT--T-SSSCCEEEE-E----TTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             HHHHhcc--C-CCcCeEEec-c----ceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCE
Confidence            9999998  4 555555433 2    2399999999999998 421        23457999999999999998   999


Q ss_pred             eccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccc
Q 013790          215 YRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIE  267 (436)
Q Consensus       215 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  267 (436)
                      ||||||+||||+ ++.+||+|||+++               .+..++|||++.
T Consensus       216 HrDlkp~NILl~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~  252 (282)
T 1zar_A          216 HGDLSQYNVLVS-EEGIWIIDFPQSV---------------EVGEEGWREILE  252 (282)
T ss_dssp             CSCCSTTSEEEE-TTEEEECCCTTCE---------------ETTSTTHHHHHH
T ss_pred             eCCCCHHHEEEE-CCcEEEEECCCCe---------------ECCCCCHHHHHH
Confidence            999999999999 9999999999986               344578999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=4e-21  Score=177.82  Aligned_cols=136  Identities=16%  Similarity=0.118  Sum_probs=104.8

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceE--EEEEEeccCcch------------------------hHHHHHHHH
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATV--VAIKKLNRDGLQ------------------------GHKQWVAEV  134 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~  134 (436)
                      |.+.+.||+|+||.||+|.+.       .+++.  ||||++......                        ....+.+|+
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~-------~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~  121 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGV-------FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEF  121 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEE-------ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEc-------CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHH
Confidence            677889999999999999873       25677  999987543211                        113578899


Q ss_pred             HHHhccCCCCc--eeeeeEeeecCCcceeEEEEEEecCC-C----CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhh-
Q 013790          135 QFLGVLEHPNL--VKLIGYCAVDGERGIQRLLVYEFMLN-R----SLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLH-  206 (436)
Q Consensus       135 ~~l~~l~hpnI--v~~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH-  206 (436)
                      .++..+.|++|  ..++++  .      ..++||||+.+ |    +|.++...     .++..+..++.|++.||.||| 
T Consensus       122 ~~l~~l~~~~i~~p~~~~~--~------~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~  188 (258)
T 1zth_A          122 RNLERAKEAGVSVPQPYTY--M------KNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ  188 (258)
T ss_dssp             HHHHHHHHTTCCCCCEEEE--E------TTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCeEEEc--C------CCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH
Confidence            99999988864  333332  1      13899999942 3    77776532     234567899999999999999 


Q ss_pred             cCCCCceeeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          207 EGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       207 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      +.   ||+||||||+|||++.  .++|+|||+|..
T Consensus       189 ~~---givHrDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          189 EA---ELVHADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             TS---CEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             HC---CEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence            87   9999999999999998  999999999864

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=5.6e-18  Score=163.32  Aligned_cols=136  Identities=13%  Similarity=0.108  Sum_probs=97.4

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--------------hHHH--------HHHHHHHH
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--------------GHKQ--------WVAEVQFL  137 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------~~~~--------~~~E~~~l  137 (436)
                      =|.+...||.|+||.||+|...        +++.||||+++.....              ....        ...|...|
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~--------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL  167 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE--------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM  167 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT--------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCEeeeCCceEEEEEECC--------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence            3899999999999999999853        5789999987532110              0111        23456666


Q ss_pred             hccCCCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeecc
Q 013790          138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRD  217 (436)
Q Consensus       138 ~~l~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~D  217 (436)
                      .++.+.++.-..-+...  .    .+|||||+.|++|.++..      .  .....++.||+.+|.|||..   ||||||
T Consensus       168 ~rL~~~gv~vp~p~~~~--~----~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~---gIVHrD  230 (397)
T 4gyi_A          168 KALYEEGFPVPEPIAQS--R----HTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKH---GLIHGD  230 (397)
T ss_dssp             HHHHHTTCSCCCEEEEE--T----TEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             HHHHhcCCCCCeeeecc--C----ceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHC---CCcCCC
Confidence            66654443221111111  1    279999999988876542      1  23457889999999999998   999999


Q ss_pred             CCCCcEEEcCCC----------ceEEeeccCCC
Q 013790          218 FKASNVLLDENF----------RPKLSDFGLAR  240 (436)
Q Consensus       218 lkp~NIll~~~~----------~~kl~Dfg~a~  240 (436)
                      |||.||||+++|          .+.|+||+-+.
T Consensus       231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred             CCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence            999999998776          38999999775

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.46  E-value=3e-13  Score=124.87  Aligned_cols=147  Identities=16%  Similarity=0.077  Sum_probs=111.7

Q ss_pred             HHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCCceeeeeEe
Q 013790           74 MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNLVKLIGYC  152 (436)
Q Consensus        74 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~  152 (436)
                      +......|.+...++.|+++.||++..         .+..+++|............+.+|+.+++.+. +..+.++++++
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~---------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~   79 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVG---------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE   79 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEEC---------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEEC---------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence            344557898888899999999999863         25679999987532222346888999999885 67788888887


Q ss_pred             eecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------
Q 013790          153 AVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG------------------------  208 (436)
Q Consensus       153 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~------------------------  208 (436)
                      ...+    ..|+||||++|.+|.+.+.       +......++.+++.+|..||+.                        
T Consensus        80 ~~~~----~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (263)
T 3tm0_A           80 RHDG----WSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN  148 (263)
T ss_dssp             EETT----EEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred             ecCC----ceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhc
Confidence            6543    3599999999999988642       1123447889999999999981                        


Q ss_pred             --------------------------------CCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          209 --------------------------------LEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       209 --------------------------------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                                                      ....++|+|++|.|||+++++.+.|+||+.+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                            01369999999999999876667799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.25  E-value=1.4e-11  Score=113.17  Aligned_cols=137  Identities=14%  Similarity=0.082  Sum_probs=96.1

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCC--ceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN--LVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~  156 (436)
                      .++.+....+.|..+.||++...        ++..+++|.....   ....+.+|+.+++.+.+.+  +.+++++....+
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~--------~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~   88 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQ--------GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG   88 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECT--------TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred             CCCceEecccCCCCceEEEEecC--------CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC
Confidence            35555443345667999998642        3566999987654   2235678999998886544  455777765443


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------------------------
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL---------------------------  209 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---------------------------  209 (436)
                          ..++||||++|.+|.  ..     ...   ...++.+++..|..||+..                           
T Consensus        89 ----~~~~v~e~i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (264)
T 1nd4_A           89 ----RDWLLLGEVPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVD  154 (264)
T ss_dssp             ----CEEEEEECCSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCC
T ss_pred             ----CCEEEEEecCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCcc
Confidence                259999999998884  21     111   2367788888888888741                           


Q ss_pred             ----------------------------CCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          210 ----------------------------EVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       210 ----------------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                                                  ...++|+|++|.|||++.++.+.|+|||.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          155 QDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             chhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                        1239999999999999887767899999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.17  E-value=1.3e-10  Score=112.28  Aligned_cols=147  Identities=14%  Similarity=0.181  Sum_probs=105.5

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEec--cCc-chhHHHHHHHHHHHhccC--CCCceeeeeEeeec
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLN--RDG-LQGHKQWVAEVQFLGVLE--HPNLVKLIGYCAVD  155 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~  155 (436)
                      ...++.|+.|.++.||+....         +..+++|+..  ... ......+.+|+.+++.+.  +..+.+++.++...
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~~---------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~  110 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVTP---------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE  110 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEECS---------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred             CceEEEcCCcccceEEEEEEC---------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence            344678999999999998742         3568888775  322 122346788999999887  45577888877654


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL--------------------------  209 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--------------------------  209 (436)
                      ... ...|+||||++|..+.+..    ...++......++.+++..|+.||...                          
T Consensus       111 ~~~-g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (359)
T 3dxp_A          111 SVI-GRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ  185 (359)
T ss_dssp             TTT-SSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred             Ccc-CCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence            221 2348999999998775422    134678888899999999999999720                          


Q ss_pred             -----------------------------CCceeeccCCCCcEEEcCCCc--eEEeeccCCCC
Q 013790          210 -----------------------------EVQVIYRDFKASNVLLDENFR--PKLSDFGLARE  241 (436)
Q Consensus       210 -----------------------------~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~  241 (436)
                                                   ...++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                         247999999999999987653  68999998853

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.16  E-value=6.1e-11  Score=111.87  Aligned_cols=186  Identities=18%  Similarity=0.188  Sum_probs=120.9

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCC--ceeeeeEeeecCCcce
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPN--LVKLIGYCAVDGERGI  160 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpn--Iv~~~~~~~~~~~~~~  160 (436)
                      ++.++.|.+..||+..            ..+++|+....  .....+.+|+.+++.+. +..  +...+......+ ...
T Consensus        25 i~~~~~G~~n~v~~v~------------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~-~~~   89 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN------------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE-TYQ   89 (304)
T ss_dssp             CCEEEECSSEEEEEST------------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS-SCS
T ss_pred             eEecCCCCcceEEEEC------------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC-CCC
Confidence            4568999999999852            23888886533  33467889999998874 333  334444332221 112


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG--------------------------------  208 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~--------------------------------  208 (436)
                      ..|+||++++|.+|.+...    ..++..+...++.+++..|..||+.                                
T Consensus        90 ~~~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (304)
T 3sg8_A           90 MSFAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL  165 (304)
T ss_dssp             CSCEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred             cceEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence            3388999999988875432    2467777888888998888888861                                


Q ss_pred             -----------------------CCCceeeccCCCCcEEEcC--CCceEEeeccCCCCCCCCCCcccccccccCCCc---
Q 013790          209 -----------------------LEVQVIYRDFKASNVLLDE--NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY---  260 (436)
Q Consensus       209 -----------------------~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y---  260 (436)
                                             ....++|+|++|.||+++.  ++.+.|+||+.+........      ......+   
T Consensus       166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~  239 (304)
T 3sg8_A          166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEE  239 (304)
T ss_dssp             CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTS
T ss_pred             CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccc
Confidence                                   1135899999999999998  56688999998864211100      0000111   


Q ss_pred             cccccccc-----CCC---------CchhhHHHHHHHHHHHHhCCCCC
Q 013790          261 AAPDYIET-----GHL---------TAKSDVWSFGVVLYEMLTGRRSL  294 (436)
Q Consensus       261 ~aPE~~~~-----~~~---------~~~~DvwSlGvil~elltg~~pf  294 (436)
                      ..|+....     +..         ..-.+.|++|.++|.+.+|..+|
T Consensus       240 ~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          240 YGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            22222110     111         12368999999999999998776

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.56  E-value=3.7e-07  Score=84.04  Aligned_cols=135  Identities=19%  Similarity=0.111  Sum_probs=93.2

Q ss_pred             cccccCce-EEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCCceeeeeEeeecCCcceeEE
Q 013790           86 KIGEGGFG-SVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVDGERGIQRL  163 (436)
Q Consensus        86 ~ig~G~~g-~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~  163 (436)
                      .+..|..| .||+....       ..+..+++|+-...   ....+.+|+..|+.+. +--+.++++++...+    ..+
T Consensus        31 ~~~~G~S~~~v~rl~~~-------~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~----~~~   96 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGK-------PNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD----DAW   96 (272)
T ss_dssp             EEECSSSSCEEEEEECC-------TTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT----EEE
T ss_pred             EccCCCcCCeEEEEEec-------CCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECC----eEE
Confidence            45556655 68986633       34566888886533   3446788999988875 323567777776554    349


Q ss_pred             EEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------------------
Q 013790          164 LVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL----------------------------------  209 (436)
Q Consensus       164 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~----------------------------------  209 (436)
                      +|||+++|.++.+.....      ......++.+++..|..||...                                  
T Consensus        97 lvme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (272)
T 4gkh_A           97 LLTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE  170 (272)
T ss_dssp             EEEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred             EEEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence            999999998888765321      1233456667777777777521                                  


Q ss_pred             ---------------------CCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          210 ---------------------EVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       210 ---------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                                           ...++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                                 1137999999999999988777899999874

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.50  E-value=7.1e-07  Score=83.93  Aligned_cols=136  Identities=18%  Similarity=0.138  Sum_probs=92.3

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCC---CceeeeeEeeecCCcce
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHP---NLVKLIGYCAVDGERGI  160 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~~~~~~~~  160 (436)
                      +..++.|....||+.            +..+++|+...  ......+.+|+.+|+.+.+.   .+.+.+.++....   .
T Consensus        24 v~~l~~G~~n~v~~v------------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~---g   86 (306)
T 3tdw_A           24 VESLGEGFRNYAILV------------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD---G   86 (306)
T ss_dssp             EEEEEECSSEEEEEE------------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT---S
T ss_pred             eeecCCCcceeEEEE------------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCC---C
Confidence            456888888899986            13378887532  23346788999999999752   2455555554221   2


Q ss_pred             eEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q 013790          161 QRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEG--------------------------------  208 (436)
Q Consensus       161 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~--------------------------------  208 (436)
                      ..++||+|++|.+|......    .++......++.+++..|..||+.                                
T Consensus        87 ~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~  162 (306)
T 3tdw_A           87 NPFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFP  162 (306)
T ss_dssp             CEEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGG
T ss_pred             ceEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccc
Confidence            34899999999888764221    245555556666666666666642                                


Q ss_pred             -------------------------CCCceeeccCCCCcEEEcC---CCc-eEEeeccCCC
Q 013790          209 -------------------------LEVQVIYRDFKASNVLLDE---NFR-PKLSDFGLAR  240 (436)
Q Consensus       209 -------------------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~Dfg~a~  240 (436)
                                               ....++|+|++|.|||++.   ++. +.|+||+.+.
T Consensus       163 ~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          163 LLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             GSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             ccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                                     1225699999999999987   455 5899999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.40  E-value=8.2e-07  Score=85.30  Aligned_cols=91  Identities=5%  Similarity=-0.034  Sum_probs=54.2

Q ss_pred             cccc-cccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccC-C--CCceeeeeEeeecC
Q 013790           84 MLKI-GEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLE-H--PNLVKLIGYCAVDG  156 (436)
Q Consensus        84 ~~~i-g~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~~~  156 (436)
                      .+.| +.|....+|+....... ++..++..+++|+.....   ......+.+|+.+++.+. +  -.+.+++.++....
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~-~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQ-DGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEE-TTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEECCCCCccceEEEEEEeccc-CCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            4567 88889999987642000 000025678888865432   111235677888888775 2  34667777665432


Q ss_pred             CcceeEEEEEEecCCCCHHH
Q 013790          157 ERGIQRLLVYEFMLNRSLED  176 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~  176 (436)
                      . ....++||||++|.++.+
T Consensus       104 ~-~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          104 V-LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             T-TSSCEEEEECCCCBCCCB
T ss_pred             c-cCCceEEEEecCCCChhh
Confidence            1 122489999998876543

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.30  E-value=3e-06  Score=82.61  Aligned_cols=76  Identities=14%  Similarity=0.067  Sum_probs=47.5

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-------hhHHHHHHHHHHHhccCC--CC-ceeeeeEee
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-------QGHKQWVAEVQFLGVLEH--PN-LVKLIGYCA  153 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--pn-Iv~~~~~~~  153 (436)
                      .+.||.|.++.||++...       ..+..++||.......       .....+..|..+++.+..  |. +.+++.+. 
T Consensus        35 ~~~lg~G~~n~vyrv~~~-------~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-  106 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQ-------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-  106 (397)
T ss_dssp             EEECCSSSSEEEEEEEC-----------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-
T ss_pred             EEECCCCceEEEEEEEEC-------CCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-
Confidence            567999999999999643       2356799998653211       123456778888887742  33 34555432 


Q ss_pred             ecCCcceeEEEEEEecCCC
Q 013790          154 VDGERGIQRLLVYEFMLNR  172 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~g  172 (436)
                       ...    .++||||+.+.
T Consensus       107 -~~~----~~lvmE~l~g~  120 (397)
T 2olc_A          107 -TEM----AVTVMEDLSHL  120 (397)
T ss_dssp             -TTT----TEEEECCCTTS
T ss_pred             -CCc----cEEEEEeCCCc
Confidence             222    28999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.97  E-value=5.5e-05  Score=71.74  Aligned_cols=30  Identities=23%  Similarity=0.277  Sum_probs=27.3

Q ss_pred             CceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          211 VQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       211 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            489999999999999888899999999774

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.94  E-value=4.4e-05  Score=71.69  Aligned_cols=139  Identities=14%  Similarity=0.126  Sum_probs=87.5

Q ss_pred             cccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC---CCCceeeeeEeeecCCc
Q 013790           82 SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE---HPNLVKLIGYCAVDGER  158 (436)
Q Consensus        82 ~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~  158 (436)
                      ...+.|+.|.+..+|+...         ++..+++|+....   ....+..|+..|+.|.   ...+.+.+.++...+  
T Consensus        39 ~~~~~l~gG~~n~~y~v~~---------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g--  104 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND---------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG--  104 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES---------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS--
T ss_pred             eeeEEeCCccceeeeEEEE---------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC--
Confidence            3456789999999999763         3457888987543   2456888998888874   255777777765433  


Q ss_pred             ceeEEEEEEecCCCCHHH-----------HhhcCCC-C-------------------CCCHHHHH---HHH---------
Q 013790          159 GIQRLLVYEFMLNRSLED-----------HLFNRAF-P-------------------PLPWKTRL---HII---------  195 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~---------  195 (436)
                        ..++||||+++..+..           .|+.... .                   .-+|....   ++.         
T Consensus       105 --~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~  182 (312)
T 3jr1_A          105 --HSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEK  182 (312)
T ss_dssp             --EEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHH
T ss_pred             --ceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHc
Confidence              3599999999876421           1222111 0                   01343321   011         


Q ss_pred             -------HHHHHHH-HHhhc-CCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          196 -------LGAAEGL-AYLHE-GLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       196 -------~ql~~~l-~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                             ..++..+ ..|.. ...+.++|+|+.+.|++++.++ +.|+||.
T Consensus       183 g~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          183 GLIFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             TCCCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             CCChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence                   1122122 23421 1246899999999999999887 8899974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.91  E-value=0.00011  Score=68.09  Aligned_cols=80  Identities=19%  Similarity=0.242  Sum_probs=56.4

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCC---CceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHP---NLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~~~  155 (436)
                      .....+..+|.|..+.||+....        +++.|++|+...........+.+|+..|+.|.-.   -+.+.+++.   
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~--------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---   83 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA--------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---   83 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET--------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC--------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---
Confidence            35666788999999999999864        5788999987655444445688899999888522   234444432   


Q ss_pred             CCcceeEEEEEEecCCCCH
Q 013790          156 GERGIQRLLVYEFMLNRSL  174 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL  174 (436)
                       ..    ++||||+.++..
T Consensus        84 -~~----~lv~e~l~~~~~   97 (288)
T 3f7w_A           84 -DR----TLAMEWVDERPP   97 (288)
T ss_dssp             -TT----EEEEECCCCCCC
T ss_pred             -Cc----eEEEEeecccCC
Confidence             12    889999987653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.72  E-value=0.00026  Score=69.45  Aligned_cols=30  Identities=13%  Similarity=0.203  Sum_probs=26.9

Q ss_pred             CceeeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          211 VQVIYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       211 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      ..++|+|++|.|||++.++ +.|+||+.+..
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            3899999999999998877 99999998863

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.64  E-value=0.00029  Score=61.46  Aligned_cols=101  Identities=16%  Similarity=0.055  Sum_probs=66.2

Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccc
Q 013790          172 RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS  251 (436)
Q Consensus       172 gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  251 (436)
                      -+|.+.|...+ .++++.++|.++.|.+.+|.-+-...  .-..+=+.|..|+|..+|.|.+.+ +.+.           
T Consensus        33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-----------
Confidence            37888887654 58999999999999999987762110  111233457899999999988764 2110           


Q ss_pred             cccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCC
Q 013790          252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR  291 (436)
Q Consensus       252 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~  291 (436)
                         .....+.|||... ...+.+.=|||||+++|..+--.
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence               1233466888763 34467889999999999988743

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.62  E-value=0.00017  Score=67.27  Aligned_cols=29  Identities=21%  Similarity=0.150  Sum_probs=24.9

Q ss_pred             CceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          211 VQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       211 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++|+|+.|.||+ ..++.+.|+||..+.
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence            46899999999999 566778999998774

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.61  E-value=0.00018  Score=70.76  Aligned_cols=82  Identities=21%  Similarity=0.248  Sum_probs=50.2

Q ss_pred             ccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCc-eeeeeEeeecCCccee
Q 013790           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL-VKLIGYCAVDGERGIQ  161 (436)
Q Consensus        83 ~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~~~  161 (436)
                      .++.|+.|-...||++............+..+++|+......  ...+.+|+.+++.|...++ .++++.+.  +     
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~-----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G-----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T-----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C-----
Confidence            356788888999999876421111111346788998743221  1455678888888853333 56666542  1     


Q ss_pred             EEEEEEecCCCCH
Q 013790          162 RLLVYEFMLNRSL  174 (436)
Q Consensus       162 ~~lv~e~~~~gsL  174 (436)
                       .+|++|++|.+|
T Consensus       148 -g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 -GRLEEYIPSRPL  159 (429)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -CEEEEEeCCccc
Confidence             379999976443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.51  E-value=0.00051  Score=66.17  Aligned_cols=148  Identities=16%  Similarity=0.162  Sum_probs=82.8

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCCceeeeeEeeecCCcceeE
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVDGERGIQR  162 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~  162 (436)
                      ++.|..|-...+|++...........++..+++|+.... ........+|..+++.|. +.-..++++++.  +      
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~------  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E------  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T------
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C------
Confidence            356777888999998764211111223567889986332 223456668999888875 322356665543  1      


Q ss_pred             EEEEEecCCCCHHHH-----------------hhcCC---CCCC--CHHHHHHHHHHHHH-------------------H
Q 013790          163 LLVYEFMLNRSLEDH-----------------LFNRA---FPPL--PWKTRLHIILGAAE-------------------G  201 (436)
Q Consensus       163 ~lv~e~~~~gsL~~~-----------------l~~~~---~~~l--~~~~~~~i~~ql~~-------------------~  201 (436)
                      -+||||++|.+|..-                 |+...   ....  -+.++.++..++..                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            279999988655311                 11111   1112  23445555544322                   1


Q ss_pred             HHHh----hcC-CCCceeeccCCCCcEEEcCC----CceEEeeccCCC
Q 013790          202 LAYL----HEG-LEVQVIYRDFKASNVLLDEN----FRPKLSDFGLAR  240 (436)
Q Consensus       202 l~~L----H~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~  240 (436)
                      +..|    ... ....++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            2222    211 23479999999999999876    789999998874

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.46  E-value=0.00079  Score=63.18  Aligned_cols=159  Identities=17%  Similarity=0.138  Sum_probs=82.8

Q ss_pred             cCHHHHHHhhcCCcc-----cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCC
Q 013790           69 FSYSEMRQATNDFSR-----MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHP  143 (436)
Q Consensus        69 ~~~~~~~~~~~~~~~-----~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp  143 (436)
                      ++.+++......|.+     ++.|+.|....+|+....         +..+++|+.....  ....+..|+.++..|...
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~---------~g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~   75 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT---------KDPLILTLYEKRV--EKNDLPFFLGLMQHLAAK   75 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES---------SCCEEEEEECC-----CCHHHHHHHHHHHHHHT
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC---------CccEEEEEeCCCC--CHHHHHHHHHHHHHHHHC
Confidence            344556555555654     345677888999998643         2258899886531  123455677777666422


Q ss_pred             C--ceeeeeEeeecCC----cceeEEEEEEecCCCCHHH--------------Hhhc--CC-CCC----CC---HHHHHH
Q 013790          144 N--LVKLIGYCAVDGE----RGIQRLLVYEFMLNRSLED--------------HLFN--RA-FPP----LP---WKTRLH  193 (436)
Q Consensus       144 n--Iv~~~~~~~~~~~----~~~~~~lv~e~~~~gsL~~--------------~l~~--~~-~~~----l~---~~~~~~  193 (436)
                      +  +.+++...  ++.    .....+++|+|++|..+..              .++.  .. ..+    ..   |...+.
T Consensus        76 g~~vP~~~~~~--~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~  153 (322)
T 2ppq_A           76 GLSCPLPLPRK--DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWD  153 (322)
T ss_dssp             TCCCCCBCCBT--TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHH
T ss_pred             CCCCCcccCCC--CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHH
Confidence            2  22332211  110    0123489999998865321              0111  00 000    11   211100


Q ss_pred             ------------HHHHHHHHHHHhhc----CCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          194 ------------IILGAAEGLAYLHE----GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       194 ------------i~~ql~~~l~~LH~----~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                                  +...+...+..+..    ....+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       154 ~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          154 KSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                        00113334444442    123489999999999999987666899998774

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.38  E-value=0.0012  Score=62.30  Aligned_cols=31  Identities=32%  Similarity=0.372  Sum_probs=27.2

Q ss_pred             CceeeccCCCCcEEEcCC----CceEEeeccCCCC
Q 013790          211 VQVIYRDFKASNVLLDEN----FRPKLSDFGLARE  241 (436)
Q Consensus       211 ~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~  241 (436)
                      ..++|||+.+.|||++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            489999999999999874    6799999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.30  E-value=0.001  Score=65.82  Aligned_cols=75  Identities=17%  Similarity=0.069  Sum_probs=45.7

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCc-eeeeeEeeecCCcceeE
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL-VKLIGYCAVDGERGIQR  162 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~~~~  162 (436)
                      ++.|+.|-...+|++...       ..+..+++|+......... .-.+|+.+++.|...++ .++++.+.  +      
T Consensus       113 i~~lsgG~tN~~y~v~~~-------~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~------  176 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDM-------SKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N------  176 (458)
T ss_dssp             EEEECC--CEEEEEEEET-------TTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T------
T ss_pred             EEEcCCCeEeEEEEEEEC-------CCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C------
Confidence            456888888999998753       1236788888643221111 12478888888875444 46666652  1      


Q ss_pred             EEEEEecCCCCH
Q 013790          163 LLVYEFMLNRSL  174 (436)
Q Consensus       163 ~lv~e~~~~gsL  174 (436)
                      .+||||++|.+|
T Consensus       177 G~v~e~I~G~~l  188 (458)
T 2qg7_A          177 GRIEEFMDGYAL  188 (458)
T ss_dssp             EEEEECCCSEEC
T ss_pred             eEEEEeeCCccC
Confidence            359999987544

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.24  E-value=0.0036  Score=58.79  Aligned_cols=141  Identities=16%  Similarity=0.177  Sum_probs=76.6

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCC--ceeeeeEeeecCC----c
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN--LVKLIGYCAVDGE----R  158 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~----~  158 (436)
                      ..|+ |....||+....        ++..+++|...... .....+..|..++..+....  +++++..   ++.    .
T Consensus        32 ~~l~-g~~n~~y~v~~~--------~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~---~g~~~~~~   98 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE--------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAF---NGQTLLNH   98 (328)
T ss_dssp             EEEC-CSSSEEEEECCT--------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCB---TTBSCEEE
T ss_pred             Eeec-CcccceEEEEcC--------CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeec---CCcEEEEE
Confidence            4566 888899987532        34568999986432 12345667888777774222  3344332   111    0


Q ss_pred             ceeEEEEEEecCCCCHH-----HH---------hhc----CC---CCCCCHHHH----------------------HHHH
Q 013790          159 GIQRLLVYEFMLNRSLE-----DH---------LFN----RA---FPPLPWKTR----------------------LHII  195 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~-----~~---------l~~----~~---~~~l~~~~~----------------------~~i~  195 (436)
                      ....+++|+|++|..+.     ..         ++.    ..   ...+.+...                      ...+
T Consensus        99 ~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  178 (328)
T 1zyl_A           99 QGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKAT  178 (328)
T ss_dssp             TTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHH
T ss_pred             CCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHH
Confidence            12347899999875432     11         111    00   011221111                      1112


Q ss_pred             HHHHHHHHHhhc-CCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          196 LGAAEGLAYLHE-GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       196 ~ql~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++..+.-+-. .....++|+|+++.|||++ + .+.|+||+.+.
T Consensus       179 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          179 DELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             HHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             HHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            222222222211 1234789999999999999 4 89999998775

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.20  E-value=0.00079  Score=64.64  Aligned_cols=82  Identities=13%  Similarity=0.148  Sum_probs=43.4

Q ss_pred             cccccccCceEEEEEEecCCC-CCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCC-ceeeeeEeeecCCccee
Q 013790           84 MLKIGEGGFGSVYKSSIKPAA-GDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN-LVKLIGYCAVDGERGIQ  161 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~~~  161 (436)
                      +..|+.|....+|+....... ......+..+++|+...... .......|..+++.+...+ ..++++..  .+     
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-----  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-----  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-----
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--CC-----
Confidence            456788888999998753100 00001125788888654321 1112356788887775333 34565443  22     


Q ss_pred             EEEEEEecCCCCH
Q 013790          162 RLLVYEFMLNRSL  174 (436)
Q Consensus       162 ~~lv~e~~~~gsL  174 (436)
                       ++||+|++|.++
T Consensus       110 -~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 -GRIEEWLYGDPL  121 (369)
T ss_dssp             -EEEEECCCSEEC
T ss_pred             -cEEEEEecCCcC
Confidence             689999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.64  E-value=0.0096  Score=56.34  Aligned_cols=30  Identities=20%  Similarity=0.181  Sum_probs=27.3

Q ss_pred             CceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          211 VQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       211 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            479999999999999988889999998775

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.35  E-value=0.012  Score=57.48  Aligned_cols=147  Identities=14%  Similarity=0.122  Sum_probs=82.1

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCCceeeeeEeeecCCcceeE
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVDGERGIQR  162 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~  162 (436)
                      ++.|..|-...+|+........+....+..+++++..... ...-...+|..+++.+. +.-..++++.+  .+      
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~------  145 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PE------  145 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT------
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC------
Confidence            4567778889999987642111101125678888864322 11112346888887775 32234555433  22      


Q ss_pred             EEEEEecCCCCHHHH--------------h---hc----C-------CCCCCCHHHHHHHHHHH----------------
Q 013790          163 LLVYEFMLNRSLEDH--------------L---FN----R-------AFPPLPWKTRLHIILGA----------------  198 (436)
Q Consensus       163 ~lv~e~~~~gsL~~~--------------l---~~----~-------~~~~l~~~~~~~i~~ql----------------  198 (436)
                      ++||+|++|.+|..-              +   +.    .       ...+..+..+..+..++                
T Consensus       146 ~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~  225 (424)
T 3mes_A          146 GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELY  225 (424)
T ss_dssp             EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHH
T ss_pred             CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccH
Confidence            789999988654210              0   00    0       11122244443433322                


Q ss_pred             ---HHHHHHhhc---------------------CCCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          199 ---AEGLAYLHE---------------------GLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       199 ---~~~l~~LH~---------------------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                         ...+.+|..                     .....++|+|+.+.||+ +.++.+.|+||..+.
T Consensus       226 ~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          226 SKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             HHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence               112223221                     11347899999999999 888899999998874

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.63  E-value=0.047  Score=52.82  Aligned_cols=29  Identities=28%  Similarity=0.364  Sum_probs=24.9

Q ss_pred             ceeeccCCCCcEEE------cCCCceEEeeccCCC
Q 013790          212 QVIYRDFKASNVLL------DENFRPKLSDFGLAR  240 (436)
Q Consensus       212 ~ivH~Dlkp~NIll------~~~~~~kl~Dfg~a~  240 (436)
                      .++|+|+.+.|||+      +++..+.++||.+|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            46799999999999      456779999999874

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.31  E-value=0.49  Score=41.09  Aligned_cols=116  Identities=8%  Similarity=0.086  Sum_probs=76.1

Q ss_pred             CCCCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCC
Q 013790          141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKA  220 (436)
Q Consensus       141 ~hpnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp  220 (436)
                      .||+++.. .+-..++      -++..|-...+...|-.   ...++....++++.+|+....+++..     +|--|.|
T Consensus        43 ~~~~Fl~~-~I~e~eD------~v~~~y~~~~~~~~f~~---ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P  107 (215)
T 4ann_A           43 HSPYFIDA-ELTELRD------SFQIHYDINDNHTPFDN---IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAP  107 (215)
T ss_dssp             CCTTBCCE-EEEECSS------EEEEEECCCTTSEEGGG---GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSG
T ss_pred             cCCcccce-EEEEccc------EEEEEEEcCcccCCHHH---HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEec
Confidence            58888866 3333332      23334433333333321   12478889999999999888666543     6888999


Q ss_pred             CcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 013790          221 SNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE  295 (436)
Q Consensus       221 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~  295 (436)
                      +||+++.++.++++-.|+...                   ++|.-     ++...=+-.+=+++..+++++..|+
T Consensus       108 ~NL~f~~~~~p~i~~RGik~~-------------------l~P~~-----~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          108 DELFFTRDGLPIAKTRGLQNV-------------------VDPLP-----VSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GGEEECTTSCEEESCCEETTT-------------------BSCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             ceEEEcCCCCEEEEEccCccC-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999998776432                   23321     1222233458889999999988875

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.41  E-value=1.8  Score=37.67  Aligned_cols=82  Identities=9%  Similarity=0.144  Sum_probs=60.0

Q ss_pred             CCCHHHHHHHHHHHHHHHH-HhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccc
Q 013790          185 PLPWKTRLHIILGAAEGLA-YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP  263 (436)
Q Consensus       185 ~l~~~~~~~i~~ql~~~l~-~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  263 (436)
                      .++...+++++.+|+.... +++.     -+|--|.|+||+++.++.++|.-.|+-..                   ++|
T Consensus        81 ~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~f~~~~~p~i~hRGi~~~-------------------lpP  136 (219)
T 4ano_A           81 KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLMFNRALEPFFLHVGVKES-------------------LPP  136 (219)
T ss_dssp             TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEEECTTCCEEESCCEETTT-------------------BSS
T ss_pred             hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEEEeCCCcEEEEEcCCccc-------------------CCC
Confidence            4788899999999988776 5654     46888999999999999999998876432                   333


Q ss_pred             cccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 013790          264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE  295 (436)
Q Consensus       264 E~~~~~~~~~~~DvwSlGvil~elltg~~pf~  295 (436)
                      .-+     +..-=+-++=+++..++.++..|+
T Consensus       137 ~e~-----~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          137 DEW-----DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             CSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             CCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            222     111223357888889999888775

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.74  E-value=0.12  Score=50.85  Aligned_cols=63  Identities=11%  Similarity=0.159  Sum_probs=18.1

Q ss_pred             cccccccccCceEEEEEEecCCCCCCCCcceEEEE------EEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEee
Q 013790           82 SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAI------KKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCA  153 (436)
Q Consensus        82 ~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vav------K~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  153 (436)
                      .+.+.||   ||.||+|.+..       ...+||+      |.......  .....+.+|..+++.++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~-------~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYK-------KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC----------------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccc-------cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            3456676   99999999861       2346777      66543221  22345788899999999999999988765


Q ss_pred             e
Q 013790          154 V  154 (436)
Q Consensus       154 ~  154 (436)
                      .
T Consensus       215 ~  215 (463)
T 3cxl_A          215 H  215 (463)
T ss_dssp             E
T ss_pred             e
Confidence            3

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	436
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-67
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-65
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-63
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-62
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-61
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-61
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-60
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-60
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-59
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-59
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-58
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-58
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-58
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-56
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-54
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-54
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-52
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-51
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-48
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-47
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-45
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-45
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-42
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-41
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-35
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-15

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 3e-67
 Identities = 74/296 (25%), Positives = 124/296 (41%), Gaps = 36/296 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQF 136
              +   +IG G FG+VYK                VA+K LN      Q  + +  EV  
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWH----------GDVAVKMLNVTAPTPQQLQAFKNEVGV 57

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           L    H N++  +GY         Q  +V ++    SL  HL             + I  
Sbjct: 58  LRKTRHVNILLFMGYS-----TAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIAR 111

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             A+G+ YLH      +I+RD K++N+ L E+   K+ DFGLA        +H    + G
Sbjct: 112 QTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168

Query: 257 TFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 313
           +  + AP+ I        + +SDV++FG+VLYE++TG+            +++  V +  
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRG- 225

Query: 314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                    + P L  +   N  + + RL   CL K   +RP   Q++  ++ + +
Sbjct: 226 --------YLSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  208 bits (530), Expect = 6e-65
 Identities = 78/318 (24%), Positives = 139/318 (43%), Gaps = 41/318 (12%)

Query: 69  FSYSEMRQATNDFSRML---------KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKL 119
           F++ +  +A  +F++ +          IG G FG V    +K            VAIK L
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLK----LPGKREIFVAIKTL 62

Query: 120 NRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHL 178
                 +  + +++E   +G  +HPN++ L G            +++ EFM N SL D  
Sbjct: 63  KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV----MIITEFMENGSL-DSF 117

Query: 179 FNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL 238
             +          + ++ G A G+ YL +   +  ++RD  A N+L++ N   K+SDFGL
Sbjct: 118 LRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGL 174

Query: 239 AREGPMVGHTHVSTAVVG---TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
           +R           T+ +G      + AP+ I+    T+ SDVWS+G+V++E+++      
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234

Query: 296 RNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 355
            +   T Q ++  ++Q            D RL        A  + +L  +C  K    RP
Sbjct: 235 WD--MTNQDVINAIEQ------------DYRLPPPMDCPSA--LHQLMLDCWQKDRNHRP 278

Query: 356 KMSQVVERLKQIVQVSNE 373
           K  Q+V  L ++++  N 
Sbjct: 279 KFGQIVNTLDKMIRNPNS 296

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 1e-63
 Identities = 64/302 (21%), Positives = 122/302 (40%), Gaps = 32/302 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
            IG+G FG V++         G      VA+K  +    +   +  AE+    +L H N+
Sbjct: 10  SIGKGRFGEVWR---------GKWRGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI 59

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           +  I     D     Q  LV ++  + SL D+L       +  +  + + L  A GLA+L
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHL 116

Query: 206 HEGLEVQ-----VIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHT--HVSTAVVGTF 258
           H  +        + +RD K+ N+L+ +N    ++D GLA        T        VGT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 259 GYAAPDYIET------GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY 312
            Y AP+ ++            ++D+++ G+V +E+     S+       +    + V   
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR-CSIGGIHEDYQLPYYDLVPSD 235

Query: 313 PADSKKFGLI----MDPRLEKEYSINEA-RKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
           P+  +   ++    + P +   +   EA R + ++   C   +   R    ++ + L Q+
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

Query: 368 VQ 369
            Q
Sbjct: 296 SQ 297

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 6e-62
 Identities = 73/289 (25%), Positives = 119/289 (41%), Gaps = 38/289 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
            +   +  IG+G FG V           G      VA+K +  D     + ++AE   + 
Sbjct: 7   KELKLLQTIGKGEFGDVML---------GDYRGNKVAVKCIKNDATA--QAFLAEASVMT 55

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            L H NLV+L+G    +        +V E+M   SL D+L +R    L     L   L  
Sbjct: 56  QLRHSNLVQLLGVIVEEKGG---LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
            E + YL        ++RD  A NVL+ E+   K+SDFGL +E      T          
Sbjct: 113 CEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPV 164

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 318
            + AP+ +     + KSDVWSFG++L+E+ +  R      P   + ++  V++       
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEK------- 215

Query: 319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
                  +++       A  +  +  NC    +  RP   Q+ E+L+ I
Sbjct: 216 -----GYKMDAPDGCPPA--VYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 3e-61
 Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 34/289 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
                + ++G G FG V+               T VA+K L +        ++AE   + 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYN--------GHTKVAVKSLKQGS-MSPDAFLAEANLMK 63

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            L+H  LV+L      +        ++ E+M N SL D L   +   L     L +    
Sbjct: 64  QLQHQRLVRLYAVVTQE-----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           AEG+A++ E      I+RD +A+N+L+ +    K++DFGLAR                  
Sbjct: 119 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPI 174

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 318
            + AP+ I  G  T KSDVWSFG++L E++T  R        T   +++ +++       
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEVIQNLER------- 225

Query: 319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
                  R+ +  +  E  ++ +L   C  +  +DRP    +   L+  
Sbjct: 226 -----GYRMVRPDNCPE--ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 5e-61
 Identities = 79/291 (27%), Positives = 131/291 (45%), Gaps = 34/291 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           ++ + + +IG G FG V+                 VAIK +        + ++ E + + 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL--------NKDKVAIKTIREGA-MSEEDFIEEAEVMM 55

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            L HP LV+L G C           LV+EFM +  L D+L  +       +T L + L  
Sbjct: 56  KLSHPKLVQLYGVCLEQAPI----CLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDV 110

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
            EG+AYL E     VI+RD  A N L+ EN   K+SDFG+ R          ST      
Sbjct: 111 CEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPV 166

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 318
            +A+P+       ++KSDVWSFGV+++E+ +  +    NR  +E  ++E +         
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFR---- 220

Query: 319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
              +  PRL   +          + ++C  +  +DRP  S+++ +L +I +
Sbjct: 221 ---LYKPRLASTHVYQ-------IMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 1e-60
 Identities = 67/285 (23%), Positives = 122/285 (42%), Gaps = 32/285 (11%)

Query: 85  LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFLGVLEHP 143
           +++G G FGSV +   +        +   VAIK L +   +   ++ + E Q +  L++P
Sbjct: 15  IELGCGNFGSVRQGVYR-----MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 69

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
            +V+LIG C     +    +LV E      L   L  +    +P      ++   + G+ 
Sbjct: 70  YIVRLIGVC-----QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMK 123

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVVGTFGYAA 262
           YL E      ++RD  A NVLL      K+SDFGL++  G    +    +A      + A
Sbjct: 124 YLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
           P+ I     +++SDVWS+GV ++E L+  +   +        ++ +++Q           
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK--MKGPEVMAFIEQ----------- 227

Query: 323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
              R+E         ++  L  +C     +DRP    V +R++  
Sbjct: 228 -GKRMECPPECPP--ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 3e-60
 Identities = 71/316 (22%), Positives = 126/316 (39%), Gaps = 46/316 (14%)

Query: 74  MRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-HKQWVA 132
           M    +DF ++ ++G G  G V+K S KP          V+A K ++ +       Q + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKP-------SGLVMARKLIHLEIKPAIRNQIIR 53

Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           E+Q L     P +V   G    DGE      +  E M   SL+  L       +P +   
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEI----SICMEHMDGGSLDQVLKKAG--RIPEQILG 107

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
            + +   +GL YL E  + ++++RD K SN+L++     KL DFG++ +        ++ 
Sbjct: 108 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMAN 161

Query: 253 AVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY 312
           + VGT  Y +P+ ++  H + +SD+WS G+ L EM  GR  +     K  + +     + 
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221

Query: 313 PADSKKFGLIMDPRLEKEYSINEARKIGR--------------------------LADNC 346
            A           R    Y ++    +                              + C
Sbjct: 222 DAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 281

Query: 347 LSKSSKDRPKMSQVVE 362
           L K+  +R  + Q++ 
Sbjct: 282 LIKNPAERADLKQLMV 297

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (497), Expect = 5e-60
 Identities = 73/323 (22%), Positives = 124/323 (38%), Gaps = 48/323 (14%)

Query: 70  SYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-HK 128
               +    N+   +  IGEG FG V+++             T+VA+K L  +       
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPF--TMVAVKMLKEEASADMQA 61

Query: 129 QWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR------- 181
            +  E   +   ++PN+VKL+G CAV         L++E+M    L + L +        
Sbjct: 62  DFQREAALMAEFDNPNIVKLLGVCAVGKPM----CLLFEYMAYGDLNEFLRSMSPHTVCS 117

Query: 182 ---------------AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD 226
                            PPL    +L I    A G+AYL E    + ++RD    N L+ 
Sbjct: 118 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVG 174

Query: 227 ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYE 286
           EN   K++DFGL+R      +            +  P+ I     T +SDVW++GVVL+E
Sbjct: 175 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234

Query: 287 MLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNC 346
           + +             + ++ +             + D  +      N   ++  L   C
Sbjct: 235 IFSYGLQPYYG--MAHEEVIYY-------------VRDGNIL-ACPENCPLELYNLMRLC 278

Query: 347 LSKSSKDRPKMSQVVERLKQIVQ 369
            SK   DRP    +   L+++ +
Sbjct: 279 WSKLPADRPSFCSIHRILQRMCE 301

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  194 bits (493), Expect = 1e-59
 Identities = 72/301 (23%), Positives = 126/301 (41%), Gaps = 32/301 (10%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
            D +   K+G G +G VY+       G     +  VA+K L  D ++  ++++ E   + 
Sbjct: 17  TDITMKHKLGGGQYGEVYE-------GVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMK 68

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            ++HPNLV+L+G C  +    I      EFM   +L D+L       +     L++    
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYII----TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           +  + YL +      I+RD  A N L+ EN   K++DFGL+R                  
Sbjct: 125 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPI 180

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 318
            + AP+ +     + KSDVW+FGV+L+E+ T   S          ++ E           
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--IDLSQVYE----------- 227

Query: 319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSFD 378
              +++     E       K+  L   C   +  DRP  +++ +  + + Q S+  D  +
Sbjct: 228 ---LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 284

Query: 379 K 379
           K
Sbjct: 285 K 285

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 1e-59
 Identities = 67/311 (21%), Positives = 117/311 (37%), Gaps = 42/311 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV-AEVQFL 137
           N  S    +G G FG V +++         +    VA+K L        ++ + +E++ L
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAM--TVAVKMLKPSAHLTEREALMSELKVL 80

Query: 138 GVLE-HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--------------- 181
             L  H N+V L+G C + G      L++ E+     L + L  +               
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPT----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136

Query: 182 -AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAR 240
                L  +  L      A+G+A+L        I+RD  A N+LL      K+ DFGLAR
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 241 EGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPK 300
           +     +  V         + AP+ I     T +SDVWS+G+ L+E+ +   S     P 
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253

Query: 301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
             +               F  ++          +   ++  +   C       RP   Q+
Sbjct: 254 DSK---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298

Query: 361 VERLKQIVQVS 371
           V+ +++ +  S
Sbjct: 299 VQLIEKQISES 309

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 2e-59
 Identities = 57/289 (19%), Positives = 111/289 (38%), Gaps = 34/289 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
            D + + ++G G FG V     +            VAIK +         +++ E + + 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWR--------GQYDVAIKMIKEGS-MSEDEFIEEAKVMM 54

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            L H  LV+L G C           ++ E+M N  L ++L          +  L +    
Sbjct: 55  NLSHEKLVQLYGVCTKQRPI----FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDV 109

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
            E + YL      Q ++RD  A N L+++    K+SDFGL+R          S       
Sbjct: 110 CEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPV 165

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 318
            ++ P+ +     ++KSD+W+FGV+++E+ +  +      P       E  +        
Sbjct: 166 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAEH------- 213

Query: 319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
               +   L        + K+  +  +C  + + +RP    ++  +  +
Sbjct: 214 ----IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 2e-59
 Identities = 69/291 (23%), Positives = 111/291 (38%), Gaps = 34/291 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
                 +K+G+G FG V+  +            T VAIK L        + ++ E Q + 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWN--------GTTRVAIKTLKPG-TMSPEAFLQEAQVMK 67

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            L H  LV+L    + +        +V E+M   SL D L       L     + +    
Sbjct: 68  KLRHEKLVQLYAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           A G+AY+     +  ++RD +A+N+L+ EN   K++DFGLAR                  
Sbjct: 123 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPI 178

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 318
            + AP+    G  T KSDVWSFG++L E+ T  R          + +L+ V++       
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVER------- 229

Query: 319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                               +  L   C  K  ++RP    +   L+    
Sbjct: 230 -------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 1e-58
 Identities = 83/317 (26%), Positives = 132/317 (41%), Gaps = 37/317 (11%)

Query: 56  PELYEEKAHNLRVFSYSEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVA 115
           PEL +   H   V   S +      F+    IG G FG VY  ++     D   +    A
Sbjct: 11  PELVQAVQH--VVIGPSSLIV---HFNE--VIGRGHFGCVYHGTLL----DNDGKKIHCA 59

Query: 116 IKKLNRDGLQGH-KQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSL 174
           +K LNR    G   Q++ E   +    HPN++ L+G C          L+V  +M +  L
Sbjct: 60  VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS---PLVVLPYMKHGDL 116

Query: 175 EDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS 234
            + + N    P   K  +   L  A+G+ +L      + ++RD  A N +LDE F  K++
Sbjct: 117 RNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVA 172

Query: 235 DFGLARE--GPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRR 292
           DFGLAR+         H  T       + A + ++T   T KSDVWSFGV+L+E++T   
Sbjct: 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232

Query: 293 SLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSK 352
                 P  +    +             L+   RL +     +   +  +   C    ++
Sbjct: 233 -----PPYPDVNTFDITVY---------LLQGRRLLQPEYCPD--PLYEVMLKCWHPKAE 276

Query: 353 DRPKMSQVVERLKQIVQ 369
            RP  S++V R+  I  
Sbjct: 277 MRPSFSELVSRISAIFS 293

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 3e-58
 Identities = 68/293 (23%), Positives = 118/293 (40%), Gaps = 35/293 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG--HKQWVAEVQFLGVLEHP 143
           ++G G FG+V K                VA+K L  +        + +AE   +  L++P
Sbjct: 14  ELGSGNFGTVKK-----GYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 68

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
            +V++IG C  +       +LV E      L  +L       +  K  + ++   + G+ 
Sbjct: 69  YIVRMIGICEAES-----WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMK 121

Query: 204 YLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVVGTFGYAA 262
           YL E      ++RD  A NVLL      K+SDFGL++       +    T       + A
Sbjct: 122 YLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
           P+ I     ++KSDVWSFGV+++E  +  +   R        +   +++           
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG--MKGSEVTAMLEK----------- 225

Query: 323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI-VQVSNEG 374
              R+          ++  L + C +   ++RP  + V  RL+     V NEG
Sbjct: 226 -GERMGCPAGCPR--EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 4e-58
 Identities = 67/297 (22%), Positives = 126/297 (42%), Gaps = 29/297 (9%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHK-QWVAEVQFL 137
           +  +R   IG G FG VYK  +K        +   VAIK L     +  +  ++ E   +
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLK---TSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
           G   H N+++L G  +         +++ E+M N +L+  L  +          + ++ G
Sbjct: 64  GQFSHHNIIRLEGVISKYKPM----MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRG 118

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVVG 256
            A G+ YL     +  ++RD  A N+L++ N   K+SDFGL+R        T+ ++    
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 316
              + AP+ I     T+ SDVWSFG+V++E++T               +++ +       
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKAI------- 226

Query: 317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE 373
                  +        ++    I +L   C  +    RPK + +V  L ++++  + 
Sbjct: 227 -------NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 4e-58
 Identities = 61/280 (21%), Positives = 109/280 (38%), Gaps = 33/280 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHP 143
           +IG G F +VYK       G  T     VA  +L    L     +++  E + L  L+HP
Sbjct: 16  EIGRGSFKTVYK-------GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 144 NLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLA 203
           N+V+         +     +LV E M + +L+ +L       +  K          +GL 
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQ 126

Query: 204 YLHEGLEVQVIYRDFKASNVLL-DENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
           +LH      +I+RD K  N+ +       K+ D GLA     +     + AV+GT  + A
Sbjct: 127 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMA 181

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
           P+  E        DV++FG+ + EM T        +     ++   V             
Sbjct: 182 PEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGV--------- 229

Query: 323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
             P    + +I E +    + + C+ ++  +R  +  ++ 
Sbjct: 230 -KPASFDKVAIPEVK---EIIEGCIRQNKDERYSIKDLLN 265

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 1e-57
 Identities = 72/293 (24%), Positives = 113/293 (38%), Gaps = 32/293 (10%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQ 135
            D   + K+G+G FG V +      +G        VA+K L  D L   +    ++ EV 
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTV----SVAVKCLKPDVLSQPEAMDDFIREVN 63

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            +  L+H NL++L G       +     +V E     SL D L           T     
Sbjct: 64  AMHSLDHRNLIRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYA 117

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHV-STAV 254
           +  AEG+ YL      + I+RD  A N+LL      K+ DFGL R  P     +V     
Sbjct: 118 VQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174

Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 314
              F + AP+ ++T   +  SD W FGV L+EM T  +           ++L  + +   
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDK--- 229

Query: 315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI 367
                      RL +     +   I  +   C +   +DRP    + + L + 
Sbjct: 230 --------EGERLPRPEDCPQ--DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 4e-57
 Identities = 78/307 (25%), Positives = 127/307 (41%), Gaps = 47/307 (15%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFL 137
           ND      IGEG FG V K+ IK             AIK++        H+ +  E++ L
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIK-----KDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 64

Query: 138 GVLE-HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFP------------ 184
             L  HPN++ L+G C   G       L  E+  + +L D L                  
Sbjct: 65  CKLGHHPNIINLLGACEHRGYL----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120

Query: 185 --PLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 242
              L  +  LH     A G+ YL +    Q I+RD  A N+L+ EN+  K++DFGL+R  
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-- 175

Query: 243 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE 302
                    T       + A + +     T  SDVWS+GV+L+E+++   +     P   
Sbjct: 176 -GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCG 229

Query: 303 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
               E  ++         L    RLEK  + ++  ++  L   C  +   +RP  +Q++ 
Sbjct: 230 MTCAELYEK---------LPQGYRLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILV 278

Query: 363 RLKQIVQ 369
            L ++++
Sbjct: 279 SLNRMLE 285

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 4e-57
 Identities = 63/310 (20%), Positives = 116/310 (37%), Gaps = 47/310 (15%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFL 137
            +      +G G FG V  ++        T  +  VA+K L         +  ++E++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAY--GISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94

Query: 138 GVLE-HPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--------------- 181
             L  H N+V L+G C + G       L++E+     L ++L ++               
Sbjct: 95  TQLGSHENIVNLLGACTLSG----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150

Query: 182 ------AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD 235
                     L ++  L      A+G+ +L        ++RD  A NVL+      K+ D
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICD 207

Query: 236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLE 295
           FGLAR+     +  V         + AP+ +  G  T KSDVWS+G++L+E+ +   +  
Sbjct: 208 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267

Query: 296 RNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP 355
              P                   F  ++    + +       +I  +  +C +  S+ RP
Sbjct: 268 PGIPVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 312

Query: 356 KMSQVVERLK 365
               +   L 
Sbjct: 313 SFPNLTSFLG 322

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-56
 Identities = 61/291 (20%), Positives = 123/291 (42%), Gaps = 29/291 (9%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLG 138
           +F ++  +G G FG+VYK    P   +G      VAIK+L      + +K+ + E   + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            +++P++ +L+G C     +     L+ + M    L D++          +  L+  +  
Sbjct: 67  SVDNPHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQI 120

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
           A+G+ YL +    ++++RD  A NVL+      K++DFGLA+        + +       
Sbjct: 121 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 259 GYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK 318
            + A + I     T +SDVWS+GV ++E++T         P     +   +++       
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEK------- 228

Query: 319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
                  RL +         +  +   C    +  RPK  +++    ++ +
Sbjct: 229 -----GERLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 6e-56
 Identities = 66/289 (22%), Positives = 115/289 (39%), Gaps = 34/289 (11%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFL 137
           D+  +  IG G +G   K           S+  ++  K+L+   +     +  V+EV  L
Sbjct: 5   DYEVLYTIGTGSYGRCQK-------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 57

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFN--RAFPPLPWKTRLHII 195
             L+HPN+V+            +   +V E+     L   +    +    L  +  L ++
Sbjct: 58  RELKHPNIVRYYDRIIDRTNTTL--YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115

Query: 196 LGAAEGLAYLHEGLEV--QVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
                 L   H   +    V++RD K +NV LD     KL DFGLAR   +   T  + A
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKA 173

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 313
            VGT  Y +P+ +       KSD+WS G +LYE+             +++ L   +++  
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGK 230

Query: 314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                       R+   YS +E  +   +    L+     RP + +++E
Sbjct: 231 ----------FRRIPYRYS-DELNE---IITRMLNLKDYHRPSVEEILE 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  184 bits (468), Expect = 2e-55
 Identities = 88/325 (27%), Positives = 137/325 (42%), Gaps = 46/325 (14%)

Query: 81  FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQFL 137
           FS + +IG G FG+VY              + VVAIKK++  G Q +++W   + EV+FL
Sbjct: 17  FSDLREIGHGSFGAVYF-------ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
             L HPN ++  G    +        LV E+ L  + +    ++   PL       +  G
Sbjct: 70  QKLRHPNTIQYRGCYLREHTA----WLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHG 123

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
           A +GLAYLH      +I+RD KA N+LL E    KL DFG A           + + VGT
Sbjct: 124 ALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGT 174

Query: 258 FGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 314
             + AP+ I     G    K DVWS G+   E+   +  L           L  + Q   
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNE- 230

Query: 315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER--LKQIVQVSN 372
                     P L+  +     R      D+CL K  +DRP    +++   + +    + 
Sbjct: 231 ---------SPALQSGHWSEYFRN---FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 278

Query: 373 EGDSFDKTFEEICEEDPVEAQTKQK 397
             D   +T + + E D ++ +  +K
Sbjct: 279 IMDLIQRTKDAVRELDNLQYRKMKK 303

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 4e-54
 Identities = 63/286 (22%), Positives = 104/286 (36%), Gaps = 33/286 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFL 137
            D+  +  +GEG +G V                  VA+K ++    +   +    E+   
Sbjct: 5   EDWDLVQTLGEGAYGEVQL-------AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 57

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
            +L H N+VK  G+      +     L  E+     L D +       +P          
Sbjct: 58  KMLNHENVVKFYGHRREGNIQ----YLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQ 111

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
              G+ YLH    + + +RD K  N+LLDE    K+SDFGLA          +   + GT
Sbjct: 112 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

Query: 258 FGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 316
             Y AP+ ++         DVWS G+VL  ML G    ++    + Q   +W ++     
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD-SCQEYSDWKEK----- 222

Query: 317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                     L     I+ A     L    L ++   R  +  + +
Sbjct: 223 -------KTYLNPWKKIDSAPL--ALLHKILVENPSARITIPDIKK 259

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 7e-54
 Identities = 65/289 (22%), Positives = 117/289 (40%), Gaps = 38/289 (13%)

Query: 80  DFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           DF  ++  +G+G FG VYK             + + A K ++    +  + ++ E+  L 
Sbjct: 12  DFWEIIGELGDGAFGKVYK-------AQNKETSVLAAAKVIDTKSEEELEDYMVEIDILA 64

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
             +HPN+VKL+     +        ++ EF    +++  +      PL       +    
Sbjct: 65  SCDHPNIVKLLDAFYYENNL----WILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQT 119

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTF 258
            + L YLH+    ++I+RD KA N+L   +   KL+DFG++ +           + +GT 
Sbjct: 120 LDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTP 174

Query: 259 GYAAPDYI-----ETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 313
            + AP+ +     +      K+DVWS G+ L EM           P   + LL+  +  P
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MRVLLKIAKSEP 232

Query: 314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                      P L +    +   K       CL K+   R   SQ+++
Sbjct: 233 -----------PTLAQPSRWSSNFK--DFLKKCLEKNVDARWTTSQLLQ 268

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-53
 Identities = 68/308 (22%), Positives = 131/308 (42%), Gaps = 34/308 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFL 137
              +   ++G+G FG VY+   K    D     T VAIK +N    ++   +++ E   +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPE--TRVAIKTVNEAASMRERIEFLNEASVM 77

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLF--------NRAFPPLPWK 189
                 ++V+L+G  +         L++ E M    L+ +L         N    P    
Sbjct: 78  KEFNCHHVVRLLGVVSQGQPT----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133

Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
             + +    A+G+AYL+     + ++RD  A N ++ E+F  K+ DFG+ R+     +  
Sbjct: 134 KMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190

Query: 250 VSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 309
                +    + +P+ ++ G  T  SDVWSFGVVL+E+ T      +    + +++L +V
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--LSNEQVLRFV 248

Query: 310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
            +               L+K  +  +   +  L   C   + K RP   +++  +K+ ++
Sbjct: 249 ME------------GGLLDKPDNCPD--MLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

Query: 370 VSNEGDSF 377
                 SF
Sbjct: 295 PGFREVSF 302

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 5e-53
 Identities = 71/287 (24%), Positives = 112/287 (39%), Gaps = 41/287 (14%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQ 135
            DF     +G+G FG+VY                ++A+K L +  L       Q   EV+
Sbjct: 6   EDFEIGRPLGKGKFGNVYL-------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 58

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
               L HPN+++L GY        +    + E+    ++   L  +       +     I
Sbjct: 59  IQSHLRHPNILRLYGYFHDATRVYL----ILEYAPLGTVYREL--QKLSKFDEQRTATYI 112

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
              A  L+Y H     +VI+RD K  N+LL      K++DFG +   P    +   T + 
Sbjct: 113 TELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC 165

Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
           GT  Y  P+ IE      K D+WS GV+ YE L G+   E N   T Q   + + +    
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISR---- 218

Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                  ++       +   AR    L    L  +   RP + +V+E
Sbjct: 219 -------VEFTFPDFVT-EGARD---LISRLLKHNPSQRPMLREVLE 254

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 9e-53
 Identities = 74/309 (23%), Positives = 133/309 (43%), Gaps = 39/309 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQFL 137
           +       +GEG FG V  +       D  +  T VA+K L  D  +      ++E++ +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 138 GVL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPP----------- 185
            ++ +H N++ L+G C     +     ++ E+    +L ++L  R  P            
Sbjct: 73  KMIGKHKNIINLLGAC----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 186 ---LPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 242
              L  K  +      A G+ YL      + I+RD  A NVL+ E+   K++DFGLAR+ 
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

Query: 243 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE 302
             + +   +T       + AP+ +     T +SDVWSFGV+L+E+ T   S     P   
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--V 243

Query: 303 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
           + L + +++              R++K  +     ++  +  +C       RP   Q+VE
Sbjct: 244 EELFKLLKE------------GHRMDKPSNCTN--ELYMMMRDCWHAVPSQRPTFKQLVE 289

Query: 363 RLKQIVQVS 371
            L +IV ++
Sbjct: 290 DLDRIVALT 298

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 2e-52
 Identities = 69/309 (22%), Positives = 120/309 (38%), Gaps = 39/309 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFL 137
           +       +G G FG V ++       D T+    VA+K L        H+  ++E++ L
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAF--GIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70

Query: 138 G-VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNR--------------A 182
             +  H N+V L+G C   G      +++ EF    +L  +L ++               
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGP---LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 127

Query: 183 FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG 242
              L  +  +      A+G+ +L      + I+RD  A N+LL E    K+ DFGLAR+ 
Sbjct: 128 KDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDI 184

Query: 243 PMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE 302
                            + AP+ I     T +SDVWSFGV+L+E+ +   S     P   
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPG 239

Query: 303 QRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
            ++ E   +           +              ++ +   +C       RP  S++VE
Sbjct: 240 VKIDEEFCR----------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289

Query: 363 RLKQIVQVS 371
            L  ++Q +
Sbjct: 290 HLGNLLQAN 298

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 5e-52
 Identities = 60/285 (21%), Positives = 112/285 (39%), Gaps = 34/285 (11%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFL 137
              ++R  KIG+G  G+VY            +    VAI+++N       +  + E+  +
Sbjct: 19  KKKYTRFEKIGQGASGTVYT-------AMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
              ++PN+V  +    V  E      +V E++   SL D +       +       +   
Sbjct: 72  RENKNPNIVNYLDSYLVGDEL----WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRE 124

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
             + L +LH     QVI+RD K+ N+LL  +   KL+DFG   +  +       + +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGT 179

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK 317
             + AP+ +       K D+WS G++  EM+ G         +   R L  +        
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN---ENPLRALYLIATNG---- 232

Query: 318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                  P L+    ++   +     + CL    + R    ++++
Sbjct: 233 ------TPELQNPEKLSAIFR--DFLNRCLDMDVEKRGSAKELLQ 269

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-51
 Identities = 64/285 (22%), Positives = 110/285 (38%), Gaps = 31/285 (10%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-HKQWVAEVQFLGVLEHPN 144
            IGEG FG V++           + A  VAIK           ++++ E   +   +HP+
Sbjct: 14  CIGEGQFGDVHQGIYM----SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +VKLIG    +        ++ E      L   L  R    L   + +      +  LAY
Sbjct: 70  IVKLIGVITEN-----PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAY 123

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 264
           L      + ++RD  A NVL+  N   KL DFGL+R        + ++       + AP+
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 179

Query: 265 YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD 324
            I     T+ SDVW FGV ++E+L       +        ++  ++              
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIEN------------G 225

Query: 325 PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ 369
            RL    +      +  L   C +     RP+ +++  +L  I++
Sbjct: 226 ERLPMPPNCPPT--LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  166 bits (422), Expect = 3e-49
 Identities = 66/295 (22%), Positives = 124/295 (42%), Gaps = 31/295 (10%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG---HKQWVAEV 134
           ++ +     +G GG   V+                 VA+K L  D  +    + ++  E 
Sbjct: 6   SDRYELGEILGFGGMSEVHL-------ARDLRLHRDVAVKVLRADLARDPSFYLRFRREA 58

Query: 135 QFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
           Q    L HP +V +      +   G    +V E++   +L D +      P+  K  + +
Sbjct: 59  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEV 116

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST-A 253
           I  A + L + H+     +I+RD K +N+++      K+ DFG+AR     G++   T A
Sbjct: 117 IADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP 313
           V+GT  Y +P+      + A+SDV+S G VLYE+LTG      + P       + V++ P
Sbjct: 174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQHVREDP 231

Query: 314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-MSQVVERLKQI 367
                    +   L+             +    L+K+ ++R +  +++   L ++
Sbjct: 232 IPPSARHEGLSADLD------------AVVLKALAKNPENRYQTAAEMRADLVRV 274

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 6e-48
 Identities = 55/289 (19%), Positives = 104/289 (35%), Gaps = 37/289 (12%)

Query: 75  RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWV 131
           ++   DF     +GEG F +V             + +   AIK L +  +          
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVL-------ARELATSREYAIKILEKRHIIKENKVPYVT 56

Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR 191
            E   +  L+HP  VKL      D +          +  N  L  ++             
Sbjct: 57  RERDVMSRLDHPFFVKLYFTFQDDEKL----YFGLSYAKNGELLKYIRK--IGSFDETCT 110

Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
                     L YLH      +I+RD K  N+LL+E+   +++DFG A+          +
Sbjct: 111 RFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167

Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 311
            + VGT  Y +P+ +        SD+W+ G ++Y+++ G       R   E  + + + +
Sbjct: 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIK 224

Query: 312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQV 360
                      ++    +++   +AR    L +  L   +  R    ++
Sbjct: 225 -----------LEYDFPEKFF-PKAR---DLVEKLLVLDATKRLGCEEM 258

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 6e-48
 Identities = 69/300 (23%), Positives = 122/300 (40%), Gaps = 26/300 (8%)

Query: 77  ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-----KQWV 131
           A   +  + +IGEG +G V+K      A D  +    VA+K++     +        + V
Sbjct: 5   ADQQYECVAEIGEGAYGKVFK------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 58

Query: 132 AEVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTR 191
           A ++ L   EHPN+V+L   C V       +L +    +++ L  +L     P +P +T 
Sbjct: 59  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 118

Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS 251
             ++     GL +LH     +V++RD K  N+L+  + + KL+DFGLAR   +       
Sbjct: 119 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMAL 172

Query: 252 TAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 311
           T+VV T  Y AP+ +         D+WS G +  EM   +     +    +   +  V  
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232

Query: 312 YPADSKKFGLIMDPRLE---------KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
            P +      +  PR           +++  +       L   CL+ +   R      + 
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  162 bits (411), Expect = 8e-47
 Identities = 59/286 (20%), Positives = 104/286 (36%), Gaps = 34/286 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           + +    ++G G FG V++           +     A K +        +    E+Q + 
Sbjct: 26  DHYDIHEELGTGAFGVVHR-------VTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 78

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
           VL HP LV L      D E     +++YEFM    L + + +     +     +  +   
Sbjct: 79  VLRHPTLVNLHDAFEDDNEM----VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQV 133

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLL--DENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
            +GL ++HE      ++ D K  N++     +   KL DFGL      +          G
Sbjct: 134 CKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTG 187

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 316
           T  +AAP+  E   +   +D+WS GV+ Y +L+G         + +   L  V+    + 
Sbjct: 188 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG---GENDDETLRNVKSCDWN- 243

Query: 317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                 MD       S  + +         L      R  + Q +E
Sbjct: 244 ------MDDSAFSGIS-EDGKD---FIRKLLLADPNTRMTIHQALE 279

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  157 bits (397), Expect = 4e-45
 Identities = 56/278 (20%), Positives = 104/278 (37%), Gaps = 31/278 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWV-AEVQFLGVLEHPN 144
            +G G F  V          +      +VAIK + +  L+G +  +  E+  L  ++HPN
Sbjct: 16  VLGTGAFSEVIL-------AEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68

Query: 145 LVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAY 204
           +V L       G       L+ + +    L D +  +       +    +I    + + Y
Sbjct: 69  IVALDDIYESGGHL----YLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKY 122

Query: 205 LHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPD 264
           LH+   V    +        LDE+ +  +SDFGL++   M     V +   GT GY AP+
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPE 179

Query: 265 YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIMD 324
            +     +   D WS GV+ Y +L G         + + +L E + +            +
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILK-----------AE 225

Query: 325 PRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
              +  Y  + +        + + K  + R    Q ++
Sbjct: 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  157 bits (399), Expect = 5e-45
 Identities = 54/286 (18%), Positives = 113/286 (39%), Gaps = 34/286 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           + +  + ++G G FG V++           +   V   K +N            E+  + 
Sbjct: 29  DYYDILEELGSGAFGVVHR-------CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN 81

Query: 139 VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGA 198
            L HP L+ L        E     +L+ EF+    L D +    +  +     ++ +  A
Sbjct: 82  QLHHPKLINLHDAFEDKYEM----VLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQA 136

Query: 199 AEGLAYLHEGLEVQVIYRDFKASNVLLD--ENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
            EGL ++HE     +++ D K  N++ +  +    K+ DFGLA +   +    +      
Sbjct: 137 CEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTA 190

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 316
           T  +AAP+ ++   +   +D+W+ GV+ Y +L+G         + +   L+ V++     
Sbjct: 191 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKR----- 242

Query: 317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                  D   +++   + + +      N L K  + R  +   +E
Sbjct: 243 ------CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  154 bits (390), Expect = 3e-44
 Identities = 48/307 (15%), Positives = 97/307 (31%), Gaps = 39/307 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           +IGEG FG +++       G        VAIK   R       Q   E +   +L     
Sbjct: 12  RIGEGSFGVIFE-------GTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           +  + Y    G+ G+  +LV + +      + L +        KT           +  +
Sbjct: 63  IPNVYYF---GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117

Query: 206 HEGLEVQVIYRDFKASNVLLDENFRP-----KLSDFGLAR-----EGPMVGHTHVSTAVV 255
           HE     ++YRD K  N L+            + DFG+ +                  + 
Sbjct: 118 HE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
           GT  Y + +       + + D+ + G V    L G    +  +  T ++  E + +    
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-- 232

Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGD 375
                        +E       +  +      + +    P    +     ++++      
Sbjct: 233 --------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE--RLNT 282

Query: 376 SFDKTFE 382
           + D+ F+
Sbjct: 283 TEDENFD 289

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 8e-44
 Identities = 56/279 (20%), Positives = 105/279 (37%), Gaps = 35/279 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
            +G G FG V++          TS       K +   G         E+  L +  H N+
Sbjct: 12  DLGRGEFGIVHR-------CVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNI 63

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           + L        E     ++++EF+    + + +   AF  L  +  +  +    E L +L
Sbjct: 64  LHLHESFESMEEL----VMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFL 118

Query: 206 HEGLEVQVIYRDFKASNVLLD--ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAP 263
           H      + + D +  N++     +   K+ +FG AR+   +        +     Y AP
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAP 172

Query: 264 DYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLIM 323
           +  +   ++  +D+WS G ++Y +L+G         +T Q+++E +              
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFL---AETNQQIIENIMNAE-------YTF 222

Query: 324 DPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
           D    KE S  EA       D  L K  K R   S+ ++
Sbjct: 223 DEEAFKEIS-IEAM---DFVDRLLVKERKSRMTASEALQ 257

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (384), Expect = 2e-43
 Identities = 63/305 (20%), Positives = 108/305 (35%), Gaps = 37/305 (12%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           KIG G FG +Y        G   +    VAIK         H Q   E +   +++    
Sbjct: 14  KIGSGSFGDIYL-------GTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVG 64

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           +  I +C  +G+     ++V E +      + LFN        KT L +       + Y+
Sbjct: 65  IPTIRWCGAEGDY---NVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119

Query: 206 HEGLEVQVIYRDFKASNVL---LDENFRPKLSDFGLAR-----EGPMVGHTHVSTAVVGT 257
           H       I+RD K  N L     +     + DFGLA+               +  + GT
Sbjct: 120 HS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK 317
             YA+ +       + + D+ S G VL     G    +  +  T+++  E + +      
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-- 234

Query: 318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNEGDSF 377
                    L K Y      +     + C S    D+P  S + +  + +     +G S+
Sbjct: 235 ----TPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH--RQGFSY 284

Query: 378 DKTFE 382
           D  F+
Sbjct: 285 DYVFD 289

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 6e-43
 Identities = 71/351 (20%), Positives = 128/351 (36%), Gaps = 42/351 (11%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH-KQWVAEVQF 136
              ++ +  IGEG +G V                  VAIKK++    Q + ++ + E++ 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCS-------AYDNVNKVRVAIKKISPFEHQTYCQRTLREIKI 59

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           L    H N++ +           ++ + +   ++   L   L  +    L      + + 
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLY 116

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE-GPMVGHTHVSTAVV 255
               GL Y+H      V++RD K SN+LL+     K+ DFGLAR   P   HT   T  V
Sbjct: 117 QILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173

Query: 256 GTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 314
            T  Y AP+ +      T   D+WS G +L EML+ R          +   +  +   P+
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233

Query: 315 DSKKFGLIMDPRLEKEYSINEARKIG-------------RLADNCLSKSSKDRPKMSQVV 361
                 +I         S+    K+               L D  L+ +   R ++ Q +
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293

Query: 362 ERLKQIVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHEPSEAWKRRMAHL 412
                          + + + +  +E P+     +   E  +  K ++  L
Sbjct: 294 A------------HPYLEQYYDPSDE-PIAEAPFKFDMELDDLPKEKLKEL 331

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 1e-42
 Identities = 70/329 (21%), Positives = 113/329 (34%), Gaps = 60/329 (18%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQ 135
            DF     +G+G FG V+         +        AIK L +D +         + E +
Sbjct: 2   EDFILHKMLGKGSFGKVFL-------AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 54

Query: 136 FLG-VLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
            L    EHP L  +                  E++    L  H+ +              
Sbjct: 55  VLSLAWEHPFLTHMFCTFQTKENLFFV----MEYLNGGDLMYHIQSC--HKFDLSRATFY 108

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
                 GL +LH      ++YRD K  N+LLD++   K++DFG+ +E  +          
Sbjct: 109 AAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTF 163

Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA 314
            GT  Y AP+ +         D WSFGV+LYEML G+        + E+ L   ++    
Sbjct: 164 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIRM--- 217

Query: 315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVV-----------ER 363
                    +P   +     EA+    L      +  + R  +   +           E 
Sbjct: 218 --------DNPFYPRWLE-KEAKD---LLVKLFVREPEKRLGVRGDIRQHPLFREINWEE 265

Query: 364 LKQ-------IVQVSNEGDS--FDKTFEE 383
           L++         +V +  D   FDK F  
Sbjct: 266 LERKEIDPPFRPKVKSPFDCSNFDKEFLN 294

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  147 bits (372), Expect = 6e-42
 Identities = 62/299 (20%), Positives = 112/299 (37%), Gaps = 49/299 (16%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---------QGHKQW 130
           ++     +G G    V +   KP            A+K ++  G          +  +  
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKP---TCK----EYAVKIIDVTGGGSFSAEEVQELREAT 56

Query: 131 VAEVQFLGVL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWK 189
           + EV  L  +  HPN+++L        E      LV++ M    L D+L  +    L  K
Sbjct: 57  LKEVDILRKVSGHPNIIQLKDTY----ETNTFFFLVFDLMKKGELFDYLTEK--VTLSEK 110

Query: 190 TRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTH 249
               I+    E +  LH+   + +++RD K  N+LLD++   KL+DFG + +   +    
Sbjct: 111 ETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGE 164

Query: 250 VSTAVVGTFGYAAPDYIETGHL------TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ 303
               V GT  Y AP+ IE            + D+WS GV++Y +L G        P   +
Sbjct: 165 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHR 218

Query: 304 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
           + +  ++   + + +FG                  +  L    L    + R    + + 
Sbjct: 219 KQMLMLRMIMSGNYQFGSPEWDDYSDT--------VKDLVSRFLVVQPQKRYTAEEALA 269

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 7e-42
 Identities = 75/340 (22%), Positives = 128/340 (37%), Gaps = 40/340 (11%)

Query: 75  RQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEV 134
           R     ++    IG G FG VY++ +            +VAIKK+ +D     +    E+
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLC-------DSGELVAIKKVLQD----KRFKNREL 64

Query: 135 QFLGVLEHPNLVKLIGYCAVDGERG--IQRLLVYEFMLNRSLEDHL-FNRAFPPLPWKTR 191
           Q +  L+H N+V+L  +    GE+   +   LV +++          ++RA   LP    
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124

Query: 192 LHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREGPMVGHTHV 250
              +      LAY+H      + +RD K  N+LLD +    KL DFG A++  +V     
Sbjct: 125 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPN 179

Query: 251 STAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ 310
            + +   +  A          T+  DVWS G VL E+L G+     +    +   +  V 
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

Query: 311 QYP-----------ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
             P               KF  I      K +      +   L    L  +   R    +
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299

Query: 360 VVER--LKQI----VQVSNEGDS---FDKTFEEICEEDPV 390
                   ++    V++ N  D+   F+ T +E+    P+
Sbjct: 300 ACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPL 339

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  149 bits (377), Expect = 8e-42
 Identities = 62/288 (21%), Positives = 103/288 (35%), Gaps = 42/288 (14%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH------KQWVA 132
           NDFS    IG GGFG VY                + A+K L++  ++             
Sbjct: 4   NDFSVHRIIGRGGFGEVYG-------CRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 56

Query: 133 EVQFLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
            +  +   + P +V +        +       + + M    L  HL              
Sbjct: 57  MLSLVSTGDCPFIVCMSYAFHTPDKL----SFILDLMNGGDLHYHLSQH--GVFSEADMR 110

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVST 252
                   GL ++H      V+YRD K +N+LLDE+   ++SD GLA +           
Sbjct: 111 FYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPH 163

Query: 253 AVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 311
           A VGT GY AP+ ++ G    + +D +S G +L+++L G     +++ K +  +      
Sbjct: 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223

Query: 312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
                          L   +S  E R    L +  L +    R     
Sbjct: 224 MA-----------VELPDSFS-PELRS---LLEGLLQRDVNRRLGCLG 256

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 4e-41
 Identities = 66/296 (22%), Positives = 112/296 (37%), Gaps = 29/296 (9%)

Query: 80  DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFL 137
           +F ++ KIGEG +G VYK               VVA+KK+  D          + E+  L
Sbjct: 3   NFQKVEKIGEGTYGVVYK-------ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 55

Query: 138 GVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
             L HPN+VKL+     +      +L +    L++ L+  +   A   +P       +  
Sbjct: 56  KELNHPNIVKLLDVIHTEN-----KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGT 257
             +GLA+ H     +V++RD K  N+L++     KL+DFGLAR    V     +  VV  
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARA-FGVPVRTYTHEVVTL 166

Query: 258 FGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK 317
           +  A    +   + +   D+WS G +  EM+T R     +    +   +      P +  
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226

Query: 318 KFGLIMDPRLEKEYSINEARKIGR-----------LADNCLSKSSKDRPKMSQVVE 362
             G+   P  +  +     +   +           L    L      R      + 
Sbjct: 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  146 bits (368), Expect = 7e-41
 Identities = 64/239 (26%), Positives = 101/239 (42%), Gaps = 25/239 (10%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQ---WVAEVQ 135
            DF  +  +G G FG V+                  A+K L ++ +   KQ      E  
Sbjct: 4   QDFQILRTLGTGSFGRVHL-------IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL 56

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L ++ HP ++++ G          Q  ++ +++    L   L        P        
Sbjct: 57  MLSIVTHPFIIRMWGTFQDAQ----QIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYA 110

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
                 L YLH      +IYRD K  N+LLD+N   K++DFG A+  P V +T     + 
Sbjct: 111 AEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LC 162

Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSL-ERNRPKTEQRLLEWVQQYP 313
           GT  Y AP+ + T       D WSFG+++YEML G     + N  KT +++L    ++P
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP 221

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 5e-40
 Identities = 66/293 (22%), Positives = 108/293 (36%), Gaps = 34/293 (11%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-----HKQWVAEVQFLGVL 140
            +GEG F +VYK           +   +VAIKK+            ++  + E++ L  L
Sbjct: 5   FLGEGQFATVYK-------ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57

Query: 141 EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAE 200
            HPN++ L+              LV++FM          N     L        +L   +
Sbjct: 58  SHPNIIGLLDAFGHKSNI----SLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQ 111

Query: 201 GLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGY 260
           GL YLH+     +++RD K +N+LLDEN   KL+DFGLA+           T  V T  Y
Sbjct: 112 GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWY 166

Query: 261 AAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKF 319
            AP+ +    +     D+W+ G +L E+L     L  +    +   +      P + +  
Sbjct: 167 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 226

Query: 320 GLIMDPRLEKEYSINEARKIGR----------LADNCLSKSSKDRPKMSQVVE 362
            +   P      S                   L       +   R   +Q ++
Sbjct: 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 7e-40
 Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 43/287 (14%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVA------EVQFLGV 139
           ++G G F  V K           S     A K + +   +  ++ V+      EV  L  
Sbjct: 17  ELGSGQFAVVKK-------CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 140 LEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAA 199
           ++HPN++ L        +     +L+ E +    L D L  +    L  +     +    
Sbjct: 70  IQHPNVITLHEVYENKTDV----ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQIL 123

Query: 200 EGLAYLHEGLEVQVIYRDFKASNVLLDEN----FRPKLSDFGLAREGPMVGHTHVSTAVV 255
            G+ YLH    +Q+ + D K  N++L +      R K+ DFGLA +   +   +    + 
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIF 177

Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
           GT  + AP+ +    L  ++D+WS GV+ Y +L+G      +   T+Q  L  V      
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA---- 230

Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                  ++   E EY  N +          L K  K R  +   ++
Sbjct: 231 -------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  142 bits (358), Expect = 8e-40
 Identities = 62/297 (20%), Positives = 109/297 (36%), Gaps = 31/297 (10%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQF 136
             +  + KIGEG +G VYK      A +   E    A+KK+  +          + E+  
Sbjct: 2   EKYHGLEKIGEGTYGVVYK------AQNNYGE--TFALKKIRLEKEDEGIPSTTIREISI 53

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           L  L+H N+VKL            + +LV+E +     +          L   T    +L
Sbjct: 54  LKELKHSNIVKLYDVI----HTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLL 107

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
               G+AY H+    +V++RD K  N+L++     K++DFGLAR   +    +    +V 
Sbjct: 108 QLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVT 163

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 316
            +  A    + +   +   D+WS G +  EM+ G           +   +  +   P   
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223

Query: 317 KKFGLIMDPRLEKEYSINEARKIGR-----------LADNCLSKSSKDRPKMSQVVE 362
               +   P+ +  +++ E                 L    L      R    Q +E
Sbjct: 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 5e-38
 Identities = 62/307 (20%), Positives = 113/307 (36%), Gaps = 35/307 (11%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG--HKQWVAEVQF 136
           + + ++ KIG+G FG V+K                VA+KK+  +  +       + E++ 
Sbjct: 10  SKYEKLAKIGQGTFGEVFK-------ARHRKTGQKVALKKVLMENEKEGFPITALREIKI 62

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQR----LLVYEFMLNRSLEDHLFNRAFPPLPWKTRL 192
           L +L+H N+V LI  C        +      LV++F  +              L    R+
Sbjct: 63  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV 122

Query: 193 HIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVS- 251
                    L  L+     ++++RD KA+NVL+  +   KL+DFGLAR   +  ++  + 
Sbjct: 123 -----MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177

Query: 252 -TAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWV 309
            T  V T  Y  P+ +          D+W  G ++ EM T    ++ N  + +  L+  +
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237

Query: 310 QQYPADSKKFGLIMDPRLEKEYSINEARKIGR--------------LADNCLSKSSKDRP 355
                      +      EK   +   ++  +              L D  L      R 
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

Query: 356 KMSQVVE 362
                + 
Sbjct: 298 DSDDALN 304

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-37
 Identities = 71/284 (25%), Positives = 100/284 (35%), Gaps = 39/284 (13%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQ 135
           NDF  +  +G+G FG V             +     A+K L ++ +    +    V E +
Sbjct: 5   NDFDYLKLLGKGTFGKVIL-------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L    HP L  L                  E+     L  HL          +      
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFV----MEYANGGELFFHLSRE--RVFTEERARFYG 111

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
                 L YLH      V+YRD K  N++LD++   K++DFGL +EG   G T       
Sbjct: 112 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFC 166

Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
           GT  Y AP+ +E        D W  GVV+YEM+ GR        +  +RL E +      
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEE-- 221

Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
                     R  +  S  EA+    L    L K  K R     
Sbjct: 222 ---------IRFPRTLS-PEAK---SLLAGLLKKDPKQRLGGGP 252

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-37
 Identities = 56/280 (20%), Positives = 93/280 (33%), Gaps = 32/280 (11%)

Query: 87  IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG-VLEHPNL 145
           +G G  G V +                 A+K L         +   EV+      + P++
Sbjct: 20  LGLGINGKVLQ-------IFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHI 67

Query: 146 VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYL 205
           V+++             L+V E +    L   + +R       +    I+    E + YL
Sbjct: 68  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127

Query: 206 HEGLEVQVIYRDFKASNVLLD---ENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA 262
           H    + + +RD K  N+L      N   KL+DFG A+E       +  T    T  Y A
Sbjct: 128 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCYTPYYVA 181

Query: 263 PDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFGLI 322
           P+ +         D+WS GV++Y +L G        P      L          +     
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRMGQYE 235

Query: 323 MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
                  E S  E +    L  N L      R  +++ + 
Sbjct: 236 FPNPEWSEVS-EEVK---MLIRNLLKTEPTQRMTITEFMN 271

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 3e-36
 Identities = 60/287 (20%), Positives = 103/287 (35%), Gaps = 53/287 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGH------KQWVAEVQFLGV 139
            +G GGFGSVY        G   S+   VAIK + +D +          +   EV  L  
Sbjct: 11  LLGSGGFGSVYS-------GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 140 L--EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
           +      +++L+ +           +L+ E                  L  +        
Sbjct: 64  VSSGFSGVIRLLDWFERPD----SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQ 118

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLDEN-FRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             E + + H      V++RD K  N+L+D N    KL DFG       +    V T   G
Sbjct: 119 VLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA----LLKDTVYTDFDG 171

Query: 257 TFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
           T  Y+ P++I    +    + VWS G++LY+M+ G    E +  +  +  + + Q+  ++
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-HDEEIIRGQVFFRQRVSSE 230

Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVE 362
            +                        L   CL+    DRP   ++  
Sbjct: 231 CQH-----------------------LIRWCLALRPSDRPTFEEIQN 254

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 7e-36
 Identities = 60/325 (18%), Positives = 119/325 (36%), Gaps = 35/325 (10%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQF 136
             +  +  +G G +G+V                  VAIKKL R        K+   E++ 
Sbjct: 18  AVYRDLQPVGSGAYGAVCS-------AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           L  + H N++ L+     D                 +    L       L       ++ 
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVY 128

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
              +GL Y+H      +I+RD K  N+ ++E+   K+ DFGLAR+      + ++  VV 
Sbjct: 129 QMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVT 181

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR------------RSLERNRPKTEQR 304
            +  A    +     T   D+WS G ++ EM+TG+            + + +        
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241

Query: 305 LLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGR-LADNCLSKSSKDRPKMSQVVER 363
            ++ +Q   A +   GL    + +    +  A  +   L +  L   ++ R    + +  
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301

Query: 364 --LKQIVQVSNEGD--SFDKTFEEI 384
              + +    +E     +D +F+++
Sbjct: 302 PYFESLHDTEDEPQVQKYDDSFDDV 326

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 1e-35
 Identities = 58/298 (19%), Positives = 104/298 (34%), Gaps = 31/298 (10%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQF 136
             + ++ KIGEG +G+V+K               +VA+K++  D          + E+  
Sbjct: 2   QKYEKLEKIGEGTYGTVFK-------AKNRETHEIVALKRVRLDDDDEGVPSSALREICL 54

Query: 137 LGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIIL 196
           L  L+H N+V+L            +  LV+EF      +             +     + 
Sbjct: 55  LKELKHKNIVRLHDVL----HSDKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKSFLF 108

Query: 197 GAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
              +GL + H      V++RD K  N+L++ N   KL++FGLAR    +     S  VV 
Sbjct: 109 QLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVT 164

Query: 257 TFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS 316
            +             +   D+WS G +  E+    R L       +Q    +        
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224

Query: 317 KKFGLIMDPRLEKEYSINEARKIGR------------LADNCLSKSSKDRPKMSQVVE 362
           +++  +      K Y +  A                 L  N L  +   R    + ++
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 1e-32
 Identities = 70/325 (21%), Positives = 121/325 (37%), Gaps = 35/325 (10%)

Query: 78  TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQ 135
              +  +  +G G +GSV            T     VA+KKL+R        K+   E++
Sbjct: 17  PERYQNLSPVGSGAYGSVCA-------AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 69

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  ++H N++ L+              +     L  +  +++       L       +I
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLI 127

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
                GL Y+H      +I+RD K SN+ ++E+   K+ DFGLAR        +V+T   
Sbjct: 128 YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT--- 181

Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR------------RSLERNRPKTEQ 303
             +  A    +   H     D+WS G ++ E+LTGR            + + R       
Sbjct: 182 -RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240

Query: 304 RLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGR-LADNCLSKSSKDRPKMSQVVE 362
            LL+ +    A +    L   P++        A  +   L +  L   S  R   +Q + 
Sbjct: 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

Query: 363 R--LKQIVQVSNE--GDSFDKTFEE 383
                Q     +E   D +D++FE 
Sbjct: 301 HAYFAQYHDPDDEPVADPYDQSFES 325

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (311), Expect = 1e-32
 Identities = 68/347 (19%), Positives = 114/347 (32%), Gaps = 66/347 (19%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQW---VAEVQ 135
           + F R+  +G G FG V                   A+K L++  +   KQ    + E +
Sbjct: 41  DQFDRIKTLGTGSFGRVML-------VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
            L  +  P LVKL        +      +V E++    +  HL                 
Sbjct: 94  ILQAVNFPFLVKLEFSF----KDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYA 147

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVV 255
                   YLH    + +IYRD K  N+L+D+    +++DFG A+       T     + 
Sbjct: 148 AQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LC 199

Query: 256 GTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD 315
           GT    AP+ I +       D W+ GV++YEM  G             ++ E +      
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF---ADQPIQIYEKIVS---- 252

Query: 316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-MSQVVERLKQ-------- 366
                     R    +S      +  L  N L      R   +   V  +K         
Sbjct: 253 -------GKVRFPSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301

Query: 367 -------------IVQVSNEGDSFDKTFEEICEEDPVEAQTKQKQHE 400
                        I +    GD+ +  F++  EE+   +  ++   E
Sbjct: 302 WIAIYQRKVEAPFIPKFKGPGDTSN--FDDYEEEEIRVSINEKCGKE 346

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  122 bits (307), Expect = 4e-32
 Identities = 56/307 (18%), Positives = 105/307 (34%), Gaps = 46/307 (14%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLG 138
           +D+  + K+G G +  V++           +    V +K L        K+   E++ L 
Sbjct: 35  DDYQLVRKLGRGKYSEVFE-------AINITNNEKVVVKILKPVK---KKKIKREIKILE 84

Query: 139 VL-EHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILG 197
            L   PN++ L         R     LV+E + N   +          L        +  
Sbjct: 85  NLRGGPNIITLADIVKDPVSRTPA--LVFEHVNNTDFKQLY-----QTLTDYDIRFYMYE 137

Query: 198 AAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREGPMVGHTHVSTAVVG 256
             + L Y H    + +++RD K  NV++D E+ + +L D+GLA               V 
Sbjct: 138 ILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE---FYHPGQEYNVRVA 191

Query: 257 TFGYAAPD-YIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-----------R 304
           +  +  P+  ++        D+WS G +L  M+  +          +Q            
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251

Query: 305 LLEWVQQY-----PADSKKFGLIMDPRLEKEYSINEARKIGRLA----DNCLSKSSKDRP 355
           L +++ +Y     P  +   G     R E+         +   A    D  L    + R 
Sbjct: 252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 311

Query: 356 KMSQVVE 362
              + +E
Sbjct: 312 TAREAME 318

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 1e-30
 Identities = 63/312 (20%), Positives = 109/312 (34%), Gaps = 46/312 (14%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQF 136
             +  +  IG G  G V                  VAIKKL+R        K+   E+  
Sbjct: 17  KRYQNLKPIGSGAQGIVCA-------AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69

Query: 137 LGVLEHPNLVKLIGYCAVDG--ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
           +  + H N++ L+         E      LV E M     +             +   ++
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYL 124

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAV 254
           +     G+ +LH      +I+RD K SN+++  +   K+ DFGLAR     G + + T  
Sbjct: 125 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPY 178

Query: 255 VGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR----------------RSLERNR 298
           V T  Y AP+ I         D+WS G ++ EM+  +                  L    
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238

Query: 299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGR--------LADNCLSKS 350
           P+  ++L   V+ Y  +  K+  +  P+L  +       +  +        L    L   
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298

Query: 351 SKDRPKMSQVVE 362
              R  +   ++
Sbjct: 299 PAKRISVDDALQ 310

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 2e-30
 Identities = 68/288 (23%), Positives = 107/288 (37%), Gaps = 35/288 (12%)

Query: 79  NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----QGHKQWVAEV 134
            +F  +  +G G +G V+          G     + A+K L +  +    +  +    E 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGK----LYAMKVLKKATIVQKAKTTEHTRTER 79

Query: 135 QFLGVLEH-PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLH 193
           Q L  +   P LV L      + +  +      +++    L  HL  R            
Sbjct: 80  QVLEHIRQSPFLVTLHYAFQTETKLHLI----LDYINGGELFTHLSQRERFTEHE----- 130

Query: 194 IILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTA 253
           + +   E +  L    ++ +IYRD K  N+LLD N    L+DFGL++E      T  +  
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYD 189

Query: 254 VVGTFGYAAPDYIETGH--LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQ 311
             GT  Y APD +  G        D WS GV++YE+LTG      +  K  Q  +     
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI----- 244

Query: 312 YPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQ 359
                 +  L  +P   +E S   A+    L    L K  K R     
Sbjct: 245 -----SRRILKSEPPYPQEMS-ALAK---DLIQRLLMKDPKKRLGCGP 283

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  105 bits (261), Expect = 1e-25
 Identities = 46/239 (19%), Positives = 90/239 (37%), Gaps = 23/239 (9%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNL 145
           K+G G F +V+               T VA+K +  D +   +    E++ L  +   + 
Sbjct: 20  KLGWGHFSTVWL-------AKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADN 71

Query: 146 -----------VKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHI 194
                      +KL+ +    G  G+  ++V+E +    L           +P      I
Sbjct: 72  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE-HRGIPLIYVKQI 130

Query: 195 ILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD-ENFRPKLSDFGLAREGPMVGHTHVSTA 253
                 GL Y+H      +I+ D K  NVL++  +    L    +A  G    +    T 
Sbjct: 131 SKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188

Query: 254 VVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY 312
            + T  Y +P+ +        +D+WS   +++E++TG    E +   +  +  + + Q 
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 71.4 bits (174), Expect = 4e-15
 Identities = 25/166 (15%), Positives = 46/166 (27%), Gaps = 31/166 (18%)

Query: 86  KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL----------QGHKQWVAEVQ 135
            +GEG   +V+                   +K                  G   +     
Sbjct: 7   LMGEGKESAVFN------CYSEKFG--ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAI 58

Query: 136 FLGVLEHPNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHII 195
                E   L KL G              VY +  N  L + +  +    +  +    ++
Sbjct: 59  RSARNEFRALQKLQGLAVPK---------VYAWEGNAVLMELIDAKELYRVRVENPDEVL 109

Query: 196 LGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE 241
               E +A  +      +++ D    NVL+ E     + DF  + E
Sbjct: 110 DMILEEVAKFY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVE 151

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	436
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.76
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.01
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.97
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.47
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.88
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.75

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-56  Score=416.20  Aligned_cols=262  Identities=28%  Similarity=0.462  Sum_probs=206.5

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC--cchhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD--GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++.+.||+|+||.||+|+++          ..||||+++..  .....+.|.+|+.++++++|||||++++++...
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~----------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~   76 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH----------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP   76 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS----------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC----------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc
Confidence            468999999999999999999864          24999998754  334457899999999999999999999987543


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                           ..++||||+++|+|.+++.... ..+++..+..|+.||+.||+|||++   +||||||||+||||+.++.+||+|
T Consensus        77 -----~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~D  147 (276)
T d1uwha_          77 -----QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGD  147 (276)
T ss_dssp             -----SCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECC
T ss_pred             -----EEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcc
Confidence                 2489999999999999997644 4699999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      ||+|+...............||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+......  +...+...
T Consensus       148 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~~~~~~  225 (276)
T d1uwha_         148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIFMVGRG  225 (276)
T ss_dssp             CCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHHHHT
T ss_pred             ccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHHHHhcC
Confidence            999986433333334456789999999999864   3589999999999999999999999987654332  21222211


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      ..         .+.+ ...+..++..+.+||.+||+.||.+|||+.+|+++|+.+.+.
T Consensus       226 ~~---------~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         226 YL---------SPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             SC---------CCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CC---------CCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            11         0100 112233457899999999999999999999999999988653

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-57  Score=418.45  Aligned_cols=256  Identities=23%  Similarity=0.332  Sum_probs=205.8

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      +.++|++++.||+|+||.||+|.++       .+++.||||+++.... ...+.+.+|+.+++.++||||+++++++...
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~   75 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNR-------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG   75 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             CCcceEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence            3568999999999999999999976       5688999999876533 2345688999999999999999999999876


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+|
T Consensus        76 ~----~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~D  146 (271)
T d1nvra_          76 N----IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISD  146 (271)
T ss_dssp             T----EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECC
T ss_pred             c----eeEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEcc
Confidence            5    459999999999999999654  4799999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      ||+|+...............||+.|||||++.+..+ +.++|||||||++|||+||+.||......... ..........
T Consensus       147 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~~~~~~  225 (271)
T d1nvra_         147 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTY  225 (271)
T ss_dssp             CTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHHTTCTT
T ss_pred             chhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHHhcCCCC
Confidence            999986433333334456789999999999988776 57899999999999999999999765433221 1111111100


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                    .......+..+.+||.+||+.||.+|||+.+++++
T Consensus       226 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         226 --------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             --------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                          00111234678899999999999999999999765

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-56  Score=416.73  Aligned_cols=251  Identities=22%  Similarity=0.360  Sum_probs=209.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ++|++++.||+|+||.||+|..+       .+++.||||++........+.+.+|+.+++.++|||||++++++...+  
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~-------~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--   90 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDV-------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--   90 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBT-------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred             cccEEEEEEecCcCcEEEEEEEC-------CCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC--
Confidence            47999999999999999999865       568899999998766566678999999999999999999999998765  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..|+||||++||+|.+++...   .+++..+..++.||+.||.|||++   ||+||||||+||||+.+|.+||+|||+
T Consensus        91 --~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~  162 (293)
T d1yhwa1          91 --ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF  162 (293)
T ss_dssp             --EEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             --EEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchh
Confidence              359999999999999988653   599999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  318 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  318 (436)
                      |+...  ..........||+.|+|||++.+..++.++|||||||++|+|+||..||.+.......  ..........   
T Consensus       163 a~~~~--~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~~~~~---  235 (293)
T d1yhwa1         163 CAQIT--PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIATNGTPE---  235 (293)
T ss_dssp             CEECC--STTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHHHCSCC---
T ss_pred             heeec--cccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH--HHHHhCCCCC---
Confidence            98532  2223345567999999999999999999999999999999999999999876543221  1111111100   


Q ss_pred             cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       319 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                ...+...+..+.+||.+||+.||.+|||+.|+++|
T Consensus       236 ----------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         236 ----------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             ----------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             ----------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                      01122334778999999999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.2e-56  Score=416.02  Aligned_cols=261  Identities=26%  Similarity=0.398  Sum_probs=215.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++.+.||+|+||.||+|.++       .+++.||||+++.+. ...+.+.+|+.+|++++|||||+++|+|...+.
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWK-------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEG-------GGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEC-------CCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence            468999999999999999999986       568899999997654 345789999999999999999999999976654


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .++||||+++|+|.+++.......+++..++.|+.||+.||+|||++   +|+||||||+||||+.++.+||+|||
T Consensus        88 ----~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  160 (287)
T d1opja_          88 ----FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG  160 (287)
T ss_dssp             ----CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             ----eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccc
Confidence                49999999999999999877667899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      +|+.... ..........|++.|+|||++.+..++.++|||||||++|||++|..||......  ..+...+...     
T Consensus       161 ~a~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~~i~~~-----  232 (287)
T d1opja_         161 LSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKD-----  232 (287)
T ss_dssp             CTTTCCS-SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTT-----
T ss_pred             ceeecCC-CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHHHHhcC-----
Confidence            9986322 2222333456889999999999999999999999999999999977666443322  1222222211     


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                               .....+...+..+.+||.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       233 ---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         233 ---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             ---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                     01112233457899999999999999999999999999888653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=408.58  Aligned_cols=256  Identities=29%  Similarity=0.441  Sum_probs=201.3

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ++|++++.||+|+||.||+|.++        ++..||||+++... ...+.|.+|+.++++++||||++++|+|...+. 
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~--------~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~-   74 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL--------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP-   74 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET--------TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC--------CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCc-
Confidence            57999999999999999999975        45689999997654 345679999999999999999999999987654 


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                         .++||||+++|+|.+++.... ..+++..++.++.|+|.||.|||++   +|+||||||+||||+.++.+||+|||+
T Consensus        75 ---~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGl  147 (263)
T d1sm2a_          75 ---ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGM  147 (263)
T ss_dssp             ---CEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-
T ss_pred             ---eEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccch
Confidence               499999999999999987654 4689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG-RRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ++..... .........||+.|+|||++.+..++.++|||||||++|||+|+ .+||.....   ..+...+.....   
T Consensus       148 a~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i~~~~~---  220 (263)
T d1sm2a_         148 TRFVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFR---  220 (263)
T ss_dssp             ------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHHHHTCC---
T ss_pred             heeccCC-CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHHHhcCC---
Confidence            9753221 12223346789999999999999999999999999999999995 555554332   223332222111   


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                             .    ..+..++..+.+||.+||+.||.+|||+.+|+++|+++.+
T Consensus       221 -------~----~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         221 -------L----YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             -------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------C----CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                   0    1122234678999999999999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=407.33  Aligned_cols=247  Identities=28%  Similarity=0.424  Sum_probs=207.2

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|++++.||+|+||.||+|.++       .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++...
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~   78 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREK-------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA   78 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hHeEEEEEEecCCCcEEEEEEEC-------CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC
Confidence            57999999999999999999976       567899999986542   22346788999999999999999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..++||||+++|+|.+++....  .+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|
T Consensus        79 ~----~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~D  149 (263)
T d2j4za1          79 T----RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD  149 (263)
T ss_dssp             S----EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             C----EEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecc
Confidence            4    4599999999999999997643  699999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||+|+....    .......||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+...   ....+....  
T Consensus       150 FG~a~~~~~----~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~~~--  220 (263)
T d2j4za1         150 FGWSVHAPS----SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKRISRVE--  220 (263)
T ss_dssp             CCSCSCCCC----CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTTC--
T ss_pred             cceeeecCC----CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HHHHHHcCC--
Confidence            999975321    22345679999999999999999999999999999999999999998754432   222222111  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                               ..    ++...+..+.+||.+||+.||.+|||+.|+++|
T Consensus       221 ---------~~----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         221 ---------FT----FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             ---------CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ---------CC----CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence                     11    122234678899999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.2e-55  Score=412.73  Aligned_cols=263  Identities=26%  Similarity=0.427  Sum_probs=203.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|++.+.||+|+||+||+|.++...    .....||||.+.... ....+.|.+|+.+|++++|||||+++|++...+.
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPG----KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC-------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCC----CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            56788899999999999999986211    234579999987653 3345679999999999999999999999976654


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++   +|+||||||+||||+.++++||+|||
T Consensus       102 ----~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  173 (299)
T d1jpaa_         102 ----VMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFG  173 (299)
T ss_dssp             ----CEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             ----EEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcc
Confidence                499999999999999887643 4699999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCc---ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcc
Q 013790          238 LAREGPMVGHT---HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       238 ~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +++........   .......||+.|||||.+.++.++.++|||||||++|||+| |..||.+....   .+...+....
T Consensus       174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~~~~  250 (299)
T d1jpaa_         174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIEQDY  250 (299)
T ss_dssp             ----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTTC
T ss_pred             cceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCC
Confidence            99853222111   11223457899999999999999999999999999999998 89999876543   2333332211


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      .              ...+..++..+.+||.+||+.||.+|||+.+|++.|+++++.
T Consensus       251 ~--------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         251 R--------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             C--------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             C--------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            0              112233457899999999999999999999999999998864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=414.14  Aligned_cols=253  Identities=24%  Similarity=0.406  Sum_probs=208.6

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      +.|++++.||+|+||.||+|.++       .+++.||||++........+.+.+|+++|++++|||||++++++..++  
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--   82 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNK-------ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--   82 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred             cCeEEeEEEeeCCCcEEEEEEEC-------CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--
Confidence            46899999999999999999976       567899999998776666778999999999999999999999998765  


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                        ..++||||+++|+|.+++.+.. .++++..+..++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+
T Consensus        83 --~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~  156 (288)
T d2jfla1          83 --NLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGV  156 (288)
T ss_dssp             --EEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             --eEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechh
Confidence              3599999999999999986543 4699999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIE-----TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |+..  ...........||+.|||||++.     +..|+.++|||||||++|||+||..||.+.++....  .......+
T Consensus       157 a~~~--~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~--~~i~~~~~  232 (288)
T d2jfla1         157 SAKN--TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL--LKIAKSEP  232 (288)
T ss_dssp             CEEC--HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HHHHHSCC
T ss_pred             hhcc--CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH--HHHHcCCC
Confidence            9642  11122334578999999999983     456889999999999999999999999876544321  11111111


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .           .+  ..+...+..+.+||.+||+.||.+|||+.|+++|
T Consensus       233 ~-----------~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         233 P-----------TL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             C-----------CC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             C-----------CC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0           00  1122335788999999999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-56  Score=411.54  Aligned_cols=257  Identities=25%  Similarity=0.363  Sum_probs=196.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|++++.||+|+||.||+|..+       .+++.||+|.+.....  ...+.+.+|+.++++++||||+++++++....
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   76 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRK-------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   76 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred             hhCEEeEEEecCCCeEEEEEEEC-------CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence            58999999999999999999976       5678999999876532  33466889999999999999999999986543


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCceeeccCCCCcEEEcCCCceE
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNR--AFPPLPWKTRLHIILGAAEGLAYLHEGL--EVQVIYRDFKASNVLLDENFRPK  232 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~k  232 (436)
                      ..  .+|+||||+++|+|.+++...  ....+++..++.++.||+.||.|||++.  ..+|+||||||+||||+.++.+|
T Consensus        77 ~~--~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk  154 (269)
T d2java1          77 NT--TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  154 (269)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred             CC--EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence            22  468999999999999998642  2357999999999999999999999861  11499999999999999999999


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |+|||+|+...  ..........||+.|||||++.+..++.++|||||||++|||+||+.||.+.+...   +...+...
T Consensus       155 l~DFG~a~~~~--~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~~i~~~  229 (269)
T d2java1         155 LGDFGLARILN--HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKIREG  229 (269)
T ss_dssp             ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHT
T ss_pred             Eeeccceeecc--cCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHHHHHcC
Confidence            99999998532  22233445789999999999999999999999999999999999999998654432   22222211


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..          +.    .+...+..+.+||.+||+.||.+|||+.||+++
T Consensus       230 ~~----------~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         230 KF----------RR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             CC----------CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CC----------CC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            11          01    112234678999999999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-55  Score=409.08  Aligned_cols=259  Identities=26%  Similarity=0.397  Sum_probs=209.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++++.||+|+||.||+|.++        ++..||||+++... ...+.|.+|+.++++++|||||+++|++... .
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~   81 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN--------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-P   81 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET--------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC--------CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccC-C
Confidence            468999999999999999999975        46789999997654 3456799999999999999999999987543 2


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .++||||+++|+|.+++.......+++..++.|+.||+.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus        82 ----~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG  154 (272)
T d1qpca_          82 ----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFG  154 (272)
T ss_dssp             ----CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             ----eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeecccc
Confidence                48999999999999988765545699999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      +|+.... ..........||+.|||||++.++.++.++|||||||++|||+||..|+......  ..+...+....    
T Consensus       155 la~~~~~-~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~i~~~~----  227 (272)
T d1qpca_         155 LARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLERGY----  227 (272)
T ss_dssp             TCEECSS-SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTC----
T ss_pred             ceEEccC-CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHHHHhcC----
Confidence            9986432 2223334567899999999999999999999999999999999965554432221  22222222110    


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                            .+    ..+...+..+.+||.+||+.||++|||+.+|++.|+++...
T Consensus       228 ------~~----~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         228 ------RM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CC----CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                  01    11223346789999999999999999999999999988753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-55  Score=415.76  Aligned_cols=263  Identities=24%  Similarity=0.402  Sum_probs=210.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||+||+|++....  .......||+|.+... .......+.+|+.++.++ +|||||++++++...
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGIS--KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCS--SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCC--cccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            368999999999999999999987322  2234568999998654 333446789999999998 899999999999876


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA---------------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVI  214 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~iv  214 (436)
                      +.    .++||||+++|+|.++|....                     ...+++..++.++.||+.||+|||++   +|+
T Consensus       114 ~~----~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~Ii  186 (325)
T d1rjba_         114 GP----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV  186 (325)
T ss_dssp             SS----CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             Ce----EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            54    499999999999999997643                     13589999999999999999999998   999


Q ss_pred             eccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCC
Q 013790          215 YRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRS  293 (436)
Q Consensus       215 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p  293 (436)
                      ||||||+|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |..|
T Consensus       187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P  266 (325)
T d1rjba_         187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  266 (325)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence            999999999999999999999999986433333333445678999999999999999999999999999999998 8999


Q ss_pred             CCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 013790          294 LERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLK  365 (436)
Q Consensus       294 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~  365 (436)
                      |.+......  +...+...              .....+..++..+.+||.+||+.||++|||+.+|+++|.
T Consensus       267 f~~~~~~~~--~~~~~~~~--------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         267 YPGIPVDAN--FYKLIQNG--------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             STTCCCSHH--HHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCHHHH--HHHHHhcC--------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            987554322  22222211              011122334578999999999999999999999999985

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=402.68  Aligned_cols=250  Identities=22%  Similarity=0.337  Sum_probs=201.3

Q ss_pred             cccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcc
Q 013790           82 SRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERG  159 (436)
Q Consensus        82 ~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  159 (436)
                      ++.+.||+|+||+||+|.++       .+++.||+|.+....  ....+.+.+|+++|++++|||||++++++.......
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~-------~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   84 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDT-------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK   84 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             EeeeEEecCcCcEEEEEEEC-------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence            56678999999999999976       567889999986543  234467899999999999999999999987654444


Q ss_pred             eeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc--eeeccCCCCcEEEc-CCCceEEeec
Q 013790          160 IQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQ--VIYRDFKASNVLLD-ENFRPKLSDF  236 (436)
Q Consensus       160 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~Df  236 (436)
                      ..+++||||+++|+|.+++.+.  ..+++..+..++.||+.||+|||++   +  |+||||||+||||+ .++.+||+||
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DF  159 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDL  159 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             CEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeec
Confidence            5679999999999999999764  3699999999999999999999997   6  99999999999996 5899999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      |+|+...    ........||+.|||||++.+ .++.++|||||||++|||++|+.||.+.....  .+...+...... 
T Consensus       160 Gla~~~~----~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~~i~~~~~~-  231 (270)
T d1t4ha_         160 GLATLKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSGVKP-  231 (270)
T ss_dssp             TGGGGCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHTTTCCC-
T ss_pred             Ccceecc----CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHHHHHcCCCC-
Confidence            9997421    223345689999999999865 59999999999999999999999997654322  222222211110 


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                              ..+    +...++++.+||.+||+.||++|||+.|+++|
T Consensus       232 --------~~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         232 --------ASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             --------GGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --------ccc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence                    111    11223568899999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=405.88  Aligned_cols=260  Identities=25%  Similarity=0.423  Sum_probs=210.0

Q ss_pred             cCCccccc-ccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLK-IGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~-ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|.+.+. ||+|+||.||+|.++     ...++..||||+++... ....+.|.+|+.+|++++|||||+++|++..+ 
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~-----~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYR-----MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC--------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             cCeEECCcEEecccCeEEEEEEEe-----cCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence            46777774 999999999999876     33456789999997653 33457799999999999999999999998643 


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+||
T Consensus        82 ----~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DF  153 (285)
T d1u59a_          82 ----ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF  153 (285)
T ss_dssp             ----SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred             ----eEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccc
Confidence                2589999999999999986543 4799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCC-cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhccc
Q 013790          237 GLAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |+++....... ........||+.|+|||++.++.++.++|||||||++|||+| |..||.+.....   +...+.... 
T Consensus       154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~i~~~~-  229 (285)
T d1u59a_         154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQGK-  229 (285)
T ss_dssp             TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHTTC-
T ss_pred             hhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC-
Confidence            99986432222 222334568999999999999999999999999999999998 999998765432   222222110 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                               .+    ..+..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       230 ---------~~----~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         230 ---------RM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             ---------CC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CC----CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                     01    1223345789999999999999999999999999987754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-54  Score=402.72  Aligned_cols=252  Identities=25%  Similarity=0.410  Sum_probs=203.1

Q ss_pred             ccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeE
Q 013790           85 LKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQR  162 (436)
Q Consensus        85 ~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  162 (436)
                      ++||+|+||.||+|.++     ....++.||||+++...  ....+.+.+|+.+|++++|||||+++|+|..++     .
T Consensus        13 k~iG~G~fG~Vy~~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~-----~   82 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQ-----MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-----W   82 (277)
T ss_dssp             EEEEECSSEEEEEEEEE-----CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS-----E
T ss_pred             CCcccCCCeEEEEEEEc-----cCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCC-----E
Confidence            46999999999999986     33467899999996542  233467999999999999999999999985432     4


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCC
Q 013790          163 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG  242 (436)
Q Consensus       163 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  242 (436)
                      ++||||+++|+|.+++....  .+++..++.|+.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++..
T Consensus        83 ~lvmE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~  157 (277)
T d1xbba_          83 MLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  157 (277)
T ss_dssp             EEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhc
Confidence            89999999999999997653  699999999999999999999998   9999999999999999999999999999854


Q ss_pred             CCCCC-cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          243 PMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       243 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ..... ........||+.|||||++.+..++.++|||||||++|||+| |..||.+.....   +...+....       
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~~i~~~~-------  227 (277)
T d1xbba_         158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEKGE-------  227 (277)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTC-------
T ss_pred             cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHHHHHcCC-------
Confidence            32222 222334578999999999999999999999999999999998 899998765432   223222210       


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                         .+    ..+..++..+.+||.+||+.||.+|||+.+|++.|+...
T Consensus       228 ---~~----~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         228 ---RM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             ---CC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---CC----CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence               01    122334578999999999999999999999999988764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-54  Score=397.51  Aligned_cols=253  Identities=23%  Similarity=0.383  Sum_probs=210.7

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ++|++++.||+|+||+||+|+++        +++.||||+++.... ..+.|.+|+.++++++||||++++|+|..++. 
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~--------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~-   73 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR--------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-   73 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET--------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSS-
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC--------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc-
Confidence            68999999999999999999975        577899999976543 45689999999999999999999999976553 


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                         .++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++   +|+||||||+||||+.++.+||+|||+
T Consensus        74 ---~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~  146 (258)
T d1k2pa_          74 ---IFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGL  146 (258)
T ss_dssp             ---EEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSS
T ss_pred             ---eEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchh
Confidence               599999999999999986654 4689999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCcc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADSK  317 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  317 (436)
                      ++..... .........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.....   +...+.....   
T Consensus       147 a~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~~i~~~~~---  219 (258)
T d1k2pa_         147 SRYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIAQGLR---  219 (258)
T ss_dssp             CCBCSSS-SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHHTTCC---
T ss_pred             heeccCC-CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHHHHHhCCC---
Confidence            9753222 2223334678999999999999999999999999999999998 899998765432   2222222100   


Q ss_pred             ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 013790          318 KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQ  366 (436)
Q Consensus       318 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~  366 (436)
                                 ...+...+..+.+||.+||+.||++|||+.+|+++|.+
T Consensus       220 -----------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         220 -----------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -----------CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                       01122334689999999999999999999999999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.1e-54  Score=413.97  Aligned_cols=254  Identities=22%  Similarity=0.327  Sum_probs=211.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++++.||+|+||.||+|.++       .+++.||||++........+.+.+|+.+|++++|||||++++++...+ 
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~-------~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-   96 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTER-------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-   96 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET-------TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT-
T ss_pred             ccCeEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence            468999999999999999999976       578999999998776666778999999999999999999999998765 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc--CCCceEEee
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD--ENFRPKLSD  235 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~D  235 (436)
                         ..|+||||++||+|.+++.... ..+++..+..|+.||+.||.|||++   ||+||||||+||||+  .++.+||+|
T Consensus        97 ---~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~D  169 (350)
T d1koaa2          97 ---EMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLID  169 (350)
T ss_dssp             ---EEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECC
T ss_pred             ---EEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEee
Confidence               4599999999999999996543 4699999999999999999999999   999999999999995  468899999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||+|+...   .........||+.|||||++.+..++.++|||||||++|+|+||..||.+.+...   ....+......
T Consensus       170 FG~a~~~~---~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~~~~~  243 (350)
T d1koaa2         170 FGLTAHLD---PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRNVKSCDWN  243 (350)
T ss_dssp             CTTCEECC---TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCCC
T ss_pred             cchheecc---cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCC
Confidence            99998532   2333455789999999999999999999999999999999999999998664432   22222211110


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                 +........+..+.+||.+||..||.+|||+.|+++|
T Consensus       244 -----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         244 -----------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             -----------SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             -----------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                       0111112234678899999999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=406.97  Aligned_cols=251  Identities=21%  Similarity=0.288  Sum_probs=204.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|++++.||+|+||.||+|.++       .+++.||||++....   ....+.+.+|+.++++++||||+++++++..+
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~   80 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLAREL-------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD   80 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred             CCCEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence            57999999999999999999976       567899999987542   22346789999999999999999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..|+||||+++|+|.+++....  .+++..+..++.|++.||+|||++   +|+||||||+||||+.++.+||+|
T Consensus        81 ~----~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~D  151 (288)
T d1uu3a_          81 E----KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITD  151 (288)
T ss_dssp             S----EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred             C----EEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecc
Confidence            4    4599999999999999987653  699999999999999999999999   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||+|+...............||+.|||||++.+..++.++|||||||++|+|+||..||.+.+...   +...+....  
T Consensus       152 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~~~~--  226 (288)
T d1uu3a_         152 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IFQKIIKLE--  226 (288)
T ss_dssp             CTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHTTC--
T ss_pred             cccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HHHHHHcCC--
Confidence            999986433333344456789999999999999999999999999999999999999998754332   222222111  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                               ..+    +...+..+.+||.+||+.||.+|||+.|++.+
T Consensus       227 ---------~~~----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         227 ---------YDF----PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             ---------CCC----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             ---------CCC----CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence                     011    12234678899999999999999999998665

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-54  Score=408.47  Aligned_cols=253  Identities=23%  Similarity=0.367  Sum_probs=192.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .+.|++.+.||+|+||+||+|.++       .+++.||||++...... ....+.+|+.+|+.++||||+++++++...+
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   80 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDK-------RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG   80 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEET-------TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEEEEeeccCeEEEEEEEC-------CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            357999999999999999999976       56789999999765332 3356788999999999999999999997654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc---CCCceEE
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKL  233 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl  233 (436)
                          ..|+||||++||+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||+.   .++.+||
T Consensus        81 ----~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl  151 (307)
T d1a06a_          81 ----HLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMI  151 (307)
T ss_dssp             ----EEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             ----EEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEE
Confidence                469999999999999999764  3799999999999999999999998   999999999999994   5789999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      +|||+|+..   ..........||+.|||||++.+..|+.++|||||||++|+|++|..||.+.....   +...+....
T Consensus       152 ~DFG~a~~~---~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~~~~  225 (307)
T d1a06a_         152 SDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQILKAE  225 (307)
T ss_dssp             CCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHTTC
T ss_pred             eccceeEEc---cCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHhccC
Confidence            999999752   22333445679999999999999999999999999999999999999998654332   222222111


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .           .+........+..+.+||.+||+.||.+|||+.|+++|
T Consensus       226 ~-----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         226 Y-----------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             C-----------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             C-----------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            0           01111122334678999999999999999999999886

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-55  Score=415.84  Aligned_cols=266  Identities=26%  Similarity=0.402  Sum_probs=205.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++++.||+|+||+||+|.++       .+++.||+|+++... ......+.+|+.+|+.++|||||+++++|...+
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   77 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHK-------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG   77 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEET-------TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred             ccCCEEEEEEecCCCeEEEEEEEC-------CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            578999999999999999999975       578999999997553 333567899999999999999999999998665


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                          ..|+||||+++|+|.+++.+..  .+++..+..++.|++.||.|||+ +   +|+||||||+||||+.+|.+||+|
T Consensus        78 ----~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~D  148 (322)
T d1s9ja_          78 ----EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCD  148 (322)
T ss_dssp             ----EEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECC
T ss_pred             ----EEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEee
Confidence                4699999999999999997653  69999999999999999999997 5   899999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHH-HHhhccc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE-WVQQYPA  314 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~-~~~~~~~  314 (436)
                      ||+|+..    ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+......... .......
T Consensus       149 FGla~~~----~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~  224 (322)
T d1s9ja_         149 FGVSGQL----IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA  224 (322)
T ss_dssp             CCCCHHH----HHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------
T ss_pred             CCCcccc----CCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcc
Confidence            9999742    1223345789999999999999999999999999999999999999997654432211100 0000000


Q ss_pred             Cc----c---------------------ccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DS----K---------------------KFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~----~---------------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..    .                     ....+.............+.++.+||.+||..||.+|||+.|+++|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ---------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            00    0                     0000000000000011124678899999999999999999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-54  Score=401.45  Aligned_cols=265  Identities=25%  Similarity=0.407  Sum_probs=204.9

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|++.+.||+|+||.||+|.++...   ......||||++..... .....|.+|+.++++++|||||+++|++...+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSS---GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCC---CEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence            57889999999999999999987321   12446899999976533 334578999999999999999999999976553


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus        84 ----~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  155 (283)
T d1mqba_          84 ----MMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFG  155 (283)
T ss_dssp             ----EEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             ----eEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccc
Confidence                599999999999999887654 4799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCC-cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGH-THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      +++....... ........||+.|||||++.++.++.++|||||||++|||+||..|+......  ..+...+....   
T Consensus       156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i~~~~---  230 (283)
T d1mqba_         156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAINDGF---  230 (283)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTC---
T ss_pred             hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHHhccC---
Confidence            9985322211 22233456899999999999999999999999999999999966555433221  22333222111   


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                                 ....+..++..+.+||.+||+.||++|||+.+|++.|+.+++.
T Consensus       231 -----------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         231 -----------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             -----------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -----------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence                       1122233457899999999999999999999999999998764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.6e-54  Score=412.04  Aligned_cols=254  Identities=21%  Similarity=0.326  Sum_probs=211.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++++.||+|+||.||+|..+       .+++.||||++..........+.+|+.+|++++|||||++++++..++ 
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-   99 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEK-------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-   99 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-
T ss_pred             ccceEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence            357999999999999999999975       568899999998776666678899999999999999999999997654 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc--CCCceEEee
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD--ENFRPKLSD  235 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~D  235 (436)
                         .+|+|||||+||+|.+++.... .++++..++.|+.||+.||.|||++   ||+||||||+||||+  .++.+||+|
T Consensus       100 ---~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~D  172 (352)
T d1koba_         100 ---EMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIID  172 (352)
T ss_dssp             ---EEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECC
T ss_pred             ---EEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEee
Confidence               4599999999999999886543 4699999999999999999999998   999999999999997  678999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||+|+...   .........||+.|+|||++.+..++.++|||||||++|+|+||..||.+.....   ....+..... 
T Consensus       173 FGla~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~~~~-  245 (352)
T d1koba_         173 FGLATKLN---PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVKRCDW-  245 (352)
T ss_dssp             CTTCEECC---TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHHCCC-
T ss_pred             cccceecC---CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCC-
Confidence            99998632   2333455679999999999999999999999999999999999999998765432   2222221111 


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                .+........+..+.+||.+||+.||.+|||+.|+++|
T Consensus       246 ----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         246 ----------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             ----------CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ----------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                      01111222334678999999999999999999999886

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.5e-54  Score=406.91  Aligned_cols=247  Identities=33%  Similarity=0.472  Sum_probs=202.4

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ..|+.++.||+|+||.||+|++.       .+++.||||++.....   ...+.+.+|+.+|++++|||||++++++...
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   87 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDV-------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE   87 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             HhcEeeEEEecCCCeEEEEEEEC-------CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC
Confidence            35999999999999999999975       5788999999876533   2335688999999999999999999999775


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..|+|||||.+|+|..++...  .++++..+..++.||+.||.|||++   ||+||||||+||||+.++.+||+|
T Consensus        88 ~----~~~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~D  158 (309)
T d1u5ra_          88 H----TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGD  158 (309)
T ss_dssp             T----EEEEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECC
T ss_pred             C----EEEEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEee
Confidence            4    359999999999998776554  3799999999999999999999999   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET---GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      ||+|+...      ......||+.|||||++.+   +.|+.++|||||||++|||++|..||.+......  + ..+...
T Consensus       159 FG~a~~~~------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~--~-~~i~~~  229 (309)
T d1u5ra_         159 FGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L-YHIAQN  229 (309)
T ss_dssp             CTTCBSSS------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H-HHHHHS
T ss_pred             cccccccC------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH--H-HHHHhC
Confidence            99997532      2234679999999999864   4689999999999999999999999987554322  1 111111


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..          +.+   .+...+..+.+||.+||+.||.+|||+.++++|
T Consensus       230 ~~----------~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         230 ES----------PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             CC----------CCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CC----------CCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            10          000   111234678999999999999999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-54  Score=404.35  Aligned_cols=270  Identities=24%  Similarity=0.352  Sum_probs=206.5

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhcc-CCCCceeeeeEeee
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVL-EHPNLVKLIGYCAV  154 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  154 (436)
                      ..++|++++.||+|+||.||+|.+....  ...+++.||||+++.... ...+.+.+|..++.++ +|+||+.+++++..
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~--~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGID--KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTT--SSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCC--cccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            3468999999999999999999987332  335678999999975432 3345677888888777 68999999998876


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCC
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKA  220 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp  220 (436)
                      ++.   ..++||||+++|+|.+++....              ...+++..++.++.||+.||.|||++   +|+||||||
T Consensus        89 ~~~---~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp  162 (299)
T d1ywna1          89 PGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA  162 (299)
T ss_dssp             TTS---CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred             CCC---eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCc
Confidence            543   3589999999999999997542              23588999999999999999999998   999999999


Q ss_pred             CcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCc
Q 013790          221 SNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG-RRSLERNRP  299 (436)
Q Consensus       221 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~  299 (436)
                      +||||+.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+|| .+||.+...
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999864333333444567899999999999999999999999999999999996 567866543


Q ss_pred             hhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          300 KTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      ...  +...+....          .+    ..+...+..+.+||.+||+.||.+|||+.+|+++|+++++.
T Consensus       243 ~~~--~~~~~~~~~----------~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         243 DEE--FCRRLKEGT----------RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             SHH--HHHHHHHTC----------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHH--HHHHHhcCC----------CC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            221  222221111          01    11222346789999999999999999999999999999864

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-53  Score=404.10  Aligned_cols=262  Identities=23%  Similarity=0.379  Sum_probs=207.7

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      ++|++++.||+|+||.||+|.+...   +...+..||+|.+... .....+.+.+|+.++++++|||||+++|+|.... 
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPE---GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC-------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCC---CCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence            5799999999999999999998621   1223457999998654 3344578999999999999999999999997543 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .++++||+.+|+|.+++.... ..+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||
T Consensus        85 ----~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFG  156 (317)
T d1xkka_          85 ----VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG  156 (317)
T ss_dssp             ----EEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCS
T ss_pred             ----eeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccc
Confidence                378999999999999987654 5799999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      +|+...............||+.|+|||++.++.++.++|||||||++|||+| |.+||.+.........+   .....  
T Consensus       157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i---~~~~~--  231 (317)
T d1xkka_         157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EKGER--  231 (317)
T ss_dssp             HHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH---HHTCC--
T ss_pred             cceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH---HcCCC--
Confidence            9986433333333445578999999999999999999999999999999998 89999876544332222   21100  


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                              +    ..+..++..+.+||.+||+.||.+|||+.+|+.+|+.+..
T Consensus       232 --------~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         232 --------L----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             --------C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------C----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                    0    1122334678999999999999999999999999988753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=400.24  Aligned_cols=253  Identities=24%  Similarity=0.350  Sum_probs=206.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc------hhHHHHHHHHHHHhccCCCCceeeeeE
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL------QGHKQWVAEVQFLGVLEHPNLVKLIGY  151 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~  151 (436)
                      .+.|++++.||+|+||.||+|.++       .+++.||||++.....      ...+.+.+|+.+|++++|||||+++++
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~-------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~   81 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREK-------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV   81 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEEC-------CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            357999999999999999999976       5788999999865422      234679999999999999999999999


Q ss_pred             eeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC--
Q 013790          152 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF--  229 (436)
Q Consensus       152 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~--  229 (436)
                      +...+    ..|+|||||++|+|.+++....  .+++..+..++.|++.||+|||++   +|+||||||+|||++.++  
T Consensus        82 ~~~~~----~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~  152 (293)
T d1jksa_          82 YENKT----DVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVP  152 (293)
T ss_dssp             EECSS----EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSS
T ss_pred             EEECC----EEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCc
Confidence            97654    4699999999999999997653  699999999999999999999999   999999999999998776  


Q ss_pred             --ceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 013790          230 --RPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLE  307 (436)
Q Consensus       230 --~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  307 (436)
                        .+||+|||+|+...   .........||+.|+|||++.+..++.++|||||||++|||+||..||.+.+...   ...
T Consensus       153 ~~~vkl~DfG~a~~~~---~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~  226 (293)
T d1jksa_         153 KPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA  226 (293)
T ss_dssp             SCCEEECCCTTCEECT---TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH
T ss_pred             ccceEecchhhhhhcC---CCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHH
Confidence              49999999997532   2233445679999999999999999999999999999999999999998754332   222


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .+......           +....+...+..+.+||.+||+.||.+|||+.++++|
T Consensus       227 ~i~~~~~~-----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         227 NVSAVNYE-----------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             HHHTTCCC-----------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHhcCCC-----------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            22211110           0011111234678899999999999999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-53  Score=393.46  Aligned_cols=262  Identities=24%  Similarity=0.343  Sum_probs=202.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++.+.||+|+||.||+|.+...    ...+..||||.++.... ...+.+.+|+.++++++||||++++|++.. +
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~   80 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSP----ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N   80 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecC----CceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            35899999999999999999988622    23457899999875433 334679999999999999999999999853 2


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++   +|+||||||+||+++.++.+||+||
T Consensus        81 ----~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~Df  152 (273)
T d1mp8a_          81 ----PVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF  152 (273)
T ss_dssp             ----SCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             ----eEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccc
Confidence                2499999999999999886654 4789999999999999999999999   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |+|+.... ..........||+.|+|||++.+..++.++|||||||++|||+| |.+||........   ...+..... 
T Consensus       153 G~a~~~~~-~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~~i~~~~~-  227 (273)
T d1mp8a_         153 GLSRYMED-STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENGER-  227 (273)
T ss_dssp             -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTTCC-
T ss_pred             hhheeccC-CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HHHHHcCCC-
Confidence            99985321 12223345678999999999999999999999999999999998 8999987655432   222221110 


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                               .    ..+..++..+.+||.+||+.||.+|||+.+|+++|+++++.
T Consensus       228 ---------~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         228 ---------L----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             ---------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------C----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                     0    12233457899999999999999999999999999998754

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-53  Score=396.96  Aligned_cols=258  Identities=27%  Similarity=0.372  Sum_probs=205.0

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ++|++.+.||+|+||.||+|.++        ++..||||+++... ...+.|.+|+.++++++|||||+++|++..+ . 
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~--------~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~-   85 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWN--------GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-P-   85 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--------TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S-
T ss_pred             HHEEEeeEEeeCCCeEEEEEEEC--------CCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecC-C-
Confidence            58999999999999999999975        34579999997554 3457899999999999999999999998543 2 


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccC
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGL  238 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  238 (436)
                         .++||||+++|+|..++.......+++..++.++.||+.||+|||++   +|+||||||+||||+.++++||+|||+
T Consensus        86 ---~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGl  159 (285)
T d1fmka3          86 ---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL  159 (285)
T ss_dssp             ---CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             ---eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccch
Confidence               48999999999999998765555799999999999999999999998   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccc
Q 013790          239 AREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKK  318 (436)
Q Consensus       239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  318 (436)
                      ++.... ..........||+.|+|||++.++.++.++|||||||++|||+||..||......  ..+...+....     
T Consensus       160 a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~~~-----  231 (285)
T d1fmka3         160 ARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGY-----  231 (285)
T ss_dssp             TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTC-----
T ss_pred             hhhccC-CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHhcC-----
Confidence            975321 1222334467899999999999999999999999999999999976655443222  22333322110     


Q ss_pred             cccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          319 FGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       319 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                           .    ...+..++..+.+||.+||+.||++|||+.+|++.|++.+..
T Consensus       232 -----~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         232 -----R----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             -----C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -----C----CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence                 0    112233457899999999999999999999999999887753

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.5e-53  Score=399.74  Aligned_cols=266  Identities=27%  Similarity=0.439  Sum_probs=213.1

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch-hHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ-GHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ..++|++++.||+|+||.||+|+++...  ...+++.||||+++..... ..+.+.+|+.+++.++||||++++++|...
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~--~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~   88 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLL--PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG   88 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSS--TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCc--cCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence            4578999999999999999999986322  2356789999999765433 356799999999999999999999999766


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCce
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA----------------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQV  213 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~i  213 (436)
                      +.    .+++|||+.+|+|.+++....                      ...+++..++.|+.|++.||+|||++   +|
T Consensus        89 ~~----~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i  161 (301)
T d1lufa_          89 KP----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF  161 (301)
T ss_dssp             SS----CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             Cc----eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence            54    499999999999999996432                      23588999999999999999999998   99


Q ss_pred             eeccCCCCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCC-C
Q 013790          214 IYRDFKASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR-R  292 (436)
Q Consensus       214 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~  292 (436)
                      |||||||+||||+.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            999999999999999999999999997432222233334567889999999999999999999999999999999985 5


Q ss_pred             CCCCCCchhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhh
Q 013790          293 SLERNRPKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIV  368 (436)
Q Consensus       293 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~  368 (436)
                      ||.+.....   +...+.....          +    ..+...+..+.+||.+||+.||.+|||+.+|++.|+++.
T Consensus       242 p~~~~~~~e---~~~~v~~~~~----------~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         242 PYYGMAHEE---VIYYVRDGNI----------L----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTTTSCHHH---HHHHHHTTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCHHH---HHHHHHcCCC----------C----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            777654432   2232222111          1    112233467899999999999999999999999999874

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.2e-52  Score=392.35  Aligned_cols=265  Identities=24%  Similarity=0.351  Sum_probs=209.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc---hhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL---QGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++.+.||+|+||.||+|.+.       .+++.||||++.....   ...+.+.+|+.+++.++||||+++++++..
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~   78 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDL-------RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA   78 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeee
Confidence            367999999999999999999975       5789999999976533   234578999999999999999999999988


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+......|+||||++|++|.+++....  ++++..+..++.||+.||.|||++   ||+||||||+||||+.++.++|+
T Consensus        79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~  153 (277)
T d1o6ya_          79 ETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVM  153 (277)
T ss_dssp             ECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEEC
T ss_pred             ccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceee
Confidence            7766667899999999999999987653  699999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCC-CCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          235 DFGLAREGPMV-GHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       235 Dfg~a~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |||.+...... ..........||+.|+|||++.+..++.++|||||||++|+|+||..||.+.++...  ....+...+
T Consensus       154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~~~~~~~~  231 (277)
T d1o6ya_         154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVREDP  231 (277)
T ss_dssp             CCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHCCC
T ss_pred             hhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH--HHHHHhcCC
Confidence            99998643221 122334456899999999999999999999999999999999999999987654322  112222111


Q ss_pred             cCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHHhh
Q 013790          314 ADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-KMSQVVERLKQIV  368 (436)
Q Consensus       314 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~eil~~L~~~~  368 (436)
                      ...            .......+..+.+||.+||+.||.+|| |+++++..|.++.
T Consensus       232 ~~~------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         232 IPP------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CCG------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCC------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            110            011122346789999999999999999 8999999888764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=392.66  Aligned_cols=253  Identities=28%  Similarity=0.445  Sum_probs=203.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++++.||+|+||.||+|.++         +..||||+++.+.  ..+.+.+|+.++++++||||++++|+|..+..
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~   74 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR---------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   74 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET---------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC---------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence            357899999999999999999874         5679999997653  44679999999999999999999999865432


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                         ..++||||+++|+|.++|..+....+++..++.|+.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        75 ---~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg  148 (262)
T d1byga_          75 ---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFG  148 (262)
T ss_dssp             ---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             ---cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccc
Confidence               248999999999999999765444689999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      +++...     .......+|..|+|||++.++.++.++|||||||++|||+| |.+||.......   +..++...    
T Consensus       149 ~s~~~~-----~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~~~----  216 (262)
T d1byga_         149 LTKEAS-----STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKG----  216 (262)
T ss_dssp             C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTTT----
T ss_pred             cceecC-----CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcC----
Confidence            997521     12234568899999999999999999999999999999998 788887654432   33333211    


Q ss_pred             cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          317 KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       317 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                            ..+    ..+...+..+.+||.+||+.||.+|||+.+|+++|+.+..
T Consensus       217 ------~~~----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         217 ------YKM----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             ------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCC----CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                  011    1222334788999999999999999999999999998864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=400.23  Aligned_cols=250  Identities=28%  Similarity=0.382  Sum_probs=208.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++++.||+|+||.||+|+.+       .+++.||||++++..   ....+.+.+|+.+|+.++||||+++++++..
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~-------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   76 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREK-------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             hHhcEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence            468999999999999999999976       578899999997542   2234678899999999999999999999986


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      ..    .+|+||||++||+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+||+
T Consensus        77 ~~----~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~  147 (337)
T d1o6la_          77 HD----RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKIT  147 (337)
T ss_dssp             SS----EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             cc----ccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEe
Confidence            55    4699999999999999997654  689999999999999999999999   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||+|+...  .........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+...   +...+.... 
T Consensus       148 DFG~a~~~~--~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~i~~~~-  221 (337)
T d1o6la_         148 DFGLCKEGI--SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELILMEE-  221 (337)
T ss_dssp             CCTTCBCSC--CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCC-
T ss_pred             ecccccccc--cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHHHHhcCC-
Confidence            999998532  22333456789999999999999999999999999999999999999998765432   222222111 


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~  363 (436)
                                ..    ++...+..+.+||.+||+.||.+||+     +.+|++|
T Consensus       222 ----------~~----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         222 ----------IR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ----------CC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----------CC----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                      11    12223467889999999999999995     8888875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=394.23  Aligned_cols=269  Identities=27%  Similarity=0.422  Sum_probs=213.1

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||.||+|+....+.....++..||||+++.... .....+.+|...+.++ +|||||+++++|..+
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            46899999999999999999998755544455678899999976643 3346788899999888 799999999999876


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCC
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA--------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKAS  221 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~  221 (436)
                      +.    .++||||+.+|+|.++|..+.              ...+++..++.++.||+.||+|||++   +||||||||+
T Consensus        92 ~~----~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~  164 (299)
T d1fgka_          92 GP----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  164 (299)
T ss_dssp             SS----CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             Ce----EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence            53    499999999999999997553              23589999999999999999999999   9999999999


Q ss_pred             cEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCch
Q 013790          222 NVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPK  300 (436)
Q Consensus       222 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~  300 (436)
                      |||++.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |.+||.+....
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            99999999999999999986433333344455678999999999999999999999999999999998 78888766543


Q ss_pred             hhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          301 TEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      .   +...+....          .+    ..+...+..+.+||.+||+.||.+|||+.+|++.|++++..
T Consensus       245 ~---~~~~i~~~~----------~~----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         245 E---LFKLLKEGH----------RM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             H---HHHHHHTTC----------CC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H---HHHHHHcCC----------CC----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            2   222222111          01    11222346789999999999999999999999999998753

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-53  Score=391.28  Aligned_cols=261  Identities=26%  Similarity=0.388  Sum_probs=201.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAV  154 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  154 (436)
                      .++|++++.||+|+||.||+|.+...    ......||||+++...   ....+.|.+|+.++++++||||++++|++..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~----~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~   82 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAP----SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   82 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECT----TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECC----CCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            35799999999999999999987632    2345689999987542   2334678999999999999999999999964


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      . .    .++||||+++|+|.+++..+. ..+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+
T Consensus        83 ~-~----~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~  153 (273)
T d1u46a_          83 P-P----MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG  153 (273)
T ss_dssp             S-S----CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred             c-c----hheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeec
Confidence            3 2    389999999999999887644 4699999999999999999999998   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCc-ccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHHHhhc
Q 013790          235 DFGLAREGPMVGHT-HVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       235 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |||+++........ .......|+..|+|||++.+..++.++|||||||++|||+| |..||.+.+...   ...++...
T Consensus       154 DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i~~~  230 (273)
T d1u46a_         154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDKE  230 (273)
T ss_dssp             CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTS
T ss_pred             cchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHHHhC
Confidence            99999864333222 22334567889999999999999999999999999999998 899998764433   23332221


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHh
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQI  367 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~  367 (436)
                      ..             ....+...+..+.+||.+||+.||++|||+.+|++.|.+.
T Consensus       231 ~~-------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         231 GE-------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            11             0111223346799999999999999999999999888754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.5e-52  Score=393.50  Aligned_cols=246  Identities=25%  Similarity=0.407  Sum_probs=205.8

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|++++.||+|+||.||+|+++       .+++.||||++....   ....+.+.+|+.+++.++||||+++++++...
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   76 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSR-------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA   76 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred             hHeEEEEEEecCcCcEEEEEEEC-------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence            57999999999999999999976       568899999997542   23356789999999999999999999999765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      +    ..|+||||+.||+|..++....  .+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+||+|
T Consensus        77 ~----~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~D  147 (316)
T d1fota_          77 Q----QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITD  147 (316)
T ss_dssp             S----EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred             C----eeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEec
Confidence            4    4699999999999999997654  688999999999999999999999   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||+|+...     .......||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.+....   ...+....  
T Consensus       148 FG~a~~~~-----~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i~~~~--  217 (316)
T d1fota_         148 FGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---YEKILNAE--  217 (316)
T ss_dssp             CSSCEECS-----SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHHCC--
T ss_pred             CccceEec-----cccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH---HHHHHcCC--
Confidence            99998632     123456899999999999999999999999999999999999999987654322   22121111  


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                               .    .++...+..+.+++.+||..||.+||     |+++|++|
T Consensus       218 ---------~----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         218 ---------L----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ---------C----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ---------C----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                     0    11122346788999999999999996     89999876

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=398.56  Aligned_cols=258  Identities=21%  Similarity=0.253  Sum_probs=204.3

Q ss_pred             hcCCcccc-cccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRML-KIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~-~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|.++. .||+|+||.||+|.+.       .+++.||||++...     ..+.+|+.++.++ +|||||++++++...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNK-------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEEC-------CCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            46899875 5999999999999975       56789999998643     4677899887654 899999999998764


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC---CCceE
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE---NFRPK  232 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~k  232 (436)
                      ......+|+|||||+||+|.++|..+....+++..+..|+.||+.||+|||++   ||+||||||+|||++.   ++.+|
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~K  154 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILK  154 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEE
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccc
Confidence            33345679999999999999999876666899999999999999999999998   9999999999999975   56799


Q ss_pred             EeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          233 LSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      |+|||+|+....   ........||+.|||||++.+..|+.++|||||||++|+|+||..||.+.........+.  ...
T Consensus       155 l~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~--~~i  229 (335)
T d2ozaa1         155 LTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--TRI  229 (335)
T ss_dssp             ECCCTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CC
T ss_pred             ccccceeeeccC---CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH--HHH
Confidence            999999985322   223345679999999999999999999999999999999999999997654322111100  000


Q ss_pred             ccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..        ....++.......+..+.+||.+||+.||.+|||+.++++|
T Consensus       230 ~~--------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         230 RM--------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CS--------CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hc--------CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            00        00011111123446789999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=391.30  Aligned_cols=268  Identities=24%  Similarity=0.377  Sum_probs=216.3

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc-hhHHHHHHHHHHHhcc-CCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL-QGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  155 (436)
                      .++|++.+.||+|+||.||+|+++...  +..+++.||||+++.... .....+.+|+.+++.+ +|||||+++|+|...
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~--~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLI--KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSS--STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccc--cCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            468999999999999999999986322  235788999999976533 3445788999999999 699999999999766


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCC
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRA----------------FPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFK  219 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlk  219 (436)
                      ..    .++||||+++|+|.+++....                ...+++..+..++.||+.||+|||++   +++|||||
T Consensus       100 ~~----~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLK  172 (311)
T d1t46a_         100 GP----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA  172 (311)
T ss_dssp             SS----CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             CE----EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccc
Confidence            54    499999999999999997542                23689999999999999999999999   99999999


Q ss_pred             CCcEEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 013790          220 ASNVLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLT-GRRSLERNR  298 (436)
Q Consensus       220 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~  298 (436)
                      |+|||++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |.+||....
T Consensus       173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999986544444445556789999999999999999999999999999999999 566665544


Q ss_pred             chhhHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          299 PKTEQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                      ....  +...+....          .+    ..+...+..+.+||.+||+.||.+|||+.+|++.|++++..
T Consensus       253 ~~~~--~~~~i~~~~----------~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         253 VDSK--FYKMIKEGF----------RM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             SSHH--HHHHHHHTC----------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHH--HHHHHhcCC----------CC----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            3222  112221110          01    11222347799999999999999999999999999988754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.9e-52  Score=384.92  Aligned_cols=253  Identities=23%  Similarity=0.322  Sum_probs=205.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---------hHHHHHHHHHHHhccC-CCCcee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---------GHKQWVAEVQFLGVLE-HPNLVK  147 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-hpnIv~  147 (436)
                      .++|++.+.||+|+||+||+|+.+       .+++.||||++......         ..+.+.+|+.++++++ ||||++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~-------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~   74 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHK-------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ   74 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             cccCEEceEEecCcCeEEEEEEEC-------CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Confidence            468999999999999999999875       56899999998754321         1245888999999997 999999


Q ss_pred             eeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC
Q 013790          148 LIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE  227 (436)
Q Consensus       148 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  227 (436)
                      +++++...+    ..|+||||+++|+|.++|..+.  ++++..+..++.||+.||+|||++   +|+||||||+||||+.
T Consensus        75 ~~~~~~~~~----~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~  145 (277)
T d1phka_          75 LKDTYETNT----FFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDD  145 (277)
T ss_dssp             EEEEEECSS----EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred             EEeecccCc----ceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcC
Confidence            999997654    4699999999999999997654  799999999999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCCCCCCCCCCcccccccccCCCccccccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchh
Q 013790          228 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET------GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKT  301 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  301 (436)
                      ++.+||+|||+++...   .........||+.|+|||.+.+      ..++.++||||+||++|+|+||+.||.+.+...
T Consensus       146 ~~~~kl~DFG~a~~~~---~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~  222 (277)
T d1phka_         146 DMNIKLTDFGFSCQLD---PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML  222 (277)
T ss_dssp             TCCEEECCCTTCEECC---TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             CCCeEEccchheeEcc---CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH
Confidence            9999999999998532   2223455679999999999854      356889999999999999999999998765433


Q ss_pred             hHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          302 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .   ...+.....           .+........++.+.+||.+||+.||.+|||+.+|++|
T Consensus       223 ~---~~~i~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         223 M---LRMIMSGNY-----------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             H---HHHHHHTCC-----------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             H---HHHHHhCCC-----------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            2   221111110           01111122345789999999999999999999999775

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-52  Score=391.85  Aligned_cols=261  Identities=29%  Similarity=0.437  Sum_probs=207.3

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhcc-CCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVL-EHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  156 (436)
                      ++|++.+.||+|+||.||+|.++     .......||||.+... .....+.+.+|+.+|.++ +|||||+++|++...+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIK-----KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEE-----ETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             HHcEEEEEEeeCCCcEEEEEEEC-----CCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            68999999999999999999987     2223346888887544 223445789999999998 7999999999998765


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCc
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNR--------------AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN  222 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~N  222 (436)
                          ..++||||+++|+|.++|...              ....+++..++.++.||+.||.|||++   +|+||||||+|
T Consensus        85 ----~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~N  157 (309)
T d1fvra_          85 ----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARN  157 (309)
T ss_dssp             ----EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             ----eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---Cccccccccce
Confidence                459999999999999999654              235799999999999999999999998   99999999999


Q ss_pred             EEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCchh
Q 013790          223 VLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGR-RSLERNRPKT  301 (436)
Q Consensus       223 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~pf~~~~~~~  301 (436)
                      ||++.++.+||+|||+++...   .........||..|+|||.+.++.++.++|||||||++|||++|. +||.+.+.. 
T Consensus       158 IL~~~~~~~kl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~-  233 (309)
T d1fvra_         158 ILVGENYVAKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-  233 (309)
T ss_dssp             EEECGGGCEEECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-
T ss_pred             EEEcCCCceEEcccccccccc---ccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH-
Confidence            999999999999999997522   222233456899999999999999999999999999999999975 567654432 


Q ss_pred             hHHHHHHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          302 EQRLLEWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                        .+...+....          .+    ..+...+..+.+||.+||+.||++|||+.+|+++|+++++..
T Consensus       234 --~~~~~i~~~~----------~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         234 --ELYEKLPQGY----------RL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             --HHHHHGGGTC----------CC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             --HHHHHHHhcC----------CC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence              2333322110          01    122334578999999999999999999999999999998644

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.1e-51  Score=399.19  Aligned_cols=251  Identities=24%  Similarity=0.364  Sum_probs=201.7

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch---hHHHH---HHHHHHHhccCCCCceeeeeE
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ---GHKQW---VAEVQFLGVLEHPNLVKLIGY  151 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~---~~E~~~l~~l~hpnIv~~~~~  151 (436)
                      .++|++++.||+|+||.||+|.++       .+++.||||++......   ....+   ..++.+++.++|||||+++++
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~-------~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~   75 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKA-------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA   75 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEEC-------CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEE
Confidence            368999999999999999999976       56889999998643221   11223   345778888899999999999


Q ss_pred             eeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCce
Q 013790          152 CAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  231 (436)
Q Consensus       152 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  231 (436)
                      +...+    .+|+||||++||+|.++|....  .+++..+..++.||+.||.|||++   +|+||||||+||||+.+|.+
T Consensus        76 ~~~~~----~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~i  146 (364)
T d1omwa3          76 FHTPD----KLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHV  146 (364)
T ss_dssp             EECSS----EEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCE
T ss_pred             EEECC----EEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcE
Confidence            97654    4599999999999999997653  689999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          232 KLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      ||+|||+|+....    .......||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+........+.....
T Consensus       147 Kl~DFGla~~~~~----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~  222 (364)
T d1omwa3         147 RISDLGLACDFSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL  222 (364)
T ss_dssp             EECCCTTCEECSS----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS
T ss_pred             EEeeeceeeecCC----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence            9999999985321    22345679999999999964 568999999999999999999999998765443332222211


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~  363 (436)
                      ..           ..    ..+...+..+.+||.+||+.||.+|||     +++|++|
T Consensus       223 ~~-----------~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         223 TM-----------AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             SC-----------CC----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             cC-----------CC----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            11           01    111223467899999999999999999     6899876

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-51  Score=395.36  Aligned_cols=246  Identities=24%  Similarity=0.347  Sum_probs=205.7

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      ++|++++.||+|+||.||+|.++       .+++.||||++....   ....+.+.+|+.+|+.++||||+++++++...
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~-------~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~  113 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHK-------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN  113 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cCeEEEEEeecCcCcEEEEEEEC-------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc
Confidence            58999999999999999999976       578899999986542   23346788999999999999999999998765


Q ss_pred             CCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEee
Q 013790          156 GERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSD  235 (436)
Q Consensus       156 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  235 (436)
                      .    ..++||||+.+|+|.+++....  .+++..+..++.||+.||.|||++   +||||||||+||||+.+|.+||+|
T Consensus       114 ~----~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~D  184 (350)
T d1rdqe_         114 S----NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTD  184 (350)
T ss_dssp             S----EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             c----ccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeee
Confidence            4    3599999999999999997654  699999999999999999999998   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||+|+...     .......||+.|||||++.+..++.++|||||||++|+|+||..||.+.+...   +...+..... 
T Consensus       185 FG~a~~~~-----~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~~~~~-  255 (350)
T d1rdqe_         185 FGFAKRVK-----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKIVSGKV-  255 (350)
T ss_dssp             CTTCEECS-----SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCC-
T ss_pred             ceeeeecc-----cccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---HHHHHhcCCC-
Confidence            99998632     12345679999999999999999999999999999999999999998764332   2222221110 


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRP-----KMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  363 (436)
                                .    .+...+..+.+||.+||..||.+|+     |+.+|++|
T Consensus       256 ----------~----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         256 ----------R----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ----------C----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----------C----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                      0    1122346788999999999999994     89999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=391.09  Aligned_cols=253  Identities=18%  Similarity=0.278  Sum_probs=206.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++|++++.||+|+||.||+|.++       .+++.||||+++.... ....+.+|+.+|+.++||||+++++++...+ 
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~-------~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-   74 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVET-------SSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESME-   74 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-
T ss_pred             ccceEEEEEEecCCCeEEEEEEEC-------CCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-
Confidence            468999999999999999999976       5688999999976643 3456889999999999999999999997655 


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC--CCceEEee
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE--NFRPKLSD  235 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~D  235 (436)
                         .+|+|||||.||+|.++|.... ..+++..+..|+.||+.||.|||++   ||+||||||+|||++.  .+.+||+|
T Consensus        75 ---~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~D  147 (321)
T d1tkia_          75 ---ELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIE  147 (321)
T ss_dssp             ---EEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             ---EEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcc
Confidence               4699999999999999997643 3699999999999999999999998   9999999999999985  45899999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      ||+++...   .........||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+...   +...+......
T Consensus       148 FG~~~~~~---~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~~~i~~~~~~  221 (321)
T d1tkia_         148 FGQARQLK---PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIMNAEYT  221 (321)
T ss_dssp             CTTCEECC---TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHHTCCC
T ss_pred             cchhhccc---cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCC
Confidence            99998532   2233445678999999999999999999999999999999999999998765432   22222211100


Q ss_pred             ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                 +........+..+.+||.+||..||.+|||+.|+++|
T Consensus       222 -----------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         222 -----------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             -----------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----------CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                       0000011124678899999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-51  Score=389.23  Aligned_cols=249  Identities=24%  Similarity=0.402  Sum_probs=203.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc---chhHHHHHHHHHHHh-ccCCCCceeeeeEeee
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG---LQGHKQWVAEVQFLG-VLEHPNLVKLIGYCAV  154 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~  154 (436)
                      ++|++++.||+|+||+||+|+++       .+++.||||++.+..   ....+.+..|..++. .++||||+++++++..
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~-------~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~   74 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFK-------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT   74 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             CCeEEeeEEecCCCcEEEEEEEC-------CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc
Confidence            58999999999999999999976       578999999997542   223345666776665 6899999999999976


Q ss_pred             cCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          155 DGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       155 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .+    ..|+||||+++|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        75 ~~----~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~  145 (320)
T d1xjda_          75 KE----NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIA  145 (320)
T ss_dssp             SS----EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             CC----ceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecc
Confidence            55    4699999999999999997653  689999999999999999999999   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |||+++....  .........||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.++..   +...+...  
T Consensus       146 DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~~--  218 (320)
T d1xjda_         146 DFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIRMD--  218 (320)
T ss_dssp             CCTTCBCCCC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHC--
T ss_pred             ccchhhhccc--ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHcC--
Confidence            9999985322  2233445689999999999999999999999999999999999999998765433   22222111  


Q ss_pred             CccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHH-HHHHH
Q 013790          315 DSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMS-QVVER  363 (436)
Q Consensus       315 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~~  363 (436)
                               .+.+    +...+..+.+||.+||..||.+|||+. ++++|
T Consensus       219 ---------~~~~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         219 ---------NPFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             ---------CCCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ---------CCCC----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence                     1111    122346789999999999999999995 77654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-51  Score=384.74  Aligned_cols=268  Identities=26%  Similarity=0.379  Sum_probs=202.4

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|++++.||+|+||.||+|.+.       .+++.||||++.....  ...+.+.+|+.++++++|||||++++++...+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~   74 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNK-------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN   74 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCCEeccEEecCcCeEEEEEEEC-------CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence            58999999999999999999975       5788999999965432  23567899999999999999999999998755


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..|+||||+. +++.+++.......+++..+..++.||+.||.|||++   +||||||||+|||++.++.+||+||
T Consensus        75 ----~~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DF  146 (298)
T d1gz8a_          75 ----KLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADF  146 (298)
T ss_dssp             ----EEEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECST
T ss_pred             ----ceeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccC
Confidence                4599999995 4566666555556799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |+|+...  ..........||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..............+..
T Consensus       147 G~a~~~~--~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~  224 (298)
T d1gz8a_         147 GLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE  224 (298)
T ss_dssp             THHHHHC--CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             Ccceecc--CCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence            9997532  2233344567999999999886655 578999999999999999999999876543321111111111110


Q ss_pred             cc--ccccc--cCCcccC-------cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SK--KFGLI--MDPRLEK-------EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~--~~~~~--~~~~l~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..  .....  .......       ......+..+.+|+.+||..||.+|||+.|+++|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00  00000  0000000       0111234678899999999999999999999986

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=388.05  Aligned_cols=271  Identities=22%  Similarity=0.284  Sum_probs=205.7

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      .+|.+.+.||+|+||.||+|++         +++.||||+++..... ......|+..+..++||||+++++++...+..
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~---------~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~   72 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW---------RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE---------TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE---------CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCc
Confidence            4688889999999999999986         3678999999754321 12233455566688999999999999987766


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCceeeccCCCCcEEEcCCCceEE
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL-----EVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ...+|+||||+++|+|.++|.+.   .+++..++.++.|++.||+|||+..     ..+|+||||||+||||+.++.+||
T Consensus        73 ~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl  149 (303)
T d1vjya_          73 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             ceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence            66789999999999999999764   5899999999999999999999731     249999999999999999999999


Q ss_pred             eeccCCCCCCCCCCc--ccccccccCCCcccccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCchhh---
Q 013790          234 SDFGLAREGPMVGHT--HVSTAVVGTFGYAAPDYIETGH------LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTE---  302 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltg~~pf~~~~~~~~---  302 (436)
                      +|||+++........  .......||+.|+|||++.+..      ++.++|||||||+||||+||..||........   
T Consensus       150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~  229 (303)
T d1vjya_         150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             EecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence            999999753222221  1234567999999999987642      56789999999999999999988754332110   


Q ss_pred             ---------HHHHHHHhhcccCccccccccCCcccCc-CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          303 ---------QRLLEWVQQYPADSKKFGLIMDPRLEKE-YSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       303 ---------~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                               ..+...+.         .....+.+... .+...+..+.+|+.+||+.||.+|||+.||++.|+++.+..
T Consensus       230 ~~~~~~~~~~~~~~~~~---------~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         230 DLVPSDPSVEEMRKVVC---------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             TTSCSSCCHHHHHHHHT---------TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hcccccchHHHHHHHHh---------ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence                     00111000         00112222222 13445677999999999999999999999999999987644

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=384.54  Aligned_cols=260  Identities=27%  Similarity=0.401  Sum_probs=204.3

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-cchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCcceeE
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-GLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGERGIQR  162 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  162 (436)
                      .++||+|+||+||+|++...+    .....||||.++.. .....+.|.+|+++|++++||||++++|++.....   ..
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~---~~  104 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDND----GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SP  104 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC--------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT---EE
T ss_pred             ceEEeecCCeEEEEEEEECCC----CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC---ce
Confidence            468999999999999986221    23457999999753 44455789999999999999999999999875432   35


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCCC
Q 013790          163 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLAREG  242 (436)
Q Consensus       163 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  242 (436)
                      ++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+||||++++.+||+|||+++..
T Consensus       105 ~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~  180 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM  180 (311)
T ss_dssp             EEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred             EEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhc
Confidence            89999999999999987654 4678899999999999999999998   9999999999999999999999999999854


Q ss_pred             CCCC--CcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCccccc
Q 013790          243 PMVG--HTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADSKKFG  320 (436)
Q Consensus       243 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (436)
                      ....  .........||..|+|||.+.+..++.++||||||+++|||+||..||......  ..+..++.....      
T Consensus       181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~~g~~------  252 (311)
T d1r0pa_         181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGRR------  252 (311)
T ss_dssp             TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCC------
T ss_pred             cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCC------
Confidence            3221  112233457899999999999999999999999999999999988887643221  112222211110      


Q ss_pred             cccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhh
Q 013790          321 LIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQV  370 (436)
Q Consensus       321 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~  370 (436)
                          +    ..+..++..+.+||.+||+.||++|||+.||+++|+++++.
T Consensus       253 ----~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         253 ----L----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             ----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----C----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                0    11222346789999999999999999999999999999764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-51  Score=383.65  Aligned_cols=263  Identities=25%  Similarity=0.284  Sum_probs=196.1

Q ss_pred             ccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchh-----HHHHHHHHHHHhccCCCCceeeeeEeeecCC
Q 013790           83 RMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQG-----HKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE  157 (436)
Q Consensus        83 ~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  157 (436)
                      .++.||+|+||+||+|.++       .+++.||||+++......     .+.+.+|+.+++.++|||||++++++...+.
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~   74 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDK-------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   74 (299)
T ss_dssp             EEEEEEEETTEEEEEEECS-------SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             cceEeccCcCeEEEEEEEC-------CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc
Confidence            4678999999999999965       578899999987543221     2468899999999999999999999987654


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeecc
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDFG  237 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  237 (436)
                          .++||||+.++++..++..  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        75 ----~~ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG  145 (299)
T d1ua2a_          75 ----ISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFG  145 (299)
T ss_dssp             ----CEEEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             ----eeehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCc
Confidence                4999999988777766543  34689999999999999999999999   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccCc
Q 013790          238 LAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPADS  316 (436)
Q Consensus       238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  316 (436)
                      +++...  ..........||+.|+|||++.+ ..++.++|||||||++|||+||.+||.+.........+......+...
T Consensus       146 ~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~  223 (299)
T d1ua2a_         146 LAKSFG--SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE  223 (299)
T ss_dssp             GGSTTT--SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             cccccC--CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            997532  22223345679999999999865 467999999999999999999999998765443222111111111110


Q ss_pred             c-----cccc-ccCCcccC----cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          317 K-----KFGL-IMDPRLEK----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       317 ~-----~~~~-~~~~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .     .... ........    ......+..+.+||.+||+.||++|||+.|+++|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            0     0000 00000000    0011234678999999999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=384.59  Aligned_cols=266  Identities=24%  Similarity=0.401  Sum_probs=212.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      .++|++++.||+|+||.||+|.++...  ....++.||||+++... ......+.+|+.++++++||||++++|++...+
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~--~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVV--KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEE--TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcc--cCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            468999999999999999999875211  11346789999997543 233456899999999999999999999997665


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCC
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNR--------AFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDEN  228 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  228 (436)
                      .    .++||||+.+|+|.+++...        ....+++..+..++.|++.||.|||++   +|+||||||+||||+.+
T Consensus        97 ~----~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          97 P----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  169 (308)
T ss_dssp             S----CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred             c----eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCC
Confidence            4    49999999999999998642        123578999999999999999999998   99999999999999999


Q ss_pred             CceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCchhhHHHHH
Q 013790          229 FRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTG-RRSLERNRPKTEQRLLE  307 (436)
Q Consensus       229 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~~  307 (436)
                      +++||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+|| .+||.+.+...   ...
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---~~~  246 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLR  246 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HHH
T ss_pred             ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence            99999999999853333333344555789999999999999999999999999999999998 47776654322   222


Q ss_pred             HHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhh
Q 013790          308 WVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQ  369 (436)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~  369 (436)
                      .+.....          +    ..+..++..+.+||.+||+.||++|||+.+|+++|++.++
T Consensus       247 ~i~~~~~----------~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         247 FVMEGGL----------L----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHTTCC----------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHhCCC----------C----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            2221100          0    1122334679999999999999999999999999987764

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-50  Score=380.35  Aligned_cols=274  Identities=24%  Similarity=0.345  Sum_probs=205.6

Q ss_pred             hhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch--hHHHHHHHHHHHhcc---CCCCceeeeeE
Q 013790           77 ATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ--GHKQWVAEVQFLGVL---EHPNLVKLIGY  151 (436)
Q Consensus        77 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~~~~~  151 (436)
                      ..++|++++.||+|+||+||+|.+.      ..+++.||||++......  ....+.+|+.+++.|   +||||++++++
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~------~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~   78 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDL------KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV   78 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEET------TTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEE------CCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeee
Confidence            3579999999999999999999864      124678999998654222  223456777777666   79999999999


Q ss_pred             eeecC-CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCc
Q 013790          152 CAVDG-ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFR  230 (436)
Q Consensus       152 ~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  230 (436)
                      +.... ......+++|||+.++++..... .....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.
T Consensus        79 ~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~  154 (305)
T d1blxa_          79 CTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQ  154 (305)
T ss_dssp             EEEEECSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred             ecccccccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCC
Confidence            86532 23456799999998776655443 3345799999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          231 PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      +||+|||+++.   ...........||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.++......+....
T Consensus       155 ~kl~dfg~~~~---~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  231 (305)
T d1blxa_         155 IKLADFGLARI---YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI  231 (305)
T ss_dssp             EEECSCCSCCC---CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             eeecchhhhhh---hcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence            99999999874   233444566789999999999999999999999999999999999999998765543322221111


Q ss_pred             hcccCcc-c-----cccc---cCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          311 QYPADSK-K-----FGLI---MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       311 ~~~~~~~-~-----~~~~---~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..+.... .     ....   .............+..+.+||.+||+.||.+|||+.|+++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            1111000 0     0000   00000111222335678899999999999999999999886

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.6e-49  Score=372.94  Aligned_cols=266  Identities=24%  Similarity=0.307  Sum_probs=199.0

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|++++.||+|+||+||+|.++        +++.||||++.....  ...+.+.+|+.+|++++||||+++++++...+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   73 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN--------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK   73 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET--------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS
T ss_pred             CCceeccEEecCCCcEEEEEEeC--------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC
Confidence            58999999999999999999864        568899999976533  23578999999999999999999999998765


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      .    .+++|||+.++.+..+....  ..+++..+..++.||+.||+|||+.   +|+||||||+||||+.++.+||+||
T Consensus        74 ~----~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~Df  144 (286)
T d1ob3a_          74 R----LVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADF  144 (286)
T ss_dssp             C----EEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCT
T ss_pred             c----eeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccc
Confidence            4    48999999776666665433  4799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcccC
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPAD  315 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  315 (436)
                      |++....  ..........|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+..............+..
T Consensus       145 G~a~~~~--~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~  222 (286)
T d1ob3a_         145 GLARAFG--IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS  222 (286)
T ss_dssp             THHHHHC--C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             ccceecc--cCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCCh
Confidence            9987522  12223344568999999999865 45689999999999999999999999865543322111111111110


Q ss_pred             cc-----cccc------ccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          316 SK-----KFGL------IMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       316 ~~-----~~~~------~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..     ....      ...+..........+..+.+||.+||+.||++|||+.|+++|
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00     0000      000000011122334678899999999999999999999865

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-51  Score=380.56  Aligned_cols=242  Identities=25%  Similarity=0.388  Sum_probs=196.0

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch------hHHHHHHHHHHHhccC--CCCceeee
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ------GHKQWVAEVQFLGVLE--HPNLVKLI  149 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~~~  149 (436)
                      .++|++.+.||+|+||.||+|++.       .+++.||||++......      ....+.+|+.++++++  ||||++++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~   75 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRV-------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL   75 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEE
Confidence            468999999999999999999976       56889999998654221      1234668999999987  89999999


Q ss_pred             eEeeecCCcceeEEEEEEecCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC-
Q 013790          150 GYCAVDGERGIQRLLVYEFMLN-RSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-  227 (436)
Q Consensus       150 ~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-  227 (436)
                      +++...+    ..++||||+.+ +++.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++. 
T Consensus        76 ~~~~~~~----~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~  146 (273)
T d1xwsa_          76 DWFERPD----SFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN  146 (273)
T ss_dssp             EEEECSS----EEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETT
T ss_pred             EEEeeCC----eEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecC
Confidence            9997655    45999999976 67888886543  699999999999999999999999   9999999999999985 


Q ss_pred             CCceEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 013790          228 NFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHL-TAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  306 (436)
Q Consensus       228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  306 (436)
                      ++.+||+|||+|+...    ........||+.|+|||++.+..+ +.++|||||||++|+|+||+.||....     .+.
T Consensus       147 ~~~vkl~DFG~a~~~~----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~  217 (273)
T d1xwsa_         147 RGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII  217 (273)
T ss_dssp             TTEEEECCCTTCEECC----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH
T ss_pred             CCeEEECccccceecc----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHh
Confidence            5799999999997532    223345679999999999987765 567999999999999999999997521     111


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                         ...            ..+...    .+.++.+||.+||+.||.+|||+.|++++
T Consensus       218 ---~~~------------~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         218 ---RGQ------------VFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             ---HCC------------CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---hcc------------cCCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence               110            011112    23678899999999999999999999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=375.91  Aligned_cols=273  Identities=23%  Similarity=0.309  Sum_probs=202.9

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc-chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG-LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ..+|++++.||+|+||+||+|..+       .+++.||||++.... ....+.+.+|+.+|+.++||||+++++++....
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~   79 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDN-------VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   79 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEET-------TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             CCCeEEEEEEeeccCeEEEEEEEC-------CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence            357999999999999999999865       578899999997553 334567889999999999999999999997665


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                      ......+++++|+.+|+|.+++...   .+++..+..++.||+.||+|||++   ||+||||||+||||+.++.+||+||
T Consensus        80 ~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~Df  153 (345)
T d1pmea_          80 IEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDF  153 (345)
T ss_dssp             TTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             ccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEccc
Confidence            4333345566677799999999754   599999999999999999999999   9999999999999999999999999


Q ss_pred             cCCCCCCCCC-CcccccccccCCCcccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhccc
Q 013790          237 GLAREGPMVG-HTHVSTAVVGTFGYAAPDYIE-TGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  314 (436)
                      |+++...... .........||+.|+|||++. +..++.++||||+||++|+|++|+.||..............+...+.
T Consensus       154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~  233 (345)
T d1pmea_         154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS  233 (345)
T ss_dssp             TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCC
Confidence            9997532211 112234567999999999984 45678999999999999999999999987654333222221111111


Q ss_pred             Ccccc--------cccc-CCccc----CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DSKKF--------GLIM-DPRLE----KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~~~~--------~~~~-~~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .....        .... .+...    .......+..+.+|+.+||..||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000        0000 00000    00111223578899999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-48  Score=374.73  Aligned_cols=271  Identities=25%  Similarity=0.314  Sum_probs=199.2

Q ss_pred             CCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCC--
Q 013790           80 DFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGE--  157 (436)
Q Consensus        80 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--  157 (436)
                      +|+.++.||+|+||+||+|+++       .+++.||||++.....    ...+|+.+|++++||||+++++++...+.  
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~   89 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLC-------DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK   89 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEET-------TTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred             CcEeeeEEeeCcCeEEEEEEEC-------CCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccC
Confidence            6899999999999999999976       5688999999976532    23469999999999999999999875432  


Q ss_pred             cceeEEEEEEecCCCCHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC-ceEEee
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLF-NRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-RPKLSD  235 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~D  235 (436)
                      ...++++||||++++.+..... ......+++..+..++.||+.||+|||++   ||+||||||+||||+.++ .+||+|
T Consensus        90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~D  166 (350)
T d1q5ka_          90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCD  166 (350)
T ss_dssp             SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECC
T ss_pred             CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEec
Confidence            3446789999997654333322 12345799999999999999999999998   999999999999999775 899999


Q ss_pred             ccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc-
Q 013790          236 FGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP-  313 (436)
Q Consensus       236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~-  313 (436)
                      ||+++...   .........||+.|+|||.+.+ ..++.++|||||||++|||++|..||...........+......+ 
T Consensus       167 FG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~  243 (350)
T d1q5ka_         167 FGSAKQLV---RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT  243 (350)
T ss_dssp             CTTCEECC---TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccchhhcc---CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCCh
Confidence            99997532   2223345679999999998765 578999999999999999999999998665432211111100000 


Q ss_pred             --------cC--ccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHHh
Q 013790          314 --------AD--SKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER--LKQI  367 (436)
Q Consensus       314 --------~~--~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~~  367 (436)
                              ..  ...+.......+........+..+.+||.+||..||.+|||+.|+++|  |+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             HHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence                    00  000000001111111122335678899999999999999999999986  4444

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.4e-48  Score=364.22  Aligned_cols=266  Identities=21%  Similarity=0.267  Sum_probs=201.8

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCceeeeeEeeecCCc
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDGER  158 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  158 (436)
                      ++|++++.||+|+||.||+|++.       .+++.||||++.....  .+.+..|+++++.++|+|++..++.+...+. 
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~-------~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~-   76 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDI-------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD-   76 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET-------TTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETT-
T ss_pred             CEEEEeEEEeeCCCcEEEEEEEC-------CCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCC-
Confidence            57999999999999999999975       5678999999875532  2457889999999998887776666654433 


Q ss_pred             ceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEc---CCCceEEee
Q 013790          159 GIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLD---ENFRPKLSD  235 (436)
Q Consensus       159 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~D  235 (436)
                        ..++||||+ +++|.+.+.... ..+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|
T Consensus        77 --~~~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~D  149 (299)
T d1ckia_          77 --YNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID  149 (299)
T ss_dssp             --EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred             --EEEEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeec
Confidence              458999998 667777765443 4799999999999999999999999   999999999999985   456799999


Q ss_pred             ccCCCCCCCCCC-----cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHh
Q 013790          236 FGLAREGPMVGH-----THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQ  310 (436)
Q Consensus       236 fg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  310 (436)
                      ||+|+.......     ........||+.|||||++.+..++.++|||||||++|||+||..||................
T Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~  229 (299)
T d1ckia_         150 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  229 (299)
T ss_dssp             CSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH
T ss_pred             cCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh
Confidence            999985422211     122345679999999999999999999999999999999999999998765433322211111


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhc
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVS  371 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~  371 (436)
                      ......      ..+    ......+..+.+||..||+.||++||++.+|.+.|+.+....
T Consensus       230 ~~~~~~------~~~----~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         230 EKKMST------PIE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HHHHHS------CHH----HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccCCC------Chh----HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            000000      000    011123467899999999999999999999999998886544

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-48  Score=373.17  Aligned_cols=266  Identities=24%  Similarity=0.328  Sum_probs=199.4

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||+||+|.++       .+++.||||+++....  ...+.+.+|+.+|+.++|||||++++++...
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~   89 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDG-------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   89 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEET-------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence            468999999999999999999975       5688999999975432  3346788999999999999999999999765


Q ss_pred             CC--cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          156 GE--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       156 ~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      +.  ....+|+||||+ +.+|..++...   .+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||
T Consensus        90 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl  162 (346)
T d1cm8a_          90 ETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKI  162 (346)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred             ccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccc
Confidence            43  223469999999 67888877543   599999999999999999999999   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhc
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIET-GHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQY  312 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  312 (436)
                      +|||+|+...     .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..............
T Consensus       163 ~Dfg~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~  237 (346)
T d1cm8a_         163 LDFGLARQAD-----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT  237 (346)
T ss_dssp             CCCTTCEECC-----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ccccceeccC-----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCC
Confidence            9999997532     22345679999999999876 45689999999999999999999999876543322221111111


Q ss_pred             ccCc--------------cccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          313 PADS--------------KKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       313 ~~~~--------------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      +...              ..+.......+. ......+..+.+||.+||..||.+|||+.|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             CCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CcHHHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000              000000000010 1112234678899999999999999999999987

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=365.85  Aligned_cols=274  Identities=22%  Similarity=0.292  Sum_probs=200.6

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcc--hhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGL--QGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||+||+|++.       .+++.||||++.....  .....+.+|+.+|+.++||||+++++++...
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~   81 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHR-------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   81 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             cCCEEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence            478999999999999999999975       5788999999865432  2346788999999999999999999988653


Q ss_pred             CC----cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCce
Q 013790          156 GE----RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRP  231 (436)
Q Consensus       156 ~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  231 (436)
                      ..    .....++||||+.++.+..+..  ....+++..+..++.||+.||.|||++   ||+||||||+||||+.++.+
T Consensus        82 ~~~~~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~  156 (318)
T d3blha1          82 ASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVL  156 (318)
T ss_dssp             ---------CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCE
T ss_pred             cccccccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcE
Confidence            21    1234699999997776665443  234789999999999999999999998   99999999999999999999


Q ss_pred             EEeeccCCCCCCCCC--CcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHH
Q 013790          232 KLSDFGLAREGPMVG--HTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEW  308 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  308 (436)
                      ||+|||+++......  .........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+............
T Consensus       157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~  236 (318)
T d3blha1         157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ  236 (318)
T ss_dssp             EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence            999999997533211  12223345799999999998765 689999999999999999999999987665444333322


Q ss_pred             HhhcccCccc--c-----ccccCCcccCcCCH-------HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          309 VQQYPADSKK--F-----GLIMDPRLEKEYSI-------NEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       309 ~~~~~~~~~~--~-----~~~~~~~l~~~~~~-------~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ....+.....  .     ..............       ..+..+.+||.+||..||++|||+.|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            2221111000  0     00000000000111       113467799999999999999999999977

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.9e-47  Score=359.52  Aligned_cols=268  Identities=18%  Similarity=0.192  Sum_probs=210.2

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCC-CCceeeeeEeeecC
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEH-PNLVKLIGYCAVDG  156 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~  156 (436)
                      .++|++++.||+|+||.||+|++.       .+++.||||++....  ....+.+|+++++.+.| +||+.+++++....
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~-------~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   74 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNL-------LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   74 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEET-------TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             CCceEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence            368999999999999999999976       568899999986543  23456788999998875 89999998887654


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcC-----CCce
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDE-----NFRP  231 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~  231 (436)
                          ..++||||+ +++|.+++.... ..+++.++..++.|++.||.|||++   ||+||||||+||||+.     ++.+
T Consensus        75 ----~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~v  145 (293)
T d1csna_          75 ----HNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMI  145 (293)
T ss_dssp             ----EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCE
T ss_pred             ----ccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCce
Confidence                359999998 789999987654 4699999999999999999999999   9999999999999964     6789


Q ss_pred             EEeeccCCCCCCCCCC-----cccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 013790          232 KLSDFGLAREGPMVGH-----THVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL  306 (436)
Q Consensus       232 kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  306 (436)
                      ||+|||+|+.......     ........||+.|||||++.+..++.++|||||||++|||+||..||.+..........
T Consensus       146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~  225 (293)
T d1csna_         146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY  225 (293)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred             EEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH
Confidence            9999999975322111     12234567999999999999999999999999999999999999999876554433222


Q ss_pred             HHHhhcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHHhhhhcCC
Q 013790          307 EWVQQYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVERLKQIVQVSNE  373 (436)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~  373 (436)
                      ..+...... ...     +.+    ....+.++.+++..||..+|++||+++.+.+.|+++++..+.
T Consensus       226 ~~i~~~~~~-~~~-----~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~  282 (293)
T d1csna_         226 ERIGEKKQS-TPL-----REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  282 (293)
T ss_dssp             HHHHHHHHH-SCH-----HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHHHhccCC-CCh-----HHh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence            222111000 000     001    112246788999999999999999999999999998876543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.5e-47  Score=363.11  Aligned_cols=262  Identities=20%  Similarity=0.304  Sum_probs=200.5

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCCceeeeeEeeecCC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVDGE  157 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~  157 (436)
                      ++|++++.||+|+||+||+|+.+       .+++.||||+++...   .+.+.+|+.+|+.+. ||||+++++++.....
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~-------~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~  104 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINI-------TNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVS  104 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             cCeEEEEEEecCcCeEEEEEEEC-------CCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence            58999999999999999999975       578999999997543   457889999999996 9999999999875433


Q ss_pred             cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCC-ceEEeec
Q 013790          158 RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENF-RPKLSDF  236 (436)
Q Consensus       158 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Df  236 (436)
                      .  ..++||||+.+++|..+.     ..+++..+..++.||+.||.|||++   ||+||||||+||||+.++ .+||+||
T Consensus       105 ~--~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DF  174 (328)
T d3bqca1         105 R--TPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDW  174 (328)
T ss_dssp             C--SEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCG
T ss_pred             C--ceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccc
Confidence            2  469999999999997764     3599999999999999999999999   999999999999998654 6999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHH--H-------
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL--L-------  306 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~--~-------  306 (436)
                      |+|+...   .........||+.|+|||.+.+. .++.++|||||||++|+|++|..||...........  .       
T Consensus       175 G~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~  251 (328)
T d3bqca1         175 GLAEFYH---PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED  251 (328)
T ss_dssp             GGCEECC---TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred             ccceecc---CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCch
Confidence            9997532   22234556789999999998765 579999999999999999999999976554332111  1       


Q ss_pred             --HHHhhcccC-ccccccccCC--------cccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          307 --EWVQQYPAD-SKKFGLIMDP--------RLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       307 --~~~~~~~~~-~~~~~~~~~~--------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                        .+....... ...+......        ..........+.++.+||.+||..||.+|||+.|+++|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              111111000 0011111000        00111112234678899999999999999999999875

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-47  Score=357.03  Aligned_cols=267  Identities=23%  Similarity=0.305  Sum_probs=203.6

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|++++.||+|+||+||+|++.       .+++.||||+++...  ......+.+|+.+++.++||||+++++++....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   74 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNR-------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK   74 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEET-------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCEeeeEEecCcCeEEEEEEEC-------CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc
Confidence            58999999999999999999975       578899999986543  234578899999999999999999999997665


Q ss_pred             CcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEeec
Q 013790          157 ERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLSDF  236 (436)
Q Consensus       157 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  236 (436)
                          ..++|++++.+++|..++...  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        75 ----~~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DF  145 (292)
T d1unla_          75 ----KLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANF  145 (292)
T ss_dssp             ----EEEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             ----ceeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeec
Confidence                358999999999888887544  4789999999999999999999998   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccccccCCCcccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHHHhhccc
Q 013790          237 GLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGH-LTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQ-RLLEWVQQYPA  314 (436)
Q Consensus       237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~  314 (436)
                      |.++....  .........+++.|+|||++.+.. ++.++|||||||++|||++|..||......... ..+......+.
T Consensus       146 G~a~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  223 (292)
T d1unla_         146 GLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  223 (292)
T ss_dssp             TTCEECCS--CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             chhhcccC--CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCC
Confidence            99986322  222333456778999999987654 689999999999999999999997654433221 11111111111


Q ss_pred             Cc--cccccc---------cCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          315 DS--KKFGLI---------MDPRLEKEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       315 ~~--~~~~~~---------~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      ..  ......         .............+..+.+|+.+||+.||.+|||++|+++|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00  000000         00000011222334678899999999999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-47  Score=366.79  Aligned_cols=267  Identities=23%  Similarity=0.281  Sum_probs=196.0

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeecC
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVDG  156 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  156 (436)
                      ++|++++.||+|+||+||+|.+.       .+++.||||++....  ......+.+|+.+++.++||||+++++++...+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~-------~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~   89 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDA-------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEET-------TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             CCeEEEEEeecCcCeEEEEEEEC-------CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence            68999999999999999999975       578999999997553  233456889999999999999999999987654


Q ss_pred             C--cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          157 E--RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       157 ~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .  .....|+||||+.++ +.+.+.    ..+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+|++
T Consensus        90 ~~~~~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~  161 (355)
T d2b1pa1          90 TLEEFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_dssp             STTTCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred             ccccCceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeee
Confidence            2  345789999999665 444442    3589999999999999999999999   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HHH----
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLL-EWV----  309 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~~----  309 (436)
                      |||+++..   ..........||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+ ...    
T Consensus       162 df~~~~~~---~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~  238 (355)
T d2b1pa1         162 DFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  238 (355)
T ss_dssp             CCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             chhhhhcc---ccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCC
Confidence            99998752   2333445667999999999999999999999999999999999999999866543221111 100    


Q ss_pred             ---------------hhcc-cCccccccccCCccc---CcCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          310 ---------------QQYP-ADSKKFGLIMDPRLE---KEYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       310 ---------------~~~~-~~~~~~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                                     ...+ ...............   .......+..+.+||.+||..||++|||+.||++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                           0000 000000001111110   11223456789999999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=364.80  Aligned_cols=256  Identities=27%  Similarity=0.377  Sum_probs=202.6

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc----chhHHHHHHHHHHHhccCC-CCceeeeeEee
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG----LQGHKQWVAEVQFLGVLEH-PNLVKLIGYCA  153 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~  153 (436)
                      ++|++++.||+|+||+||+|....    +..+++.||||+++...    ....+.+.+|+.++++++| |||+++++++.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~   99 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKIS----GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ   99 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECS----STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECc----cCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence            679999999999999999998742    22468899999987542    2234567889999999976 89999999987


Q ss_pred             ecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEE
Q 013790          154 VDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKL  233 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  233 (436)
                      ...    ..+++|||+.+|+|.+++....  .+++..+..++.||+.||.|||++   +|+||||||+|||++.+|.+||
T Consensus       100 ~~~----~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL  170 (322)
T d1vzoa_         100 TET----KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL  170 (322)
T ss_dssp             ETT----EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred             cCC----ceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEE
Confidence            665    3599999999999999997654  578899999999999999999998   9999999999999999999999


Q ss_pred             eeccCCCCCCCCCCcccccccccCCCcccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHH-HHHHh
Q 013790          234 SDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG--HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRL-LEWVQ  310 (436)
Q Consensus       234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~~  310 (436)
                      +|||+++... ...........|++.|+|||.+.+.  .++.++|||||||+||+|++|..||.+......... .....
T Consensus       171 ~DFG~a~~~~-~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~  249 (322)
T d1vzoa_         171 TDFGLSKEFV-ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL  249 (322)
T ss_dssp             SCSSEEEECC-GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred             eeccchhhhc-ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc
Confidence            9999997532 1223334456899999999999764  468899999999999999999999976554332221 11111


Q ss_pred             hcccCccccccccCCcccCcCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 013790          311 QYPADSKKFGLIMDPRLEKEYSINEARKIGRLADNCLSKSSKDRPK-----MSQVVER  363 (436)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~  363 (436)
                      ...           +    ..+...+..+.+||.+||+.||.+|||     ++|+++|
T Consensus       250 ~~~-----------~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         250 KSE-----------P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             HCC-----------C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             cCC-----------C----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            110           1    112233578999999999999999994     7888765

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-46  Score=359.68  Aligned_cols=266  Identities=24%  Similarity=0.359  Sum_probs=199.8

Q ss_pred             hcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCc--chhHHHHHHHHHHHhccCCCCceeeeeEeeec
Q 013790           78 TNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDG--LQGHKQWVAEVQFLGVLEHPNLVKLIGYCAVD  155 (436)
Q Consensus        78 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  155 (436)
                      .++|++++.||+|+||+||+|...       .+++.||||++....  ....+.+.+|+.+|+.++||||+++++++...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~   89 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDT-------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   89 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEET-------TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEEC-------CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeec
Confidence            468999999999999999999865       578999999997553  23446788999999999999999999988643


Q ss_pred             CC-cceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCcEEEcCCCceEEe
Q 013790          156 GE-RGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASNVLLDENFRPKLS  234 (436)
Q Consensus       156 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  234 (436)
                      .. .....+++++|+.+|+|.+++..+   .+++..+..++.||+.||+|||++   ||+||||||+|||++.+|.+|++
T Consensus        90 ~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~  163 (348)
T d2gfsa1          90 RSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL  163 (348)
T ss_dssp             SSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccccc
Confidence            22 112235677788899999999543   699999999999999999999999   99999999999999999999999


Q ss_pred             eccCCCCCCCCCCcccccccccCCCcccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchhhHHHHHHHhhcc
Q 013790          235 DFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETG-HLTAKSDVWSFGVVLYEMLTGRRSLERNRPKTEQRLLEWVQQYP  313 (436)
Q Consensus       235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  313 (436)
                      |||++...     ........||+.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+......+
T Consensus       164 dfg~a~~~-----~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~  238 (348)
T d2gfsa1         164 DFGLARHT-----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  238 (348)
T ss_dssp             CC----CC-----TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccchhccc-----CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99998642     2334556789999999987665 56889999999999999999999998765443322221111110


Q ss_pred             cCcccccc---------ccC--CcccC----cCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 013790          314 ADSKKFGL---------IMD--PRLEK----EYSINEARKIGRLADNCLSKSSKDRPKMSQVVER  363 (436)
Q Consensus       314 ~~~~~~~~---------~~~--~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  363 (436)
                      .  .....         ...  .....    ......+..+.+||.+||..||.+|||+.|+++|
T Consensus       239 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         239 G--AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             C--HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             C--hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            0  00000         000  00000    0011234678899999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-42  Score=334.47  Aligned_cols=267  Identities=20%  Similarity=0.262  Sum_probs=193.2

Q ss_pred             cCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-----------CCCcee
Q 013790           79 NDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-----------HPNLVK  147 (436)
Q Consensus        79 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~  147 (436)
                      ++|++++.||+|+||+||+|+.+       .+++.||||+++.... ..+.+.+|+.+++.++           |+||++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~-------~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~   84 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDM-------VNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   84 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET-------TTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEEC-------CCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEE
Confidence            35999999999999999999965       5789999999986542 3456788998888775           578999


Q ss_pred             eeeEeeecCCcceeEEEEEEecCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCceeeccCCCCcEEE
Q 013790          148 LIGYCAVDGERGIQRLLVYEFMLNR-SLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-GLEVQVIYRDFKASNVLL  225 (436)
Q Consensus       148 ~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dlkp~NIll  225 (436)
                      +++++...+...  .+++++++..+ +............+++..+..++.||+.||.|||+ .   ||+||||||+||||
T Consensus        85 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll  159 (362)
T d1q8ya_          85 LLDHFNHKGPNG--VHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLM  159 (362)
T ss_dssp             CCEEEEEEETTE--EEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEE
T ss_pred             EEEEeeeccccc--eeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeee
Confidence            999887655443  34555554333 44444444555678999999999999999999998 5   99999999999999


Q ss_pred             cCCCc------eEEeeccCCCCCCCCCCcccccccccCCCcccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 013790          226 DENFR------PKLSDFGLAREGPMVGHTHVSTAVVGTFGYAAPDYIETGHLTAKSDVWSFGVVLYEMLTGRRSLERNRP  299 (436)
Q Consensus       226 ~~~~~------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~  299 (436)
                      +.++.      ++++|||.+....     .......||+.|+|||++.+..++.++|||||||++++|++|+.||.....
T Consensus       160 ~~~~~~~~~~~~kl~dfg~s~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~  234 (362)
T d1q8ya_         160 EIVDSPENLIQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  234 (362)
T ss_dssp             EEEETTTTEEEEEECCCTTCEETT-----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             eccCcccccceeeEeecccccccc-----cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence            86654      9999999987521     223456799999999999999999999999999999999999999975432


Q ss_pred             hhh----HHHHHHHhhcccCcc-----------------ccccccCC---------cccCcCCHHHHHHHHHHHHHhhcC
Q 013790          300 KTE----QRLLEWVQQYPADSK-----------------KFGLIMDP---------RLEKEYSINEARKIGRLADNCLSK  349 (436)
Q Consensus       300 ~~~----~~~~~~~~~~~~~~~-----------------~~~~~~~~---------~l~~~~~~~~~~~l~~li~~cl~~  349 (436)
                      ...    ..+...+........                 ....+...         ..........+..+.+||.+||..
T Consensus       235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~  314 (362)
T d1q8ya_         235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL  314 (362)
T ss_dssp             ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence            211    111111111100000                 00000000         001123456778899999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 013790          350 SSKDRPKMSQVVER  363 (436)
Q Consensus       350 dp~~RPs~~eil~~  363 (436)
                      ||.+|||+.|+|+|
T Consensus       315 dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         315 DPRKRADAGGLVNH  328 (362)
T ss_dssp             STTTCBCHHHHHTC
T ss_pred             ChhHCcCHHHHhcC
Confidence            99999999999886

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=4e-25  Score=193.20  Aligned_cols=164  Identities=15%  Similarity=0.081  Sum_probs=117.6

Q ss_pred             CcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcch------------------hHHHHHHHHHHHhccCC
Q 013790           81 FSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQ------------------GHKQWVAEVQFLGVLEH  142 (436)
Q Consensus        81 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h  142 (436)
                      +.+.++||+|+||.||+|...        +++.||||+++.....                  .......|+..+.++.|
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~--------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~   73 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE--------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG   73 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET--------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred             chhCCEeeeCcceEEEEEECC--------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccC
Confidence            346789999999999999864        5788999987532110                  11234568889999999


Q ss_pred             CCceeeeeEeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceeeccCCCCc
Q 013790          143 PNLVKLIGYCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGLEVQVIYRDFKASN  222 (436)
Q Consensus       143 pnIv~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dlkp~N  222 (436)
                      ++++..+++..    .    +++|||+.+..+.+         ++......++.|++.+|.|||++   ||+||||||+|
T Consensus        74 ~~v~~~~~~~~----~----~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~N  133 (191)
T d1zara2          74 LAVPKVYAWEG----N----AVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN  133 (191)
T ss_dssp             SSSCCEEEEET----T----EEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred             CCcceEEEecC----C----EEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhh
Confidence            99998876531    1    79999998765543         33445678999999999999998   99999999999


Q ss_pred             EEEcCCCceEEeeccCCCCCCCCCCcccccccccCCCccc------ccccccCCCCchhhHHHHHHHH
Q 013790          223 VLLDENFRPKLSDFGLAREGPMVGHTHVSTAVVGTFGYAA------PDYIETGHLTAKSDVWSFGVVL  284 (436)
Q Consensus       223 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DvwSlGvil  284 (436)
                      ||+++++ ++|+|||+|+.......          ..|..      .+.+ ...|+.++|+||+.--+
T Consensus       134 ILv~~~~-~~liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         134 VLVSEEG-IWIIDFPQSVEVGEEGW----------REILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EEEETTE-EEECCCTTCEETTSTTH----------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             eeeeCCC-EEEEECCCcccCCCCCc----------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            9999654 89999999864211100          00111      1111 35678889999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.76  E-value=3e-08  Score=88.79  Aligned_cols=149  Identities=16%  Similarity=0.100  Sum_probs=100.6

Q ss_pred             HHHHHhhcCCcccccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCCceeeee
Q 013790           72 SEMRQATNDFSRMLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNLVKLIG  150 (436)
Q Consensus        72 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~  150 (436)
                      .++......|+..+..+.++.+.||+...         ++..+++|+...........+.+|...+..+. +--+.+++.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~---------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~   77 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG---------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLH   77 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC---------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe---------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEE
Confidence            36677778888877665555678998763         45567888876554434445677888887764 323556666


Q ss_pred             EeeecCCcceeEEEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------------------
Q 013790          151 YCAVDGERGIQRLLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHEGL---------------------  209 (436)
Q Consensus       151 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---------------------  209 (436)
                      +...++    ..++||++++|.++.+.....       .....++.+++..+..||+..                     
T Consensus        78 ~~~~~~----~~~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~  146 (263)
T d1j7la_          78 FERHDG----WSNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL  146 (263)
T ss_dssp             EEEETT----EEEEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred             EEecCC----ceEEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHH
Confidence            665443    348999999998887654221       122334556666666666421                     


Q ss_pred             -----------------------------------CCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          210 -----------------------------------EVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       210 -----------------------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                                                         ...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                               0137999999999999987777899999774

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.01  E-value=1.5e-05  Score=70.10  Aligned_cols=130  Identities=16%  Similarity=0.138  Sum_probs=78.6

Q ss_pred             cccccCc-eEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCC--ceeeeeEeeecCCcceeE
Q 013790           86 KIGEGGF-GSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPN--LVKLIGYCAVDGERGIQR  162 (436)
Q Consensus        86 ~ig~G~~-g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~~~~  162 (436)
                      .+..|.. +.||+....        .+..+++|.......   ..+..|+..++.+....  +.+++.+....+    ..
T Consensus        17 ~~~~G~s~~~v~r~~~~--------~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~----~~   81 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ--------GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAG----RD   81 (255)
T ss_dssp             ECSCTTSSCEEEEEECT--------TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSS----CE
T ss_pred             EcCCcccCCeEEEEEeC--------CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeeccccc----ce
Confidence            4455554 678988643        455688887654432   24566777777664322  456666655443    24


Q ss_pred             EEEEEecCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-----------------------------------
Q 013790          163 LLVYEFMLNRSLEDHLFNRAFPPLPWKTRLHIILGAAEGLAYLHE-----------------------------------  207 (436)
Q Consensus       163 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-----------------------------------  207 (436)
                      ++||++++|.++.+..       ...   ..++.+++..|.-||.                                   
T Consensus        82 ~~v~~~i~G~~~~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (255)
T d1nd4a_          82 WLLLGEVPGQDLLSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE  151 (255)
T ss_dssp             EEEEECCSSEETTTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred             EEEEEeeecccccccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccc
Confidence            8999999886654311       111   1112233333333332                                   


Q ss_pred             ----------------C----CCCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          208 ----------------G----LEVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       208 ----------------~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                                      .    ....++|+|+.|.|||++.+..+-|+||+.+.
T Consensus       152 ~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         152 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                            1    11247999999999999987777899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.97  E-value=1.6e-05  Score=75.11  Aligned_cols=78  Identities=14%  Similarity=0.029  Sum_probs=47.3

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccC-------cchhHHHHHHHHHHHhccC-C--CCceeeeeEee
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRD-------GLQGHKQWVAEVQFLGVLE-H--PNLVKLIGYCA  153 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~  153 (436)
                      .+.||.|....||+....       .+++.|+||.-...       ......+...|++.|+.+. +  ..+.+++.+..
T Consensus        31 ~~eig~G~~N~vfrV~~~-------~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~  103 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQ-------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT  103 (392)
T ss_dssp             EEECCSSSSEEEEEEEC-----------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET
T ss_pred             EEEeCCCceEeEEEEEeC-------CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC
Confidence            456899999999998743       34567889975321       1112345566888887663 2  34556655432


Q ss_pred             ecCCcceeEEEEEEecCCCCH
Q 013790          154 VDGERGIQRLLVYEFMLNRSL  174 (436)
Q Consensus       154 ~~~~~~~~~~lv~e~~~~gsL  174 (436)
                        ...    ++|||++.+..+
T Consensus       104 --~~~----~lvmE~L~~~~~  118 (392)
T d2pula1         104 --EMA----VTVMEDLSHLKI  118 (392)
T ss_dssp             --TTT----EEEECCCTTSEE
T ss_pred             --CCC----EEEEeccCCccc
Confidence              222    789999976543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.47  E-value=0.00021  Score=67.16  Aligned_cols=81  Identities=19%  Similarity=0.181  Sum_probs=52.4

Q ss_pred             cccccccCceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccC-CCCceeeeeEeeecCCcceeE
Q 013790           84 MLKIGEGGFGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLE-HPNLVKLIGYCAVDGERGIQR  162 (436)
Q Consensus        84 ~~~ig~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~  162 (436)
                      ++.|+.|-.-.+|++...............|.+++.....  ......+|..+++.+. +.-..++++++.  +      
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~------  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G------  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T------
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C------
Confidence            4678888899999998764332223345667777765322  2234567888888875 433457777663  2      


Q ss_pred             EEEEEecCCCCH
Q 013790          163 LLVYEFMLNRSL  174 (436)
Q Consensus       163 ~lv~e~~~~gsL  174 (436)
                      .+|+||++|.+|
T Consensus       117 g~I~efi~g~~l  128 (395)
T d1nw1a_         117 GRLEEYIPSRPL  128 (395)
T ss_dssp             EEEECCCCEEEC
T ss_pred             ceEEEEeccccC
Confidence            679999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.88  E-value=0.0016  Score=58.69  Aligned_cols=31  Identities=29%  Similarity=0.225  Sum_probs=27.8

Q ss_pred             CCceeeccCCCCcEEEcCCCceEEeeccCCC
Q 013790          210 EVQVIYRDFKASNVLLDENFRPKLSDFGLAR  240 (436)
Q Consensus       210 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  240 (436)
                      ..|+||+|+.++||+++.+...-|+||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4589999999999999998888999999874

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.75  E-value=0.0029  Score=57.33  Aligned_cols=137  Identities=18%  Similarity=0.146  Sum_probs=73.3

Q ss_pred             ceEEEEEEecCCCCCCCCcceEEEEEEeccCcchhHHHHHHHHHHHhccCCCCce--eeeeEeeecC---CcceeEEEEE
Q 013790           92 FGSVYKSSIKPAAGDGTSEATVVAIKKLNRDGLQGHKQWVAEVQFLGVLEHPNLV--KLIGYCAVDG---ERGIQRLLVY  166 (436)
Q Consensus        92 ~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv--~~~~~~~~~~---~~~~~~~lv~  166 (436)
                      --.||++...        ++..|++|+.... ....+++..|+..+..|...+|.  ..+.  ...+   ......+.++
T Consensus        35 EN~vy~v~~~--------dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~--~~g~~~~~~~~~~~~l~  103 (325)
T d1zyla1          35 ENRVYQFQDE--------DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVA--FNGQTLLNHQGFYFAVF  103 (325)
T ss_dssp             SSEEEEECCT--------TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCC--BTTBSCEEETTEEEEEE
T ss_pred             cceeEEEEcC--------CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCcee--cCCCeeeeeeeEEEEEE
Confidence            3579998653        6778999987644 22446677888888877532221  1111  0000   1122457889


Q ss_pred             EecCCCCHH-----HH------h---h----cCC---CCCCCH-------------------H---HHHHHHHHHHHHHH
Q 013790          167 EFMLNRSLE-----DH------L---F----NRA---FPPLPW-------------------K---TRLHIILGAAEGLA  203 (436)
Q Consensus       167 e~~~~gsL~-----~~------l---~----~~~---~~~l~~-------------------~---~~~~i~~ql~~~l~  203 (436)
                      +++.|..+.     .+      +   +    ...   ...++.                   .   .....+.++...+.
T Consensus       104 ~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  183 (325)
T d1zyla1         104 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT  183 (325)
T ss_dssp             ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred             eecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHH
Confidence            988763321     11      0   0    000   011111                   1   11223333333332


Q ss_pred             Hh-hcCCCCceeeccCCCCcEEEcCCCceEEeeccCCCC
Q 013790          204 YL-HEGLEVQVIYRDFKASNVLLDENFRPKLSDFGLARE  241 (436)
Q Consensus       204 ~L-H~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  241 (436)
                      -+ ......++||+|+.+.|||++++  ..++||+-+..
T Consensus       184 ~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         184 AHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             HHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             HhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            22 12234589999999999999743  45899998753